<SEC-DOCUMENT>0000950170-25-033077.txt : 20250305
<SEC-HEADER>0000950170-25-033077.hdr.sgml : 20250305
<ACCEPTANCE-DATETIME>20250305073050
ACCESSION NUMBER:		0000950170-25-033077
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250305
DATE AS OF CHANGE:		20250305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TScan Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001783328
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				825282075
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40603
		FILM NUMBER:		25708868

	BUSINESS ADDRESS:	
		STREET 1:		880 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		857-399-9500

	MAIL ADDRESS:	
		STREET 1:		880 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>tcrx-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-04T09:44:22.5485+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:tcrx="http://www.tscan.com/20241231" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_2ad2c9c9-dc61-47dd-ad6d-a55ef5249627" name="dei:DocumentFiscalPeriodFocus" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a">FY</ix:nonNumeric><ix:nonNumeric id="F_59f3ee8b-e621-4dd4-ab25-4fcca5d19985" name="dei:EntityCentralIndexKey" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a">0001783328</ix:nonNumeric><ix:nonNumeric id="F_bd1b4663-68c9-4379-a94e-77356b42b1b9" name="dei:AmendmentFlag" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonFraction id="F_932e05b7-27e6-43f0-b747-18268e09c280" name="us-gaap:CommitmentsAndContingencies" contextRef="C_67b999bc-f4c8-49b5-89ed-d7a3accc676d" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_cab03e13-a6ef-4d41-874e-e22967c6a34b" name="us-gaap:CommitmentsAndContingencies" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_454fce7d-d7b0-40b3-a92d-04bed9475480" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a">http://www.tscan.com/20241231#CollaborationAndLicenseRevenue</ix:nonNumeric><ix:nonNumeric id="F_009427c9-5661-4694-967b-b879b975ff06" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439">http://www.tscan.com/20241231#CollaborationAndLicenseRevenue</ix:nonNumeric><ix:nonNumeric id="F_397b54bf-b523-4a3d-a66b-ad04f717b80a" name="us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" contextRef="C_dd4d0c32-dea8-4923-a9f1-ea5f1fab19f8">http://fasb.org/us-gaap/2024#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember</ix:nonNumeric><ix:nonFraction id="F_b6b6acc4-5182-4b15-9f8c-8955c5b3abae" name="us-gaap:NumberOfReportableSegments" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" unitRef="U_Segment" decimals="INF" format="ixt:num-dot-decimal">1</ix:nonFraction><ix:nonNumeric id="F_cbe52327-d80a-4329-8a4a-2b886fa94469" name="tcrx:LicenseAgreementDate" contextRef="C_15c7b52a-5ecb-4134-84b7-1a74eee635a3" format="ixt:date-monthname-day-year-en">March 31, 2020</ix:nonNumeric><ix:nonNumeric id="F_026c18d0-35e8-4519-bb36-24650b15093c" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</ix:nonNumeric><ix:nonFraction id="F_5592acb1-cb7d-4895-8078-3175a9a958ae" name="us-gaap:NumberOfOperatingSegments" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" unitRef="U_Segment" decimals="INF" format="ixt:num-dot-decimal">1</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tcrx-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="C_80888537-091b-4982-a3a1-aa3b6067c04e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-15</xbrli:startDate><xbrli:endDate>2021-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_80adfaa9-7e64-4331-ae56-d2faf130122e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_818e4bd0-25da-4c16-803e-b15c22766a34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_836b34f7-350d-42ee-8942-99d2e7240d11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_83a90602-679a-44dc-a030-989afce6a82d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_846a05b5-9501-4749-9b63-f20303696a58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_874977e6-74c8-4492-baa5-8b92c0c45d13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tcrx:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_878ab1e3-bef4-47de-91e0-8a585da44965"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:PersonnelExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_88f996d7-3176-4d96-acc4-bca75e20d973"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8a10b701-7769-47a2-87ad-7867a7c281c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8a2e7250-3d27-46fd-80fc-d497b85993ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8e328758-f2ae-4a01-a2b8-6f6ee7b7ece5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8e8d9511-84eb-4a2f-b5e9-8f63d38450b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8e91d61a-7205-4849-ab44-bbb90d9d7dbc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_901900fe-6930-49a3-b719-454de9021201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-09</xbrli:startDate><xbrli:endDate>2022-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9426554d-c3a3-495e-89a1-e0ff0f0562ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_95966560-3a74-4921-9ee9-1cddcc96757d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a6fdb37-0d38-4efb-bcdc-bcac4dfcba88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ef145db-1e48-427f-ba89-3edcc3e04fab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a40cc202-27f4-4dcd-b6c9-0784f4fc3205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-24</xbrli:startDate><xbrli:endDate>2024-04-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a5bfb76e-5ddb-45ec-a10d-3be626faa8a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a91d2167-0cf7-47f7-be6c-7f55b7976009"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:AmgenAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:AmgenIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-08</xbrli:startDate><xbrli:endDate>2023-05-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-20</xbrli:startDate><xbrli:endDate>2024-12-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aed4f300-d032-41f1-b165-0845aef59189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:ClinicalStudiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_af039233-7db2-4aeb-8cc9-c9ea8e5f25e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af892904-1677-4b5c-bfa4-d77070df30ae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b0702c7d-48d2-4169-904c-8f9b8552db95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b2dd2d19-d373-450a-b7db-9467c2752ca1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b5d97542-6fb5-42e4-a0c9-e6757cce391a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b699eca8-c73b-466a-b522-9fe9e9a9ad35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b6ea31a6-d30f-4f27-baef-ea2115d03cdf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b78729c9-8909-4f4c-9a42-47160fbaf8ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b93aece8-a971-452c-bfad-9ca3124815c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ba7a6494-c61e-47ca-8fa7-218c1cdf4d7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bba2662b-9ecc-409c-9943-54cd0c91a519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_be6fc315-0b98-4523-a42d-bcf78bc16296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bf7b2383-6668-4795-a6b0-55806e641321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bf8bbac7-91a5-4162-9f6f-1c2c9d31aa38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:StockBasedCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bfb0ef5e-b57c-4a0a-a092-a98856d36448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c042479b-b737-4e26-b3ca-35e98d7d1ce2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c18aa170-88bc-4410-a5a3-854b425c1c5d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:OfficeAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c2b1d23e-b281-4f16-828a-e82b56e3f3ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c337686d-fa86-4eb8-97bb-fc4b534480c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:NovartisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tcrx:ResearchFundingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3b11d96-c0b1-4481-9a60-4395a254fe3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c42f4a3b-18a2-4352-9d50-5db3b2991bb9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c4c91cdd-5048-4fbf-83f0-0e66b2d854d4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cdeccc8f-9224-4c97-9f7a-3c445b23e58a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tcrx:WedbushSecuritiesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tcrx:SalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ce86777f-8d50-4ea4-a1de-67ffd1ad8ce1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cef715b9-0023-4326-a474-9157cf7c6faa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d15727e8-0174-48c5-9477-9969a5d1e3b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:OfficeAndComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d31ec83e-19e4-4031-83bc-b96faa6d3fd3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d3be5aa9-5dfb-4969-963a-9472152a5c98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:ClinicalStudiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d4c09ebb-c7e3-4e42-8f5e-44b4747af4be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d5ad2e31-c21e-4c2b-89a1-288c3b0bea88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:NovartisAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d64f6a5d-5103-4e27-8e28-50297b0314a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tcrx:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-24</xbrli:startDate><xbrli:endDate>2024-04-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d9dfa2cb-1ca0-4680-9350-28dac51ee6d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:FacilityRelatedAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dd4d0c32-dea8-4923-a9f1-ea5f1fab19f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_de26ea6d-2d44-490b-b9c4-ac54b2019aaf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dffc028f-7182-46b3-bb44-cd753163cfd5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e012286d-5a3c-48f3-9f8b-f6f2434cc024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-28</xbrli:startDate><xbrli:endDate>2024-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e4bef360-1194-4876-bd72-1ba957b48289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e646531e-fd6d-4b4a-a38b-4580a5b023cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e687bdb4-a5f4-4929-88c0-7990ae1b71a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e798deb2-ca9c-4e28-89b6-772abe4bb270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e909c65f-32e5-477f-948c-5fbf09b1bfec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:StockBasedCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ece742b4-8819-47df-8c84-c8b14935ab7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ecf6ccb4-e42d-49a5-88f5-a3479b52cfb1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-15</xbrli:startDate><xbrli:endDate>2021-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ed049b2f-3575-4247-9693-a137665029cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-20</xbrli:startDate><xbrli:endDate>2024-12-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ed36ab97-8daf-4e07-80c2-c1cddcb96e73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:NovartisAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ed51e302-8869-4a0f-962b-de9484e3aa0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ed8ad1a6-62b7-4058-824e-b48462749a75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tcrx:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eddbe2e8-9268-426b-a979-bd5adb43d23b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ee786513-1c43-4280-a1f0-021ef922f07e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:LegalAndProfessionalFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f113cfc8-bb00-4b79-a4d9-fb6c7cf9dd11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-20</xbrli:startDate><xbrli:endDate>2024-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f2e7699a-775b-485c-844c-dcfb47970cac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f5d697f7-128e-4876-a4f5-90f1a98fe9b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-27</xbrli:startDate><xbrli:endDate>2024-12-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f89cf5f2-e2a0-41fd-aa77-165139327dd5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:PersonnelExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f9a562f2-21ee-4a9b-a421-f3871446c2f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fb5bb604-09b8-4938-997b-19cc6a0d0d04"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fbb18820-4b97-463e-90e8-1723d8fab29c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fbfc4486-e4d3-49f0-973d-16204216ca9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fdf71ac3-3b5b-4e4e-9f5b-32fe46c5a168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fdf7f67a-bc90-4d6f-a82f-8fb0241be3b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_003184ab-3c81-4f7b-9c86-6fc2202ca43e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-09</xbrli:startDate><xbrli:endDate>2022-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_034fde6a-ad94-4842-9909-97bb9d9de862"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tcrx:WedbushSecuritiesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tcrx:SalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_03eb41a8-990a-4e35-bb1b-5a37935b24be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_043660e4-f867-48a8-898e-eecc448695b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-09</xbrli:startDate><xbrli:endDate>2022-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09f0d8e0-903f-4e84-86fc-40c0b86d33f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:FacilityRelatedAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0d869bf5-158b-47a4-9b8b-51e8110fb2d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_12bf6ad2-0a5b-44a7-a68c-7aaa96219405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_15c7b52a-5ecb-4134-84b7-1a74eee635a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_169ccb09-f794-4b53-b335-3240e68654d4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_197387ea-3040-4c38-8433-659c61aae89f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-26</xbrli:startDate><xbrli:endDate>2024-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1ae85ee9-048d-4bdf-b70c-933ca1975ec4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tcrx:WedbushSecuritiesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tcrx:SalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1d992a94-aafd-45cd-b390-139470ececc8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1daea7ab-e482-4c92-8f38-cdfc5e71c091"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1dbc7479-5045-494d-a301-5d8982738033"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:LaboratorySuppliesResearchMaterialsAndStudiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1f54b526-5c78-40d4-b51e-3bb57d254eee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:NovartisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-31</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1fd87468-b7a0-44c8-958d-699705148443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2094de61-2463-4b5a-b0a4-fca50236ad0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:AmgenAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:AmgenIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21496e54-0681-4b2a-a747-485e2a96f47c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21f58568-ecea-492b-a352-08d9e9a7f42b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_25583bb8-7b3e-423a-98e6-e7ade07bd068"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">tcrx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_261fba08-f9db-48e2-b812-47707c7e98ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_27fc5f66-3d18-42fb-8a66-2da06b8921bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2862a7f8-f1a2-48bd-bc36-db1c53bfedf9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_289ecc5d-92a2-42ce-b62b-77ce749bb8ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2a2ebcf4-40ec-47ac-8e0a-274ca41d986c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-27</xbrli:startDate><xbrli:endDate>2024-12-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2b9a5142-5c09-4228-8993-64954bfc0d19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2c53342d-2049-4853-81f6-ec35e8e6267f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2c6c9c99-f3b5-4d27-93cc-9263f4bf5003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_320b3a46-ac25-4647-8016-94baaf69c8d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3314d2d1-6f78-49b7-8dc7-033a9967337c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:LaboratorySuppliesResearchMaterialsAndStudiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_331dd2a3-95d1-44e8-add3-bfa57011870e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_332482d9-8141-410d-8864-204366a2aed0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-08</xbrli:startDate><xbrli:endDate>2023-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_34147130-543b-4bb3-9ad4-1f11d70023ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_34b3c74f-add1-4a1b-b372-3aa22b07f70c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-08</xbrli:startDate><xbrli:endDate>2023-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_379aeeb9-bc7c-43c4-9634-0092d863e599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3893ceb7-51f2-43b7-a23b-018b3f1f7b4f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3bf172b3-d914-487d-92f6-91b61a2ded94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3d025609-eb03-453e-8fb0-40e7424de1c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-30</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d8664d3-d512-4213-ac6c-cd3db870f7c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3df7ac2b-49aa-499b-bf47-812e00e80ff4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:AmgenAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:AmgenIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e156d80-5523-4597-bd1f-80a161d4d41c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3fda7817-04f6-40d1-b034-58df0d9f5ec2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3ffa6fa9-6b57-4d35-bd3a-b88d3505d57f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4368cad2-f9e8-40de-bd6d-33ad7e1e108f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:LegalAndProfessionalFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_460d78bc-0419-42c2-a4cd-42262517b953"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_46be3025-25e5-4ca5-aecb-96f1a7b4e50d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:NovartisAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47d4a7b8-0689-4bad-9d3a-73d2b5ff4403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48705e18-c435-4ea3-8f65-3174ccb08c15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48c5a331-9cb5-4678-b525-bcdd61cc8454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a97a8a0-1e04-4ff3-a4c3-35e097fb1306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c8ea6f2-9fff-4333-984a-67566fab4877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_523e5640-f362-49dd-8cd8-0a9f19fa77ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:AmgenAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:AmgenIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_52a3b19e-f226-4939-bba1-6190de6d2bba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_540ebf28-46d3-4e16-843f-afe078c63280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:DepreciationExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5458543f-e28b-4c69-8779-01decdc01ab6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:OfficeAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5dc478f0-33ed-4f00-97fe-edffa3ee70cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5fce13ba-5c69-4650-bed4-a3ea2c8f6f3e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-08</xbrli:startDate><xbrli:endDate>2023-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6003d2b4-d18b-4884-abfc-799d0a8bb89d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:DepreciationExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_61ed6f0b-459e-4d88-9516-a58d66772426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_64da7f3d-8b21-4b26-8c42-acd6857d10cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-24</xbrli:startDate><xbrli:endDate>2024-04-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_653bc1a9-0ec3-4132-946f-23cdbffd6e8c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_66e41251-c3d9-4ef4-96d0-e6b667f2d454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_67b999bc-f4c8-49b5-89ed-d7a3accc676d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68816447-84c0-44e4-a1c7-b78689002f3a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_68a5546e-4aca-41b8-aaed-3be56fa94165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_69f2d878-b10b-4938-9603-81cf10c7f68a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6c96b539-1a31-47e8-94ff-6a44016523a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7161914d-36e4-4f31-8cd4-0984db2302a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:OfficeAndComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_76bbc888-71d6-4496-aac8-fb489f0bd98f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_78a26315-739e-4dd5-ae26-f5f8ac025ff6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c36265d-e56e-41bb-b9a4-c45feaed4d8c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7dd0c966-6e37-4efa-b9a2-7c425a19b0ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001783328</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>tcrx:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Facility"><xbrli:measure>tcrx:Facility</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="border-top:1.5pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c858a10c-29f9-4057-acf5-3d259cdd3343" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Mark One)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:96%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;padding-left:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_4a445587-c256-4c36-8cd2-1410624d3c50" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_70fffb19-1111-4217-9e95-145df2f013ea" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8e285191-5d69-4b4c-8bff-747794985cbc" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a9351877-4f7e-4fad-922d-adef67e0fc1e" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:96%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;padding-left:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_640ee51a-cb9d-4fed-b88b-22a1cd9ccc49" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">                     </span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File Number </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5bcc1695-03c9-4782-9a6e-23604e838eb4" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">001-40603</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:20pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d5fa51bf-01be-4bc9-9fc2-0ca2c13b05f0" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:20pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as specified in its Charter)</span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"/>
    <td style="width:50%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_41f150f2-a48c-46e6-9691-ca99a01936e3" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9e6f7003-c908-4d5d-95c5-a56062610e5f" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">82-5282075</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(I.R.S. Employer</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span><ix:nonNumeric id="F_da6d1563-9b7d-4dd2-9e59-8e53b050a8c1" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">830 Winter Street</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span><ix:nonNumeric id="F_e2203f98-4ec7-4a20-84c0-d9b99b5943f8" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Waltham</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_11818e95-62a2-43b9-918c-ca3f56434051" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_4f4e4ea0-aeac-4aaa-815f-70bdb9c982a1" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">02451</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: (</span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e198d43b-4e44-482c-945c-8702d9bd5b35" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">857</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0010419c-bcd3-4a70-848b-a5b48c33616b" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">399-9500</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:38%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:15%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Symbol(s)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_e0a76e2f-06ed-4304-b282-80c04655eaa3" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Voting Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_2cfc7a2e-09c8-4828-8ddb-0c3ca212a6a8" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TCRX</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_c3bc1856-7f6c-42db-92ea-f692de5a1589" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Global Market, LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4d38b922-a5b7-4970-b6c0-41936b6fe959" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityWellKnownSeasonedIssuer"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  YES </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_804ea366-8071-4116-90e2-c31b2b4fd8b7" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityVoluntaryFilers"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_532612fc-af30-471f-b40f-7f95f55463e1" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityCurrentReportingStatus"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     NO </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).  </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d4557f49-2286-421c-82f7-e6c0763ed06b" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityInteractiveDataCurrent"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     NO </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:18.9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:55.84%;box-sizing:content-box;"/>
    <td style="width:1.06%;box-sizing:content-box;"/>
    <td style="width:20.08%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:2.12%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:2.15pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_c20bc9fc-359a-46d0-8784-f60cf3b78a79" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_f69be7c4-8fa7-4181-9d76-dc812a3890fc" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:2.15pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_6de6fd17-64cc-4281-90e4-bae804452223" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_fb6ee188-ec14-48b6-a162-243edca63c75" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_463cd22b-2490-40ac-9e0d-e109372a3697" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  </span><span style="font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_93c0b8ee-a4d6-4fb3-bbc2-4ee093a21a10" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).  </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  YES </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     NO </span><span style="font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_3e360cbb-4aaf-4147-824b-4449732ee6ed" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant, based on the closing price of the shares of common stock on The Nasdaq Global Market, LLC on June 30, 2024, was $</span><span style="font-size:7.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb357501-1ee9-4371-9760-dc41f5e8267d" contextRef="C_289ecc5d-92a2-42ce-b62b-77ce749bb8ad" name="dei:EntityPublicFloat" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201,649,026</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of shares of Registrant&#8217;s Common Stock outstanding as of February 28, 2025 was </span><span style="font-size:7.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f685f9eb-cf2a-4f7c-8f5f-29e3ed83f94f" contextRef="C_dffc028f-7182-46b3-bb44-cd753163cfd5" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">52,314,039</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of voting common stock, $0.0001 par value per share, outstanding and </span><span style="font-size:7pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7681701f-41c1-43aa-bc4c-5479a6f64c17" contextRef="C_c4c91cdd-5048-4fbf-83f0-0e66b2d854d4" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,276,588</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of non-voting common stock, $0.0001 par value per share, outstanding.</span></p>
  <div style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9e755f51-415e-4446-b989-7df9e900b168" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10%;box-sizing:content-box;"/>
    <td style="width:84%;box-sizing:content-box;"/>
    <td style="width:6%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART I.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_business"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1C.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 2.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_properties"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">108</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 3.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_legal_proceeding"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">108</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 4.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">108</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART II.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 5.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_market_for_registra_common_equity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">109</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 6.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_selected_financial_data"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">[Reserved]</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">109</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7_mda"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_quantitative_qualitative_disclosu"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Data About Market Risk</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 8.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_8_financial_statements_supp_data"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9_changes_in_and_dis_with_acc"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9a_controls_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9b_other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9C.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item9c_disclosure"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Disclosures Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART III.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 10.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_10_directors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">122</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 11.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_11_executivecomp"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 12.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_12_security"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Security Ownership and Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">132</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 13.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_13_certain_relationships"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">135</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 14.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_14_principalaccountingfees"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Principal Accounting Fees and Services</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">138</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART IV.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 15.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_15_exhibits_financial_stmt_schedule"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits, Financial Statement Schedules</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 16.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_16_10k_summary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">142</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">i</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report on Form 10-K, or Annual Report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this Annual Report are forward-looking statements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, you can identify forward-looking statements by words such as &#8220;may,&#8221; &#8220;can,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;possible&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements contained in this Annual Report include, but are not limited to, statements about:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the beneficial characteristics, safety, efficacy, therapeutic effects and potential advantages of our T cell receptor (TCR)-engineered T cell, or TCR-T, therapy product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding our preclinical studies being predictive of clinical trial results;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing of the initiation, progress and expected results of our preclinical studies, clinical trials and our research and development programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing of and our ability to submit applications for, and obtain and, if approved, maintain regulatory approvals for our TCR-T therapy product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding clinical trial results being predictive of continued development and commercial success of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our plans relating to developing and commercializing our TCR-T therapy product candidates, if approved, including sales strategy;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">estimates of the size of the addressable market for our TCR-T therapy product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our manufacturing capabilities and the scalable nature of our manufacturing process;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our estimates regarding expenses, future milestone payments and revenue, capital requirements and needs for additional financing;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding competition;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our anticipated growth strategies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to attract or retain key personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish and maintain development partnerships and collaborations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding federal, state and foreign regulatory requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory developments in the U.S. and foreign countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain and maintain intellectual property protection for our proprietary platform technology and our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the anticipated trends and challenges in our business and the market in which we operate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the sufficiency of our existing capital resources to fund our future operating expenses and capital expenditure requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the effects of any public health crises in regions where we, our partners, or other third parties on which we rely, on any of the foregoing or other aspects of our business or operations; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the effects of rising inflation rates and the impact on operating costs, liquidity and access to credit on any of the foregoing or other aspects of our business operations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the effects of global economic uncertainty and financial market volatility caused by political instability, or new or increased international tariffs, changes in U.S. policy, changes in international trade relationships and conflicts, such as the ongoing conflict between Russia and Ukraine, on any of the foregoing or other aspects of our business or operations including our ability to obtain additional financing; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our anticipated use of our existing cash resources and our ability to obtain additional financing in the future.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any forward-looking statements in this Annual Report reflect our current views with respect to future events or to our future financial performance and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions included in this Annual Report, particularly those described in the &#8220;Risk Factors&#8221; section in Part I, Item 1A of this Annual Report, that could cause actual results or events to differ materially from the forward-looking statements that we make. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time and it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. In light of these risks, uncertainties and assumptions, the forward- looking events and circumstances discussed in this Annual Report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements contained in this Annual Report are made as of the date of this Annual Report, and although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, advancements, discoveries, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, except as required by law, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Annual Report to conform these statements to actual results or to changes in our expectations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You should read this Annual Report and the documents that we have filed as an exhibit to this Annual Report with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, this Annual Report contains estimates, projections and other information concerning our industry, our business and the markets for our product candidates, including data regarding the estimated size of such markets and the incidence of certain medical conditions. We obtained the industry, market and similar data set forth in this Annual Report from our internal estimates and research, and from academic and industry research, publications, surveys and studies conducted by third parties, including governmental agencies. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable. Our estimates of the potential market opportunities for our product candidates include a number of key assumptions based on our industry knowledge, industry publications and third-party research, surveys and studies, which may be based on a small sample size and fail to accurately reflect market opportunities. Information based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by us and third parties, industry, medical and general publications, government data and similar sources. This Annual Report contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless stated otherwise, references in this Annual Report to &#8220;us,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;our Company,&#8221; or &#8220;the Company&#8221; and similar terms refer to TScan Therapeutics, Inc.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISK FACTOR SUMMARY</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business operations are subject to numerous risks that, if realized, could materially and adversely affect our business, financial condition, results of operations, and future growth prospects. These risks are discussed more fully in Part I, Item 1A. &#8220;Risk Factors&#8221; in this Annual Report on Form 10-K. These risks include, but are not limited to, the following:</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Business and Industry</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant losses since inception, and we expect to incur losses over the next several years and may not be able to achieve or sustain revenues or profitability in the future.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business depends upon the success of our proprietary platform. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our limited operating history may make it difficult to evaluate the success of our business to date and to assess our future viability. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never generated any revenue from sales of our TCR-T therapy product candidates, and our ability to generate revenue from product sales and become profitable depends significantly on our success in a number of areas.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will need to obtain substantial additional funding to complete the development and any commercialization of our product candidates, if approved. If we are unable to raise this necessary capital when needed, we could be forced to delay, reduce or eliminate our product development programs, commercialization efforts or other operations. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our intellectual property or product candidates on unfavorable terms to us. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Global economic uncertainty and financial market volatility caused by political instability, changes in international trade relationships and conflicts could make it more difficult for us to access financing and could adversely affect our business and operations.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. Congress or the Trump administration, may make substantial changes to fiscal, tax, and other federal policies that may adversely affect our business.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent volatility in capital markets and lower market prices for many securities may affect our ability to access new capital through sales of shares of our common stock or issuance of indebtedness, which may impact our liquidity, limit our ability to grow our business, pursue acquisitions or improve our operating infrastructure and restrict our ability to compete in our markets.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations and its financial condition and results of operations.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The terms of our loan agreement place restrictions on our operating and financial flexibility. If we raise additional capital through debt financing, the terms of any new debt could further restrict our operating and financial flexibility.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to the Development of Our Product Candidates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our approach to the discovery and development of product candidates based on our proprietary platform represents a novel approach to cancer treatment, which creates significant challenges for us. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are early in our development efforts. If we are unable to advance our product candidates through clinical development, obtain regulatory approval and ultimately commercialize our product candidates, or experience significant delays in doing so, our business will be materially harmed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although many of our personnel have extensive experience in clinical development and manufacturing at other companies, we have limited direct experience as a company in conducting clinical trials and managing a manufacturing facility for our product candidates. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our preclinical studies and clinical trials may fail to demonstrate adequately the safety, potency and purity of any of our product candidates, which would prevent or delay development, regulatory approval and commercialization.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business could be adversely affected by the effects of health epidemics in regions where we, our partners or other third parties on which we rely have significant manufacturing facilities, concentrations of potential clinical trial sites or other business operations.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may rely on third parties to manufacture our clinical product supplies, and we may rely on third parties to produce and process our product candidates, if licensed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot guarantee that our product candidates will show any functionality in the solid tumor microenvironment.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Allogeneic hematopoietic cell transplantation (HCT) is a high-risk procedure that may result in complications or adverse events for patients in our clinical trials including those unrelated to the use of our product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates may cause undesirable side effects or have other properties that could halt their clinical development, prevent their regulatory approval, require expansion of the trial size, limit their commercial potential, or result in other significant negative consequences. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market opportunities for our product candidates may be relatively small. In addition, our estimates of the prevalence of our target patient populations may be inaccurate. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face significant competition, and our operating results will suffer if we fail to compete effectively.  </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Manufacturing</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing and administering our product candidates is complex and we may encounter difficulties in production, particularly with respect to process development or scaling up of our manufacturing capabilities. If we encounter such difficulties, our ability to provide supply of our TCR-T therapy product candidates for clinical trials or for commercial purposes could be delayed or stopped. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although many of our personnel have experience in clinical manufacturing at other companies, we have limited experience as a company managing manufacturing for our product candidates, which will be costly and time-consuming, and which may not be successful. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may have difficulty validating our manufacturing process as we manufacture TCR-T therapy product candidates from an increasingly diverse patient population for our clinical trials. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Government Regulation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The regulatory approval process is lengthy and time-consuming, and we may experience significant delays in the clinical development and regulatory approval of our product candidates. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be unable to obtain regulatory approval for our product candidates under applicable regulatory requirements. The denial or delay of any such approval would delay commercialization of our product candidates and adversely impact our potential to generate revenue, our business and our results of operations.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Intellectual Property</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to obtain and maintain patent protection for any product candidates we develop and for our technology, or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize products, product candidates and technology similar or identical to ours, and our ability to successfully commercialize any product candidates we may develop and our technology may be adversely affected.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are currently, and expect in the future to be, party to material license or collaboration agreements, which may impose numerous obligations and restrictions on us. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third-party claims of intellectual property infringement, misappropriation or other violations may prevent or delay our product candidate discovery and development efforts.  </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Reliance on Third Parties</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on third parties to conduct our clinical trials. If these third parties do not properly and successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval of or commercialize our product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have in the past and may in the future form or seek collaborations or strategic alliances or enter into additional licensing arrangements, and we may not realize the benefits of such collaborations, alliances or licensing arrangements. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Risk Factors</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rising inflation rates may result in increased operating costs and reduced liquidity and affect our ability to access credit.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART I</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_1_business"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1. Business</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. Our approach is based on the central premise that we can learn from patients who are winning their fight against cancer to treat those who are not. Over the past several years, we have built our ImmunoBank, a repository of therapeutic TCRs that recognize diverse targets and are associated with multiple human leukocyte antigen, or HLA, types. We then use these TCRs to manufacture enhanced TCR-T therapies to treat a broad population of patients with both hematologic, or heme, and solid tumor malignancies. Every TCR in our ImmunoBank has come from our proprietary platform technologies, and we are continuing to expand our ImmunoBank.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are advancing a robust pipeline of TCR-T therapy product candidates for the treatment of patients with heme malignancies and solid tumors. Our lead product candidates, TSC-100 and TSC-101, are in development for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL), who are undergoing allogeneic hematopoietic cell transplantation (HCT). The products are designed to eliminate residual disease and promote complete donor chimerism, thereby preventing relapse. TSC-100 and TSC-101 target the antigens HA-1 and HA-2, respectively, which are well-recognized TCR targets that were first identified in patients with exceptional responses to HCT-associated immunotherapy. We are currently conducting a multi-arm Phase 1 "umbrella" clinical study of TSC-100 and TSC-101, the ALLOHA&#153; Phase 1 heme trial, with 15 clinical sites activated, and we plan to open additional sites before the end of 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we are developing multiple TCR-T therapy product candidates for the treatment of solid tumors. One of the challenges of treating solid tumors is that they are heterogeneous &#8211; not every tumor cell expresses a given target and some tumor cells lose half their HLA genes. To address this challenge, we are developing what we refer to as multiplex TCR-T therapy, or T-Plex, in which we treat a patient with more than one TCR-T therapy product candidate at a time. We are designing these multiplex therapies to be a simultaneous administration of up to three highly active TCR-T therapy product candidates, selected from our ImmunoBank, that are customized for each patient based on which targets are expressed in their tumors and which HLA genes are still intact. We continue to prioritize expanding the ImmunoBank with TCRs for additional targets and multiple HLA types for each target. We have now advanced seven TCR-T therapy product candidates into Phase 1 development for solid tumors: TSC-203-A0201 (PRAME, HLA-A*02:01); TSC-200-A0201 (HPV16, HLA-A*02:01); TSC-201-B0702 (MAGE-C2, HLA-B*07:02); TSC-202-A0201 (MAGE-A4, HLA-A*02:01); TSC-204-A0201 (MAGE-A1, HLA-A*02:01); TSC-204-C0702 (MAGE-A1, HLA-C*07:02); and TSC-204-A0101 (MAGE-A1, HLA-A*01:01). In addition to clearing these seven solid-tumor investigational new drug (IND) applications, the U.S. Food and Drug Administration (FDA) has cleared our IND application for T-Plex, enabling us to treat patients with multiplex TCR-T therapy. We plan to further expand the ImmunoBank by filing IND applications for additional TCR-T therapy product candidates. We have initiated a Phase 1 solid tumor clinical trial, the PLEXI-T&#153; trial, with 15 clinical sites activated, and we plan to open additional sites before the end of 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have an internal good manufacturing practices, or GMP, facility to manufacture clinical supply for our TCR-T therapy product candidates. This facility allows us to rapidly, cost-effectively, and consistently manufacture our TCR-Ts. Our TCR-T therapy product candidates are manufactured using a non-viral transposon/transposase system. This non-viral platform approach can be rapidly applied to new TCR-T therapy product candidates in a cost-effective manner without the need for extensive process development. The larger cargo capacity of our non-viral vector delivery system allows us to include additional T cell enhancements in our product candidates. In both our heme and solid tumor programs, we are introducing the gene for CD8&#945;/&#946; along with the TCR gene, which enables us to engineer both cytotoxic and helper T cells with our TCRs. We believe this enhancement has the potential to improve responses to TCR-T therapy in the clinic compared to engineering cytotoxic T cells alone. In our solid tumor program, we are also adding a dominant-negative (DN) form of TGF&#946;RII to our T cells, which enables them to proliferate despite the presence of TGF&#946; in the hostile tumor microenvironment. This has the potential to enhance T cell persistence. Our GMP facility has the estimated capacity to manufacture clinical trial materials for up to 250 TCR-T components per year. To further increase our existing clinical manufacturing capacity and prepare for potential commercialization, we have engaged a global contract development and manufacturing organization, or CDMO, with worldwide commercial capabilities to support both the heme and solid tumor programs. The CDMO is on track to add capacity and to support additional clinical manufacturing of the heme program in the second half of 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T cells are an essential component of the adaptive immune system and provide protection against cancer, infection, and autoimmune disorders. Multiple approaches have been and are continuing to be explored to develop effective T cell-based therapies for the treatment of cancer, including checkpoint inhibitor therapy, tumor infiltrating lymphocyte, or TIL, therapy, and chimeric antigen receptor (CAR) T cell, or CAR-T, therapy. The success of checkpoint inhibitor and TIL therapy depends on the specific T-cells present in the patient. If their T-cells do not have appropriate anti-cancer specificities, the therapy is unlikely to be effective. In addition, TIL therapy has, to date, shown limited applicability for the treatment of heme malignancies. In contrast, CAR-T therapy has proven effective</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in certain heme malignancies of lymphoid origin but has shown only limited activity in myeloid malignancies or solid tumors. To address a broader patient population, we believe additional T cell-based approaches are needed that more closely mimic the way the immune system recognizes and fights cancer.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The successful development of TCR-T therapy product candidates has three key prerequisites: (i) an effective anti-cancer TCR; (ii) knowledge of the precise peptide antigen that is recognized by the TCR; and (iii) confirmation that the TCR does not recognize problematic off-targets. We believe our approach provides us with the following key advantages:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our TCR-T therapy product candidates are based on highly active TCRs that are clinically relevant. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many other approaches to T cell therapy rely on</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">specifically expanding T cells that are already present in the patient. Our platform analyzes anti-cancer T cells from a broad set of individuals, including patients responding to immunotherapy as well as healthy donors, to find the most active and clinically relevant TCRs against each target. We believe that we can develop TCR-T therapy product candidates for a wide range of patients, including those who do not have T cells that efficiently recognize their cancers.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our TCR-T therapy product candidates are designed to be used in combination with each other. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have built the ImmunoBank of TCRs to allow for</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">multiplexed TCR-T therapy, which has the potential to address the heterogeneous nature of solid tumors and address resistance due to target or HLA loss. We continue to expand the ImmunoBank with TCRs for additional targets as well as multiple common HLA types for each target.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our approach is expandable. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ImmunoBank has the flexibility to be used with new and optimized methods of T cell engineering that we may</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">develop over time. We are currently employing the validated approach of patient-specific </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ex vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> engineering, but as the field evolves, our TCRs may be transitioned to "off-the-shelf" methods, including allogeneic T cells or </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> engineering. As we expand the ImmunoBank to include TCRs across additional targets and HLA types, we believe we will increase the eligible patient population for our clinical trials, which will allow for rapid and efficient clinical trial enrollment with fewer screen failures. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Pipeline</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are advancing a robust pipeline of TCR-T therapy product candidates for the treatment of patients with heme malignancies and solid tumors. Our lead product candidates, TSC-100 and TSC-101, are in development for the treatment of patients with heme malignancies to eliminate residual disease and prevent relapse following HCT.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we are developing multiple TCR-T therapy product candidates for the treatment of various solid tumors. We have developed and continue to expand the ImmunoBank with the goal of delivering customized multiplex TCR-T therapy to a wide range of patients with cancer. Our current proprietary pipeline is summarized in the figure below.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_0.jpg" alt="img181012247_0.jpg" style="width:720px;height:335px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to our proprietary pipeline programs noted above, we have also entered into collaborations with strategic partners for applications of our platform technologies. We have a collaboration with Amgen Inc., or Amgen, to identify the antigens recognized by T cells in patients with Crohn's disease. Amgen will evaluate a variety of modalities to create therapeutic candidates based on targets discovered by TScan and will retain all global development and commercial rights.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With our differentiated platform as the foundation, we are building a three-pillar research and development strategy to create transformational TCR-T therapy product candidates for patients.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Heme Program.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We are developing TCR-T therapy product candidates to treat patients with heme malignancies, including AML, MDS, and ALL who are undergoing allogeneic HCT. In the first phase of our clinical development strategy, we are initially focusing on clinically validated cancer targets that have been discovered in patients with exceptional responses to HCT-associated immunotherapy, including HA-1 and HA-2. Additionally, we are planning to expand our heme program to include additional HLA types. We have now advanced TSC-102-A0301, which targets an HLA-A*03:01-restricted epitope on CD45, into IND-enabling activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></div></div>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are currently enrolling patients in a multi-arm Phase 1 "umbrella" clinical study with 15 clinical sites activated and additional sites planned to be opened in 2025. The study protocol allows us to conduct clinical trials of TSC-100 and TSC-101 in parallel, with patients enrolled in treatment arms based on their genotype. Patients who are positive for the target antigen, HA-1 or HA-2, as well as the HLA-A*02:01 allele, which is the HLA type required to display HA-1 and HA-2 on the cell surface for recognition by a T cell, are eligible for enrollment. Eligible patients require donors who are negative for either the target antigen or the HLA-A*02:01 allele.</span></p>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Through the development of our heme malignancies program, we have built a foundation of manufacturing, clinical, and regulatory capabilities, which we are also applying to the development of our broader portfolio of TCR-T therapy product candidates for solid tumors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Solid Tumor Program</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We are developing a portfolio of autologous TCR-T therapy product candidates designed to be used in combination with each other to treat and eliminate solid tumors. Our solid tumor product candidates are designed to elicit anti-tumor responses in patients by targeting cancer-specific antigens in their tumor cells. Our TCR-T therapy product candidates include: (i) well-recognized cancer targets that have demonstrated anti-tumor activity in clinical trials as well as novel targets that were identified by TargetScan from the T cells of patients responding to immunotherapy, and (ii) naturally occurring TCRs specific to a patient&#8217;s HLA type that recognize these cancer-specific targets. Such targets are not only commonly shared among patients with the same cancer type, but also frequently expressed in multiple solid tumor types, enabling clinical development across multiple indications. Our first seven product candidates address known and novel targets: E7 of HPV16 for TSC-200-A0201, MAGE-C2 for TSC-201-B0702, MAGE-A4 for TSC-202-A0201, PRAME for TSC-203-A0201, and MAGE-A1 for TSC-204-A0201, TSC-204-C0702, and TSC-204-A0101.</span></div></div>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have built and continue to expand the ImmunoBank to enable customized multiplex TCR-T therapy for a wide range of solid tumor patients. Our initial solid tumor indications include non-small cell lung cancer, sarcoma, head &amp; neck cancer, cervical cancer, and anal &amp; genital cancer. For each patient with a solid tumor malignancy, we first analyze the patient's tumor to determine which targets are expressed at high levels and which HLA genes are still intact. We then access the ImmunoBank and select up to three TCRs that match their HLA type and address the most highly expressed targets in their tumor. We will use this set of TCRs to genetically reprogram their T cells to recognize these targets, and the resulting T cells will be infused back into the patient as a multiplex TCR-T therapy.</span></p>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enabled by the additional cargo capacity of our non-viral vector delivery system, we are also introducing enhancements to our product candidates to deepen tumor responses and prolong duration of response. By introducing the gene for CD8&#945;/&#946; along with the TCR gene, we are able to engineer both cytotoxic and helper T cells, which we believe has the potential to improve responses to treatment with TCR-T therapy in the clinic compared to engineering cytotoxic T cells alone. We are also adding DN-TGF&#946;RII to T cells, which allows them to proliferate despite the presence of TGF&#946; in the hostile tumor microenvironment. This has the potential to enhance T cell persistence.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Partnerships and Collaborations. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T cells play a fundamental role in many other therapeutic areas beyond cancer, such as</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">autoimmune disorders and infectious diseases. We believe that our TargetScan technology is well suited to discover novel antigens for the development of therapeutics, diagnostics, and vaccines in these other therapeutic areas. We intend to opportunistically pursue collaborations with strategic partners for applications of our platform technologies outside our core focus of oncology.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Strategy</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our mission is to create life-changing TCR-T therapy product candidates for patients by unleashing the untapped potential of the human immune system. Our goal is to use our proprietary platform technologies to identify novel tumor-specific antigens and clinically active TCRs to become a leader in the development of engineered T cell therapies for the treatment of heme malignancies and solid tumors. Our strategy includes the following key elements:</span></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advance our lead product candidates, TSC-100 and TSC-101, through clinical development.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our two lead programs,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TSC-100 and TSC-101, are designed to target HA-1 and HA-2, respectively, both of which are antigens with clinically demonstrated anti-tumor effects in patients who naturally develop T cells specific to these targets. We are currently enrolling patients in a multi-arm Phase 1 clinical study of TSC-100 and TSC-101 with 15 clinical sites activated and additional sites planned to be added in 2025. The study protocol allows us to conduct clinical trials of TSC-100 and TSC-101 in parallel, with patients enrolled in treatment arms based on their genotype. In addition, through our heme malignancies program, we have established a foundation of manufacturing, clinical and regulatory capabilities to support the development of our broad portfolio of TCR-T therapy product candidates.</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advance our solid tumor program through clinical development.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are initially developing our solid tumor TCR-T therapy product candidates against five selected target antigens that are frequently expressed across multiple solid tumor types. Our first seven solid tumor TCR-T therapy product candidates address known and novel targets, including E7 of HPV16 for TSC-200-A0201, MAGE-C2 for TSC-201-B0702, MAGE-A4 for TSC-202-A0201, PRAME for TSC-203-A0201, and MAGE-A1 for TSC-204-A0201, TSC-204-C0702, and TSC-204-A0101. We believe that the treatment of solid tumors will require a combination of several therapeutic TCRs, which we refer to as 'multiplex therapy'. We plan to expand the ImmunoBank to broaden the reach of multiplex TCR-T therapy for the treatment of solid tumors.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leverage our proprietary platform technologies to expand the ImmunoBank of therapeutic TCRs to treat a wide range of tumor types</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our TargetScan technology enables us to identify novel antigens that are broadly expressed across multiple types of solid tumors. To ensure that the antigens identified are clinically relevant, we use TCRs from tumor samples of patients with exceptional responses to immunotherapy. Our platform allows us to assess the specificity and cytotoxicity of these TCRs to develop a portfolio of TCR-T therapy product candidates with therapeutic potential. We continue to prioritize expanding the ImmunoBank with TCRs for additional targets as well as multiple common HLA types for each target, thus enabling us to address tumor heterogeneity and resistance that may arise from target loss or HLA loss.</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Maintain manufacturing capabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that in-house manufacturing capabilities substantially facilitate the successful early development of cell therapies. For our TCR-T therapy product candidates, we have developed a non-viral gene delivery system, which we refer to as T-Integrate, based on transposons that are designed to enable cost-effective and consistent cell manufacturing with short development times. We have built an internal, fully operational GMP manufacturing facility that we believe provides sufficient capacity to support our clinical programs in both heme malignancies and solid tumors. Additionally, we have engaged a global CDMO with commercial capabilities to further increase manufacturing capacity for both the heme and solid tumor programs and prepare for potential commercial manufacturing. The CDMO is on track to support clinical manufacturing of the heme program in the second half of 2025. The additional cargo capacity of our non-viral vector delivery system allows us to add T cell enhancements to our product candidates. By introducing the gene for CD8&#945;/&#946; along with the TCR gene, we are able to engineer both cytotoxic and helper T cells, which we believe has the potential to improve responses to TCR-T therapy in the clinic compared to engineering cytotoxic T cells alone. We are also adding DN-TGF&#946;RII to T cells, which enables them to proliferate despite the presence of TGF&#946; in the hostile tumor microenvironment. This has the potential to enhance T cell persistence. Having treated over 30 patients with six different TCR-T candidates across both heme and solid tumor malignancies, we consider our approach to be validated.</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Develop next generation T cell engineering capabilities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our long-term vision is to develop off-the-shelf products, either through allogeneic T-cell engineering or </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> engineering, and provide customized multiplex TCR-T therapy to patients with a wide range of malignancies. Although our initial solid tumor programs are autologous, we are developing T cell engineering technologies and in-house manufacturing capabilities to transition our therapeutic TCRs to alternative modalities. </span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Opportunistically pursue strategic partnerships and collaborations to maximize the full potential of our platform</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our platform represents</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a powerful tool to identify targets and TCRs in therapeutic areas outside of oncology, such as autoimmune disorders and infectious diseases. We intend to seek strategic partners with proven clinical development and commercialization capabilities for certain targets and/or assets that do not overlap with our internal programs or our core focus. To date, we have a research collaboration and license agreement with Amgen to identify the antigens recognized by T cells in patients with Crohn&#8217;s disease. Under the terms of the agreement, TScan received a $30.0 million upfront payment and is eligible to earn success-based milestone payments of over $500 million, based upon the achievement of certain development and commercial milestones as well as tiered single-digit royalty payments on net sales of products developed </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from the collaboration. Amgen will evaluate a variety of modalities to create therapeutics based on targets discovered by TScan and will retain all global development and commercial rights to such therapeutics. We have also expanded our target discovery capabilities to include both CD8+ and CD4+ T-cells by engineering our platform to include class II antigen presentation. This capability allows for us to expand discovery efforts into T cell-mediated autoimmune disorders that have a strong Major Histocompatibility Complexes, or MHC, class II linkage. We intend to leverage this new capability to identify the pathogenic autoantigens driving T-cell mediated autoimmune disorders.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Background on T Cell Therapies</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The human immune system constantly provides a natural and highly effective defense against cancer, which only forms when tumor cells find a way to evade the immune system. The treatment of cancer was revolutionized over a decade ago with the advent of immunotherapy &#8211; therapeutic approaches designed to re-enable or re-direct immune cells to recognize and fight cancer. Over the past 10 years, a suite of immuno-oncology drugs has been approved and adopted as part of routine clinical practice. Successes in immuno-oncology came initially from the approval of immune checkpoint inhibitors and more recently from the development of cellular therapies, such as CAR-T and TIL therapies. These therapies all harness the power of cytotoxic T cells in fighting both heme malignancies and solid tumors. Although these therapies have demonstrated compelling efficacy, they are only effective in a subset of patients. To address a broader patient population, we believe additional T cell-based approaches are needed that more closely mimic the way the immune system recognizes and fights cancer in patients who are responding to immunotherapy.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview of T Cell Biology</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T cells are an essential component of the adaptive immune system and provide protection against cancer, infection, and autoimmune disorders. T cells are classically divided into two primary types of activating cells: helper T cells and cytotoxic T cells. Helper T cells, which express the CD4 co-receptor, function by providing signals to other immune cells for activation and recruitment. Cytotoxic T cells, which express the CD8 co-receptor, function by killing any cells in the human body that are expressing unnatural proteins, including proteins that are not expressed in normal tissue, proteins that arise from mutated genes, or proteins derived from pathogens. By definition, tumor cells are abnormal and make a wide variety of unnatural proteins. T cells are activated and exert their helper or cytotoxic function when their TCRs recognize antigens displayed on the surface of malignant or infected cells.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Virtually every cell in the body has a mechanism for displaying on its surface a sampling of every protein that is being made by the cell. This includes all normal proteins as well as aberrant proteins if the cell is cancerous or proteins from pathogens if the cell has been infected. Cellular proteins are broken down into short fragments, or peptides, by the proteasome, and these peptides are loaded into MHCs to be displayed on the outside of the cell. These peptide/MHC complexes are recognized by TCRs on cytotoxic CD8+ T cells, as shown in the graphic below. Because the TCR recognizes both the peptide and the MHC, a TCR only functions correctly when both the peptide and the correct MHC are present.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:22pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TCRs on Cytotoxic CD8+ T Cells Recognize the</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Peptide/MHC Complexes of Tumor Cells</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_1.jpg" alt="img181012247_1.jpg" style="width:424px;height:386px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MHC proteins, which present different peptides to the human immune system, are highly variable among people. An individual&#8217;s MHC proteins are determined by their HLA type. Although there are many different HLA types, some are quite common. For example, 42% of individuals in the U.S. are positive for the HLA-A*02:01 allele, or variant. TCRs are often referred to as &#8220;HLA-restricted&#8221; because they are only able to interact with specific HLA types. For this reason, TCR-Ts harness the specificity of the TCR-peptide-MHC interaction to selectively target tumor cells.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Current Approaches to T Cell Therapy</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Multiple approaches are being explored to develop effective T cell-based therapies for the treatment of cancer. One approach is to isolate naturally occurring T cells from a patient&#8217;s tumor, referred to as TILs, expand and activate those cells </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ex vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and then return them to the patient via intravenous infusion. Although the targets of these T cells are not known, it is presumed that T cells isolated from a tumor are enriched in T cells directed against cancer cells. This approach, however, depends on the anti-cancer T cells present in the patient. If the patient&#8217;s TILs do not have appropriate anti-cancer specificities or if their anti-cancer TILs cannot be adequately expanded </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ex vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the therapy is unlikely to be effective.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A different approach that has proven effective in certain heme malignancies is to identify targets that are highly expressed on the surface of tumor cells, such as CD19. Antibody fragments that recognize these targets are used to create an artificial construct that links the antibody to key signaling elements required for T cell activation. The resulting CAR is incorporated genetically into a patient&#8217;s T cells, thereby redirecting those cells to recognize and fight the patient&#8217;s cancer. Although CAR-T therapies have been highly effective in certain tumor types, leading to multiple approved products, the benefit of these therapies and the addressable cancer indications have been limited by several factors. First, it is likely that there is a relatively limited set of truly tumor-specific cell surface antigens. In general, most antigens expressed on the surface of tumor cells are also expressed on normal cells, resulting in therapies that, even if effective, have a narrow therapeutic window and are vulnerable to potentially life-threatening toxicities. Second, CAR-T cells rely on antibody fragments that recognize cell-surface proteins, precluding intracellular proteins as potential targets. Third, CAR-T therapies generally do not efficiently penetrate solid tumors, which to date has limited their applicability to heme malignancies.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In contrast to CAR-T therapies, naturally occurring TCRs offer two important benefits compared to antibody-containing artificial receptors. First, TCRs are the natural receptors used by the T cell to recognize foreign antigens. As such, they are optimized to stimulate the T cell appropriately when they engage their targets on a tumor cell. An appropriately stimulated T cell will not only kill the tumor</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cell, but also produce cytokines that stimulate other immune cells and make copies of itself, or proliferate, to further augment the immune response. Balancing all the cellular responses of a T cell is something that has been finely tuned over millions of years of evolution and is best mediated by naturally occurring TCRs, rather than by artificial constructs. Second, TCRs can recognize a much broader set of antigens, including peptides derived from both cell surface and intracellular proteins, whereas CARs are restricted to recognizing only cell surface proteins. MHC-I peptides are predominantly derived from intracellular proteins rather than extracellular proteins, which dramatically increases the universe of potential cancer-specific antigens that can be recognized by TCRs compared to CARs. We believe TCR-T therapy combines the benefits of TIL and CAR-T therapies while uniquely addressing their key limitations, as shown below.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Building on the Remarkable Success of Immunotherapy</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_2.jpg" alt="img181012247_2.jpg" style="width:720px;height:292px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The development of TCR-T therapy product candidates requires three key prerequisites: (i) an effective anti-cancer TCR; (ii) knowledge of the precise peptide antigen that is recognized by the TCR; and (iii) confirmation that the TCR does not recognize problematic off-targets. Each of these prerequisites is technically challenging. Historically, targets of anti-cancer T cell clones were identified through a manual and labor-intensive process, and the identification of each target was often a multi-year project. As a result, only a few dozen targets have been identified to date and most clinical development efforts are focused on a short list of the most promising targets.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Two key shortcomings in the TCR field remain: low response rates and limited duration of response. These are in part related to solid tumors being heterogenous, and to poor persistence of engineered T cells in patients. We believe we can overcome these known issues by adding enhancements to our product candidates, such as the addition of CD8&#945;/&#946; to improve persistence compared to CD8&#945; alone. We are also co-introducing DN-TGF&#946;RII, which is designed to overcome immunosuppression from TGF&#946; in the tumor microenvironment.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Approach</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our approach is based on the central premise that we can learn from patients who are winning their fight against cancer in order to treat those who are not. Using our proprietary platform technologies, we are analyzing the T cells of cancer patients with exceptional responses to immunotherapy to discover clinically relevant targets and TCRs. We have built and are expanding the ImmunoBank with the goal of delivering customized multiplex TCR-T therapy to a wide range of patients with cancers.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our discovery process enables us to build and expand the ImmunoBank with what we believe represents the most active TCRs isolated from a large group of diverse patients who are responding to immunotherapy. We are developing TCR-T therapy product candidates that use these clinically relevant TCRs to reprogram the T cells of patients who do not spontaneously generate effective anti-cancer T cells and thus do not respond to immunotherapy. Such patients will first have their tumors undergo HLA typing and testing for the presence of tumor-specific targets. Next, to manufacture engineered T cells, white blood cells will be obtained from either the patient or a healthy donor using a procedure called leukapheresis. We will then transport these white blood cells to our in-house manufacturing facility, where we isolate the T cells and genetically engineer them using TCR sequences from the ImmunoBank. We believe the continued expansion and diversification of the ImmunoBank will enable us to deliver customized multiplexed TCR-T therapies to more</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patients, where each patient&#8217;s T cells are engineered with multiple TCRs that are matched to their specific tumor and HLA type. For example, if a patient&#8217;s tumor expresses high levels of a particular cancer target, their T cells will be reprogrammed with a TCR that recognizes that particular cancer target. The FDA's clearance of our T-Plex IND application for the simultaneous administration of different TCRs, as well as secondary IND applications for the first seven TCRs in our solid tumor program, allows us to rapidly and efficiently expand the ImmunoBank and enables us to work toward our goal of bringing customized, multiplex therapies to patients.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_3.jpg" alt="img181012247_3.jpg" style="width:642px;height:263px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once the T cells are engineered with a combination of the most relevant TCRs, they will be transported back to the treatment facility and reintroduced into the patient by intravenous infusion. Following the infusion, the engineered T cells, which are designed to recognize multiple targets expressed by the patient&#8217;s tumor, will proliferate </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and mount an anti-cancer immune response.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Key Features of Our Approach</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe there are three key advantages to our approach:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our TCR-T therapy product candidates are based on highly active TCRs that are clinically relevant. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many other approaches to T cell therapy rely on</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">specifically expanding T cells that are already present in the patient. Our platform analyzes anti-cancer T cells from a wide variety of patients who are responding to immunotherapy in order to find the most active and clinically relevant TCRs against each target. We believe that we can develop TCR-T therapy product candidates for a wide range of patients, including those who do not have T cells that efficiently recognize their cancers.</span></div></div>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our TCR-T therapy product candidates are designed to be used in combination with each other. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have built and are expanding the ImmunoBank of TCRs to allow for</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">multiplex TCR-T therapy, which has the potential to address the heterogeneous nature of solid tumors and address resistance developing due to loss of a single target. We believe this approach may allow us to overcome the limitations and challenges of TCR-T development to date. We continue to prioritize expanding the ImmunoBank with TCRs for additional targets as well as multiple common HLA types for each target, thus enabling us to address tumor heterogeneity and resistance that may arise from target loss or HLA loss. As the ImmunoBank is populated with more TCRs, we expect that patient eligibility will expand, as will our target market opportunities. </span></div></div>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our approach is expandable. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ImmunoBank has the flexibility to be used with new and optimized methods of T cell engineering that we may</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">develop over time. We have built the ImmunoBank to be compatible with both autologous and allogeneic engineering technologies in order to potentially transition to generating off-the-shelf, allogeneic T cells that have been pre-engineered with our TCRs for direct administration to patients.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Heme Malignancies Program</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing our heme malignancies program to treat patients with AML, MDS, or ALL who are undergoing allogeneic HCT. In the first phase of our clinical development strategy, we are initially focusing on well-recognized cancer targets that have been discovered in patients with exceptional responses to HCT-associated immunotherapy, including HA-1 and HA-2. Our program is based on the well-established observation that patients who are mismatched with their donors for minor histocompatibility antigens, or miHAs, such as HA-1 or HA-2, and naturally mount a T cell response against those antigens, show significantly lower relapse rates following HCT. By developing TSC-100 and TSC-101, TScan aims to recreate this natural graft versus leukemia response to prevent relapse in patients undergoing HCT.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We plan to further expand this program with the addition of TCRs targeting additional antigens across different HLA types. For example, TSC-102-A0301, a TCR-T therapy product candidate targeting an HLA-A*03:01-restricted epitope on CD45, is currently in IND-enabling activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Minor histocompatibility antigens like HA-1 and HA-2, and lineage-specific antigens like CD45, are distinct from other cancer-associated antigens such as WT1 previously targeted by TCR-Ts in heme malignancies. As shown below, cancer-associated antigens like WT1 have low and heterogenous expression and were previously selected so that normal blood cells in the patient would be spared. WT1-targeted TCR-Ts proved to have relatively poor efficacy in patients with ALL and AML, potentially due to the rapid emergence of resistant tumor cells that lacked WT1 expression and thus escaped killing by engineered T cells. HA-1, HA-2, and CD45, in contrast, have high and homogenous expression, making it less likely for tumors cells to escape due to low antigen expression. Although HA-1, HA-2, and CD45 are also expressed in normal blood cells, treating patients who are positive for these antigens, but have undergone hematopoietic cell transplantation from donors who are negative, ensures that the engineered T cells selectively eliminate all the patient&#8217;s blood cells &#8211; malignant, pre-malignant, or normal &#8211; while sparing donor-derived normal blood cells. This strategy therefore enables high levels of anti-cancer efficacy with what we believe to be less risk of life-threatening toxicities to normal cells.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_4.jpg" alt="img181012247_4.jpg" style="width:403px;height:282px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are conducting a Phase 1 clinical trial of our lead TCR-T therapy product candidates, TSC-100 and TSC-101, in parallel, with patients enrolled in treatment arms based on their genotype, as shown below. Patients who are positive for the target antigen, HA-1 or HA-2, as well as the HLA-A*02:01 allele, which is the HLA type required to display HA-1 and HA-2 on the cell surface for recognition by a T cell, are eligible for enrollment, provided they are paired with donors who are negative for either the target antigen or the HLA-A*02:01 allele.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ALLOHA&#153;, a Multi-arm Phase 1 Trial for TSC-100 and TSC-101 in Subjects with AML, ALL, and MDS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_5.jpg" alt="img181012247_5.jpg" style="width:720px;height:374px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Background on Heme Malignancies</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HCT has become the standard of care for many heme malignancies. When a patient with leukemia undergoes HCT, they start by receiving a conditioning regimen of high dose chemotherapy with or without radiation. This regimen is intended to kill both the patient&#8217;s leukemia cells as well as their native blood cells and blood cell precursors, including hematopoietic stem cells in their bone marrow. The patient then receives hematopoietic stem cells from an HLA-matched donor. The stem cells engraft in their bone marrow and start to repopulate their body with new blood cells, which are now genetically identical to the donor. HCT has demonstrated the rare opportunity in cancer treatment to generate long-term remissions or cures. For example, patients with AML who receive HCT have a five-year post-transplant survival rate of up to 50%.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Approximately 7,350 allogeneic HCT procedures are performed yearly in the U.S. in patients with AML, MDS, or ALL. As a curative therapy for many heme malignancies, use of HCT has been steadily increasing over the last two decades, with increased use driven largely by increasing donor qualification, an increase in disease prevalence due to aging populations, and improved conditioning regimens permitting broader use in older and frailer patient segments. In addition, newer, more effective leukemia therapies continue to drive an increasing use of HCT in patients who previously failed to achieve proper remission prior to transplant. While the approval of CAR-T therapies has significantly impacted the treatment of B cell malignancies over the last decade, HCT in non-B cell malignancies is anticipated to remain the standard of care for patients. An example of the limitations associated with CAR-T therapy is the difficulty differentiating tumor from normal cells as seen with CD19-targeted CAR-T therapies. CD19 is a target highly expressed on the surface of tumor cells, as well as normal B cells, which are also eliminated by CD19 targeted CAR-T cells. While loss of B cells does not generally lead to serious complications, toxicity on other normal myeloid blood cell types such as neutrophils would cause a life-threatening complication called febrile neutropenia in which bacterial infections occur due to the loss of neutrophils. This is one reason why CAR-T therapies cannot be used in non-B cell heme malignancies such as myeloid leukemias and HCT remains the standard of care for those patients.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">However, despite the increasing use of HCT and the resulting clinical benefits or cures, approximately 40% of the patients who receive HCT relapse within two years, at which point there are limited treatment options, and the prognosis is very poor. Clinical observations have shown that if the T cells of the donor recognize certain miHAs in the patient&#8217;s leukemia cells, such as proteins that have single amino acid differences between the patient and the donor, the T cells of the donor drive a specific graft vs. leukemia, or GvL, effect, whereby the engrafted donor T cells detect remaining leukemia as foreign and eliminate the remaining disease. As a result,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patient often experiences a long-term remission from their cancer, or even a complete cure. If the miHAs are also expressed in non-hematopoietic tissues, the patient may develop graft vs. host disease, or GvHD, but if the miHAs are only expressed in blood cells, a specific GvL effect is observed without an increase in GvHD. Our heme malignancies program is focused on targeting miHAs that are exclusively expressed in hematopoietic cells in order to induce the GvL effect while potentially mitigating the risk of GvHD.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TSC-100</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TSC-100 is an allogeneic, donor derived TCR-T therapy product candidate directed at eliminating all native blood cells, including residual cancer cells, in HA-1-positive and HLA-A*02:01-positive patients with heme malignancies who undergo HCT using a donor who is either HA-1-negative or HLA-A*02:01-negative. We selected this product candidate based on its superior affinity, cytotoxic activity, and specificity compared to the other potential candidates. TSC-100 is designed to elicit an anti-tumor response in patients by targeting HA-1, which is present on malignant and normal blood cells of HA-1-positive patients but not on any of the new, donor-derived blood cells they receive from a donor who is either HA-1-negative or HLA-A*02:01-negative. We believe that donor T cells specifically engineered to express this TCR will generate an anti-tumor effect in patients, leading to a reduction in relapse rates and an increase in long-term survival.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HA-1 was one of the first miHAs to be discovered in a patient undergoing HCT. HA-1 is a peptide antigen derived from the protein ARHGAP45, which is an intracellular protein expressed at high levels in all blood cells but not in any other tissue. ARHGAP45 comes in two forms. In HA-1-positive individuals, the peptide has the sequence VL</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">H</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DDLLEA and, if the individual has the HLA type A*02:01, the antigen is efficiently displayed on the surface of blood cells. In HA-1-negative individuals, the peptide has the sequence VL</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DDLLEA, and the HA-1 antigen is not displayed. Approximately 60% of people have the VL</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">H</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DDLLEA sequence and approximately 42% of people in the U.S. have the HLA type A*02:01, which means that approximately 25% of individuals in the U.S. are HA-1-positive with the specific HLA type required for antigen expression. Studies of patients receiving HCT have shown that in cases where the T cells of an HA-1-negative donor naturally develop a response to HA-1 in an HA-1-positive patient, the T cells mediate a specific GvL effect, and the patient often experiences a long-term remission. TSC-100 is based on this clinical observation and is designed to specifically cause this GvL effect in patients receiving HCT.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing TSC-100 as a treatment for patients with cancer who are HA-1-positive and have been deemed eligible for HCT. For each patient, a healthy donor who is HA-1-negative or HLA-A*02:01-negative will be identified. Hematopoietic stem cells isolated from that donor will be used as the source of transplant material. In parallel, T cells isolated from the same donor will be genetically engineered to recognize HA-1. Once engraftment of donor stem cells is established in the patient, TSC-100 will be infused into the patient with the goal of eliciting a highly specific anti-tumor effect. The engineered donor T cells are designed to recognize and eliminate all of the patient&#8217;s native blood cells, including residual leukemia cells, which are HA-1-positive, thereby preventing relapse and potentially promoting complete cures. Because the patient&#8217;s new healthy blood cells are derived from the donor and are therefore either HA-1-negative or HLA-A*02:01-negative, we believe that TSC-100 should have minimal toxic side effects.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because people inherit two copies of every chromosome, one from their mother and one from their father, everyone has two copies of the ARHGAP45 gene. HA-1-positive patients can therefore be either homozygous for HA-1 (+/+), with both genes encoding the HA-1-positive peptide (VL</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">H</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DDLLEA), or heterozygous for HA-1 (+/-), with one gene encoding the HA-1-positive peptide and the other encoding the HA-1-negative peptide (VL</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DDLLEA). To ensure that TSC-100 can effectively eliminate healthy blood cells and leukemia cells that are either homozygous HA-1-positive (+/+) or heterozygous HA-1-positive (+/-), we assessed the activity of TSC-100 against blood cells derived from a variety of healthy donors and patients with AML and ALL.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TSC-101</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Like TSC-100, TSC-101 is an allogeneic, donor derived TCR-T therapy product candidate directed at eliminating residual cancer cells in HA-2-positive and HLA-A*02:01-positive patients with heme malignancies who undergo HCT using a donor who is either HA-2-negative or HLA-A*02:01-negative. HA-2, which is derived from the protein MYO1G, is another miHA that has been identified to be clinically relevant. In patients who naturally develop HA-2-specific T cells, a GvL effect has been observed and these patients experience long-term remissions. We are developing TSC-101 based on a highly active TCR we discovered that recognizes HA-2.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unlike HA-1, the HA-2 antigen is highly prevalent, with approximately 95% of individuals in the U.S. being HA-2-positive. However, as with HA-1, a specific HLA type, HLA-A*02:01, which is present in approximately 42% of individuals in the U.S., is required to display the HA-2 antigen on the cell surface for recognition by a T cell. As a result, approximately 40% of HCT patients would be positive for both HA-2 and HLA-A*02:01 and therefore be eligible for treatment with TSC-101 using a donor who is negative for HLA-A*02:01, regardless of whether the donor is HA-2-positive or HA-2-negative. Such donors are straightforward to identify and should be available to most patients who undergo half-matched, or haploidentical, transplantation using family members as donors, as</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patients typically have between two and three potential haploidentical donors. A summary of the treatment paradigm for TSC-101 is shown below.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patient Journey for TSC-101</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_6.jpg" alt="img181012247_6.jpg" style="width:649px;height:318px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TSC-102-A0301</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Like TSC-100 and TSC-101, TSC-102-A0301 is an allogeneic, donor derived TCR-T therapy product candidate directed at eliminating residual cancer cells in patients with heme malignancies who are HLA-A*03:01-positive undergoing HCT using a donor who is HLA-A*03:01-negative. CD45, which is derived from the protein PTPRC, is an antigen that has been identified to be clinically relevant. For example, radiolabeled CD45 is in clinical trials for relapsed AML, and a CAR-T product candidate targeting CD45 with epitope-edited HSCs is in pre-clinical development. We are developing TSC-102-A0301 based on a highly active TCR we discovered that recognizes a CD45 antigen presented on HLA-A*03:01. TSC-102-A0301 is currently in IND-enabling activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CD45 antigen is expressed on all nucleated cells of hematopoietic origin. As with TSC-100 and TSC-101, a specific HLA type, HLA-A*03:01, which is present in approximately 22% individuals in the U.S. is required to display the CD45 antigen on the cell surface for recognition by TSC-102-A0301. HLA-A*03:01 negative donors are straightforward to identify and should be available to most patients who undergo HLA half-matched, or haploidentical, transplantation using family members as donors. HLA-A*03:01 negative donors can also be mismatched unrelated donors readily identified through donor registries such as the National Marrow Donor Program. Having such donor options thus enables virtually all HLA-A*03:01 positive patients to potentially qualify for treatment with TSC-102-A0301.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Development Plan for Our Heme Malignancies Program</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Background on Types of HCT</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patients with acute leukemias who undergo allogeneic HCT have heterogeneous outcomes that are primarily related to two main variables: (i) the intensity or doses of the conditioning regimen they receive prior to the stem cell infusion and (ii) the type of donor who provides the stem cells.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">High-intensity conditioning regimens are called myeloablative conditioning and are associated with higher mortality rates. They are therefore reserved for young and relatively fit patients. Lower-intensity regimens are called reduced-intensity conditioning, or RIC, and are better tolerated, but are associated with higher relapse rates. Our heme malignancies TCR-T therapy product candidates are designed to substantially reduce relapse rates, and we are enrolling patients into our ongoing Phase 1 clinical trial who are eligible for RIC-based HCT with the goal of improving clinical outcomes for these patients.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are different types of donors who are eligible for allogeneic HCT procedures. Donors who are siblings of the patient and are perfectly matched for eight out of eight HLA alleles are considered the highest priority donor type for patients undergoing allogeneic HCT, but these types of donors are available for less than a third of patients. For most patients, the choice is between an unrelated donor who is perfectly matched for eight out of eight HLA alleles, referred to as a matched unrelated donor, or MUD, or a family member such as a sibling or child who has a half-match with the patient, referred to as a haploidentical donor, or haplo. Historically, haplo donor transplantation was associated with much higher GvHD than MUD transplants, but a recent treatment regimen that uses chemotherapy given three days after stem cell infusion called post-transplantation cyclophosphamide, or PTCy, specifically kills immune cells that cause GvHD. As a result, haplo transplants with PTCy have recently achieved equivalent outcomes as MUD transplants and are rapidly increasing in usage in the U.S. and worldwide.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The use of haplo greatly expands the donor pool for patients undergoing HCT and provides patients with the optionality to choose donors who are mismatched on specific HLA types, such as A*02:01, as opposed to being mismatched on certain minor antigens, such as HA-1 or HA-2. We are developing our product candidates with a specific focus on patients undergoing haplo donor transplantation with donors who are negative for either the miHA or the specific HLA type. We believe the engineered donor T cells will recognize any residual leukemia cells, which are target-positive, in the patient and prevent relapse with the potential to promote complete cures. Because the patient&#8217;s new healthy blood cells are derived from the donor and are therefore either target-negative or not able to express the target, we expect that these product candidates should have minimal toxic side effects.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 1 Clinical Trial</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The clinical studies for TSC-100 and TSC-101 are well underway, within a multi-arm, controlled, Phase 1, "umbrella" design clinical trial to investigate the safety and efficacy of TSC-100 and TSC-101 in patients with AML, MDS, and ALL that are undergoing HCT following RIC. We are currently treating patients at the third and final dose level.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Phase 1 clinical trial is designed to include measurements of early surrogate markers of efficacy, such as donor chimerism, or the percentage of blood cells that are donor-derived, and whether patients continue to have detectable residual leukemia, referred to as minimal residual disease, or MRD, in their post-transplant bone marrow biopsy, both of which are predictors of relapse. As shown in the graphic below, we are also including a control arm, comprising patients who do not meet the HLA or miHA genetic criteria and are treated with standard RIC haplo transplantation alone. Comparisons of both safety and efficacy outcomes with this control arm will potentially enable all patients treated with TSC-100 or TSC-101 to be included as part of the efficacy analysis for the initial Phase 1 trial prior to transitioning the program into a registrational trial towards a potential future biologics license application, or BLA, filing.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Multi-Arm Phase 1 Clinical Trial Design</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_7.jpg" alt="img181012247_7.jpg" style="width:720px;height:374px;"/></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical data</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2024 we reported updated results from the ongoing Phase 1 ALLOHA&#153; trial, which we presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition. At that time, 38 patients had been enrolled in the trial and undergone HCT, with 26 in the treatment arm and 12 in the control arm. The key endpoints in the trial are safety and efficacy, with exploratory endpoints of donor chimerism and MRD.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As shown below, event-free survival favored the treatment arm (HR=0.30; P=0.04) and early trends suggested a lower probability of relapse (HR=0.28; P=0.14).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_8.jpg" alt="img181012247_8.jpg" style="width:529px;height:320px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the latest data cut (December 2, 2024, shown below), 2 of 26 (8%) of treatment-arm patients relapsed compared to 4 of 12 (33%) control-arm patients. One treatment-arm relapse and subsequent mortality occurred in a very high-risk patient who was taken to transplant without first achieving complete remission, and the other was an extramedullary relapse in the patient's central nervous system with no evidence of systemic relapse. Median time to relapse was not evaluable in the treatment-arm versus 160 days in the control arm. Eight of 38 (21%) patients in the study had TP53 mutations, with 6 cases in the treatment-arm and 2 cases in the control arm. Of the 4 patients in the treatment arm with these mutations who received TCR-T cell infusions, none has relapsed, and one patient has now been relapse-free for 22 months. Of the two patients in the control arm with mutated TP53, both relapsed within 6 months of transplant and died shortly thereafter.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_9.jpg" alt="img181012247_9.jpg" style="width:657px;height:347px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TSC-100 and TSC-101 infusions were generally well-tolerated at all three dose levels with no dose-limiting toxicities. Observed adverse events were similar across the treatment and control arms and were generally consistent with post-HCT adverse events. TSC-100 and TSC-101 TCR-T cells were detected at all time points in all treated patients, including those who have been on study for over a year, with clear evidence of a dose-persistence relationship (shown below).</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_10.jpg" alt="img181012247_10.jpg" style="width:652px;height:338px;"/></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anticipated timeline</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have now successfully manufactured our product candidates and dosed patients in both treatment arms of the Phase 1 clinical trial. Patients have been enrolled up to the third dose level in both treatment arms with no dose limiting toxicities thus far, suggesting that the third dose level will likely become the recommended Phase 2 dose. We have opened expansion cohorts at dose level 3 to further characterize safety and evaluate translational and efficacy endpoints. We plan to continue development of TSC-101 only, as TSC-101 enables treatment of ~98% of patients with the HLA type A*02:01. We expect to initiate a registrational trial for TSC-101, pending further feedback from regulatory authorities, in the second half of 2025. We plan to present additional data from the Phase 1 trial by the end of the year, including two-year relapse data on the initial patients. We also plan to file an IND application for TSC-102-A0301, a TCR-T therapy product candidate targeting an HLA-A*03:01-restricted epitope on CD45, in the second half of 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Future market expansion opportunities</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If TSC-100 and TSC-101 demonstrate the ability to significantly reduce relapse rates after HCT, there could potentially be new opportunities to expand the curative potential of HCT combined with TSC products to greater numbers of patients. Currently, only about 7,350 patients with AML, MDS, or ALL undergo HCT per year in the U.S. out of approximately 35,000 patients diagnosed each year. There are two reasons for this relatively modest rate of transplant use. First, only patients who achieve a clinical complete remission (CR) are referred for HCT since the relapse rates of patients not in CR are considered too high to effectively use HCT. If HCT, combined with either TSC-100 or TSC-101, markedly reduces relapse rates, patients who do not achieve CR could possibly undergo HCT and benefit from its curative potential. This market expansion would require a separate clinical trial. Second, while RIC has enabled many more elderly and frail patients to undergo transplantation, the chemotherapy and radiation doses used for conditioning are still high and considered too toxic for most patients over the age of 65 or those with underlying comorbidities. This is because the conditioning regimen of HCT is considered the primary modality for eliminating residual leukemia cells and reducing doses further would result in greater relapse rates. If the relapse rates could be reduced by treatment with either TSC-100 or TSC-101 post HCT, however, a clinical trial could test the use of minimal intensity conditioning prior to HCT. If successful, this would further expand the curative potential of HCT combined with TSC-100 or TSC-101 therapy to older, frailer patients. We could also expand the addressable market through the addition of TCRs for other HLA types, of which TSC-102-A0301 is an example of this approach.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A final market expansion opportunity could occur from the use of either TSC-100 or TSC-101 as a chemotherapy and radiation-free conditioning regimen for non-malignant diseases such as sickle cell anemia which are currently treated with HCT. Since chemotherapy and radiation are associated with the risk of long-term toxicities such as cancer, heart damage, lung damage and infertility, cellular therapies such as TSC-100 or TSC-101 could reduce those risks and increase the numbers of patients willing to undergo HCT for non-malignant diseases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Solid Tumor Program</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing a portfolio of autologous TCR-T therapy product candidates designed to be used in combination with each other to treat and eliminate solid tumors. Our solid tumor product candidates are designed to elicit an anti-tumor response in patients by targeting cancer-specific antigens in their tumor cells. Our TCR-T therapy product candidates include: (i) well-recognized cancer targets that have demonstrated anti-tumor activity in clinical trials as well as novel targets that were identified by TargetScan from the T cells of patients responding to immunotherapy and (ii) naturally occurring TCRs specific to a patient&#8217;s HLA type that recognize these cancer-specific targets. Such targets are not only commonly shared among patients with the same cancer type, but also frequently expressed in multiple solid tumor types, enabling clinical development across multiple indications. Our seven solid tumor TCR-T therapy product candidates address known and novel targets, including HPV16 for TSC-200-A0201, MAGE-C2 for TSC-201-B0702, MAGE-A4 for TSC-202-A0201, PRAME for TSC-203-A0201, and MAGE-A1 for TSC-204-A0201, TSC-204-C0702, and TSC-204-A0101. To date, we have received FDA clearance for eight INDs for the treatment of solid tumors. These include a primary IND for the entire solid tumor program, which we refer to as T-Plex, which supports the simultaneous use of multiple TCRs to create customized multiplex TCR-T therapy product candidates based on target and HLA expression. The FDA has also cleared INDs for TSC-203-A0201 (PRAME, HLA-A*02:01); TSC-200-A0201 (HPV16, HLA-A*02:01); TSC-201-B0702 (MAGE-C2, HLA-B*07:02); TSC-202-A0201 (MAGE-A4, HLA-A*02:01); TSC-204-A0201 (MAGE-A1, HLA-A*02:01); TSC-204-C0702 (MAGE-A1, HLA-C*07:02); and TSC-204-A0101 (MAGE-A1, HLA-A*01:01). We plan to further expand the ImmunoBank by filing INDs for additional TCRs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have built the ImmunoBank, a repository of highly active TCRs, to enable multiplex TCR-T therapy. We are expanding the ImmunoBank with additional TCRs that recognize diverse targets and are associated with multiple HLA types to provide a broad array of therapeutic options for patients with various types of solid tumors. For patients with a solid tumor malignancy, we analyze their tumor to determine which targets are expressed at high levels in their cancer. We then access the ImmunoBank and select up to three TCRs that match their HLA type and address the most highly expressed targets in their tumor. We use this set of TCRs to genetically reprogram their T cells to recognize these targets and the resulting engineered T cells are infused back into the patient simultaneously as a multiplex TCR-T therapy.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We Are Building the ImmunoBank of TCRs to Enable Multiplex TCR-T Therapy</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_11.jpg" alt="img181012247_11.jpg" style="width:720px;height:310px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TCR-T Therapy Product Candidates for the Treatment of Solid Tumors</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Immunotherapy has reshaped the treatment of solid tumors by demonstrating that tumor shrinkage, eradication, and long-term durable responses can be obtained by stimulating the patient&#8217;s own immune system to attack their cancer cells. Immune checkpoint inhibitors, such as nivolumab or pembrolizumab, work by unleashing anti-cancer T cells that are already present in a patient&#8217;s tumor, enabling those T cells to recognize and eliminate their cancer. For patients who respond to checkpoint inhibitors, these agents have been shown to be very effective. However, only a subset of patients responds to checkpoint inhibitors, highlighting the need for T cell-based therapies that can treat those patients who do not respond. Despite their efficacy in only a subset of patients, checkpoint inhibitors have annual sales of about $25 billion in the U.S.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One reason why patients do not respond to current immunotherapy treatments is that they lack T cells with highly active TCRs that recognize cancer-specific antigens in their tumors. By reprogramming the patient&#8217;s own T cells to recognize these targets, we believe that we can expand the dramatic responses observed with checkpoint inhibitor therapy to the patients for whom these therapies are ineffective.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Solution</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our solid tumor program is designed to overcome key solid tumor resistance mechanisms of target loss and HLA loss. Solid tumors are notoriously heterogeneous, with a solid tumor often expressing more than one target antigen. We believe that by targeting multiple antigens expressed on in-tact HLAs, we will be able to drive deep and durable responses. We continue to prioritize expanding the ImmunoBank with TCRs across different targets and HLA types to potentially enable customized multiplex TCR-T therapy.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Solid Tumor Product Candidates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our seven clinical-stage solid tumor TCR-T therapy product candidates address known and novel targets, including E7 of HPV16 for TSC-200-A0201, MAGE-C2 for TSC-201-B0702, MAGE-A4 for TSC-202-A0201, PRAME for TSC-203-A0201, and MAGE-A1 for TSC-204-A0201, TSC-204-C0702, and TSC-204-A0101. All of these targets are frequently expressed in the solid tumors of interest to us, including NSCLC, sarcoma, head and neck cancer, cervical cancer, and anal and genital cancer. In 2024, it is estimated that in the U.S., approximately 190,000 patients were diagnosed with NSCLC, 14,000 with sarcoma, 58,000 with head and neck cancer, 14,000 with cervical cancer, and 28,000 with anal and genital cancer. We have advanced a combination of known and novel targets into clinical development, which is allowing us to use the product candidates targeting known antigens as backbones for our initial clinical trials evaluating multiplex TCR-T therapy. For example, we plan to evaluate TSC-203-A0201, which targets PRAME, a well-known and clinically validated tumor-specific protein, in combination with TSC-201-B0702 targeting MAGE-C2.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TSC-200 (HPV16)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing the TSC-200 series of product candidates as TCR-Ts targeting human papilloma virus, or HPV. Over 25% of head and neck cancers are caused by HPV infection, including up to 70% of oropharangeal cancers. HPV antigens are a particularly compelling set of targets as HPV proteins drive tumorigenesis in these cancers, which means that these proteins are (1) present in every tumor cell in an HPV-positive tumor and (2) essential to the survival of the tumor cell. In addition to head and neck cancers, HPV is found in more than 90% of cervical, anal and genital cancers. Phase 1 clinical data from the National Cancer Institute showed tumor regression with objective clinical responses in 50% of patients with metastatic HPV-positive cancers who were treated with a TCR-T therapy candidate targeting E7 of HPV16, which we believe provides clinical support for the inclusion of an HPV16-targeting TCR-T, TSC-200-A0201, in our multiplex TCR-T treatment strategy. We have advanced TSC-200-A0201 (HPV16, HLA-A*02:01) into Phase 1 development. We also intend to extend our discovery efforts to include additional HPV16-derived antigens presented on other HLA types as the program advances, such as TSC-200-C0702 (HPV16, HLA-C*07:02), currently in discovery.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TSC-201 (MAGE-C2)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing the TSC-201 series of TCR-T therapy product candidates as TCR-Ts targeting melanoma-associated antigen C2, or MAGE-C2. We initially identified MAGE-C2 as the target of T cells from a melanoma patient responding to TIL therapy. MAGE-C2 is a cancer testis antigen, or CTA, that is exclusively expressed in testis and is not expressed in normal adult tissues. The testis is an immune-privileged tissue and, as a result, we believe that targeting MAGE-C2 should not pose a significant safety concern. In addition, MAGE-C2, which contributes to tumorigenesis by suppressing the cellular mechanisms responsible for controlling cell division, is selectively expressed across multiple different types of tumors, including approximately 25% of head and neck cancers, and approximately 50% of non-small cell lung cancers. Tumors expressing MAGE-C2 have been shown to be associated with metastasis and poor patient survival. We are currently advancing three MAGE-C2 TCRs: TSC-201-B0702 (MAGE-C2, HLA-B*07:02), currently in Phase 1 development; TSC-201-A0201 (MAGE-C2, HLA-A*02:01), currently in discovery; and TSC-201-A2402 (MAGE-C2, HLA-A*24:02), currently in discovery. We are also using ReceptorScan to identify additional TCRs for MAGE-C2 epitopes presented on other HLA alleles to further expand the ImmunoBank and increase the addressable patient population.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TSC-202 (MAGE-A4)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing the TSC-202 series of TCR-T therapy product candidates as TCR-Ts targeting melanoma-associated antigen 4, or MAGE-A4. MAGE-A4 is a clinically established CTA that contributes to tumorigenesis by interfering with cell cycle arrest. MAGE-A4 is expressed in 33% of cervical cancers enabling multiplexing with TSC-200, and MAGE-A4 is expressed in 50% of non-small cell lung cancers, 40% of head and neck cancers, and 20-70% of sarcomas depending on sub-type. We have advanced one MAGE-A4 TCR-T therapy product candidate, TSC-202-A0201, into Phase 1 development.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TSC-203 (PRAME)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing the TSC-203 series of TCR-T therapy product candidates as TCR-Ts targeting Preferentially Expressed Antigen in Melanoma, or PRAME. Like MAGE-C2, PRAME contributes to tumorigenesis by suppressing cellular signals that control cell division, and higher expression levels of PRAME in tumors correlate with increased metastasis and poor patient outcomes. PRAME is a CTA that, like MAGE-C2 and MAGE-A4, is absent in adult tissues except in the ovaries and testis. Approximately 50% of NSCLCs, approximately 25% of cervical cancers, approximately 90% of head and neck cancers, and approximately 10-90% of sarcomas (depending on sub-type) express PRAME. Notably, sarcoma subtypes that highly express PRAME also highly express MAGE-A4, making this an attractive indication for multiplex therapy. We are currently advancing three PRAME TCR-T therapy product candidates: TSC-203-A0201 (PRAME, HLA-A*02:01), currently in Phase 1 development; TSC-203-B0702 (PRAME, HLA-B*07:02), currently in lead optimization; and TSC-203-A2402 (PRAME, HLA-A*24:02) currently in discovery.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TSC-204 (MAGE-A1)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing the TSC-204 series of TCR-T therapy product candidates as TCR-Ts targeting melanoma-associated antigen 1, or MAGE-A1. MAGE-A1 is a cancer/testis gene frequently overexpressed in a wide variety of solid tumors, including approximately 45% of head and neck cancers, 50% of cervical cancers and 50% of NSCLC. Using our TargetScan platform, we initially identified MAGE-A1 as one of the targets of expanded T cells from a head and neck cancer patient responding to checkpoint inhibitor therapy. Multiple different TCRs from this patient recognize a novel HLA-C*07:02-restricted epitope of MAGE-A1, and one of these TCRs is the basis of TSC-204-C0702 (MAGE-A1, HLA-C*07:02), currently in Phase 1 development. In addition to this TCR-T therapy product candidate, we further expanded the TSC-204 series by using ReceptorScan to identify additional TCRs for MAGE-A1 epitopes presented on several other common HLA alleles to further expand the addressable patient population. We are currently advancing five MAGE-A1 TCR-T therapy product candidates: TSC-204-A0201 (MAGE-A1, HLA-A*02:01), currently in Phase 1 development; TSC-204-C0702 (MAGE-A1, HLA-C*07:02), currently in Phase 1 development; TSC-204-A0101 (MAGE-A1, HLA-A*01:01) currently in Phase 1 development; TSC-204-A0301 (MAGE-A1, HLA-A*03:01) currently in discovery; and TSC-204-B0702 (MAGE-A1, HLA-B*07:02) currently in discovery.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are continuing to leverage our platform technologies to expand patient eligibility for multiplex TCR-T therapy. We plan to expand the ImmunoBank to address different HLA types to enable customized multiplex TCR-T therapy product candidates while also addressing the potential issue of HLA loss leading to resistance for a wide range of solid tumor patients.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Development Plan for Our Solid Tumor Program</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the initial first-in-human studies for our solid tumor TCR-T therapy product candidates, we are evaluating multiple TCRs in parallel to determine the safety and preliminary efficacy of multiplex TCR-T therapy. The FDA has cleared our IND application for T-Plex, which serves as the primary IND application for our solid tumor program, enabling customized simultaneous administration of TCR-T therapy product candidates to be administered to patients based on the targets and HLAs expressed in their tumors. Specific TCRs for each patient are chosen from the ImmunoBank consisting of high affinity, naturally occurring TCRs that recognize a variety of prevalent cancer-specific targets and are associated with common HLA types. Each unique TCR-T therapy product candidate has been or will be filed as a secondary IND application and will reference the primary T-Plex IND application.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the T-Plex IND application, the FDA has cleared secondary IND applications for seven TCR-T therapy product candidates: TSC-203-A0201 (PRAME, HLA-A*02:01); TSC-200-A0201 (HPV16, HLA-A*02:01); TSC-201-B0702 (MAGE-C2, HLA-B*07:02); TSC-202-A0201 (MAGE-A4, HLA-A*02:01); TSC-204-A0201 (MAGE-A1, HLA-A*02:01); TSC-204-C0702 (MAGE-A1, HLA-C*07:02); and TSC-204-A0101 (MAGE-A1, HLA-A*01:01). We have initiated a multicenter Phase 1 clinical trial to evaluate the safety, preliminary efficacy, and feasibility of repeat dosing of multiplex TCR-T therapy. We are enrolling patients with NSCLC, sarcoma, head and neck cancer, cervical cancer, and anal and genital cancer. We expect that many of the clinical trial sites enrolling patients in our heme malignancies program are planning to join our solid tumor Phase 1 study. We are currently enrolling and treating patients in this study.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After establishing single agent safety for each of our initial solid tumor TCR-T therapy product candidates in a multi-arm Phase 1 clinical trial, we plan to test our solid tumor TCR-T therapy product candidates in combination with other TCR-T therapy product candidates in the ImmunoBank in patients who are positive for the respective targets of these therapies. We will explore up to three-TCR simultaneous administrations in patients who are positive for the respective targets. A summary of our planned Phase 1 clinical strategy is shown below.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dose Escalation Scheme Provides a Rapid Path to Multiplex TCR-T Therapy in Phase 1</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_12.jpg" alt="img181012247_12.jpg" style="width:720px;height:340px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anticipated timeline</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we advance our solid tumor program, we anticipate submitting IND filings for additional TCRs. We believe this trial will serve as the first step towards our long-term goal of expanding the ImmunoBank to provide customized multiplex TCR-T therapy product candidates for virtually any patient with a solid tumor malignancy. We have successfully manufactured product candidates and infused patients with singleplex therapy and expect to dose our first multiplex patient in the first half of 2025. We plan to report safety and response data for multiplex therapy in the second half of 2025.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ImmunoBank &#8211; Flexible Content for Diverse Platforms</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current clinical development strategy is based on autologous T cell engineering. As the field of T cell engineering evolves, a wide variety of additional manufacturing platforms are being developed that may further improve TCR-T products. For example, companies such as Lyell Immunopharma, Inc. are developing methods to enhance autologous T cell engineering to provide improved duration of efficacy, while companies such as Allogene Therapeutics, Inc. are developing ways to engineer allogeneic T cells and companies such as Umoja Biopharma, Inc. are developing ways to engineer T cells </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All of these engineering platforms require validated &#8220;content&#8221; &#8211; TCRs that recognize tumor-specific antigens on cancer cells without recognizing problematic off-targets. As we advance the ImmunoBank of TCRs through clinical development, we intend to continue to optimize our own manufacturing platform, in preparation for potential commercial manufacturing. Ultimately, we aspire to build the largest collection of validated TCR &#8220;content&#8221; that can be used with a variety of T cell engineering platforms.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Expansion Opportunities Beyond Oncology</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our primary focus is on the development of T cell therapies to treat cancer. However, T cells play a fundamental role in many other disease areas, such as infectious disease and autoimmune disorders. We believe that our TargetScan technology is well suited to discover novel antigens for the development of therapeutics, diagnostics, and vaccines in these other areas. We intend to build additional corporate value by opportunistically pursuing collaborations with strategic partners for applications of our platform technologies outside our core focus.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Diseases</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TargetScan can also be used for novel target discovery in additional infectious diseases and autoimmune disorders. For example, infections such as tuberculosis, influenza, and HIV have been shown to be T cell-mediated and are associated with high mortality rates. In addition, many autoimmune disorders such as rheumatoid arthritis, psoriasis, and scleroderma are largely T cell-mediated, but with poorly defined instigating self-antigens. Our TargetScan technology, which provides an unbiased, genome-wide method to discover the natural targets of disease-relevant T cells, is well positioned to identify these self-antigens. We believe the discovery of these targets could enable the development of novel, more targeted therapeutic approaches to treat these diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Platform</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our proprietary platform is designed to: (i) discover anti-cancer TCRs from patients with exceptional responses to immunotherapy; (ii) determine novel targets of clinically relevant TCRs; (iii) discover novel TCRs that recognize clinically validated targets; (iv) identify off-target interactions of TCRs to eliminate candidates that could potentially pose a safety risk; and (v) manufacture TCR-T therapy product candidates efficiently and consistently without the use of viral vectors using our T-Integrate technology. The central elements of our platform that we believe differentiate us from other cell therapy companies are TargetScan, ReceptorScan, SafetyScan, the ImmunoBank, and T-Integrate.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img181012247_13.jpg" alt="img181012247_13.jpg" style="width:430px;height:285px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TargetScan. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the core of our proprietary platform is TargetScan, which enables us to identify natural targets of TCRs using an</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unbiased, genome-wide, high-throughput screen. We have developed this technology to be extremely versatile and applicable across multiple therapeutic areas, including cancer, autoimmune disorders, and infectious diseases. It can be applied to virtually any TCR that plays a role in the cause or prevention of disease. Using TargetScan, we have identified approximately 200 novel antigens as targets of tumor infiltrating T cells from patients who are actively responding to immunotherapy. We believe this provides us with a competitive advantage, because not only are we among the first to identify these targets as tumor-specific antigens, but we have also already identified highly active TCRs that recognize these targets. Two of our pipeline programs emerged from TargetScan: TSC-201-B0702 (MAGE-C2, HLA-B*07:02) and TSC-204-C0702 (MAGE-A1, HLA-C*07:02), the latter of which was featured in the peer-reviewed journal </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cell</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ReceptorScan. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To further expand our ability to discover and develop therapeutic TCRs, we have developed our proprietary ReceptorScan technology</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to enable us to identify and clone highly active TCRs that recognize known or clinically validated targets. We co-culture hundreds of millions of CD8+ T cells from either healthy donors or cancer patients with dendritic cells, also referred to as antigen-presenting cells, that display the target antigen of interest to the T cells. T cells that recognize the target of interest proliferate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and are subsequently isolated based on their ability to recognize a fluorescently labeled version of the target. We then use single cell sequencing to identify the specific TCR sequences that recognize the target. Our novel technologies allow us to gene-synthesize hundreds of TCRs simultaneously and to rapidly sort through hundreds of target-specific TCRs in a single high-throughput screen to identify the most active clones. Using ReceptorScan, we have identified our two lead TCR-T therapy product candidates, TSC-100 targeting HA-1 and TSC-101 targeting HA-2, as well as several other pipeline programs, including TSC-203-A0201 (PRAME, HLA-A*02:01), TSC-200-A0201 (HPV16, HLA-A*02:01), TSC-204-A0201 (MAGE-A1, HLA-A*02:01), TSC-204-A0101 (MAGE-A1, HLA-A*01:01), and TSC-202-A0201 (MAGE-A4, HLA-A*02:01).</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">SafetyScan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. SafetyScan is designed to identify potential off-target interactions of a given TCR and eliminate those TCR candidates that cross-react with proteins expressed at high levels in normal tissue. We believe this will allow us to reduce the risk and enhance the potential safety profile of our TCR-T therapy product candidates early in development before we initiate clinical trials.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ImmunoBank.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We are expanding the ImmunoBank, our diverse repository of therapeutic TCRs, to allow for</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">multiplex TCR-T therapy, which has the potential to address the heterogeneous nature of solid tumors and address resistance developing due to loss of a single HLA haplotype. We believe this approach may allow us to overcome the limitations and challenges of TCR-T development to date. We continue to prioritize expanding the ImmunoBank with TCRs for additional targets as well as multiple HLA types for each target, thus helping us overcome the key solid tumor resistance mechanisms of target loss and HLA loss. Finally, we are expanding the ImmunoBank to have the flexibility to be used with new and optimized methods of T cell engineering that we may</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">develop over time. We have built the ImmunoBank to be compatible with autologous, allogeneic, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> engineering technologies in order to potentially transition to generating off-the-shelf products for direct, customized administration to patients.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">T-Integrate. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing cell therapies is highly complex, and associated challenges have led to significant delays or failures in the development of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">many cell therapies. To enable the rapid, cost-effective, and consistent manufacturing of TCR-T therapy product candidates, we have developed a non-viral vector delivery system that we refer to as T-Integrate. Our TCR-T therapy product candidates are manufactured using a transposon/transposase system, in which the DNA encoding the TCR is manufactured as a Nanoplasmid&#153;, a non-viral vector. The Nanoplasmid, together with an mRNA sequence encoding a transposase enzyme, is introduced into the T cell by electroporation. After the T cell translates the mRNA into protein, the transposase enzyme inserts the TCR sequence from the Nanoplasmid, as well as any enhancements such as CD8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">b</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and DN-TGF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">b</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RII, into the genome of the T cell. This system is highly reproducible, as the only required components are a Nanoplasmid, which is different for each TCR product, and an mRNA, which is constant for all TCR products. Unlike lentivirus, both components are routinely manufactured in a cost-effective manner without the need for extensive process development.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a 51,100 square-foot GMP manufacturing facility (consisting of GMP clean room suites, laboratories, warehouse and office space) to manufacture clinical supply for our TCR-T therapy product candidates. Our manufacturing platform has enabled us to efficiently develop and manufacture many different TCR-T therapy product candidates, allowing us to deliver customized multiplex therapy to patients with cancer. We have successfully manufactured product candidates and have dosed patients in both our heme malignancies and solid tumor Phase 1 programs. The FDA has cleared eight IND applications for our solid tumor program, including our primary IND application T-Plex, which supports the use of multiple TCR-T therapy product candidates to create customized multiplex TCR-T therapy, as well as IND applications for TSC-200-A0201 (HPV16, HLA-A*02:01), TSC-201-B0702 (MAGE-C2, HLA-B*07:02), TSC-202 (MAGE-A4, HLA-A*02:01), TSC-203-A0201 (PRAME, HLA-A*02:01), TSC-204-A0201 (MAGE-A1, HLA-A*02:01), TSC-204-C0702 (MAGE-A1, HLA-C*07:02), and TSC-204-A0101 (MAGE-A1, HLA-A*01:01), demonstrating our manufacturing capabilities. To further increase our clinical manufacturing capacity and prepare for potential commercialization, we have engaged a global contract development and manufacturing organization, or CDMO, with worldwide commercial capabilities to support both the heme and solid tumor programs. The CDMO is on track to support clinical manufacturing of the heme program in the second half of 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">License and Collaboration Agreements</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Collaboration Agreement with Amgen</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 8, 2023, we entered into a Research Collaboration and License Agreement with Amgen Inc. (Amgen), or the Amgen Agreement, to identify antigens recognized by T cells in patients with Crohn&#8217;s disease utilizing our proprietary target discovery platform, or TargetScan. Under the terms of the Amgen Agreement, Amgen will then evaluate a variety of modalities to create therapeutics based on targets discovered by TScan and will retain all global development and commercialization rights. Amgen made an upfront payment of $30.0 million to us, and we are eligible to earn success-based milestone payments of over $500 million based upon the achievement of certain development and commercial milestones, as well as tiered single-digit royalty payments on net sales of products developed from the collaboration, subject to reductions set forth in the Amgen Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exclusive Patent License Agreement with BWH</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 5, 2018, we entered into an Exclusive Patent License Agreement with The Brigham and Women&#8217;s Hospital, Inc., or BWH, as amended on July 26, 2019 and further amended and restated on April 20, 2021, or, collectively, the BWH Agreement, pursuant to which we obtained an exclusive, sublicensable, worldwide license to practice under certain of BWH&#8217;s patent rights for identifying T cell epitopes, which are relevant to our TargetScan technology for identifying potential therapeutic products. The original 2018 BWH Agreement granted us the right to practice BWH&#8217;s patent rights in a certain field of use, MHC Class I License Field. In connection with the amendment and restatement of the BWH Agreement in 2021, we expanded the field of use in which we are authorized to practice BWH&#8217;s patent rights to include MHC Class II uses and applications in exchange for certain additional payments to BWH. We are obligated to use commercially reasonable efforts to develop and commercialize at least one product or process that practices the licensed patent rights and at least one therapeutic or diagnostic product or process directed to an epitope identified through practicing the licensed patent rights.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon execution of the amendment of the BWH Agreement dated April 20, 2021, we paid an additional one-time fee of $466,500. We are required to pay BWH up to an aggregate of $12.72 million upon the achievement of certain clinical, regulatory and sales milestones for therapeutic products and processes. We are obligated to pay a low double-digit percentage of all non-royalty income we receive under sublicenses of BWH&#8217;s patent rights. We are also obligated to pay a low single-digit percentage of all non-royalty income we receive under agreements with third parties, or Collaborators, where we practice under BWH&#8217;s patent rights in connection with the research or development of one or more therapeutic products or processes with or for such third party, or Collaboration Agreements. We are also obligated to pay tiered royalties in the high single-digit percentage range on annual net sales of products and processes that practice the licensed patent rights and in the low single-digit percentage range on annual net sales of therapeutic and diagnostic products and processes directed to an epitope identified through practicing the licensed patent rights (other than those sold by Collaborators), with the royalty percentage for such products and processes decreasing to lower than one-percent royalties if directed to epitopes identified through practicing the licensed patent rights after December 31, 2019. For therapeutic and diagnostic products and processes directed to an epitope identified through practicing the licensed patent rights and sold by a Collaborator, we are obligated to pay lower than one-percent royalties of the Collaborator&#8217;s annual net sales of such products and processes. For products and processes sold by us, our affiliates or sublicensees, such royalties only apply to products and processes directed to epitopes in a defined field of use MHC Class I field identified prior to December 31, 2022, and products and processes based on epitopes in the MHC Class II field identified prior to September 30, 2023. For products or processes directed to epitopes identified under a Collaboration Agreement, such royalties apply regardless of when the epitopes were identified. For each applicable product or process, the royalty term continues until the tenth (10</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) anniversary of the first commercial sale of such product or process. The royalty rates are also subject to reduction upon certain other events. Within 60 days of each anniversary of December 5</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, we are obligated to pay BWH a non-refundable, mid-five-figure minimum annual royalty, which amount is creditable against royalties subsequently due on net sales of products and processes in such calendar year.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The BWH Agreement will terminate upon the later of (a) the last to expire or abandoned valid claim within the licensed patents, and (b) one year after the last sale for which a royalty is due. The current expected expiration date for the last-to-expire licensed patent right is June 8, 2038 (absent any adjustments or extensions of term). We also have the right to terminate the BWH Agreement in its entirety or on a country-by-country basis, for any reason upon 90 days&#8217; prior written notice to BWH. BWH may terminate the BWH Agreement: (i) without notice if we fail to maintain insurance required by the BWH Agreement; (ii) upon notice within 60 days of our bankruptcy; (iii) upon notice within 60 days after notice by BWH of our default in the performance of any obligation under the BWH Agreement that is not cured within such 60-day period; (iv) if we fail to make any payments due under the BWH Agreement and do not cure such failure within 10 days after receiving BWH notice thereof; or (v) if we or any of our affiliates challenge the validity, enforceability or scope of any of the patent rights licensed to us under the BWH Agreement.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Non-Exclusive License Agreement with Provincial Health Services Authority</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 15, 2020, we entered into a Non-Exclusive License Agreement with the Provincial Health Services Authority of British Columbia, or PHSA, and such agreement, the PHSA Agreement. Pursuant to the PHSA Agreement, we obtained a non-exclusive, perpetual, non-transferable, sublicensable, worldwide license to practice certain of PHSA&#8217;s patent rights for identifying T cell epitopes, which epitopes are relevant to our platform for identifying potential TCR-T therapy product candidates. Any sublicenses we grant to PHSA&#8217;s patent rights must also include a license of our own intellectual property; we are not permitted to sublicense PHSA&#8217;s rights on a standalone basis.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the PHSA Agreement, we paid PHSA a one-time, non-refundable upfront fee of $500,000 as well as reimbursement for previously incurred patent prosecution costs of approximately $50,000. Starting on the first anniversary of the effective date of the PHSA Agreement and continuing for five years thereafter, we are required to pay PHSA a mid-five-figure annual license fee, of which the first installment has been paid. In addition, we are obligated to pay a mid-six-figure fee for each sublicense and each further sublicense granted by one of our sublicensees or a sublicensee of our sublicensee (through multiple tiers) of the rights granted to us under the PHSA Agreement.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PHSA Agreement will terminate upon the last to expire patent licensed under the PHSA Agreement. We also have the right to terminate the PHSA Agreement at any time, but such termination will not be effective until the later of (a) October 16, 2023, and (b) the date we have paid PHSA total aggregate fees equal to the upfront fee plus five years of annual license fees totaling $750,000. PHSA may terminate the PHSA Agreement upon giving us two separate written notices at least 30 days apart if: (i) we or any of our affiliates challenge the validity, enforceability or scope of any of the patents licensed to us under the PHSA Agreement; (ii) we owe unpaid fees due under the PHSA Agreement in excess of $100,000; or (iii) we breach material terms of the PHSA Agreement regarding sublicense restrictions (such as failing to pay the sublicense fee or sublicensing PHSA technology on a standalone basis) or our obligation to indemnify PHSA for damages resulting from our research or commercialization of PHSA&#8217;s patent rights and, in each case described above, such termination will be effective only if we fail to cure such breach after receiving PHSA&#8217;s two separate notices.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Royalty Agreement</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with our incorporation in April 2018, we entered into a royalty agreement with one of our founders. We amended and restated this royalty agreement in June 2018, and our founder assigned his rights and obligations under the royalty agreement to one of his affiliated entities in January 2021. Pursuant to the royalty agreement, we are required to pay him a royalty of 1% of net sales (as defined in the royalty agreement) of any product sold by us or by any of our direct or indirect licensees for use in the treatment of any disease or disorder covered by a pending patent application or issued patent held or controlled by us as of the last date that the founder was providing services to us as a director or consultant under a written agreement. Royalties are payable with respect to each applicable product on a country-by-country and product-by-product basis, beginning on the first commercial sale of the first royalty-bearing product and ending on the later of (i) the date on which the exploitation of such royalty-bearing product is no longer covered by such patent in such country or (ii) the 15th anniversary of the first commercial sale of the first royalty-bearing product in such country. We may not assign our rights and obligations under the royalty agreement except in the event of a change in control relating to our company. The term of the royalty agreement continues until expiration of the last applicable royalty term.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have built in-house cell therapy manufacturing capabilities as one of the key components of our platform. The manufacturing of cell therapies requires the integration of several distinct components. Primary human blood cells are the source of T cells, along with a vector that delivers the desired genetic elements into these T cells. As a more operationally flexible and cost-efficient alternative to lentivirus, we have developed a manufacturing platform to genetically engineer T cells using a transposon/transposase system, which we refer to as T-Integrate.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have designed our programs to use a transposon vector and corresponding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectively inserts our TCRs and other exogenous genes, such as CD8, at random locations in the genome. The transposon is delivered as a Nanoplasmid&#153; and has no antibiotic selection element, reducing the risk of inadvertent transmission of antibiotic resistance into T cells. The transposase is delivered as mRNA. mRNA is transiently expressed in the cell, reducing exposure of cells to prolonged transposase activity, which could result in multiple transposition events where the transposon would be moved around the genome.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have developed a manufacturing process currently producing product for clinical studies, using industry standard equipment and instrumentation. The equipment and instrumentation used in our manufacturing facility allows for functionally closed processes in a small footprint. For clinical product manufacturing, we use single-use bag and tubing kits, supplies, and process reagents that are available from well-established vendors who specialize in supplying clinical grade reagents for the cell and gene therapy industry. Our TCR-T therapy product candidates are released and characterized using well-developed analytical methods. The final product used in clinical studies is cryopreserved, simplifying logistics and reducing risk of delivery failures to support patient dosing. We have controls and safeguards throughout the entire process to ensure product identity, integrity, sterility, and chain of custody. A clearly defined and documented manufacturing process, performed by trained operators using specialized instrumentation in an appropriately designed, commissioned, and operated manufacturing facility is critical for the manufacturing of safe, effective, and well-characterized cell therapies.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cell product manufacturing facility in Waltham, MA has been designed and built to support multiple programs through Phase 1 and Phase 2 clinical development, with a projected capacity to support up to 250 TCR-T components per year. We believe internalizing our manufacturing process and product testing enables us to better control this key aspect of clinical development and reduces the risk of program delay due to third-party reliance. We continue to refine our manufacturing process to ensure it is commercially viable with focus on cost, consistency, and manufacturing success rate. We have engaged a CDMO with global capabilities to support increased capacity and potential commercial manufacturing. The CDMO is on track to support clinical manufacturing of the heme program in the second half of 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe our novel and proprietary platform technologies, TargetScan, SafetyScan, and ReceptorScan, and our in-house cell therapy expertise constitute a meaningful competitive advantage in successfully developing novel and highly safe and effective treatments for cancer. However, the biopharmaceutical industry in general, and the cell therapy field in particular, is characterized by rapidly advancing and changing technologies, intense competition, and a strong emphasis on intellectual property. We face substantial and increasing competition from many different sources, including large and specialty biopharmaceutical companies, academic research institutions, governmental agencies, and public and private research institutions. Competitors may compete with us in hiring scientific and management personnel, establishing clinical study sites, recruiting patients to participate in clinical trials, and acquiring technologies complementary to, or necessary for, our programs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face competition from segments of the pharmaceutical, biotechnology and other related markets that pursue the development of TCR-based or cell-based therapies for the treatment of cancer. We expect to compete with a number of other TCR-based companies, utilizing both cell therapy and other therapeutic modalities, such as Immatics N.V., Adaptimmune Therapeutics, Plc., Affini-T Therapeutics, Inc., Medigene AG, T-Knife GmbH, Enara Bio Ltd., Immunocore Holdings, Plc., and 3T Biosciences Inc. We may also face competition from companies focused on other T cell therapies (e.g., TIL, CAR-T, gammadelta T cells) such as Iovance Biotherapeutics, Inc., Instil Bio, Inc., Achilles Therapeutics plc, Kite Pharma, Inc., a subsidiary of Gilead, Inc. (including Yescarta, which is approved for the treatment for large B cell lymphoma or follicular lymphoma, two types of non-Hodgkin lymphoma), Juno Therapeutics, Inc., a subsidiary of Bristol-Myers Squibb, Inc., Regeneron Pharmaceuticals, Inc., through their acquisition of 2seventy Bio, Inc.&#8217;s research pipeline, AstraZeneca plc, through their acquisition of Gracell Biotechnologies, Inc., Legend Biotech Corporation, Autolus Therapeutics plc, Sana Biotechnology, Inc., Lyell Immunopharma, Inc., Allogene Therapeutics, Inc., Century Therapeutics, Inc., and Adicet Bio, Inc. There are also companies utilizing other cell-based approaches that may be competitive to our product candidates. For example, companies such as Takeda Pharmaceutical Company, Ltd., Celyad, S.A., ImmunityBio, Inc., Celularity, Inc., Fate Therapeutics, Inc., and Nkarta, Inc. are developing therapies that target and/or engineer natural killer, or NK, cells. In addition, for our lead programs, TSC-100 and TSC-101, we may face competition from BlueSphere Bio, VOR Biopharma, Inc., IN8bio, Inc., Orca Biosystems, Inc., and Marker Therapeutics, Inc., who are also developing cell therapies in the post-HCT setting. The named companies are not fully inclusive of all possible competitive threats.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, we also face competition more broadly across the oncology market for cost-effective and reimbursable cancer treatments. The most common methods of treating patients with cancer are surgery, radiation, and drug therapy, including chemotherapy, hormone therapy, biologic therapy, such as monoclonal and bispecific antibodies, immunotherapy, cell-based therapy, and targeted therapy, or a combination of any such treatments. There are a variety of available drug therapies marketed for cancer. In many cases, these drugs are administered in combination to enhance efficacy. While our TCR-T therapy product candidates, if any are approved, may compete with these existing drugs and other therapies, to the extent they are ultimately used in combination with or as an adjunct to these therapies, our TCR-T therapy product candidates may not be competitive with them. Some of these drugs are branded and subject to patent protection, and others are available on a generic basis. As a result, obtaining market acceptance of, and gaining a significant share of the market for, and commanding a certain price for any of our TCR-T therapy product candidates that we successfully introduce to the market may pose challenges. In addition, many companies are developing new oncology therapeutics, and we cannot predict what the standard of care will be as our product candidates progress through clinical development.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We could see a reduction or elimination in our commercial opportunity if our competitors develop and commercialize drugs that are safer, more effective, have fewer or less severe side effects, are more convenient to administer, are less expensive, are more accessible, or receive a more favorable label than our TCR-T therapy product candidates. Our competitors also may obtain FDA or other regulatory approval for their drugs more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. The key competitive factors affecting the success of all of our TCR-T therapy product candidates, if approved, are likely to be their efficacy, safety, convenience, accessibility, price, and the availability of reimbursement from government and other third-party payors.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends in part on our ability to obtain, maintain and protect our proprietary technology and intellectual property and proprietary rights and to operate our business without infringing, misappropriating and otherwise violating the intellectual property and proprietary rights of third parties. We rely on a combination of patent applications, trademarks, trade secrets, and other intellectual property rights and measures to protect the intellectual property rights that we consider important to our business. We also rely on know-how and continuing technological innovation to develop and maintain our competitive position. We also seek to protect our proprietary rights by entering into confidentiality agreements and proprietary information agreements with suppliers, employees, consultants and others who may have access to our proprietary information. The steps we have taken to protect our trade secrets, trademarks, patent applications and other intellectual property and proprietary rights may not be adequate, and third parties could infringe, misappropriate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or misuse our intellectual property. If this were to occur, it could harm our reputation and adversely affect our business, competitive position, financial condition or results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the date hereof, our patent portfolio includes a patent family exclusively licensed from BWH, including a granted U.S. patent, a pending U.S. non-provisional patent application, and multiple foreign granted patents and non-provisional patent applications, relating to methods and compositions for identifying target antigens specific to T cells. In addition, we have filed applications in multiple patent families including multiple pending U.S. provisional patent applications, multiple granted foreign patents, and more than 140 pending international and foreign patent applications. The claims of these patent applications are directed toward various aspects of our therapy candidates and research programs, including compositions of matter and uses thereof directed to SARS-CoV-2 immunodominant antigens, anti-SARS-CoV-2 TCRs, anti-SARS-CoV-2 vaccines, anti-HA-1 TCRs (including the TSC-100 TCR-T therapy product candidate), anti-HA-2 TCRs (including the TSC-101 TCR-T therapy product candidate), anti-HPV TCRs (including the TSC-200 TCR-T therapy product candidate), anti-MAGE-C2 TCRs (including the TSC-201 TCR-T therapy product candidate), anti-MAGE-A4 TCRs (including the TSC-202 TCR-T therapy product candidate), anti-PRAME TCRs (including the TSC-203 TCR-T therapy product candidate), and anti-MAGE-A1 TCRs (including the TSC-204 TCR-T therapy product candidate), as well as platform technologies including a phospholipid scrambling reporter-based T cell antigen screening platform and certain screening methods thereof, and a TCR multiplexing platform and certain therapeutic methods thereof.  These patent applications, if issued, are expected to expire on various dates from 2038 through 2045, in each case without taking into account any possible patent term adjustments or extensions and assuming that appropriate maintenance and governmental fees are paid.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Heme Malignancies Program Product Patent Families</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have filed multiple patent families encompassing pending U.S. and foreign patent applications covering aspects of our heme malignancies programs including claims to the composition-of-matter and uses thereof of TSC-100, TSC-101, and other anti-HA-1 and anti-HA-2 TCRs and related T cell therapies. We expect the issued Australian and Singaporean patents, as well as any additional patents within these families, if issued, to expire no earlier than 2041 (without taking into account any possible patent term adjustments or extensions and assuming that appropriate maintenance and governmental fees are paid).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Solid Tumor Program Product Patent Families</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have filed multiple patent families encompassing pending U.S. and foreign patent applications covering aspects of our solid tumor programs including claims to the composition-of-matter of anti-HPV, anti-MAGE-C2, anti-MAGE-A4, anti-PRAME, anti-MAGE-A1 TCRs, and related T cell therapies. We expect the issued Australian patents, as well as any additional patents within these families, if issued, to expire no earlier than 2042 (without taking into account any possible patent term adjustments or extensions and assuming that appropriate maintenance and governmental fees are paid).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Infectious Disease Product Patent Families</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have filed multiple patent families encompassing pending U.S. and foreign patent applications covering aspects of our infectious disease programs including claims to the composition-of-matter of SARS-CoV-2 immunodominant antigens, anti-SARS-CoV-2 TCRs, and the composition-of-matter of certain SARS-CoV-2 vaccines. We expect the issued Australian and Democratic Republic of the Congo patents, as well as any additional patents within these families, if issued, to expire no earlier than 2041 (without taking into account any possible patent term adjustments or extensions and assuming that appropriate maintenance and governmental fees are paid). Certain of these pending patent applications are jointly owned by us and AHS Hospital Corporation, or AHS. AHS has exclusively licensed their interest in such patent applications to us.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Platform Technology</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have filed a patent family encompassing pending U.S. and foreign patent applications covering aspects of our reporter-based T cell antigen screening platform. We expect any claims within this family, if issued, to expire no earlier than 2041 (without taking into account any possible patent term adjustments or extensions and assuming that appropriate maintenance and governmental fees are paid).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we have filed several patent families encompassing pending U.S. and foreign patent applications covering certain multiplexed TCR compositions and certain therapeutic methods thereof. We expect any claims within these families, if issued, to expire no earlier than 2043 (without taking into account any possible patent term adjustments or extensions and assuming that appropriate maintenance and governmental fees are paid).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our pending patent applications may not result in issued patents and we can give no assurance that any patents that might issue in the future will protect our products or provide us with any competitive advantage. Moreover, U.S. provisional patent applications are not eligible to become issued patents until, among other things, we file a non-provisional patent application within 12 months of filing of one or more of our related provisional patent applications. With regard to such U.S. provisional patent applications, if we do not timely file any non-provisional patent applications, we may lose our priority date with respect to our provisional patent applications and any patent protection on the inventions disclosed in our provisional patent applications. While we generally intend to timely file non-provisional patent applications relating to our provisional patent applications, we cannot predict whether any such patent applications will result in the issuance of patents that provide us with any competitive advantage. For more information regarding the risks related to our intellectual property, please see &#8220;Item 1A. Risk Factors&#8212;Risks Related to Our Intellectual Property&#8221; in this Annual Report.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Third-Party Intellectual Property Rights</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For certain aspects of our business, we rely on certain technology and intellectual property rights that we in-license from third parties. We have an exclusive patent license from BWH to a patent family directed to aspects of a granzyme B (GzB)-based antigen screening technology platform, as well as compositions-of-matter and certain screening methods thereof (consisting of one granted U.S. patent, one pending U.S. patent application, a granted patent in each of Australia, France, Germany, Great Britain, Japan, Netherlands, Switzerland, and six foreign patent applications pending in Australia, Canada, China, Europe, Hong Kong, and Japan). Any patents issuing from the U.S. and foreign patent applications are expected to expire no earlier than 2038 (without taking into account any possible patent term adjustments or extensions and assuming that appropriate maintenance and governmental fees are paid). We also have a non-exclusive, perpetual, non-transferable patent license from PHSA to a patent family directed to granzyme-based antigen screening methods consisting of an issued U.S. patent that is expected to expire on August 4, 2035 (assuming that appropriate maintenance and governmental fees are paid) and issued Canadian patent that is expected to expire March 25, 2035 (assuming that appropriate maintenance and governmental fees are paid).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the date hereof, we own or have rights to U.S. and foreign trademark registrations and applications that cover certain aspects of our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Regulation</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">FDA Regulation and Marketing Approval</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the U.S., the FDA regulates drugs under the Federal Food, Drug and Cosmetic Act, or FDCA, and biologics under the Public Health Service Act, the regulations promulgated under both laws and other federal, state, and local statutes and regulations. Failure to comply with the applicable U.S. regulatory requirements at any time during the product development process, approval process or after approval may subject an applicant to administrative or judicial sanctions and non-approval of product candidates. These sanctions could include, among other things, the imposition by the FDA of a clinical hold on trials, the FDA&#8217;s refusal to approve pending applications or related supplements, withdrawal of an approval, untitled or warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, restitution, disgorgement, civil penalties, or criminal prosecution. Such actions by government agencies could also require us to expend a large amount of resources to respond to the actions. Any agency or judicial enforcement action could have a material adverse effect on us.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA and comparable regulatory agencies in state and local jurisdictions and in foreign countries impose substantial requirements upon the clinical development, approval, manufacture, distribution and marketing of pharmaceutical products. These agencies and other federal, state and local entities regulate research and development activities and the testing, manufacture, quality control, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, post-approval monitoring, advertising, promotion, sampling and import and export of our products. Our drugs must be approved by the FDA as biologics through the BLA approval process applicable to gene therapy product candidates before they may be legally marketed in the U.S.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Within the FDA, the FDA&#8217;s Center for Biologics Evaluation and Research, or CBER, regulates gene therapy products and has published guidance documents with respect to the development of these types of products. The FDA also has published guidance documents related to, among other things, gene therapy products in general, their preclinical assessment, observing subjects involved in gene therapy studies for delayed adverse events, potency testing, and chemistry, manufacturing and control information in gene therapy INDs.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process required by the FDA before a biologic may be marketed in the U.S. generally involves the following:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">completion of non-clinical laboratory tests, animal studies and formulation studies conducted according to Good Laboratory Practice, or GLP, or other applicable regulations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission of an IND application, which allows clinical trials to begin unless the FDA objects within 30 days;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the proposed drug or biologic for its intended use or uses conducted in accordance with FDA regulations and Good Clinical Practices, or GCP, which are international ethical and scientific quality standards meant to ensure that the rights, safety and well-being of trial participants are protected, and that the integrity of the data is maintained;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preparation and submission to the FDA of a BLA;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission of a user fee for FDA review of the BLA;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;" id="page20_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">review of the product by an FDA advisory committee, where appropriate or if applicable;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of pre-approval inspection of manufacturing facilities and clinical trial sites at which the product, or components thereof, are produced to assess compliance with current Good Manufacturing Practice, or cGMP, requirements, and if applicable, the FDA&#8217;s current Good Tissue Practice, or cGTP, requirements, and of selected clinical trial sites to assess compliance with GCP requirements; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA approval of a BLA which must occur before a biologic can be marketed or sold.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Studies</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preclinical studies include laboratory evaluation of the purity and stability of the manufactured drug substance or active pharmaceutical ingredient and the formulated drug or drug product, as well as </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and animal studies to assess the safety and activity of the drug for initial testing in humans and to establish a rationale for therapeutic use. The conduct of preclinical studies is subject to federal regulations and requirements, including GLP regulations. The results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature and plans for clinical studies, among other things, are submitted to the FDA as part of an IND application.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Companies usually must complete some long-term preclinical testing, such as animal tests of reproductive adverse events and carcinogenicity and must also develop additional information about the chemistry and physical characteristics of the drug and finalize a process for manufacturing the drug in commercial quantities in accordance with, or cGMP, requirements. The manufacturing process must be capable of consistently producing quality batches of the drug candidate and, among other things, the manufacturer must develop methods for testing the identity, strength, quality, and purity of the final drug product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the drug candidate does not undergo unacceptable deterioration over its shelf life.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">IND Application and Clinical Trials</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCP requirements. Clinical trials are conducted under written study protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. Prior to commencing the first clinical trial, an initial IND application, which contains the results of preclinical testing along with other information, such as information about product chemistry, manufacturing and controls and a proposed protocol, must be submitted to the FDA. The IND application automatically becomes effective 30 days after receipt by the FDA unless the FDA, within the 30-day time period, raises concerns or questions about the drug product or the conduct of the clinical trial and imposes a clinical hold. A clinical hold may also be imposed at any time while the IND application is in effect. In such a case, the IND application sponsor must resolve any outstanding concerns with the FDA before the clinical trial may begin or re-commence. Accordingly, submission of an IND application may or may not result in the FDA allowing clinical trials to commence or continue.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the submission of an IND application to the FDA before initiation of a clinical trial in the U.S., certain human clinical trials involving recombinant or synthetic nucleic acid molecules are subject to oversight of institutional biosafety committees, or IBCs, as set forth in the National Institutes for Health, or NIH, Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, or NIH Guidelines. </span><span style="color:#242424;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the NIH Guidelines, recombinant and synthetic nucleic acids are defined as: (i) molecules that are constructed by joining nucleic acid molecules and that can replicate in a living cell (i.e., recombinant nucleic acids); (ii) nucleic acid molecules that are chemically or by other means synthesized or amplified, including those that are chemically or otherwise modified but can base pair with naturally occurring nucleic acid molecules (i.e., synthetic nucleic acids); or (iii) molecules that result from the replication of those described in (i) or (ii). </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specifically, under the NIH Guidelines, supervision of human gene transfer trials includes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">evaluation and assessment by an Institutional Biosafety Committee (IBC), a local institutional committee that reviews and oversees research utilizing recombinant or synthetic nucleic acid molecules at that institution. The IBC assesses the safety of the research and identifies any potential risk to public health or the environment, and such review may result in some delay before initiation of a clinical trial. While the NIH Guidelines are not mandatory unless the research in question is being conducted at or sponsored by institutions receiving NIH funding of recombinant or synthetic nucleic acid molecule research, many companies and other institutions not otherwise subject to the NIH Guidelines voluntarily follow them.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A sponsor who wishes to conduct a clinical trial outside the U.S. may, but need not, obtain FDA authorization to conduct the clinical trial under an IND application. If a foreign clinical trial is not conducted under an IND application, the sponsor may submit data from the clinical trial to the FDA in support of a BLA or IND application so long as the clinical trial is conducted in compliance with GCP, and the FDA is able to validate the data from the study through an onsite inspection if the agency deems it necessary.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A separate submission to the existing IND application must be made for each successive clinical trial to be conducted during product development. Further, an independent Institutional Review Board, or IRB, for each site at which the clinical trial will be conducted must review and approve the clinical trial before it commences at that site. Informed written consent must also be obtained from each trial subject. Regulatory authorities including the FDA, or IRB, or the sponsor, may suspend or terminate a clinical trial at any time on various grounds, including a finding that the participants are being exposed to an unacceptable health risk or that the clinical trial is not being conducted in accordance with FDA requirements. Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board or committee. This group provides authorization as to whether or not a trial may move forward at designated check points based on access to certain data from the trial and may recommend halting the clinical trial if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human clinical trials for BLA approval typically involve a three-phase process, although some phases may overlap or be combined. Phase 1, the initial clinical evaluations, consists of administering the drug and testing for safety and tolerated dosages and in some indications, such as rare disease, as preliminary evidence of efficacy in humans. Phase 2 involves a study to evaluate the effectiveness of the drug for a particular indication and to determine optimal dosage and dose interval and to identify possible adverse side effects and risks in a larger patient group. When a product is found safe, and initial efficacy is established in Phase 2, it is then evaluated in Phase 3 clinical trials. Phase 3 trials consist of expanded multi-location testing for efficacy and safety to evaluate the overall benefit-to-risk index of the investigational drug in relationship to the disease treated. In March 2022, the FDA released a final guidance, &#8220;Expansion Cohorts: Use in First-In-Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics,&#8221; which outlines how drug developers can utilize an adaptive trial design in early stages of oncology drug development (i.e., the first-in-human clinical trial) to compress the traditional three phases of trials into one continuous trial called an expansion cohort trial. Expansion cohort trials can potentially bring efficiency to drug development and reduce developmental costs and time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="page21_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All clinical trials must be conducted in accordance with FDA regulations, GCP requirements and their protocols in order for the data to be considered reliable for regulatory purposes. Progress reports detailing the results of the clinical trials must be submitted at least annually to the FDA and more frequently if serious adverse events occur. The results of preclinical and human clinical testing are submitted to the FDA in the form of a BLA for approval to commence commercial sales. Our clinical trials may not be completed successfully within any specified period, or at all. Government regulation may delay or prevent marketing of product candidates or new drugs for a considerable period of time and impose costly procedures upon our activities.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disclosure of Clinical Trial Information</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sponsors of clinical trials of FDA-regulated products, including drugs, are required to register and disclose certain clinical trial information. Information related to the product, patient population, phase of investigation, study sites and investigators, and other aspects of the clinical trial is then made public as part of the registration. Sponsors are also obligated to disclose the results of their clinical trials after completion. Disclosure of the results of these trials can be delayed until the new product or new indication being studied has been approved up to a maximum of two years. Competitors may use this publicly available information to gain knowledge regarding the progress of development programs.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Biologics License Application Approval Process</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to obtain approval to market a drug in the U.S., a marketing application must be submitted to the FDA that provides data establishing to the FDA&#8217;s satisfaction the safety and effectiveness of the investigational drug for the proposed indication. The application includes all relevant data available from pertinent non-clinical or preclinical studies and clinical trials, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing, controls and proposed labeling, among other things. Data can come from company-sponsored clinical trials intended to test the safety and effectiveness of a use of a product, or from a number of alternative sources, including studies initiated by investigators that meet GCP requirements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the development of a new drug, sponsors are given opportunities to meet with the FDA at certain points. These points may be prior to submission of an IND application, at the End-of-Phase 1 or 2, and before a Biologics License Application, or BLA, is submitted. Meetings at other times may be requested. These meetings can provide an opportunity for the sponsor to share information about the data gathered to date, for the FDA to provide advice and for the sponsor and the FDA to reach agreement on the next phase of development.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of product development, non-clinical studies and clinical trials, along with descriptions of the manufacturing process, analytical tests conducted on the chemistry of the drug, proposed labeling and other relevant information are submitted to the FDA as part of a BLA requesting approval to market the product for its intended indication. The FDA reviews all BLAs submitted to ensure that they are sufficiently complete for substantive review before it accepts them for filing. It may request additional information rather than accept a BLA for filing. In this event, the BLA must be resubmitted with the additional requested information. The resubmitted application also is subject to review before the FDA accepts it for filing. The FDA has 60 days from its receipt of a BLA to conduct an initial review to determine whether the application will be accepted for filing based on the agency&#8217;s threshold determination that the application is sufficiently complete to permit substantive review. The FDA reviews a BLA to determine, among other things, whether the proposed product is safe and potent, or effective, for its intended use, and has an acceptable purity profile, and whether the product is being manufactured in accordance with cGMP to assure and preserve the product&#8217;s identity, safety, strength, quality, potency and purity. The FDA has agreed to specific performance goals on the review of BLA&#8217;s. Specifically, under the goals and policies agreed to by the FDA under the Prescription Drug User Fee Act, or PDUFA, as amended, the FDA has ten months, from the filing date, in which to complete its initial review of an original BLA and respond to the applicant, and six months from the filing date of an original BLA designated for priority review. The review process may be extended by the FDA for three additional months to consider certain late-submitted information or information intended to clarify information already provided in the submission. After the FDA completes its substantive review of a BLA, it will communicate to the sponsor that the drug will either be approved, or it will issue a complete response letter to communicate that the BLA will not be approved in its current form and inform the sponsor of changes that must be made or additional clinical, non-clinical or manufacturing data that must be received before the application can be approved, with no implication regarding the ultimate approvability of the application or the timing of any such approval, if ever. If or when those deficiencies have been addressed to the FDA&#8217;s satisfaction in a resubmission of the BLA, the FDA may issue an approval letter. The FDA has committed to reviewing such resubmissions in two to six months depending on the type of information included. The FDA may refer applications for novel drug products or drug products that present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation, and a recommendation as to whether the application should be approved and, if so, under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before approving a BLA, the FDA typically will inspect the facilities at which the product is manufactured. The FDA will not approve the product unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and are adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA, the FDA may inspect one or more clinical sites to assure compliance with GCP. For a gene therapy product, the FDA also will not approve the product if the manufacturer is not in compliance with current Good Tissue Practice, or cGTP. These are FDA regulations that govern the methods used in, and the facilities and controls used for, the manufacture of human cells, tissues, and cellular and tissue-based products, or HCT/Ps, which are human cells or tissue intended for implantation, transplant, infusion, or transfer into a human recipient. The primary intent of the cGTP requirements is to ensure that cell and tissue-based products are manufactured in a manner designed to prevent the introduction, transmission and spread of communicable disease. FDA regulations also require tissue establishments to register and list their HCT/Ps with the FDA and, when applicable, to evaluate donors through appropriate screening and testing. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it typically will outline the deficiencies and often will request additional testing or information. This may significantly delay further review of the application. If the FDA finds that a clinical site did not conduct the clinical trial in accordance with GCP, the FDA may determine the data generated by the clinical site should be excluded from the primary efficacy analyses provided in the BLA. Additionally, notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="page22_1">&#160;</p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may require, or companies may pursue, additional clinical trials after a product is approved. These so-called Phase 4 or post-approval trials may be made a condition to be satisfied for continuing drug approval. The results of Phase 4 trials can confirm the effectiveness of a product candidate and can provide important safety information. In addition, the FDA has authority to require sponsors to conduct post-marketing trials to specifically address safety issues identified by the agency. See &#8220;Post-Marketing Requirements&#8221; below.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA also has authority to require a Risk Evaluation and Mitigation Strategy, or REMS, from manufacturers to ensure that the benefits of a drug outweigh its risks. A sponsor may also voluntarily propose a REMS as part of the BLA submission. The need for a REMS is determined as part of the review of the BLA. Based on statutory standards, elements of a REMS may include &#8220;Dear Doctor letters,&#8221; a medication guide, more elaborate targeted educational programs, and in some cases distribution and use restrictions, referred to as elements to assure safe use, or ETASU. ETASU can include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring and the use of patient registries. These elements are negotiated as part of the BLA approval, and in some cases the approval date may be delayed. Once adopted, REMS are subject to periodic assessment and modification.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes to some of the conditions established in an approved application, including changes in indications, labeling, manufacturing processes or facilities, require submission and FDA approval of a new BLA or BLA supplement before the change can be implemented. A BLA supplement for a new indication typically requires clinical data similar to that in the original application, and the FDA uses the same procedures and actions in reviewing BLA supplements as it does in reviewing BLAs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if a product candidate receives regulatory approval, the approval may be limited to specific disease states, patient populations and dosages, or might contain significant limitations on use in the form of warnings, precautions or contraindications, or in the form of onerous risk management plans, restrictions on distribution or use, or post-marketing trial requirements. Further, even after regulatory approval is obtained, later discovery of previously unknown problems with a product may result in restrictions on the product, including safety labeling or imposition of a REMS, the requirement to conduct post-market studies or clinical trials or even complete withdrawal of the product from the market. Delay in obtaining, or failure to obtain, regulatory approval for our products, or obtaining approval but for significantly limited use, would harm our business. In addition, we cannot predict what adverse governmental regulations may arise from future U.S. or foreign governmental action.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Hatch-Waxman Amendments</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Amendments, a portion of a product&#8217;s U.S. patent term that was lost during clinical development and regulatory review by the FDA may be restored by returning up to five years of patent life for a patent that covers a new product or its use. This period is generally one-half the time between the effective date of an IND application (falling after issuance of the patent) and the submission date of a BLA, plus the time between the submission date of a BLA and the approval of that application, provided that the sponsor acted with diligence. Patent term restorations, however, cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval and only one patent applicable to an approved drug may be extended and the extension must be applied for prior to expiration of the patent. The U.S. Patent and Trademark Office, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Market Exclusivity</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Patient Protection and Affordable Care Act, as amended by the Health Care Education and Reconciliation Act, or, collectively, the ACA, signed into law on March 23, 2010, includes a subtitle called the Biologics Price Competition and Innovation Act of 2009, or the BPCIA, which created an abbreviated approval pathway for biological products shown to be similar to, or interchangeable with, an FDA-approved reference biological product. Bio similarity, which requires that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity, and potency, can be shown through analytical studies, animal studies, and a clinical trial or trials. Interchangeability requires that a product is biosimilar to the reference product, and the product must demonstrate that it can be expected to produce the same clinical results as the reference product and, for products administered multiple times, the biologic and the reference biologic may be switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. However, complexities associated with the larger, and often more complex, structure of biological products, as well as the process by which such products are manufactured, pose significant hurdles to implementation that are still being worked out by the FDA.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reference biological product is granted four- and 12-year exclusivity periods from the time of first licensure of the product. FDA will not accept an application for a biosimilar or interchangeable product based on the reference biological product until four years after the date of first licensure of the reference product, and FDA will not approve an application for a biosimilar or interchangeable product based on the reference biological product until 12 years after the date of first licensure of the reference product. The FDA may approve multiple &#8220;first&#8221; interchangeable products so long as they are all approved on the same first day of marketing. &#8220;First licensure&#8221; typically means the initial date the particular product at issue was approved in the U.S. Date of first licensure does not include the date of licensure of (and a new period of exclusivity is not available for) a biological product if the licensure is for a supplement for the biological product or for a subsequent application by the same sponsor or manufacturer of the biological product (or licensor, predecessor in interest, or other related entity) for a change (not including a modification to the structure of the biological product) that results in a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">new indication, route of administration, dosing schedule, dosage form, delivery system, delivery device or strength, or for a modification to the structure of the biological product that does not result in a change in safety, purity, or potency. Therefore, one must determine whether a new product includes a modification to the structure of a previously approved product that results in a change in safety, purity, or potency to assess whether the licensure of the new product is a first licensure that triggers its own period of exclusivity. Whether a subsequent application, if approved, warrants exclusivity as the &#8220;first licensure&#8221; of a biological product is determined on a case-by-case basis with data submitted by the sponsor.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="page23_1">&#160;</p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, under the Orphan Drug Act, the FDA may designate a biologic product as an &#8220;orphan drug&#8221; if it is intended to treat a rare disease or condition (generally meaning that it affects fewer than 200,000 individuals in the U.S., or more in cases in which there is no reasonable expectation that the cost of developing and making a biologic product available in the U.S. for treatment of the disease or condition will be recovered from sales of the product). Orphan product designation must be requested before submitting a BLA. After FDA grants orphan product designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by FDA. Orphan product designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process. If a product with orphan status receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to orphan product exclusivity, meaning that the FDA may not approve any other applications to market the same drug or biologic product for the same indication for seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan exclusivity or if the party holding the exclusivity fails to assure the availability of sufficient quantities of the drug to meet the needs of patients with the disease or condition for which the drug was designated. Competitors, however, may receive approval of different products for the same indication than that for which the orphan product has exclusivity or obtain approval for the same product but for a different indication for which the orphan product has exclusivity. Orphan medicinal product status in the EU has similar, but not identical, benefits.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pediatric exclusivity is another type of non-patent marketing exclusivity in the U.S. and, if granted, provides for the attachment of an additional six months to existing exclusivity periods for all formulations, dosage forms, and indications of the biologic. This six-month exclusivity may be granted if a BLA sponsor submits pediatric data that fairly respond to a written request from the FDA for such data.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rare Pediatric Disease Designation and Priority Review Vouchers</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the FDCA, the FDA incentivizes the development of drugs and biological products that meet the definition of a &#8220;rare pediatric disease,&#8221; defined to mean a serious or life-threatening disease in which the serious of life-threatening manifestations primarily affect individuals aged from birth to 18 years and the disease affects fewer than 200,000 individuals in the U.S. or affects more than 200,000 in the U.S. and for which there is no reasonable expectation that the cost of developing and making in the U.S. a drug or biological product for such disease or condition will be received from sales in the U.S. of such drug or biological product. The sponsor of a product candidate for a rare pediatric disease may be eligible for a voucher that can be used to obtain a priority review for a subsequent human drug or biological product application after the date of approval of the rare pediatric disease drug or biological product, referred to as a priority review voucher, or PRV. A sponsor may request rare pediatric disease designation from the FDA prior to the submission of its BLA. A rare pediatric disease designation does not guarantee that a sponsor will receive a PRV upon approval of its BLA. Moreover, a sponsor who chooses not to submit a rare pediatric disease designation request may nonetheless receive a PRV upon approval of their marketing application if they request such a voucher in their original marketing application and meet all of the eligibility criteria. If a PRV is received, it may be sold or transferred an unlimited number of times.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under current statutory sunset provisions, the FDA may award a PRV for an approved rare pediatric disease product application only if the sponsor has received rare pediatric disease designation for the drug by December 20, 2024, and after September 30, 2026, the FDA may not award any rare pediatric disease PRVs. Congress may vote to reauthorize this program, but its future remains unknown at this time.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expedited Development and Review Programs</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA is authorized to expedite the review of BLAs in several ways. Under the Fast Track program, the sponsor of a biologic product candidate may request the FDA to designate the product for a specific indication as a Fast Track product concurrent with or after the filing of the IND application. Biologic products are eligible for Fast Track designation if they are intended to treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs for the condition. Fast Track designation applies to the combination of the product candidate and the specific indication for which it is being studied. In addition to other benefits, such as the ability to have greater interactions with the FDA, the FDA may initiate review of sections of a Fast Track BLA before the application is complete, a process known as rolling review.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any product submitted to the FDA for marketing, including under a Fast Track program, may be eligible for other types of FDA programs intended to expedite development and review, such as regenerative medicine advanced therapy, or RMAT, designation, priority review and accelerated approval. To qualify for RMAT designation, the product candidate must be a regenerative medicine therapy,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">which is defined as a cell therapy, therapeutic tissue engineering product, human cell and tissue product, or any combination product using such therapies or products, except for those regulated solely under Section 361 of the Public Health Service Act and part 1271 of Title 21 of the Code of Federal Regulations; is intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition; and preliminary clinical evidence indicates that the product has the potential to address unmet medical needs for such disease or condition. A gene therapy product may meet the definition of a regenerative medicine therapy for purposes of RMAT designation. A BLA for a product candidate that has received RMAT designation may be eligible for priority review or accelerated approval through use of surrogate or intermediate endpoints reasonably likely to predict long-term clinical benefit, or reliance upon data obtained from a meaningful number of sites. Benefits of RMAT designation also include early interactions with the FDA to discuss any potential surrogate or intermediate endpoint to be used to support accelerated approval. A product candidate with RMAT designation that is granted accelerated approval and is subject to post-approval requirements may fulfill such requirements through the submission of clinical evidence from clinical studies, patient registries, or other sources of real-world evidence, such as electronic health records; the collection of larger confirmatory data sets; or post-approval monitoring of all patients treated with such therapy prior to its approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="page24_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A product candidate including one that received Fast Track or RMAT designation is eligible for priority review if it treats a serious</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">condition and, if approved, it would be a significant improvement in the safety or effectiveness of the treatment, diagnosis or prevention of a serious condition compared to available therapies. The FDA aims to complete its review of priority review applications within six months of the filing date, compared to 10 months for standard review.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, a biologic product may be eligible for accelerated approval if it is designed to treat a serious or life-threatening disease or condition and demonstrates an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit, or on the basis of an effect on a clinical endpoint other than survival or irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity and prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require that a sponsor of a drug or biologic product candidate receiving accelerated approval perform adequate and well-controlled post-marketing clinical trials and, under the Food and Drug Omnibus Reform Act of 2022, or FDORA, the FDA is now permitted to require that such trials be underway prior to approval or within a specific time period after the date of approval for a product granted accelerated approval. Under FDORA, the FDA has increased authority for expedited procedures to withdraw approval of a drug or indication approved under accelerated approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, the FDA currently requires, unless otherwise informed by the agency, pre-approval of promotional materials </span><span style="color:#242424;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">intended for dissemination or publication</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or the time period for FDA review or approval may not be shortened. Fast Track designation, priority review and accelerated approval do not change the standards for approval but may expedite the development or approval process.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, under FDORA, a platform technology incorporated within or utilized by a biological product is eligible for designation as a designated platform technology if (1) the platform technology is incorporated in, or utilized by, a biological product approved under a BLA; (2) preliminary evidence submitted by the sponsor of the licensed biological product, or a sponsor that has been granted a right of reference to data submitted in the application for such biological product, demonstrates that the platform technology has the potential to be incorporated in, or utilized by, more than one biological product without an adverse effect on quality, manufacturing, or safety; and (3) data or information submitted by the applicable person indicates that incorporation or utilization of the platform technology has a reasonable likelihood to bring significant efficiencies to the biological product development or manufacturing process and to the review process. A sponsor may request the FDA to designate a platform technology as a designated platform technology concurrently with, or at any time after, submission of an IND application for a biological product that incorporates or utilizes the platform technology that is the subject of the request. If so designated, the FDA may expedite the development and review of any subsequent original BLA for a biological product that uses or incorporates the platform technology. Designated platform technology status does not ensure that a biological product will be developed more quickly or receive FDA approval. In addition, the FDA may revoke a designation if the FDA determines that a designated platform technology no longer meets the criteria for such designation.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Post-Marketing Requirements</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following approval of a new product, a pharmaceutical company and the approved product are subject to continuing regulation by the FDA, including, among other things, monitoring and recordkeeping activities, reporting to the applicable regulatory authorities of adverse experiences with the product, providing the regulatory authorities with updated safety and efficacy information, product sampling and distribution requirements, and complying with promotion and advertising requirements, which include, among others, standards for direct-to-consumer advertising, restrictions on promoting drugs for uses or in patient populations that are not described in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the drug&#8217;s approved labeling, or off-label use, limitations on industry-sponsored scientific and educational activities and requirements for promotional activities involving the internet. Although physicians may, in their independent professional medical judgment, prescribe legally available drugs for off-label uses, manufacturers typically may not market or promote such off-label uses. Modifications or enhancements to the product or its labeling or changes of the site of manufacture are often subject to the approval of the FDA and other regulators, who may or may not grant approval or may include a lengthy review process.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prescription drug advertising is subject to federal, state, and foreign regulations. In the U.S., the FDA regulates prescription drug promotion, including direct-to-consumer advertising. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first use. Any distribution of prescription drug products and pharmaceutical samples must comply with the U.S. Prescription Drug Marketing Act, a part of the FDCA. Additionally, under FDORA, sponsors of approved biologics must provide 6 months&#8217; notice to the FDA of any changes in marketing status, such as the withdrawal of a drug, and failure to do so could result in the FDA placing the product on a list of discontinued products, which would revoke the product&#8217;s ability to be marketed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the U.S., once a product is approved, its manufacturing is subject to comprehensive and continuing regulation by the FDA. The FDA regulations require that products be manufactured in specific approved facilities and in accordance with cGMP. cGMP regulations require among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. Drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and other laws. Additionally, manufacturers and other parties involved in the supply chain for prescription drug products must also comply with product tracking and racing requirements and for notifying the FDA of counterfeit, diverted, stolen and intentionally adulterated products or products that are otherwise unfit for distribution in the U.S. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance. These regulations also impose certain organizational, procedural and documentation requirements with respect to manufacturing and quality assurance activities. BLA holders using contract manufacturers, laboratories or packagers are responsible for the selection and monitoring of qualified firms, and, in certain circumstances, qualified suppliers to these firms. These firms and, where applicable, their suppliers are subject to inspections by the FDA at any time, and the discovery of violative conditions, including failure to conform to cGMP, could result in enforcement actions that interrupt the operation of any such product or may result in restrictions on a product, manufacturer, or holder of an approved BLA, including, among other things, recall or withdrawal of the product from the market. In addition, the manufacturer and/or holder of an approved BLA are subject to annual product and establishment fees. These fees are typically increased annually.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA also may require post-marketing testing, also known as Phase 4 testing, to monitor the effects of an approved product or place conditions on an approval via a REMS that could restrict the distribution or use of the product. Discovery of previously unknown problems with a product or the failure to comply with applicable FDA requirements can have negative consequences, including adverse publicity, judicial or administrative enforcement, untitled or warning letters from the FDA, mandated corrective advertising or communications with doctors, withdrawal of approval, and civil or criminal penalties, among others. Newly discovered or developed safety or effectiveness data may require changes to a product&#8217;s approved labeling, including the addition of new warnings and contraindications, and also may require the implementation of other risk management measures. Also, new government requirements, including those resulting from new legislation, may be established, or the FDA&#8217;s policies may change, which could delay or prevent regulatory approval of our products under development.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Coverage and Reimbursement</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales of any products for which we receive regulatory approval for commercial sale will depend in part on the availability of reimbursement from third-party payors, including government healthcare program administrative authorities, managed care organizations, private health insurers, and other entities. Patients who are prescribed medications for the treatment of their conditions, and their prescribing physicians, generally rely on third-party payors to reimburse all or part of the costs associated with their prescription drugs. Patients are unlikely to use our products unless coverage is provided, and reimbursement is adequate to cover a significant portion of the cost of our products. Therefore, our products, once approved, may not obtain market acceptance unless coverage is provided, and reimbursement is adequate to cover a significant portion of the cost of our products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the U.S., no uniform policy of coverage and reimbursement for drug or biological products exists. The process for determining whether a third-party payor will provide coverage for a drug product typically is separate from the process for setting the price of a drug product or for establishing the reimbursement rate that the payor will pay for the drug product once coverage is approved. Third-party payors may limit coverage to specific drug products on an approved list, also known as a formulary, which might not include all of the FDA-approved drugs for a particular indication. A decision by a third-party payor not to cover our product candidates could reduce physician utilization of our products once approved. Moreover, a third-party payor&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Adequate third-party reimbursement may not be available to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development. Additionally, coverage and reimbursement for drug products can differ significantly from payor to payor. One third-party payor&#8217;s decision to cover a particular drug product or service does not ensure that other payors will also provide coverage for the medical product or service or will provide coverage at an adequate reimbursement rate. As a result, the coverage determination process will require us to provide scientific and clinical support for the use of our products to each payor separately and will be a time-consuming process.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The containment of healthcare costs has become a priority of federal, state, and foreign governments, and the prices of drugs have been a focus in this effort. Third-party payors are increasingly challenging the prices charged for drug products and medical services, examining the medical necessity, and reviewing the cost effectiveness of drug products and medical services, in addition to questioning safety and efficacy. If these third-party payors do not consider our products to be cost-effective compared to other available therapies, they may not cover our products after FDA approval or, if they do, the level of payment may not be sufficient to allow us to sell our products at a profit.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The American Recovery and Reinvestment Act of 2009 provided funding for the federal government to compare the effectiveness of different treatments for the same illness. The plan for the research was published in 2012 by the Department of Health and Human Services, the Agency for Healthcare Research and Quality and the National Institutes for Health, and periodic reports on the status of the research and related expenditures will be made to Congress. Although the results of the comparative effectiveness studies are not intended to mandate coverage policies for public or private payors, it is not clear what effect, if any, the research will have on the sales of our product candidates, if any such product or the condition that it is intended to treat is the subject of a study. It is also possible that comparative effectiveness research demonstrating benefits in a competitor&#8217;s product could adversely affect the sales of our product candidates, once approved. If third-party payors do not consider our products to be cost-effective compared to other available therapies, they may not cover our products after approval as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow us to sell our products on a profitable basis.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, in some foreign countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. For example, the EU provides options for its member states to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. A member state may approve a specific price for the medicinal product, or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our products. Historically, products launched in the EU do not follow price structures of the U.S. and generally tend to be significantly lower.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="page26_1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti-Kickback and False Claims Laws and Other Regulatory Matters</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the U.S., among other things, the research, manufacturing, distribution, sale and promotion of drug products and medical devices are potentially subject to regulation and enforcement by various federal, state and local authorities in addition to the FDA, including the Centers for Medicare &amp; Medicaid Services, other divisions of the U.S. Department of Health and Human Services (HHS) (e.g., the Office of Inspector General), the Drug Enforcement Administration, the Consumer Product Safety Commission, the Federal Trade Commission, the Occupational Safety &amp; Health Administration, the Environmental Protection Agency, state Attorneys General and other state and local government agencies. Our current and future business activities, including for example, sales, marketing, and scientific/educational grant programs must comply with healthcare regulatory laws, as applicable, which may include the Federal Anti-Kickback Statute, the Federal False Claims Act, as amended, the privacy and security regulations promulgated under the Health Insurance Portability and Accountability Act, or HIPAA, as amended, physician payment transparency laws, and similar state laws. Pricing and rebate programs must comply with the Medicaid Drug Rebate Program requirements of the Omnibus Budget Reconciliation Act of 1990, as amended, and the Veterans Health Care Act of 1992, as amended. If products are made available to authorized users of the Federal Supply Schedule of the General Services Administration, additional laws and requirements apply. All of these activities are also potentially subject to federal and state consumer protection and unfair competition laws.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The distribution of pharmaceutical products is subject to additional requirements and regulations, including extensive record-keeping, licensing, storage, and security requirements intended to prevent the unauthorized sale of pharmaceutical products.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Federal Anti-Kickback Statute makes it illegal for any person or entity, including a prescription drug manufacturer (or a party acting on its behalf) to knowingly and willfully, directly or indirectly, in cash or in kind, solicit, receive, offer, or pay any remuneration that is intended to induce the referral of business, including the purchasing, leasing, ordering or arranging for or recommending the purchase, lease or order of, any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as Medicare or Medicaid. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value. The Federal Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on one hand and prescribers, purchasers, and formulary managers on the other. Although there are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution, the exceptions and safe harbors are drawn narrowly. Practices that involve remuneration that may be alleged to be intended to induce prescribing, purchases or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the Federal Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. Additionally, the intent standard under the Federal Anti-Kickback Statute was amended by the ACA to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the ACA codified case law that a claim including items or services resulting from a violation of the Federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the Federal False Claims Act. Violations of this law are punishable by up to five years in prison, criminal fines, administrative civil money penalties, and exclusion from participation in federal healthcare programs. In addition, many states have adopted laws similar to the Federal Anti-Kickback Statute. Some of these state prohibitions apply to the referral of patients for healthcare services reimbursed by any insurer, not just federal healthcare programs such as Medicare and Medicaid. Due to the breadth of these federal and state anti-kickback laws, and the potential for additional legal or regulatory change in this area, it is possible that our future business activities, including our sales and marketing practices and/or our future relationships with physicians and the medical community might be challenged under anti-kickback laws, which could harm us.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal false claims and false statement laws, including the civil False Claims Act, prohibits any person or entity from, among other things, knowingly presenting, or causing to be presented, for payment to federal programs (including Medicare and Medicaid) claims for items or services, including drugs, that are false or fraudulent. Although we would not submit claims directly to payors, manufacturers can be held liable under these laws if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims by, for example, providing inaccurate billing or coding information to customers or promoting a product off-label. In addition, our future activities relating to the reporting of wholesaler or estimated retail prices for our products, the reporting of prices used to calculate Medicaid rebate information and other information affecting federal, state, and third-party reimbursement for our products, and the sale and marketing of our products, are subject to scrutiny under this law. The federal False Claims Act also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the federal False Claims Act and to share in any monetary recovery. For example, pharmaceutical companies have been found liable under the Federal Civil False Claims Act in connection with their off-label promotion of drugs. Penalties for a civil False Claims Act violation include three times the actual damages sustained by the government, plus mandatory civil penalties for each separate false claim, the potential for exclusion from participation in federal healthcare programs, and, although the Federal False Claims Act is a civil statute, conduct that results in a False Claims Act violation may also implicate various federal criminal statutes. If the government were to allege that we were, or convict us of, violating these false claims laws, we could be subject to a substantial fine and may suffer a decline in our stock price. In addition, private individuals have the ability to bring actions under the Federal Civil False Claims Act and certain states have enacted laws modeled after the Federal False Claims Act.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, HIPAA created additional federal criminal statutes that prohibit, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors and knowingly and willfully falsifying, concealing, or covering up a material fact or making any materially false, fictitious, or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="page27_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are also an increasing number of state laws that require manufacturers to make reports to states on pricing and marketing information. Many of these laws contain ambiguities as to what is required to comply with the laws. For example, federal government price reporting laws, which require us to calculate and report complex pricing metrics in an accurate and timely manner to government programs. In addition, as discussed below, a similar federal requirement under the Physician Payments Sunshine Act, requires certain manufacturers to track and report to the federal government certain payments provided to physicians, certain other licensed health care practitioners and teaching hospitals made in the previous calendar year, as well as certain ownership and investment interests held by physicians (defined to include doctors, dentists, optometrists, podiatrists, and chiropractors), certain other licensed healthcare practitioners, and their immediate family members. These laws may affect our sales, marketing, and other promotional activities by imposing administrative and compliance burdens on us. In addition, given the lack of clarity with respect to these laws and their implementation, our reporting actions could be subject to the penalty provisions of the pertinent state and federal authorities.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, we may be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their respective implementing regulations, including the Final Omnibus Rule published on January 25, 2013, imposes specified requirements relating to the privacy, security, and transmission of individually identifiable health information on certain types of individuals and organizations. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. In addition, there may be other federal, state and non-U.S. laws which govern the privacy and security of health and other personal information in certain circumstances, many of which differ from each other and from HIPAA in significant ways and may not have the same effect, thus complicating compliance efforts.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The failure to comply with regulatory requirements subjects us to possible legal or regulatory action. Depending on the circumstances, failure to meet applicable regulatory requirements can result in significant criminal, civil and/or administrative penalties, damages, fines, disgorgement, exclusion from participation in federal healthcare programs, such as Medicare and Medicaid, injunctions, recall or seizure of products, total or partial suspension of production, denial or withdrawal of product approvals, refusal to allow us to enter into supply contracts, including government contracts, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We plan to develop a comprehensive compliance program that establishes internal controls to facilitate adherence to the law and program requirements to which we will or may become subject because we intend to commercialize products that could be reimbursed under a federal healthcare program and other governmental healthcare programs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in law or the interpretation of existing law could impact our business in the future by requiring, for example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to product labeling; (iii) the recall or discontinuation of our products; or (iv) additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Healthcare Legislative Reform</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In both the U.S. and certain foreign jurisdictions, there have been a number of legislative and regulatory changes to the health care system that could impact our ability to sell our products profitably. In particular, in 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively, the ACA, was enacted, which, among other things, subjected biologic products to potential competition by lower-cost biosimilars; increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program; extended the Medicaid Drug Rebate program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations; subjected manufacturers to new annual fees and taxes for certain branded prescription drugs; created a Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part D; and provided incentives to programs that increase the federal government&#8217;s comparative effectiveness research.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other legislative changes have been proposed and adopted since the ACA was enacted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Budget Control Act of 2011, which, among other things, created measures for spending reductions by Congress. This includes aggregate reductions of Medicare payments to providers of 2% per fiscal year. Subsequent legislation extended the 2% reduction which remains in effect through 2031. Due to the Statutory Pay-As-You-Go Act of 2010, estimated budget deficit increases resulting from the American Rescue Plan Act of 2021, and subsequent legislation, Medicare payments to providers were further reduced starting on January 1, 2025; however legislation has been introduced in the U.S. Congress that would, if enacted, reverse these payment reductions. In addition to provider payment cuts under Medicare, the American Rescue Plan Act of 2021 also eliminated the statutory Medicaid drug rebate cap, previously set at 100% of a drug&#8217;s average manufacturer price, for single source and innovator multiple source drugs, beginning January 1, 2024. These laws and regulations may result in additional reductions in Medicare and other healthcare funding available for healthcare providers and may otherwise affect the prices we may obtain for any of our product candidates for which we may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The American Taxpayer Relief Act of 2012, among other things, reduced Medicare payments to several providers and increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 13, 2017, CMS published a final rule that gives states greater flexibility in setting benchmarks for insurers in the individual and small group marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 30, 2018, the Right to Try Act, was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a pharmaceutical manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On&#8239;May 23, 2019, CMS published a final rule to allow Medicare Advantage Plans the option of using step therapy for Part B drugs beginning January 1, 2020.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There has been increasing legislative and enforcement interest in the U.S. with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At a federal level, President Trump reversed some of President Biden&#8217;s executive orders including rescinding Executive Order 14087 entitled &#8220;Lowering Prescription Drug Costs for Americans." President Trump may issue new executive orders designed to impact drug pricing.  A number of these and other proposed measures may require authorization through additional legislation to become effective. Congress and the Trump administration have indicated that they will continue to seek new legislative measures to control drug costs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Inflation Reduction Act of 2022 (IRA) includes several provisions that may impact our business to varying degrees, including provisions that reduce the out-of-pocket spending cap for Medicare Part D beneficiaries from $7,050 to $2,000 which began in 2025, thereby effectively eliminating the coverage gap; impose new manufacturer financial liability on certain drugs under Medicare Part D, allow the U.S. government to negotiate Medicare Part B and Part D price caps for certain high-cost drugs and biologics without generic or biosimilar competition; require companies to pay rebates to Medicare for certain drug prices that increase faster than inflation; and delay until January 1, 2032 the implementation of the HHS rebate rule that would have limited the fees that pharmacy benefit managers can charge. Further, under the IRA, orphan drugs are exempted from the Medicare drug price negotiation program, but only if they have one orphan designation and for which the only approved indication is for that disease or condition. If a product receives multiple orphan designations or has multiple approved indications, it may not qualify for the orphan drug exemption. The implementation of the IRA is currently subject to ongoing litigation challenging the constitutionality of the IRA&#8217;s Medicare drug price negotiation program. The outcome of these challenges on the IRA, and the effects of the IRA on our business and the healthcare industry in general are not yet known.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that the healthcare reform measures that have been adopted and may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product and could seriously harm our future revenues. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private third-party payors.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal, and state levels directed at broadening the availability of healthcare and containing or lowering the cost of healthcare. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products. Such reforms could have an adverse effect on anticipated revenue from product candidates that we may successfully develop and for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="page28_1">&#160;</p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">European Union Drug Review and Approval</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Trial Approval</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, an applicant for authorization of a clinical trial must obtain prior approval from the national competent authority of the EU Member States in which the clinical trial is to be conducted. Furthermore, the applicant may only start a clinical trial at a specific study site after the relevant independent ethics committee has issued a favorable opinion. In April 2014, the EU adopted the Clinical Trials Regulation (EU) No 536/2014, which replaced the Clinical Trials Directive 2001/20/EC on January 31, 2022. It overhauls the system of approvals for clinical trials in the EU. Specifically, the Clinical Trials Regulation, which is directly applicable in all EU Member States (meaning that no national implementing legislation in each EU Member State is required), aims at simplifying and streamlining the approval of clinical trials in the EU. For instance, it provides for a streamlined application procedure via a single-entry point (instead of submitting applications separately to each national competent authority and ethics committee in the Member States in which the trial will be conducted) and strictly defined deadlines for the assessment of clinical trial applications. The Clinical Trials Regulation also makes it more efficient for EU Member States to evaluate and authorize applications together, via the Clinical Trials Information System. The transitory provisions of the Clinical Trials Regulation provide that, by January 31, 2025, all ongoing clinical trials must have transitioned to the Clinical Trials Regulation.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketing Authorization</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, medicinal products can only be commercialized after obtaining a marketing authorization. There are two types of marketing authorizations: (1) the centralized authorization, which is issued by the European Commission through the centralized procedure based on the opinion of the Committee for Medicinal Products for Human Use, or CHMP, a body of the EMA, and which is valid throughout the entire territory of the European Economic Area, or EEA (comprising the EU Member States plus Norway, Iceland and Liechtenstein); and (2) national marketing authorizations, which are issued by the competent authorities of the Member States and only authorize marketing in that Member State&#8217;s national territory and not the EEA as a whole.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The centralized procedure is mandatory for certain types of products, such as biotechnology medicinal products, orphan medicinal products, advanced therapy medicinal products (i.e., gene-therapy, somatic cell-therapy, and tissue-engineered medicines) and medicinal products containing a new active substance indicated for the treatment of HIV/AIDS, cancer, neurodegenerative disorders, diabetes, autoimmune disorders and other immune dysfunctions and viral diseases. The centralized procedure is optional for products containing a new active substance not yet authorized in the EU, or for products that constitute a significant therapeutic, scientific, or technical innovation or which are in the interest of public health in the EU. The EMA is responsible for the scientific evaluation of marketing authorization applications in the centralized procedure. The maximum timeframe for the evaluation of a marketing authorization application by the EMA is 210 days from receipt of a valid application, excluding clock stops when additional information or written or oral explanation is to be provided by the applicant in response to questions of the CHMP. Clock stops may extend the timeframe of evaluation of an application considerably beyond 210 days. Where the CHMP gives a positive opinion, the EMA provides the opinion together with supporting documentation to the European Commission, who makes the final decision to grant a marketing authorization, which is issued within 67 days of receipt of the EMA&#8217;s recommendation. Accelerated assessment may be granted by the CHMP in exceptional cases, when a medicinal product is of major interest from the point of view of public health and, in particular, from the viewpoint of therapeutic innovation. If the CHMP accepts such a request, the timeframe of 210 days for assessment will be reduced to 150 days (excluding clock stops), but it is possible that the CHMP may revert to the standard time limit for the centralized procedure if it determines that the application is no longer appropriate to conduct an accelerated assessment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">National marketing authorizations are for products not falling within the mandatory scope of the centralized procedure. Where a product has already been authorized for marketing in a Member State of the EU, this marketing authorization can be recognized in another Member State through the mutual recognition procedure. If the product has not received a national marketing authorization in any Member State at the time of application, it can be approved simultaneously in various Member States through the decentralized procedure. Under the decentralized procedure an identical dossier is submitted to the competent authorities of each of the Member States in which an authorization is sought, one of which is selected by the applicant as the Reference Member State, or RMS. If the RMS proposes to authorize the product, and the other Member States do not raise objections, the product is granted a national marketing authorization in all the Member States where the authorization was sought.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the above-described procedures, before granting the marketing authorization, the EMA or the competent authorities of the Member States of the EU make an assessment of the risk-benefit balance of the product on the basis of scientific criteria concerning its quality, safety, and efficacy.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="page29_1">&#160;</p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulatory exclusivity</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, innovative products authorized for marketing (i.e., reference products) may qualify for eight years of data exclusivity and an additional two years of market exclusivity upon marketing authorization. The data exclusivity period prevents generic or biosimilar applicants from relying on the preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization in the EU during a period of eight years from the date on which the reference product was first authorized in the EU. The market exclusivity period prevents a successful generic or biosimilar applicant from commercializing its product in the EU until ten years have elapsed from the initial authorization of the reference product. The ten-year market exclusivity period can be extended to a maximum of 11 years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. Even if an innovative medicinal product gains the prescribed period of data exclusivity, however, another company may market another version of the product if such company obtained marketing authorization based on a marketing authorization application with a complete and independent data package of pharmaceutical tests, preclinical tests, and clinical trials.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Orphan designation and exclusivity</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The criteria for designating an orphan medicinal product in the EU are similar in principle to those in the U.S. Under Regulation (EC) 141/2000, a medicinal product may be designated as an orphan product if the following criteria are fulfilled: (i) it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition; (ii) either (a) such condition affects no more than five in 10,000 persons in the EU when the application is made, or (b) the product, without the benefits derived from orphan status, would not generate sufficient return in the EU to justify the necessary investment in its development; and (iii) there exists no satisfactory method of diagnosis, prevention or treatment of such condition authorized for marketing in the EU, or if such a method exists, the product will be of significant benefit to those affected by the condition, as defined in Regulation (EC) 847/2000. Orphan medicinal products are eligible for financial incentives such as reduction of fees or fee waivers and are, upon grant of a marketing authorization, entitled to ten years of market exclusivity for the approved therapeutic indication. The application for orphan designation must be submitted before the application for marketing authorization. The applicant will receive a fee reduction for the marketing authorization application if the orphan designation has been granted, but not if the designation is still pending at the time the marketing authorization is submitted. Orphan designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ten-year market exclusivity period may be reduced to six years if, at the end of the fifth year, it is established that the product no longer meets the criteria for orphan designation, for example, if the product is sufficiently profitable not to justify maintenance of market exclusivity. Otherwise, during the period of market exclusivity, a marketing authorization may only be granted in the EU to a &#8220;similar medicinal product&#8221; to the authorized orphan product for the same therapeutic indication if:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a second applicant can establish that its product, although similar to the authorized orphan product, is safer, more effective, or otherwise clinically superior;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the marketing authorization holder for the authorized orphan product consents to a second orphan medicinal product application; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the marketing authorization holder for the authorized orphan product cannot supply enough orphan medicinal product.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A &#8220;similar medicinal product&#8221; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PRIME designation</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In March 2016, the EMA launched an initiative to facilitate development of product candidates in indications, often rare, for which few or no therapies currently exist. The PRIority MEdicines, or PRIME, scheme is intended to encourage product development in areas of unmet medical need and provides accelerated assessment of products representing substantial innovation, where the marketing authorization application will be made through the centralized procedure. Eligible products must target conditions for which there is an unmet medical need (i.e., there is no satisfactory method of diagnosis, prevention or treatment in the EU or, if there is, the new medicine will bring a major therapeutic advantage) and they must show potential to benefit patients with unmet medical needs based on early clinical data. Products from small- and medium-sized enterprises may qualify for earlier entry into the PRIME scheme than larger companies. Many benefits accrue to sponsors of product candidates with PRIME designation, including but not limited to, early and proactive regulatory dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and accelerated marketing authorization application assessment once a dossier has been submitted. Importantly, a dedicated contact and rapporteur from the EMA&#8217;s CHMP or Committee for Advanced Therapies are appointed early in PRIME scheme facilitating increased</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">understanding of the product at the EMA&#8217;s committee level. A kick-off meeting initiates these relationships and includes a team of multidisciplinary experts at the EMA to provide guidance on the overall development and regulatory strategies. Where, during the course of development, a medicine no longer meets the eligibility criteria, support under the PRIME scheme may be withdrawn.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All of the aforementioned EU rules are generally applicable in the EEA.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reform of the Regulatory Framework in the European Union</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The European Commission introduced legislative proposals in April 2023 that, if implemented, will replace the current regulatory framework in the EU for all medicines (including those for rare diseases and for children). The European Commission has provided the legislative proposals to the European Parliament and the European Council for their review and approval, and, in April 2024, the European Parliament proposed amendments to the legislative proposals. Once the European Commission&#8217;s legislative proposals are approved (with or without amendment), they will be adopted into EU law.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="page30_1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Brexit and the Regulatory Framework in the United Kingdom</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The UK formally left the EU on January 31, 2020, and the EU and the UK have concluded a trade and cooperation agreement, or TCA, which was provisionally applicable since January 1, 2021 and has been formally applicable since May 1, 2021. The TCA includes specific provisions concerning pharmaceuticals, which include the mutual recognition of GMP, inspections of manufacturing facilities for medicinal products and GMP documents issued but does not provide for wholesale mutual recognition of UK and EU pharmaceutical regulations. At present, the UK has implemented EU legislation on the marketing, promotion and sale of medicinal products through the Human Medicines Regulations 2012 (as amended). The regulatory regime in the UK therefore largely aligns with current EU regulations, however it is possible that these regimes will diverge in the future now that the UK&#8217;s regulatory system is independent from the EU and the TCA does not provide for mutual recognition of UK and EU pharmaceutical legislation. For example, the EU Clinical Trials Regulation does not apply in the UK and the current UK clinical trials legislation is based on the now repealed Clinical Trials Directive 2001/20/EC. However, on December 12, 2024, the UK government introduced a legislative proposal &#8211; the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 &#8211; that, if implemented, will replace the current regulatory framework for clinical trials in the UK. The legislative proposal aims to provide a more flexible regime to make it easier to conduct clinical trials in the UK and increase the transparency of clinical trials conducted in the UK. This includes a notification scheme to enable lower-risk clinical trials to be automatically approved by the MHRA, where the risk is similar to that of standard medical care (although such trials would still require ethics committee approval). Such Regulations are expected to come into force in early 2026. Notwithstanding that there is no wholesale recognition of EU pharmaceutical legislation under the TCA, under a new framework put in place by the MHRA on January 1, 2024, the MHRA may take into account decisions on the approval of marketing authorizations from the EMA (and certain other regulators) when considering an application for UK marketing authorizations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 27, 2023, the UK government and the European Commission announced a political agreement in principle to replace the Northern Ireland Protocol with a new set of arrangements, known as the &#8220;Windsor Framework&#8221;. The Windsor Framework was approved by the EU-UK Joint Committee on March 24, 2023, and the medicines aspects of the Windsor Framework have applied since January 1, 2025. This new framework fundamentally changes the existing system under the Northern Ireland Protocol, including with respect to the regulation of medicinal products in the UK. In particular, the MHRA is now responsible for approving all medicinal products destined for the UK market (Great Britain and Northern Ireland), and the EMA no longer has any role in approving medicinal products destined for Northern Ireland under the EU centralized procedure. A single UK-wide marketing authorization will be granted by the MHRA for all novel medicinal products to be sold in the UK, enabling products to be sold in a single pack and under a single authorization throughout the UK. In addition, the new arrangements require all medicines placed on the UK market to be labeled &#8220;UK only&#8221;, indicating they are not for sale in the EU.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Foreign Corrupt Practices Act</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Foreign Corrupt Practices Act, or the FCPA, prohibits any U.S. individual or business from paying, offering, or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the U.S. to comply with accounting provisions requiring us to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Additional Regulation</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the foregoing, state and federal laws regarding environmental protection and hazardous substances, including the Occupational Safety and Health Act, the Resource Conservancy and Recovery Act and the Toxic Substances Control Act, affect our business. These and other laws govern our use, handling and disposal of various biological, chemical and radioactive substances used in, and wastes generated by, our operations. If our operations result in contamination of the environment or expose individuals to hazardous substances, we could be liable for damages and governmental fines. We believe that we are in material compliance with applicable environmental laws and that continued compliance therewith will not have a material adverse effect on our business. We cannot predict, however, how changes in these laws may affect our future operations.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Regulations</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also subject to numerous federal, state and local laws relating to such matters as safe working conditions, manufacturing practices, environmental protection, fire hazard control, and disposal of hazardous or potentially hazardous substances. We may incur significant costs to comply with such laws and regulations now or in the future.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human Capital</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 28, 2025, we had 194 full-time employees and 1 part-time employee, 41 of whom have Ph.D. or M.D. degrees. Of these full-time employees, 158 employees are engaged in research and development activities and 36 are engaged in finance, business development and other general and administrative functions. None of our employees are represented by labor unions or covered by collective bargaining agreements, and we have not experienced any work stoppages. We consider our relations with our employees to be good.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize that attracting, motivating and retaining talent at all levels is vital to our continued success. Our employees are a significant asset, and we aim to create an equitable, inclusive and empowering environment in which our employees can grow and advance their careers, with the overall goal of developing, expanding and retaining our workforce to support our current pipeline and future business goals. By focusing on employee retention and engagement, we also improve our ability to support our clinical trials, our pipeline, our platform technologies, business and operations, and also protect the long-term interests of our securityholders.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success also depends on our ability to attract, engage and retain a diverse group of employees. Our efforts to recruit and retain a diverse and passionate workforce include providing competitive compensation and benefits packages and ensuring we listen to our employees.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We value innovation, passion, data-driven decision making, persistence and honesty, and are building a diverse environment where our employees can thrive and be inspired to make exceptional contributions to bring novel and more effective therapies to cancer patients.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, motivating and integrating our existing and future employees. The principal purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through grants of stock-based compensation awards and payments of cash-based performance bonus awards, in order to increase stockholder value and the success of our company by motivating our employees to perform to the best of their abilities and achieve our objectives. We are committed to providing a competitive and comprehensive benefits package to our employees. Our benefits package provides a balance of protection along with the flexibility to meet the individual health and wellness needs of our employees. We plan to continue to refine our efforts related to optimizing our use of human capital as we grow, including improvements in the way we hire, develop, motivate and retain employees.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Facilities</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our corporate headquarters is located at 830 Winter Street in Waltham, Massachusetts. The facility at 830 Winter Street is 51,100 square feet consisting of GMP clean room, laboratory, warehouse and office space, with a lease expiration of October 2029. We also lease a facility at 880 Winter Street which is 113,487 square feet of office and laboratory space with a lease termination date of December 2032.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that these facilities are adequate to meet our needs for the immediate future, and that, should it be needed, suitable additional space will be available to accommodate any such expansion of our operations.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are not currently a party to any material legal proceedings. From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:7pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Available Information</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our website address is </span><span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">https://www.tscan.com/</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The information contained on, or that can be accessed through, our website is not incorporated by reference into this Annual Report on Form 10-K or in any other report or document we have filed or may file with the Securities and Exchange Commission, or SEC, and any reference to our website address is intended to be an inactive textual reference only. We will make available on our website, free of charge, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The SEC maintains an Internet site, http://www.sec.gov, containing reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we routinely post on the &#8220;Investors and Media&#8221; page of our website investor and scientific presentations, SEC filings, press releases, public conference calls and webcasts and other statements about our business and results of operations, some of which may contain information that may be deemed material to investors. Accordingly, investors should monitor these portions of our website, in addition to following our press releases, SEC filings, public conference calls and webcasts, as well as our social media channels (our Twitter and LinkedIn). This list of channels may be updated from time to time on our investor relations website and may include other social media channels than the ones described above. The contents of our website or these channels, or any other website that may be accessed from our website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A copy of our Corporate Governance Guidelines, and Code of Conduct are posted on our website, </span><span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">https://www.tscan.com</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and are available in print to any person who requests copies by contacting us by calling (857) 399-9500 or by writing to TScan Therapeutics, Inc., 830 Winter Street, Waltham, Massachusetts 02451, Attention: Zoran Zdraveski.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1A. Risk Factors</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business involves a high degree of risk. You should carefully consider the material and other risks and uncertainties described and summarized below, as well as the other information in this Annual Report on Form 10-K, including our consolidated financial statements and related notes and the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Special Note Regarding Forward-Looking Statements,&#8221; as well as our other filings with the SEC, before you make an investment decision. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of factors that are described below and elsewhere in this Annual Report on Form 10-K. The risks described below are not the only risks that we face. The occurrence of any of the events or developments described below could materially and adversely affect our business, financial condition, results of operations and prospects. As a result, the market price of our common stock could decline, and you may lose all or part of your investment in our common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="font-size:10pt;margin-top:22pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISK FACTORS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Business and Industry</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have incurred significant losses since inception, and we expect to incur losses over the next several years and may not be able to achieve or sustain revenues or profitability in the future.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investment in biotechnology product development is a highly speculative undertaking and entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain regulatory approval and become commercially viable. We are still in the early stages of development of our product candidates and have initiated clinical trials for certain of our product candidates. We have no products licensed for commercial sale and have not generated any revenue from product sales to date, and we continue to incur significant research and development and other expenses related to our ongoing operations. We have financed our operations primarily through equity issuances, borrowings under secured loan agreements in September 2022 and December 2024 and upfront payments under our existing or previous collaborations.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant net losses in each period since our inception in April 2018. For the years ended December 31, 2024, 2023 and 2022, we reported net losses of $127.5 million, $89.2 million, and $66.2 million, respectively. As of December 31, 2024, we had an accumulated deficit of $375.1 million. We expect to continue to incur significant losses for the foreseeable future, and we expect these losses to increase substantially if and as we:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">continue our research and development efforts to identify and develop product candidates and submit additional IND applications for such product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conduct preclinical studies and commence and complete clinical trials for our current and future product candidates based on our proprietary platform; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">develop processes suitable for manufacturing and clinical development;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">continue to develop and expand our manufacturing capabilities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seek marketing approvals for any of our product candidates that successfully complete clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">build commercial infrastructure to support sales and marketing for our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expand, maintain and protect our intellectual property portfolio; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hire additional personnel; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">continue to operate as a public company. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the numerous risks and uncertainties associated with biotechnology product research and development, we are unable to accurately predict the timing or amount of the increased expenses we will incur or when, if ever, we will be able to achieve profitability. Even if we succeed in commercializing one or more of our product candidates, we will continue to incur substantial research and development expenses and other expenditures to develop, seek regulatory approval for, and market additional product candidates. We may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business. The size of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenue. Our prior losses and expected future losses have had and will continue to have an adverse effect on our stockholders&#8217; equity and working capital.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business depends upon the success of our proprietary platform.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends on our ability to use our proprietary platform (i) to discover the natural targets of clinically relevant TCRs through our TargetScan technology, (ii) to discover highly active TCRs for known targets through our ReceptorScan technology, (iii) to genetically engineer patient- or donor-derived T cells safely and reproducibly through our T-Integrate technology, (iv) to obtain regulatory approval for product candidates derived from our proprietary platform and related technologies, and (v) to then commercialize our product candidates that address one or more indications. All of our product candidates will require significant additional clinical and non-clinical development, review and approval by the FDA or other regulatory authorities in one or more jurisdictions, substantial investment, access to sufficient commercial manufacturing capacity and significant marketing efforts before they can be successfully commercialized. Our product candidates are currently being evaluated in humans and may never become commercialized. Moreover, all of our current product candidates are being developed using our proprietary platform and leveraging the same or similar technology, manufacturing process and development program. As a result, an issue with one product candidate or failure of any one program to obtain regulatory approval could adversely impact our ability to successfully develop and commercialize all of our other product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the success of our proprietary platform in discovering novel targets for TCR-T therapy product candidates is dependent on us obtaining tumor samples from cancer patients who actively respond to cancer immunotherapies. If our ability to obtain a significant amount of such tumor samples in a timely manner is compromised due to unforeseen circumstances, we may not be successful in discovering novel targets and creating new product candidates based on such targets.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our limited operating history may make it difficult to evaluate the success of our business to date and to assess our future viability.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biotechnology company with a limited operating history. We commenced operations in April 2018, and our operations to date have been limited to organizing and staffing our Company, business planning, raising capital, conducting discovery and research activities, filing patent applications, identifying potential product candidates, undertaking preclinical studies and initiating clinical trials, entering into licenses and collaborations, establishing capabilities to manufacture our product candidates, and establishing arrangements for component materials for such manufacturing. Although we have initiated clinical trials for certain of our product candidates, we have not yet demonstrated our ability to successfully conduct or complete any clinical trials, obtain marketing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approvals, manufacture clinical or commercial-scale product or arrange for a third party to do so on our behalf, or conduct sales, marketing and distribution activities necessary for successful product commercialization. Consequently, any predictions about our future success or viability may not be as accurate as they could be if we had a longer operating history.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as a young business, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. We eventually may need to transition at some point from a company with a research and development focus to a company capable of supporting commercial activities. We may not be successful in such a transition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect our financial condition and operating results to continue to fluctuate significantly from quarter to quarter and year to year due to a variety of factors, many of which are beyond our control. Accordingly, the results of any quarterly or annual periods should not be relied upon as indications of future operating performance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have never generated any revenue from sales of our TCR-T therapy product candidates and our ability to generate revenue from product sales and become profitable depends significantly on our success in a number of areas.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to become profitable depends upon our ability to generate revenue. To date, we have not generated any revenue from sales of any of our product candidates. We do not expect to generate significant revenue unless or until we successfully complete clinical development and obtain regulatory approval of, and then successfully commercialize, at least one of our product candidates. Although we have initiated clinical trials for certain of our product candidates, we have not yet demonstrated an ability to successfully complete clinical trials of our product candidates, obtain marketing approvals, manufacture a commercial-scale medicine, or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful commercialization to enable us to generate any revenue from product sales. Our other product candidates are in various stages of preclinical development and, as such, we face significant translational risk as we work to advance these product candidates to the clinical stage. Our ability to generate revenue depends on a number of factors, including, but not limited to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to develop processes suitable for clinical manufacturing and to obtain related chemistry, manufacturing, and controls (CMC) regulatory approvals; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">timely completion of our preclinical studies and clinical trials, which may be significantly slower or cost more than we currently anticipate and will depend substantially upon the performance of third-party contractors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to continue to complete IND-enabling studies and to continue to successfully submit INDs or comparable applications; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether we are required by the FDA or similar foreign regulatory authorities to conduct additional clinical trials or other studies beyond those planned to support the approval and commercialization of our product candidates or any future product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to demonstrate to the satisfaction of the FDA and similar foreign regulatory authorities the safety, potency, purity and acceptable risk to benefit profile of our product candidates or any future product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence, duration and severity of potential side effects or other safety issues, including adverse events, experienced with our product candidates or future product candidates, if any; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timely receipt of necessary marketing approvals from the FDA and similar foreign regulatory authorities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the willingness of physicians, operators of clinics and patients to utilize or adopt any of our product candidates or future product candidates to treat heme malignancies or solid tumors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability and the ability of our third-party contractors to manufacture adequate clinical and commercial supplies of our product candidates or any future product candidates, to remain in good standing with regulatory authorities and to develop, validate and maintain commercially viable manufacturing processes that are compliant with current good manufacturing practice (cGMP); </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to successfully develop a commercial strategy and thereafter commercialize our product candidates or any future product candidates in the U.S. and internationally, if licensed for marketing, reimbursement, sale and distribution in such countries and territories, whether alone or in collaboration with others; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patient demand for our product candidates and any future product candidates, if licensed; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish, obtain, maintain, protect and enforce intellectual property and proprietary rights in and to our product candidates or any future product candidates. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the factors listed above are beyond our control and could cause us to experience significant delays or prevent us from obtaining regulatory approvals or commercializing our product candidates. Even if we are able to commercialize our product candidates, we may not achieve profitability soon after generating product sales, if ever. If we are unable to generate sufficient revenue through the sale of our product candidates or any future product candidates, we may be unable to continue operations without continued funding.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will need to obtain substantial additional funding to complete the development and any commercialization of our product candidates, if approved. If we are unable to raise this necessary capital when needed, we could be forced to delay, reduce or eliminate our product development programs, commercialization efforts or other operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since our inception, we have financed our operations through equity issuances, upfront payments under our collaborations and through our debt financings. The development of biotechnology product candidates is capital intensive and we expect our expenses to increase substantially during the next few years. As our product candidates enter and advance through preclinical studies and clinical trials, we will need substantial additional funds to expand our clinical, regulatory, quality and manufacturing capabilities. In addition, if we obtain marketing approval for any of our product candidates, we expect to incur significant commercialization expenses related to marketing, sales, manufacturing and distribution. Furthermore, we expect to continue to incur additional costs associated with operating as a public company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had $290.1 million in cash, cash equivalents and marketable securities. We believe that our existing cash, cash equivalents and marketable securities will enable us to fund our current operating plan into the first quarter of 2027. Accordingly, our existing cash, cash equivalents and marketable securities will not be sufficient for us to fund any of our product candidates through regulatory approval, and we will need to raise substantial additional capital to complete the development and commercialization of our product candidates through equity offerings, debt financings, marketing and distribution arrangements and other collaborations, strategic alliances and licensing arrangements or other sources. We may also need to raise additional funds sooner if we choose to pursue additional indications for our product candidates or otherwise expand more rapidly than we presently anticipate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have based these estimates on assumptions that may prove to be incorrect or require adjustment as a result of business decisions, and we could utilize our available capital resources sooner than we currently expect. Our future capital requirements will depend on many factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, rate of progress, costs and results of our drug discovery, preclinical or clinical development activities, laboratory testing and clinical trials for our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and scope of clinical programs we decide to pursue; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope and costs of manufacturing development and commercial manufacturing activities and our ability to scale them up or out; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or in-license other product candidates and technologies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost, timing and outcome of regulatory review of our product candidates, including the potential for regulatory authorities to require that we conduct more studies and trials than those that we currently expect to conduct and the costs of post-marketing studies or risk evaluation and mitigation strategies that could be required by regulatory authorities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential changes in the regulatory environment and enforcement rules; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost and timing of establishing sales and marketing capabilities, if any of our product candidates receive marketing approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining, obtaining, protecting and enforcing our intellectual property and proprietary rights and defending intellectual property-related claims; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish new and maintain existing licensing or collaboration arrangements and the progress of the development efforts of third parties with whom we may enter into such arrangements; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of any public health crises or other external disruptions on our business, results of operations, development plans (including any supply related matters) and financial position; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our efforts to enhance operational systems and our ability to attract, hire and retain qualified personnel, including personnel to support the development of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential changes in pharmaceutical pricing and reimbursement infrastructure; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs associated with being a public company; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost associated with commercializing our product candidates, if they receive marketing approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Identifying potential product candidates and conducting preclinical studies and clinical trials is a time consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval. In addition, our product candidates, if approved, may not achieve product sales or commercial success. We do not expect to have any products commercially available for sale for many years, if at all. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. Adequate additional financing may not be available to us on acceptable terms, or at all, and may be impacted by the economic climate and market conditions. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, limit, reduce or eliminate our research and development programs or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. In addition, attempting to secure additional financing may divert the time and attention of management from day-to-day activities and distract from our research and development efforts. We may also seek additional capital due to favorable market conditions or strategic considerations, even if we believe we have sufficient funds for our current or future operating plans.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our intellectual property or product candidates on unfavorable terms to us.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may seek additional capital through a variety of means, including through collaboration arrangements, public or private equity or debt financings, third-party (including government) funding and marketing and distribution arrangements, as well as other strategic alliances and licensing arrangements or any combination of these approaches. However, there can be no assurance that we will be able to raise capital on commercially reasonable terms or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, our stockholder ownership interest will be diluted, and the terms may include liquidation preferences or other rights, powers or preferences that may adversely affect rights of our stockholders. To the extent that debt financing is available, and we choose to raise additional capital in the form of debt, such debt financing may involve agreements that include covenants limiting or restricting our ability to take certain actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional capital pursuant to collaborations, licensing arrangements or other strategic partnerships, such agreements may require us to relinquish rights to our technologies or product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to raise additional funds through equity or debt financings, or through collaborations, licensing arrangements or strategic partnerships or other sources when needed, we may be required to delay, limit, reduce or terminate our product development or commercialization efforts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Global economic uncertainty and financial market volatility caused by political instability, changes in international trade relationships and conflicts could make it more difficult for us to access financing and could adversely affect our business and operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to raise capital is subject to the risk of adverse changes in the market value of our stock. Periods of macroeconomic weakness or recession and heightened market volatility caused by adverse geopolitical developments could increase these risks, potentially resulting in adverse impacts on our ability to raise further capital on favorable terms. The impact of geopolitical tension, such as a deterioration in the bilateral relationship between the U.S. and China or in the ongoing conflicts between Russia and Ukraine, including resulting sanctions, export controls or other restrictive actions that may be imposed by the U.S. and/or other countries against governmental or other entities in, for example, Russia, also could lead to disruption, instability and volatility in global trade patterns, which may in turn impact our ability to source necessary reagents, raw materials and other inputs for our research and development operations. In addition, political developments impacting government spending and international trade, including changes in trade agreements, potential government shutdowns and trade disputes and tariffs, including tariffs that have been or may in the future be imposed by the United States or other countries and future legislation or actions taken by the United States or other countries that restrict trade, and protectionist or retaliatory measures taken by the United States or other countries, may negatively impact markets and cause weaker macroeconomic conditions. Any of the abovementioned factors could affect our business, prospects, financial condition, and operating results. The extent and duration of any political instability and resulting market disruptions are impossible to predict but could be substantial. Any such disruptions may also have the effect of heightening many of the other risks and uncertainties described elsewhere in this &#8220;Risk Factors&#8221; section.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The U.S. Congress, the Trump administration, or any new administration may make substantial changes to fiscal, tax, and other federal policies that may adversely affect our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2017, the U.S. Congress and the Trump administration made substantial changes to U.S. policies, which included comprehensive corporate and individual tax reform. In addition, the Trump administration called for significant changes to U.S. trade,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">healthcare, immigration and government regulatory policy in President Trump&#8217;s second term. The transitions between the Trump and Biden presidential terms led to substantial changes in the direction and focus of administrative and regulatory policies. Changes to U.S. policy implemented by the U.S. Congress, the Trump administration or any future administration have impacted and may in the future impact, among other things, the U.S. and global economy, international trade relations, unemployment, immigration, healthcare, taxation, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business. Until we know what policy changes are made, whether those policy changes are challenged and subsequently upheld by the court system and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent volatility in capital markets and lower market prices for many securities may affect our ability to access new capital through sales of shares of our common stock or issuance of indebtedness, which may impact our liquidity, limit our ability to grow our business, pursue acquisitions or improve our operating infrastructure and restrict our ability to compete in our markets.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operations consume substantial amounts of cash, and we intend to continue to make significant investments to support our business growth, respond to business challenges or opportunities, develop new products, retain or expand our current levels of personnel, support our programs, enhance our operating infrastructure, and potentially acquire complementary businesses and technologies. Our future capital requirements may be significantly different from our current estimates and will depend on many factors, including the need to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">finance unanticipated working capital requirements, including clinical manufacturing capacity; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">support our discovery and preclinical development activities, and clinical trials for our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pursue acquisitions or other strategic relationships; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respond to competitive pressures. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accordingly, we may need to pursue equity or debt financings to meet our capital needs. With uncertainty in the capital markets and other factors, such financing may not be available on terms favorable to us or at all. If we raise additional funds through further issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences, and privileges superior to those of holders of our common stock. Any debt financing secured by us in the future could involve additional restrictive covenants relating to our capital-raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. If we are unable to obtain adequate financing or financing on terms satisfactory to us, we could face significant limitations on our ability to invest in our operations and otherwise suffer harm to our business.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations and its financial condition and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. Although we are not a borrower or party to any financial instruments with any financial institution currently in receivership, if any of our lenders or counterparties to any such instruments were to be placed into receivership, we may be unable to access such funds.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inflation and rapid increases in interest rates have led to a decline in the trading value of previously issued government securities with interest rates below current market interest rates. Although the U.S. Department of Treasury, FDIC and Federal Reserve Board have announced a program to provide up to $25 billion of loans to financial institutions secured by certain of such government securities held by financial institutions to mitigate the risk of potential losses on the sale of such instruments, widespread demands for customer withdrawals or other liquidity needs of financial institutions for immediate liquidity may exceed the capacity of such program. There is no guarantee that the U.S. Department of Treasury, FDIC and Federal Reserve Board will provide access to uninsured funds in the future in the event of the closure of other banks or financial institutions, or that they would do so in a timely fashion.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we assess our banking relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect us, the financial institutions with which we have credit agreements or arrangements directly, or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of events or concerns that involve one or more of these factors could include a variety of material and adverse impacts on our current and projected business operations and our financial condition and results of operations. These could include, but may not be limited to, the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delayed access to deposits or other financial assets or the uninsured loss of deposits or other financial assets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loss of access to revolving existing credit facilities or other working capital sources and/or the inability to refund, roll over or extend the maturity of, or enter into new credit facilities or other working capital resources;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential or actual breach of contractual obligations that require us to maintain letters or credit or other credit support arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential or actual breach of financial covenants in our credit agreements or credit arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential or actual cross-defaults in other credit agreements, credit arrangements or operating or financing agreements; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">termination of cash management arrangements and/or delays in accessing or actual loss of funds subject to cash management arrangements.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or fulfill our other obligations, result in breaches of our financial and/or contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our current and/or projected business operations and financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, any further deterioration in the macroeconomic economy or financial services industry could lead to losses or defaults by our suppliers, which in turn, could have a material adverse effect on our current and/or projected business operations and results of operations and financial condition. For example, a supplier may determine that it will no longer deal with us as a customer. In addition, a supplier could be adversely affected by any of the liquidity or other risks that are described above as factors that could result in material adverse impacts on us, including but not limited to delayed access or loss of access to uninsured deposits or loss of the ability to draw on existing credit facilities involving a troubled or failed financial institution. Any supplier bankruptcy or insolvency, or any breach or default by a supplier, or the loss of any significant supplier relationships, could result in material losses to us and may material adverse impacts on our business.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The terms of our loan agreement place restrictions on our operating and financial flexibility. If we raise additional capital through debt financing, the terms of any new debt could further restrict our operating and financial flexibility.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 20, 2024 (the SVB Loan Effective Date), we entered into a Loan and Security Agreement (SVB Loan Agreement) with Silicon Valley Bank, a division of First-Citizens Bank &amp; Trust Company (SVB), pursuant to which, SVB will extend up to $52.5 million in a term loan facility, of which $32.5 million was fully funded at the SVB Loan Effective Date. A second tranche of $20.0 million may be funded at SVB&#8217;s sole discretion on or prior to June 30, 2026. Our obligations under the SVB Loan Agreement, are secured by a first-priority security interest on substantially all of our assets (other than intellectual property), subject to certain exceptions and will be guaranteed by each of our future direct or indirect subsidiaries, subject to certain exceptions. The SVB Loan Agreement contains customary representations and warranties, events of default and affirmative and negative covenants, including covenants that limit or restrict our and our subsidiaries&#8217; ability to, among other things, dispose of assets, make changes to its business, management, ownership or business locations, merge or consolidate, incur additional indebtedness, grant liens on its assets, pay dividends or other distributions, repurchase equity, make investments, and enter into certain transactions with affiliates, in each case subject to certain thresholds and exceptions. The SVB Loan Agreement does not require us to comply with a financial maintenance covenant. Upon the occurrence of an event of default, a default interest rate of an additional 3% may be applied to the outstanding loan balance at the sole</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">discretion of SVB and SVB may declare all outstanding obligations immediately due and payable and exercise all of its rights and remedies as set forth in the SVB Loan Agreement and under applicable law. Any declaration by SVB of an event of default could significantly harm our business and prospects and could cause the price of our common stock to decline. We may not have enough available cash or be able to raise additional funds through equity or debt financings to repay these outstanding obligations at the time any event of default occurs. Further, if we raise any additional capital through debt financing, the terms of such additional debt could further restrict our operating and financial flexibility.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to the Development of Our Product Candidates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our approach to the discovery and development of product candidates based on our proprietary platform represents a novel approach to cancer treatment, which creates significant challenges for us.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future success depends on the successful development of our product candidates, which target heme malignancies and solid tumors utilizing TCR-T therapy candidates. Advancing our product candidates creates significant challenges for us, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">educating medical personnel about the administration of TCR-T therapy candidates on a stand-alone basis or in combination with built-in immune and tumor modulators; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">educating medical personnel regarding the potential side effect profile related to our product candidates, such as the potential adverse side effects related to cytokine release syndrome, graft vs host disease (GvHD), neurotoxicity or autoimmune or rheumatologic disorders, which are the most common adverse side effects associated with engineered T cell therapies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">administering chemotherapy to patients in advance of administering our product candidates, which may increase the risk of adverse side effects; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sourcing clinical and, if licensed, commercial, supplies for the materials used to manufacture and process our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manufacturing TCR-T therapy candidates efficiently and consistently without the use of viral vectors using our T-Integrate technology; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">developing a complete shipment lifecycle and supply chain, including efficiently managing the shipment of patient cells from and to clinical sites, minimizing potential contamination to the cell product and effectively scaling manufacturing capacity to meet demand; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">developing processes suitable for clinical manufacturing and obtaining related CMC regulatory approvals; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">managing costs of inputs and other supplies while scaling production; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">using medicines to manage adverse side effects of our product candidates, which may not adequately control the side effects and/or may have a detrimental impact on the potency of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">using medicines to manage adverse side effects of chemotherapy and/or allogeneic stem cell transplantation, used prior to the administration of our product candidates, which may not adequately control the side effects and/or may have a detrimental impact on the potency of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining and maintaining regulatory approval from the FDA or comparable foreign regulatory authority for our product candidates; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establishing sales and marketing capabilities upon obtaining any regulatory approval to gain market acceptance of a novel therapy. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In developing our product candidates, we have not exhaustively explored different options in the design of the TCR construct and in the method for manufacturing TCR-T therapies. We may find that our existing TCR-T therapy product candidates and manufacturing process may be substantially improved with future design or process changes, necessitating development of new or additional TCR constructs and further clinical testing, which may delay the commercial launch of our product candidates. For example:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have made several TCR constructs and used preclinical studies to select product candidates to advance into clinical trials. The preclinical studies are limited in their ability to predict behavior in patients. As we gain experience working with TCR constructs, we may decide to select other TCR constructs for clinical development. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process by which patient cells are converted into a TCR-T product has many steps that can influence quality and activity. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have explored a subset of variables and expect to continue to improve and optimize the manufacturing process. Depending upon the nature of the process changes, we may be compelled to perform bridging studies and/or to re-start clinical development, causing delays in time to market and potentially introducing a risk of failure if new processes do not perform as expected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are early in our development efforts. If we are unable to advance our product candidates through clinical development, obtain regulatory approval and ultimately commercialize our product candidates, or experience significant delays in doing so, our business will be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are early in our development efforts. We have initiated clinical trials for a number of our product candidates, and other product candidates are still in preclinical development. Our ability to generate product revenues, which we do not expect will occur for many years, if ever, will depend significantly on the successful development and eventual commercialization of one or more of our product candidates. The success of our product candidates will depend on several factors, including the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">successful development of a process suitable for clinical manufacturing; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">successful completion of preclinical studies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">successful initiation of clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">successful patient enrollment in and completion of clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">receipt and related terms of marketing approvals and licensures from applicable regulatory authorities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining and maintaining patent and trade secret protection and regulatory exclusivity for our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">making arrangements with third-party manufacturers, or expanding our manufacturing capabilities, for both clinical and commercial supplies of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establishing sales, marketing and distribution capabilities and launching commercial sales of our product candidates, if and when approved, whether alone or in collaboration with others; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">acceptance of our product candidates, if and when approved, by patients, the medical community and third-party payors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining and maintaining third-party coverage and adequate reimbursement; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintaining a continued acceptable safety profile of our product candidates following licensure; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">effectively competing with other therapies including other cancer therapies. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or be unable to successfully commercialize our product candidates, which would materially harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Although many of our personnel have extensive experience in clinical development and manufacturing at other companies, we have limited direct experience as a company in conducting clinical trials and managing a manufacturing facility for our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although many of our personnel have extensive experience in clinical development and manufacturing at other companies, we have limited experience as a company in conducting clinical trials at TScan. In part because of this lack of experience, we cannot be certain that our ongoing preclinical studies or clinical trials will be completed on time or if the planned preclinical studies and clinical trials will begin or be completed on time, if at all. Large-scale clinical trials would require significant additional financial and management resources and reliance on third-party clinical investigators, contract research organizations (CROs) and consultants. Relying on third-party clinical investigators, CROs and consultants may force us to encounter delays that are outside of our control.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we have expanded our existing cell manufacturing facility, we have limited direct experience as a company in expanding or managing a manufacturing facility. In part because of this lack of experience, we cannot be certain that any further expansion of our existing manufacturing facility will be completed on time, if at all, or if the planned clinical trials will begin or be completed on time, if at all. In part because of our inexperience, we may have unacceptable or inconsistent product quality success rates and yields, and we may be unable to maintain adequate quality control, quality assurance and qualified personnel. In addition, when we switch from manufacturing in our own facility to manufacturing in a different facility (for example, at an external CDMO) for one or more of our product candidates or make changes to our manufacturing process, we may need to conduct additional preclinical studies to bridge our modified product candidates to earlier versions. Failure to successfully further expand our existing manufacturing capabilities could adversely affect our process and clinical development timelines, regulatory approvals, and the commercial viability</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business is highly dependent on our current product candidates, and we must complete IND-enabling studies and clinical testing before we can seek regulatory approval and begin commercialization of any of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is no guarantee that any of our product candidates will proceed through preclinical or clinical development or achieve regulatory approval. The process for obtaining marketing approval for any product candidate is very long and risky and there will be significant challenges for us to address in order to obtain marketing approval as planned or, if at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is no guarantee that the results obtained in current and planned preclinical studies or clinical trials of our current or future product candidates will be sufficient to obtain regulatory approval or marketing authorization for such product candidates. Negative results in the development of our lead product candidates may also impact our ability to obtain regulatory approval for our other product candidates, either at all or within anticipated timeframes because, although other product candidates may target different indications, the underlying proprietary platform, manufacturing process and development process is the same for all of our product candidates. Accordingly, a failure in any one of our programs may affect the ability to obtain regulatory approval to continue or conduct clinical programs for other product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, because we have limited financial and personnel resources and are placing significant focus on the development of our lead product candidates, we may forgo or delay pursuit of opportunities with other future product candidates that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs and other future product candidates for specific indications may not yield any commercially viable future product candidates. If we do not accurately evaluate the commercial potential or target market for a particular current or future product candidate, we may relinquish valuable rights to those product candidates through collaborations, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our preclinical studies and clinical trials may fail to demonstrate adequately the safety, potency and purity of any of our product candidates, which would prevent or delay development, regulatory approval and commercialization.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before obtaining regulatory approvals for the commercial sale of our product candidates, we must demonstrate through lengthy, complex and expensive preclinical studies and clinical trials that our product candidates are both safe and effective for use in each target indication. Preclinical and clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the preclinical study and clinical trial processes, and, because our product candidates are in an early stage of development, there is a high risk of failure, and we may never succeed in developing marketable products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of preclinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. There is typically an extremely high rate of attrition from the failure of product candidates proceeding through preclinical studies and clinical trials. Product candidates in later stages of clinical trials may fail to show the desired safety, potency and purity profile despite having progressed through preclinical studies and initial clinical trials. A number of companies in the biotechnology industry have suffered significant setbacks in advanced clinical trials due to lack of potency or efficacy, insufficient durability of potency or efficacy or unacceptable safety issues, notwithstanding promising results in earlier trials. Most product candidates that commence preclinical studies and clinical trials are never approved as products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any preclinical studies or clinical trials that we may conduct may not demonstrate the safety, potency and purity necessary to obtain regulatory approval to market our product candidates. If the results of our ongoing or future preclinical studies and clinical trials are inconclusive with respect to the safety, potency and purity of our product candidates, if we do not meet the clinical endpoints with statistical and clinically meaningful significance, or if there are safety concerns associated with our product candidates, we may be prevented or delayed in obtaining marketing approval for such product candidates. In some instances, there can be significant variability in safety, potency or purity results between different preclinical studies and clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the clinical trial protocols and the rate of dropout among clinical trial participants.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical development involves a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future clinical trial results. If our preclinical studies and clinical trials are not sufficient to support regulatory approval of any of our product candidates, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development of such product candidate.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot be certain that our ongoing and future preclinical study and clinical trial results will be sufficient to support regulatory approval of our product candidates. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Human clinical trials are expensive and difficult to design and implement, in part because they are subject to rigorous regulatory requirements. Failure or delay can occur at any time during the clinical trial process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may experience delays in obtaining the FDA&#8217;s authorization to initiate clinical trials under future IND applications, completing ongoing preclinical studies of our other product candidates, and initiating or completing our planned preclinical studies and clinical trials. Additionally, we cannot be certain that preclinical studies or clinical trials for our product candidates will begin on time, not require redesign, enroll an adequate number of subjects on time, or be completed on schedule, if at all. Clinical trials can be delayed or terminated for a variety of reasons, including delays or failures related to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA or comparable foreign regulatory authorities disagreeing as to the design or implementation of our clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in obtaining regulatory approval to commence a clinical trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reaching agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining institutional review board (IRB) approval at each clinical trial site; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recruiting or retaining an adequate number of suitable patients to participate in a clinical trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">having subjects complete a clinical trial or return for post-treatment follow-up; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trial sites deviating from the approved clinical trial protocol or dropping out of a clinical trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">addressing subject safety concerns that arise during the course of a clinical trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adding a sufficient number of clinical trial sites; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining sufficient product supply of product candidate for use in preclinical studies or clinical trials from third-party suppliers. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may experience numerous adverse or unforeseen events during, or as a result of, preclinical studies and clinical trials that could delay or prevent our ability to receive marketing approval or commercialize our product candidates, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may receive feedback from regulatory authorities that requires us to modify the design of our clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon our research efforts for our other product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of patients required for clinical trials of our product candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate or participants may drop out of our clinical trials at a higher rate than we anticipate; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our third-party contractors may fail to comply with regulatory requirements, fail to maintain adequate quality controls or be unable to provide us with sufficient product supply to conduct and complete preclinical studies or clinical trials of our product candidates in a timely manner, or at all; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we or our investigators might have to suspend or terminate clinical trials of our product candidates for various reasons, including non-compliance with regulatory requirements, a finding that our product candidates have undesirable side effects or other unexpected characteristics or a finding that the participants are being exposed to unacceptable health risks; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of clinical trials of our product candidates may be greater than we anticipate; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any public health crises may hinder our development or commercialization activities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the quality of our product candidates or other materials necessary to conduct preclinical studies or clinical trials of our product candidates may be insufficient or inadequate; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulators may revise the requirements for approving our product candidates, or such requirements may not be as we anticipate; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our current or future collaborators may conduct clinical trials in ways they view as advantageous to them but that are suboptimal for us. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are required to conduct additional clinical trials or other testing of our product candidates beyond those that we currently contemplate, if we are unable to successfully complete clinical trials of our product candidates or other testing, if the results of these trials or tests are not positive or are only moderately positive or if there are safety concerns, our business and results of operations may be adversely affected and we may incur significant additional costs. Accordingly, our clinical trial costs are likely to be significantly higher than those for more conventional therapeutic technologies or drug product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We could also encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions in which such clinical trials are being conducted, by the data safety monitoring board for such clinical trial or by the FDA or other regulatory authorities. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical trial protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from the product candidates, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we experience delays in the completion, or termination, of any preclinical study or clinical trial of our product candidates, the commercial prospects of our product candidates may be harmed, and our ability to generate revenues from any of these product candidates will be delayed or not realized at all. In addition, any delays in completing our preclinical studies or clinical trials may increase our costs, slow down our product candidate development and approval process and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business could be adversely affected by the effects of health epidemics in regions where we, our partners or other third parties on which we rely have significant manufacturing facilities, concentrations of potential clinical trial sites or other business operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Public health crises such as pandemics, epidemics, or similar outbreaks could adversely impact our business. For example, our materials suppliers could be disrupted by conditions related to epidemics, possibly resulting in disruption to our supply chain. If our suppliers are unable or fail to fulfill their obligations to us for any reason, we may not be able to manufacture our products and satisfy customer demand or our obligations under sales agreements in a timely manner, and our business could be harmed as a result.  Even when such public health crises are largely resolved, the lingering effects of such crises may continue to adversely affect our business operations, and the extent of the impact on our development and regulatory efforts and the future value of and market for our common stock will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may rely on third parties to manufacture our clinical product supplies, and we may rely on third parties to produce and process our product candidates, if licensed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have established facilities and engaged third-party contract manufacturers to manufacture our current product candidates. We rely on outside vendors to manufacture supplies for our manufacturing process, and we expect to rely on outside vendors to manufacture our product candidates for registration-enabling additional clinical trials as well as commercial sales. We have not yet manufactured or processed any product candidates on a commercial scale and may not be able to do so. We plan to optimize the existing manufacturing process to support product commercialization. The process modifications we intend to introduce will require regulatory approval of our product candidates, which could delay the commercialization of the products. We cannot be sure that such changes in the process will result in therapies that are efficacious and viable for commercial sale. In addition, changes in the manufacturing process may result in the need to conduct additional bridging clinical trials to demonstrate product comparability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The facilities used by us or any third-party contract manufacturers to manufacture and commercialize our product candidates must be approved by the FDA or other foreign regulatory authorities following inspections that will be conducted after we submit a Biologics License Application (BLA) to the FDA or other foreign regulatory authorities to support commercialization. We may not control the manufacturing process of, and may be completely dependent on, third-party contract manufacturing partners for compliance with cGMPs and any other regulatory requirements of the FDA or other regulatory authorities for the manufacture of our product candidates. We have limited control over the ability of any third-party contract manufacturers we engage to maintain adequate quality control, quality assurance and qualified personnel. Even with oversight, the third party may not be able to meet proper quality standards or its contractual obligations. If the FDA or a comparable foreign regulatory authority does not approve these facilities for the manufacture of our product candidates or if it withdraws any approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market our product candidates, if licensed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We, and any third-party contract manufacturers we engage to support our clinical trials, may experience manufacturing difficulties due to limited manufacturing experience, resource constraints or as a result of labor disputes, geopolitical and economic tensions with China, including as a result of the escalation of tariffs or other trade restrictions under the new administration or if previously proposed federal legislation known as the BIOSECURE ACT or a similar law were to be enacted, or unstable political environments.</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The pharmaceutical industry in general, and our suppliers or other third parties on which we rely, may depend on China-based suppliers for certain raw materials, products and services, or other activities. If we or our suppliers are unable to depend on these China-based suppliers or service providers, we may not be able to engage a backup or alternative supplier in a timely manner or at all. This, in turn, could materially and adversely affect our or our suppliers&#8217; ability to manufacture or supply products and product candidates which could materially and adversely affect our business. If we or any third-party contract manufacturers we engage were to encounter any of these</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulties, our ability to manufacture sufficient product supply for our preclinical studies and clinical trials, or to provide products for patients once approved, would be jeopardized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the materials and regents we expect to use in our processes are single or sole source, and/or have limited stability and as such supply disruptions could materially impact our ability to develop or manufacture products. In addition, the cell processing equipment and tubing that we use in our current manufacturing process is currently sourced from a single supplier. Any interruption in the supply by those single source suppliers could impact our ability to continue development of any and all of our product candidates on the anticipated timelines or at all. We may be unable to obtain these materials and products for an indeterminate period of time if any of these third parties were to cease or interrupt production or otherwise fail to supply these materials or products to us for any reason, including due to regulatory requirements or actions (including recalls), adverse financial developments at or affecting the supplier, or labor shortages or disputes. Regional or single-source dependencies may in some cases accentuate these risks.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We cannot guarantee that our product candidates will show any functionality in the solid tumor microenvironment.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot guarantee that our solid tumor product candidates will show any functionality in the solid tumor microenvironment. The cellular environment in which solid tumor cells thrive is generally hostile to T cells due to factors such as the presence of immunosuppressive cells, humoral factors and limited access to nutrients. Our TCR-T-based product candidates may not be able to access the solid tumor, and even if they do, they may not be able to exert anti-tumor effects in a hostile solid tumor microenvironment. As a result, our product candidates may not demonstrate potency in solid tumors. If we are unable to make our product candidates function in solid tumors, our development plans and business may be significantly harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Since the number of patients that we plan to dose in our initial clinical trials may be small, the results from such clinical trial, once completed, may be less reliable than results achieved in larger clinical trials, which may hinder our efforts to obtain regulatory approval for our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preliminary results of clinical trials with smaller sample sizes can be disproportionately influenced by various biases associated with the conduct of small clinical trials, such as the potential failure of the smaller sample size to accurately depict the features of the broader patient population, which limits the ability to generalize the results across a broader community, thus making the clinical trial results less reliable than clinical trials with a larger number of patients. As a result, there may be less certainty that such product candidates would achieve a statistically significant effect in any future clinical trials. If we conduct any future clinical trials, we may not achieve a statistically significant result or the same level of statistical significance, if any, that we might have anticipated based on the results observed in our initial clinical trials. In addition, patients who are undergoing allogeneic HCT are very sick and may pass away from complications of their standard clinical transplantation and treatments thus making it difficult to ascertain the beneficial effects of the added T cell therapy. Further, toxicities of the T cell therapy may be difficult to distinguish from the toxicity of the transplantation itself.</span></p>
  <p style="margin-left:4.533%;text-indent:0.433%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Allogeneic HCT is a high-risk procedure that may result in complications or adverse events for patients in our clinical trials including those unrelated to the use of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stem cell transplantation can cure patients across multiple diseases, but its use carries with it risks of toxicity, serious adverse events and death. Because many therapies are used to prepare or treat patients undergoing allogeneic HCT, patients in our clinical trials or patients that use any of our product candidates may be subject to many of the risks that are currently inherent to this procedure. In particular, stem cell transplant involves certain known potential post-procedure complications that may manifest several weeks or months after a transplant and which may be more common in certain patient populations. For example, autoimmune cytopenia is a known and severe frequent complication of the transplant procedure in certain patients, that can result in death. If these or other serious adverse events, undesirable side effects, or unexpected characteristics are identified during the development of any of our product candidates, we may need to limit, delay or abandon our further clinical development of those product candidates, even if such events, effects or characteristics were the result of stem cell transplant or related procedures generally, and not directly or specifically caused or exacerbated by our product candidates. All serious adverse events or unexpected side effects are continually monitored per the clinical trial&#8217;s approved protocol. If serious adverse events are determined to be directly or specifically caused or exacerbated by our hematology product candidates, we would follow the clinical trial protocol&#8217;s requirements, which call for our data safety monitoring committee to review all available clinical data in making a recommendation regarding the trial&#8217;s continuation.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to file IND applications or IND amendments to commence additional clinical trials on the timelines we expect, and even if we are able to, the FDA may not permit us to proceed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have initiated clinical trials for our solid tumor program and we expect to submit additional IND applications for our solid tumor program. However, we may not be able to file such IND application on the timelines we expect. For example, we may experience manufacturing delays or other delays with IND-enabling studies. Moreover, we cannot be sure that submission of an IND application</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">will result in the FDA allowing clinical trials to begin, or that, once begun, issues will not arise that suspend or terminate clinical trials. Additionally, even if such regulatory authorities agree with the design and implementation of the clinical trials set forth in an IND application, we cannot guarantee that such regulatory authorities will not change their requirements in the future. These considerations also apply to new clinical trials we may submit as amendments to existing IND applications.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, one of our key goals is to develop treatments consisting of a combination of TCR-Ts, which we refer to as multiplex TCR-T therapy. Our plan is to assess the safety and preliminary efficacy of multiplex TCR-T therapy early in the clinical development of our product candidates. While the FDA has cleared our T-Plex IND application, which allows us to combine our product candidates with each other in a multiplex TCR-T therapy, we must still provide safety data for each individual product candidate or each variation or combination of a multiplex TCR-T therapy. Any such requirements could result in material delays in the development timelines of our multiplex TCR-T therapy candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates may cause undesirable side effects or have other properties that could halt their clinical development, prevent their regulatory approval, require expansion of the trial size, limit their commercial potential, or result in other significant negative consequences.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Undesirable side effects caused by our product candidates could cause us or regulatory authorities, including IRBs, to interrupt, delay, or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other comparable foreign regulatory authorities. Further, clinical trials by their nature utilize a sample of the potential patient population. With a limited number of subjects and limited duration of exposure, rare and severe side effects of our product candidates may only be uncovered with a significantly larger number of patients exposed to the drug. Because of the design of the dose escalation of our planned Phase 1 clinical trials, undesirable side effects could also result in an expansion in the size of our clinical trials, increasing the expected costs and timeline of our clinical trials. Additionally, results of our clinical trials could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics, which may stem from our therapies specifically or may be due to an illness from which the clinical trial subject is suffering.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, there could be an increased risk of GvHD with our TCR-T therapy product candidates in the post-HCT setting. GvHD is a common toxicity in patients undergoing allogeneic HCT, the focus of our heme malignancies program. GvHD occurs because donor T cells, which are part of the standard stem cell product, misrecognize antigens in the patient as foreign and attack tissues and organs that express those antigens. GvHD may be worsened by our TCR-T therapy product candidates because they are derived from donor T cells. While the engineered T cells express a new TCR that is specific for the intended target antigen and is not expected to cause GvHD, those T cells may have low levels of endogenous TCR that have the potential to misrecognize patient antigens as foreign and worsen GvHD.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In solid tumor patients, autoimmunity may occur after TCR-T treatment. TCR-T therapies are generated from a patient&#8217;s own T cells isolated from their peripheral blood. There is a risk that this process will expand a patient&#8217;s own T cell that has autoreactivity, or that may recognize healthy cells, and upon re-infusion may trigger an autoimmune reaction resulting in damage to normal tissues and potentially even death.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Autoimmune reaction triggered by an interaction between a patient&#8217;s naturally occurring antibodies and engineered T cells is a theoretical safety risk of product candidates we develop using our proprietary platform. If a patient&#8217;s self-generated antibodies were directed to a target expressed on the surface of cells in normal tissue (autoantibodies), engineered T cells would be directed to attack these same tissues, potentially resulting in off-tumor effects. These autoantibodies may be present whether or not the patient has an active autoimmune disorder. In our clinical testing, we plan to take steps to minimize the likelihood that this occurs, for example by excluding patients with a history of a severe autoimmune disorder from our trials. There is no guarantee, however, that we will be able to implement interventions to address the risk of autoimmune reactions if and when they occur.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, immunogenicity, which is the reaction between a patient&#8217;s immune system and a foreign protein outside of the autoimmune context, is an additional theoretical safety risk of product candidates we develop using our proprietary platform. Patients&#8217; immune systems may recognize the TCR construct on the TCR-T product as a foreign protein and fight against it, potentially rendering it ineffective, or even provoking an allergic/anaphylactoid response or other adverse side effects. The immunogenic potential of novel therapeutics like TCR-T therapies is difficult to predict. There is no guarantee that we will be able to implement interventions to address the risk of observation of immunogenic reactions if and when they occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If unacceptable toxicities arise in the development of our product candidates, we could suspend or terminate our clinical trials or the FDA or comparable foreign regulatory authorities, or local regulatory authorities such as IRBs, could order us to cease clinical trials. Competent national health authorities, such as the FDA, could also deny approval of our product candidates for any or all targeted indications. Treatment-related side effects could also affect patient recruitment or the ability of enrolled patients to complete the clinical trial or result in potential product liability claims. In addition, these side effects may not be appropriately recognized or managed by the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">treating medical staff, as toxicities resulting from T cell therapy are not normally encountered in the general patient population and by medical personnel. We expect to have to train medical personnel using our product candidates to understand the side effect profile of our product candidates for both our planned clinical trials and upon any commercialization of any product candidates, if licensed. Inadequate training in recognizing or managing the potential side effects of our product candidates could result in patient deaths. Any of these occurrences may significantly harm our reputation as well as business, financial condition and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Certain patients may lack sufficient T cells for our autologous product candidates to be effective.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For autologous TCR-T therapy, our TCR-T therapy product candidates are manufactured by using a vector to insert genetic information encoding the TCR construct into the patient&#8217;s own T cells. This manufacturing process is dependent on collecting a sufficient number of T cells from the patient at the clinical site. We may not be able to effectively treat some patients if an insufficient number of T cells were collected at the clinical site to enable our manufacturing process, which could adversely impact our ability to progress the clinical development of such product candidates and could also adversely impact the commercial viability of such product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates may target healthy cells expressing target antigens leading to potentially fatal adverse effects.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates target specific antigens that are also potentially expressed on healthy cells. Our product candidates may target healthy cells, leading to serious and potentially fatal adverse effects. In our planned clinical trials of our product candidates, we plan to use a dose escalation model to closely monitor the effect of our product candidates on vital organs and other potential side effects. Even though we intend to closely monitor the side effects of our product candidates in both preclinical studies and clinical trials, we cannot guarantee that products will not target and kill healthy cells.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates may have serious and potentially fatal cross-reactivity to other peptides or protein sequences within the body.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates may recognize and bind to a peptide unrelated to the target antigen to which it is designed to bind. If this peptide is expressed within normal tissues, our product candidates may target and kill the normal tissue in a patient, leading to serious and potentially fatal adverse effects. Detection of any cross-reactivity may halt or delay any ongoing clinical trials for any of our TCR-T therapy product candidates and prevent or delay regulatory approval. Unknown cross-reactivity of the TCR-T binding domain to related proteins could also occur. We have also developed a preclinical screening process to identify cross-reactivity of T cell binders. Any cross-reactivity that impacts patient safety could materially impact our ability to advance our product candidates into clinical trials or to proceed to marketing approval and commercialization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The vectors used to manufacture our TCR-T therapy product candidates may incorrectly modify the genetic material of a patient&#8217;s T cells, potentially triggering the development of a new cancer or other adverse events.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our TCR-T therapy product candidates are manufactured by using a vector to insert genetic information encoding the TCR construct into the patient&#8217;s T cells. The TCR construct is then integrated into the natural TCR complex and transported to the surface of the patient&#8217;s T cells. Because the vector modifies the genetic information of the T cell, there is a risk that modification will occur in the wrong place in the T cell&#8217;s genetic code, leading to vector-related insertional oncogenesis, and causing the T cell to become cancerous. If the cancerous T cell is then administered to the patient with the TCR-T therapy product candidates, the cancerous T cell could trigger the development of a new cancer in the patient. We use non-viral transposon/transposase to insert genetic information into T cells. The risk of insertional oncogenesis remains a concern for gene therapy and we cannot guarantee that it will not occur in any of our ongoing or planned preclinical studies or clinical trials. There is also the potential risk of delayed adverse events following exposure to gene therapy products due to persistent biological activity of the genetic material or other components of vectors used to carry the genetic material. The FDA has stated that vectors possess characteristics that may pose high risks of delayed adverse events. Non-viral transposon/transposase systems have limited clinical history, and their safety profile is still to be determined. If any such adverse events occur, further advancement of our preclinical studies or clinical trials could be halted or delayed, which would have a material adverse effect on our business and operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may experience difficulties in patient enrollment in our clinical trials for a variety of reasons. The timely completion of clinical trials in accordance with their approved protocols depends on, among other things, our ability to enroll a sufficient number of patients who remain in the clinical trial until its conclusion. The enrollment of patients depends on many factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patient eligibility criteria defined in the clinical trial protocol, particularly those who meet the requisite genetic criteria. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for our heme malignancies program, the ability to find a donor who must be mismatched with the patient either for the HLA type or the minor antigen type to ensure that the engineered T cell therapy does not recognize donor-derived blood cells; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any impact of public health crises on clinical trial initiation and enrollment; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the size of the patient population required for analysis of the clinical trial&#8217;s primary endpoints; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the proximity of patients to clinical trial sites; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the design of the clinical trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to recruit clinical trial investigators with the appropriate competencies and experience; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain and maintain patient consents; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reporting of the preliminary results of any of our clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">risk that patients enrolled in clinical trials will drop out of the clinical trial or pass away from disease-related complications or complications from their standard clinical therapy before they can experience benefits of the engineered T cell therapy; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for patients in our solid tumor program, the patient's need for sufficient T cells in order for the engineered T cell product to be manufactured from their autologous T cells. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, our clinical trials will compete with other clinical trials for product candidates that are in the same therapeutic areas as our product candidates, and this competition will reduce the number and types of patients available to us because some patients who might have opted to enroll in our clinical trials may instead opt to enroll in a clinical trial being conducted by one of our competitors. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our clinical trials at such clinical trial sites. Moreover, because our product candidates represent a departure from more commonly used methods for cancer treatment, potential patients and their doctors may be inclined to use conventional therapies, such as chemotherapy and HCT, rather than enroll patients in any future clinical trial. Additionally, because some of our clinical trials are expected to be in patients with relapsed/refractory cancer, the patients are typically in the late stages of their disease and may experience disease progression independent from our product candidates, making them unevaluable for purposes of the clinical trial and requiring additional patient enrollment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delays in completing patient enrollment may result in increased costs or may affect the timing or outcome of our ongoing and planned clinical trials, which could prevent completion or commencement of these clinical trials and adversely affect our ability to advance the development of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and development of biotechnology products is inherently risky. We may not be successful in our efforts to use and enhance our TScan technology discovery platform and TCR technologies to create a pipeline of product candidates and develop commercially successful products, or we may expend our limited resources on programs that do not yield a successful product candidate and fail to capitalize on product candidates or diseases that may be more profitable or for which there is a greater likelihood of success. If we fail to develop additional product candidates, our commercial opportunity will be limited.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are at an early stage of development and our TScan technology discovery platform has not yet led, and may never lead, to approved or commercially successful products. All of our current product candidates are being developed by leveraging the same or similar underlying proprietary platform, manufacturing process and development program. As a result, an issue with one product candidate or failure of any one program to obtain regulatory approval could lead to a failure of our entire pipeline of product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we are successful in continuing to build our pipeline, obtaining regulatory approvals and commercializing additional product candidates may require substantial additional funding and are prone to the risks of failure inherent in biotechnology product development.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investment in biotechnology product development involves significant risk that any potential product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain regulatory approval, and become commercially viable. We cannot provide any assurance that we will be able to successfully advance any of these additional product candidates through the development process. Our research programs may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development or commercialization for many reasons, including the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our research methodology, including our screening technology, may not successfully identify additional product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our pursuit of difficult-to-drug targets may make it challenging to design potential product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">results of clinical trials conducted by others on similar indications or on compounds with similar mechanisms of action could result in our having to conduct additional or cost prohibitive clinical trials, which could delay development and possibly make commercialization prohibitively expensive; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may encounter product manufacturing difficulties that limit yield, produce undesirable characteristics, that increase the cost of goods, cause delays, or make the product candidates unmarketable; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our product candidates may cause adverse effects in patients or subjects, even after successful initial toxicology studies, which may make the product candidates unmarketable; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our product candidates may not demonstrate a meaningful benefit to patients or subjects; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our collaboration partners may change their development profiles or plans for potential product candidates or abandon a therapeutic area or the development of a partnered product. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of these events occur, we may be forced to abandon our development efforts for a program or programs, which would have a material adverse effect on our business, operating results and prospects and could potentially cause us to cease operations. Research programs to identify new product candidates require substantial technical, financial and human resources. We may focus our efforts and resources on potential programs or product candidates that ultimately prove to be unsuccessful.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to identify suitable compounds for preclinical and clinical development, we will not be able to obtain revenues from the sale of drugs in future periods, which likely would result in significant harm to our business prospects and financial position.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The market opportunities for our product candidates may be relatively small. In addition, our estimates of the prevalence of our target patient populations may be inaccurate.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cancer therapies are sometimes characterized as first line, second line, or third line, and the FDA often approves new therapies initially only for a particular line of use. When cancer is detected early enough, first-line therapy is sometimes adequate to cure the cancer or prolong life without a cure. Whenever first-line, usually chemotherapy, antibody drugs, tumor-targeted small molecules, hormone therapy, radiation therapy, surgery, or a combination of these, proves unsuccessful (refractory disease) or the cancer returns after a disease-free interval (relapsed disease), subsequent lines of therapy may be required to manage the disease and/or disease-related side-effects. We expect to initially seek approval for use of our TCR-T therapy product candidates to treat patients with heme malignancies, including acute myeloid leukemia, or AML, myelodysplastic syndromes, or MDS, and acute lymphocytic leukemia, or ALL, who are undergoing allogeneic HCT. While HCT provides a potentially curable option for patients with intermediate and high-risk disease, disease relapse remains the main cause of treatment failure and constitutes a significant unmet medical need. For our solid tumor product candidates, we expect to initially seek approval in patients with a history of relapsed disease or refractory disease. For those product candidates that prove to be sufficiently safe and beneficial, if any, we would expect to seek approval in earlier lines of therapy, as appropriate, but there is no guarantee that our product candidates would be licensed for an earlier line of therapy, and, prior to any such approvals, we may have to conduct additional clinical trials. Consequently, the potentially addressable patient population for our product candidates may be extremely limited or may not be amenable to treatment with our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our projections of both the number of people who have the cancers we are targeting, as well as the subset of people with these cancers in a position to receive a particular line or type of therapy and who have the potential to benefit from treatment with our product candidates, are based on our beliefs and estimates. These estimates have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations or market research, and may prove to be incorrect. Further, new therapies may change the estimated incidence or prevalence of the cancers that we are targeting. Consequently, even if our product candidates are approved, the number of patients that may be eligible for treatment with our product candidates may turn out to be much lower than expected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates rely on the use of protein binding domains, or binders, to target specific cancers, which we may develop, or which may be developed by third parties. We are limited in our ability to apply our product candidates to a wider range of potential target cancers by our ability to develop, partner for or acquire these binders on commercially reasonable terms.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TCR-T therapies require the use of antigen-specific protein binding domains (binders) which guide the TCR-Ts and bind to the antigens on the surface of a tumor to target specific types of cancers. Our ability to develop and commercialize our product candidates will depend on our ability to develop these binders or partner for such binders on commercially reasonable terms for use in clinical trials as well as the availability of such binders for use in commercialized products, if licensed. We cannot ensure that we will have a steady supply of binders that we can utilize in combination with the TCR construct to develop our product candidates. If we are unable to enter into such collaborations on commercially reasonable terms or fail to realize the benefits of any such collaboration, we may be limited to using antibody fragments that we are able to independently develop which may limit the ability of our product candidates to target and kill cancer cells.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The failure to enter into a successful collaboration or to develop our own binders may delay our development timelines, increase our costs and jeopardize our ability to develop future product candidates as a commercially viable drug, which could result in delays in product development and harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We currently have no marketing and sales organization and have no experience as a company in marketing products. If we are unable to establish marketing and sales capabilities or to enter into agreements with third parties to market and sell our product candidates, if licensed, we may not be able to generate product revenue.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently have no sales, marketing or distribution capabilities and have no experience as a company in marketing products. We intend to develop an in-house marketing organization and sales force, which will require significant capital expenditures, management resources and time. We will have to compete with other pharmaceutical and biotechnology companies to recruit, hire, train and retain marketing and sales personnel.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable or decide not to establish internal sales, marketing and distribution capabilities, we will pursue collaborative arrangements regarding the sales and marketing of our product candidates, if licensed. However, there can be no assurance that we will be able to establish or maintain such collaborative arrangements, or if we are able to do so, that they will have effective sales forces. Any revenue we receive will depend upon the efforts of such third parties, which may not be successful. We may have little or no control over the marketing and sales efforts of such third parties and our revenue from product sales may be lower than if we had commercialized our product candidates ourselves. We may also face competition in our search for third parties to assist us with the sales and marketing efforts of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There can be no assurance that we will be able to develop in-house sales and distribution capabilities or establish or maintain relationships with third-party collaborators to commercialize any product in the U.S. or overseas.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we obtain regulatory approval of our product candidates, the products may not gain market acceptance among physicians, patients, hospitals, cancer treatment centers and others in the medical community.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The use of engineered T cells as a potential cancer treatment is a recent development and may not become broadly accepted by physicians, patients, hospitals, cancer treatment centers and others in the medical community. Various factors will influence whether our product candidates are accepted in the market, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the clinical indications for which our product candidates are licensed; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">physicians, hospitals, cancer treatment centers and patients considering our product candidates as a safe and effective treatment; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the potential and perceived advantages of our product candidates over alternative treatments; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to demonstrate the advantages of our product candidates over other TCR-T therapies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence and severity of any side effects; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence and severity of any side effects for other adoptive cell therapies, TCR-T therapies and public perception of other adoptive cell therapies and TCR-T therapies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product labeling or product insert requirements of the FDA or other regulatory authorities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limitations or warnings contained in the labeling approved by the FDA; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing of market introduction of our product candidates as well as competitive products; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of treatment in relation to alternative treatments; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of adequate coverage, reimbursement and pricing by third-party payors and government authorities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">willingness of patients to pay out-of-pocket in the absence of coverage by third-party payors and government authorities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">relative convenience and ease of administration, including as compared to alternative treatments and competitive therapies; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the effectiveness of our sales and marketing efforts. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, although we are not utilizing embryonic stem cells or replication competent vectors, adverse publicity due to the ethical and social controversies surrounding the therapeutic use of such technologies, and reported side effects from any clinical trials using these technologies or the failure of such clinical trials to demonstrate that these therapies are safe and effective may limit market acceptance of our product candidates. If our product candidates are licensed but fail to achieve market acceptance among physicians, patients, hospitals, cancer treatment centers or others in the medical community, we will not be able to generate significant revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, although our product candidates differ in certain ways from other TCR-T therapy approaches, serious adverse events or deaths in other clinical trials involving engineered TCR, or other T cell products or with our use of licensed TCR-T therapy candidates, even if not ultimately attributable to our product candidates, could negatively impact our business. For example, in November 2023, the FDA announced that it would conduct an investigation into reports of T cell malignancies following BCMA-directed or CD19-directed autologous CAR-T cell immunotherapies following reports of T cell lymphoma in patients receiving these therapies. In January 2024, the FDA determined that new safety information related to T cell malignancies should be included in the boxed warning in the labeling for BCMA- and CD-19-directed genetically modified autologous T cell immunotherapies. While our TCR-T therapy product candidates utilize a different mechanism of action, the FDA&#8217;s investigation into CAR-T therapies and other similar actions could result in increased government regulation, unfavorable public perception and publicity, potential impacts on enrollment in our clinical trials, potential regulatory delays in the testing, approval or licensing of our product candidates, stricter labeling requirements, or decreased demand for our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if our product candidates achieve market acceptance, we may not be able to maintain that market acceptance over time if new products or technologies are introduced that are more favorably received than our product candidates, are more cost effective or render our product candidates obsolete.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A variety of risks associated with marketing our product candidates internationally could materially adversely affect our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We plan to seek regulatory approval of our product candidates outside of the U.S. and, accordingly, we expect that we will be subject to additional risks related to operating in foreign countries if we obtain the necessary approvals, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">differing regulatory requirements in foreign countries; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unexpected changes in tariffs (including tariffs that have been or may in the future be imposed by the United States or other countries), trade barriers (including further legislation or actions taken by the United States or other countries that restrict trade), price and exchange controls and other regulatory requirements; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">economic weakness, including inflation, or political instability in particular foreign economies and markets; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign taxes, including withholding of payroll taxes; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulties staffing and managing foreign operations; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">workforce uncertainty in countries where labor unrest is more common than in the U.S.; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential liability under the Foreign Corrupt Practices Act of 1977 or comparable foreign regulations; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the U.S.; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">business interruptions resulting from geo-political actions, including war and terrorism. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These and other risks associated with international operations may materially adversely affect our ability to attain or maintain profitable operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We face significant competition, and our operating results will suffer if we fail to compete effectively.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The biotechnology industry is characterized by intense competition and rapid innovation. Our competitors may be able to develop other products or drugs that are able to achieve similar or better results. Our potential competitors include larger biotechnology and pharmaceutical companies with greater resources than us, academic institutions, governmental agencies, public and private research institutions and early stage or smaller companies. Many of our competitors have substantially greater financial, technical and other resources, such as larger research and development staff, experienced marketing and manufacturing organizations and well-established sales forces. Further, our competitors may have more financial resources, greater access to capital and diversified product offerings and revenue sources, which may give our competitors an advantage over us. In addition, many of these competitors are active in seeking patent protection and licensing arrangements in anticipation of collecting royalties for use of technology that they have developed. Mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more resources being concentrated in our competitors. Competition may increase further as a result of advances in the commercial applicability of technologies and greater availability of capital for investment in these industries. Our competitors, either alone or with collaborative partners, may succeed in developing, acquiring or licensing on an exclusive basis drug or biologic products that are more effective, safer, more easily commercialized or less costly than our product candidates or may develop proprietary technologies or secure patent protection that we may need for the development of our technologies and products. We believe the key competitive factors that will affect the development and commercial success of our product candidates are safety, potency, purity, tolerability, reliability, convenience of use, price and reimbursement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specifically, by genetically engineering T cell therapies, we face significant competition in the TCR space from many companies. For additional information regarding our competition, see &#8220;Item 1. Business &#8211; Competition&#8221; in this Annual Report. Even if we obtain regulatory approval of our product candidates, the availability and price of our competitors&#8217; products could limit the demand and the price we are able to charge for our product candidates. We may not be able to implement our business plan if the acceptance of our product candidates is inhibited by price competition or the reluctance of physicians to switch from existing methods of treatment to our product candidates, or if physicians switch to other new drug or biologic products or choose to reserve our product candidates for use in limited circumstances. Moreover, the development and manufacturing costs associated with engineered T cell therapies may make it difficult to compete with alternative products that may be simpler and cheaper to develop and manufacture.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our internal computer systems, or those used by our third-party CROs, our clinical sites, or other contractors or consultants, may fail or suffer cybersecurity incidents, data breaches or other unauthorized or improper access, which could result in a material disruption of the development programs of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Despite the implementation of security measures, our internal computer systems and those of our current and future CROs, our clinical sites, and other contractors and consultants are vulnerable, and like companies in our industry, we have experienced a variety of disruptions and data privacy and information security threats and incidents. These cyberattacks may include cybersecurity incidents, data breaches, attacks by hackers and other malicious third parties (including the deployment of computer viruses, malware, ransomware, denial-of-service attacks, social engineering fraud (including phishing attacks), and other events that affect service reliability and threaten the confidentiality, integrity, and availability of information), unauthorized access, natural disasters, fires, terrorism, war, telecommunications or electrical interruptions or failures, employee error or malfeasance or other malicious or inadvertent disruptions, including inadvertent or intentional wrongful actions by insider employees and vendors. For example, the ongoing conflict between Russia and Ukraine has led to an increase in cyberattacks on the Ukraine, including its government, companies, institutions and people, as well on the financial and communications infrastructure of other countries, companies and individuals therein. Additionally, the increased usage of computers operated on home networks may make our or our partners&#8217; systems more susceptible to cybersecurity incidents or data breaches. While we have not experienced any such material system failure, cybersecurity incident, or data breaches, if such a material event were to occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our business operations. For example, the loss of data from ongoing or completed or future preclinical studies and clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, similar events relating to the computer systems of our third party vendors or manufacturers could also have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unauthorized disclosure of sensitive or confidential data, including personally identifiable information, whether through a cybersecurity incident, data breach, systems failure, employee negligence, fraud or misappropriation, or otherwise, or unauthorized access to or through our information systems and networks, whether by our employees or third parties, could result in negative publicity, legal liability and damage to our reputation. Unauthorized disclosure of personally identifiable information could also expose us to sanctions for violations of data privacy laws and regulations around the world.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we become more dependent on information technologies to conduct our operations, cybersecurity incidents, including deliberate attacks and attempts to gain unauthorized access to computer systems and networks, may increase in frequency and sophistication. These threats pose a risk to the security of our systems and networks and to the confidentiality, availability and integrity of our data, and these risks apply both to us and to third parties on whose systems we rely for the conduct of our business. Because the techniques used to obtain unauthorized access, disable or degrade service or sabotage systems change frequently and often are not recognized until launched against a target, we and our partners or collaborators may be unable to anticipate these techniques or to implement adequate preventative measures. Further, we do not have any control over the operations of the facilities or technology of our cloud and service providers, including any third-party vendors that collect, process and store personal data on our behalf. Our systems, servers and platforms and those of our service providers may be vulnerable to cybersecurity incidents or data breaches, computer viruses or physical or electronic break-ins that our or their security measures may not detect. Individuals able to circumvent such security measures may misappropriate our confidential or proprietary information, disrupt our operations, damage our computers or otherwise impair our reputation and business. We may need to expend significant resources and make significant capital investments to protect against cybersecurity incidents or data breaches or to mitigate the impact of any such cybersecurity incidents or data breaches. There can be no assurance that we or our third-party providers will be successful in preventing cyber-attacks or successfully mitigating their effects. To the extent that any disruption or cybersecurity incident or data breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the further development and commercialization of our product candidates could be delayed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cybersecurity incidents, loss of data or modification of information, and other disruptions could compromise information related to our business or prevent us from accessing critical information, result in a significant disruption of our activities and expose us to liability, which could adversely affect our business and our reputation.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of our business, we collect and store information, including personal information, intellectual property and proprietary business information that we own or control or have an obligation to protect. For example, we collect and store research and development information, employee data, commercial information, customer information and business and financial information. We and our service providers, including security and infrastructure vendors, manage and maintain our data using a combination of on-site systems and cloud-based data centers. We face a number of risks related to protecting critical information, including inappropriate use or disclosure, unauthorized access or acquisition, or inappropriate modification of, critical information. We also face the risk of being unable to access our critical information or technology systems due to actual or threats of ransomware, unauthorized encryption, or other malicious activity. We face the risk of being unable to adequately monitor, audit and modify our controls over our critical information. These risks extend to third-party service providers and subcontractors we use to assist us in managing our information or otherwise process it on our behalf. The secure processing, storage, maintenance and transmission of our critical information is vital to our operations and business strategy, and we devote significant resources to protecting such information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we take reasonable measures to protect critical information and other data from unauthorized access, acquisition, use or disclosure, our information technology and infrastructure and that of our service providers handling and storing information on our behalf may be vulnerable to a variety of disruptions, including cybersecurity incidents, data breaches, attacks by hackers and other malicious third parties (including the deployment of computer viruses, malware, ransomware, denial-of-service attacks, social engineering (including phishing attacks), and other events that affect service reliability and threaten the confidentiality, integrity, and availability of information), unauthorized access, natural disasters, fires, terrorism, war, telecommunications or electrical interruptions or failures, employee error or malfeasance or other malicious or inadvertent disruptions. In particular, the risk of a cybersecurity incident, data breach or disruption, particularly through cyber-attacks or cyber intrusion, has generally increased as the number, intensity, and sophistication of attempted attacks and intrusions from around the world have increased. We may not be able to anticipate all types of security threats, and we may not be able to implement preventive measures that are effective against all such security threats. Because the techniques used by cyber criminals change frequently, may not be recognized until launched, and can originate from a wide variety of sources, including outside groups such as external service providers, organized crime affiliates or terrorist organizations, we and our service providers and other partners may be unable to anticipate these techniques or implement adequate preventative measures. Further, we do not have any control over the operations of the facilities or technology of third parties that collect, process and store sensitive information on our behalf. Any unauthorized access or acquisition, cybersecurity incident, data breach, or other loss, of information could result in legal claims or proceedings, and liability under federal, state or foreign laws regarding the privacy and protection of information, including personal information, and could disrupt our operations and harm our reputation. In addition, notice of cybersecurity incidents or data breaches may be required to affected individuals, regulators, credit reporting agencies or the media. Any such publication or notice could harm our reputation and our ability to compete. The financial exposure from the events referenced above could either not be insured against or not be fully covered through any insurance that we may maintain, and there can be no assurance that the limitations of liability in any of our contracts would be enforceable or adequate or would otherwise protect us from liabilities or damages as a result of the events referenced above. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Manufacturing</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Manufacturing and administering our product candidates is complex and we may encounter difficulties in production, particularly with respect to process development or scaling up of our manufacturing capabilities. If we encounter such difficulties, our ability to provide supply of our TCR-T therapy product candidates for clinical trials or for commercial purposes could be delayed or stopped.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process of manufacturing and administering our product candidates is complex and highly regulated. The manufacture of our product candidates involves complex processes, including the manufacture of a transposon containing the genetic information for our TCR construct, a transposase used to insert the transposon genetic information into the T cell genome, and manufacturing operations to ensure the safety, integrity, strength, sterility, purity, and quality of the final product. More specifically, the manufacture of our product candidates includes harvesting white blood cells from the patient, isolating certain T cells from the white blood cells, combining patient T cells with our delivery vector through a process known as transfection, selection of modified T cells from the population, expanding the selected transfected T cells to obtain the desired dose, aseptically filling product into vessels suitable for storage, distribution, and clinical dosing, and ultimately infusing the engineered T cells back into the patient&#8217;s body. As a result of the complexities entailed in this process, our manufacturing and supply costs may be higher than those of more traditional manufacturing processes and the manufacturing process may be less reliable and more difficult to reproduce. Additionally, the number of facilities that are capable of harvesting patients&#8217; cells for the manufacture of our product candidates and other autologous cell therapy products and product candidates is limited. As the number of autologous cell therapy products and product candidates increases, the limited number of facilities capable of harvesting patients&#8217; cells could result in delays in the manufacture and administration of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently rely on our internal manufacturing facility for clinical manufacturing, and any disruption to this facility could impact our ability to advance our clinical trials. We currently rely on third parties for the manufacture of our non-viral vector and other components of our manufacturing process, and we have engaged a global third-party manufacturer to support the manufacture of products for our clinical trials. These third-party manufacturers may incorporate their own proprietary processes into our components. We have limited control and oversight of a third party&#8217;s proprietary process, and a third party may elect to modify its process without our consent or knowledge. These modifications could negatively impact our manufacturing, including product loss or failure that requires additional manufacturing runs or a change in manufacturer, both of which could significantly increase the cost of and significantly delay the manufacture of our product candidates. In addition, we are currently reliant on a single manufacturer for our transposon and transposase components, and many of the critical raw materials and reagents used in the process are single or sole source. These third-party providers may not be able to provide adequate resources, capacity to meet our needs, timely delivery of material, or may change internal processes or specifications that adversely affect our process or product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our manufacturing process is and will be susceptible to product loss or failure due to logistical issues, manufacturing issues associated with the differences in patients&#8217; white blood cells, interruptions in the manufacturing process or supply chain, contamination, equipment or reagent failure, process design flaws, operator error, power failures, supplier error and variability in patient characteristics. Even minor deviations from normal manufacturing processes could result in reduced production yields, product defects, product rejection, or other supply disruptions. If for any reason we lose a patient&#8217;s white blood cells, such material gets contaminated or processing steps fail at any point, the manufacturing process of the TCR-T therapy product candidate for that patient will need to be restarted, if possible, and the resulting delay may adversely affect that patient&#8217;s outcome. If microbial, viral, or other contaminations are discovered in our product candidates or in the manufacturing facilities in which our product candidates or critical raw materials or reagents are made or administered, such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As our product candidates progress through preclinical studies and clinical trials towards licensure and commercialization, it is expected that various aspects of the manufacturing and administration process will be altered in an effort to optimize processes and results. We have already identified some improvements to our manufacturing and administration processes, but these changes may not achieve the intended objectives, and could cause our product candidates to perform inadequately affecting the results of ongoing or future clinical trials. In addition, any changes may require amendments to be made to regulatory applications or necessitate development of new or additional TCR constructs and further clinical testing, which may further delay the timeframes under which modified manufacturing processes can be used for any of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Developing a commercially viable process is a difficult and uncertain task, and there are risks associated with scaling to the level required for advanced clinical trials or commercialization, including, among others, increased costs, potential problems with process scale-out or scale-up, process reproducibility, stability issues, lot consistency, facility suitability or capacity, staffing, and availability of reagents or raw materials. Competitors have had difficulty reliably producing T cell therapies in the commercial setting. If we experience similar challenges manufacturing product candidates to approved specifications, this may limit our product candidates&#8217; utilization and our ability to receive payment for these product candidates once approved. We may ultimately be unable to reduce the expenses associated with our product candidates to levels that will allow us to achieve a profitable return on investment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Although many of our personnel have experience in clinical manufacturing at other companies, we have limited experience as a company managing manufacturing for our product candidates, which will be costly, time-consuming, and which may not be successful.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have limited experience as a company in setting up, building or managing a manufacturing facility or manufacturing suite, and may never be successful in managing our own manufacturing suite, manufacturing facility or manufacturing capability. We will need to hire additional personnel to manage our operations and facilities and develop the necessary infrastructure to continue the research and development, and eventual commercialization, if licensed, of our product candidates. If we fail to recruit the required personnel, manage our growth effectively, have inadequate facility design or construction, or fail to select the correct location, the development and production of our product candidates could be curtailed or delayed. Although we have established a manufacturing facility, our manufacturing capabilities could be affected by cost-overruns, unexpected delays, equipment failures, design or construction flaws, labor shortages, supply disruptions, natural disasters, power failures and numerous other factors that could prevent us from realizing the intended benefits of our manufacturing strategy and have a material adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the FDA, the European Medicines Agency (EMA), and other foreign regulatory authorities may require us to submit samples of any lot of any licensed product together with the protocols showing the results of applicable tests at any time. Under some circumstances, the FDA, the EMA or other foreign regulatory authorities may require that we not distribute a lot until the relevant agency authorizes its release. Slight deviations in the manufacturing process, including those affecting quality attributes and stability, may result in unacceptable changes in the product that could result in lot failures or product recalls, or inability to manufacture product in the future. Lot failures or product recalls could cause us to delay or forgo product launches or clinical trials, which could be costly to us and otherwise harm our business, financial condition, results of operations and prospects. Problems in our manufacturing process or quality control testing could restrict our ability to meet market demand for our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also may encounter problems hiring and retaining the experienced scientific, quality-control and manufacturing personnel needed to operate our manufacturing processes and facility, which could result in delays in production or difficulties in maintaining compliance with applicable regulatory requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may have difficulty validating our manufacturing process as we manufacture TCR-T therapy product candidates from an increasingly diverse patient population for our clinical trials.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we develop our clinical products, we may encounter unforeseen difficulties due to quality, quantity, supply timing, or variability issues with donor starting materials and may not be able to develop a robust process or incur additional costs or delays in developing a robust process due to starting material variation or supply.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we believe our current manufacturing process is scalable for commercialization, we may encounter challenges in validating our process due to the heterogeneity of the product starting material. While we anticipate that during the early phases of our clinical trials we will be able to adapt our process to account for these differences resulting in a more robust process, we cannot guarantee that issues relating to the heterogeneity of the starting material will not impact our ability to manufacture our product candidates for clinical or commercial distribution.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Government Regulation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The regulatory approval process is lengthy and time-consuming, and we may experience significant delays in the clinical development and regulatory approval of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not previously submitted a BLA to the FDA or similar licensure applications to comparable foreign regulatory authorities. A BLA, or similar licensing application, must include extensive preclinical and clinical data and supporting information to establish the product candidate&#8217;s safety, purity, and potency for each desired indication and must also include significant information regarding the manufacturing controls for the product. We expect the novel nature of our product candidates to create further challenges in obtaining regulatory approval. Accordingly, the regulatory approval pathway for our product candidates may be uncertain, complex, expensive and lengthy, and licensure may not be obtained.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also experience delays in completing planned clinical trials for a variety of reasons, including delays related to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of financial resources to commence and complete the planned trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reaching agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining approval at each clinical trial site by an IRB or ethics committee; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recruiting suitable patients to participate in a clinical trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">having patients complete a clinical trial or return for post-treatment follow-up; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">70</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trial sites deviating from trial protocol or dropping out of a trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adding new clinical trial sites; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manufacturing sufficient quantities of qualified materials under cGMPs, including current Good Tissue Practice (cGTPs), and applying them on a subject-by-subject basis for use in clinical trials.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We could also experience delays if physicians encounter unresolved ethical issues associated with enrolling patients in clinical trials of our product candidates in lieu of prescribing existing treatments that have established safety, efficacy, potency and purity profiles. Further, a clinical trial may be suspended or terminated by us, the IRBs for the institutions in which such trials are being conducted, the data monitoring committee for such trial, or by the FDA or other regulatory authorities due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a product candidate, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. If we experience termination of, or delays in the completion of, any clinical trial of our product candidates, the commercial prospects for our product candidates will be harmed, and our ability to generate product revenue will be delayed. In addition, any delays in completing our clinical trials will increase our costs, slow down our product development and approval process and jeopardize our ability to commence product sales and generate revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securing regulatory approval also requires the submission of information about the biologic manufacturing process and inspection of manufacturing facilities by the relevant regulatory authority. The FDA or comparable foreign regulatory authorities may fail to approve our manufacturing processes or facilities, whether run by us or our third-party CDMOs. In addition, if we make manufacturing changes to our product candidates in the future, we may need to conduct additional preclinical studies or clinical trials to bridge our modified product candidates to earlier versions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may ultimately lead to the denial of regulatory approval of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be unable to obtain regulatory approval for our product candidates under applicable regulatory requirements. The denial or delay of any such approval would delay commercialization of our product candidates and adversely impact our potential to generate revenue, our business and our results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The research, testing, manufacturing, labeling, licensure, sale, marketing and distribution of biologic products are subject to extensive regulation by the FDA and other regulatory authorities in the U.S. and other countries, and such regulations differ from country to country. We are not permitted to market our product candidates in the U.S. or in any foreign countries until they receive the requisite licensure from the applicable regulatory authorities of such jurisdictions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA or any foreign regulatory authorities can delay, limit or deny licensure of our product candidates for many reasons, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our inability to demonstrate to the satisfaction of the FDA or the applicable foreign regulatory authority that any of our product candidates are safe, potent and pure; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA&#8217;s or the applicable foreign regulatory agency&#8217;s disagreement with our trial protocol or the interpretation of data from preclinical studies or clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our inability to demonstrate that the clinical and other benefits of any of our product candidates outweigh any safety or other perceived risks; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA&#8217;s or the applicable foreign regulatory agency&#8217;s requirement for additional preclinical studies or clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for licensure; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA&#8217;s or the applicable foreign regulatory agency&#8217;s failure to approve our manufacturing processes or facilities or those of third-party manufacturers upon which we rely; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the potential for approval policies or regulations of the FDA or the applicable foreign regulatory authorities to significantly change in a manner rendering our clinical data insufficient for licensure; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">71</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the data collected from clinical trials of our product candidates may not be sufficient to the satisfaction of the FDA or comparable foreign regulatory authorities to support the submission of a BLA or other comparable submission in foreign jurisdictions or to obtain licensure of our product candidates in the U.S. or elsewhere; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these factors, some of which are beyond our control, may result in our failing to obtain regulatory approval to market any of our product candidates, which would significantly harm our business, results of operations, and prospects. Of the large number of biological products in development, only a small percentage successfully complete the FDA or other regulatory approval processes and are commercialized. Even if we eventually complete clinical testing and receive licensure from the FDA or applicable foreign regulatory authorities for any of our product candidates, the FDA or the applicable foreign regulatory agency may grant licensure contingent on the performance of costly additional clinical trials which may be required after licensure. The FDA or the applicable foreign regulatory agency also may license our product candidates for a more limited indication or a narrower patient population than we originally requested, and the FDA, or applicable foreign regulatory agency, may not license our product candidates with the labeling that we believe is necessary or desirable for the successful commercialization of such product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, even if the trials are successfully completed, preclinical and clinical data are often susceptible to varying interpretations and analyses, and we cannot guarantee that the FDA or comparable foreign regulatory authorities will interpret the results as we do, and more clinical trials could be required before we submit our product candidates for approval. To the extent that the results of the clinical trials are not satisfactory to the FDA or comparable foreign regulatory authorities for support of a marketing application, approval of our product candidates may be significantly delayed, or we may be required to expend significant additional resources, which may not be available to us, to conduct additional clinical trials in support of potential approval of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any delay in obtaining, or inability to obtain, applicable regulatory approval would delay or prevent commercialization of our product candidates and would materially adversely impact our business and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may seek orphan drug status for some of our current or future product candidates, but we may be unable to obtain such designations or to maintain the benefits associated with orphan drug status, including market exclusivity, which may cause our revenue, if any, to be reduced.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition, defined as a disease or condition with a patient population of fewer than 200,000 in the U.S., or a patient population greater than 200,000 in the U.S. when there is no reasonable expectation that the cost of developing and making available the drug or biologic in the U.S. will be recovered from sales in the U.S. for that drug or biologic. Orphan drug designation must be requested before submitting a BLA. In the U.S., orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and user-fee waivers. After the FDA grants orphan drug designation, the generic identity of the drug and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a product that has orphan drug designation subsequently receives the first FDA approval for a particular active ingredient for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications, including a BLA, to market the same biologic for the same indication for seven years, except in limited circumstances such as a showing of clinical superiority to the product with orphan drug exclusivity or if FDA finds that the holder of the orphan drug exclusivity has not shown that it can assure the availability of sufficient quantities of the orphan drug to meet the needs of patients with the disease or condition for which the drug was designated. As a result, even if one of our product candidates receives orphan exclusivity, the FDA can still approve other drugs that have a different active ingredient for use in treating the same indication or disease. Furthermore, the FDA can waive orphan exclusivity if we are unable to manufacture sufficient supply of our product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may seek orphan drug designation for some or all of our current or future product candidates in additional orphan indications in which there is a medically plausible basis for the use of these products. Even when we obtain orphan drug designation, exclusive marketing rights in the U.S. may be limited if we seek licensure for an indication broader than the orphan designated indication and may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. In addition, although we intend to seek orphan drug designation for other product candidates, we may never receive such designations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">72</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not know if, when, or how the FDA may change the orphan drug regulations and policies in the future, and it is uncertain how any changes might affect our business. Depending on what changes the FDA may make to its orphan drug regulations and policies, our business could be adversely impacted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A Breakthrough Therapy designation by the FDA, even if granted for any of our product candidates, may not lead to a faster development or regulatory review or approval process and it does not increase the likelihood that our product candidates will receive marketing approval.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We plan to seek a Breakthrough Therapy designation for our current product candidates and may seek Breakthrough Therapy designation for some or all of our future product candidates. A Breakthrough Therapy is defined as a drug or biologic that is intended, alone or in combination with one or more other drugs or biologics, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the drug, or biologic, may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For product candidates that have been designated as Breakthrough Therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Biologics designated as Breakthrough Therapies by the FDA may also be eligible for other expedited approval programs, including Accelerated Approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designation as a Breakthrough Therapy is within the discretion of the FDA. Accordingly, even if we believe one of our product candidates meets the criteria for designation as a Breakthrough Therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a Breakthrough Therapy designation for a product candidate may not result in a faster development process, review or licensure compared to candidate products considered for licensure under non-expedited FDA review procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify as Breakthrough Therapies, the FDA may later decide that the product no longer meets the conditions for qualification. Thus, even though we intend to seek Breakthrough Therapy designation for some or all of our future product candidates for the treatment of various cancers, there can be no assurance that we will receive Breakthrough Therapy designation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A Fast Track designation by the FDA, even if granted for any of our current or future product candidates, may not lead to a faster development or regulatory review or approval process, and does not increase the likelihood that our product candidates will receive marketing approval.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a drug is intended for the treatment of a serious or life-threatening condition and the drug demonstrates the potential to address unmet medical needs for this condition, the drug sponsor may apply for FDA Fast Track designation for a particular indication. We plan to seek Fast Track designation for our current product candidates and may seek Fast Track designation for certain of our future product candidates, but there is no assurance that the FDA will grant this status to any of our proposed product candidates. Marketing applications filed by sponsors of products in Fast Track development may qualify for priority review under the policies and procedures offered by the FDA, but the Fast Track designation does not assure any such qualification or ultimate marketing approval by the FDA. The FDA has broad discretion whether or not to grant Fast Track designation, so even if we believe a particular product candidate is eligible for this designation, there can be no assurance that the FDA would decide to grant it. Even if we do receive Fast Track designation, we may not experience a faster development process, review or licensure compared to conventional FDA procedures, and receiving a Fast Track designation does not provide assurance of ultimate FDA approval. In addition, the FDA may withdraw Fast Track designation if it believes that the designation is no longer supported by data from our clinical development program. In addition, the FDA may withdraw any Fast Track designation at any time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may seek Accelerated Approval from the FDA for any of our current or future product candidates. Accelerated Approval, even if granted, for any of our current or future product candidates, may not lead to a faster development, or regulatory review or approval process, and it does not increase the likelihood that our product candidates will receive marketing approval.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We plan to seek approval of our current product candidates and may seek approval of future product candidates using the FDA&#8217;s Accelerated Approval pathway. A product may be eligible for Accelerated Approval if it treats a serious or life-threatening condition and generally provides a meaningful advantage over available therapies. In addition, it must demonstrate an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality (IMM) that is reasonably likely to predict an effect on IMM or other clinical benefit. As a condition of approval, the FDA may require that a sponsor of a drug or biologic receiving Accelerated Approval perform adequate and well-controlled post-marketing clinical trials. These confirmatory trials must be completed with due diligence. In addition, the FDA currently requires, unless otherwise informed by the agency, pre-approval of promotional materials for products receiving Accelerated Approval, which could adversely impact the timing of the commercial launch of the product. Even if we do receive Accelerated Approval, we may not experience a faster development, regulatory review or approval process for that product. In addition, receiving Accelerated Approval does not provide assurance of ultimate FDA approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">73</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A Regenerative Medicine Advanced Therapy (RMAT) designation by the FDA, even if granted for any of our product candidates, may not lead to a faster development or regulatory review or approval process, and does not increase the likelihood that our product candidates will receive marketing approval and we may be unable to obtain or maintain the benefits associated with such designation.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have obtained and may continue to seek an RMAT designation for some of our product candidates. In May 2024, we announced that the FDA granted RMAT designation for TSC-100 and TSC-101 for the treatment of patients with AML, ALL, and MDS undergoing HCT with reduced intensity conditioning. An RMAT is defined as cell therapies, therapeutic tissue engineering products, human cell and tissue products, and combination products using any such therapies or products, except for those regulated solely under Section 361 of the Public Health Service Act. The RMAT program is intended to facilitate efficient development and expedite review of RMATs which are intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition and where preliminary clinical evidence indicates the product has the potential to address unmet medical needs for such disease or condition. A BLA for an RMAT may be eligible for priority review if it meets the criteria for priority review, or for accelerated approval based on surrogate or intermediate endpoints reasonably likely to predict long-term clinical benefit or reliance upon data obtained from a meaningful number of sites. Benefits of RMAT designation include all the benefits of the Fast Track and Breakthrough Therapy designation programs, including early interactions with the FDA, which could include interactions with FDA to discuss any potential surrogate or intermediate endpoint to be used to support accelerated approval. An RMAT that is granted accelerated approval and is subject to post-approval requirements may fulfill such requirements through the submission of clinical evidence, clinical studies, patient registries, or other sources of real-world evidence, such as electronic health records; the collection of larger confirmatory data sets; or post-approval monitoring of all patients treated with such therapy prior to its approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RMAT designation is within the discretion of the FDA. Accordingly, even if we believe one of our product candidates meets the criteria for RMAT designation and seek RMAT designation for such product candidate, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of RMAT designation for a product candidate may not result in a faster development, review or approval process compared to product candidates considered for approval under non-expedited FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify for RMAT designation, the FDA may later decide that the product candidate no longer meets the conditions for qualification.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may seek designation for our TargetScan platform as a designated platform technology, but we might not receive such designation, and even if we do, such designation may not lead to a faster regulatory review or approval process</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may seek designation for our TargetScan platform as a designated platform technology. Under the Food and Drug Omnibus Reform Act of 2022 (FDORA), a platform technology incorporated within or utilized by a biological product is eligible for designation as a designated platform technology if (1) the platform technology is incorporated in, or utilized by, a biological product approved under a BLA; (2) preliminary evidence submitted by the sponsor of the licensed biological product, or a sponsor that has been granted a right of reference to data submitted in the application for such biological product, demonstrates that the platform technology has the potential to be incorporated in, or utilized by, more than one biological product without an adverse effect on quality, manufacturing, or safety; and (3) data or information submitted by the applicable person indicates that incorporation or utilization of the platform technology has a reasonable likelihood to bring significant efficiencies to the biological product development or manufacturing process and to the review process. A sponsor may request the FDA to designate a platform technology as a designated platform technology concurrently with, or at any time after, submission of an IND application for a biological product that incorporates or utilizes the platform technology that is the subject of the request. If so designated, the FDA may expedite the development and review of any subsequent original BLA for a biological product that uses or incorporates the platform technology. Even if we believe our TargetScan platform technology meets the criteria for such designation, the FDA may disagree and instead determine not to grant such designation. In addition, the receipt of such designation for a platform technology does not ensure that a biological product will be developed more quickly or receive FDA approval. Moreover, the FDA may revoke a designation if the FDA determines that a designated platform technology no longer meets the criteria for such designation.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, while a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA grants marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing and promotion of the product candidate in those countries. Approval and licensure procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the U.S., including additional preclinical studies or clinical trials as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the U.S., a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for any of our product candidates for which we receive marketing approval is also subject to approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">74</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also submit marketing applications in other countries. Regulatory authorities in jurisdictions outside of the U.S. have requirements for approval of product candidates with which we must comply prior to marketing in those jurisdictions. Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our product candidates in certain countries. If we fail to comply with the regulatory requirements in international markets and/or receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we receive regulatory approval of our product candidates, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any regulatory approvals that we receive for our product candidates will require surveillance to monitor the safety, potency and purity of the product candidate. The FDA may also require a risk evaluation and mitigation strategy in order to license our product candidates, which could entail requirements for a medication guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In addition, if the FDA or a comparable foreign regulatory authority approves our product candidates, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export and recordkeeping for our product candidates will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with cGMPs, cGTPs and good clinical practices (GCPs) for any clinical trials that we conduct post-licensure. Manufacturers and manufacturers&#8217; facilities are required to comply with extensive FDA, and comparable foreign regulatory authority requirements, including ensuring that quality control and manufacturing procedures conform to cGMP regulations and applicable product tracking and tracing requirements. Later discovery of previously unknown problems with our product candidates, including adverse events of unanticipated severity or frequency, or with our manufacturing processes (or those of third parties we engage), or failure to comply with regulatory requirements, may result in, among other things:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the marketing or manufacturing of our product candidates, withdrawal of the product from the market or voluntary or mandatory product recalls; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">under FDORA, sponsors of approved drugs and biologics must provide six months&#8217; notice to the FDA of any changes in marketing status, such as the withdrawal of a product, and failure to do so could result in the FDA placing the product on a list of discontinued products, which would revoke the product&#8217;s ability to be marketed;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">revisions to the labeling, including limitation on approved uses or the addition of additional warnings, contraindications or other safety information, including boxed warnings; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imposition of a REMS, which may include distribution or use restrictions; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">requirements to conduct additional post-market clinical trials to assess the safety of the product; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, warning letters or holds on clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or suspension or revocation of license approvals; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure or detention, or refusal to permit the import or export of our product candidates; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the U.S. or abroad. In addition, the U.S. Supreme Court's July 2024 decision to overturn established case law giving deference to regulatory agencies' interpretations of ambiguous statutory language has introduced uncertainty regarding the extent to which the FDA's regulations, policies, and decisions may become subject to increasing legal challenges, delays, and/or changes. This decision may result in more lawsuits against the FDA to challenge longstanding decisions and policies of the FDA, which could undermine the FDA&#8217;s authority, lead to uncertainties in the industry, and disrupt the FDA&#8217;s normal operations, any of which could delay the FDA&#8217;s review of our regulatory submissions. We cannot predict the full impact of this decision, future judicial challenges brought against the FDA, or the nature or extent of government regulation that may arise from future legislation or administrative action. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">75</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The third-party payer or insurance coverage and reimbursement status of newly-approved products are uncertain. Our product candidates may become subject to unfavorable pricing regulations, third-party coverage and reimbursement practices, or healthcare reform initiatives, which would harm our business. Failure to obtain or maintain adequate coverage and reimbursement for new or current products could limit our ability to market those products and decrease our ability to generate revenue.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The regulations that govern marketing approvals, pricing, coverage and reimbursement for new drugs vary widely from country to country. In the U.S., recently enacted legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenue we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if any product candidates we may develop obtain marketing approval. For more information, please see &#8220;Item 1. Business &#8211; Government Regulation &#8211; Coverage and Reimbursement&#8221; in this Annual Report.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the U.S. and markets in other countries, patients generally rely on third-party payors to reimburse all or part of the costs associated with their treatment. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product acceptance. Our ability to successfully commercialize our product candidates will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. Government authorities and other third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. The availability of coverage and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford treatments such as cell therapy products. Sales of these or other product candidates that we may identify will depend substantially, both domestically and abroad, on the extent to which the costs of our product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. If coverage and adequate reimbursement are not available, or are available only to limited levels, we may not be able to successfully commercialize our product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reimbursement by a third-party payor may depend upon a number of factors, including, but not limited to, the third-party payor&#8217;s determination that use of a product is:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a covered benefit under its health plan; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">safe, effective and medically necessary; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">appropriate for the specific patient; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cost-effective; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">neither experimental nor investigational. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. In general, the prices of medicines under such systems are substantially lower than in the U.S. Other countries allow companies to fix their own prices for medicines but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the U.S., the reimbursement for products may be reduced compared with the U.S. and may be insufficient to generate commercially reasonable revenues and profits.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is also significant uncertainty related to the insurance coverage and reimbursement of newly approved products and coverage may be more limited than the purposes for which the medicine is approved by the FDA or comparable foreign regulatory authorities. In the U.S., the principal decisions about reimbursement for new medicines are typically made by the Centers for Medicaid and Medicare Services (CMS), an agency within the U.S. Department of Health and Human Services (HHS). CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree. No uniform policy of coverage and reimbursement for products exists among third-party payors and coverage and reimbursement levels for products can differ significantly from payor to payor. As a result, the coverage determination process is often a time consuming and costly process that may require us to provide scientific and clinical support for the use of our product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. It</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">76</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">is difficult to predict what CMS will decide with respect to reimbursement for fundamentally novel products such as ours. Reimbursement agencies in Europe may be more conservative than CMS. For example, a number of cancer drugs have been approved for reimbursement in the U.S. and have not been approved for reimbursement in certain European countries. Moreover, eligibility for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale, and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services. Our inability to promptly obtain coverage and profitable payment rates from both government-funded and private payors for any approved products we may develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize product candidates, and our overall financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the U.S. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, the level of reimbursement. In addition, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price, or ASP, and best price. Penalties may apply in some cases when such metrics are not submitted accurately and timely. Further, these prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, the level of reimbursement. Reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. In order to obtain reimbursement, physicians may need to show that patients have superior treatment outcomes with our product candidates compared to standard of care drugs, including lower-priced biosimilar versions of standard of care drugs. We expect to experience pricing pressures in connection with the sale of any of our product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The impact of recent healthcare reform legislation and other changes in the healthcare industry and in healthcare spending on us is currently unknown and may adversely affect our business model.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our revenue prospects could be affected by changes in healthcare spending and policy in the U.S. and abroad. We operate in a highly regulated industry and new laws, regulations or judicial decisions, or new interpretations of existing laws, regulations or decisions, related to healthcare availability, the method of delivery or payment for healthcare products and services could negatively impact our business, operations and financial condition. For more information on healthcare laws and regulations that may impact us, please see &#8220;Item 1. Business &#8211; Government Regulation &#8211; Healthcare Legislative Reform&#8221; in this Annual Report.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal and state levels directed at broadening the availability of healthcare and containing or lowering the cost of healthcare. We cannot predict the initiatives that may be adopted in the future, including repeal, replacement or significant revisions to the Affordable Care Act. The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the demand for our product candidates, if we obtain regulatory approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to set a price that we believe is fair for our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain coverage and reimbursement approval for a product candidate; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to generate revenue and achieve or maintain profitability; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the level of taxes that we are required to pay; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of capital. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">77</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors, which may adversely affect our future profitability. We expect that the healthcare reform measures that have been adopted and may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product and could seriously harm our future revenues. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our products.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulatory requirements in the U.S. and abroad governing cell therapy products have changed frequently and may continue to change in the future, which could negatively impact our ability to complete clinical trials and commercialize our product candidates in a timely manner, if at all.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulatory requirements in the U.S. and abroad governing cell therapy products have changed frequently and may continue to change in the future. The FDA has established an office, called the Office of Therapeutic Products within its Center for Biologics Evaluation and Research to meet its growing cell and gene therapy workload. The FDA also established the Cellular, Tissue and Gene Therapies Advisory Committee to advise its review. Under guidelines issued by the National Institutes of Health, or NIH, certain gene therapy clinical trials are subject to review and oversight by an institutional biosafety committee, or IBC, a local institutional committee that reviews and oversees research utilizing recombinant or synthetic nucleic acid molecules at that institution. Before such a clinical trial can begin, the institution&#8217;s institutional review board, or IRB, and its IBC assess the safety of the research and identifies any potential risk to public health or the environment. While the NIH guidelines are not mandatory unless the research in question is being conducted at or sponsored by institutions receiving NIH funding of recombinant or synthetic nucleic acid molecule research, many companies and other institutions not otherwise subject to the NIH guidelines voluntarily follow them. Moreover, serious adverse events or developments in clinical trials of gene therapy product candidates conducted by others may cause the FDA or other regulatory bodies to initiate a clinical hold on our clinical trials or otherwise change the requirements for approval of any of our product candidates. Although the FDA decides whether individual cell and gene therapy protocols may proceed, the review process and determinations of other reviewing bodies can impede or delay the initiation of a clinical trial, even if the FDA has reviewed the trial and approved its initiation.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inadequate funding for the FDA, the SEC and other government agencies could hinder their ability to hire and retain key personnel, and substantial changes in leadership, personnel, and policy could prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disruptions at the FDA and other agencies, including substantial leadership, personnel, and policy changes, may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown or substantial leadership, personnel, and policy changes occur, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, in our operations as a public company, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations. Such changes could significantly impact the ability of the FDA to timely review and take action on our regulatory submissions, which could have a material adverse effect on our business. Further, in our operations as a public company, future government shutdowns or substantial leadership, personnel, and policy changes could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With the change in the U.S. presidential administration in 2025, there is substantial uncertainty as to whether and how the new administration will seek to modify or revise the requirements and policies of the FDA and other regulatory agencies with jurisdiction over our product candidates. This uncertainty could present new challenges and/or opportunities as we navigate development of our product candidates. Any delay in obtaining, or our inability to obtain, applicable regulatory approvals would delay or prevent development and commercialization of our product candidates and could materially adversely impact our business and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">78</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our employees, independent contractors, consultants, commercial partners and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are exposed to the risk of employee fraud or other illegal activity by our employees, independent contractors, consultants, commercial partners and vendors. Misconduct by these parties could include intentional, reckless and/or negligent conduct that fails to: comply with the regulations of the FDA and other similar foreign regulatory authorities, provide true, complete and accurate information to the FDA and other similar foreign regulatory authorities, comply with manufacturing standards we have established, comply with healthcare fraud and abuse laws in the U.S. and similar foreign fraudulent misconduct laws or report financial information or data accurately or to disclose unauthorized activities to us. If we obtain FDA approval of any of our product candidates and begin commercializing those products in the U.S., our potential exposure under such laws and regulations will increase significantly, and our costs associated with compliance with such laws and regulations are also likely to increase. These laws may impact, among other things, our current activities with principal investigators and research patients, as well as proposed and future sales, marketing and education programs. In particular, the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commission(s), certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials. For more information, please see &#8220;Item 1. Business &#8211; Government Regulation &#8211; Anti-Kickback and False Claims Laws and Other Regulatory Matters&#8221; in this Annual Report.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we are subject to state and foreign equivalents of each of the healthcare laws described above, among others, some of which may be broader in scope and may apply regardless of the payor.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted a code of conduct, but it is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent inappropriate conduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could be subject to challenge under one or more of such laws. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant criminal, civil and administrative sanctions including monetary penalties, damages, fines, disgorgement, individual imprisonment, and exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, reputational harm, and we may be required to curtail or restructure our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risk of our being found in violation of these laws is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply with multiple jurisdictions with different compliance and/or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the EU. The provision of benefits or advantages to induce or reward improper performance generally is governed by the national anti-bribery laws of EU Member States and the Bribery Act 2010 (Bribery Act) in the UK. Infringement of these laws could result in substantial fines and imprisonment. Payments made to physicians in certain EU Member States must be publicly disclosed. EU Directive 2001/83/EC, which is the EU Directive governing medicinal products for human use, further provides that, where medicinal products are being promoted to persons qualified to prescribe or supply them, no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to such persons unless they are inexpensive and relevant to the practice of medicine or pharmacy. This provision has been transposed into the Human Medicines Regulations 2012 and so remains applicable in the UK despite its departure from the EU. Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#8217;s employer, his or her competent professional organization and/or the regulatory authorities of the individual EU Member States.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">79</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These requirements are provided in the national laws, industry codes or professional codes of conduct, applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are currently subject to, and may in the future become subject to additional, federal, state and foreign laws and regulations, industry guidelines, and contractual requirements, imposing obligations on how we collect, store, use and process personal information. Our actual or perceived failure to comply with such obligations could harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are, and may increasingly become, subject to various laws and regulations, as well as contractual obligations and mandatory industry standards relating to privacy and security in the jurisdictions in which we operate. The regulatory environment related to data privacy and security is increasingly rigorous, with new and constantly changing requirements applicable to our business, and enforcement practices are likely to remain uncertain for the foreseeable future. These laws and regulations may be interpreted and applied differently over time and from jurisdiction to jurisdiction, and it is possible that they will be interpreted and applied in ways that may have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the U.S., various federal and state regulators, including governmental agencies like the Federal Trade Commission, have adopted, or are considering adopting, laws and regulations concerning personal information and data security. Certain state laws may be more stringent or broader in scope, or offer greater individual rights, with respect to personal information than federal, international or other state laws, and such laws may differ from each other, all of which may complicate compliance efforts. For example, the California Consumer Privacy Act (CCPA) as amended by the California Privacy Rights Act (CPRA) created individual privacy rights for California residents and imposed obligations on companies that process their personal information and meet certain revenue or volume processing thresholds. Among other things, the CCPA requires covered companies to provide certain disclosures to California residents and provide such residents with new data protection and privacy rights, including the ability to opt-out of certain sales of personal information. The amendments introduced by the CPRA significantly modified the CCPA by expanding residents&#8217; rights with respect to certain personal information and created a new state agency to oversee implementation and enforcement efforts, among other changes. The CCPA provides for civil penalties for violations, as well as a private right of action for certain data breaches. This private right of action may increase the likelihood of, and risks associated with, data breach litigation, including class action litigation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Similar laws have been passed in numerous other states and a number of other states have proposed new privacy laws, some of which are similar to the above discussed recently passed laws. Such proposed legislation, if enacted, may add additional complexity, variation in requirements, restrictions and potential legal risk, require additional investment of resources in compliance programs, impact strategies and the availability of previously useful data and could result in increased compliance costs and/or changes in business practices and policies. The existence of comprehensive privacy laws in different states in the country would make our compliance obligations more complex and costly and may increase the likelihood that we may be subject to enforcement actions or otherwise incur liability for noncompliance. In addition, laws in all 50 U.S. states require businesses to provide notice to individuals if certain of their personal information has been disclosed as a result of a qualifying data breach. There are also states that are specifically regulating health information. For example, the state of Washington has enacted a comprehensive health privacy law that regulates the collection and sharing of health information and has a private right of action, which further increases the relevant compliance risk. Connecticut and Nevada have also passed similar laws regulating consumer health data. In addition, other states have proposed and/or passed legislation that regulates the privacy and/or security of certain specific types of information. For example, a small number of states have passed laws that regulate biometric data specifically. These various privacy and security laws may impact our business activities, including our identification of research subjects, relationships with business partners and ultimately the marketing and distribution of our products. State laws are changing rapidly and there is discussion in the U.S. Congress of a new comprehensive federal data privacy law to which we may likely become subject, if enacted.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internationally, laws, regulations and standards in many jurisdictions apply broadly to the collection, use, retention, security, disclosure, transfer, marketing or other processing of personal data. For example, the collection, use, storage, disclosure, transfer, or other processing of personal data regarding individuals in the European Economic Area (EEA), including personal health data, is subject to the EU General Data Protection Regulation 2016/679 (EU GDPR), and with regards individuals based in the UK, the EU GDPR in such form as incorporated into the laws of the UK (UK GDPR, together with EU GDPR referred to as &#8220;GDPR&#8221;) which became effective on May 25, 2018. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to having a legal basis or condition for processing personal data, stricter requirements relating to the processing of sensitive data (such as health data), where required by GDPR obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches, requirements to conduct data protection impact assessments for high risk processing and taking certain measures when engaging third-party processors. The GDPR permits data protection authorities to impose large penalties for violations of the GDPR, including potential fines of up to &#8364;20 million (&#163;17.5 million in UK) or 4% of annual global revenues, whichever is greater. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">80</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from violations of the GDPR. The GDPR increased our responsibility and liability in relation to personal data that we process where such processing is subject to the GDPR, and we may be required to put in place additional mechanisms to ensure compliance with the GDPR, including as implemented by individual countries. Compliance with the GDPR will be a rigorous and time-intensive process that may increase our cost of doing business or require us to change our business practices, and despite those efforts, there is a risk that we may be subject to fines and penalties, litigation, and reputational harm in connection with our European activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The GDPR provides that EEA Member States may make their own further laws and regulations in relation to the processing of genetic, biometric or health data, which could result in differences between EEA Member States, limit our ability to use and share personal data or could cause our costs to increase, and harm our business and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significantly, the GDPR imposes strict rules on the transfer of personal data out of the EEA and UK to other regions outside the EEA/UK, or third countries, that have not been deemed to offer &#8220;adequate&#8221; privacy protections by the competent data protection authorities, including the U.S. in certain circumstances, unless a derogation exists or adequate international transfer safeguards are put in place, such as, for example, the European Commission approved Standard Contractual Clauses (the EU SCCs) and the UK International Data Transfer Agreement/Addendum (the UK IDTA). Where relying on the EU SCCs or UK IDTA for data transfers, we may also be required to carry out transfer impact assessments on the transfers made pursuant to the EU SCCs and UK IDTA, on a case-by-case basis, to ensure the law in the recipient country provides &#8220;essentially equivalent&#8221; protections to safeguard the transferred personal data as provided in the EEA and UK, and may be required to adopt supplementary measures if this standard is not met. Further, the EU and the U.S. have adopted its adequacy decision for the EU-U.S. Data Privacy Framework ("Framework"), which entered into force on July 11, 2023. This Framework provides that the protection of personal data transferred between the EU and the U.S. is comparable to that offered in the EU. This provides a further avenue to ensuring transfers to the U.S. are carried out in line with GDPR. There has been an extension to the Framework to cover UK transfers to the U.S. The Framework could be challenged like its predecessor frameworks. The international transfer obligations under the EEA and UK data protection regimes will require significant effort and cost and may result in us needing to make strategic considerations around where EEA and UK personal data is located and which service providers we can utilize for the processing of EEA and UK personal data. Any inability to transfer personal data from the EEA to the U.S. in compliance with data protection laws may impede our ability to conduct trials and may adversely affect our business and financial position.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although the UK is regarded as one of the third countries under the EU GDPR, the European Commission has adopted an adequacy decision in favor of the UK, enabling data transfers from EEA member states to the UK without additional safeguards. The UK government has confirmed that personal data transfers from the UK to the EEA remain free flowing. The UK Government introduced the Data Protection and Digital Information Bill which failed in the UK legislative process. A new Data (Use and Access) Bill (UK Bill) has now been introduced into parliament.  If passed, the final version of the UK Bill may have the effect of further altering the similarities between the UK and EEA data protection regime.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Further, this may lead to additional compliance costs and could increase our overall risk. Further, the competent authorities in the EEA Member States may interpret GDPR obligations slightly differently from country to country and therefore we do not expect to operate in a uniform legal landscape in the EEA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The potential of the respective provisions and enforcement of the EU GDPR and UK GDPR further diverging in the future creates additional regulatory challenges and uncertainties for us. All of these evolving compliance and operational requirements impose significant costs, such as costs related to organizational changes, implementing additional protection technologies, training employees and engaging consultants and legal advisors, which are likely to increase over time. In addition, such requirements may require us to modify our data processing practices and policies, utilize management&#8217;s time and/or divert resources from other initiatives and projects. Any failure or perceived failure by us to comply with any applicable federal, state or foreign laws and regulations relating to data privacy and security could result in damage to our reputation, as well as proceedings or litigation by governmental agencies or other third parties, including class action privacy litigation in certain jurisdictions, which would subject us to significant fines, sanctions, awards, injunctions, penalties or judgments. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological and radioactive materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">81</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological, hazardous or radioactive materials.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we are able to commercialize any product candidates, the products may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, which would harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The regulations that govern marketing approvals, pricing, coverage and reimbursement for new drug products vary widely from country to country. Current and future legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. To obtain reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product candidate in a particular country, but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenues, if any, we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain marketing approval. For more information, please see &#8220;Item 1. Business &#8211; Government Regulation &#8211; Coverage and Reimbursement&#8221; in this Annual Report.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to commercialize any product candidates successfully also will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government healthcare programs, private health insurers and other organizations. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Increasingly, government authorities and third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. Coverage and reimbursement may not be available for any product that we commercialize and, even if these are available, the level of reimbursement may not be satisfactory. Reimbursement may affect the demand for, or the price of, any product candidate for which we obtain marketing approval. Obtaining and maintaining adequate reimbursement for our product candidates may be difficult. We may be required to conduct expensive pharmacoeconomic studies to justify coverage and reimbursement or the level of reimbursement relative to other therapies. If coverage and adequate reimbursement are not available or reimbursement is available only to limited levels, we may not be able to successfully commercialize any product candidate for which we obtain marketing approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There may be significant delays in obtaining coverage and reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA or similar regulatory authorities outside of the U.S. Moreover, eligibility for coverage and reimbursement does not imply that a drug will be paid for in all cases or at a rate that covers our costs, including research, development, intellectual property, manufacture, sale and distribution expenses. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the U.S. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement policies. Our inability to promptly obtain coverage and adequate reimbursement rates from both government-funded and private payors for any approved products that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our overall financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Intellectual Property</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to obtain and maintain patent protection for any product candidates we develop and for our technology, or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize products, product candidates and technology similar or identical to ours, and our ability to successfully commercialize any product candidates we may develop, and our technology may be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success will depend in large part on our ability and the ability of our licensors and collaborators to obtain and maintain patent protection and other intellectual property and proprietary rights in the U.S. and other countries with respect to our technology and our product candidates, their respective components, formulations, combination therapies, methods used to manufacture them and methods of treatment and development that are important to our business, as well as our ability to operate our business without infringing, misappropriating or otherwise violating the intellectual property rights of others.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">82</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given the early stage of development of our product candidates, our patent portfolio is similarly at an early stage. If we do not obtain meaningful patent coverage for our product candidates, their respective components, formulations, combination therapies, methods used to manufacture them and methods of treatment, competitors may be able to erode or negate any competitive advantage we may have, which would likely harm our business and ability to achieve profitability. To establish our proprietary position, we have filed provisional patent applications and corresponding Patent Cooperation Treaty (PCT), national, and regional applications related to our novel product candidates that are important to our business, and we have exclusively licensed a patent family from the Brigham and Women's Hospital, Inc. (BWH); we may in the future also license or purchase issued patents or pending patent applications filed by others. U.S. provisional patent applications are not eligible to become issued patents until, among other things, we file a non-provisional patent application within 12 months of filing of one or more of our related provisional patent applications. With regard to such U.S. provisional patent applications, if we do not timely file any non-provisional patent applications, we may lose our priority date with respect to our provisional patent applications and any patent protection on the inventions disclosed in our provisional patent applications. While we intend to timely file non-provisional patent applications relating to our provisional patent applications, we cannot predict whether any such patent applications will result in the issuance of patents that provide us with any competitive advantage. If we are unable to secure or maintain patent protection with respect to our antibody technology and any proprietary products and technology we develop, our business, financial condition, results of operations, and prospects could be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the scope of the patent protection we or our existing and potential licensors obtain, if any, is not sufficiently broad, we may not be able to prevent others from developing and commercializing technology and products similar or identical to ours. The degree of patent protection we require to successfully compete in the marketplace may be unavailable or severely limited and may not adequately protect our business or permit us to gain or keep any competitive advantage. We cannot provide any assurances that any of our owned or exclusively licensed pending patent applications that mature into issued patents will include claims with a scope sufficient to protect our current and future product candidates or otherwise provide any competitive advantage. In addition, to the extent that we license intellectual property now or in the future, we cannot provide any assurances that those licenses will remain in force. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the U.S. Furthermore, patents have a limited lifespan. In the U.S., if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. Various extensions may be available; however, the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired for a product candidate, we may be open to competition. Given the amount of time required for the development, testing and regulatory review of new product candidates, any patents that we may obtain in the future protecting such candidates might expire before or shortly after commercialization of such candidates, if any. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing product candidates similar or identical to ours.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if they are unchallenged, our issued patents or pending patent applications, if issued, may not provide us with any meaningful protection or prevent competitors or other third parties from designing around our patent claims to circumvent any patents that may issue by developing similar or alternative technologies or therapeutics in a non-infringing manner. For example, a third party may develop a competitive therapy that provides benefits similar to one or more of our product candidates but that uses a formulation and/or a device that falls outside the scope of our patent claims. If any patent protection that we may obtain in the future from the patent applications we hold or pursue with respect to our product candidates is not sufficiently broad to impede such competition, our ability to successfully commercialize our product candidates could be negatively affected, which would harm our business. Similar risks apply to patents or patent applications that we have in-licensed or may in the future in-license.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patent positions of life sciences companies can be uncertain and involve complex factual and legal questions and are subject of much litigation. No consistent policy governing the scope of claims allowable in the field of binding protein therapeutics, including antibodies and T cell receptors, has emerged in the U.S. The scope of patent protection in jurisdictions outside of the U.S. is also uncertain. Changes in either the patent laws or in their interpretation in any jurisdiction that we seek patent protection may diminish our ability to protect our inventions, obtain, maintain, protect and enforce our intellectual property and other proprietary rights; and, more generally, may affect the value of our intellectual property, including the narrowing of the scope of any patents that we may obtain in the future and any that we may license.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent prosecution process is complex, expensive, time-consuming and inconsistent across jurisdictions. We may not be able to file, prosecute, maintain, enforce, or license all necessary or desirable patent rights at a commercially reasonable cost or in a timely manner. In addition, we do not intend to pursue, and may not obtain, patent protection in all potentially relevant markets. It is possible that we will fail to identify important patentable aspects of our research and development efforts in time to obtain appropriate or any patent protection or fail to file patent applications covering inventions made in the course of development and commercialization activities before a competitor or another third party files a patent application covering, or publishes information disclosing, a similar, independently-developed invention. Such competitor&#8217;s or other third party&#8217;s patent application may pose obstacles to our ability to obtain patent protection or limit the scope of the patent protection we may obtain. While we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research and development efforts, including for example, our employees, corporate collaborators, external academic scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach the agreements and disclose such output before a patent application is</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">83</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">filed, thereby endangering our ability to seek patent protection. In addition, publications of discoveries in the scientific and scholarly literature often lag behind the actual discoveries, and patent applications in the U.S. and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Consequently, we cannot be certain that we or our licensors were the first to make the inventions claimed in our owned or in-licensed patent rights and patent applications or were the first to file for patent protection on the inventions claimed in our pending patent applications.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The issuance, scope, validity, enforceability and commercial value of our and our current or future licensors&#8217; patent rights are highly uncertain. Our and our licensors&#8217; pending and future patent applications may not result in patents being issued that protect our technology or product candidates, in whole or in part, or which effectively exclude others from commercializing competitive technologies and product candidates. Further, the scope of the invention claimed in a patent application can be significantly reduced before the patent is issued, and this scope can be reinterpreted after issuance. Even where patent applications we currently own or that we license now or in the future issue as patents, they may not issue in a form that will provide us with adequate protection to prevent competitors or other third parties from competing with us, or otherwise provide us with a competitive advantage. Any patents that eventually issue may be challenged, narrowed or invalidated by third parties. Consequently, we do not know whether any of our product candidates will be protectable or remain protected by valid and enforceable patent rights. Our competitors or other third parties may be able to evade or circumvent our patent rights by developing new alternative technologies or products in a non-infringing manner.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The issuance or grant of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and patents we may obtain in the future may be challenged, invalidated, narrowed or held to be enforceable, including in the courts or patent offices in the U.S. and abroad, or circumvented. There may be prior art of which we are not aware that may affect the validity or enforceability of a patent claim. There also may be prior art of which we are aware, but which we do not believe affects the validity or enforceability of a claim, but which may, nonetheless, ultimately be found to affect the validity or enforceability of a claim. We may become subject to a third-party pre-issuance submission of prior art or opposition, derivation, revocation, re-examination, post-grant and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">inter partes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> review, or interference proceeding and other similar proceedings challenging any patent rights we have or may obtain in the future or the patent rights of others, including based on priority of invention or other features of patentability, in the U.S. Patent and Trademark Office (USPTO) or other foreign patent office. An unfavorable determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, any patent rights we have or may obtain in the future, allow third parties to use or commercialize our technology or product candidates and compete directly with us, without payment to us (as they can now), or extinguish our ability to manufacture or commercialize product candidates without infringing third-party patent rights. Such proceedings also may result in substantial cost and require significant time from our scientists and management, even if the eventual outcome is favorable to us. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, given the amount of time required for the development, testing and regulatory review of new product candidates, any patents we have or may obtain in the future protecting such candidates might expire before or shortly after commercialization of such candidates, if any. As a result, our intellectual property may never provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. Moreover, any patents or patent applications that we own or may own or in-license in the future may be co-owned with third parties. If we are unable to obtain an exclusive license to any such third-party co-owners&#8217; interest in any such patents or patent applications, such co-owners may be able to license their rights to other third parties, including our competitors, thereby enabling our competitors to market competing products and technology. In addition, we or our licensors may need the cooperation of any such co-owners of any patents that we own or may own or in-license in the future in order to enforce such patents against third parties, and such cooperation may not be provided to us or our licensors. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We could be unsuccessful in obtaining meaningful patent protection on one or more components of our platform technology.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that an important factor in our competitive position is our screening technology platform to identify future product candidates and therapeutic targets. Our screening platform is based in part on technology processes that are (or will be) publicly disclosed in patents and patent applications owned by or licensed to us. Even if such patents and patent applications provide broad protection, it may be difficult or impossible to detect whether a competitor is practicing the proprietary methods claimed in such patents or patent applications in order to discover their own product candidates and therapeutic targets. In such cases, any existing patents, or patents that may issue from patent applications, owned by or licensed to us would not provide us protection to prevent such activity. Additionally, a competitor may also practice such methods in a jurisdiction where we have no relevant patent protection. Our competitive position could be weakened by competitors or other third parties practicing the methods claimed in these patent applications in a manner we do not detect or in jurisdictions in which we or our licensors do not obtain any relevant patent protection.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">84</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with any of our obligations under existing or future agreements pursuant to which we license intellectual property rights or technology, if the licenses are terminated or if disputes regarding these licenses arise, we could lose significant rights or technology that are material to our business and could interfere with our ability to operate our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a party to technology licenses, including in-license agreements with BWH and PHSA, and we may enter into additional licenses in the future. Such licenses do, and may in the future, impose commercial, contingent payment, royalty, insurance, indemnification, and other obligations on us. If we fail to comply with these obligations, our licensors may have the right to terminate the license, in which event we could lose valuable rights under our collaboration agreements and our ability to develop product candidates could be impaired. Additionally, should any such license agreement be terminated for any reason, there may be a limited number of replacement licensors, and a significant amount of time may be required to transition to a replacement licensor.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our rights to develop and commercialize our product candidates are subject in part to the terms and conditions of third-party licenses, pursuant to which we have acquired rights from the applicable licensors. Our rights with respect to such intellectual property may terminate, in whole or in part, if we fail to meet applicable requirements or milestones relating to development and commercialization. We may also lose our rights to develop and commercialize our product candidates under such agreements if we fail to pay required milestones or royalties. In the event of an early termination of our license agreements, all rights licensed and developed by us under these agreements may be extinguished, which may have an adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on certain of our licensors to prepare, file and prosecute patent applications and maintain patents and otherwise protect the intellectual property we license from them and may continue to do so in the future. We have limited or no control over these activities or any other intellectual property that may be related to our in-licensed intellectual property. For example, we cannot be certain that such activities by these licensors have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights. We have limited or no control over the manner in which our licensors initiate an infringement proceeding against a third-party infringer of the intellectual property rights, or defend certain of the intellectual property that is licensed to us. It is possible that any licensors&#8217; infringement proceeding or defense activities may be less vigorous than had we conducted them ourselves.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These agreements may be complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, a third party may in the future bring claims that our performance under our license agreements, including our sponsoring of clinical trials, interferes with such third party&#8217;s rights under its agreement with one of our licensors. If any such claim were successful, it may adversely affect our rights and ability to advance our product candidates as clinical candidates or subject us to liability for monetary damages, any of which would have an adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are currently, and expect in the future to be, party to material license or collaboration agreements, which may impose numerous obligations and restrictions on us.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are currently, and expect in the future to be, party to material license or collaboration agreements. These agreements typically impose numerous obligations and restrictions on us, such as various diligence, commercialization, insurance and payment obligations, among others, in order to maintain such licenses. Any of these restrictions or obligations could delay or otherwise negatively impact a transaction that we may wish to enter into. In addition, any termination of these licenses could result in the loss of significant rights and could harm our ability to commercialize our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Licensing of intellectual property is of high importance to our business and involves complex legal, business and scientific issues. Disputes may also arise between us and our licensors regarding intellectual property subject to a license or collaboration agreement, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope of rights granted under the license or collaboration agreement and other interpretation-related issues; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether, and the extent to which, our product candidates, technology and processes infringe on intellectual property of the licensor that is not subject to the licensing or collaboration agreement; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our right to sublicense patent and other intellectual property rights to third parties under collaborative development relationships; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">85</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the calculation and existence of certain payment obligations under the license or collaboration agreement; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization of our product candidates, and what activities satisfy those diligence obligations; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inventorship and ownership of inventions, know-how and other intellectual property and proprietary rights resulting from the joint creation or use of intellectual property by our licensors and us and our partners; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the priority of invention of patented technology. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are generally also subject to all of the same risks with respect to protection of intellectual property that we license, as we are for intellectual property that we own, and our success will depend in part on the ability of our licensors to adequately obtain, maintain, protect and enforce patent protection for our licensed intellectual property, especially with respect to patent rights which we exclusively in-license. If we or our licensors fail to adequately protect this intellectual property, our ability to commercialize products could suffer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on certain of our licensors to prepare, file and prosecute patent applications and maintain patents and otherwise protect the intellectual property we license from them and may continue to do so in the future. We have limited control over these activities or any other intellectual property that may be related to our in-licensed intellectual property. For example, we cannot be certain that such activities by these licensors have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights. We have limited control over the manner in which our licensors initiate an infringement proceeding against a third-party infringer of the intellectual property rights, or defend certain of the intellectual property that is licensed to us. It is possible that any licensors&#8217; infringement proceeding or defense activities may be less vigorous than had we conducted them ourselves or may not be conducted in accordance with our best interests.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, certain of our licenses may not provide us with exclusive rights to use the licensed intellectual property and technology, or may not provide us with exclusive rights to use such intellectual property and technology in all relevant fields of use and in all territories in which we may wish to develop or commercialize our technology and product candidates in the future. For example, a portion of our intellectual property portfolio is non-exclusively licensed to us and may be used by our licensors or licensed to third parties, and such third parties may have certain enforcement rights with respect to such intellectual property. Thus, patent rights licensed to us could be put at risk of being invalidated or interpreted narrowly in litigation filed by or against our licensors or another licensee or in administrative proceedings brought by or against our licensors or another licensee in response to such litigation or for other reasons. As a result, we may not be able to prevent competitors or other third parties from developing and commercializing competitive products, including in territories covered by our licenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our proprietary position may depend upon patents that are manufacturing, formulation or method-of-use patents, which may not prevent a competitor or other third party from using the same product candidate for another use.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Composition-of-matter patents are generally considered to be the strongest form of intellectual property protection for drug products because such patents provide protection without regard to any particular method of use or manufacture or formulation of the active pharmaceutical ingredient used. We currently have a limited number of issued patents, but our pending owned U.S. and international patent applications include claims directed to certain compositions-of-matter and certain methods of use of our product candidates. We cannot be certain that claims in any issued patent, or patent that may issue from our pending owned or in-licensed patent applications, will cover the composition-of-matter of any of our current or future product candidates. If we are unsuccessful in obtaining issued patents that cover the composition-of-matter of any of our current or future product candidates, competitors may be able to erode or negate any competitive advantage we may have and our business, financial condition, results of operations and prospects could be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our efforts to protect the proprietary nature of the intellectual property related to our technologies are not adequate, we may not be able to compete effectively in our market.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Biotechnology and pharmaceutical companies generally, and we in particular, compete in a crowded competitive space characterized by rapidly evolving technologies and aggressive defense of intellectual property. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent process. There are situations in which noncompliance can result in abandonment or lapse of a patent or patent application,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">86</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market earlier than would otherwise have been the case.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely upon a combination of patent rights, confidentiality agreements, trade secret protection and license agreements to protect the intellectual property related to our technologies. Any disclosure to or misappropriation by third parties of our confidential proprietary information could enable competitors or other third parties to quickly duplicate or surpass our technological achievements, thus eroding our competitive position in our market. We, or any partners, collaborators, licensees or licensors may fail to identify patentable aspects of inventions made in the course of development and commercialization activities before it is too late to obtain patent protection on them. Therefore, we may miss potential opportunities to strengthen our patent position.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is possible that defects of form in the preparation or filing of our patent applications may exist, or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we or any partners, collaborators, licensees or licensors fail to establish, maintain or protect such patent rights and other intellectual property rights, such rights may be reduced or eliminated. If any partners, collaborators, licensees or licensors are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised. If there are material defects in the form, preparation, prosecution, or enforcement of our patent applications, any patents that may issue from such patent applications may be invalid and/or unenforceable, and such applications may never result in valid, enforceable patents. Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Currently, our patents and patent applications are directed to our TCR-T therapy candidates and accompanying technologies. We seek or plan to seek patent protection for our proprietary platform and product candidates by filing and prosecuting patent applications in the U.S. and other countries as appropriate. Our patent portfolio also includes patent families exclusively licensed from BWH, which include issued and pending U.S. and foreign non-provisional patent applications. Any patents that have issued or may issue from any non-provisional patent applications claiming priority to these provisional patent applications would be expected to expire on various dates from 2038 through 2045, in each case without taking into account any possible patent term adjustments or extensions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We anticipate additional patent applications will be filed both in the U.S. and in other countries, as appropriate. However, we cannot predict:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether and when any patents will issue; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the degree and range of protection that any patents that may issue will afford us against competitors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether any of our intellectual property will provide any competitive advantage; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether any patents that may issue may be challenged, invalidated, modified, revoked, circumvented or found to be unenforceable; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether or not others will obtain patents claiming inventions similar to those covered by our patent applications; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether we will need to initiate or defend litigation or administrative proceedings, which may be costly regardless of whether we win or lose. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we cannot be certain that the claims in our pending patent applications covering the composition of matter of our product candidates will be considered patentable by the USPTO or patent offices in foreign countries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Method-of-use patents protect the use of a product for the specified method. If we obtain any of these types of patents, they would not prevent a competitor from making and marketing a product that is identical to one of our product candidates for an indication that is outside the scope of the patented method. Moreover, even if competitors do not actively promote their product for our targeted indications, physicians may prescribe these products &#8220;off-label.&#8221; Although off-label prescriptions may induce or contribute to the infringement of method-of-use patents, the practice is common, and such infringement is difficult to prevent or prosecute.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The strength of patents in the biotechnology and pharmaceutical field involves complex legal and scientific questions and can be uncertain. The patent applications that we own or in-license may fail to result in issued patents with claims that cover our product candidates or uses thereof in the U.S. or in other foreign countries. Even if the patents do successfully issue, third parties may challenge the validity, enforceability or scope thereof, which may result in such patents being narrowed, invalidated or held unenforceable. If the breadth or strength of protection provided by the patent applications we hold with respect to our product candidates is threatened, it could dissuade companies from collaborating with us to develop, and threaten our ability to commercialize, our product candidates. Further, if we encounter delays in our clinical trials, the period of time during which we could market our product candidates under patent protection would be reduced. Since patent applications in the U.S. and most other countries are confidential for a period of time after filing, we cannot be certain that we were the first to file any patent application related to our product candidates. Various post-grant review proceedings, such as </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">inter partes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> review and post-grant review, are available for any interested third party to challenge the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">87</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patentability of claims in any patents issued to us or our licensors. While these post-grant review proceedings have been used less frequently to invalidate biotech patents, they have been successful regarding other technologies, and these relatively new procedures are still changing, and those changes might affect future results. No assurance can be given that, if challenged, any patents that we or our licensors may obtain would be declared by a court to be valid or enforceable or that, even if found valid and enforceable, a competitor&#8217;s technology or product would be found by a court to infringe any such patent. We may analyze patents or patent applications of our competitors that we believe are relevant and conclude that our activities do not infringe any valid claims of those patents or patent applications, but our conclusions may be erroneous or our competitors may obtain patents with issued claims, including in patents we consider to be unrelated, that block our efforts or that our product candidates or our activities infringe. Others may independently develop products that have the same effect as our product candidates without infringing any patents we may obtain or any of our other intellectual property rights, or they may design around the claims of any patents that we may obtain.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent and future patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of any patents we may obtain. In March 2013, under the Leahy-Smith America Invents Act (America Invents Act) the U.S. moved from a &#8220;first to invent&#8221; to a &#8220;first-to-file&#8221; system. Under a &#8220;first-to-file&#8221; system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to a patent on the invention regardless of whether another inventor had made the invention earlier. The America Invents Act included a number of other significant changes to U.S. patent law, including provisions that have affected the way patent applications are prosecuted, redefined prior art and established a new post-grant review system. The effects of these changes are still unclear as the USPTO only recently developed new regulations and procedures in connection with the America Invents Act, and many of the substantive changes to patent law, including the &#8220;first-to-file&#8221; provisions, only became effective in March 2013. Moreover, the courts have yet to address many of these provisions. Overall, the America Invents Act and its implementation have increased the uncertainties and costs surrounding the prosecution of our patent applications and any enforcement or defense of any patents that we may obtain, which could have a material adverse effect on our business and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage. For example:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">others may be able to make or use compounds or cells that are similar to the biological compositions of our product candidates but that are not covered by the claims of any patents that we may obtain; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the active biological ingredients in our current product candidates may eventually become commercially available in biosimilar drug products, and no patent protection may be available with regard to formulation or method of use; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we or our licensors, as the case may be, might not have been the first to file patent applications for these inventions; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there may be prior public disclosures that could invalidate any patents that we or our licensors may obtain; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inventors of our owned or in-licensed patent applications may become involved with competitors, develop products or processes that design around any patents that we may obtain, or become adverse to us or patent applications on which they are named as inventors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">it is possible that our owned or in-licensed patent applications omit individual(s) that should be listed as inventor(s) or include individual(s) that should not be listed as inventor(s), which may cause any patents that may issue from these patent applications to be held invalid or unenforceable; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we have engaged and may continue to engage in scientific collaborations, and such collaborators may develop adjacent or competing products to ours that are outside the scope of any patents that we may obtain; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not develop additional proprietary technologies for which we can obtain patent protection; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product candidates or diagnostic tests we develop may be covered by third parties&#8217; patents or other exclusive rights; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patents of others may have an adverse effect on our business. </span></div></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the protection afforded by any patent rights we may obtain, we seek to rely on trade secret protection, confidentiality agreements, and license agreements to protect our proprietary know-how, information, technology and other proprietary information that is not patentable, processes for which patents are difficult to enforce and any other elements of our product discovery and development processes that involve proprietary know-how, information, or technology that we have not sought to protect through patent applications. For example, significant elements of our product candidates, including aspects of sample preparation, methods of manufacturing, cell culturing conditions, computational-biological algorithms, and related processes and software, are based on unpatented trade secrets that are not publicly disclosed. It is our policy to require our employees, consultants, outside scientific collaborators, sponsored researchers and other advisors to execute confidentiality agreements upon the commencement of employment</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">88</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or consulting relationships with us. These agreements generally provide that all confidential information concerning our business or financial affairs developed or made known to the individual or entity during the course of the party&#8217;s relationship with us is to be kept confidential and not disclosed to third parties except in specific circumstances. In the case of employees, the agreements provide that all inventions conceived by the individual, and which are related to our current or planned business or research and development or made during normal working hours, on our premises or using our equipment or proprietary information, are our exclusive property. In addition, we take other appropriate precautions, such as physical and technological security measures, to guard against misappropriation of our proprietary technology by third parties. Despite these measures, we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. Furthermore, the laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the U.S. Courts outside the U.S. are sometimes less willing to protect trade secrets. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the U.S. and abroad. If we choose to go to court to stop a third party from using any of our trade secrets, we may incur substantial costs. These lawsuits may consume our time and other resources even if we are successful. If we are unable to prevent unauthorized disclosure of our material intellectual property to third parties, we will not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, operating results and financial condition. For more information, see &#8220;Risks Related to Our Intellectual Property &#8211; We have limited foreign intellectual property rights and may not be able to protect our intellectual property rights throughout the world.&#8221;</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Third-party claims of intellectual property infringement, misappropriation or other violations may prevent or delay our product candidate discovery and development efforts.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial success depends in part on our avoiding infringement, misappropriation or other violation of the patents and proprietary rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries. We may be exposed to, or threatened with, future litigation by third parties having patent or other intellectual property rights alleging that our product candidates and/or technologies infringe their intellectual property rights. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates or identifying potential product candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our product candidates may give rise to claims of infringement of the patent rights of others. Moreover, it is not always clear to industry participants, including us, which patents cover various types of drugs, products or their methods of use or manufacture. Because of the large number of patents and patent applications in our fields, there is a risk that third parties may allege they have patent rights encompassing our product candidates, technologies or methods.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a third party claims that we infringe, misappropriate or otherwise violate its intellectual property rights, we may face a number of issues, including, but not limited to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">infringement, misappropriation and other violation of intellectual property claims which, regardless of merit, may be expensive and time-consuming to litigate and may divert our management&#8217;s attention from our core business; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">substantial damages for infringement, misappropriation or other violation which we may have to pay if a court decides that the product candidate or technology at issue infringes on, misappropriates or otherwise violates the third party&#8217;s rights, and, if the court finds that the infringement was willful, we could be ordered to pay treble damages and the patent owner&#8217;s attorneys&#8217; fees; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a court prohibiting us from developing, manufacturing, marketing or selling our product candidates, or from using our proprietary technologies, unless the third party licenses its product rights to us, which it is not required to do; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if a license is available from a third party, we may have to pay substantial royalties, upfront fees and other amounts, and/or grant cross-licenses to intellectual property rights for our product candidates or using our proprietary technologies; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">redesigning our product candidates or processes so they do not infringe third-party intellectual property rights, which may not be possible or may require substantial monetary expenditures and time. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some of our competitors or other third parties may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations or could otherwise have a material adverse effect on our business, results of operations, financial condition and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">89</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third parties may assert that we are employing their proprietary technology without authorization. Generally, conducting preclinical and clinical trials and other development activities in the U.S. is not considered an act of infringement. If any of our product candidates is licensed by the FDA, a third party may then seek to enforce its patent by filing a patent infringement lawsuit against us. While we do not believe that any claims that could otherwise have a materially adverse effect on the commercialization of our product candidates, if licensed, are valid and enforceable, we may be incorrect in this belief, or we may not be able to prove it in litigation. In this regard, patents issued in the U.S. by law enjoy a presumption of validity that can be rebutted only with evidence that is &#8220;clear and convincing&#8221;, a heightened standard of proof. As a result, there is no assurance that a court of competent jurisdiction would invalidate the claims of any such U.S. patent. If any third-party patent were held by a court of competent jurisdiction to cover the manufacturing process of our product candidates, constructs or molecules used in or formed during the manufacturing process, or any final product itself, or aspects of our formulations, processes for manufacture or methods of use, including combination therapy or patient selection methods, the holder of any such patent may be able to block our ability to commercialize the product candidate unless we obtained a license under the applicable patent, or until such patent expires or it is finally determined to be held invalid or unenforceable. In any case, such a license may not be available on commercially reasonable terms or at all. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, or at all, our ability to commercialize our product candidates may be impaired or delayed, which could in turn significantly harm our business. Even if we obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us, and it could require us to make substantial licensing and royalty payments. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock. Any of the foregoing events could harm our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Parties making claims against us may seek and obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize our product candidates. Defense of these claims, regardless of their merit, could involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, obtain one or more licenses from third parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure. We cannot predict whether any such license would be available at all or whether it would be available on commercially reasonable terms. Furthermore, even in the absence of litigation, we may need or may choose to obtain licenses from third parties to advance our research or allow commercialization of our product candidates. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all. In that event, we would be unable to further develop and commercialize our product candidates. Any of the foregoing events could harm our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be successful in obtaining or maintaining necessary rights to product components and processes for our development pipeline through acquisitions and in-licenses.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because additional product candidates may require the use of proprietary rights held by third parties, the growth of our business will likely depend in part on our ability to acquire, in-license or use these proprietary rights. In addition, while we have certain patent rights directed to certain TCR constructs, we may not be able to obtain intellectual property to broad T cell or TCR constructs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates may also require specific formulations to work effectively and efficiently and rights to these formulations may be held by others. Similarly, efficient production or delivery of our product candidates may also require specific compositions or methods, and the rights to these may be owned by third parties. We may be unable to acquire or in-license any formulations, compositions, methods of use, processes or other third-party intellectual property rights that we identify as necessary or important to our business operations. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all, which would harm our business. We may need to cease use of the compositions or methods covered by such third-party intellectual property rights, and may need to seek to develop alternative approaches that do not infringe on such intellectual property rights which may entail additional costs and development delays, even if we were able to develop such alternatives, which may not be feasible. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop or license replacement technology. Moreover, the specific antibodies that will be used with our product candidates may be covered by the intellectual property rights of others.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we may collaborate with academic institutions to accelerate our preclinical research or development under written agreements with these institutions. In certain cases, these institutions provide us with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to others, potentially blocking our ability to pursue our program. If we are unable to successfully obtain rights to required third-party intellectual property or to maintain the existing intellectual property rights we have, we may have to abandon development of such program and our business and financial condition could suffer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">90</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The licensing and acquisition of third-party intellectual property rights is a competitive area, and companies that may be more established or have greater resources than we do may also be pursuing strategies to license or acquire third-party intellectual property rights that we may consider necessary or attractive in order to commercialize our product candidates. More established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may eventually become involved in lawsuits to protect or enforce our intellectual property and proprietary rights, including any patents that we or our licensors may obtain in the future, which could be expensive, time-consuming and unsuccessful.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the future, competitors or other third parties may infringe any patents that we or our licensors may obtain. To counter any such future infringement or unauthorized use, we may eventually be required to file infringement claims, which can be expensive and time-consuming. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents or that our licensors&#8217; patents are invalid or unenforceable. In addition, in a patent infringement proceeding, a court may decide that one or more patents that we may obtain in the future is not valid or is unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly or may refuse to stop the other party from using the technology at issue on the grounds that such patents, if any, do not cover the technology in question. An adverse result in any litigation or defense proceedings could put one or more of such patents, if any, at risk of being invalidated, held unenforceable, or interpreted narrowly and could put our patent applications at risk of not issuing. Asserting any patent rights we may obtain in the future, and defending challenges to our rights, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from our business and we may find it impractical or undesirable to enforce our intellectual property against some third parties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Post-grant, interference or derivation proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the validity or priority of inventions with respect to our or our licensors&#8217; patent applications or any patents that may issue therefrom. An unfavorable outcome could result in a loss of any patent rights we may have. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or proceeding. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock. Any of the foregoing events could harm our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Obtaining and maintaining our patent protection depends on compliance with various procedures, document submission, fee payments and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some of our patent applications may be allowed in the future. We cannot be certain that an allowed patent application will become an issued patent. There may be events that cause withdrawal of the allowance of a patent application. For example, after a patent application has been allowed, but prior to being issued, material that could be relevant to patentability may be identified. In such circumstances, the applicant may pull the application from allowance in order for the USPTO or foreign patent agency to review the application in view of the new material. In that circumstance, the USPTO or the other agency may not re-allow an application in view of the new material. Further, periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and/or patent applications will be due to be paid to the USPTO and foreign patent agencies at several stages over the lifetime of the patents and/or patent applications. The USPTO and various foreign governmental patent agencies also require compliance with a number of procedural, documentary and other similar provisions during the patent application process and following the issuance of a patent. We also may be dependent on our licensors to take the necessary action to comply with these requirements with respect to our licensed intellectual property. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. In such an event, our competitors and other third parties might be able to enter the market without infringing our or our licensors&#8217; patents and patent applications, which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we obtain any patents covering our product candidates, they could nonetheless be found invalid or unenforceable if challenged in court or the USPTO.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Our owned or in-licensed patents, and any of our owned or in-licensed patent applications that may issue in the future, may be challenged at the USPTO or foreign patent offices in re-examination, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">inter partes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> review, post-grant review and equivalent proceedings in foreign jurisdictions (such as opposition proceedings). Such proceedings could result in the revocation of or amendment to such patents in such a way that they no longer cover</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">91</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our product candidates or technologies. If we or one of our licensing partners initiates legal proceedings against a third party to enforce a patent that we may obtain in the future covering one of our product candidates, the defendant could counterclaim that such patent is invalid and/or unenforceable. In patent litigation in the U.S., counterclaims alleging invalidity and/or unenforceability are commonplace, and there are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the U.S. or abroad, even outside the context of litigation. Such mechanisms include re-examination, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">inter partes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> review, post-grant review and equivalent proceedings in foreign jurisdictions (such as opposition proceedings). Such proceedings could result in revocation or amendment to any patents we may obtain in the future in such a way that they would no longer cover our product candidates. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we, our patent counsel and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, or if we are otherwise unable to adequately protect our rights, we would lose at least part, and perhaps all, of any patent protection we may eventually obtain on our product candidates and technologies. Such a loss of patent protection could have a material adverse impact on our business, financial condition, results of operations and prospects and our ability to commercialize or license our technology and product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes to patent law and its interpretation in the U.S. and in foreign jurisdictions could diminish the value of patents in general and may impact the validity, scope or enforceability of our patent rights, thereby impairing our ability to protect our product candidates and technologies.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As is the case with other biotechnology companies, our success is heavily dependent on intellectual property, particularly any patents that may issue from our pending patent applications. Changes in either the patent laws or in their interpretation in any jurisdiction that we seek patent protection may diminish our ability to protect our inventions, obtain, maintain and enforce our intellectual property and proprietary rights and, more generally, may affect the value of our intellectual property and proprietary rights. The U.S. continues to adapt to wide-ranging patent reform legislation that became effective starting in 2012. Moreover, various courts, including the U.S. Supreme Court, have rendered decisions that have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents once obtained. Depending on decisions by Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce patents that we might obtain in the future. For example, in the case </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Assoc. for Molecular Pathology v. Myriad Genetics, Inc.,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the U.S. Supreme Court held that certain claims to DNA molecules are not patentable. We cannot predict how future decisions by the courts, Congress or the USPTO may impact the value of our pending patent applications. Similarly, any adverse changes in the laws and regulations governing patents in other jurisdictions could have an adverse effect on our ability to obtain and effectively enforce our patent rights and have a material adverse effect on our business and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have limited foreign intellectual property rights and may not be able to protect our intellectual property rights throughout the world.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as the laws in the U.S., and we may encounter difficulties in protecting and defending such rights in foreign jurisdictions. Consequently, we may not be able to prevent third parties from practicing our inventions in some or all countries outside the U.S., or from selling or importing products made using our inventions in and into the U.S. or other jurisdictions. Competitors or other third parties may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and further, may also export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as in the U.S. These products may compete with our product candidates and our patent rights or other intellectual property rights may not be effective or sufficient to prevent them from competing. In addition, certain countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to other parties. Furthermore, many countries limit the enforceability of patents against other parties, including government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of any patents. We will need to decide whether, and in which jurisdictions, to pursue protection for the various inventions in our portfolio prior to applicable filing deadlines.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">92</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology products and biotechnology, which could make it difficult for us to stop the infringement, misappropriation or other violation of our intellectual property rights, including any infringement of any patents we may obtain in the future in such countries, or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce any patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patent applications at risk of not issuing, any patent rights at risk of being invalidated or interpreted narrowly and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to establish our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims challenging the inventorship or ownership of our patent rights and other intellectual property.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be subject to claims that former employees, collaborators or other third parties have an interest in our intellectual property as an inventor or co-inventor. It is our policy to enter into confidentiality and intellectual property assignment agreements with our employees, consultants, and contractors. These agreements generally provide that inventions conceived by the party in the course of rendering services to us will be our exclusive property. However, such agreements may not be honored and may not effectively assign intellectual property rights to us. For instance, the assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against current or former employees, consultants, and contractors, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Moreover, there may be circumstances where we are unable to negotiate for such ownership rights.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disputes regarding ownership or inventorship of intellectual property can also arise in other contexts, such as collaborations and sponsored research. If we are subject to a dispute challenging our rights in or to inventions or other intellectual property, such a dispute could be expensive and time consuming. If we are unsuccessful in defending such claims, in addition to paying monetary damages, unless we are able to obtain a license, which might not be available on commercially reasonable terms or at all, we could lose valuable rights in intellectual property, such as the exclusive ownership of, or right to use, intellectual property that we regard as our own or that is important to our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees, and certain customers, licensors or partners may defer engaging with us until the particular dispute is resolved. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed trade secrets or other confidential information of their former employers or other third parties or claims asserting ownership of what we regard as our own intellectual property.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have received, and will continue to receive, confidential and proprietary information from third parties. In addition, we have employed and expect to continue to employ individuals who were previously employed at university or other biotechnology or pharmaceutical companies, including our competitors or potential competitors, in some cases until recently. Although we try to ensure that our employees, consultants, advisors and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we, our employees, advisors, consultants or independent contractors have deliberately, inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information of these former employers, competitors or other third parties, or to claims that we have improperly used or obtained such trade secrets. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed confidential information of these third parties or our employees&#8217; former employers or our consultants&#8217; or contractors&#8217; current or former clients or customers. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to our management and employees. If we are not successful in defending such claims, in addition to paying monetary damages, we could lose access or exclusive access to valuable intellectual property rights and face increased competition to our business. Any of the foregoing could harm our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims, and damages resulting from claims, that we or our employees have wrongfully used or disclosed alleged trade secrets of our competitors or are in breach of non-competition or non-solicitation agreements with our competitors.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of our employees were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors, in some cases until recently. We may be subject to claims that we or our employees have inadvertently or otherwise used or disclosed trade secrets or other proprietary information belonging to these former employers or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">93</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">competitors. In addition, we have been and may in the future be subject to claims that we caused an employee to breach the terms of his or her non-competition or non-solicitation agreement. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and could be a distraction to management. If our defense to those claims fails, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Any litigation or the threat thereof may adversely affect our ability to hire employees. A loss of key personnel or their work product could hamper or prevent our ability to commercialize product candidates or potential products, which could have an adverse effect on our business, results of operations, financial condition and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time. If we do not obtain patent term extension and data exclusivity for any of our current or future product candidates, our business may be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending upon the timing, duration, conditions and specifics of any FDA marketing approval of any of our current or future product candidates that we may receive, one or more U.S. patents that we may obtain in the future may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Amendments) and one or more of our foreign patent rights may be eligible for patent term extension under similar legislation, for example, in the EU. In the U.S., the Hatch-Waxman Amendments permit a patent extension term of up to five years as compensation for effective patent term lost during product development and the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. However, there are no assurances that the FDA or any comparable foreign regulatory authority or national patent office will grant such extensions, in whole or in part. For example, we may not be granted an extension if we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to the expiration of relevant patents, or otherwise fail to satisfy other applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or term of any such extension is less than we request, the period during which we can enforce our patent rights for the applicable product candidate will be shortened, and our competitors or other third parties may obtain approval to market competing products following expiration of any patents that we may obtain in the future, and our business, financial condition, results of operations, and prospects could be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our trademarks are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on both registered and common law protection for our trademarks for use in connection with our product candidates and services in various countries. These trademarks may not afford adequate protection. Our trademark applications may be provisionally or ultimately refused by the USPTO or the trademark agencies of other countries, or such applications may be challenged by others. We also may not have the financial resources to enforce the rights under these trademarks, which may enable others to use the trademarks and dilute their value. Our trademarks may be challenged, infringed, circumvented or declared generic or determined to be infringing the trademarks of others. In such a case, we may not be able to protect or derive any value from such trademarks or may be required to cease using a conflicting mark entirely. The value of our trademarks may also be diminished by our own actions, such as failing to impose appropriate quality control when licensing our trademarks. Any of the foregoing could impair the value of, or ability to use, our trademarks, reduce our ability to compete effectively, and have an adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Certain of our in-licensed patent rights are, and our future owned and in-licensed patent rights may be, subject to a reservation of rights by one or more third parties, including government march-in rights with regards to certain patents, that may limit our ability to exclude third parties from commercializing product candidates similar or identical to ours.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain of our in-licensed patent rights may be subject to a reservation of rights by one or more third parties. Pursuant to the Bayh-Dole Act, the U.S. government has march-in rights with regards to government-funded technology. For example, the U.S. government has certain rights, including march-in rights, to patent rights and technology funded by the U.S. government and licensed to us from BWH. When new technologies are developed with government funding, in order to secure ownership of such patent rights, the recipient of such funding is required to comply with certain government regulations, including timely disclosing the inventions claimed in such patent rights to the U.S. government and timely electing title to such inventions. Any failure to timely elect title to such inventions may provide the U.S. government with the right to, at any time, take title to such inventions. Additionally, the U.S. government generally obtains certain rights in any resulting patents, including a non-exclusive license authorizing the government to use the invention or to have others use the invention on its behalf. If the government decides to exercise these rights, it is not required to engage us as its contractor in connection with doing so. These rights may permit the U.S. government to disclose our confidential information to third parties and to exercise march-in rights to use or allow third parties to use our licensed technology. The U.S. government can exercise its march-in rights if it determines that action is necessary because we fail to achieve practical application of the government-funded technology, because action is necessary to alleviate health or safety needs, to meet requirements of federal regulations, or to give</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">94</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preference to U.S. industry. In addition, our rights in such inventions may be subject to certain requirements to manufacture products embodying such inventions in the U.S. Any exercise by the government of any of the foregoing rights could harm our competitive position, business, financial condition, results of operations, and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Reliance on Third Parties</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We rely on third parties to help us conduct our clinical trials. If these third parties do not properly and successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval of or commercialize our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We utilize and depend upon independent investigators and collaborators, such as medical institutions, CROs, CDMOs and strategic partners to help us conduct our preclinical studies and clinical trials under agreements with us. We have and expect to have to negotiate budgets and contracts with CROs, trial sites and CDMOs which may result in delays to our development timelines and increased costs. We will rely heavily on these third parties over the course of our clinical trials, and we control only certain aspects of their activities. As a result, we will have less direct control over the conduct, timing and completion of these clinical trials and the management of data developed through clinical trials than would be the case if we were relying entirely upon our own staff. Nevertheless, we are responsible for ensuring that each of our studies is conducted in accordance with applicable protocol, legal and regulatory requirements and scientific standards, and our reliance on third parties does not relieve us of our regulatory responsibilities. We and these third parties are required to comply with GCPs, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for product candidates in clinical development. Regulatory authorities enforce these GCPs through periodic inspections of trial sponsors, principal investigators and trial sites. If we or any of these third parties fail to comply with applicable GCP regulations, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot provide assurance that, upon inspection, such regulatory authorities will determine that any of our clinical trials comply with the GCP regulations. In addition, our clinical trials must be conducted with biologic product produced under cGMP regulations, including cGTP regulations, and will require a large number of test patients. Our failure or any failure by these third parties to comply with these regulations or to recruit a sufficient number of patients may require us to repeat clinical trials, which would delay the regulatory approval process. Moreover, our business may be implicated if any of these third parties violates federal or state fraud and abuse or false claims laws and regulations or healthcare privacy and security laws.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any third parties conducting our clinical trials are not and will not be our employees and, except for remedies available to us under our agreements with such third parties, we cannot control whether or not they devote sufficient time and resources to our ongoing, clinical and non-clinical product candidates. These third parties may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials or other drug development activities, which could affect their performance on our behalf. If these third parties do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated and we may not be able to complete development of, obtain regulatory approval of or successfully commercialize our product candidates. As a result, our financial results and the commercial prospects for our product candidates would be harmed, our costs could increase and our ability to generate revenue could be delayed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Switching or adding third parties to conduct our clinical trials involves substantial cost and requires extensive management time and focus. In addition, there is a natural transition period when a new third party commences work. As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have in the past and may in the future form or seek collaborations or strategic alliances or enter into additional licensing arrangements in the future, and we may not realize the benefits of such collaborations, alliances or licensing arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have in the past and may in the future form or seek strategic alliances, create joint ventures or collaborations, or enter into additional licensing arrangements with third parties that we believe will complement or augment our development and commercialization efforts with respect to our product candidates and any future product candidates that we may develop. Any of these relationships may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute our existing stockholders or disrupt our management and business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Moreover, we may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for our product candidates because they may be deemed to be at too early of a stage of development for collaborative effort and third parties may not view our product candidates as having the requisite potential to demonstrate safety, potency and purity and obtain marketing approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">95</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, collaborations involving our product candidates are subject to numerous risks, which may include the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to a collaboration; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not perform their obligations as expected; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not pursue development and commercialization of our product candidates or may elect not to continue or renew development or commercialization of our product candidates based on clinical trial results, changes in their strategic focus due to the acquisition of competitive products, availability of funding or other external factors, such as a business combination that diverts resources or creates competing priorities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial, abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a collaborator with marketing and distribution rights to one or more products may not commit sufficient resources to their marketing and distribution; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property or proprietary rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disputes may arise between us and a collaborator that cause the delay or termination of the research, development or commercialization of our product candidates, or that result in costly litigation or arbitration that diverts management attention and resources; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and type of our collaborations could adversely affect our attractiveness to future collaborators or acquirers; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there may be conflicts between different collaborators that could negatively affect those collaborations and potentially others; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may own or co-own intellectual property covering our product candidates that results from our collaborating with them, and in such cases, we would not have the exclusive right to commercialize such intellectual property. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result, if we enter into additional collaboration agreements and strategic partnerships or license our product candidates, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture, which could delay our timelines or otherwise adversely affect our business. We also cannot be certain that, following a strategic transaction or license, we will achieve the revenue or specific net income that justifies such transaction. Any delays in entering into new collaborations or strategic partnership agreements related to our product candidates could delay the development and commercialization of our product candidates in certain geographies for certain indications, which would harm our business prospects, financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our collaboration agreements may grant our collaborators exclusive rights under certain of our intellectual property and may therefore preclude us from entering into collaborations with others relating to the same or similar compounds, therapeutic targets, indications or diseases. Our Amgen Agreement, to identify antigens recognized by T cells in patients with Crohn&#8217;s disease, grants Amgen options to evaluate a variety of modalities to create therapeutics based on targets discovered by us, and Amgen will retain all global development and commercialization rights. Amgen may terminate the Amgen Agreement in its entirety for our insolvency, uncured material breach, or failure to comply with specified compliance provisions or subject to a specified negotiation mechanism. Amgen may terminate the Amgen Agreement in its entirety upon 90 days&#8217; prior written notice to us. If a collaboration agreement is terminated, in whole or in part, we may be unable to continue the development and commercialization of the applicable product candidates, and even if we are able to do so, such efforts may be delayed and result in additional costs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may in the future determine to partner with additional pharmaceutical and biotechnology companies for development and potential commercialization of therapeutic products. We face significant competition in seeking appropriate collaborators. Our ability to reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s evaluation of a number of factors. If we elect to fund and undertake development or commercialization activities on our own, we may need to obtain additional expertise and additional capital, which may not be available to us on acceptable terms or at all. If we fail to enter into collaborations and do not have sufficient funds or expertise to undertake the necessary development and commercialization activities, we may not be able to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">96</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">further develop our product candidates or bring them to market or continue to develop our discovery platform and our business, prospects, financial condition and results of operations may be materially and adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have engaged a global third-party manufacturer to manufacture products for our clinical trials. In the future, we may rely on the use of manufacturing suites in third-party GMP facilities or third parties to manufacture our product candidates. Our business could be harmed if we are unable to use third-party manufacturing suites or if the third-party manufacturers fail to provide us with sufficient quantities of our product candidates or fail to do so at acceptable quality levels, prices, or timing.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have manufacturing capacity at our facilities in Waltham, Massachusetts, but we have not yet manufactured our product candidates on a commercial scale and may not be able to do so for any of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are using third parties as part of our manufacturing process to support our clinical trials for our product candidates, and we may also use them for product candidates in the future. Our anticipated reliance on a limited number of third-party manufacturers exposes us to the following risks:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be unable to identify manufacturers on acceptable terms or at all because the number of potential manufacturers is limited, and the FDA must inspect any manufacturers for current cGMP and cGTP compliance as part of our marketing application; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a new manufacturer would have to be educated in, or develop substantially equivalent processes for, the production of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our manufacturers may have little or no experience with autologous cell products, which are products made from a patient&#8217;s own cells, and therefore may require a significant amount of support from us in order to implement and maintain the infrastructure and processes required to manufacture our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our third-party manufacturers might be unable to timely manufacture our product candidates or produce the quantity and quality required to meet our clinical and commercial needs, if any; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our third-party suppliers or collaborators from whom we receive our antibodies used in combination with our product candidates may be unable to timely manufacture or provide the applicable antibody or produce the quantity and quality required to meet our clinical and commercial needs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contract manufacturers may not be able to execute our manufacturing procedures and other logistical support requirements appropriately; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our future contract manufacturers may not perform as agreed, may not devote sufficient resources to our product candidates or may not remain in the contract manufacturing business for the time required to supply our clinical trials or to successfully produce, store, and distribute our product, if any; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manufacturers are subject to ongoing periodic unannounced inspection by the FDA and corresponding state agencies to ensure strict compliance with cGMP, cGTP and other government regulations and corresponding foreign standards. We do not have control over third-party manufacturers&#8217; compliance with these regulations and standards; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not own, or may have to share, the intellectual property rights to any improvements made by our third-party manufacturers in the manufacturing process for our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our third-party manufacturers could breach or terminate their agreements with us; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">raw materials and components used in the manufacturing process, particularly those for which we have no other source or supplier, may not be available or may not be suitable or acceptable for use due to material or component defects; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our contract manufacturers and critical reagent suppliers may be subject to inclement weather, as well as natural or man-made disasters; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our contract manufacturers may have unacceptable or inconsistent product quality success rates and yields, and we have no direct control over our contract manufacturers&#8217; ability to maintain adequate quality control, quality assurance and qualified personnel; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our contract manufacturers may be adversely affected by the geopolitical and economic tensions with China, the ongoing conflicts between Russia-Ukraine, political unrest in countries where we or our partners operate, earthquakes, flooding, fires, and other natural or man-made disasters, equipment failures, labor shortages, power failures, and numerous other factors. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">97</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each of these risks could delay or prevent the completion of our clinical trials or the approval of any of our product candidates by the FDA, result in higher costs or adversely impact commercialization of our product candidates. In addition, we will rely on third parties to perform certain specification tests on our product candidates prior to delivery to patients. If these tests are not appropriately done and test data are not reliable, patients could be put at risk of serious harm and the FDA could place significant restrictions on our Company until deficiencies are remedied.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The manufacture of cellular-based drug products is complex and requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. Manufacturers of such products often encounter difficulties in production, particularly in scaling up or out, validating the production process and assuring high reliability of the manufacturing process (including the absence of contamination). These problems include logistics and shipping, difficulties with production costs and yields, quality control, including stability of the product, intermediates, or raw materials, product testing, operator error and availability of qualified personnel, as well as compliance with strictly enforced federal, state and foreign regulations. Furthermore, if contaminants are discovered in our supply of our product candidates or in the manufacturing facilities, such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination. We cannot provide assurance that any stability failures or other issues relating to the manufacture of our product candidates will not occur in the future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may fail to manage the logistics of collecting and shipping patient material to our manufacturing site (or that of any third party we engage) and shipping the product candidate back to the patient. Logistical and shipment delays and problems caused by us, our vendors or other factors not in our control, such as weather, could prevent or delay the delivery of product candidates to patients. Additionally, we have to maintain a complex chain of identity and chain of custody with respect to patient material as it moves to the manufacturing facility, through the manufacturing process and back to the patient. Failure to maintain chain of identity and chain of custody could result in patient death, loss of product or regulatory action.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates rely on the availability of specialty materials, which may not be available to us on acceptable terms or at all.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates require specialty materials, some of which are manufactured by small companies with limited resources and experience to support a commercial product. We may not be able to contract with them on acceptable terms or at all. In addition, a number of our suppliers normally support blood-based hospital businesses and generally do not have the capacity to support commercial products manufactured under cGMP by biotechnology firms or may divert their resources towards hospitals rather than us. Our suppliers may be ill-equipped to support our needs, especially in non-routine circumstances like an FDA inspection or medical crisis, such as widespread contamination. We may experience delays in receiving key materials to support clinical or commercial manufacturing. For example, in 2020, we experienced significant delays in receiving shipments of materials utilized in our cell expansion process as a result of the distributor prioritizing distribution of such products for medical use, rather than product candidate development, and, subsequently, increased demand following the easing of state and federal workplace restrictions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, some of our raw materials are currently sourced from a single supplier, or a small number of suppliers. We also use certain biologic materials, that are available from multiple suppliers, but each version may perform differently, requiring us to characterize them and potentially modify the manufacturing process if we change suppliers. We cannot be sure that these suppliers will remain in business, or that they will not be purchased by one of our competitors or another company that is not interested in continuing to produce these materials for our intended purpose. Accordingly, if we no longer have access to these suppliers, we may experience delays in our clinical or commercial manufacturing which could harm our business or results of operations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our manufacturing process needs to comply with FDA or other regulatory agency regulations relating to the quality and reliability of such processes. Any failure to comply with relevant regulations could result in delays in or termination of our clinical programs and suspension or withdrawal of any regulatory approvals.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to commercially produce our product candidates either at our own facility or at a third party&#8217;s facility, we will need to comply with the FDA&#8217;s or other regulatory agencies' cGMP regulations and guidelines, including cGTPs. We may encounter difficulties in achieving quality control and quality assurance and may experience shortages in qualified personnel. We are subject to inspections by the FDA and comparable foreign regulatory authorities to confirm compliance with applicable regulatory requirements. Any failure to follow cGMP, cGTP or other regulatory requirements or delay, interruption or other issues that arise in the manufacture, fill-finish, packaging, or storage of our TCR-T therapy product candidates as a result of a failure of our facilities or the facilities or operations of third parties to comply with regulatory requirements or pass any regulatory authority inspection could significantly impair our ability to develop and commercialize our TCR-T therapy product candidates, including leading to significant delays in the availability of our TCR-T therapy product candidates for our clinical trials or the termination of or suspension of a clinical trial, or the delay or prevention of a filing or approval of marketing applications for our product candidates. Significant non-compliance could also result in the imposition of sanctions, including warning or untitled letters, fines, injunctions, civil penalties, failure of regulatory authorities to grant</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">98</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">marketing approvals for our product candidates, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could damage our reputation and our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our third-party manufacturers use hazardous and biological materials in a manner that causes injury or violates applicable law, we may be liable for damages.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our research and development activities involve the controlled use of potentially hazardous substances, including chemical and biological materials, by our third-party manufacturers. Our manufacturing is (and any third-party manufacturers we engage are) subject to federal, state and local laws and regulations in the U.S. governing the use, manufacture, storage, handling and disposal of medical and hazardous materials. Although we believe that our manufacturers&#8217; procedures for using, handling, storing and disposing of these materials comply with legally prescribed standards, we cannot completely eliminate the risk of contamination or injury resulting from medical or hazardous materials. As a result of any such contamination or injury, we may incur liability or local, city, state or federal authorities may curtail the use of these materials and interrupt our business operations. In the event of an accident, we could be held liable for damages or penalized with fines, and the liability could exceed our resources. We do not have any insurance for liabilities arising from medical or hazardous materials. Compliance with applicable environmental laws and regulations is expensive, and current or future environmental regulations may impair our research, development and production efforts, which could harm our business, prospects, financial condition or results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Employee Matters and Managing Growth</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are highly dependent on our key personnel, and if we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to compete in the highly competitive biotechnology and pharmaceutical industries depends upon our ability to attract and retain highly qualified managerial, scientific and medical personnel. We are highly dependent on our management, scientific and medical personnel. The loss of the services of any of our executive officers, other key employees and other scientific and medical advisors, and an inability to find suitable replacements could result in delays in product development and harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conduct our operations at our facility in Waltham, Massachusetts. This region is headquarters to many other biotechnology companies and many academic and research institutions. Competition for skilled personnel in our market is intense and may limit our ability to hire and retain highly qualified personnel on acceptable terms or at all. Changes to U.S. immigration and work authorization laws and regulations, including those that restrain the flow of scientific and professional talent, can be significantly affected by political forces and levels of economic activity. Our business may be materially adversely affected if legislative or administrative changes to immigration or visa laws and regulations, including as a result of the change in the U.S. presidential administration, impair our hiring processes and goals or projects involving personnel who are not U.S. citizens.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To encourage valuable employees to remain at our Company, in addition to salary and cash incentives, we have provided stock options that vest over time. The value to employees of stock options that vest over time may be significantly affected by movements in our stock price that are beyond our control and may at any time be insufficient to counteract more lucrative offers from other companies. Despite our efforts to retain valuable employees, members of our management, scientific and development teams may terminate their employment with us on short notice. Although we have employment agreements with our key employees, these employment agreements provide for at-will employment, which means that any of our employees could leave our employment at any time, with or without notice. Our success also depends on our ability to continue to attract, retain and motivate highly skilled junior, mid-level and senior managers as well as junior, mid-level and senior scientific and medical personnel.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will need to grow the size of our organization, and we may experience difficulties in managing this growth.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 28, 2025, we had 194 full-time employees and 1 part-time employees. As our development and commercialization plans and strategies develop, and as we continue operating as a public company, we expect to need additional managerial, operational, sales, marketing, financial and other personnel, as well as additional facilities to expand our operations. Future growth would impose significant added responsibilities on members of management, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identifying, recruiting, integrating, maintaining and motivating additional employees; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">managing our internal development efforts effectively, including the clinical and FDA review process for our product candidates, while complying with our contractual obligations to contractors and other third parties; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">improving our operational, financial and management controls, reporting systems and procedures. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">99</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future financial performance and our ability to commercialize our product candidates will depend, in part, on our ability to effectively manage any future growth, and our management may also have to divert a disproportionate amount of its attention away from day-to-day activities in order to devote a substantial amount of time to managing these growth activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent organizations, advisors and consultants to provide certain services, including substantially all aspects of regulatory approval, and clinical trial management. There can be no assurance that the services of independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by consultants is compromised for any reason, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain regulatory approval of our product candidates or otherwise advance our business. There can be no assurance that we will be able to manage our existing consultants or find other competent outside contractors and consultants on economically reasonable terms, or at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, or we are not able to effectively build out new facilities to accommodate this expansion, we may not be able to successfully implement the tasks necessary to further develop and commercialize our product candidates and, accordingly, may not achieve our research, development and commercialization goals.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit commercialization of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face an inherent risk of product liability as a result of the planned clinical testing of our product candidates and will face an even greater risk if we commercialize any products. For example, we may be sued if our product candidates cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit commercialization of our product candidates. Even successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">decreased demand for our product candidates or products that we may develop; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injury to our reputation; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">withdrawal of clinical trial participants; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">initiation of investigations by regulators; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">costs to defend the related litigation; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a diversion of management&#8217;s time and our resources; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">substantial monetary awards to trial participants or patients; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product recalls, withdrawals or labeling, marketing or promotional restrictions; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loss of revenue; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">exhaustion of any available insurance and our capital resources; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inability to commercialize any product candidate; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a decline in our share price. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to obtain or retain sufficient product liability insurance at an acceptable cost to protect against potential product liability claims could prevent or inhibit the commercialization of products we develop, alone or with corporate collaborators. Although we have clinical trial insurance, our insurance policies also have various exclusions, and we may be subject to a product liability claim for which we have no coverage. We may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. Even if our agreements with any future corporate collaborators entitle us to indemnification against losses, such indemnification may not be available or adequate should any claim arise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">100</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as one or more shareholders or groups of shareholders who own at least 5 percent of the corporation&#8217;s equity increasing their equity ownership in the aggregate by a greater than 50 percentage point change (by value) over a three-year period), the corporation&#8217;s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change taxable income may be limited. As a result of our public offerings, our most recent private placements and other transactions that have occurred over the past three years, we have experienced, such an &#8220;ownership change.&#8221; We may also experience ownership changes in the future as a result of subsequent shifts in our stock ownership or other transactions. As of December 31, 2024, we had U.S. federal net operating loss carryforwards of $113.6 million and U.S. federal research and development tax credit carryforwards of $17.9 million that expire through 2043 and which could be limited if we experience an &#8220;ownership change.&#8221; Under the current law, federal net operating loss carryforwards generated in taxable years beginning after December 31, 2017 will not be subject to expiration. However, any such net operating loss carryforwards may only offset 80% of our annual taxable income in taxable years beginning after December 31, 2020. State net operating loss carryforwards and other tax attributes may be similarly limited. Any such limitations may result in increased tax liabilities that could adversely affect our business, results of operations, financial position and cash flows.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Common Stock and Our Status as a Public Company</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We do not know whether an active trading market will continue to develop or be sustained for our common stock and, as a result, it may be difficult for our stockholders to sell their shares of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock began trading on the Nasdaq Global Market in July 2021. Prior to July 2021, there was no public market for our common stock, and we cannot assure you that an active trading market for our shares will continue to develop or be sustained. As a result, it may be difficult for our stockholders to sell their shares without depressing the market price of our common stock, or at all.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The price of our common stock is volatile and fluctuates substantially, which could result in substantial losses for our stockholders.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our stock price has been, and is likely to continue to be, volatile. The stock market in general, and the market for smaller biotechnology companies in particular, have experienced extreme price volatility and volume fluctuations that have often been unrelated to the operating performance of particular companies. As a result of this volatility, our stockholders may not be able to sell their common stock at or above the price they paid for their shares. The market price for our common stock may be influenced by many factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">overall performance of the equity markets; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our operating performance and the performance of other similar companies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">results from our ongoing clinical trials and future clinical trials with our current and future product candidates or of our competitors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in the commencement, enrollment and the ultimate completion of clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in our projected operating results that we provide to the public, our failure to meet these projections or changes in recommendations by securities analysts that elect to follow our common stock; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory actions with respect to our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory or legal developments in the U.S. and other countries; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the level of expenses related to future product candidates or clinical development programs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our failure to achieve product development or commercialization goals or regulatory approval milestones in the timeframe we announce; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in hospital or emergency care partner practices; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announcements of acquisitions, strategic alliances or significant agreements by us or by our competitors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">developments or disputes concerning intellectual property or proprietary rights; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain, maintain, protect and enforce our intellectual property and proprietary rights; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recruitment or departure of key personnel; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the economy as a whole and market conditions in our industry, including conditions resulting from ongoing conflicts between Russia and Ukraine;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">101</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">variations in our financial results or the financial results of companies that are perceived to be similar to us; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">financing or other corporate transactions, or inability to obtain additional funding; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trading activity by a limited number of stockholders who together beneficially own a substantial amount of our outstanding common stock; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the expiration of market standoff or contractual lock-up agreements, as applicable; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the size of our market float; and  </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the other factors described in this &#8220;Risk Factors&#8221; section. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many biotechnology companies. Stock prices of many biotechnology companies have fluctuated in a manner unrelated or disproportionate to the operating performance of those companies. In the past, stockholders have filed securities class action litigation following periods of market volatility. If we were to become involved in securities litigation, it could subject us to substantial costs, divert resources and the attention of management from our business and adversely affect our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading market for our common stock will depend in part on the research and reports that securities or industry analysts publish about us or our business. If no or only very few securities analysts commence coverage of us, or if industry analysts cease coverage of us, the trading price for our common stock would be negatively affected. If one or more of the analysts who cover us downgrade our common stock or publish inaccurate or unfavorable research about our business, our common stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our common stock could decrease, which might cause our common stock price and trading volume to decline.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Substantial amounts of our outstanding shares may be sold into the market. If there are substantial sales of shares of our common stock, the price of our common stock could decline.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The price of our common stock could decline if there are substantial sales of our common stock, particularly sales by our directors, executive officers and significant stockholders, or if there is a large number of shares of our common stock available for sale and the market perceives that sales will occur. Shares held by directors, executive officers and their affiliates will be subject to volume limitations or other restrictions</span><span style="color:#0061fe;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">under Rule 144 under the Securities Act of 1933, as amended, or the Securities Act, and various vesting agreements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain of our stockholders have rights, subject to some conditions above, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or our stockholders. We also have registered shares of common stock that we have issued and may issue under our employee equity incentive plans. Once we register these shares, they will be able to be sold freely in the public market upon issuance.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market price of the shares of our common stock could decline as a result of the sale of a substantial number of our shares of common stock in the public market or the perception in the market that the holders of a large number of shares intend to sell their shares.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The concentration of our stock ownership will likely limit our stockholders&#8217; ability to influence corporate matters, including the ability to influence the outcome of director elections and other matters requiring stockholder approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 28, 2025, our executive officers, directors, and entities affiliated with such persons beneficially owned, in the aggregate, approximately 29% of our outstanding voting stock and approximately 34% of our outstanding common stock. As a result, these stockholders, acting together, have significant influence over all matters that require approval by our stockholders, including the election of directors and approval of significant corporate transactions. Corporate actions might be taken even if other stockholders, oppose them. This concentration of ownership may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you or other stockholders may feel are in your or their best interest as one of our stockholders. This concentration of ownership might also have the effect of delaying or preventing a change of control of our Company that other stockholders may view as beneficial.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">102</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are an &#8220;emerging growth company&#8221; and a &#8220;smaller reporting company,&#8221; and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies and smaller reporting companies will make our common stock less attractive to investors.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are an &#8220;emerging growth company&#8221; as defined in the JOBS Act and we intend to take advantage of some of the exemptions from reporting requirements that are applicable to other public companies that are not emerging growth companies, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the option to present only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes Oxley Act; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not being required to disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the chief executive officer&#8217;s compensation to median employee compensation; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not being required to submit certain executive compensation matters to stockholder advisory votes, such as &#8220;say-on-pay,&#8221; &#8220;say-on-frequency,&#8221; and &#8220;say-on-golden parachutes.&#8221; </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The JOBS Act permits an &#8220;emerging growth company&#8221; such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We have elected to take advantage of this extended transition period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. We may take advantage of these reporting exemptions until we are no longer an emerging growth company. We would cease to be an emerging growth company on the date that is the earliest of (i) the last day of the fiscal year in which we have total annual gross revenue of $1.235 billion or more; (ii) December 31, 2026; (iii) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years; or (iv) the last day of the fiscal year in which we are deemed to be a large accelerated filer under the rules of the SEC, which means the market value of our voting and non-voting common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even after we no longer qualify as an emerging growth company, we may still qualify as a &#8220;smaller reporting company,&#8221; which would allow us to continue to take advantage of many of the same exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, as amended (Sarbanes-Oxley Act) and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Requirements associated with being a public company will increase our costs significantly, as well as divert significant company resources and management attention.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a public company, and particularly after we are no longer an &#8220;emerging growth company,&#8221; we will incur significant legal, accounting and other expenses that we did not incur as a private company, including costs associated with public company reporting requirements. We also anticipate that we will incur costs associated with relatively recently adopted corporate governance requirements, including requirements of the SEC, and the Nasdaq Global Market. We expect these rules and regulations to increase our legal and financial compliance costs and to make some activities more time-consuming and costly. We also expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified individuals to serve on our board of directors or as executive officers.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">103</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to maintain proper and effective internal controls, our ability to produce accurate and timely financial statements could be impaired, which could result in sanctions or other penalties that would harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with the Sarbanes-Oxley Act or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are required to disclose changes made in our internal controls and procedures on a quarterly basis and our management will be required to assess the effectiveness of these controls annually. However, for as long as we are an &#8220;emerging growth company&#8221; under JOBS Act, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to the Sarbanes-Oxley Act. We would cease to be an emerging growth company on the date that is the earliest of (i) the last day of the fiscal year in which we have total annual gross revenue of $1.235 billion or more; (ii) December 31, 2026; (iii) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years; or (iv) the last day of the fiscal year in which we are deemed to be a large accelerated filer under the rules of the SEC, which means the market value of our voting and non-voting common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th. An independent assessment of the effectiveness of our internal controls over financial reporting could detect problems that our management&#8217;s assessment might not. Undetected material weaknesses in our internal controls over financial reporting could lead to financial statement restatements and require us to incur the expense of remediation.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will have broad discretion in the use of our cash and cash equivalents and may not use them effectively.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will have broad discretion in the application of our cash and cash equivalents, including working capital and other general corporate purposes, and our stockholders may disagree with how we spend or invest these proceeds. We may spend our funds in ways that do not improve our results of operations or enhance the value of our common stock. The failure by our management to apply these funds effectively could adversely affect our business and financial condition. Pending their use, we may invest our cash and cash equivalents in a manner that does not produce income or that loses value. These investments may not yield a favorable return to our stockholders.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We do not intend to pay dividends for the foreseeable future.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never declared nor paid cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future. Consequently, stockholders must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our operating results may fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or our guidance.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our quarterly and annual operating results may fluctuate significantly in the future, which makes it difficult for us to predict our future operating results. Our operating results may fluctuate due to a variety of factors, many of which are outside of our control and may be difficult to predict, including the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing and success or failure of clinical trials for our product candidates or competing product candidates, including the nature of the data obtained from such clinical trials, or any other change in the competitive landscape of our industry, including consolidation among our competitors or partners; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to successfully recruit patients for preclinical studies and clinical trials, and any delays caused by difficulties in such recruitment efforts; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain regulatory approval for our product candidates, and the timing and scope of any such approvals we may receive; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing and cost of, and level of investment in, research and development activities relating to our product candidates, which may change from time to time; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">104</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of manufacturing our product candidates, which may vary depending on the quantity of production and the terms of our agreements with manufacturers; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to attract, hire and retain qualified personnel; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenditures that we will or may incur to develop additional product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the level of demand for our product candidates should they receive approval, which may vary significantly; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the risk/benefit profile, cost and reimbursement policies with respect to our product candidates, if approved, and existing and potential future drugs that compete with our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the changing and volatile U.S., European and global economic environments; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">future accounting pronouncements or changes in our accounting policies. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful. This variability and unpredictability could also result in our failing to meet the expectations of industry or financial analysts or investors for any period. If our revenue or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated guidance we may provide.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Delaware law and provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our status as a Delaware corporation and the anti-takeover provisions of the Delaware General Corporation Law may discourage, delay or prevent a change in control by prohibiting us from engaging in a business combination with an interested stockholder for a period of three years after the person becomes an interested stockholder, even if a change of control would be beneficial to our existing stockholders. In addition, our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that may make the acquisition of our Company more difficult, including the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a classified board of directors with three-year staggered terms, which could delay the ability of stockholders to change the membership of a majority of our board of directors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability of our board of directors to issue shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquiror; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of our board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the requirement that a special meeting of stockholders may be called only by a majority vote of our entire board of directors, the chairman of our board of directors or our chief executive officer, which could delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the requirement for the affirmative vote of holders of at least 66-2/3% of the voting power of all of the then-outstanding shares of the voting stock, voting together as a single class, to amend the provisions of our amended and restated certificate of incorporation or our amended and restated bylaws, which may inhibit the ability of an acquiror to effect such amendments to facilitate an unsolicited takeover attempt; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">advance notice procedures with which stockholders must comply to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders&#8217; meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#8217;s own slate of directors or otherwise attempting to obtain control of us. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">105</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as a Delaware corporation, we are subject to Section 203 of the Delaware General Corporation Law. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time. A Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or bylaws approved by its stockholders. However, we have not opted out of this provision.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These and other provisions in our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could make it more difficult for stockholders or potential acquirors to obtain control of our board of directors or initiate actions that are opposed by our then-current board of directors, including delay or impede a merger, tender offer or proxy contest involving our Company. The existence of these provisions could negatively affect the price of our common stock and limit opportunities for stockholders to realize value in a corporate transaction.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and the federal district courts of the U.S. is the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a breach of fiduciary duty, any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our certificate of incorporation or our bylaws or any action asserting a claim against us that is governed by the internal affairs doctrine. This provision does not apply to claims brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Our amended and restated certificate of incorporation provides further that the federal district courts of the U.S. is the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. These choices of forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees and may discourage these types of lawsuits. Furthermore, the enforceability of similar choice of forum provisions in other companies&#8217; certificates of incorporation has been challenged in legal proceedings, and it is possible that a court could find these types of provisions to be inapplicable or unenforceable. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive-forum provisions, and there can be no assurance that such provisions will be enforced by a court in those other jurisdictions. If a court were to find the exclusive-forum provision contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Risk Factors</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in tax legislation could adversely affect our business and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rules dealing with U.S. federal, state, and local and non-U.S. taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department and other taxing authorities. Changes to tax laws or tax rulings (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many such changes have been made and changes are likely to continue to occur in the future. It cannot be predicted whether, when, in what form, or with what effective dates, new tax laws may be enacted, or regulations and rulings may be promulgated or issued under existing or new tax laws, which could result in an increase in our or our shareholders&#8217; tax liability or require changes in the manner in which we operate in order to minimize or mitigate any adverse effects of changes in tax law or in the interpretation thereof.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rising inflation rates may result in increased operating costs and reduced liquidity, and affect our ability to access credit.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Increased inflation may result in increased operating costs (including our labor costs), reduced liquidity, and limitations on our ability to access credit or otherwise raise debt and equity capital. In addition, the U.S. Federal Reserve System has repeatedly raised, and may continue to raise, interest rates in response to concerns about inflation. Increases in interest rates, especially if coupled with reduced government spending and volatility in financial markets, may have the effect of further increasing economic uncertainty and heightening these risks.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We could be subject to securities class action litigation.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant for us because biotechnology companies have experienced significant stock price volatility in recent years. If we face such litigation, it could result in substantial costs and a diversion of management&#8217;s attention and resources, which could harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">106</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operations, and those of our CROs, CDMOs and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics and other natural or man-made disasters or business interruptions, for which we are predominantly self-insured. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses. Our ability to obtain clinical supplies of our product candidates could be disrupted if the operations of these suppliers are affected by a man-made or natural disaster or other business interruption.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1B. Unresolved Staff Comments</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not Applicable</span></p>
  <div><ix:nonNumeric id="F_01eb8aa7-0db6-41e4-ab64-21e2942d0d91" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true" continuedAt="F_01eb8aa7-0db6-41e4-ab64-21e2942d0d91_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Management and Strategy</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7b9bb5c1-434e-46da-8aba-0880b4086754" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the importance of safeguarding the security of our computer systems, software, networks, and other technology assets. We have implemented processes for identifying, assessing, and mitigating cybersecurity risks and we have </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bd5bd7f7-2b1d-4539-9294-de085466cd82" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">implemented a cybersecurity risk management program</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that is informed by recognized industry standards and frameworks and incorporates elements of the same, including elements of the National Institute of Standards and Technology (NIST) Cybersecurity Framework.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management program incorporates a number of components, including, but not limited to, information security policies and operating procedures, periodic information security risk assessments and other vulnerability analyses, and ongoing monitoring of critical risks from cybersecurity threats using automated tools. Additionally, we have implemented a process to conduct cybersecurity awareness training for employees during onboarding and thereafter.</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain a Cybersecurity Incident Response Plan, or CIRP, which is designed to guide our response to cyber incidents, including to mitigate and contain any potential cybersecurity incidents that could affect our systems, network, or data. The CIRP identifies the individuals responsible for developing, maintaining, and following procedures related to cybersecurity incident response, including escalation protocols. We also </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_04c7bcaa-c636-4fdd-982e-52e3141f66d9" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">engage</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> external third-party consultants to provide services, such as penetration testing, which is conducted on an annual basis, along with ongoing vulnerability scans. These consultants also perform annual assessments of our cybersecurity program, which involve, among other things, review of our IT security measures and processes for alignment with the NIST Cybersecurity Framework and provision of threat intelligence regarding emerging risks to our information systems.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f35b419e-cc72-4d2e-bd3c-05645ffc02db" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our cybersecurity risk management program, we maintain processes around third-party vendor risk management, including a framework for managing third-party information security risks.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> This framework, which applies to select third parties who have access to our systems and/or process our information, includes processes for assessing and reviewing the cybersecurity practices of such third-parties, including a review of available security audit reporting and certifications and inclusion of security requirements in contracts, as appropriate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7b16b46a-f559-475c-8da6-836dddf96946" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not been materially affected by cybersecurity threats. We may, from time to time, experience threats to and security incidents related to our data systems but we do not believe they are reasonably likely to materially affect our business strategy, results of operations or financial condition.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> For more information, please see the risk factors entitled &#8220;Our internal computer systems, or those used by our third-party CROs or other contractors or consultants, may fail or suffer cybersecurity incidents, data breaches or other unauthorized or improper access, which could result in a material disruption of the development programs of our product candidates&#8221; and &#8220;Cybersecurity incidents, loss of data or modification of information, and other disruptions could compromise information related to our business or prevent us from accessing critical information, result in a significant disruption of our activities and expose us to liability, which could adversely affect our business and our reputation&#8221; in Item 1A- Risk Factors in this Annual Report on Form 10-K.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Governance</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_603b80f0-81cc-46e3-8357-a3d1d80a1a16" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true" continuedAt="F_603b80f0-81cc-46e3-8357-a3d1d80a1a16_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_42f1bf83-4b9d-48de-9224-53a14a6a1016" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_df947706-450b-4ae0-9d91-8e8aa9c2ab36" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of Information Technology and Security, or Head of IT, has primary responsibility for day-to-day management of our cybersecurity risk management program,</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> including leading a dedicated team of information technology professionals to monitor cybersecurity risks on behalf of TScan.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d8bd629e-82c5-414a-932c-0967932b35d7" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of IT has over 16 years&#8217; experience with information technology and cybersecurity risk management programs. </span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">107</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_01eb8aa7-0db6-41e4-ab64-21e2942d0d91_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_603b80f0-81cc-46e3-8357-a3d1d80a1a16_1"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ea76ce46-92d0-4efa-99b1-5e6ae173d528" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This team is responsible for assessing potential vulnerabilities and exposures to cybersecurity threats, implementing controls and measures designed to mitigate these risks, and regularly monitoring and updating these policies, to adapt to evolving threats.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> If an incident arises, the </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9b66cd9e-d7ac-4b9f-a412-72be570d4d6d" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" continuedAt="F_9b66cd9e-d7ac-4b9f-a412-72be570d4d6d_1" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head of IT notifies our Chief Legal and Compliance Officer, and Chief Financial Officer, who will raise issues to those charged with governance, as appropriate.</span></ix:nonNumeric></span></ix:continuation></span><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_9b66cd9e-d7ac-4b9f-a412-72be570d4d6d_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><ix:nonNumeric id="F_3f67f54a-26f1-4679-85ce-f6edcc05210b" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors, as a whole and through its committees, is responsible for our overall enterprise risk management program, which incorporates as an element our cybersecurity risk management program. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_66473f7d-8f10-4b65-be2f-e0bb8ee2229f" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit committee, a subcommittee of our board of directors, has been delegated responsibility for oversight of cybersecurity risk management, which includes reviewing our cybersecurity and other information, technology risks, controls and procedures, including our plans to mitigate and respond to cybersecurity risks. The Head of IT, alongside the Chief Legal and Compliance Officer, and Chief Financial Officer, provide quarterly reports to the audit committee covering cybersecurity and other information technology risks affecting us. These reports may include reviewing our current infrastructure and the status of key cybersecurity initiatives, including the status of ongoing mitigation efforts, providing insights into the latest cybersecurity threats, and discussing any recent security incidents impacting our peer companies. </span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_908eadf6-ea56-45a9-b1a9-d3ddbcd282eb" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Periodically, or in the event of a critical cybersecurity incident, the Chief Legal and Compliance Officer, and Chief Financial Officer will provide our full board of directors with findings and recommendations from these reports.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2. Properties</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our corporate headquarters is located at 830 Winter Street in Waltham, Massachusetts. The facility at 830 Winter Street is 51,100 square feet of laboratory space, with a lease expiration of October 2029. We also lease a facility at 880 Winter Street which is 113,487 square feet of office and laboratory space with a lease termination date of December 2032. We believe our facilities are sufficient to meet our current needs for the foreseeable future.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3. L</span><span id="item_3_legal_proceeding"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">egal Proceedings</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are not currently a party to any material legal proceedings. From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 4. Mine Safe</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ty Disclosures</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">108</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_5_market_for_registra_common_equity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5. Market for Registrant's Common Equity, Related Stoc</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">kholder Matters and Issuer Purchases of Equity Securities</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Market Information</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock has been publicly traded on The Nasdaq Global Market under the symbol &#8220;TCRX&#8221; since July 16, 2021. Prior to that time, there was no public market for our common stock.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of February 28, 2025, there were approximately 70 holders of record of our common stock. This number does not include beneficial owners whose shares are held by nominees in street name.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividends</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not declared or paid any cash dividends on our capital stock since our inception. We intend to retain future earnings, if any, to finance the operation and expansion of our business and do not anticipate paying any cash dividends to holders of common stock in the foreseeable future.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities authorized for issuance under equity compensation plans</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information about our equity compensation plans is incorporated herein by reference to Item 12, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of this Annual Report on Form 10-K</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Sale of Unregistered Equity Securities</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, we did not issue or sell any unregistered securities, except as previously reported on our Current Report on Form 8-K filed on November 21, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Use of Proceeds</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2021, our Registration Statement on Form S-1 (No. 333-225491) was declared effective by the SEC pursuant to which we issued and sold an aggregate of 6,666,667 shares of voting common stock at a public offering price of $15.00 per share for aggregate net cash proceeds of $89.6 million, after deducting $7.0 million underwriting discounts and commissions, and $3.4 million in offering costs borne by us. No payments for such expenses were made directly or indirectly to (i) any of our officers or directors or their associates, (ii) any persons owning 10% or more of any class of our equity securities or (iii) any of our affiliates. The sale and issuance of 6,666,667 shares closed on July 20, 2021. Morgan Stanley &amp; Co. LLC, Jefferies LLC, Cowen and Company LLC and Barclays Capital Inc. acted as joint book-running managers for the offering. There has been no material change in the planned use of proceeds from our initial public offering as described in our final prospectus filed pursuant to Rule 424(b)(4) under the Securities Act with the SEC.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_6_selected_financial_data"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 6. [</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reserved]</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">109</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7_mda"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7. Management&#8217;s Discussion and Analys</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">is of Financial Condition and Results of Operations</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes appearing at the end of this Annual Report on Form 10-K. Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report on Form 10-K, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the &#8220;Risk Factors&#8221; section of this Annual Report on Form 10-K, our actual results could differ materially from the results described in, or implied by, the forward-looking statements contained in the following discussion and analysis.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. Our approach is based on the central premise that we can learn from patients who are winning their fight against cancer to treat those who are not. Over the past several years, we have built our ImmunoBank, a repository of therapeutic TCRs that recognize diverse targets and are associated with multiple human leukocyte antigen, or HLA, types. We then use these TCRs to manufacture enhanced TCR-T therapies to treat a broad population of patients with both hematologic, or heme, and solid tumor malignancies. Every TCR in our ImmunoBank has come from our proprietary platform technologies, and we are continuing to expand our ImmunoBank.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are advancing a robust pipeline of TCR-T therapy product candidates for the treatment of patients with heme malignancies and solid tumors. Our lead product candidates, TSC-100 and TSC-101, are in development for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL), who are undergoing allogeneic hematopoietic cell transplantation (HCT). The products are designed to eliminate residual disease and promote complete donor chimerism, thereby preventing relapse. TSC-100 and TSC-101 target the antigens HA-1 and HA-2, respectively, which are well-recognized TCR targets that were first identified in patients with exceptional responses to HCT-associated immunotherapy. We are currently conducting a multi-arm Phase 1 "umbrella" clinical study of TSC-100 and TSC-101, the ALLOHA&#153; Phase 1 heme trial, with 15 clinical sites activated, and we plan to open additional sites before the end of 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we are developing multiple TCR-T therapy product candidates for the treatment of solid tumors. One of the challenges of treating solid tumors is that they are heterogeneous &#8211; not every tumor cell expresses a given target and some tumor cells lose half their HLA genes. To address this challenge, we are developing what we refer to as multiplex TCR-T therapy, or T-Plex, in which we treat a patient with more than one TCR-T therapy product candidate at a time. We are designing these multiplex therapies to be a simultaneous administration of up to three highly active TCR-T therapy product candidates, selected from our ImmunoBank, that are customized for each patient based on which targets are expressed in their tumors and which HLA genes are still intact. We continue to prioritize expanding the ImmunoBank with TCRs for additional targets and multiple HLA types for each target. We have now advanced seven TCR-T therapy product candidates into Phase 1 development for solid tumors: TSC-203-A0201 (PRAME, HLA-A*02:01); TSC-200-A0201 (HPV16, HLA-A*02:01); TSC-201-B0702 (MAGE-C2, HLA-B*07:02); TSC-202-A0201 (MAGE-A4, HLA-A*02:01); TSC-204-A0201 (MAGE-A1, HLA-A*02:01); TSC-204-C0702 (MAGE-A1, HLA-C*07:02); and TSC-204-A0101 (MAGE-A1, HLA-A*01:01). In addition to clearing these seven solid-tumor investigational new drug (IND) applications, the U.S. Food and Drug Administration (FDA) has cleared our IND application for T-Plex, enabling us to treat patients with multiplex TCR-T therapy. We plan to further expand the ImmunoBank by filing IND applications for additional TCR-T therapy product candidates. We have initiated a Phase 1 solid tumor clinical trial, the PLEXI-T&#153; trial, with 15 clinical sites activated, and we plan to open additional sites before the end of 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since our inception in 2018, we have devoted our efforts to raising capital, obtaining financing, filing, prosecuting and maintaining intellectual property rights, organizing and staffing our Company and incurring research and development costs related to the identification of novel targets for TCRs and development of TCR-T therapy product candidates to target and eliminate cancer cells. We do not have any therapies approved for sale and have not generated any revenue from product sales. To date, we have funded our operations primarily with proceeds from sales of capital stock, revenue received under our collaboration agreements, as well as debt facilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Components of Results of Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, our revenue has primarily been derived from our collaboration and licensing agreements, which have been in the scope of ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We have not generated any revenue from the sale of therapies to date, nor do we expect to generate revenues therefrom in the near future, if at all. If our development efforts for our product candidates are successful and result in regulatory approval or if we enter into additional license or collaboration agreements with third parties, we may generate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">110</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional revenue in the future from sales of our therapies, payments from license or collaboration agreements that we may enter into with third parties, or any combination thereof. However, there can be no assurance as to when we will generate such revenue, if at all. We expect that our revenue for at least the next several years will be derived primarily from collaborations and licenses that we may enter into in the future, if any.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Collaboration Revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Novartis</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In March 2020, we entered into a Collaboration and License Agreement (the Novartis Agreement) with Novartis Institutes for BioMedical Research, Inc. (Novartis), to collaborate on their research efforts to discover and develop novel TCR-T therapies. Under the Novartis Agreement, we identified and characterized TCRs in accordance with a research plan and transferred data arising from the research plan. The collaboration included an upfront fee and research funding together totaling $30.0 million. During the year ended December 31, 2023, we recognized $5.8 million of revenue associated with the Novartis Agreement, of which $1.9 million related to cost reimbursements under the Novartis Agreement that offset costs incurred within research and development expenses in the statements of operations. In March 2023, all performance obligations were considered fulfilled, and the arrangement was completed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amgen</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 8, 2023, the Company entered into a Collaboration Agreement with Amgen Inc. (the Amgen Agreement) to identify antigens recognized by T cells in patients with Crohn&#8217;s disease in accordance with a research plan. Under the terms of the Agreement, Amgen will retain all global development and commercialization rights.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The collaboration included an upfront fee of $30.0 million. We have identified performance obligations for research and development activities, the license, data reporting and participation in joint steering and research committees, which were determined to be a single combined performance obligation due to the services and licenses being highly interrelated. During the years ended December 31, 2024 and 2023, we recognized $2.8 million and $14.2 million, respectively, of revenue associated with the Amgen Agreement. The research term of the Amgen Agreement is expected to be approximately 3 years.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See Note 9, Collaboration and License Agreements, to our audited financial statements included elsewhere in this Annual Report.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses consist primarily of costs incurred in connection with our research activities, including our therapeutic discovery efforts, preclinical and clinical trials, and the development of our proprietary platform technologies and product candidates. We expense research and development costs as incurred, which include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">employee-related expenses, including salaries, bonuses, benefits, stock-based compensation, and other related costs for those employees involved in research and development efforts; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenses incurred in connection with our research programs, including under agreements with third parties, such as consultants and contract research organizations, or CROs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of raw materials, developing and scaling our manufacturing process, and manufacturing our product candidates for use in our research and preclinical studies, including under agreements with third parties, such as consultants, contractors, and contract development and manufacturing organizations, or CDMOs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">laboratory supplies and research materials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">facilities, depreciation, and other expenses, which include direct and allocated expenses for rent and maintenance of facilities and insurance; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payments made under third-party licensing agreements. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expense research and development costs as incurred. Non-refundable advance payments that we make for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related goods are delivered or the services are performed, or when it is no longer expected that the goods will be delivered or the services rendered. Upfront payments under license agreements are expensed upon receipt of the license, and annual maintenance fees under license agreements are expensed in the period in which they are incurred. Milestone payments under license</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">111</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">agreements are accrued, with a corresponding expense being recognized, in the period in which the milestone is determined to be probable of achievement and the related amount is reasonably estimable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our direct external research and development expenses consist of costs that include fees, reimbursed materials, direct material costs, and other costs paid to consultants, contractors, CDMOs and CROs in connection with our development and manufacturing activities. We do not allocate employee costs, general laboratory supplies, and facilities expenses, including depreciation or other indirect costs, to specific product development programs because these costs are deployed across multiple programs and our platform technology and, as such, are not separately classified.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Product candidates in later stages of clinical development generally have higher development costs than those in preclinical and earlier stages of clinical development, primarily due increased size and duration of later stage clinical trials. We expect that our research and development expenses will increase substantially in connection with our planned preclinical and clinical development activities in the near term and in the future. At this time, we cannot accurately estimate or know the nature, timing and costs of the efforts that will be necessary to complete the preclinical and clinical development of any of our product candidates. The successful development and commercialization of our product candidates is highly uncertain. This is due to the numerous risks and uncertainties associated with therapeutic development and commercialization, including the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and scope of preclinical and clinical programs we decide to pursue; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing and progress of preclinical and clinical development activities for each program; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to raise additional funds necessary to complete preclinical and clinical development of and commercialize our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the progress of the development efforts of parties with whom we may enter into collaboration arrangements; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to maintain our current research and development programs and to establish new ones; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish new licensing or collaboration arrangements; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the successful initiation and completion of clinical trials with safety, tolerability and efficacy profiles that are satisfactory to the U.S. Food and Drug Administration, or the FDA, or any comparable foreign regulatory authority; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the receipt and related terms of regulatory approvals from applicable regulatory authorities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of raw materials for use in the manufacture of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to consistently manufacture our product candidates for use in clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish and operate a manufacturing facility, or secure manufacturing supply through relationships with third parties; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain and maintain patents, trade secret protection and regulatory exclusivity, both in the U.S. and internationally; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to protect our rights in our intellectual property portfolio; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the commercialization of our product candidates, if and when approved; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining and maintaining third-party insurance coverage and adequate reimbursement; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the acceptance of our product candidates, if approved, by patients, the medical community and third-party payors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">competition with other products and therapies; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a continued acceptable safety profile of our therapies following approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A change in the outcome of any of these variables with respect to the development of any of our product candidates could significantly change the costs and timing associated with the development of these product candidates. We may never succeed in obtaining regulatory approval for any of our product candidates or in establishing market acceptance for any product candidates that may be approved.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses consist primarily of salaries and personnel expenses, including stock-based compensation, for our personnel in executive, legal, finance and accounting, human resources, and other administrative functions. General and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">112</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">administrative expenses also include legal fees relating to corporate matters; professional fees paid for accounting, auditing, consulting, and tax services; insurance costs; travel expenses; and facility costs not otherwise included in research and development expenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We anticipate that our general and administrative expenses will increase in the future as we increase our headcount to support our continued research activities and development of our product candidates. We have incurred significantly increased accounting, audit, legal, regulatory, compliance and director and officer insurance costs as well as investor and public relations expenses associated with operating as a public company and anticipate these expenses to increase in 2025 as we continue to expand the business. In addition, if we obtain regulatory approval for a product candidate and do not enter into a third-party commercialization collaboration, we expect to incur significant expenses related to building a sales and marketing team to support sales, marketing and distribution activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the unrecognized compensation cost related to outstanding options, inclusive of research and development and general and administrative, was $24.0 million, which is expected to be recognized over a weighted-average period of 2.66 years.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since our inception, we have not recorded any U.S. federal or state income tax benefits for the net losses we have incurred in any year or for our earned research and development tax credits, due to the uncertainty of realizing a benefit from those items. As of December 31, 2024, we had federal and state net operating loss carryforwards of $113.6 million and $118.3 million, respectively, which may be used to offset future taxable income, if any. The state amounts expire at various dates through 2043. The federal net operating losses generated in and after 2018 can be carried forward indefinitely. As of December 31, 2024, we had federal and state tax credit carryforwards of $17.9 million and $9.5 million, which expire at various dates through 2043 and 2038, respectively. Due to the degree of uncertainty related to the ultimate use of the deferred tax assets, we have fully reserved these tax benefits, as the determination of the realization of the deferred tax benefits was not determined to be more likely than not.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Years ended December 31, 2024 and 2023</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our results of operations for the years ended December 31, 2024 and 2023 (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.863%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.764000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.764000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.764000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration and license revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,816</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,049</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(18,233</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,350</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88,153</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,197</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,287</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,354</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,933</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">137,637</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,507</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,130</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(134,821</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(93,458</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(41,363</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other (expense) income:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and other income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,065</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,999</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,066</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,653</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,759</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,090</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,090</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,322</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,240</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,082</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net Loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(127,499</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(89,218</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(38,281</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue for the years ended December 31, 2024 and 2023 was $2.8 million and $21.0 million, respectively. The decrease was primarily due to the timing of research activities performed pursuant to our collaboration agreements. Revenue for the 2024 period was related solely to our collaboration agreement with Amgen which commenced in May 2023. Revenue for the 2023 period was primarily driven by $14.2 million related to our collaboration agreement with Amgen, and $5.8 million related to our collaboration agreement with Novartis, which concluded in March 2023.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">113</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our research and development expenses for the years ended December 31, 2024 and 2023 (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.863%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.764000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.764000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.764000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,742</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,165</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,577</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory supplies, research materials and studies</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,468</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,101</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,367</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Clinical studies</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,245</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,214</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,031</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility-related and other</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,669</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,298</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">371</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,846</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,876</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,970</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,380</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,499</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,119</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total research and development expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,350</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88,153</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,197</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses increased $19.2 million and was primarily attributable to a $9.0 million increase in clinical studies expense driven by enrollment in the ALLOHA Phase 1 heme clinical trial as well as start-up activities and enrollment in the PLEXI-T Phase 1 solid tumor clinical trial. There was also a $7.6 million increase in personnel expenses due to additional headcount in support of expanded research and development activities, a $1.4 million increase in laboratory supplies, research materials and studies due to start-up activities with a global contract development and manufacturing organization, or CDMO, a $0.4 million increase in facility-related expenses, and a $1.1 million decrease in depreciation expense. Research and development expenses included non-cash stock compensation of $4.8 million and $2.9 million for the years ended December 31, 2024 and 2023, respectively.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our general and administrative expenses for the years ended December 31, 2024 and 2023 (in thousands):</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.863%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.764000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.764000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.764000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,900</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,065</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,835</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal and professional fees</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,380</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,119</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility-related and other</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,576</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,976</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(400</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,703</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,332</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,371</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">862</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(134</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total general and administrative expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,287</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,354</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,933</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses increased by $3.9 million and was primarily due to a $1.8 million increase in personnel expenses due to additional headcount. There was also a $0.3 million increase in legal and professional fees, a $0.4 million decrease in facility-related expenses, and a $0.1 million decrease in depreciation expense. General and administrative expenses included non-cash stock compensation expense of $4.7 million and $2.3 million for the years ended December 31, 2024 and 2023, respectively.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other (Expense) Income</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other income has increased $3.1 million primarily due to a $4.1 million increase in interest income attributable to higher cash balances available for investment, offset by a $1.1 million non-recurring charge for loss on extinguishment of debt related to the K2HV Loan Agreement repayment.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sources of Liquidity</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not generated any revenue from product sales and have incurred net losses and negative cash flows from our operations. Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures, and to a lesser extent, general and administrative expenditures. Under the terms of the Amgen Agreement, we received an upfront payment of $30.0 million in July 2023. In addition, we are eligible to earn success-based milestone payments of over $500 million, based upon the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">114</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">achievement of certain clinical development and commercial milestones, as well as tiered single-digit royalty payments on net sales of products developed from the collaboration, subject to reductions set forth in the Amgen Agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 1, 2023, we completed an underwritten public offering of (a) 23,287,134 shares of the Company's Voting Common Stock, inclusive of the underwriters&#8217; 30-day option to purchase 297,660 additional shares of Voting Common Stock, at a price of $2.00 per share, and (b) the Pre-Funded Warrants to purchase up to 47,010,526 shares of the Voting Common Stock, at a price of $1.9999 per warrant with an exercise price of $0.0001 per share. The Company received aggregate net proceeds from the offering of $134.7 million after deducting underwriting discounts, commissions and other offering expenses.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 24, 2024, we completed an underwritten public offering resulting in the issuance and sale of (a) 4,958,068 shares of Voting Common Stock, including the partial exercise of the underwriters&#8217; option to purchase 2,485,487 additional shares of Voting Common Stock, at the closing market price on April 16, 2024, of $7.13 per share, and (b) Pre-Funded Warrants to purchase up to 18,577,419 shares of the Voting Common Stock, at a price of $7.1299 per warrant with an exercise price of $0.0001 per share. We received aggregate net proceeds of approximately $161.4 million after deducting underwriting discounts, commissions and other estimated offering expenses.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the K2HV Loan Agreement dated September 9, 2022, K2HV extended an initial convertible term loan of $30.0 million to the Company in accordance with the K2HV Loan Agreement. On November 20, 2024, K2HV converted $15.0 million outstanding principal under the loan in exchange for 3,134,796 shares of our voting common stock. On December 20, 2024, we entered into a loan agreement with SVB (the SVB Loan Agreement), terminated the K2HV Loan Agreement and repaid all remaining outstanding loan obligations to K2HV. The SVB Loan Agreement provides for term loans up to an aggregate principal amount of $52.5 million, of which $32.5 million was provided on the closing date. We have the option to draw a second tranche of $20.0 million at the lender's sole discretion on or prior to June 30, 2026. See &#8220;Notes to Condensed Consolidated Financial Statements&#8221; and &#8220;Item 1A. Risk factors&#8212;The terms of our loan agreement place restrictions on our operating and financial flexibility. If we raise additional capital through debt financing, the terms of any new debt could further restrict our operating and financial flexibility&#8221; for additional details regarding the SVB Loan Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 27, 2024, we completed a registered direct offering with an existing investor for the issuance of pre-funded warrants to purchase up to 7,500,000 shares of the Company's Voting Common Stock with an exercise price of $0.0001 per warrant. The pre-funded warrants were issued at a purchase price of $4.00 per warrant, resulting in gross proceeds of approximately $30.0 million, before deducting offering expenses of $0.2 million.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had cash, cash equivalents and marketable securities of $290.1 million, excluding restricted cash of $5.0 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Funding requirements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance our research programs into preclinical and clinical development. The timing and amount of our operating expenditures will depend largely on:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the identification of additional research programs and product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, progress, results and costs of research and development for our current and future product candidates, including our current and planned clinical trials, and ongoing preclinical development for our current and future product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs, timing and outcome of regulatory review of any product candidates we may develop; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our decision to initiate a clinical trial, not to initiate a clinical trial or to terminate a clinical trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our decision to develop and expand our manufacturing capabilities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our decision to invest in facilities to enable growth;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">investing in next-generation T cell engineering capabilities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in laws or regulations applicable to any product candidates we may develop, including but not limited to clinical trial requirements for approvals; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost and timing of obtaining materials to produce adequate supply for any preclinical or clinical development of any product candidate we may develop; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs and timing of future commercialization activities, including manufacturing, marketing, sales and distribution, for any product candidate we may develop for which we obtain marketing approval; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">115</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the legal costs involved in prosecuting patent applications and enforcing patent claims and other intellectual property claims; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additions or departures of key scientific or management personnel; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish and maintain collaborations on favorable terms, if at all, as well as the costs and timing of any collaboration, license or other arrangement, including the terms and timing of any milestone payments thereunder; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of continuing to operate as a public company. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that our existing cash, cash equivalents and marketable securities will enable us to fund our planned operating expenses and capital expenditure requirements into the first quarter of 2027. We have based this estimate on assumptions that may prove to be wrong, and we could utilize our available capital resources sooner than we expect.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If we raise additional funds through additional collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts, or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not yet received regulatory approval for or commercialized any of our product candidates and do not expect to generate revenue from product sales for several years, if at all. We do not expect to generate any product revenue unless and until we (1) complete development of any of our product candidates; (2) obtain applicable regulatory approvals; and (3) successfully commercialize or enter into collaborative agreements for our product candidates. We do not know with certainty when, or if, any of these items will ultimately occur. We expect to incur continuing significant losses for the foreseeable future and our losses to increase as we ramp up our preclinical and clinical development programs. We may encounter unforeseen expenses, difficulties, complications, delays and other currently unknown factors that could adversely affect our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we remain an emerging growth company and a smaller reporting company, we are not required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, as we continue to evolve as a business, we will incur increased costs related to legal and financial compliance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will require additional capital to develop our product candidates and fund our operations into the foreseeable future. We anticipate that we will eventually need to raise substantial additional capital, the requirements for which will depend on many factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, timing, rate of progress and costs of our drug discovery efforts, preclinical development activities, laboratory testing and clinical trials for our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and scope of clinical programs we decide to pursue; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost, timing and outcome of preparing for and undergoing regulatory review of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope and costs of development and manufacturing activities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost and timing associated with commercializing our product candidates, if they receive marketing approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the amount of revenue, if any, received from commercial sales of our product candidates, should any of our product candidates receive marketing approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the achievement of milestones or occurrence of other developments that trigger payments under any collaboration agreements we might have at such time; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or in-license other product candidates and technologies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">116</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish and maintain collaborations on favorable terms, if at all; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our efforts to enhance operational systems and our ability to attract, hire and retain qualified personnel, including personnel to support the development of our product candidates and, ultimately, the sale of our products, following FDA approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our implementation of various computerized information systems; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">impact of health crises and other external disruptions on our clinical development or operations; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs associated with being a public company. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A change in the outcome of any of these or other variables with respect to the development of any of our product candidates could significantly change the costs and timing associated with the development of that product candidate. Furthermore, our operating plans may change in the future, and we will continue to require additional capital to meet operational needs and capital requirements associated with such operating plans. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments or engage in certain merger, consolidation or asset sale transactions, in addition to those contained in our SVB Loan Agreement. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adequate funding may not be available to us on acceptable terms or at all. If we are unable to raise capital when needed it could have a negative impact on our financial condition and our ability to pursue our business strategies. If we are unable to raise additional funds as required, we may need to delay, reduce, or terminate some or all development programs and clinical trials. We may also be required to sell or license our rights to product candidates in certain territories or indications that we would otherwise prefer to develop and commercialize ourselves. If we are required to enter into collaborations and other arrangements to address our liquidity needs, we may have to give up certain rights that limit our ability to develop and commercialize our product candidates. See Part 2, Item 1A. &#8220;Risk Factors&#8221; of this Annual Report for additional risks associated with our substantial capital requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our sources and uses of cash for each of the periods presented (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.477%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(110,822</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(61,358</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(49,464</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(52,613</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(60,759</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,146</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">208,765</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">135,443</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,322</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45,330</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,326</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,004</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Activities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, net cash used in operating activities of $110.8 million was primarily driven by our net loss of $127.5 million, partially offset by non-cash charges of $11.6 million related to depreciation expense, accretion of marketable securities, stock-based compensation, non-cash interest expense related to note payable, and loss on extinguishment of debt. During 2024, working capital changes contributed $5.1 million to our cash flows. The change in working capital was primarily driven by the timing of payments to our vendors.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023, net cash used in operating activities of $61.4 million was primarily driven by our net loss of $89.2 million, partially offset by non-cash charges of $10.3 million related to depreciation expense, accretion of marketable securities, stock-based compensation, and non-cash interest expense related to note payable. During 2023, working capital changes contributed $17.6 million to our cash flows. The change in working capital was primarily driven by changes in deferred revenue arising from the Amgen and Novartis arrangements as well as the timing of payments to our vendors.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing Activities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, net cash used in investing activities was $52.6 million and $60.8 million, respectively, primarily related to the purchases of property and equipment, and purchases and maturities of marketable securities.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financing Activities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, net cash provided by financing activities was $208.8 million, consisting of net proceeds of $161.4 million from our follow-on public offering in April 2024, cash proceeds of $32.5 million from borrowings under SVB Loan Agreement, cash proceeds of $30.0 million from our direct offering in December 2024, $1.7 million of proceeds from the exercise of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">117</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">stock options, and $0.3 million of proceeds from the issuance of common stock under 2021 ESPP. These proceeds are partially offset by $17.1 million of repayments of the K2HV Loan Agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023, net cash provided by financing activities was $135.4 million, consisting of net proceeds of $134.7 million from our follow-on public offering in June 2023 and $0.7 million of proceeds from the exercise of stock options.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Accounting Policies and Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States, or GAAP. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue recognition</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, our revenues have primarily consisted of consideration related to the Novartis Agreement and the Amgen Agreement, which we are accounting for under ASC 606. In accordance with ASC 606, we recognize revenue when our customers obtain control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, we perform the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the assessment of the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when, or as we satisfy each performance obligation.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the accounting for arrangements under ASC 606, we must use significant judgment to determine the performance obligations based on the determination under step (ii) above. We also use judgment to determine whether milestones or other variable consideration, except for royalties and sales-based milestones, should be included in the transaction price as described below. We recognize revenue based on those amounts when, or as, the performance obligations under the contract are satisfied.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We utilize judgment to assess the nature of the performance obligation to determine whether the performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition. The measure of progress, and the resulting periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the arrangement, which are subject to review by the joint steering committee, or JSC. Such a change could have a material impact on the amount of revenue we record in future periods. We concluded that the transfer of control to the customer for the performance obligation occurs over the time period that the research and development services are provided by us. We recognize revenue for the performance obligation as those services are provided using an input method, based on the cumulative costs incurred compared to the total estimated costs expected to be incurred to satisfy the performance obligation. The cost-to-cost method is, in management&#8217;s judgment, the best measure of progress towards satisfying the performance condition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the inception of each arrangement that includes research, development or regulatory milestone payments, we evaluate whether the milestones are considered likely to be met and estimate the amount to be considered for inclusion in the transaction price using the most-likely-amount method. If it is probable that a significant reversal in the amount of cumulative revenue recognized would not occur, the associated milestone value is included in the transaction price. For milestone payments due upon events that are not within our control, such as regulatory approvals, we are not able to assert that it is likely that the regulatory approval will be granted and that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur until those approvals are received. In making this assessment, we evaluate factors such as the scientific, clinical, regulatory, commercial, and other risks that must be overcome to achieve the particular milestone. There is considerable judgment involved in determining whether it is probable that a significant reversal in the amount of cumulative revenue recognized would not occur.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">118</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We reevaluate the transaction price and our total estimated costs expected to be incurred at the end of each reporting period and as uncertain events, such as changes to the expected timing and cost of certain research, development and manufacturing activities that we are responsible for, are resolved or other changes in circumstances occur. If necessary, we will adjust our estimate of the transaction price or our estimates of the total costs expected to be incurred. To date, we have not had any significant changes in our estimates.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued research and development expenses</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the process of preparing our financial statements, we are required to estimate our accrued research and development expenses. This process involves estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of actual costs. The majority of our service providers invoice us in arrears for services performed, on a pre-determined schedule or when contractual milestones are met; however, some require advance payments. We make estimates of our accrued expenses as of each balance sheet date in the financial statements based on facts and circumstances known to us at that time. At each period end, we corroborate the accuracy of these estimates with the service providers and make adjustments, if necessary. Examples of estimated accrued research and development expenses include those related to fees paid to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Vendors in connection with discovery and preclinical development activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CROs in connection with preclinical and clinical studies and testing; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CDMOs in connection with the process development and scale up activities and the production of materials.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We record the expense and accrual related to contract research and manufacturing based on our estimates of the services received and efforts expended considering a number of factors, including our knowledge of the progress towards completion of the research, development, and manufacturing activities; invoicing to date under contracts; communication from the contract research organizations, contract development and manufacturing organizations and other companies of any actual costs incurred during the period that have not yet been invoiced; and the costs included in the contracts and purchase orders. The financial terms of these agreements are subject to negotiation, vary from contract to contract, and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the expense. In accruing service fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, we adjust the accrual or the amount of prepaid expense accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in reporting amounts that are too high or too low in any particular period. To date, there have not been any material adjustments to our prior estimates of accrued research and development expenses.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A description of recently adopted or issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 to our consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging Growth Company and Smaller Reporting Company Status</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Jumpstart Our Business Startups Act of 2012 permits an &#8220;emerging growth company&#8221; such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected not to &#8220;opt out&#8221; of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we will adopt the new or revised standard at the time private companies adopt the new or revised standard and will do so until such time that we either (i) irrevocably elect to &#8220;opt out&#8221; of such extended transition period or (ii) no longer qualify as an emerging growth company. We may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for private companies.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also a &#8220;smaller reporting company&#8221;, meaning that the market value of our stock held by non-affiliates plus the aggregate amount of gross proceeds to us as a result of the IPO is less than $700 million and our annual revenue was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">119</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_quantitative_qualitative_disclosu"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7A. Quantitative and Qualitat</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ive Disclosures About Market Risk</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a smaller reporting company, as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide the information required under this item.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_8_financial_statements_supp_data"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Financial Statements and Supplementary Data</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The financial statements required to be filed pursuant to this Item 8 are appended to this Annual Report on Form 10-K. An index of those financial statements is found in Item 15, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exhibits and Financial Statement Schedules</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of this Annual Report on Form 10-K.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9_changes_in_and_dis_with_acc"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9. Changes in and Disagreements with Acc</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ountants on Accounting and Financial Disclosure</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9a_controls_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9A. Controls and Procedures</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management, under the supervision and with the participation of our Principal Executive Officer (our Chief Executive Officer) and Principal Financial and Accounting Officer (our Chief Financial Officer), has evaluated the effectiveness of our disclosure controls and procedures as of period end. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December 31, 2024, our Principal Executive Officer and Principal Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management's Report on Internal Control over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of consolidated financial statements for external purposes in accordance with U.S. generally accepted accounting principles or &#8220;GAAP&#8221;. Internal control over financial reporting is a process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:
</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of our company;
</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provide reasonable assurances regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material adverse effect on our financial statements.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2024, the end of our fiscal year. Management based its assessment on criteria established in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Internal Control-Integrated Framework</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Management&#8217;s assessment included evaluation of elements such as the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies, and our overall control environment.
</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">120</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on this assessment, management has concluded that our internal controls over financial reporting were effective as of December 31, 2024 and provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with GAAP. We reviewed the results of management&#8217;s assessment with the Audit Committee of our Board of Directors.
</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Attestation Report of the Registered Public Accounting Firm</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Our report was not subject to attestation by our independent registered public accounting firm pursuant to the rules of the Securities and Exchange Commission for &#8220;emerging growth companies&#8221; that permit us to provide only management&#8217;s report in this report.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the three months ended December 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inherent Limitations on Effectiveness of Internal Controls</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In designing and evaluating the disclosure controls and procedures, management does not expect that our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control systems are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Our management, including our Chief Executive Officer and Chief Financial Officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_9b_other_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9B. Other Information</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1bd949c8-53a7-4d48-a003-a2af6c1a6ad8" contextRef="C_8a2e7250-3d27-46fd-80fc-d497b85993ad" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_7d351c3f-1ebf-4e82-893d-3955fb686305" contextRef="C_8a2e7250-3d27-46fd-80fc-d497b85993ad" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_a3e07261-13f3-4fbc-a172-b349d110abf3" contextRef="C_8a2e7250-3d27-46fd-80fc-d497b85993ad" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_44f15190-f0fb-48f5-93c1-cde8fc7f0b7e" contextRef="C_8a2e7250-3d27-46fd-80fc-d497b85993ad" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of our directors or &#8220;officers,&#8221; as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, adopted or terminated a Rule 10b5-1 trading plan or arrangement or a non-Rule 10b5-1 trading plan or arrangement, as defined in Item 408(c) of Regulation S-K, during the three months ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item9c_disclosure"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not Applicable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">121</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART III</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_10_directors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 10. Directors, Executive Officers and Corporate Governance.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information About Our Directors</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table identifies our current directors and sets forth certain information regarding the members of our board of directors, including their ages as of February 28, 2025, and years of tenure on our board of directors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30.96%;box-sizing:content-box;"/>
    <td style="width:1.9%;box-sizing:content-box;"/>
    <td style="width:44.92%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.48%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.86%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Positions and Offices Held with TScan</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Director Since</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Age</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stephen Biggar, M.D., Ph.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2021</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director, Chief Executive Officer</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Katina Dorton, J.D., M.B.A.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2021</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R. Keith Woods</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gabriela Gruia, M.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2021</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Barbara Klencke, M.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Garry Nicholson</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The names and certain biographical information about our current directors, including each director&#8217;s business experience, director position held, information regarding involvement in certain legal or administrative proceeding, if applicable, and the director&#8217;s experiences, qualifications, attributes, or skills are set forth below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stephen Biggar, M.D., Ph.D. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">has served as a member of our board of directors since March 2021. Dr. Biggar is a partner at Baker Bros. Advisors LP (&#8220;Baker Bros.&#8221;), a biotechnology-focused investment advisor. Dr. Biggar joined Baker Bros. in April 2000. Dr. Biggar serves on the boards of Kiniksa Pharmaceuticals International, plc., Acadia Pharmaceuticals Inc., and Notch Therapeutics, Inc. Dr. Biggar received an M.D. and a Ph.D. in Immunology from Stanford University and received a B.S. in Genetics from the University of Rochester. We believe that Dr. Biggar is qualified to serve as a member of our board of directors due to his extensive experience in the life sciences industry.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> has served as our Chief Executive Officer and as a member of our board of directors since May 2023. He was previously our acting Chief Executive Officer from March 2023 to May 2023, and our Chief Scientific and Operating Officer from December 2018 to May 2023. He has over two decades of experience in academia and industry, founding companies and driving research from early-stage discovery through drug approval. Prior to joining TScan, Dr. MacBeath served as the Chief Scientific Officer at Abpro Corporation from March 2017 to July 2018, where he advanced T cell-engaging bispecific antibodies through pre-clinical development. Previously, Dr. MacBeath served as Co-founder and SVP of Discovery at Merrimack Pharmaceuticals, Inc. from February 2014 to October 2016. Dr. MacBeath began his career in academia, where he served as the first fellow at Harvard&#8217;s Bauer Center for Genomics Research, as an Assistant Professor and later Associate Professor in the Department of Chemistry &amp; Chemical Biology at Harvard University, and as Lecturer and Principal Investigator at Harvard Medical School. Dr. MacBeath received his undergraduate degree from the University of Manitoba, his Ph.D. from The Scripps Research Institute, and postdoctoral training with Dr. Stuart Schreiber at Harvard University. We believe that Dr. MacBeath is qualified to serve on our board of directors because of the perspective and experience he provides as our Chief Executive Officer as well as his broad experience within the life sciences industry.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Katina Dorton, J.D., M.B.A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">has served as a member of our board of directors since March 2021. Ms. Dorton also serves as a member of the board of directors, as chair of the audit committee, and as a member of the compensation and human capital management committee of Fulcrum Therapeutics, Inc., since January 2020, as a member of the board of directors, as chair of the audit committee, and as a member of the human resources and compensation committee of Mallinckrodt plc since February 2024. In addition, Ms. Dorton was a member of the board of directors of US Ecology, Inc., from 2014 to 2022 until its acquisition by Republic Services, Inc. Ms. Dorton also served as a member of the board of directors and chair of the audit committee of Pandion Therapeutics, Inc., a biopharmaceutical company, from 2020 until its acquisition by Merck &amp; Co., Inc., in 2021. Previously, Ms. Dorton held CFO positions at several biotechnology companies, including Nodthera Inc., a company developing medicines to inhibit the NLRP3 inflammasome from 2020 to 2022, Repare Therapeutics Inc., a synthetic lethality and DNA repair-focused oncology company from 2019 to 2020, AVROBIO, Inc., a lentiviral gene therapy company from 2017 through 2018, and Immatics GmbH, a biotechnology company from 2015 through 2017. Earlier in her career, Ms. Dorton served as a Managing Director in investment banking for Morgan Stanley and Needham &amp; Company and as an attorney at Sullivan &amp; Cromwell. Ms. Dorton received her J.D. from the University of Virginia School of Law, her M.B.A. from George Washington University and her B.A. from Duke University. We believe that Ms. Dorton is qualified to serve on our board of directors due to her extensive leadership experience in multiple publicly-traded and privately-held pharmaceutical and biotechnology companies, and expertise in developing, financing and providing executive leadership in numerous biopharmaceutical companies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">122</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">R. Keith Woods </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">has served as a member of our board of directors since December 2023. Mr. Woods has over three decades of experience in the biopharmaceutical sector, having served most recently as Chief Operating Officer of argenx U.S. Inc., from April 2018 to June 2023, where he led the company through its transition from an R&amp;D organization to a global commercial organization. During this time, he oversaw key teams in preparation for argenx&#8217;s first product launch, including sales, marketing, market access and reimbursement, business operations, patient services and medical affairs. In 2023, Mr. Woods transitioned from this role to serve as a strategic commercial advisor to the board of directors of argenx. Prior to argenx, Keith served as senior vice president of North American operations for Alexion Pharmaceuticals, Inc., where he managed a team of several hundred people in the U.S. and Canada and was responsible for more than $1 billion in annual sales. Prior to joining Alexion, Mr. Woods held various positions of increasing responsibility within Roche, Amgen, and Eisai Co., Ltd., over a span of 20 years. Keith currently serves on the board of directors of X4 Pharmaceuticals, Inc., Neurogene Inc., and Rocket Pharmaceuticals, Inc. He holds a Bachelor of Science in marketing from Florida State University. We believe that Mr. Woods is qualified to serve on our board of directors because of his significant experience in commercialization, sales, global operations, supply chain, and business strategy in the life sciences industry.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Gabriela Gruia, M.D.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> has served as a member of our board of directors since May 2021. Dr. Gruia founded Gabriela Gruia Consulting, LLC in January 2021. Prior to that, Dr. Gruia served as the Chief Development Officer at Ichnos Sciences Inc. from February 2020 to January 2021, where she oversaw several key functions including Regulatory Sciences, Clinical Operations, Clinical Pharmacology, Biostatistics and Drug Safety. Prior to her time at Ichnos Sciences Inc., Dr. Gruia served as Senior Vice President and Head of Regulatory Affairs for Novartis Oncology from February 2008 through February 2020, where she was responsible for leading the oncology regulatory affairs organization. Dr. Gruia has served on the boards of directors for Aprea Therapeutics, Inc. since 2023, Netris Pharma since 2023, and Molecular Templates, Inc. from March 2022 until its dissolution in December 2024. Dr. Gruia received her doctorate in medicine from Bucharest Medical School in Romania and has a Masters in Breast Pathology and Mammography from Rene Huguenin/Curie Institute Cancer Center in Paris, France. She received her training in oncology and hematology from Rene Descartes University in Paris, France. We believe that Dr. Gruia is qualified to serve as a member of our board of directors due to her extensive leadership experience in the life sciences industry.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Barbara Klencke, M.D. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">has served as a member of our board of directors since April 2023. She also currently serves as an independent board member of Xencor since September 2023, ALX Oncology since January 2025, and Immune-Onc Therapeutics, Inc. since 2022. She has previously served as an independent board member of eFFECTOR Therapeutics, Inc. from 2021 until 2024 and Lexent Bio from 2017 until that company&#8217;s acquisition by Foundation Medicine in 2020. Dr. Klencke previously served as the Chief Medical and Chief Development Officer of Sierra Oncology Inc., a publicly traded clinical-stage biopharmaceutical company from 2015 until 2023 following its acquisition by GlaxoSmithKline plc in 2022. From 2011 to 2015, Dr. Klencke served as SVP, Global Development, at Onyx Pharmaceuticals, which was acquired by Amgen Inc., in 2013. She also led a variety of both early- and late-stage oncology programs while at Genentech, Inc. from 2003 to 2011. She completed Internal Medicine and Hematology/Oncology training at the University of California, San Francisco and remained there as an Assistant Professor of Medicine in Oncology focusing on clinical research from 1995 to 2002. Dr. Klencke holds a B.S. from Indiana University and an M.D. from the University of California, Davis. We believe that Dr. Klencke is qualified to serve as a member of our board of directors due to her significant scientific expertise in biotechnology.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Garry Nicholson</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> has served as a member of our board of directors since June 2024. Mr. Nicholson has more than 35 years of pharmaceutical and biotech oncology experience. From August 2015 to November 2016, he served as President and Chief Executive Officer of XTuit Pharmaceuticals, where he also was a member of the board of directors. Beginning in May 2008, he led the global oncology franchise at Pfizer until his departure in May 2015 as President, Pfizer Oncology. His responsibilities included global commercialization and sales, clinical development and regulatory strategy, and business development. Under his leadership, the company developed and launched Ibrance&#174; (palbociclib), the first cyclin-dependent kinase (&#8220;CDK&#8221;) 4/6 inhibitor approved in the U.S. and Europe. During his tenure at Pfizer, Mr. Nicholson served on the board of directors of the Pfizer Foundation and was a member of the company&#8217;s Portfolio, Strategy and Investment Committee, which set corporate research and development priorities and investment strategy. Earlier in his career, Mr. Nicholson held various leadership positions in the oncology division of Eli Lilly and Company. In addition, he has served as an advisor to AMPATH, a consortium of North American universities and health centers, Moi University, Moi Teaching and Referral Hospital, and the Government of Kenya, which helps build sustainable healthcare systems in developing nations. Mr. Nicholson began his career in healthcare as a pharmacy intern at Emory University. He currently serves as chair of the board of directors at Abdera Therapeutics Inc., a privately held biopharmaceutical company and serves as chair of the board of directors of Day One Biopharmaceuticals, Inc., a publicly traded clinical and commercial stage biopharmaceutical company. He also currently serves as a member of the board of directors at Avenzo Therapeutics, a privately held clinical stage company.  Mr. Nicholson previously served as a member of the board of directors of G1 Therapeutics, a commercial stage company, and of NextCure, Inc., a publicly traded clinical stage biopharmaceutical company, Turning Point Therapeutics, Inc., a publicly traded clinical stage precision oncology company, Five Prime Therapeutics, Inc., a publicly traded clinical stage pharmaceutical company, TESARO, Inc., a publicly traded oncology-focused biopharmaceutical company, Tmunity Therapeutics Inc., a privately held biotechnology company, SQZ Biotechnologies, Inc., a privately held biotechnology company and Personal Genome Diagnostics Inc., a privately held cancer genomics company. Mr. Nicholson holds an M.B.A. from the University of South Carolina and earned his B.S. in Pharmacy at the University of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">123</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">North Carolina at Chapel Hill. We believe Mr. Nicholson is qualified to serve as a member of our Board of Directors based on his significant experience in the life sciences, biotechnology and pharmaceutical industries and his knowledge of strategic and operational leadership priorities and corporate development matters.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are no family relationships between or among any of our directors or executive officers. The principal occupation and employment during the past five years of each of our directors was carried on, in each case except as specifically identified in this Annual Report on Form 10-K with a corporation or organization that is not a parent, subsidiary or other affiliate of us. Except as described in &#8220;Item 10. Directors, Executive Officers and Corporate Governance &#8211; Identifying and Evaluating Director Nominees,&#8221; there is no arrangement or understanding between any of our directors and any other person or persons pursuant to which he or she is to be selected as a director.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Officers Who Are Not Directors</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table identifies our executive officers, other than as otherwise noted above, and sets forth their current positions and years of tenure at TScan, their ages as of February 28, 2025, and certain other demographic information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30.96%;box-sizing:content-box;"/>
    <td style="width:1.9%;box-sizing:content-box;"/>
    <td style="width:44.92%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.48%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.86%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Positions and Offices Held with TScan</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Officer Since</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Age</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jason A. Amello</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer and Treasurer</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Zoran Zdraveski, J.D., Ph.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Legal and Strategy Officer and Secretary</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2021</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chrystal Louis, M.D., M.P.H.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Medical Officer</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Jason A. Amello</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> has served as our Chief Financial Officer and Treasurer since January 2024. Prior to joining TScan, from September 2022 to January 2024, Mr. Amello was the Chief Financial Officer, Treasurer and Secretary at Candel Therapeutics, Inc. Prior to Candel, Mr. Amello served as Chief Financial Officer and Treasurer of Saniona AB from September 2020 to April 2022, and Senior Vice President, Chief Financial Officer and Treasurer of Akebia Therapeutics, Inc. from September 2013 to August 2020. Mr. Amello was also Executive Vice President, Chief Financial Officer and Treasurer of Alaunos Therapeutics, Inc. (formerly known as ZIOPHARM Oncology, Inc.) from May 2012 to May 2013. From April 2000 until June 2011, Mr. Amello served in various positions of increasing responsibility at Genzyme Corporation (acquired by Sanofi), including Senior Vice President, Chief Accounting Officer and Corporate Controller, and also led the Strategic Financial Services group through which he served as a key advisor on all of Genzyme&#8217;s mergers and acquisitions and other strategic transactions, including the sale of the company to Sanofi. Earlier in his career, Mr. Amello spent ten years in the business advisory and assurance practice of Deloitte, serving in various roles of increasing responsibility through Senior Manager. Since October 2017, Mr. Amello served as a member of the Board of Directors of Acer Therapeutics, Inc. until its acquisition by Zevra Therapeutics in November 2023 and was chairman of its audit committee. Mr. Amello also served on the Board of Directors of New England Baptist Hospital from 2015 to 2023 and was chairman of the Quality of Care Committee and a member of the Finance and Investment Committee. Mr. Amello received his B.S. in accounting from Boston College and is a Certified Public Accountant in the Commonwealth of Massachusetts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Zoran Zdraveski, J.D., Ph.D.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, has served as our Chief Legal and Strategy Officer and Secretary since September 2021. He has more than 20 years of legal, IP and business operations experience in the biopharmaceutical industry. Prior to joining TScan, from April 2017 to April 2021, Dr. Zdraveski served as the Chief Legal and Technology Operations Officer at Magenta Therapeutics Inc., where he established the legal team and managed all aspects of legal, intellectual property and compliance both before and after Magenta&#8217;s 2018 initial public offering. Prior to Magenta, he was the Vice President and Associate General Counsel at Epizyme Inc. from July 2012 to April 2017. Prior to joining Epizyme, he held patent counsel positions at Ironwood and Genzyme Therapeutics. Dr. Zdraveski holds an M.S. in Chemistry and a B.F.A. and B.A. in Art and Chemistry from Southern Methodist University, a J.D. from Suffolk University Law School, and a Ph.D. in Biochemistry from the Massachusetts Institute of Technology.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Chrystal Louis, M.D., M.P.H.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, has served as our Chief Medical Officer since April 2024. Prior to joining TScan, from November 2022 to March 2024, Dr. Louis was the SVP of hematology clinical development at Zentalis Pharmaceuticals, Inc. Prior to Zentalis, Dr. Louis served as VP, Head of Medical Affairs at CRISPR Therapeutics, Inc. from July 2020 to November 2022. From October 2016 to July 2020, Dr. Louis served in various positions of increasing responsibility at Celgene Corporation (acquired by Bristol Myers Squibb Company), including Executive Director, Myeloid Diseases, U.S. Medical Affairs, Executive Director, Oncology, U.S. Medical Affairs and Executive Director, Pancreatic/GI Disease Lead, U.S. Medical Affairs. From September 2014 to October 2016, Dr Louis also served in the role of clinical development and project leadership strategy at Merrimack Pharmaceuticals, Inc. Prior to joining industry, Dr. Louis was an Assistant Professor at Texas Children&#8217;s Cancer Center and Hematology Service, Baylor College of Medicine, where she worked on the early development of CAR-T cell therapy products for solid tumor malignancies. Dr. Louis received her M.D. from Tulane University School of Medicine, her Masters Degree in Public Health from Tulane University School of Public Health and Tropical Medicine, and her B.A. in Political Science and B.S. in Chemistry from Southwestern University at Georgetown, TX.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">124</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The principal occupation and employment during the past five years of each of our executive officers was carried on, in each case except as specifically identified above, with a corporation or organization that is not a parent, subsidiary or other affiliate of us. There is no arrangement or understanding between any of our executive officers and any other person or persons pursuant to which he was or is to be selected as an executive officer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board Committees</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors has established an audit committee, a compensation committee, a nominating and corporate governance committee, and a research and clinical development committee. Each of the audit committee, compensation committee and nominating and corporate governance committee operates under a charter that satisfies the applicable standards of the SEC and Nasdaq. Each such committee reviews its respective charter at least annually. A current copy of the charter for each of the audit committee, compensation committee, nominating and corporate governance committee, and research and clinical development committee is posted on the corporate governance section of our website</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> www.tscan.com</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Audit Committee</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Katina Dorton, Gabriela Gruia, Barbara Klencke and R. Keith Woods serve on the audit committee, which is chaired by Ms. Dorton. Our board of directors has determined that each member of the audit committee is &#8220;independent&#8221; for audit committee purposes as that term is defined by the rules of the SEC and Nasdaq, and that each has sufficient knowledge in financial and auditing matters to serve on the audit committee. Our board of directors has designated Ms. Dorton as an &#8220;audit committee financial expert,&#8221; as defined under the applicable rules of the SEC. During the fiscal year ended December 31, 2024, the audit committee met five times. The audit committee assists our board of directors with its oversight of the integrity of our financial statements; our compliance with legal and regulatory requirements; the qualifications, independence and performance of the independent registered public accounting firm; the design and implementation of our risk assessment and risk management. Among other things, our audit committee is responsible for reviewing and discussing with our management the adequacy and effectiveness of our disclosure controls and procedures. The audit committee also discusses with our management and independent registered public accounting firm the annual audit plan and scope of audit activities, scope and timing of the annual audit of our financial statements, and the results of the audit, quarterly reviews of our financial statements and, as appropriate, initiates inquiries into certain aspects of our financial affairs. Our audit committee is responsible for establishing and overseeing procedures for the receipt, retention and treatment of any complaints regarding accounting, internal accounting controls or auditing matters, as well as for the confidential and anonymous submissions by our employees of concerns regarding questionable accounting or auditing matters. In addition, our audit committee has direct responsibility for the appointment, compensation, retention and oversight of the work of our independent registered public accounting firm. Our audit committee has sole authority to approve the hiring and discharging of our independent registered public accounting firm, all audit engagement terms and fees and all permissible non-audit engagements with the independent auditor. Our audit committee reviews and oversees all related person transactions in accordance with our policies and procedures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All audit and non-audit services, other than de minimis non-audit services, to be provided to us by our independent registered public accounting firm must be approved in advance by our audit committee.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compensation Committee</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stephen Biggar, Katina Dorton, Barbara Klencke and R. Keith Woods serve on the compensation committee, which is chaired by Dr. Biggar. Our board of directors has determined that each member of the compensation committee is &#8220;independent&#8221; as defined in the applicable Nasdaq rules. During the fiscal year ended December 31, 2024, the compensation committee met four times. Our compensation committee assists our board of directors with its oversight of the forms and amount of compensation for our executive officers (including officers reporting under Section 16 of the Exchange Act), the administration of our compensation and equity and non-equity incentive plans for employees and other service providers and certain other matters related to our compensation programs. The compensation committee, among other responsibilities, evaluates the performance of our chief executive officer and, in consultation with him, evaluates the performance of our other executive officers (including officers reporting under Section 16 of the Exchange Act).</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nominating and Corporate Governance Committee</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stephen Biggar, Katina Dorton and Gabriela Gruia serve on the nominating and corporate governance committee, which is chaired by Mr. Biggar. Our board of directors has determined that each member of the nominating and corporate governance committee is &#8220;independent&#8221; as defined in the applicable Nasdaq rules. During the fiscal year ended December 31, 2024, the nominating and corporate governance committee held two meetings. The nominating and corporate governance committee assists our board of directors with its oversight of and identification of individuals qualified to become members of our board of directors, consistent with criteria approved by our board of directors, and selects, or recommends that our board of directors selects, director nominees; develops and recommends to our board of directors a set of corporate governance guidelines; leads the annual performance review of the board of directors, its committees and management; and oversees any related matters required by federal securities laws.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">125</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The nominating and corporate governance committee considers candidates for board membership suggested by its members and the chief executive officer. Additionally, in selecting nominees for directors, the nominating and corporate governance committee will review candidates recommended by stockholders in the same manner and using the same general criteria as candidates recruited by the committee and/or recommended by our board of directors. The nominating and corporate governance committee will also consider whether to nominate any person proposed by a stockholder in accordance with the provisions of our bylaws relating to stockholder nominations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Clinical Development Committee</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stephen Biggar, Gabriela Gruia, Barbara Klencke, Gavin MacBeath, and Garry Nicholson serve on the research and clinical development committee, which is chaired by Dr. Klencke. During the fiscal year ended December 31, 2024, the research and clinical development committee met five times. Our research and clinical development committee assists our board of directors with its oversight of our research and clinical development activities and assists us in evaluating science and technology issues.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Identifying and Evaluating Director Nominees</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors is responsible for filling vacancies on our board of directors and for nominating candidates for election by our stockholders each year in the class of directors whose term expires at the relevant annual meeting. The board of directors delegates the selection and nomination process to the nominating and corporate governance committee, with the expectation that other members of the board of directors, and of management, will be requested to take part in the process as appropriate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generally, the nominating and corporate governance committee identifies candidates for director nominees in consultation with management, through the use of search firms or other advisors, through the recommendations submitted by stockholders or through such other methods as the nominating and corporate governance committee deems to be helpful to identify candidates. However, we do not have a formal policy concerning the diversity of the board of directors. Once candidates have been identified, the nominating and corporate governance committee confirms that the candidates meet all of the minimum qualifications for director nominees established by the nominating and corporate governance committee. The nominating and corporate governance committee may gather information about the candidates through interviews, detailed questionnaires, comprehensive background checks or any other means that the nominating and corporate governance committee deems to be appropriate in the evaluation process. The nominating and corporate governance committee then meets as a group to discuss and evaluate the qualities and skills of each candidate, both on an individual basis and taking into account the overall composition and needs of our board of directors. Based on the results of the evaluation process, the nominating and corporate governance committee recommends candidates for the board of directors&#8217; approval to fill a vacancy or as director nominees for election to the board of directors by our stockholders each year in the class of directors whose term expires at the relevant annual meeting. Although the nominating and corporate governance committee does not have a formal diversity policy and does not follow any ratio or formula with respect to diversity in order to determine the appropriate composition of the board of directors, the nominating and corporate governance committee and the full board of directors are committed to creating a board of directors with diversity, including diversity of expertise, experience, background, race and gender, and are committed to identifying, recruiting and advancing candidates offering such diversity in future searches.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board and Committee Meeting Attendance</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The full board of directors met four times during 2024. During 2024, each member of the board of directors attended in person or participated in 75% or more of the aggregate of (i) the total number of meetings of the board of directors (held during the period for which such person has been a director), and (ii) the total number of meetings held by all committees of the board of directors on which such person served (during the periods that such person served), other than Timothy Barberich who did not attend any meetings of the board of directors during 2024 prior to his departure from the board of directors in June 2024. Directors are responsible for attending the annual meeting of shareholders to the extent practicable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Code of Business Conduct and Ethics</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted a written code of conduct that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A current copy of the code is posted on the corporate governance section of our website, which is located at</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> https://ir.tscan.com/corporate-governance/governance-overview</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If we make any substantive amendments to, or grant any waivers from, the code of business conduct and ethics for any officer or director, we will disclose the nature of such amendment or waiver on our website or in a current report on Form 8-K.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">126</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delinquent Section 16(a) Reports</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who beneficially own more than 10% of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. Officers, directors and greater than 10% beneficial owners are required by SEC regulations to furnish us with copies of all Section 16(a) forms they file. To our knowledge, based solely on our review of Forms 3, 4 and 5, and any amendments thereto, filed by such reporting persons and/or written representations that no Form 5 was required, we believe that during the fiscal year ended December 31, 2024, all filing requirements applicable to our executive officers, directors and persons who beneficially own more than 10% percent of a registered class of our equity securities under the Exchange Act were met in a timely manner except for one late Form 4 filing by each of Gavin MacBeath, Zoran Zdraveski and Leiden Dworak, in each case with respect to an award of stock options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation Recovery Policy</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the requirements of the SEC and Nasdaq listing rules, our board of directors adopted a compensation recovery policy on September 21, 2023, effective as of October 2, 2023. The compensation recovery policy provides that in the event we are required to prepare a restatement of financial statements due to material noncompliance with any financial reporting requirement under securities laws, we will seek to recover any incentive-based compensation that was based upon the attainment of a financial reporting measure and that was received by any current or former executive officer during the three-year period preceding the date that the restatement was required if such compensation exceeds the amount that the executive officers would have received based on the restated financial statements. We have filed this policy as an Exhibit to this Annual Report on Form 10-K.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted an insider trading policy that governs the purchase, sale, and/or other transactions of our securities by our directors, officers and employees that is reasonably designed to promote compliance with insider trading laws, rules and regulations, and any listing standards&#8221; that apply to us. A copy of our insider trading policy is filed as Exhibit 19.1 to this Annual Report on Form 10-K. In addition, with regard to our trading in our own securities, it is the our policy to comply with the applicable insider trading laws, rules and regulations, and any exchange listing standards when engaging in transactions in our securities.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_11_executivecomp"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 11. Executive Compensation.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our named executive officers for the fiscal year ended December 31, 2024, are:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D., </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Jason A. Amello, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Financial Officer and Treasurer</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chrystal Louis, M.D., M.P.H.,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Chief Medical Officer</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">127</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary Compensation Table</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the compensation awarded to, earned by or paid to each of our named executive officers for the years indicated.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:22.52%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.58%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.02%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.06%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:13.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.54%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.18%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name and Principal Position</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Salary ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Bonus ($)</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">(5)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Option Awards ($)</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-Equity Incentive Plan Compensation ($)</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">All Other Compensation ($)</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">734,944</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">392,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,727</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,760,671</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">545,121</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,342,541</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">296,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,392</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,196,054</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jason A. Amello</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(4)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">463,542</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,966,550</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">230,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,800</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,733,892</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:20pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Financial Officer and Treasurer</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chrystal Louis, M.D., M.P.H.</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(6)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">343,125</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,480,336</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">162,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,030,461</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:20pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Medical Officer</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The amounts reported represent the aggregate grant date fair value of the stock options awarded to the named executive officers during fiscal year 2024, calculated in accordance with ASC Topic 718. Such grant date fair value does not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the awards reported in this column are set forth in Note 6 to our financial statements for the year ended December 31, 2024, which are included in our Form 10-K filed with the SEC on March 5, 2025. The amounts reported in this column reflect the accounting cost for the stock options and does not correspond to the actual economic value that may be received upon exercise of the stock option or any sale of any of the underlying shares of common stock. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Represents performance-based cash bonuses awarded to our named executive officers. See &#8220;Narrative Disclosures to the Summary Compensation Table -Non-Equity Incentive Plan Compensation&#8221; below for a description of this compensation. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts for 2024 represent matching 401(k) plan contributions. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Amello was appointed our Chief Financial Officer and Treasurer on January 29, 2024, and accordingly his 2024 base salary represents the amount paid from the commencement of his employment through December 31, 2024.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Represents one-time signing bonuses paid to Mr. Amello and Dr. Louis in connection with the commencement of their employment.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Louis was appointed our Chief Medical Officer on April 8, 2024, and accordingly her 2024 base salary represents the amount paid from the commencement of her employment through December 31, 2024.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Narrative to Summary Compensation Table</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Base salaries and annual incentive opportunities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The base salaries of all of our named executive officers are reviewed from time to time and adjusted when our board of directors or its compensation committee determines an adjustment is appropriate. For our 2024 fiscal year, the base salary for Dr. MacBeath, Mr. Amello, and Dr. Louis were $620,000, $500,000 and $495,000, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each of our named executive officers is eligible to earn an incentive bonus each fiscal year, with such bonus awarded based on individual performance goals, as well as achievement of corporate goals related to our product development and advancement of pre-clinical studies established by our chief executive officer and approved by our board of directors. During our fiscal year ended December 31, 2024, our named executive officers were eligible to earn cash incentive bonuses based on a combination of corporate and individual goals. We require that participants continue to be employed through the payment date to receive a bonus. For our 2024 fiscal year, Dr. MacBeath, Mr. Amello, and Dr. Louis target annual bonuses as a percentage of base salary were 55%, 40% and 40%, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to agreements with us, each of Dr. MacBeath, Mr. Amello, and Dr. Louis are, eligible to receive certain acceleration benefits in the event of our change in control, as described in the footnotes to the &#8220;Outstanding equity awards at the year ended December 31, 2024&#8221; table and under the &#8220;Agreements with Our Named Executive Officers and Potential Payments upon Termination or Change of Control&#8221; section below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">128</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We offer stock options to our employees, including our named executive officers, as the long-term incentive component of our compensation program. Our stock options allow our employees to purchase shares of our common stock at a price equal to the fair market value of our common stock on the date of grant. Generally, our stock options granted to new hires have vested as to 25% of the total number of option shares on the first anniversary of the award and in equal monthly installments over the following 36 months.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Policy on the Timing of Awards of Options and Other Option-Like Instruments</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We generally grant annual equity awards, including stock option grants to our named executive officers, in the first quarter of each fiscal year. In addition, new hires receive equity grants at the time of their hiring. During 2024, the compensation committee did not take into account any material nonpublic information when determining the timing and terms of equity incentive awards, and we did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. During 2024, we did not grant stock options to our named executive officers during any period beginning four business days before and ending one business day after the filing or furnishing of a Form 10-Q, 10-K or 8-K that discloses material nonpublic information.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee benefits and perquisites</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our named executive officers are eligible to participate in our health and welfare plans to the same extent as are full-time employees generally. We generally do not provide our named executive officers with perquisites or other personal benefits.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Retirement benefits</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have established a 401(k) tax-deferred savings plan, which permits participants, including our named executive officers, to make contributions by salary deduction pursuant to Section 401(k) of the Internal Revenue Code. We are responsible for administrative costs of the 401(k) plan. We match 100% of every dollar contributed up to four percent of salary, subject to certain limitations under the Internal Revenue Code.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outstanding equity awards at the year ended December 31, 2024</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth information regarding each unexercised option and all unvested stock held by each of our named executive officers as of December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:16.2%;box-sizing:content-box;"/>
    <td style="width:1.06%;box-sizing:content-box;"/>
    <td style="width:14.28%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.48%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:13.46%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:20.86%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.06%;box-sizing:content-box;"/>
    <td style="width:14.6%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="13" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Option Awards</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name </span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Vesting Commencement Date</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of securities underlying unexercised options exercisable </span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">(#) (1)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of securities underlying unexercised options unexercisable </span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">(#)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Option exercise price ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Option expiration date</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/25/2022</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,416</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,584</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.27</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7/25/2032</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2/2/2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,333</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,667</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.81</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2/2/2033</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2/2/2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">585,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.49</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/13/2033</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/24/2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">212,285</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">324,015</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.49</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6/13/2033</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/12/2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">160,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.00</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/12/2034</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/18/2022</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102,083</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37,917</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.85</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/18/2032</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/3/2018</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,302</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.97</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/24/2029</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/5/2019</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,575</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.46</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12/18/2029</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/25/2021</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">163,106</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,471</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.82</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/27/2031</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jason A. Amello</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1/29/2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">750,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.15</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2/1/2034</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chrystal Louis, M.D., M.P.H.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4/22/2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">380,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.62</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5/1/2034</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each of the option awards vest as follows: 25% of the shares vest on the first anniversary of the vesting commencement date, and 1/48th of the shares vest upon the completion of each month of continuous service thereafter. Each executive is eligible to receive acceleration in the case of certain involuntary terminations that occur in connection with a change in control, as described under the &#8220;Agreements with Our Named Executive Officers and Potential Payments upon Termination or Change of Control&#8221; section below.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">129</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employment agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agreements with Our Named Executive Officers and Potential Payments upon Termination or Change of Control</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We entered into employment agreements with each of our named executive officers, as summarized below. The employment agreements provide for at-will employment and, other than in the context of a termination without cause or a resignation for good reason (as such terms are defined in the employment agreements), may be terminated at any time. The severance and acceleration benefits that our named executive officers are entitled to are summarized below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agreements with Gavin MacBeath, Ph.D.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We entered into an employment agreement, effective as of April 23, 2021, with Dr. MacBeath (the &#8220;2021 MacBeath Agreement&#8221;). Pursuant to the terms of the employment agreement, Dr. MacBeath received an annual base salary and is eligible to receive an incentive performance bonus of a specified percentage of his annual base salary, which bonus amount is determined by our board of directors and dependent on the achievement of specific company, team and individual performance objectives.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, Dr. MacBeath previously entered into our standard proprietary information and inventions agreement, which contains one-year post-termination non-solicitation and non-competition provisions, provided that such one-year period will automatically be extended for an additional year following the separation date if Dr. MacBeath breaches a fiduciary duty to the Company or unlawfully takes, physically or electronically, any property belonging to the Company. In the event of Dr. MacBeath&#8217;s termination without cause or resignation for good reason in the three months prior to or 12 months following a change in control, then the restrictive covenants are no longer enforceable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. MacBeath was appointed as our acting Chief Executive Officer, effective as of March 28, 2023 and was later appointed as Chief Executive Officer, effective May 24, 2023. In connection with such appointment, we entered into a new employment agreement (the &#8220;2023 MacBeath Agreement&#8221;), superseding the 2021 MacBeath Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2023 MacBeath Agreement provides Dr. MacBeath with severance benefits if the Company terminates his employment without cause or resigns for good reason (as each such term is defined in the 2023 MacBeath Agreement), equal to (i) salary continuation at his base salary for eighteen months following the separation and (ii) payment of the employer share of COBRA premiums for up to eighteen months, subject to Dr. MacBeath executing a general release of claims against the Company. If such separation without cause or for good reason occurs within the three months prior or 12 months following a change of control, then Dr. MacBeath will be entitled to a lump sum payment equal to (i) one-and-one-half (1.5) times his (x) base salary plus (y) annual target bonus, plus (ii) pro-rata target bonus and (iii) payment COBRA premiums for up to 18 months. If the Company is subject to a change of control and in the three months prior or twelve months following Dr. MacBeath is terminated without cause or resigns for good reason, then 100% of any unvested shares or equity awards shall immediately vest and be non-forfeitable. The Company&#8217;s obligation to make severance payments during the applicable severance period will cease immediately upon Dr. MacBeath&#8217;s material breach of his restrictive covenants as set forth in the Company&#8217;s standard proprietary information and inventions agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agreements with Jason A. Amello</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We entered into an employment agreement, effective as of January 29, 2024 with Mr. Amello (the &#8220;Amello Employment Agreement&#8221;). Pursuant to the terms of the Amello Employment Agreement, Mr. Amello joined us as our Chief Financial Officer on January 29, 2024. Mr. Amello is eligible to receive an annual base salary and is also eligible to receive an annual performance bonus of a specified percentage of his annual base salary, subject to his achievement of certain performance metrics to be approved and updated by our board of directors on an annual basis. Mr. Amello also received a one-time signing bonus of $60,000.  In the event Mr. Amello leaves within 12 months of receiving such bonus (other than due to a termination without cause or a resignation for good reason (as each such term is defined in the Amello Employment Agreement)), Mr. Amello will be required to repay such signing bonus.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The employment agreement also provides Mr. Amello with severance benefits if the Company terminates his employment without cause or if Mr. Amello resigns for good reason equal to (i) salary continuation at his base salary for 12 months following the separation and (ii) COBRA premiums coverage for up to 12 months. If such separation without cause or for good reason occurs in the three months prior to a change of control or within 12 months at or following a change of control, then Mr. Amello will be entitled to (i) a lump sum cash payment equal to one times (x) his base salary plus (y) his annual target bonus, (ii) his pro rata target bonus for the number of days worked in the fiscal year of such separation, (iii) COBRA premiums coverage for up to 12 months and (iv) accelerated vesting of all unvested stock option and equity awards. Such severance payments and benefits are conditioned upon Mr. Amello executing a general release of all claims that he may have against the Company. The Company&#8217;s obligation to make severance payments during the applicable severance period will cease immediately upon Mr. Amello&#8217;s material breach of the proprietary information and inventions agreement between him and the Company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">130</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Amello also entered into our standard proprietary information and inventions agreement, which contains one-year post-termination non-solicitation and non-competition provisions, provided that such one-year period will automatically be extended for an additional one year if Mr. Amello engages in any activity in violation of such provisions.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agreements with Chrystal Louis, M.D., M.P.H.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We entered into an employment agreement, effective as of April 4, 2024 with Dr. Louis (the &#8220;Louis Employment Agreement&#8221;). Pursuant to the terms of the Louis Employment Agreement, Dr. Louis joined us as our Chief Medical Officer on April 4, 2024. Dr. Louis is eligible to receive an annual base salary and is also eligible to receive an annual performance bonus of a specified percentage of her annual base salary, subject to her achievement of certain performance metrics to be approved and updated by our board of directors on an annual basis. Dr. Louis also received a one-time signing bonus of $45,000.  In the event Dr. Louis leaves within 12 months of receiving such bonus, Dr. Louis will be required to repay such signing bonus.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The employment agreement also provides Dr. Louis with severance benefits if the Company terminates her employment without cause or if Dr. Louis resigns for good reason (as each such term is defined in the Louis Employment Agreement) equal to (i) salary continuation at her base salary for 12 months following the separation (plus her full target bonus for the prior fiscal year, to the extent not yet paid) and (ii) COBRA premiums coverage for up to 12 months. If such separation without cause or for good reason occurs in the three months prior to a change of control or within 12 months at or following a change of control, then Dr. Louis will be entitled to (i) a lump sum cash payment equal to one times (x) her base salary plus (y) her annual target bonus, (ii) her pro rata target bonus for the number of days worked in the fiscal year of such separation,  and (iii) accelerated vesting of all unvested stock option and equity awards. Such severance payments and benefits are conditioned upon Dr. Louis executing a general release of all claims that she may have against the Company. The Company&#8217;s obligation to make severance payments during the applicable severance period will cease immediately upon Dr. Louis&#8217;s material breach of the proprietary information and inventions agreement between her and the Company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Plan Compensation Information</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides information as of December 31, 2024 with respect to the shares of our common stock that may be issued under our existing equity compensation plans.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:28.24%;box-sizing:content-box;"/>
    <td style="width:1.14%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:19.08%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.14%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:14.14%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.14%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:29.12%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity Compensation Plan Information</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Plan Category</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of securities to be issued upon exercise of outstanding options, warrants and rights</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted average exercise price of outstanding options, warrants and rights</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of securities remaining available for future issuance under equity compensation plan (excluding securities in first column</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity compensation plan approved by security holders </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)(2)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,467,782</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.22</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,766,978</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity compensation plan not approved by security holders</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,467,782</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.22</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,766,978</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes the following plans: our 2018 Equity Incentive Plan (the &#8220;2018 Plan&#8221;), our 2021 Equity Incentive Plan (as amended, the &#8220;2021 Plan&#8221;) and our 2021 Employee Stock Purchase Plan (the &#8220;2021 ESPP&#8221;). </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, a total of 5,781,492 shares of our common stock have been reserved for issuance pursuant to the 2021 Plan which number excludes the 5,187,142 shares that were added to the plan as a result of the automatic annual increase on January 1, 2025. The 2021 Plan provides that the number of shares reserved and available for issuance under the plan will automatically increase each January 1, beginning on January 1, 2022, by four percent of the total outstanding common shares on the immediately preceding December 31 or such number of shares as determined by our board of directors. This number will be subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. The shares of common stock underlying any awards that are forfeited, cancelled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without the issuance of stock, expire or are otherwise terminated, other than by exercise, under the 2021 Plan and the 2018 Plan will be added back to the shares of common stock available for issuance under the 2021 Plan. The Company no longer makes grants under the 2018 Plan. As of December 31, 2024, a total of 985,486 shares of our common stock have been reserved for issuance pursuant to the 2021 ESPP, which number excludes the 565,906 shares that were added to the plan as a result of the automatic annual increase on January 1, 2025. The 2021 ESPP provides that the number of shares reserved and available for issuance under the plan will automatically increase each January 1, beginning on January 1, 2022, by the lesser of one percent of the outstanding number of shares of our common stock on the immediately preceding December 31 or such number of shares as determined by our board of directors. This number will be subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">131</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-Employee Director Compensation</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors adopted and maintains a non-employee director compensation policy, which is designed to enable us to attract and retain, on a long-term basis, highly qualified non-employee directors. Under the policy, each director who is not an employee is paid cash and equity compensation. The fees paid to non-employee directors for service on the board of directors and for service on each committee of the board of directors on which the director is a member are as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:65.127%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:14.377%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.92%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:14.577%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Member Annual Fee ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chairperson Additional Annual Fee ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Board of Directors</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Audit Committee</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,500</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,500</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Committee</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and Clinical Development Committee</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nominating and Corporate Governance Committee</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also reimburse our non-employee directors for reasonable travel and out-of-pocket expenses incurred in connection with attending our board of director and committee meetings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, each new non-employee director elected to our board of directors will be granted an option to purchase up to 47,500 shares of our common stock on the date of such director&#8217;s election or appointment to the board of directors, which will vest in the following manner, subject to the director&#8217;s continued service on our board of directors through such vesting date: in full upon the earlier to occur of the first anniversary of the date of grant or the date of the next annual meeting. On the date of each annual meeting of stockholders of our company, each non-employee director will be granted an additional option to purchase 47,500 shares of our common stock, which will vest in the following manner, subject to the director&#8217;s continued service on our board of directors through such vesting date: in full upon the earlier to occur of the first anniversary of the date of grant or the date of the next annual meeting.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Director Compensation Table</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below shows all compensation earned by or paid to our non-employee directors during 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:28.086%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:18.884%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:15.703%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.44%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.382%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fees earned or paid in cash ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Option awards ($)</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">(1)(2)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">All other compensation ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stephen Biggar, M.D., Ph.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,301</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">307,073</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">382,374</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Katina Dorton, J.D., M.B.A.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">307,073</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">376,073</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gabriela Gruia, M.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56,500</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">307,073</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">363,573</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Barbara Klencke, M.D.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,500</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">307,073</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">370,573</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R. Keith Woods</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54,163</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">307,073</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">361,236</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Garry Nicholson</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,045</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">464,377</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">491,421</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Timothy Barberich</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,978</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,978</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The amounts in this column represent the aggregate grant date fair value of option awards granted to the non-employee director in the applicable fiscal year computed in accordance with FASB ASC Topic 718. See Note 6 to our financial statements for the year ended December 31, 2024, which are included in this Form 10-K. See Note 6 of the notes to our consolidated financial statements appearing in this Form 10-K for a discussion of our assumptions made in determining the grant date fair value of our equity awards. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, our non-employee directors held outstanding stock options as follows: Dr. Biggar (options to purchase 91,646 shares), Ms. Dorton (options to purchase 140,426 shares), Dr. Gruia (options to purchase 109,938 shares), Dr. Klencke (options to purchase 93,170 shares), Mr. Woods (options to purchase 65,000 shares) and Mr. Nicholson (options to purchase 71,250 shares). Mr. Barberich did not hold any outstanding options or unvested shares.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Barberich resigned from the board of directors effective June 12, 2024.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_12_security"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 12. Sec</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">urity Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth information, to the extent known by us or ascertainable from public filings, with respect to the beneficial ownership of our common stock as of February 28, 2025, by:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">each of our directors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">each of our named executive officers;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">132</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all of our directors and executive officers as a group; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">each person, or group of affiliated persons, who is known by us to beneficially own more than five percent of our voting common stock.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The column entitled &#8220;Percentage of Shares Beneficially Owned&#8221; is based on a total of 52,314,039 shares of our voting common stock outstanding as of February 28, 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to our voting common stock. Shares of our voting common stock subject to options that are currently exercisable or exercisable within 60 days of February 28, 2025 are considered outstanding and beneficially owned by the person holding the options for the purpose of calculating the percentage ownership of that person but not for the purpose of calculating the percentage ownership of any other person. Except as otherwise noted, the persons and entities in this table have sole voting and investing power with respect to all of the shares of our common stock beneficially owned by them, subject to community property laws, where applicable. Except as otherwise indicated in the table below, addresses of named beneficial owners are in care of TScan Therapeutics, Inc., 830 Winter Street, Waltham, MA 02451.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.789%;box-sizing:content-box;"/>
    <td style="width:1.78%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:17.984%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.78%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:28.666%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of Beneficial Owner</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares Beneficially Owned</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Percentage of Shares Beneficially Owned</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Greater-than-five Percent Stockholders:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entities affiliated with Lynx1 Capital Management, L.P.</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,357,347</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.24</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entities affiliated with EcoR1 Capital, LLC</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.56</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entities affiliated with BlackRock, Inc.</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,633,276</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.86</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entities affiliated with Biotechnology Value Fund, L.P.</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(4)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,681,509</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.04</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entities affiliated with K2 HealthVentures Equity Trust LLC</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(5)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,602,700</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.89</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entities affiliated with Adage Capital Partners, L.P.</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(6)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,500,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.69</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Entities affiliated with Baker Bros. Advisors, L.P.</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(7)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,784,792</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.32</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Named Executive Officers and Directors:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D., </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(8)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">985,989</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.88</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jason A. Amello, </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Financial Officer and Treasurer</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(9)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">234,375</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chrystal Louis, M.D., M.P.H., </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Chief Medical Officer</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(10)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">95,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stephen Biggar, M.D., Ph.D., </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Director</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(11)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,146</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Katina Dorton, J.D., M.B.A., </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Director</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(12)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92,926</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gabriela Gruia, M.D., </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Director</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(13)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,438</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Barbara Klencke, </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Director</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(14)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">112,621</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R. Keith Woods, </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Director</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(15)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,500</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Garry Nicholson, </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">All current executive officers and directors as a group (10 persons)</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(16)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1,932,367</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">3.69</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Represents beneficial ownership of less than one percent.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information herein is based solely on a Schedule 13G/A filed by Lynx1 Capital Management LP (&#8220;Lynx1&#8221;) and Weston Nichols with the SEC on February 14, 2025. Consists of 5,357,347 shares of voting common stock held by Lynx1. Lynx1 is the investment manager to Lynx1 Master Fund LP (&#8220;Lynx1 Fund&#8221;), with respect to the shares of voting common stock directly held by the Lynx1 Fund. Weston Nichols is the sole member of Lynx1 Capital Management GP LLC, the general partner of Lynx1, with respect to the shares of voting common stock directly held by Lynx1 Fund. Mr. Nichols shares voting and investment power over the shares held by Lynx1 Fund and as a result may be deemed to have beneficial ownership of such shares. The address for the foregoing persons is c/o Lynx1, 151 Calle de San Francisco, Suite 200, PMB 1237, San Juan, PR 00901-1607. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information herein is based solely on a Schedule 13G filed by EcoR1 Capital, LLC (&#8220;EcoR1&#8221;) and EcoR1 Capital Fund Qualified, L.P. (&#8220;Qualified Fund&#8221;) and Oleg Nodelman (collectively, the &#8220;EcoR1 Filers&#8221;) with the SEC on June 5, 2023. Consists of 5,000,000 shares of voting common stock. EcoR1 is the general partner and investment adviser of investment funds, including Qualified Fund. Mr. Nodelman is the control person of EcoR1. Qualified Fund filed this Schedule 13G on June 5, 2023 jointly with the other Filers, but not as a member of a group and it expressly disclaims membership in a group. Such filing should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any of the shares of voting common stock covered by this Schedule 13G. Each Filer also disclaims beneficial ownership of the Stock except to the extent of that person&#8217;s pecuniary interest therein. The address of the EcoR1 Filers is 357 Tehama Street #3, San Francisco, CA 94103.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">133</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information herein is based solely on a Schedule 13G filed by BlackRock, Inc. (&#8220;BlackRock&#8221;) with the SEC on November 8, 2024. Consists of 4,633,276 shares of voting common stock, for which BlackRock has sole voting power and sole dispositive power. The address of BlackRock is 50 Hudson Yards, New York, NY 10001.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information herein is based solely on a Schedule 13G filed by Biotechnology Value Fund, L.P. (&#8220;BVF&#8221;), Biotechnology Value Trading Fund OS LP (&#8220;Trading Fund OS&#8221;), BVF I GP LLC (&#8220;BVF GP&#8221;), BVF GP Holdings LLC (&#8220;BVF GPH&#8221;), Biotechnology Value Fund II, L.P. (&#8220;BVF2&#8221;), BVF Partners L.P. (&#8220;Partners&#8221;), BVF II GP LLC (&#8220;BVF2 GP&#8221;), BVF Inc., BVF Partners OS Ltd (&#8220;Partners OS&#8221;) and Mark N. Lampert with the SEC on November 14, 2024. Consists of (i) 3,681,509 shares of voting common stock held by BVF, including 2,083,529 shares of voting common stock underlying certain pre-funded warrants held by it, (ii) 1,210,605 shares of voting common stock held by BVF2, (iii) 140,576 shares of voting common stock held by Trading Fund OS  and (iv) 40,313 shares of voting common stock held by a certain Partners managed account (&#8220;Partners Managed Account&#8221;). These amounts exclude (i) 4,289,365 shares of voting common stock issuable upon the exercise of pre-funded warrants held by BVF, (ii) 4,983,846 shares of voting common stock issuable upon the exercise of pre-funded warrants held by BVF2, (iii) 503,238 shares of voting common stock issuable upon the exercise of pre-funded warrants held by Trading Fund OS and (iv) 200,548 shares of voting common stock issuable upon the exercise of pre-funded warrants held by Partners Managed Account, which pre-funded warrants may not be exercised if, upon giving effect to such exercise, would cause the aggregate number of shares of voting common stock beneficially owned by such holder (together with its affiliates and other attribution parties) to exceed 4.99% of the number of shares of voting common stock of the Company that would be outstanding immediately after giving effect to the exercise. The holders of pre-funded warrants may increase or decrease such beneficial ownership limitation percentage not in excess of 19.99% by providing the Company with at least 61 days&#8217; prior notice of any increase. BVF GP, as the general partner of BVF, may be deemed to beneficially own the 3,681,509 shares of voting common stock and beneficially owned and 4,289,365 shares of voting common stock issuable upon the exercise of pre-funded warrants held by BVF. BVF2 GP, as the general partner of BVF2, may be deemed to beneficially own the 1,210,605 shares of voting common stock beneficially owned and 4,983,846 shares of voting common stock issuable upon the exercise of pre-funded warrants held by BVF2. Partners OS, as the general partner of Trading Fund OS, may be deemed to beneficially own the 140,576 shares of voting common stock beneficially owned and 503,238 shares of voting common stock issuable upon the exercise of pre-funded warrants held by Trading Fund OS. BVF GPH, as the sole member of each of BVF GP and BVF2 GP, may be deemed to beneficially own the 4,892,114 shares of voting common stock beneficially owned in the aggregate by BVF and BVF2. Partners, as the investment manager of BVF, BVF2 and Trading Fund OS, and the sole member of Partners OS, may be deemed to beneficially own 5,073,003 shares of voting common stock beneficially owned in the aggregate by BVF, BVF2 and Trading Fund OS and held in the Partners Managed Account, including 40,313 shares of voting common stock in the Partners Managed Account and excluding 200,548 shares of voting common stock issuable upon the exercise of pre-funded warrants held in the Partners Managed Account. BVF Inc., as the general partner of Partners, may be deemed to beneficially own the 5,073,003 shares of voting common stock beneficially owned by Partners. Mr. Lampert, as a director and officer of BVF Inc., may be deemed to beneficially own the 5,073,003 shares of voting common stock beneficially owned by BVF Inc. BVF GP, BVF GPH, Partners, BVF Inc. and Mr. Lampert share voting and dispositive power over the shares of voting common stock beneficially owned by BVF. BVF GPH, Partners, BVF Inc. and Mr. Lampert share voting and dispositive power over the shares of voting common stock beneficially owned by BVF2. Partners, BVF Inc. and Mr. Lampert share voting and dispositive power over the shares of voting common stock beneficially owned by Trading Fund OS and held in the Partners Managed Account. BVF GP disclaims beneficial ownership of the shares of voting common stock beneficially owned by BVF. BVF2 GP disclaims beneficial ownership of the shares of voting common stock beneficially owned by BVF2. Partners OS disclaims beneficial ownership of the shares of voting common stock beneficially owned by Trading Fund OS. BVF GPH disclaims beneficial ownership of the shares of voting common stock beneficially owned by BVF and BVF2. Each of Partners, BVF Inc. and Mr. Lampert disclaims beneficial ownership of the shares of voting common stock beneficially owned by BVF, BVF2 and Trading Fund OS and held in the Partners Managed Account. The business address of BVF, BVF GP, BVF2, BVF2 GP, BVF GPH, Partners, BVF Inc., Mr. Lampert and Dr. Hrustanovic is 44 Montgomery St., 40th Floor, San Francisco, California 94104. The business address of Trading Fund OS and Partners OS is PO Box 309 Ugland House, Grand Cayman, KY1-1104, Cayman Islands.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information herein is based solely on a Schedule 13G/A filed by K2 HealthVentures Equity Trust LLC (&#8220;K2HV&#8221;), Parag Shah and Anup Arora with the SEC on February 14, 2025. Consists of 3,602,700 shares of voting common stock held directly by K2HV. K2HV is an investment vehicle for holding equity securities and may be deemed to directly beneficially own the shares of voting common stock that it holds directly and has the right to acquire within 60 days upon conversion of the convertible term loans. Mr. Shah and Mr. Arora serve as the managing members of K2HV and, in such capacities, may be deemed to indirectly beneficially own the shares of voting common stock that K2HV holds directly. The address for the above referenced entities and individuals is 855 Boylston Street, 10th Floor, Boston, MA 02116.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information herein is based solely on a Schedule 13G/A filed by Adage Capital Partners, L.P. (&#8220;ACP&#8221;), Adage Capital Partners GP, L.L.C. (&#8220;ACPGP&#8221;), Adage Capital Management, L.P. (&#8220;ACM&#8221;), Robert Atchinson and Phillip Gross with the SEC on February 7, 2024. Consists of 3,900,000 shares of voting common stock directly owned by ACP. ACPGP is the general partner of ACP. ACM is the investment manager of ACP. Adage Capital Advisors, L.L.C. (&#8220;ACA&#8221;) is managing member of ACPGP. Adage Capital Partners LLC (&#8220;ACPLLC&#8221;) is general partner of ACM. Robert Atchinson and Phillip Gross are managing members </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">134</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of ACA and ACPLLC. Robert Atchinson and Phillip Gross may be deemed to shared voting and dispositive power over the shares held directly by ACP. The principal address of each reporting person is 200 Clarendon Street, 52nd Floor, Boston, Massachusetts 02116.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(7)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information herein is based solely on a Schedule 13D/A filed by Baker Bros. Advisors LP (&#8220;BBA&#8221;), Baker Bros. Advisors (GP) LLC (&#8220;BBA-GP&#8221;), Felix J. Baker and Julian C. Baker with the SEC on April 23, 2024. Consists of (i) 256,209 shares of voting common stock held by 667, L.P. (&#8220;667&#8221;) and (ii) 2,528,583 shares of voting common stock held by Baker Brothers Life Sciences, L.P. (&#8220;Baker Life Sciences&#8221; and together with 667, the &#8220;BBA Funds&#8221;). These amounts exclude (i) 4,018,678 shares of voting common stock issuable upon exercise of pre-funded warrants held by 667 and (ii) 43,158,741 shares of voting common stock issuable upon the exercise of pre-funded warrants held by Baker Life Sciences. The pre-funded warrants held by the BBA Funds are only exercisable to the extent that after giving effect to such exercise the holders thereof, together with their affiliates and any members of a Section 13(d) group with such holders, would beneficially own, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, no more than 4.99% of the outstanding shares of voting common stock of the Company (the &#8220;Maximum Percentage&#8221;). By written notice to the Company, the BBA Funds may from time to time increase or decrease the Maximum Percentage applicable to that BBA Fund to any other percentage not in excess of 19.99%. Any such increase will not be effective until the 61st day after such notice is delivered to the Company. As a result of this restriction, the number of shares that may be issued upon exercise of the pre-funded warrants by the BBA Funds may change depending upon changes in the number of outstanding shares of voting common stock of the Company. The pre-funded warrants held by the BBA Funds are not currently exercisable due to the effect of the Maximum Percentage. The BBA-GP is the sole general partner of the Adviser. Pursuant to management agreements, as amended, among BBA-GP, Baker Life Sciences, and 667, and their respective general partners, the BBA Funds&#8217; respective general partners relinquished to BBA-GP all discretion and authority with respect to the investment and voting power of the securities held by the BBA Funds, and thus BBA-GP has complete and unlimited discretion and authority with respect to the BBA Funds&#8217; investments and voting power over investments. BBA-GP, Felix J. Baker and Julian C. Baker as management members of the BBA-GP, and the BBA may be deemed to be beneficial owners of the securities of the Company held by the Funds. The address for the above referenced entities and individuals is 860 Washington Street, 3rd Floor, New York, NY 10014. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(8)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of (i) 49,767 shares of voting common stock held by Dr. MacBeath and (ii) 936,222 shares of voting common stock subject to options held by Dr. MacBeath that are vested and exercisable within 60 days of February 28, 2025.  </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(9)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of 234,375 shares of voting common stock subject to options held by Mr. Amello that are vested and exercisable within 60 days of February 28, 2025. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(10)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of 95,000 shares of voting common stock subject to options held by Dr. Louis that are vested and exercisable within 60 days of February 28, 2025. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(11)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of 44,146 shares of voting common stock subject to options held by Dr. Biggar that are vested and exercisable within 60 days of February 28, 2025. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(12)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of 92,926 shares of voting common stock subject to options held by Ms. Dorton that are vested and exercisable within 60 days of February 28, 2025. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(13)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of 62,438 shares of voting common stock subject to options held by Dr. Gruia that are vested and exercisable within 60 days of February 28, 2025.  </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(14)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of (i) 45,000 shares of voting common stock held by and 42,621 shares of voting common stock subject to options held by Dr. Klencke that are vested and exercisable within 60 days of February 28, 2025 and (ii) 25,000 shares of voting common stock held by the Klencke Huestis Trust, for which Dr. Klencke serves as co-trustee along with her spouse. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(15)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of 17,500 shares of voting common stock subject to options held by Dr. Woods that are vested and exercisable within 60 days of February 28, 2025. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(16)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of (i) 124,483 shares of voting common stock and (ii) 1,746,634 shares of voting common stock underlying options that are vested and exercisable within 60 days of February 28, 2025.</span></div></div>
  <p style="text-indent:-3.878%;padding-left:3.733%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_13_certain_relationships"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 13. C</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ertain Relationships and Related Transactions, and Director Independence.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other than the compensation agreements and other arrangements described under &#8220;Executive compensation&#8221; and &#8220;Director compensation&#8221; in this Form 10-K and the transactions described below, since January 1, 2023, there has not been and there is not currently proposed, any transaction or series of similar transactions to which we were, or will be, a party in which the amount involved exceeded, or will exceed, $120,000 (or, if less, 1% of the average of our total assets amounts at December 31, 2023 and 2024) and in which any director, executive officer, holder of five percent or more of any class of our capital stock or any member of the immediate family of, or entities affiliated with, any of the foregoing persons, had, or will have, a direct or indirect material interest.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">135</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agreements with Our Stockholders</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with our preferred stock financings prior to our IPO, we entered into an investors&#8217; rights agreement, voting agreement, right of first refusal agreement and product interest rights agreement, in each case, with the purchasers of our preferred stock and certain holders of our common stock. All of the material provisions of these agreements terminated immediately prior to the completion of our IPO, other than the provisions relating to registration rights, which continued in effect following the completion of our IPO and entitle the holders of such rights to demand that we file a registration statement, subject to certain limitations, and to request that their shares be covered by a registration statement that we are otherwise filing. Such provisions relating to registration rights terminated on July 20, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nominating Rights and Registration Rights Agreements with the BBA Funds</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with our Series C convertible preferred stock financing, we entered into a nominating agreement (the Nominating Agreement) with Baker Brothers Life Sciences, L.P. and 667, L.P. (collectively, the &#8220;BBA Funds&#8221;) which was subsequently amended and restated on April 22, 2021, pursuant to which, among other things, we agreed to support the nomination of, and cause our board of directors (or the nominating committee thereof) to include in the slate of nominees recommended to our stockholders for election as directors at each annual or special meeting of our stockholders at which directors are to be elected, one person designated from time to time by the BBA Funds, subject to the requirements of fiduciary duties under applicable law and the terms and conditions of the Nominating Agreement. The agreement only applies during the period beginning at the closing of our IPO and for the three years thereafter, as long as (1) the BBA Funds and their affiliates, collectively, beneficially own at least 75% of the Series C convertible preferred stock purchased by the BBA Funds in such Series C convertible preferred stock financing, or such number of shares of our common stock issued upon conversion of such number of shares of Series C convertible preferred stock (in either case, as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification or similar transaction), and (2) the BBA Funds and their affiliates, collectively, beneficially own at least two percent of our then outstanding voting common stock. Our obligations under the Nominating Agreement terminated on July 20, 2024.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also in connection with our Series C convertible preferred stock financing, we entered into a Registration Rights Agreement with the BBA Funds, pursuant to which, among other things, we agreed to provide the BBA Funds with certain &#8220;resale&#8221; registration rights and related &#8220;piggy-back&#8221; rights.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Rights with K2 Health Ventures</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 9, 2022, we entered into a Loan and Security Agreement (the K2HV Loan Agreement) with K2 Health Ventures LLC (K2HV) pursuant to which K2HV may provide us with convertible term loans in an aggregate principal amount of up to $60.0 million, of which $30.0 million was fully funded at the closing date in September 2022. On November 20, 2024, K2HV converted $15.0 million of the outstanding principal amount under the loan in exchange for 3,134,796 shares of our voting common stock. On December 20, 2024, we terminated the K2HV Loan Agreement and repaid all remaining outstanding obligations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Participation in our 2024 Public Offering</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 24, 2024, we completed an underwritten public offering resulting in the issuance and sale of (a) 4,958,068 shares of Voting Common Stock, including the partial exercise of the underwriters&#8217; option to purchase 2,485,487 additional shares of Voting Common Stock, at the closing market price on April 16, 2024, of $7.13 per share, and (b) Pre-Funded Warrants to purchase up to 18,577,419 shares of the Voting Common Stock, at a price of $7.1299 per warrant with an exercise price of $0.0001 per share. We received aggregate net proceeds of approximately $161.4 million after deducting underwriting discounts, commissions and other</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">136</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">estimated offering expenses. The following table summarizes purchases of the shares of our voting common stock and the pre-funded warrants by our related persons in connection with such underwritten public offering:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:43.5%;box-sizing:content-box;"/>
    <td style="width:1.48%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.28%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.26%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:17.68%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.74%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:16.06%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares of Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares of Common Stock Issuable Upon the Exercise of Pre-Funded Warrants</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Purchase Price</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:11pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adage Capital Partners, L.P.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,350,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,625,365</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">667, L.P.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">825,968</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,889,069</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:11pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Baker Brothers Life Sciences, L.P.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,851,451</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,109,960</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Biotechnology Value Fund, L.P.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,289,181</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,191,732</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:11pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Biotechnology Value Fund II, L.P.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,132,502</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,074,626</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Biotechnology Value Trading Fund OS LP</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56,019</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">399,410</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:11pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSI BVF SPV, LLC</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72,298</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,478</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:11pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lynx1 Master Fund LP</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,649,500</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:11pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">18,577,419</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">132,455,140</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the public offering, we agreed, among other things, to indemnify the underwriters in connection with the Securities Act of 1933, as amended. The public offering was made pursuant to the shelf registration statement on Form S-3 (File No. 333-277699) that was filed with the SEC on March 6, 2024, and that was declared effective by the SEC on April 12, 2024, and a related prospectus supplement and its accompany base prospectus, filed with the SEC on April 18, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Participation in our 2024 Registered Direct Offering</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 27, 2024, we completed a registered direct offering with an existing investor Lynx1 Master Fund LP (&#8220;Lynx1&#8221;) and an investment fund advised by Lynx1 resulting to in the sale and issuance of pre-funded warrants to purchase up to 7,500,000 shares of the Company's Voting Common Stock, at a purchase price of $4.00 per warrant with an exercise price of $0.0001 per share, for aggregate gross proceeds of approximately $30.0 million, before deducting offering expenses of  $0.2 million.  Of these prefunded warrants, prefunded warrants to purchase up to 150,000 shares of Voting Common Stock for gross proceeds of $600,000 were sold to Lynx1 and prefunded warrants to purchase up to 7,350,000 shares of Voting Common Stock for gross proceeds of $29.4 million were sold to an investment fund advised by Lynx1.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The public offering was made pursuant to the shelf registration statement on Form S-3 (File No. 333-268260) that was filed with the SEC on November 9, 2022, and that was declared effective by the SEC on May 16, 2023, and a related prospectus supplement and its accompany base prospectus filed with the SEC on December 26, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Related person transaction policy</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors adopted a written related person transaction policy providing that transactions with our directors, officers and holders of five percent or more of our voting securities and their affiliates, each a related person, must be approved by our audit committee. This policy became effective on July 15, 2021. Pursuant to this policy, the audit committee has the primary responsibility for reviewing and approving or disapproving &#8220;related person transactions,&#8221; which are transactions between us and related persons in which the aggregate amount involved exceeds or may be expected to exceed the lesser of (i) $120,000 and (ii) one percent of the average of the Company&#8217;s total assets at year end for the last two completed fiscal years, and in which a related person has or will have a direct or indirect material interest. For purposes of this policy, a related person is defined as a director, executive officer, nominee for director, or greater than five percent beneficial owner of our common stock, in each case since the beginning of the most recently completed year, and their immediate family members.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As appropriate for the circumstances, the audit committee will review and consider, among other things:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the related person&#8217;s interest in the related person transaction; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the approximate dollar amount involved in the related person transaction; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the approximate dollar amount of the related person&#8217;s interest in the transaction without regard to the amount of any profit or loss; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the transaction was undertaken in the ordinary course of our business; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">137</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the terms of the transaction are no less favorable to us than terms that could have been reached with an unrelated third party; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the business purpose for entering into a transaction with a related person versus an unrelated third party; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any other material information regarding the transaction of the related person&#8217;s interest in the transaction. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limitation of Liability and Indemnification of Officers and Directors</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any breach of their duty of loyalty to our company or our stockholders; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any transaction from which they derived an improper personal benefit. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to that amendment or repeal. If the Delaware General Corporation Law is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of our directors will be further limited to the greatest extent permitted by the Delaware General Corporation Law.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, our bylaws provide that we will indemnify, to the fullest extent permitted by law, any person who is or was a party or is threatened to be made a party to any action, suit or proceeding by reason of the fact that he or she is or was one of our directors or officers or is or was serving at our request as a director or officer of another corporation, partnership, joint venture, trust, or other enterprise. Our bylaws provide that we may indemnify to the fullest extent permitted by law any person who is or was a party or is threatened to be made a party to any action, suit, or proceeding by reason of the fact that he or she is or was one of our employees or agents or is or was serving at our request as an employee or agent of another corporation, partnership, joint venture, trust or other enterprise. Our bylaws also provide that we must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to very limited exceptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have entered into and in the future plan to enter into agreements to indemnify our directors and executive officers. These agreements, among other things, require us to indemnify these individuals for certain expenses (including attorneys&#8217; fees), judgments, fines and settlement amounts reasonably incurred by such person in any action or proceeding, including any action by or in our right, on account of any services undertaken by such person on behalf of our company or that person&#8217;s status as a member of our board of directors to the maximum extent allowed under Delaware law.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_14_principalaccountingfees"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 14. Principal Accountant Fees and Services.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan incurred the following fees from Deloitte for the audit of the consolidated financial statements and for other services provided during the years ended December 31, 2024 and 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:35.267%;box-sizing:content-box;"/>
    <td style="width:2.42%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:27.946%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:2.42%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:27.946%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year 2024 ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fiscal Year 2023 ($)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Audit Fees</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">847,750</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">773,153</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Audit-Related Fees</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax Fees</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">All Other Fees</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-kerning:none;min-width:fit-content;">(3)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,790</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Fees</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">847,750</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">776,943</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit fees consist of fees for the audit of our annual financial statements, the review of our interim financial statements included in our quarterly reports on Form 10-Q and fees related to our follow-on offering, including comfort letters and consents. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tax fees consist of fees for tax compliance, advice and tax services. There were no tax fees in fiscal years 2023 and 2024. </span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All other fees disclosed in this table were related to the fees for access to technical accounting software resource provided by Deloitte. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">138</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee Pre-Approval Policy and Procedures</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit committee has adopted policies and procedures relating to the approval of all audit and non-audit services that are to be performed by our independent registered public accounting firm. This policy provides that we will not engage our independent registered public accounting firm to render audit or non-audit services unless the service is specifically approved in advance by our audit committee, or the engagement is entered into pursuant to the pre-approval procedure described below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, our audit committee may pre-approve specified types of services that are expected to be provided to us by our independent registered public accounting firm during the next 12 months. Any such pre-approval details the particular service or type of services to be provided and is also generally subject to a maximum dollar amount.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During our 2023 and 2024 fiscal years, no services were provided to us by Deloitte other than in accordance with the pre-approval policies and procedures described above.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">139</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART IV</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_15_exhibits_financial_stmt_schedule"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 15. Exhibits, Fin</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ancial Statement Schedules</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For a list of the financial statements included herein, see Index to the Consolidated Financial Statements on page F-1 of this Annual Report on Form 10-K, incorporated into this Item by reference.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial statement schedules have been omitted because they are either not required or not applicable or the information is included in the consolidated financial statements or the notes thereto.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibits:</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:91%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521219696/d172723dex31.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amended and Restated Certificate of Incorporation of TScan Therapeutics, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 20, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521219696/d172723dex32.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amended and Restated Bylaws of TScan Therapeutics, Inc. (incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 20, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex42.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fourth Amended and Restated Investors&#8217; Rights Agreement, dated January 15, 2021, by and among the Registrant and the other parties thereto (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex43.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Registration Rights Agreement made as of January 15, 2021 by and between the Registrant and the other parties thereto (incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex44.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amended and Restated Nominating Agreement, dated April 22, 2021, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P. (incorporated by reference to Exhibit 4.4 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1783328/000095017022003175/tcrx-ex4_4.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Description of the Registrant&#8217;s securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (incorporated by reference to Exhibit 4.4 to the Registrant's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 9, 2022).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1783328/000119312523157307/d476076dex41.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Registrant's Current Report on Form 8-K, filed with the Securities and Exchange Commission on May 31, 2023).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001783328/000119312524098509/d816959d8k.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Registrant's Current Report on Form 8-K, filed with the Securities and Exchange Commission on April 17, 2024).</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001783328/000119312524284671/d861236d8k.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Registrant's Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 26, 2024).</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000095017021004987/tcrx-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease, by and between TScan Therapeutics, Inc. and BXP Waltham Woods LLC, dated November 29, 2021 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 2, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex102.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2018 Stock Option Plan, as amended and forms of agreements thereunder (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001783328/000119312524161151/d785285d8k.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amended and Restated TScan Therapeutics, Inc. 2021 Equity Incentive Plan and form of agreements thereunder (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 14, 2024).</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1783328/000119312521129264/d107876dex104.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2021 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex105.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amended and Restated Exclusive Patent License Agreement by and between the Registrant and The Brigham and Women&#8217;s Hospital, Inc. dated April 20, 2021 (incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1783328/000095017023040961/tcrx-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration Agreement by and between the Registrant and Amgen, Inc., dated as of May 8, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on August 10, 2023).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">140</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:91%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex106.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease by and between PPF OFF 828-830 Winter Street LLC and the Registrant, dated August 13, 2019 (incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Registration Statement on S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:91%;box-sizing:content-box;"/>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1783328/000095017023061533/tcrx-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">First Amendment to Lease by and between PPF OFF 828-830 Winter Street LLC and the Registrant, dated November 8, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 9, 2023).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex10_9.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Second Amendment to Lease by and between PPF OFF 828-830 Winter Street LLC and the Registrant, dated October 28, 2024.</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0200000000000005pt;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1783328/000119312521129264/d107876dex108.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration and License Agreement by and between the Registrant and Novartis Institutes for Biomedical Research, dated as of March 27, 2020 (incorporated by reference to Exhibit 10.8 to the Registrant&#8217;s Registration Statement on S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex109.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-Exclusive License Agreement by and between the Registrant and Provincial Health Services Authority, dated as of October 15, 2020 (incorporated by reference to Exhibit 10.9 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex1010.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Royalty Agreement, dated as of June 12, 2018 (incorporated by reference to Exhibit 10.10 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1783328/000095017024026875/tcrx-ex10_14.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employment Agreement, dated May 25, 2023, by and between the Registrant and Gavin MacBeath, Ph.D (incorporated by reference to Exhibit 10.14 to the Registrant's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 6, 2024).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex1018.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Management Cash Incentive Plan (incorporated by reference to Exhibit 10.18 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1783328/000095017024026875/tcrx-ex10_17.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employment Agreement, dated July 28, 2021, by and between the Registrant and Zoran Zdraveski (incorporated by reference to Exhibit 10.17 to the Registrant's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 6, 2024).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001783328/000095017024058198/tcrx-20240331.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employment Agreement, dated January 29, 2024, by and between the Registrant and Jason A. Amello (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 13, 2024).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001783328/000095017024095066/tcrx-20240630.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Employment Agreement, dated April 4, 2024, by and between the Registrant and Chrystal Louis (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 12, 2024).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001783328/000119312521129264/d107876dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Registration Statement on Form S-1, filed with the Securities and Exchange Commission on April 23, 2021).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.19</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1783328/000119312522242437/d323376dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loan and Security Agreement, dated September 9, 2022, by and among TScan Therapeutics, Inc., K2 HealthVentures LLC and Ankura Trust Company, LLC (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 12, 2022).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.20&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001783328/000119312524283673/d920508d8k.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loan and Security Agreement, dated December 20, 2024, by and among TScan Therapeutics, Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 23, 2024).</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex19.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Insider Trader Policy.</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex21.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">List of Subsidiaries of Registrant.</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex23_1.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm.</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">141</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:91%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.1**</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex32_1.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.2**</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tcrx-ex32_2.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001783328/000095017024026875/tcrx-20231231.htm"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compensation Recovery Policy (incorporated by reference to Exhibit 97 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 6, 2024).</span></a></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:86.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Filed herewith.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">** Furnished herewith</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"># Indicates a management contract or any compensatory plan, contract or arrangement.<br/>&#134; Certain portions of this exhibit have been omitted because they are not material and would likely cause competitive harm to the registrant if disclosed.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_16_10k_summary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 16. Form 10-K Summary</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">142</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30.854%;box-sizing:content-box;"/>
    <td style="width:2.48%;box-sizing:content-box;"/>
    <td style="width:6.619%;box-sizing:content-box;"/>
    <td style="width:60.048%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td colspan="2" style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 5, 2025</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;By:</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:1pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gavin MacBeath</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D.</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer (Principal Executive Officer)</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 5, 2025</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jason A. Amello</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jason A. Amello</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer (Principal Financial and Accounting Officer)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each person whose individual signature appears below hereby authorizes and appoints Gavin MacBeath and Jason A. Amello, and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this Annual Report on Form 10-K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant in the capacities and on March [5], 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:36%;box-sizing:content-box;"/>
    <td style="width:2%;box-sizing:content-box;"/>
    <td style="width:40%;box-sizing:content-box;"/>
    <td style="width:2%;box-sizing:content-box;"/>
    <td style="width:20%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Signature</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gavin MacBeath</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td rowspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director (Principal Executive Officer)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gavin MacBeath, Ph.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="border-top:1pt solid #ffffff03;padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jason A. Amello</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jason A. Amello</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Garry Nicholson</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Garry Nicholson</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Stephen Biggar</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stephen Biggar, M.D., Ph.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Katina Dorton</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Katina Dorton, J.D., M.B.A.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gabriela Gruia</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gabriela Gruia, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Barbara Klencke</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Barbara Klencke, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ R. Keith Woods</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R. Keith Woods</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">143</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:93%;box-sizing:content-box;"/>
    <td style="width:7%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#reportinderegisterepublicaccountingfirm_"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (PCAOB ID No. </span><span><ix:nonNumeric id="F_19bca5a7-6834-4073-8c0e-d151f9740da0" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:AuditorFirmId"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">34</span></ix:nonNumeric></span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">)</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_balance_sheets_"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statements_of_operations_t"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations and Comprehensive Loss</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidatedstatemestockholdersequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Stockholders&#8217; Equity</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statementscash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_consolidatedfinancialstatements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="reportinderegisterepublicaccountingfirm_"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the stockholders and Board of Directors of TScan Therapeutics, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3e4a3c0d-6415-44d3-a6d8-213990b9b4ba" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:AuditorOpinionTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of TScan Therapeutics, Inc. and subsidiary (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, stockholders' equity, and cash flows for the years then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ </span><span><ix:nonNumeric id="F_d2be3a10-f26f-4096-9928-b9b76e58ee0a" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deloitte &amp; Touche LLP</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:nonNumeric id="F_494f3b45-49f0-47ec-baff-44c6232454f0" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Boston, Massachusetts</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company&#8217;s auditor since 2020.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_balance_sheets_"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share data)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_847bbcbd-0b91-4f8f-8eb4-9cca7458be1f" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178,689</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_712d2bb4-1f2c-4345-9e58-225c117fc8e0" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133,359</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_923f829c-90c5-467b-8bce-2cd96ef8cbaf" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,421</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df7a9231-3a1e-48f9-a6f2-24121dbbffdd" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,685</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1153738-8a09-45cc-844d-a429889c55f2" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,612</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b09ca66-1151-4879-a18f-2e9750bc6c3a" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,193</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08de269e-3746-4dc4-8fcc-4a17c208fba2" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">292,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b05a5784-a60c-4b52-ad5e-ea09562dc79f" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194,237</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1aebd406-33e5-4eaf-b6de-192d31862c2f" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,242</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4888f001-9377-4184-b102-f876368164c1" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,742</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80d38919-f4db-4a1d-bf97-fb863970d203" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,357</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ec718b5-fe18-4057-ac1b-028c031b995c" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,492</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c275ae49-64d0-4759-81f0-3f40030e3f3b" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,031</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_726572a6-559b-4ab9-94c3-39333625c577" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,031</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term deposit and other assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96afe660-52da-4e65-ae7f-7a06ff5ed3b9" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DepositsAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,766</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7796987c-5d1d-471e-8bb7-8efe9568fa6c" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DepositsAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,647</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3601bad-3c05-4fa1-9723-480b4ac70a25" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">371,118</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d40257f-ab78-4987-8908-9915ad04d217" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">272,149</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities and Stockholders' Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dba1879b-e62c-41c2-a2b2-4e7010e2235e" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,278</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c281b53-e147-4337-9fc6-2fdb0e7494db" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,374</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a56ebff8-dff0-4a8d-81a4-eb7adfe9fbd4" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,410</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33a6f854-5f81-4a63-9b49-7c23b60762c2" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,716</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability, current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dca01456-36de-4141-9996-19011c6bfb35" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,570</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5bdcb054-0e51-49e6-b7e6-6ba8b95b82fb" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,246</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue, current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2bf73cfe-6a4a-4c83-916a-fef3f150656e" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DeferredRevenueCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,698</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e245abac-1ec2-4012-8f50-e2fbeb6f47c2" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DeferredRevenueCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,137</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current portion of long-term debt</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13023444-2a8e-4a89-b221-293323c07afb" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,347</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77d02377-2e8d-4df8-94e1-e82489678afe" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,956</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d95ac6d9-01d1-476b-ae8e-d9938c4e031c" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,820</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue, net of current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1cdaaba-b1c5-4236-8bc5-b7403be33295" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DeferredRevenueNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,246</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8734508-3ee7-4666-a064-ef68523ce0da" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DeferredRevenueNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,622</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability, net of current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9933c1c8-15e9-4a00-b699-b447a3c4b858" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,739</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c219d46-1dfb-45ec-a17e-19f4987eac95" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,140</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt and accrued interest</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1211948-4a08-4af0-a014-a53d9feacf3e" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,072</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5529e4f4-1278-461e-be34-298daf7069c4" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,700</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long term liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14839591-db87-43f0-820b-054ba356050a" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">135</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af747e2c-a076-4d04-b2cb-fd0505f3e25a" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130,148</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7aa3947-0e69-4a9c-9e21-b6251c0b2ffe" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">121,282</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_932e05b7-27e6-43f0-b747-18268e09c280;"><span style="-sec-ix-hidden:F_cab03e13-a6ef-4d41-874e-e22967c6a34b;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies</span></span></span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(Note 10)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders' equity:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred Stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1756bf26-6a86-4825-9f3e-489f70e2256a" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_627091c1-8c57-44b1-83c1-c19b82322549" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13776cb6-155e-4e2e-b596-e5a22af02a48" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ba03000a-0989-4cd8-af63-f64fd9a36a79" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff20bf82-c139-4451-8fc6-996ce97b93f0" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_7f56ccc3-882d-4234-958b-b21c602d37dc" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_1034f01f-92ab-4340-a66c-dc1b8dd8eb5e" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_8c0d084c-274b-48be-a307-288b0d37e273" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1c8eb90-24eb-4a13-a280-0a4dfa727c05" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_deef4567-94f6-4aa2-ab7b-88f6db5e9f06" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Voting common stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_918c0860-cde5-4cc2-9596-957cc32de892" contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_e900a7e9-6781-4647-ae67-2c9d27251c1d" contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bb19474-20ad-4808-98c0-0e3befd334c8" contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e647e288-de8f-4d3a-a0e0-3be5c4071240" contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">300,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53c354a8-902d-4322-87d1-4efc9fea2fe4" contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2d4db22a-70e7-42df-8310-0a4e1625addb" contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">52,314,039</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb1d430d-8041-4aa7-9a5c-2459674e1ca7" contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cfcb0d97-d38d-464f-909f-3f6176c7f1ff" contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">43,552,941</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023, respectively</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13884a2b-2c13-4f46-ac68-1467cd5eab5e" contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7295e88-172f-499a-b0d1-c275b6d0bbd6" contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-voting common stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a18cbad-dbc9-4058-93f9-3acff1b4edd0" contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_db1c21a8-7f22-4c7b-81fb-12df864d6c2a" contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98094f56-3e74-4689-bbcb-df509e5f778c" contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c40c6db5-47b0-4ea1-9453-9fd6de01f28f" contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e988228-801d-475c-b9c3-aae978c26d48" contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4b2bc226-1817-4853-8fcf-ac81805a4623" contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_303c35ed-d91a-4f3e-869c-620c12fd4c7b" contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_99e1aa23-203d-42ba-903f-f0b13885e821" contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,276,588</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_402b0227-ed4d-4425-967a-bcf8c89ecebf" contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddec6d4a-df6a-4a7b-b693-8177bd148e4b" contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84a27b2e-d192-4ff7-b633-35f75ca29ddc" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">616,009</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2423841e-1aed-485f-b057-f58c67b26213" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">398,459</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a319dacc-3b95-418c-832f-6310de1cdfa5" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6476db62-937f-4d05-b258-5438286a8c3e" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">375,096</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a817924-7abc-4863-b6ee-2476e3da6ec0" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">247,597</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders' equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a56f6f3e-1a1d-42f9-824f-ea75a343faf8" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">240,970</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85e630be-08a7-4853-8dfc-1e8ac99e9f88" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150,867</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders' equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_642e3508-8360-44b4-a9f1-30e93a8fb4f0" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">371,118</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_506ff4ef-87b5-4079-aeca-04b2360b9132" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">272,149</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_statements_of_operations_t"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and Comprehensive Loss</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share data)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.313%;box-sizing:content-box;"/>
    <td style="width:1.5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.843%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.843%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_454fce7d-d7b0-40b3-a92d-04bed9475480;"><span style="-sec-ix-hidden:F_009427c9-5661-4694-967b-b879b975ff06;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration and license revenue</span></span></span></span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef1a6991-a002-45ac-898b-32807e0b38e7" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,816</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1811c07d-04c2-4249-9c26-dce370a4c46a" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,049</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33916257-e4aa-43be-95b5-2a76d1693adf" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107,350</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fd8a861-877b-46df-8295-eaa7b24508d1" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88,153</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8d2d2c4-8fd4-4ae0-a804-8e784dc835d8" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,287</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1cfd43e-c559-4c82-92d2-1fd58861c40b" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,354</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc92d9c4-87b5-40fa-9425-7bc29713b3c7" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">137,637</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5fc971d-3898-4fbb-a29e-b1890de91040" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">114,507</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99cc39e9-7bc1-4386-9448-0a3475edc7e8" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">134,821</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef3190f0-3665-44dd-ae79-fc59790a84b9" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">93,458</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other (expense) income:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and other income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5aec1403-ddda-492e-a6b1-56d3128a41bb" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,065</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c2ac4a8-caa9-4a29-90b5-359fc1d95d98" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,999</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d3d75e4-fd80-4cf4-be22-97a86568c15b" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,653</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63009f8e-6f27-4d66-90ff-8c0860d2638d" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,759</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91e23306-db1b-4ab2-b787-003ab9495061" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,090</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9afff08-2352-45e9-ac1a-5c0345ec3f7d" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,322</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a593be1d-7b2d-45b0-922e-fee07e726574" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,240</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa92b8ac-1a62-45f2-a16b-8837bbb31a41" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">127,499</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e942d3c-9fee-48fa-aef0-739eea89e8a5" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">89,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05850cf6-5150-4eab-a3e3-93ec899ed9ce" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_46b4579c-080c-4738-af78-4e6e108fca61" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.14</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_268a6903-8511-4d35-ad3b-babe650ec554" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_96ae14b2-51b5-4b49-9f2f-b723c1bb339e" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.36</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average common shares outstanding&#8212;basic and diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5ae9ffd-e4ad-46b5-ae05-b780d65acb2c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_5762c584-7294-4e1b-b4ae-03b4dfd20182" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">111,990,417</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73bc72e9-6cc6-494f-be32-453cd01a81bd" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3ccd0d18-d3c2-458c-8f35-e32634b8ac19" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">65,599,858</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Comprehensive loss:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net Loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00c0ae65-a50b-4af4-8dd9-5a359b26bb46" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">127,499</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4028c84a-2ff2-4dc9-a8f8-d80687a40771" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">89,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other comprehensive gain:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on available-for-sale securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8508a598-63f8-43e5-affb-9f2d15cf57a2" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d4c0ffc-930f-4fae-a3e2-d040e649e4da" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">127,448</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aed3149e-9e7e-4aa0-8166-d1971779f112" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">89,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidatedstatemestockholdersequity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Stockholders&#8217; Equity</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share data and issuance costs)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:29.114%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.179%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.239000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.179%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.699%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.699%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.218999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.699%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.978999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Other</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Voting Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-voting Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Paid-In</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Comprehensive</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stockholders&#8217;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Loss</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deficit</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balances at January 1, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_273f109d-384a-4691-bc49-ba21a8a724e5" contextRef="C_9a6fdb37-0d38-4efb-bcdc-bcac4dfcba88" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">19,082,820</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_141f90b0-2f53-4a12-ab8b-1ef4bfdd17df" contextRef="C_9a6fdb37-0d38-4efb-bcdc-bcac4dfcba88" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10777a2a-1930-4d89-b45f-6971f1e38ca4" contextRef="C_3893ceb7-51f2-43b7-a23b-018b3f1f7b4f" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">5,143,134</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc55d590-e607-4953-964b-cf9ccf265ae4" contextRef="C_3893ceb7-51f2-43b7-a23b-018b3f1f7b4f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2444112d-6a13-44c7-8513-e86b6e2b99ac" contextRef="C_9426554d-c3a3-495e-89a1-e0ff0f0562ec" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257,810</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69942b34-af5d-4d38-83ec-8cf2e1b00117" contextRef="C_b6ea31a6-d30f-4f27-baef-ea2115d03cdf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">158,379</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdb3e88b-9379-49dd-a2f3-ec6261a6ef35" contextRef="C_67b999bc-f4c8-49b5-89ed-d7a3accc676d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">99,434</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa19264a-328d-4aa5-8481-1a831d988449" contextRef="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">316,441</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2f30ef2-0a81-4d10-bf94-ff23d8f0cb6c" contextRef="C_169ccb09-f794-4b53-b335-3240e68654d4" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">711</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6e0cb7d-f3d1-485f-aed3-eba064d3bad4" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">711</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock, net of offering costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_570680fe-1120-4041-ab40-a17369fa09c8" contextRef="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">23,287,134</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06702ddd-94ca-466f-9038-f75dd0550651" contextRef="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e615f32a-1ac8-489f-8cf7-83b47721a984" contextRef="C_169ccb09-f794-4b53-b335-3240e68654d4" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,412</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6ad0d50-1f75-45a3-af92-d6f12c861e5d" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,414</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of pre-funded warrants, net of offering costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7108574-6bd0-45c4-bcd0-09fa905205f7" contextRef="C_169ccb09-f794-4b53-b335-3240e68654d4" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92,318</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d698129-87c4-4cf5-a282-37e6b56ea7cc" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92,318</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of non-voting common stock to voting common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7720c58f-1029-4e69-8038-5ebeafdbd84c" contextRef="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">866,546</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0bee5f32-2fd9-401a-928f-a12f89913f85" contextRef="C_eddbe2e8-9268-426b-a979-bd5adb43d23b" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" sign="-" format="ixt:num-dot-decimal">866,546</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f82a04ee-c451-4c0f-bf16-9cf1ae5cd0a4" contextRef="C_169ccb09-f794-4b53-b335-3240e68654d4" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,208</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1136f689-a96a-48cf-aeb9-07bb132c0b08" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,208</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df7e9faa-bd08-40a6-a97c-d8ff3bdd945d" contextRef="C_bfb0ef5e-b57c-4a0a-a092-a98856d36448" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">89,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1459c216-291f-49c0-a6b0-11377004fd2e" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">89,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balances at December 31, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0ebb08c-2804-427a-9514-2f74473e91de" contextRef="C_fdf7f67a-bc90-4d6f-a82f-8fb0241be3b3" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">43,552,941</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3885dfea-6dfd-43ff-9e31-f5ad509c3560" contextRef="C_fdf7f67a-bc90-4d6f-a82f-8fb0241be3b3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f513ee0b-f01e-47a7-af0d-71f77b9d5364" contextRef="C_c042479b-b737-4e26-b3ca-35e98d7d1ce2" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,276,588</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ca8bc63-89c2-44c5-a053-ada52c5df5ab" contextRef="C_c042479b-b737-4e26-b3ca-35e98d7d1ce2" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09555e94-c921-44a0-8f2d-efdcbc19b4b7" contextRef="C_c2b1d23e-b281-4f16-828a-e82b56e3f3ac" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">398,459</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_499f78be-30d7-4a3d-b5de-6d66ec3f3b5b" contextRef="C_3bf172b3-d914-487d-92f6-91b61a2ded94" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">247,597</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60ca89e2-a1a6-432d-b728-e53c77f03a20" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150,867</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ba967c3-7fff-493d-a36a-1bd6135bf6cb" contextRef="C_846a05b5-9501-4749-9b63-f20303696a58" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">586,081</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dffab4e0-5f60-4c29-94dc-e9ad69831ba7" contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,717</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_199d4335-f650-4a00-ade7-e0e8034335f5" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,717</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock under employee stock purchase plan</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5db3093-881a-41d5-8ada-82e86157eb0e" contextRef="C_846a05b5-9501-4749-9b63-f20303696a58" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">82,153</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5952944c-97cc-4c63-a444-f6edc5a3c70f" contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">333</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7710fd19-5a45-4eef-aaa7-f74747878fed" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">333</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock, net of offering costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e28830f1-c84e-4eae-b378-b2c69cb5be57" contextRef="C_846a05b5-9501-4749-9b63-f20303696a58" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,958,068</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a93dd2b6-d832-42cd-a68c-101ebfa0ec28" contextRef="C_846a05b5-9501-4749-9b63-f20303696a58" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1aec4d47-e041-42de-b9bf-767b51b904bd" contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,130</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1c99f3e-7dbe-4543-a632-5c5bdda39aeb" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,131</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of pre-funded warrants, net of offering costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_197d10e1-1cac-4e2d-bb40-a3e835878440" contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">158,071</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1afa491-444f-41ef-a665-db804381e57c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">158,071</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of convertible debt</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77713429-9527-48d2-a731-dfd42b55184f" contextRef="C_846a05b5-9501-4749-9b63-f20303696a58" name="tcrx:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">3,134,796</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cc1c056-c27e-40cf-a65e-84c8861c6bc6" contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,750</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a26845f-77b3-417f-8b3b-a5b91f41919b" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,750</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b98271c8-a03b-4bbd-bc3f-b1e3ceca51d5" contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,549</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f081d8f1-b7a8-445f-a60c-d2b9df056e40" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,549</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a389b7b3-03ea-4d1c-aac3-db1d37a0859a" contextRef="C_a5bfb76e-5ddb-45ec-a10d-3be626faa8a8" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">127,499</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44b822d3-fd28-4568-9142-244f40e7e11a" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">127,499</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on available-for-sale securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fec7b4d-de3e-4e44-8c4d-466124c384f2" contextRef="C_d4c09ebb-c7e3-4e42-8f5e-44b4747af4be" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18f5d0aa-d572-461a-8d5f-e83ea9973946" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balances at December 31, 2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41aa9edb-47d8-44e5-81c9-d99831fb1f42" contextRef="C_331dd2a3-95d1-44e8-add3-bfa57011870e" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">52,314,039</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_567e38a4-1d46-42fb-80d6-a42acecd6bc4" contextRef="C_331dd2a3-95d1-44e8-add3-bfa57011870e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5135e3ed-4fcf-4118-9b32-18260f274dd0" contextRef="C_2b9a5142-5c09-4228-8993-64954bfc0d19" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,276,588</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72ad9d95-3ef0-4d92-9436-f6adf6d26847" contextRef="C_2b9a5142-5c09-4228-8993-64954bfc0d19" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_367f4a73-95ab-4a3a-92d3-9cb825fe074d" contextRef="C_2c6c9c99-f3b5-4d27-93cc-9263f4bf5003" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">616,009</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d219cb7e-c6cf-457b-af65-2877baf521d8" contextRef="C_cef715b9-0023-4326-a474-9157cf7c6faa" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a247287d-b9dc-45b9-b76e-9c43d0d934bb" contextRef="C_7c36265d-e56e-41bb-b9a4-c45feaed4d8c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">375,096</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7df6d485-6344-4a81-8830-3d837d85679a" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">240,970</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_statementscash_flows"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:69%;box-sizing:content-box;"/>
    <td style="width:2.26%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.68%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.38%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.68%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be7df806-bb08-415d-8d3c-3187f4024785" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">127,499</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31a84d30-5dc6-4e64-8995-f5d470198f5c" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">89,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:10pt;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a5ab502-72e3-4c27-a505-49cdb6af09a0" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,108</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b222319-8a16-4741-9d42-9ebb3a5f0cd5" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,361</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accretion of marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1fb09d9-9416-409f-aa86-56a58e546f94" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:AccretionOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,897</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_458f44c2-f9e2-4786-adce-629a62bd0366" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="tcrx:AccretionOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,072</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash interest expense related to loan payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba179873-196f-4557-9225-108e88947b40" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:NonCashInterestExpenseOnLoanPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">773</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38f78ef2-bf34-4701-9a7f-71dfd61979e9" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="tcrx:NonCashInterestExpenseOnLoanPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">757</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2842d0d-5aaf-40dc-889c-f34bb5c5fc4a" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,090</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3efff1d-05b4-4ec1-a947-2dfb9190ab51" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,549</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17801b64-57cb-409f-956c-2fd558cf8fa4" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,208</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;text-indent:20pt;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in current assets and liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a4f7bac-d2c5-4b97-9670-072f73eea115" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">538</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ad42e2f-b38f-4f91-a74a-776d275b4958" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">985</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets and lease liabilities, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad634820-51cb-4f9c-8a0b-8e99fdc4a376" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,881</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c42638e-5c10-4925-adbb-15f378e69838" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">935</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec3d73a0-c659-4ad2-ae99-5813d151c1d8" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,994</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e73368f7-adaf-4d95-8ae2-d1c9bfd5f592" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">52</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expense and other liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d07fe71b-3ba0-4352-97c9-58f5cc687c4c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,532</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49c09683-2d1d-4c47-b527-879b0556c19b" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,853</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c94d482c-dabb-4053-a371-51d583f6131e" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,815</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c9cacb9-f9b9-438a-9813-a37591c7667e" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,885</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6dd01cd-6f12-4d6e-9dcd-722990dc1bdf" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">110,822</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04d23fd0-71d0-4ffa-858b-6f2fdcfb15e2" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">61,358</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41593f20-a40a-48eb-bf2f-e3275eea5307" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,825</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b4f072d-994e-4949-ba50-59f1805b5d81" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,146</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84adc221-c2a1-485a-b469-af544218e5b3" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">241,445</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d8c3ecd-4fcd-4d6c-bac0-fb87b2b5e305" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77,613</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from maturities of marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_291ec103-5217-4602-a4f2-da314a2e5933" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192,657</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1e515c1-5c4b-4eed-bd0b-e2ababedf8dc" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ec4e330-6ed9-49fb-ab24-6768a88fad18" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">52,613</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31bf7c43-fdd5-44ea-8ebb-e77988cd9a7a" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">60,759</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repayment of loan payable, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_993bd262-1881-4d0c-81a2-056601588ff0" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:RepaymentsOfNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,144</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from borrowings under loan agreement, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_737f5deb-dcf8-4e7b-a45e-0e623a4ab832" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ProceedsFromLinesOfCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,457</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuance of common stock, net of offering costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aba31585-ef47-401e-b58d-2cd0686d1656" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,131</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca954d7a-6612-4547-8146-9d9700fed2c9" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,414</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuance of pre-funded warrants, net of offering costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdc1e2b0-08a9-47e0-8b60-a08466add628" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">158,271</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd8b4cf0-3752-43c3-b591-e3f12cd89c0d" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92,318</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock under employee stock purchase plan</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64791f08-868b-434f-9bcb-bf57d3d651dc" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">333</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60c7fcc3-b138-41fb-9514-ec3f530aeb31" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,717</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_992fbadb-5c2d-48c8-aedf-68d626c2dfe3" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">711</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d916140-b81c-4680-8e2e-f9b28bd756ea" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,765</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b471731-a58f-4df2-95c2-4855e30688a5" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">135,443</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net increase in cash, cash equivalents and restricted cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3bd5703-5775-451c-8459-cb4b9227fde2" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,330</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13e1dfa1-d635-4049-8c43-1f464c544ee6" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,326</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and restricted cash - beginning of year</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_033d98b4-c16b-4bad-b9a6-a62bb51a1b88" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138,390</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07e0c670-9609-4b41-beb6-87d503f1d4e3" contextRef="C_67b999bc-f4c8-49b5-89ed-d7a3accc676d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">125,064</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and restricted cash - end of year</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd5f1dc2-fd23-4aa5-89ec-f9f5a050b7d1" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">183,720</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1606b606-028a-41e7-b8f3-aaf81f352a03" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138,390</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Summary of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_703e4b98-e45b-4d04-83a2-ad4eb2bca515" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178,689</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59c7f6e7-d6ef-4e59-970a-2f54cf922512" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133,359</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b4e3cf6-7079-451d-b7dd-36629735f361" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,031</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13ac584e-0f54-40f1-ac12-ccc813973f28" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,031</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents, and restricted cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_752be7f1-fe44-493c-a2ae-6621754105a3" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">183,720</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c81ed050-9363-4308-aade-a997ba888e1b" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138,390</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosure of cash flow information:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for interest</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff6464c5-d805-46d8-867a-42f0b3254d1f" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,881</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2e1d0bc-b761-4d49-a24c-6e41f7572de5" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,002</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosure of non-cash investing and financing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt issuance costs not yet paid</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f32fa429-2afa-462f-8768-e3dda405fb0c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">400</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing costs not yet paid</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c708d10a-7fad-4514-a470-8d6044f82af3" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:FinancingCostsNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">200</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability arising from obtaining right-of-use asset</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a4fac64-fa3b-46ff-99a5-5048db79e1ca" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,133</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aef08a68-578a-4a0c-9dcc-1f7a242afadc" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,214</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of property and equipment in accounts payable and accrued liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_443ffcf4-c2ff-4c51-9d41-bbdafa0a2c1d" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80d895d2-3070-4975-b087-339137eef42c" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">301</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock upon note conversion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de346595-1abe-4b5e-b517-8e7d710a7077" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ConversionOfStockAmountConverted1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,750</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TSCAN THERAPEUTICS, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_consolidatedfinancialstatements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d12ba335-fff9-4638-887b-65faf7bbef65" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. Nature of Business and Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nature of Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc. (the Company) is a biotechnology company that was incorporated in Delaware on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ddc2de20-671b-48e6-964f-30a603d98feb" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="dei:EntityIncorporationDateOfIncorporation" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">April 17, 2018</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and has a principal place of business in Waltham, Massachusetts. The Company is a biopharmaceutical company focused on developing a pipeline of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks, Uncertainties and Going Concern</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks common to companies in the biotechnology industry, including, but not limited to, successful development of technology, obtaining additional funding, protection of proprietary technology, compliance with government regulations, risks of failure of preclinical studies, clinical studies and clinical trials, the need to obtain marketing approval for its product candidates and the ability to successfully market its therapies any products that receive approval, fluctuations in operating results, economic pressure impacting therapeutic pricing, dependence on key personnel, risks associated with changes in technologies, development by competitors of technological innovations and the ability to scale manufacturing to large scale production. Product candidates currently under development will require significant additional research and development efforts, including preclinical and clinical testing and regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel and infrastructure and extensive compliance-reporting capabilities. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from therapy sales.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has primarily funded its operations with proceeds from sales of capital stock, including the IPO completed in July 2021, issuance of convertible debt in September 2022, issuance of term loan in December 2024 and with payments received under its license and collaboration agreements. Since its inception, the Company has incurred recurring losses, including net losses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd657cd2-c301-4b41-a458-4308b4e8caef" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">127.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6cd53e36-319c-4657-af1a-6158b1224e17" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">89.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024, the Company had an accumulated deficit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2039dfa4-ed1a-42c7-be23-422173b45822" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">375.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company expects to continue to generate operating losses in the foreseeable future. The Company expects that its cash and cash equivalents and marketable securities as of December 31, 2024 will be sufficient to fund the Company&#8217;s operations for at least the next twelve months from the date of the issuance of the financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will need to obtain substantial additional funding through equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements in order to fund its research and development and ongoing operating expenses. The Company may not be able to obtain financing on acceptable terms, when needed or at all, and the Company may not be able to enter into collaborations, strategic alliances or licensing arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company&#8217;s stockholders. Any collaborations, strategic alliances or licensing arrangements may require the Company to relinquish rights to certain of its technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to the Company. If the Company is unable to obtain funding, the Company could be forced to delay, limit, reduce or eliminate some or all of its research and development programs, pipeline expansion or future commercialization efforts or grant rights to develop and market product candidates, which could adversely affect its business prospects. Although management will continue to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations when needed or at all.</span></p></ix:nonNumeric></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5e86a856-2828-4b98-9e19-c09143705309" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_5e86a856-2828-4b98-9e19-c09143705309_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_97b7dbad-607a-4f54-8e35-fa7e4c81fd08" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements reflect the operations of the Company and the Company&#8217;s wholly owned subsidiary, TScan Securities Corporation. The accompanying consolidated financial statements have been prepared in conformity with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification, or ASC, and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB.</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5e86a856-2828-4b98-9e19-c09143705309_1" continuedAt="F_5e86a856-2828-4b98-9e19-c09143705309_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1da78fd1-f632-478f-8503-f21894d0f36d" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ConsolidationPolicyTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation.</span></p></ix:nonNumeric></div><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_186a8bd6-5a2b-42f9-b85f-54e7e1566651" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience, known trends and other market-specific or relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5391b744-e82f-458c-bd35-d8a807cfa110" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true" continuedAt="F_5391b744-e82f-458c-bd35-d8a807cfa110_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_5391b744-e82f-458c-bd35-d8a807cfa110_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash includes cash in readily available checking and money market accounts. Cash equivalents include all highly liquid investments maturing within 90 days from the date of purchase. The cash equivalents consisted of money market funds and government securities.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_71059b9e-67cf-4da4-a372-1756217732c1" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Cash</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Company&#8217;s facility lease agreements, the Company is required to provide letters of credit totaling of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e90bd30f-e75d-42a1-b5d0-ec8f5d110a38" contextRef="C_21496e54-0681-4b2a-a747-485e2a96f47c" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of the landlords to serve as security deposits. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the cash securing the letter of credit was classified as restricted cash (non-current) on the consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_98f3e251-6822-40b4-b26f-b2642337628c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:MarketableSecuritiesPolicy" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies all of its marketable securities as available-for-sale based upon its intent with regard to such investments.  Unrealized gains on available-for-sale debt securities are reported as a component of accumulated other comprehensive loss in stockholders&#8217; equity. The amortized cost of debt securities in this category is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in interest and other income, net. Realized gains and losses and declines in value judged to be other than temporary on available-for-sale securities, are included in interest and investment income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest and other income, net. To determine whether an other-than-temporary impairment exists, the Company considers whether it has the ability and intent to hold the investment until a market price recovery, and whether evidence indicating the recoverability of the cost of the investment outweighs evidence to the contrary.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3289e425-2654-479d-86a2-19022e8f7cb1" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ConcentrationRiskCreditRisk" escape="true" continuedAt="F_3289e425-2654-479d-86a2-19022e8f7cb1_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_3289e425-2654-479d-86a2-19022e8f7cb1_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company&#8217;s cash deposits on hand at any one financial institution often exceed federally insured limits. The Company places its cash in financial institutions that management believes to be of high credit quality. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><ix:nonNumeric id="F_d45f6f6c-c63b-4e9b-a47f-64a4d0baff1a" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true" continuedAt="F_d45f6f6c-c63b-4e9b-a47f-64a4d0baff1a_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_64ceefbd-6b10-4396-9451-2db8e48189d8" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the respective assets as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:44%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:55%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated useful life</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_601f5a36-7dca-4b7f-9256-c733422d1140" contextRef="C_8e328758-f2ae-4a01-a2b8-6f6ee7b7ece5" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><ix:nonNumeric id="F_cc3724f2-4d43-4776-8300-1874af4abf69" contextRef="C_3e156d80-5523-4597-bd1f-80a161d4d41c" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_aa64aab3-2df3-479d-bedf-9ac2dba065fd" contextRef="C_fbb18820-4b97-463e-90e8-1723d8fab29c" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><ix:nonNumeric id="F_98638fe0-b0db-46cd-afb7-2d3ea49105ba" contextRef="C_80adfaa9-7e64-4331-ae56-d2faf130122e" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_24816350-e9b7-4f9d-96da-63586983fe99" contextRef="C_7161914d-36e4-4f31-8cd4-0984db2302a0" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><ix:nonNumeric id="F_acea1014-cc40-4150-b270-fc9d7a4dfd9f" contextRef="C_d15727e8-0174-48c5-9477-9969a5d1e3b3" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5 </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_60b8f969-9035-4a0f-8969-52e54fef83fc" contextRef="C_68a5546e-4aca-41b8-aaed-3be56fa94165" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><ix:nonNumeric id="F_aebe2d66-5d35-4c56-8404-754027ac32b4" contextRef="C_03eb41a8-990a-4e35-bb1b-5a37935b24be" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_397b54bf-b523-4a3d-a66b-ad04f717b80a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></span></span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of the asset's estimated useful life or the remaining lease term</span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5e86a856-2828-4b98-9e19-c09143705309_2" continuedAt="F_5e86a856-2828-4b98-9e19-c09143705309_3"><div><ix:continuation id="F_d45f6f6c-c63b-4e9b-a47f-64a4d0baff1a_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major additions and betterments are capitalized; expenditures for repairs and maintenance, which do not improve or extend the life of the respective assets, are charged to operating expense as incurred. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ccaee56e-0a22-4f92-bb66-fc0be47d3836" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Long-lived assets to be held and used, including property and equipment, are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. Evaluation of the recoverability of the asset or asset group is based on an estimate of undiscounted future cash flows resulting from the use of the asset or asset group and its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the asset or asset group, an impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. The Company did not record any impairment losses on long-lived assets during the periods presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a8d4a39f-4ee1-4ec7-9646-d214fbecf95d" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain assets and liabilities are carried at fair value under US GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the user of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">quoted prices for similar assets and liabilities in active markets </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">quoted prices for identical or similar assets or liabilities in markets that are not active </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g., interest rate   and yield curve quotes at commonly quoted intervals) </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inputs that are derived principally from or corroborated by observable market data by correlation or other means </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Unobservable inputs for the assets or liability (i.e., supported by little or no market activity). Level 3 inputs include management&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). </span></div></div></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_786dfb98-11cf-4d41-866f-72027fc56057" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true" continuedAt="F_786dfb98-11cf-4d41-866f-72027fc56057_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records leases under ASU No. 2016-02 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Topic 842) whereby the Company determines if an arrangement is or contains a lease at inception. For leases with a term of 12 months or less, the Company has elected to not recognize a right-of-use asset or lease liability. The Company&#8217;s operating leases are recognized on the consolidated balance sheets as other noncurrent assets, other current liabilities, and other noncurrent liabilities. The Company does not have any finance leases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_786dfb98-11cf-4d41-866f-72027fc56057_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the rate implicit on the Company&#8217;s leases are not readily determinable, the Company uses an estimate of its incremental borrowing rate for secured borrowings with terms similar to the lease term based on the information available at the lease commencement date in determining the present value of lease payments. Operating lease right-of-use assets also include the effect of any lease payments made, including lease payments made in advance of lease commencement and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5e86a856-2828-4b98-9e19-c09143705309_3" continuedAt="F_5e86a856-2828-4b98-9e19-c09143705309_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cd08591e-f715-4414-9b88-1d8e795870a3" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true" continuedAt="F_cd08591e-f715-4414-9b88-1d8e795870a3_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_cd08591e-f715-4414-9b88-1d8e795870a3_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and development costs that are paid in advance of performance (if any) are capitalized as a prepaid expense and amortized over the service period as the services are provided.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0fb8233d-ebed-47ad-9acb-bec1bb94d733" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:AccruedResearchAndManufacturingContractCostsPolicyTextBlock" escape="true" continuedAt="F_0fb8233d-ebed-47ad-9acb-bec1bb94d733_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued Research and Manufacturing Contract Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_0fb8233d-ebed-47ad-9acb-bec1bb94d733_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has entered into various research and development and manufacturing contracts. These agreements are generally cancelable, and related payments are recorded as the corresponding expenses are incurred. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research studies or clinical trials and manufacturing activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#8217;s estimates. The Company&#8217;s historical accrual estimates have not been materially different from the actual costs</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_77db35f1-2d72-4cb1-b719-8a65b143a51d" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:PatentCostsPolicyTextBlock" escape="true" continuedAt="F_77db35f1-2d72-4cb1-b719-8a65b143a51d_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_77db35f1-2d72-4cb1-b719-8a65b143a51d_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><ix:nonNumeric id="F_2941dc8b-fa89-4fc1-a83e-75d6da17a19e" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true" continuedAt="F_2941dc8b-fa89-4fc1-a83e-75d6da17a19e_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for revenue under ASU No. 2014-19, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 606). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, certain collaboration arrangements and financial instruments. ASC 606 provides a five-step framework whereby revenue is recognized when control of promised goods or services is transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify the contract(s) with a customer; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify the performance obligations in the contract; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">determine the transaction price; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iv)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">allocate the transaction price to the performance obligations in the contract; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(v)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recognize revenue when (or as) the performance obligations are satisfied. </span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration that it is entitled to in exchange for the goods or services the Company transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined with other promised goods and services until a distinct combined performance obligation is identified.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company then allocates the transaction price (that is, the amount of consideration the Company expects to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated revenue when (or as) each performance obligation is satisfied. The allocation is based upon standalone selling price. The standalone selling price is the price at which an entity would sell a promised good or service separately to a customer. Because the Company have not sold the same goods or services in our contracts separately to any customers on a standalone basis, the Company estimated the standalone selling price of each performance obligation by taking into consideration internal estimates of research and development personnel needed to perform the research and development services, estimates of expected cash outflows to third parties for services and supplies and typical gross profit margins.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company enters into collaboration and licensing arrangements that are within the scope of ASC 606, under which the Company may exclusively license to third parties&#8217; rights to develop, manufacture and commercialize its product candidates as well as options to acquire additional rights. The terms of these arrangements typically include payment to the Company of one or more of the following: nonrefundable, upfront license fees; development, regulatory and sales milestone payments; and royalties on net sales of licensed products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is typically recognized using a cost-to-cost input model as the measure of progress. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete the Company&#8217;s performance obligations under an arrangement. The Company evaluates the measure of progress each reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5e86a856-2828-4b98-9e19-c09143705309_4" continuedAt="F_5e86a856-2828-4b98-9e19-c09143705309_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2941dc8b-fa89-4fc1-a83e-75d6da17a19e_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">period and, if necessary, adjusts the measure of performance and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts received prior to revenue recognition are recorded as deferred revenue in the balance sheets. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue in the balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion in the balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_11fd80c6-5758-45b2-9054-06503514d972" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" escape="true" continuedAt="F_11fd80c6-5758-45b2-9054-06503514d972_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Customer Options</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_11fd80c6-5758-45b2-9054-06503514d972_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options that are not determined to be material rights are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement. To date, none of our arrangements have included any material rights. The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The observable price of a good or service sold separately provides the best evidence of standalone selling price. However, when standalone selling prices are not readily available, the Company is required to estimate the standalone selling price of each performance obligation. Key assumptions to determine the standalone selling price. Amounts allocated to a material right are not recognized as revenue until the option is exercised or terminates.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af05ca69-23c3-43bb-90b2-3b399f4584e6" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:RevenueMilestonePaymentsPolicyTextBlock" escape="true" continuedAt="F_af05ca69-23c3-43bb-90b2-3b399f4584e6_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Milestone Payments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_af05ca69-23c3-43bb-90b2-3b399f4584e6_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For each arrangement that includes milestone payments upon the achievement of performance-based milestones, such as development and regulatory milestones, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant reversal of revenue would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. Upfront and ongoing development milestones per the Company&#8217;s collaboration and license agreement are not subject to refund if the development activities are not successful. The Company reevaluates the probability of achievement of such milestones and any related constraint at each reporting period, and any adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. To date, the Company has not recognized any milestone revenues.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fd41eb48-dd82-4f4d-8d5d-edcd85b16b63" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:RevenueFromRoyaltiesPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Royalties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license to the Company&#8217;s intellectual property is deemed to be the predominant item to which the royalties relate as it is the primary driver of value, the Company recognizes revenue when the related sales occur in accordance with the sales-based royalty exception. To date, the Company has not recognized any royalty revenue resulting from the Company&#8217;s collaboration and licensing agreements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fbd0bfe3-b8bb-4a7d-b5f8-4179cf6a160b" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true" continuedAt="F_fbd0bfe3-b8bb-4a7d-b5f8-4179cf6a160b_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided to reduce the deferred tax asset to an amount, which, more likely than not, will be realized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_fbd0bfe3-b8bb-4a7d-b5f8-4179cf6a160b_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes the tax benefit from any uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. Interest and penalties associated with uncertain tax positions are recorded as a component of income tax expense. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60b12656-3fc0-465e-80b8-167bb1912bd4" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_4146f26b-0f21-448d-9177-a23615673fc1" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t identified any uncertain tax positions for which reserves would be required.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5e86a856-2828-4b98-9e19-c09143705309_5" continuedAt="F_5e86a856-2828-4b98-9e19-c09143705309_6"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5b91a8fb-2155-487b-b94d-ce1b4cd8cb91" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which discrete information is available for evaluation by the chief operating decision maker, who is the CEO, in deciding how to allocate resources and in assessing performance. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. All of the Company&#8217;s assets are held in the U.S.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d3a6fa60-e7dd-48c7-8943-24ca3dc201b4" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true" continuedAt="F_d3a6fa60-e7dd-48c7-8943-24ca3dc201b4_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for stock option awards at fair value, which is measured using the Black-Scholes option-pricing model. The measurement date is generally the date of grant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes stock-based compensation expense over the requisite service period, which is generally the vesting period of the respective award. For awards that include performance-based vesting conditions, stock-based compensation expense is recognized using the accelerated attribution method when the performance condition is deemed to be probable. The Company accounts for forfeitures as they occur. The Company determines the fair value of restricted stock awards in reference to the fair value of its common stock less any applicable purchase price</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_d3a6fa60-e7dd-48c7-8943-24ca3dc201b4_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#8217;s salary and related costs are classified or in which the award recipient&#8217;s service payments are classified.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_877538bb-9d20-4818-9560-540d32a0c304" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Loss</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive loss includes net loss as well as other changes in stockholders&#8217; equity that result from transactions and economic events other than those with stockholders. The Company&#8217;s only element of other comprehensive income was unrealized gains on marketable securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5acd4b4f-3536-4c0d-95c9-7292e0fe8ca0" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true" continuedAt="F_5acd4b4f-3536-4c0d-95c9-7292e0fe8ca0_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per share is calculated by dividing net loss by the weighted average common shares outstanding during the period.</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_5acd4b4f-3536-4c0d-95c9-7292e0fe8ca0_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Diluted net loss per share is calculated by adjusting weighted average common shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, determined using the treasury-stock and if-converted methods. For purposes of the diluted net income (loss) per share calculation, convertible debt and stock options are considered to be common stock equivalents. All common stock equivalents have been excluded from the calculation of diluted net loss per share as their effect would be anti-dilutive for all periods presented. Therefore, basic and diluted net loss per share were the same for all periods presented.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><ix:nonNumeric id="F_a5f51676-26d4-4be9-8e56-6b3726eb3740" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true" continuedAt="F_a5f51676-26d4-4be9-8e56-6b3726eb3740_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, &#8220;Segment Reporting - Improvements to Reportable Segment Disclosures.&#8221; The ASU requires disclosure of incremental segment information on an annual and interim basis and also requires companies with a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b6b6acc4-5182-4b15-9f8c-8955c5b3abae;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment to provide all disclosures required by this ASU and all existing segment disclosures in Accounting Standard Codification (&#8220;ASC&#8221;) 280, &#8220;Segment Reporting.&#8221; The Company adopted this standard for this fiscal year ended December 31, 2024. The adoption of ASU 2023-07 did not have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements Not Yet Effective</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, &#8220;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#8221; This ASU updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. This ASU is effective for annual periods beginning after December 15, 2024, and is applicable to the Company&#8217;s fiscal year beginning January 1, 2025, with early application permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-04, Debt-Debt with Conversions and Other Options. ASU 2024-04 is intended to clarify requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion. This ASU is effective for all entities for annual reporting periods beginning after</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_5e86a856-2828-4b98-9e19-c09143705309_6"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_a5f51676-26d4-4be9-8e56-6b3726eb3740_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures. ASU 2024-03 is intended to improve disclosures about a public business entity&#8217;s expense and provide more detailed information to investors about the types of expenses in commonly presented expense captions. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></ix:continuation></div></ix:continuation></div>
  <div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_154e5e5d-1919-4231-a0d4-3220fa5f17dc" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true" continuedAt="F_154e5e5d-1919-4231-a0d4-3220fa5f17dc_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e94b3a4d-3670-45de-b4c9-1c458b4932ba" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment consist of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.32%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.52%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9075662d-689f-46f9-b38b-d9176688265f" contextRef="C_76bbc888-71d6-4496-aac8-fb489f0bd98f" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,371</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe4f1978-e61f-45c1-b6e3-debf94ca89f4" contextRef="C_b78729c9-8909-4f4c-9a42-47160fbaf8ff" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,653</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25b68454-60df-47d5-93ab-3866f44656e0" contextRef="C_dd4d0c32-dea8-4923-a9f1-ea5f1fab19f8" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,258</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc9719f4-1473-4372-b724-e77b23e8740c" contextRef="C_ba7a6494-c61e-47ca-8fa7-218c1cdf4d7c" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,159</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddf0a75b-073a-4e08-a946-9195b6060bd6" contextRef="C_b93aece8-a971-452c-bfad-9ca3124815c4" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,721</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93755cef-b436-436c-8b1b-3705668e8e3a" contextRef="C_e687bdb4-a5f4-4929-88c0-7990ae1b71a5" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,519</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1c69a90-5a9f-424e-bc0b-f145fb4d02ed" contextRef="C_c18aa170-88bc-4410-a5a3-854b425c1c5d" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,496</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58d98ee3-f16f-49e0-a149-a684c14f0ac9" contextRef="C_5458543f-e28b-4c69-8779-01decdc01ab6" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,460</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Construction-in-progress</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8343da8-26ae-4ecf-8d48-95e3d4935641" contextRef="C_fbfc4486-e4d3-49f0-973d-16204216ca9a" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e68af088-579c-4ade-8e49-93ac88d1aa31" contextRef="C_8e91d61a-7205-4849-ab44-bbb90d9d7dbc" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">548</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c46e1f6e-a0ad-40dd-afcc-62333fa49e64" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,946</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d5a05f8-ed8b-424d-b92e-66b3ed2f7e3e" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,339</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: accumulated depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c4e3322-3209-4bb4-b64f-e3a41e7e71f7" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,704</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7978653a-e6c0-43fe-9cbe-6bfafb475cbb" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,597</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c29c763-616d-46b6-bc13-d7b658b41f9c" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,242</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d0235ba-7f1f-4128-b0d7-bc19c26caa47" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,742</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_154e5e5d-1919-4231-a0d4-3220fa5f17dc_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation and amortization expense for the years ended December 31, 2024 and 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a88efe9-2da3-4912-95ae-0a5de237611c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52eeb735-a233-4384-b374-cc58993f0395" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div><ix:nonNumeric id="F_e7552f9f-ca34-4a70-9d94-f74dbcc52f58" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:FairValueDisclosuresTextBlock" escape="true" continuedAt="F_e7552f9f-ca34-4a70-9d94-f74dbcc52f58_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e0fd44ce-b371-49fc-9fe6-60d8f9b90289" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables set forth by level, within the fair value hierarchy, the assets carried at fair value (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.38%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair value measurements at December 31, 2024 using:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Active <br/>Markets<br/>(Level 1)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents &#8211; money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5a6ac72-d2ee-4b6b-a7be-c3b6213b1234" contextRef="C_8a10b701-7769-47a2-87ad-7867a7c281c4" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">169,744</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1647326b-7448-4810-9786-f1a31dacc514" contextRef="C_379aeeb9-bc7c-43c4-9634-0092d863e599" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">169,744</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e06d5d21-c11b-4c76-be79-c38a90e8a4bf" contextRef="C_b2dd2d19-d373-450a-b7db-9467c2752ca1" name="us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,421</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f5b84f7-d160-4af6-8715-4bff7ebc712d" contextRef="C_de26ea6d-2d44-490b-b9c4-ac54b2019aaf" name="us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,421</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c3af41f-6979-40c1-b43b-64e97d33b98b" contextRef="C_836b34f7-350d-42ee-8942-99d2e7240d11" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">281,165</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c40d36eb-ad62-4c25-8e30-5ca0c0381a40" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">281,165</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.38%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair value measurements at December 31, 2023 using:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Active <br/>Markets<br/>(Level 1)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents &#8211; money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8379f7eb-7fd7-4188-8212-485c0afbebe3" contextRef="C_2c53342d-2049-4853-81f6-ec35e8e6267f" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,299</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_627d8ef6-a8c6-4b74-af4b-2aeeed48848f" contextRef="C_12bf6ad2-0a5b-44a7-a68c-7aaa96219405" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,299</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents &#8211; government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37274fb3-7f7c-4e48-ba3e-c6670b903fba" contextRef="C_2862a7f8-f1a2-48bd-bc36-db1c53bfedf9" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,483</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f3698ef-520b-424b-be57-dc5ab9f6c99a" contextRef="C_61ed6f0b-459e-4d88-9516-a58d66772426" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,483</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f66e8ac0-5451-41f5-8d34-96ad6c9e9061" contextRef="C_2862a7f8-f1a2-48bd-bc36-db1c53bfedf9" name="us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,685</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b97f928b-c2b7-4bb9-b6b6-cc33ea07ee8d" contextRef="C_61ed6f0b-459e-4d88-9516-a58d66772426" name="us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,685</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad055004-4ad3-4fc7-8de2-5d6b75c2d2bf" contextRef="C_3fda7817-04f6-40d1-b034-58df0d9f5ec2" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">187,467</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af0e0408-466a-4f25-bd69-314c7764c620" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">187,467</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds and government securities are valued by the Company based on quoted market prices, which represent a Level 1 measurement within the fair value hierarchy. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e536919e-d56c-48f7-a6e0-1f99c0133883" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:FairValueAssetLevel1ToLevel2TransfersAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_2de17632-d625-4ef2-9ff4-b20a363c4d66" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:FairValueAssetLevel2ToLevel1TransfersAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_9319856f-8a21-4a30-9c16-5b708ce52cbb" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:FairValueAssetLevel1ToLevel2TransfersAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_44fb260b-48d0-44af-9e66-49662b2abde9" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:FairValueAssetLevel2ToLevel1TransfersAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_5c420671-ed2a-45f8-9814-27c713f06d09" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_b04d5bb4-82a5-46cc-8035-54900b94cd6f" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_90ecca4c-c828-4c29-b9b4-983835613443" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f4eaa188-6abe-4754-9338-fec939bd417e" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> transfers among Level 1, Level 2, or Level 3 categories in the periods presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e7552f9f-ca34-4a70-9d94-f74dbcc52f58_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Assets and Liabilities Not Carried at Fair Value</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's convertible long-term debt was carried at amortized cost. The fair value of the convertible long-term debt was estimated to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33362e5c-b70b-4fd9-b3ba-40e5ccd81c51" contextRef="C_c42f4a3b-18a2-4352-9d50-5db3b2991bb9" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">38.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million at December 31, 2023. Fair value was determined using a convertible bond model using a binomial lattice approach. We classified the fair value disclosures for the long-term debt within level 3 of the fair value hierarchy because the fair value is derived using significant unobservable inputs, which include discount rates and volatility. The Company's convertible long-term debt was extinguished on December 20, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying value of accounts payable and accrued expenses that are reported on the consolidated balance sheets approximate fair value due to the short-term nature of these liabilities. Based on the borrowing rates currently available to the Company for bank loans with similar maturities, the fair value of long-term debt is approximately equal to its carrying amount as of December 31, 2024.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_66fd7856-7ee9-4096-97ac-027d16fc5ee3" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Accrued Expenses and Other Current Liabilities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_11987a5f-b564-447d-ba06-b7e759158594" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" escape="true" continuedAt="F_11987a5f-b564-447d-ba06-b7e759158594_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued employee compensation and benefits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_575c55a7-6147-48a5-8a73-5d902f185521" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,845</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba4c7f67-2255-4b40-912e-c874859e5a49" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,478</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c09636e-defa-4277-b77b-e2d59408b737" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:AccruedResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,735</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6446f5d6-38bf-4ada-8d0a-3b60ab07ce07" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:AccruedResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,537</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued consulting and professional services</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a563910-84c5-40c2-bd2f-5b8cce8161cb" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,473</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4c9ae49-b94c-4549-aa97-8889da8c06f4" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,026</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued legal services and license fee</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fca2ec7-1282-416e-a293-73a0c8c7cbdd" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:AccruedLegalServicesAndLicenseFeeCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">281</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6abab3f-cc69-463a-b9b3-4aa7cd6977ad" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:AccruedLegalServicesAndLicenseFeeCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">250</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48c6c580-0bd3-4816-8ef6-8c883c09b566" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c76e9baf-7d98-4bca-a6b3-aa3ec1e5b011" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">425</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7a3dd75-78f4-4bc4-ac13-25f64b9b6e97" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,410</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e668dce-4a03-464d-b8d1-741ff1224caa" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,716</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <div><ix:continuation id="F_11987a5f-b564-447d-ba06-b7e759158594_1"></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_e9dece03-c80c-4fc4-9fa6-347cf5576b5c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true" continuedAt="F_e9dece03-c80c-4fc4-9fa6-347cf5576b5c_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Stockholders' Equity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ATM Program</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 16, 2023, the Company entered into a sales agreement (the Sales Agreement) with Wedbush Securities, Inc. (Wedbush), as sales agent, pursuant to which the Company could offer, issue and sell up to an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a75f6880-a141-46c3-b288-ee6c308be7ae" contextRef="C_1ae85ee9-048d-4bdf-b70c-933ca1975ec4" name="tcrx:CommonStockSharesReservedForFutureIssuance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">75.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of shares of the Company's voting common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58b10157-6caf-4c64-b876-ae4010eb4dad" contextRef="C_034fde6a-ad94-4842-9909-97bb9d9de862" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (Voting Common Stock), from time to time in &#8220;at-the-market&#8221; (ATM) offerings during the term of the Sales Agreement under a registration statement on Form S-3 (File No. 333-268260) filed with the SEC, which was declared effective on May 16, 2023. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95be894e-2704-4165-aac7-7715e05250b1" contextRef="C_cdeccc8f-9224-4c97-9f7a-3c445b23e58a" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Voting Common Stock has been sold under this Sales Agreement to date.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Offerings</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 1, 2023, the Company completed an underwritten public offering resulting in the issuance and sale of (a) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d0e9a0a-ee5a-4006-a636-56d28dc15fbb" contextRef="C_ed8ad1a6-62b7-4058-824e-b48462749a75" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">23,287,134</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Voting Common Stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ae7742d-4581-4e10-8f73-687e07887bed" contextRef="C_ece742b4-8819-47df-8c84-c8b14935ab7f" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">2.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and (b) pre-funded warrants (Pre-Funded Warrants) to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e0c9f94-2289-484e-87e0-16d63b886052" contextRef="C_be6fc315-0b98-4523-a42d-bcf78bc16296" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">47,010,526</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Voting Common Stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_253d26dd-7947-48a2-b471-84cbe161b59e" contextRef="C_1fd87468-b7a0-44c8-958d-699705148443" name="tcrx:CommonStockPricePerWarrant" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">1.9999</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per warrant with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a34773dd-c6be-49f5-a4ca-a3e7d683ce96" contextRef="C_be6fc315-0b98-4523-a42d-bcf78bc16296" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The Company received aggregate net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f346e8d8-02b4-4958-b8f0-5355f6c0b829" contextRef="C_3d8664d3-d512-4213-ac6c-cd3db870f7c3" name="tcrx:ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">134.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting underwriting discounts, commissions and other offering expenses, with $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2e88959-df9f-4ee2-993c-e4d9c5516d87" contextRef="C_3d8664d3-d512-4213-ac6c-cd3db870f7c3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">42.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million allocated to the Voting Common Stock and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce2d8118-5891-430b-b6a2-6bd425446d85" contextRef="C_3d8664d3-d512-4213-ac6c-cd3db870f7c3" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">92.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million allocated to Pre-Funded Warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 24, 2024, the Company completed an underwritten public offering resulting in the issuance and sale of (a) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_568054a4-6481-40e8-ae74-160532f458f8" contextRef="C_d64f6a5d-5103-4e27-8e28-50297b0314a4" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,958,068</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Voting Common Stock, including the partial exercise of the underwriters&#8217; option to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c9d49ed-2068-4641-9b2d-f7e224a7b9d2" contextRef="C_d64f6a5d-5103-4e27-8e28-50297b0314a4" name="tcrx:UnderwriterOptionToPurchaseNumberOfAdditionalShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,485,487</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of Voting Common Stock, at the closing market price on April 16, 2024, of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0930390c-c180-4189-a99f-ce12bbcafb4f" contextRef="C_874977e6-74c8-4492-baa5-8b92c0c45d13" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">7.13</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and (b) Pre-Funded Warrants to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50c45856-5c39-48ce-a3ad-8e3437db6f07" contextRef="C_69f2d878-b10b-4938-9603-81cf10c7f68a" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">18,577,419</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Voting Common Stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ff75ad8-e317-4b2c-b2c6-90e193c0db9e" contextRef="C_64da7f3d-8b21-4b26-8c42-acd6857d10cc" name="tcrx:CommonStockPricePerWarrant" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">7.1299</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per warrant with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_405d4072-49d2-499d-bc42-52d0f1521ab4" contextRef="C_69f2d878-b10b-4938-9603-81cf10c7f68a" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The Company received aggregate net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1ebb94e-9e5f-45c6-b37c-e7ececbd4acb" contextRef="C_a40cc202-27f4-4dcd-b6c9-0784f4fc3205" name="tcrx:ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">161.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting underwriting discounts, commissions and other offering expenses, with $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40bf579f-67a7-4222-81f2-393d91e73d81" contextRef="C_a40cc202-27f4-4dcd-b6c9-0784f4fc3205" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">33.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million allocated to the Voting Common Stock and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2381b7aa-df89-4bb1-afdb-8f39d9d45066" contextRef="C_a40cc202-27f4-4dcd-b6c9-0784f4fc3205" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">128.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million allocated to Pre-Funded Warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 27, 2024, the Company completed a registered direct offering with an existing investor for the issuance of pre-funded warrants to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1be4e0c-c206-43ca-bd6a-ca51ac08065b" contextRef="C_e646531e-fd6d-4b4a-a38b-4580a5b023cc" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,500,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company's Voting Common Stock, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1f744ce-270f-40d0-9b91-04752c337752" contextRef="C_ce86777f-8d50-4ea4-a1de-67ffd1ad8ce1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per warrant. The pre-funded warrants were issued at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24cbfe0a-f265-420a-abea-938d215adb89" contextRef="C_2a2ebcf4-40ec-47ac-8e0a-274ca41d986c" name="tcrx:CommonStockPricePerWarrant" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per warrant, resulting in gross proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39a9bb06-a8c2-40fc-8d31-6826f716c6de" contextRef="C_f5d697f7-128e-4876-a4f5-90f1a98fe9b1" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, before deducting offering expenses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48b3e0c8-15cb-49ae-8901-ff406631ce78" contextRef="C_f5d697f7-128e-4876-a4f5-90f1a98fe9b1" name="tcrx:WarrantIssuanceCostsOfferingExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pre-Funded Warrants are immediately exercisable subject to certain ownership limitations, have an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_890f704b-30d2-4056-a106-0a833ca4f843" contextRef="C_c3b11d96-c0b1-4481-9a60-4395a254fe3f" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">share, may be exercised at any time and do not expire. The Pre-Funded Warrants were determined to be equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e9dece03-c80c-4fc4-9fa6-347cf5576b5c_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">addition, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Pre-Funded Warrants do not provide any guarantee of value or return. As such, proceeds received from the issuance from the Pre-Funded Warrants were recorded as a component of stockholders&#8217; equity within additional paid-in capital. As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a959db65-76b7-431a-b11e-0b8404525ee5" contextRef="C_6c96b539-1a31-47e8-94ff-6a44016523a3" name="tcrx:ClassOfStockWarrantsExercised" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants have been exercised.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_4bc1e304-dadf-4bc1-be39-839cd2234acb" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_4bc1e304-dadf-4bc1-be39-839cd2234acb_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2021 Equity Incentive Plan</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Equity Incentive Plan (the 2021 Plan) was approved by the Company&#8217;s Board on April 22, 2021 and became effective immediately, although </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15640ac2-1a71-415f-97ce-b23501fa8356" contextRef="C_1d992a94-aafd-45cd-b390-139470ececc8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> awards were permitted to be granted under the 2021 Plan until July 15, 2021. The 2021 Plan replaced the 2018 Plan, however, awards outstanding under the 2018 Plan continue to be go</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">verned by their existing terms. In addition, shares of common stock subject to awards granted under the 2018 Plan that cease to be subject to such awards by forfeiture or otherwise after the termination of the 2018 Plan will be available for issuance under the 2021 Plan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59d7aed1-80ba-4fea-a68d-15f8c8ba6e99" contextRef="C_4a97a8a0-1e04-4ff3-a4c3-35e097fb1306" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,278,048</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock initially reserved for issuance under the 2021 Plan and as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d54341bd-e29d-432e-a5df-2843cbe2ab20" contextRef="C_3ffa6fa9-6b57-4d35-bd3a-b88d3505d57f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,781,492</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> sh</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ares of common stock available for issuance. The number of shares reserved for issuance under the 2021 Plan will be increased automatically on the first business day of each fiscal year, commencing in 2022 and ending in 2031. The aggregate number of common shares that may be issued under the 2021 Plan shall automatically increase by a number equal to the least of (a) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfa905c3-1ba8-4a22-86b6-258d0e9f7643" contextRef="C_ecf6ccb4-e42d-49a5-88f5-a3479b52cfb1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="INF">4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the number of the total outstanding common shares on the last day of the preceding fiscal year, or (b) a number of shares common stock determined by the Company&#8217;s Board.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2021 Employee Stock Purchase Plan</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Employee Stock Purchase Plan (the "2021 ESPP") was approved by the Company&#8217;s Board on April 22, 2021 and became effective immediately, although </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_920de4a4-ab5c-417d-8920-b89509f21d7f" contextRef="C_8e8d9511-84eb-4a2f-b5e9-8f63d38450b0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> awards were permitted to be granted under the 2021 Plan until July 15, 2021. A total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c819bab9-c447-4882-b334-6332e0f97e28" contextRef="C_653bc1a9-0ec3-4132-946f-23cdbffd6e8c" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">254,390</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock were initially reserved for issuance under the 2021 ESPP. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7209f33-bfc7-4fc5-a1d2-687734ebc8ad" contextRef="C_261fba08-f9db-48e2-b812-47707c7e98ab" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">228,533</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29d9a0fb-ed71-4cfe-a2d5-d3eb183b8ba0" contextRef="C_4c8ea6f2-9fff-4333-984a-67566fab4877" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">146,380</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued under the 2021 ESPP, respectively. As of December 31, 2024, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dda8b339-52bb-455f-88f6-b5bceff9bafb" contextRef="C_b699eca8-c73b-466a-b522-9fe9e9a9ad35" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">985,486</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock available for issuance under the 2021 ESPP.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The number of shares reserved for issuance will automatically be increased on the first business day of each fiscal year, commencing on January 1, 2022 and ending on January 1, 2041. The aggregate number of shares of common stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the least of (i) one percent (</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d4e8937-d198-4bd8-b8dd-9c491c174aa8" contextRef="C_80888537-091b-4982-a3a1-aa3b6067c04e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%) of the total number of shares of common stock actually issued and outstanding on the last day of the preceding fiscal year, or (ii) a number of shares of common stock determined by the Company&#8217;s Board.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Compensation</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_efdebbe5-b88c-41be-8343-2513819e4311" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense related to stock options and the stock purchase plan for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023 was classified in the consolidated statement of operations as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41527c88-d6f7-46a8-b603-e65daafbff0d" contextRef="C_b5d97542-6fb5-42e4-a0c9-e6757cce391a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,846</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcf5b5ac-dca7-4723-9bd8-75e04eefd2ea" contextRef="C_ed51e302-8869-4a0f-962b-de9484e3aa0c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,876</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68fee488-d77c-4149-946c-ec6cb53da657" contextRef="C_21f58568-ecea-492b-a352-08d9e9a7f42b" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,703</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0bbb16ce-d6e2-4859-98b8-01e4c91c40fb" contextRef="C_e4bef360-1194-4876-bd72-1ba957b48289" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,332</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93d9cc18-d706-405f-bbed-08369ad97bc2" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,549</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f09f5232-214c-4d67-a449-bc46cd575bd8" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,208</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Options</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company typically grants stock options at exercise prices deemed by the Board to be equal to the fair value of the common stock at the time of grant, based upon the quoted price of the Company&#8217;s common stock.
</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock option grants is estimated using the Black-Scholes option-pricing model. The Company lacks sufficient company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. For options with service-based vesting conditions, the expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3030714-e52e-498b-adce-7a72deae6f99" contextRef="C_95966560-3a74-4921-9ee9-1cddcc96757d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t expect to pay any cash dividends in the foreseeable future.
</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:12pt;font-family:Times New Roman;"><ix:continuation id="F_4bc1e304-dadf-4bc1-be39-839cd2234acb_1"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_539af728-f58d-40f0-af73-dab97b5dd778" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The weighted-average for each of the assumptions the Company used to determine the grant-date fair value of options granted were as follows</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.12%;box-sizing:content-box;"/>
        <td style="width:1.1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.34%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.34%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk free interest rate</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a960c7e7-a8cd-4d26-9d47-842eed2eb1dd" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.03</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e99b5fcb-3d2b-4678-9da3-ca19744d8446" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.95</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_0477b96e-6d0a-4b4a-bc59-3002a8d6ac79" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.19</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_f26be8b3-3185-4cba-9ae0-0dc082a38e77" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.36</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65088a65-d178-493b-8195-a5a42e154c6f" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5b45549-6f56-43f2-8472-2a027a0b40e5" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility of underlying common stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4c4e4b3-4492-426d-9570-34fdb1c56814" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">89</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6f1695e-45bd-4225-8461-36e65380f466" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">87</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c660d426-3f8c-4149-93ab-23d177d3857c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the stock option a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ctivity:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.4%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.664%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.844000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.664%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stock<br/>Options</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Life <br/>(in Years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intrinsic<br/>Value<br/>(in<br/>thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding January 1, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb165a40-652e-4c60-9c2d-f53fcb4d2c1d" contextRef="C_66e41251-c3d9-4ef4-96d0-e6b667f2d454" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,398,250</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4c1490b-f845-4b30-8c8b-532c3ea6b579" contextRef="C_66e41251-c3d9-4ef4-96d0-e6b667f2d454" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">3.34</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_ac1f438a-31b3-4cfa-89fd-09f11d3786d4" contextRef="C_320b3a46-ac25-4647-8016-94baaf69c8d5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.87</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc3c59d2-c72e-4651-aaab-47646f03d735" contextRef="C_66e41251-c3d9-4ef4-96d0-e6b667f2d454" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,278</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb18ef9a-6a63-459c-ac89-ce8fe99b3c85" contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,501,849</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90f3fbcc-a57a-493e-a991-342d9c667317" contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">6.45</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e86d6f5d-0aa2-4780-925c-e03a56c84f90" contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">586,081</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74cf9bfa-341a-495e-bfb3-266cc128a0d2" contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.93</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Canceled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9767b13-600f-476f-a5ca-4d37f9d92fd1" contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">846,236</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1e4bdfd-a965-4d21-9db0-a2feb2f61994" contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.52</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7680127c-cee3-4154-8a6d-3d27d674f476" contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,467,782</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd28cea1-9830-422d-bcef-ab16c3e73157" contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.22</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_d4ea92eb-e275-4954-83c9-bdedb142b6e2" contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.29</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f479241-aa4c-4ef7-8c33-c54c61fcc29d" contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,912</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options vested or expected to vest as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5e45895-b69d-4278-a848-4875fa3fcb37" contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,467,782</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cfcfc43-85ea-4921-99f1-815813752486" contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.22</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_a95bb862-c3d7-4170-9fc5-3d6468b4b54f" contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.29</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1ca3d25-9a6d-458c-b0e0-a0f7b415b47a" contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,912</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options exercisable as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ec57431-13f6-4963-80c2-203b6fc066fc" contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,463,893</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6233b83-18f4-477e-9427-2b8e81a21eb7" contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.20</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_3c345294-ea6a-45ea-a812-2db435286549" contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.32</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_caee9bfc-d6e6-476a-90a1-e8c7ca6a7c72" contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,116</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_664c8319-ad82-46ad-be9f-d9836f6f92dc" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other information related to the option activity for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average fair value of options granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98776686-4433-418d-abb3-fb5371792aff" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">4.90</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b945b12-b108-49aa-bdae-de966f3135cf" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.17</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intrinsic value of options exercised (in thousands)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b621849-e43c-43f2-a297-ac4cb2d230cc" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,954</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54398381-d65c-47c8-99b8-a8b4055c2eee" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">152</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the unrecognized compensation cost related to outstanding options was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03e62083-67fb-4e09-a4c9-875d56bf5bd9" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">24.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d562f89c-5c29-4f06-8832-d3577117cdbc" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.66</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_ecf99d0d-67fe-464a-bdee-d5b9ca4c387c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_ecf99d0d-67fe-464a-bdee-d5b9ca4c387c_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, the Company did not record an income tax provision due to the losses incurred and a full valuation allowance provided on the net deferred tax assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c6eb08ce-20fd-407d-a0ae-7620cd5a5c23" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the federal statutory income tax rate to the effective tax rate is as follows</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.96%;box-sizing:content-box;"/>
        <td style="width:9.7%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.620000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.04%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.68%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Taxes at U.S. statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cbaaa4c5-029d-4621-a974-3aaf455db881" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">21.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_557e1657-cd24-4979-908f-5a48e9c03311" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">21.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Changes from statutory rate:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State taxes, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d522e8c0-75ab-476b-857b-56537df91339" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cec6fe13-5eec-4f60-ad7b-8762f6cc8b9a" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">8.5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0116800-9a16-47f3-9ff2-7a1d5c68c025" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42ab320e-c2b1-4166-9521-8f04b9fa6012" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">5.4</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e04933ca-cb26-42ec-81bf-434fbb186cc0" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">0.9</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ddc581a-2d88-44f1-a7ac-8afc762fbd19" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6254ede8-807c-4a2e-bdb7-2ac267027f62" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">30.9</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_018a3a6e-ae54-4270-8a63-104b57c65ac2" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">34.1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9aa9300-9622-4c30-8ab9-34896a50bf5a" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">1.7</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d7f4879-94f1-4a4c-a567-ef89e5980195" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effective income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0907587-cfca-4bfc-b120-f49f35d0163a" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99437632-6c2a-40a3-9022-74dbafc54927" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_ecf99d0d-67fe-464a-bdee-d5b9ca4c387c_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred tax assets and liabilities reflect the net tax effects of net operating loss carryovers and temporary differences between the carrying amount of assets and liabilities for financial reporting and the amounts used for income tax purposes. </span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_389400ee-c991-4b9c-b8af-d844e1821524" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_389400ee-c991-4b9c-b8af-d844e1821524_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities were as follows (in thousands): </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:continuation id="F_389400ee-c991-4b9c-b8af-d844e1821524_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.946%;box-sizing:content-box;"/>
        <td style="width:10.178%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.138%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.52%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.218999999999999%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a4b370e-aeac-4c64-9e64-7f2abdc3d7c7" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,332</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb9b5d3f-1ccc-4f93-8c98-95f615762dcd" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,201</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87d955d4-252f-41b2-b42f-5b55cf33cbe4" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,427</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b436c568-a7d3-4adf-93c6-0cbf8a00c953" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,939</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f97c0896-5475-4c31-b2a2-7c394157a9cc" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DeferredTaxAssetsDeferredIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,536</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_988fc336-28a3-4158-a41b-36ff6951ddcc" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DeferredTaxAssetsDeferredIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,305</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f299419-9862-4c99-aaf4-c2f956a00811" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:DeferredTaxAssetsDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,216</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e25c78cb-546f-4b0b-9a61-11aa932ae79d" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:DeferredTaxAssetsDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,159</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f7da7ca-db08-4b09-a921-eac43e7b3341" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:DeferredTaxAssetsAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">432</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bfd8cf76-e085-461f-911f-f753253c070d" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:DeferredTaxAssetsAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">479</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36268737-f129-45b6-8158-2748b35aebb5" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,681</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de111f0b-cdf7-40fc-acde-9d24cbce8b11" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,126</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold liability</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f77abe67-3702-474c-8db4-61c3a28c9b6a" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:DeferredTaxAssetsLeaseholdLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,842</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a15358b6-fccf-4949-a7b4-4e8430e2a378" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:DeferredTaxAssetsLeaseholdLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,044</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized R&amp;D costs</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29a90439-1b3f-45d6-9840-70195ff445e8" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,315</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d13346e-becf-4712-80b8-139e6998c5c3" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,515</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d16898f7-ade3-4c85-8396-f034d5dbad70" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,391</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2239bb3d-3092-4347-b373-bdb51cb67cb6" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,824</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4698c0bb-7971-4bce-ac06-ff697c2be5a8" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">139,172</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_646498d2-b52f-4fc5-86b9-901b5dbf22e4" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">99,592</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right of use Asset</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c00336d2-48c8-406a-905d-b25fc4eab9ce" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:DeferredTaxLiabilitiesRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,582</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2d4a851-1bd8-450e-9459-959c34c7284d" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:DeferredTaxLiabilitiesRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,346</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73bffae2-1b73-4a67-84f5-cb90ad66bdeb" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">121,590</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c75f980-9203-426d-ad86-a127843b3ddf" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82,246</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net deferred tax assets and liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the need for a valuation allowance, the Company has given consideration to its cumulative book income and loss positions. The Company has assessed the available means of recovering deferred tax assets, including the ability to carryback net operating losses, the existence of reversing taxable temporary differences, the availability of tax planning strategies and forecasted future taxable income. As of December 31, 2024, the Company maintains a full valuation allowance against its net deferred tax assets. The valuation allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42a650f2-437e-4aa2-8e89-8e42872eca94" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">39.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d43bae6-b8a3-4078-8923-631ea01cc729" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the years ended December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company had U.S. federal net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07bbc537-b09a-494a-940f-0ef9a85ec635" contextRef="C_bf7b2383-6668-4795-a6b0-55806e641321" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">113.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The U.S. federal net operating losses have an indefinite life carryforward. As of December 31, 2024, the Company had Massachusetts net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac2533a5-738a-4d72-99e8-4dd935ab47f0" contextRef="C_48705e18-c435-4ea3-8f65-3174ccb08c15" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">118.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million that expire at various dates through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cfb29f46-8053-4c86-8993-7afca732fd6f" contextRef="C_68816447-84c0-44e4-a1c7-b78689002f3a" name="tcrx:OperatingLossCarryForwardsExpirationYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2043</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company had U.S. R&amp;D federal credit carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_506709bb-0a4e-4299-afe0-d9e949ed8bc5" contextRef="C_fdf71ac3-3b5b-4e4e-9f5b-32fe46c5a168" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">17.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million that expire at various dates through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fe097440-8826-45df-a99d-c9210802b191" contextRef="C_83a90602-679a-44dc-a030-989afce6a82d" name="tcrx:TaxCreditCarryforwardExpirationYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2043</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company had U.S. state R&amp;D tax credit carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_989c3e46-2220-4273-b263-2cbe5580e9ca" contextRef="C_af039233-7db2-4aeb-8cc9-c9ea8e5f25e3" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million that expire at various dates through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_75e8acbc-b230-4053-8d1b-3723d73c9d36" contextRef="C_b0702c7d-48d2-4169-904c-8f9b8552db95" name="tcrx:TaxCreditCarryforwardExpirationYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2038</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under Sections 382 and 383 of the U.S. Internal Revenue Code, if a corporation undergoes an ownership change, the corporation's ability to use its pre-change net operating loss carryforwards and other pre-change attributes, such as net operating losses and research tax credits, to offset its post-change income and taxes may be limited. In general, an ownership change generally occurs if there is a cumulative change in ownership by 5% stockholders that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under U.S. state tax laws. The Company has experienced an ownership change in the past and may experience ownership changes in the future as a result of future transactions in its share capital, some of which may be outside the control of the Company. As a result, if the Company earns net taxable income, its ability to use its pre-change net operating loss carryforwards, or other pre-change tax attributes, to offset U.S. federal and state taxable income and taxes is subject to significant limitations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounted for uncertain tax positions using a more likely than not threshold for recognizing and resolving uncertain tax positions. The evaluation of uncertain tax positions is based on factors that include, but are not limited to, changes in tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, new audit activity and changes in facts or circumstances related to a tax position. The Company evaluates uncertain tax positions on an annual basis and adjusts the level of the liability to reflect any subsequent changes in the relevant facts surrounding the uncertain positions. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes. For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_506215bc-7dea-4e28-85f3-a9e052f6a454" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_872dc3cc-c3ff-47c9-a32e-df90b88bb7d1" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued interest or penalties in the consolidated statements of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to taxation for federal and Massachusetts purposes. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_40e7a8e5-8618-4f69-b02c-a1c73f1cf55c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:IncomeTaxExaminationDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company is subject to examination by these taxing authorities for all years since inception. </span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_e6715c07-b2b1-437c-9774-78b75be24f65" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:CollaborativeAndLicenseArrangementDisclosureTextBlock" escape="true" continuedAt="F_e6715c07-b2b1-437c-9774-78b75be24f65_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. Collaboration and License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Amgen</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9b522a76-e5be-472d-b4a9-5cbd095266fd" contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009" name="tcrx:LicenseAgreementDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">May 8, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company entered into a Collaboration Agreement with Amgen Inc. (the Amgen Agreement) to identify antigens recognized by T cells in patients with Crohn&#8217;s disease in accordance with a research plan. Under the terms of the Amgen Agreement, Amgen will retain all global development and commercialization rights. The proceeds from the Amgen Agreements included an upfront payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb54eac8-0249-4044-94cf-32c04086edc5" contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009" name="tcrx:LicenseUpfrontPaymentReceivable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which was collected in July 2023. In addition, the Company is eligible to earn success-based milestone payments of over $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_868a63c2-8b12-46f2-a6b9-18da925561df" contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009" name="tcrx:PotentialMilestonePayment" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">500</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, based upon the achievement of certain clinical development and commercial milestones, as well as tiered single-digit royalty payments on net sales of products developed from the collaboration, subject to reductions set forth in the Amgen Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that Amgen meets the definition of a customer, as the Company is delivering research and development activities and a license of intellectual property. The Company identified performance obligations for research and development activities, the license, data reporting and participation in joint steering and research committees, which were determined to be a single combined performance obligation due to the services and licenses being highly interrelated.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For a certain time period during the term of the Amgen Agreement, Amgen has an option to add targets to the collaboration for payments specified in the agreement. Pursuant to the Amgen Agreement, the option for Amgen to select additional targets and to license, develop, and commercialize targets is not a performance obligation at the outset as these are customer options that do not represent material rights.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company looked to the promises in the arrangement to determine the method of recognition that best depicted the transfer of the services and the satisfaction of the combined performance obligations. The Company concluded that the performance of the research services over the expected research term was the predominant promise within the performance obligation. The Company will recognize the revenue associated with the performance obligation using an input method. The method of measuring progress towards delivery of the services incorporates actual internal and external costs incurred, relative to total internal and external costs expected to be incurred to satisfy the performance obligation. Changes in estimates of total internal and external costs expected to be incurred are recognized in the period of change as a cumulative catch-up adjustment. As costs are incurred, the Company will recognized revenue over time. At this time, it is estimated that the research term will be approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_61b8c938-cb83-46b0-8c50-67a54fa2b4bd" contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009" name="tcrx:ExpectsResearchTerm" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determined the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ec23798-2c54-4577-b970-18d223372e3a" contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009" name="tcrx:LicenseUpfrontPaymentReceivable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upfront payment to be the entirety of the consideration to be included in the transaction price. The option to add additional targets was not included in the transaction price as this option was assessed to be improbable at this time. The potential milestone and royalty payments that the Company is eligible to receive were also excluded from the transaction price, as all milestone and royalty amounts were fully constrained based on the assessed probability of achievement. The Company will continue to assess the probability of the option to add additional targets and the probability of milestone achievement throughout the research term and will adjust the consideration in the contract accordingly.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024 and 2023 the Company recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c1fcb7a-a42b-4fa8-8191-4e5f88824838" contextRef="C_3df7ac2b-49aa-499b-bf47-812e00e80ff4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d61b433f-5bed-47b0-8854-236ea001bd51" contextRef="C_523e5640-f362-49dd-8cd8-0a9f19fa77ed" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">14.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, of revenue associated with the Amgen Agreement. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06ac194c-4aa6-4ea1-8a60-dff18e67d6c2" contextRef="C_2094de61-2463-4b5a-b0a4-fca50236ad0a" name="us-gaap:DeferredRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of deferred revenue, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6da7fa0d-1883-4c51-8d3a-08fa01e03db5" contextRef="C_2094de61-2463-4b5a-b0a4-fca50236ad0a" name="us-gaap:DeferredRevenueNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is classified as long-term.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Novartis</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_cbe52327-d80a-4329-8a4a-2b886fa94469;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2020</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company entered into a Collaboration and License Agreement (the Novartis Agreement) with Novartis Institutes For BioMedical Research, Inc. (Novartis) to collaborate on their research efforts to discover and develop novel TCR-T therapies. At the inception date of the Novartis Agreement, Novartis or its affiliates held an ownership interest of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d10930f-0490-4f92-8fef-f53eb13584d5" contextRef="C_d5ad2e31-c21e-4c2b-89a1-288c3b0bea88" name="us-gaap:MinorityInterestOwnershipPercentageByParent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% in the Company, and at December 31, 2024 and 2023, Novartis held less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23a1ca3f-8af5-4a9e-b1f3-75709b253e2e" contextRef="C_ed36ab97-8daf-4e07-80c2-c1cddcb96e73" name="us-gaap:MinorityInterestOwnershipPercentageByParent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_440eb794-0fdd-4c9e-960f-ed2f0c34d2be" contextRef="C_46be3025-25e5-4ca5-aecb-96f1a7b4e50d" name="us-gaap:MinorityInterestOwnershipPercentageByParent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the common shares outstanding. Under the Novartis Agreement, the Company was to identify and characterize TCRs in accordance with a research plan, and transfer data arising from the research plan. The Novartis Agreement provided for payments of an upfront fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45946ce9-75d1-432a-a5aa-8fef5f332460" contextRef="C_15c7b52a-5ecb-4134-84b7-1a74eee635a3" name="tcrx:LicenseUpfrontPaymentReceivable" unitRef="U_USD" scale="6" decimals="-5">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, research funding totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f30cff2-4021-43bf-8c3d-021fd18d20b6" contextRef="C_c337686d-fa86-4eb8-97bb-fc4b534480c7" name="tcrx:LicenseUpfrontPaymentReceived" unitRef="U_USD" scale="6" decimals="-5">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and potential milestone payments contingent on clinical, regulatory and sales success.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that the performance of the research services was the predominant performance obligation and was recognizing the revenue associated with the performance obligation using the input method, according to the actual costs incurred as a percentage of total expected costs to complete the research services.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determined that the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5af2bfd6-7935-49f2-9e08-5af6ff0f7cfa" contextRef="C_1f54b526-5c78-40d4-b51e-3bb57d254eee" name="tcrx:LicenseUpfrontPaymentReceivable" unitRef="U_USD" scale="6" decimals="-5">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upfront payment, together with the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0237d27e-0d50-40fb-81a6-3b598f39a09d" contextRef="C_c337686d-fa86-4eb8-97bb-fc4b534480c7" name="tcrx:LicenseUpfrontPaymentReceived" unitRef="U_USD" scale="6" decimals="-5">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of estimated research costs to be reimbursed by Novartis to be the entirety of the consideration to be included in the transaction price as of the outset of the arrangement. The potential milestone payments that the Company is eligible to receive were excluded from the transaction price, as all milestone amounts were fully constrained based on the assessed probability of achievement.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e6715c07-b2b1-437c-9774-78b75be24f65_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 202</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3 the Company recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4315028-b41a-4509-bbe4-b7c55d474b64" contextRef="C_f9a562f2-21ee-4a9b-a421-f3871446c2f8" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of revenue associated with the Novartis Agreement, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19ba24f4-372c-4a0b-9408-16da51fedb41" contextRef="C_f9a562f2-21ee-4a9b-a421-f3871446c2f8" name="tcrx:ReimbursementCost" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million r</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">elated to cost reimbursements under the Novartis Agreement that offset costs incurred within research and development expenses in the statements of operations. The research term ended in March 2023.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_4d89a9dc-8cdd-4609-ab88-3ded2a9630bd" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_4d89a9dc-8cdd-4609-ab88-3ded2a9630bd_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfaf0241-9067-4064-a4ac-0459d34f26e8" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:NumberOfLeasesFacilities" unitRef="U_Facility" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> facilities at 880 Winter Street and 830 Winter Street in Waltham, Massachusetts. Each lease has specified terms and includes renewal options. Given uncertainty as to the Company's intentions with respect to these leases, the renewal options were not deemed reasonably certain.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:nonNumeric id="F_c8e873d6-7e7c-4bd7-a347-df8babe44ba5" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:LessorOperatingLeaseDescription" continuedAt="F_c8e873d6-7e7c-4bd7-a347-df8babe44ba5_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 8, 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> entered into a lease amendment extending the expiration date of the 830 Winter Street Lease from </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_84fc213e-3ebb-419d-b635-db506c4729ff" contextRef="C_34b3c74f-add1-4a1b-b372-3aa22b07f70c" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 30, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_749a9336-cfa3-4abb-8c89-f7775ab0eb46" contextRef="C_332482d9-8141-410d-8864-204366a2aed0" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 31, 2029</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and provides for one option to renew the 830 Winter Street Lease for a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1d68bc2f-4ca1-4ab9-8c4c-5c7a42cfde95" contextRef="C_5dc478f0-33ed-4f00-97fe-edffa3ee70cb" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period commencing on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f4187b9b-74ef-4f54-8d2e-4e6bbeac2b4f" contextRef="C_5fce13ba-5c69-4650-bed4-a3ea2c8f6f3e" name="tcrx:LesseeOperatingLeaseCommencingDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 1, 2029</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, resulting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in an increase in the lease liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_121c7574-19a4-4e91-82a9-daacf9ca6046" contextRef="C_5dc478f0-33ed-4f00-97fe-edffa3ee70cb" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_c8e873d6-7e7c-4bd7-a347-df8babe44ba5_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 28, 2024, the Company entered into a second lease amendment expanding the rentable space of 830 Winter Street. The amendment provides for an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef8abf03-6be9-40e9-8e02-6c4dfc3c9cc4" contextRef="C_af892904-1677-4b5c-bfa4-d77070df30ae" name="tcrx:LeaseSpaceForFacility" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">25,628</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of space with a commencement date of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c6b34091-2a76-40e7-a058-c2bd8e023b48" contextRef="C_e012286d-5a3c-48f3-9f8b-f6f2434cc024" name="tcrx:LesseeOperatingLeaseCommencingDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 1, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and an expiration date of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_edf2aa2a-f614-461f-98f9-6103c5dd5e86" contextRef="C_e012286d-5a3c-48f3-9f8b-f6f2434cc024" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 31, 2029</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with one option to review for a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d9e8a6d-1373-48b0-b34c-81c3f2fc26a0" contextRef="C_af892904-1677-4b5c-bfa4-d77070df30ae" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period. This amendment resulted in an increase in the lease liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9bf9f74-e719-4228-886d-f66012d5b235" contextRef="C_af892904-1677-4b5c-bfa4-d77070df30ae" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary of lease cost</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e1820cbd-4279-42e3-9d4a-96b4f390420c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="tcrx:SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the presentation in the Company's consolidated balance sheets of its operating leases (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.842%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.842%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f4c5a5b-286f-40a1-af34-58c01c02f429" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,357</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3bafaf3a-1fc1-4c0b-8917-7564bc8541da" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,492</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, current</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3ff564d-5ff2-4067-9eea-11e2a0784354" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,570</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7153afdd-3fd6-45b6-93a0-8f2028e2dd5e" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,246</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82393441-e546-4ef9-b7db-2aae1316d62e" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,739</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ff906d4-60a2-4889-8174-8b58087f8911" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,140</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21869b90-91cb-4a77-83cd-66e3a1ef5043" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,309</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a845928-4af8-46e2-aaad-17b82bbeac92" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,386</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_74845fbf-b6dc-4b78-ba11-cee4414dbfc0" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the effect of lease costs in the Company's consolidated statement of operations (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.843%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aee6347c-b8a9-4895-afec-5b2b8ca22656" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,564</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de6f09b5-8a6a-45cb-8d86-d2b05280fe6c" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,626</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5e187d2-f10f-454f-b0af-56440ea731b6" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:ShortTermLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12c0e380-b4ac-45db-85ed-619289760f72" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,408</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_118ad7a0-360b-4979-b831-c75ff00b099e" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,120</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b05eb00d-0c56-42b3-b59a-f542f1c782ae" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,972</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55b2451e-5dae-4712-b530-ef75a9c4abe6" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,790</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, the Company made cash payments for operating leases of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7cfe531b-e2bf-4afe-84b2-712f33f3dd17" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c348a86-5986-4e43-9d34-a0e88829e419" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4d89a9dc-8cdd-4609-ab88-3ded2a9630bd_1"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bd611a15-74e7-4e88-9941-36056f54d6c4" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future payments of operating lease liabilities are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"/>
        <td style="width:1.8%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.757%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4bc51460-f9b1-4418-b4ec-00fcd9fc8d47" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,089</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1410bc6b-fbd8-4d5f-bac8-6cf0611779a2" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,958</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25fd8c65-523c-4dab-b3c0-f9115e4a83d0" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,329</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44211f7f-6a28-4816-be44-abbd2598d5ff" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,712</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029 and thereafter</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83f199da-1974-4453-b1aa-4c909b4c1b7b" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,994</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total future payments of operating lease liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1562cfd-b285-45fe-87b5-18f06d7f40be" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94,082</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cfb37dd-9e78-49d4-b75c-590f974d1910" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,773</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of operating lease liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3730a8a0-ae13-4e72-a1f8-d9b27563c67f" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,309</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the weighted average remaining lease term was </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f0bb82bb-0dd7-4356-b3ee-f7fd4edb265c" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and the weighted average incremental borrowing rate used to determine the operating lease liability was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f10b9f90-f5d8-4b20-888c-88e0f4903428" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of December 31, 2023, the weighted average remaining lease term was </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3a45c242-a720-444b-9020-044b0b42ca73" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8.6</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and the weighted average incremental borrowing rate used to determine the operating lease liability was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a81556c-3344-4d7b-8f7f-05e8962bb15b" contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d" name="tcrx:OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">10.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Brigham and Women&#8217;s License Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company obtained the worldwide exclusive license to its foundational technology from The Brigham and Women&#8217;s Hospital, Inc. (or BWH). The license, as amended, grants worldwide exclusive use to the patent underlying the TargetScan technology in exchange for fees including development milestones and various royalties on product sales should they occur in the future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Royalty Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2018, the Company amended and restated an existing royalty agreement with one of its founders. Under the amended and restated royalty agreement, the Company agreed to pay the founder an aggregate royalty of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ab378b8-2634-4992-aadf-118a8754f85e" contextRef="C_3d025609-eb03-453e-8fb0-40e7424de1c0" name="tcrx:PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold" unitRef="U_pure" scale="-2" decimals="2">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of net sales of any product sold by the Company or by any of its direct or indirect licensees for use in the treatment of any disease or disorder covered by a pending patent application or issued patent held or controlled by the Company as of the last date that the founder was providing services to the Company as a director or consultant under a written agreement in perpetuity. Royalties are payable with respect to each applicable product for a defined period of time set forth in the royalty agreement. The founder assigned his rights and obligations under the royalty agreement to one of his affiliated entities in January 2021.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_b6d7bc37-d2e2-47fb-ab5f-2a32a675a7c2" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:DebtDisclosureTextBlock" escape="true" continuedAt="F_b6d7bc37-d2e2-47fb-ab5f-2a32a675a7c2_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. Loan and Security Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">K2 HealthVentures LLC</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 9, 2022 (the Closing Date), the Company entered into a Loan and Security Agreement (the Loan Agreement) with K2 HealthVentures LLC (K2HV), pursuant to which convertible term loans in an aggregate principal amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e38b679-bf5c-4db9-9100-038528b19200" contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="INF" format="ixt:num-dot-decimal">60.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is available to the Company in three tranches, subject to certain terms and conditions. The Company drew the first tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d526211-faff-4851-940e-99dfd0d76f8a" contextRef="C_34147130-543b-4bb3-9ad4-1f11d70023ea" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from K2HV on the Closing Date. The Company had the option to draw the second tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ade80599-7da2-4a36-8878-d815c43fb78e" contextRef="C_460d78bc-0419-42c2-a4cd-42262517b953" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon the achievement of certain financial and clinical milestones and an uncommitted third tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4159351b-d1d7-4205-a797-3edad1dccf0c" contextRef="C_9ef145db-1e48-427f-ba89-3edcc3e04fab" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million could be funded by joint agreement of the Company and K2HV. On the Closing Date, the Company paid a facility fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_090a92fa-cb69-4d1c-a650-856db5731e3d" contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad" name="tcrx:FacilityFeePaid" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to K2HV and is subject to an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12a3146a-3060-41a3-a979-3b274146bf82" contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad" name="tcrx:PrincipalAmountIncreasePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of any amount drawn on third tranche.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term loan was expected to mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2dd3eed8-cfb9-4c23-b7eb-3dbbe0ca7586" contextRef="C_901900fe-6930-49a3-b719-454de9021201" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 1, 2026</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the Maturity Date), and was subject to interest only payments for </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1b1ba8dd-9cc3-4e6d-993a-f4053ffa369f" contextRef="C_901900fe-6930-49a3-b719-454de9021201" name="tcrx:InterestOnlyPaymentTerm" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months, which could be extended to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_38aae029-b5b4-459e-a96c-c31ca15a52a2" contextRef="C_901900fe-6930-49a3-b719-454de9021201" name="tcrx:InterestOnlyPaymentExtendedTerm" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months upon achievement of certain financial and clinical milestones, following which the term loans would amortize in equal monthly installments until maturity. The Company had the ability to repay the loan at any time either in cash or in shares, subject to applicable premiums as specified in the Loan Agreement. The term loans accrued interest at a per annum rate equal to the greater of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d0bbb26-6a66-443b-a9dc-8f69e7235bbb" contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">8.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and (ii) the sum of (A) the prime rate (as last quoted in The Wall Street Journal) and (B) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65fa59b3-b4a1-4a76-9b9b-940cd5cf7c81" contextRef="C_901900fe-6930-49a3-b719-454de9021201" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, subject to a cap of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9df463b-6259-43b2-bc4d-754277563963" contextRef="C_901900fe-6930-49a3-b719-454de9021201" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.90</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 26, 2024, K2HV confirmed to the Company that the amortization commencement date would be October 1, 2025, thereby extending the interest-only period under the Loan Agreement for </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_eff69a13-0977-4ec1-bc0d-648ed543d5b5" contextRef="C_197387ea-3040-4c38-8433-659c61aae89f" name="tcrx:InterestOnlyPaymentExtendedTerm" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months. This extension met the definition of an accounting debt modification in accordance with ASC 470-50 and was accounted for prospectively as a yield adjustment, with no resulting gain or loss recognized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_b6d7bc37-d2e2-47fb-ab5f-2a32a675a7c2_1" continuedAt="F_b6d7bc37-d2e2-47fb-ab5f-2a32a675a7c2_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The lenders could elect at any time following the closing prior to the payment in full of the term loans to convert any portion of the principal amount of the term loans then outstanding into shares of the Company's common stock. The first tranche of the loan was convertible at the option of K2HV at a conversion price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb01331b-e705-4926-b6dd-cf4ba298c535" contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">4.785</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and future tranches could be convertible as specified in the agreement, provided that, such price shall be subject to the applicable conversion price floor and other adjustments in accordance with the Loan Agreement. The embedded conversion option met the derivative accounting scope exception since the embedded conversion option was indexed to the Company&#8217;s own common stock and qualifies for classification within stockholders&#8217; equity.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had the option to prepay all, but not less than all, of the outstanding principal balance of the term loans under the Loan Agreement subject to a prepayment fee ranging from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eeb3f882-8c5a-4a94-b946-58d9a9f4fc91" contextRef="C_003184ab-3c81-4f7b-9c86-6fc2202ca43e" name="tcrx:PercentageOfLoanPrepaymentFeeRange" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09a87bd8-66c4-4dba-9e11-5183ade2f9a2" contextRef="C_043660e4-f867-48a8-898e-eecc448695b5" name="tcrx:PercentageOfLoanPrepaymentFeeRange" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% depending upon when the prepayment occurs. The Company was obligated to pay a final fee equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d7509ec-2d0c-4d6e-b245-bab308b59865" contextRef="C_901900fe-6930-49a3-b719-454de9021201" name="tcrx:FinalFeePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">6.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the aggregate amount of the term loans funded (the Exit Fee), to occur upon the earliest of (i) the maturity date, (ii) the acceleration of the term loans, and (iii) the prepayment of the term loans. If, upon equity conversion, K2HV received gross proceeds in an amount equal to at least 1.5 multiplied by the principal amount converted from the sale or other disposition of such Conversion Shares (as defined in the Loan Agreement), then as to such principal amount, the Exit Fee would be reduced to zero.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 20, 2024, K2HV elected to convert $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e883c054-2297-480d-b6fd-716d64c0e89c" contextRef="C_f113cfc8-bb00-4b79-a4d9-fb6c7cf9dd11" name="us-gaap:DebtConversionOriginalDebtAmount1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the outstanding principal balance into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd3e61b7-0f57-405d-93cf-63fb7b682519" contextRef="C_f113cfc8-bb00-4b79-a4d9-fb6c7cf9dd11" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,134,796</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company's voting common stock at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9133819a-47ef-4e72-986d-280d74294109" contextRef="C_78a26315-739e-4dd5-ae26-f5f8ac025ff6" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">4.785</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in accordance with the agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 20, 2024 the Company repaid the remaining obligation of the debt agreement, which included $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d939e73-aa93-4722-9d1b-6d37e41fb0fd" contextRef="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4" name="us-gaap:DebtInstrumentRepaidPrincipal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in remaining principal, a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ed3f77b-da2b-401a-b7ff-561edf727ff7" contextRef="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4" name="tcrx:DebtInstrumentExitFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million Exit Fee, and a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4561a8ea-e526-40b7-913f-952adb559b29" contextRef="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4" name="tcrx:DebtInstrumentPrepaymentFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million prepayment fee. The Company recognized a loss from extinguishment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d27a4cd7-ed7b-4f4c-a4e8-658ffff7c20e" contextRef="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84a1fb01-69ae-40d6-ba2d-2d60005c05e1" contextRef="C_bba2662b-9ecc-409c-9943-54cd0c91a519" name="us-gaap:InterestExpenseLongTermDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1836b5e-dd5a-4177-9cba-6d04481e5197" contextRef="C_d31ec83e-19e4-4031-83bc-b96faa6d3fd3" name="us-gaap:InterestExpenseLongTermDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in interest expense for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The effective interest rate on the Loan Agreement, including the amortization of the debt discount and issuance costs, and accretion of the Exit Fee, was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc61c94a-a5f5-4d66-b077-4eb3262a4cbf" contextRef="C_bba2662b-9ecc-409c-9943-54cd0c91a519" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">12.61</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% upon extinguishment.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Silicon Valley Bank</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 20, 2024 (the effective date), the Company entered into a Loan and Security Agreement (SVB Loan Agreement) with Silicon Valley Bank, a division of First-Citizens Bank &amp; Trust Company (SVB). Under the SVB Loan Agreement, SVB will extend up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5818e6b2-eb30-4380-9853-8d3a597cc642" contextRef="C_1daea7ab-e482-4c92-8f38-cdfc5e71c091" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="INF" format="ixt:num-dot-decimal">52.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in a term loan facility, consisting of a first tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7914293-100b-4051-8b44-d39a4960e86d" contextRef="C_fb5bb604-09b8-4938-997b-19cc6a0d0d04" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">32.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million fully funded on the Effective Date and a second tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c713838e-a8f9-432e-8582-1d06c4dc825c" contextRef="C_47d4a7b8-0689-4bad-9d3a-73d2b5ff4403" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to be available to the Company at the Lender&#8217;s sole discretion on or prior to June 30, 2026.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e0983faf-b391-4023-ac79-9a776bab2c6f" contextRef="C_7dd0c966-6e37-4efa-b9a2-7c425a19b0ba" name="us-gaap:DebtInstrumentPaymentTerms"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term loans will mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2276ea46-2450-482e-9fbe-3dd364a961f2" contextRef="C_ed049b2f-3575-4247-9693-a137665029cf" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 1, 2029</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and will be subject to monthly interest only payments until September 30, 2027, provided the Company achieves certain financial and clinical milestones, following which the term loans will amortize in equal monthly installments until maturity. If the Company does not achieve such financial and clinical milestones by June 30, 2026, the maturity date will be September 1, 2028, and the interest only period will end on September 30, 2026, following which the term loans will amortize in equal monthly installments until maturity. </span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term loans will accrue interest at a per annum rate equal to the greater of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45e6323a-0d49-4db5-ae4b-2a83f74523fd" contextRef="C_1daea7ab-e482-4c92-8f38-cdfc5e71c091" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">7.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and (ii) the prime rate (as last quoted in The Wall Street Journal), minus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2fe2ae4-2a54-46a2-af0f-4a42d41420b5" contextRef="C_ed049b2f-3575-4247-9693-a137665029cf" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%; provided that such interest rate shall not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3ce7ebd-0163-4dcb-815f-79f8e4b416eb" contextRef="C_27fc5f66-3d18-42fb-8a66-2da06b8921bc" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">9.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum. The Company will be liable for a final payment that is due on the earliest to occur of (a) the maturity date, (b) the repayment of the term loans in full, and (c) the date upon which the term loans are accelerated by the Lender, in an amount equal to the aggregate original principal amount of the term loans extended by the Lender to the Company, multiplied by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eed9077c-c736-4a22-936e-e070a9aff038" contextRef="C_ed049b2f-3575-4247-9693-a137665029cf" name="tcrx:FinalFeePercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (Exit Fee). In addition, the Company will be liable for a prepayment fee equal to (x) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29ad648a-752e-499e-8bef-d5f1feacb67b" contextRef="C_ed049b2f-3575-4247-9693-a137665029cf" name="tcrx:PercentageOfLoanPrepaymentFeeInTwelveMonths" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of term loans prepaid during the first year of the term, (y) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be018253-f17f-442d-a977-9a7901c0ea60" contextRef="C_ed049b2f-3575-4247-9693-a137665029cf" name="tcrx:PercentageOfLoanPrepaymentFeeInYearTwo" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of term loans prepaid during the second year of the term, and (z) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8aebe53-1108-4bce-a537-ae67f98bd5da" contextRef="C_ed049b2f-3575-4247-9693-a137665029cf" name="tcrx:PercentageOfLoanPrepaymentFeeInAfterYearTwo" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of term loans prepaid thereafter. The term loans will automatically accelerate upon the occurrence of a bankruptcy or insolvency event involving the Company or its subsidiaries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SVB Loan Agreement contains customary representations and warranties, events of default and affirmative and negative covenants, including covenants that limit or restrict the Company&#8217;s and its subsidiaries&#8217; ability to, among other things, dispose of assets, make changes to its business, management, ownership or business locations, merge or consolidate, incur additional indebtedness, grant liens on its assets, pay dividends or other distributions, repurchase equity, make investments, and enter into certain transactions with affiliates, in each case subject to certain thresholds and exceptions. The New Loan Agreement does not require the Company to comply with a financial maintenance covenant. As collateral for its obligations under the New Loan Agreement, the Company granted the Lender a first-priority security interest on substantially all of the Company&#8217;s assets (other than intellectual property), subject to certain exceptions. The Company&#8217;s obligations under the SVB Loan Agreement will be guaranteed by each of the Company&#8217;s future direct or indirect subsidiaries, subject to certain exceptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_b6d7bc37-d2e2-47fb-ab5f-2a32a675a7c2_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29ef0d5d-542d-4d87-bdf2-cda8886003f4" contextRef="C_7dd0c966-6e37-4efa-b9a2-7c425a19b0ba" name="us-gaap:InterestExpenseLongTermDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in interest expense for the year ended December 31, 2024. The effective interest rate on the SVB Loan Agreement, including the amortization of the debt discount and issuance costs, and accretion of the Exit Fee, was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf245ad5-a9f8-478e-9f89-0b163567ed90" contextRef="C_7dd0c966-6e37-4efa-b9a2-7c425a19b0ba" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">8.46</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% at December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e711d439-fe44-4821-a768-acc0cc4283aa" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" escape="true" continuedAt="F_e711d439-fe44-4821-a768-acc0cc4283aa_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future principal payments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:74.68%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:23.32%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1f99b85-a2e3-418d-908d-2c90933c960d" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,063</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad0e5ef3-a712-4f2d-a597-6e39db2a5271" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,250</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9479940-4e78-4414-a9ca-2b8e5fa804a7" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,187</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total principal payments</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f3f03a1-fb44-4b58-a17b-9663c50c6423" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Plus: Final payment fee</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7931540e-387d-4a34-a5d4-dc07fe40f3cc" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="tcrx:LongTermDebtFinalPaymentFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,625</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: unamortized debt discount and final fee</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6b60f3e-7844-4bf2-b0a4-7155c0c032ec" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:DebtInstrumentUnamortizedDiscount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,053</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6c2dd37-f875-495f-b778-00522b8f0bf7" contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34" name="us-gaap:LongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,072</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <div><ix:continuation id="F_e711d439-fe44-4821-a768-acc0cc4283aa_1"></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8e9e6cd7-09c0-4970-a530-200d9288e81c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Retirement Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company initiated a defined contribution plan under Section 401(k) of the IRC (the Plan) covering all qualified employees effective January 1, 2019. Employee contributions are voluntary and are determined on an individual basis subject to the maximum allowable under federal tax regulations. The Company made contributions to the Plan of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0d86cb1-1330-4e9e-90b0-a941d3930a62" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2df67b1a-9a40-441c-98cb-62f2d4d3f391" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_d0e9bdf2-42a2-4394-b426-9b2890dea8e4" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true" continuedAt="F_d0e9bdf2-42a2-4394-b426-9b2890dea8e4_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. Segment Reporting</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of the entity for which separate financial information is made available and that is regularly evaluated by the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_026c18d0-35e8-4519-bb36-24650b15093c;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief operating decision maker (CODM)</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in making decisions regarding resource allocation and assessing performance. The Company's CODM is its chief executive officer and the Company manages its operations as a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_5592acb1-cb7d-4895-8078-3175a9a958ae;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> segment for the purposes of assessing performance and making operating decisions. The Company is focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_63ae97c4-e83d-4979-84eb-3bd03dacbfcd" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM assesses the Company's performance by reviewing GAAP net loss and significant expenses by function along with the annual budget. The chief operating decision maker considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources.</span></ix:nonNumeric></span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_d0e9bdf2-42a2-4394-b426-9b2890dea8e4_1"><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_ce962c67-3a3a-4e36-b514-db82e839b080" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides information about the Company's single operating segment which includes significant expenses by function along with significant non-cash expense items.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.86%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.54%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.06%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.54%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Revenue:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration and license revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fd6eca7-fde1-42f5-b348-9c86d9c78c2f" contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,816</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af5deda2-6269-4abf-935c-44793d3f81be" contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,049</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d4c0b7a-24e8-4d33-84cc-95a997824ad6" contextRef="C_f89cf5f2-e2a0-41fd-aa77-165139327dd5" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,742</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_029237cb-f96a-44aa-989c-4f7d806e48ac" contextRef="C_878ab1e3-bef4-47de-91e0-8a585da44965" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,165</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory supplies, research materials and studies</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21fea491-8d36-4058-82df-16d9693acd5f" contextRef="C_3314d2d1-6f78-49b7-8dc7-033a9967337c" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,468</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d64dc12a-bf6f-4f82-a82a-841d74bd6c40" contextRef="C_1dbc7479-5045-494d-a301-5d8982738033" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,101</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Clinical studies</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f698f34b-586e-4b55-9812-dbc0723461d0" contextRef="C_d3be5aa9-5dfb-4969-963a-9472152a5c98" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,245</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db0b371c-64a2-43de-b750-a1c94d438202" contextRef="C_aed4f300-d032-41f1-b165-0845aef59189" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,214</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility-related and other</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb5c9f46-5c2d-4a17-a955-b1884b6f8d0e" contextRef="C_09f0d8e0-903f-4e84-86fc-40c0b86d33f4" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,669</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b27b5170-6468-4f17-bdc2-a96efe3c131e" contextRef="C_d9dfa2cb-1ca0-4680-9350-28dac51ee6d0" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,298</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f11035d7-ad62-42b8-b9dd-a6275abf18ba" contextRef="C_bf8bbac7-91a5-4162-9f6f-1c2c9d31aa38" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,846</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_938bf6cf-a031-45bb-b7b1-ea49dbeaabae" contextRef="C_e909c65f-32e5-477f-948c-5fbf09b1bfec" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,876</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b91d88b0-abca-48f2-a365-56f5b13cae9e" contextRef="C_540ebf28-46d3-4e16-843f-afe078c63280" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,380</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f63a5a30-150b-47b6-990a-4d2a5be81acf" contextRef="C_6003d2b4-d18b-4884-abfc-799d0a8bb89d" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,499</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85239dce-905a-47e9-a067-5af557c9cf59" contextRef="C_f89cf5f2-e2a0-41fd-aa77-165139327dd5" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,900</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ea96dc4-a9c4-416c-9d6d-334aa62b459e" contextRef="C_878ab1e3-bef4-47de-91e0-8a585da44965" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,065</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal and professional fees</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afcc06d0-d5f5-46e5-bbe2-97180cef19f8" contextRef="C_4368cad2-f9e8-40de-bd6d-33ad7e1e108f" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,380</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6494111-4d5a-47f3-99b8-9b2e06f1aa91" contextRef="C_ee786513-1c43-4280-a1f0-021ef922f07e" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,119</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility-related and other</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc1f19fd-2ea5-42fd-90cb-e46af0bdea18" contextRef="C_09f0d8e0-903f-4e84-86fc-40c0b86d33f4" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,576</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b05fdc5b-1f1a-4eda-a09f-bccd4a8929d4" contextRef="C_d9dfa2cb-1ca0-4680-9350-28dac51ee6d0" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,976</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d78cbe4d-4880-4d18-99e8-e8182d5a1025" contextRef="C_bf8bbac7-91a5-4162-9f6f-1c2c9d31aa38" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,703</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a041d703-f3d2-4925-b971-dda03d35027c" contextRef="C_e909c65f-32e5-477f-948c-5fbf09b1bfec" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,332</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation Expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_540120f2-38c9-4a72-9e55-925f58acfc5b" contextRef="C_540ebf28-46d3-4e16-843f-afe078c63280" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">728</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df441fa6-ed89-4d6b-a39d-d77a4d229b79" contextRef="C_6003d2b4-d18b-4884-abfc-799d0a8bb89d" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">862</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af8dac8e-1124-4c1f-ab67-be875cf08fb2" contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">134,821</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20abec85-8963-4255-9f4d-9d5cec70b1c1" contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">93,458</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other (expense) income:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3f73e6d-f1ed-4dde-aeab-2dbeeed08867" contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,065</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7edd31c2-605a-4dd5-83b4-015762d68e4f" contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,999</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8e494f8-c5c3-4c4b-8b3a-fd37bc703870" contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,653</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a88a082e-316a-4ebf-a0aa-fa7aa1e04b30" contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,759</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5349ae29-a85e-4a10-ab99-cb3ebe55951f" contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,090</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Loss</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0bfc5df9-97fe-41c4-8e10-2b55546ae538" contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">127,499</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d273ff55-80f0-43a0-bdf5-db3857ad6ba6" contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">89,218</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_ff0d9ca6-4ac7-4917-ae9d-5412e4ab73f7" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14. Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a6a8e439-e7a2-4fbe-963c-8b2f495c2b73" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net loss per share was calculated as follows (in thousands, except share and per share data):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b174d30d-9f75-49d2-a7e0-79ce23e6b5f1" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">127,499</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_920c8d4b-9adb-4abb-b6a1-ce0e5b080da0" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">89,218</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_841d4874-e089-4865-833e-3bbfdc04e59b" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7c5cba1a-17e4-45d1-af8e-1718a91d96bc" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">111,990,417</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10c03447-1ba7-4e36-8f63-1e7d432e721f" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e45f6f82-0bf4-49eb-abb8-5dc85768fbf5" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">65,599,858</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12f10b37-99fb-4d66-bc44-166506c68825" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e6ea574e-37f2-4cac-9bd2-e20e22d0f7da" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.14</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87da4b93-0d15-46ef-a99f-f49f32ea6b9a" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_32e6dc89-6c38-4526-8423-d5267c177d9e" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.36</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34ac23ec-bad8-4547-ae27-349f6c54b2ea" contextRef="C_6c96b539-1a31-47e8-94ff-6a44016523a3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">73,087,945</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company's common stock issuable upon exercise of the Pre-Funded Warrants described in Note 6 are included as outstanding common stock in the calculation of basic and diluted net loss per share.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has two classes of common stock, each with identical participation rights to earnings and liquidation preferences, and therefore the calculation of net loss per share as described above is identical to the calculation under the two-class method. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bd362657-8905-4b39-962d-8ae9715a400c" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true" continuedAt="F_bd362657-8905-4b39-962d-8ae9715a400c_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_bd362657-8905-4b39-962d-8ae9715a400c_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_156aa11a-d543-4c90-90b2-0c714d82a24a" contextRef="C_e798deb2-ca9c-4e28-89b6-772abe4bb270" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">12,467,782</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b3e8153-33a7-4b41-a1fd-a8065f6e1554" contextRef="C_52a3b19e-f226-4939-bba1-6190de6d2bba" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">10,398,250</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Potential shares issuable under the ESPP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa6fe4a7-3c4a-45e1-839e-99cec1cc4711" contextRef="C_25583bb8-7b3e-423a-98e6-e7ade07bd068" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">138,133</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock issuable upon conversion of Loan Agreement</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6dd1bb0-a96b-4ef4-ba14-8923c8f7141e" contextRef="C_0d869bf5-158b-47a4-9b8b-51e8110fb2d8" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,269,592</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d5cf0c3-54a8-4233-8660-94ca690cb4f3" contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">12,605,915</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8feae428-c578-4088-b0bb-54c78ad7d30c" contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">16,667,842</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>2
<FILENAME>tcrx-ex10_9.htm
<DESCRIPTION>EX-10.9
<TEXT>
<html>
 <head>
  <title>EX-10.9</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.9</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">830 WINTER STREET</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WALTHAM, MASSACHUSETTS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Building</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECOND AMENDMENT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Second Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:36.32%;box-sizing:content-box;"></td>
    <td style="width:63.68%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0in;text-indent:36pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:6.667%;text-indent:0;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">EXECUTION DATE:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 28, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Execution Date</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;)</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0in;text-indent:36pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:6.667%;text-indent:0;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LANDLORD:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PPF OFF 828-830 Winter Street LLC, a Delaware limited liability company</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:31.7pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0in;text-indent:36pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:6.667%;text-indent:0;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TENANT:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc., a Delaware corporation</font></p></td>
   </tr>
   <tr style="height:46.1pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0in;text-indent:36pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:6.667%;text-indent:0;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">EXISTING PREMISES:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Approximately 25,472 rentable square feet of space in the Building, consisting of approximately 24,826 rentable square feet of space on the third (3</font><font style="color:#000000;top:-5.628pt;white-space:pre-wrap;font-size:8.040000000000001pt;position:relative;font-kerning:none;min-width:fit-content;">rd</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">) floor of the Building and approximately 646 rentable square feet of space in the basement of the Building, as more particularly described in the Existing Lease (as defined below).</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0in;text-indent:36pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:6.667%;text-indent:0;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">EXISTING LEASE:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 13, 2019 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Original Lease</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;), as amended by that certain First Amendment dated as of November 8, 2023 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">First Amendment</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0in;text-indent:36pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:6.667%;text-indent:0;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">EXPANSION PREMISES:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Approximately 25,628 rentable square feet comprised of the following:</font></p><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Prime Expansion Premises</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">:  Approximately 24,132 rentable square feet of space on the third (3</font><font style="color:#000000;top:-5.628pt;white-space:pre-wrap;font-size:8.040000000000001pt;position:relative;font-kerning:none;min-width:fit-content;">rd</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">) floor of the Building, as shown on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibit 1A, Second Amendment</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Basement Expansion Premises</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">: The following areas located in the basement of the Building, all as shown on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibit 1B, Second Amendment</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;attached hereto and (except with respect to the Hazardous Waste and Chemical Storage Expansion Premises) dedicated for Tenant&#x2019;s use in common with any tenant occupying the portion of the second floor of the Building located directly underneath the Prime Expansion Premises (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Floor Tenant</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;), as more particularly set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Section 1.3(C)</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">. The portion of the Basement Expansion Premises allocated to Tenant comprises approximately 1,496 rentable square feet of space.</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PH System Expansion Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">; </font></div></div></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:36.32%;box-sizing:content-box;"></td>
    <td style="width:63.68%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;text-indent:72pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:0;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hazardous Waste and Chemical Storage Expansion Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">; and </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:0;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mechanical Systems Expansion Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which contains the following systems: (i) RODI; (ii) Compressed Air; and (iii) Central Vacuum. </font></div></div><p style="margin-left:6.667%;text-indent:0;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Prime Expansion Premises, PH System Expansion Premises, Hazardous Waste and Chemical Storage Expansion Premises, and Mechanical Systems Expansion Premises shall be subject to all of the same terms and conditions applicable to the Prime Premises, PH System Premises, Hazardous Waste and Chemical Storage Premises, and Mechanical Systems Premises, respectively, under the Original Lease, including, without limitation, with respect to the permitted use of each such area.</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0in;text-indent:36pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:6.667%;text-indent:0;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;text-indent:17pt;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="margin-left:3.147%;text-indent:0;font-size:12pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">BACKGROUND</font></p></td>
   </tr>
  </table>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WHEREAS, Landlord and Tenant desire to amend the Existing Lease to reflect, among other provisions, the expansion of the Existing Premises to include the Expansion Premises, and to amend and modify certain other provisions of the Existing Lease, all upon the terms and conditions hereinafter set forth.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOW, THEREFORE, the Existing Lease is hereby amended as follows (the Existing Lease, as further amended by this Second Amendment, shall hereafter be referred to as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lease</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  Any capitalized terms used herein shall have the same definition as set forth in the Existing Lease, except to the extent otherwise set forth in this Second Amendment.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXPANSION PREMISES </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Demise of the Expansion Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Landlord hereby demises and leases to Tenant, and Tenant hereby leases from Landlord, the Expansion Premises for a term commencing on the Expansion Premises Commencement Date (as hereinafter defined) and expiring on the Extended Expiration Date (as defined in the First Amendment), unless earlier terminated in accordance with the provisions of the Lease.  The &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Expansion Premises Commencement Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall be the date Landlord delivers the Expansion Premises to Tenant, broom clean, vacant and free of the prior tenant&#x2019;s personal property, and otherwise in its &#x201c;as is&#x201d; &#x201c;where is&#x201d; condition.  The Expansion Premises Commencement Date shall be December 1, 2024. The &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Expansion Premises Rent Commencement Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall be the date that is two (2) months after the Expansion Premises Commencement Date.  Said demise of the Expansion Premises shall be upon all of the terms and conditions of the Existing Lease applicable to the Existing Premises, except as otherwise set forth in this Second Amendment.  From and after the Expansion Premises Commencement Date, all </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">references in the Lease to &#x201c;Premises&#x201d; shall be deemed to mean both the &#x201c;Existing Premises&#x201d; and the &#x201c;Expansion Premises,&#x201d; and the Premises shall then be deemed to contain, and the defined term &#x201c;Premises Rentable Area&#x201d; shall mean, a total of 51,100 rentable square feet.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basement Expansion Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  From and after the Expansion Premises Commencement Date, Tenant shall have the exclusive right to use that portion of the basement of the Building comprised of the Hazardous Waste and Chemical Storage Expansion Premises, and the right, in common with the Second Floor Tenant, to use the PH System Expansion Premises and the Mechanical Systems Expansion Premises, all as substantially shown on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 1B, Second Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for the Permitted Uses. Without limiting the generality of the foregoing, nothing in this Section shall preclude Tenant from using any portion of the basement of the Building that comprises a portion of the Building&#x2019;s Common Areas. Tenant hereby acknowledges and agrees that Tenant&#x2019;s allocation of 1,496 rentable square feet of the Basement Expansion Premises is solely for the purposes of determining Rent and Operating Costs, and said allocation shall not affect Tenant&#x2019;s and the Second Floor Tenant&#x2019;s respective rights to use the aforementioned portions of the Basement Expansion Premises in common with each other. </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivery</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Subject to Landlord&#x2019;s obligation to maintain the Basement Expansion Premises and systems contained therein in good condition and repair as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 1(B)(ii)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> below, Tenant shall take the Basement Expansion Premises &#x201c;as is&#x201d; in the condition in which the Basement Expansion Premises is in as of the Expansion Premises Commencement Date, without any obligation on the part of Landlord to prepare or construct the Basement Expansion Premises for Tenant&#x2019;s use or occupancy.  Without limiting the foregoing, Landlord makes no warranties or representations to Tenant as to the suitability of the Basement Expansion Premises for the Permitted Uses.  Tenant shall have no right to make any changes, alterations, additions, decorations or other improvements to the Basement Expansion Premises without Landlord&#x2019;s prior written consent.  </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Maintenance and Repair</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  From and after the Expansion Premises Commencement Date, Landlord shall maintain the Basement Expansion Premises and systems contained therein in good condition and repair, and shall obtain, and maintain all governmental permits and approvals necessary for the operation and maintenance of the Basement Expansion Premises.  Landlord shall be responsible for all costs, charges and expenses incurred from time to time in connection with or arising out of the operation, use, maintenance, repair, refurbishment or replacement of the Basement Expansion Premises and any of the systems contained therein (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basement Expansion Premises Costs</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and such Basement Expansion Premises Costs shall be included in Operating Costs, except, subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 14.5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Lease, to the extent such costs are caused by the negligence or willful misconduct of Tenant. Notwithstanding anything in this Lease to the contrary, with respect to the Basement Expansion Premises Costs, Landlord and Tenant hereby acknowledge and agree that Tenant&#x2019;s proportionate share shall equal 63.02% (based on the ratio of Tenant&#x2019;s allocation of the Basement Expansion Premises (1,496 rentable square feet) to the total rentable square footage of the Basement Expansion Premises (2,374 rentable square feet)).  Upon written request from Tenant, not more than one time per quarter, Landlord shall provide records of maintenance for equipment in the Basement Expansion Premises.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">iii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rules and Regulations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Tenant shall comply with all reasonable rules and regulations promulgated by Landlord in the use and operation of the Basement Expansion Premises.  </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Expansion Premises Base Rent; Additional Rent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Base Rent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In addition to Base Rent set forth in the Existing Lease with respect to the Existing Premises, from and after the Expansion Premises Rent Commencement Date, Tenant shall pay Base Rent for the Expansion Premises as set forth below: </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:11%;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:26.5%;box-sizing:content-box;"></td>
    <td style="width:33.74%;box-sizing:content-box;"></td>
    <td style="width:39.76%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Rent Year</font></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Annual Base Rent &#x2013; Expansion Premises</font></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Monthly Payment &#x2013; Expansion Premises</font></p></td>
   </tr>
   <tr style="height:2.15pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rent Year 1</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$1,960,542.00</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$163,378.50</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rent Year 2</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$2,019,358.26</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$168,279.86</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rent Year 3</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$2,079,939.01</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$173,328.25</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rent Year 4</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$2,142,337.18</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$178,528.10</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Rent Year 5*</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$2,206,607.29</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$183,883.94</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Prorated for any partial year</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rent Year 1 shall be the twelve-(12)-month period commencing as of the Expansion Premises Rent Commencement Date, except that if the Expansion Premises Rent Commencement Date occurs on other than the first day of a calendar month, then Rent Year 1 shall commence as of the Expansion Premises Rent Commencement Date and shall end on the last day of the calendar year in which the first anniversary of the Expansion Premises Rent Commencement Date occurs.  Each Rent Year after Rent Year 1 shall be the twelve-(12)-month period immediately following the preceding Rent Year; provided, however, the last Rent Year shall expire on the Extended Expiration Date.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional Rent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  From and after the Expansion Premises Commencement Date Tenant shall pay (i) Tenant&#x2019;s Share of Operating Costs and Taxes in accordance with the provisions of Sections 5.2 and 5.3 of the Existing Lease, respectively; provided however, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s Share</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean twenty-seven and forty-five hundredths percent (27.45%) (i.e., a fraction, the numerator of which is the Premises Rentable Area and the denominator of which is the Building Rentable Area), (ii) all charges for utilities furnished to the Expansion Premises and any equipment exclusively serving the Expansion Premises, as additional rent, subject to and in accordance with the terms and conditions of Article 9 of the Existing Lease, and (iii) all other additional rent and other charges payable pursuant to the Existing Lease with respect to the Expansion Premises.  All such amounts shall be payable in accordance with the terms and provisions of the Existing Lease.</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDITION OF EXPANSION PREMISES; ADDITIONAL LANDLORD&#x2019;S CONTRIBUTION </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Condition</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Expansion Premises has been decommissioned, as summarized in that certain Laboratory Decomissioning Report Prepared For: National Resilience, Inc., dated August 5, 2024, prepared by Triumvirate Environmental, Inc.  Tenant acknowledges and agrees </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">that Tenant is leasing the Expansion Premises in its &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS IS</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WHERE IS</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; condition and with all faults on the Expansion Premises Commencement Date, without representations or warranties, express or implied, in fact or by law, of any kind, and without recourse to Landlord but, prior to Tenant&#x2019;s occupancy of the Expansion Premises, Landlord shall remove the built-in equipment from room 3W312 and valving off and draining the RODI loop within the expansion premises.  Without limitation of the foregoing, Landlord shall have no obligation to perform any work, supply any materials, incur any expense, or make any alterations or improvements to prepare the Expansion Premises for initial occupancy by Tenant.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord&#x2019;s Second Amendment Contribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Landlord shall provide to Tenant a tenant improvement allowance (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord&#x2019;s Second Amendment Contribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) of up to $2,681,540.00 (i.e., $20.00 per rentable square foot of the Existing Premises, $75.00 per rentable square foot of the Expansion Premises, plus the additional amount of $250,000.00) to be used by Tenant solely for hard and soft costs incurred by Tenant for the construction and installation of improvements in and to the Premises and the preparation of the Premises for Tenant&#x2019;s use and occupancy (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s Second Amendment Work</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), including, without limitation, costs of construction, architectural and engineering fees, project management fees, cabling and wiring, furniture and moving costs, subject to a mutually agreed-upon space plan and Landlord&#x2019;s approval of Tenant&#x2019;s contractor in accordance with the provisions of the Existing Lease.  Tenant shall pay all costs of Tenant&#x2019;s Second Amendment Work in excess of the Landlord&#x2019;s Second Amendment Contribution. The right to receive the Landlord&#x2019;s Second Amendment Contribution is for the exclusive benefit of Tenant, and in no event shall such right be assigned to or be enforceable by or for the benefit of any third party, including any contractor, subcontractor, materialman, laborer, architect, engineer, attorney or other person or entity.  Landlord shall pay the Landlord&#x2019;s Second Amendment Contribution to Tenant in accordance with the terms and conditions of Section 6 of Exhibit 4 of the Existing Lease applicable to Landlord&#x2019;s Contribution; provided however, (i) &#x201c;Landlord&#x2019;s Proportion&#x201d; with respect to the Landlord&#x2019;s Second Amendment Contribution shall be a fraction, the numerator of which is the Landlord&#x2019;s Second Amendment Contribution and the denominator of which is the total budget for Tenant&#x2019;s Second Amendment Work, (ii) the &#x201c;Outside Requisition Date&#x201d; with respect to the Landlord&#x2019;s Second Amendment Contribution shall be the date that is eighteen (18) months after the Expansion Premises Commencement Date, and upon the occurrence of the Outside Requisition Date, any amount of the Landlord&#x2019;s Second Amendment Contribution which has not been previously disbursed or for which Tenant has not delivered a Rent Credit Request (as hereinafter defined) in accordance with the provisions of this Section 2(C) shall be retained by Landlord and Tenant shall have no further right or claim thereto, and (iii) the last sentence of Section 5 of Exhibit 4 shall not apply and in lieu thereof, if after completion of the Tenant&#x2019;s Second Amendment Work and payment in full of all costs and expenses relating to the Tenant&#x2019;s Second Amendment Work the entire Landlord&#x2019;s Second Amendment Contribution has not been expended, then upon request made by Tenant by not later than the Outside Requisition Date, the lesser of (x) the remaining balance of the Landlord&#x2019;s Second Amendment Contribution, if any, or (y) $536,308.00 (i.e., twenty percent (20%) of the Landlord&#x2019;s Second Amendment Contribution) , may be applied as a credit on a monthly basis, toward payments required to be made by Tenant to Landlord on account of the Base Rent payable under the Lease, provided that all of the following conditions are satisfied: (A) all of the Tenant&#x2019;s Second Amendment Work have been completed and Tenant has provided Landlord with all of the items described in Section 6(ii) of Exhibit 4 of the Original Lease; (B) the Lease is in full force and effect; (C) no Event of Default then exists under the Lease; and (D) Tenant shall provide not less than thirty (30) days prior notice </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of its request for application of said amount as a credit against the Base Rent payable under the Lease (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rent Credit Request</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), which Rent Credit Request be delivered  to Landlord by not later than the Outside Requisition Date and shall specify the amount of such credit and the applicable installments of Base Rent to which said amount is to be applied.  Notwithstanding the foregoing to the contrary, Tenant shall have the right, at any time prior to the date that is eighteen (18) months after the Expansion Premises Commencement Date, to apply $536,308.00 of the Landlord&#x2019;s Second Amendment Contribution as a credit on a monthly basis, toward payments required to be made by Tenant to Landlord on account of the Base Rent payable under the Lease, provided the conditions in (B) &#x2013; (D) above are satisfied.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord&#x2019;s First Amendment Contribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Tenant acknowledges and agrees that Tenant has not requested payment by Landlord of any portion of Landlord&#x2019;s First Amendment Contribution, Landlord has not disbursed any portion of Landlord&#x2019;s First Amendment Contribution, and Landlord&#x2019;s Second Amendment Contribution is being provided to Tenant in lieu of Landlord&#x2019;s First Amendment Contribution.  Accordingly, all references to Landlord&#x2019;s First Amendment Contribution set forth in the First Amendment are hereby deleted in their entirety.  Tenant shall not be entitled to any portion of Landlord&#x2019;s First Amendment Contribution, and Landlord shall have no obligations or liabilities with respect to Landlord&#x2019;s First Amendment Contribution. </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MODIFIED LEASE PROVISIONS</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Parking</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The parties hereby acknowledge that pursuant to Section 1.3(b) of the Existing Lease, Landlord has made available to Tenant up to sixty-four (64) unreserved parking spaces located in the Parking Areas for Tenant&#x2019;s use, eleven (11) of which are located within the 830 Garage and the remaining fifty-three (53) of which are located within the 828 Garage and the surface parking areas of the Building, all as more particularly set forth in the Existing Lease. From and after the Expansion Premises Commencement Date, Landlord shall, subject to the terms of the Lease, including, without limitation, Section 1.3(b) of the Existing Lease, make available up to an additional sixty-four (64) unreserved parking spaces located in the Parking Areas for Tenant&#x2019;s use, ten (10) of which are located within the 830 Garage and the remaining fifty-four (54) of which are located within the 828 Garage and the surface parking areas of the Building. The use of such additional parking spaces shall be upon all of the same terms and conditions as are applicable to the use of the Parking Spaces (as such term is defined in Section 1.3(b) of the Existing Lease), and from and after the Expansion Premises Commencement Date, the term &#x201c;Parking Spaces&#x201d; shall mean and refer to, collectively, the sixty-four (64) parking spaces described in Section 1.3(b) of the Existing Lease and the additional sixty-four (64) spaces described herein, for a total of one hundred twenty-eight (128) Parking Spaces, twenty one (21) of which are located within the 830 Garage and the remaining one hundred seven (107) of which are located within the 828 Garage and the surface parking areas of the Building.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Control Areas</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  &#x201c;Tenant&#x2019;s Control Areas,&#x201d; as defined in Section 17.1 of the Existing Lease, with respect to the Expansion Premises, shall consist of the areas shown on the plan attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 8-1, Second Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Tenant&#x2019;s rights to utilize each of such control areas are in addition to Tenant&#x2019;s right under Section 17.1 of the Existing Lease and shall be in accordance with the terms and conditions of Section 17.1 of the Existing Lease.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MISCELLANEOUS </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Broker</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Tenant and Landlord each warrants and represents that it has dealt with no broker in connection with the consummation of this Second Amendment other than Cresa and CBRE (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Second Amendment Brokers</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  Tenant and Landlord each agrees to defend, indemnify and save the other harmless from and against any claims arising in breach of the indemnifying party&#x2019;s representation and warranty set forth in the immediately preceding sentence.  Landlord shall be solely responsible for the payment of any brokerage commission to the Second Amendment Brokers.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ratification; Representations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In all other respects, except as expressly modified herein, the Existing Lease is hereby ratified and confirmed.  The submission of drafts of this document for examination and negotiation does not constitute an offer, or a reservation of or option for any of the terms and conditions set forth in this Second Amendment, and this Second Amendment shall not be binding upon Landlord or Tenant unless and until Landlord shall have executed and delivered a fully executed copy of this Second Amendment to Tenant.  Tenant hereby represents and warrants to Landlord as follows: (i) the execution and delivery of this Second Amendment by Tenant has been duly authorized by all requisite limited liability company action, (ii) neither the Lease nor the interest of Tenant therein has been assigned, sublet, encumbered or otherwise transferred; (iii) to the best knowledge of Tenant, there are no defenses or counterclaims to the enforcement of the Lease or the liabilities and obligations of Tenant thereunder; (iv) except as set forth herein, Tenant is not entitled to any offset, abatement or reduction of rent under the Lease; (v) to the best knowledge of Tenant, neither Landlord or Tenant is in breach or default of any of its respective obligations under the Lease; (vi) Landlord has performed all work and constructed all improvements required pursuant to the Lease and, except for Landlord&#x2019;s Second Amendment Contribution, has provided all allowances and contributions required pursuant to the Lease; and (vii) Landlord has made no representations or warranties, except as expressly and specifically set forth in this Second Amendment or as expressly and specifically set forth in the Lease as of the date of the Lease.  To the best knowledge of Landlord, neither Landlord or Tenant is in breach or default of any of its respective obligations under the Lease.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Conflict</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In the event that any of the provisions of the Existing Lease are inconsistent with this Second Amendment or the state of facts contemplated hereby, the provisions of this Second Amendment shall control.  </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Second Amendment may be executed in any number of counterparts and by each of the undersigned on separate counterparts, which counterparts taken together shall constitute one and the same instrument.  This Second Amendment may be executed by electronic signature, which shall be considered as an original signature for all purposes and shall have the same force and effect as an original signature.  Without limitation, in addition to electronically produced signatures, &#x201c;electronic signature&#x201d; shall include faxed versions of an original signature or electronically scanned and transmitted versions (e.g., via pdf) of an original signature.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[BALANCE OF PAGE INTENTIONALLY LEFT BLANK;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES ON FOLLOWING PAGE]</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXECUTED as of the date first above written.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:6%;box-sizing:content-box;"></td>
    <td style="width:94%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LANDLORD:</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PPF OFF 828-830 WINTER STREET, LLC,</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a Delaware limited liability company</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PPF MASS REIT, LLC, a Delaware</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">limited liability company, its Sole Member</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.383%;box-sizing:content-box;"></td>
    <td style="width:93.617%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PPF OP, LP, a Delaware limited</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">partnership, its Sole Partner</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:88.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.818%;box-sizing:content-box;"></td>
    <td style="width:93.182%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PPF OPGP, LLC, a Delaware</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">limited liability company, its</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General Partner</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:82.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:7.317%;box-sizing:content-box;"></td>
    <td style="width:92.683%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prime Property Fund, LLC,</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a Delaware limited liability company,</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">its Sole Member</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:76.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:7.792%;box-sizing:content-box;"></td>
    <td style="width:92.208%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Morgan Stanley Real Estate</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Advisor, Inc., a Delaware</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">corporation, its Investment Adviser</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:25.602%;border-spacing:0;table-layout:auto;width:51.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:9.316%;box-sizing:content-box;"></td>
    <td style="width:13.994%;box-sizing:content-box;"></td>
    <td style="width:76.689%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:6%;box-sizing:content-box;"></td>
    <td style="width:5%;box-sizing:content-box;"></td>
    <td style="width:40%;box-sizing:content-box;"></td>
    <td style="width:49%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="4" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TENANT:</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="4" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="4" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">T</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scan Therapeutics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a Delaware corporation</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">______________________________________</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name: _________________________</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:__________________________</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Signature Page to Second Amendment</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19
<SEQUENCE>3
<FILENAME>tcrx-ex19.htm
<DESCRIPTION>EX-19
<TEXT>
<html>
 <head>
  <title>EX-19</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1.26in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 19</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:39.12%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img200782950_0.jpg" alt="img200782950_0.jpg" style="width:195px;height:57px;"></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1.26in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;box-sizing:content-box;"></td>
    <td style="width:3%;box-sizing:content-box;"></td>
    <td style="width:82.76%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:5.24%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Page</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Introduction</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal Prohibitions on Insider Trading</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">B.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Detection and Prosecution of Insider Trading</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">C.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Penalties for Violation of Insider Trading Laws and This Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">D.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compliance Officer</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">E.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reporting Violations</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personal responsibility</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Persons and Transactions Covered by This Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Persons Covered by This Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">B.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Types of Transactions Covered by This Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">C.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Responsibilities Regarding the Non-Public Information of Other Companies</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">D.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Applicability of This Policy after Your Departure</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">E.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No Exceptions Based on Personal Circumstances</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Material Non-Public Information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;Material&#x201d; Information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">B.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201c;Non-Public&#x201d; Information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Policies Regarding Material Non-Public Information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Confidentiality of Non-Public Information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">B.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No Trading on Material Non-Public Information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">C.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No Disclosing Material Non-Public Information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">D.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Responding to Outside Inquiries for Information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trading Blackout Periods</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Quarterly Blackout Periods</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">B.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Special Blackout Periods</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">C.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No &#x201c;Safe Harbors&#x201d;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-Clearance of Trades</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional Restrictions and Guidance</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short Sales</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">B.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derivative Securities and Hedging Transactions</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">C.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Using Company Securities as Collateral for Loans</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">D.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holding Company Securities in Margin Accounts</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">E.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Placing Open Orders with Brokers</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Limited Exceptions</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Transactions Pursuant to a Trading Plan that Complies with SEC Rules</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">B.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receipt and Vesting of Stock Options, Restricted Stock Units, Restricted Stock and Stock Appreciation Rights</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">C.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercise of Stock Options for Cash</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</font></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1.26in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;box-sizing:content-box;"></td>
    <td style="width:3%;box-sizing:content-box;"></td>
    <td style="width:82.76%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:5.24%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">D.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases from the Employee Stock Purchase Plan</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">E.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock Splits, Stock Dividends and Similar Transactions</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F.</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Bona Fide Gifts and Inheritance</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">G.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in Form of Ownership</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">H.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other Exceptions</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Compliance with Section 16 of the Securities Exchange Act</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Obligations under Section 16</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">B.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Notification Requirements to Facilitate Section 16 Reporting</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">C.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personal Responsibility</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional Information</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Availability of Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">B.</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amendments</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Schedule I (Individuals Subject to Quarterly Blackout Periods)</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Schedule II (Individuals Subject to Pre-Clearance Requirements)</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Schedule III (Individuals Subject to Section 16 Reporting and Liability Provisions)</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Appendix A (Requirements for Rule 10b5-1 Trading Plans)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1.26in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Introduction</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) opposes the unauthorized disclosure of any non-public information you obtain in the course of your service with the Company and the misuse of material non-public information in securities trading. This Insider Trading Policy (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) prohibits the unauthorized disclosure and misuse of any non-public information.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal Prohibitions on Insider Trading</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The antifraud provisions of U.S. federal securities laws prohibit directors, officers, employees and other individuals who possess material non-public information from trading on the basis of that information. Your transactions will be considered &#x201c;on the basis of&#x201d; material non-public information if you are aware of the material non-public information at the time of the transaction. It is not a defense that you did not &#x201c;use&#x201d; the information for purposes of the transaction. It is also not a defense that you had a financial hardship that required you to transact in securities.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosing material non-public information directly or indirectly to others who then trade based on that information or making recommendations or expressing opinions as to transactions in securities while aware of material non-public information (which is sometime referred to as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tipping</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) is also illegal. Both the &#x201c;tipper&#x201d; who provides the information, recommendation or opinion and the &#x201c;tippee&#x201d; who trades based on it may be liable.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These illegal activities are commonly referred to as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">insider trading</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d; State securities laws and securities laws of other jurisdictions also impose restrictions on insider trading.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company, as well as individual directors, officers and other supervisory personnel, may be subject to liability as &#x201c;controlling persons&#x201d; for failure to take appropriate steps to prevent insider trading by those under their supervision, influence or control.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Detection and Prosecution of Insider Trading</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Financial Industry Regulatory Authority (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FINRA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and the New York Stock Exchange use sophisticated electronic surveillance techniques to investigate and detect insider trading, and the SEC and the U.S. Department of Justice pursue insider trading violations vigorously. Regulators have successfully prosecuted cases involving trading through foreign accounts, trading by family members and friends, and trading involving only a small number of shares.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1.26in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:3.75pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Penalties for Violation of Insider Trading Laws and This Policy</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Civil and Criminal Penalties</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the effective date of this Policy, potential penalties for insider trading violations under</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S. federal securities laws include:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">damages in a private lawsuit;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disgorging any profits made or losses avoided;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imprisonment for up to 20 years;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">criminal fines of up to $5 million for individuals and $25 million for entities;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">civil fines of up to three times the profit gained or loss avoided;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a bar against serving as an officer or director of a public company; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an injunction against future violations.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Civil and criminal penalties also apply to tipping. The SEC has imposed large penalties in tipping cases even when the tipper did not trade or gain any benefit from the tippee&#x2019;s trading.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Penalties for Controlling Persons</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The penalty for insider trading violations of controlling persons is a civil fine of up to the greater of $1 million or three times the profit gained or loss avoided as a result of the insider trading violations, as well as potential criminal fines and imprisonment.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disciplinary Actions</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Company has a reasonable basis to conclude that you have failed to comply with this Policy, you may be subject to disciplinary action, up to and including dismissal for cause, whether or not your failure to comply with this Policy results in a violation of law. It is not necessary for the Company to wait for the filing or conclusion of any civil or criminal action against you before taking disciplinary action. In addition, the Company may give stop transfer and other instructions to the Company&#x2019;s transfer agent to enforce compliance with this Policy.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance Officer</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You should direct any questions, requests or reports to the Company&#x2019;s Compliance Officer or their appointed designee (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance Officer</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). A Compliance Officer is generally responsible for the administration of this Policy. A Compliance Officer may select others to assist with the execution of his or her duties.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1.26in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">E.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reporting Violations</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is your responsibility to help enforce this Policy. You should be alert to possible violations and promptly report violations or suspected violations of this Policy to a Compliance Officer. If your situation requires that your identity be kept secret, your anonymity will be preserved to the greatest extent reasonably possible. If you wish to remain anonymous, you may: send a letter addressed to a Compliance Officer at the Company, 830 Winter Street, Waltham, MA 02451; leave an anonymous message on the ethics hotline at the toll free number (833) 412-2332; or online at https</font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">://www.whistleblowerservices.com/tscan.</font></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> If you make an anonymous report, please provide as much detail as possible, including any evidence that you have.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">F.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Personal responsibility</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are responsible for complying with this Policy and applicable laws and regulations. You should use your best judgment at all times and consult with your personal legal and financial advisors, as needed. You should seek assistance from a Compliance Officer if you have any questions at all. The rules relating to insider trading can be complex, and a violation of insider trading laws can carry severe consequences.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Persons and Transactions Covered by This Policy</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Persons Covered by This Policy</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy applies to all directors, officers, employees and agents (such as consultants and independent contractors) of the Company. References to the Company include subsidiaries of the Company. References in this Policy to &#x201c;you&#x201d; (as well as general references to directors, officers, employees and agents of the Company) should also be understood to include members of your immediate family, persons with whom you share a household, persons who are your economic dependents and any other individuals or entities whose transactions in securities you influence, direct or control (including, for example, a venture or other investment fund or strategic investor, if you influence, direct or control transactions by the fund). Notwithstanding the foregoing, this Policy, does not apply to an entity that is affiliated or associated with a director, if the entity&#x2019;s principal business is the investment of securities (an investment fund or partnership) and that entity has established its own insider trading controls and procedures in compliance with applicable securities laws. You are responsible for making sure that these other individuals and entities comply with this Policy.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Types of Transactions Covered by This Policy</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as discussed in &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below, this Policy applies to all transactions involving the securities of the Company. It also applies to </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">all </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">transactions </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">involving </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the securities of other companies about which you possess material non-public information obtained in the course of your service with the Company. This Policy therefore applies to purchases, sales and other transfers of common stock, options, warrants, preferred stock, debt securities (such as debentures, bonds and notes) and other securities. This Policy also applies to any arrangements that affect economic exposure from changes in the prices of these securities (e.g., transactions in derivative securities (such as exchange-traded put or call options), hedging transactions, short sales and certain decisions with respect to participation in benefit plans). This Policy also applies to any offers by you with respect to the transactions discussed above. There are no exceptions from insider trading laws or this Policy based on the size of the transaction.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Responsibilities Regarding the Non-Public Information of Other Companies</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy prohibits the unauthorized disclosure or other misuse of any non-public information of other companies, such as the Company&#x2019;s distributors, vendors, customers, collaborators, suppliers and competitors. This Policy also prohibits insider trading and tipping based on the material non-public information of other companies.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Applicability of This Policy after Your Departure</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are expected to comply with this Policy until such time as you are no longer affiliated with the Company and you no longer possess any material non-public information subject to this Policy.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">E.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Exceptions Based on Personal Circumstances</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There may be instances where you suffer financial harm or other hardship or are otherwise required to forego a planned transaction because of the restrictions imposed by this Policy. Personal financial emergency or other personal circumstances will not limit your liability under securities laws and will not excuse a failure to comply with this Policy.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Material Non-Public Information</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Material&#x201d; Information</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information is material if there is a substantial likelihood that a reasonable investor would consider it important in deciding whether to buy, hold or sell securities or would view the information as significantly altering the total mix of information in the marketplace. In general, any information that could reasonably be expected to affect the market price of a security is likely to be material. Both positive and negative information may be material.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is not possible to define all categories of &#x201c;material&#x201d; information. However, some examples of information that could be regarded as material include information with respect to:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial results, financial condition, earnings pre-announcements, guidance, projections or forecasts; note that information about the results of the Company&#x2019;s operations for even a portion of a quarter might be material in helping predict the Company&#x2019;s financial results for the quarter;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restatements of financial results, or material impairments, write-offs or restructurings;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant developments in research and development, regulatory approvals for the Company&#x2019;s product candidiates or relating to intellectual property;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in independent auditors, or notification that the Company may no longer rely on an audit report;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Business plans or budgets;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Creation of significant financial obligations, or any significant default under or acceleration of the payment of any financial obligation;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Impending bankruptcy or financial liquidity problems;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant developments involving business relationships, including entering into, modifying, or terminating significant agreements or orders with customers, suppliers, distributors, manufacturers or other business partners;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Product introductions, modifications, defects or recalls or significant pricing changes or other announcements of a significant nature;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant legal or regulatory developments, whether actual or threatened;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major events involving the Company&#x2019;s securities, including calls of securities for redemption, adoption of stock repurchase programs, option repricings, stock splits, changes in dividend policies, public or private securities offerings, modification to the rights of security holders, or notice of delisting of our securities from trading on a securities exchange;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The existence of a special blackout period in which you may not trade securities;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant corporate events, such as a pending or proposed merger, joint venture or tender offer, a significant investment, the acquisition or disposition of a significant business or asset or a change in control of the Company; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major personnel changes, such as changes in senior management or lay-offs.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you have any questions as to whether information should be considered &#x201c;material,&#x201d; you should consult with a Compliance Officer. In general, it is advisable to resolve any close questions as to the materiality of any information by assuming that the information is material.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Non-Public&#x201d; Information</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information is considered non-public until it has been broadly disseminated to the public for long enough to be reflected in the price of the security. As a general rule, you should consider information to be non-public until at least one </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">full trading day </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">has elapsed after the information has been broadly disseminated to the public in a press release, a public filing with the SEC, a pre- announced public webcast or another broad, non-exclusionary form of public communication. However, depending upon the form of the announcement and the nature of the information, it is possible that information may not be fully absorbed by the marketplace until later. Unless you have seen material information publicly disseminated, you should assume the information is non- public. Any questions as to whether information is non-public should be directed to a Compliance Officer.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trading day</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a day on which national stock exchanges are open for trading. A &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">full</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; trading day has elapsed when, after the public disclosure, trading in the relevant security has opened and then closed.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Policies Regarding Material Non-Public Information</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Confidentiality of Non-Public Information</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy prohibits the unauthorized use or disclosure of non-public information relating to the Company or other companies. All non-public information you obtain in the course of your service with the Company may only be used for legitimate the Company business purposes. In addition, you should handle others&#x2019; non-public information in accordance with the terms of any relevant nondisclosure agreements, and the use of any such non-public information should be limited to the purpose for which it was disclosed.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You must use all reasonable efforts to safeguard non-public information in the Company&#x2019;s possession.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All officers, employees and agents of the Company are required to sign and comply with an agreement addressing confidential information and invention assignment.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Trading on Material Non-Public Information</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as discussed in &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below, you may not, directly or indirectly through others, engage in any transaction involving the Company&#x2019;s securities while aware of material non- public information relating to the Company. It does not matter that you did not &#x201c;use&#x201d; the information in your transaction.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Similarly, you may not engage in transactions involving the securities of any other company if you are aware of material non-public information about that company (except if the transactions are similar to those presented in &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below). For example, you may be aware of a proposed transaction involving a prospective business relationship or transaction with another company. If information about that transaction constitutes material non-public information for that other company, you would be prohibited from engaging in transactions involving the securities of that other company (as well as transactions involving the Company securities, if that information is material to the Company). &#x201c;Materiality&#x201d; is company-specific&#x2014;information that is not material to the Company may be material to another company.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Disclosing Material Non-Public Information</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not disclose non-public information about the Company or any other company, unless required by law, or unless (i) disclosure is required for legitimate Company business purposes, (ii) you are authorized to disclose the information and (iii) appropriate steps have been taken to prevent misuse of that information (including entering an appropriate nondisclosure agreement that restricts the disclosure and use of the information, if applicable). This restriction also applies to internal Company communications and to communications with agents of the Company. In cases where disclosing non-public information to third parties is required, you should coordinate with the Legal Department.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, you may not make recommendations or express opinions on the basis of material non- public information as to trading in the securities of companies to which such information relates. You are prohibited from engaging in these actions whether or not you derive any profit or personal benefit from doing so. This prohibition against disclosure of material non-public information includes disclosure (even anonymous disclosure) via the Internet, blogs, investor forums, chat rooms, social media, or the like.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Responding to Outside Inquiries for Information</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event you receive an inquiry from someone outside of the Company, such as a stock analyst or news reporter, for information, you should refer the inquiry to the Chief Financial Officer or the Investor Relations Department. Your disclosure of information could result in SEC enforcement actions against the Company, including injunctions and severe monetary penalties. Please consult the Company&#x2019;s investor relations and communications policy for more details.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Blackout Periods</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To limit the likelihood of trading at times when there is a significant risk of insider trading exposure, the Company has instituted quarterly trading blackout periods and may institute special trading blackout periods from time to time.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is important to note that whether or not you are subject to blackout periods, you remain subject to the prohibitions on trading on the basis of material non-public information and any other applicable restrictions in this Policy.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Quarterly Blackout Periods</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as discussed in &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below, all Company directors, executive officers and other employees and agents identified by the Company must refrain from conducting transactions involving the Company&#x2019;s securities during quarterly blackout periods. Even if you are not specifically identified as being subject to quarterly blackout periods, you should exercise caution when engaging in transactions during quarterly blackout periods because of the heightened risk of insider trading exposure.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Quarterly blackout periods start two (2) business days prior to the last day of the last month of each fiscal quarter and end at the beginning of the second full trading day following the date of public disclosure of the financial results for that fiscal quarter. This period is a particularly sensitive time for transactions involving the Company&#x2019;s securities from the perspective of compliance with applicable securities laws due to the fact that, during these periods, individuals may often possess or have access to material non-public information relevant to the expected financial results for the quarter.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All the Company directors, officers, employees and agents identified by the Company (such as consultants and independent contractors) are subject to quarterly blackout periods as listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule I</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. From time to time, the Company may identify other persons who should be subject to quarterly blackout periods, and a Compliance Officer may update and revise </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule I </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">as appropriate.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will notify you when each quarterly blackout period starts and ends so that you will know when you may and may not engage in any transaction involving the Company&#x2019;s securities. You are responsible for complying with the blackout period described in this Policy regardless of whether you receive notification from the Company about the period.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Special Blackout Periods</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company may also prohibit directors, officers, employees and agents from engaging in transactions involving the Company&#x2019;s securities when, in the judgment of a Compliance Officer, a trading blackout is warranted. The Company will generally impose special blackout periods when there are material developments known to the Company that have not yet been disclosed to the public. For example, the Company may impose a special blackout period in anticipation of announcing interim earnings guidance or a significant transaction or business development. Special blackout periods may be declared for any reason.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will notify you if you are subject to a special blackout period, in which case you may not engage in any transaction involving the Company&#x2019;s securities until instructed that it is permissible, and you should not disclose the existence of the special blackout period to others.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No &#x201c;Safe Harbors&#x201d;</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are no &#x201c;safe harbors&#x201d; for trades made at particular times, and you should exercise good judgment at all times. Even when a quarterly blackout period is not in effect, you may be prohibited from engaging in transactions involving the Company&#x2019;s securities because you possess material non-public information, are subject to a special blackout period or are otherwise restricted under this Policy.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Clearance of Trades</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as discussed in &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; below, directors and executive officers must refrain from engaging in any transaction involving the Company&#x2019;s securities without first obtaining pre</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">- </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clearance of the transaction from a Compliance Officer. In addition, as listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule II</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has determined that certain other employees and agents of the Company that may have regular or special access to material non-public information must refrain from engaging in any transaction involving the Company&#x2019;s securities without first obtaining pre</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clearance of the transaction from a Compliance Officer. A Compliance Officer may not engage in a transaction involving the Company&#x2019;s securities unless the other Compliance Officer has pre-cleared the transaction. Individuals subject to pre</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clearance requirements are listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule II</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. From time to time, the Company may identify other persons subject to the pre</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clearance requirements set forth above, and a Compliance Officer may update and revise </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule II </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">as appropriate.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These pre-clearance procedures are intended to decrease insider trading risks associated with transactions by individuals with regular or special access to material non-public information. In addition, requiring pre</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clearance of transactions by directors and officers facilitates compliance with Rule 144 resale restrictions under the Securities Act of 1933, as amended, and the liability and reporting provisions of Section 16 under the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). Pre-clearance of a trade, however, is not a defense to a claim of insider trading and does not excuse you from otherwise complying with insider trading laws or this Policy. Further, pre-clearance of a transaction does not constitute an affirmation by the Company or a Compliance Officer that you are not in possession of material non-public information.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A Compliance Officer is under no obligation to approve a transaction submitted for pre-clearance, and may determine not to permit the transaction.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional Restrictions and Guidance</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This section addresses certain types of transactions that may expose you and the Company to significant risks. You should understand that, even though a transaction may not be expressly prohibited by this section, you are responsible for ensuring that the transaction otherwise complies with this Policy, including the general prohibition against insider trading as well as pre-clearance procedures and blackout periods, if applicable.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Short Sales</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy prohibits short sales (i.e., the sale of a security that must be borrowed to make delivery) and &#x201c;selling short against the box&#x201d; (i.e., a sale with a delayed delivery) with respect to Company securities. Short sales may signal to the market possible bad news about the Company or a general lack of confidence in the Company&#x2019;s prospects, and an expectation that the value of the Company&#x2019;s securities will decline. In addition, short sales are effectively a bet against the Company&#x2019;s success and may reduce the seller&#x2019;s incentive to improve the Company&#x2019;s performance. Short sales may also create a suspicion that the seller is engaged in insider trading.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Derivative Securities and Hedging Transactions</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy prohibits transactions in publicly-traded options, such as puts and calls, and other derivative securities with respect to the Company&#x2019;s securities. This prohibition extends to any hedging or similar transaction designed to decrease the risks associated with holding the Company securities. Stock options, restricted stock units, restricted stock, stock appreciation rights and other securities issued pursuant to the Company benefit plans or other compensatory arrangements with the Company are not subject to this prohibition.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transactions in derivative securities may reflect a short-term and speculative interest in the Company&#x2019;s securities and may create the appearance of impropriety, even where a transaction does not involve trading on material non-public information. Trading in derivatives may also focus attention on short-term performance at the expense of the Company&#x2019;s long-term objectives. In addition, the application of securities laws to derivatives transactions can be complex, and persons engaging in derivatives transactions run an increased risk of violating securities laws.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Using Company Securities as Collateral for Loans</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not pledge the Company securities as collateral for loans without the approval of a Compliance Officer. If you default on the loan, the lender may sell the pledged securities as collateral in a foreclosure sale. The sale, even though not initiated at your request, is still considered a sale for your benefit. If made at a time when you are aware of material non-public information or otherwise are not permitted to trade in the Company securities, the sale may result in inadvertent insider trading violations, Section 16 violations (for officers and directors), violations of this Policy and unfavorable publicity for you and the Company. For these reasons, even if you are permitted to pledge the Company securities as collateral for loans, you should exercise caution when doing so.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holding Company Securities in Margin Accounts</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not hold the Company securities in margin accounts without the approval of a Compliance Officer. Under typical margin arrangements, if you fail to meet a margin call, the broker may be entitled to sell securities held in the margin account without your consent. The sale, even though not initiated at your request, is still considered a sale for your benefit. If made at a time when you are aware of material non-public information or are otherwise not permitted to trade in the Company securities, the sale may result in inadvertent insider trading violations, Section 16 violations (for officers and directors), violations of this Policy and unfavorable publicity for you and the Company. For these reasons, even if you are permitted to hold the Company securities in margin accounts, you should exercise caution when doing so.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">E.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Placing Open Orders with Brokers</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except in accordance with an approved trading plan (as discussed below), you should exercise caution when placing open orders, such as limit orders or stop orders, with brokers, particularly where the order is likely to remain outstanding for an extended period of time. Open orders may result in the execution of a trade at a time when you are aware of material non-public information or otherwise are not permitted to trade in the Company securities, which may result in inadvertent insider trading violations, Section 16 violations (for officers and directors), violations of this Policy and unfavorable publicity for you and the Company. If you are subject to blackout periods or pre-clearance requirements, you should inform your broker when you place any open order at the time the order is placed.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limited Exceptions</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are certain limited exceptions to the restrictions imposed by the Company under this Policy. Please be aware that even if a transaction is subject to an exception to this Policy, you will need to separately assess whether the transaction complies with applicable law. For example, even if a transaction is indicated as exempt from this Policy, you may need to comply with the &#x201c;short-swing&#x201d; trading restrictions under Section 16 of the Exchange Act, if applicable. You are responsible for complying with applicable law at all times.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transactions Pursuant to a Trading Plan that Complies with SEC Rules</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC has enacted rules that provide an affirmative defense against alleged violations of U.S. federal insider trading laws for transactions pursuant to trading plans that meet certain requirements. In general, these rules, as set forth in Rule 10b5-1 under the Exchange Act, provide for an affirmative defense if you enter into a contract, provide instructions or adopt a written plan for trading securities when you are not aware of material non-public information. The contract, instructions or plan must (i) specify the amount, price and date of the transaction, (ii) specify an objective method for determining the amount, price and date of the transaction and/or (iii) place any subsequent discretion for determining the amount, price and date of the transaction in another person who is not, at the time of the transaction, aware of material non-public information.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transactions made pursuant to a written trading plan that (i) complies with the affirmative defense set forth in Rule 10b5-1, (ii) complies with the requirements set forth in Appendix A hereto and (iii) is approved by a Compliance Officer, are not subject to the restrictions in this Policy against trades made while aware of material non-public information or to the pre-clearance procedures or blackout periods established under this Policy. In approving a trading plan, a Compliance Officer may, in furtherance of the objectives expressed in this Policy, impose criteria in addition to those set forth in Rule 10b5-1. You should therefore confer with a Compliance Officer prior to entering into any trading plan.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC rules regarding trading plans are complex, and you must comply with them completely for your trading plan to be effective. The description provided above is only a summary, and the Company strongly advises that you consult with your personal legal advisor if you intend to adopt a trading plan. While trading plans are subject to the Company review and approval, you are ultimately responsible for compliance with Rule 10b5-1 and this Policy.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A Compliance Officer must keep a copy of each adopted trading plan. The Company may publicly disclose information regarding trading plans that you may enter.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Receipt and Vesting of Stock Options, Restricted Stock Units, Restricted Stock and Stock Appreciation Rights</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions under this Policy do not apply to the grant or award of stock options, restricted stock units, restricted stock or stock appreciation rights issued or offered by the Company, or the mandatory &#x201c;sell to cover taxes&#x201d; for restricted stock units. The trading restrictions under this Policy also do not apply to the vesting, cancellation or forfeiture of stock options, restricted stock units, restricted stock or stock appreciation rights in accordance with applicable plans and agreements. The trading restrictions do apply, however, to any subsequent sales of any such securities or the common stock underlying such securities, including discretionary &#x201c;sell to cover taxes&#x201d; for restricted stock units or &#x201c;net exercises&#x201d; of stock options.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise of Stock Options for Cash</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions under this Policy do not apply to the exercise of stock options for cash under the Company&#x2019;s stock option plans. Likewise, the trading restrictions under this Policy do not apply to the exercise of stock options in a stock-for-stock exercise with the Company or an election to have the Company withhold securities to cover tax obligations in connection with an option exercise. However, the trading restrictions under this Policy do apply to (i) the sale of any securities issued upon the exercise of a stock option, (ii) a cashless exercise of a stock option through a</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">broker, because this involves selling a portion of the underlying shares to cover the costs of exercise, and (iii) any other market sale for the purpose of generating the cash needed to pay the exercise price of an option or to pay withholding taxes related to the settlement of restricted stock units or stock option exercises.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchases from the Employee Stock Purchase Plan</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions in this Policy do not apply to elections with respect to participation in the Company&#x2019;s employee stock purchase plan or to purchases of securities under the plan. However, the trading restrictions do apply to any subsequent sales of any such securities acquired therefrom.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">E.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock Splits, Stock Dividends and Similar Transactions</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions under this Policy do not apply to a change in the number of securities held as a result of a stock split or stock dividend applying equally to all securities of a class, or similar transactions.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">F.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bona Fide Gifts and Inheritance</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading restrictions under this Policy do not apply to bona fide gifts involving the Company securities or transfers by will or the laws of descent and distribution. However, the trading restrictions under this Policy do apply to the sale of any gifted or inherited securities if the recipient, for example, an immediate family member, is subject to this Policy. See &#x201c;Persons and Transactions Covered by this Policy&#x201d; above. In other words, you cannot use a gift to conduct a transaction that otherwise would be prohibited under this Policy. Please also note that under the Company&#x2019;s stock option plans, a stock option or other equity award may not be gifted or transferred except under very limited circumstances.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">G.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Change in Form of Ownership</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transactions that involve merely a change in the form in which you own securities are not subject to the trading restrictions under this Policy. For example, you may transfer shares to an inter vivos trust of which you are the sole beneficiary during your lifetime.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">H.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Exceptions</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any other exception from this Policy must be approved by a Compliance Officer, in consultation with the Board of Directors or an independent committee of the Board of Directors.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance with Section 16 of the Securities Exchange Act</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obligations under Section 16</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 16 of the Exchange Act, and the related rules and regulations, set forth (i) reporting obligations, (ii) limitations on &#x201c;short-swing&#x201d; transactions and (iii) limitations on short sales and other transactions applicable to directors, officers, large shareholders and certain other persons.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#x2019;s Board of Directors has determined that those persons listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule III </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">are required to comply with Section 16 of the Exchange Act, and the related rules and regulations, because of their positions with the Company. A Compliance Officer may amend </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule III </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from time to time as appropriate to reflect the election of new officers or directors, any change in the responsibilities of officers or other employees and any promotions, demotions, resignations or departures.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule III </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">is not necessarily an exhaustive list of persons subject to Section 16 requirements at any given time. Even if you are not listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule III</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, you may be subject to Section 16 reporting obligations because of your shareholdings, for example.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notification Requirements to Facilitate Section 16 Reporting</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To facilitate timely reporting of transactions pursuant to Section 16 requirements, if you are subject to Section 16 reporting requirements you must provide, or must ensure that your broker provides, the Company with detailed information (e.g., trade date, number of shares, exact price, etc.) regarding your transactions involving the Company&#x2019;s securities, including gifts, transfers, pledges and transactions pursuant to a trading plan, both prior to the transaction (to confirm compliance with pre-clearance procedures, if applicable) and on the date of the transaction.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Personal Responsibility</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The obligation to file Section 16 reports, and to otherwise comply with Section 16, is personal. The Company is not responsible for the failure to comply with Section 16 requirements.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.85in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nformation</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Availability of Policy</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy will be made available to all the Company directors, officers, employees and agents when they commence service with the Company. You are required to acknowledge that you understand, and agree to comply with, this Policy.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendments</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is committed to continuously reviewing and updating this Policy and any other the Company policies and procedures. The Company therefore reserves the right to amend, alter or terminate this Policy at any time and for any reason, subject to applicable law. A current copy of the Company&#x2019;s policies regarding insider trading may be obtained by contacting a Compliance Officer.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*     *     *</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nothing in this Policy creates or implies an employment contract or term of employment.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The policies in this Policy do not constitute a complete list of the Company policies or a complete list of the types of conduct that can result in discipline, up to and including discharge.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.79in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.4in;z-index:-3;min-height:1.15in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule I</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individuals Subject to Quarterly Blackout Periods</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All directors, officers, employees and agents (such as consultants and independent contractors) of the Company.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1.15in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule II</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individuals Subject to Pre-Clearance Requirements</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All Directors, Senior Vice Presidents or above, any other Direct Reports to the Chief Executive Officer, designated employees working in Finance or Accounting, designated Vice Presidents, or any administrative assistant to any of the individuals listed herein.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Schedule III</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individuals Subject to Section 16 Reporting and Liability Provisions</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All Directors and all Section 16 Officers as designated by the Board of Directors from time to time.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appendix A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Requirements for Rule 10b5-1 Trading Plans</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A Rule 10b5-1 &#x201c;trading plan&#x201d; involving purchases or sales of the Company securities must comply with the requirements of Rule 10b5-1 and must meet the following requirements:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading plan must be in writing and signed by the person adopting the trading plan.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading plan must be adopted at a time when:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the person adopting the trading plan is not aware of any material non-public information; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:5.9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there is no quarterly, special or other trading blackout in effect with respect to the person adopting the trading plan.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading plan must include a written representation by the insider that such insider is not aware of any material nonpublic information concerning the Company and that such insider is adopting the trading plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The individual adopting the trading plan may not have entered into or altered a corresponding or hedging transaction or position with respect to the securities subject to the trading plan and must agree not to enter into any such transaction while the trading plan is in effect.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each trading plan used by an insider must be subject to a &#x201c;cooling off&#x201d; period prior to the first trade after adoption or modification, as follows:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For insiders other than directors and executive officers, the first trade under the trading plan may not occur until after the later of (i) the termination of the current quarterly blackout period, if then in effect, following adoption or modification of the trading plan and (ii) 30 calendar days after adoption or modification of the trading plan.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For insiders that are directors or executive officers, the first trade under the trading plan may not occur until after the later of (i) 90 calendar days after adoption or modification of the trading plan and (ii) two business days following the filing of a Form 10-Q or Form 10-K for the fiscal quarter in which the plan was adopted or modified (but not to exceed 120 days after adoption or modification of the trading plan).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading plan must have a minimum term of one year and a maximum term of two years (each starting from the time when trades may first occur in accordance with these requirements).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All transactions during the term of the trading plan (except for the other &#x201c;Limited Exceptions&#x201d; identified in the Company&#x2019;s insider trading policy) must be conducted through the trading plan.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regarding modifications:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading plan may only be modified when the person modifying the trading plan is not aware of material non-public information.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading plan may only be modified when there is no quarterly, special or other blackout in effect with respect to the person modifying the plan.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The first trade under the modified trading plan must be subject to the &#x201c;cooling off&#x201d; period as specified in item 5 above. The existing plan would remain in effect until the modified plan comes into effect.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The modified trading plan must have a minimum duration of one year and a maximum term of two years (each starting from the time when trades may first occur under the modified plan in accordance with these requirements).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A person may only modify a trading plan once in a one-year period.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise approved by the Compliance Officer in situations where having multiple plans in place at one time is permissible under the provisions of Rule 10b5-1, an insider may have only one trading plan in effect at any time.  However, an insider may adopt a new trading plan while an existing trading plan is in place so long as (i) the first trade under the new trading plan may not occur prior to the expiration of the existing trading plan in accordance with its terms and (ii) the new trading plan complies with the cooling off period and other requirements of this Policy.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During any 12-month period, an insider may enter into only one trading plan that is designed to effect the purchase or sale or other transfer of the total amount of the Company&#x2019;s securities covered by the trading plan in a single transaction; provided the Compliance Officer may approve an additional non-concurrent single-trade trading plan if that plan is in place solely to satisfy withholding tax requirements and the insider does not control the timing of such sales.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the person that adopted the trading plan terminates the plan prior to its stated duration, he or she may not trade in the Company&#x2019;s securities until the completion of the next upcoming quarterly blackout period after termination (or, if the plan is terminated during a quarterly blackout period, the end of that blackout period).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company must be promptly notified of any modification or termination of the trading plan, including any suspension of trading under the plan.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">14.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the trading plan grants discretion to a stockbroker or other person with respect to the execution of trades under the plan:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the person adopting the trading plan may not confer with the person administering the trading plan regarding the Company or its securities; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the person administering the trading plan must provide prompt notice to the Company of the execution of a transaction pursuant to the plan.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">15.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All transactions under the trading plan must be in accordance with applicable law.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">16.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading plan (including any modified trading plan) must meet such other requirements as a Compliance Officer may determine.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">17.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A Compliance Officer must approve and keep a copy of each adopted trading plan.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certification</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">            </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have received and read a copy of the TScan Therapeutics, Inc. Insider Trading Policy. I hereby agree to comply with the specific requirements of the Policy in all respects during my employment or other service relationship with TScan Therapeutics, Inc., and for such period of time after cessation of my service as provided in the policy. I understand that my failure to comply in all respects with the Policy is a basis for termination of my employment or other service relationship with TScan Therapeutics, Inc.</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Please print name)</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Signature)</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:9.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Date)</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.19in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>tcrx-ex21.htm
<DESCRIPTION>EX-21
<TEXT>
<html>
 <head>
  <title>EX-21</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.8in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 21</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsidiaries</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"></td>
    <td style="width:50%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Subsidiary</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jurisdiction of Incorporation</font></p><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">or Organization</font></p></td>
   </tr>
   <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TScan Securities Corporation</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Massachusetts</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>tcrx-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consent to the incorporation by reference in Registration Statement Nos. 333-257941, 333-263380, 333-270343, 333-272733, 333-277695 and 333-280212 on Form S-8 and Registration Statement Nos. 333-268260, 333-268261 and 333-277699 on Form S-3 of our report dated March 5, 2025, relating to the financial statements of TScan Therapeutics, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Deloitte &amp; Touche LLP</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:13.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Boston, Massachusetts</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 5, 2025</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>tcrx-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Gavin MacBeath</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, certify that:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Report </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.46%;box-sizing:content-box;"></td>
    <td style="width:5.04%;box-sizing:content-box;"></td>
    <td style="width:3.04%;box-sizing:content-box;"></td>
    <td style="width:46.46%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 5, 2025</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">Gavin MacBeath</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gavin MacBeath</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>tcrx-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Jason A. Amello, certify that:</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report of TScan Therapeutics, Inc.;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.46%;box-sizing:content-box;"></td>
    <td style="width:5.04%;box-sizing:content-box;"></td>
    <td style="width:3.04%;box-sizing:content-box;"></td>
    <td style="width:46.46%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 5, 2025</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jason A. Amello</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Jason A. Amello</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>tcrx-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Annual Report of TScan Therapeutics, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ending December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.87%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.617714099641811%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:7.87%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.617714099641811%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.46%;box-sizing:content-box;"></td>
    <td style="width:5.04%;box-sizing:content-box;"></td>
    <td style="width:3.04%;box-sizing:content-box;"></td>
    <td style="width:46.46%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 5, 2025</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gavin MacBeath</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gavin MacBeath</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Principal Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>tcrx-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.2</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Annual Report of TScan Therapeutics, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ending December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.451%;box-sizing:content-box;"></td>
    <td style="width:5.059%;box-sizing:content-box;"></td>
    <td style="width:3.039%;box-sizing:content-box;"></td>
    <td style="width:46.451%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 5, 2025</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jason A. Amello</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Jason A. Amello</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Principal Financial and Accounting Officer</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img181012247_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_0.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (F!)L# 2(  A$! Q$!_\0
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M!M-*2NFTTGHQ*46YQ33E3DX5(IIN$TDW":WC)*46XRLTFG:S04445 PHHHH
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MZ(L*Q%25,80)@D;<&GV]O;VD$5K:P0VUM!&L4%O;Q)#!#$@VI'%%&JQQQH
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M0QFM@.98P"73( .:UD^XO(/RKRHPIX'*CL/0=A65K\OD:)JDWVO[!Y5C</\
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MDU6_!#6_CSJ_B[2OV==#T[6X/AC\#[R[_:/\/>(]=^(/[</QK\,_#CQA\5_
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MFZ;KW<'[;%XS%*,(.G&FL9BJV*=)+GG=4Y5I0BTXW@H^ZFFV4445S&H4444
M8MRZ#7]+C,NGK(^G:LRPRVY?4I%2;3 [V=SC;#:QEE%[$2#,[VC 'R3C:K&N
M)MNNZ9!]L\OS-/U63[#]@\W[3Y<NG#[1_:.,V?V7S-GV;(^V?:=Y!^RC&S3>
MT?3_ -NEY+\+^M[I2MY_XE_Z3'?5_C;3I:S91112*"O!?VJ 3^S'^T4 ,D_
MWXK@#U/_  @FNX'XU[U16=:G[6C5I<W+[6G.GS6OR\\7'FM=7M>]KJ_=&^%K
M?5L3A\1R\_U>O1K<G-R\_LJD9\O-:7+S<MN;EE:][/8_"GXB_ WXF7G[&WQ+
M_:(^*FO^ H]2TS_@G-J'P>\ ^&/AIHNN6Y'A76O#V@>++G7/''B'Q%>37&N:
M]%)HNEVVDZ38Z39:/H7FZU/%-?R:JQ@[GQ[XD;]EOQ#\>?#T_C+X\>.OAS-^
MRI\$_B)JFG:]\>?'EOKEEX]\2_%_6OAUJWBK2_B?J%_J>J_!KPW?V$NF7GCN
M]\"PZ3H'A70-*OM8\/\ AW3FLD@/[.TR2..:-XI426*5&CDCD57CDC=2KHZ,
M"KHZDJRL"K*2""#7T%?.YXC$U*E3#Q^J5,1C:DL$IQ4)8?&SS'$RPTJGLFY.
M.89C/,95I0;J8JG3G[.+IT'1\NA@HT<+A*#J2E6PT,.OK24H2=7#RX=I0JTX
M1J+V-LMX?661C"IS+#8RIS5)-5EBOP:\%>//%&N_";]J#PO!^TAX"\#>%/!W
M[0WP>3P3K.M?M>?%CQ3\,=<T+4? _ASQ-XO^#NC?M>^)(]%^*VD:)XWU&PUJ
MR_M_2'N)] UN75-$T:*[L))K*3$\6?'+Q!\1[CX*6L'C5/@9\&?$/[-?B37O
MA[>_&G]M?XP?!ZSNOBCI/Q1\3^%/$6M67QY\-6'B+5_CE=^&-%TCPWXB\!VW
MC776TK6?!'B"W\6/HVHQW;C3/WV?3=.EL/[+DT^RDTSR4M_[.>U@>P^SQA1'
M!]D:,V_DQA5"1>7L4*NU1@8+K3--OH8;:]T^RO+>WDBE@M[JT@N(8)8/]1+#
M%+&\<<D/_+)T56C_ ("M3+-:,IIO"SY56H5%_M-3VEZ?#CR*=:59*-:>)E75
M+-*5:I5G/"XFG-X:5+$XG%8VMK"C*$+<\>?V52FI*E#ECS9U3S=15)IT?9SI
MQJ9?B(JFOK6%K.GB?;X6EAL'0^3/%?Q\\,_LV_LC^$/C+^T+XU\-^-+CP[X$
M\ '5O%WARXL&T3XC?$#5-+TVSTR^\(ZAJBZ5I=O!XPUZX6\TO6M1?1])TZPO
M'UC4KG2]*M;J>W^$_#'B/P]JG[+/C_PU\-?C!\*_B%\;?VY_VC;SP_XVD^!_
MCSP]X]\,?##Q)\;+:T?QKH>EZOX:OKU'D^%_P(\,ZQJ<^LW"VT^MZUI$^O)%
M!;ZG;1Q_M97$ZY\._!_B3QEX(\?ZWI!O_%7PX3Q*O@O4)+_4T@T23Q=I]OI.
MOW<6E0WD>D75_=Z7;#3X-0O[&ZO=.L[G4+?3I[2/4K];G&ECL,J^,K5\+S?7
M<7&K5ITW2CAWE\<7AL?4RF>%5",)8?'XG"4:>+JTYT73H4\*\+2I?5J]+'I4
MJM.A@Z5&LX3P-*4J-:7/.JLQC@L7@L%F"J2FYJ6 CBZM6G0FZD:\JV*6)J5)
M5<-4P7Y1?M_^,/ _AGP99?"#P?\ &'X-0Z9\.-;^ ZZ[^QO!I-K8_'?XQ/X<
M\6>%-5\&^%O!'B5/%%SK>G6VHZ;8^&HM._L/X4Z]))%H5]8OXLTBVDOGTC]C
MXG+Q1.T;1,\:.T3XWQEE!,;X)&Y"=K8)&0<$BJ\FGV$UW;ZA-8V<M_:))':W
MLEM#)=VT<HQ*EO<LAFA20$B18W57'W@:N5A6QCK82CAYJ<JT<9C,=7Q%2<9R
MKU\;1P-*K)VIQJ2;>"C+GKU:\U"4*,91A13J5"A&G5C*FHTZ5/"8?!TJ,$U&
M-/#NHX>ZI>SCR^UE&/LZ<)26M>=9JG[(HHHKB-PHHHH **** "BBB@ HHHH
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M<G/'VBDX<T>=0:4W"ZYE%R32DU?E;32=FTUH? W_  ]5_P"">/\ T==\,?\
MO_KG_P IJ['XD_\ !17]B3X0WGA;3_B'^T9X T"_\9^']"\5^'[-)=7UFZN/
M#?B:SAU'P_K=_!H&EZI)H>G:OI]Q#?6-SKJZ:D]G(ERI\D[Z_,*;X'?!4?\
M!<6U\ CX/_"[_A!3^QM_;9\%?\*_\)_\(D=:_M^\3^USX<_LC^QSJFQ53[>;
M/[7M 7S< "L3]I7X-?M'_P#!/_\ :1_:!_;;^$OP:^%O[2'[,?Q2\*Z!'\7O
MAOK$%AIGBWX:>#?">DZ?I][9>'X9K26"U\)V-K8 P?V-IGB33;?10EKKOA.V
MM-"M-87Z>.7Y-*65\U;%X:&99=C<?3GBL3AJ=%UL+F..RRAET\3]6<,)/%U,
M%4KQQU:$\/1C%4*E-U*T*D>-RQ?M,?2I4X8BM@ZV74%1I1E[:JL?@<LS*>)I
M0E4_??5*&/=)X&#C7Q53EJ4JU.%.<)_MY\2/VE/@'\(/AKI?QA^)7Q:\$^$O
MAIKMKIU[X>\7:CK5N^F^)8-7LUU'2SX92S-S>>))M0T]A?VEMH=M?W,]D'NH
MX6@C>1<WX _M4_L\_M2:1K&M_ 'XK>&?B58^'KBVM=>BT=[ZSU719;U9GL3J
MVA:U9:9KFGPWZVUS]@N;O3HK:]-K=+:RS-;3B/\  S6_'7P@_;._X*6?\$X;
M35_"UC;?LS:E^R]<_$;X4?"7Q%I.G6?A.#Q7%;_$*,Z!/X:A0^';A]"U/P5I
M6E?V;:P2Z7<Q^%+"V@@EL)$BE_;[XGZA\"/V.-'\2?'32/@3K<FJ^+;CPKX0
M\4I^SY\)?^$B\9Z_!8/K$V@3ZOH'A6&R-W8:,;O48WUB[7S+9+JVM))WC^R0
MIAC<LP^7T:<,5#&QS#'8C,*6$PRE0<,'+!9YBLDIX;&R47]9Q5:O@<0ZOU>5
M"GAW4P_+]83F12Q$\3-0PTJ-2-#!Y9B\16<:D88F./RZAFM2>&IMJIAZ%'"8
MF#IU*WMW7JTZU&4:/+*</?\ XB_$KX?_  B\(:OX_P#B?XQ\.^ _!>A0B;5O
M$OBC5+72-*M YVPQ-<W<D:RW5S)B&SLH!+>7MPR6]I!-.Z1MBZ3\;/A+K?PH
MA^.FG?$'PP_P?G\/3^+$^(MSJ46G^%E\-VOF_:-8GU+4?LL=M90F"57DN1$0
MZ%-N\A3^;'[:&B_ _P#;4_81^(_[0WB/X7_$"TNOA;\)/CSKWPS\/_%[P_XD
M\ ZSX:\5P>&;[2W\3ZGX!N[V.TO;^T;24N/"VHZO!J$5E'/)J&FK#<RB6/\
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M./\ PNOX-?\ 16_AE_X7OA7_ .6M'_"Z_@U_T5OX9?\ A>^%?_EK1_K5PO\
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M_#+_ ,+WPK_\M:/^%U_!K_HK?PR_\+WPK_\ +6C_ %JX7_Z*3(/_  \9=_\
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M %JX7_Z*3(/_  \9=_\ -'FOO#^Q\W_Z%69?^$.*_P#E7FOO/H[_ (2S3O\
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M:W_=M;32W/>^ _@9X0^''Q0^,GQ4\,WWB"#4OCC=^#=5\8^&IKK36\(6VO\
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M_G('_$=N"_\ H'S[_P (<+_\\/ZL_*_X@45^W_\ PPQ^S[_T!?$/_A3ZE_\
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M_P 1VX+_ .@?/O\ PAPO_P \/ZL_*_X@45^W_P#PPQ^S[_T!?$/_ (4^I?\
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M"^(?_"GU+_XJC_AAC]GW_H"^(?\ PI]2_P#BJ/\ B3/Q;_Z#>#/_  \9E_\
M.0/^([<%_P#0/GW_ (0X7_YX?U9^5_Q HK]O_P#AAC]GW_H"^(?_  I]2_\
MBJ/^&&/V??\ H"^(?_"GU+_XJC_B3/Q;_P"@W@S_ ,/&9?\ SD#_ (CMP7_T
M#Y]_X0X7_P">']6?E?\ $"BOV_\ ^&&/V??^@+XA_P#"GU+_ .*H_P"&&/V?
M?^@+XA_\*?4O_BJ/^),_%O\ Z#>#/_#QF7_SD#_B.W!?_0/GW_A#A?\ YX?U
M9^5_Q HK]O\ _AAC]GW_ * OB'_PI]2_^*H_X88_9]_Z OB'_P *?4O_ (JC
M_B3/Q;_Z#>#/_#QF7_SD#_B.W!?_ $#Y]_X0X7_YX?U9^5_Q HK]O_\ AAC]
MGW_H"^(?_"GU+_XJII/V%?V?5C@;^Q->'F([?+XJU-F.V61/WB[_ -VWRX50
M &0*_5B:/^),_%O_ *#>#/\ P\9E_P#.0/\ B.W!?_0/GW_A#A?_ )X?U9^5
M_P .J*_;_P#X88_9]_Z OB'_ ,*?4O\ XJC_ (88_9]_Z OB'_PI]2_^*H_X
MDS\6_P#H-X,_\/&9?_.0/^([<%_] ^??^$.%_P#GA_5GY7_$"BOV_P#^&&/V
M??\ H"^(?_"GU+_XJC_AAC]GW_H"^(?_  I]2_\ BJ/^),_%O_H-X,_\/&9?
M_.0/^([<%_\ 0/GW_A#A?_GA_5GY7_$"BOV__P"&&/V??^@+XA_\*?4O_BJ/
M^&&/V??^@+XA_P#"GU+_ .*H_P"),_%O_H-X,_\ #QF7_P Y _XCMP7_ - ^
M??\ A#A?_GA_5GY7_$"BOV__ .&&/V??^@+XA_\ "GU+_P"*H_X88_9]_P"@
M+XA_\*?4O_BJ/^),_%O_ *#>#/\ P\9E_P#.0/\ B.W!?_0/GW_A#A?_ )X?
MU9^5_P 0**_;_P#X88_9]_Z OB'_ ,*?4O\ XJC_ (88_9]_Z OB'_PI]2_^
M*H_XDS\6_P#H-X,_\/&9?_.0/^([<%_] ^??^$.%_P#GA_5GY7_$"BOV_P#^
M&&/V??\ H"^(?_"GU+_XJC_AAC]GW_H"^(?_  I]2_\ BJ/^),_%O_H-X,_\
M/&9?_.0/^([<%_\ 0/GW_A#A?_GA_5GY7_$"BOV__P"&&/V??^@+XA_\*?4O
M_BJ/^&&/V??^@+XA_P#"GU+_ .*H_P"),_%O_H-X,_\ #QF7_P Y _XCMP7_
M - ^??\ A#A?_GA_5GY7_$"BOV__ .&&/V??^@+XA_\ "GU+_P"*H_X88_9]
M_P"@+XA_\*?4O_BJ/^),_%O_ *#>#/\ P\9E_P#.0/\ B.W!?_0/GW_A#A?_
M )X?U9^5_P 0**_<2']A;]GUYH4_L37COEC3$GBG4T0[G P[A@40Y^9P05&3
MGBHV_87_ &?0Q']B^(."1QXHU(CKV.[D>AH_XDS\6_\ H-X,_P##QF7_ ,Y
M_P"([<%_] ^??^$.%_\ GA_5GY7_  _HK]O_ /AAC]GW_H"^(?\ PI]2_P#B
MJ/\ AAC]GW_H"^(?_"GU+_XJC_B3/Q;_ .@W@S_P\9E_\Y _XCMP7_T#Y]_X
M0X7_ .>']6?E?\0**_;_ /X88_9]_P"@+XA_\*?4O_BJ/^&&/V??^@+XA_\
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MC$T9\RY\QSOZI>,O9U,'A<SG&BZ-6WLZM.EA,5@+.,Y/V=:C)M\USU:BBBN
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M )8_^!O_ .0/<:*\.N/V:_@5='4&N/AGX=E.J_"*V^ FHEDO/]+^#UF%%KX
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MY]Y_^_,G_P 31]EN?^?>?_OS)_\ $UJ?\)%K'_/T/_ >V_\ C-'_  D6L?\
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M?^ ]M_\ &:/^$BUC_GZ'_@/;?_&: ,O[+<_\^\__ 'YD_P#B:/LMS_S[S_\
M?F3_ .)K4_X2+6/^?H?^ ]M_\9H_X2+6/^?H?^ ]M_\ &: *-O:W)N( ;5V!
MFB!6:.1(F&]?EE; VQGH[9&%R<\5$UK<[F_T:8<G@12$#GL=O(]/:MFW\0:N
M\\*?:$??-&NQXK>-'W.HVO((@45LX9P05!)!!&:B;Q%JX8C[4HP3P(+8@<]
M?*.1Z'/- &5]EN?^?>?_ +\R?_$T?9;G_GWG_P"_,G_Q-:G_  D6L?\ /T/_
M  'MO_C-'_"1:Q_S]#_P'MO_ (S0!E_9;G_GWG_[\R?_ !-'V6Y_Y]Y_^_,G
M_P 36I_PD6L?\_0_\![;_P",T?\ "1:Q_P _0_\  >V_^,T 9?V6Y_Y]Y_\
MOS)_\31]EN?^?>?_ +\R?_$UJ?\ "1:Q_P _0_\  >V_^,T?\)%K'_/T/_ >
MV_\ C- &7]EN?^?>?_OS)_\ $T?9;G_GWG_[\R?_ !-:G_"1:Q_S]#_P'MO_
M (S1_P )%K'_ #]#_P ![;_XS0!E_9;G_GWG_P"_,G_Q-'V6Y_Y]Y_\ OS)_
M\36I_P )%K'_ #]#_P ![;_XS1_PD6L?\_0_\![;_P",T 9?V6Y_Y]Y_^_,G
M_P 31]EN?^?>?_OS)_\ $UJ?\)%K'_/T/_ >V_\ C-'_  D6L?\ /T/_  'M
MO_C- &7]EN?^?>?_ +\R?_$T?9;G_GWG_P"_,G_Q-:G_  D6L?\ /T/_  'M
MO_C-'_"1:Q_S]#_P'MO_ (S0!E_9;G_GWG_[\R?_ !-'V6Y_Y]Y_^_,G_P 3
M6I_PD6L?\_0_\![;_P",T?\ "1:Q_P _0_\  >V_^,T 4DM;G[-,?LK$^;
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M6/\ GZ'_ (#VW_QF@#+^RW/_ #[S_P#?F3_XFC[+<_\ /O/_ -^9/_B:U/\
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MM;2_LKR%X;JPO8(;JUNK=\+)%<6LZR13PL&"NDD;(V0&!S5H         #
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M6^YD\8:(SN?.DP95^VGRV PJK@;HU1^=V:_G6HH_XG>XQ_Z(OAG_ ,*LT_\
MEWK_ $M3_B7_ "/_ *'V;?\ @G!__(>O]+7^B/\ X7]\#_\ HK?P\_\ "MT7
M_P"3*/\ A?WP/_Z*W\//_"MT7_Y,K^=RBC_B=[C'_HB^&?\ PJS3_P"7>O\
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MN,?^B+X9_P#"K-/_ )=Z_P!+4_XE_P C_P"A]FW_ ()P?_R'K_2U_HH@^/\
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ML-D=6DL-1P%?-,5EN98'#8"GBLNP]2EB98KHJ\58"4J]6&7U9>VKUVL!4G;
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M5YI<M'"U,17JN%"E5JT^[\<?LH?#+QYXH\6>*M0N_%&DW'B_]FS7OV6+S2M
MO=&L=%TWX;>(-2?4[B[T:TN-!O9[3Q-92,+;3KR:[NM'M[2..*70IW4RGS'P
M+^P5X&\-7_PQG\<_&3]H#X[:)\%YM#O?A9X)^+OBOP3)X$\'ZQX7L$TSPOKT
M7A?X;_#KX<:?K^M^&K) F@W_ (N7Q"^E3DWUFL5^%NE]P\'?'*U\7_'_ .-7
MP'C\.7%C=?!OPO\ "GQ-<^)7U*.>WU]/BC;>*;F"S@TQ;**33VT8>&626:2]
MNQ>F\4I%;" B4^"OQRM?C)KGQUT6V\.7&@-\$/C1K7P=N;B?4H]07Q%<:-X:
M\+>(GUZ"..RM#IL-POB=+1=/D>]DC:S:8W;"<11;4:V8TO:1I5*D72PD,QDW
M*$IT\.L?)T\73G-N4*L<PS^I*$Z4EB85,?5G&T54E#*M##M*%6$5'V]/+N11
M<8NIB<HH5(X248)*5&MD^3X>-2E)/#SHX.E1JISY82\;U[]BX^-/$^FS?$;]
MHSX^?$CX5:'\0]/^*>C_  /\5WWPXF\))XKT77AXF\/6FJ^*].^'FG?$_P 1
M>$?#>MQVU]H7A36_&]W86SV.GP7LM_:6<=O7KG[.?@OXJ>$/"7BV\^,?BN\\
M1>,O'GQ0\=_$)=&EUN\\0:3\-_#GB+4T3PK\-/#.HWN&?1?"^@6%AYJVT5O8
M'7;W6I=/@2SEAS] 45S_ %NM[#ZNW%TN5P2]G!-<[PKJU&XQ7/B*ZP.!A6Q=
M3GQ4Z6#H4/;*BITYZRA&=1U97YW.$V[M?PEC%3IK^2A"688VHL/3Y:#K8B=>
M5-UE"<2BBBN8L**** "BBB@ HHHH *9(XC1Y",A$9R!U(4$D#\J?6'XGUVV\
M+>&O$/B>\L-;U6T\.:'JVNW6E^&M$U+Q-XCU*VTBPN-0GL/#_AS1K:\UCQ!K
M=Y%;M;Z5HFE6EUJ6JW\D%A8VT]U<11,I1G*+C3=IR3C!VYK3:M%\O6SMIUV&
MFDTWJDTVKVTZZ]-.I^"=SXC\1']@SX%?&W2=)U/Q1\0/C+_P43\'_%S6M%TO
M5=/T?5?%NM:S^TAK^G:1X535M8O=-TBT4>'M \.^$K)M8O[72K*SL+6.[F@M
M(&*?5$/Q-^+?CG_@H3^RQ;?$?X$^,O@1;VGP6_:9>PLO$GQ ^&GC*#Q47?X6
M&::&/X:^+?$T%HVCF.(,=:%H\IOT-CYHCN3'SW@'X:Z+X8^%?Q!^!GQ8\!_M
M"Q^#_P!EK]I31OVD?A#J_P .?A9XOUR;Q]X*USXAK\7_ (<^'_#T=KX/\02>
M+]5\*ZYXHU3PE\1?!7ANU/B?1+/0WNIY]*CE2[7Z?^+ ^&WB'XH2_%O5="_:
M>L?&/P!^#GBK2M,G\!?"'QEJ-EJVA_'ZV\-0:B_@R$?#_79?'?Q$\*'0=.N'
MT+PO=7EUX1N1?-XJT&ZC01V_TSQ,*+YJ>$]M3E7X@Q6"A+VO-@\%F_ F6Y1D
MN%A[.<80K4:[P^7XJC7IUE@X0O&$:D>8X:M/VV(K7JJE>.%P^(Q$4FL5B<+Q
MIG&:8_$\LE*^&Q&'Q"QN&E15*595_9\[BH*/Y7ZQ^UQ\*(?VSX/VK%_:"\$#
M4M+_ &EU_9'F^#8^(FDC66_9O;3CX%O_ !TW@L:I]L<Q_'6:7Q^M[_9IF;PA
M;17WF?80)3^VX^,?PI^)/C#QA\ @?B,_B+^R_$&C>(HW^&'QO\%Z ;!;4V6K
M#1OBY-X/T#P<]PT%YC3=1\+^-WO9I"+C0[J2> 2Q_-NL> _@!H7[+GCC]D2Z
M^'/[0^I_"[P1\#-!T;4[_2O@[XYUOQAX@T;Q7:HL.H^#=9T[P1/I_C7XN:?J
MER?$GB/2_#>CW^I>'?$*37NKZ!:10R6J^O\ B7X@Z!8?#/QW\,Y;3]J0-X1^
M"VAK>^/_  O\)?'%[\0M1L?$^A1Z':ZGX"UG3? MSI'BCXP:3YXU;6M"\.:#
M?ZCX;UF.2YU+PW:00/:KS8YX:MA:>%I87$XCZA2G@\)4DX4%CJ#PN%A0K3IO
M#U8T%4QT,5F>.H3]M5Q.)SZHHXJ$:%I:4G-XM8KVL<+]:FJE:&M66!]EBZM6
MG'VD)TY8NK# 8FAE>'KQ=)8?#9#A7.G7>(BJ7QU\ /A#\+= _;_\4WO[)_A'
M3? OP:^$OP9U?X:_M":AX1:[A\$^/_C;K?B'2-5\->&+E'N)K'Q/X]^'V@6N
MHZCXQ\3,UYJ^FR^(+/0]:U!K^XGMT^@/^"?DTFE^ /CI\,(FSH/P2_:S^/GP
MR\'19RMCX07Q#9^.M#TF(]!;:)!XX?1K.-<)!:6$$$:K'$J+Y7\#?A;X8_9*
MAN])\(?$[]OGQKX%^#_P^M_&X^%FM?!GPCJ_@WQ=;^-(9Y!I^DW/@?\ 9K\)
M^+/'GQ-M=2U!]9\1:'I'C"X\86>MK+>^+XIP;Y)>H_9,\0W_ ,$?A1\0V^)W
MPW^,T'Q.\2ZQXT_:J^)^EZ!\(?'_ (GM$U'XS>*[K5].\!>$-2T/0KVQ\;^.
M?!_AL^']!U_PCX8N-3US3)]+N7N+.*W16&^(<JE.K35>IC:%')Z6"HU:T:JQ
M=?'U\\AF4,15A67._94:V:TJ'LYXB.78+&X'+JF(JRJ1K5LE;WI*C"A5K9QA
ML4X4G#V-+!83(<5E;BIP4>9U*D,MGB(SC3>*QGML72HQITG"A^C]%>':G\>_
M#VEGQ.)O ?QONO\ A%?A_HWQ%NSIOP2^)6I#5=-UL1F#P[X9-GX=F'B7Q]9>
M8!K'@+1OM?BK2"L@U#3(/+?!J/Q[\/::?$8E\!_&^Y_X1GX=:3\2KK^S_@E\
M2M0&I:7K&PP^&_#IM/#LH\0_$.S\P?VM\/=(-UXMTHK)]NTJ#RWQX2P]=VM2
MGK:WNO6ZBU]ZG!KRDNYV<\?YE]_K_DSW&BO#K_X]^'M/.OB7P'\;[C_A'?AM
MI?Q0N38?!+XE7PU#2M5V>3X8T$VOAV0:]\2+7S!_:?PXTO[3XPTS;)]MTF'R
MWP7OQ[\/6)UL2> _C?/_ &%\,-.^*UP;+X)?$J\%_I&I;/*\+:(;?P[(-:^)
MMMO']H_#33OM'C/3]K_:]'BV-@^KUW_RZGK:WNOKRV^_FC_X$NX<\?YEUZ]K
MW_)^MM#W&BO#KOX]^'K,ZP'\!_&^;^Q?A78_%N<VGP2^)5T+W1K\*8_">D&#
MPZXU?XHV^\?;OA?8&?QO8E7%SHT91L%S\>_#UJ=4#^ _C?+_ &5\)K/XP3&V
M^"7Q*N1=Z+>A2GA'3##X=<:G\5H=V+SX56?G>.K0AQ<:)'L;!]7K_P#/J?3I
MWY;?^E1^]!SQ_F7]?T_N?9GN-%>'3_'OP];G4 W@/XWR?V=\(;7XS2^1\$OB
M5.+C1+K!3P=8&+PZPO\ XMQ;O])^$MJ9?'ML0WG:&FUL>L^'=:@\2^']"\16
MMEK&FVVOZ/IFM6^G>(=(U#P_K]A!JME!?0V6N:!JT%KJNB:Q:QSK!J>D:G:V
MVH:;>QSV5[!#<PR1K,J52"4IPE%-V3:LFVK_ ):C4DW9.[W$MK@/KNK6WV^.
M8P6.DR'3A:&.6R$[ZD!</>[0+I;WR2J0AV^RFT=B%^T<[-8UM<;]<U6U_M'S
MO(L=)E_LO[%Y7V'SWU(?:OM^T&[^W^3L\C<?L?V+< /M))C\4>(+?PGX9\0^
M*;S3]=U6T\-Z'JNO76E^&-#U/Q/XEU&WTBQGOYK'P_X;T6VO-8\0:W=QV[0:
M5HNDVEUJ6J7TD%C8V\US/%&TM-R44KN2@DDM6W%6LK1W;[:WO>7Q-1>C_P 4
MM;WVD_[TMMMU:UN6/PKG?#?PN\">$?&WQ$^(OA[0AIWC+XKS^&+GQ_K(U+5[
MH^()O!NBGP]X:<V%[?W.F:9_9NCDV871K+3DN\FXOEN;K]]7C?B;]C#]G+Q;
M\/\ P=\,-6\#ZQ;^#OA_X[\3?$SP7;>'/B9\5?!VM^'?''C'5O%>N>)->T[Q
MAX0\;Z'XQCEU34_''BF:2S?7WTVWBU:2SM+.WLK:RM[;LK_X]^'M./B 2^ _
MC?<?\(Y\-]*^)UU]@^"7Q*OQJ.E:L$,/AG0#:^'91K_Q'M/, U3X=:5]I\7Z
M65D^VZ3#Y;X+[X]^'K Z\)/ ?QOG/A_X9Z;\4KG[#\$OB5>B_P!)U0(8O"^A
M&V\.R#7/B5:^8/[3^&VF?:?&6F[9/MFD0^6V.A0QBE3E%5U*E]6]E)2FI4_J
ML:<,)[-IWA]6A[*&'Y;>QBH1I\J22:G&,:D%)*%5356"=HU%5A4IU%4BM)JI
M"I5A44D^:%2I&5XSDG0^%'[+_P %_@KXCO\ QAX"T'Q,OBS4O#%IX+N_$OC3
MXH?%3XI:\?"MEK>I>)+;0K?5OBCXU\97UE8+K>K7U_)%93VYGD>WCN&E@L;&
M*V[WP]\*? /A3Q_\0?BAX>T :9XX^*D'A2#Q_K$.IZS)#XC'@G3[K2?#,\^C
M7&HS:#9WVG:9>36#ZCINF65_J%JEK#J=S>)8V0M^1O?CWX>L3K0D\!_&^?\
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M:9/IVLZWX9\0>'?$V@W/VO0_$WA?Q1X:U#2?$7AOQ#I%SF6PU?1M3L[R(/-
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M_P#FCR_/NSXQ_P"&)?V=/^A-U#_PK/%'_P MJ/\ AB7]G3_H3=0_\*SQ1_\
M+:OL[_A&M6_YXQ_]_P"+_P"*H_X1K5O^>,?_ '_B_P#BJ/\ B#_A1_T;7@7_
M ,1;)?\ YB\OS[L/]>.,O^BKXB_\/&8?_-'E^?=GQC_PQ+^SI_T)NH?^%9XH
M_P#EM1_PQ+^SI_T)NH?^%9XH_P#EM7V=_P (UJW_ #QC_P"_\7_Q5'_"-:M_
MSQC_ ._\7_Q5'_$'_"C_ *-KP+_XBV2__,7E^?=A_KQQE_T5?$7_ (>,P_\
MFCR_/NSXQ_X8E_9T_P"A-U#_ ,*SQ1_\MJ/^&)?V=/\ H3=0_P#"L\4?_+:O
ML[_A&M6_YXQ_]_XO_BJ/^$:U;_GC'_W_ (O_ (JC_B#_ (4?]&UX%_\ $6R7
M_P"8O+\^[#_7CC+_ **OB+_P\9A_\T>7Y]V?&/\ PQ+^SI_T)NH?^%9XH_\
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MH_X8E_9T_P"A-U#_ ,*SQ1_\MJ^SO^$:U;_GC'_W_B_^*H_X1K5O^>,?_?\
MB_\ BJ/^(/\ A1_T;7@7_P 1;)?_ )B\OS[L/]>.,O\ HJ^(O_#QF'_S1Y?G
MW9\8_P##$O[.G_0FZA_X5GBC_P"6U'_#$O[.G_0FZA_X5GBC_P"6U?9W_"-:
MM_SQC_[_ ,7_ ,51_P (UJW_ #QC_P"_\7_Q5'_$'_"C_HVO O\ XBV2_P#S
M%Y?GW8?Z\<9?]%7Q%_X>,P_^:/+\^[/C'_AB7]G3_H3=0_\ "L\4?_+:C_AB
M7]G3_H3=0_\ "L\4?_+:OL[_ (1K5O\ GC'_ -_XO_BJ/^$:U;_GC'_W_B_^
M*H_X@_X4?]&UX%_\1;)?_F+R_/NP_P!>.,O^BKXB_P##QF'_ ,T>7Y]V?&/_
M  Q+^SI_T)NH?^%9XH_^6U'_  Q+^SI_T)NH?^%9XH_^6U?9W_"-:M_SQC_[
M_P 7_P 51_PC6K?\\8_^_P#%_P#%4?\ $'_"C_HVO O_ (BV2_\ S%Y?GW8?
MZ\<9?]%7Q%_X>,P_^:/+\^[/C'_AB7]G3_H3=0_\*SQ1_P#+:C_AB7]G3_H3
M=0_\*SQ1_P#+:OL[_A&M6_YXQ_\ ?^+_ .*H_P"$:U;_ )XQ_P#?^+_XJC_B
M#_A1_P!&UX%_\1;)?_F+R_/NP_UXXR_Z*OB+_P /&8?_ #1Y?GW9\8_\,2_L
MZ?\ 0FZA_P"%9XH_^6U'_#$O[.G_ $)NH?\ A6>*/_EM7V=_PC6K?\\8_P#O
M_%_\51_PC6K?\\8_^_\ %_\ %4?\0?\ "C_HVO O_B+9+_\ ,7E^?=A_KQQE
M_P!%7Q%_X>,P_P#FCR_/NSXQ_P"&)?V=/^A-U#_PK/%'_P MJ/\ AB7]G3_H
M3=0_\*SQ1_\ +:OL[_A&M6_YXQ_]_P"+_P"*H_X1K5O^>,?_ '_B_P#BJ/\
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M%S]BLKBZC_<GQ?\ M1R_%;0O$^@_L$>.OV<?C[\8O!MQX6U'Q-HVL_$.\OO
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M(>[72;VRM[*:&_T6\,6IZ?/JMG:W=G#<7L,4GE/AC]IOX ?\%#OVV_!'Q_\
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MAG6];N8Q:.UW-#9Z;')#-?Q2KQ_[6/[9NF? ']F[2?CUX*T2S^($/CC0GO?
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M@L324H3C)TFJ;3E&48NG/EK4INC44*T85:<Y4U"I"3L4445RFIY1J,LHU"_
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M.>$_^3_JS\K_ *_>=+_SUD_[[;_&CSI?^>LG_?;?XU^0/_#Q+XF?]"/X%_\
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M_P 1_,O_ )5_5GY7/^(*\>_] &!_\.>$_P#D_P"K/RO^OWG2_P#/63_OMO\
M&CSI?^>LG_?;?XU^0/\ P\2^)G_0C^!?_*__ /+>C_AXE\3/^A'\"_\ E?\
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M!?\ RO\ _P MZ/\ AXE\3/\ H1_ O_E?_P#EO1_Q-OX*_P#0YSC_ ,1_,O\
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M?_)_U9^5_P!?O.E_YZR?]]M_C1YTO_/63_OMO\:_('_AXE\3/^A'\"_^5_\
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M7_GK)_WVW^-'G2_\]9/^^V_QJ.B@"3SI?^>LG_?;?XT>=+_SUD_[[;_&HZ*
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M//$/P\\8?#K4O$6B^$M"MKS6_$'_  B<GB#3-1O--T6QOM5.E0WES:VLPM9
M/%?#WB6W\3_$_P#:[_:LUOX>?M(V'P-\?^"/@A\"/"-WX)^'_P 7/!WQFUS2
M/"K^,K_QE\4/#W@W1;7PU\;]!\/:+J7C>VL;'Q!HNC6GB;[/I6HZKI-A-:P"
M6OUNHI4L<Z="I2J4_;3E4KRC6G4DG&EB_J,<72FDKU'4I82K2IU.>$J2QV*E
M)5IQPLL,YTHRE3<&Z4(X;"86<*:C%.GE^.Q69X&5)VM1J4<=B85I^[.%2&$P
M])4X0>)^L?B_^R_I^F^!-;_;4\1>%?A1\??BO^QUK7A7POXNL=(^+7PF\6^(
M_C7\9?BF;'5;3XAZ+X5TOXQ:-HGQ<^+GAR70;7P_IMDOQ+.I#^V%GTG0-0_L
MY;A#Z5/X]?\ 9@_:P^.OQ.\6?"KXR7_PX_:(^#7P*U'X:W'PZ^#WCKXA36?C
M/X9:+XH\/ZA\)-=T;X?Z%X@G\&^);JSU71KK1H]?BTOP]('O[8ZO;M83!?U6
MHK2MF*KRDITZKISP5++ZKEB.;%5<-1H2I0E.NZ/LWB:4XX:>'K/#.%*&$HT)
MT:U*555)C0454OR<U2N\2HPA*%&G5^L8#$?NZ7M'*$*\L%4>.C&JIXJIC<36
MA4P]5494OPL^)OA?X@?";_@D]IO[..N?"7XR^)_C3\3? ?C'4K?P?\+?A#\1
M/BJGAK7?%?Q3G^)EUX;\6:M\/_#GB#2?"]YI=KXI&F(=9N[."_O-,U"/3GN4
MM)67]C?A-XZT_P"(_@+0?%6F:#XZ\-6MU!)9_P!C_$?P%XN^&GBRUFTR5K"<
MW_A'QQH^A>(K&&:6W>6QGNM.BAO[-X;RT>:WFCD;T:BIQ6.ABHXCFPZIU*^/
MQ..3IU)>RI?69W=&-.<9S<*=-0A&4JSFW%SDWS<L14IWPLI57.6'HU*4Y3C'
MFKRK1P_M:DG'EC"4ZF&I348PY8ISBD^9.)1117G&Y_.C\:_V?_C5K'QD^+6K
MZ7\,_%M]IFJ_$WQ[J6G7UMI<LEO>6%]XJU6ZM+J"0'#PW%O+'-$XX9'5AUKS
M+_AF[X\?]$I\9_\ @HE_QK^B#4O^0C?_ /7[=?\ H^2J5?QOF7T,."LSS''Y
MC5XMXHIU<PQN*QM2G3IY3R0GBJ]2O.$.;!.7)&51QCS-NR5VWJ?NF%\>,_PF
M%PV%ADN3RAAL/1P\92EC>:4:-.-.,I6Q"7,U%-V25WHK'\]G_#-WQX_Z)3XS
M_P#!1+_C1_PS=\>/^B4^,_\ P42_XU_0G17%_P 21\#_ /18<5_^"\H_^83?
M_B/_ !#_ -"/)O\ P+'?_-!_/9_PS=\>/^B4^,__  42_P"-'_#-WQX_Z)3X
MS_\ !1+_ (U_0G11_P 21\#_ /18<5_^"\H_^80_XC_Q#_T(\F_\"QW_ ,T'
M\]G_  S=\>/^B4^,_P#P42_XT?\ #-WQX_Z)3XS_ /!1+_C7]"=%'_$D? __
M $6'%?\ X+RC_P"80_XC_P 0_P#0CR;_ ,"QW_S0?SV?\,W?'C_HE/C/_P %
M$O\ C1_PS=\>/^B4^,__  42_P"-?T)T4?\ $D? _P#T6'%?_@O*/_F$/^(_
M\0_]"/)O_ L=_P#-!_/9_P ,W?'C_HE/C/\ \%$O^-'_  S=\>/^B4^,_P#P
M42_XU_0G11_Q)'P/_P!%AQ7_ ."\H_\ F$/^(_\ $/\ T(\F_P# L=_\T'\]
MG_#-WQX_Z)3XS_\ !1+_ (T?\,W?'C_HE/C/_P %$O\ C7]"=%'_ !)'P/\
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MX\?]$I\9_P#@HE_QK^A.BC_B2/@?_HL.*_\ P7E'_P PA_Q'_B'_ *$>3?\
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MU1,,,PQC!(QG..>F>^.F: $HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** +")FVF?R2VV6!?/#X6+>LY\LQ_QF7;D-_!Y9'\?->K")FVF?RF;;+ O
MG!\+'N6<["G\;2[<JW\ C(XW\UZ "BBB@ HHHH **** "BBB@ HHHH ****
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MTXSO>]ZG);56^Q*]TV^EK>9^XU%?AS_Q#]_L/_\ 0V_M(?\ AS?#W_S 4?\
M$/W^P_\ ]#;^TA_X<WP]_P#,!77]5R7_ *&^*_\ #3_]_F?M,3_T#P_\'^G_
M $Z\W]WF?N-17X<_\0_?[#__ $-O[2'_ (<WP]_\P%'_ !#]_L/_ /0V_M(?
M^'-\/?\ S 4?5<E_Z&^*_P##3_\ ?X>TQ/\ T#P_\'^G_3KS?W>9^XU%?AS_
M ,0_?[#_ /T-O[2'_AS?#W_S 4?\0_?[#_\ T-O[2'_AS?#W_P P%'U7)?\
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M^K4^:I6K8BH_;J\J^(JSK5ZK_=:SJ5:M6I.6\I2D_M'[C45^'/\ Q#]_L/\
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MYO[O,_<:BOPY_P"(?O\ 8?\ ^AM_:0_\.;X>_P#F H_XA^_V'_\ H;?VD/\
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MX:?_ +_#VF)_Z!X?^#_3_IUYO[O,_<:BOPY_XA^_V'_^AM_:0_\ #F^'O_F
MH_XA^_V'_P#H;?VD/_#F^'O_ )@*/JN2_P#0WQ7_ (:?_O\ #VF)_P"@>'_@
M_P!/^G7F_N\S]QJ*_#G_ (A^_P!A_P#Z&W]I#_PYOA[_ .8"C_B'[_8?_P"A
MM_:0_P##F^'O_F H^JY+_P!#?%?^&G_[_#VF)_Z!X?\ @_T_Z=>;^[S/W&HK
M\.?^(?O]A_\ Z&W]I#_PYOA[_P"8"C_B'[_8?_Z&W]I#_P .;X>_^8"CZKDO
M_0WQ7_AI_P#O\/:8G_H'A_X/]/\ IUYO[O,_<:BOPY_XA^_V'_\ H;?VD/\
MPYOA[_Y@*/\ B'[_ &'_ /H;?VD/_#F^'O\ Y@*/JN2_]#?%?^&G_P"_P]IB
M?^@>'_@_T_Z=>;^[S/W&HK\.?^(?O]A__H;?VD/_  YOA[_Y@*/^(?O]A_\
MZ&W]I#_PYOA[_P"8"CZKDO\ T-\5_P"&G_[_  ]IB?\ H'A_X/\ 3_IUYO[O
M,_6O4O\ D(W_ /U^W7_H^2J5?C+>?\$'OV+H+NZ@3Q5^T,4AN9XD+?$C0"Q6
M.5D7<?\ A!!DX R<#)["JW_#B/\ 8Q_Z&G]H7_PX^@__ #"T?5<E_P"AOBO_
M  TK_P">']6]+GM,3_T#P_\ !_I_TZ\W]WF?M'17XN?\.(_V,?\ H:?VA?\
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MOQ<_X<1_L8_]#3^T+_X<?0?_ )A:/^'$?[&/_0T_M"_^''T'_P"86CZKDO\
MT-L7_P"&E?\ SP_JS\KGM,3_ - \/_!_I_TZ\W]WF?M'17XN?\.(_P!C'_H:
M?VA?_#CZ#_\ ,+1_PXC_ &,?^AI_:%_\./H/_P PM'U7)?\ H;8O_P -*_\
MGA_5GY7/:8G_ *!X?^#_ $_Z=>;^[S/VCHK\7/\ AQ'^QC_T-/[0O_AQ]!_^
M86C_ (<1_L8_]#3^T+_X<?0?_F%H^JY+_P!#;%_^&E?_ #P_JS\KGM,3_P!
M\/\ P?Z?].O-_=YG[1T5^+G_  XC_8Q_Z&G]H7_PX^@__,+1_P .(_V,?^AI
M_:%_\./H/_S"T?5<E_Z&V+_\-*_^>']6?E<]IB?^@>'_ (/]/^G7F_N\S]HZ
ML0+N2Y/EO)LM]VY7VB+]]"OF./XT^;R]G]Z16_AK\5/^'$?[&/\ T-/[0O\
MX<?0?_F%J:+_ ((/_L8.LY/B;]HA_+A\P%/B3X? C/FQ)YDF? A+)ARFU<'>
MZ'. 03ZKDO\ T-L7_P"&E?\ SP_JS\KGM,3_ - \/_!_I_TZ\W]WF?L[17XN
M?\.(_P!C'_H:?VA?_#CZ#_\ ,+1_PXC_ &,?^AI_:%_\./H/_P PM'U7)?\
MH;8O_P -*_\ GA_5GY7/:8G_ *!X?^#_ $_Z=>;^[S/VCHK\7/\ AQ'^QC_T
M-/[0O_AQ]!_^86C_ (<1_L8_]#3^T+_X<?0?_F%H^JY+_P!#;%_^&E?_ #P_
MJS\KGM,3_P! \/\ P?Z?].O-_=YG[1T5^+G_  XC_8Q_Z&G]H7_PX^@__,+1
M_P .(_V,?^AI_:%_\./H/_S"T?5<E_Z&V+_\-*_^>']6?E<]IB?^@>'_ (/]
M/^G7F_N\S]HZ*_%S_AQ'^QC_ -#3^T+_ .''T'_YA:/^'$?[&/\ T-/[0O\
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ME<]IB?\ H'A_X/\ 3_IUYO[O,_:.BOQ<_P"'$?[&/_0T_M"_^''T'_YA:/\
MAQ'^QC_T-/[0O_AQ]!_^86CZKDO_ $-L7_X:5_\ /#^K/RN>TQ/_ $#P_P#!
M_I_TZ\W]WF?M'17XN?\ #B/]C'_H:?VA?_#CZ#_\PM'_  XC_8Q_Z&G]H7_P
MX^@__,+1]5R7_H;8O_PTK_YX?U9^5SVF)_Z!X?\ @_T_Z=>;^[S/VCHK\7/^
M'$?[&/\ T-/[0O\ X<?0?_F%H_X<1_L8_P#0T_M"_P#AQ]!_^86CZKDO_0VQ
M?_AI7_SP_JS\KGM,3_T#P_\ !_I_TZ\W]WF?M'17XN?\.(_V,?\ H:?VA?\
MPX^@_P#S"T?\.(_V,?\ H:?VA?\ PX^@_P#S"T?5<E_Z&V+_ /#2O_GA_5GY
M7/:8G_H'A_X/]/\ IUYO[O,_:M%S;3/Y3MME@42AL)'N6<[&3^)I-N5;^$(P
M_CYKU^,2_P#!!_\ 8P-O+)_PDW[1)*20H)1\2/#XC3>)25=?^$$W%GV H0P
M"/D$E<0_\.(_V,?^AI_:%_\ #CZ#_P#,+1]5R7_H;XK_ ,-*_P#G@'M,3_T#
MP_\ !_I_TZ\W]WF?M'17XN?\.(_V,?\ H:?VA?\ PX^@_P#S"T?\.(_V,?\
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MXC/^'RO_  4+_P"BT:1_X:OX4_\ S&T?\/E?^"A?_1:-(_\ #5_"G_YC:/\
MB 7&?_0=PY_X6YC_ /.D/^)R?"W_ *$_'/\ X:LD_P#HC_JS\K_VYT5_$9_P
M^5_X*%_]%HTC_P -7\*?_F-H_P"'RO\ P4+_ .BT:1_X:OX4_P#S&T?\0"XS
M_P"@[AS_ ,+<Q_\ G2'_ !.3X6_]"?CG_P -62?_ $1_U9^5_P"W.BOXC/\
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M3I(W#:V/A7\*AD9!P<>#>1D X.1D XR!1_Q +C/_ *#N'/\ PMS'_P"=(?\
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M?_F-H_X@%QG_ -!W#G_A;F/_ ,Z0_P")R?"W_H3\<_\ AJR3_P"B/^K/RO\
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MJR3_ .B/^K/RO_;G17\1G_#Y7_@H7_T6C2/_  U?PI_^8VC_ (?*_P#!0O\
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M?^W.BOXC/^'RO_!0O_HM&D?^&K^%/_S&T?\ #Y7_ (*%_P#1:-(_\-7\*?\
MYC:/^(!<9_\ 0=PY_P"%N8__ #I#_B<GPM_Z$_'/_AJR3_Z(_P"K/RO_ &\V
MPW7$"['DS-$-D1VR/EU&R-OX7;HA[,0:B;AF&".3P>2.>A]QWK^(P?\ !9;_
M (*&*0R_&G205(((^%?PJ!!!R""/!H((/(((([4G_#Y7_@H6>OQHTC_PU?PJ
M_P#F-H_X@%QG_P!!W#G_ (6YC_\ .D/^)R?"W_H3\<_^&K)/_HC_ *L_*_\
M;G17\1G_  ^5_P""A?\ T6C2/_#5_"G_ .8VC_A\K_P4+_Z+1I'_ (:OX4__
M #&T?\0"XS_Z#N'/_"W,?_G2'_$Y/A;_ -"?CG_PU9)_]$?]6?E?^W.BOXC/
M^'RO_!0O_HM&D?\ AJ_A3_\ ,;1_P^5_X*%_]%HTC_PU?PI_^8VC_B 7&?\
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MQ"N5G^61>\C8S$>P63UYKT %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%P]/#_5</.E\965OXR^&?[ /[1D7BWX1_&N;Q]^UMXI_:W\:^$?AIX)^$/Q
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MA_T+?PW_ /#CZ3_\CU_0C_P^%_X)U?\ 1PC_ /AI?CA_\[6C_A\+_P $ZO\
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M.0_V\/\ H6_AO_X<?2?_ )'K^T*BC_B/'&__ #YR+_P@Q/\ \WA_Q)]X3_\
M05Q?_P"'C __ #G_ *N_*W\7O_#D/]O#_H6_AO\ ^''TG_Y'I[?\$0/V\U5'
M;PS\.560%HV/Q&TH!U5F1BI^S\@.K*2.A!':O[/ZL2C$-J<3C,<AS*?W3?OY
M1FV]$&,2?]-A(>]'_$>.-_\ GSD7_A!B?_F\/^)/O"?_ *"N+_\ P\8'_P"<
M_P#5WY6_BU_X<A_MX?\ 0M_#?_PX^D__ "/1_P .0_V\/^A;^&__ (<?2?\
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M)_\ F\/^)/O"?_H*XO\ _#Q@?_G/_5WY6_B]_P"'(?[>'_0M_#?_ ,./I/\
M\CT?\.0_V\/^A;^&_P#X<?2?_D>O[0J*/^(\<;_\^<B_\(,3_P#-X?\ $GWA
M/_T%<7_^'C __.?^KORM_%[_ ,.0_P!O#_H6_AO_ .''TG_Y'H_X<A_MX?\
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M%RL_RRCO(V,Q'L%D]>:]6$'^C3';.<2P#<I_T<96?B88_P!8<9A.> )?6J]
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 >@^$_^0=-_P!?LG_H
MBVKIZYCPG_R#IO\ K]D_]$6U=/0 4444 %%%% !7BG[2O_)N?Q^_[(I\5/\
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MN>(M:\.V]WJFJ7482T2>\N7(:61;:W@A#'D1Q(O:N'_X=V_L.?\ 1KOP?_\
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MK_3T_@5HK^^K_AW;^PY_T:[\'_\ PE;7_P"*H_X=V_L.?]&N_!__ ,)6U_\
MBJ/^)@^'?^A'G7_@6!_^:0_XDMXV_P"BMX5_\ S?_P"8?7^GI_ K17]]7_#N
MW]AS_HUWX/\ _A*VO_Q5'_#NW]AS_HUWX/\ _A*VO_Q5'_$P?#O_ $(\Z_\
M L#_ /-(?\26\;?]%;PK_P" 9O\ _,/K_3T_@5HK^^K_ (=V_L.?]&N_!_\
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MYB/[["BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JQ*/W-KQ<#,4G,O\
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M;;<W)!OE]HU3F\_Y8_\ @3\_[GI][[*_N-%>':U^SWX#UX^-C?:K\48CX_\
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M'54NA$S,C* 2I Z0>)?#C:^WA1?$&B-XH33QJS^&QJM@=?32S(L(U)M'$_\
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M_P *8^,/_1*/B5_X0OBC_P"5='_$*/"[_H64/_#]FG_SS\U]X?\ $Q?T@O\
MHH,7_P"(AP]_\X#^B?\ XB'M$_Z-/U7_ ,/1:?\ SKZ/^(A[1/\ HT_5?_#T
M6G_SKZ_G8_X4Q\8?^B4?$K_PA?%'_P JZ/\ A3'QA_Z)1\2O_"%\4?\ RKH_
MXA1X7?\ 0LH?^'[-/_GGYK[P_P")B_I!?]%!B_\ Q$.'O_G ?T3_ /$0]HG_
M $:?JO\ X>BT_P#G7U(G_!Q#HB"4?\,HZR/,CV$)\:[-0PWH^)!_PJX[X\H#
ML^7+A&S\N#_.I_PICXP_]$H^)7_A"^*/_E72CX+_ !B.<?"?XEG R<>!/%'
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M3]5_\/1:?_.OH_XB'M$_Z-/U7_P]%I_\Z^OYV/\ A3'QA_Z)1\2O_"%\4?\
MRKH_X4Q\8?\ HE'Q*_\ "%\4?_*NC_B%'A=_T+*'_A^S3_YY^:^\/^)B_I!?
M]%!B_P#Q$.'O_G ?T3_\1#VB?]&GZK_X>BT_^=?1_P 1#VB?]&GZK_X>BT_^
M=?7\['_"F/C#_P!$H^)7_A"^*/\ Y5T?\*8^,/\ T2CXE?\ A"^*/_E71_Q"
MCPN_Z%E#_P /V:?_ #S\U]X?\3%_2"_Z*#%_^(AP]_\ . _HG_XB'M$_Z-/U
M7_P]%I_\Z^C_ (B'M$_Z-/U7_P /1:?_ #KZ_G8_X4Q\8?\ HE'Q*_\ "%\4
M?_*NC_A3'QA_Z)1\2O\ PA?%'_RKH_XA1X7?]"RA_P"'[-/_ )Y^:^\/^)B_
MI!?]%!B__$0X>_\ G ?T3_\ $0]HG_1I^J_^'HM/_G7T?\1#VB?]&GZK_P"'
MHM/_ )U]?SL?\*8^,/\ T2CXE?\ A"^*/_E71_PICXP_]$H^)7_A"^*/_E71
M_P 0H\+O^A90_P##]FG_ ,\_-?>'_$Q?T@O^B@Q?_B(</?\ S@/Z)_\ B(>T
M3_HT_5?_  ]%I_\ .OH_XB'M$_Z-/U7_ ,/1:?\ SKZ_G8_X4Q\8?^B4?$K_
M ,(7Q1_\JZ/^%,?&'_HE'Q*_\(7Q1_\ *NC_ (A1X7?]"RA_X?LT_P#GGYK[
MP_XF+^D%_P!%!B__ !$.'O\ YP']$_\ Q$/:)_T:?JO_ (>BT_\ G7U(_P#P
M<0Z(R1)_PRCK)\I64!_C59LBAI'?$2_\*N&Q26)89;+EFR,X'\ZG_"F/C#_T
M2CXE?^$+XH_^5=*?@O\ &(8)^$_Q+ /()\">*.1G&1_Q*N>01]1BC_B%'A=_
MT+*'_A^S3_YY^:^\/^)B_I!?]%!B_P#Q$.'O_G ?T3?\1#VB?]&GZK_X>BT_
M^=?1_P 1#VB?]&GZK_X>BT_^=?7\['_"F/C#_P!$H^)7_A"^*/\ Y5T?\*8^
M,/\ T2CXE?\ A"^*/_E71_Q"CPN_Z%E#_P /V:?_ #S\U]X?\3%_2"_Z*#%_
M^(AP]_\ . _HG_XB'M$_Z-/U7_P]%I_\Z^C_ (B'M$_Z-/U7_P /1:?_ #KZ
M_G8_X4Q\8?\ HE'Q*_\ "%\4?_*NC_A3'QA_Z)1\2O\ PA?%'_RKH_XA1X7?
M]"RA_P"'[-/_ )Y^:^\/^)B_I!?]%!B__$0X>_\ G ?T3_\ $0]HG_1I^J_^
M'HM/_G7T?\1#VB?]&GZK_P"'HM/_ )U]?SL?\*8^,/\ T2CXE?\ A"^*/_E7
M1_PICXP_]$H^)7_A"^*/_E71_P 0H\+O^A90_P##]FG_ ,\_-?>'_$Q?T@O^
MB@Q?_B(</?\ S@/Z)_\ B(>T3_HT_5?_  ]%I_\ .OH_XB'M$_Z-/U7_ ,/1
M:?\ SKZ_G8_X4Q\8?^B4?$K_ ,(7Q1_\JZ/^%,?&'_HE'Q*_\(7Q1_\ *NC_
M (A1X7?]"RA_X?LT_P#GGYK[P_XF+^D%_P!%!B__ !$.'O\ YP']$_\ Q$/:
M)_T:?JO_ (>BT_\ G7T?\1#VB?\ 1I^J_P#AZ+3_ .=?7\['_"F/C#_T2CXE
M?^$+XH_^5='_  ICXP_]$H^)7_A"^*/_ )5T?\0H\+O^A90_\/V:?_//S7WA
M_P 3%_2"_P"B@Q?_ (B'#W_S@/Z)_P#B(>T3_HT_5?\ P]%I_P#.OH_XB'M$
M_P"C3]5_\/1:?_.OK^=C_A3'QA_Z)1\2O_"%\4?_ "KH_P"%,?&'_HE'Q*_\
M(7Q1_P#*NC_B%'A=_P!"RA_X?LT_^>?FOO#_ (F+^D%_T4&+_P#$0X>_^<!_
M1/\ \1#VB?\ 1I^J_P#AZ+3_ .=?1_Q$/:)_T:?JO_AZ+3_YU]?SL?\ "F/C
M#_T2CXE?^$+XH_\ E71_PICXP_\ 1*/B5_X0OBC_ .5='_$*/"[_ *%E#_P_
M9I_\\_-?>'_$Q?T@O^B@Q?\ XB'#W_S@/Z)_^(A[1/\ HT_5?_#T6G_SKZ/^
M(A[1/^C3]5_\/1:?_.OK^=C_ (4Q\8?^B4?$K_PA?%'_ ,JZ/^%,?&'_ *)1
M\2O_  A?%'_RKH_XA1X7?]"RA_X?LT_^>?FOO#_B8OZ07_108O\ \1#A[_YP
M']%47_!Q!HD<D<@_90UA2CHX:/XU6:2 JP;*/_PJX[7&,JV#M;!P<8II_P"#
MA[1"2?\ AE#5N23S\:+0GGU/_"K^3ZGO7\ZX^#'QA) 'PG^)9). !X$\4$DG
MH /[*Y)H_P"%,?&'_HE'Q*_\(7Q1_P#*JC_B%'A=_P!"RA_X?LT_^>?FOO#_
M (F+^D%_T4&+_P#$0X>_^<!_1/\ \1#VB?\ 1I^J_P#AZ+3_ .=?1_Q$/:)_
MT:?JO_AZ+3_YU]?SL?\ "F/C#_T2CXE?^$+XH_\ E71_PICXP_\ 1*/B5_X0
MOBC_ .5='_$*/"[_ *%E#_P_9I_\\_-?>'_$Q?T@O^B@Q?\ XB'#W_S@/Z)_
M^(A[1/\ HT_5?_#T6G_SKZ/^(A[1/^C3]5_\/1:?_.OK^=C_ (4Q\8?^B4?$
MK_PA?%'_ ,JZ/^%,?&'_ *)1\2O_  A?%'_RKH_XA1X7?]"RA_X?LT_^>?FO
MO#_B8OZ07_108O\ \1#A[_YP']$__$0]HG_1I^J_^'HM/_G7T?\ $0]HG_1I
M^J_^'HM/_G7U_.Q_PICXP_\ 1*/B5_X0OBC_ .5='_"F/C#_ -$H^)7_ (0O
MBC_Y5T?\0H\+O^A90_\ #]FG_P \_-?>'_$Q?T@O^B@Q?_B(</?_ #@/Z)_^
M(A[1/^C3]5_\/1:?_.OJW8?\'#?A62\MDU/]ECQ!::>\\:WEU8?%O3M1O(+8
MN!-+;6%Q\/M+@NYT3<T=O+J-E'*X"-<PAC(O\YO_  ICXP_]$H^)7_A"^*/_
M )5U;L/@3\;]4O+;3M,^#GQ4U#4+V>.VL[&R^'OBVZN[JXF<)%!;V\&D/---
M([!$CC1G9B H)-3+PI\+5&3>74(I)MR_M[,URJWQ7EF3CI>^J:[IHJ'TBOI!
MN<$L]Q=1N44J?^I^0/G;:M"T,A4WS/W;1:D[^ZT[,_OY_9[^/_PX_:<^%'AG
MXQ?"O4KF_P#"OB6*=!;ZC;+8ZUH>K6,IMM6\/Z]8)-<)9ZOI5TK07*07-W97
M"&&^TV]OM-N[.]N/:J_,?_@DM^S+\0_V7?V4(?#/Q2M)=&\:>/O'>M_$[4/"
MMQ*DEUX2M=9T/PQX?TS1-0$3/%%JKZ?X7M]5U.U5VDL+K4WTVY"75E.B_IQ7
M\A\1X/+LOS[-L%E&*^NY9A<?B*."Q7/&I[6A";4&JL$H5E'6"K02A64?:P2C
M-'^E_ V9YYG/!_#>:\2Y?_9>?8_)\%BLUP'LYT?J^,JT8RJ)X>JW5PSG=598
M6JW5PLIO#U&YTY,****\4^J"BBB@ HHHH L(?]&F&Z89E@.U1^X.%GYE.>)%
MZ0C'(,OI5>K"'_1IAOF&98#L4?N&PL_S2G/$BY_=#'(:4]JKT %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!Z#X3_Y!TW_7[)_Z(MJZ>N8\)_\
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M7U&'2-R0ZG):SND38OQ'_:6^ EU^U_\ LU?M6Z9\5O!'C+]F_1O 7QF_9_\
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M><83$?6L!B94Z.+K?[3*,W"G77Y__%^3X._ML?MS?\$^?V5-%U&_OOV';/\
M9OM?C#X3\!6VK:_IVG^,UTO1?&-OH&DZW)<WRZ]<3:+I_@S3/#]U'?WLFLZ?
M#!XFM!>Q7>H7LY_6FQ^&7[#'_!-6P\=?&FRM]!_9U\'?$:;P9X4\4M%>^)KC
MP=>:UHY\02^'7L?#L/\ ;0T[5[J#4-2BNY]-M8(+J"TBDN(UF2:>?P;XP_\
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M83+JRQ=7"RQ;PKQF:T<+4E*,84:>4Y5EF9\^)BZ4IS^N5,?/ 8://1G1JXC
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MOV(/^CI/@Q_X6FF?_'*_@.HH_P")?.'O^A[G/_@&!_\ E ?\3I<:?]$CPO\
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MEW_B)<$_UT_/NS^JW_ASK_P3M_Z('<_^'8^-'_SPJ/\ ASK_ ,$[?^B!W/\
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MZ[_T]#_B/?T=O^C&9=_XB7!/]=/S[L_JM_X<Z_\ !.W_ *('<_\ AV/C1_\
M/"KZ7_9Y_8G_ &6_V7+W6M8^!_PET;P5KVKZ=)87OB*2_P#$7BSQ'/82W-G+
M/I47B#QCK&OZMIFE7$EK;W%S8:=>6EC<W%I;23V\DJ(X_B[_ .'C/[<W_1T/
MQ:_\*)O_ (S7Z"_\$Y/^"J7[35O^T;\.?A+\:/B#JWQ8^'?QA\6:-\/)$\30
M6%WXB\-^(?%VHV>D>&]8TC7H;2WU-[0:_+I=MJNF:C<WFFC3)[VZL[:VOT2=
MO%XA\-/$V&39A5Q?&=?.L+0PU3$8C+*F<9U56*I4(NK4C&EBT\/5G&,7*%.J
MXJ3BDI*;BCZG@OQY\ ZO%&2X;+?"S"\+9AC,=0P6"SVAPOPK0E@,3BYQP]&I
M/$9=)8W#T93J*G5K8=3E3C)RE!PYVOZWZ***_G0_M\**** "BBB@ HHHH **
M** "BBB@ HHHH **** "K$K9AM5\QWV12#8R[5BS/*VV-OXU;/F,>SNR]JKU
M8E;=#:KYKOLBD&QDVK#F>5MB-_&&SYC-V9RO\- %>BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH FMFVW$#;WBVS1-YD:[WCPZG>B_P 3I]Y5[D =
MZC;EF.2?F/)&">>I'8GTJ2V;;<0-YC1;9HF\U%WO'AU/F*G\3)C<J_Q$ =ZB
M8Y9CG.23D\$\]2.V>M "4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %A&Q;3KYD@W2P'R@N8WVK.-[O_  M'NPB_Q"1C_#Q7JPC8MID\UUW2P'R0
MF4DVK/\ .S_PM'NPJ_QB1NNWBO0 4444 %%%% !1110 4444 %%%% !1110
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M37XE? [1O@S+J_A'X/:UH/A?2#X?^(NM^/=+\21^%M9^,OBS5KT&/58-(O\
M1F\9VIN7M)=2M]5L5NTT^T]6A_JHZN"GC*F%2AC:ZS*GAJ>;*G6P\\FR3V-3
M"+V/NTX9I#-E5BZE*?UB=25"F\NE@U#Y[%/Q&6&S:CEV'S%^UP67RR&OC:_#
MCQ.&K4^(.('CZ.92^M6GB*N3U,E^KSC2KTOJ-.A#$UHYQ',G4]3^'?QG^(C?
M%N3X&_&KP/X2\+^,M2\!7OQ*\$^(OAYXNU;Q;X.\7>&]%UO2_#WBBRF3Q#X5
M\(ZWX<\2>&]1U[0'GTZ6VU?3M1TW6+:]LM8$T-Y86WGFL?&S]I32_P!H*_\
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M>+?[7TS2O$$_C)-8LH(-*TW2VCOUT[PK?60E,UA+(OV>[G3RG3+!MRK\N_\
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M/#/_ #VU+\H__C5'_$;>/O\ H.P'_ALPO_R/]7?E8_XE0\&_^A3G'_A^Q_\
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M4;/#/_/;4ORC_P#C5'_$;>/O^@[ ?^&S"_\ R/\ 5WY6/^)4/!O_ *%.<?\
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MU0!SM%=%L\,_\]M2_*/_ .-4;/#/_/;4ORC_ /C5 '.T5T6SPS_SVU+\H_\
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MF)IQ2;7L:=;V'/-K2'M*L:L:,9-2J?5\1**<:4F>W45\3?MN?M)?$?\ 9_\
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M^[]C+_H2OVB/_"*\ _\ STZ/^']W[&7_ $)7[1'_ (17@'_YZ='_ !#;CO\
MZ)?-?_!,?_DP_P"(Z^$'_1P.'?\ PJG_ /*O/\^S/VVHK\2?^']W[&7_ $)7
M[1'_ (17@'_YZ='_  _N_8R_Z$K]HC_PBO /_P ].C_B&W'?_1+YK_X)C_\
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M^?9G[845^)/_  _N_8R_Z$K]HC_PBO /_P ].C_A_=^QE_T)7[1'_A%> ?\
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MJ\_S[,_;:BOQ)_X?W?L9?]"5^T1_X17@'_YZ='_#^[]C+_H2OVB/_"*\ _\
MSTZ/^(;<=_\ 1+YK_P""8_\ R8?\1U\(/^C@<._^%4__ )5Y_GV9^VU%?B3_
M ,/[OV,O^A*_:(_\(KP#_P#/3H_X?W?L9?\ 0E?M$?\ A%> ?_GIT?\ $-N.
M_P#HE\U_\$Q_^3#_ (CKX0?]' X=_P#"J?\ \J\_S[,_;:BOQ)_X?W?L9?\
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M_P J\_S[,_;:BOQ)_P"']W[&7_0E?M$?^$5X!_\ GIT?\/[OV,O^A*_:(_\
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MO_@F/_R8?\1U\(/^C@<._P#A5/\ ^5>?Y]F?MK17XD_\/[OV,O\ H2OVB/\
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M/_RKJ>'X/?"$+<9^&'PVCS 0 W@3PPYE/FQ'RT)TH^6Q +^8"#M1DS\^"?\
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M7_1*_AQ_X0_AG_Y5T?\ $P^$_P"B5Q/_ (=J7_SO]?Z>A_Q)-F?_ $<+ ?\
MB.8C_P"?'K_3T_SCJ*_T<?\ A3GPB_Z)7\./_"'\,_\ RKH_X4Y\(O\ HE?P
MX_\ "'\,_P#RKH_XF'PG_1*XG_P[4O\ YW^O]/0_XDFS/_HX6 _\1S$?_/CU
M_IZ?YQU%?Z./_"G/A%_T2OX<?^$/X9_^5='_  ISX1?]$K^''_A#^&?_ )5T
M?\3#X3_HE<3_ .':E_\ ._U_IZ'_ !)-F?\ T<+ ?^(YB/\ Y\>O]/3_ #CJ
M*_T<?^%.?"+_ *)7\./_  A_#/\ \JZ/^%.?"+_HE?PX_P#"'\,__*NC_B8?
M"?\ 1*XG_P .U+_YW^O]/0_XDFS/_HX6 _\ $<Q'_P ^/7^GI_G'45_HX_\
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M  ISX1?]$K^''_A#^&?_ )5T?\3#X3_HE<3_ .':E_\ ._U_IZ'_ !)-F?\
MT<+ ?^(YB/\ Y\>O]/3_ #CJ*_T<?^%.?"+_ *)7\./_  A_#/\ \JZ/^%.?
M"+_HE?PX_P#"'\,__*NC_B8?"?\ 1*XG_P .U+_YW^O]/0_XDFS/_HX6 _\
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M6$;%M,GFJNZ6!O)*9>3:LXWB3'R+%NPR[AO,@.#MJO0 4444 %%%% !1110
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M[GX ?^';\!__ "XH_P"'@?[(O_1W/P _\.WX#_\ EQ1_86=_]";-?_#=B_\
MY2'^M_"?_14<._\ A[RW_P":3ZA_L[4/^?&\_P# :?\ ^(H_L[4/^?&\_P#
M:?\ ^(KY>_X>!_LB_P#1W/P _P##M^ __EQ1_P / _V1?^CN?@!_X=OP'_\
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M+_T=S\ /_#M^ _\ Y<4?V%G?_0FS7_PW8O\ ^4A_K?PG_P!%1P[_ .'O+?\
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M"SO_ *$V:_\ ANQ?_P I#_6_A/\ Z*CAW_P]Y;_\TGU#_9VH?\^-Y_X#3_\
MQ%']G:A_SXWG_@-/_P#$5\O?\/ _V1?^CN?@!_X=OP'_ /+BC_AX'^R+_P!'
M<_ #_P .WX#_ /EQ1_86=_\ 0FS7_P -V+_^4A_K?PG_ -%1P[_X>\M_^:3Z
MA_L[4/\ GQO/_ :?_P"(H_L[4/\ GQO/_ :?_P"(KY>_X>!_LB_]'<_ #_P[
M?@/_ .7%'_#P/]D7_H[GX ?^';\!_P#RXH_L+._^A-FO_ANQ?_RD/];^$_\
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M! Y-,;_@H'^R)DX_:Z_9_(R<$?%OP& 1GJ!_;'2C^PL[_P"A-FO_ (;L7_\
M*0_UOX3_ .BHX=_\/>6__-)]0?V=J'_/C>?^ T__ ,11_9VH?\^-Y_X#3_\
MQ%?+W_#P/]D7_H[GX ?^';\!_P#RXH_X>!_LB_\ 1W/P _\ #M^ _P#Y<4?V
M%G?_ $)LU_\ #=B__E(?ZW\)_P#14<._^'O+?_FD^H?[.U#_ )\;S_P&G_\
MB*/[.U#_ )\;S_P&G_\ B*^7O^'@?[(O_1W/P _\.WX#_P#EQ1_P\#_9%_Z.
MY^ '_AV_ ?\ \N*/["SO_H39K_X;L7_\I#_6_A/_ **CAW_P]Y;_ /-)]0_V
M=J'_ #XWG_@-/_\ $4?V=J'_ #XWG_@-/_\ $5\O?\/ _P!D7_H[GX ?^';\
M!_\ RXH_X>!_LB_]'<_ #_P[?@/_ .7%']A9W_T)LU_\-V+_ /E(?ZW\)_\
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MA_SXWG_@-/\ _$59_MS5?^?V7\D_^(H_MS5?^?V7\D_^(H K?V=J'_/C>?\
M@-/_ /$4?V=J'_/C>?\ @-/_ /$59_MS5?\ G]E_)/\ XBC^W-5_Y_9?R3_X
MB@"M_9VH?\^-Y_X#3_\ Q%']G:A_SXWG_@-/_P#$59_MS5?^?V7\D_\ B*/[
M<U7_ )_9?R3_ .(H 1+#4!;3I]EN5W2V[>4;.8O)M6<;U?R_E6/=AER-Y=3C
MY:K_ -G:A_SXWG_@-/\ _$5?76M3,$I.H,&$D05"BF1@1+N9&V8"J0H<'DED
M(Z',/]N:K_S^R_DG_P 10!6_L[4/^?&\_P# :?\ ^(H_L[4/^?&\_P# :?\
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M/^?&\_\  :?_ .(JS_;FJ_\ /[+^2?\ Q%']N:K_ ,_LOY)_\10!6_L[4/\
MGQO/_ :?_P"(H_L[4/\ GQO/_ :?_P"(JS_;FJ_\_LOY)_\ $4?VYJO_ #^R
M_DG_ ,10!6_L[4/^?&\_\!I__B*/[.U#_GQO/_ :?_XBK/\ ;FJ_\_LOY)_\
M11_;FJ_\_LOY)_\ $4 =?X8BDAL9XY8WB<7LA*2(R. ;>V()5@",CD9'(Y%=
M)7/>&[B:YLKB:>0RRM>.&=L9(6WME'0 <  =*Z&@ HHHH **** "O%/VE?\
MDW/X_?\ 9%/BI_Z@NO5[77BG[2O_ ";G\?O^R*?%3_U!=>KLR[_D88'_ +#,
M+_Z?@>7GG_(ESC_L5YA_ZB5B']F+_DVO]GK_ +(=\)O_ % M KW&O#OV8O\
MDVO]GK_LAWPF_P#4"T"O<:>9?\C''_\ 8;BO_3]061?\B/)O^Q5EW_J)1"BB
MBN(]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO=W=I86MS?7
MUS;V5E96\UU>7EW-';6MI:V\;2W%S<W$S)#!;P1(\LTTKI'%&K.[*JDBQ6'X
MG\-:%XS\-^(/"'BC3H=8\->*=%U3P[X@TFY:5+?4]%UJRGT[5-/G>"2&=8KR
MRN9[>1H98I520F.1' 8*7-RRY4G*SY5)M1<K:*32;2;M=I-I:I/8J')SQ]HY
M*'-'G<$I34+KF<8R<4Y)7Y4Y13=DVEJ<!_PO[X$?]%K^$G_AR/!W_P N:T?$
MWQG^#W@HZ&OC+XK_  U\)-XGMX+KPVOB;QUX7T$^(;6ZV_9KG0QJNJ6AU:WN
M=R^1-8?:(YMR^6S9%?SD2_L!?L?K_P %A[;]G0?!#P^/@J_[*/\ PGK> AK'
MBW^S3XO_ +;NK;^V_MO_  D/]L_:/(C2/R1J7V3:H_T?.2<3]I?X,:5^Q?\
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M*Y_Q)SXJ?]#/@G_P[9O_ /0__5GY7_B4HK^V;_AS!_P3[_Z)3XD_\.C\1?\
MYHZ/^','_!/O_HE/B3_PZ/Q%_P#FCH_XCYP7_P! ?$7_ (0X#_YZ?U9^5S_B
M3GQ4_P"AGP3_ .';-_\ Z'_ZL_*_\3-%?VS?\.8/^"??_1*?$G_AT?B+_P#-
M'1_PY@_X)]_]$I\2?^'1^(O_ ,T='_$?."_^@/B+_P (<!_\]/ZL_*Y_Q)SX
MJ?\ 0SX)_P##MF__ -#_ /5GY7_B9HK^V;_AS!_P3[_Z)3XD_P##H_$7_P":
M.C_AS!_P3[_Z)3XD_P##H_$7_P":.C_B/G!?_0'Q%_X0X#_YZ?U9^5S_ (DY
M\5/^AGP3_P"';-__ *'_ .K/RO\ Q,T5_;-_PY@_X)]_]$I\2?\ AT?B+_\
M-'1_PY@_X)]_]$I\2?\ AT?B+_\ -'1_Q'S@O_H#XB_\(<!_\]/ZL_*Y_P 2
M<^*G_0SX)_\ #MF__P!#_P#5GY7_ (F:*_MF_P"','_!/O\ Z)3XD_\ #H_$
M7_YHZ/\ AS!_P3[_ .B4^)/_  Z/Q%_^:.C_ (CYP7_T!\1?^$. _P#GI_5G
MY7/^).?%3_H9\$_^';-__H?_ *L_*_\ $S17]LW_  Y@_P""??\ T2GQ)_X=
M'XB__-'1_P .8/\ @GW_ -$I\2?^'1^(O_S1T?\ $?."_P#H#XB_\(<!_P#/
M3^K/RN?\2<^*G_0SX)_\.V;_ /T/_P!6?E?^)FBO[9O^','_  3[_P"B4^)/
M_#H_$7_YHZ/^','_  3[_P"B4^)/_#H_$7_YHZ/^(^<%_P#0'Q%_X0X#_P">
MG]6?E<_XDY\5/^AGP3_X=LW_ /H?_JS\K_Q,T5_;-_PY@_X)]_\ 1*?$G_AT
M?B+_ /-'1_PY@_X)]_\ 1*?$G_AT?B+_ /-'1_Q'S@O_ * ^(O\ PAP'_P ]
M/ZL_*Y_Q)SXJ?]#/@G_P[9O_ /0__5GY7_B9HK^V;_AS!_P3[_Z)3XD_\.C\
M1?\ YHZE?_@B[_P3Z5(6'PL\0L9$9F5?BC\1MT9$KJ%DSXCP&*J&7;@;&7(W
M9)/^(^<%_P#0'Q%_X0X#_P">G]6?E<_XDY\5/^AGP3_X=LW_ /H?_JS\K_Q*
M45_;-_PY@_X)]_\ 1*?$G_AT?B+_ /-'1_PY@_X)]_\ 1*?$G_AT?B+_ /-'
M1_Q'S@O_ * ^(O\ PAP'_P ]/ZL_*Y_Q)SXJ?]#/@G_P[9O_ /0__5GY7_B9
MHK^V;_AS!_P3[_Z)3XD_\.C\1?\ YHZ/^','_!/O_HE/B3_PZ/Q%_P#FCH_X
MCYP7_P! ?$7_ (0X#_YZ?U9^5S_B3GQ4_P"AGP3_ .';-_\ Z'_ZL_*_\3-%
M?VS?\.8/^"??_1*?$G_AT?B+_P#-'1_PY@_X)]_]$I\2?^'1^(O_ ,T='_$?
M."_^@/B+_P (<!_\]/ZL_*Y_Q)SXJ?\ 0SX)_P##MF__ -#_ /5GY7_B9HK^
MV;_AS!_P3[_Z)3XD_P##H_$7_P":.C_AS!_P3[_Z)3XD_P##H_$7_P":.C_B
M/G!?_0'Q%_X0X#_YZ?U9^5S_ (DY\5/^AGP3_P"';-__ *'_ .K/RO\ Q,T5
M_;-_PY@_X)]_]$I\2?\ AT?B+_\ -'1_PY@_X)]_]$I\2?\ AT?B+_\ -'1_
MQ'S@O_H#XB_\(<!_\]/ZL_*Y_P 2<^*G_0SX)_\ #MF__P!#_P#5GY7_ (F:
M*_MF_P"','_!/O\ Z)3XD_\ #H_$7_YHZ/\ AS!_P3[_ .B4^)/_  Z/Q%_^
M:.C_ (CYP7_T!\1?^$. _P#GI_5GY7/^).?%3_H9\$_^';-__H?_ *L_*_\
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M]/\ $BV_Q U6#]J^_P#'O@'4DUW4QXF\6:6EP/"MMXZNO'=O->V<LV@))?\
MA.)8_L[3S^5;R17)^W/V&+EM$U']KWX26Y(\/_"3]K?XBV/A&W7_ (]],\/?
M$70_"GQ=;1K11\D5KINO>.]=2"W0!;>*1(E"HJJ.S$XO,,)F&)=/&T*F-RG
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M&5?_ ,-./\O^H;^K>@?\2M^-O_0BP?\ XD>3>7_4=_5O0_EJ_MK6?^@MJ?\
MX'W7_P =H_MK6?\ H+:G_P"!]U_\=K^I7_B'Q^#G_1PGQ,_\)CPM_P#'*/\
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M;_XY1_Q#X_!S_HX3XF?^$QX6_P#CE'_$9?#O_H95_P#PTX_R_P"H;^K>@?\
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MHHH **** "BBB@ HHHH **** "BBB@#T'PG_ ,@Z;_K]D_\ 1%M73US'A/\
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M;.PT><Q2NNJ2V]OZ+\#_ -D3P%\!/&'QJF\$6OA33?A!\5]>\(>,-#^"&E^
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M;_T.W[.W_A:^/_\ YU='_#A#]LW_ *';]G;_ ,+7Q_\ _.KKTO[<\&>_!/\
MX:\O_P#F/S_/LSPO]4_I1_R^*W_B09UY?]3/T^[RT^3?^'J?_!0'_HY/Q3_X
M3O@'_P"9*C_AZG_P4!_Z.3\4_P#A.^ ?_F2KZR_X<(?MF_\ 0[?L[?\ A:^/
M_P#YU='_  X0_;-_Z';]G;_PM?'_ /\ .KH_MSP9[\$_^&O+_P#YC\_S[,/]
M4_I1_P OBM_XD&=>7_4S]/N\M/DW_AZG_P % ?\ HY/Q3_X3O@'_ .9*C_AZ
MG_P4!_Z.3\4_^$[X!_\ F2KZR_X<(?MF_P#0[?L[?^%KX_\ _G5T?\.$/VS?
M^AV_9V_\+7Q__P#.KH_MSP9[\$_^&O+_ /YC\_S[,/\ 5/Z4?\OBM_XD&=>7
M_4S]/N\M/DW_ (>I_P#!0'_HY/Q3_P"$[X!_^9*C_AZG_P % ?\ HY/Q3_X3
MO@'_ .9*OK+_ (<(?MF_]#M^SM_X6OC_ /\ G5T?\.$/VS?^AV_9V_\ "U\?
M_P#SJZ/[<\&>_!/_ (:\O_\ F/S_ #[,/]4_I1_R^*W_ (D&=>7_ %,_3[O+
M3Y-_X>I_\% ?^CD_%/\ X3O@'_YDJ/\ AZG_ ,% ?^CD_%/_ (3O@'_YDJ^L
MO^'"'[9O_0[?L[?^%KX__P#G5T?\.$/VS?\ H=OV=O\ PM?'_P#\ZNC^W/!G
MOP3_ .&O+_\ YC\_S[,/]4_I1_R^*W_B09UY?]3/T^[RT^3?^'J?_!0'_HY/
MQ3_X3O@'_P"9*C_AZG_P4!_Z.3\4_P#A.^ ?_F2KZR_X<(?MF_\ 0[?L[?\
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MOI.K:A:IHUY!J=K->63:E#J%MJ4-I8W&GWOA?_#A#]LW_H=OV=O_  M?'_\
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MQ[:,KKFJR_9[Y ]CI2BYEFW:?/L?428[.#/[FX@W@WCX'G++:CGRZV*F6_\
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M4W_R11]L\.?] FX_\"IO_DBO\_G_ (>,_MS?]'0_%K_PHF_^,T?\/&?VYO\
MHZ'XM?\ A1-_\9H_XE]XC_Z'F2?=CO\ YF]?Z>A_Q.CP/_T2?%?WY1_\\#_0
M&^V>'/\ H$W'_@5-_P#)%'VSPY_T";C_ ,"IO_DBO\_G_AXS^W-_T=#\6O\
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MT  7_$OO$?\ T.\D^['?_,H?\3H\#_\ 1)\5_?E'_P \#_0%^V>'/^@3<?\
M@5-_\D4?;/#G_0)N/_ J;_Y(K_/Y_P"'C/[<W_1T/Q:_\*)O_C-'_#QG]N;_
M *.A^+7_ (43?_&:?_$OO$?_ $/,D^['?_,WK_3T/^)T>!_^B3XK^_*/_G@?
MZ WVSPY_T";C_P "IO\ Y(H^V>'/^@3<?^!4W_R17^?S_P /&?VYO^CH?BU_
MX43?_&:/^'C/[<W_ $=#\6O_  HF_P#C-'_$OO$?_0\R3[L=_P#,WK_3T/\
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M_HD^*_ORC_YX'^@-]L\.?] FX_\  J;_ .2*/MGAS_H$W'_@5-_\D5_G\_\
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MS>-LB=V=E(MK4,2S,Y.YLD?,<9QQTK=KF/"?_(.F_P"OV3_T1;5T] !1110
M4444 %>*?M*_\FY_'[_LBGQ4_P#4%UZO:Z\4_:5_Y-S^/W_9%/BI_P"H+KU=
MF7?\C# _]AF%_P#3\#R\\_Y$N<?]BO,/_42L0_LQ?\FU_L]?]D.^$W_J!:!7
MN->'?LQ?\FU_L]?]D.^$W_J!:!7N-/,O^1CC_P#L-Q7_ *?J"R+_ )$>3?\
M8JR[_P!1*(4445Q'JA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/C308KO7]>\+ZQK&A:V&@DM+;6+>QN+&0+7H/P?_ &RM8\3>,OC_ .&/CO\
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M/_PB_B'_ //8H_X?X_ME_P#0B_LY_P#A%_$/_P">Q1[+QZ_Z".'/_ <%Y?\
M3CU_'R#V_P!#S_H#XY_\"S3_ .:OZL_*_6_\0_G[3/\ T63X%?\ @3X__P#F
M*H_XA_/VF?\ HLGP*_\  GQ__P#,57)?\/\ ']LO_H1?V<__  B_B'_\]BC_
M (?X_ME_]"+^SG_X1?Q#_P#GL4>R\>O^@CAS_P !P7E_TX]?Q\@]O]#S_H#X
MY_\  LT_^:OZL_*_6_\ $/Y^TS_T63X%?^!/C_\ ^8JC_B'\_:9_Z+)\"O\
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M $(O[.?_ (1?Q#_^>Q1_P_Q_;+_Z$7]G/_PB_B'_ //8H]EX]?\ 01PY_P"
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M<.?^ X+R_P"G'K^/D'M_H>?] ?'/_@6:?_-7]6?E?K?^(?S]IG_HLGP*_P#
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M?E?K?^(?S]IG_HLGP*_\"?'_ /\ ,51_Q#^?M,_]%D^!7_@3X_\ _F*KDO\
MA_C^V7_T(O[.?_A%_$/_ .>Q1_P_Q_;+_P"A%_9S_P#"+^(?_P ]BCV7CU_T
M$<.?^ X+R_Z<>OX^0>W^AY_T!\<_^!9I_P#-7]6?E?K?^(?S]IG_ *+)\"O_
M  )\?_\ S%4?\0_G[3/_ $63X%?^!/C_ /\ F*KDO^'^/[9?_0B_LY_^$7\0
M_P#Y[%'_  _Q_;+_ .A%_9S_ /"+^(?_ ,]BCV7CU_T$<.?^ X+R_P"G'K^/
MD'M_H>?] ?'/_@6:?_-7]6?E?K?^(?S]IG_HLGP*_P# GQ__ /,51_Q#^?M,
M_P#19/@5_P"!/C__ .8JN2_X?X_ME_\ 0B_LY_\ A%_$/_Y[%'_#_']LO_H1
M?V<__"+^(?\ \]BCV7CU_P!!'#G_ (#@O+_IQZ_CY![?Z'G_ $!\<_\ @6:?
M_-7]6?E?K?\ B'\_:9_Z+)\"O_ GQ_\ _,51_P 0_G[3/_19/@5_X$^/_P#Y
MBJY+_A_C^V7_ -"+^SG_ .$7\0__ )[%'_#_ !_;+_Z$7]G/_P (OXA__/8H
M]EX]?]!'#G_@."\O^G'K^/D'M_H>?] ?'/\ X%FG_P U?U9^5^M_XA_/VF?^
MBR? K_P)\?\ _P Q5'_$/Y^TS_T63X%?^!/C_P#^8JN2_P"'^/[9?_0B_LY_
M^$7\0_\ Y[%'_#_']LO_ *$7]G/_ ,(OXA__ #V*/9>/7_01PY_X#@O+_IQZ
M_CY![?Z'G_0'QS_X%FG_ ,U?U9^5^M_XA_/VF?\ HLGP*_\  GQ__P#,51_Q
M#^?M,_\ 19/@5_X$^/\ _P"8JN2_X?X_ME_]"+^SG_X1?Q#_ /GL4?\ #_']
MLO\ Z$7]G/\ \(OXA_\ SV*/9>/7_01PY_X#@O+_ *<>OX^0>W^AY_T!\<_^
M!9I_\U?U9^5^PC_X-^?VFI9(XQ\9O@0ID=4#/=^/U12[!0SL?!.%49RS'@ $
M]J:?^#?O]ID$C_A<OP)."1D77C\@X[@_\(5R/0URD?\ P7T_;+CD1_\ A OV
M<'V.K[)/!7Q$9'VD':ZCXL@E&QA@""02,CK33_P7R_;+))_X03]G(9).!X+^
M(F!GL/\ B['0=J/9>/7_ $$<.?\ @."\O^G'K^/D'M_H>?\ 0'QS_P"!9I_\
MU?U9^5^L_P"(?S]IG_HLGP*_\"?'_P#\Q5'_ !#^?M,_]%D^!7_@3X__ /F*
MKDO^'^/[9?\ T(O[.?\ X1?Q#_\ GL4?\/\ ']LO_H1?V<__  B_B'_\]BCV
M7CU_T$<.?^ X+R_Z<>OX^0>W^AY_T!\<_P#@6:?_ #5_5GY7ZW_B'\_:9_Z+
M)\"O_ GQ_P#_ #%4?\0_G[3/_19/@5_X$^/_ /YBJY+_ (?X_ME_]"+^SG_X
M1?Q#_P#GL4?\/\?VR_\ H1?V<_\ PB_B'_\ /8H]EX]?]!'#G_@."\O^G'K^
M/D'M_H>?] ?'/_@6:?\ S5_5GY7ZW_B'\_:9_P"BR? K_P "?'__ ,Q5'_$/
MY^TS_P!%D^!7_@3X_P#_ )BJY+_A_C^V7_T(O[.?_A%_$/\ ^>Q1_P /\?VR
M_P#H1?V<_P#PB_B'_P#/8H]EX]?]!'#G_@."\O\ IQZ_CY![?Z'G_0'QS_X%
MFG_S5_5GY7ZW_B'\_:9_Z+)\"O\ P)\?_P#S%5M>'O\ @WV^.]QK-A%XK^.O
MPDTKP^\ZC4[_ ,/:?XQ\0:S;VV<NUAI.I:1X9LKN<CA4N-:LHP3N,AQM;SC_
M (?X_ME_]"+^SG_X1?Q#_P#GL5M>'O\ @OU^U;::Q8W'B?X7? 37-!CG4ZGI
M>CZ+X]\.ZK=VH/SQ:?K=SX_\16NG7+=$N;G0M5A3G=9R$@B*E+Q[]G4Y<1P^
MY<DN54UE_M.;ETY/:T%2Y[_#[1JGS?%[IM0K_0Z]O1]I@^,^3VM/G]O+.G0Y
M>:/-[98;%/$.E:_M/87J\JE[.\^6_P#43\"/@MX+_9W^$7@7X,?#Z"YB\*>
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M>F:987P\0ZYX<T:^B>]NK:ZO_#WB?4-/_MRQU":UTBQLK-M%OM2UB"6P^O\
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M8ZJZEX8:G3AAZM53KO#8?ZP^#G[2W[=7P%_;*^ 7[-W[9WCGX8?%?PU^U)X
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MQE*%?'4Z$6DHU,/3Q-:O+#<SC%UJ^!HT,-*G5ABJ=?RKX)_#EO@+^QMKFO\
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MR>/U?%_6:GUFARO()N/L:SG3LY2:Y6G)M-G\_P!_PZQ_;_\ ^C:_%O\ X//
MW_S54?\ #K']O_\ Z-K\6_\ @\\#?_-57] /_#^[]C+_ *$K]HC_ ,(KP#_\
M].C_ (?W?L9?]"5^T1_X17@'_P">G77_ *\>,O\ T0&#_P#"/,/_ )Z^O]+7
MSO\ B$OT7/\ H\N9_P#ASR;_ .A[S_/LS^?[_AUC^W__ -&U^+?_  >>!O\
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M7XM_\'G@;_YJJ_H!_P"']W[&7_0E?M$?^$5X!_\ GIT?\/[OV,O^A*_:(_\
M"*\ _P#STZ/]>/&7_H@,'_X1YA_\]?7^EJ?\0E^BY_T>7,__  YY-_\ 0]Y_
MGV9_/]_PZQ_;_P#^C:_%O_@\\#?_ #54?\.L?V__ /HVOQ;_ .#SP-_\U5?T
M _\ #^[]C+_H2OVB/_"*\ __ #TZ/^']W[&7_0E?M$?^$5X!_P#GIT?Z\>,O
M_1 8/_PCS#_YZ^O]+4_XA+]%S_H\N9_^'/)O_H>\_P ^S/Y_O^'6/[?_ /T;
M7XM_\'G@;_YJJ/\ AUC^W_\ ]&U^+?\ P>>!O_FJK^@'_A_=^QE_T)7[1'_A
M%> ?_GIT?\/[OV,O^A*_:(_\(KP#_P#/3H_UX\9?^B P?_A'F'_SU]?Z6I_Q
M"7Z+G_1Y<S_\.>3?_0]Y_GV9_/\ ?\.L?V__ /HVOQ;_ .#SP-_\U5'_  ZQ
M_;__ .C:_%O_ (// W_S55_0#_P_N_8R_P"A*_:(_P#"*\ __/3H_P"']W[&
M7_0E?M$?^$5X!_\ GIT?Z\>,O_1 8/\ \(\P_P#GKZ_TM3_B$OT7/^CRYG_X
M<\F_^A[S_/LS^?[_ (=8_M__ /1M?BW_ ,'G@;_YJJ<O_!*[_@H P<K^S5XL
MPB[VSKW@487<JY&?%8+'<P&%R<9., D?O_\ \/[OV,O^A*_:(_\ "*\ _P#S
MTZD3_@OC^Q@@E!\#?M#.7CV*6\%> LQMO1O,7'Q3^]M5DYXVNQZXH_UX\9?^
MB P?_A'F'_SU]?Z6I_Q"7Z+G_1Y<S_\ #GDW_P!#WG^?9G\_7_#K']O_ /Z-
MK\6_^#SP-_\ -51_PZQ_;_\ ^C:_%O\ X// W_S55_0#_P /[OV,O^A*_:(_
M\(KP#_\ /3H_X?W?L9?]"5^T1_X17@'_ .>G1_KQXR_]$!@__"/,/_GKZ_TM
M3_B$OT7/^CRYG_X<\F_^A[S_ #[,_G^_X=8_M_\ _1M?BW_P>>!O_FJH_P"'
M6/[?_P#T;7XM_P#!YX&_^:JOZ ?^']W[&7_0E?M$?^$5X!_^>G1_P_N_8R_Z
M$K]HC_PBO /_ ,].C_7CQE_Z(#!_^$>8?_/7U_I:G_$)?HN?]'ES/_PYY-_]
M#WG^?9G\_P!_PZQ_;_\ ^C:_%O\ X// W_S54?\ #K']O_\ Z-K\6_\ @\\#
M?_-57] /_#^[]C+_ *$K]HC_ ,(KP#_\].C_ (?W?L9?]"5^T1_X17@'_P">
MG1_KQXR_]$!@_P#PCS#_ .>OK_2U/^(2_1<_Z/+F?_ASR;_Z'O/\^S/Y_O\
MAUC^W_\ ]&U^+?\ P>>!O_FJH_X=8_M__P#1M?BW_P 'G@;_ .:JOZ ?^']W
M[&7_ $)7[1'_ (17@'_YZ='_  _N_8R_Z$K]HC_PBO /_P ].C_7CQE_Z(#!
M_P#A'F'_ ,]?7^EJ?\0E^BY_T>7,_P#PYY-_]#WG^?9G\_W_  ZQ_;__ .C:
M_%O_ (// W_S54?\.L?V_P#_ *-K\6_^#SP-_P#-57] /_#^[]C+_H2OVB/_
M  BO /\ \].C_A_=^QE_T)7[1'_A%> ?_GIT?Z\>,O\ T0&#_P#"/,/_ )Z^
MO]+4_P"(2_1<_P"CRYG_ .'/)O\ Z'O/\^S/Y_O^'6/[?_\ T;7XM_\ !YX&
M_P#FJH_X=8_M_P#_ $;7XM_\'G@;_P":JOZ ?^']W[&7_0E?M$?^$5X!_P#G
MIT?\/[OV,O\ H2OVB/\ PBO /_STZ/\ 7CQE_P"B P?_ (1YA_\ /7U_I:G_
M !"7Z+G_ $>7,_\ PYY-_P#0]Y_GV9_/]_PZQ_;_ /\ HVOQ;_X// W_ ,U5
M'_#K']O_ /Z-K\6_^#SP-_\ -57] /\ P_N_8R_Z$K]HC_PBO /_ ,].C_A_
M=^QE_P!"5^T1_P"$5X!_^>G1_KQXR_\ 1 8/_P (\P_^>OK_ $M3_B$OT7/^
MCRYG_P"'/)O_ *'O/\^S/Y_O^'6/[?\ _P!&U^+?_!YX&_\ FJH_X=8_M_\
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M _\ STZ/^']W[&7_ $)7[1'_ (17@'_YZ='^O'C+_P!$!@__  CS#_YZ^O\
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M\\#?_-51_P .L?V__P#HVOQ;_P"#SP-_\U5?T _\/[OV,O\ H2OVB/\ PBO
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M>-+'QWXT\>ZI%9>,8)IO#VKGP?H&J:.NLW=A?74&E76KVMG/-'=EH4]X\/\
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MJI\.[R/498[^UGC:]BNKF*YV>;%/+&RNW$_\/+O^"2G_ $'?!/\ XCCXW_\
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M/A%_T2OX<?\ A#^&?_E71_PISX1?]$K^''_A#^&?_E71_P 3#X3_ *)7$_\
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MIO\ H3/V'/\ OCX,?_'Z/^%.?\$IO^A,_8<_[X^#'_Q^C_B.6#_Z)'B/_P
MI?UU7WA_Q*1FG_1RN!__  =B/+_/\N^G\+U%?W0_\*<_X)3?]"9^PY_WQ\&/
M_C]'_"G/^"4W_0F?L.?]\?!C_P"/T?\ $<L'_P!$CQ'_ . 4OZZK[P_XE(S3
M_HY7 _\ X.Q'E_G^7?3^%ZBO[H?^%.?\$IO^A,_8<_[X^#'_ ,?H_P"%.?\
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M!N5 _.[-5ZL2IMAM6\D1[XI&\P2;S/B>5=Y3)\HIM\H+@;@@?G=F@"O1110
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M)"G2]M+&8C$=!1117C'>?YK?[5G_ "=%^TE_V7SXQ?\ JP_$5>!U_:S\1?\
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M  WT_P#YJ#_B43Q;_P"J7_\ #U5_^8/ZL_*_\;%%?V3_ /#B']BG^_\ &_\
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M_P#$T?9[C_GA-_WZ?_XF@"&BIOL]Q_SPF_[]/_\ $T?9[C_GA-_WZ?\ ^)H
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M .)H AHJ;[/<?\\)O^_3_P#Q-'V>X_YX3?\ ?I__ (F@"&BIOL]Q_P \)O\
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M[Z_X*??]):/%/_AH8/\ YKJ_<6BC^W,=_)E__AJRS_YD#ZK2[U?_  ?6\O\
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M^"GW_26CQ3_X:&#_ .:ZC_AWU_P4^_Z2T>*?_#0P?_-=7[BT4?VYCOY,O_\
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M_5E;\<?^&*/^"G?_ $E9\6?^&IMO_FHH_P"&*/\ @IW_ -)6?%G_ (:FV_\
MFHK]CJ*/[<QW\F7_ /AJRS_YD#ZK2[U?_!];R_Z>>7]65OQQ_P"&*/\ @IW_
M -)6?%G_ (:FV_\ FHH_X8H_X*=_])6?%G_AJ;;_ .:BOV.HH_MS'?R9?_X:
MLL_^9 ^JTN]7_P 'UO+_ *>>7]65OQQ_X8H_X*=_])6?%G_AJ;;_ .:BC_AB
MC_@IW_TE9\6?^&IMO_FHK]CJ*/[<QW\F7_\ AJRS_P"9 ^JTN]7_ ,'UO+_I
MYY?U96_''_ABC_@IW_TE9\6?^&IMO_FHH_X8H_X*=_\ 25GQ9_X:FV_^:BOV
M.HH_MS'?R9?_ .&K+/\ YD#ZK2[U?_!];R_Z>>7]65OQQ_X8H_X*=_\ 25GQ
M9_X:FV_^:BC_ (8H_P""G?\ TE9\6?\ AJ;;_P":BOV.HH_MS'?R9?\ ^&K+
M/_F0/JM+O5_\'UO+_IYY?U96_''_ (8H_P""G?\ TE9\6?\ AJ;;_P":BC_A
MBC_@IW_TE9\6?^&IMO\ YJ*_8ZBC^W,=_)E__AJRS_YD#ZK2[U?_  ?6\O\
MIYY?U96_''_ABC_@IW_TE9\6?^&IMO\ YJ*/^&*/^"G?_25GQ9_X:FV_^:BO
MV.HH_MS'?R9?_P"&K+/_ )D#ZK2[U?\ P?6\O^GGE_5E;\<?^&*/^"G?_25G
MQ9_X:FV_^:BI$_8D_P""GT@D9/\ @JQXM80Q^;(?^%4VHVIO2/<<^*1D;Y$7
M R<L.,9(_8JK$"[DN3Y32[+?=N#[!#^^A7S6'\:C=Y>S^](K?PT?VYCOY,O_
M /#5EG_S('U6EWJ_^#ZWE_T\\OZLK?C3_P ,4?\ !3O_ *2L^+/_  U-M_\
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MDK/BS_PU-M_\U%'_  Q1_P %._\ I*SXL_\ #4VW_P U%?L=11_;F._DR_\
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M?U96_''_ (8H_P""G?\ TE9\6?\ AJ;;_P":BC_ABC_@IW_TE9\6?^&IMO\
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MBC_@IW_TE9\6?^&IMO\ YJ*_8ZBC^W,=_)E__AJRS_YD#ZK2[U?_  ?6\O\
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M;#8W,*$9\/9935.FJL:M2%.ACLRKU85'3PE2,I5XT:--5'A8QK^W7M%37O\
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M']<OM)N+FV6;5$E$$\MH\L(E59!&ZAU5L@<7_P /TO@?_P!$7^*W_@=X0_\
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M-\:V3W5SK1U/39=0%]8LNMZ5L@MO*\B53'+F1@=Z_=K^BOXB_P#!'.Q\!_\
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M"N5G^61<<N^,Q'/ 63UJO0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'H/A/\ Y!TW_7[)_P"B+:NGKF/"?_(.F_Z_9/\ T1;5T] !1110 444
M4 %>/?M#_P#) /CE_P!D>^)G_J%:W7L-<#\5O"^H>-_A=\2?!>D2VD.J^+_
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MEGF$9QYH23Y91C)7M))W1]CT5\AV'B?]NQ[ZR34_@U^R[;Z<]W;KJ$]E\?\
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M ,C4?\(GJ/\ SVLO^_D__P C4 <Q173_ /")ZC_SVLO^_D__ ,C4?\(GJ/\
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M/4?^>UE_W\G_ /D:@#F**Z?_ (1/4?\ GM9?]_)__D:C_A$]1_Y[67_?R?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
-HHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img181012247_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (3 D<# 2(  A$! Q$!_\0
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MU7L:_BN_X) _\%,H_P!E?Q9%\"?C7K<T7[/OC?56DTW7KMY9[?X5>*[]@O\
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M3^%GP*U8PPW\(L=:^$OP26PWB7S;RYU%M3\8_$HD31/+96LWC%(Y!#*MAIT
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M110 4444 %%%% !1110 4444 %%%% !1110![A1117GGH&'XD_Y M[_V[?\
MI7!7E=>J>)/^0+>_]NW_ *5P5Y7750^!_P")_DCEK_&O\*_-A1116QB%%%%
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M3_@OC^WOI.W[?/\ !KQ-CK_;?PYGM]W*GYO^$;\1^'\="/EV\,W<*5ZS6?\
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MH)C5518SH_AS3=/**BDJH3[/M"J2J@8!( -?P&>"K6\^._[3'A.SNH[B>_\
MC'\<]#@NHV$=Q=27/Q \>VR7 ?<%BFF,FK.7+!8G;<6VH3C_ $,Z_HWQKM@L
MOX*R=-<V#P.*]I%.]E1H9=A:3]&Z=9)^6A_"_P!$=2S7._%KBJ2?)FF;Y<J,
MVFKRQ6+SW,<2KMMII5\(VM7[VKV"BBBOP$_MD**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /<****\\] P_$G_(%O?^W;_P!*X*\K
MKU3Q)_R!;W_MV_\ 2N"O*ZZJ'P/_ !/\D<M?XU_A7YL****V,0HHHH ****
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MDCQ'4:M:\\ORBI+_ ,#J8"4[^?-?S/AJOT:/!"K4]K+@6@I)WM2SSB:C3O\
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M?@G%.)O^$=3X VLFEE@/LYUJ7XB>.EUX1'.[SA8P^&_/!  0VVTDEL?T??\
M!.Z[\$WO[#'[*4_P_%@/#P^!_@.WG73F1H8_%5GHT%GX^BN&3Y6U2+QY!XDC
MUMN&;65ORX#E@/Z&R[,Z?AOX=</Y]E.5X#'9SQ+BZOUS'XZE.K3I48NO*.$4
MJ-2C6BO8T80A1C6A3]JL57G&<O=/X@S[A^MX\>.?&O!?$O$6<Y1PMP%EF'>5
MY-E&)HX:OB,7.."A4S)PQ-#%8:;^LXJI5JXF>%J5EAY9?A:52G!N;_ET_81_
MX*R?M#?LB?$RR^#O[4.I>.?&GP?L]87PEXK\/?$2'5)?B9\&KN"^:SO-0TR?
M6X/^$I:'P_(S1ZQX#UQYXXK&S-IH$&BWT1CN_P"TC2M5TW7=+TW6]&OK75-'
MUFPL]5TK4[&:.YLM1TW4+>.[L;ZSN(F:*XM;NUFBN+>:-FCEAD21&*L#7\F'
M_!Q?\//AWH7Q>_9^^(VAQ6MG\2OB!X.\::5X^@M5BB?4]$\$7WA>'P-KVHPQ
M1(TNI.-?\2:"=3N9)KB\TO0=)TU62UT*WC'[A?\ !([Q+KWBO_@G1^S#JGB.
M2274+7PKXH\-6[2;]PT'P9\1O&7@_P +1C>S-Y<7AC0M(BBP0GE(GEJL>U1X
MGB-@,HS?A;ASQ"RS+Z>45\ZQ,\!F>!HQC&C4Q,5C%]8A&,:<6U5R_$IUU3B\
M32JT*E5*HI.7UG@3G/$W#'B)QUX(<09Y6XGP?"F HYQD&<8F4ZF)H9?-Y5;
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MVL=9\?\ B[4XUTN/6X=&;?=:5HFGZ8LEMH-I>B'5[IM6U&XU2RLY#:V5M[_
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MHCA7M_$D5N8_$:6D4%MI?BR/4(HK+3M*U#08I_U1K^0W]N;]G3XF_P#!)O\
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M8?\ P4+\1?L-_%Q;7Q!-?:Q\ ?B'?V-E\3_#$;33OHDI:*UMOB+X<M(TF?\
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M2DR(5\GQUX&LK]E@U&U8"STG3OC-\-X+YDO+&06=GJD-Y)#FRT#Q1IVIV/\
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M=M+1=,U&VU"WGOQ>?<E%--K9]4_FMF!^;/P;_P""7/P*^#'Q@^$?QWL/B/\
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M:EHUY;ZQ\0;F";2K-UDT_P /0:[JR:F- _>WP3>^)O\ @B)\3M)^%7C"\O\
MQ3_P2N^-'CJZ@^&7Q)U(RWOB']B[XF>,+^6];P1\1]6*/<:M\'?%.J332Z-X
MPU.62YT:X:>?6+I+VWU*Y\5?T'5P?Q0^&/@/XT?#SQE\*?B?X:TSQAX \?:!
MJ'AKQ5X;U>!9[+4]*U&$Q2H<XDMKNW?R[S3M0M7AOM+U&WM=2T^XMKZUMYX_
MQRKCJE>5JR3HM*+IQTM_?B^E1/5-Z;Q:Y6T?U\HVV>O=[/R:[?B=M;W%O=V\
M%W:3PW5K=0Q7%M<V\J36]Q;S(LD,\$T;-'+#-&RR12QLR2(RNC%2"9J_$W]@
M/XE_$']D+X]:[_P2G_:.\1:EXDMO#>@3^-OV#/C'KR*DWQ@_9_L8I9KWX9:G
M?JYAN/B#\%HHI]+ELB(+NY\-Z5>7%MI]GX:TOPU>:W^V5<M6FZ<N6ZE%I2A-
M;3A+X9+M?9K>,DXO5,I._EW79A11168PHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ]PHHHKSST##\2?\@6]_[=O_ $K@KRNO5/$G
M_(%O?^W;_P!*X*\KKJH? _\ $_R1RU_C7^%?FPHHHK8Q"BBB@ HHHH ****
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M_ [C#%0C*GF>:4IJ=6A5FE&NWB(I>VS6M;EK5HVA@8*-"C&G4A"&%_F;PO\
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M]U'8V40L] DV=$/WM*5)_'34JM+NUO5I^G*O:171QG;6;)>COWLG^C_1_P#
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M>*-#TCQ)X>UBV>RU?0=?TVRUC1M4LY,>9::CI>HP7-C?6TF!O@N8)8GP-R'
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M(]+\-Z?<7_V(1ZDCK^U=:5X*%1\G\.:52G_@FN9+UCK!_P!Z+$GIKNM'Z_\
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M/@/\5FT_6/C+\(?A'\27\+P7$VEZI\3O '@WQ@WAVV!^U7<NGWOBK2=1.D0
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M\T**** "BBB@ HHHH **** "BBB@ HHHH **** /<****\\] P_$G_(%O?\
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MTY4\/2J2A.34KUJE:;Y8OFNY2D4445ZIPA1110 4444 %%%% !1110 4444
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M><L54Q#YO9U*6(550A"-XWBZ;TC->\ZD72^N****X3T0HHHH **** "BBB@
MHHHH **** "BBB@#W"BBBO//0,/Q)_R!;W_MV_\ 2N"O*Z]4\2?\@6]_[=O_
M $K@KRNNJA\#_P 3_)'+7^-?X5^;"BBBMC$**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "OYL?^"Q?_)S7@7_ +(3X9_]6!\3Z_I.
MK^;'_@L7_P G->!?^R$^&?\ U8'Q/KWN&_\ D9P_Z\UOR1_%'T_O^4=\R_[*
MOA?_ -2JY^3M%%%?H1_A,%?JQ\8/^43'[*?_ &6SQ9_ZD'Q]K\IZ_5CXP?\
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M,PR!?+_V<_V^_P!E3]I_X9^+/BI\.?C!X"MM!^'J>/-0^)&F^(?B!\.(=?\
MAMX5\!>+/&'A>Y\??$&ST+QEX@L_!W@+Q'9^"M3\<>$?%.O:C9:=K'@"[TSQ
M+(]G%/<6]H>SJ6;Y)6BXJ7NO1R^&^FG-;3N!]DT5X-X<_:H_9A\8^#KOXB^$
M?VCO@-XI^'UAXJTKP)?>.O#GQ?\ A[KG@ZS\;Z]-IMMH?@V[\3Z9XANM$M_%
M6LW&M:/!I7AZ:^35]1FU;38K.SF>_M5EYSX[_M(Z7\+-%U4>!A\,OB3X]\+^
M/O@GX0\<?#_7/CO\.OA->^!]*^-?C+3O#&A>(?$VI^+KBXCTR]O+"ZOM7\$>
M$KNQ@UWXHWFF_P#"-^"DO=7O+=0E";=N5IWMK[J3NEJY62UE'=I*ZON@OU_+
M7\CZ<HKR37_C_P# ?PI\2O#_ ,&?%/QL^$?AKXP>++>SNO"OPIU_XD>#=&^)
M7B6UU&:^M]/N?#_@74=9MO%&LV]]/IFI06<VG:7<QW4VGWT<#.]I<+'ZW2::
MM=-75U=6NNZ[H HHHI %%%% !1110 4444 >X4445YYZ!A^)/^0+>_\ ;M_Z
M5P5Y77JGB3_D"WO_ &[?^E<%>5UU4/@?^)_DCEK_ !K_  K\V%%%%;&(4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !117*>*/'G@?P/#%<>-/&7
MA3PA;S[C!/XH\1:1X?AF"??,4NK7EHDFS^+8S;>^*:C*32BG)O9)-M^B6H'5
MT5X,?VJ/V802#^T?\!@02"#\7_AZ"".""#XBR"#P0>E)_P -4_LP?]'(? 7_
M ,/!\/?_ )HJV^K8G_H'K_\ @JI_\CYK[R>:/\T?O7]=5]Y[U7XI_P#!4_\
M9.^+'Q7\4^#?C'\,/#.H>.$T7P?;^!_$7AW0('OO$=K#9:]K>LZ;JMGI$;&Z
MU6UEE\175K<1:7;W-Y:F%+B>$VF^:#],C^U5^R^ 3_PT?\!>!GCXO_#XGCT
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M=;V%?&WFZF'I4:;I_NTW^O&IG_@HY_PMV8Z,G[$P^ P\<0_9TU.3XZGXNO\
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M\$+>YU/QQ\,-7?P]:DF3Q1X:EM/%6@)$-W^D7=UH<UY/I,!VM\VM6NFL,#*
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M,<4K6\SVUU:W5G?06FI:9J%G<1R6]]IFIV=GJ-E.C0W5K#("M>AU^)_[&?\
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M5/$G_(%O?^W;_P!*X*\KKJH? _\ $_R1RU_C7^%?FPHHHK8Q"BBB@#YHUO\
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MTPCMXY98^^H **** "OR1_X+,_\ )K_@/_LO7A?_ -5[\4:_6ZOR1_X+,_\
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MT)+EI]0U)+VUU:"RFM=.D,0NH0:DNK?POIULEIKY>2_,_)KXX>"O!K?LT?\
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MH3^#UT<>'I;U;ZW@O1=2:<TXNX(;D2>=&CJ"Y]M]'IK_ '4K^4E;FOU;^_\
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M/_LO7A?_ -5[\4:_6ZOR1_X+,_\ )K_@/_LO7A?_ -5[\4:]/)O^1I@?^O\
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M0GQA)X"E^(2ZD+[^T_LG_"-#1XFM#>^;_:@U(K$-&-J3=C^0"OTC3_E$'/\
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M_2N"O*ZZJ'P/_$_R1RU_C7^%?FPHHHK8Q"BBB@ HHHH **** "BBB@ HHHH
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M=/\ P1_])05_(C_P7V_Y/$^&W_9M/@[_ -6C\9*_KNK^1'_@OMS^V)\-L?\
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M](T_Y1!S_P#:2.T_]9AO:_-ROTC3_E$'/_VDCM/_ %F&]K@XBVR3_LHLJ_\
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M_P NHNJ]'^+5OR9]-4445@,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#W"BBBO//0,/Q)_R!;W_MV_]*X*\KKU3Q)_R!;W_MV_]*X*\KKJH? _
M\3_)'+7^-?X5^;"BBBMC$**** "BOR+_ ."H_P #_@LGPGT'X@I\(/A<OC[Q
M'^T/\#M/\0^.%\ >$U\7Z]8:IXNL=-U.QUGQ*-)&M:I9ZCIT<=A?6U]>SPW=
MDB6MPDD"K&.T^-OP]^'6D?';]F7]C_X=>!_#'PD^#_QPE^,7Q$^.OA_X3Z+H
M_P ,(/B7H/PW\$V=GI/@/77\&VVCS:GX<\4:AKJ0^.M/=5?7/"^EKH$T[Z;?
MWR0G2_K^%O\ ,I1ND[O7FTM_*E)]>ST]#]0**^&OCK^S]\%?A'^SM^U1XJ^$
M_P -/"OPMU/4_P!F/XR:)JUK\.-.7P+X;UFUM_ WB+4;&\UOP;X6;2O"&M:_
MI5P)H]%\4ZIH=WXFT2PU#5]*TC5[+3-:U>SO?SN^#NF_!_6K[_@F_P"'/V:O
MA_#\+?VB=,TGX6_$/XT^+T^&>L? &3QK\"M)^'5A;?&*TO\ 5?%&@>!IOVA(
MO'?B2719-'G\&VOQ)M);O3]1\6W.M:-HJW6J:F HIZW=M>G97UUTOMU_0_?:
MFNZ1H\DCK''&K/)([!$1$!9G=F(55502S$@  DD 4ZOP,_X+US?&6'X1?!\^
M$Y]>B^#,WB+Q-!\6%T4W4>GOKKIX<_X5VGBV2UEQ+HTLG_"2C38;R-=+&NQV
M;7+2ZF^A+$"BN:2C=*[W?];]EU>A^^*.DB))&ZR1R*KQR(P='1P&5T925964
M@JP)!!!!(-.K^9K_ ((QR_MV-X0UB/X=_P#"LV_9JB^(?A@ZO_PNP?$)=26U
MDEN_^$\'P#E\-(VEMJ*Z>MO)K</B(GPVOB!M&-D([N?Q1(W[(>./^'BW_"U;
MW_A6H_8J'P0_MW2_[./C@_',_%4^&MME_;1O1H"CPBNN[O[2&EB MI^T637;
M9:=5"I0Y9./-'UO;MOV>OYGVK17Q=\8#_P %$?\ A8FI?\*"7]BX_"81:1_9
M ^,#_'$?$1IO[/M3KO\ :1\%H?#21'5?MJZ1]E$CC3Q:M>9N3,@M?&S_ (>"
M?\)?;_\ #.0_8X_X0+^PM.^UGXV'XV?\)>?$NZX_M<6Z^!%_L8:$%^R'3C(Q
MU!F-P+E5"QE@GEVUCJK[_GY_\$^QZ*^/?C)_PW]]M\(_\,^C]CW^SO\ A$-.
M_P"$\/QD/QI^VGQ]YUQ_:P\(KX)7R!X0$'V0Z<=98ZTTQN!<JJ+&63XG']O_
M /X1[X:?\*97]CP>*SX8C/QB_P"%G/\ &IO#R^,_(L/-7X:?\(JBZD_AC[2=
M3\M_%.S51 MAN0R-<; +;:K6_7:W?]#[#K\BO^"S]S%!^R_X%#'?,/CGX>N4
MMH\/=3Q6WP]^)PF,$&0\NQIH8SM&!)/"C$&5,_6?CK_AO[_A77PP_P"%9C]C
MW_A;7V74_P#A<Y\='XT_\*Z%[_HG]CCX8+X?7_A)3:G_ $XZF?%;"9<6@M5;
M=,5_&O\ ;^_9I^+7A;X/:5^T3^U'\2[/XC_M">*?C-IW@^PTSP3>ZO#\&_A=
M\.KOPQ\0]6@\)_#O1-7TW2=0+WT^D:7>:QK.KVAU*>6WBMI9KZ[74]>UWTLG
MO_:>"M9/V\;-]-'KL[M;I;-Z-I:K.LDJ4VVK6V6K;3T[63ZOMLF]#V7_ ()&
M_#.]^-O[,GQJ\+_&?0/"'B/X">(_BQ:+IOPVU73]1;7W\7Z#HO@;7=3U?Q!J
M4-W:V[Z-/;V_@S^S]&6.63[;IVI&],5K(8+^'_@M-I6F:'IG[*FBZ)IMAH^C
MZ39?%_3=*TG2[.WT_3-,TZRA^$EO9V&GV%I'#:V5E:6\<<%M:VT4<$$*)%%&
MB*JCZ)_X(S?\FO\ CS_LO7BC_P!5[\+J\%_X+=?\VR?]UH_]Y/7LX2#AQ5RR
MG*K)5<1S5)\JE-_4ZK;:BHQ6NRBDDK)*R,:COAM$HKEA:*O9>]%:7;?17;=W
MU/O3_@F-_P F._!'_NI/_JWO'U?>E?!?_!,;_DQWX(_]U)_]6]X^K[TKP<R_
MY&./_P"PW%?^GZAM3_AT_P#!'_TE!7\B/_!?;_D\3X;?]FT^#O\ U:/QDK^N
MZOY$?^"^W_)XGPV_[-I\'?\ JT?C)7Z;X*?\ESA_^Q;F/_IN!_-_TKO^318W
M_L>Y'_Z?J'X>T445_8Q_ET%?I&G_ "B#G_[21VG_ *S#>U^;E?I&G_*(.?\
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M/N[+@9_8ZMYZ8>C'^:=:I\G[."_&G+[V2MY/T2^Z[_,****P*"BBB@ HHHH
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M.LI5%'!QE74.52H\S:****_!C^QPHHHH **** "BBB@ HHHH **** "BBB@
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MKJH? _\ $_R1RU_C7^%?FPHHHK8Q"BBB@ HHHH **** "BBB@ HHHH ****
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MCC-?_4WA8_LSHHHK\=/ZD"OY0?\ @I9_R>Q\:?\ NG/_ *J7P'7]7U?R@_\
M!2S_ )/8^-/_ '3G_P!5+X#K]4\(?^2EQW_8CQ/_ *GY8?SE])[_ )('*/\
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MP'_V7KPO_P"J]^*->GDW_(TP/_7^/Y,RK_PI^B_-!_P1F_Y-?\>?]EZ\4?\
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M3_D"WO\ V[?^E<%>5UU4/@?^)_DCEK_&O\*_-A1116QB%%%% !1110 4444
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ME'A'[6/[%^C_ !DANO&WP_ALM!^)L8>:\C)2UTKQDHCP(=1)VQ6>L!D06^K
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M;_M7717]R-*CUIQYY_\ 7RK:4D_.,%3@^SBUT$NK[O3T7Z7N%%%%<XPHHHH
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MWLV^@F^G5[?Y_+?\#]!OV%?V9-,_8]_9-^"7[/ED;>XU3P-X.LV\;:O!AO\
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M5*U>O6G&G2HT:47.K5JU)M0ITZ<(RG.<FHQBG*3239B_%[XO?#KX#_#KQ/\
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M8\B2\U&^F,.GZ3IEL)+[5M5N[/3+"&>]N[>&1I-M))MMI)+=MZ)+S; ^*?\
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MVGB*]OM-U2ZU"/P''-?Z7XG?5=%U37[W0[.]TJ+4;[1K;Y#_ &6X?AI\)_\
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M(9V(4".WMH(YKN]NI(;.R@N+N>&&3\,_!GAGQ]_P6@^)NA_&#XHZ/XA\ _\
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MRD-*#7I5?S/?\'"O[5$FC>%_AU^R)X8O]EUXO-K\4_BD+>5=W_".:3J%S9^
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M]ITC&]KP7QVEHU:/+%WWTZO??[@/T ^.?[?GQZUS]I70?V;/V/-"_9Y%[<?
M*V_:'O/B-^TQKWBK1/"/B/PGJ.EP:[9Z?X,M/"^IZ)>S7D.A7$.IW%W-=7\
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M!?Z1?ZWID-OE;FWE\.:OIB78<&Z:ZA*I7X7_ +4G@72[3]N7]M.V_:P^.?\
MPS^OQ!UR.X^%.N^-/V,])_:L@^)'P]NX;O3_  MI/PT\3:M;7&K_  XUK1-
M31M%T_4?"#Z4/MEM>:?>>)=)U+P[!!-]1>&O"+>"_P!HO_@A_P"&8M4\>:_9
MZ9X*^+"Z7JWQ)\$R?#SQG=:+-=ZOJ6CKJ_@M_$?B\^'TLM$N["WTVR_X2/5
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M*R04445^NGQ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110![A1117GGH&?JMJU[IUW;)]^2+*#U>-EE1>A^\R 9QQG-
M>0$%258$,"000000<$$'D$'@@\@U[?6!J7AVRU!VF!:VG8Y>2( K(>?FDC.
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MHMJ46FFG9IIW33Z-/5,_G%^ DMU\*?VI="T&_<P/IWC37/ &I";]UO:[EO\
MPY&'W\*/[0:UF4G@E%(/(:OW*KY9^(_[ *>-_C!K7Q9TGXKGPO+JWB6R\4Q:
M)_P@O]K?8M2MC9SSL-37QCI1G%UJ%M+>;OL$+1&X\K]Z8_-?[>_X0S_J)?\
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; %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img181012247_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_2.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 'T!- # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **\:^*'[0_P,^"R _%3XK>!_!%PPC:/3-:U^RCUV=)0&22U\
M/P23ZY=Q%2':6VT^6-$97=E5@3\R77_!4G]A"SG>WF^/-N\D9PS6OP[^+5]
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M/_XL7@__ .?!^A%%?GO_ ,/4OV"_^B[_ /F,/C+_ /.\H_X>I?L%_P#1=_\
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M/_XL7@__ .?!^A%%?GO_ ,/4OV"_^B[_ /F,/C+_ /.\H_X>I?L%_P#1=_\
MS&'QE_\ G>4?V9F7_0NQW_A)B/\ Y6'_ !'KP,_Z/1X3_P#BQ>#_ /Y\'Z$4
M5^>__#U+]@O_ *+O_P"8P^,O_P [RC_AZE^P7_T7?_S&'QE_^=Y1_9F9?]"[
M'?\ A)B/_E8?\1Z\#/\ H]'A/_XL7@__ .?!^A%%?GO_ ,/4OV"_^B[_ /F,
M/C+_ /.\H_X>I?L%_P#1=_\ S&'QE_\ G>4?V9F7_0NQW_A)B/\ Y6'_ !'K
MP,_Z/1X3_P#BQ>#_ /Y\'Z$45^>__#U+]@O_ *+O_P"8P^,O_P [RC_AZE^P
M7_T7?_S&'QE_^=Y1_9F9?]"['?\ A)B/_E8?\1Z\#/\ H]'A/_XL7@__ .?!
M^A%%?GO_ ,/4OV"_^B[_ /F,/C+_ /.\H_X>I?L%_P#1=_\ S&'QE_\ G>4?
MV9F7_0NQW_A)B/\ Y6'_ !'KP,_Z/1X3_P#BQ>#_ /Y\'Z$45^>__#U+]@O_
M *+O_P"8P^,O_P [RC_AZE^P7_T7?_S&'QE_^=Y1_9F9?]"['?\ A)B/_E8?
M\1Z\#/\ H]'A/_XL7@__ .?!^A%%?GO_ ,/4OV"_^B[_ /F,/C+_ /.\H_X>
MI?L%_P#1=_\ S&'QE_\ G>4?V9F7_0NQW_A)B/\ Y6'_ !'KP,_Z/1X3_P#B
MQ>#_ /Y\'Z$45^>__#U+]@O_ *+O_P"8P^,O_P [RC_AZE^P7_T7?_S&'QE_
M^=Y1_9F9?]"['?\ A)B/_E8?\1Z\#/\ H]'A/_XL7@__ .?!^A%%?GO_ ,/4
MOV"_^B[_ /F,/C+_ /.\H_X>I?L%_P#1=_\ S&'QE_\ G>4?V9F7_0NQW_A)
MB/\ Y6'_ !'KP,_Z/1X3_P#BQ>#_ /Y\'Z$45^>__#U+]@O_ *+O_P"8P^,O
M_P [RC_AZE^P7_T7?_S&'QE_^=Y1_9F9?]"['?\ A)B/_E8?\1Z\#/\ H]'A
M/_XL7@__ .?!^A%%?GO_ ,/4OV"_^B[_ /F,/C+_ /.\H_X>I?L%_P#1=_\
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MC?=N;3XF_%IYX^O*+?>.;VV/_;2W<<=.N?T1HH_M3,O^AACO_"NN_P ZA,O
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M*59(9])U&TN+&1(V1'B#0'RI$22/:Z*P_G:^*7@.Z_X(Z_MJ?"WXM?!ZYO\
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MZ;RV((#X)! J:3A&K2E47-352#J1[P4DY+YQNCHE=QDD[-IV?9VT?WGY:_\
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MXQI2IJ4X0=>--SM-B<K1O4FZ+J^^XNM>*]EI'VDE[3D=2S<E+1OE<K:'!_\
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M7]DGX,_&;P9\*?A=\+],^ WB>S^(FO\ PW\*>./$_P +])\0?"CP_K6N^'_
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MT_1/"LNGQS?8=1TVV_.?Q=^R;^T;KOC+7OB?^S_^Q[^T1X3_ &"=*^-'P_\
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MJG@+XO\ PF\1?$3XF^,/V>;7POX]T_3=.U&2RO\ PK8^(8[#5OBA\4M*GO\
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M4U6ITU!2E["52/M"G.=)3K1E4G2IU;*,G-N4)TX)VYVY24:S7*W=I<R3MO\
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M&2<;KF47A,"E)K>S::3M9M-=&6D_K,G;3V$%?I?VE30^(O\ @KCX5^(7B/\
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M[)RDY-+1)MWT71:Z'Z]3@J=.%--M0A&"<G>348J*<GU;M=OJPHHHJ2PHHHH
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MK8:CJ^NZJXTO0M,NVAU2[TK\YK/]D;_@J-^WY;CQ!^UW^T#)^RG\'?$(,R?
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M=4)E,=W+X&,EMINGB$RLR)X)OO!4Q94WW3*'5_DS6OB3_P %4O\ @F(JZ_\
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M>(?@QKVD7>H>._BUIM]XF^'.H'0]-U/1_#S?!KQ3\/\ Q/XQU/4-3OKZVN=
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MX_U#P!J!:;X@P.B:8]KXIL]/T?1K6S:ULVEMY+F_OOLG]E_]G3XN?&O]F_\
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M\)/X;^VS:I9QPW$B>$D@-B\L4-M!.4N8_P S/CWX!\1Z-^W)^T[\0?B=\/\
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M/\7/CC\'O&W[+$?[0WAAOC-XGG^(OCSX9^*=)^)L7P_U'2Y?'.I1KKU_X/\
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M1EHU%V5[V;NKZ]3YV_X*%>/?VFO G["?ASQ)K'B_0?A'^T%-\:?@[H^L:_\
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M !.L/!GA70_"GASX>"'PSXE\/SZ#!K+Z]XW3Q9;:G#JUG=_;=0DU&R^RZO\
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M^+_#!\/>-/#%P+V3XI3^(H?#^J3WFM^-M1OYM.MM1T;0]*L[32/#BP:G[O\
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MINVBBXRO)-+XK<B3NI-M*5[Q:N]))'RG\6/B_P"*/V9?V]K[Q#XW\8^+]2^
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M-%<117%O+'/!/&DT,T+K+%-%*H>.6*1"R21R(RNCHQ5U(9200:_@H^+'Q8^
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M&G9KJ@HHHKF+"BBB@ HHHH _GO\ ^"[_ /S:O_W7#_WD%?T(5_/?_P %W_\
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M-#NKR^T^VUFUTGQ-KNEW]QI5Q?Z7J5C!J,-N]I+>:=?6T<S36EPD?P_\._\
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M1<\'BI48N')!4*5&"AS1E.:X(X&R7@#+,7E&15,?+!8O,99FX8_$0Q,Z->>
MR_ 5(4:D*%&2I5(Y?#$U%5]K5EB\1BJKJ\E2%.F5_/7_ ,%L;_2?%WQN_P""
M>'P'^('BVYT+X&>/_BKX@UCXU6*^)(O"FCKX5TKQ!\,M+NO%GB/6KZX@TO3;
M'PCX5U?QS>Q:S>M&FAVD^M7_ )R-Y;Q?T*5^(/\ P4+_ &$?VA?VN/VTOV;?
M$WABS\+P?L^>#?A[J/ASXB^(];\16%G=Z?'XFU_7[/XAZ3:>'_LFIZSJM_KO
M@.]TVU\.&STP:=-JJ3VNJZ]X6C$6LP^UX=8G X'BC#X[,<;0P&'P>7YS6CB:
MU2%-PQ+RG&4<*Z#GOBHXBK3J8:,?WGMH1=/WU%'RWC?@,WS;P^QN49+E6+SG
M&9IG/"^%G@<+1J5E4P4>(\LQ6/\ KD:>L<NG@\-6I8^=2U&.&JU/;M4G-K](
M/AO^QU^R=\./AA>_"OP#\"/A;;?#3Q-8P1ZYHUQX<T[Q1;^,;0PK]EN?%&L>
M(5UG5?&$@A*-:ZAKVI:I<(NQX+A0$(_#7PY\.?@U^R3_ ,%L_@!X"_92U*#P
MI\-/BK\.O&NC_%WP?X>\;S^)O"\'C:UT7XKR:GX$O[5M4U/4-'O=(U3POX"\
M3'PMK-TYT/6+O3I[*UL-.FAL8?Z+OA?X0O/A[\,_AWX!U'76\4:AX'\"^$O"
M%_XF:P;2V\17GAK0-/T6ZUUM,:_U1M.;5Y[)]0-@VIZBUH;@VYO[PQFXD_!7
M7_\ @FQ^U/X2_;>^#7[27A.U\"^*M*;]NOXY_%OQI=Z)XLCL_P#A"_@!\2?%
M/@O6M%?5[#Q-9>%[G4_&)TF;XEV>KZ3X5L_%,EMJ4^@1)KNJ:3,IT#U^#LUI
M3Q'%M#-^)*OL,RR/.L+368XNLL-FN,K8#%K"XO$?6ZG*\32J4:$L-.M%UU5J
M4Z<&IM1?S/B=PY7I8/PWQ?#? F'^N9!Q9PKF%:61Y;AOK_#V5X7.<LEF&6X)
MY=24E@,11Q6+ACJ6&FL'+#8>M7JQE1C*<?Z)****_+S^@0HHHH *_(+]J']@
MCXL?$K]K2_\ VDO!_A3]D;X[Z-KWPPT#X>I\//VQ=$\<>(-!^&-[H=W>R2^(
M/ FC>']'\3:!K2:PEX]YJ.FZQ8Z)<KJ#3M8:U8O=2W=?K[175A,96P5256@X
MJ4Z<J4U)-J5.;BY1NG&4;N,7>,HNR<6W%R3SJ4XU4HRO924E:VC5[/5-=7NG
MWW/A?_@GO^RUXR_9"^"'B3X5^-M8\"ZWJ.H?&3XG>/-,NOASIM]H?AB+PYXM
MU>"ZT.TMO#M[8V:^&9X+*W43>&M/EU;2=!#1Z7IVN:O;6J7TOPWJ-I^U ?\
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MBT[14HJSZ2:DU?U2>EGI:]M#XR\*?LZ>--#_ &[OBS^U#>:KX7D\!>._V?\
MX?\ PHT?1K:\U9_%]OX@\+>)]1UO4KW4[&718=&@T:6UNH8[&>UUZ]O9I_-6
MXT^UC1)9/>?CIX'U;XG?!+XQ_#;0;C3K37?B%\*_B%X'T6[U>:YM])M=6\6>
M$M7T'3KC5)[*TU"\ATZ&\U"&2]FM+"]N8[997@M+F54A?U2BN*>)JSJ4:LG%
MSH0H4Z?NV2CAXQA3375I15WUU-%"*4DKVDY2>O63N_S/%?V;/AQKGP=_9U^
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ML[1D^3E;DVE07.Y.4FKTVH\SLW2LXN5_B:DE);:K6^A^5?P6_8R^/GP^T_\
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MG_R\J4YZ-Z>R<917SG%R:6CYN]V_@BV_9*\5WW[4O[7OQ>U[7_#D'P\_:.^
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M4OYJGWQ_^0#_ (BAG_\ T!Y/_P"$^-_^>!]L?\+<^'G_ $,'_E)US_Y6T?\
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MK_(/];,Q_P"?."_\%U__ )I/>/\ A,_#7_02_P#)._\ _D6C_A,_#7_02_\
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MU_D'^MF8_P#/G!?^"Z__ ,TGO'_"9^&O^@E_Y)W_ /\ (M'_  F?AK_H)?\
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MB?%;X;> M2U!$DL-/\:>.O"_A:^ODD=HXWL[37-4L;BY1W1D1H8W#.K*I)!
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M_D-77_8+G_\ 2NRKV2N2M\;]$?H_#'_(KC_U_K?G$_GO_P""$'_-U'_=#_\
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MBUS68M.A\/P>)G/B>WECT1K"#P:FE)&3XP34(=#SJ<+*GGOASP'J/C7X/?\
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M*O#Z]PTG_D%:9_V#[+_TFBK"OM'U?Y'TW#/^\8G_ *\Q_P#2T?B?_P %EO\
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MITJJC)1455]E.3BX0J0XW]F_XS?$CX@>$/VS]4\6>(5U2_\ A+^U%^T5\./
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M9U,M]A2Q&(H5?"?CUX@_:S\&?%/]B7]G#X??M$VH\3_&'3/VA[?XF?%OQ/\
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MBCZ__P!.O_)__M _XA1_U/\ _P Q?_X1/S?HK](**/K_ /TZ_P#)_P#[0/\
MB%'_ %/_ /S%_P#X1/S?HK](**/K_P#TZ_\ )_\ [0/^(4?]3_\ \Q?_ .$3
M\WZ*_2"BCZ__ -.O_)__ +0/^(4?]3__ ,Q?_P"$3\WZ*_2"BCZ__P!.O_)_
M_M _XA1_U/\ _P Q?_X1/S?HK](**/K_ /TZ_P#)_P#[0/\ B%'_ %/_ /S%
M_P#X1/S?HK](**/K_P#TZ_\ )_\ [0/^(4?]3_\ \Q?_ .$3\WZ*_2"BCZ__
M -.O_)__ +0/^(4?]3__ ,Q?_P"$3\WZ*_2"BCZ__P!.O_)__M _XA1_U/\
M_P Q?_X1/S?HK](**/K_ /TZ_P#)_P#[0/\ B%'_ %/_ /S%_P#X1/S?HK](
M**/K_P#TZ_\ )_\ [0/^(4?]3_\ \Q?_ .$3\WZ*_2"BCZ__ -.O_)__ +0/
M^(4?]3__ ,Q?_P"$3\WZ*_2"BCZ__P!.O_)__M _XA1_U/\ _P Q?_X1/S?H
MK](**/K_ /TZ_P#)_P#[0/\ B%'_ %/_ /S%_P#X1/S?HK](**/K_P#TZ_\
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M?HKZ@HH]O_<_\F_^U#_5#_J8_P#EI_\ ?)\OT5]044>W_N?^3?\ VH?ZH?\
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MM[O^OP/K,+AJ6#H4\/0CRTZ4;1N[MMMN4I/2\I2;E)V2NW9)62_GO_X(0?\
M-U'_ '0__P!Z_7]"%?SW_P#!"#_FZC_NA_\ [U^OZ$*]OB3_ )'6-_[EO_42
M@?RM]!W_ )1<\,/^[U_]>'Q:%%%%>&?U@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 445P/Q!\;P^"=)CN$BCNM4OG
M>'3;25F6-FC"F>YG*8<V]JLD>]$97EDEBB5XP[2QU&+G)1BKN3LE_7XG+CL;
MALNPE?&XRHJ.&P\'4JU&F[*ZC%)*[E.<G&$(I-RG*,4KM'?45\):A\0_&NI3
MO/-XDU6W+-D1:?=RZ; @&0J)#8M FU0<98,[8#2.[Y8T/^$R\7_]#5XD_P#!
MYJG_ ,E5V+ SMK.*?:S?XZ'YO/Q3RQ3DJ>68Z<$VHRE4H0E)=&X*4U&_;F9]
M^45\!_\ "9>+_P#H:O$G_@\U3_Y*H_X3+Q?_ -#5XD_\'FJ?_)5'U&?_ #\C
M]S)_XBIE_P#T*L9_X.H?Y'WY17P'_P )EXO_ .AJ\2?^#S5/_DJC_A,O%_\
MT-7B3_P>:I_\E4?49_\ /R/W,/\ B*F7_P#0JQG_ (.H?Y'WY17P'_PF7B__
M *&KQ)_X/-4_^2J/^$R\7_\ 0U>)/_!YJG_R51]1G_S\C]S#_B*F7_\ 0JQG
M_@ZA_D??E%? ?_"9>+_^AJ\2?^#S5/\ Y*H_X3+Q?_T-7B3_ ,'FJ?\ R51]
M1G_S\C]S#_B*F7_]"K&?^#J'^1]^45\!_P#"9>+_ /H:O$G_ (/-4_\ DJC_
M (3+Q?\ ]#5XD_\ !YJG_P E4?49_P#/R/W,/^(J9?\ ]"K&?^#J'^1]^45\
M!_\ "9>+_P#H:O$G_@\U3_Y*H_X3+Q?_ -#5XD_\'FJ?_)5'U&?_ #\C]S#_
M (BIE_\ T*L9_P"#J'^1]^45\!_\)EXO_P"AJ\2?^#S5/_DJC_A,O%__ $-7
MB3_P>:I_\E4?49_\_(_<P_XBIE__ $*L9_X.H?Y'WY17P'_PF7B__H:O$G_@
M\U3_ .2J/^$R\7_]#5XD_P#!YJG_ ,E4?49_\_(_<P_XBIE__0JQG_@ZA_D?
M?E%? ?\ PF7B_P#Z&KQ)_P"#S5/_ )*H_P"$R\7_ /0U>)/_  >:I_\ )5'U
M&?\ S\C]S#_B*F7_ /0JQG_@ZA_D??E%? ?_  F7B_\ Z&KQ)_X/-4_^2J/^
M$R\7_P#0U>)/_!YJG_R51]1G_P _(_<P_P"(J9?_ -"K&?\ @ZA_D??E%? ?
M_"9>+_\ H:O$G_@\U3_Y*H_X3+Q?_P!#5XD_\'FJ?_)5'U&?_/R/W,/^(J9?
M_P!"K&?^#J'^1]^45\!_\)EXO_Z&KQ)_X/-4_P#DJC_A,O%__0U>)/\ P>:I
M_P#)5'U&?_/R/W,/^(J9?_T*L9_X.H?Y'WY17P'_ ,)EXO\ ^AJ\2?\ @\U3
M_P"2J/\ A,O%_P#T-7B3_P 'FJ?_ "51]1G_ ,_(_<P_XBIE_P#T*L9_X.H?
MY'WY17P'_P )EXO_ .AJ\2?^#S5/_DJC_A,O%_\ T-7B3_P>:I_\E4?49_\
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M_"K-^SS7?9OV+NVXW;5SG Q^Y7]N:U_T&-4_\&%W_P#'J]C'4F\GR*-U[O\
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MQJG_ (,+O_X]1_;FM?\ 08U3_P &%W_\>H]@_P"9?<P_UMPW_0)7_P# Z?\
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M45\Y_P!N:U_T&-4_\&%W_P#'J/[<UK_H,:I_X,+O_P"/4>P?\R^YA_K;AO\
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M !1110 5\G_'J61O%.E0%OW4?A^"5%["2;4=221O^!+;Q _[HKZPKY+^//\
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M&:@VG/\ $/4&@*ZY;^*X+'2]/>..(-M;5IG_ 'LHJ\+F%3#2J.2=55*$,/\
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MS6NJ1>(5\*2:*TDO]N7J7=LOAF.RG5+.0VHN+.WF2]X[_8C\ ^/[;X6ZG?\
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M<TG3/#GAJQ;Q'<V<26LGB#6XM8U8*D-PMVM[:V=U;_17Q=^%'@?XY?#;Q?\
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M6,Q<J.,PU.EBZ<L5B)0K*5:HY?-]W^R]\/[SXD_'/XI2ZMXO'B+]H#X9Z/\
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M![3"T8T8TL!5E@H0PDZV AAJL\/"%*<Y0A&*****XSY,**** "BBB@ HHHH
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M:QJWB*^TB5](,]M;Z9Y]R%KZN_:HTS5]=^%K>'M._9KTG]JK3]?U^PTSQ/\
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M"N6@E*#]BH2JX>4FIOGA3?M%4Y7[::G**<6U%S7OW<4TE#Z.\(_M[>,!X_\
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M>U:9_JK]F;X0_$/X>_'O]MGQOXOT :1X9^+WQ7\&>)/AYJ/]K:+?MX@T32/
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M\//^A?\ _*MKG_RRH_X5'\//^A?_ /*MKG_RRH^NTOY:GW1_^3#_ (A?G_\
MT&9/_P"%&-_^=Y\3T5]L?\*C^'G_ $+_ /Y5M<_^65'_  J/X>?]"_\ ^5;7
M/_EE1]=I?RU/NC_\F'_$+\__ .@S)_\ PHQO_P [SXGHK[8_X5'\//\ H7__
M "K:Y_\ +*C_ (5'\//^A?\ _*MKG_RRH^NTOY:GW1_^3#_B%^?_ /09D_\
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M17VQ_P *C^'G_0O_ /E6US_Y94?\*C^'G_0O_P#E6US_ .65'UVE_+4^Z/\
M\F'_ !"_/_\ H,R?_P *,;_\[SXGHK[8_P"%1_#S_H7_ /RK:Y_\LJ/^%1_#
MS_H7_P#RK:Y_\LJ/KM+^6I]T?_DP_P"(7Y__ -!F3_\ A1C?_G>?G+X4^%7@
M+P1XM^(?COPSH)T_Q;\5M1T;5/'VMRZKK6I7.OW?AW3I-)T,-'JNHWUMIMII
M6G2RVUEIVCP:?IT*RRNMKYDCNWH5?;'_  J/X>?]"_\ ^5;7/_EE1_PJ/X>?
M]"__ .5;7/\ Y954LPA-\T_;3E:,;RM)\L(J$(W<V[1C&,8K:,4DK))%3\,N
M(JCYIX[*9RY8QYIXK'2?+"*A"-W@&^6$(QA%;1C%12221\3T5]L?\*C^'G_0
MO_\ E6US_P"65'_"H_AY_P!"_P#^5;7/_EE4_7:7\M3[H_\ R9/_ !"_/_\
MH,R?_P *,;_\[SXGHK[8_P"%1_#S_H7_ /RK:Y_\LJ/^%1_#S_H7_P#RK:Y_
M\LJ/KM+^6I]T?_DP_P"(7Y__ -!F3_\ A1C?_G>?$]%?;'_"H_AY_P!"_P#^
M5;7/_EE1_P *C^'G_0O_ /E6US_Y94?7:7\M3[H__)A_Q"_/_P#H,R?_ ,*,
M;_\ .\^)Z*^V/^%1_#S_ *%__P JVN?_ "RH_P"%1_#S_H7_ /RK:Y_\LJ/K
MM+^6I]T?_DP_XA?G_P#T&9/_ .%&-_\ G>?$]%?;'_"H_AY_T+__ )5M<_\
MEE1_PJ/X>?\ 0O\ _E6US_Y94?7:7\M3[H__ "8?\0OS_P#Z#,G_ /"C&_\
MSO/B>BOMC_A4?P\_Z%__ ,JVN?\ RRH_X5'\//\ H7__ "K:Y_\ +*CZ[2_E
MJ?='_P"3#_B%^?\ _09D_P#X48W_ .=Y\3T5]L?\*C^'G_0O_P#E6US_ .65
M'_"H_AY_T+__ )5M<_\ EE1]=I?RU/NC_P#)A_Q"_/\ _H,R?_PHQO\ \[SX
MGHK[8_X5'\//^A?_ /*MKG_RRH_X5'\//^A?_P#*MKG_ ,LJ/KM+^6I]T?\
MY,/^(7Y__P!!F3_^%&-_^=Y\3T5]L?\ "H_AY_T+_P#Y5M<_^65'_"H_AY_T
M+_\ Y5M<_P#EE1]=I?RU/NC_ /)A_P 0OS__ *#,G_\ "C&__.\^)Z*^V/\
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MU_T#?_)R_P#_ )*H_P"$,\-?] W_ ,G+_P#^2J/;P[2^Y?YA_JGF/_/[!?\
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MO_\ Y*H]O#M+[E_F'^J>8_\ /[!?^#*__P S'@]%>\?\(9X:_P"@;_Y.7_\
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MR1]OA,-3P>&HX:E=PHP44WO)W<I2=M+SDY2=M+MVT/Y[_P#@A!_S=1_W0_\
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M4445@>*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;_X6'K7_ #ZZ7_WXN_\ Y-H_X6'K7_/KI?\ WXN__DVCV,_+[P_UFRK^>O\
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M $#?#?\ X!ZI_P#+BCZG6[1_\"0?\1'X9_Y^XS_PDG_\D?6E%?)?_"^?%_\
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M+Y\7_P#0-\-_^ >J?_+BCZG6[1_\"0?\1'X9_P"?N,_\))__ "1]:45\E_\
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MI_\ +BCZG6[1_P# D'_$1^&?^?N,_P#"2?\ \D?6E%?)?_"^?%__ $#?#?\
MX!ZI_P#+BC_A?/B__H&^&_\ P#U3_P"7%'U.MVC_ .!(/^(C\,_\_<9_X23_
M /DCZTHKY+_X7SXO_P"@;X;_ / /5/\ Y<4?\+Y\7_\ 0-\-_P#@'JG_ ,N*
M/J=;M'_P)!_Q$?AG_G[C/_"2?_R1]:45\E_\+Y\7_P#0-\-_^ >J?_+BC_A?
M/B__ *!OAO\ \ ]4_P#EQ1]3K=H_^!(/^(C\,_\ /W&?^$D__DCZTHKY+_X7
MSXO_ .@;X;_\ ]4_^7%'_"^?%_\ T#?#?_@'JG_RXH^IUNT?_ D'_$1^&?\
MG[C/_"2?_P D?6E%?)?_  OGQ?\ ] WPW_X!ZI_\N*/^%\^+_P#H&^&__ /5
M/_EQ1]3K=H_^!(/^(C\,_P#/W&?^$D__ )(^M**^2_\ A?/B_P#Z!OAO_P
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ME2E:5K-R46I1DGRNS3Y6[26G-%VDKJZ04445QF04444 %%%% !1110 4444
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M\OK?[-^A_MM?LJ?#;2/V8-#_ &:O#OQ.\-^!/%7B#3? 7QV/QB\$^'/"]UX
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MQN3U_;QJ2Y,-CXQA6J4?9U:7+7BH+V4I^TIQ=^:E-:(HHHK$\H_GO_X+O_\
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MP;\??@QK?A06?Q+\;Z/^U#;>&?#0UWPW<G4;CXBCQBO@V(ZQ:ZQ/X?LSK/\
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M>U75?#UXTJZ?)IZRK=^%O"UVLES87,C>*?%+7?BR[5=*_7'XA?!3X3?%?5_
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M1?@U;>+O$-Q8^(-%LTN_$5GK>LR'5+>[U34]66W27R-+FM[#9;K[WX<_:!^
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MU'1-2T+1K?6I-1U?3]8T^YMK_2KS3[:XM]0LKB"ZM))H)8Y&?\?O^2$?&O\
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MING3A#%X%8S&U8TEA)X*O_3S1117RY_-84444 %%%% !1110 4444 ?SW_\
M!=__ )M7_P"ZX?\ O(*_H0K^>_\ X+O_ /-J_P#W7#_WD%?T(5[F/_Y$N0?]
MU3_U+@?R?X0_\I1_2_\ ^]?_ /UWF9GC?Q#_ .0U:_\ 8+@_]*[VN#KO/B'_
M ,AJU_[!<'_I7>UP=<%/X(^A^N9U_P C7&_]?G_Z3$****L\LJ:AI]AJUA>Z
M5JME::GIFIVESI^I:;J%M#>6&H6%Y"]M>65[9W*26]W:7=O))!<VT\<D,\,C
MQ2HZ.RG\#?BK\+_BA_P2A^+&H_M$_L]Z9JOC7]CCQYJ]J/C-\'([B:YD^'<]
MU<"&'4]*>=I#;6-N\YB\*>)9B19.\?@[Q9-):W.CZK=_O[5#5=*TS7=,U'1-
M:T^RU?1]7L;O3-5TK4K6&]T[4M.OX)+6]L+^SN4DM[NSN[:62WN;:>-X9X9'
MCD1D8@_1</<05<DK5Z5:A#,,GS&$</G&45Y-4,=AU*\91DKO#XW#R_>X+&4[
M5<-62<6X2J0G\EQ7PI1XDH8:OA\34RGB#*:DL5D&?X:,7BLLQ;C:4)Q=HXK+
ML7%*AF.7UFZ&+P[<9*-6-*K3_"3]D_P'XJ_X*,_M+7W[=OQMT*6Q^!7PXU.X
M\.?LV?#+6'-S9W-_H-[F+Q!>6GFR6ERFAZ@IU36[V-9;76O'9CTZ"XDTCP<=
M./[U5S7@WP=X8^'OA3P]X'\%Z+8^'/"?A32;+0_#^AZ;%Y5GINEZ?"L%K;1*
M2SN0B[IIYGDN+F=I+BYEEN)9)7Z6EQ)GKSS'0G0H_4LJP%&.!R;+8N\,#E]%
MOV4&TVJF)K-NOC*[<IU\1.<G)Q4%%\'<,+AG+*D,3B7F.>9IB)YGQ%F\XI5,
MSS;$*/MJD59>RP>'2CALOPL5&GAL)2IPC!3=24BBBBOGCZP*J7]_8Z58WNJ:
MI>VFFZ9IMI<W^HZC?W,-G8V%C9PO<7=[>W=P\=O:VEK;QR3W-S/)'#!#&\LK
MJBLPMUY/\>O^2&?&C_LD_P 1?_4/UBKIQYZD(-VYYQC?MS22O\KCBKM+NTOO
M9%I_[0/P&U;Q#H/A+2OC;\(M3\5^*=.TO6/#'AC3_B3X-O?$/B/2=<LH=3T7
M5-!T6VUJ74M7T[6--N+?4-+OM/MKBVU"RGAN[26:"5)&O^/?C9\&?A5<Z?9?
M%#XM_#'X;WFK()=*M/'OCWPKX/N=3C,DD0DT^#Q#JVG2WB&6*6(/;)(IDBD3
M.Y& _"?Q+\%OA3X4_P"".WPG^+7AGP%X9T+XH:!%^SK\2],^(>FZ5:0>-8O&
MVK?&+P'H5YKDGB@Q-K<TQTG7+ZPM[>6^:TL;1;*TLH+>UT^RA@]S_:2^*^F:
MO^U-\?/A_P"$?@Y^POIFM_#GP5X 'Q3^+W[:/B0V,OC'1O$W@Z+7M-T;P3I.
MGZ5J/B"7P]H6D72V&KS60ETUM88QW44%Y):-=^XLIHSJ25*=>=.E6QE"LY>Q
MI24L'4P=-U$W*25.H\9348J-2ISKEY7&3G'L6&A*7NN;C&56$K\D6G3E2CS7
M;MRMU4DDI2OILVU]X_M+?MG?"[]F^V^"USJVO> ]7_X7%\3_ (=>$(%U#XE^
M'?"PT3X=>-;][76/C2CW,.I_VQX)\&VOD7^I7Z+I^AR17=N+KQ-I4<B3M[UH
M?QD^$/B<>!V\-_%7X;^(5^)H\2'X;'0_'/AC5A\01X-$I\7GP.;#5+@>+!X5
M$$Y\2'0?MXT,0R_VG]E\M\?S^>%;?PC)_P $U_\ @F[XV\>V'AF[T?PE^VSX
M%L?$OB36;"#4=.T7X9:;^T?\6+#5;"\U+5K::\3P9'I6GZ=:W=I?L;:ZM+6S
M6_AEE517V]^T?XB^%'@S]KO_ ()=?$+1=;\ >'/@IHNN?M>^&(_%6A7V@V'P
MZTS6O&/PPT_0M(TV+4])=/#UG+JOBJWU+3GVRQ1C5X[U+IHYH[ED=7*Z$7'#
MP59UJ=3.*<ZZ5X5IY=2KU*=.-/7EG5E2A%1C)RM.6DWRL<L-!6@N?G4L7%SZ
M3="$I1271R<8I)._O/?0_4-O'7@A?$&L>$F\8^%5\5>'="@\4>(/#+>(=('B
M#0O#5T\T=MXBUC1C>#4=,T*XDM[B.#5KVV@L)7@F6.X9HG"\GH/QW^!_BG5$
MT/PQ\9?A3XCUJ3PRGC2/1]!^(GA#5]4?P=);QW<?BQ-/T_6+B[;PR]I-%=)K
MRPG2VMY8YENC&ZL?S'\*?$?P)\3OV^OVS-:^'OBK1_&.C:3^QAHOAF\UC0+I
M=0TG^W-'UW7AJEC::G"#9:C]ADN(X+BYTZ>ZM$N5FM?M!N;:XBBX#]GK1?@/
M\"/^"26F_'37_@1X6^(EW<?"36-5\;V,EA:1>(?'C>)O%A\-SZ5K/BV:TOM9
MM?#LL7]DVFIP1M/8V'AS3/L]OILEO:QVK8_V73C&*F\1[:K++J5.E&%-2]KC
MZ$ZMI>TE!)0<.6*;7-S+FE%)LAX:*23]ISR=",8I13YJ\'*SYFK6M9;7O=M6
MU_7KP3\<_@E\2]8O_#WPX^,7PL^(&OZ5"]QJFA^"?B#X2\5ZQIL$4JP23W^F
M:%J]_>V<,<SI"\EQ!&B2LL;,'8 ^%_L@?%;Q[\4[S]K*'QWKHUR/X8_MC_%S
MX4^" -+T?3#HW@+PQH7@*^T/0B='T_3SJ1L;G6]3?^U-5-]K%R+@)>:A<+#
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MIK'QE_9/_;,^(OA/X@_%2/Q9X%_:D^/WB*P^$"^.M;;X'?$6W\":IH_B6_\
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M#.C.M/V]*E1CC*G(H0>(:HXC 48PG*7*GS?69-2<?W:2?+/5/]$?^$[\$?\
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MB2[ATHF:1E/;?L<?##X8ZGXZ_;<^)OB?PKX;O_%5A^V;\5M%A\6ZY:6EQ?\
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M:@;C4KR.TMDN+F18(@GKG_"O-:_Y^M+_ ._]W_\ (5'_  KS6O\ GZTO_O\
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M/.W-=2YK7M?F2=][I/=(/[(S>UOJF(M>]M+7;3O;FWO9W[J_33Q+4_AW\/\
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M*[S_ (5YK7_/UI?_ '_N_P#Y"H_X5YK7_/UI?_?^[_\ D*E[2'\R%_8N:_\
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MNGZ!I5G8>)]9\39_X235_$-G;6D=OK6I^(-S?VW?ZE'<W6K9/V^6XR:^D_\
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MH;Q?_P!!+PW_ .!FJ?\ RGH_X4-XO_Z"7AO_ ,#-4_\ E/4_6*/_ #\C^/\
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M/EY8.-Y*_1117GG[$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0_\ EAU%%<O_ ,)GX:_Z"7_DG?\ _P BT?\ "9^&O^@E_P"2=_\ _(M')/\
MEE_X"_\ (/[2R[_H/P7_ (54/_EAU%%<O_PF?AK_ *"7_DG?_P#R+1_PF?AK
M_H)?^2=__P#(M')/^67_ ("_\@_M++O^@_!?^%5#_P"6'445R_\ PF?AK_H)
M?^2=_P#_ "+1_P )GX:_Z"7_ ))W_P#\BT<D_P"67_@+_P @_M++O^@_!?\
MA50_^6'445R__"9^&O\ H)?^2=__ /(M'_"9^&O^@E_Y)W__ ,BT<D_Y9?\
M@+_R#^TLN_Z#\%_X54/_ )8=117+_P#"9^&O^@E_Y)W_ /\ (M'_  F?AK_H
M)?\ DG?_ /R+1R3_ )9?^ O_ "#^TLN_Z#\%_P"%5#_Y8=117+_\)GX:_P"@
ME_Y)W_\ \BT?\)GX:_Z"7_DG?_\ R+1R3_EE_P" O_(/[2R[_H/P7_A50_\
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M#^TLN_Z#\%_X54/_ )8=117+_P#"9^&O^@E_Y)W_ /\ (M'_  F?AK_H)?\
MDG?_ /R+1R3_ )9?^ O_ "#^TLN_Z#\%_P"%5#_Y8=117+_\)GX:_P"@E_Y)
MW_\ \BT?\)GX:_Z"7_DG?_\ R+1R3_EE_P" O_(/[2R[_H/P7_A50_\ EAU%
M%<O_ ,)GX:_Z"7_DG?\ _P BT?\ "9^&O^@E_P"2=_\ _(M')/\ EE_X"_\
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M /R+1R3_ )9?^ O_ "#^TLN_Z#\%_P"%5#_Y8=117+_\)GX:_P"@E_Y)W_\
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M_+STBBO-_P#A;GP\_P"A@_\ *3KG_P K:/\ A;GP\_Z&#_RDZY_\K:/8U?\
MGU4_\ E_D'^L.0?]#S)__#G@O_EYZ117F_\ PMSX>?\ 0P?^4G7/_E;1_P +
M<^'G_0P?^4G7/_E;1[&K_P ^JG_@$O\ (/\ 6'(/^AYD_P#X<\%_\O/2**\W
M_P"%N?#S_H8/_*3KG_RMH_X6Y\//^A@_\I.N?_*VCV-7_GU4_P# )?Y!_K#D
M'_0\R?\ \.>"_P#EYZ117F__  MSX>?]#!_Y2=<_^5M'_"W/AY_T,'_E)US_
M .5M'L:O_/JI_P" 2_R#_6'(/^AYD_\ X<\%_P#+STBBO-_^%N?#S_H8/_*3
MKG_RMH_X6Y\//^A@_P#*3KG_ ,K:/8U?^?53_P  E_D'^L.0?]#S)_\ PYX+
M_P"7GI%%>;_\+<^'G_0P?^4G7/\ Y6T?\+<^'G_0P?\ E)US_P"5M'L:O_/J
MI_X!+_(/]8<@_P"AYD__ (<\%_\ +STBBO-_^%N?#S_H8/\ RDZY_P#*VC_A
M;GP\_P"A@_\ *3KG_P K:/8U?^?53_P"7^0?ZPY!_P!#S)__  YX+_Y>>D45
MYO\ \+<^'G_0P?\ E)US_P"5M'_"W/AY_P!#!_Y2=<_^5M'L:O\ SZJ?^ 2_
MR#_6'(/^AYD__ASP7_R\](HKS?\ X6Y\//\ H8/_ "DZY_\ *VC_ (6Y\//^
MA@_\I.N?_*VCV-7_ )]5/_ )?Y!_K#D'_0\R?_PYX+_Y>>D45YO_ ,+<^'G_
M $,'_E)US_Y6T?\ "W/AY_T,'_E)US_Y6T>QJ_\ /JI_X!+_ "#_ %AR#_H>
M9/\ ^'/!?_+STBBO-_\ A;GP\_Z&#_RDZY_\K:/^%N?#S_H8/_*3KG_RMH]C
M5_Y]5/\ P"7^0?ZPY!_T/,G_ /#G@O\ Y>>D45YO_P +<^'G_0P?^4G7/_E;
M1_PMSX>?]#!_Y2=<_P#E;1[&K_SZJ?\ @$O\@_UAR#_H>9/_ .'/!?\ R\](
MHKS?_A;GP\_Z&#_RDZY_\K:/^%N?#S_H8/\ RDZY_P#*VCV-7_GU4_\  )?Y
M!_K#D'_0\R?_ ,.>"_\ EYZ117F__"W/AY_T,'_E)US_ .5M'_"W/AY_T,'_
M )2=<_\ E;1[&K_SZJ?^ 2_R#_6'(/\ H>9/_P"'/!?_ "\](HKS?_A;GP\_
MZ&#_ ,I.N?\ RMH_X6Y\//\ H8/_ "DZY_\ *VCV-7_GU4_\ E_D'^L.0?\
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MH3BI-QDD4445D>6%%%% '\]__!=__FU?_NN'_O(*_H0K^>__ (+O_P#-J_\
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M;L?!VA>(CI]W ][X8U[7=-\1:7<LVGZII=GJ$4MJG=_"']LG]FGX\>,+_P
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MIQ5K15-6NU]9]Z$N5ODJ^T5Y*[2IPIJ/NPBE905FHI6TY=-?S&^+5GJ>H?\
M!33X0V6BW7V#5KK]C#XTVVFZ@3(BZ?J%SXOT^WL;UY(DDDC2VO)8)"Z1NZD#
M8CN54^'_ +"_[3_[/7P7_9S^&O[+7Q6M]1\,_'[PEXHU+P-XT^"E[X#\1:SX
MNU;QSJ/Q'O9H?$JVL6BW-AJVEZE-J&G^(SXHGO?L%E:QM,UX@L(-W[4T5E_:
M%.>'AAJN'G*$(8=1E2Q"I3]KAI8MPG)NA43A)8N2=.RFG!2A5C>2<^WBX*G*
M#:2A9QGROFINI9N\))IJH]+732:DMC^:G]I3]I_XJ_$/PU^V'\-?%?QN\'?
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M.K^"'7X=^(-<\>P>.]$OK"_L];M-9NKLW\['2[BUT6UT.\;^E#X0>'+7P?\
M"7X7>$;&;Q!<V7A;X=>"?#EG<>++1=/\53VNB>&M,TRWF\36"1PI9>()8;5'
MUFT2*);;46N85C0(%'HE%1F&92Q^KINE>K4KSBI473=6HDI."IX:C-+1I>UJ
M5Y\O*G-N+E)5\0Z^O*XWE*<E>'+S223<5&G!I:?:E-VM=MJ[****\PYPHHHH
M **** "BBB@ HHHH _#_ /X(T_\ -Q__ '2#_P!ZC7[8:M_R"M3_ .P?>_\
MI-+7XG_\$:?^;C_^Z0?^]1K]L-6_Y!6I_P#8/O?_ $FEKV<]_P"1QBO7#_\
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MVM8W,'C%5O2</:9CC<?K4Y^7ZXJ*]E\$;^S5%?O-.>Z]R/+K^,?P0T'1I_\
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MXH\>?M8V'A/X"^$;GQ_\.(/CAJVO^!_CU;:;K_P*\:^*+GX>?%@S7$^M^(_
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M7%K?_/?['O[9WB>'Q+J?[*W[7H3P/^T#X!BDM-/\1Z]/;V6E?$G1K"U:XBU
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MBSA@TK0TAO?I#5-/^*/P+^*/[&'C;_AH#XP_$:X^/OCJ+P7\6?#/CGQ(EYX
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M*HJ;7+47-BI0<M(KDG*UO9RG^IU%?A-\/[[]L&WN/@M\0/!7A3]M?Q%XKO\
MQ!X)U7XBZA\4_B?X"\0?!'QKX*\0" ^,'T_X=V_B$VGA2%]/O3>^$KG0[:SN
M-'BBC>Y^T7F+F/U_XY7WC/P-\>?B+XJ_:3^(7[5_P_\ @A<ZSX2;X/\ Q-^
M?C"XTSX.^"M#GM=/LKW3OBKX<T"UU"_M-7;Q&[QW&L^*M"UW2-2BG\JW6UA>
MW2XIY7:K[-8JC-^SG)1I-5*LYPG"#IPI0FW*4E-5(JZG*G&;4.:#@7+)6JWL
M5C</4DZ<Y1C1<:M:I4IU:=)TJ=&G.4I2E[15(1NJDZ4:C5+G@X'Z]45%!/!=
M00W-M-%<6UQ%'/;W$$B303P3()(IH98RT<L4L;*\<B,R.C!E)4@U+7DGAA11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7TA^SY_P S=_W
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MEA_V1(=:\;GX;/X?O?#AUM]3T)O&_P!BO_$<_B>>8:D/#2Z#]K&H7$D<;_\
M"->0MH%C-NTH,YH>/?V._!/C+QCHOQ!T'XC_ !I^$GC72_ NE?#:_P#$7PE\
M:Z?X:O?%/@[1)6N-,TOQ+%J7AS7K*[DM)W:6'4+"UTW48VV".Z1(8%B^MZ*Y
MHXS%1E*2K3YI3JU)7LU*=;E]K*2::ES\D')--7BFDFKG+''XR,YS6(GS5*E:
MK.]FIU,1R>VE.+3C+VGLX.2DFKPBTDTF?%UI^PG\'K#X0:W\$[77?B2/".O_
M !?L_C7>WUWXET[5/$Y\66>J:'JXM6UW5O#]_->:3=7>@6IOGU2+4->O/M%[
M--KS74ZW$7O/C'X.>&/&_P 3O@Y\5]6O==@\1_!"Z\>7?A.ST^ZL(=%OY?B'
MX4?P?K0\06UQIEU?7:6VER--I8T[4=*,%\?-NS>P@6]>L44I8K$3DY2K3E)^
MVNV[M^WIJE6_\&4TH2[I$SQN*G)RG7J2D_;MR;NW]:I*CB+O_I[2BH3[Q1\3
M:W^PK\/+WQ)X[UGPM\4OC]\+O#_Q/UN\\2>/OAO\,/B/!X7\ >)-=U6)8M>U
M*73V\/7^MZ5<>(\%M<_L#Q!I*7H8P;([18K>/V./]G3X<2>,?CWXPUBWU+Q)
M_P -'^'_  5X7^)'AK79[*X\,2:)X&\.ZUX7T^ST>TM-.LM2LQJ.F:]?'5I;
MO5=0E>Z$$^G/IOE;&]VHIRQF)DK2K3:Y%"]TI.*E2FDY)*4FI4*+4FW).G#6
MR'/'XR:2EB*CM"-.]TI.$9T:D5*:2E)J>'H24I-R3I0]ZRL?&?@3]BKPMX!O
M?"<5A\;OVE]8\$^!M6T/5O"OPJU_XKBY^'NE'PO?6VI^&M+>RL/#^F^(=5T#
M0[ZRL9K#0=;\2:GI02RM+:XM9[2%;>I_B-^QEX:^*VM^([CQO\;/VC]6\#>+
M=8AU;Q#\'#\2[2+X6ZA%#=V]]_8*Z8OAD^)+'PW)<6L+/HVG>*K.V55*P^4&
M.?L6BG]=Q7/[3VTO:6LI\L+IW4N9/ETJ<R4O:*U2ZOS7*_M'&^T5;ZQ)54K*
M:C!23YE/G34=*G.E)U5:HY)2<KJY%!!!:P0VUM#%;VUO%'!;V\$:0P000H(X
MH88HPL<444:JD<:*J(BA5 4 5+117*<04444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5])?L^HP3Q8Y4[&;0T5NQ9!J[.H]U$B$_P"\*\$T
M?0=8U^ZCL](T^YOII'"9BC/DQ=,M/<-B"WC4$%I)I$09'.2 ?M'X?^#X_!F@
MQV#NDVHW3_:]4N(RQC>Y90JPPEE5C;VT8$4995,C>9.4C,Q1>3&3BJ3A=<TG
M&RZV4DVWV6G7?IUM^A^'64XVOGF'S-4:D,%@:>)E+$3@XTZE2MAJN&A1IR:2
MG->V=22C=0C#WW%R@I=Q1117E'[Z%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ?-G[7'P L/VF?@#X^^$UP\5M
MJVK:>NI^$=2FR$TOQEHC_P!H>'KJ5@1MM)[R+^S-3(RQTK4+Y8QYC(P_*?\
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M\]__  _?_P"K5_\ S.'_ .*"C_A^_P#]6K_^9P__ !04?ZMYU_T!?^7&$_\
MEX?\3Q?1<_Z.?_YI7B'_ /0D?T(45_/?_P /W_\ JU?_ ,SA_P#B@H_X?O\
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M_F</_P 4%'^K>=?] 7_EQA/_ )>'_$\7T7/^CG_^:5XA_P#T)']"%%?SW_\
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M1?7.&ZCC]?R;@/*<:HXW-,9G&&<\'5Q^(HTZ&&H5*V'Q-##1Q$,7'Z._9'^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img181012247_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_3.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %: TP# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHK\^OCY^U?\ $3X6?MO?L=_LU^']&\%WG@7]H.Q^(]SX
MSU;6=.URX\6:9)X0T2\U+3!X8OK+Q'IVCV23SVZ)?#5=!UII8BRV[6SD2*TF
M[VZ)M^B5V!^@M%? GC']JCXA>'O^"C7PE_9"LM'\&R_#7QY^SWKGQ8UC7+K3
M];?QQ;>(],UKQQIT%EINI1>(8- AT5X/#-@\UM=>&;R^:6:[9-2C22&.WJ_\
M$V_VK_B)^V)\"_%OQ.^)FC>"]"U[0?C+XW^'EG:>!=.US3-(DT7PUI_AJ[L;
MJYM_$'B/Q/>OJDLFLW2W<\5_#:2)' (;*!ED:5\KM?2R2?\ X%>WY ?H+17P
M%_P4&_:Q\=_LO^ ?AAIWP8T#PEXQ^/?QS^+WA+X3_"KPEXTMM9O- OKS6;M%
MU;4]2M="UGP]J#V=BLNG:6)8=:LQ:ZEK^F7<R75I#<V[Z?[!O[7TG[4O[+\7
MQF^(\'ACP+XS\&:]XX\'?&G3[%Y=&\)>#?$W@:Y:]U-Q-KNM:O/I>E1^$[W0
MM?O)-6UF<:>M[<B:Z>V@6X<Y7R\UM&[>?7IVNFO4#[JHKXH^"/\ P47_ &+O
MVC?B0/A'\'/CIHOBWXARV.L:A8^'9_#?CKPL^M6^@@2ZM'X<U/QCX6\/Z-XF
MOK2S$^K'3/#^HZGJ4V@V&K>(+:TFT31]5U"S^UZ336C33[-6 ****0!1110
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M])0_VA/_  &^(_\ ]$)1_P .V/VK?^DH?[0G_@-\1_\ Z(2OV,HH]C3[2_\
M Y__ "7DON _'/\ X=L?M6_])0_VA/\ P&^(_P#]$)1_P[8_:M_Z2A_M"?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJM"M3PD*N'OAL1*O&*_?[5_^"MG[*VFZB]E96?Q4\06RS-$NKZ1X0TJ'3Y$
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M7UO3KX>K1DE*DT?TA45_-[_PG?\ P7-_Y\?&7_ANOV=O_F8H_P"$[_X+F_\
M/CXR_P##=?L[?_,Q7[/[=?\ /NM_X!_P?-?>?S ?TA45_-[_ ,)W_P %S?\
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MTA45_-[_ ,)W_P %S?\ GQ\9?^&Z_9V_^9BC_A._^"YO_/CXR_\ #=?L[?\
MS,4>W7_/NM_X!_P?-?>!_2%17\WO_"=_\%S?^?'QE_X;K]G;_P"9BC_A._\
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M4C2Q-"K&G4JTO9U9E%%?EY\/_P#@IAHWB[]N+Q9^QOK_ ,);OP?8Z9XM\:>
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MB:WM?"_Q0BN9XH2PDDAMI+RTCGE12D+W5LDC*T\0;Q?P#\//!?Q8_P""F/\
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M4/#.ES0^&3\0-,\,WAN+B*XT>Q\=P0RQ75WO8R7=U)-]&V_[+GP[;]H_Q/\
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M2L_N ^1OVM/V'7T?]GWP/\,OV1OA5H<_PW\,?'/1?BO\7?V:-+\;:G\.]/\
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M0 4444 %%%% !1110 4444 %?S:_\$,/^2F?'O\ [$7PG_ZD%_7])5?S:_\
M!##_ )*9\>_^Q%\)_P#J07]85/XM#UG^40/Z2J_';_@MQ+)'^RCX#5)'19OV
M@?"<4RH[*LL8^'GQ4F$<H! D03112A&!4211N!N12/V)K\<_^"W7_)J7P_\
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M$L)4S*E@W+VT\)'$4ZM)55&TI4,1R<RP]9T_RL_X<9_"G_HNGQ"_\)SPW_\
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M%KXQ?\G@_P#!)O\ [(7^PC_ZM#5*_9SX"?\ )ZW[?G_=JW_JIM9K\ZHOA?\
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M#?\ !.#]KF&>TB,=[\0?VR1>130(4NPVE7UI*+F-TVSAH81:R"4.#%$(6^5
MH_<.BES>7\O5='?HE_P/,#^?WXGVT(_X-\M-BCMX@G_#/OPCN3&D2;/./Q,\
M%WDEP45<>:;C?=/+C?YVZ=FWY:OW*^&._P#X5K\//-W^9_P@WA/S/,SOW_V!
MI^_?N^;?NSNW<YSGFNXHI-W5K?:D_P#P*VGRL!^"'[)_[47P=_X)\/\ M,_
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M9:V^7;7ZWQ:_Y.KXF_\ 9P>,_P#UH\R/Y:_^&F_^"T'_ $+?[0G_ (B1H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5\&?\%.OB#XI^%?["_P >_'_@GQWXF^&OBSPWIO@JYT'QCX0LEO\ 7].O
M[GXF>"]/CLK6)[_35AM?$"WC>'=6U$W3?V3H^K7^JBTU$V8T^Z^\Z^%O^"EO
MQ'3X3?L/?'SQW-X,\ ?$.VTS1?"NFWW@KXGV6IZAX*\0Z;XI^(/A+PGJ=CJE
MMHVI:/JOVP:?KES/X?N+#5+&YLO$<.DWL=Q&;?-5'XH]?>6GS _%CXU:'^V+
M^SE9?LU>)?$G_!76]U32OC_XDT[PC+JMII6D:QHG@V[\0:%J5SIGC!O[3\:W
M%IXF^%%AK=DFC^+?B#);:*WA2WN[?68]!U.9&TU/V\_X)V_';QQ^TM^QE\#O
MC3\2C:2^.O%VC^)K7Q)=V-C!IEOJE_X1\=^*?!(UL:?:1PV5E+KMOX<@UBYM
MK"WMM/BN;Z9-/MK:S$$$?Y(_L]>$/^"".H>*]&T+P/J6F^*/'WQGMHOAEHGA
M;Q:/C])/:ZA\5K.?P5=>&]"M]4@:S\,ZOJG_  DS:+::]+KESJ_AJ?[/?:+X
MLL+J!]8F_H2^'_P_\&?"OP7X;^'?P\\/:?X4\%>$-+@T;PYX>TM9%LM+TZW+
M,D$1GDFN)G>1Y)[BYN9I[J[N99KFZGFN)9)6N;5DK-.][N*AIVLM^BOY: =A
M11160!7\VO\ P0P_Y*9\>_\ L1?"?_J07]?TE5_-K_P0P_Y*9\>_^Q%\)_\
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M^<_^"5W_ #7;_NF'_O0Z^4R_C/-<DS3Z.7"&$AA997QOPIG7]KSJTI3Q,/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^+
M/^"B/Q<T_P"!/[&OQL^*NI?#SP;\58?"VF^$Q;^!/B%HL/B+P5K.JZY\0/"?
MAO0Y_$FB3O&FHZ;HFLZQ8>()8$FM[G?I2/:75K=I#<1?:=?E?^U%^UA\(O#_
M .U7K/[&W[5MW\(=$_9:^(?['R?$K5=4\?/K&F:SKOQ$U+XP7_@ZU\)1:[%K
M\&F0:6?#.A7_ (@TZ*QT2V\2V6MZ4=7L?$ENMI%;)4%>2T;LTVENTFKV\P/R
MI^#W[0_QZ;]H3X6>%_'O[*'_  3C^$&D:1^V;\,?V?/%_C3P'\%8E\9Z'XUN
M;NU\8:=9^#-4A\5>+H[>Z\8Z)I5_9>!?&MAILUE::\UE=2:IH86#4D_JFK\)
MO 7PN_X(U:M^TA\$?B1X!^-7@O5?BEX1E^$_@KX:^"M-^*<U[H?B+QAX&TK0
M? /PHU:\T22%]0UCQMI\6E>'+6RNEU:"VU?5[.VU'6;#4M0N+VXNOW9JJC3Y
M;)K36Z:U=N[=_P#A@"BBBLP"OYM?^"&'_)3/CW_V(OA/_P!2"_K^DJOYM?\
M@AA_R4SX]_\ 8B^$_P#U(+^L*G\6AZS_ "B!_257XY_\%NO^34OA_P#]G">%
M/_5;_%BOV,K\<_\ @MU_R:E\/_\ LX3PI_ZK?XL55?\ A3]%^: ]:^$G_*)M
M/^S0?B)_Z@GBFOK[]E[_ )-G_9V_[(7\)/\ U /#]?(/PD_Y1-I_V:#\1/\
MU!/%-?E==?'[_@J[X9T?P#H/PE\(?%*U^&>F?"OX56W@9_ GP TKXB^'[[PT
MGP]\.?V7JB^*KOX;^)I[O4=1MMEWJMH^J,-,U"6?3TAC2V4O\HYJ'&M-M2=^
M$TK15W_R-H^:]/4_0?\ FU2_[."__6<B?L9\>_V<_'WQ$_:G^!/Q8\/QV#^$
MO!I\(?\ "37,][:P7&FCP9XUU/Q<"EI+.EU??VO%J"V%L+*&;[-/$TMUY<+*
MU?>]?RU_\--_\%H/^A;_ &A/_$2-!_\ G+T?\--_\%H/^A;_ &A/_$2-!_\
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M$DW&2C.$K.\9QE9K^EOX8>&;OP5\-?AYX-U"6*>_\)>!O"7AF]G@R8)KO0=
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M:7<VI^'O^$ATR&74=#_M>UL_[6L(I+RP^T6Z-(/SR\/?M]?$[0_C'\'OAO\
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M@:[N#'=DR^5?VZYW1RY^K:E2YE=.ZUL_1V?XH HHHI@%?S:_\$,/^2F?'O\
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M[/XBU+7O[46/2K'1]/OOM MYIGFBB*,WR'\3?"WQ&^%W_!([_@GUX<U_X?\
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M/Q-X&OO#L.L7\.K/ -7U:]OK*_U^*YMFO3;_ - U%'.T[V;LK).3:_X;;3R
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M_P FI?#_ /[.$\*?^JW^+%?L97XY_P#!;K_DU+X?_P#9PGA3_P!5O\6*JO\
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MV?'=?DO_ ,&\W_-WG_= ?_>UU^M'_!-;_DRGX+?]U&_]6SX[KY@_X)-_L/\
MQB_8U/[1X^+2Z+&/'OB/P-I?A Z1J=GJ7]K:%X /CK;XGE%E<W/]G6^O#QA
M;32K\PZI9_8;@7L$?F1;OD_#3$4:?A;E="=6$:V(X4X)]A3D[3J^QP>&G5Y%
MUY(M2EV3N?H/$>>Y/@,']+[)<;F.%PV;9_X@Y-_8N7U:JAB<R_LKQ+SW%YC]
M4IO6K]3PTX5Z]O@IR4GH?L/7XA_\%\/^3/OAO_V<IX/_ /57_&.OV\K\TO\
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M/$>(HXOB'/<7AJD:V'Q6<YIB*%6-^6K1K8ZO4I5(W2?+.$HR5TG9ZI,_FO\
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MGZQ_P5V_Y1S_ +37_8O>#/\ U:'@>A17-%7NFXZ[:-@?;?B3XG:!X7^$>O\
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M9V$UM!&L)@TM%?)_>6[B_)I-Z=[V:7=V[@?OC17X[>+O$?B_Q5_P3\UG6?\
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M[0_LO^UH/.V?9/[1BW?:5^+/B/\ \$\]3\:?L<_L\?LL:!\<!X1UW]GGQ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK\<0?$7P]XK\*Z]XGTKPQ?Z;8Q2Z5I+Z)J8DUNWGBU.!I9XXXI/):"<13Q_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(CXN?'_]G>T'CGQ+X(TGP>=.^.'PMU3^VM \ ?\ "<[?%9&F>+K[^S;77O\
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M /PHS_A3'_"*?V)_PEW]MFZ-UCQ)_:HTW^Q_[.S:&[^W@1']A_\ AJ']F?\
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M<_\ @FQ_R=;_ ,%0_P#LX2V_]61^T)7[&5E1_AQ]9_\ I<@"BBBM0"OYM?\
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M"[>&-,/AR?4-&N;J?2)'\2ZN^H7-O;6-O!)<W<B6?ZAU_,1XU^%OB3Q??_\
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M +.$MO\ U9'[0E?L965'^''UG_Z7( HHHK4 K^;7_@AA_P E,^/?_8B^$_\
MU(+^OZ2J_FU_X(8?\E,^/?\ V(OA/_U(+^L*G\6AZS_*('])5?CG_P %NO\
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MY\/G4SJO]HZ?]M&M?\*=_P"%3_\ "-_V1]L_M<W)N,:__:0L/[*^P9M3="]
MC/ZF5^F>,.=93G/_ !"W^RLPPN8?V5X.<$9+F7U6K&K]2S; ?VG]<R_$\O\
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MY?J\,?*EF.#K4\)*:KU:-9UJ<)4Z5:5/] J_F3_X+/\ _)T7@/\ [('X7_\
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M&6U?&/\ P1%_Y-2^('_9PGBO_P!5O\)Z;_CQ_P"O<O\ TH#]C****V ****
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M^"K/_1D?_FMG[1__ ,VE?T(44_93_P"?T_N7E_E^/K='\]__  \#_P""K/\
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M;VSTSQ+J^G2265WXFDU/7-(N++0HTB$<MSI5OK-]&=@3370%E^\/&WQY\(>
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MT;5="T75-)@MK#4=6LK/5+O5;W3K339C>"[N(ETG5VL/FBX^$_Q!^-/[//\
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M-X:\'S&+6K!H+_1;B7PSHTMYH,VEW<MFDDSLQR+D<M=DT];:M*VR7?17:[]
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MG_SOJ:__  2Z_P""BL:/))^U'X+CCC5GDD?XV_'-$1$!9G=F^'P55502S$@
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M^=]1_P .M_\ @HQ_T=#X-_\ #U_'3_YWU?TA44?5X=Y_^!/^O^'?E8/YO?\
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M]MUC2=/T_6"UM%)(;O0+O5;&,J8Y+I)<(3]-P/5Z*** "BBB@ HHHH ****
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MU_PZM_8+_P"B$?\ F3_C+_\ /#H_X=6_L%_]$(_\R?\ &7_YX=+_ &CO1_\
M)_\ +^KORL'"_P##X#]BK_H9O'7_ (0&L_XT?\/@/V*O^AF\=?\ A :S_C7=
M?\.K?V"_^B$?^9/^,O\ \\.C_AU;^P7_ -$(_P#,G_&7_P">'1_M'>C_ .3_
M .7]7?E8.%_X? ?L5?\ 0S>.O_" UG_&C_A\!^Q5_P!#-XZ_\(#6?\:[K_AU
M;^P7_P!$(_\ ,G_&7_YX='_#JW]@O_HA'_F3_C+_ //#H_VCO1_\G_R_J[\K
M!PO_  ^ _8J_Z&;QU_X0&L_XT?\ #X#]BK_H9O'7_A :S_C7=?\ #JW]@O\
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M_C1_P^ _8J_Z&;QU_P"$!K/^-=U_PZM_8+_Z(1_YD_XR_P#SPZ/^'5O[!?\
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MK.HR:3]IUC2]0N])W7MI;S?;]#GTS4QY?EK>B)WC;YET/_@FW\09_P#@F/\
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MC*YO/#>GZG)HWB"UTAK+QIHUA8:QI]K*UC?V4VNBREL;W]?/ #>.V\$^%?\
MA9\'A:V^(@T+34\:Q^"-0U34_"!\21VT<>K3>&[S6])T/5Y-'N;M9+FQBU'2
M[:[M895M9FN6@-U.YM.UK>>UV[+6_:VB71IWUU8==11168!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img181012247_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_4.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %; >\# 2(  A$! Q$!_\0
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M/_F1KZHHH^NXS_H+Q/\ X/J__)A[.G_S[A_X#'_(^5_^&%OV(_\ HSG]E?\
M\1[^$G_S(T?\,+?L1_\ 1G/[*_\ XCW\)/\ YD:^J**/KN,_Z"\3_P"#ZO\
M\F'LZ?\ S[A_X#'_ "/E?_AA;]B/_HSG]E?_ ,1[^$G_ ,R-'_#"W[$?_1G/
M[*__ (CW\)/_ )D:^J**/KN,_P"@O$_^#ZO_ ,F'LZ?_ #[A_P" Q_R/E?\
MX86_8C_Z,Y_97_\ $>_A)_\ ,C1_PPM^Q'_T9S^RO_XCW\)/_F1KZHHH^NXS
M_H+Q/_@^K_\ )A[.G_S[A_X#'_(^5_\ AA;]B/\ Z,Y_97_\1[^$G_S(T?\
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MV%EAZDJ.(PTJ%6%N>E6HNE4CS14H\T)QC*/-&49*Z5XM-:-,^5_^&%OV(_\
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M1_9"B@#^0-_V=_\ @M+IW["]]_P0RL?V2O NH?#.XT6^_9CTS_@J/?\ QV\
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MI]S>Z3<W6BZG#M@UC1IK#5K=$@O8T7VNOS-_X)4_M7:I^U)^R[X9U7QUXB\
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M-W<62Q:0NJ6UP^I1W3:=I]__ "+%4<0^7%'^[3]Z2S$2XD=O,G;[0VQF9C;
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MQ&ZZK>^%W\-ZH]^MWHVJZ#X4\0:)KXU+PMKVCB\F\1ZXVEZ-<16^DOKKP_I
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M.T3I*@+8DC970LI!K\&+#PMXY\<Z;I6EZ-'+XH?Q5<HEA8O=KXEAAU#6-/\
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M&]8^"G@[4K?PAXCU#0](\7^%_%4OC/5;+P+X+\!>--)\5W6HZCK.KZCI?[#
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M42JT*,<)2H0I4Z[G7C",?;U:M;GJS****Y3Y<*_//_@J#\"/BC^T1^R-XQ\
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M[3X1,)M/76]-LM1U'2"T[VUX;FSL;B2X6R;3)5CM;^>:+T:BN/,,%2S+ XK
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MWPU75_%C/%/;;+&WTFULU6%?VQK\2/VU?"/[<7Q@_:.^ 'C#P!^QG_;G@O\
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M(_&_A^WC33=6^'FGS>&=2M/"ND:_IFKZ_P"--+M])@MSKUEHEK_PC'@"_O\
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M\1W^NS:5I.C:EJ<T*>;J#3V]G%K2:)H^M?VB5_/O_P $D?@S\$?B=9ZEX_\
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MQCJ&FRV7A7P]?7ZS*T6K237+Z18V:-;%'6UDE@MV_"!_^"4/_!7&R_9ROO\
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MP8VB7^G:K9W.A:GIGBS1]4T76] UN#6DL%T:^T35;'5SJ,EO:V$K7%RD,O\
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MSUNRT/4-5U"+7-1BU"=M3&EQLC6]JEG"7&E:;ID=_J,L,:MJOB#5$O?$&NW
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MK?7E@?P_=:E.GO<-MK-:5G)7IU5[L5)OW=$[QE97L[Z:I*^MG_(GTX*%.O\
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M,I0J-1<G1IU8R<;JR]K"2T;:TZ^:/PGQ3Q'@?G>/PN1>)7$>"PN99-3EB*.
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MB\/4C5H8K"8FE"MA\11JQ;C5I5J,X5*=2+<9PE&2;3N%%%%(Z0HHHH ****
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M?ZQ]7^L>R]O["A[7D]I[&ES<D2BBBLCZ **** "BBB@ HHHH **** "BBB@
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M ,,J/^&^_P#JRK_@H!_XCC_^&5 'Z 45^?\ _P -]_\ 5E7_  4 _P#$<?\
M\,J/^&^_^K*O^"@'_B./_P"&5 'Z 45^?_\ PWW_ -65?\% /_$<?_PRH_X;
M[_ZLJ_X* ?\ B./_ .&5 'Z 45^?_P#PWW_U95_P4 _\1Q__  RH_P"&^_\
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MA;6]E8V5O#:6=G:0QVUK:6EM&L-O;6UO"J0P6\$*)%##$B1Q1HJ(JJH L44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img181012247_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_5.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )9!((# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **_G&_X+
M8_&OX@:=\2?AW\#M(\1:MH_@6?X;6GC_ %S2M,OI[&W\1:OK7BGQ7H%O'K2V
MS1-J-II=KX562RM+IY;2.XOI[A8!.$D7\&*^KR_A>>-PE+%3QD:'MDY1IJ@Z
MK4+M)RE[:E9NU[)-)6UO=+_/#QF^G[EWA5XC<1>'^7^&.)XI?#.)I8#'9OB.
M+H</PJX]X:C7Q%+#8*/#.>2GA\/*LJ*Q%7$TI5JD*DHX>-/DG/\ T(**_P ]
M^BNW_4S_ *F7_EG_ /?1^7?\5/\ _JQ__G2__P GY_H045_GOT4?ZF?]3+_R
MS_\ OH/^*G__ %8__P Z7_\ D_/]""BO\]^BC_4S_J9?^6?_ -]!_P 5/_\
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M@_XJ?_\ 5C__ #I?_P"3\_T(**_SWZ*/]3/^IE_Y9_\ WT'_ !4__P"K'_\
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M@ HHHH **** "BBB@ HHHH _EK_X+=?\G6_#_P#[-[\*?^K(^+%?CG7[&?\
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MWJ&E6U[JFD7>E:A?ZG/;W$.FZM#<QZA-!):V[(MP?RN_X<B_M6_]% _9[_\
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M5[2J<TDHIJ*_EK_X<B_M6_\ 10/V>_\ PJ_B/_\ .GH_X<B_M6_]% _9[_\
M"K^(_P#\Z>OZE**XO]:<V_GH?^"(_P"9ZG_%/OZ.G_0MXL_\2G%?_*#^6O\
MX<B_M6_]% _9[_\ "K^(_P#\Z>C_ (<B_M6_]% _9[_\*OXC_P#SIZ_J4HH_
MUIS;^>A_X(C_ )A_Q3[^CI_T+>+/_$IQ7_R@_EK_ .'(O[5O_10/V>__  J_
MB/\ _.GH_P"'(O[5O_10/V>__"K^(_\ \Z>OZE**/]:<V_GH?^"(_P"8?\4^
M_HZ?]"WBS_Q*<5_\H/Y:_P#AR+^U;_T4#]GO_P *OXC_ /SIZ/\ AR+^U;_T
M4#]GO_PJ_B/_ /.GK^I2BC_6G-OYZ'_@B/\ F'_%/OZ.G_0MXL_\2G%?_*#^
M6O\ X<B_M6_]% _9[_\ "K^(_P#\Z>C_ (<B_M6_]% _9[_\*OXC_P#SIZ_J
M4HH_UIS;^>A_X(C_ )A_Q3[^CI_T+>+/_$IQ7_R@_EK_ .'(O[5O_10/V>__
M  J_B/\ _.GH_P"'(O[5O_10/V>__"K^(_\ \Z>OZE**/]:<V_GH?^"(_P"8
M?\4^_HZ?]"WBS_Q*<5_\H/Y:_P#AR+^U;_T4#]GO_P *OXC_ /SIZ/\ AR+^
MU;_T4#]GO_PJ_B/_ /.GK^I2BC_6G-OYZ'_@B/\ F'_%/OZ.G_0MXL_\2G%?
M_*#^6O\ X<B_M6_]% _9[_\ "K^(_P#\Z>C_ (<B_M6_]% _9[_\*OXC_P#S
MIZ_J4HH_UIS;^>A_X(C_ )A_Q3[^CI_T+>+/_$IQ7_R@_EK_ .'(O[5O_10/
MV>__  J_B/\ _.GH_P"'(O[5O_10/V>__"K^(_\ \Z>OZE**/]:<V_GH?^"(
M_P"8?\4^_HZ?]"WBS_Q*<5_\H/Y:_P#AR+^U;_T4#]GO_P *OXC_ /SIZ/\
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M_P *36O_ )EZ_>2BC_B3WP>_Y]\3_P#A\7_S%_5WY6/^(X<<_P ^4_\ AO\
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M-?\ PI-:_P#F7K]Y**XO^)/?![_GWQ/_ .'Q?_,7]7?E;U/^(X<<_P ^4_\
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M?_#?_P#=S\&_^':W[0G_ $$_AK_X4FM?_,O1_P .UOVA/^@G\-?_  I-:_\
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M;NUN8VAN+:YMYE>&>WGA=XIH94>.6-V1U96(,ZJJJJJH55 554 *J@8"J!@
M    # ' KV:F:4*F4T, LOHQQ5*K7<L<I+EE1K0P44XX7V:A3QEL%3IU,7&?
M[RC>]%8BI7Q-7Y:AP_C*7$F+SEYUBIY=B,-@XPREP:J4\5A:N:5&IYA[9U:V
M67S2M6HY;.C^YQ-K8IX&CA<#AUHHHKQCZD**** "BBB@ HHHH **** "BBB@
M HHHH **KSWEI:X^TW5O;Y&1Y\\4.1ZCS&7(JK_;.C_]!73?_ ZU_P#CM92K
MT8/EG6I1DMXRJ0BU\FT^J^\M4ZDE=0FT]FHR:?S2-*BLW^V='_Z"NF_^!UK_
M /':/[9T?_H*Z;_X'6O_ ,=J?K.&_P"@BA_X-I__ "7FOO'[*K_S[J?^ 2_R
M\U]YI45F_P!LZ/\ ]!73?_ ZU_\ CM']LZ/_ -!73?\ P.M?_CM'UG#?]!%#
M_P &T_\ Y+S7WA[*K_S[J?\ @$O\O-?>:5%9O]LZ/_T%=-_\#K7_ ..T?VSH
M_P#T%=-_\#K7_P".T?6<-_T$4/\ P;3_ /DO-?>'LJO_ #[J?^ 2_P O-?>:
M5%9O]LZ/_P!!73?_  .M?_CM']LZ/_T%=-_\#K7_ ..T?6<-_P!!%#_P;3_^
M2\U]X>RJ_P#/NI_X!+_+S7WFE16;_;.C_P#05TW_ ,#K7_X[1_;.C_\ 05TW
M_P #K7_X[1]9PW_010_\&T__ )+S7WA[*K_S[J?^ 2_R\U]YI45F_P!LZ/\
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MM'UG#?\ 010_\&T__DO-?>'LJO\ S[J?^ 2_R\U]YI45F_VSH_\ T%=-_P#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC=ZN*C>[3;^9S2A"C7C*FE&-6/,XK1*2=I671/1VVO>VFB****^A/-"BBB@
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MBOSX^C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH TM&_P"0QI7_ &$K'_TJBKWZO =&_P"0QI7_ &$K'_TJBKWZON^$
MO]VQ?_7^'_IL\#.?XE#_  3_ /2D%%%%?6GC!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% 'B/Q*_Y#MI_V"8/_ $LOZ\]KT+XE?\AV
MT_[!,'_I9?UY[7VF7_[EA_\ KVOS9O'9>B_(****[!A1110 5ROCOQ./!/@?
MQEXS:R.I+X1\*>(?$[:<+@6AOQH&D7FJFR%V8+D6INA:>0+@V]P(3)YGD2[?
M+;JJ^2?VOOV3/A-^U3\/;FQ^(7@(>.?%?@SPYXXN?A6A\5>)O# TOQ?KNB1P
MVDI?0O$7A_3[T7.I:7HH*>(C>:;"+?,B102W1DTI*FZD%5E*--R7-*,5)I>C
MG35F]&^=65WJU9Q4<U"3II2FE[JDW%-^JC-W2NTN5W=EHG==I^RO\=T_::^
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M'P)%>W.KV$^@V^B0:9(?"MZ;6:R\07]U(+BU$ME!F7ROG/P3_P $[?BE8?\
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M/X@GM-/NF.GWZZGJ%@(LZAI\!N+!;WG/!7_!6WQ1KFF? GXA^-/V._'/P_\
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M>OW=IX%\4K!X"\$^'Y-$O+*)M6U._?0SIL>I_P#")VSZK%JTM[J"W6_\0?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M /)==911];Q?_03B/_!U3_Y(+ON_O9R?_"#^%O\ H%_^3NH__)='_"#^%O\
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M**/KN,_Z"\3_ .#ZO_R8?V;EW_0!@O\ PEH?_*SF_P#A$?#W_0/_ /)N^_\
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M_P _)?<9O]C:/_T"M-_\ ;7_ .-4?V-H_P#T"M-_\ ;7_P"-5I44?5L-_P!
M]#_P53_^1\E]P>UJ_P#/RI_X'+_/R7W&;_8VC_\ 0*TW_P  ;7_XU1_8VC_]
M K3?_ &U_P#C5:5%'U;#?] ]#_P53_\ D?)?<'M:O_/RI_X'+_/R7W&;_8VC
M_P#0*TW_ , ;7_XU1_8VC_\ 0*TW_P  ;7_XU6E11]6PW_0/0_\ !5/_ .1\
ME]P>UJ_\_*G_ ('+_/R7W&;_ &-H_P#T"M-_\ ;7_P"-4?V-H_\ T"M-_P#
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M;_8VC_\ 0*TW_P  ;7_XU1_8VC_] K3?_ &U_P#C5:5%'U;#?] ]#_P53_\
MD?)?<'M:O_/RI_X'+_/R7W&;_8VC_P#0*TW_ , ;7_XU1_8VC_\ 0*TW_P
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M $47"?\ XAF<?_1YZ_TM?GO_ (:W_92_Z.;_ &>__#T?#C_YI*/^&M_V4O\
MHYO]GO\ \/1\./\ YI*^A**.;#?\^:__ (44_P#YE#ZGQS_T47"?_B&9Q_\
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M-3S8G!X>#HJGRQ@X4Y1J2Q*G/'2E"C*<*4*5&K'#S4YRC&5;DIQ^&;<X2O\
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MN_M%)Q4DYPE'Y3BOQL\3L-BO%?%</U\/#+,CX+XNSSAB&)\/\^Q-/+\7ET>
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M*"\BL8HGNH+FXGM/,?\ @JA\/[-KG]F'XJ2>(O%\FH0?M)?!WX>VGA1]<8>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5\__ +3]O='X-:SK-I:W5\W@;Q;\)_BG<6=E;3WMW=:=
M\(OBWX&^*&K6\%I:I+<W$DNE^$;Q!#;1O.^XK"K2%17T!15TI^SJTZEK^SG"
M=KVOR24K7L[7M:]G;L>5GN5K.\CSG)77>&6;Y5F.5O$QIJK+#K'X2MA'75)S
MIJHZ2J^T5-S@IN/*YQO=5-/U"QU:PLM4TR\MM0TW4K2VU#3K^RGCN;.^L;R%
M+BTO+2YA9XKBVN;>2.:">)VCEB=)$9E8$VZ^;;3X'^+_   T]K\"/BA!\/\
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M+/\ PLX&_P#HS_JS\K_0E%?/?_"-_M6_]%H_9[_\1D^(_P#]%O1_PC?[5O\
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M@TDA?Z"HKH^M8KFYOK.(YKWYO;5.:ZG3J)WYKW52E2G??GI4Y?%"+7R#\/N
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M110 4444 %%%% 'B'B3]G'X,>+O&/CGQ_P"(?!BZAXN^)/PIU;X(^-=7&O\
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MM*24\#A(MQDKQDD\.FTUJGLUL4HPDKQE)J[5U5FU=;K2>ZZGRO\ \,]_%O\
MZ/I_:H_\)']B/_Z#FD/[/OQ?0%H?VY_VGVE7YHUO/!G[%<]FSKRJW4-I^R+I
M]U+;LP FCMK^RN'C++#=V\A65/JFBI^MU?Y,-_X18/\ ^4#]G'O/_P &5/\
MY(^0_#?Q$^+GPD^)?@WX4_'W6/"_CGPQ\4+W6-%^%'QPT+1CX)O;KQKI]A?>
M)(/A=\2_!PO=3T.S\3:MX8TW7-1\'^+_  OJ-CHOBIO#.J:/=>$O#>MMI*:_
M]>5\K?MA*(OAEX!U.+,=_I?[5/[%;:?<J<26QUS]KGX*^$M6\L] +_PYXBUO
M2)P0=UIJ-PHPS*R_5-.ORSI4:ZA&$IRJTJD81482G25.7M(PBE&"E"M!.$$H
MJ492C&*E9$;J4H7;247&^K2=U9MZNSBW=W>NK84445REA1110!\]_LD_\FJ_
MLTC^[\ O@^GTV?#[P^N/J,8/O7OEY>6FGVEU?W]U;6-A8VT]Y>WMY/%;6EG:
M6T337-U=7,S)#;VUO"CRSSRND442-)(RHI(\#_9*_P"36?V;Q_=^!?PH3_OC
MP-H:_P!*Q_VV-0O=(_8T_:WU73;F2SU'3/V8_CUJ%A=PD+-:WME\*_%=S:W,
M1(($D$\4<J$@@,H)!Z5UU*?M<?.E>WM<7*G?MSUG&_RO<^1X$?+P'P;+^7A'
MAY_=DV#9Y[X,UK]H+]I[3+7XD>&/B.W[.7P/\0Q3WGPS3PKX/\*^+OC-\0?"
M-U.C:!\2M:UCXG:'XG\"> ]*\4Z5$NM^%/!L?P[\4ZNNAZQI^J>(_$%KJ$LO
MAG3>V_X9[^+?_1]/[5'_ (2/[$?_ -!S7TUIFFV.C:;I^D:9;1V>FZ58VFFZ
M?:1 B*UL;&".UM+:,$DB."WBCB0$DA5&235ZB6*?,U2I8>%--J$)8;#U9*/3
MFJ5:4YSE;64I2=W>R4;17U2IZ>]*;EU:G.*;\HQDDEY)+[[L^5_^&>_BW_T?
M3^U1_P"$C^Q'_P#0<T?\,]_%O_H^G]JC_P )']B/_P"@YKZHHJ?K=7^3#?\
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M'C<+5GAZM?#5*F$QF'KX:=7#5Z^%JRI.KAJ]:A.G5F4445F>V%%%% !1110
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M^T)_ZJ3Q=72?LE_\FO\ [/8_N_!OX=)_WQX5TQ?Z5S?[=/\ R9'^V-_V:O\
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M:Q;PZXEODQ21KZA\1OVHM-USPCJ^A?#SP7XFU;6M6TS4].UN_P#'NA:S\//
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ[I?P9U7X0?M+>%OBE//XLT?Q-XN\7>)?&6KZUK&I:MX1L+KPA-X*\/PVO\
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MB/Q7K<U]?M>,_9+^*WQ]\?\ Q;^!U_XO_:/^#7@?]H:[^.GC-/V@_@_\2O\
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M(FHFVNM4T:WE%H_B5]92^>UFU-)$@_L@->?:9(U1;?(+ALI7]@"LK*K*P96
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MH_\ "1_8C_\ H.:/^&>_BW_T?3^U1_X2/[$?_P!!S7U111];J_R8;_PBP?\
M\H#V<>\__!E3_P"2/SM^%W@+X[^-O'G[2'A;5OVW_P!I.WL/@_\ &/P_\/\
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MX8?VQ)\+/A#X0\7;(K?X@>)H/$>JR>*OB%XHT9YM#TV/2K'P^DTLL]N!]O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\&MJ$?B7QAH))6._NVM;G0[S7--U!40_VUXFOUT>[F5=0\-^#SIDT=S+WX7
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M_P""EG[8Z?#'X2?'+5_@A\&KOX=_$?XKK\,=(\.Z;=^,;#XB?$2[FO-;Q<>
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MRRE2PV:9U1S+#M8!X?\ =8^E3QE/X<3"-:,TO#?^'WO[4/\ T3CX"?\ A/\
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MO&:>(KZ[TRZTC5#X6O+?3KK2-=T5#I]T/#UO>F*6W/\ ITUY=KL>\F4^M_\
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M[_\ 1'OA)_W]\8__ "_I5_X+C?'7<-WP>^$I7(W!9_&*L5SR QUY@I(X!*L
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MIE2R)5JO]E>R]M[/]YR.LY>RYH_\_OL\_+?EZ\M^A_/_ -(6I]+.?#N1?\3
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M*+WQY>Z'>7&AQ7MS+HFFW%@OAC6(T70=-FMM#LGBNU5M-T^S5H5D21Y/:_\
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M]:]M#_B+O[1>.CX0XLD^_P#Q"K*7^,,EY?N/T(_X?F_"K_HA7Q!_\*3PY_\
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M8Q244DDDD%%%%!04444 %%%% !1110 4444 ?$/[;'[&>C?M8>$]#N]&UP>
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M36?&^I>//VB/B5XYLY?!'P9EL+R6T\'Q^!?"7]@2Q&8:FVHOJ=Z+KQ)^D?\
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M>RC&*LHW>[TF-*45!-Q?++F>EG\*BDGZKF;?6RV1](T445YAL%%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<=F$J&(Q].$Z&%S'+ZV#Q&#KU8U(ODYDN' \7T<[Q-++>+\ORK%Y=C*D</\
MVC@LJR_*\TR?VLE"&+P>(R[#X6-2GAY.-2KA<5"O2KTX.+7-9GNX((!!!!&0
M1R"#T(/<&BOQ-^%O_!2/6? /P^\*>"]>^&+>--2\,Z5%H[>)9/'C:/+J5G92
M21:69[!_!^L.EQ::8+.QGG?4;B2]EMGO9#&]PT4???\ #U'_ *H3_P"9/_\
MQ>5Y6 ^E7X(XG X+$XSBVIEN+Q&$PU?%9=5X>XJQ%7 8FK1A4KX*IB,+D57"
MUZF%JRE0G6PU6KAZLJ;G1J3IRC)]F)\'/$"EB*]*ADL<51I5JM.CBH9GD]*&
M)I0G*-.O"E6S&%:G&M!*I&G5A"I!249QC)-+]=**_(O_ (>H_P#5"?\ S)__
M .+RC_AZC_U0G_S)_P#^+RNO_B:3P)_Z+K_S6.,?_H>,?^(0>(G_ $3W_F6R
M/_YYGZZ45^1?_#U'_JA/_F3_ /\ %Y1_P]1_ZH3_ .9/_P#Q>4?\32>!/_1=
M?^:QQC_]#P?\0@\1/^B>_P#,MD?_ ,\S]=**_(O_ (>H_P#5"?\ S)__ .+R
MC_AZC_U0G_S)_P#^+RC_ (FD\"?^BZ_\UCC'_P"AX/\ B$'B)_T3W_F6R/\
M^>9^NE%?D7_P]1_ZH3_YD_\ _%Y1_P /4?\ JA/_ )D__P#%Y1_Q-)X$_P#1
M=?\ FL<8_P#T/!_Q"#Q$_P"B>_\ ,MD?_P \S]=**_(O_AZC_P!4)_\ ,G__
M (O*/^'J/_5"?_,G_P#XO*/^)I/ G_HNO_-8XQ_^AX/^(0>(G_1/?^9;(_\
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M3_YD_P#_ !>4?\/4?^J$_P#F3_\ \7E=W_$TG@3_ -%U_P":QQC_ /0\<_\
MQ"#Q$_Z)[_S+9'_\\S]=*^#OVQ/VP%^!$5MX)\$0V&J_$K5[+[;-->%;C3_!
M^FS96UOKZT4_Z9JM]AWTS3I7CACAC_M"_$EN]I:ZA\^?\/4?^J$_^9/_ /Q>
M5^8GQ,\>:I\3_B!XN^(&LAH[[Q7KE[JS6K3M=#3[6:0IIVE17#1PM-;:1IT=
MIIEK(T43-;6D1**?E'X_XU_2IX:EPB\N\)N)9XSB'-,2L-BLRIY5G.75<ERQ
M4Y3KXG"SSC+,%3ECL3/V>%P]2C[6>%ISKXB+HXBGAJB^WX"\'<V6=K%<9Y5&
MAEF#I>VI866,P.*AC\6Y*-.E6C@<77DL/2CS5JL:G)&M*-.DU.G*K$?XS^*/
MQ%^(E]/J/C?QKXD\37,[.Q75-6NYK.%9&W/#9Z<)$TZPML\K:6-K;6R?P1*.
M*W/AW\<OBQ\*]2M]1\$>.?$&DK#*DLNE/J%Q>Z!?!, Q:CH5X\VEWB,@,8:6
MV\^%6)MIH9-KKY/17^?%'B/B'#YHL\H9[G%+.555?^UH9GC8YE[9/F]J\:JW
MUESOJY.HVW>[=V?TQ/*\LJ8-Y?4R[ SP#A[/ZE+"4'A/9VMR?5W3]DHVTY5"
MQ_1Q^RG^T_I/[1?A:\^V6EKH7C[PT((_$N@P3E[:Y@F&RW\0:,)2;@Z7=RJ\
M,UM*TLVEW@%K///%-97=W]85_+_\ ?C-JGP&^)FD?$/3=/;6H;.TU+3=6T :
MBVDQZYI>I6DD+V4]^MGJ)MU@O5L=4A;[%<*+O3K8M&RYK]#/^'J/_5"?_,G_
M /XO*_T:\)/I6\&U^#<'1\4>)%EG%F KU<#7K+)<ZQJSC"4H4IX7-I/)LJQF
M%H5ZT:DL-B:+G2G+$X6KB8T:='$4HK^7.-?!O/:>>UZG"&5?6\FQ-.&(ITWC
M\!0>!K3E.-;!)8_&T*U2G!P56E44915*M"DYRG2FW^NE%?D7_P /4?\ JA/_
M )D__P#%Y1_P]1_ZH3_YD_\ _%Y7Z;_Q-)X$_P#1=?\ FL<8_P#T/'R?_$(/
M$3_HGO\ S+9'_P#/,_72BOR+_P"'J/\ U0G_ ,R?_P#B\H_X>H_]4)_\R?\
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M(/$3_HGO_,MD?_SS/UTHK\B_^'J/_5"?_,G_ /XO*/\ AZC_ -4)_P#,G_\
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M\H_XFD\"?^BZ_P#-8XQ_^AX/^(0>(G_1/?\ F6R/_P">9^NE%?D7_P /4?\
MJA/_ )D__P#%Y1_P]1_ZH3_YD_\ _%Y1_P 32>!/_1=?^:QQC_\ 0\'_ !"#
MQ$_Z)[_S+9'_ //,_72BOR+_ .'J/_5"?_,G_P#XO*/^'J/_ %0G_P R?_\
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M4HPJG[/45^1?_#U'_JA/_F3_ /\ %Y1_P]1_ZH3_ .9/_P#Q>5U?\32>!/\
MT77_ )K'&/\ ]#QC_P 0@\1/^B>_\RV1_P#SS/UTHK\B_P#AZC_U0G_S)_\
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M_P#1=?\ FL<8_P#T/!_Q"#Q$_P"B>_\ ,MD?_P \S]=**_(O_AZC_P!4)_\
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MO E'#YAA(Y'*IALTRW-LGQE#$YKG6+I/+,\S%YMFF#PT,5F-98"EBLQ?UN^
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MZ&WX1?\ @^\9?_,#1_P[(^/7_0V_"+_P?>,O_F!K]T:*/^)0O!K_ * N(/\
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M_P P-'_#LCX]?]#;\(O_  ?>,O\ Y@:_=&BC_B4+P:_Z N(/_#]7_P#E0?\
M$;>.O^@C+/\ PW4__D_ZN_*WX7?\.R/CU_T-OPB_\'WC+_Y@:/\ AV1\>O\
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M?A%_X/O&7_S U^Z-%'_$H7@U_P! 7$'_ (?J_P#\J#_B-O'7_01EG_ANI_\
MR?\ 5WY6_"[_ (=D?'K_ *&WX1?^#[QE_P#,#1_P[(^/7_0V_"+_ ,'WC+_Y
M@:_=&BC_ (E"\&O^@+B#_P /U?\ ^5!_Q&WCK_H(RS_PW4__ )/^KORM^%W_
M  [(^/7_ $-OPB_\'WC+_P"8&C_AV1\>O^AM^$7_ (/O&7_S U^Z-%'_ !*%
MX-?] 7$'_A^K_P#RH/\ B-O'7_01EG_ANI__ "?]7?E;\+O^'9'QZ_Z&WX1?
M^#[QE_\ ,#1_P[(^/7_0V_"+_P 'WC+_ .8&OW1HH_XE"\&O^@+B#_P_5_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MARV@'P?\+?\ @D5X8^-/B#QSJ_PJ_:ULOB3\ _A9H6F67Q!^-'PX_9X^*7Q
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MM:N/&_PIT+2O#U[%J7C?PQI<^D3:C)!H^DSZGKGGZ5"ES_P2S^#>N_&;X9?
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MC]F?_NLW_K/WQ6KZI_X.-O\ D]WX6_\ 9JW@C_U;GQQKY6_X(G?\I./V9_\
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M:/JM?3W%K=W<Z:2LHM\SYK0TG&W,U?F25VS\B**^S_V\OV1K?]B/X]2? ?\
MX6=:_%35]+\%>$_$GB76K/PK+X2MM&USQ-:W&H/X;AL9]?\ $,M_%9:;_9E_
M!K#W%@]]!JD0DTFQDA='^,*]'#UZ6*HTL10EST:T(U*4^6<.:$E>,N6<8S2:
MU7-%.VMC&490E*$E:46U)73LUNKIM?B%%%%;$A1110 4444 %%%% !7]4G_!
MLU_S>O\ ]VW_ /O>J_E;K^J3_@V:_P";U_\ NV__ -[U7S?%W_)/9A_W*?\
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M337+.+33:E>T;NZ/RPHK]./VG_\ @ES\=?@9X\T'X;?"SPW\6_VG?$MI\/\
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M2>"D:>UT>"3,&HWUUIOZ>?\ $,U_U>O_ .:W_P#X^J/^(9K_ *O7_P#-;_\
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MQ-\0-!L;*'P]=:%*+W1XYM4MK<2&P_2S_B&:_P"KU_\ S6__ /'U1_Q#-?\
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M(U]CF-[^RB][IRHM23IQI-23F[IP@D_-M[L_GN_:8\0?LLZQXE\+Z?\ LE^
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M)X?BC^'_ (@\7^&-=T^^EBU#0Q+I^F:LFGZQ<:8C>F_\0S7_ %>O_P":W_\
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M.ZO^V%<_#KXK)\.?!'[,C_!?X#>'TT/P5<^,=-\4K;VAM]3\4:7+XZ@T'0M
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M )F#ZAB_^?7_ )4I?_)G\K=%?U2?\0S7_5Z__FM__P"/JC_B&:_ZO7_\UO\
M_P ?5'^MW#W_ $,/_+3'?_,P?4,7_P ^O_*E+_Y,_E;HK^J3_B&:_P"KU_\
MS6__ /'U1_Q#-?\ 5Z__ )K?_P#CZH_UNX>_Z&'_ ):8[_YF#ZAB_P#GU_Y4
MI?\ R9_*W7]4G_!LU_S>O_W;?_[WJC_B&:_ZO7_\UO\ _P ?5?JE_P $S?\
M@F;_ ,.Z?^%V?\7L_P"%P_\ "X?^%;_\TW_X5]_PCO\ PK[_ (3W_J??&_\
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M-]/N(KR/P[IWB"WM-5M/:_\ B&:_ZO7_ /-;_P#\?5'_ !#-?]7K_P#FM_\
M^/JO$6/X0]E2HO,\7*G1C7IP3CF,6J.)4/K%!N&&BW2K<D747Q-WM)*4D^GV
M68<TI*C33ER-ZT?BA?DFKS=I1N[/\#\XOB5_P40^%7Q2^"W[&_PE\5^&?B%J
MS^!/VJ?%/[4/[6NL2Z#X4M+7QCK_ (S^)VN^-=>T_P"&>DQ^,+E-=1M'\>>-
M-*M!XMN?!RQFTT2TDDDAO[Z\T[]6?@E\;S_P4I_X>&Z3'^S3\?/B1^SE\>_'
M7P>;3=9\!?$#]GSP#\4?!H^&?A;P,NG>%_$&F?$WXN:)9Z?H5QJ'@[3O$;W7
MA6X\7Z='/KWBB&>QFO\ 6)WK@_\ B&:_ZO7_ /-;_P#\?5'_ !#-?]7K_P#F
MM_\ ^/JHQ&/X5J4K8;,OJ]:,ZE2E6GA,SJJE.KC:6.G.$*4<-)356C35-QJQ
M4(0C'EDE9N%+'*5YT>>+24HJI17,E3E32;DYJW+*5_=NW)N]V?%O_!</X@_"
MZ+QE^RY^S#\)8]!M/#O[,/P6?1M3T+PQXAM_%.D^#/$?BZ71;:[\$3:W#+)-
MJ&MZ'I/@G1+O5[V]2.]O&U:VNKP"]ENHXO!!^V)^S+XE_P""8OA+]C7Q]X)^
M-A^+WPO\?>,OB3X%UOPC<^";'X8ZWXN\0W/C2VT74_'.H:E?77BI]/\ #^B>
M.K[?HFC>'([G4=1T33(O^$CM--O;Z!/U-_XAFO\ J]?_ ,UO_P#Q]4?\0S7_
M %>O_P":W_\ X^JZ:&<<+TL'@L)/-*M3ZE66)A66'S"G.>(YJLZE25L/)\M2
M5>KS0<I.TM9.2YB)X?&RJ5:BH1C[6/(X\])I0M%)+WUJE&-FDMMK:'RQ^UQ_
MP4V_9C_:E\$^(/$$'C+_ (*1_"7XJZO\)D\+P_!SX<?%GP1HG[);^.;30-0M
M;&^UWP[)KE_K>J>&[G5+JVM/$8TO0/#MWKOA^S CT_2]6N+F[F^./VF_VP?@
MI\=/AI_P3U^">D>&_B3IOPU_9;^'VD^'/C%'>V'A[2[[Q7XAUN;P4OQ)U#P/
MINE>+KZUO([BW\-:I/X?U37=3\/:E=W>M2+>6VC@SW,OZW?\0S7_ %>O_P":
MW_\ X^J/^(9K_J]?_P UO_\ Q]4L/FO".%]BJ685DL-.I4H)T<>_9RJ4)X=V
M?U5-\M*<XP<W*2;O=NP3H8^IS<U*+<TE)\U).24E/^?2\DFTK+39'RZW_!6_
MX/#]O/\ :)_; 3P=\5'T75_V8)?@7^S5X4.@>#H-2\/ZTVG>&+V/4/B T7CU
M[+0]%7Q;IWB2</X5N/$UY'I&OIMT][NT>.X^#_&7[7'PXO\ _@FI\(OV,/!V
MC>.])^(>B_'CQ%\8?BYKMS9Z)9>!_$T4T/C'3/#=CIE_8>)+K7=8FMM)U3PH
M]];:WX;TRSM]1T"*2VFNS8:?<-^R7_$,U_U>O_YK?_\ CZH_XAFO^KU__-;_
M /\ 'U3I9KPA1=%T\=47L'@W!.ACVO\ 8:-6CAU+_9?>457J5)7UE5ESMW20
M2H9A/FYJ2][VE_>I?\O)1E*WO]>2*79*Q\D^(?AGXI_82_X)!?%;P=\78M+\
M"_'']MGXP?#Z3PQX4TWQ'H6I^+KWX*>%+3PWXML]3UEM U&\>VTB62Q\2VNH
MV2W-S'I\'C32]'UI;34-?U#2;?JKK_@I_P#L(^._$O[.'[2OQ@^ 'Q\\1?M5
M?LT?"KP]X*\(>#]"U3P'9?LXZCXJ\'276J>&/%4YOM:G\5Z7/I'B:\NM:T6>
MQ\.22:,9+".]M/$T_A_1+JV^C/\ B&:_ZO7_ /-;_P#\?5'_ !#-?]7K_P#F
MM_\ ^/JL?[3X8JJI/%YM4JXBKB,17G6P^%S'"7CB:5+#SH*,:=6:HO#T*5-J
M564FXN491O95['&QLJ=!1A&$(J,YT:EG"3FIW<DN;GE)_"EK9IV/A;Q%_P %
M1/AQ\2/A%\#_  K\2/#/Q#;QU-^WQ9?M>_M477AS0?#(\)^+?"^F^)]5ET[P
M7X"2^\<Q:GJ\VF^"(_!WAW3+#Q5!H-E:'PKIT4^M7PM$OY_2=1_X*J_LR_%W
MQ1^WUX(_: ^&_P =/^&??VPO%7P_\1Z#K/PK?P1IWQJ\,1_#?P[X0\,Z)::O
M!KOB7_A%3'-;^ O#.H):1ZSK>FZ?*NLZ5>6?B'3=8E\KZ@_XAFO^KU__ #6_
M_P#'U1_Q#-?]7K_^:W__ (^JIYAP;KRXVK!WE*#IT<P@Z,I8FABE*E;#>XX5
M<-05/=1ITHT[<JL'LLQT3I1:LDTY4GS)0E3M*\];QG*_=R;/BC_AZE\(O"/Q
MZ_8GT_X._"GQQX!_8T_8RU'7KO1?!CS:%??%?QKJ'C;0=:T3QAXRUZ*/6H/#
M#^()%\0:O>VNF)KZ0ZCJ6L>)=0U375.OPVNB_5&G?\%N_P!FN^^,OQMU/QQ\
M&/BMKO[/][X7^",7P#^&EOI7@J.XL?'?PC\;Z_\ %VX\6^/].?QW%H^D:CKG
MQ4U;2M6?5=$O_%UPUCX7T>2_L+R836C]?_Q#-?\ 5Z__ )K?_P#CZH_XAFO^
MKU__ #6__P#'U6=3%\%55'GQE7FC2]ESJGF7M&_K+Q<JTI_5W)XB=>4Y2K7Y
MN6I.*M%V1&GF4;VIQUES6O1MI#V:C;GMR*"2Y;6T1^"7B?\ ;M_:XUWXA?$_
MXBZ+^T+\9/AWJ/Q:\<:MX^\5Z-\-/BCX\\#^')M9U*&UT^!8M(\/^(;*V>#1
M]!T[1_#.DM=+<75KX?T32=,-P\%C"J_KA\*/^"HW[!NE^&?V#=7^,'P(^/OB
MCXK?L7_#RV\ Z'#HC> 9_AIIVI-I/AO2M3^)NCZ=J'B_3-6\4>,&;PE8:CH>
MGZXGA[2-"U+4[O4!)?ZGHVA:C![[_P 0S7_5Z_\ YK?_ /CZH_XAFO\ J]?_
M ,UO_P#Q]5TXK-N#\5"G3EC)4534HQ>%PV/P\G"5">&<)2IX5.4/8SE!)MVB
MVMFTXIX?,*;;5-2O9M3G2FKJ:FFDYZ/FBGIUUW2M2D^+W[-B_P#!-[XN?&+]
MJ?3_ (XZW\,O^"B/[=WQ5\<1V?PKO/"%O\5?#^A:'XEO=2\'6R+XKU4>')M*
M\-7_ ,(;32[O37O[VTL%UB*#3=]M9VF/QI_X*!?MD>&_VKO%WPM\/_"GP5JO
MPV_9[_9[^&ND?"KX*>"->NK:\\06FAV%K8V]_K7B&>UNM1A76-5ATO1]/E@B
MU;5D2RT*PGFU"[U"YO[B7]H_^(9K_J]?_P UO_\ Q]4?\0S7_5Z__FM__P"/
MJLL#FG"V#KSQ#S2I6J>VKU:,98;,(TJ"JPA1BH4O82BZL,-3IX=UG9SA%VC#
MF:*J4,=4@H*A&,>6,9>_2<I<K<G>7,GRN;<U'HWN[7/Y6Z_JD_X-FO\ F]?_
M +MO_P#>]4?\0S7_ %>O_P":W_\ X^J_5+_@F;_P3-_X=T_\+L_XO9_PN'_A
M</\ PK?_ )IO_P *^_X1W_A7W_">_P#4^^-_[7_M?_A-_P#J&?8/[,_Y??MO
M^B3Q'Q'DV/R;&83"8SVN(J_5_9T_J^*I\WL\50J3]^I0A!6A"4O>DKVLKMI-
MX/!XBEB*=2I3Y81Y[OGINUX2BM(R;W:6B/U2HHHK\N/;"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#P>:G_ /)5<Y11[.G_ ,^X?^ Q_P @N^[^]G1_\)CXN_Z&GQ'_ .#S4_\
MY*H_X3'Q=_T-/B/_ ,'FI_\ R57.44>SI_\ /N'_ (#'_(+ON_O9T?\ PF/B
M[_H:?$?_ (/-3_\ DJC_ (3'Q=_T-/B/_P 'FI__ "57.44>SI_\^X?^ Q_R
M"[[O[V='_P )CXN_Z&GQ'_X/-3_^2J/^$Q\7?]#3XC_\'FI__)5<Y11[.G_S
M[A_X#'_(+ON_O9T?_"8^+O\ H:?$?_@\U/\ ^2J/^$Q\7?\ 0T^(_P#P>:G_
M /)5<Y11[.G_ ,^X?^ Q_P @N^[^]G1_\)CXN_Z&GQ'_ .#S4_\ Y*H_X3'Q
M=_T-/B/_ ,'FI_\ R57.5^27_!2;]H'XB?L]_%K]D/Q5X)N_&.H:9#;?M&Z]
MXF^'WAO6M5T_1_'H\*^#O!=[H]OXNTNPNX+;6-&T.:\O-3G>]M[V32; ZG?:
M?";L!9.C"X)8NO&A3A34YQJRC>,;-TJ4ZO+?1+FY.5-M)-IO1,B=3V<7)MV3
MBG9O[4E&_P KW/V0_P"$Q\7?]#3XC_\ !YJ?_P E4?\ "8^+O^AI\1_^#S4_
M_DJOQDT;]J:?]E/]FCX0?$3QGXSO?VF?BS^U-XCG\4:4^M?%BQ\%?#K3;C5[
M&WU/4=&TGQ5X\GD\*?"_P-X'BNK#0YK%['3XXM>NKA;^UL$CF33>T^%'_!3'
M0_B-JOPDL]5^%B^%M*^('Q<\3_ KQ7XAL_B1H_C'1? WQ+TW1M.UCPA9:=K6
MAZ /#?COPYX^_M$V6C^(](U^P6*?3M1N%T^]L%L;N_WEE-;EG4IT(5*495(>
MT2IQYG2YO:.-.<E5Y4X3C%N"YY+D2YVH$K$1NDY.,K1;B[NW-:R;5XW]Y-ZZ
M)W>FI^L__"8^+O\ H:?$?_@\U/\ ^2J/^$Q\7?\ 0T^(_P#P>:G_ /)5?'/P
M*_:<TWXQ_!7QA\?-3\+3^"/AWH.N_$AO#VI2ZO\ V_+XJ^'GP\GNK:7Q^L4.
MDZ7_ &:-4FTO6T30HCJOV7^S<QZQ?"X4Q_#WP^_X*AZ'\;M>B^'%_P#"NU\%
M:7\5O!_Q'7X=>)-.^,O@/X@^(6N?#_AG6=12V^('P\\*Q'Q'\,;K4;:R==/C
M\0RNT]RZ-;?:-.2XU*"(997FZRCAH_[.[5_X5X-*4I)+F3G*,8RE*$.:45&5
MTK,;KQ2C[[]]7A\6J=DGMHFVDF[)W5C]I_\ A,?%W_0T^(__  >:G_\ )5'_
M  F/B[_H:?$?_@\U/_Y*K^?[]CWXO6G@'P?_ ,$_=$U&?XGO877P/_:@\6WN
MG>&/B NF^!K^R\':MXUUBX7Q3\,G\.7*>.M<AM[!E\*7K>+O#B:#?2><8+]6
MV#T#P=_P4Z\0_':7Q?X,TKX!S>'?#MY\"?C!\3KKQUX,_:4\&:IXS\(^%/"?
M@[Q#-8:A>Z3X?\(:G>^ O&.I>(H=$T/3[#693K_AR\UNR\3G1-6TFQ/VK>>3
M55.HJ=*G4ITG/FJ/V%+W85JU&ZC.I>3E["4E"/-+HD]&X6*BXIN33E:T?>>K
MA"35TM+<Z5W9/?NE^X/_  F/B[_H:?$?_@\U/_Y*H_X3'Q=_T-/B/_P>:G_\
ME5_.[H7QB^(MG^T'^R'\2OA;\+/'WQV\6ZW^P5//:^#/%/Q8T67QEJ-I/XVU
MBYU#5O%WQ1U[0='LM;U&VM[#S+F^B\+P7VN:I)96EGI*SW";/KSP7^USHOQ[
M^*'_  3_ /%&BZ=\3_"0^+TG[4]AJO@ZQ^(PT?PEI.N?#7P5;+JNE_$OP@OA
M&=/BDEI<0F\\#W::QX.;PO>W(UJ>UO[J>?1K0JY/.G:2A3G#V=6<Y)45*$J4
M,14<)051S2<,-4<:C2C)J48<THV9'$*5]6GS)+65I*3@KIV2T<U=:M:7LF?K
M-_PF/B[_ *&GQ'_X/-3_ /DJC_A,?%W_ $-/B/\ \'FI_P#R57\^7[&_Q,UO
MP?\ !W_@FAX=T#3OB#XE\1>,=$_;TOM#\)>'_BI;>!/ WB[6?!%YXVUW2]"^
M(WAZ_P##&L6?B_[?>-!9^$-3O-?\-VO@'6+F;Q%<)KL)?3T]"_9W_P""@?Q[
MTK]GFP^,7[0GPL/B/P1_PN_1/AYJOQ?@\:^#=)FL_#_BCQ+XFT?6-8;P'X5\
M&P0V]A\*[[3O#_A^Z?5;K2)?%\GB&TO=/U%S:WK4ZN2U(2J*G&A44*KI13=*
MG4JOZSB<-%TZ<IMMRGA9OEOSZVBIJ,I(6)B^7F<HWCS/XFH^Y";NTNBFM;6T
MNVKI'[E_\)CXN_Z&GQ'_ .#S4_\ Y*H_X3'Q=_T-/B/_ ,'FI_\ R57RE\$O
MC[_PNSQI\>]#TGPC)IOA'X+?$9?A=IWC=M<34(O''BG2=.6Y\;V]OI,>E6J:
M+%X4O[BPTY7&KZS_ &H+P7##37B:U;Y?\*?M_>,?'+>//%WA7]EWQEJ/P&\*
M6_Q?CT?XV2>-M&BTW6]7^$OA'Q-XGE@U7PM!HEWJ_AC0?$MQX;/A_3/$\EQJ
MUG!K.JZ;8S6TFH/+81\L<NJR=2*H4[THTY3YI4(I*K'GIQ3E)*4Y1U5.+=32
M2<4XR2MUHI)N4O>O:RF_A=F[)-I)_:=EJG>S1^IO_"8^+O\ H:?$?_@\U/\
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M^+O^AI\1_P#@\U/_ .2J/^$Q\7?]#3XC_P#!YJ?_ ,E5SE%'LZ?_ #[A_P"
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M\^UO]E[PKXB\2?'C7-9_9?\ VU[W1_VAX;J?QQX ;XK?LDP^ K#Q/<Z]X?\
M$D?CSPQHMO\ M!Q7>G>-K#5_#EK+I^M7VIZJEM:7FJZ6+1]+U"6SK]<**(YC
M6@VXQA%MR;:GB$[RJ*JW?V]T_:14[JS4E=- Z,6K.[5DM5#9+E2^':VA^14/
M[.&N7'PT^)WPG\5^"/\ @IE\2/"7Q1T7P_H=_!\2?C[^Q_XQG\*VOAS7K3Q!
M:3>"$U3XVOIVB7=U<6-M9:A+<:?J*3Z=$EO'%#(B3I[1XR\'S>//&'P/\9>(
M?V4?VKIKKX"^'/B/X6\,:5;>-_V0;72->TCXI>!K3X?>)8_%@C_:'_M6XFCT
M*S232Y] U7PZ]KJ$LMQ-]JB\JVB_0VBE+,*LGS.%._[QW4J\=:M)4:C2C623
MG22A)K=+OJ"HQ75]/Y7\,N9;QZ2U1^17P%_9#T'X3_%OX0^-]-^$G[>$K?#'
M4_$6F^!X/BC\7_V4?%'PW^'FA?$#2=3\,>((8_#N@?%Z^U^P\,:9:Z_>Z]<6
MWA&RN?$%W>VL=PUOXAN533;K]=:**QQ.*JXJ<9U;.48\J:<W[O-*=O?G/[4Y
M2TM=R;=VRH0C334=F[].R71+HDOD%%%%<Y84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445QV
M@_$3X?\ BK7O$OA;POXY\'>)/$_@RXCM/&'AS0?$VBZQKWA2ZFDGABMO$ND:
M??7&H:%<2S6MU%'#JEO:R/);3HJEH9 K49--I-J*O)I-J*O:[:V5VE=]78+K
MOOMYG8T444@"BBB@ HHHH ***QM9\1>'_#HTL^(-=T;0AK>LV'AW13K.J66F
M#5_$&JLZ:7H6EF]G@%_K.I/'(EAI=IYM[>-&ZV\$A1@&DV[)-OLM6!LT444@
M"BBB@ K\I/\ @I+\!?&7[0/C_P#9&\(>'=)\;'0+OQ5\4=$\9>,_"&CZMJ$'
M@'3?$WASP[IMMK>OZAIUO):Z3I[LER#_ &I<6EIJ44%U8&1EDD6OU;KROQQ\
M'/"7Q"U:WUK7M7^*FGWEKIT6EQP^!_CI\;?ACI+6T-S=W:2W&@_#;XA>$]"N
M]1:6]F2;5[O3IM6N+9+2RGO9+/3[""VZ<'7^K8B%>[3A&HHM14FG.G.FG9R@
MO=Y^;5[I731%2'/!QZ-Q;UMI&2E:]GO:VQ^'/Q8\*?M,^+?V9O@I\%_$7P#^
M(<6B?LX?$^;P+\;O"'@/X=>*]4T#XN^#=)T]K7P+X[\$>'?"?BKX4ZC\1O#E
MW!;ZH_B33_"GCK1I4\1W=EK=]J6DO>V;6D.G_"_QE\&/V6O#?[2WAJQ^+NFZ
MG^RW^TC>_$;PM\-_C!\,-7^"^M:#\)?%EGX5\/?$OX?>%]&\0_$SXM>(9? N
MLPRZ9<66J:EXRNIC%I?B&*2TO=2:6\O/V:_X9A^&W_0R_M#?^)=?M7__ #Z:
MP/%'[&WP.\<:#J'A;QH?C/XO\,:LD$>J^'/%'[47[3VOZ#J:6UU!>VR:AI&K
M?&&[T^\2WO;:VNX%N;>0175O!<1A98HW7UHYM1M"FXSC2^L2JU80HP:G&K*3
MKQM+$-IU(SJ04HSBU3:IMN*N^?ZO+5W3ERJ*;D[IQMRO2%M'&+:M9M7MJ>+_
M +'7PZ^(FA_L?^)_%Z2BR^/'[147Q'^.E[J%X0C6GCOXF6%S=^"!-)=NYBMM
M,TN/PNQMYRD5G-]K4PQ9E#?EY^R1\"/BAX?^*/AF]USX>?M*_#;XFVG@_P"+
M=G\5==O_ (!>/Y_ 7Q:O-0\)>)?*TWQG\8?$?[0OBSP]K5Q+<&T/A?4?"OPB
M\/1:CX@EM8?LMW?&SUN/]P[7]E?X6V-M;V5EKOQ_L[.S@AM;2TM?VM/VJ[>V
MM;:WC6*"WMX(OC.D4$$$2)%##$BQQQJJ(JJH G_X9A^&W_0R_M#?^)=?M7__
M #Z:QAF4(?7+.I_M<FW^XI^Y'EG&-.SKR4J<8S2C%KW7"$HM-)E.BW[.]OW:
M2^-V;NFW\"M)M;]FTTUH?C?^SI^RGXU^%+_\$[_BYH7P]^,^B_%76?'/B_0O
MCY<:I9>.W;PSX CN-7TG2-)\5^']2M_L/@CPTFBX2P6]L=+@NEOVN#+<RM92
M0>!S?L\?%2XU_P &IK_[,W[3&H_M&:-^V!HOC#XO?&N_TWQ/KWPQ\4?#W_A+
M+M-*ET>[AU:_T;7I=-EOX-1E\0Z3H2P:)I"ZO/>ZZVGWWV>Q_H,_X9A^&W_0
MR_M#?^)=?M7_ /SZ:/\ AF'X;?\ 0R_M#?\ B77[5_\ \^FMUG*4YU)>TE*?
M,G)PM+E=6M4C3;6)3E2@JSA&G*\?<INWNV)^K:**LDNE[J_+"+E9PTD^2_,O
MYGW/Y\/B;\/-4^(OQ)_;&TWP'\$?C[X]^.$'[7>NM\&OBA\.[W75^'?PJU!/
M$EA=>*)?%9T_6%TOP]J.IZ7!:LNL:GH$C7L4-@+?7](_L:7S?5/VC_@G\5]?
M^)?[1J_%7]GG]I'XS_''Q%JFA#]ESXR_#'_A(IOA1X#TV.WTU;<W-WI&KZ3H
M?A5;5XI'U!=5TZ]\VZ29GLM G=M<E_9?0?V+_@/X5NO$%]X7A^,7AN]\6:Q/
MXA\4WF@_M/?M.:/=>)=?N0%N=<\07&G?%^WEUG6+A0%GU/47N;V4 "2=@*Z3
M_AF'X;?]#+^T-_XEU^U?_P#/IJO[9I1E3Y(U>6G3C!.46IW2P]TI1Q2Y*4G0
M]^C&T*BJ5.;6>B^K2L[M7>]GI]JS:<'>2YM)/565M%8_);XS_!CX]7VJ_M?+
MJW@'X@^+_$?B#]B3X#>#QX@TCPMXA\06GCGXCZ'<^#!XNL/#NJV&FS6_B;64
MO[/4KV]M=+:YO%C2:YFMXT5RM5OV*-1\.^-]3\%^$?AU\4]0\'?&C]@36+_X
MHR^(+KQO?Z1K7[0ME>VOB#PS::WXCU&5(]&\9P^*=#T"\C\/+J%A*L$%Q9/I
M@T;4-6M+S]<_^&8?AM_T,O[0W_B77[5__P ^FH;G]FKX76=O/=W?BS]H"UM+
M6&6YN;FY_:__ &K(+>VMX$:6:>>:7XUK'###&K22RR,J1HK.[!02,HYLHPC"
M$JD4E%-1I))RA2HTJ<N58G>FZ,:D/Y9/39-4\/=W:3WWE=V;;:NX=;M/NOG?
M\-!\"I#^QS\%?#^D?LV_M,>$_'7@_P =^/\ 7/&?P[U_X(?$#X@>!OBM\2H_
M _P[TJ]\0>.?#5KXRTWQ7X;\*>)+9=.T[P'XET>RMM(T[5?#'C!QI&GSA+V^
M_?G]G]-;A^!OPAMO$?@O_A7.MV?PX\'6&H>!/[1U#5CX2EL-!L;-=":_U>[O
M]8G;3XH(X&_MC4-0U>)E,&J:A?7\5Q=S<-I'[//PA\0:3I>O:#XY^.NMZ%K>
MG66KZ+K6D?MC_M3:EI.KZ3J5M%>Z=JFEZC9?&Z:SU#3M0LYH;NRO;2:6VNK:
M:*>"62*1'/NWA3PQIO@S0+#PWI%SXBO-.TW[5]GN?%?B_P 6>/-?D^V7MS?S
M?;_%?CC6O$7BC5=D]U+':_VIK%Y]ALEMM-LOL^G6=I:P<V.QT<535.U3FC7J
MU7[1.Z]JY.4;^UFW9M)<T6TE:,HI.,KI4G!WTLXJ.G6R23^%+6W2V^J>ZZ&B
MBBO+-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT[X/S
MM#X]TJ,$@75OJ<#8/!5=.N;D!N>1NMU..?F"G'&1YC7HWPE_Y*#X?_[BO_ID
MU*L<2KX>O?\ Y\U']T&U^**A\<?\4?S1]I4445\J=P4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!YS\6O^2?>(/^X5_P"GO3:^+:^TOBU_
MR3[Q!_W"O_3WIM?%M>]E?^[S_P"OTO\ TBF<M?XU_A7YL*\.\$_LV?!#X<_%
M/QW\:_!7P_TW0?B?\2X[J+QKXJM[_6YYM82_U"TU;4A'IM[JESHND_VKJMC9
MZGJ[:)ING-JVHV\5[J)NKE?-KW&BO5C4G!3C"<XQJ1Y9J,G%3C=/EFDTI1ND
M[.ZND]T8-)M-I-IW3:3:?==GZ!1114#///BU?^/M+^&/CV^^%>A#Q+\2H/"F
MM_\ "":(U[HVG1WOBN2QFAT(3WGB&ZL]%AM;?4)(+NZ_M&YBMY+:"6(EF=4;
MX8L/V2/B5\%HOV6/$GP_^('Q ^+>M? _Q+9^'-:\&:\_P;T?0H?AO\2;'^R/
MC3J'A_4;;P)X"\3:K?)J(TOQC90^+_'.N7^H2Z&OG#4M>EANJ_2"^OK+3+*\
MU+4KRUT_3M/M;B^O[^^N(K2RL;*TB>>ZO+RZG>."VM;:".2:XN)I$BAB1Y)'
M5%9AS]UXZ\$6/AS2_&%[XQ\*V?A'7!H1T3Q3=>(=(M_#FL#Q3-:6_ADZ7K<U
MXFF:@/$4^H6$&A&TNIO[7FO;2/3_ +0]S"K]5'$5:4>6G"$HRF^;FI\[J<U.
M5/V;>Z2A.HE[-PG:I.\FFK1*$9.[;32TL[6LU*_GJHWO=:+0_&O]G5-?^R?L
MPWWQ NO%V@> KWQ#\;_#'[.GQ"\)>!/ ]AHFJ^/_ (]V?Q#UBRUO7O$R_'7Q
M'\5/$.DSZ%%XGO\ PU->? +X274^L2Z/KOCVYM)+"6>?WO\ 9O\ V=?B%X4U
M3]GG0OB?I'[0MK>?L[6FNZ?H.L6.L_LA+\ 6U*3PQJOA36M3TB?P3I/AG]HK
M6/"_CZ"9M8L[/QIH7_"2RZI?V%WX^DNM5L]2UB7[P\._ SX)>$/%,_CGPG\'
M?A9X7\;74FHRW/C#P[\/O"6B^*;B75V=]6DG\0:;I%MJTTFJ/+(VHO)=LUZT
MCM<F4NQ/5>-_&OAGX<>#_$OCWQGJ?]C>$_!^BZAXA\1ZM]CU#4?[.T?2[=[N
M_O/L.E6E]J5WY%O&\GV>QL[JZEV[(8)'(4]5;'RJRE"C27[Z\;.FN=2G*OI2
M4)/WI+$3C)Z^TE)M0AS.+SA144G*3]VST>CLH;W6R<$TE:R6[LFO./C#X'^(
MGQ-M_P#A M)U3P!X<^&>O:6UOX\U?7_"EK\2/%NK6\VH6Z7?ACPYX+\4V+?#
M?3$NM(6XE7Q=XTMOB/IT-Z\=C<?"_4(%.HCYR_:,^#?BC0/V3&_9L^"'PY^(
M_P 4Y=0T'1]#TO59?&/P[BA\/Q^%_$7A755/B*Y\?^/? T6EV.JVMI?1>&_#
MOPX\.R^$?#,5A_8.D>'/!?AFVT'31](^(?V??V=?B3JLWCCQ?\#/@UXWU_Q!
M;Z?=7GBGQ7\+O!>OZ_JT$.G6EEICW^JZWH-SJMS]FTJVLK*U6\F9[6RMK:T1
M8XH(XD]+\*>$/"?@/0+#PIX'\,>'?!GA?2OM7]E^&_"FBZ;X=T#3?MU[<ZE>
M_8-'TBVL].L_MFHWEW?W7V>VC^T7MU<W4V^>>61N:&(]BJ+@^9TJD*OLITE&
MFZD=5*4X5O:5'&5N5/E5KZ15XNW#FYKZ<T7'F4KM1=M$G'E2:WWU[[GP3^T3
M\+O%?[0'B+X9:A\4OV=OB)\2/@-;>%/%4VJ_ 6Q\=?"GPUX\\+_%]M2ET?0O
M'/B2ZM/B_P"'?">N:;_P@]WKEEH \,_%W4KK0KK6WOKG1(]2<OIOT+^SG\//
M'&C?LX>%?AO\<PFLZS)H'B#0=7T;4-4B\07NG^"-6U+5XO"_@?Q-XBLO*M/$
MFO\ AOP'>:/X4\2:YISSVFI:IIU[/:ZOKZ%?$>K?255-0U"PTFPOM5U6^L],
MTO3+.YU#4M2U"YALK#3["RA>YO+Z^O+EX[>TL[2WCDGN;F>2.&"&-Y971$9@
MIXJI4HPH*,(PA-2@H>TO&2<_AYIR46^?WI1BISY*?/*3BF-0BI.=VVU9WMJK
M+>R3?PZ7=E=V23/Q5\%_L^_%'XU?#/\ :2\&?VC9:IK'P,\,:C^QA\#M?O\
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M+9W5UJ?AJ\6YM+,_0VI_L^?"36?%/CKQAJGAF\O=3^)VBKX?^(FFR^+/&?\
MPAOC;3H]!@\+PGQ/\/4\0KX!UG4;;P]:VVD6FMWWAJ;6K2RMX8K;4(O*0KRN
MG?LD_ G3='\2Z&OASQ5J5IXK\$0_#/5;KQ'\6?B]XLURV^'45P+F;P'X<\3>
M)_'>K^(_!W@_4Y4@&O\ AOPAJNAZ1XCAL["VU^TU*VT^QBMSZSA)<KG3;DH4
MXRM0I6;A0I4TU:I#E5.K&=5V2>(C)4JCA%)HY*BO9JUVU[\KZR;L[Q>\;1Z\
MK3DKMGP[XL_:9NOVE/V9?B+\7+SX=^##\,/#?Q3_ &=/"7AOP)XEU77=1\3R
M>/7^*'PFD\7>(]?U_P"'GCK1+,>'=*E\:Z?-\-;.R>&3Q);:58^-M<6Z\+^)
M;'PU)]>>!_B;\<?BGX^^(5WX._X51HWPQ^%_QHN?A'JWASQ+I'BR^\>^)[;P
MU'H[^-O%=AXTTCQ-#H'A>XMTUDS>%?"M[\/_ !&-:.EK!JWB;P_%K27^C^A:
MU^S1\$=?G\63:AX&ACC\<6_PXMO%6GZ3KOBC0-%U9?A'JVDZS\.)GT'0=;TW
M1;6]\*W>A:/;V.H6-A:W\^CZ=;>'K^YN] C_ +--BZ_9V^$5WX\O/B.WAW5+
M;Q+J>NZ#XIUJWTWQOX\TCP?XB\4>%GLI?#GB;Q/\.=*\3V?P\\3^(M$N=,TJ
M]TW7?$'A;4M5M-0TC1]0BNUO=)TZXMB>(PDH2A"E."YIRIQE"-6--3AAHN-I
M58WDW2JWK:3=XR45)VIBA433;B]%S.[3DTYZW4=%K'W=M&N]_P X/A9XA^*U
MWH_["^G_  ?\1^!O@_X<\5_$#]JW2+GP:OACXF>,O"=Q?^&[WXU7TEYXCL[S
MXXZ+JOBO2[M=-&J6.AZEK49T+QG/_P )%IVI#2;2Q\*VW?P?M 7'P@T[XS1^
M"O!&BZ3XC\>?\% O%7PF@U33O"7Q<^)MK'>WGP[\.>,O$/Q&U_P%X8U?7O%W
MB_Q"VAZ#?V-KX+\!7G@O2]0NTTR>VMM#L++Q#JC_ &E/^S'\%I?"7@WP3;^&
M=8T;1?AYXB\1^*_ ]UX8\?\ Q%\)>*_"^N^+Y/$DOBB[T?QYX8\6:1XYM(->
M_P"$N\0PZIIR>(O[,N[34!92V;6EG806NCJ7[._P>U;2/%.B7GA*06GC'XDC
MXPZQ=V7B3Q9IFNVWQ/6'2K>+QOX9\3Z9KMIXD\$Z]!;Z-86UK=^#-5T#[+;B
M[@MDBAU+4DN[EC,+.;<Z=5TY.I>/+!2:EBJE>$ISYVZLE"<4XU>9<T&N9J;D
MI5*<5HXIJUG=VTIQ@TE;W4W'>-G9]&DCY;B_:,_:0O/A_KE[8?#?49-7\+_&
MCP]X/U7XDS_LT_'G3M%U/X1^(_#S:K_PM#PQ^SAX@\0:!\;O$&H>'/$UQ8>
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MFY'*3AS**ERMNUU!*"=MU%**V6EC97LKVO97M=J]M;7UMZZ]PHHHJ!A1110
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MZ-!9:UJ.I:M<M?S26\=M])>$?@?\%OA_;Z]:> _A!\+O!-IXJL5TSQ/;>$?
M'A/PW;^(]-1+J)-/UZ'1M)LH]8L4CO;V-;34%N(%2[ND$86XE#[5<5@XS_=T
MJ=2-I?#AZ=-2NN6";E",H2HR3JJ=*,?:\RI5-(<SF$*C7O.2>E[S<K6LW97:
M:E\+3;Y?BCNT?!'PQ\4?'#XEZ[\%_ACX1^,,_P )?#\G[ ?P2^+TD7@OX=?"
MC=+X^UN76_#R"R@U[P/KOA_P[X2=8M,:_P##6B^&8K6"TTBPLO"S>%XC?G4.
M ?\ :I^.'Q#\(?"DZ9XH^)7A3Q+XB_8V'QD0? ?X*6OQ4U3Q7\9M;UB[\/\
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M_P#"3_%K_A$/^$5_L_\ X1?_ (1?_AF/QW_8'_"-_P!D?\2K^P?[*^R?V/\
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M\2[^U?LOV'[=_HGG_:/W=>4O^S)^S;)H5MX7D_9[^!\GAFRU:^U^S\.O\)_
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M2)\?-#NYM<\01:GJNC:/-I7PK\06T6J:6\\.DZVZ3:2/T%KXZ^%WP_\ C_\
M";QM\85T[PE\'O%'@?XJ_'OQ!\5$UZ]^+OC7PWXKT/0?$FE^$M$N;%_!\'P*
M\1Z1J.KZ=;>')KZ"$>.;&SU">YCL9+[3XT:_/5AO9\N(YE!S]G'V:G*E'WN>
M/,XNM&4;J-]$E)KX6GJ9SO>%KI7=[*3TMI?E:>]O+N?&.K?MD^/+_P /_$3Q
M+IOC[XV:)?\ B7]JZP^ /@_2K?\ 9D\0W7AGX:_#_P#X6II/A"X\2Z$=2^!]
MSK'B+XP3^&].UR>7P'XM\3^(]6@\3ZQ#X=_X5E::U%8:2OVIX1_:!TGPC+\8
MHOBC\3M(U3PC\+9_A)IVC:IJG@[QEHOQBGG^(?@+0]?MM/\ B1X4MO ?A31M
M4^(/B?6]5_XICPC\*O!R7\-E/9:%JWAZR\61WNFQ\+_PRQ\0?^$0_L#^V/!O
MVS_AOG_AJ?S?[0UO[-_PK[_A>/\ PLS^Q]__  CWF_\ "9?V%_HG]G^3_8G]
MK_N/^$A^Q_Z?3?B#^RS\2-?^('QA^)'AO6_ \6L:S\:_V=OC3\,=+UVYUO\
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M^9W[3WPP\7>-_BY^S-X5U+5/#L7C+X]^%]7^%G[0]CX:MM1AT/6_@Y\.M?\
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M .O-7_TB14/CC_BC^:/M*BBBOE3N"BBB@ HHHH **** "BBB@ HHHH ****
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MA%TE3E&DGS.4JD9RE2BVN6*YZO\ *D[;<LG9WAI=.SNG.VW*TE)K=^F_%/\
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M_'/AC5?CO/XZ^"OBG3?$&A>(O'FA>&=4T7]GC1-#T/P'X8O_ !3H%MX<\?\
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M/4/$%FEW#/KGAH:!9Q7-U#-K\Z164TGQ36Z\'_M>?LT>/Y9!#X<\;>#OB_\
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M?B;I7Q,T+X96>G>-OBU\4?B[INH>!?B+XJ\77MK>_$WQG>^)W\,7VF:_\)O
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MO-7_ -(D:P^./^*/YH^TJ***^5.X**** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%M3\)Z5K$K:D\NK:;X<O=*GT>QU.5]:UAI+^ULXKIVU;4F:4F_NC+MV'P]\
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MW++=)J4]V]ZMS)).LPE=F*:=\#_@MH_BJY\=:1\(/A=I?C>]UNZ\37GC'3O
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MCGN)M0@OQ=Z9=MIZ_J;_ ,**\(_]!'Q'_P"!>F?_ "HH_P"%%>$?^@CXC_\
M O3/_E141SBE"3G"I.$I<M^2FH+W)1E'W8I15I1C+1*[5W>[&\/)V32=KVN[
M[Z/<_*#6?V0_!?BWP]\3],\?>//B;X_\3?%G2_"?ASQ'\2?$5YX%M/&>G>#_
M  1K$?B'PWX-\+6GA;P#X;\">'?#UIK\FJZU>16/@D:CK>IZ[J-WKFHZE+;Z
M*=(^GM:TJWUW1]6T2[>:.TUC3;_2KF2V9$N([?4+66TF>!Y8YHUF6.9FB:2*
M5%<*7C=05/V#_P **\(_]!'Q'_X%Z9_\J*/^%%>$?^@CXC_\"],_^5%*>;TI
MVYJE1J+YHKDLHOEA#W8JRBN6G"*2224(I)) L/)7LEJK/6]]6];[ZM[]S\P=
M _9@\!>&;+]G&VT?6O&-M=_LP:;>Z'X"UC[?H;ZIK7AW5O"J>$==\/>,RWAW
M[#JFDZ[8V^F7^H1:58Z%<)K6BZ/J>GW-A+81J<.V_9#^'VE^!?ACX0\.^*?B
M)X7UOX-ZUXFUSX<?$[0]6\.I\0?#T_C/7;[6_%FGN^H>%=0\&:WH/B%;^32-
M7T#Q#X,U;2+[2[>Q,]F^J6-KJ<7ZM?\ "BO"/_01\1_^!>F?_*BC_A17A'_H
M(^(__ O3/_E15_VW&Z?MJMTW+X-VW5<DULXR=:M>+O%JI---2:#ZL_Y8[66N
MWP[=K<D;/=<JML?"G@'P1=>";'5(M2\>^//B-J^M:F-4U+Q'X^U+1I[YI(["
MRTNVL]+T3PGH'A+P3X9TRVLM/M@=/\*>$]#MK^_:]UW5TU'Q!JNJZK>\SX8^
M"/A3PI<?&FYT[4/$,TGQU\3WOBSQ<+V[TV1-.U&^\(Z/X,FA\."#2;8VEDNE
MZ):3QQZFVKSB_DN)6N7MWCM8OT1_X45X1_Z"/B/_ ,"],_\ E11_PHKPC_T$
M?$?_ (%Z9_\ *BH_M:C>;4YKG24DJ=DU&4915E9)1<8N*225DDK*P_82TT6E
M[7=]]'ZWZMGY5V?[)O@K0O#WP=TWP3XT^(_@#Q5\$/!?_"N?"'Q.\+W_ (0?
MQOJ'@26QM+34/"GC*U\1^"_$'@'Q?HFH76G:7KALM:\#W$>D>(],L]<\-?V'
M?B>6?J?$O[/NA>-/@_KWP>\9>.?B5XJL?%&JV>MZ_P",M;U[2;GQG?:C8^*=
M+\60&U*>'H?!^@::EYH]E8P>'_#/A#1?#MAIBRQ:9I-E=SRWK?I7_P **\(_
M]!'Q'_X%Z9_\J*/^%%>$?^@CXC_\"],_^5%4\Z@W&3JU'*,_:1E[-<RDI.:M
M*W-93DYJ-^52;DHW=Q?5GJN56:Y6KZ6LEMMLDK[V25SY0KY+TG]C[P/X7\*_
M!?0O OCKXF^!/$7P(T'6/"7@KXD^'[WP-=^-;SPCXAA*Z]X6\56OBCP%XB\!
M>(]&U.\ATO5Q%>>!Q<Z7K&B:;J&A76E2MJ/]H?K'_P **\(_]!'Q'_X%Z9_\
MJ*/^%%>$?^@CXC_\"],_^5%3#-Z-.ZA4J14FG)<EXRM&</>B[J2Y*E2+333C
M.2::8WAY/=)VT6NVJ>EO.*=]TUH?ESX5_95^'?A+4_A=KMEJ_C2_U_X8>.?B
M-\2_[<U?5],O=2\>^.OBKX6UOPGXR\1^/95T.&*\NKVQUVYNK2U\-0^%]-TZ
MZMM/M[.RBT>T72FYS1OV.?!GA'2_AC!\/OB+\5_A[XE^%.@^*_"6A^//#=_X
M"O/$VM>$/&6O2^)M8\+^+;#Q9\/?$W@C7M(37G@U73!+X/AO=)O;*VN;"]@F
M:[DNOUI_X45X1_Z"/B/_ ,"],_\ E11_PHKPC_T$?$?_ (%Z9_\ *BK_ +;C
M>[K57?1J4%)--U6TXM.+C>M5]UIQ]]Z;6GZKM[L=-M;-?#L]U\$=?(_)WQ7^
MQI\)_%_P6T[X(:AJ/CBTT6U\57_CK5/&%AKUD/B%XJ\:>(CKX\=>)_$_B"^T
M:_M-0U3XA1>+/%-IXJ^SZ396:Z;KUWI/AVT\/Z5:Z39Z=V&E?LS_  TTKXH?
M$SXJ)'J]WJ/Q5\+CPCX@\,7<^FKX/T_2;G1O#.@:[_PC^GV.DV6IZ=<>*=,\
M&>%8?$+2ZS>073Z'93VMO93"9Y?TR_X45X1_Z"/B/_P+TS_Y44?\**\(_P#0
M1\1_^!>F?_*BAYW%IIUZS4N>^CU]I*$YZ[^]*G!NW6/F[GU75/ECI:VO\J:7
MW)M'YD^ _P!GP>!-)M_!W_"X/BSXO^%]EX;OO!UA\+/&8^%FI>&;3PM=6$FE
M6>A_\)%IOPNT?XHWUKHNER+I^F3:K\0M0OFM884U2[U-E9FY7P-^R-X9\$^)
M?A/XCF^*OQH\9Q_ Z#5-.^%GAWQCXB\)W'AWPMH>K>$M;\%W&B-:Z#X'\/7W
MB&*'1-8ABLM9\5:CKGBRR&B:5:V_B%-,DUG3]7_6#_A17A'_ *"/B/\ \"],
M_P#E11_PHKPC_P!!'Q'_ .!>F?\ RHH_MN'O_O)KVB:G:E"/-S1E&3=HKWI1
MG*,YJTIQDXR;6@?57I[J]VUO>;M9II;[)Q32V35TC\S_ (D_L]Z5\0_B3X0^
M+EE\1?B9\.?'O@;PKXC\(:!JW@*^\'+:KI7BJ_TJ]UC^U-$\:>"O&>AZZ\JZ
M3';6]OK.G7VEVGG?VI;Z='XAT_0]9TKYW^//['.F^(/@A\)/@3\.])UR_P!.
MM/C/HVL>.O'-YXCTZW\7Q>&_%,7BP_'#QWXEU6XN-(G\1:O\1M)\0>(_#FN:
M3H-JL5U<^-8H+'P_8^%-*-EIO[<?\**\(_\ 01\1_P#@7IG_ ,J*/^%%>$?^
M@CXC_P# O3/_ )455//(4G2<:D[46G!.&B:Y^6]FG)1=2;49-Q3G/2TI)CPK
MES72][?7TOY*_*KM:Z+6Z1\,>/?A]H/Q"^&OC3X5ZF;O2O#'CCP/XC^'VH'P
M^;.QOM-T'Q+H%YX<NSHAN+*]T^SN[/3[V0Z:9].N[.WFCA\VRG@1H'Z#P[HE
MIX9\/Z%X;L)+B:Q\/Z/IFB64MV\<EW+::5906%O)=20Q6\+W#PVZ-,\4$,;2
M%C'%&I"+]C_\**\(_P#01\1_^!>F?_*BC_A17A'_ *"/B/\ \"],_P#E16']
MJ8=QY.>IR\SE;D=N9I)OU:27R*]A*][*]K;].Q^<&D?L]?#>P\(_%SP'JMC>
M^+O"7QL\:>.O&_CG1?$\]K<6\]]\0C;G7-,TV32[+2;BQTNW-M&^CR>=-K6F
MSJMU'K+W<4%Q%%\/?@E?^ ]1T"YOOC=\;?B%I7A/1)-"\,>&/'&N^#5T73K9
MK2TTZ&[U:?P5X$\&>(?'VIV>FV@M+74/B;KOC6=)Y[G6W:3Q+*-:7])/^%%>
M$?\ H(^(_P#P+TS_ .5%'_"BO"/_ $$?$?\ X%Z9_P#*BK_MBDU*+J5&IN[3
MIIZ\O*W&]W%N*49.-G**Y6VM!?5Y:625MK2?>]GW2>J3O;H?D1^Q!\!-0^ _
MPGU>S\1:'+X=\6^./'7B;Q9J?A^[U/3=?O/"7AR*Z7P[\./ BZ_I5[J-A?Z=
MX0^'VB>';*T@T^\?2["ZGU&*QC022R3=WXM_9>^&WC=OCO\ \)#<^*9T_:"B
M\!'Q6MIK$&G2>'=2^&>G6EGX+UWP1>6&G6^H:/K.C:AI^F^(H+K4+O68AKVG
M6DXMUL5ET^7]//\ A17A'_H(^(__  +TS_Y44?\ "BO"/_01\1_^!>F?_*BK
MGG<)UJE?VE2%2I)2DX1DK<LXU(*+;<DH2A!QNVUR1U;5Q+#-1C&R:BK*[\G%
MW]4W?U/RCUC]DGPMXNLOB2/B+\1_BE\1O$?Q,^%>H?!>]\:^(Y_AWI.O^&?A
MWJMY=:GJ.C>$].\"?#GP=X*L[B^U:YCU.]U?5O"6M:O>3Z?I5M=7TVF:99V$
M7TWHNE6^A:/I.B6CS26FCZ;8Z5;27+(]Q);Z?:Q6D+SO%'#&TS1PJTK1Q1(S
MEBD:*0H^P?\ A17A'_H(^(__  +TS_Y44?\ "BO"/_01\1_^!>F?_*BLYYO2
MJ)1G4FXQ=XQ5-1C%\L8^[&*48KEC%622TVO<I8>2=TE?9N^K]6]_5ZGY$:[^
MQ7X+U3PIXL^&>D_$_P",7A#X*^-=0O+_ %SX*:!J?P_OO D<>K75M?Z_I'A[
M4/&/PX\5_$/P=X>UW4H)M2N/#_A#QWH6CZ3?:CJ<WABST$7DBCTSQ!^SEX \
M2?'+PM\?;^X\0Q^*O"VGV%K'H%K>:;'X+US4]$T[QQI'ACQ3XBT>32)KW4?%
M/A+2OB/XTT_PWJJ:M;?V=;:W,I@F:"U:#]*_^%%>$?\ H(^(_P#P+TS_ .5%
M'_"BO"/_ $$?$?\ X%Z9_P#*BK>=Q?\ R^JZQJ1;4$G)55&-1S:5YRFH04I2
M;D^6.MTA?5G_ "QW36NW*[JW9)MV2LE=Z:GYQZ/\!O"&B>%?C3X0M=2\22:;
M\=?%'Q \6>+I[B\TM[[3M1^)&BVNA:Y!X<ECT>*WM+*UM+2.32H]3MM7G@N6
M=[RYOHBL*\(_[*NE6&N> ?$O@GXN_%SX<Z[\/O@UHOP*T_4?#"?"35FU?P-H
M5Y9W]K_;EK\0?A-XWL'UF:\T^TGNM0TBUT=&,/EPVL$,DL;_ *K_ /"BO"/_
M $$?$?\ X%Z9_P#*BC_A17A'_H(^(_\ P+TS_P"5%)9S33;]I-\WQ*5-24O=
M4=8R3B_=25FNB#ZL]/=6FUI-6UOI;SU/@?X5?"CPC\'/"I\*^$8]5FCO-5U#
MQ'XBU_Q#JU[K_BKQCXNUIXYM?\8>*]=U"22YU7Q#KMS&L][.!;V5NBP:?I5C
MIVDV=CI]K\<?L\?L?ZII_P /O!=E\9O$GQ&BC\-?&3XA?%<_!&Y\1>!]6^&O
M_"2)\5_'6O\ P]\12W.E:#J7BM;6/2[_ ,->-%\'Z?\ $2W\'GQ3$FIZ[X5?
M6IM>@N_V_P#^%%>$?^@CXC_\"],_^5%'_"BO"/\ T$?$?_@7IG_RHJHYW3C&
MJE.?-5G"<YN#E4YH1J13C)M\KM5D^9+F34>64;.Z>&;Y=%:*:2OI9N+V_P"W
M5Y;W3/R_N_V6?AI?_#/XF_"N_NO%5UH/Q0^)'C/XLW^I_P!K6EGXD\,>._&'
MC%O'L6M>#=6TW3+(:3/X2\5+:ZGX3:\MM4DMVL;:WUJ37+9[R&Z\7^/'[*6M
M:W\'_P!H6\T3Q/X^^-WQR^(WP:O_ (7^&]6^(&I?#G1+FVT);N35K7PEH=IX
M1\+?"_P#HUG?ZW*=3U'4]0TQ=1O;J*U6^UEK2SM+>']J/^%%>$?^@CXC_P#
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MZ'-<:#;>,(O#+36BM#HL "!/UQ_X45X1_P"@CXC_ / O3/\ Y44?\**\(_\
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M ?\ F'L9^7WGRA17U?\ \**\(_\ 01\1_P#@7IG_ ,J*/^%%>$?^@CXC_P#
MO3/_ )44?VEA>\__  !_YA[&?E]Y\H45]7_\**\(_P#01\1_^!>F?_*BC_A1
M7A'_ *"/B/\ \"],_P#E11_:6%[S_P# '_F'L9^7WGRA17U?_P **\(_]!'Q
M'_X%Z9_\J*/^%%>$?^@CXC_\"],_^5%']I87O/\ \ ?^8>QGY?>?*%%?5_\
MPHKPC_T$?$?_ (%Z9_\ *BC_ (45X1_Z"/B/_P "],_^5%']I87O/_P!_P"8
M>QGY?>?*%%?5_P#PHKPC_P!!'Q'_ .!>F?\ RHH_X45X1_Z"/B/_ ,"],_\
ME11_:6%[S_\  '_F'L9^7WGRA17U?_PHKPC_ -!'Q'_X%Z9_\J*/^%%>$?\
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M]7_\**\(_P#01\1_^!>F?_*BC_A17A'_ *"/B/\ \"],_P#E11_:6%[S_P#
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MX_?!SX.V/Q(\;6'Q5U[X6Z->3?LCR?&WQ5JUG\);[XV1VVDW_B6X\)ZOX?\
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MXF_%RYUSX@C6?'7Q'L?C'H][+'H^HWT7P2EAU75=8\(?=?Q7^+_QS\%_LO\
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MPSX^L?"G[3=OJ>K7=S?ZCH&F0Z/::-XGG\4?M.?M=3>/]8M/!;?LX:=X&?\
M;*'[(V@6?BCP1\3=9\66T-[X+NO$S?%+6-7TGXGZ#H]]+X9N'LD'PYLM"T]?
M',-O=0'XB_#Q[R*[L%_9=>Z7M<-=T_:6]LG*,6H2ASP47.#JPG&=/GBKQ;O:
M4)QB_;PZ*;UY?AT;6CLVTGRNZ=GNM+IIO]4Z*_)36/VPO%N@V7@KQG\4+_PO
MX=UCP!X:_P""B^D_$/Q5X8TSXL77@--<_9=\9Z+X*TGQ;IOP<TSXMZ;:>,-&
MUJWM8-?E\*^-M6USQ'H=Q<WNA^#/'WA8WFJ>)=5]G_9?^.W[27QFO_C7\/OB
M)I7@WX;_ !(^#GCKX5FZN=<^&-K8R7_@+QYX3TKQ?>Z!K'PX\$?M6?&:R\+^
M,I=/74QHOB5OC=K4=K:ZWH.HZW\,XI=,NM*UM3RVO3I3JRE3C"G?G<G):1Q+
MPLI4[1DZD(5/9\_*E.*JP;ARR4F1KPE)12;;M9*W6"FD];)M7MK9\K5[JQ^@
ME%?E=_P4.\<?&#P+\4/V8_$/PD\1^,K:?P1H?Q[^,/B7P!X<\0:QI^B_%3P[
M\)%^$?B#Q1X0\3>'=.O[.R\6RWWP_NO'5AX3L=2BNSIWBC4].U'3X)+N(6]Q
MXGJ?Q[\<_%G]HM/C5X!^*7CFW^ 7COX#?MD^&/@SX?T7Q'K>C^"_%.E? 'PI
M\+A_PNZ'0[/48K&Y\1ZO\5O&WQ(T7PUXBN;+^TXO!O@OPCJ>GW%DVJ7-I#I1
MRJI6HT:ZJPC"M1Q%174O=G0G42HNVG/5A2J5*;ZQIU='[.0I5XQE*'*VXRA'
MIJIJ/O+RBY*,NS<?YD?M[17XG>#-7\2?"S3?V,;[P;^T?\0M$\2?M%?LH^.O
M%7QHN?C?\8O''QJ\)^#UT+]G(_$/3OVDKK3?C1XP\50?#_3?!GQ/ETC3]=?1
MK[PSX$UK3?$KZ-K&G2&QTV2P^L?V*+G7?!NN?$OX"?$5_B@OQB^'7A/X2^)_
M'B>*?C[XJ_:7^'6LP^,;?QGH>D^/?AK\1?B',WQ-\--XWNO FLW'BCX9>.-(
M\%6_AS4=*@O?!/A2ZT#4I_&/BF*^7>QI5*L:WM%"*G&/L^2;@L1/"U)2BYNT
M8U863INLG&<'4]DYQ3<*W,XIQM?2][J[A&:2=MW&77EU3Y>:S/T HKXR_:4^
M+'QW\*_$WX4?##X'W'PDTJ[\<_#/]H+X@Z_X@^*WA7QCXPM]-_X4ZOPJ?1+'
M2-%\(>.O 4EU_;]WX\N=*U4WNLV_]G6\L'B&TEO)=#D\,>)_E;1/VS/VK1\,
M[WQOK/A;X)^(-;\3?LB>#/VT? _ACP;X;\>0-X;\!VWB_1+GXD?#G7[K6/B!
M++\0O&%]\+=<AO?!GB/1+3X?V6D^.+6ZTZ^\*>+],>S>ZBEEU>M2IU82HVJ.
M/+"4VIVE5J4E*7N\L8\U*K)MRTC!MI.5-3<JT(R<6I7C>[2NM(J5M[W]Z*6F
MK?D[?KM17Y+>)OVZ?CAXKOO#L/P \!>'O&6A_&7XV_%#P#\!/$5CX8TCQ7<:
M]X#^!O@'3=0\=>+I](\<_M%?LW>&/%=YXH^(,'CC3/#-I8_$OP=)H'@_P3J&
MLS6'C/4WN--L.;\;?'CXO_#;XC1?&/XA_#CP]X'^-2?L6^"_#^M>#=?UZPN?
M!?A7Q?XV_:MT'X9V?BGQ'J?A37_%-K#X(T>?Q#:?$'Q!I.E>+]7NM-\,07OA
M\^,9;^UD\0C6.4XB\(SE2A4J+W*/M(.MS<SII3IN2E3BJL:E*<FG[.I3E&25
MX.4O$05VE)I;RY7RVMS73LTWRM22T;3NMG;]C:*_+_Q%^U5^T)X-\9>(O@%J
MM]\#-=^*O_"\_P!G[X4^'OC'IG@;QOHOPPT+3_CCX*\:>.IG\:?!ZY^+6N^(
MY/%GA^S^'&J:-I>BV/QQTR#Q1=?$+X<ZHT^@Q/<:7JO@7PD_:K\8_LU>&/'?
MC/XEK\//&/P^\0_M _MU:7XSU_P%;:UIL5_\>_A[;2>/_!6D^#KW4?$/B&VT
MW0OBIIW@?XE^%]&\$:E;^(O$ECX]G\'>&-/\9>)]0E-OKI'*<1.#E&5.4VJ<
MJ-.+;=:G4INK&<7)145*"]V$[5').,H0=KCKP3U32U4I.UHN,E%IZN]F]6KJ
MVJ;/V]HK\U[C]H7]JGX=^*[/2/CSIOPQ\#VVJ_"JZO? L.A?"7QGXGT#XN?&
M'PS^S]J_Q6^(_AK2_BCHGQVUBQ^%"^#/$/AWQ8;#P?\ $?P \_Q \#>$;[4_
M 7Q#U[5)M=@\&?+'Q;_:8^,'Q*_9X\:>%OBC=_!KQ%IWQD_8U\%_M/>#[[X.
MZ-XHTB/P!;7/Q/\  F@ZEX'\4ZEXB\<^-H/'JZDGB[2I?#/C/2[#X>1RW7A/
MQG:7'A.X!MIM.*64UZLZ<54HN%25%*I3DZB<:LN63@[1A4=)*;FE-)2A.CS>
MVC*FFZ\4G[LKI2T:2^%)ZZMJ]TEIK=2MRZG[GT5^7UK^V-\9[K]K33/A/X?T
M/PMXY^#_ (F^)/QO^$>A:[/X"M?AG=CXB?![X4Z_\0=4\-:7XSOOVD?'WB_Q
M<-#\0Z"W@;Q7XDOOV8/A[X.^UW,FK>'?$.JVL.D0^(_(_$GQW_:M\<:1\#]!
MO_BKX!^$WQQT;]JSX6>"?B[\/)?V>?BAX8MO!EQXU\!^+=7T+PGXANM._:MU
MCPU\9O!.H3:9>ZFFL>"/'DGACQO:3>'L?\(KK>@ZEIMPHY57;@IU*,%.E"M>
M]23A";JQO4A"G*=/DJ4G2J.<8J-25.";E.*:=>-G92;4G'[*3:Y7I)R47=24
ME9N\4WLF?L[17Y?>'_C]\8=0^*.K?!'P!J7P]\+^,?&?[2G[0VAQ>//B58?%
M7XJ^&;#PY\'/AW\,-?O-,T3X?:A\;/#FHV^N>)=1\:P3Z;H'A3Q_X1\">%=!
MT/Q%J5CX-N]0GO)KKZ:_:1\=?'GX9?#7PAK_ ,.[+PQK5]9ZY8Q_&GQQ_P *
MTU_X@6/@7P+9^%=>O_$OQ%T#X'Z/\7/ ?C3QA86WB.PT>&X\)^%OB1XE\=Z3
MX?U.[NO#_AOXE:MIRZ9=XSP52%2C3<Z<95US4U)M>Y[T>=V4E:4X3A"$7*K.
M44E3O."E:JIJ4DFU'1V[Z.RO9Z)IMM**3U>CM]3T5^:5C^V3\1=1^)&@_!C0
MXOASXK\8?%'QE^SOXH^"OBZT\-^*/#/A_P 5?LP_$OX=ZQ\0OB1\3KOP9K7C
M2ZUYM4\*0_"7XPZ#9-%XCL;+2-:\4_!NQ\0Z7/J6I+IGBWA?"'[;GQ\T?PIX
M3^*OQ/\ #_PI\4^#?B%\'/VK_B1H'@'X;>&_&?ACQEH&I_LS".^T[3KWQKXA
M\<^,]*\6P_$?1K+4WFM++P!X4N/!6L7NG:=!?>-[2RN-3O\ 3^R\59?PU*48
M2A!SY9U%.E4K1<8R2Y;PHUK^T<+3HSINT^6,I]O3O;7JF[72:E&+3:WUG':]
MU)-7C=K]9Z*_#/5_C]\?_A_\1/BA\:=;US]GKXB?%&V_86^!GC/P?9^#-!\:
M>%? UGI_Q(^-K6]EH/BS2+OXA^/?$5U%;W.K:M/IGCO2_$.G0>(],FLKN+P-
MI<FDW,&M?37Q:_:'_:;^'=Y\7M M/&7[-*:O^S/^SUIGQ[^).K^-/AI\0/"V
MG_&.+Q%K/Q+FTW1OASHD7QWU.Y^%'AC1="^'#^&]7^(FO:]\8UU#Q[K#Q0>$
M-*L](-AJ>DLIK*4(QJT9<ZCJW.*NU0O9<CERJ>)H4U)J+<JE^50A4G!+$1:;
M<9*WH]/>MUWM&3MJK1WNTG^F5%?DYXV_:V_:QN?$'CK4/AMH_P  M%\(^'/C
M-^RU\%M%\+_$?PQ\2=0\976M?M._#SX.ZLNI>(/$V@^.-%TS1[;X;^+_ (L6
M,UU:6G@O4[OQEH,%]HH7P7JFD0Z]XA3Q%^V7^TO81^%_A-X:\"^#_'7QXU/]
MH/XY?!B]\4>#?!-@_A#5M-^#OA33_B%#K.@?"CXG?M/?!Y+35];\*>(M+M[W
M1=0_:5O)M,D\-^*_$6FKXAM6MM!L9658EJ#4\/[T5.2=5+V4/8QQ$YU).*BH
MTZ4X2GRRD[RY8J4HS46Z\$VK3T=E[OQ/FY4HZW;<KI7MW=DU?]9**_/)OCW^
MU3X?\0?L]W/QD\ ^%?@7X"\;6?P^\+?$K5KGP)>?&B1OCCXU^)-WX#TKX91Z
MK\,?CJ(_@O9>-8'\*WG@_P ?Z[H'QF^'6E^(/&=OX,\5^,;/7=-T6/QQ[9^T
M+XV^+_P?_95^/GQ#TZ\T#Q?\4O!/PZ^)WBGPA=>%?!.IZ+IEG)8V.KWWA2XG
M\)ZIXG\?W>MW?A+3OL5YKRKJL=KXONM)O9+/2?#=MJ<6FZ?SO!U%.C3]I1E*
MO45*FX3<Z;FZGLW^^C%T6HMQE+EJ2<8S@VM6E2J)J3M)**YGS+E=K7^%VDKZ
MI72U36Z/J&BOR?L?$#_"_P 3^'=%^!VL_M.?$SXH_$O]G3XB>-/@E\6/BU\;
MO^%T?LN_M-Z_H/P[\(^-H-=N_ =S\=]7U[P&]YKFMZ%)8S?#'X;_  0T+.N:
MOIOA:6\\"K86)XSXA?MA?%/XY>%O _Q#^ L6BZ=X 3]HC]A_P?X3@E\9^)_!
M>H>-_B!\1(=*^(?Q6^'GC_QKX>L?$+:7X$T70O'7P\^'WB?1[?X;^(KNQ\7:
M?\0=.UR#5+_2[GPEH73'*JM2473G%TI*+]I4Y:;CSU/91YH\\E'FJ*:2E-2C
M[*K[6-.5.<8PZ\4G=.]]E>5[)-V=NB:;TL^:/*Y*2;_9.BOQ&^)'C[X^:_XX
M_:#\(_$S7-7^&MQ<_M-?\$Q_ 9\,?!;]H/XJ:GH^@>"?BI\5?#_A[QW8>#_B
M#9>%_@?XN\,3>/=!OKJV\5?\(UH'AVZ=Y>-6OY8XKQ?M+]G:YO\ P?\ M-?M
M._ CP_X[\;_$'X6?#_P=\ _&.GQ?$#QQXK^)?B#X4_$CXB6GQ#C\7?#1O'_Q
M!UGQ-X\\16>K>%/"OP^^*=MIOB+Q-J\OA/\ X3R2&P-CH.N:%IUI-7+I4J,Z
MCJQE.%.%9PBE*#IRC@F[5H3E%R4L;32LN22A-JIS.$).-92DERM)R<;MV=TZ
MF\6DTOW;OK=75UNU]ST5^?\ ^VC^TE\9/@UXD^'?@;X(Z+IFM>*/&/P[^-GC
MR2*7X&_%S]HC5+K4OAJ?AUI_@WP='X&^#7BOPCKOA/3/'^O>/)=-N_BSXHU%
MO W@ZXTFULM9A:?7K.:WX^Y_:3_:)\*ZK\=;SXH^(_@=X#\$?LQ_L]^"?B+\
M5=0LOA!\0O&?B75/'OC;X8>+-?NXO#^CZ7\=K'3M*\+>"/%GAZ*\FTD:QXNU
M/QKHSS^%[3Q-X2N7B\=I%/+J]2C3K*5-1JQE.$6YNI)1KQPRM"-.3DYUYPIQ
M4>9WDG)1C[PW6C&3BU*\6DW965X\^K;5DHIMMZ:.UVK'Z845^%/Q,^,W[27[
M0?PP\=_!/XIZ'\-/!'B+PG^UQ^Q'X*\6:1XZ^#%C>Z7XM\!?&+Q[\,]?TCPM
MX[^$_A#]K7XPZ196T.O&TU'QAI4_QIU+_A8GPVOY/!.I>&? -UJMUKC?;7[%
MT/Q>LO''[5_AKQ?X_P# .O?#WX<_'K_A7G@CP3X2^''B?P?#X%M--^"'P&UK
M1=$\(-J?Q?\ '&A^%?AWI?A_6X;6T^'6D>%[2*'Q-/KGBZTUZULO$">%]-TK
M9:Z%"I5GB*+G3][V<%.<9TY+"NG.%51Y'[18J,DGRI12O+F;C%1K<TE%0ERO
M3F;2:DN:Z<;WTY6KZZWLK:O[\HK\P-%_:[_:*\<:SXO^$?PX\#?##Q+^T'\'
MM'_:?G^+WA.ZCU[1M";7/ 6K:5I7[-.E^%;O4_%EI#IK?'#3/%_A[QS;-XMU
MRTT^YT+P_P"*=,NM9\%"_P!+\2679>(/BCJ_Q7_8,_:JU;Q/XDTSQ!XS\._"
M7]H3P=XWM-.^$'B_X(3>$/%6C_#+5I]2\%:QX'\9?$/XJ71UKP^FH6\-[XAT
M+QYXC\'^(Q+#JOA34[_19[6^NHEEU:#IJI*$5.K3IVBW4E&-6;A"K)17+&G-
M)3I2G*"K0E%TG)<SBU6B[VN[)O6R3:2;2=]6KVDDGRM-2MU_0VBOR=T[]J+X
M\?!SP=K?@/QI'\&=;\3VGPF_8ZUKX4^*-+T#QEX3\ ^!D_:7^)7B+X&P'XSR
MZMXX\0ZAXFT3X4ZUH.E^)-3\2>&YOAX/B)ILMSI*:-\,[N[M]0L^F\2?M(?M
M8>'Y?B]X)M;'X2^+=<^ _P 3_ .F_%/XQ^"/A+XV\2:)X:^$OC;X.77Q+OO%
M#_LU?\+ZT_QUK'B3P7J[Z'IWB#PWX-^-OB_Q=J'@S7],\:^%? 7B#4;J/P8*
M_LNO>252@XIJTW.24H-4/?C[MVD\30AR*]64ZG+3ISY967MHZ:2N]+6U3]YV
M>O:$G?X4E=M75_T\HK\Z_P!G+QU\7?B#^U9\;-4/QG\&>-?@O+\&OV7_ !OX
M?\.:?\.?'NB&>P^(_A?XD:CHWB#P=_;_ ,9-9L? W]LW&F3:KXF2]\$ZGJ'B
M:P/A[2)VT34/"USJ>L>(?'_XS_%'XE^-/[(_M3X3>'/A3\*?^"C?[(OP1'@G
M4M'\1/\ &3Q'KMA\0O@M\1?^$RM?%7_":0>&[2QU&37#_9'@;_A7-Y>7_@[3
M=1\8_P#";PM;_P!B,HY;.6(]A[6"M2P]:I/EJ+V:Q$:4HT^2482=1>UBFM(]
MYQU2'62CS.+5Y2C%7B[\K:O=-JVC??R9^P=%?E?#^T3\9?!.B^&?$L46B>#O
M@4OQ_P#VLO!GQ2^+GB;PI\6OVCY= O? _P"U]XY^$?PX\-3Z/)\>M&^(G@'3
M/%F@>'YE?QS86/Q(^&7@SQ%>6.F+X'^&/@#3]-LFM?#?]KO]I7QWXR\;^-+_
M .$^G>$_V7/"GB;]I#PKXF\>:SX:\'2W_P )[?X%7/C[1;3Q=XCGT/\ :FUW
MXG_$#4M3U_P';6_B+X46O[,7PPU;0SXO\G3O'.NZ5X4@\4>.!Y974:DU.BH4
MY5(-RJ*+=2G.<?81WC/$24)3C1A*<^5P32E5I1F*O&Z5I7:B]%>R:B^9]5!<
MR3DTE=/I&37ZC45^1GPN_:]_;'^(WAGXZ:;I'PQ\)Z[\1/ O@_\ 9=^)O@*(
M_#SPYX9UK4OAK\>O$/CV'Q#KEY\(M%_;/^*FG:UK7ASP7X"N_%WAOP?KG[0G
MPA\7>(XK];*ZT'2KI?#\/BXU;]M?]I;QMK_A_P '_LM^ M ^/FJ:+\$M$^+7
MB?Q)%\,M/^&>E?$S4_$GC?XA>";+PSH?@WXZ?M9?!OQ[\#=%T?6_A?K6@^*/
M%MQIW[26JZ%K.N0KJO@339-!TS3OB#;RG$J4XNIADJ;CSU'74:4(SI4ZM.=2
MI)*%.-5580IJ;C.4^>T>6E5E!>WA9.T]=ERN[:DXM);MQ:;E:Z2MK>44_P!<
MZ*YO1HO%G]J:_>:YJ6B2Z!?-H\WA/0K/PW=Z7XA\-PII4":Y9^*O$)\8^(=)
M\67=UK/VB[T^YT30O"=KI.GM'I4T?B">$ZY<_A3^S7\1OB;>:_X3NY_%G[0'
MAG4O$OPY_;NU_P 5^(?B_P#&SQ5XX\"?':S\!_$'4- \$6WP$\,:C\2OB'I?
M@/Q3\)+DZ9<ZQ%%X?^"?BN/PU97MQI&C>-_#5SJNK:+CAL"\3"O.-6*]C[/2
MUU)SI5JK6KC+W(T)Q?)"I>;3TI*56-3JJ#@G%^]?Y)2A&_S<T]6M-/BM%_OU
M17XW_L\7NL?M'KX*\'?&SXT?&;PII?@7]@7]DCXE^%4\(?&OQ]\(M=\::[\4
M?!FOW'Q5^//BGQIX2\0>'?%/Q(O/#>L>'/#_ (>>#Q-KFO\ @7PWJ-UJ6I^*
M= U#6?&-E<P^T_M<_&CXGV'[-7Q';P'X3^*^A3>'IO@?+X&_:$OO'GP?T3PC
M\61JGQI^%6CK<Z!KGP:^(/B/Q[H]EXZT?5[R;4K^Z^$?A?19= N]7BATCR;F
MQT*_TEELXXJEA/:P]K.I2IR<K0IQ5>5-4I0E*:=5\M1.I",5*#32YU&4HI5D
MX2J<KY5&36[;Y$W)-)>[JM&VT[IZ72?Z3T5^*W[0'QZ_:E\!^//VF;_Q9=>'
M_@[?^&_V5/V=M2TFU^&/Q6\1_&7P7X%T?QK^TWXX\#^/OC4L'CWX/?"_1=+\
M8>&O!,VKZEJ,EQX$UBRBT;P9HMWJ>N7EG$^FZ7] _'#X#> ? W[/O[0EYX.^
M.W[3%]XE\#_ #6_B=H-I+^V7^T+J6O>'-=T?P3\2I?"_Q';4[;XHQ^,;C3O&
M^H:1/%+H&MZQ?_"?4[SX?K<>%_!FEZI;^+[K66\NY%1=:NE[><(0]C"-=)RA
MAYR<IQJQIJ,5BJ24HSDI-37NN,5,]K=R48_"FWS/E=DY)633EKR2O=*VF]W;
M]***\%_9F\(V/A+X)_#_ .QZUX]\07/B?PKX7\8:UJGQ%^)_Q(^*^NW.NZ[X
M5T.34Y(/$'Q0\5^+]<T[3)98!/;^'M,U"S\/6%S->7.GZ7:SWU[)<?,GQ;_:
MB^-7PZ\6?MC>(]/TKX>:M\)_V1OA5HOCL^#X_"WBF[^)7Q*UCQ'\+?$/B^*R
ME\<KX[T[PM\._#GAC6M*T^]UK79/ 'CJ>_\ "UUK,9T_0+G0H=6UGFIX25:M
M5I49*7L]G4M3<VZU.A"*2<TI3JU815Y<JOS3E&"E)4ZBC&,I*W-T6MO=<WKI
MHHQ;>EW:R3=D?HK17Y9VO[3G[96@>$+./XD_##P1X.UGXE?&3X"?"OX-_%+Q
M1X:\(Z5X+FC^+VH:]:^)-8UWX7_"C]K_ /:,N];M_"%MH>E?\(Y/_P +R\!K
M\0];^(&@Z%96VAQZ'?ZOJ_)?LP?&7XA>#?BU)\-=<O?AOXDN?C)^W=^U?X,^
M(7B7PUI>MZ=IL^K?#+X%:-XLM9?!.FWGBS69/#%]>ZIX4G_MWPOK>K>.;G08
M;?6M"CUO4KC2G\12]+RNLJ=:?M:$_91G./LI^TC4A3I^UJ2C.*Y4H033BWS^
MTBX2A&S:GV\;Q7+)<S2?,N5IMJ,4T]7=M.ZTLTTV?KS17YD?!S]JOXY?M&:E
M\,/"_P /=<^!O@;5/$/PN\?_ !A\1>*M?\!^+_B9HGB/PYH?QVU[X2>&M'\!
M>&M$^,OPZN++_B5:&-<\1^,;[Q?XFL5N]7T*WT_PY';:GYMO-X+_ &JOVI_'
MGQN\>)X8^ ,VO?L]?#OXT_$OX/>*;[3M-^'Z>)M/M?AG;:GI]_XRL?%EY^TW
M%XRUS6=9\0V.FWFD?#./]E;3!=>'O$E@]G\1+_[-#J>K1++<1%U8SG0A*C&4
MIQJ55"S4Y0A!2FHPE.JX3]G&,FWRM3Y&XJ0JT6HM1FU)I)J-]TFVTFVE&ZYF
MTM]+GZ8T5^3O[-OQ8^*GQJ_:5_99^)OQ)\1_!+4;/XF?L(?M ?%;P=X5^%&G
M^([+6_ .B^/_ (J_L;WG_"->.+[7O&?BJ+Q;/IT6GV6DVGC72]+\"VFL>(](
M\;Z;_P (=IRZ%%+<=CXT^/'QAT+XU?$3P!\+O^$&L=<\4_MD?"SX$VNM_$EO
MBIX[\.Z%X9UW]B:W^-.I>(;+P5%\4=&TK3=5T[6M'"Q>'? LGP^\-^*(1<OK
MT<'B_7=5^((J66U8U'2]I!SAAYUZCU4(*&(E0G%R=I-1Y7)RC!W?NQC*/OL5
M:-N:SLYJ"[N\%).VRO>VK\VUL?IC17Y.Z-\6_P!IGXD?&3]CB1OB-\-O!<E[
MXJ_;5^&_Q3\,Z3X$^(&H>#O'6N?LX_%?4_A?X@UG3-+/QLT)K>W\0Z9X/EU7
MP!:^(H_%5Y\.-3U#4M3O;GQG;SMI4&7\/?VT_P!KSQM\.?B1\>I/@+HNF?!.
MU^$'[0'C_P &Z[JMCX(T^W\)>(/A?8^(+CP9HVO:KH7[47C;QU\4(=:U#PYJ
M&@^+K-_@;\ =1\/:G&X$A2*0*WE59*ZJX>Z]V2E4]G:I[?$T(TH.I&*J3F\+
M6G%0;NHM?&X1FE7C>W+/R:C?3DA)R=KV2]I%._5WV3:_7:BOS-M/V@_VQC8_
M$CPE9>%OA!\1?BS:?!W]F[XZ^!+/P!X.U_2[#2O"/QB\>>-O#'Q$\/:EX<\=
M_'#0;?XE>)OAMHG@?4-=\,SP?$CX-V?Q(9S92VG@N_%K87WSG^T3^TE\2/%?
MPK^(WB'X6_%W2H=5A_8OUOQ])\5M"\(_M _"BV_M?PU\?+OP-XHM="^"_B7X
MUZ?+\,O$=B^EW^CGQ%XAAU;X@:+?V5W;7>L7WAR1?#L;I956J5(P]I22E4IT
M^>+G.,?:PISA.=HKEA*,WR\UIS=.JJ<)*E4<25>*5^65[-V=DW9M-*[U:MK:
MZ2:NUS1O^WU%?FK\0OVHOCU\(_B<O[//B;_A4WC#XP?$J'X&/^S[K^A> _&/
MA#P?XF3Q5XUU;PQ\=KWQ5X5U#XJ^,-<CC^$7A_1)_'\MCH/BF=V\/:QH<,]]
M=7/]HRVGO/Q4^)?Q<O/CUX._9^^#VO?##P-K&J?"+QE\8];\7_$_P%XF^*$%
MWIOAOQEX*\%6GAOPYX,\+_%3X/72S&Z\62ZGKWB>[\67EOI"0Z%I47AV]D\1
MMJ6CX/ U8NFY2IJ%6G.K"I>;@Z-.$9RJV4'4Y/><%:#E[6%2FXJ4)6OVL==)
M7BU%QTNI2=E'>U]GO;E<7>S1]8T5^;EQ^U7\9E\:2^*;?_A3H^$-E^V=IW['
MMS\+I]%\5?\ "YKFYO\ 7]/\#/\ $*V^(J>.!X8M[VVUC5(OB0/AM)\'[F2X
M^$ME-J)\>VUU=K?V7 ^#?VU?C_IFC^%/B5\3= ^$WB3P)\0_!7[6_B#PUX%^
M''ASQKX>\<Z)J'[,SZI?Z2-2\9^(/&_BW1_$J>/]'\-:U;76D6'@+P]/X7U>
M_P!)>VUKQ/:VUW%<Z+*\2X\R=)]%'GM)U/9U*LJ2O%+GA3I3G*3:I.W+&I*;
M47/MX7MKZVTM>,5+>]G*22TOU:25S]8:*_!SQK\7OC!:>*O&_P 5OB!XE^%'
MBOQ3JO\ P3O^&_Q.\/P?"$?%7X5VVBZ)X]^.6C36VBWM_H'QDU'Q[?06LZ7X
MTGXC^&?'?@>+QG!]LL&\&:%;Z/?#7O;)OB#\>?#^G_MHZWXL^)/A_P :^%O#
M/[<_P*^&OA?PSIVG?%[P-K_A6T\9>)?V.K<VNE>./#?Q_P#[0TOPI8^%?'\[
M7/@/2=+TK1O$OC*X\1^(?$CZEX*\;:S\,SL\IFN7]_!N3A%6C.TIRJ8:FXP;
MM=Q>)@VZBI1=M).[Y95=._N/1-[K9*4M?51>W-8_7>BOS5\+_M7_ !JU;QE\
M-/%%\?@S+\)OBQ^U)\3OV9]*^%%IHOBRQ^.O@N3X?7OQ)T4^+/$?C*;QSJ?A
MK6=>@NOAC?\ B'QC\-[;X6>'F\(^'->MT_X3?5I-"FU#6O'M-_:W_:/US]G_
M %#QO\3X/@]<6?Q=_P"">/[1_P"U#X)TSX8Z9\7/A_K7@S7OA!I'PTM+GP_K
M?C2S^+DOB6_M/$T'Q>T;6-/UWP%>_#;Q;X)O--U#3=)\0W]_::9XRFR658AR
MY7*DGS1@TI7ESMUE.FDU%.5)8>M*3YE3:A[E23E&]>VAVEM?9;>Y9O5Z/GC:
MUVKZI6=OV+HK\R;C]I?]H33?'/BUM,C^#X^#GPL^/?['GP+U;1-5\/?$+5_B
MEXGL/VF-'_9\TR^UVS\<W/Q(71=)U#P3XG^-EOJ,$FK^%?%4WBW1+>XL+^;1
M=6TS^W/$MKX ?M,?M*?&SX\6NE1:%X4M_@C9>)OVD=+\<-%\ ?C#I;>%['X4
M_$/4_AI\+8?#'[3&O?$JV^#7QBU/XFW%H?&6IR?#+P+K,7A+3](UGPEJ]G9Z
MB5\164O+:ZIRK.5+V<*:J2ES/1RHK$1I22B^6I*E*+5W[+GG"E[3VLHP8JT6
MU&TKMV2M_>Y&UKJE*]^MDY6Y4V?I917Y(^/?B9\6_@U^T;^V/\4?!$_PYF\$
M>%/$'[&EIX^\+>*O#?B;6/%7C33/&<>D>#+ZV\'^)](\8^&M(^'-_P"&](UB
M]U:TU+6O"_Q0M_%.I7-KIDVD>$K72)=2UWTSX:_M-_M3_%']H+Q3I'ACX'6U
MY^SUX,^//C_X'^*=?DMOA_8:CH%K\/Q?Z/?^/Y?&]Y^TP/&6I7-_XAM=-U.T
M^'D?[*6GA_"OB"TN+/X@ZC]DAU+5W++:JI^VC5H>R5&%64JE2-*TYT*%?V"4
MW:57EKPY.5N,]FXSO3B*LKV<97YW&T5S:*<H<[MM&\7>^J[-6;_2*BOQF\'_
M +6G[=7C3PI\-M?M;K]DS2)_B?\ LE^/?VJ[1;CX9_&'4XO"NG_#>3PO83^#
M+FWC^-6FOXJO?'%YX\\)WL6M17GA.#X>VR>(M.?3OB3+8:;J>K]GXL_;P^*K
M?$7X.R?#W0O#FJ_#7Q9KG[&NA_%31M5\ V,5U\.-0_:WU[PWINDZ';_%W5_V
ME?!NM>*O%%CHGB2#Q38Z=X"_98\>Z1%801P>)-?T-'UJ_P##5O*,4I<BG0;2
MG=J<N6,H3]ER2DX**E.K>E3N^64TES)3I.:^L4[7M*VEM%JFN:ZUU2BU)]4G
M>VDK?K-17Y$?#OXV?M,>"="^(MMK'Q,^%WC77?B%^W[XI_9Q^'^L^*_ GC^'
M0OA5<WWB'7;R]U76K2Z^.>L7GB;PI_9.D6N@?#;X4Z+JOP\DL?$6K:5ITWCB
M_MM5C%KU=M^U?^T3JWB_P7\$K'6/V==+^(^H_M)?&C]GS7?BIJ/A/QSJ/P[U
MO_A6GPLT#XOZ9XA\&_#"'XK:5KT7B*;3M=?P#XC\ WGQ=U?^S_%VA>(-2M_%
MK0:>?#[J65UE*:C4HRC!3G*=ZD4J5.FZE2JTZ?,XPLX.,5*HY)N%.4+28J\7
M:\9)NR2]UZN2BE=2M=W3WLNK3T/U,HK\G?"'[9GQ_P#B_P"&=!@\#W?[/OPT
M\6>'_P!G?XB_&GX@>)OB+X=\:>,? ?C74/AQ\5_&?P>NT^'VFZ1\3/A]J7@[
MX?ZGJ7P^U#QQJ'C/6_$GQ!G\)^&/&G@C3)-'\17$L^N7O*:M^W%\3K>/6/%W
MP^^&-Q<>,?C'%^PQI/@GPKJGB#7/&,'@[6OVB/AMXT\:7EO>>$O'GQC^$'PT
MN;K1SHH\,6EEX<\1? 5O&7B'4-,G\5:_J&H0Z;;(UE&*<IP?LU.F^6:<XI4W
M[:%).I)VBH/FE-2INHU&#4HQ;0?6(63]ZSU3MO[O-HE=W6BL[7;TNDS]C:*_
M*+_A/?VU_$?QF_8UL?'=WX5^ NLZ_P"(OV@]*\6>!]7\(RZ]IWQ$T+PGX?L=
M8TGQ-J/AOX:_M4>*_#&A7.K>&)3%H'A:_P#'WQ)G\ >*[2_\3RZWXFT^YB\/
MQ:?P(^/GQM^)U_X%^$OPYUKX9^ M4'A?XY?%#Q1XD^*&B?%KXZW6M:/X>_:D
M\<_";1O#GA>RUOX]>$_%EI):6NBS:GKNOZWX]\3:/H!U+PWX:\,^#]'\.G3[
M#2YEELXPYU7H3BH\\Y0E*=.G!3Q4.9SA&7.I/"R<?91J7YES<K6HJZ;MR33O
M9)I*3=J;M9M6M[17YFMM+GZE45\M?'/XG?$W2?BA\$O@G\)M6^'/A+Q3\6M/
M^*GBB?QO\3_"?B#X@:%IVA_"G3_";7OAS2/ _AKX@_"O4=9\4^(KWQUIE_:7
MK^.;*ST;P_X9\3W4VD:O+);FR^>=/_:6_:S\4?M(>)_AMX#^#FF>+/AM\(/B
MU\./A'\6]:_L#P+X>GEM/$7@KP!XM\8_%:TUWQ)^UAI7CCP5I6DV'CR?Q#X2
M\ V?[.GQ?'B_PYX8MH=.^)\FL^+KRW\!8TL#5JP]HJE""]C.O^]JJE^[C6]@
MGS32A>I63IPCSWNFYJ$+2=RJQB[6D_>4?=BY:N*D]%K91:;=K6>EVFE^E=%?
MCO\ L/\ _)9_A%_V0/\ ;>_];XLZZK7_ (S?M+_"JX_X*!^,['Q_\+/'<7@3
M]ISX/^!OAGX!\5>"?']K!X53XG^ /V/+31HY]<A^,VLKIW@ZR\.?$35!JFB:
M!X.TH:]\5QXP^*=K=:=8>);CX;:;T3RR2Q$\/"M"4XJ+CSQE#GE/&1P<8KE]
MHH^]*,W*4DDFUJU<B-=."FXM)[V:=OW2J/LWI=*R=[>=C]7J*_*3XZ_M>?M!
M_ [QYIOA:UN_AU\5;?P#J'[/>E_'RXT;X&R_#SPYI5S\>/BE-X/T(:1XT\:?
MMFW'B/1M2U?PZLUWH>A>#_@Y^T"UAJVEI)XFU?3K'7Q!X>[;PG^TY^T%?_%#
MP_)KUO\ !N;X3>*OVO?CI^RCI'AO2/#'C:P^(EM+\.O#?Q>\1>#O'FH^.KSQ
MWJ?AHQZE=_#.+PYXE\,VWPZ9H;>[D\6Z7X@:6X7P980\LQ'LE64J,J<H3G%J
M4TWR4U6Y>2<(SC*5*4*L.:,8RA.$E+WD/V\.;E:DI)I-63M=\M[IM64KQ=FV
MFFK'Z2T5^4%O^U]^T7IOA+0_#GC.[^$'A+]HO6?CK\"OA!XR^'OBSX.^/?"V
M@_!)/CHGBFPT*^E\067QZ\:>&/V@XKK4=%34?!6M_#GQSX0TSQC%9R>#-?M/
MAUXRU6_M_!?#ZQ^T7XGU'XD_#?QE\5M4\$Z7X@_9I\:_\% ?!7BKX@^$/"'B
M:?P!K%I\*/@YI/B5?'.G?#B;QEK?BJ*#3M&O[>P\3>!K?XC:MJ,GB7P_XATO
M3?%-NUQ;?8;CE6(;DG*#251IPYYN?)0E6A*"Y8\].JU&$)P<N=3C5IQJ4VI-
M.O"RLGJXK6RMS2C%IN[LXW;:=K-.+:9^R]%?C9X3_;B_:LUG2?&WAK4_!_PS
MT7XE6/Q4_9"\(>#[WQKX"/A'3AX7_:FU'4+&+4_%O@+X<_M1?M"M9:AH=I8)
MKFEQK\6M/U/4K/4+:UUCPIX?98KV\[#6?C%^T[XW\3_LZ^'[7XF_"CP+XM\(
M_MV_&?\ 9]^(>LV'PT^(,W@'XHIH'[,GQM\>^"M0E\"Q_'_1-3TS0&T2&*SU
M#X?ZYXY\:BY^+%OX*^(6D^);*T\%KX-\3$LIKP<E.KAXJ,9S<E.<UR1PZQ*J
M)0A*3A*,J<59.?-->Y:,W$]O%I6C-MM))I)WY^1K5I73N^UEOJK_ *QT5^2M
MO^V-\=O&'QHUKX<>&QX5'PM^(^G?M9^&_@Y\4M5^$#>$7TWQE^SS>/I6HW=O
M#:_M:^*?'7Q4T?PKK5CK?@_Q3=WOPJ_9TMM4UV/3O$'A?7HM/=-'O.)\+_M)
M?%WX/?L__LE_$[XB:M8_&C6Y_P!@3XT_'HWVFWOQ3\&MJ\?@[X>?LSZMX<M_
MB*EU\6?'7AGQOJN?%^K:C\0OC!XJ\,:OJ=C;IJ?B;P/X=\%+>^*-*\3"RFN^
M6//3=2I94Z47+GDW3Q$FI.480IRA/#5*52-249PFG[KLN8^L0UTE9;R:TLW!
M)JUVTU4C)-)IKKV_:"BORL\<?M6_M-?"L_$+P/K6H?LW?%#X@Z7X2_9:\:^#
M_%_@CPO\0/"/@&SA^/\ ^T)HWP2OO#GC/PQ=_$[XAZW+&+2ZU'Q+X)\:Z7XQ
ML$UNTBEN)O!+1:1/!J7V+^SO\0/B9XMG^.'@[XMW7@75O&?P4^,B_#2X\2_#
MGPUK_@WPQXITK5?A!\(_C#H>KP^%/$WC+X@:KH.H0Z5\5[71-5LG\7ZW;/J&
MCW%Y9W*VUU'#'A5P%:C2E5E*E*"LURRES2@XT'[2,91BU%/$T8M2Y9WGI!QC
M)JXU8R:BE)-]UHG[VC:;U]R3TNM-]5?Z.HHHKB- HHHH **** "L2_\ #7AS
M5=8T'Q#J?A_1-1U_PLVIOX8UR_TJPO-8\./K5G_9VL/H.IW$$E[H[:MI_P#H
M.IMI\]N;^S_T6Z,L'R5MT4TVM4VG9K1VT:::]&FTUU3:>@?U]VQX]XV_9X^
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MX5\0ZQX>U75+C0M.M-"AU*PU9[?PKHOA^S:'61I.E>'(;S3-*TBR&KZQ-?\
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MS9OH0O[+29]0M])CTC4KZ'1['2Y-571GO]-OOHBBFL17C+F5:KS*;J7<Y/\
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M_A<W_"IOAG_PN#[-]C_X6M_P@?A;_A9/V3^RO["^R_\ "=?V5_PE'V;^Q/\
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56VLDN_\ F_O?<****@84444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img181012247_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_6.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ) !)8# 2(  A$! Q$!_\0
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MHHH **** "BBB@ HHHH **** "BBB@ HHKYD^.GQ._:5\"ZWHMC\#_V6]/\
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MIXZ.>5\IHX]2PM;-*&75,!3K4ZL9XB/L:O)]O45^<'A?_@HYX-^(?[47PH^
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MNAK<%EI4+B40M81R(U<7^S#^VO\ M-_M.:'\-?B+H'[$VG:)\%OB!K<]C/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH _-?_ ()"?\H[?V>O^ZL_^KQ^)E> _$GX-?'S_@FMX2\>?&/]
ME;XBZ1XR_9H\/ZM>^/?&G[+OQ4L5*>%])U&Y@77Y?A?X]LYHM1LTBEO+B]LM
M%GBL8[9+2VEO5\;ZF\\%]^DGP-_9J^'?P%_9_P!%_9L\-S^(_$?PYT;3/&6C
M;_&&HV=SX@U+3/'7B#Q%XBUVTU'4O#NF>&K?:;CQ/J-E:2Z?I^GW$%@MLK32
MWD<EY+\J'_@EQ\'+O3K#P?X@^-G[67BSX.Z=J%I>0_ 7Q+\<;N]^$CVEC=?;
M+30YM*M]!L_$K:';S9:&T7Q4DL3$31W*7*1SI]'3S#"/,LRQ%2N_J6,Q]6O4
MPM3!K$0Q>&EB*M6.DJD71Q,(S:I37)*FYS:K07-&7[Y@^-^&*O'_ (@YYC\X
MJ+A+BGC7,,XQW#6/X5I9WA>)L@KYWFF848VJX[#U,HS_  V'QCAEF,I/!XC!
M5,;B)T\WPT?;4<1XU9_$3PKXY_X*B_LJ?%#6;6_TK0_B[_P3ZMM<^$,6KS10
M+:^-O$_BGQ%XLU#32LP"-K4?P]U"[LKZ&W$5Q++<6*9=%$+?L%J]U?6.DZG>
MZ9IDNMZE9Z=>W6GZ-#=6EC-J]];VTLMIID5[?R0V-G+?SI':1W5Y+%:6[RB6
MXD2%'8?.GQ\_9$^"G[1?@SPAX+\;:+J.B1_#FYMKOX:^)O >IMX3\7_#N>UM
MK6RC'@_6[2&4Z7;/:6%A!-I[VUQITW]G:;-):-<Z;I\]MQ/PH_8G\._#/XA^
M&OB;K7Q]_:G^-?B/P;!K4/A2W^-_QCF\8>']!?7]'N=!U2\M?#^F:#X<TRXO
M[C2[RZMC>:C!>S9ECF9FFL["2UX\36P.+I8>I[6K0J87#/#K#2I2JQJ*E4JS
MH<E:-2'+&I&I&-;F490DISA[3F27R_$.:<&\399DF-699CD^/X=X?J9%3X>Q
M&65<SH8Z.7X_,\9D[PN:4,=A8T*&-HXVAA\U=>%&M@\1#%XW#+'^VA278?"3
MXO\ [0WC;Q<NB?$S]D3Q-\%O#)TV]NV\:ZM\9/@]XXM%O[<PBTTK^P_!'B#4
MM;,M^))2EV+;[);^0WVB1#)&&^4OC79VFG_\%0_V"+"PM;:QL+'X0?M"6=E9
M6<$5M:6=I;>#;Z&VM;6VA5(;>VMX42*"")$BBB18XU5% 'ZG5^8^K_\ !,#P
MKKOC;0/B/JO[7W[<][X[\)VVL67A7Q7/\9O!TNO>&K#7XG@UFPT/5)/A4][I
MMEJ-O(]O=V]M.D<\+&.0,I.7@,1A%6Q%2LZ>!A/!8K#0IT:>)K0E/$X:O051
MNK6K37(ZD7).=G&_)%.][X,S[A>GF^>9AF<L#P=A<5PEQ'P]A<ORC!\19MAL
M1B^(>'LYR6..G+,<US?%TOJE7'4*F(C/%J%2BVL+1C-5.?"\?R/;_P#!8?X#
MMJ+Q)8:A^QSXSL?#BS1/F7Q!;>-?%]]K*6DK(8OM(T)()9%B<31VL<WG;8YX
MA)/\1A%?_P#!7C]G:'3 +F_T+]E'XC:CXG6UR\NG:%?>(=>T[1KC4RG^KM)]
M9N#!:K*2/M5Q&0H,T;-]*?&G]C#X9?'7PY\*+#Q=XJ^*FE^//@M!9)\/_CEX
M2\9)H/QITNZ@TZQT_4M3N/%J:3<V%_J/B,Z=:W^O2W.A/#<:DLEW9P6!FE5]
M/]GS]D/X:_L\:[XQ\:Z1K_Q'^)7Q.\?16=GXL^*_QC\6GQQ\0M5TG3F5['0_
M[873])L[+1K:1(I!9:?IEHL[V]G]J:=;"P6VW^O814(5%4JO$4\KKY8J"I6A
M)U)5H1K^UY[*G[&LYN#C[3VT>6S@^=>PN,>%J63X;'0QV/GGF!\-LW\.H9+'
M+.3"8FMC\5FV&IYVLS>)4:>!_LK-7BYX:>%^N_VK0]@Z<L/5>,A\Z?M(6-EI
MO_!0?_@EM8:=9VMA8VD7[:L-K965O%:VEM"GP-T )#;VT"1PPQ*.%CC144=
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M41Y;4>(HX_#EQ=QB1757M;75IK@2[283%YJD,BL/D/\ :!T+6OA_XW_X)/\
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M*^5K.[DEU%%MKM6MYBDP*#\X[[X>_P#""?M@?L ? K7+[1_%/A3X<_"WX_\
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M;/)Y/G1*\$D4KU]+^,'PZUKXJ>*?@IIOB+[3\3?!?AK1?%_B7PS_ &1KL/\
M9OAWQ%,\&CZC_;-QID7A^\^V2HR?9-/U6ZOK?&ZZMH%()_#R\\3_ !8_:$\!
M_P#!*CXH^.?C/XVL_&OCGX\>+]'U'5/#GAWX06$6G:OI6H?%"PLO&>DZ=?\
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M>TSQC;:QXRT#7)]4TJ_@UKP]=ZKIEYI0T![S7X[[R+K3]/N?LTVSL],_8_\
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M\7)IL,7Q=Q)CYYC4Q^;8C'5,UE2GCJF-C1Q=2K6H8/\ LZEB(3Q%*I+#8J.
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M'N-9^(NHP33D'):5?#]IH4"L>A$$$*XZ*#S7<P?\$=_^">T4#0R?!#4+F0@
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M-&\,WB1Y4^./%B17ECI3QR'9+HFEPZOXA25/*OM/TN&5+T?A3K7Q9_X*6_\
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M%>2PN$M^-!O\3Q:GTJO'.<U*/&%"E%/6G3X:X7<'Y-U<GJ5+>DT_,_E@UO\
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ML4$C7&G>'UN$TC0+?5_$%^]UK7]$W[#O[ WPH_8M\#P6NCVMEXL^+&LVD?\
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M"A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH>&I-,US6)+W09EDVVUSJ<.CZBS(_G:5 NQG^@:&FM'H_P#/4 HHHI %%%%
M!17F/A7XR_#;QM\2?BK\(O#'B5=4^(GP1_X0;_A:'AT:5KEHWA?_ (63H-QX
MG\%;M4O],M=%U?\ MO0[2XOA_8&I:K_9XC^SZK]ANV2!O3J/Z^_8 HHHH **
M*Y;QSXEG\&>"O&'C"U\.>(/&%SX4\+>(/$MOX1\)V7]I>*?%,^A:3=ZI#X<\
M-:=OC^W^(-;DM5TS1K+S$^U:C=6T&]?,R#<#J:*\\^$WCR[^*'PV\&?$"_\
M WC3X:7OBS0[75[OP%\1=(.@^-O"UQ/N6;2?$.D-)))8WL$B,PBF\J=K=X9)
M[>UF=[:+T.C8 HKS'X9?&7X;?&/_ (6#_P *W\2KXD_X57\3_%GP:\>[=*US
M2O[ ^)/@?[!_PE/AIO[<TS3/[2;2_P"U+'.JZ/\ VAH=YY__ !+]3N_+F\O
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M;'1-6N=/FL;V6WFGO--AO7M-6EM_V#_8C_;(^&?@GX=^.KO3?#/CAOAEXO\
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M^$?CC0[:]EGL[33_ !+^SGJ.L&SFNH[_ $C6?"GAO0+^6&2UM;"YK\"O%#?
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M1I+/Q#::+XIBURZMUTKPWXUF\9:=^LJ(D:)'&BQQQJJ(B*%1$4!51%4!555
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M.?$VFQ^$83X=\*AKJ[M=;U+2]5DT$!K"YU\Q>)=<\2^,+70D;PYX+T#ZHG\
M?M[Z]$VD7O[0/[/W@"V2-4/C7P'\"O$&O^,M1, $<3WFD>.?B'>^$;:6= 99
M6@M)X;:61T@MGA"*.\^$?[*'@'X9>*3\3-?USQE\9/C/-92V$GQ;^+6MGQ+X
MFTNPNHW%WH_@VQ2&TT#P+H#RW.H^1IWAO2[.Z6SU*[TZ\U*_M'V5BJN PU.H
MH*$I5%*,U3J5:]>=-[TE6GA\-1P]*HFX5*D(UZ[C>/+"]U]+B<@\7^.LYRBI
MFE3,L%A<EKX/'9?7S;)LBX4X7R[.<*H^SXBQ/#F5\9\;\1\:Y]E.(BLPR?*,
MRQO"_"-#'QH8F6+S".'=&I9_9+^%/B?X3_!ZTM?B%]C;XJ_$#Q/XL^+GQ:?3
MS;FS7XB_$C6KCQ#KMA;M9SW5E)%H,5Q8^&TGL;FXLKH:.+JSF>VFB-?2]%%>
M16JRK5:E:=N:I.4VHJT4Y._+%=(QVBND4ET/Z1X=R+ \,9#E'#N6>W> R7+L
M+EN&GBJOM\76IX6C&E]9QF(Y8/$XW$RC+$8S$RBI8C$U:M::YJC"BBBLSV0H
MHHH *\'_ &C?V;_A7^U)\,M7^%WQ7T&'5=)ODEN-'U:%(X]>\(Z\()8;+Q)X
M:U%D:33]5L3(>/GM+^V:;3=3MKS3;JZM9?>**TI5:E"I"M1G*E5IR4Z=2$G&
M<)1=U*,EJFF=N79EC\GQ^$S3*\9B,OS' 8BGBL%C<)5E1Q&&Q%&2E3JTJL&I
M0G&2W3LU=---I_QI^$?%/[1?_!&O]K"_\/\ B.TN/$_PV\2/%_:]A;F6V\+?
M&#X=QWDB6'B;P]).9(-(\:: LLOEJ[R76@ZLU[H>H27N@:HT^I?UQ?"#XN>
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M,EBMSJ+6.H7TFGV_R\LGP=/A_%9G*I7K8B./P^&P5?"SG/ XBFX2EC77P];
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MPU:)X'^'^I7<1,TD=OK&F?#'Q?\ $NP.J7DVE?%#PO;PF6+]*OC)^QU^R_\
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M)O-%\BQTVU#KJ,ES:V,K7/Z1S_L1^+/BC\&?C-\)?VLOVDO&'[0\GQ=7PO\
M9=>LO!7A?X3V'PRN?!EQ)J7A_5/ASX5\.S:Q8:/K,>MFUU/5M1NKR^?7!IUG
M8ZC'+:&[CNM7X>_LY?M=:#KW@A?B)^WEK?Q \ ^#=5T?4+KPUI/P"\!>!_%G
MCFST)TEL]%\;_$0>(/$UY?:??R06R>(IM$T+0-3UZU%W!<W\;WTTXM22O=Q;
MN[W32DN6*2TC?2S6MM[[NZ#Y5\(?\I&/^"H__9M'P2_]5?/7NW_!(G_E'/\
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M_P#VLO@=^TM'X@M/AGXIN%\8>#+N73O'OPP\8Z+JO@?XJ> M2MWAANK/Q9X
M\36NG^(-.2WNIEL&U6&UN]"FU&.YT^UU6XO+.ZAA[L5D&;X3#SQ5;!REAJ3B
MJ]?#5L/C:6'<FHQ6*J8.K7CAG.4HQ@L0Z;E*244VTGY. XRX:S+&4LNPV:0I
MX_$J4L)@\=A\9E>)QL81<YRP%',\/A)X^-.$93J/!QKJ$8RE-I1DU](T445X
MY].%%9NLZSI'AS1]6\0^(-4T[0]!T'3;[6=;UO5[VVTW2='TC2[66^U+5-4U
M&\DAM+#3M/LH)KN]O;J:*VM;:&6>>1(HV8?DOXI_:O\ CG\>_#FO_%/X5_$S
MX<_L0?L9Z1)%;:+^U7\>O"5GJ_Q#^+=P7G$&M?"GX:^.-6\/^&-!\$:M+"+/
M1-2\?VUWXC\3I>:=>^'_  \;P:EH=EZ^5Y+B\U=25*5'#X:C.E3K8S$NLJ$*
MU=N-##TX8>CB,7B\77<9.C@\#AL5BZD(5:L:#I4JLX?-<0\59;PXJ-/$0Q.-
MQ^)I8BOALKP"PSQ=7#82,98O&UJN-Q.!R[+LNPJG3CB,SS;'X#+:-6M0P\\6
ML1B,/2J_KU17\_*?$CX Q:BES8_\%4_^"AND>+M*AM[Z'QEXO^&^O_\ "EK?
M5F@2YBU36-"US]EK2?!%[X1U"-I=0L+36/$9\/76E&%XM<NH?L]S/]:^$_VF
MOCA^S?<^#KG]ISQIX&_:-_9>^)NJ>%-(\!?MQ?##3?#7@W3O#&L^,)(['1[/
MXX^!='UG4/#>C^#]5UB0Z?I7Q6\':E)X4TYVTN'Q/!8W>O)'I/M8O@S'4(Q5
M&LZF(FFZ."Q>79KE6*QG*N>:R]YE@L/A<944&I1PL,3''UM8T,'5:/E,N\4\
MGQ=2;Q.%5'!4I16*S;+<[X<XBR_*U4E[.G+.ED6;8W'Y70E5O3J9A6P$\GPM
ME+&YGAHM'ZHU^%'_  6K_8OB^*/PQB_:>\!:0K?$#X2:<\7Q!M["UB%SXH^&
M",99M6NW0"6YOOA_+YFH)(<D>&+S7#/(Z:3IL"?NO5>\L[34+2ZL+^UM[ZQO
M;>>SO;*\@BN;2[M+F)H;FUNK:97AN+>XA=XIX)4>*6)VCD5E8@_.Y;CZV68V
MAC:+]ZE/WH7LJM)Z5*4O*<;J]GRNTEK%']">'O&^:^'?%V3<6Y1)NOEF)3Q.
M%<W"EF.7U?W>/RZNTFO98O#N=-2<9.A6]EB::5:C3E'\>_\ @CK^V7_PT%\#
M_P#A3?C;56NOBQ\#=.L-,$UW+)+>^*_AJ/+L?#/B!YIG:2[O]"<)X7UV3YW"
MPZ#J-W-)=ZX^W]C*_C?\<:=K'_!*?_@I?9Z[I%M?1?"MM<3Q#I5M$)737/@7
M\0;B>TUK0XB\1-]=^$F74M,M"RLTFO\ A+3[]L!XV/\ 8AI.JZ;KVE:9KFC7
MMOJ6D:SI]EJNE:C:2"6TO]-U&VCO+&]MI5^66WNK6:*>&1>'CD5AP:];B7 T
M:&)HYA@U_L&;4EBZ%E94ZDK2K4K+2+C*2FHZ<G.Z:7N,_3_I"\&Y5D_$65<<
M<*0OP7XF9='B?)W"*C2P>/Q"IULWRSDC>-"5*KB*6*6']U8;ZW/!0BE@Y):%
M%?C+^V#K_CG6?^"@/@'X2VOQ3^+GA#X=:Q^Q+\8O&^K^%_AU\4O'7PZL]0\5
M^%=6\0ZEX=\0/<>"M=T34+35],U#2]+E&IZ9>6-_?V%DWAO5;F_\*:GK>A:I
M^>/AC]I']HOXH^"/V/[7XJ?':3P!X"\<_L2_$2?P_P#%#XB?M5_$/]C_ ,,>
M(?VA/#WQ>\7?#F37_$?QI^'7@OQ1J7Q'\=>#/A_I'@;Q':_#[QK/9:/KUWJ%
M_P"(=:U+5-4U&[M-<]G+^ L5F&"P>-IYA0C#$X>CBJE+V3]M3IXBEFU6E"BI
MU:<,162R;%RJP<Z,:=)TZD:E1^TA2_A?.?&/+\FS;,\IK9+C*E3 8[%9?1Q*
MQ$%AJU?!8CAK#XBIB94Z%:K@L*Y<59;##552Q-2MB(UZ$Z%%>PJU_P"JBBOY
M9_B+\6?V@_%7CG6O@I\1?VKH-,^)EM\+_P!B/2?A?\;/AM^V=IW[._P#%GXC
M2W\1_%OXHS:5?_$CX3^*/VA8?B;X5O&O(/%OP\\"^/IX-2N8=%T6'PD(])MU
M]/\ CY^U3KVB?M&^&M*^&'Q ^(/AO7OAQ_P4+^$/P!UKP_X]_:X^(MY\0/%?
MPTM=-\.Z=XCMY_V/=/\ #=G\/KG]GO7KC6AIFB_'KQEXK\1_$SQ=K4-EJ6M>
M(Y]<\2VL&G]4?#?'3G0HTLPH5ZM;"5,8W1IIT*=#V& K8>NZE6O1JNA7ECXT
M=</'%0JT*\HX2I05.M4\^7CIE%.CC,37R;&83#X7,J&5QCBJ\HXNOBWB\VPN
M-PL*.'P>)PZQ>#643Q5OKDLOJX?%X2$\RP^,E7PE#]S?B%^U'^S]\+O /C+X
MG^+OBGX:_P"$(^'GC>#X:^.M9\+/??$"3PE\0I]4TK1CX)U_2/ %GXGUO3/%
M-KJ6N:1;ZEH=UIL>HZ2NHVMQJEO9VTHFKWROY/?&FO6G[/W[.G_!3ZQ^&_QB
M^*'P\_: \+?M]:T-*T*T_:&^+<7CN+X+>(?B/\$+;1_'MQX<U'X@7%WK-QXI
M\^?2-4^,>I:?J'C3Q/I]U'H6O^,=1TZ[@L9?I3Q'X^_:1MOVW-=_X)WV?Q3^
M,L=OXQ_:^\%?M(:#\0K+XD>+)/$.C?LGW'@;7_''C_X6Z=XOO=1&NZ7X<TW7
M='TSPQINE3ZE+8)+]OTRTL=7COR)>C$>'M*5"53!YC.G&@LPQ=>MF%.-)5,J
MP&!X>QF(Q=##TE-6P\<[]IS+%UOK=%7ITL/]6G/$\6"\:\1#%PH9IDE*M/%O
M),MPF&R:K/$.CQ#G6;<:9;@\MQ>-Q$Z;OCI\+>P5.6787^S<4W&M7QOUVG3P
M/]%U%?SC?LA_$O\ :2^(WQG^'&J>-_VE?A_X'^-.D_M+?$W2/CE\%_BK^UWX
M_L_'/C'P$MYJ>E_\*T\'_L0:EX"C^'?A6;0=$@T[7_ /BWPAXCFNM1,5[J6I
M:B[W4UMH_P#1S7R'$?#U7AS%TL'6Q5'%5*E*524J*:A%PK5*5X2O*-6A64%6
MPU:,DZE&I%U*5"HI4H_IO W&N'XXRW$YGA<OQ67T:.)A1IPQ<HNK.-3"T,3R
MU:?+">'Q>&E6EA,=A9PE&ABJ-2-#$8N@Z=>91117SQ]J%%%% !1110 4444
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M5R7=B?L,<_[,X8R_ Q;C6S>I+,,3;1NA%0="#Z\LE[":6W-">BOK_57&4_\
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MS*E3HXQ82O94L;AIT*V)P.99?4G>E',<IQN/P#KQG0^L^VA*FO+/B?\ LO?
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MCJVGZ=!:0W5Q-!!+\-?%KXQ?#_\ :B\"Z]^SM\ M;C^)_P 0OBS:VG@V_M-
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M?\1?']_>W7COPOX>^&OB;Q?K$&F:CJ-_<7-QXBN?"(^%OQF^'7AS6M6N+_\
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M_P#FBH_X94_X*5?])7O_ #17X"?_ #14^5?SQ^Z?_P B!^H5%?E[_P ,J?\
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M5/\ @I5_TE>_\T5^ G_S14<J_GC]T_\ Y$#]0J*_+W_AE3_@I5_TE>_\T5^
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M4?BW\5O$5AX.\(ND%U:7ME>'0)-2NO%T^GWT#6FHV7AVZL9CBX"M]:U^</\
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M'CA_$G_!/#]I#XCZ-\3OB)K/P1@^/7[*WQVN6FMOB7\.?'OA'5(]*N$U'Q)
MI\3G4_ ?C=-&UGP=X_@ALO$OCKP _BG0/%-QK&HZ5KLFH_>?[$?QNUK]HO\
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MQ/\ L>Z9HL7Q!^)?Q)_X*9?M2>#M<O?[.3XT:Y\4O$WPA^#.M:Q EY<:M:>
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M ?!OPL\$^%_AS\/?#UAX5\$^#-%L?#_AGP]IB2+9Z7I6GPK#;P*\\DUU=3,
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M:YIWAZ:T_>.OYE=*\3>*/@M^Q/\ L"^*(=;333^R]^W_ /&'PU\<%-C8W_\
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M5WK]1*_)#X3>'-1TK]M7]D+X073A_$'[+G_!.&ZA^)&H6[1W]N-=\9:U\*_
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M=.E%U]I_MG_L;>-OVF_VOOV4/$WV3Q;I7P=\#>%OBO:>/_B/X"\=:/X*\:^
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MGX#\2Z/>>']6T3P?>66BZ#_8T<FC:A>Z=:2F.ZETZUNKF+3VMEN;@2U_ ?\
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MOQ.^%WQ ^'L=[=>;]EM)/&GA/5O#:75SY*2S?9[=M2$LWE1R2^6C>6COA3^
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M^./[0OQ5\4?%'7OV8OV5[30;/X@>%] TW7/C?\>?',"W7PX_9R\/^)=/GO\
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M7B;5]2CW;)7']C<,,5O%%!!%'!!!&D,,,*+'%#%&H2.**- J1QQHH1$10J*
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M X:6)PV)H1K86M^4'P9\+?M<_ #1O!^@_ P?#G]J']G1=2\0:_H/B7P]X_\
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M*#8Z1XEU<027LL>V/2_%[I)N,7B&VM[+]@?^"<_[='AS]LWX0VDFKWVF:?\
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MAQKW[*_[-/A#7/ 9^%7C?PSJOQ _:)\.?&'X?ZKX@UK1?!E[IR:O\0M;\/\
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MX)A_&+2OVBOV;_$'B2[^%5OJYD\/^,K6,W^H>#!>RCS? GQ1LHHOL6IZ!J2
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MP5PU_P",TNJ?LZ?L=0^($\/^(+W_ (1G6?B9I%IJ*^,/B$+MC9/X;^'>CV\
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M](U+XF?#&WTOP=^T3IEGYD=^1'8Z#\3K>SA"0Z%XO:--EMK:PQI;Z'XMVF6
M+%IFN"YTH6=SHGU649MA:V%>29TY3P%1KZKB=ZF JWLG&34G&E=[V:IIRC*,
MJ4Y*/]*^%_B;PYFO#E3P@\776Q'!6-JPEPYQ$FI8_@C,W*2HUJ-><:DZ>6>T
MJ2?,HU(8-5*]&O1K9;BJ].A^L]M<V]Y;P7=I/#=6EU#%<VMU;2I/;W-O.BRP
MSP31,T<T,T;+)%+&S)(C*Z,5()FK^2G]AS_@I;\3OV'_ !#=_LR?M5^&_%U_
M\//"VKCP^EOJ$,I\>_!>X29%FM;>QNSYGB#P4D4JWD6B0W GLK)TO_"=Q>V4
MD&C7W]4W@+X@>"?BCX2T7QW\._%&B^,O"'B&TCO='\0:!?0W^GW<,B@LGF1,
M7M[NW<F"]L+I(+[3[I);.^MK>ZAEA3S,VR7%Y152JI5<-4UPV,IZT:\&E*+3
M3DH3Y6FX2=]W!SA:;_/O%'PCXF\+LRA3S&$<RX>S"7M.'^*L!'VF4YSA*D%6
MH2A5ISJPPV+=&2G5P56HY:2JX:IBL(Z6*J]A1117D'Y6? 7[6?[".G_M@?$/
MP-JWQ ^+7C30_A9X1\+ZUIL_PT\+165I+<^++][Y;/QGIVN:A_:.GV6I107M
MM!<KJ'AG6 UOHEI:6S00:GJ1KYQ\3_#;XQ^%=*\+^ _VG?V0+#]K[PG\,;1-
M'^'O[1W[-VLZ!X!^,>F>$K?S-*T+1[SX<#Q!\/?%WA_Q"EG'%<:W'\-O'!\&
M+#/9L@DO-.GO)OV+HKTJ.:8BE3I49*%6E135&+YZ,Z+;DY3I5L-.C6C.7,U-
MRG.-1<OM83Y(<N? F!R+P]S_ (IXGR'(, L^XSQ^#S+B#.ZN)S>GGM?%8# 1
MRO!+!Y_@LSPF=9;@<+@%4H4<DP6.I9!&5:MB)Y5/$3]JOQ3M/A+XI\;0>(=%
M^ 7_  3GL?!$?CCP_J?A34_C?^W=\16\1:QHFERV^=3TM?!:>,_BY\7Y;>]9
MO)T671_$VB:3+?P:;>7=Q#;V(-I]*_L*_P#!/S3/V+M3^(FN3?$&T^)VN>-]
M,\+Z)9ZQ)X"L?"E_H.D:(VI7^JV-K=OKWB?4EL=?UK48KVXTJWU.WL%_L?2Y
MKQ-2OH8;FT_1>BJKYOBJU&KAXM4Z-915://5KU*W)*,H.I6Q-2M43BXK2E*E
M3>MX:FW&-#)^->*N'>-LSR3#4N*N%\+F. RSB&CF7$-?.ZN79KAWAL7E>:YG
MF.<XW%9KD\H-5Z61XR<\CPV80I9KALMHYG2I8N#)(XYHWBE1)8I4:.2.15>.
M2-U*NCHP*NCJ2K*P*LI(((->:6/P4^#FE^+[+X@:7\*?ASI?CO35O5L?&6F>
M"O#FG^*+5=1M)["^6+7K/3H=35;NRNKFTG7[21);W$\3 I-(&].HKS8SG%24
M9RBI)QDHR:4HO1J235TUHT]&>?B\LRW'SPM7'Y?@<;4P6(I8K!5,7A*&)GA,
M51G&K1Q.%G6ISEA\12J0A4I5J3A4ISC&<)*44U^'NC_#[X@Q?!"[^!?PNU+4
M--_:F_8#^+?BG7O!>BVVI2:5JGQ)^$_B[5]:UGP_KNGVZWEC%>:#XI\(>*(;
M5O#8UR2VU#4_"J^$?$\]I8>)A!+^B_@/]L?X#>)O 7ASQ5XE^)_P]\':_>V5
MA;^+/!VI>*8;76_!/BQK!)]:\,:]I.LVVC>(=+N=%O?.T^>;6=#TM7F2%0H:
MZMA-K_';]G#3?BYJGAGQ_P"%/%^L_"#XX^ XY+?P3\7_  I:6M[J=KI-S<"Z
MO?"7B[0+V2'2O'G@:^N ;J?PMKK_ &>"\:>?3[JR34-8AU/Y4\=?##]HKQ!Y
M7_"[OV-OV1_VM-9LTCM=*\=:)XN@^'&O&P@C>W)UK3_B'X!\3207]\L%O=7%
MIH/B1=%M97$=M$R1QBV]N53#8^$/:RC&I[2I5FO:TJ%6$ZS4JZA/$.&'JX>I
M5O6IQ=6G5H2G5I\LX.,I?RQA<DXX\'\?CJ7#^ Q>,RQY/E>0Y=B?[!X@XMX;
MS/*>'*?U#A3$9CEW!T,SXTR#C#).'EA^&,YQ-#A_.,AXKP66Y+F\<=E6.IX[
M 82S^T5^UQI'Q'M;7X&_LQ:K=^.OBOXOO;.*U;2O#<=_H+:>/M8,D^HZ[;;+
M7P]9:HFEZEXJ\;V.FW.B:#X8M-:AT_Q-IWCJ?PU8W.Q\-O#>FWG[6'PF^&/A
M>]36_"/[#/[+R>!]8URS946U^)/Q+A\)>&M+\,ZDK$M/=-\/?AW+XBNHK>2X
MBT^>^LX+J9+R22%*7@[X3?M33:3<^&OA?\*/V9/V$/"&O0/;:_JO@F&#XJ?%
MN I"FR[TJ/0/#G@3X?37EPRM;?VEKE]K%WIL<AN;6&>ZMX)6^T_@S\&/!GP*
M\&GP;X,_MF\2]UG5/%'B;Q-XHU6;7_&/CCQCKLD<NO\ C+QEK]PD<VM>)=:E
MAA:^OFB@B$<%M:6EM:V5K;6T45JN&PU!TJ#BY.-6,8QJPK5'*M!4JM;$5:4?
M86C1=2E1HTIU6G5G.<TE&,_1X8X?XWX[XJPW$?%=+&4L#3Q^19AC<5B<DS7A
M;*J>"X8QTL]R/AKA3ASB/$OBMU\1Q11R?B#BCB3B+*LCHUZ.29;E.5996Q%7
M&XW+O6****\4_J0*^-OVSOVV/A1^QA\.I?%'C:]BU?QKK5M>Q?#SX<6%S&NO
M>+M5@CVB61/G?2O#-A/) =<\17$1M[*)UMK2.^U:YL--N_%OV[/^"FWPA_8Y
ML+CPII@M/B9\<;RTD;3?A_I6HQ"Q\,--"YL]5^(FIV[2OHMGN,<\&@0*WB/5
MX6B,4&FZ==#7+?\ "K]E?]D3]H'_ (*F?&C5_P!H3]H3Q'K]E\*FU?9XD\;2
M1?8Y_$,>GSR>5\.OA/83QR6&GZ7I@:2QN=0MX)='\-*]P\B:KX@EFM+CZ?*<
MBA.B\USB3PF4TDIIRO&MC'?W:5"/Q\LVK<Z7-.]J5_>G3_HKPQ\&<+B\JGXD
M^*F)J\+>&66QAB8RK<U#-.+*MVZ&79/A],2\/BI1Y'BJ4/:XJ+=++>9NMC<#
M4_93_9K^-/\ P5;_ &CO%'QU^/.M:K'\+M,UJ"3QWXDMQ+96]S%;E;C2/A#\
M-H7,L6G06MA+''<S0M,OAW2)GU;49KWQ%J]F=6_KP\(^$?#/@+PQH/@OP9H>
MG>&O"GAC2[/1= T'2;=+73M*TNPA6"UM+6%/NI'&HW.Y>6:0O--))-([MC_#
M7X9^!/@_X)T#X=?#3PQI?A#P9X9LUL='T/283%;P1@EY9YY7:2YOM0O)F>ZU
M'4KZ:XO]1O)9KR]N9[F:25NZKBSK.:F:UH1A#ZO@,-%4\%A(V4*5-)14I*/N
MNI))7MI"-H1NDY2^3\7?%?&^)>:X6C@\*LBX+X?I1P'"?"^'5.EALMP-*$:,
M,17I4+4)8^O2IP4W#FI86BH8/#RE3ISJURBBBO%/R$**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O$/C]^SG
M\'_VF_ EW\//C)X/L/%.B2>=/I=XP^S:]X8U26![>/7/"^MQ+]MT;5H%;B6!
MVMKR(&RU.UO].EN+.;V^BKI5:E&I"K1G.E5IR4H5(2<9PDMG&46FFNZ9V9?F
M./RG&X7,LKQN*R[,,%6CB,)C<%7J8;%8:M!WA5H5Z,H5*<X])0DG9M/1M'\A
M_P ?/^"<O[87_!/WQA+\<_V8_&/BOQEX-T%I9X?&?@&"6W\>^&-+E=I)['QW
MX*MA?0ZYX?CAB0:KJ-I;:QX9NH(7N]?TK0[8I;#[A_9'_P""YG@CQ):Z7X._
M:TT0^"/$@,-FOQ3\(:;=7_@O4^(H4N_$OARV>\UOPW=R,3)=W.BPZUH\LC23
MK9Z#9HL"_P!!]?F7^U-_P2B_98_:8?4_$-KX?;X/?$N_:6X?QQ\.;6TL;74K
MZ0J6N?$_@UA%X?UPRN'FO+NTCT37[Z:1I+C7F)(/UM//<OS6G'#\1X5RJ12A
M2S3"1C#$P7_3Z"5IQ6K?+&<-=,/S/F/Z@P7C3P/XEX##9%X]\.SQ..P]..&R
M_P 2.&*%'"<08.&R>9X6C3Y,51@Y3J26'H8G#7=X9)*NY8A_H1X)\>>"OB5X
M;T_QA\/O%GA[QKX6U6,2:?X@\,:O8ZUI-T"J.R)>Z?-/")X@ZK<6SLMQ;R$Q
M3Q1R H.LK^07Q1^P1_P4L_8,\1:IXO\ V>]<\7>*_#$;&>?Q+\#M3N;Y]4M+
M<"6"/Q=\);MI]2U62)4:26T;P_XMT:U:+/\ :3DQ%_9?@M_P7;^,O@:[/A;]
MIGX1:9XW?3I6L;_7?"JR?#WQQ93PX$S:UX:OX+SP]J-\LBO&]I90>#(XMZE@
M6B9)HJ\*U:\'7R7&X7-:&ZC"I"EB8)ZJ-2G.2BI):-2G";?_ "[5TCBS/Z-&
M99OA:V=>$?%W#GB9DB2J1PV#Q^&R[B+"0FN:-''9?BJL<-3K4XNTH5L5@\74
MDKQR^G*:IK^I6BORY^%'_!8C]AKXG_9;;4?B#K7PJU>Y"!=+^*/AF^T>%)#@
M.)/$>A/XC\)6\:,<"2]U^TWK\P48<+]\>#/C;\&?B/Y/_"O?BU\,_'1GV^2O
M@_QWX7\2O(6Z!(]&U2\<L>FW;N!R" 017SV)R['X1M8K!XFA;K4HU(Q?G&;C
MR27G&37F?AF?<!\:\+U)T^(N%.(,G<+WJ8_*<;0P\DMYTL5*C]6K4T]/:4:L
MZ=].:Z/3J***XSY,***Y7Q1XZ\$>"+87OC3QCX5\(690R"[\4>(=(T"V,:DA
MG$^K7EI$44@@MOV@@Y/!IQC*348Q<I/913;?HE=LUHT:V(J1HX>C5KUINT*5
M&G.K4F^T804I2?DDV=517P'\4_\ @J#^PW\)DF35OCUX7\7:E&&\K2/A@MW\
M1[BYD4$F%=2\*0:CX<M91@J?[3URP17_ ';.'^6OR\^-O_!?O28[6[T[]G;X
M)7]U?,94M?%?Q?OX+.RM]H*I*/!7A'4+NXOED8B5#+XUTQHD15DMI&F98/8P
MG#V<XUKV. KQ@_\ EY7C]7IV_F4ZW(I)?W.9]$F]#]4X7\"_%CB^=+^R>"<Y
MI8:LU;,,WP_]B8!4WO6CB<U>$CB*<5J_JBQ$Y6<80G/W3^CFXN+>TMY[N[GA
MM;6UAEN+FYN)4AM[>WA1I)IYYI&6.*&&-6DEED94C16=V"@D?DE^U5_P6,_9
MG^ L6J^&_AM?+\>?B3;)<6T.G^#KV(> ]*U!!+&O]O>.@LUA=Q0S(#+:^%(=
M?G<J;:XFTUV\^/\ %M]#_P""K_\ P4H*#4T\?O\ ##5YXY?^)KY7PB^"L5F<
M&&Y33_+TF/QI;VF\".XM;'QIK49D=M\A\YE_5']ES_@A_P# WX8_V?XF_:%U
MF3XX^,(?+N/^$9MEO-!^&&FW*[F\M[*.6+7O%ODOL*S:O=:9I5V@:.\\,R(Q
M%>PLGR7*/?SK,(XS$1LUEN7/G?,K-QKUKQ<5T<9/#O2\9RV/U:GX5>$/A:OK
MGB]QQA^*L\H.\> . JSQ4W6A9NAFV9N6&JX>+O:=*M+(YKEYJ.)Q2?LW^3NG
M>&_^"@?_  5[\>KJVJW%S9_"[2M69XM1O8]0\+? OP KN+>Y@\.V&;J;Q5XD
MMH"T<JV[^)/%922--8U.QTR2.>'^B_\ 8J_X)X_!']C#0HKKP_9Q^-OBU?6<
MMMXC^+>O:=##K=Q#<[#<:3X9L/.O(?"7AYC&N^PL;F>_U#:C:UJNJ>3:+:_<
MFAZ#H?AC2-.\/>&M&TKP]H&D6L=EI.AZ'IUGI.D:790C$5IIVFV$-O965K$"
M1';VT$42#A4%:M>?F?$.(QU)8+"TJ>79;#2&#PR45.*V]O.*BZC;U<4HP<G>
M49S2F?"^(OCMGW&.6QX3X=R_!\">'V%7LL)PKD*C0CB:$6W%YQBZ-.A+'2G)
MNK4P].G0P<ZKC5KT<3B::Q3****^>/PH**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#\O?\ @C%_RC5_9N_[K#_ZOOXI5^H5?E[_ ,$8O^4:O[-W
M_=8?_5]_%*OU"JI_'+_%+\V 4445(!1110 4444 %%%% !1110 4444 %%%%
M %'5-+TS6]-O]'UK3K'5](U2TN+#4]*U2TM[_3=1L+N)H+JRO[&[CEM;NTN8
M7>&XMKB*2&:)VCD1D8@_S>_MS_\ !&35=+U*Z^,G[$T5S!<VU[)KVJ?!M=5^
MP7^D7=M(U^FJ?"K6[FX@=&M[B-9K?PI?7L=W:S*H\-:E*?L.@P?TH45Z669M
MC<IK>VPE2RE95:,[RH5HJ]HU:=U>UWRRBXSC=\LDFT_T'P[\3N+O#'-WFG#&
M/Y*5?EAF648M3Q&3YO0CS)4<PP:G!3<5*:HXFE.CB\/SS5&O"-2I&?\ +/\
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M5C;PO\4Y8_AYK,%PZJR6BW.OS0^'=3N'W!8UT+7M6CDES#'(TH*#Q\=P[F^
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M[ZC\3?%-Q<,]N;3P+X5@BU!?#L=Z6VV5]/%J/BN=)(IK.U\,:C%MKQGX6_\
M!-?]O#]NKQ/:_%7]I?Q?XD\!^']4\N8^*OB[)?ZGXUN-,F,,GV?PA\-?/L9M
M%L3$RO:V>IGP;HRQA9;"*Y0"-OZ$_P!DS]@#]G7]CW3XY_AWX9;7/'TUJUOJ
MWQ3\8+9ZKXVO$GB2.\M--NTM;>T\,Z/<%2'TK0+:R2YB$2ZM/JMQ"+IO85#A
M_(/?Q-6&>9E#X<-1LL#0J+_G[-\T:O*]&I*;Z2P\'[R_5Z63^!W@E?$Y_F.&
M\9/$##).AD&6<L>#,HQD=?\ A0Q<UB*&/E1J*4)QK+%SNDJN2X6IRUX?CM^P
MW_P1I\1>*M6MOC3^VT-3A^U:F=?LO@]<ZF;SQ!XHN[N1[Z;5OBIKT%W<75I'
M>74WVJY\-VEX==U"=Y/^$BU#3"EWI%]_2AHVBZ/X<TG3M!\/:3IFA:'I%I!8
M:3HVC6%KI>DZ986R".VLM.TZQB@L[*TMXU6."VMH8H8D 2-%4 5IT5\_FF;X
MW-JWM<747+&ZHT*:<:%"+^S3A=ZNRYIR<IRLDY-))?AOB-XH\7>*&:QS+B;'
M)X?#<T,KR;!1EA\GRBA*R=+ X-SG:<HQBJN*KSK8NNHPC4KRITZ5.F4445YA
M^=A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5X1\8/V8/V>OC]$%^,7P>\">/;I8O(AU
MG6-"MD\36D&S9Y%CXJL!9^);"$J%S%9:K!&3'$Q7=%&4]WHK2E5JT9JI1J5*
M52/PSI3E3FO246I+Y,[<OS+,<IQ5/'95C\;EF-HW=+&9?BJ^"Q5)O=T\1AJE
M.M"]E?EFKGXD_%;_ ((3?LJ^+S<7?PR\5_$CX07\A?R+*'4K?QYX6MPQ)4'3
M?$RKXFF,9P%+>-%RF0X9R)!\+^,_^#?WXRV!F/P\^/WPT\4A-Q@'C#PYXH\"
M22@<J'&C'XA)$YZ#$DB@]7 Y']3U%>]A^*L^PR48XZ=6*^SB*=*NWZU*D'6?
M_@P_:\B^DOXTY#3A0I<9XG,\/"W[K/<%E^<5)V_Y^8[&86IF<M-'_MVMVWK9
MK^1E/^"6G_!4WP8HM/"?C61K:T_=VP\(?M :IHUML0_*;6+4+WP\T49ZHKPP
M,.Z*:7_AB[_@MK8_\2^S\5_'0V4GRNUE^UYI,%CM'3?;R_%ZUF9?0"U<CT%?
MURT5U_ZY9C+^)@\JJOO4P<V[]]*\=3ZC_B;#CNKKC>$O#+,I[NICN%L54FY[
M\[=+.:*YV_>O:U];'\C?_#M[_@KCXFX\0>,_%<8D^_\ \)'^TK/J0YZ^9]A\
M4:SN]\;\^]=%X7_X(.?M2>)[DZE\2/B_\)?#<MXXDNI+;4/&/CC7@Q #-=K-
MH&A6,TP P#'KMPK  &5>W]85%*7&>;I-488'#7ZT,*DU\JDZD?O3,ZOTL_%*
M-.5/*L+P9P^YKE=7)N&J=.:BMH\N.Q>/I-)ZI2I25S\!/AC_ ,$!?@SHEQ#=
M?%KXW^/OB!Y960Z9X/T'1OAUITK<%K>[FOKOQWJ=Q;YRI>RO-)N)  ZO!DI7
MZ9?!W_@GW^QS\"I[+4/A_P# ?P6FNV!62U\3^*K>Z\=>)+>Z&"U[9:OXRN=<
MN=)NW(/[S1CIR1H[PP1Q0,8C]DT5Y&+SS-\:FL3F&(G%JTJ<)JC2DO[U*@J=
M-_.+/R_B;QE\4N+XU*6?\;Y[B<-63C5P6%Q,<IRZK%JSC5R[*(8' U59M6J8
M>6C?=A1117E'YF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% 'Y>_\$8O^4:O[-W_=8?\ U??Q2K]0J_+W_@C%_P HU?V;O^ZP_P#J
M^_BE7ZA54_CE_BE^; ****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /GCXW_ +)W[.?[1MI);_&7X1>#O&EXT!MH?$5QIW]F>,;&'RQ&L>G>
M,M%?3O%%C$H6,BWMM6CMF:*$R0R") OX]?%[_@@/\,-9FO=0^"7QK\5^!I)&
M::U\.^/-$L?&^D*S8Q9P:UI=SX8U>PM%.3'/>6OB&[50$E-PQ,H_H,HKU,%G
M6:9<E'"8VM3@MJ4FJM%>E*JITU?JXQ3\S]'X0\7?$C@2,*7"_%V;8#!P:Y<M
MJU*>8Y5%7NU#+,RIXO TG-:2G1H4ZC5O?346OY%;G_@E]_P5$_9MO[FX^!/B
MV^U2SWO.]_\  [XV7G@E[B($$?;]'\2ZE\/[J[F=,+<64-OJL;LKQ(]U%M>1
M/^&A_P#@MG\""%\1:1\>M2TJTXN)?%/P9TWXC:,P0]+GQ;;^$=9F0L%8AHO$
M<+RJ&<,X4L/ZZZ*]G_6VK6TS#*LJQ[ZSJX91JR\W)NI%/SC"/D?K7_$T&9YL
ME'CCPT\,^-'RJ-7%X_A^-',:UE;FGB:M3'4(5/Y94,'24/LQ/Y&_^'PW_!1O
MPUQX@\!>#)/+^_\ \)%\&_%6F].#O^Q:YHVWGKC;CMBC_A^7^W!JN;+3?AW\
M#5NXOW<ATSX>_$.ZO-YZ>9#<?$J^B63D846R#I\O-?UR44?ZP9,]9<+8)OIR
MXAP7SBL*T_3YB_XCAX3S]^M]&_A&55?"Z&?RPU*_]ZA#AV49+R;T[G\C#_\
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M  1B_P"4:O[-W_=8?_5]_%*OU"JI_'+_ !2_-@%%%%2 4444 %%%% !1110
M4444 %%%% !1110 5D:[X?T'Q3I-[H/B;1-(\1Z'J41@U'1==TVSU?2;^ D$
MPWNG:A#<6=U$2 3'/#(A(!QQ6O133:::;33333LTUJFFM4T]F7"I.E.%2E.=
M.I3E&=.I"3A.$XM2C.$XM2C*,DG&46FFDTTT?DY\=?\ @C/^QO\ %^2YU7PK
MH.N? [Q'.6E-W\,KZ&'PW/.Q;'VOP7K=OJFB6UJJM@6OAD>&1N2-C*0)%E_+
M7XD?\$(/VB?!%Z==^!GQF\%>.9-.F-UIT>K)K7PO\7Q.N3"-.GM9?$VC&[CS
ML-S/XBT9'YE41;O)7^JVBO?P?$^=8-*$<9*O26GLL5&.(BU_*YS3K*-M+1JQ
M5M%T/VWA;Z1GB]PI2IX7#<5XC.,OIQY/[/XDH4<\HSII65)XK&1EF=.BHW@J
M5#'TH*'NJ*2C;^1%? __  7%^ :JEE/^TAJMG8*!:PZ=XMT;X[V"P1<1):Z4
MNK_$!5@V*/+LS8(R)B-K:,@QB=/^"G/_  5=\ @Z?XT\&ZM=7MH=MT_CK]G:
M\T&_W  $74&C:+X3@A;()(2T@P2>   /ZYZ*[?\ 6?#UM<9P_E&(EUG3I*A)
M_P#;THUI?+FWU/L7](S),TO/BWP-\+L\Q+UEBL%ED<HQ$I/XG*O6H9OB&I:M
MKVUN:TMTC^1K_A^/^W)HO^C:M\//@@UP_P"[0ZQ\._B#97 D/ V1VWQ'TY#)
MD'"F%@3G*'I2_P##X[_@HIXFX\/^ ? J>9_J_P#A'/@_XMU(\]/+^V^(=9W=
M>-V_/?-?UR44?V_DRUCPM@N;O+$N4?\ P%X6WXB_XCAX3P]^E]&_A%5GJY5L
M_E7HW\L/+AV,(KR4K,_D4/[3G_!:SXZDQ^%]$^..G:5<DK$_@[X':?X(TB-G
MR"(_%]UX.L;I2!CB;Q*_E@!P$)9V8G_!-3_@JI^TM=VQ^.'B;6]/TN22.:*\
M^./QOF\4V=K'NWEK3P[X<U?QY?Z?)&=QBLWTC30),9\E&\T?UW44?ZV5*'_(
MORG*<"^DX8;FJQ\U.+I)ONY0=^Q7_$SV.RA-<#^%_AEP;))JEB\'D"Q&8T7;
M2<,51GE]*57JYU\+6YOM1;U/YY/A'_P0#\ :9)9W_P </CEXE\6,CI-<^'/A
MSH-CX1T_*8)M)?$6O2^)=0OK65AB:6VT70;LPLT<$EO+MN5_8;X&?L>_LU?L
MW6\*?!WX0^$O"NIQPK!)XIDLWUOQI=+L*2?:?&&O2ZEXB:.8M(\EI'J,5BK2
M.(;6*/"+]*T5X^-SO-<Q3CB\;6J4WO2BU2HM=G2I*%.5NCE&3\[MGY/QAXP^
M)?'<)T>)N+LUQN"J7Y\LP\Z>695)7]V-3+<LIX3!U^1:1GB*-:HE=N;<I-E%
M%%>4?FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH:GKNN7$$?F7*Z'X7\/V.K^)=82U5HENYM-TFZAM)+BTAN)(I;RU2;A/@/\
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MOKMFN;B1CY.?Y1@/J/\ :N60ITZ<9X>3^K1Q<,%CL#BZN.PU#,L-AL?4KXS
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MV"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,)3H8U4ECL)E^$Q689C5GF%*E&*P>+S#,<P4L/E]1_6L#@,!3^NQ5;%Q:[^
M<#C<]X@K<88JG@E0G5S#,JV,RMXB649CG699=DN28>CDF)KSD\TRW)<CR5PQ
MN=45_9V;YQF]?^RJCPV6S3Z.BOPJ_;;_ &Q/CKX2_:_\0_ OPK^U7\*?V+/
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M3[OXB>/_  5X"M=6NC8Z5<^-/%6A>%K?4[U0C-9Z?-KE_8QWMTJR(3;VS23
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MB<VR[#T\'EM3%XG$5L5"EAZ56<:BA^BM%?G;XA_;W?X:^%?VF%^,'PD;P_\
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M?4L-[2G7A.K4A6IS]ES0JQJ5Z]2-2+4XSK59*2E4FV4445RGH!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!^7O\ P1B_Y1J_LW?]UA_]7W\4J_3/
M5;FZLM+U*\LK1[^\M+"\N;2QCYDO;J"WDEM[2,;E^>YE1(4^9?F<?,.H_,S_
M ((Q?\HU?V;O^ZP_^K[^*5?J%52^.6E_>>G?78BI%SA.$9RIRE"48U(I.4')
M-*<5).+E%OF2DFFUJFM#\+/ =IX)U+X&?\$Q/AAXYTNY\;?#7XD7WCSQ)XOT
MB35;NVTK6O'&OZA;Z=81>(/(N;2;4DT_QG\6-7U5].8RPW%SI,T,B20!MW[G
MQ116\44$$4<,$,:10PQ(L<444:A(XHHT"I''&BA$1 %50%4  "OQ#E^"&OZY
M\,_%W[*WA>&+3/CW^Q1\8-1^,/[.UOJ-U9VFI^._@WXNU_6_$'@_6=(U:\G&
MFS:I9S:U>::^JQV$^B>&/'OA/P59>(K=/M-Y;R?4FC_\%'_A=IFGZAHGQ)T3
MQ'X/^)/ACPEIMWKOA[Q%'X7^'LOB#QUY.E1:QX0\(^&O'WC/2?&GVF"]U":2
MWO-2T5?#MQ;:?J,.C^)_$$\%@VK^]F&'JXMQ>&YJSC6Q4Y4U*[Y,57>)H8A0
MORVK4:]-.:2NZ?)+^&[?QUX.<8Y#X>4<7AN.)X'AFEC^'. \MRS-<3A^6E_:
M7 ?!^%X'XNX+GF*P_P!9EBN%^)>%LVQ%+*L14FH4\ZACL+3C/.4L1U7_  4H
MN?$MI^R-\1KGPW'<2M:QPW^K^181WWV;3M+MK[5;74WD?3M0?33HGB&QT+6[
M75(7TZ6UO].LU&HQ1RR07-;PK<ZK_P /"RUQ UC-X@_80\(:UXQM((!;0S>)
M;'XRZI9Z7<:A&H(:^M;6]U[3[)Y7DF2SAFM@YAMT"^$:IXK^(_[15Q/\7_VA
M4U#]GG]BWX=6]MXFU?1-:U'4=+M_BK;:3JVB:YH$&IZ=JFDZ#XNUK2]:UNST
MF6Y74_".E1ZE''8^!OAYIWB2X\1ZOXJU'Z<_9*T'Q3XRUGXI_M6>/=%O/#6M
M?'^[\.6_P_\ !VJI(-6\$_!#P-:7EAX!M-4@N$=])\0>,IM0U;QUXDTRRO;O
M3Q+K.ED-#<PS6=I$H?5<!.G4=-SA&O"?(U)>VQ4L)RX=S5XSJT:="=:KR<T:
M?+2@Y*4XH]3"9B^/_%K+<[R6.<T<MS+%\(YCE\,SHUL%7?"W -#CRIC>,:66
MXF,,7E^0<29OQ7EG#/#SQJP>*SQXC/\ ,L-@JF!R_&5']4>-?A]X"^).D1^'
M_B+X(\(>/M!BOH=3BT3QKX:T;Q5I$6I6T5Q!;ZA'INNV5_9)?0075U##=K")
MXHKFXC214FD#?AY^P3^S/X"^-/[*O[5&F6GA7P-HOQ-OOC9\:O 7@/XGW'A#
M1)_$_@>WNO /@BVTNRTCQ"FG/K^D:!;SZK?Q7&GZ->6JI8ZIJR6D:2WDI?\
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M#>>+- O;#7?AY-9Z!IFJOMGTJSNW\3:G:W.GVQACU*/5X%N8IXK+18[#W?\
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M-L33IJC2Q&<9[F^*QV<YOB*-%*A1K9ECL54HT(QH4I0I1C!%%%%8GT84444
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M<8\95I.CA^%.&*7U_'1Q'V:6/K4HU:>!DVO>H*&)Q\8M5%@94VIG]'?[2_\
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M]@]#"?1;\/JU58SBW,N+N.<RE9U\9Q!Q#B[U)?:4'@7A<7"G)J[C4QM>I?\
MY>[6_G"T3_@W#^"4$,*^(_VD/BGJMPJ@7$NB>%?"7A^&5\G+0P7[^)7@4C&%
M>YN2#D[SG [^#_@W5_9!6W9;KXO?M)371'RS0>(/AA;6X/<M;2?"NZD8>PNU
M(]37[_45X53Q2X_JN\N)L:G>_P"[IX.BK_X:6&@DO)*WD?7T/H]^#6'BHT^
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M_@C%_P HU?V;O^ZP_P#J^_BE7ZA54_CE_BE^; ****D HHHH **** "BBB@
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M8/'9I@,=A*5>O2HXB>'QWUG#SG&=?"4Z+E4C/"_B3A<]Q.'PN+P^ H?7<3/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _+W_@C%_P HU?V;O^ZP_P#J
M^_BE7ZA5^7O_  1B_P"4:O[-W_=8?_5]_%*OU"JI_'+_ !2_-@%%%%2 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMM&E\?>&_#T@MKW[+%I7BS2O&/PMN?$"3+'#K_CG2M0D2P6"?;]^_LC?MP^
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M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!^7O_  1B_P"4:O[-W_=8?_5]_%*OU"K\O?\ @C%_RC5_9N_[K#_ZOOXI
M5^H55/XY?XI?FP"BBBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\%_:<_:#\&?LL_
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MXY(Y$)22.1"&1U)5E(9200:DK\3VW/ZM335T[IZIK9KN%%%% !1110 4444
M%%%% !1110 4444 ?E[_ ,$8O^4:O[-W_=8?_5]_%*OU"K\O?^",7_*-7]F[
M_NL/_J^_BE7ZA54_CE_BE^; ****D HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /R]_X(Q?\HU?V;O^ZP_^K[^*5?J%
M7Y>_\$8O^4:O[-W_ '6'_P!7W\4J_4*JG\<O\4OS8!1114@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <;\1?'?A[X7> /&WQ)\6W:V/A?P#X4\0>,?$%V613!H_AO2KK
M5]09/,9%:8VUI(L,98&68I&N6< _Q[_\$D/A_KG[:O\ P4B\;_M/_$FR34;/
MP!J_B;X\Z\DQ>?3XOB'XMUJ\@^'FC0,(T,2:!?W=]XB\/HJV\-LG@6UA6,01
MK:O^RW_!>#XSS?#']AN_\%Z9?M::S\</'WAGP T<#;+M_#.G"[\:>)9E;@K9
MRCPWIFA:AL.^6#7UMF5H)YBM#_@@Q\#;;X9_L40_$NZLS#XC^/GC37O%MS<3
M*J7/_"+>%+VZ\$^%; J%5A:)/I/B'7;,R;GD3Q'),K&"2%5_9.&W_JQX8<3\
M1*\,PXGQE/AC+:FTX810G/&U*<E:4?:TWC8MQUC5PE&2:9_+W',/]?\ Z0'
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MXZG.-/#U8PHSP]3VOM*?]2U%?SZ?\$M?C1\(OV;O%'[>'[,=M\5O#/C3X&_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R]_X(Q?\ *-7]F[_N
ML/\ ZOOXI5^H5?E[_P $8O\ E&K^S=_W6'_U??Q2K]0JJ?QR_P 4OS8!1114
M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y>_\
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M-=FUNTE\+:TWQ(U/6D$NIW7]@2Z7>Z1"3I>EV?BF^O+/5)HM,L)>#_X*Z?\
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M_'.R\;W_ (,/AD6NH?VDEO!X!U#3=<&NF].EFQDDN#IZVHU 7$;3-;E?R_\
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M^+'Q5^&_POL]2>2/3KOXB>.?#'@JVOWB*"5+*?Q+JFF173QF2,2+ \A0R(&
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ME:D?8-3\4_"'Q+>"/<)!JMJGC+P5;F0 >6(&TCQ[)M<L)3= QB,QR>;^U/\
MP3L^+_\ PO3]B7]F_P"(<UT+S5+CX:Z1X7\0W!??--XF\ -/X#\17-R"2\<]
M]J_AR[U H^,I=QR)F*2-FX3_ (*H? &X_:+_ &'/C7X0TJU>[\5>%=%B^*/@
MZ&)%DGGUWX>2-K]Q86L9!,EWK?AV'7O#]HBLC&YU:([L JWY<_\ !NQ^T*-:
M^'OQC_9CUB\WZAX(UFW^*W@J"5D,K^&?%'V70O%MG;J"&%IHOB.ST74'W(Q-
MUXQF_>;=D:?L=1?ZQ>#M"4+5,;P1GLX58[U(Y5F<I24[;\CQ&*IQ3^S3P52Z
M4877\P4I+@GZ3V+A5O1ROQ8X1HU,-+X*$^(LAA"FZ;;:C[58++J\I*UYU\UH
MV;G5:E_2G1117XX?T^%%%% !1110 4444 ?GYXB_X)^>&-!\7>)/B+^RY\9/
MBQ^R'XR\67T^M^)=)^%=WH&N_!KQ5XHN95,_BCQ3\$?'>CZ_X,N]8>V7[()/
M#X\+PE0)IHIKA[B2?)N?V#_B#\3(4T_]J']MG]HOXW>&%E2&\^'_ (/C\#_L
MY> ?%6BN)/MN@^/-.^#?A_1O$OB>POC)MF\KQ;I#B$"'YML3Q?HS17OQXHSR
M,87QD)UJ<8PI8ZM@L!7S2E&"4:<:.;UL+4S.DJ<4HTU3Q<?9Q24.5)(^-GX?
M\)3G4MEE6EA:TZE6OE&&S7.,)P]B:E:3G6GB>&L+F%'(,3*O.4IUW7RVHZ\Y
M2G5YY2;?"_#;X8_#WX.^#-%^'GPM\&^'_ ?@KP];+:Z3X<\-:=!INGVZA5$M
MS*D*B2]U&\=?M&I:M?R7.J:K>/+?:E>75Y--._=445X=6K4K5*E:M4G5JU9R
MJ5:M6<JE2I.;<I3J3FW*<Y2;<I2;<FVVVSZVAAZ&%H4<-A:-+#8;#TX4:&'H
M4X4:%"C3BH4Z5&E3C&G3ITX)1A3A&,812C%))(****@U"OSXU[_@H3X0\1>(
M=9\$_LL_![XO_M?^*]%U*XT'4M:^%&BV&B_!+0_$=E,GVS0_$GQ\\<WV@?#Z
MUN([+S+J"X\/7/BJSN)?)L_/BE>=K7DOVQ]6U7X[?'+X;_L-6/BB_P#!'PRU
MCX;Z_P#M$?M;>)]/U)O#NI7GP#\.:]'X6T'X<:9XFBO;:?2=/^)?C&+4M.\>
MW5M)IM];>"]&O5M]1GTV\US3KCP7]GS3/BS^V'J-I#\,;K6OV4?^"=/PXEU'
MP=\// OPEO+SX8_$+XPZ7#8S7.E^)8_%&EZ/;^)-#\.:Z=2T[Q+/+X6UWP[]
MGM]0N-$U"^\7>,KKQ%J?@O[K*>'\!2RYYMF[A.*P\,;[&O7JX?!8?#5:F(HX
M2.)6&2QV.Q^9U,+7>"RW"5< HX:G'&XG,J-&K"*_(>).-,WQ&>1X;X;56C-X
MZIE7UK"83#8W-,;CL/0P>*S.I@7CV\HRC)L@H8_!QS7/LSP^;RGF%:>58#(L
M3B<-4G/Z3/[8O[57A%9=9^+W_!-GXZZ)X/C*P_;_ (.?%#X,_M!^,4NY YB\
MWX=>$O$6C:[)I^U&,]_IDVIM;D!'M3)+;I-]7_ 7]HCX0_M+>![?Q]\'_&%C
MXETH2-9:WI39L/%7@S7(7EBO/#/CCPO=^7K/A3Q%93P3)+INKVMNUS"D>HZ=
M)?:5=65_<_GQ??L _M+_  OU^V\1_LT?MD?$2"1M;AGN='^-'CGXH^-K'[!_
M:5N\5UKL/B3Q/\0O"7C-;#2OMEIJ/A^V\ >!-2\3EK=--^(?@"6,W]>3ZE\1
M(M)\0_ C]OGP_P"%/#_PS^)NC?'O2/V.?^"@OA_PK-GP%XAT?Q;K^G^"?^$^
MUC5[9YK;7-/\$>+]5\"^._AEXQ*3ZYJW@OQIHVA:]KUW965MID797R7(LWH7
MR=X*%>;5+#SRZ6:4H1QDJ-:IA\#F.69SBLPQ5/\ M*I1GAL%F&#S&I0IXMT:
M.)PL(8FG5AY>$XJXPX:Q:7%"S2K@Z477QM'/(</XBM/+(8G"T<;F^29]PME^
M2Y?7_L.CBX8_-<ES/(Z&,K9;'$XK 8^I5P%?#5?W+HHHK\Y/W(**** "HY98
MH(I)YY(X888WEFFE=8XHHHU+R222.0D<<: L[L0JJ"S$ $U)7YZ?\%3?VA1^
MS=^Q#\9_%UE>?8_%?C#1C\*? S*R+<?\)-\0H;G1GO+,N0OVO0?#G_"0>)X,
MK("VAX,;KE3Z&59=7S?,\ORO"J^(S#&8?!TM+I3Q%6-)3EVA#FYYMZ1C%MM)
M-GC<1YY@^&<@SGB',)<N"R7+,;F>(U2<J>"P]2NZ<+[U*K@J5**NYU)QA%.4
MDG_.#_P3\AE_;1_X+'ZW\;+N.34/#NC^.OBO^T ZNC.;/P_HMS<Z-\,XM\@;
MRET;6M>\ PQ-(I9H[$1+Y<KK)'_:37\U7_!NK\ ;C1/A_P#&O]I/6+5XI/'&
MLZ=\+O!CRHJL^A>$P-;\67\!P6EM-3UW4]&TU7#(J7?A:]0JY 9?Z5:_0_&#
M,*&)XN>68.2>"X<RW Y'AXQ=X1>&INK6CT]^E5KO#5'9:X=+:*/Q+Z,F2XO
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MO\4OS8!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)Q'Q#C\I<G4R;(,MR>>*J9=5SBGAL7G&=/+,'@:*]K62_6VO@[XS_M ?MO\
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M?_-ZO@)_\SM'_#5?_!2K_I%#_P";U? 3_P"9VOU"HHYE_)'[Y_\ R0'Y>_\
M#5?_  4J_P"D4/\ YO5\!/\ YG:/^&J_^"E7_2*'_P WJ^ G_P SM?J%11S+
M^2/WS_\ D@/R]_X:K_X*5?\ 2*'_ ,WJ^ G_ ,SM'_#5?_!2K_I%#_YO5\!/
M_F=K]0J*.9?R1^^?_P D!^7O_#5?_!2K_I%#_P";U? 3_P"9VC_AJO\ X*5?
M](H?_-ZO@)_\SM?J%11S+^2/WS_^2 _+W_AJO_@I5_TBA_\ -ZO@)_\ ,[1_
MPU7_ ,%*O^D4/_F]7P$_^9VOU"HHYE_)'[Y__) ?E[_PU7_P4J_Z10_^;U?
M3_YG:/\ AJO_ (*5?](H?_-ZO@)_\SM?J%11S+^2/WS_ /D@/B+_ ()P_ CX
M@?LT?L5_ WX+_%.WTNQ\?^%=+\6ZAXETW1]3BUFTT>[\:_$+Q=X\@T.;4[9%
ML;S5-#L?$]KI&N3:5-J&B_VU9:@NB:QK>D+9:O>_;M%%)N[;>[;?W@%%%%(
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M_ +Q?I.E?!+1O _P#_;KUSQM\-A^SYK.G6W[%7_!1'P/X7EU;PW)X6BGLYO
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M)9A/)LKRKA["8+"9IBO9PS_&YGF^8X7"T<NAELZEZBBBO@#]F"BBB@ KX?\
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MK8>3EAZM6C3J5*$FTW*C4G%RI2;2;<'%W2UT04445D= 4444 %%%% 'YC?\
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M?B_X2U3X9Z#X3M?C5\<_!/A__@GI^W/X$\,^-;_]G+XN_"R;1+KQ7I?Q.M_
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M2&"W@A1Y9II72.*-&=V55)'\T7_!1;_@N%8Z2VM_ W]B._M?$NO7T$VB:_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img181012247_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_7.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )9!((# 2(  A$! Q$!_\0
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MS_\ OH/^*G__ %8__P Z7_\ D_/]""BO\]^BC_4S_J9?^6?_ -]!_P 5/_\
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M@_XJ?_\ 5C__ #I?_P"3\_T(**_SWZ*/]3/^IE_Y9_\ WT'_ !4__P"K'_\
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M@ HHHH **** "BBB@ HHHH _EK_X+=?\G6_#_P#[-[\*?^K(^+%?CG7[&?\
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MWJ&E6U[JFD7>E:A?ZG/;W$.FZM#<QZA-!):V[(MP?RN_X<B_M6_]% _9[_\
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M5[2J<TDHIJ*_EK_X<B_M6_\ 10/V>_\ PJ_B/_\ .GH_X<B_M6_]% _9[_\
M"K^(_P#\Z>OZE**XO]:<V_GH?^"(_P"9ZG_%/OZ.G_0MXL_\2G%?_*#^6O\
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M_P"8?\4^_HZ?]"WBS_Q*<5_\H/Y:_P#AR+^U;_T4#]GO_P *OXC_ /SIZ/\
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M_P *36O_ )EZ_>2BC_B3WP>_Y]\3_P#A\7_S%_5WY6/^(X<<_P ^4_\ AO\
M_NY^#?\ P[6_:$_Z"?PU_P#"DUK_ .9>C_AVM^T)_P!!/X:_^%)K7_S+U^\E
M%'_$GO@]_P ^^)__  ^+_P"8OZN_*Q_Q'#CG^?*?_#?_ /=S\&_^':W[0G_0
M3^&O_A2:U_\ ,O1_P[6_:$_Z"?PU_P#"DUK_ .9>OWDHH_XD]\'O^??$_P#X
M?%_\Q?U=^5C_ (CAQS_/E/\ X;__ +N?@W_P[6_:$_Z"?PU_\*36O_F7H_X=
MK?M"?]!/X:_^%)K7_P R]?O)11_Q)[X/?\^^)_\ P^+_ .8OZN_*Q_Q'#CG^
M?*?_  W_ /W<_!O_ (=K?M"?]!/X:_\ A2:U_P#,O1_P[6_:$_Z"?PU_\*36
MO_F7K]Y**/\ B3WP>_Y]\3_^'Q?_ #%_5WY6/^(X<<_SY3_X;_\ [N?@W_P[
M6_:$_P"@G\-?_"DUK_YEZ/\ AVM^T)_T$_AK_P"%)K7_ ,R]?O)11_Q)[X/?
M\^^)_P#P^+_YB_J[\K'_ !'#CG^?*?\ PW__ '<_!O\ X=K?M"?]!/X:_P#A
M2:U_\R]'_#M;]H3_ *"?PU_\*36O_F7K]Y**/^)/?![_ )]\3_\ A\7_ ,Q?
MU=^5C_B.''/\^4_^&_\ ^[GX-_\ #M;]H3_H)_#7_P *36O_ )EZ/^':W[0G
M_03^&O\ X4FM?_,O7[R44?\ $GO@]_S[XG_\/B_^8OZN_*Q_Q'#CG^?*?_#?
M_P#=S\&_^':W[0G_ $$_AK_X4FM?_,O1_P .UOVA/^@G\-?_  I-:_\ F7K]
MY**/^)/?![_GWQ/_ .'Q?_,7]7?E8_XCAQS_ #Y3_P"&_P#^[G\]/@3]A+XQ
M_$;1+[Q!X8UGX?3Z;IWC+XC> [E[O6M=LY5\0_"SXA>)_ACXNA2*7PQN>VM_
M%?A#6K>RNA^[OK.*"]B_=7"5V7_#M;]H3_H)_#7_ ,*36O\ YEZ_4#]C[_DD
MWBW_ +.D_;D_];6_:!KZDKMS+Z&O@UA<QQ^%I4^*/98;&XJA3YL]BY>SHUYT
MX<S^I*\N6*N[*[;=EI;R\C\?./LQR3)\PQ$\F5?'95E^,K^SRUQI^VQ6$HUZ
MG)%XB3C#GG+EBY2:C9-O<_!O_AVM^T)_T$_AK_X4FM?_ #+T?\.UOVA/^@G\
M-?\ PI-:_P#F7K]Y**XO^)/?![_GWQ/_ .'Q?_,7]7?E;U/^(X<<_P ^4_\
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M?_#?_P#=S\&_^':W[0G_ $$_AK_X4FM?_,O1_P .UOVA/^@G\-?_  I-:_\
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M;NUN8VAN+:YMYE>&>WGA=XIH94>.6-V1U96(,ZJJJJJH55 554 *J@8"J!@
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M_P #K7_X[1]9PW_010_\&T__ )+S7WA[*K_S[J?^ 2_R\U]YI45F_P!LZ/\
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MM'UG#?\ 010_\&T__DO-?>'LJO\ S[J?^ 2_R\U]YI45F_VSH_\ T%=-_P#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC=ZN*C>[3;^9S2A"C7C*FE&-6/,XK1*2=I671/1VVO>VFB****^A/-"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /$?B5_R';3_L$P
M?^EE_7GM>A?$K_D.VG_8)@_]++^O/:^TR_\ W+#_ /7M?FS>.R]%^04445V#
M"BBB@ K\A/\ @HY_R=1_P2X_[.3U#_T[?#"OU[KR+XC? ?X4?%KQ5\+O&OQ!
M\*+X@\3_  7\2R>+_AIJ9UKQ%I9\->(I9--FDU$6>BZOIUAK&Z31].?[)KUK
MJEB#;+MMAYDWF=&%JQHUHU)J3BH58VBDW>=*<(Z-Q5N:2OKHKM)O1XXBG*K2
M<(M)N5.5W>UH583>R;U46EIO8_+?4O#GQ:^.W_!37]H;X41_M,?'?X7?"_X<
M> O@W\0;7P?\-_&^HZ19WVLKH?A79IT4=S+>6&C>']3N-3U.Z\6:;I6GVY\4
MRS6_]HS[K9)*_,[4OVE_VCK;6? ?[27PN^)?[5-W\*O$G[2UOX(T?QE\5/VB
MO!5]\._&=BVN2RWWA"V_98LM+&NZ/"-,D@$VL2>(-;TG3+,FR'V?49[.\@_J
M T3X(?"_PY\6_&OQUT;PN+/XJ?$30M$\->,?%7]L^(+DZOHGAV"SMM'L1HMW
MJT_AW3A:0V%FAN-*TBQNKDPA[N>X=G9OF*;_ ()B?L*3>)]1\8#]GW0[;Q!J
M>N6OB2:[T_Q7\0],MK36+/4X]8M[G1=*T[Q?:Z1X>A%_$DDEAH-CINGW$ :R
MN+66R=[=O1H9AAH>[5HRE!4,/34?94W[T*?+7;M4IMN<N649SE/2-I4[M./'
M5PE:6M.:C)U:LY/VDU[LIJ5)+W)KW8W3C%1U=XSM?F_,7QA9?'OXJ^,/^"J'
MBFT_:X_:)^'>B?LI7_BCQK\./!/@7QWJNEZ-)JVE^$?$_B>+2]1NFNY-0@\'
M?8O!DFEIX2T6;2]-BO=5.MY>2UGL=1Y/XN_&C]J;XA_"/]EWXWWWQ+^-X^#^
MF?LQ6/BOXY6O[,?Q2\*?#[XR:%XSMO$?B[1)OC#XQ\+RQ-J'B7X>:K!X;ME,
M'V:Q\.2:CI/B2V;6?#4[%KO]W[+]F+X&Z>OQY6T\#K$O[3D-_!\<0?$?BV7_
M (3B'4]'U?0;Z-O.UZ3_ (1Q9])U[5K3_BDO[!,7VLSPF.YAMYHO&O%G_!-_
M]BGQQI'P\T/Q3\#=,U;3OA5X<A\(^!E?Q?\ $2UN])\,6VK:GKMOH=YJ=CXO
MM=3\0Z=#J^LZM?QV_B6\U=4FU*]VX2YE1G#,,,I0YZ4N6G*GR6H4I.,%AHTJ
MJ5JE-\TJJ<XR<G;23UO!DL)6M+EJ).2FY?O:B3DZ_/!N\)JT:?NM**N]%;XE
M^<_B?QIXR_:"_:\_9C^%WAO]L;XT?#SX5_%7]@+P7XTU+Q-X,\1CX=:[\0/$
MEOXK\;/<Z[8:#?WNHZ/X.^('B Z+;W6M:CI%KJ/B"TT?2-1\.6VHS:29;F/Y
M-N/B[\2OB=^RM\(]#^(OC77/BG'\)O\ @K3\-OASX.^*?B#49M9U/Q?X5TWP
MGXNN[+[;K4YN)=:N[1[M[_\ M2;4;V>:PUK3K>1@EK%/=?K1\8/^"<7@GXV?
MM5>!?'OCKPK\/M:_9I\&_LNZ7\#+3X:_VEXJT3Q-I>O>'?&/B#6?#=WX=7P]
M::;%I.A:3H>K6VG6U_8>+]/U:+RKFP&G26$S2R_4$?[%W[,4'PV^'OPBM?A/
MI5C\//A;\0M)^*W@GP]IVM>*]-&G?$/1%U)-.\4ZCJMAKUOK?B?4(X]6OHKA
M?%.I:U:W\+P0W]O=1V5DEO:QV$IQHVC*;4:<K1ITE[*2=92?.G"4JDHRA"4>
M6,%%73VBH>%Q%1U+RC%7E&[G4_>)JE9<C4E&$91E*,KN3D[-;R?X/_MJ_'#X
MZ:C\4?VM?&WP-^(?[6,?A_\ 9]\7Z-X?U_Q#I7[1W@_X3?!WX:Z\LUGH[Z'#
M\%Y])OO$'Q5L]2O]+U:&R:P\0:3?75Y]HU"YTN[LO,BN/I_Q+JWQQ_:3_:__
M &9_A>G[2?QE^#?AKXH_\$[OAS\6_B%'\(O$DGAI]6\3WWB7Q+J&JZCH=D3-
MHOA77M3O%TV&;Q/I6E?VRFAZ=_PCL<XTNZEB7]#OB7_P3K_8O^+_ (\\0?$W
MXA_ K0==\;>*H9XO$&L0^(/&VA1ZI+<V7]GSZE/I'AWQ-I.B+KDD $A\00Z;
M%K@O@-374!J0%V/8= _9L^"OACX@^#/BGH?@L67CSX>_"73/@7X/UX^(?%=T
M='^%FC7$UUIOA==,O==N-'OC;3W$S_VYJ6GWGB299#'<:Q+$ @REC\,J5*-.
ME)5*="I!2=*F[5)4J48MN52:DHU(2G=0@DFOW;GS2EI'"5^>;G43A.I&;BJD
MU>*J2E+10CRMP:C9RG>S7/RM)?R]_%?6_B-\:_V+OA1XA^*/QJ^+GBK7?A1_
MP4,U#]FRRO+[Q85M=7T&Y\'3>+;#QUK<<UK=7NJ?$CPO)-=Z9X5\7ZGJ5W>Z
M-HVL:UI;)>6]Q;M;?U<?"[P7%\._ /AOP/#XV\;?$5/#-I/I;>-/B1XD7Q=X
MZUZ6"^NC<7'B;Q&EK8C5-3MYVDL9)3:6[1):QVSQAX6SX/-^PG^RC<_"OQ7\
M%+CX1V5Q\,_&OQ$O/BSXC\-W'BGQU,UU\0[^TLK"Z\3V>N2^*'\1:+=R66GV
MMHEMHFKZ=I\-L)H(+...[NUG^@?AO\.?!?PC\#>&OAM\.]#C\-^"?"&G+I/A
MW0XKS4=033K!)99Q#]NU>\U#4[MFFFEEDN+Z]N;F621FDF<G-8XW&4L13A"D
MIP4*U6:@X4XQY:G*T[QFVI*2E>*BXM2OS:)&F&P]2C.4IN,G*E3@Y*4W+FAH
MU:22<6K6DWS)JUK:G;4445YIVA1110 4444 ?6%> ZS_ ,AC5?\ L)7W_I5+
M7OU> ZS_ ,AC5?\ L)7W_I5+7SV0?Q\1_P!>H_\ I:/B>+O]WP?_ %^J?^D(
MS:***^I/A0HHHH **** /QX^#'_*:/\ :_\ ^S:/AS_Z2_!VOASX&^)OBE;_
M +#_ ,=/VSOBY^V+^UC*/ ^M?$'X9^&O"?ACQQ-JEG8Q:SXO\/\ AW0[^2/Q
M)=W4VI^*6\3^*8+/2_%%_J"CP;H4B"PL+N+3(;63^@K1O@)\)O#_ ,9_%_[0
MFC^$EL_C!X]\,Z;X/\6>,/[;\1SMJWAS2%TE-.TXZ%<ZQ-X9L?LZZ%I0-WIN
MC6=_,+-?M%U+YD_F\IX;_9*_9W\)?!KQ/^S[HOPSTU?@[XROM9U+Q+X)U75O
M$OB&SU34->NK>_U&\DU'Q#K6J:W;W)OK.TOK&:SU.W?2+VTM;K238W%O#(GI
M+&4E:\)OW<#"3Y:;?)AX2C747)RMSW2@[:KXN79]L<335KQD],)&7NP;Y:,7
M&JHN3=G+3E:6J^*VS_ K]GGXP_M6^ /V@?$/PX\;^,OV@M&\,_$/]CKXI?%'
M3?#GQJ_:6\-?M#^)XKFV\$:[XB\(^/\ P[KOA'2/#TOPON9WT^WET_PS-:0:
M[8P-/<7EW>1W.G2VF/HGC+]I;X6?LO?L-_ML7G[7W[0GCCQ'\2_V@?"WPR\4
M?#/Q1XPN=2^&EWX"GU+QY9_8KW0KJ:=M?\036O@"]BU3Q/K]Q?ZEJ/\ ;\,]
MNVEZAHD6H7W[=?#;_@G%^Q=\(=5;7/AU\$[/PUK$GAOQ;X1FU*'QM\2M0N[K
MP[XYTU]'\3:;>3:OXRU![Q;[399;6VN;HS7FCI)(^BW&GRNSGN]0_8N_9HU7
MX1?#;X#W_P -$N/A1\(?%MAXY^'GA0^+O'D8\/>*M,G\07-EJO\ ;<7BB/Q'
MJQBG\4Z\[66N:OJ>GSC4&2XM)4M[18-YX_"N2<:+LW357]S23G",*T9I*52H
MTY.=-_'?W7>2LD]I8RAS7C3?*W!3_=4US04:JDES3J--N4/MM^[NK)'Y":_\
M3?CE\,/V[?\ A)OCS\:_C]I?PE\8_M3+X&^"OB7X5?$3PSXT_9AG\.P>*+S2
MG^"7Q3^%6F2PW/A_QS;V%JWASQ#K5Q?Q^)?#>LP:CKEWX5U=+(ZK-XYXN\3?
M&CQ9X;_X*:_%"7]N#X[_  _U']EO]IGXM-\+/AKH/Q1GTO2/LB>/+NPT?1]9
M@NKV;7;_ ,'7J65KX5\&^#;2?3_"VE:C:WGV*POGOKZP/[@0_L"?L@V_QMD_
M:*B^">@K\89?%4OCE_%;:UXODM_^$RGU$ZQ+XI3PM)XB?P='KS:N6U;^U(_#
MZ7:ZFS:@LHNV:8_)/PU_X)1?"#6/B+^T;\0/VI/ 7P_^*5_\1_VEOB+\8/A?
M=Z)XC\?6-]H?@OQCK4^LV6@>,$T\^#K;4+R*>8R7F@W)\4>'H)FN&M;R<7EQ
MO<,9A=)V<'3IT8M*A1?,X5(\T:<)3:M*"<9R<U>[E&G&[@W#%4%:33BX4Z2:
M5*G[SC4BY*$92DM8)QE)R6C<E!:Q?R[X'^,FM>(_VR_V=_CO\2Y=1T'6[S_@
MCT/B1XSU33;!)]1CGMM>^(.N:OXFTG2I4M(7EU&."7Q#I.F,5M]MW;6:W,T(
M%S)\R? 3X]?M/Z'\>_V*_','CW]J*7X5_M#_ !9B\)+J/QU_:5\&?%/PY\5/
M"MWKMKX8U:XT7X&Z-H=AJ'PN?2WGO8SJ&HZCXAA&JI:MH^IV\]G)]H_I&NOV
M;_@A>_$S3?B_=?#S2)?'FD?"J3X(:=?&XU5="MOA1+>7]\_@E?!*:@O@>32F
MFU.^CWR^')+T6-P=-%V-.2*U3P#P5_P3-_8<^'7C#0?'W@OX#:9H/B[POXOT
MGQWX?UJV\9_$F:;2?$NASRW.F7-G;WGC*YLHM.M[B8S/X>^S'P[=216K7>E3
MFSM/)F..PMIJ5&7O48TE'DA.*25;W5^\ARJ+G!J34[J+7LXRY9*8XO#VGS4I
M>]2C32Y8R2LJFB]^-DG*+3M).WP)VDOQR\;7_P"T;XL\$_\ !3+XW67[87[1
MWA!/V7/VJ/BQIWPP\ ^&?'NIVGAB.V@^(<-J=+UJ::YFU.^\)V6AFUTKPYX*
MM[FR\->'9;:6\M;"9-0U"RN+NG> ]0^-W_!1C]D3QKXI^.?QU\,ZQ\;/V$_A
MI^T5X@\1^%_B':^%]3\+ZG?:'XGU+5_ O@^Z@T5K+PQ\*=4N-#NM5UOP=!;R
MVTU[X@\5W,=[;0ZF([7]VO\ AD+]G;_A$_C?X&_X5VI\+?M'^+M;\=_&?3#X
MJ\;$^,_%?B.^CU+6-5-\?$AU+P]]JOHTN$L?"MYH>FVC K96=O&S(>9\:_L(
M?LF_$0?"#_A,OA!I^M/\!O#?AKP?\*IG\3>.+*Y\,^&/!ZVB^&]$GNM-\3V=
MSXDL=*^Q0/#%XKEUPRRFXFN6FEO+MYR.84DI)1G&\*E.,HTJ5XPG0I06G-'F
M_>PE-IO5.]VVT"QE-)KEE&\9PC*-.G>,94J<=N:/-^\@Y.\M5*][W1]<T445
MXYYH4444 %%%% '2>$?^1AT__M[_ /2&YKVRO$_"/_(PZ?\ ]O?_ *0W->V5
M\EGW^^4O^P:'_IVL?H/"?_(NK?\ 8;4_],88*\3\7?\ (PZA_P!NG_I#;5[9
M7B?B[_D8=0_[=/\ TAMJ_/>+/^1=1_[#:?\ Z8Q)]YD_^\U/^O$O_3E(YNBB
MBOSX^C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG35F]&^=65WJU9Q4<U"3II2FE[JDW%-^JC-W2NTN5W=EHG==I^RO\=T_::^
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M'P)%>W.KV$^@V^B0:9(?"MZ;6:R\07]U(+BU$ME!F7ROG/P3_P $[?BE8?\
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M/X@GM-/NF.GWZZGJ%@(LZAI\!N+!;WG/!7_!6WQ1KFF? GXA^-/V._'/P_\
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M>OW=IX%\4K!X"\$^'Y-$O+*)M6U._?0SIL>I_P#")VSZK%JTM[J"W6_\0?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#2
MT;_D,:5_V$K'_P!*HJ]^KP'1O^0QI7_82L?_ $JBKWZON^$O]VQ?_7^'_IL\
M#.?XE#_!/_TI!1117UIXP4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!XG\2E(UJS?'RMI<2@^Z7=X6'IP'7\^>V?.Z]\\:>'I-;L8Y
MK10U]8^8\29 ,\3A3+"">"Y**T6X@;@R@C><^#21R12/%*C1R1LR.CJ5='4X
M964X(((P0>0:^ORNM"KA*<(M<]).$XWU5F^5VWM)-6>U[KH;1=TNZZ>@RBBB
MO1*"ORJ^'/[&_C.W^)__  4,^%/C_2-8@_9N_:TU2/X@^&OB%X:\3^%K?6+'
MQ%XQ34I/B)H-OH5XVLZII^L+?ZS'-8:OJ7AF71)+70D\Q[V6\BMH/U5HK:E7
MJ4544+?O%!-N]XN%2%6$XM-6E&4%9NZLVFG=6SG2C4<'*_N.32TLU*$H2C)-
M.\6I.]K.Z5GW^-/'7[#GPD^('[*/AO\ 8]UG7OB%:_#/PMIOA+3-.US2]7\.
MP^.I(?!MY!?:;-=ZG=^%+W0))[J6 +J!B\,00R1R2"UALV\MX^M^#_[)WPY^
M#'Q7^*GQHT36?&OB7QS\6=*\'>']6O/&6J:/J5MX=\.>!],CTC1O#WA*+2_#
M^BSZ?I,EG:Z6M]#J5UK$\\FCZ:\=Q 8IQ<?3U%#Q%=PG3=67)4<I3C?23G*$
MYM]?>E3@WW<4'L:2E&?)'FBHJ+MLHJ48V_PJ4DNUV?-/PL_98^'_ ,'OC9\<
M/CCX,UKQI!K7[0-UH^I^._"%YJ>C3>!(M;T59C#KNAZ9!X?M=;M-5NI[W5[J
M]EO_ !#JD$EQK>IF&WMX7M8K7E/VK/V-/"G[75AIFB>./B_\?_ OA6TTZZTW
M5_!?PH\?Z;X8\'>,XKC4+'5()_&WAS5_"_B73O$5SI=YIUO+I4EU$JV3!G2-
MI0DB?8-%"Q%:-2-95)>UC&,8S=G)*$5"*U3^&*23W5EK<'1IN#IN"Y)-R<=4
MFY2<G=+O)MM;.[T/!/V<?@#IG[-GP[7X::+\2?B]\3=&MM4-]I.I_&7QC;^-
M->\/:9'HVBZ'8>$?#]Y::-H5KI/@[1[71(I='T"VL%M]/N;[4GA<1W*PQ?ES
MX3_X)@7GQ7^+W[9?B3X\:K\8OAAX4^*?QUU77O"L'PM^*V@:3H_Q>^&EYJU]
MK<-AX^\.V2^+(+G2;?4Q97ME8:YIVA:_9W<DTL;1F.)X?W!HJZ>+KTI5IPG:
MI624ZEK25IQG>-FHIMQ5[Q>FUGJ1/#4IJG&4;QI<W+"_N^]%QL[W;23=M5YW
M6A\&_%+_ ()U? 3XBW'PLU;PYJ_Q4^!7BWX.>"K#X<>!O'7P%\=R^ _&-CX&
MTN*:*P\-W6KW.FZZMW;6_P!KU"0WK6J:O<2:EJ!N]1N%N609EK_P38^ NB_"
M;0?A;X*\4?&KX<W^@>/-2^)D?Q>\!?$FYT#XSZEXTUC3KC1]5UC5_&2Z9<6E
MX]_I,T6GRVZZ'#;10VD4EK%;W,^H7%[^@M%)8O$I1BJ]2T7S).3>MY/6]^97
ME)\LKKWGIJQ_5Z%V_90O)6>EOY=DM$_=CJK/1:GY_P#AW_@FY\ ?"_A?X.>%
MM)UGXGA/@U^T!9_M,66N7OB;1M1\1^//BK:3:;*^J?$34K[PO.NKVE]'H^EV
MM]#HEMX<NYK:RB"7T4S2S2=S_P ,1?"ZV_:BO_VL-#\7?%CPIXYUZ32I_%_@
M[PMXPM-&^%WCF[T30QH.FW7C#PM!H1O=:DMX$BU 02:Y%9/K47]K26K7DUU)
M/]CT4/%8AN3=:;YXSA*[OS1J24YQ=[Z2DE+R:5K60U0HJUJ<5RRC):;2@N6+
M79I:>>M[W/@.#_@G#\!(OV2S^QQ-J_Q(O?AO'XC;Q9I_BBZUOPU_PL72-?;Q
M'_PD8U'3-8M_"%OX>@E21[G25\SPK,#HU[=V[A[F47B:][_P3S_9VU']E_P=
M^R=?6?BR;P#X!U4>(_"7BB+6[*P^(VC^+CJFKZK)XPM_$.F:/9::=?FEU[5K
M:61]!;3VL;PVXTY1!:M!]RT4/%XE_P#+ZI_&=?25OWS5G4T^TUH^GD+ZO17_
M "[A_#5+;_EVK-0\TFD^^BU/S<U3]CC4O@-\&OVA=9^"OB'XY_M&?M!?$3X4
M:G\.?#&K?'3XOV'B;Q!':ZC!-INFZ9IVJ^()/!WA32](T.;4/^$@F2\\FZGB
MT@6%I>[YTM9_HO\ 8W^"-W^SC^S#\&?@SJ3P2:UX-\)1_P#"2?9BCVL?BKQ#
MJ%_XJ\5P6LT<LT=S;6WB/7-4M[>\1PMY#$ET(XA-Y2?3%%*IB:M2FZ<VI*51
M5)2?Q-QA[."WY5&$7+E2BK<SNVK).-"G":G%-<L'345\*4I*4GM=RDU&[;?P
MJR6MRBBBL#4*<BEW5%&6=E51ZEB !QD]3VIM=[X*\-3ZC>P:G<Q,FGVDJS(S
MC NIXVW1I&#]^.-U#2M]PX\O))8#&O6AAZ4ZM1I**=D]Y2M[L5W<GHE\W9)M
M)M)79[G7@6MJ5UC50>"=1O&_!KB1E_,$&O?:\R\9:#-Y[ZO:QF2*11]M1 2T
M31H%$^T?\LV11YC ?*PWM]]F'SV25Z=+%2A4:C[:')!O1<ZDFHM].972\[+J
M?)\3X6KB,%3JTHN;PU5SG%)M^SE%QE)):OE?*VK:1;EHHL\\HHHKZ\_/ KRC
MX[?#"T^-7P6^*WPCO)H[6+XD?#_Q9X-CO9O,\O3KS7M%O-/T[5&$2LY.EW\U
MMJ"JJ2;FM@&BE4F-O5Z*<9.,HRB[2BU)/LT[I_)H:;BU);Q::]4[H_*GX._L
M4ZY\8/V4?V2_AQ^UKIOC?X??$3]E?Q;INKZ-8>%/&?@?5X-9_P"%?:A=Z;X&
M:_U2TM?&UE<^%[WPG%HL$NEVUQHNN63VDEJL]C%'%YGU;\9?V1?A[\;?C%\(
MOCEK_B?XA>'/'/P3T[Q=I_@N3P=JWA_3].#^+]/ET^YU'4H-7\+ZY=S:CI/F
M?;=%ELK_ $^"&]CC>_MM1MU-NWU316TL36E-S4N36JU&.D8JNVZD8IW?+*[3
M3;TTN:NO4<G)2Y=:C2C\,?:WYU%.[M*[33;TT/F?X$_LG?"?]G[X!S_LY>$X
M]>U[P'J4'C&'Q'>^,;ZPU'Q-XK;QU+??V_<>(=0TG2M#L+FYFL+U='ADM-*L
MA'I=C8PNLL\4MS-L?LQ_LZ>$_P!E3X0:'\%/ OB;QSXH\(^&[_6[W1+GX@:G
MHNJZWI\6O:G<:S>:9!=:!X>\,V"Z9'JEY?7EM#_9OG1RWUSON)4:-8_H"BHE
M5J34U*<I*I-5)IO24US6D_-*4E==';8B52I+GYIR?/)3G=WYIJ]I/S7,_D['
MYA:W_P $L?AK?_%WXH?&SPS^TO\ MG?"_P ;?%WQ'JWB/QA/\*_C-H7@NVG.
MJ:G/JD6A02V/P]DU>3PYHLDRVN@Z7J>K:D-,L;>UMHYG\E7KZ^^(_P ,];?]
MEGQY\&_#.I^)?'OB1O@!XH^&?A_6?&VO6NH^,/&>MM\.K[PMI6I^+?$]\-,L
M;[Q+XBOS;W6O:]>#3K6ZU2\N]0N!:0N_E^_T5<L36FZ;G/G]DXN"DEIRI))M
M)-I**5K[+0IUZLN3FES>S<7%-+3E225TDVDDEN?C!^R%_P $I_!/A7P1^SEX
MR^/-Y\7G^(?PK\OQ?)\"M8^*&F>*/@CX3^)2ZHUY)XCTKPUIL&L6<>IWCV.C
MZGJB:+XMET'4[VVC2]LKFVC-H/<?B3_P2L_9Z^(GC;XC>+K3QU^T#\-=*^,.
MJOKGQ9^&OPN^*(\,?#'XCZM/=OJ%[>>+/#%SX?U::^-_J4L^HSVT6IVUE#>W
M$\]A;69? _2ZBM)8W%2J2J>VG%ROI%M12<_:62=]I6:;O*Z3YFU<N6*Q#FY^
MUDF[Z)OE2<N:R3OM+5-W=TFVVKGYX_%O_@F?\!?BJVF6=CXP^.7PB\*6GP_\
M,?"[6/A[\&_B9+X4\!>-/ _@XSCP_H?C3P]J>C^(8]<BLH+AK=YFGM[FZ"K=
M7<LVHM+>R>K>%OV*?@IX/^+=S\6]&A\1K/<?LX:5^RNG@2YU'39O %K\)M'F
MT-[.RM[ :,GB(ZJ+3P_8:9+>7/B>XM'T\W"#3UN)%N8_KBBLWB:[BH.K-Q2:
MLWTE:]WN_ACJW=)))I$.O6<5%U)V2:M?H[7OU?PK5ZZ'YA:=_P $H?@)IOP+
M^('[.B?$[]HN]^%_CW7?"&NQ:-JOQ#\/ZJO@(^#M?U_Q-:Z7\.K6_P# T^C>
M&],UO6/$FHWGB</I.H:CK<XMKFXU%;N'[0_K/[6W_!/GX#_MG>(OAYXH^*]U
MXYTO5?AU#?6-I)X(UC0])C\2Z+?ZCINJMX?\5KK/AKQ#)>Z1;7NGRRV<>F2Z
M1=P'5-487C/- ]M]R44_K6)YU4]M-3BYR4D[-2J1C";NNLHPBF]W9/?4?UBN
MI*:JSYTY24KZWG&,9/UE&,4^]D]SXK_:&_82^$G[0WC;P?\ $^?Q5\7/@U\4
MO ^@OX4T3XD_ /QROPZ\8+X6,]Q<0>'KB^.D:S:_V;9S7NH&T%K8VMW''J-W
M;-=/:M%##\L_M-?L'^(-6^"?P'_9,^".D>)O$GPPU[]H72_B)^T1\4/B#XZT
MWQ#XHMO#6GR2WNO:OK;>(-8TK5O$^O>)[J]A^QVGA72GMH9=!2*\M=,BOFOG
M_7JBG3Q=>G[.TW*-)\U.,KN,9)2Y6K-/W')R@F^52Z6NF0Q%6'):;:IN\(N[
M479V>C3]UN\4W9/INF4445S&(4444 =+X04GQ#8D=%%TS>P^QW"_S8#\:]KK
MA/!NA2V2OJ5Y&8YYX_+MXG!#QP,59I'4_<>4JH52-ZQ@YQO*UW=?&9Q7A7QC
M]FU*-*G&DY)W4I1E.4K/JDY\O:\7;34_2N',+5PN7)5HN$J]:>(4))J482A3
MA'F3U3DJ?-9ZVDKZZ(KQ;QC&R>(+QB"!*EK(N1C*BUAB)'J-T;#/J".U>TUR
M'BOP^^K11W5H%-[;*4V$A?/AR6\L,> Z,69 W!W,N02,_'\08.KC<OE&C%SJ
M4:L*\::5Y348SA*,5UERU')+5R<>5*[1];EM:%#$IS=HU(2I\SVBVXR3?E>*
M3>RO=Z)GCU%22Q2P2-%-&\4J':\<BLCJ?1E8 @_45'7YFTTVFFFFTTU9IK1I
MIZII[H^I335T[IZIK9KN%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHI55F(5069B JJ"22>  !R23P .31OL!J:$C2:SI:
MKDD7]J_ S\L4R2-^ 5"2>PY[5[W7 ^$?#DUF_P#:=_&8YRC+;0.,21*ZX>60
M'!21E+($(W*I8M@G%=]7Z/PW@ZV$P4Y5XNG/$5?:1A)6E&FH1C!R3UBY/F=F
MDU'EOJ[+YG-*\*U>,:;4HTH\KDM4Y-WE9]4M%?:][::LHHHKZ$\T**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R;_ $+2-4;??Z?;
MW$F /-*F.8@=%,T1CE*CLI<@=A6M150G.G+FA.4)+:4).,E\TTP.3_X0?PM_
MT"__ "=U'_Y+H_X0?PM_T"__ "=U'_Y+KK**V^MXO_H)Q'_@ZI_\D.[[O[V<
MG_P@_A;_ *!?_D[J/_R71_P@_A;_ *!?_D[J/_R77644?6\7_P!!.(_\'5/_
M )(+ON_O9R?_  @_A;_H%_\ D[J/_P ET?\ "#^%O^@7_P"3NH__ "77644?
M6\7_ -!.(_\ !U3_ .2"[[O[V<G_ ,(/X6_Z!?\ Y.ZC_P#)='_"#^%O^@7_
M .3NH_\ R77644?6\7_T$XC_ ,'5/_D@N^[^]G)_\(/X6_Z!?_D[J/\ \ET?
M\(/X6_Z!?_D[J/\ \EUUE%'UO%_]!.(_\'5/_D@N^[^]G)_\(/X6_P"@7_Y.
MZC_\ET?\(/X6_P"@7_Y.ZC_\EUUE%'UO%_\ 03B/_!U3_P"2"[[O[V<G_P (
M/X6_Z!?_ ).ZC_\ )='_  @_A;_H%_\ D[J/_P EUUE%'UO%_P#03B/_  =4
M_P#D@N^[^]G)_P#"#^%O^@7_ .3NH_\ R71_P@_A;_H%_P#D[J/_ ,EUUE%'
MUO%_]!.(_P#!U3_Y(+ON_O9R?_"#^%O^@7_Y.ZC_ /)='_"#^%O^@7_Y.ZC_
M /)==911];Q?_03B/_!U3_Y(+ON_O9R?_"#^%O\ H%_^3NH__)='_"#^%O\
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M**/KN,_Z"\3_ .#ZO_R8?V;EW_0!@O\ PEH?_*SF_P#A$?#W_0/_ /)N^_\
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M_P _)?<9O]C:/_T"M-_\ ;7_ .-4?V-H_P#T"M-_\ ;7_P"-5I44?5L-_P!
M]#_P53_^1\E]P>UJ_P#/RI_X'+_/R7W&;_8VC_\ 0*TW_P  ;7_XU1_8VC_]
M K3?_ &U_P#C5:5%'U;#?] ]#_P53_\ D?)?<'M:O_/RI_X'+_/R7W&;_8VC
M_P#0*TW_ , ;7_XU1_8VC_\ 0*TW_P  ;7_XU6E11]6PW_0/0_\ !5/_ .1\
ME]P>UJ_\_*G_ ('+_/R7W&;_ &-H_P#T"M-_\ ;7_P"-4?V-H_\ T"M-_P#
M&U_^-5I44?5L-_T#T/\ P53_ /D?)?<'M:O_ #\J?^!R_P _)?<9O]C:/_T"
MM-_\ ;7_ .-4?V-H_P#T"M-_\ ;7_P"-5I44?5L-_P! ]#_P53_^1\E]P>UJ
M_P#/RI_X'+_/R7W&;_8VC_\ 0*TW_P  ;7_XU1_8VC_] K3?_ &U_P#C5:5%
M'U;#?] ]#_P53_\ D?)?<'M:O_/RI_X'+_/R7W&;_8VC_P#0*TW_ , ;7_XU
M1_8VC_\ 0*TW_P  ;7_XU6E11]6PW_0/0_\ !5/_ .1\E]P>UJ_\_*G_ ('+
M_/R7W&;_ &-H_P#T"M-_\ ;7_P"-4?V-H_\ T"M-_P# &U_^-5I44?5L-_T#
MT/\ P53_ /D?)?<'M:O_ #\J?^!R_P _)?<9O]C:/_T"M-_\ ;7_ .-4?V-H
M_P#T"M-_\ ;7_P"-5I44?5L-_P! ]#_P53_^1\E]P>UJ_P#/RI_X'+_/R7W&
M;_8VC_\ 0*TW_P  ;7_XU1_8VC_] K3?_ &U_P#C5:5%'U;#?] ]#_P53_\
MD?)?<'M:O_/RI_X'+_/R7W&;_8VC_P#0*TW_ , ;7_XU1_8VC_\ 0*TW_P
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M $47"?\ XAF<?_1YZ_TM?GO_ (:W_92_Z.;_ &>__#T?#C_YI*/^&M_V4O\
MHYO]GO\ \/1\./\ YI*^A**.;#?\^:__ (44_P#YE#ZGQS_T47"?_B&9Q_\
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M-3S8G!X>#HJGRQ@X4Y1J2Q*G/'2E"C*<*4*5&K'#S4YRC&5;DIQ^&;<X2O\
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MN_M%)Q4DYPE'Y3BOQL\3L-BO%?%</U\/#+,CX+XNSSAB&)\/\^Q-/+\7ET>
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M*"\BL8HGNH+FXGM/,?\ @JA\/[-KG]F'XJ2>(O%\FH0?M)?!WX>VGA1]<8>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5\__ +3]O='X-:SK-I:W5\W@;Q;\)_BG<6=E;3WMW=:=
M\(OBWX&^*&K6\%I:I+<W$DNE^$;Q!#;1O.^XK"K2%17T!15TI^SJTZEK^SG"
M=KVOR24K7L[7M:]G;L>5GN5K.\CSG)77>&6;Y5F.5O$QIJK+#K'X2MA'75)S
MIJHZ2J^T5-S@IN/*YQO=5-/U"QU:PLM4TR\MM0TW4K2VU#3K^RGCN;.^L;R%
M+BTO+2YA9XKBVN;>2.:">)VCEB=)$9E8$VZ^;;3X'^+_   T]K\"/BA!\/\
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M+/\ PLX&_P#HS_JS\K_0E%?/?_"-_M6_]%H_9[_\1D^(_P#]%O1_PC?[5O\
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M@TDA?Z"HKH^M8KFYOK.(YKWYO;5.:ZG3J)WYKW52E2G??GI4Y?%"+7R#\/N
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M110 4444 %%%% 'B'B3]G'X,>+O&/CGQ_P"(?!BZAXN^)/PIU;X(^-=7&O\
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MM*24\#A(MQDKQDD\.FTUJGLUL4HPDKQE)J[5U5FU=;K2>ZZGRO\ \,]_%O\
MZ/I_:H_\)']B/_Z#FD/[/OQ?0%H?VY_VGVE7YHUO/!G[%<]FSKRJW4-I^R+I
M]U+;LP FCMK^RN'C++#=V\A65/JFBI^MU?Y,-_X18/\ ^4#]G'O/_P &5/\
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M3^U1_P"$C^Q'_P#0<T?\,]_%O_H^G]JC_P )']B/_P"@YKZHHJ?K=7^3#?\
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M'C<+5GAZM?#5*F$QF'KX:=7#5Z^%JRI.KAJ]:A.G5F4445F>V%%%% !1110
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M^T)_ZJ3Q=72?LE_\FO\ [/8_N_!OX=)_WQX5TQ?Z5S?[=/\ R9'^V-_V:O\
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M:Q;PZXEODQ21KZA\1OVHM-USPCJ^A?#SP7XFU;6M6TS4].UN_P#'NA:S\//
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?*_P"QS_R23Q=_V=1^W3_ZVY^T)7U17R+^ROJ<'AV_^/7P0U7=
M8^+_ (>_'WXQ>/\ ^SKMH4N]7\!?M%?$[QA\=_!_C'3EBFE6[\/W5YXZ\1^#
M8KU!&T.O^"-?TF[BCO=.F,G533EA,3%:N-7#5I+M3BJ]*4O15*]*+\YHAZ5(
M/O&<5ZMP:7W1D_DSZZKR7X]S)#\#_B_N^+FE? &2Y^&OC;3[3XXZY+I,.D_"
M#4M3\.ZCIVE_$J];7=6T'1GB\%ZC=6OB$0:GK>D65T^GI;7&I64<IN(_6J*Y
MXRY91EORR4K:/9WVDI1?_;T9+NFM"GJFO+S_ $:?W-/S/YT-#^/VHK^SA?:+
MHOC_ ,::1X#\'_M5?LU?#O\ :L_:N^#W[;'QQ_:^^$NK?![Q?X5M-4^(?B;X
M6?M,_$S5(/&GP;72M>G\/>'/C1;^#K#PS_PIW2O%5CK]GXR>?47\1:'[9KTG
M@'XC?&']A[X2? +]K?\ :.\=?L[?$3XL?M7P^*O$G@_]I?XI:P_BNT\$?"3P
MUXVC^'_A_P#:(M]9;Q_\0_ &A>*[>=(/%>G?$WQ=XB\,ZOJ'C#P'H7Q(T5="
MN/#/AS]PZ*[WCXW<HT90?[VW[[G7-4H>R527/2E*52G/WZ<E./+&U.*BES/%
M479)R3^'[-G:,E)Q5I)*,DK-6>KNVV?S9_%3XF?'0_'_ /:(\$3?M'?";X _
M%[P)\9O!?A3]F!?VCO\ @HK\;?@%96/PF\.VW@R_\%:KIW[*DGPD\1_#?]JO
M0_BJ[>*M)\8_$'XA>,O'WBCQ1X@U/6O#:ZIX8O\ P?H8@N_&;XN?'O5_VD/V
MF/#FH?M%_!G]GSXT>%OCGX6T/]FB'X]_\% _BY^S3H.F_"W25\(:QX/U'P]^
MQ[I?P9U7X0?M+>%OBE//XLT?Q-XN\7>)?&6KZUK&I:MX1L+KPA-X*\/PVO\
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MB/Q7K<U]?M>,_9+^*WQ]\?\ Q;^!U_XO_:/^#7@?]H:[^.GC-/V@_@_\2O\
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M(FHFVNM4T:WE%H_B5]92^>UFU-)$@_L@->?:9(U1;?(+ALI7]@"LK*K*P96
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MH_\ "1_8C_\ H.:/^&>_BW_T?3^U1_X2/[$?_P!!S7U111];J_R8;_PBP?\
M\H#V<>\__!E3_P"2/SM^%W@+X[^-O'G[2'A;5OVW_P!I.WL/@_\ &/P_\/\
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MX8?VQ)\+/A#X0\7;(K?X@>)H/$>JR>*OB%XHT9YM#TV/2K'P^DTLL]N!]O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\&MJ$?B7QAH))6._NVM;G0[S7--U!40_VUXFOUT>[F5=0\-^#SIDT=S+WX7
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M_P""EG[8Z?#'X2?'+5_@A\&KOX=_$?XKK\,=(\.Z;=^,;#XB?$2[FO-;Q<>
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MRRE2PV:9U1S+#M8!X?\ =8^E3QE/X<3"-:,TO#?^'WO[4/\ T3CX"?\ A/\
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MO&:>(KZ[TRZTC5#X6O+?3KK2-=T5#I]T/#UO>F*6W/\ ITUY=KL>\F4^M_\
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M[_\ 1'OA)_W]\8__ "_I5_X+C?'7<-WP>^$I7(W!9_&*L5SR QUY@I(X!*L
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MIE2R)5JO]E>R]M[/]YR.LY>RYH_\_OL\_+?EZ\M^A_/_ -(6I]+.?#N1?\3
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M*+WQY>Z'>7&AQ7MS+HFFW%@OAC6(T70=-FMM#LGBNU5M-T^S5H5D21Y/:_\
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M]:]M#_B+O[1>.CX0XLD^_P#Q"K*7^,,EY?N/T(_X?F_"K_HA7Q!_\*3PY_\
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M8Q244DDDD%%%%!04444 %%%% !1110 4444 ?$/[;'[&>C?M8>$]#N]&UP>
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M36?&^I>//VB/B5XYLY?!'P9EL+R6T\'Q^!?"7]@2Q&8:FVHOJ=Z+KQ)^D?\
MP3TU+]B_QO\ \%O_ -N?Q[^SQXS^"VH:=X;^ 7P_\"> ]2\+?$_0_&NJ_'+Q
M?\4]<E^-/QT^)/A35;_Q)KWB#XC3>%-9L+;P9XE\1Z'>ZMIGA#1[;1O"D<^F
M^'TT;3T_?/P5^RK^R_\ #6U\<67PY_9O^ G@"S^)NG:AI'Q(M/!7P>^'OA6U
M^(.DZO'/#JNE^.+?0O#MA%XLT[4XKJYBU"RUY+^VO8[B=+F*59I V3\,/V-O
MV0O@CXIC\<_!C]E7]F[X1>-H;&\TN'QC\,/@;\,? /BF+3-15$U#3H_$/A3P
MOI.K)8WRQQK>6BW8M[I8T6>-PJ@=%;'4JKQ$E"K"5:@J*M)<M_:*HY2C>RM%
M>RC&*LHW>[TF-*45!-Q?++F>EG\*BDGZKF;?6RV1](T445YAL%%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<=F$J&(Q].$Z&%S'+ZV#Q&#KU8U(ODYDN' \7T<[Q-++>+\ORK%Y=C*D</\
MVC@LJR_*\TR?VLE"&+P>(R[#X6-2GAY.-2KA<5"O2KTX.+7-9GNX((!!!!&0
M1R"#T(/<&BOQ-^%O_!2/6? /P^\*>"]>^&+>--2\,Z5%H[>)9/'C:/+J5G92
M21:69[!_!^L.EQ::8+.QGG?4;B2]EMGO9#&]PT4???\ #U'_ *H3_P"9/_\
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MC_AZC_U0G_S)_P#^+RC_ (FD\"?^BZ_\UCC'_P"AX/\ B$'B)_T3W_F6R/\
M^>9^NE%?D7_P]1_ZH3_YD_\ _%Y1_P /4?\ JA/_ )D__P#%Y1_Q-)X$_P#1
M=?\ FL<8_P#T/!_Q"#Q$_P"B>_\ ,MD?_P \S]=**_(O_AZC_P!4)_\ ,G__
M (O*/^'J/_5"?_,G_P#XO*/^)I/ G_HNO_-8XQ_^AX/^(0>(G_1/?^9;(_\
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M3_YD_P#_ !>4?\/4?^J$_P#F3_\ \7E=W_$TG@3_ -%U_P":QQC_ /0\<_\
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M$3_HGO\ S+9'_P#/,_72BOR+_P"'J/\ U0G_ ,R?_P#B\H_X>H_]4)_\R?\
M_B\H_P")I/ G_HNO_-8XQ_\ H>#_ (A!XB?]$]_YELC_ /GF?KI17Y%_\/4?
M^J$_^9/_ /Q>4?\ #U'_ *H3_P"9/_\ Q>4?\32>!/\ T77_ )K'&/\ ]#P?
M\0@\1/\ HGO_ #+9'_\ /,_72BOR+_X>H_\ 5"?_ #)__P"+RC_AZC_U0G_S
M)_\ ^+RC_B:3P)_Z+K_S6.,?_H>#_B$'B)_T3W_F6R/_ .>9^NE%?D7_ ,/4
M?^J$_P#F3_\ \7E'_#U'_JA/_F3_ /\ %Y1_Q-)X$_\ 1=?^:QQC_P#0\'_$
M(/$3_HGO_,MD?_SS/UTHK\B_^'J/_5"?_,G_ /XO*/\ AZC_ -4)_P#,G_\
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M\H_XFD\"?^BZ_P#-8XQ_^AX/^(0>(G_1/?\ F6R/_P">9^NE%?D7_P /4?\
MJA/_ )D__P#%Y1_P]1_ZH3_YD_\ _%Y1_P 32>!/_1=?^:QQC_\ 0\'_ !"#
MQ$_Z)[_S+9'_ //,_72BOR+_ .'J/_5"?_,G_P#XO*/^'J/_ %0G_P R?_\
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M4HPJG[/45^1?_#U'_JA/_F3_ /\ %Y1_P]1_ZH3_ .9/_P#Q>5U?\32>!/\
MT77_ )K'&/\ ]#QC_P 0@\1/^B>_\RV1_P#SS/UTHK\B_P#AZC_U0G_S)_\
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M_P#1=?\ FL<8_P#T/!_Q"#Q$_P"B>_\ ,MD?_P \S]=**_(O_AZC_P!4)_\
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MO E'#YAA(Y'*IALTRW-LGQE#$YKG6+I/+,\S%YMFF#PT,5F-98"EBLQ?UN^
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MZ&WX1?\ @^\9?_,#1_P[(^/7_0V_"+_P?>,O_F!K]T:*/^)0O!K_ * N(/\
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M_P P-'_#LCX]?]#;\(O_  ?>,O\ Y@:_=&BC_B4+P:_Z N(/_#]7_P#E0?\
M$;>.O^@C+/\ PW4__D_ZN_*WX7?\.R/CU_T-OPB_\'WC+_Y@:/\ AV1\>O\
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M?A%_X/O&7_S U^Z-%'_$H7@U_P! 7$'_ (?J_P#\J#_B-O'7_01EG_ANI_\
MR?\ 5WY6_"[_ (=D?'K_ *&WX1?^#[QE_P#,#1_P[(^/7_0V_"+_ ,'WC+_Y
M@:_=&BC_ (E"\&O^@+B#_P /U?\ ^5!_Q&WCK_H(RS_PW4__ )/^KORM^%W_
M  [(^/7_ $-OPB_\'WC+_P"8&C_AV1\>O^AM^$7_ (/O&7_S U^Z-%'_ !*%
MX-?] 7$'_A^K_P#RH/\ B-O'7_01EG_ANI__ "?]7?E;\+O^'9'QZ_Z&WX1?
M^#[QE_\ ,#1_P[(^/7_0V_"+_P 'WC+_ .8&OW1HH_XE"\&O^@+B#_P_5_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MARV@'P?\+?\ @D5X8^-/B#QSJ_PJ_:ULOB3\ _A9H6F67Q!^-'PX_9X^*7Q
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MM:N/&_PIT+2O#U[%J7C?PQI<^D3:C)!H^DSZGKGGZ5"ES_P2S^#>N_&;X9?
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MC]F?_NLW_K/WQ6KZI_X.-O\ D]WX6_\ 9JW@C_U;GQQKY6_X(G?\I./V9_\
MNLW_ *S]\5J^J?\ @XV_Y/=^%O\ V:MX(_\ 5N?'&OF*_P#R6F"_[$D__4C%
MG;'_ )%U3_L)7_I%,_ 2BBOZDOVR_P#@D+\6O'?B/]BCX8_L]_LW^%-(^&'@
M#X1_#OPS\??C9X7O?@SX"\6>(O%VJZEIFD>/_$7C"PU+6M"\7>,M>\/Z'H*>
M*(]1FT+7&N+_ ,2:E8Z6ES<"YL:]S'9IA<OK86EBJD*4<2L0U5JU:=*G!8>G
M&<KNHX\TIRG"$(1?,Y2NDTF<U*A.K&;@G)PY-(Q<FW-V6R=DDFVWHDO,_EMH
MK^L/XR_LT_L<>$_VA/VX_P!K?XD_ SX>67[-_P"Q!X?^&/PH\ ?!+P-HVE^#
MO"GQ6^-^K>$O"_BBYN/%VC^&=(L[.5T\0_$7PSX.?[?;ZO;:F+Y-8\2B73]!
MDT^;\H[W_@I%X(\3ZEX=E\,?\$S/V [?Q_:>+;ZR\.01?!;^T/!NL>$]?M)M
M+T[PKXB^'=E?:3'XJ\:6^I3Z==6/C>;7;6)98)H+/PE9O>^?;\F%SFICH*>#
MR^M5A&G1E6G*M0I0I5*]"&)C1YIR_>2A2J4G6<%^[=2,;2DI)7/#JD[3JQ3<
MI**492<HQFX.5DM$VI<MW[UGLK,_)BBOZ,/^"OWQI^%G[.7Q/UK]E7X4?L:_
ML*Z1;^(?@1X??QKX^LOV<_#5E\3O!WCCQL/$2:E=_#_Q)H-_I%GX8FT[01X?
MU'P[<7>C:OJNFWUS+J/]HW DLX[3^<^NW+L;/,,+3Q;P\L/3K1C4HJ52-24Z
M<E=3?*ERWZ)W;6NQG6IJE-TU-3<6U*R:2DM&M=[=UH?U2?\ !4S_ )0B_P#!
M.;_NT/\ ]9(^(5?RMU_5)_P5,_Y0B_\ !.;_ +M#_P#62/B%7\K=>5PM_P B
MZO\ ]C+,/_3[-\=_&C_UYI?^DA1117TAQA1110 4444 %%%% !114]K:W-]<
MV]E96\]Y>7D\-K:6EK#)<7-U<W$BQ06]O!$KRSSSRND4,,2-))(RHBLS $ @
MHK^N;]M3X*_$;]BSX?>#[KX%_P#!-O\ 8(^*?P+^$/[/G@N?XP?';XZ?"WX1
M>(?&5SX^TH7>A^(9IH[OXB>"O&'B*\N(;70;][MO#_B74_$?B#7KB*TN;R?%
MH/@?P+_P1,\,:W+^S=X<\?\ [:/AOX:?%/\ :<^%.F?$'P)\);KX,ZOXC\7K
MKA\'77CCQ5X:N5T[XA6ME;Z-X2T2V=;GQGJT^C6VIZE!?:;8Z,;NUCCNOGL/
MQ)@*M#ZS6DJ%&;G[+DF\95DJ495*SJT<)"K/#NE24*LU52Y834I-)-G7/!U8
MRY(IRDK<UU[-)R:4>651Q4[R;BG'JK=3\$:*_7GX7?\ !*JQN_ %W\2_VF/V
MH_ _[,_A77OC1X@^ WP<GN/ VO\ Q,O_ (M^-_#/B[5? VIWUAIFCZQX>O?#
M_A!O$^D7MC!XBO(;[[-;66H:OKEAHNC0V.H:G^DW[9G[##?M6_M&VG[,/A/X
MO>%_A-\-?^">G[!'PWM+S7O$>G3ZOX>L?&5Q]NN-/TOQ-J$VLZ1<^'=*U[P7
MINCZ[XA\9W#ZY>:/IFB)??\ ".:Y=7\HBUJ\08"G7C251SIQC7EB<0H5U2H1
MHNE3M&2HRCB)NO7I490HS;I3DU4:FE"4QPE64.:UFW%0A>+E)RN]5S)P7)&4
MDY*TDM--3^6"BOV<US_@CWK?B^T_9D\0?LH_M#^%OVE/ W[2'B_QAX,A\:GX
M>^*/ACIG@B]\"P:M<>)=;U6RU74?$>J77A735\,^*;>35;FTT6[NK^PT>STK
M2]2?Q+IC5E?%[_@E?X)T+X!_&WXV?LY_M?>&/VFKS]G'Q98>$?C#X*TCX3^(
M/ $NCZC<ZC8Z9>KX7\0ZOXKURR\:M83WZW$4NDV::7K%I9:G%H^JWNLVB:/<
M;K.\LE*G%8E\U2:I*+P^*BZ=1UWAHQQ'-17U5RKQE2C]9]CS334;V)>&K)-N
M"LES74X-./*IWA:3YTH-2?)S635['X\45_1S\6_^"8VH_&7]I32/V2+3Q5^S
MO\(+7]F;]C#1OB9XO^*WPQ_9]N/ EMKGB.\U"PTC3_#_ ,9KS4?C#XDU3Q1X
MIOK&R;Q#??%34M<A9-.&M7I\'"21Q/X1:?\ !)[X06_B7]BWQ1I'[8>E?%?X
M#_M2_&76_A'+XU\-_!;QGI%Q:^)_#@\0V]OHNA:,OB;4-7UO0_%7B_PIJ/@"
MY\<SGPWI?A$WUMXVNX[[PO;7MY;XT^(,ME"$I59QG.FZRA&AB:ON.E5Q%-<\
M*/(JE;#TIU:=*4E4FDXQC)K6GA*R;2BFDU&[E!:\T8/1RO:,Y*+ELKW=C\/:
M*_3C_@JS\#/V4/@)^TOKG@S]E;QI;7.EZ==7.A>-_@]:Z!\1ROP7\0>'-'\,
M6<VGS_$CXA^(O$4GQ)O/%VKS^(M;N)=$EM[#PF((_#\JSS1B8_0_PO\ ^"-^
MC^(9O@5\/OC#^V!X*^"G[3'[07ARW\=^"_V=9OAAXA\;^);3P))%<:K<:GXA
MU[3_ !/HUGH&OQ>'=-UN_MO#^LZ=I]GJ.KZ)J?A^T\0-<:;J]UIF[SC PPF&
MQE:5:A3Q5-U:=.KAZ[KJ$(<]24Z-*G4G&%*/O5*R3H*#C455TYPG*?J]5U)T
MXJ,I0:BW&<.5MNT4I-I-R>BC\=_=<5)-+\0**_8[P'_P2L\">(?A_P#M._&#
MQY^U_H'PG^$/[-'[2/C7X!:CX]\3?"34]1M_&%EX'ETRVOO&.BZ/HOCVZU9]
M1UB]UC3;/PWX%TB#Q%J>KW5TENFIQ7(: =1XA_X(N^*?#_[3'B_X17?[0O@Z
MP^"'PV^!WA_]H#XE?M)>(O"-SX?TSP=X)\33>*K'2;2[\!S>*KN6?Q#>7W@W
M7[FWLW\7VFG?\(_IE[JEUJUIJ$=MH5Y+SW*E*I!XIQE3C*4^;#XF,?=5%RA&
M;HJ$ZJ^L4%[&$I57*K"*@Y.P+#5VDU"]VDK3A?5M)M<UU'W9>\THZ-WLC\2:
M*_H4_:5^'WPR_9._X([:+X,^"_QITS]H+PG^UQ^U1:^+++XGVGA'5_A^=8\'
M>#/#[Q76GKX/URYOM8T>Y\->-/AIIVGZC8:G=2W-OJ&H:B9F@;RK.#Y,_9B_
MX)D:#\9?V;=,_:B^-'[3>A?LY?#;Q5X]U#X=^#-2O/A9XH^)6G2ZOI[W5H^K
M?$+Q!HFM:#H?PH\)2ZKI^HZ;_P )7XNO(]"M9;6)M0O;-]2TJ&^FEG6%EAZN
M*K*="A'&U,%1;I8B=6O.G9-_5HT%B*<_:1JP=%TW."I.4FKM1;PU13C3CRRD
MZ2JRM*"C%/7XW+D:LXOF4K/FLK[O\GJ*_8/X7?\ !*?P_K?P\^&_C7XX?M>?
M#GX$:I^T)XXU3P1^R[X5E\">)_'UY\;#:ZNF@Z-XICDTW4M#U+PEX/\ %.I7
M.E3Z-K][H6IVD>C^(/#FH:F;"XU_2M/N_P!$OV"/V'/V??V0OVN?VN_&OQ'_
M &@-(^(%Q^PGX"CU2_FUKX':_;Z9X?\ ^$O^&^A^-9/B]"FG^*O%T%U=>"X'
M\8>#;+P7IIU3Q9K.I6=[K&FKI4L>D)=YXKB# 4*>(E2E5Q-:A"<HT:>'Q256
M4:U/#<D*WL)4G;$U:="<H2GR5'*+3E"44X86K*4$U&$9M)R<X7BG%SNX\W,O
M<BYI-*ZMT:9_+517]-OB+_@E9\5/V\/&>G_M$?&;]K_5]2U3XZ012?!SQCHG
M['?C2[TOQS\,O#NC6]EX$\>>/$\&:OHW@7X$VWCK0+.U\2:)HOBW5EU2;3-6
ML)=26V\3WE_X:TSR+X>_\$Z?V*_!?[#'[1WQ)_:.^.EAH7Q-\,_M ^+OV?M*
M^+UI\/\ XP^(O#_PG\:_"_XA7FAW.C>$_"'A3Q5HFG_&:W^*?A33;?7++Q5+
MI]QH/@^/Q.EI<.^J^#?$5M+$>(\NY(IRJU,1[7#T*M#"X?%UW3JUYRI^Y*>&
MH.M3ISA44YPIJ;<'35)UI0I2?U.M=Z14.6<HRG.G&\8I/5*<E%M2C9-V]Y/F
MY;R7\]]%?LO8?\$@M>U_]I;]F[X)^%?C7'KWPX_: _9KMOVF;KXYCX>V5EI?
M@3PC)I^J75U;S^%7^)<Q\0P6MW)X&T]=7@\3:5'._CW3[H64=MIE\Y^*?V8_
MV5[#]J7]L#PW^R_X&^)+0^'?%GBWQWI.B?%E_!<]S]H\)^#=%\3^([;QC+X'
MD\16,UJ=;T7PZERNB7'B>-M/GU&.TEU.X> O-WPS7 5*=:K#$*5/#X9XNM+V
M=9*GAU*M%RG>FFI7P];]U;VUH-^SLXMY.A53C%QUG/V<5S1?-.T796>J]^/O
M?#KOO;X^HK]UM9_X(X?"W3OA[\0/B?:_\%"/A//X+^!?Q,O?AO\ M#^);_X6
M^*K#P]\-=0T_3K&[NK#0-4M/$VKO\2_&"WVO^%- @\*>&[.&UO/$6M7'A^S\
M23Z[I-SIDO+^*?\ @C'XNTC]II?@OH?Q[\+:A\)-)_9WT7]IOQY^T7XF\%ZC
MX-\/>!?AQK6J^+M(MQJWA:7Q'K,G]MSR>#M4U"QL+GQ+I\5QH\%[J%Y=::NF
M7D2\\<_RF7-;%27+&I*3GAL735J:IN44ZE"*<^6K2E&FFZE2-2G*$9*<6[>%
MKJWN7NTE:=.5^:]MI/31IRV333::9^*-%?KS\2_^"6OAO3_"7[,/Q1_9^_:F
MT/\ :$^$7[2_[1'AC]FW3?&,'PE\2_#C5?#GC/Q/JNK:;!?#PAK_ (CU34-8
MTK3_ /A'/$<FH/<7F@2I)86@@6>SU%=0M_5OB[_P1K\'_#KPI^U;<>%OVU/"
M/Q&^)O[)G@,?$KQY\,;#X1:UI+V_A>[T[6-9T:WUSQ>OCG6-$\/^*M:TGP_J
MUY;^%K.+Q'?6 &E-K4FFVNLV5V:>>Y6G33Q$U*I*4%%X7%J4)1KPPTE6BZ"E
MAW&O4A2?MU3M*4>CN+ZM6=[03LD[JI3::<7-<KY[3O%-^XY.R?8_#"BOZ8_A
MG^P9\)_&/Q<_X)R_LG_'F/X+:%/X@_9OU+]I+Q7X<^&_P#\7>$?BY\0[G48=
M(U ?"OXU?&C0OBMKNJZB)+.R^(-[:?$!H? 6A:5=^![[PEX=TG^TO$_AJ"R^
M5O%'_!-?]G?XB_$C]I;XO?##]JWPE\,OV$_@SK=Y;>(/BQJ_PO\ B7J \"^-
M]4\4:E;6GP%\(>%_$OB:?QE\6M2\&:'-X4COO'4.O6__  EU_P"*=#B\-:-J
M=S?306>-/B# 2G*$_;P2I^U518>O4I3C/%5,+0C"4*;E.KB)TVZ5.$)>T5XT
MY3E&25/"54KKE>MK<\%)-0C4DVG*RC!27-)M66LDDT?B+17[B6W_  1:U77_
M -H;]G?X8^!OVDO#WC3X,_M'?"#QA\:/"?QUT_X;ZE87UEX5\(:5I%]+)=?#
M+4_&%O*RZK=^+O EGI\UQXUT]Q#XAO;F[MK>XT1M/O\ H/@C^Q[\)?@_X0_;
M)^,/PZ^-W[-'[65A^S]^S>P\;S?$K]F?Q+X\^'>B_%/Q/K/B^P_X0WX7ZIK/
MQ1\+:+>>);.[^'UNV@_&*+1?$MB-*\4:=<Z3X8>TU>0WESS[+N3FI59UIN-*
M48*AB8I>WQ$L+2C5FZ'+0G*O"=/DK<DU*+3BM+I86M>THJ*3:;<H/X8*;<5S
M7DE!J5XWBT]]S\&Z*_>[P+_P1,\,:W+^S=X<\?\ [:/AOX:?%/\ :<^%.F?$
M'P)\);KX,ZOXC\7KKA\'77CCQ5X:N5T[XA6ME;Z-X2T2V=;GQGJT^C6VIZE!
M?:;8Z,;NUCCNO"/AA_P2ML+GP#<?$K]IG]J+P3^S/X5\0_&KQ!\!/@U<3^!/
M$/Q.OOBUXY\,^*]8\$ZG?6>FZ+J_A^\\-^#F\2Z+?6%OXEU"*[6WAL[[4];L
MM%TE-.OM4I9[E4E)QQ,I<KBDHX;%N51SE5A'V$%0<L0N:A63=!5%%4JCDTH2
M:/JM?3W%K=W<Z:2LHM\SYK0TG&W,U?F25VS\B**^S_V\OV1K?]B/X]2? ?\
MX6=:_%35]+\%>$_$GB76K/PK+X2MM&USQ-:W&H/X;AL9]?\ $,M_%9:;_9E_
M!K#W%@]]!JD0DTFQDA='^,*]'#UZ6*HTL10EST:T(U*4^6<.:$E>,N6<8S2:
MU7-%.VMC&490E*$E:46U)73LUNKIM?B%%%%;$A1110 4444 %%%% !7]4G_!
MLU_S>O\ ]VW_ /O>J_E;K^J3_@V:_P";U_\ NV__ -[U7S?%W_)/9A_W*?\
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M337+.+33:E>T;NZ/RPHK]./VG_\ @ES\=?@9X\T'X;?"SPW\6_VG?$MI\/\
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M2>"D:>UT>"3,&HWUUIOZ>?\ $,U_U>O_ .:W_P#X^J/^(9K_ *O7_P#-;_\
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MQ-\0-!L;*'P]=:%*+W1XYM4MK<2&P_2S_B&:_P"KU_\ S6__ /'U1_Q#-?\
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M(U]CF-[^RB][IRHM23IQI-23F[IP@D_-M[L_GN_:8\0?LLZQXE\+Z?\ LE^
M/B=X0\ ^'_"T>GZUKWQF\0:?K7Q)\?>*9=4U"ZN?$&N67AN]G\%>'[:VTR33
M-*L-,\+6=C;R&UNKZ]66>Z1(/FROZI/^(9K_ *O7_P#-;_\ \?5'_$,U_P!7
MK_\ FM__ ./JO5I<5<.T:<::S.I-15N>K0S"I4E=MMRG+#-MW?HE:,4HI)82
MP.+DV_8I7Z1G22731*?_  7N[L_*W_@B=_RDX_9G_P"ZS?\ K/WQ6KZI_P"#
MC;_D]WX6_P#9JW@C_P!6Y\<:_5+]B;_@AI_PQW^TY\,_VCO^&H?^%B_\*Z_X
M3/\ XHW_ (4G_P (C_;'_"7?#[Q7X$_Y&'_A;?B?^S_[/_X2?^U?^0'??:_L
M/V'_ $;[3]LM_5?^"C?_  2 _P"'@/QN\+?&3_AH;_A4O_"-?"K0_AE_PCG_
M  J7_A//MO\ 8WB[QQXJ_MO^V/\ A9G@S[-]I_X3/[!_9O\ 9<_D_P!F_:OM
M\OVS[/:^#5X@RB7$^&S&.+O@Z>5RPTZWU?%*U9UL1-0]FZ*JOW9Q?,H.&MN:
MZ:75'"8A8*=%T_WCKJ:CSPUCRP5[\W+NGI>_D?Q3_!CQ)X3\'?&'X4>+_'MC
MJ>J>!O"OQ*\"^)/&>FZ+:65_K&H^$]#\4:7J?B*QTFQU*_TK3KW4[O1[6\M[
M"TO]4TVRN;J2*&ZO[.!Y+B/]0=9_X*&_"#Q?_P %:]+_ &[?%WAOXGW?P3T'
M7-/OM$\(QZ1X6N_B)86'AKX0OX/\,PP:)<>,K;PK!,OCJ*W\1WL4?C!H[:WN
M;Z^@FN]0"6<_Z,_\0S7_ %>O_P":W_\ X^J/^(9K_J]?_P UO_\ Q]5ZV(X@
MX6Q,YU*N83YIX/$8%N.'QT;4,4X.KRKZKI-NG"T]TE8PAA<=!)1I*RJ0JZSI
M.\H7Y;^_JE=Z=;Z]#X8^&/\ P4K_ &>_$VA?MQ?!;]K3X9_%WQC\"OVMOCOX
MI^.FE:Y\-=3T*#XK>#M7U/Q#IFI>'M/DM/$'B/3_  \8?#MIX9\(2Z1'#K-Y
MI>F3Z-<Z+>:3XC\/7ZVUK\?7'Q7_ &)?!?[4W[-GCCX(_#?XW>'O@1\'?%/@
M+Q5\0K[QYJ7ASQ9\:OBAJ?A7QN/%>HWEQHMGXDTGX;Z-]ITRRTKPY8:;H5WH
MEDJ+?:I>O-<3101_M1_Q#-?]7K_^:W__ (^J/^(9K_J]?_S6_P#_ !]5A2SG
MA2C*K*EF6(IQKP<:E&,,R5!R=".&=3V7U?D]I[*$(W:<;QC+EYDFJ>'QTE%2
MHPDXOW9-T>9)2Y^7FY[\O,V^^K5[-H_ []NC]H?2/VKOVL?C/\?_  _IVMZ3
MX>^(6OZ7/X?T[Q)'90Z]::#X>\+Z%X2T6+5H--U#5=/@O1IF@6K36]GJ5];0
M,?)BNID0.?DROZI/^(9K_J]?_P UO_\ Q]4?\0S7_5Z__FM__P"/JNZAQ1PU
MAZ-'#TL>U3H4J=&FGA<<VH4H*$$V\-JU&*5^IG+!8R<I3E2O*4G)OGI;R;;^
MWW8?\%3/^4(O_!.;_NT/_P!9(^(5?RMU_?M^U-_P3-_X:6_8B_9R_8W_ .%V
M?\(5_P * _X5#_Q<;_A6_P#PD?\ PEO_  JKX1^(?A9_R*'_  GN@_V#_;W]
MO?V[_P C1K/]E_9/[+_XF/G_ -HP_E;_ ,0S7_5Z_P#YK?\ _CZKR<@XCR;!
M8*K2Q.,]E4ECL96C'ZOBIWIU:KE3E>G0G%<T=;-\RVDD]#?%8/$5*D90I\R5
M*G%OGIK6,;-:R3T?7;L?RMT5_5)_Q#-?]7K_ /FM_P#^/JC_ (AFO^KU_P#S
M6_\ _'U7M_ZW</?]##_RTQW_ ,S'-]0Q?_/K_P J4O\ Y,_E;HK^J3_B&:_Z
MO7_\UO\ _P ?5'_$,U_U>O\ ^:W_ /X^J/\ 6[A[_H8?^6F._P#F8/J&+_Y]
M?^5*7_R9_*W17]4G_$,U_P!7K_\ FM__ ./JC_B&:_ZO7_\ -;__ ,?5'^MW
M#W_0P_\ +3'?_,P?4,7_ ,^O_*E+_P"3/Y6Z*_JD_P"(9K_J]?\ \UO_ /Q]
M4?\ $,U_U>O_ .:W_P#X^J/];N'O^AA_Y:8[_P"9@^H8O_GU_P"5*7_R9_*W
M7KO[/_C#PA\//CM\&?B!\0+36M0\#>!?BGX!\9^+M.\.66GZCKVI^'?"WBG2
M]=U?3-(L]5U/1M-GU#4;&PFLK47^J65JDLZR32^6C*W](_\ Q#-?]7K_ /FM
M_P#^/JC_ (AFO^KU_P#S6_\ _'U4U.*^':D)TY9BU&<)0;6%QR:4DXNS^JZ.
MST?1C6!QB::HZIIJ\Z5M'?7WS\X_V]OVB_\ @F[^UIXX^)'Q\\+V_P"W5I/Q
M\\?ZI\/ EIXJL/@'!\(=)T3PZ?!WA37T@TC2M?UCQB;F/X=:'JDOA^S_ .$D
M^SW'C.6QEU*]MM'ENXT^@Q_P5G_9]F_X*.ZO^V%<_#KXK)\.?!'[,C_!?X#>
M'TT/P5<^,=-\4K;VAM]3\4:7+XZ@T'0M 677_B!8/+HGB3Q'?_V=<:7,-.:3
M4]0M-+^F?^(9K_J]?_S6_P#_ !]4?\0S7_5Z_P#YK?\ _CZKR?[2X1="&'GF
M6)JTJ6'K82DJE+'R=/#UXX>$Z<&L(K1Y,-"$;WY8RJ)?'=;^QQ_,YJC",I3C
M4DXRI*\XN4DW^\>MYMNV[2['R/\ #K_@I/\ L6Z[\'_V*=-_:>^"WQV\<_&'
M]C/7=3N_#9\&:GX4A^&?BF76O$>A7]SXX\6'5O%6G^)?$OBNQ@\.:-XH71+F
MWTZPU[QG9WT6L>(AHGB#4%B^T?A]^T?\ O'?[-O_  4__;G^-/AGXJ6/PB_:
MT^/'@_\ 9Z32/!]SX<TWXMR_#CPQX#T'PUX>'AZ'6-7F\*CQ'9Z'XPOM4UVR
M&KWNBW#Z3J.G/>:I:Z6$.-_Q#-?]7K_^:W__ (^J/^(9K_J]?_S6_P#_ !]5
MSUL9PG4NZ6:XB@YUHSG^YS&:C2>-ACZM&A%T8JA[7$PC4YXJ3BTO=E9)5&GC
MXVO0A*T;+WJ*O+V;I1E/WO?M!N-GTZJ[O\\^ /\ @L=\$/@?\6/V>O!OP8^#
M'Q%TO]C'X%?"KQ[\-U\,ZU>^&XOB]XBUGXD7^E:SK_Q+OK?3=6?PBWB>'5M&
M\Z*UBURT6\E\5>-[UM3L3K%I96'D^G_\%!OV,?@3\._!O[._[)_PH^/.G?!;
MQ=^T'\-/BW^TUXZ^,-QX*U+XO^+O!OP_\>>%_%W_  K[P9H_A/Q-:^%&M[BS
M\.P:+;2ZKK>CV1TI+ZPU*RU"^\3:MXA@^WO^(9K_ *O7_P#-;_\ \?5'_$,U
M_P!7K_\ FM__ ./JMEC^#8NZQU?7DE43AF;5>K3J5JU/$5TZ#]K6A6KU*L9R
MT]HU)Q?+&R=+,7_RZAU2UH^[%J,7&/O^[%QA&+2ULK7U9\2?$#_@J'\(/$5U
M_P %1_&.A>#_ (HCQ_\ MQ:/\/OAS\,!JVF^$[71?"GPS\*>%&\ :Q+XUU*T
M\77^HZ?KVJ>%KV[G31M!TWQ+I;WNG:7I\FM6]O/<:A;Q>$?^"FOP-\#Z[_P2
MU@T;P/\ %2Y\!_L1^#O&*_%O09-/\*Z;)XJ^)'Q!\'VFC:[XD\#VD'C&^L-<
MM]&\0R:QK6B7OBA_"VI7$=_=1M!I4NIWAC^X/^(9K_J]?_S6_P#_ !]4?\0S
M7_5Z_P#YK?\ _CZJEF/!JAR?7:G*H\B3HYAI'^SUED4O]FTY,)>,&M5.4IW<
MGHO8YA>_LU>]_BI;^U]NV[SUO4LWTLDMD?S_ /[9GQ'^"/Q>_:)^(WQ0^ 6D
M_%+2?!GQ!\0ZYXXU0?&"[\,S^,;WQKXS\0ZQXJ\5W0M/"+W.C:1H4&HZS_97
MA_3%U/6KY=+TV"\U35[O4;VY\O\ =6S_ ."P7[ $_P"T-X<_;$US]G_]HJ;]
MHFQ^"ME\,5C'_"M]0^'OP_N[/3_$!GE\ 6O_  F.C:E?R:W=>(;GP]JOB;6H
M-/GM_"<971_"MA>7^KP:EU?_ !#-?]7K_P#FM_\ ^/JC_B&:_P"KU_\ S6__
M /'U5XG-N$L71P]&MF6(<</1J8>$HPS&$YT:L:<:M.K*.&7M(U%2I\R:UY;*
MT7*+4*&/IRE*-&%YSC-INBTI1<G%I.>C7,[>M]TFORJU_P#;:^#_ (L_8N_9
M>_96\2Z'\4-0O_#'[3FL_'C]J7Q%'IWAJVL_'&FZOXJ\67%Q9^#VB\6K>>)-
M=N?"?BHQ2OXHMO"5G!K6DV<<5Q):F*^L_M_7_P#@KM^S+\5_B9^W/H_QG^''
MQQG_ &>OVIO!?PC\&^"[CP!IOP]TGXR>$M&^&?ARZL)]"UA=4\777AJ+2K_Q
M)K7B#Q'I+6^M:]#H]QJ.IJ^D7R:_=0Z?[M_Q#-?]7K_^:W__ (^J/^(9K_J]
M?_S6_P#_ !]5%3,N#ZEW+'U4W4K58N-''Q=.K7Q=#&3J4[85<DE6PU%0:TC3
M@J=N5N[5',([4HM6C%IRI.\84Y4DG[^J<9ROW;;W/R@_X*&_MJ_!']IKX??L
MH_"7]G;X<>-OA5\,_P!G'P7XLT*/PIXNFTV=$U'Q'<>&X;?[#J&G^(M?N?$?
MV33?#,,MYXDUT:;J^I:MJNK7,EA%]HEEG^G/V2_^"DO[(G[)'P,N]-\$?#_]
MJ6Y^*VO?"&\\&^._@[JGC7PIKW[)'COXFW5G#97GQ>OK#7]7O_&/AW7];CM(
M+;4[/PWH=GI,>A-_8#Z9J+VEGK"?8?\ Q#-?]7K_ /FM_P#^/JC_ (AFO^KU
M_P#S6_\ _'U5SS7A&>#IX"685WAJ=2=5P]GF7-5E4JSK3]M-X=RJ\U2<I\TG
MSQE9QE%ZB5#'QJ2JJE'GE%1OS4=$DHKE7/I912TT:T::/G;X6_\ !3O]@T^'
MOV$/$GQV^!?Q_P#$'QA_8H^'FE?#OPY:>$V^'MY\+3<:19^%M*M/B3#:ZEXJ
M\/:]KOC"SA\(6.N:)IE_%H>CZ1KVJ7TM[<:]<Z;HVKVW>?'+5?%?P9_8)_;O
M_:$^)J2?#CXL_P#!3;XZ>%]6^$'A;6=:\-ZIXYOOV<]1U2T\<Z##J6DZ%J6M
M)X?BC^'_ (@\7^&-=T^^EBU#0Q+I^F:LFGZQ<:8C>F_\0S7_ %>O_P":W_\
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M.ZO^V%<_#KXK)\.?!'[,C_!?X#>'TT/P5<^,=-\4K;VAM]3\4:7+XZ@T'0M
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M )F#ZAB_^?7_ )4I?_)G\K=%?U2?\0S7_5Z__FM__P"/JC_B&:_ZO7_\UO\
M_P ?5'^MW#W_ $,/_+3'?_,P?4,7_P ^O_*E+_Y,_E;HK^J3_B&:_P"KU_\
MS6__ /'U1_Q#-?\ 5Z__ )K?_P#CZH_UNX>_Z&'_ ):8[_YF#ZAB_P#GU_Y4
MI?\ R9_*W7]4G_!LU_S>O_W;?_[WJC_B&:_ZO7_\UO\ _P ?5?JE_P $S?\
M@F;_ ,.Z?^%V?\7L_P"%P_\ "X?^%;_\TW_X5]_PCO\ PK[_ (3W_J??&_\
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M-]/N(KR/P[IWB"WM-5M/:_\ B&:_ZO7_ /-;_P#\?5'_ !#-?]7K_P#FM_\
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MX/!XBEB*=2I3Y81Y[OGINUX2BM(R;W:6B/U2HHHK\N/;"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#P>:G_ /)5<Y11[.G_ ,^X?^ Q_P @N^[^]G1_\)CXN_Z&GQ'_ .#S4_\
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M2<4XR2MUHI)N4O>O:RF_A=F[)-I)_:=EJG>S1^IO_"8^+O\ H:?$?_@\U/\
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M^+O^AI\1_P#@\U/_ .2J/^$Q\7?]#3XC_P#!YJ?_ ,E5SE%'LZ?_ #[A_P"
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M\^UO]E[PKXB\2?'C7-9_9?\ VU[W1_VAX;J?QQX ;XK?LDP^ K#Q/<Z]X?\
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M+>R3?PZ7=E=V23/Q5\%_L^_%'XU?#/\ :2\&?VC9:IK'P,\,:C^QA\#M?O\
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M+9W5UJ?AJ\6YM+,_0VI_L^?"36?%/CKQAJGAF\O=3^)VBKX?^(FFR^+/&?\
MPAOC;3H]!@\+PGQ/\/4\0KX!UG4;;P]:VVD6FMWWAJ;6K2RMX8K;4(O*0KRN
MG?LD_ G3='\2Z&OASQ5J5IXK\$0_#/5;KQ'\6?B]XLURV^'45P+F;P'X<\3>
M)_'>K^(_!W@_4Y4@&O\ AOPAJNAZ1XCAL["VU^TU*VT^QBMSZSA)<KG3;DH4
MXRM0I6;A0I4TU:I#E5.K&=5V2>(C)4JCA%)HY*BO9JUVU[\KZR;L[Q>\;1Z\
MK3DKMGP[XL_:9NOVE/V9?B+\7+SX=^##\,/#?Q3_ &=/"7AOP)XEU77=1\3R
M>/7^*'PFD\7>(]?U_P"'GCK1+,>'=*E\:Z?-\-;.R>&3Q);:58^-M<6Z\+^)
M;'PU)]>>!_B;\<?BGX^^(5WX._X51HWPQ^%_QHN?A'JWASQ+I'BR^\>^)[;P
MU'H[^-O%=AXTTCQ-#H'A>XMTUDS>%?"M[\/_ !&-:.EK!JWB;P_%K27^C^A:
MU^S1\$=?G\63:AX&ACC\<6_PXMO%6GZ3KOBC0-%U9?A'JVDZS\.)GT'0=;TW
M1;6]\*W>A:/;V.H6-A:W\^CZ=;>'K^YN] C_ +--BZ_9V^$5WX\O/B.WAW5+
M;Q+J>NZ#XIUJWTWQOX\TCP?XB\4>%GLI?#GB;Q/\.=*\3V?P\\3^(M$N=,TJ
M]TW7?$'A;4M5M-0TC1]0BNUO=)TZXMB>(PDH2A"E."YIRIQE"-6--3AAHN-I
M58WDW2JWK:3=XR45)VIBA433;B]%S.[3DTYZW4=%K'W=M&N]_P X/A9XA^*U
MWH_["^G_  ?\1^!O@_X<\5_$#]JW2+GP:OACXF>,O"=Q?^&[WXU7TEYXCL[S
MXXZ+JOBO2[M=-&J6.AZEK49T+QG/_P )%IVI#2;2Q\*VW?P?M 7'P@T[XS1^
M"O!&BZ3XC\>?\% O%7PF@U33O"7Q<^)MK'>WGP[\.>,O$/Q&U_P%X8U?7O%W
MB_Q"VAZ#?V-KX+\!7G@O2]0NTTR>VMM#L++Q#JC_ &E/^S'\%I?"7@WP3;^&
M=8T;1?AYXB\1^*_ ]UX8\?\ Q%\)>*_"^N^+Y/$DOBB[T?QYX8\6:1XYM(->
M_P"$N\0PZIIR>(O[,N[34!92V;6EG806NCJ7[._P>U;2/%.B7GA*06GC'XDC
MXPZQ=V7B3Q9IFNVWQ/6'2K>+QOX9\3Z9KMIXD\$Z]!;Z-86UK=^#-5T#[+;B
M[@MDBAU+4DN[EC,+.;<Z=5TY.I>/+!2:EBJE>$ISYVZLE"<4XU>9<T&N9J;D
MI5*<5HXIJUG=VTIQ@TE;W4W'>-G9]&DCY;B_:,_:0O/A_KE[8?#?49-7\+_&
MCP]X/U7XDS_LT_'G3M%U/X1^(_#S:K_PM#PQ^SAX@\0:!\;O$&H>'/$UQ8>
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MFY'*3AS**ERMNUU!*"=MU%**V6EC97LKVO97M=J]M;7UMZZ]PHHHJ!A1110
M4444 %%%% !1110 5Z-\)?\ DH/A_P#[BO\ Z9-2KSFO1OA+_P E!\/_ /<5
M_P#3)J58XC_=Z_\ UYJ_^D2*A\<?\4?S1]I4445\J=P4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!YS\6O^2?>(/\ N%?^GO3:^+:^TOBU
M_P D^\0?]PK_ -/>FU\6U[V5_P"[S_Z_2_\ 2*9RU_C7^%?FPKX=^"GP/_:=
M\%?M3?';XI?$OX[?\)Q\#_'4&J1_#3X8_P!N>)KW_A%);S7]*U'1G_X1[4K"
M#PUX6_X1C0K34?#F_P ,WUZ_BC^T/[8U@07L8CK[BHKUZ=:5.-6$5!JM!4Y.
M4(R:BI1E>#DFX2O%>]&SMYV:YY14G%N_NNZL[*_GW04445D4>?\ Q8TN^UOX
M6?$O1=,MY+O4M7^'_C+2].M(4>2:ZOK_ ,.ZE:6EO%'&KR2237$L<:(BL[,P
M559B ?SA\7:OI'BS_@G[^QOHV@:I8ZAJ'B_Q)^Q9X)\/013<ZAXI\/>+/ [>
M(=&0;=R7F@1^$?%$VM12*ITV'P_J\EUY:V,Y7]7J\TTCX+_!WP_XROOB+H/P
MF^&FB?$'4[C4[S4O'>D>!/"VF^,M0N];>236;J^\3V6E0ZW=W&KR2RR:G//?
M22W[RR-=-*SL3UX?$1I)<RDW3K0KT^6UG*$9+DG=IJ,FXOF5VDI+E;DG'.<'
M+9I7BXN_1-IW7FK/1]UKIK^?'C+XO?M!:?X:_:[^+VF?&2^L]._9X_:%MO!O
M@KX:IX'^'4GAC7/#.G6_PEUC7M&\<:S=^%KSQEJ5EJ6G^,K_ $_1YO#&O^#M
M>T:Y-W?7WB#74N--L]#YG]JGQI\1/'GPJ_X*$WFL?&'_ (5OX1^#-L_PMT+X
M3OHWP^DTSQ)IVM_#7PKK/]O^-=2U[0W\>-J/Q0U'QV=&^&4GA?Q?X5TZUU#3
M=)C_ +(\83Q:KIVM_J1/\// %UIOB;1KKP-X/N='\:ZL^O>,M*G\,Z+-IOBW
M7)8=.MY-9\36,EDUKKVK20:/I$#ZCJL5W>/#I6G1M,4L;98L+Q)\%/@UXR\0
M2>+?%_PE^&7BKQ5-H]WX>E\3>)/ ?A77/$$N@7^GWVDWVAR:SJFE76HOH][I
M6J:GIEWIC7)LKG3]1OK*:![:[N(Y.BEC:$)TYO#P3IN+3C2HWM!X65M8I<TG
M1K+VKO./MG)7]Z,I=.33]]ZK5.4K7?/KOLE)>[HGRK;2WY_>*OBQ^T]XF^('
MQC\!?!>Q^)C7GP8\%_"&+P%I/@.P_9ED\&^(/$'BSX=6_C07OQFN/C=XMTCX
M@2>&M;U6?_A$[1OA6OAV32]-T#Q#>QZIJVO/%;Z;W47Q.^.=_P#$[]I;5M:^
M(%QX,\.?L]?"KX:^/8_A+8Z'\/[O2+_Q9XB^%>J>+O$&@>+/'-_X>UK7I_"5
MEK&@WD$Q\-:EH^L2F[>ZL?%-K86\-C+]A>-/@;\$_B3=:=??$3X/?"WQ]>Z1
M8+I6DWGC3X?>$O%-UI>EI(\R:;IUQKFD7\UE8)-))*MG;/%;K([N(PS,3<\4
M?#+P]KGAOXCZ/H4,'@/7OB7X0N_".L>.O!^GZ?I'B^!/^$>O_#OA_58]7MK>
M*YNM1\(6FH2/X8:]EGCTED6.T6&$LAGZUAW&,?J]*/[N%-R=&#DI<V']I4E-
MRGSN<:=5IJG"=-U6HREJV>SFOMR>M[<S2:2G9))*UFXW7,U+EU['YAZ%\>OV
MFM"\#^)_CE%XE^-'C_PEX%_9*_X6;XJ\/_%?X)>'/A5X-'QYU9+67^P=#\GX
M.^"?B!XJ^'7A/15\0>*M2N/"/B37K&QT_1]*AU+XFZFFM).?5O'?C7XG?#;Q
M!H/@>X^.3?M#^'/BS^S3\<_&FL?\)3X+^$;6^@7'@3P;IFI:+XX\/6W@'P?H
M6E7?P[\;W>OOHIT3QO#XVL;L+86UIKFI+)J?G>D_!7]C.R^%7CWPQXXN+SX.
M:8?"G@;Q'X'72?@=\!E^"47CNT\3)X:BNKKXO7DWQ)^(LWQ#&FCPU#>:)9RQ
MZ-!9:UJ.I:M<M?S26\=M])>$?@?\%OA_;Z]:> _A!\+O!-IXJL5TSQ/;>$?
M'A/PW;^(]-1+J)-/UZ'1M)LH]8L4CO;V-;34%N(%2[ND$86XE#[5<5@XS_=T
MJ=2-I?#AZ=-2NN6";E",H2HR3JJ=*,?:\RI5-(<SF$*C7O.2>E[S<K6LW97:
M:E\+3;Y?BCNT?!'PQ\4?'#XEZ[\%_ACX1^,,_P )?#\G[ ?P2^+TD7@OX=?"
MC=+X^UN76_#R"R@U[P/KOA_P[X2=8M,:_P##6B^&8K6"TTBPLO"S>%XC?G4.
M ?\ :I^.'Q#\(?"DZ9XH^)7A3Q+XB_8V'QD0? ?X*6OQ4U3Q7\9M;UB[\/\
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M_P#"3_%K_A$/^$5_L_\ X1?_ (1?_AF/QW_8'_"-_P!D?\2K^P?[*^R?V/\
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M\2[^U?LOV'[=_HGG_:/W=>4O^S)^S;)H5MX7D_9[^!\GAFRU:^U^S\.O\)_
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M2)\?-#NYM<\01:GJNC:/-I7PK\06T6J:6\\.DZVZ3:2/T%KXZ^%WP_\ C_\
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MK_N/^$A^Q_Z?3?B#^RS\2-?^('QA^)'AO6_ \6L:S\:_V=OC3\,=+UVYUO\
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M^9W[3WPP\7>-_BY^S-X5U+5/#L7C+X]^%]7^%G[0]CX:MM1AT/6_@Y\.M?\
M"WQ>\3GP\-7N+N[MK33-134_ -I?ZIYT]_9?%6Z$FG6L]Y%%8_J-6&(I4:=.
MC.G*3=92ERRDI<D8/V3=U"'-SU857!I*T(Q33E=JH2DW)22M&RNDU=M<W5NU
MHN*:UUOK8****Y30**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ KT;X2_P#)0?#_ /W%?_3)J5><UZ-\)?\ DH/A_P#[BO\ Z9-2K'$?[O7_
M .O-7_TB14/CC_BC^:/M*BBBOE3N"BBB@ HHHH **** "BBB@ HHHH ****
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MA%TE3E&DGS.4JD9RE2BVN6*YZO\ *D[;<LG9WAI=.SNG.VW*TE)K=^F_%/\
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M_'/AC5?CO/XZ^"OBG3?$&A>(O'FA>&=4T7]GC1-#T/P'X8O_ !3H%MX<\?\
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M/4/$%FEW#/KGAH:!9Q7-U#-K\Z164TGQ36Z\'_M>?LT>/Y9!#X<\;>#OB_\
M 75KRX6.*QL-=UR/PM\3/!UM)>R_)%=>(KOX<ZKI5A"S127FH1V5A:--<WRV
MTM2A2>)ERQI<KP;E&%.2G35:."?.D^:I>4:T9M*4G*4E%W:DFU>2@KN5_:)-
MM6;BZNG1;Q:6BLDVK:67H6F?M1_ [5_$^G>%;#Q??R7&M>+;SP#H?B.;P1X_
ML_AOK_CBQ_M!;CPAX?\ BU>^%K?X6Z[XD-QI.IV%MHND>,+S4+W5=/O-(LK>
MXU.WEM%WO WQ]^%OQ*\7>*O!'@;6]9\1:[X(UGQ)X;\736G@;Q[%X;\/>)/"
M.MS^']?\-ZIXUO/#%MX,MO$=IJ%N\EOH+Z__ &OJ>D26WB#2K.]T"\M-3G^2
MO"O[+GQILO ?P9^ 7B"\^%\?PH^"OQ?\+_$+3OB1H?B/Q8WQ&\5>'/AWXRO_
M !OX/\/W/P\E\#Z;H?A77]3U#^QM/\2>*=.^*6LI;VEMJEUI>CR7.I0I8_3G
M[/GPL\0_"C2/B?I_B*\T:]F\:_'SXT_%/2FT6XOKF*W\/?$;QQJ7B;1+/4&O
MM.TYXM9M;"\BAU6WMDN[&"[62.TU&^A"W#36I8.$*CIU)SDG:FO:0:E%RDHU
M96I*W-%)NCI.G]J;O9.,JC:O%)=79K6RO%7ET;MS6L^BTN><G]K/P-X3_: ^
M-GPH^+WQ%^$/PRT'P+H?PEU3P'=>,/%VC^#-;\22^--(\2W_ (K$T_B?Q);6
M>L0:-/INC);_ -C:=9MI\>H!=2DNGN[5X^,\-_M4^-/%'[)W@GXOZ59^!KOX
MJ?%;XB7/PN^&NF6]IK5QX&U3Q%J7QEU_X>^'=0G@M]?FU.XT;3?"6C7/C;Q'
M+!XCM5NK#1M8GT^ZLUEM+5/>/ ?PK\0^%_C]^T!\5-0O-&F\/?%;1?@QIOAV
MSL[B^DUFRG^'6C^+]/UM]:MY].M[&WBNIM?LVTIK'4=1>>**Y:[CL72))OE[
MP%^Q?XQ^Q? /PE\4?$FGGP'\%S\=/%SV_P ,_B!\2O!_B?4_B?\ $OXC:YJ7
MA'4K3Q'X93P3KEAH_AGX?>)->L[J>QUO3KZ77=9O]+>SU/0I&NY=8_4=')).
M'U.<M5)5.3!U)5J<(6A9SQ"IPJ)S=Y2NG!7LG[6^G7VB6EK7J146W=K2#;7N
M[+5/K]9_L\?%6Y^,WPB\)^.=6LK'2?%4L>I>'_'FA:=)(UKX?^(/A'5KWPOX
MVT:".XFN+R"TM/$FDZB=-BOII+MM*DL9Y99O.6:3RO\ :=^*/QS^"7A?QA\8
M= E^$=S\,_ 47@F=_ VM:%XPU/Q_\0O[3\4:;I7B6QT[QI9>*_#WA[X?ZO>P
M:M!HW@FQE\$?$J*\UN""_P!5O(+?5O['TG-\ ?LGIX1\2?&'P]<>(?&,7P5\
M8^,] ^*'@6S\._'GX\:#\2M(\>7_ (6A\/?$X>*_&>D^*]+\7>)-%\3:AIFG
M>*+.+6O'_B"W_MJ^U:>31[&6.SG.7\1_A'^T#K_QA\(:S9:#\*_B!\$_A+;>
M'-2^%G@7QM\;/B-X6UF?XA:38PHOQ$^)EY)\%OBS=>-M>\-W0<>"&O?$<G]G
M7T7_  F>J2:CXKN;:?1YA'#+%.4)0E1_BNG54(Q]G+DFJ$)RJ656TG1DW;V=
MISA*3C%@W/D2:?-\/-%MOF5USM)?#IS6ZZ)I:GJEG\0O$^D?M7ZO\)=:UE-0
M\(^,_@I8_$SP%836&G6L_A_6O!WBL>$O'VDV^H6MI;76JVFK6OB/P=KUO#J=
MQJ-]9W,>MBVDMM,6&WC[;Q)\=?A5X0/Q2'B3Q4-*/P6\/^'_ !5\21-HGB*0
MZ!H'BJVU2Y\/:C;BWTB8^(4U9=$U:"U@\,#6;HZA83Z8\":DHM3X;:)JGC+]
MM_2;^:VBA@^#7[,=Y8^*3I=R^H:5IWCSXS^-M!O[7PZFK7.GZ9<7_P!D\._#
M:\U-"VG:?<26>H:1?SVFGB[^R2V/CC^SGXH^(_QJ^&/Q#\,:GX7LO#"V.A^%
M?CGI'B#[:]]XL\$>!OB5X8^+?@33O#]O;Z1?V5W-;>*M(U[3-;L]8N["RO/#
M_BK4(5EDQ/:7DNG0=2C&J_9)X:G.;ARQ7-%\VMHR3E5P\5RM)\U6I"<FTY7=
MYVDXJ_OM*Z>SLNK6D9O772*:5M$MSXW?M*^&/!?@'Q+?>!_&_@:S\;VOPKTC
MXQ:!>>.] ^(VK^ H_ .J^*-'\/6WB77I_ .AZAJ[6FHRZD]MI&F:8S:]=W0-
MXFFR:5I^JW-MS/B7]J^SG\9_M'?"/1/#?C?1/%/PE^'3:[X?\9OX ^(-[X?O
MM<NO!OCSQ!++JE_??#Y/!GA?3-(F\(PCPWK7B/Q)/X?^)%Q>-9>%I=2GM);2
MX\6'[%'Q.E^!?[1/P[U'Q7X.U3QAX\T7PC\)OA%J=UJ.O_V)X<^!GPKU)[OX
M;:)KTQ\.RWVC:P%UCQ+=:[IFA:?K6EQ7L]CY6J:H_GWJ^[^)_@O\3Y/BK\?]
M?\.)X#U+P7^T%\(?#7@B_OM;\3^(=!\4>"/$?@[PO\3]&T][/P_8>"/$FD^+
MM$UR\\7:$;R]F\4^$K[0;:/5IH-+U^6VL[:_U5/ P3CSJK*+FXRE.,$VI8*2
M=G&THJ#Q*4)-\_)-0M.46IO5;3MRIVNK7MI436^]^356M=7ND[V/V9OVGO!/
MQ6\#_!?1-6\6W^H?%7QA\(O#_BF_N-4\$^)_"FC>-M=T?P[X:/Q(N?!/B*]\
M+Z'X!\8W'A_7]9">(],^'^IZHGAZ666&XLK&"SF2W]>^)?QR^&WPD98_&NJ:
MZES_ &/?^([FP\*>!/'WQ%U32_#6EDK?^)]>TKX=^&/%6I>'O#-M(KPOXBUR
MUT_16N(IK9+YIX98T\:\*?L^^,-"NOV*+B\U'PO*?V;OAEK7@KQLUO=ZH\FI
MZEJ?PK\.>!XY?"9ET6'[;IW]L:++<SR:LVA3_P!G_9IEM)+K=:19O[2WP4^-
M?Q6\46Y\(>([&X^'=W\,_$7A";PE<?&?XO?!$^'?'&MZBF/B+=R_"#2+ZY^+
M=BFA^5IG_"N_&6IZ!H-L;"=K+4HI/$NJ7%KDZ>$GB8I3<*,U4E-*<$X-5:L8
MQA)TXP2<(PG%225I64F^5.DZB@]+R3BEH]G&+;:YKNS;3:?3;<]$_:,^)VH>
M&_V5_BU\7_A=XCM%U#3?@]XA\=^ _%>GPZ9K5@[?\(Y+K'A_7;*'4;;4-(U.
MTFC>VO;875I=V5U"Z&2*6)]I7X6?M*_"OQUIL6GMXRDM_$6B?#73/B/XBNO%
M/ACQ/X$TC4?!_D)!J?Q%\,Z]XL\/^'?#'C#X?K?))(_C;P1J&M>#DM;K3[R+
M55T_4M,GN>2U;X!>,;_]AJ+]F:'4O#2^/(_V:M%^#9U:2\U0>$3XGT[X>V'A
M.>_%^NC/K/\ 8+ZC:R3171T :@UD4D?2XYRULM7Q/\!OBA=>,]'\9>"?%WAC
MPEKNB?LA?$/X$:1XCDAO=4U'1?B-XEUOX<ZMX:\46NERZ6ECJ'A_1)?"&I74
MCWUXERE[+8+_ &#?VT]ZD1&&$=)TY32FJ]?DJW2]Q0I>S=3]W*4H3:GRJ+7+
M)R:4KV8W4YDTM'&-X[ZMN]O>235];[KMN=Y:_M5_ VXTSQSJMSXHUW0K?X<^
M"4^)/BJV\7?#?XG^"M8B^'\DFI0KXTT+P_XN\&Z)KWC#PR9])O;8ZSX/TW7K
M 726]JTPN+VQCN.*\8?M6_#C7_AY\7%^%OC*_@\?^'_@9X\^*G@J36O OB[P
MW!KVC:1X>U.?1_'G@2X\?>%-+\._$GPG'J<>GW$6N^%9/$_AF[MKK3[B2XN-
M.U.T>Z^'_BM^S=\6/ 'PL_:3^+'Q N](2W'[$GC[X57ED?CY\;?C_KVJ>)(K
MRR\23^+4U_XPZ!HC^'=(UB.VO8I/!^A016&C7MM%>PW.K'6[A-$^A)/@-\;/
MC3H7AW6_'3_"SPXGA3]EGXG_  J^&@\)^(/%6K2>+O%/QJ\'>&] O/&'CF/6
M?!6G-X!\/6.F^&M+FM_!?AZ\^(E_:WVKWSW'C/6H=$LTUCH^K8&"C5]K)P]H
MXWE4I22E"G2GRN$:;]JIU)\LN22Y(24G?EE>.>J[QY4I6Z*2NF[73<O=LKM7
MO=JRULCVW2/VG_ 'A#X=_"FX^)WB/7]1\<>)/@KX7^*'B2S\'?#CQW\0=6L=
M$GT/3'UCQKXFT7X5>#_$G_"&>&KW5Y;^*PU;6['0]"O[FPUBTT62?^P]4AL-
MF/X^:%+\3EMXOB!\+)?@^W[.=S\<AJT<GB63Q#_9EEXF6TN_&Y\5);M\-5^&
MEOX?8-*K:J/%*:H'O3:_V'').OCWA#X(?M"?!37KWQ'\++;X,^-;KQC\$?@Y
MX"\5Z=X_\8>-/!D/AOQY\'/#%]X9TK7?#^I^'/AQXSN/%GA#5+?5;F6_T+5+
M+PEJR3VD,UGK%JM_<6]KY]-^P%JL/A*3X:V7CFPG\*I^Q/K'[-4/B6YAO++Q
M!-X^U#QK#XQB\5/X;M;:YTVT\&&^1W?1HO$MQJ-M8LF@I+<HIUEL_98'F;=9
MQ4VO>3C)6EK4<:2@I4G1E:$%*4O;*\X<L58=ZMDN75=-5M9*\KM/F5VVE[KT
M>N_IFC_M6:'XZ_:0^&OAKP;XMU:P^&&H? ;XJ?$KQ98>-/A]XC^'#W,6DZS\
M-QX.\<Q2_$WPCX7\2'PD^DZIXK%AXATB8>$-6,&JB2ZO;O1)18>R>'/VJ/@;
MXI34I=+\5ZO;PZ;X%U'XG13>(/A]\2/"4'B+X=Z3 EUJ'C7P+/XK\(Z+%\1/
M#5M:S6ERVK> G\1V;VVH:7/%*\6JZ:]UX'XC_9X^.OQG\6PZQ\6'^#_@#0Y?
MV9_C7^S_ 'FF_##7_&?C"]M=3^*]KX.MF\::9<^(?!_@*W72ECT>]BM_!C6T
M%WX;_LNSF'C+Q9_PDLMOX/Y[PC^R3XUB\/7.E>+_  =X7;Q;HWP2\>?#7P;\
M1[G]KC]IGXLPV>N>,/!L'A'4+FP^%?Q,\(GPQX$\/>)5AAN]4M]$U[7KK0+>
MRT_3-/BUM;6&\AJ=+ N,;SE&4*:BXTZE"5GSU7S5)M4U6;O%-TDY1BD^6:L@
M4JJD]$TW>[4EIRP5E%.7+]I^\[-]5J?0>E?MA_ ?Q'9W-QX6\2>(M?G;P9K/
MCSP[:V_PR^*]N?'?AW06M(M5O?AU-<>!57XB)IES?V<.KQ^ U\2W>CK+)-J%
MK!%:W+1><^"?VN9_BCX:_9A\8>';/2? %I\9O%>FZ#XK\-?$KP?\8XM2NI-4
M\ :SXOCT3X2>*1X&\/>&_%=U;2Z:93XWO(T^'^H:7:7T-GJ8U>:RM7WK']G7
MQ;'=?LDR76J>&4C^!'P;\;?#?QE/!/J<]Q>:GXH^&_@SP=;W?A:.32;==0TR
M+4O#EU=71U6XT&X:S-DZ6TEPTD%MYSX&_9I^--AX,_8]\'>*C\+[)/V6?'VC
MWMWJOA_QCXKUIO&G@[1/AGXJ\%6^I6^G:C\./#XT+Q+<W^MV,TWAZ34-5TN&
MSBNIT\4RS"&R>5# J$G&3YO>:]I5C)Q7+BHI6]E",^:4*$](J4?:1MHFV-U6
MUIVV32>M)O6[M9.:WL^5WO=6^E="_:9^"/B+6;S1M-\:E8[.U\87D?BC5?#7
MB[0/ASJ]O\/[B2V\;MX7^*FO:!IOPU\7R>%'MK^37H/"WBS6)]-M=(UR^N8H
M[+0M9N+'QWXR_M5^&;CX&_M":K\(?%&NZ%\4?AS\%==^).B6WB[X;^+_  5K
M$6GR66L0^'_&FA>'_BSX-T2#QAX9.KZ3/;'6=+TW7O#HNDM[6^F#7MI'<5?A
MC\'?VE_AE\'I?@%X9\0?"3P[H7A3P7\1_#O@#XPV]YXHU_QO?:EJUQK#?#?4
M=2^&]SX5T/PQX/O?#XU:VU#Q)JB^-_B3:ZKJ&AF*U\-PV^OR2Z)X')^Q3\<]
M>M/BW<:YJOA/3]7\>_LE^)OV?[(:[^T'\>/CM-=^-=6UC3=73QGJ'B?XI>$K
M;4/"_AO5&CNTO/"GAC2+BWT2XM4OK7^VY-;GAT6J5' QJN4JJ<(5:?)S5*<U
M4@JJO*K#V<7RU*6OLXN4H.ZJVTBQRJM*T=6GS:--.W1\SU3ZM)/>/4^O?CE\
M9O%7PD_9/\1?&S1XM$U7Q;X<^'WAKQ)&GB.TN)-$O-0U%]#AO9=1M-(OM$F$
M##4+B81V5[8I%($VE84,1YN^_:Z^'_B'XY_L_P#PL^#_ ,2_@Y\3-/\ B5J?
MQ)M_'7_")^,M$\9Z]X>T_P )_#O5_%>A7=E_PB_B6>#25O\ 6-.6TNI]8TZ_
M@NK03V]FMM= 7*=7\>?@OXI^*/[+/B?X(>'[_0+/Q7K7@;P]X9M=0UBZU&W\
M/1W^DSZ++<S7%W9:5J&I):.NFSB"2/299F+Q"2WC#.8[_P 7_A9XV\7_ !5^
M 7Q(\'W/A9/^%.W7Q<U.]L?$M[JUI_:5]XT^%VL^#_#4-J-+TG4?,M(M>O;2
M77'EGLIK;2!<SV"W]ZD5G)C3^JNG::7M'+'6?,HJ/^S0^K<RY6VG6O[.TH*,
MKMW6A3]I=6>G[J^EV_??/K=6]VU[IZ?,\QTC]J#Q->_M.2_#NYTKPPGP0U/Q
M;XM^"WA;QBL6J6WB6[^.?@;P3X;\?Z]I=U=W>I?V//X<GL;_ ,6>$]/@@T>V
MU!O%W@O4(8M0OX+F"(?6_C'5]=T'PMK^L^&/"=[XZ\1:;I=W=:)X/T[5-%T.
M[\1ZI'$QLM*CUGQ%>Z=HNE)=3E$GU#4+I8K2W\V=8;J5([2?\^Q^PAJ.C_ C
MPE8>'/&&L3?M+>$?$'A7XMV7BO7OB[\9+GX1O\<;+Q?:^-O%^NK\/)-8O_!,
M&D^)+RZ\4:%)>I\,FU"72->NKVXTT:I=73'[*A^'3>$+OQ5XZ\$Q>)=?\?Z_
M::A*/#?CWX^?&6^^&S:CJFHP:I=6NGZ5KMY\0?#/@>QBNHS%IMYX2^&<4NDZ
M:&TC2M,L-)N9[$&(6$<J;H._)>BXRBHJK.G*-JLW[:+A3K1DESIQ=X3?+"Z8
M0]I9\ZWM*]_A4EK%+EU<6MG?1K5ZG"?LJ_%GXA_%_P !>+M7^*6C^$="\9^$
M/C!\4_ACJFF^"'U:?P_"WP]\4W7AS_1KW6KF>^U*0R6DHDU-H-+BU#:MU%H^
MEK)]CBDTOXIZAJ?[0_QAT"Y\26F@_"[X%?"SP7/XOBU:+1['3YO&WCN;7/%U
MSXBO-?NXOM6GZ1X-\ >'=-\QI-4L=-D?Q5JMQJ5C+_9.G7\>)^R[\.OC+\,(
M?B;I7Q,T+X96>G>-OBU\4?B[INH>!?B+XJ\77MK>_$WQG>^)W\,7VF:_\)O
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MO-7_ -(D:P^./^*/YH^TJ***^5.X**** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%M3\)Z5K$K:D\NK:;X<O=*GT>QU.5]:UAI+^ULXKIVU;4F:4F_NC+MV'P]\
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MW++=)J4]V]ZMS)).LPE=F*:=\#_@MH_BJY\=:1\(/A=I?C>]UNZ\37GC'3O
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MCGN)M0@OQ=Z9=MIZ_J;_ ,**\(_]!'Q'_P"!>F?_ "HH_P"%%>$?^@CXC_\
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M1\+?"_P#HUG?ZW*=3U'4]0TQ=1O;J*U6^UEK2SM+>']J/^%%>$?^@CXC_P#
MO3/_ )44?\**\(_]!'Q'_P"!>F?_ "HIPSV,)*2J3=JBJ-2IW3DI0DTVK249
MNG!3491YU%*5[*P\*Y)IQ6L>71[+6WE=7=FT[-ONS\E=-_9&\,:CI&N#X@>.
M_BCX\UG7_@GK7P,TJ]\7:QX0N[[X7^!/%^F/9>*]+\#W6B^#=*2_UK4U&EPW
MWC3X@'X@>+]1C\.:2E]X@O89M;76?6;+X(^%+'Q+\&_%,.H>(6U#X'^ ?%/P
MZ\)PR7>FFSU#1/%UEX'L=2NO$,:Z2D]WJL$/@#1FL9]-N-)M(Y+G4S/8W*S6
MJ67Z(_\ "BO"/_01\1_^!>F?_*BC_A17A'_H(^(__ O3/_E142SJ$MZM2R4D
MDH6BE.#A-1BK**E%M222NVV_>;;%AFOLKI=WU;333;ZM-+[K;:'X>_L__L8Z
M=8?LR>-?A3\2]/U[P;J'Q9\?W7C+Q!I6E:YH&J^(O!OA_P -^*](?X6> [3Q
M-''XFT2\TWPKX-\%^%-,6WM$N=,LQ=:S;Z6EM+,;P^H^-_V+_ WC?4OB)))\
M1?BWX<\,?%7QKX<^(WCKP%X<U;P3'X9UKQKX6_X1LZ9K;W^M^ =<\;V\9D\)
MZ'-<:#;>,(O#+36BM#HL "!/UQ_X45X1_P"@CXC_ / O3/\ Y44?\**\(_\
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M ?\ F'L9^7WGRA17U?\ \**\(_\ 01\1_P#@7IG_ ,J*/^%%>$?^@CXC_P#
MO3/_ )44?VEA>\__  !_YA[&?E]Y\H45]7_\**\(_P#01\1_^!>F?_*BC_A1
M7A'_ *"/B/\ \"],_P#E11_:6%[S_P# '_F'L9^7WGRA17U?_P **\(_]!'Q
M'_X%Z9_\J*/^%%>$?^@CXC_\"],_^5%']I87O/\ \ ?^8>QGY?>?*%%?5_\
MPHKPC_T$?$?_ (%Z9_\ *BC_ (45X1_Z"/B/_P "],_^5%']I87O/_P!_P"8
M>QGY?>?*%%?5_P#PHKPC_P!!'Q'_ .!>F?\ RHH_X45X1_Z"/B/_ ,"],_\
ME11_:6%[S_\  '_F'L9^7WGRA17U?_PHKPC_ -!'Q'_X%Z9_\J*/^%%>$?\
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M]7_\**\(_P#01\1_^!>F?_*BC_A17A'_ *"/B/\ \"],_P#E11_:6%[S_P#
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MX_?!SX.V/Q(\;6'Q5U[X6Z->3?LCR?&WQ5JUG\);[XV1VVDW_B6X\)ZOX?\
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MXF_%RYUSX@C6?'7Q'L?C'H][+'H^HWT7P2EAU75=8\(?=?Q7^+_QS\%_LO\
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MPSX^L?"G[3=OJ>K7=S?ZCH&F0Z/::-XGG\4?M.?M=3>/]8M/!;?LX:=X&?\
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M.IMI\]N;^S_T6Z,L'R5MT4TVM4VG9K1VT:::]&FTUU3:>@?U]VQX]XV_9X^
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MX5\0ZQX>U75+C0M.M-"AU*PU9[?PKHOA^S:'61I.E>'(;S3-*TBR&KZQ-?\
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MS9OH0O[+29]0M])CTC4KZ'1['2Y-571GO]-OOHBBFL17C+F5:KS*;J7<Y/\
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M_A<W_"IOAG_PN#[-]C_X6M_P@?A;_A9/V3^RO["^R_\ "=?V5_PE'V;^Q/\
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56VLDN_\ F_O?<****@84444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img181012247_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_8.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )_!" # 2(  A$! Q$!_\0
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MDKH,EEXO7Q%J&HV>G:Z1OTW4M7\/Z;9FT6?4[N6UTFQU"^M.?_X+;:I<V/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM^?%S))Q\$? ^,\X_P")G-T]/PK[EKX9\'_\G^_%W_LB/@;_ -.<M?F'B/\
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M.'Q]X:L+RX$-UKVJ>'1=:=I<15B;J[M]%N=3U66%2 I6QT^[GRP(B(R1Z_\
M\/4/V$O^BXJ/^Z>_%'^G@JO+OV@/V9OV=-"^/?[*FBZ-\"?A%I>C^)/&NLVG
MB'2[#X>^%;33]<M8=*EFBMM6LX-+2WU&".4"1(KN.:-6 (7@5]D?\,<_LF?]
M&T_ K_PU?@K_ .4U=_"N<9+C,QXMR6KB>*<RK\,9S@\MKXS-)\.TW6EC,BRK
M.H_589/E&6TXT(4\QC3E]8I3KNM&JU4]DZ<8_(9QDWTK*&&R7'PSCZ..%IYO
M@*V*IT,'PKXI34%0S'%X"7MI8[CK%2=24L+*:]E45/DE!<JGSM_"UI_P5K^
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M?B/),KS/#9Y6X'S/,I?1W7A+D>.3Q^+GEO%+Q?%-6KFM&OC,AIU\#E-2CG.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M5S?B[QEX0\ :!?\ BOQYXK\-^"?"VEK&VI^)?%VNZ7X;T#3EFE2"%K_6=9NK
M+3K199Y(X8S<7,8DE=(U)=E!Y_X<_%[X3?&'3;O6OA)\4/AW\4M'T^X6TO\
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M_P!(9*]LKQ/]I'_D@GQ<_P"Q#\0_^D,E?.<9_P#)'\6?]DUGO_JKQ1ZF1?\
M(\R;_L:Y=_ZET3(_91_Y-P^#?_8C:1_Z ]?0=?/G[*/_ ";A\&_^Q&TC_P!
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M_P"%!I/_ ,EU^6__  Y7_8[_ .@A\8__  MM%_\ F/H_X<K_ +'?_00^,?\
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M.5_V._\ H(?&/_PMM%_^8^CV&4_]##$_^$*\O^HCS?W>8?ZV_24_Z,SX=_\
MBWL9_P#0#_5GY7_4C_A.?!/_ $.'A;_PH-)_^2Z/^$Y\$_\ 0X>%O_"@TG_Y
M+K\M_P#ARO\ L=_]!#XQ_P#A;:+_ /,?1_PY7_8[_P"@A\8__"VT7_YCZ/89
M3_T,,3_X0KR_ZB/-_=YA_K;])3_HS/AW_P"+>QG_ - /]6?E?]2/^$Y\$_\
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M%"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#\WO\ @K'_ ,F/_%+_ *^_#'_I[MJ^KOV8
M_P#DW;X)?]DP\&?^F*RKY1_X*Q_\F/\ Q2_Z^_#'_I[MJ^KOV8_^3=O@E_V3
M#P9_Z8K*O2G_ ,BG#_\ 8=B/_3-$_ ,J_P"4G>,?^S,<%_\ K7\5GN=%%%>:
M?OX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,7B/P_HT=KJECXKL#XQLO^$0T.SN98-4TS5?#9T^YU6[5H3"8[>\6/SWP_\
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M]2L/'&DZ=H^KQ:I:1)+.GV/3=9UI$2/>(W$]Q#.DJLDD"%:^DJ_+?_@E]_R
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MK'&8W&7DZT8M.+C912M=R<OJ*BBBOW@_.0HHHH **** "BBB@ HHHH ****
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MA\1ZS(%$6EZ+IUO'YEJEQ92S->"X^UQ065PK_F;XK_;Y_P""JG@\?M%RZO\
M 3]D$6W[*UWX%7XTS6&L_%/53X9T?QWX0T/Q[!XEM8;#Q)+=Z]H?AGPEKT6L
M>+)='M+K4K"VT[57L=+U+[-&)OM< J%>&7UJ.7U(+!SE4P:KY_AZ,YWQ<(\W
ML_[/C*5-XN:I*:C#GG-TN::C&,/-J\T75C*K%NHDJCCA922:IWM?VS2?LUS6
MULES63>O[H_"=+6/X6?#2.RU^;Q59)\/_!J6GBBX@O+6X\26J^'--6WU^>VU
M!([^WFUB()J,L%\B7D+W#1W*+,K@>@5SOA#4KW6?"7A?6-2N-"O-1U;P[HFI
M7]WX7N+J[\-75[?:9;75U<>';N]CAO;K0IYY9)=(N+N&*ZGT]K>2XC25G4=%
M7Q<[N<V]W*5]M[N^RBONC%=DMCT5LO1?EZO\WZL****D84444 %%%% !7A'[
M4O\ R;'^T9_V0CXO?^J^\0U[O7A'[4O_ ";'^T9_V0CXO?\ JOO$- 'Y+_\
M!M)_RAA_8Z_[ 'C'_P!3KQ#7[OU^$'_!M)_RAA_8Z_[ 'C'_ -3KQ#7[OT %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@7[4_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?EO_P2]_Y
M/[4?_9TGQ-_].MQ7ZD5_/-^R7^WO^S[^RS?_ +1_@GXK7_BNWUW5_P!HOXD:
M]9IH'AJ76K4Z?-K=W C27,5U"(YO,C8-$5R!@@G)QZN!H5L1@\PIT*<ZM1O!
MM0@N:5E4J7=ET74_G/Q=XMX9X)\4/!3/N+L]RSAW)J5'Q,P]7,\WQ=+!8.%?
M$Y)DE/#TI5ZTHP52M/W:<;WD]$?T,T5^5/\ P^3_ &+/^@M\2/\ P@KG_P"6
M%'_#Y/\ 8L_Z"WQ(_P#""N?_ )85E_969?\ 0%B/_!;/>_XF4\ O^CO\ _\
MB18#_P"6GZK45^5/_#Y/]BS_ *"WQ(_\(*Y_^6%'_#Y/]BS_ *"WQ(_\(*Y_
M^6%']E9E_P! 6(_\%L/^)E/ +_H[_ /_ (D6 _\ EI^JU%?E3_P^3_8L_P"@
MM\2/_""N?_EA1_P^3_8L_P"@M\2/_""N?_EA1_969?\ 0%B/_!;#_B93P"_Z
M._P#_P")%@/_ ):?JM17Y4_\/D_V+/\ H+?$C_P@KG_Y84?\/D_V+/\ H+?$
MC_P@KG_Y84?V5F7_ $!8C_P6P_XF4\ O^CO\ _\ B18#_P"6GZK45^3>J?\
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MC2OVU)_ 7A/7/VFK;X,ZO^SSX>^(FD7NN:'^SQK'B70]?GNISJ>FZ1<:S?\
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MRAA_8Z_[ 'C'_P!3KQ#7[OU^$'_!M)_RAA_8Z_[ 'C'_ -3KQ#7[OT %%%%
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M^?E3_P #E_GY+[@_U?R'_H291_X;<%_\I/.C\'_A(01_PJ[X=<\?\B3X:_\
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MH)+N:[CN;R&Y^-OCU\,X_P!AC]C+]JKQ/KGQ/UCXI?&/]I;5_P"PO$GCV_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2:M%WBM7\+N[KL[NZZL[5LM]EOO\_/N%%%%2,**** "BBB@ KPC]J7_DV/\
M:,_[(1\7O_5?>(:]WKPC]J7_ )-C_:,_[(1\7O\ U7WB&@#\E_\ @VD_Y0P_
ML=?]@#QC_P"IUXAK]WZ_"#_@VD_Y0P_L=?\ 8 \8_P#J=>(:_=^@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "OS;^+'_*0GX"_P#8CZQ_Z'<U^DE?FW\6/^4A/P%_[$?6/_0[FOQS
MQK_Y$/"'_9T_#;_UJL"?=< ?\C'//^R/XI_]5-<_22BBBOV,^%"BBB@ HKY\
M_:._:"T+]GKP7;>(+[3)_$/B#7+_ /LCPIX9MIOLTFK:B(Q+/)<70AN7M=/L
M8BC7,T5M<S///9VD4)>Z$L7G/AKQ;^VY,WAS7?$?PT^"LOA_5KW3CJWA72M;
M\1:5X\T+2+NYMUNKB[N]8U2X\-->65E+-</:6\ES<&2%H#;+/B!OALS\0<BR
M[/:_#=+#YYG.;X'#X/%YMAN'\CS'.5DN&S"4HX&IFE3!4:D*$\7&%2M0PE-U
ML=/#4YXE87V'+4E]#A.&<QQ674\UG5R[ 8+$5:]#!5<SS##8%X^KADGB(8.-
M><95(T7*$*E:2AAXU9JE[;VG-%?9-%<=XH^(GP_\$26\7C3QUX.\(2W:>9:Q
M^*/$^B:!)<QEI%#VZ:M?6C3(6BE7=&&7='(,Y1L6Y/&O@V+PY)XQE\6^&8O"
M,42SR^*I->TI/#D<+S);)-)KC78TQ(FN)(X%D:Z"-,Z1 EV53]4\URM5L5AW
MF6 6(P-&6(QM!XS#JM@Z$(\\J^*I>TY\/1C%J4JE6,(*/O.26IX_U/%N%&JL
M+B?98B:I8>I["KR5ZC=E3HSY>6K-O10@Y2;T2N=-17!2?%7X7Q7^DZ7+\2/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.$\CR'!</SSSA+$8^A@Y_4<NS"MEN(P$XT\-/"8R-+#3Q.'^KJ'LN/ \?8+
MQX5R]YCFE; 99@>(L-F-:G3G&4<PS+$9DLOSJGAJE9?6,3A:>*IXF+G55:@Y
MU8TJGM7+G^$?CMX*\(_"#]K#]E.]^$NE:9X-U/Q1XAL-$\4:#X5TX:19R^'G
M\1Z'HTM]=6NG^1:2C5M)U77[2^<0AY%TG[5?-.Y#C8_96_Y/._:R_P"PCX@_
M]3<5]0_#S]E'X=> ?&L/Q&O-;^('Q(\<65I]BTOQ+\4?%/\ PE6HZ1!Y+6R_
MV<R:?IT,<D5J[VMO+/%<26D$DB6C0>8Y;I_ '[/O@KX<_$OXB?%70[_Q+<^(
M_B9/<7&NVNJWVFSZ/9-=ZDVJSKH]M::197<"/=$<7U_J#+$BHCJ2S-VY3X5<
M4TN,<HXI>5Y+D&6OQ*Q'%E;AG+L?&MALDRQ<#RX;]K3=/#8?#5LRS7,8+&XV
MA@J7L*7M825:IRRC3Y\;QCD\\CQN3K%X_,L4N%*>34\VQ6&<*N88M\01S7V<
MU.K5JPPN"PK>'P]2O/VD^22Y(WBY>7_M?^+?A5X<TCX=6/Q$^&5Y\7-:USQ>
M8/ '@RVNKBT@O-?6"*PDDO&2;[+<1E-7M[*"QO+'5$N;F]BV60\M[B#X_P#
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M7PH5<536982>&56G3Q%:A2FZ?/S-2JQ\D]F__AH[]G__ *+5\+?_  NO#?\
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MZ);'_P"%;XY_^::C_AA+]E;_ *);'_X5OCG_ .::CZQ](#_H4^#W_A_XT_\
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M /T6KX6_^%UX;_\ EC7EO_#"7[*W_1+8_P#PK?'/_P TU'_#"7[*W_1+8_\
MPK?'/_S34?6/I ?]"GP>_P##_P :?_0WZ_TM3V7AM_T&\;_^&W(O+_J:^;^[
MS/4O^&COV?\ _HM7PM_\+KPW_P#+&C_AH[]G_P#Z+5\+?_"Z\-__ "QKRW_A
MA+]E;_HEL?\ X5OCG_YIJ/\ AA+]E;_HEL?_ (5OCG_YIJ/K'T@/^A3X/?\
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MT[4D-[#<ZA_:5Z#>[KLVH/D01"O#/CO^Q%^Q;^US\7-0\5_%K0X_&_Q=\#^
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MFFF5"<Z<X5*<I0G"49PG%N,H3BU*,HR5FI1:336J:31Y3\&?A#X?^!_@BW\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>$?M2_\ )L?[1G_9
M"/B]_P"J^\0U[O7A'[4O_)L?[1G_ &0CXO?^J^\0T ?DO_P;2?\ *&']CK_L
M >,?_4Z\0U^[]?A!_P &TG_*&']CK_L >,?_ %.O$-?N_0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\;/'?_#6_P"VY\#_ +/^U7\9_#W_  AO[/'QZ_X5IX#G_L^3P[=_VY<^'O\
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M:OV$5.4O9IJHY0Y4^1IE*G/DJ1E&*]NZLIM2_A\T5&*2Y??=DN9Z)/74YO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?OVVO_$E)_\ YC*_IPHH _F/_P"(3?\ X)C?]#]^VU_XDI/_ /,91_Q";_\
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M_P &F_\ P3%R?^*]_;:'L/VE9\#VY\&D_F2?>C_B$W_X)C?]#]^VU_XDI/\
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M<O\ @@7_ ,YJ/^T_W_!1O_WC=?O]0!_,?_Q";_\ !,;_ *'[]MK_ ,24G_\
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M ,QE'_$)O_P3&_Z'[]MK_P 24G_^8ROZ<** /YC_ /B$W_X)C?\ 0_?MM?\
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M4 ?S'_\ $)O_ ,$QO^A^_;:_\24G_P#F,H_XA-_^"8W_ $/W[;7_ (DI/_\
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M (DI/_\ ,97].%% '\Q__$)O_P $QO\ H?OVVO\ Q)2?_P"8ROUT_P""?/\
MP3?^ '_!-/X;>+OA9^SWK/Q9UKPUXU\5KXQU>?XN>/9/'VL1:LMBFGB/3K]]
M+TI;*Q,$:LULMNY>8M*\C,:^_** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>]KIIJ]M;72O;H?@K^U#^S1\ _V*/C9^P%XT_8JM;[P%\:_BC^U%\/? VO\
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MA6AB)RE0YW&BYHC.IS4U*51J3<4DI0GRNI)0JRM!QE>'*YQDXN"2E:\K./\
MX(LI^UHW@'7I;^^_9WD_9Z/Q]^/7_":06^F_$L?&F7QZ;Q_MDWAJ_FU=_!$?
MA-O$ATYX(=6T^;61HOVZ.6X:_,$H^I?^"V/_ "C'_:8_[HS_ .M _"FO.?\
M@FA??$O]GC6OBA^Q]\3_ -GKX^:7JLO[0WQN\=>'?C9;?#QYOV?=6\"Z[L\0
M:!J\WQ+?5DLHM4UI[*:PM-"L;/4KV&ZU#2+:\\B<ZNFD^X_\%>O ?CCXF_\
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MB^6.L5[T;_"M8W7<_13P-\$?@O\ "_4+S5OAI\(OAA\/-5U"S_LZ_P!3\#>
M?"GA+4+[3_/BN?L%Y>Z!I.GW-S9_:8(+C[+-*\'GPQ2[/,C1AZ?117SDYSG)
MRG*4Y.UY3DY2=M%=MMZ+8[$DE9))=DK+[D%%%%2,**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X?X@_$W
MX;?"7P__ ,)9\5?B%X'^&?A7[=;:9_PDOQ!\6:#X,\/_ -I7JRM9Z?\ VSXC
MO]-T[[==K!.UM:?:?/G6&4Q1N(WQW%?CO_P6L\.Z3XO_ &>/V?\ PGK]M]MT
M+Q1^VM^S_P"'=:L_-DA^UZ3K:^,M-U*V\Z%DFB\^SN9HO-B=)(]^Y&5@".S+
M\-#&8W#8:I.4(5JBA.<$I3C&S;<5)I-V6B;2ON9UING3G-)-Q5TF[)NZ6K6M
MM3];KCQ)X=M/#L_B^ZU[1;;PG;:+)XDN?%%QJEC#X=M_#L-BVIS:]/K<DZZ;
M%HL6FJVHR:I)<K8QV*M=M.+<&2D\->)O#?C/0-(\5^#_ !!HGBOPMX@L+?5=
M!\2>&M6L-=T#6],NT$MKJ6D:QI=Q=:=J5A<QD26]Y97,UO,A#QR,I!K\'O@'
MX^\3_";]FC]OG_@G'\8=6N+[XB?LJ_ GXT7/PDU_4HQ;3?$O]FSQ!\/O$MQX
M&U[3T"F.>7PFMW::+JL4,KPZ5:ZEH>APM//HVIO#V7P+_:9\=?L_?L>_\$@O
M"O@W2/">IV/[0WBWX2_!KQG<>)K+6+R[TOPMK>F7,M[?>&&TK7-&AL_$".D?
MV6\U6'6=.B4.LVDW!=6C[ZF35(JHJ=15)?68PH2^&E7PL\'5QM/$Q;NUST::
M:CK9MP?O)I91Q"?*Y1Y;P;FMY0FJD:;@UY2DU?LK[,_<JBOAW]I;]IKQQ\&?
MVD?V(?@[X:T?PIJ'AK]I;QY\2_"WCF_URSU>XUW2+#P=X2TO7-*F\*7-AK>G
M:?97D]]J#KJ#ZQIFN0S6D:PVT%I,QN1\F0_MF?MU_%[]K#]J_P#9@_9N^%?[
M.S6W[/\ XD\'P0?%7XO7GQ LO"WA[0]?\,/J%OI?B[2O"6MW>O\ BSQ7XNUJ
MVU4>')/#=IX:TK0-(T34&UF/59V@F;EHY9B:U.-9.C"D\-+%.I5K1IPC1CB_
MJ4I2<MI>WT4%>4DUR*4FHNY5X1ER^\Y<ZIVC%MN;IJHDK=.5[[)WNTE<_96O
M'OC7\??A)^SKX:T3Q?\ &3Q<G@SP[XC\9:!\/]%U%]%\1:[]N\7^*&NET/2%
MM/#.D:U?0F]^Q73-?7-M#IMI' \E[>6T>&/Y0_!3]MK_ (*1_M2^&/'6E_!G
M]G#]GSP)\1/V??$_C7X:?'/Q!\8?$WC:Z^'_ (K^,/@W4GM[SX;?"'1O"NI6
MVM:=J-MIXLKW5]7\8^)KO1=+GUO3K62]DMQ'J%[\U?MY_M4M^UC_ ,$N/V5/
MVC-/\(_V=XCUW]K#X6IKG@#3M0\^2T\:^#+WXF:!JV@V-Y>1Q/#%JVI:.+S1
MQ?H9K?3=6T\7DDTBR2OVT,BK_7*%#$RIJG+%4\+7^KXBC4J495H5*E%R<74C
M!5H4ISIR:DK1?.HNR>4\5'V<ITTVU!SASPE%247&,K7LWRN232MKLWJ?TJ45
M^/?BS]L+]NC]FSQY\!O$/[7?PH_9QTK]G_X\_$_0OA+='X/:]\0=:^(WP0\5
M>,TE;PK_ ,+ UW7ICX1\6Z?&UO=KK%]X2T6TLR-.U$VERLHT>#6^N^,7[;_Q
M2U?]I'XD?LX?LYZ[^RQX#;X&Z'X6N_BI\5/VI/&&L0^'KWQ;XWT]=9T/P!X"
M\(>%/$7A/6-7U'2='CDO/%>NOKL^GZ-=3KI%]96&I06D.M<BRG%MQ<70G2E2
MG6>(IUH5*$84ZD:512G#F]^%6I3I\D8RE)U(."E&<9/3ZQ35[\RDI*/(XM2;
ME%R5D^CBF[MI*S3LTT?JM17XSV'_  4O^(=S^R-^V=\0KKPG\+!^T7^QK?PZ
M%XDM?#.L:MXT^!OC676;FS;PCXU\+7]EJ^E^()_"WB#3Y-1D&CRZZFJ6DNFC
MS]5!NS;VOTU^Q?\ %K]M+X[V6@_&'XV^!/@-\-_@-\1/AO;^)OA[X3\-W?CV
M\^.EMJVHS>&KCPWK/B^;4+J\\!1>%O%7AZ7Q+K\>D:;)_P )!X?6\\)Z==W>
MIS'6IX%6RO%8>E6K5O8TX4:OL6I5H<U2HZ5.O!4HJ[J*I1JPJPDO=Y?B<6XJ
M3C7IRE&,>:3E'FTB[)<SBW)[*THN+3UOY7:^_J*^>OVB?$?[2FB>'O#EA^S!
M\./A[XW\;^(O$4>EZIKWQ6\6W7AKX?\ PZT%+2XNI_%'B#3]$27Q?XK66XA@
MTJUT/PI&+]9[P7]Q,EI:21S?%_PM_:B_;+A_: ^)W[&WQ[\*?LVZ9\>[O]G+
M6?CI^SS\1_AW+\25^"WBBY@U27PCI^A>-?#WB+4[WQPJZ=XKD6[\00Z-JUAJ
M1\.Z-J\UC;C[?H^H2Y4<#5KT9UJ=3#VA&525-UX*LJ4)1C.JZ:;DH0<N:2=I
MN"=2,)07,5*K&,E%J>K45+E?+S-74>:UKO96NKZ-IZ'ZJT5^ ?\ P1R3]K]X
MOBY-?W_[-\GP(_X:]_:,_P"%NPP:9\3_ /A;]S\2#IME]OG^'=]-K#^#K?P6
M_BIO#4EM!XGL;S7AH"Z['-<OJ,EA-'^EG_!0O]H[QG^R3^Q]\7_V@_A[I'AC
M7?&'P_'@+^Q]*\96NJWOAJZ;Q7\3_!7@B^.IVNB:QH&J3"WTWQ+>75H+75[,
MK?0VSS--;K+;R[8G+)T<QAEM*M2Q-6K5I4:<X/DBZE::IPC43O[.7,US+FDE
M%J5];*85E*BZTHRA&,92::N[17,VMKJVVBN[H^I/'7COP;\,O".O>/?B#XET
MCP?X,\+V+:EXA\2Z]>1V&D:18K)'";F]NYB$BC,TT4*9RTDLL<2*SNJG7T'7
M=&\4:'HWB;P[J5GK7A_Q%I.G:[H6L:=.ESI^K:-J]G#J&F:E8W,9,=Q9W]E<
M075M.A*2P2I(I*L#7Y!_%SX^?MAV?[&_[1_[1'Q^^"7[)LGPDOOA'9>-?A/\
M#/$MAXV^(GB>"'6O$>D#2O#_ .T+8:E>6?@+Q7;OX<O[;4]0M/",VC-::VD=
MC(F(I9(=;Q;^VK\5]+E_8,^ ?P*\*? 'X?\ Q%_:=^ V@?$BTUWXJP>)M*^"
M7@RPL?!.B7MO\.? ?A#P?JVD:UJFKW=[=C2O#6A0^(K*+2-,ATNU":I)?)]E
MM936G!<DJ4YJM7IU*D:].6'A'#X:&)K-RBFVZ4)2<Y0<XRMRTU)_%+Q$$];I
M<D9).+4GSS<([Z6D[))V:OK8_1KXX_'WX2?LW>"HOB)\:?%R>"O!TWB#1/"L
M6L/HOB+7O,U[Q%<-:Z/8+I_A?2-;U0F[F1P;C[#]DM8T>:\N+>%&D'L-?@K_
M ,%:C\<(_P#@GEX?'[1#_"=OB+!^TM\*EN[OX-#Q=;^![O1DU;4CI=Y%9>.6
MGUW2]0DA\S^T;"74=6M;=T1K?5+E781_;?P;_:P^*W[3_P"T9KUA\!/#'@MO
MV-?A9/JWACQU\=?%-CK>HZI\7/B/9+<02^'_ (!SZ1XETS1)?#?AR]-NOB#Q
MKJ^F^(--O##<VFE6ZR7%E<N2RQ_4*>+IS3M5QT<15=2*PZCAEA505)\JE*I7
ME6G&$+RE4LFHPC"I)"K_ +UTVFKJFX1L^>\^=RYM6DHJ*N]$N[NC]#Z***\D
MZ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^;/VC
M/V6_A]^U"OPHLOB;J_C-?#?PG^*&@?%JU\'>'M5TO3_#/C;Q'X8$IT33_B!:
M7NAZG>ZUX=LI)[B;^R]-U#1&GEG<W-S,JQ)'])T45I*K4G3ITI3;IT>?V<'\
M,'4:E-I=Y-+F;NVE%7M%))12;DDDY6N^KLK*_IT"OFW]IG]EKX>?M6:#\,O#
MWQ&U/Q=I=C\*?C/X)^.?AR3P?J.DZ;<W?BWP';:Y::3I^LR:OH6O1W/AV[@\
M0WZ:G:64.GZE*1;M9ZM8M&QD^DJ**56I0J1JT9RIU(.\)QTE%M-77R;7S"45
M).,DFGNGU"BBBLQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7Y@_\%5?A]X\^(OPG_9UT[X?^"O%OCG4-"_;2_9]\5ZW8>#_  YJ_B6]TCPO
MHMYXD.L>(]3M-&L[VXL="TD7-NVIZM<QQV%@DT;W5Q$CAC^GU%=.$Q,L)B:.
M)C%3E1GSJ,FTF[-6;6O7H14@JD)0;:4E:ZW6J?Z'XT?\%<_V8?B?XV\(Z!^T
M]^S;X<U7Q'\=_A9X3\;_  P\2^$_#.EW>K>(?BC\"?BQH6K^$_%_A2VTRP,E
M[K5_X8/B+4/$7A_3+6RO;I'U'7;S3[6XU2.PA?PKQS\"_C[HW_!//_@F9\0/
M!WP>\<^*_BI^QWX_^"'Q8\:?! :+>:=\0-1\,Z'9:A;^*]$M?"]_;V^O#Q7:
M2RZ3&FCI9MJ5M!/J-Q+ITSV1A']!E%>A1SJO1P^$P[I4JL<'7E5A*?-S3HSI
MU:<L+-Q:?LTJ]=QDFIP]HTG912REAH2G4FI2BZD4FE:RDG%J:\_<C=;.WJ?@
M[\1/B!\=?VL?VV/V /B'H?['_P"T7\+/@C\'?B;X_DU/QI\8/ E]X5\43:IX
MI^'X_M*ZUWP1:_VM<^!O!VB'1].TVQ\5^*M0L;3Q3KFKMIVB1ROI\QD^B/V)
MOAK\1/!_[>G_  5/\8>*_ OB[PWX2^(OC3]G"]^'_BG7/#NK:7X<\<6FC^$/
MB,FLW/A'7+RTATSQ)#H\VIZ?;ZN^CW5XNEW=W!:7YM[EQ%7ZM45%7->?#SPM
M+#4Z-&6#C@HI5*DY1@LPAF#J.4VW*<JD.67PQM)N,8JT41H6FIRFY2]HZK;4
M5=NC[&UE9)*.JZ[7;U;_ #9_X)O^ O''@/\ X;T_X3?P=XH\'_\ "9_\%)OV
MH_'OA#_A*-!U30?^$I\#^(O^$&_L#QCX=_M2UM?[9\+ZW]CN_P"R=>T[[1I>
MH_9;C[)=3>3)M_(#4_V<_P!I.?\ X)2_ SX<Z%\"?B;<_%C3/V_?^$S'P_U7
MP-XLTO7+#06\9_$62P\3>)=,ET8ZMX>\&.][IL]]XJO[&+2K+3+V'4Y+C[))
M%*_]4M%:4<ZJT:]6NJ%*4JN)P>)<9.?*G@Z5:E&&C3Y9JLW)WNN5);BEAHRC
M&+E*T85(726OM)0DW\G"R7F?@M^T3XN^.?\ P46UW]FO]GFQ_8Z_:*^!.A>$
M?CSX$^+_ .T'X_\ C3X._P"$=\$^%])^'HU=+_PW\._&,&H#2_B-=ZN=0O8M
M,U;24A6X!TN9+""&[O9]+R/BE\$-._9[_;D_:.^+7QK_ &#]5_;:^ W[2\/@
M7Q;X0\5>!_@!X2_:%\>?"+QKX8T(Z#XB\,WWA36K6;4M,T/Q!,YOYM1TY8X)
M[>U\/?->W5IJRV?] %%%/.94DJ-'#0I87V%6BZ$*U=3?MJU+$3JQQ'/[6%15
M*%%0M>*IPY)QGS3<AX92;E*;E4YXR4G&-O=C*"BX6LU:4K];NZ:LK?B#\7/!
MMI\3O^"=/[:6G_ 7_@G]XC_9=O/&&C66D>$?AUI_PA\'^!_BK\7X-'NM!U"'
M7M1^%OPRTV;5;2YL)+S5]/TC2M3EU;5I(8;VXM5@6XDMQ^I?[,&BZOX;_9I_
M9X\.^(-,O]$U[0?@9\)=%UO1M4M9K'4])U?2_ /A^QU+3-1LKE([BSO["]@F
MM;NUGC2:WN(I(I45T91[G17)B,=+$4'0]FHP^M3Q*;J5*L[RH4J'*YU92E)*
M-)2NWO)I*,4HK2%)1GSWN_9JG:T8JRE*=[122UD_EO=W9^6'_!3S3/CKJUA^
MSQ:>!M*^/^O?L_/\2M5_X:FT/]EY]0'QHU7P<='MU\*6NC0>')[;QE?>&WU1
MM6'BJP\.39N;8VBW<;2BP:/X[_9+^"::-_P4M\&?%+X1_LH?M+? G]G\?LU>
M//#D?B/X\R_%/5]1USQ8WB+2KJ6\U$?$CQ1XWU7X>_;H;R'3M!\):UKFE:MJ
M\6BZEKZ>'+2.:6:7^A.BNBAF]2A@I8*-&/+*AB*$I1J5(1FL0Y2=6K2BU"K7
MIW4*=2IS*-*,8**:4U$J"E4]HY:J4)).,6TX6]V,GK&+M=Q5KR;=[71^-G_!
M/>\^)7[-WQ:_:#_9-^(G[/OQZ$7C?]JWXY_%SP)\?=+^'KW'P"O_ (=^*]*@
MU_0-1\0_$'^UCI^BZWJ0\.+IL/AZS&M:C#K6OZ1I-W'!)!JMS9>V_P#!7GP%
MXX^)W_!._P#:&\#_  W\'>*/'_C36E^%+Z-X1\%Z#JGB?Q-JXTKXW?#76M2&
MEZ%HMK>ZIJ#6.D:=?ZE=):6LSPV5G<W+J(H9&7])J*SEF3>8X;,E0A&M1JX:
MO4@I3<*U;#SC-SUNZ:J<D4X1;4=6MRE1_<SHN;<91G!.RO&,DTEIHW&^[WZG
MYR?MT^ /'/BS_@F;\6OAWX5\(>)/$_CV\^!GA;1['P9X<T;4-<\3ZAJVGMX7
M:\TS3M#TN"ZU'4-0A%I<YL[.WGN&,,@CC<C%?-WQB@\(6_[./[+/P0_:>_X)
M\_'K]I'X=6?[-'PKD;Q/\(/ =UX\\?\ PR^+&E^$=*T/7O!U]X3TB\\-_$#X
M?7UKI]A:S3>+-,UR-+R]G;P]J&F)'I]Y<I^UE%&'S*5"G3INES*GBJV+C.%:
MK0JQJ5:5.E[E2E*,H."IWB_>3YFI1:%*BI2<N;5TXTVG&,HM1DY:QDG>][/;
MR=S^7_XE_L^?M8^(/^"5\WPX\2?"_P"./B?4;C]M;2_$?P7^%/BVRO\ XD_&
M7P-^S,NK11>$=#^(<6AVE_?&YT*3^V[G5IK^".WTS3=0M%DCTS2EM+*T_0']
MG[X<?%C]@3]J>_\ V?\ PIX%\<^/?V&?VA]7UWQG\)=8\*^'_$/BVU_98^(T
M\ZWGB'P'XNN--MM1;PS\,/$4]VDN@ZYKDD&G6]T]K,UW)=V_C?5'_7^BNBMG
M=6O1JX>IAZ/L*]7%5JE*/-&/M<0J+IU8.[<:N'G14HU+N515*T*EXU9IS'"Q
MC*,U*7/!4XJ6E^6%TXOO&:E9QVC:+C9Q04445XATA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWDE;Y'D_X**_L=1:1/KC_%NZ-CI&KZKH7CF./X9_%R75/@[JFC>+3X&O+?\
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MHKFU1#E!32:]YW46XO71R:4[6V3=K]'IH?5-%%%<Q84444 %%%% !7D?@?\
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M)MZI-1T3U;5[6W/NVBBBN8L**** "BBB@ HHHH **** "BBB@ HHHH ****
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MU.?F6KYFHQM=^SC3Y6^9^Y[O,HVTE;6RU****\PW"BBB@ HHHH \K^-WQF\
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M*<Y145*<IR<>>;D91I<M1U%)ZJ5XM+>4D[WM?2R23;LK*]DD%%%%<!J%%%%
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M\RMI)]'K;T"BBBN0T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP?P=XF\7ZK_P5T_8ZTWQK^UC\+/VIO$^E_"/X[VVKZG\)?AQHO@+2_!%O?>
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MN/$.A:EKFK>*?#5SK&J^&K8&?7[3PEIOB)]-0%929<1G\]OV"OB_JG_!1?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%MQ4YRERMN[:NW9MZMK5O5@HQ5[12OH[)*Z[/N>+>!?V;?V=OA?K\OBKX9_
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M<PO?,3)VL,FO;J*4*E2FVZ<YTVTXMPE*+<7NFXM-I]5LQM)[I/U2?YG)>,O
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M]-6NC"BBBLB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M77B^?1O&_@;X-Z?9VZZ=I%IXBU;6M2:RL_TK\#>,-'^(?@GP=X_\.M<-X?\
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M814IVG.,*<\JR<H.,8*;EI9\K4;IIS:DTGRJ]DG=MI72;:^E?V<=!^)7A?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFBO%-2_:4_9ST?2_ 6N:O\?O@II6B_%5KI/A?K&I?%3P+8Z7\2'L;NQL+U/
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M6FO+\GU3\GJ%%%%9%!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.?%S0-&L_A1XKM+!-:N]22^UJ\MKM+:&QLFU[P^RM)K=II"2([_H#\3OC"/
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M)EM\7M=TN#Q-8ZGX4L/%%A\*)?"6O:GIMQJOA_7M5\(3:?XFO>R^,WQ>\,_
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M#@\4O)]FT1=9>UCUMG\FP%T6VGS3PKK_ /P3X_9ITR'Q7X(UO]C;X :-\2=
MT/7K?Q+X5U+X)?"K3/'WA:6:]'AK6H=9TB;0;7Q3H$EQ/J T/44N;_3GFFO1
M83%Y)\Z3QV*KX?$T:V%J^UQ$FH.G0GO.M5Q?*I3<IPM+$-\L5/VE'V<'R:U9
M0J4(SA*-2-H;WFME&%.]DDG=0MK:TKO7X5\J>+?V0?BUKGP+_:XT'2/#D?A_
MQOX__;C/[1F@V.E7OPS;6OBY\./!/Q&^&WCK1]#74O%&G^,/ D6N>(]*\):K
MI_@O2OB]HUWX2M/$R:-9_$/2++P;=ZO*,+3/V8_C-/\ $7X4?%SPWX,^/#^-
MA^U)J7Q8^*%[^U'XA_9+L)4.F?LI?$#X2>%O&%OI'[)NIIX3;0+[5M0\&>%]
M>CTW3KOX@7CV<FK76ER:=:+J;_?-A^TWX03XO_''X<^*YO#?@GPI\%_!?[/_
M (NE^)_B'QKI>G^'M>?X_:K\1-%T33)!J5IINFZ*UKJG@C3M.TNZ;Q!J9\3Z
MAXILK*TM;&X@@34O2OB'\;?@S\(_L_\ PM?XN?#'X8_:]/N=6M?^%A^/O"O@
MO[3I5EJ.DZ/>:G;_ /"2:MIOG:?::MKVAZ7<WD>ZV@U'6=)LI9$N=1LXIL_K
M^84[T?JU*4J\925J4YSE3Q.$P_N1E"HW*+H+#U73?,X2Y>=*R@J]E1E[W.TH
MM:W22<*DM7>/\W-&^S5[;W/Y[OC=\%?VGM&^"_QH^(/QI\#>,M'\/:1^P?X5
M^"MYIWC6Y_95T;P/H_Q"LOC9\*M;NO WP@\&_LUP7%QI7P(M+&WU2#X?W/Q$
M37/&=CI%M=Z5KL&GO%IXU_[E\3_!;XE_$3QQX[^,FN_LP?&_X4+;Z1^R]X3^
M&'@3X)>._P!E"7XJZ1X_^ ^J_%CQ=_PO*(^,?B5'\!W\(:!9>/;3X0^&="\6
M7/B3Q%KWADWLNL_#C2=*72H-"_4[4M+\#?%#P>++5].\)_$3P#XNTRPOA::E
M9Z/XN\'^)]&NA;:KI=X+>ZCU#1=:TRY"V>I6%QLN;68"VO+=VQ%)727=W:V%
MK<WU]<V]E965O-=WEY=S1VUK:6MM&TUQ<W-Q,R0P6\$*/+--*Z1Q1HSNRJI(
M*F=5IPC%8;#PJ*I434(UH4U"3PC5.-.-9*\IX;]YSJ5TTH\KYFTL-%-OGG)-
M+=Q;;7/JY<M]%.\;-6>KOH?ACXB_9<_:O\<:CXLU[]H/0_CCXMD_:,_9L^$_
MPT^+-A^RU?\ [#D.H:1J/A6/QG9^)O"WCF3]INP@?1KB:+Q+I?BFQUW]GOQ8
MFB6GQ!E\7W^D6VGP:5X%U:3[W_:5M#X7^,'[ ?C&_OKVY\-^%OVAM?\  VK7
M%Y(MS<#5OBA^SM\8? '@O7-2N'C19+BZ\6WFE^&7N!)#)+>^,$$<4QF,0Z#X
M/?MF^!_C#XN\$^%H?AS\7_A[:_%GP7KWQ%^"'B[XDZ!X3TCPS\:/!7AVXTS[
M?K?@M-"\;>)?$VCS2:/KFB>*[+P_\2?#?@+Q3>>%-5MM9AT(Q0WR6F%\<OVK
M_@WX4USQSX(\>_"CQS\1_ /PBU?X1WWQO^(%OX5\!:]\+/@SK?BC7M"\3?#W
M4O%^G^+_ !AI'C'7+[PK,?"7Q)OM1^&7@+Q_)X!T^70?%.H3Z5>VJFTN=;'5
ML12I5<)3@Z=&M#V6'C&G>EB*:P#M>I*#J0]S#THIJ;K0C0E>JK(4:48.4:DG
M>4'S3;?O1:JZZ)VE\<G_ "MS34=3YE\"?LB?%?1/A3^R_HUKX-M? ?Q%\(_M
MI?M4_%'XA^+M#U#P6OB7PMX!^+ND_M@^'O#_ (Y;6=+UN.7Q!=:II'COX+6T
M^C:7J=_KXL8=!T[6+"TMO"EY'HGFNK_LR?M$>._@;\+/A.O[/!^&7B']F[]C
MO]I[X*2ZY+XV^$U]X=^,OCCXC_ V+X2^'M,^%%SX?\9:AK]OX7^(/BBRB^)7
MBG6/C#HGPJOM-O[#PNFIV>K:E-K-YHOZ-W_[5.CZ)\7?"_PK\4_"+XV>$-*\
M=_$'6OA7X#^+WB7P]X/L/AAXR\?:)X6UGQ=-H>D1Q^.[GXF6UOJ>F>&_$:^'
M/$6N_#;1_"OB>;0[V;P_KNHZ;+8:A>U?"G[6OA_7?B%:_#CQ3\(OCK\*=7\0
M^!_&WQ'^'=W\0_!V@A/B?X0^'FH:-9>*[OPEX<\$>+_&WC_3==TZ'Q)X<U+_
M (03Q_X-\$_$"6RUW3XD\*_VI]JTZV?US,E)U?J]&4FJF)@[SDU&K+&.HZ<8
MXB\U%5\1"5-J<J$(-N,)1J39[.CMSR5N6#6VL52Y>:\-+\L&I:*3=DVFD>'^
M$OV8_B78?%CP)J.A:EXC^!/A[0_V&?A'\$9_'7PQC^#-YK6A^+/ /CFYU?\
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M]$O)--\0>(O%'B35&UA[_P +ZA<Z7J.I3IJ5KJ<][::I+/-</^_NTNED\O\
M.6/]D']I#QW\//@1\$V^ ]G\&]2^#'[)'[2G[-FO_';5/B#\,]:T_P 6^-?B
M9\)KGP+I'C3PU;^%=4\2_$)OA[XR\56+>.=>F\0Z)X=\;:1J/BZY@7P@+VPF
M\0K^\E%73S3$4JV)KJ%&53$UIUY.2J-4ZDXUX-P2JI-<N(J)1K>U2]UVNFVG
M0A*,(-RY81C!:Q]Z,7!KFO%]81NX\KW\K?BII'P$_:+LO#%UXTT3X=_M,GXO
M:3X1_9Q^&-W9_%^3_@F]JEE8?"GX;?%S2?'>J6O[-ND?#"'3?AU<_$_X97"Z
MSXA^$.O?M$:/I/AS0[V:VU2VB76X8M,6O\*/V?/VH? &L?#;XO>(_A5\1_'6
ML>$?V]OCW\:-4\'ZSXR_9PA^+^L_"KXT?LWZS\,-*\9ZK/X4\4^!/@5!XFTK
MQ-K$<_B_PIX:U?2H4N$U1_#B:Y9I:ZKJO[9T5J\XKN-2/U?!I5>>,[4JD7[.
M='V$J2DJRE&GR7M%.ZDW)-.UI6'BFGSU/=M:\D]5)24FG&W-=)7V:5K'Y0>'
M_P!EKXIZ7::9-_PKJPM-57_@J_\ $#]J74;F'5O!BW<GPLUW6_'=EIWQ%GNX
M-8+W%_>>#=6T?2&TGS9/&<6BRIHMSH\4%M-9P_J_117#B<74Q3C*HH)QYK<B
MDOC:;7O2EHK:=EW-84XT[\M]4D[VZ*RV2U[A1117,6%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% %'5-0ATG3-1U6Y65[?3+&[U"=(%1IGALK>2YE6%9'C1I62-A&KR1H
M7(#.@RP^&KW]O_P#X<^ =E^T?\1_A9\3OA'\._%*_"<_"P_$SQ=^S)X>U/XP
M2_&)TE\,VW@MX/VB=1T'19]+T66/Q9XL'Q0U[X=Q>'O"$6J^(KJ5].\->*I=
M#^V_$.GS:MH&N:5;-$EQJ>CZGI\#SLZPI->V4]M$TS1I(ZQ*\BF1DCD<("51
MSA3^8'P<_8Q^(_@CX%_"[X0'X+_LI_"#5_A[\0/V/O&'BOQW\'?&6NZI?_&B
MY_9_\>^#_$7C?Q/XWLC^SC\+KJW\6ZWIGAK4+[P\VI:UXUDOM<U^[LM7U[2;
M=)]9O?1P4,)*$Y8GE;CB,,K.HJ<O8.4_;.+]K%WTA%N-*NU%MJ-/^)'&HZB:
M4+I.,]>6ZYM.6^CV3;5W%-K=_"_H#X6_MV_"/XQ_$'5OA_X$TV_U:3P_XX\-
M?#?7O$L/Q)_9MN]$TWQMXB\ >(?'LF@II.E_'?4?'NM7.BCPIXE\+7DOAKP7
MK5KKGB/PYXHNO \_BWP?X1\6>+-#]3N_VN/V4K"T\1ZA?_M.?L]V5AX.\06'
MA+Q=>W?QH^&]M:>%?%6JC7VTOPSXCN9O$J0Z'X@U)?"OBAK#1=3>UU*\'AO7
MS;VT@T?4?L_A _94\?R>)K+5I/$'ABULHOVZ/&?[3,TNGZKK4.KP> /$OP \
M9?"BTT_3Y&\.F&+QU:>(/$5GJ!M'D&BP:9!/=Q:]/>Q1:=/Y;IO[.G[8>G?L
M]_!;X&P0_!_1K#X$'PMX=DB^&?[37Q]^"J?'[PEH/PZ\;>#XK_Q?XQ^&WP8T
MGXC?!?5+'Q7<> OB7?>'/!?B/X@V7CW5[37]!U[Q1I&EJD^M]$J&75)*5.HJ
M<%&@I0^L0C)7]I[67/6BXSFY0A&,8JE"#K1G4E&E3G,E3K):QN[RUY6U]GE5
MHNZ23;;?,Y<K44Y-(^Z?%7[1?[/G@63PI#XW^.WP;\'2^/-+M]<\#Q>*OB?X
M)\/2>,]%NUB:UUCPHFKZY9MXBTNY6>!K?4-(%Y:3+-$8YF$B;N_TOQGX/UO4
M+?2=%\5^&M7U6Z\-:7XSM=,TO7=+U#4+GP?KD]S;:)XKM[*TNI;F;PUK%S97
MEOI>NQQMI>H3VES%:74TD$JI^=W[-?[+/Q]_9VO_  #8W.F? [XI^&M4_9Q_
M9Z^ GQ7N-=\>>-] UKP=%\(;CQW#XCF^'5I<?"7QG:?$;PGXCM/'U_JUMX3\
M4:A\,3+K]O=-J.J[-;GO;'L?^"?_ ,'?&/PW\,?$O6_'Q\02W\GC"3X,?"V?
MQ1INM:)KB?LT?L\ZGXC\'?!2"]T3Q'##K>F_;I]5\=>+;3[8B)J6G>++/6+;
M[7'J!U;5,:^%PE.G7G2Q/M?9>R5.2E!K$2JR::5-+GH^R49W4W)U>53@U"2L
MX5*DG%2AR\W,VK/W%%*VM[2YF]+)6V>J9[G/^US^SO%\2-4^&4/Q7\ W^J^%
M?!?Q;\;_ !&UO3_'7@>Z\,?"6R^"OB7X:^%?&VC_ !7U)/$HN? ?B&#4OB?I
M;V^GZ[86\45MH'BMM6N]*N-*M[?4*]]^VC^R/I\GPX$W[2?P4GM_BYK^L^%_
MASJFF_$;POK&@^*-=\/VCW6L6%IXATG4;W0K5K)Q;Z6\^HZC9VLGB+4]"\+P
M3R^(_$&AZ5J'Q'X0_8Q_:H\-^'M$\/:3XF^"GP^U+X3_ +(7QN_9C^%_Q*\"
M>(_&TGQ \8:IXY\?_!SQ7X6\:^,KRY^'6D#X>"]TKX:ZO;:I#X9OO'NL?#WQ
M7XHU;QEX8UGQ=>:DEGH_1?"C]D/X_P#PYOO#'C@VWPTO/%.A?MB^,OCR?!>N
M?M!_&[XDVH^'?CG]F&W_ &?+K3[OX[_$OX9:]\2?%'C?P]=FX\1VD&O^$CI6
MLV,%KHD6O^%K0V\>E]$L)E:C)K%2E*,:BBHUJ4?:S2J^QNY4VJ:JOV,KVG&G
M%5(5G3GRU)2JE=V]Q*_*W>+?*FX\UK-7Y5S[V;=G'F5TOT%\#_&WX,?$[7/$
MOAGX;?%WX8?$+Q)X,F:W\8>'O _C[PIXLUSPI.MY<:>T'B72=!U:_O\ 0IEO
M[2[L6CU2WM7%Y:W%L5$T,B+2L?V@/@-JFO>.?"NF?&WX1:CXG^&&G:SJ_P 2
M_#EC\2?!MWKWP\TGPY,+?Q#JGCG1[?6I-0\):=H-P1!K-[K]OI]MI<Q$5]+
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MO:5>5/V>KDTTU)>[IJ[<S35W?=/E?*VW&_Z6>'/BQ\+/&'@6?XH^$OB7\/\
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I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img181012247_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_9.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *6!.0# 2(  A$! Q$!_\0
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MNOL_B34O!WA6QU(G42+>3Q5?:+:/J5I:QWMV(Z6F_P#!/S]I'2O"=AXSMO\
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M":3>:EH/A_3_  MKEG>7MI9,!?75GJL$T7VMM.OM$Z[]CKQE\7?@M^W'\?\
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M06RVME8+=R7ES;FY;].?C#\,XOC#\.?$7PYF\=?$SX:1^(O[(W>-O@]XQN_
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M*]"^#_[=?P\^*7Q:LO@5XF^%_P >OV?OBSKOA[4?%?@WP;^T#\/[#P;=>/\
M0-&5GUJ^\&:GH'B;Q?H6K2:-"KW&I:=)JMIJMM;Q3SFQ:*VN6BYYY?BHJO.-
M&I.E0J5H2J.'*VJ$K59<C;E:FK.KR\RI7]^2W*5:F^5.45*2B[7O\?PJ]K>]
M]F]G+HC[:HK\Y?B+_P %,_@_X,^(OQ%^&_@OX0_M._M"7_P=OCI/Q?\ $?[/
M7P?;XA>#OAEK40G>]T3Q5KD_B+0B-5TQ+2].IV>C6FKO9/I^I6\I%UIU]!;_
M "9\;/\ @II\0_#?[:'[+_A;X;_"3]I[Q;\"/&_PBU_Q]K7@SPA\$O".I^(_
MCK#XN^%^A>//!&N_#/\ X275-/\ %DEM\-AK\%M\1+-=5\%RZ+K>G:YI6H6.
MN)8*'WH9/F%=V5'V=\/5Q,76DJ=Z=*C[:UG>49U(.+I*:BI*49MQI\TU,L12
MC]KF]^,+15]924?1I-^]9MJUK-V3_<VBOASXC?MX^!/AYJ7PJ\&1?!S]HOQ]
M\9?BM\+M/^,5M\ ?A]\.M+U?XN^!/ =ZMO!<:I\3-+U7Q;H7A?PE)I&N32^%
M-4MY/%EXZ>*+&\TNS-Z4AFG^H/A3\0A\5? 'A_Q\/!'Q#^'!UY=2+^"OBMX8
M?P;X_P!!ETS6-0T::#Q!X=>[OULFN9=.>_TV:"^O+34M'NM/U6RN9[.]@D;C
MJ87$4J<*M2FX4YNT)-QO+6234;\SBW"?+.W)+E?+)FD:D)2<8R3DE=K739Z^
M>JNMU=71Z'1117.6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 45\!?\+L^)W_#TO\ X9Q_X2;_ (LS_P , _\ "[/^$-_L
M;P__ ,E._P"&B?\ A!/^$F_X2'^R?^$J_P"15_XE7]C?VY_PC_\ R_?V3_:7
M^F5]^UO7P\Z'L>=Q?MJ%/$0Y6W:%2_*I7C&TERNZ5UVDR8S4^:U_=DX._=6O
M;5Z:_P# "BBBL"@HHHH **** "BBB@ HHHH **** "BO&_C_ /'OX9?LR_";
MQ=\:?B[KO]@^"/!UDEQ>RPPF[U35+ZZF2TTG0-!TY7C?4M=UO4)H-/TRT$D,
M/G3?:+ZZLM.M[R^MO@BT_P""@7[3FG>&;#XP>/O^"<'Q=\)?L[W<5IK-]XXT
MSXI^"O&/Q6\.^"[MXY&\9>(_V?=*T:W\8Z?I^G::TFKZW86^JWNJ:3IT$MU<
MVOV=&G'90P&*Q-/VM*G'V?/[*,JE:A052K92=*C[>I3=>JE*+=.BIS7-&\5S
M1OG.K3@^63=[<S2C*5HWMS2Y4^57ZRLM]=&?JW1117&:!117SO\ &?\ :9\!
M? OQ[\ ?AUXMTKQ;J&N?M&_$&X^&_@>X\.V&D7>F:7K=K81:A+>>*I]2UW2+
MFQTGR9HT6?2;/6[TRDC[ $!D&E*E4K3]G2@YS<9RY5ORTX2J3>O2,(RD_),4
MI**O)I*Z5WW;27WMI>K/HBBBBLQA117P1^QY^U5X\_:&^+?[;'@#QAH?A'2=
M)_9L_: OOA5X)NO#=IK-MJ.K^'K4ZO&EYXIDU36]6MKO6FDTL2-<:3:Z+8[)
MS$-.#1^:^]/#U*M+$5H)<F&C3G5;=FE4JQI1Y5]I\\U?LKLESC&4(O>;DHZ?
MRQ<G?MHC[WHHHK H**** "BBB@ HHHH ***^!_AG^U3X]\:_\%!OVE/V3=3T
M3PA;?#WX-?"KX:>./#>N6-GK*>,M0U?QEI_AV]U2#7+ZXUVXT2?38&UN2/3X
M+#P_IUU"($:YO;LNP&]'#U*\:\J:36&H/$5;NUJ:JTJ3<>[YZT-.UWT)E-1<
M4_MR4(^K3?RTBS[XHK%\2WFM:?X=U^_\-Z1'X@\16.BZK>:#H,M]!I<6MZU;
M6,\VEZ1+J=S_ *-IT>I7R063WUQ^XM%F-Q+^[C:N"^!WB3XK>+_A3X.\1_&_
MX<6/PC^*FJ65Y+XP^'6F^*-*\:67AF]AU;4+6SMK?Q-HEQ=Z5JBWFE06&IL]
MG<SI;/?-9/(TMM(:S]FW3=6\.53C3<74@JC<HRDFJ7-[24$H-2J*+A&3C&4E
M*<4W=<RC9W:;O9\MDTK.5N5/717NTFTK)GJ]%%%0,**\!^(?[1O@?X:?'3]G
M;]GW7M,\4W?C3]ID_%L> ]1TFQTF?PSI0^#/@ZS\;^*3XMO;S6[#4[ 7NE7T
M%MH/]CZ-KQNM1WQ7XTRU479]^JYTJE.-*4XN,:T'5I-[3IJI4HN4?)5:52'^
M*#$I)N23NXOEEY/E4K/_ +=DGZ,****@84444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 45GZOJ^D^'])U/7M>U/3M$T/1-.O=7UG6=7O;;3
M=)TC2=-MI;S4=3U/4;R6&SL-.L+.&:[O;V[FBMK6VBEGGECBC=QX7_PUO^RE
M_P!'-_L]_P#AZ/AQ_P#-)6D*-6HFZ=*I42=FX0E))]FXIV9XV9\1</Y)4I4L
MYSW)LHJUX2J4:>9YI@L!4K4XRY93I0Q5>E*I",O=E*"<5+1NY]"45\]_\-;_
M +*7_1S?[/?_ (>CX<?_ #24?\-;_LI?]'-_L]_^'H^''_S25?U7$_\ 0/7_
M /!-3_Y$\S_7W@7_ *+3A/\ \2/)_P#YL/H2BOGO_AK?]E+_ *.;_9[_ /#T
M?#C_ .:2C_AK?]E+_HYO]GO_ ,/1\./_ )I*/JN)_P"@>O\ ^":G_P B'^OO
M O\ T6G"?_B1Y/\ _-A]"45\]_\ #6_[*7_1S?[/?_AZ/AQ_\TE'_#6_[*7_
M $<W^SW_ .'H^''_ ,TE'U7$_P#0/7_\$U/_ )$/]?>!?^BTX3_\2/)__FP^
MA**^>_\ AK?]E+_HYO\ 9[_\/1\./_FDH_X:W_92_P"CF_V>_P#P]'PX_P#F
MDH^JXG_H'K_^":G_ ,B'^OO O_1:<)_^)'D__P V'T)17SW_ ,-;_LI?]'-_
ML]_^'H^''_S24?\ #6_[*7_1S?[/?_AZ/AQ_\TE'U7$_] ]?_P $U/\ Y$/]
M?>!?^BTX3_\ $CR?_P";#Z$HKY[_ .&M_P!E+_HYO]GO_P /1\./_FDH_P"&
MM_V4O^CF_P!GO_P]'PX_^:2CZKB?^@>O_P"":G_R(?Z^\"_]%IPG_P")'D__
M ,V'T)17SW_PUO\ LI?]'-_L]_\ AZ/AQ_\ -)1_PUO^RE_T<W^SW_X>CX<?
M_-)1]5Q/_0/7_P#!-3_Y$/\ 7W@7_HM.$_\ Q(\G_P#FP^A**^>_^&M_V4O^
MCF_V>_\ P]'PX_\ FDH_X:W_ &4O^CF_V>__  ]'PX_^:2CZKB?^@>O_ .":
MG_R(?Z^\"_\ 1:<)_P#B1Y/_ /-A]"45\]_\-;_LI?\ 1S?[/?\ X>CX<?\
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M1^%KKQ:FKC7[CPXFIV]OJ*:'+J#Z8M]!#=K:BXB217:)\>?V&/#/B+Q=XO\
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M]D_:]^!?PE^/OC7_ () _$WXL^"K+Q;XV_:3E^&?A?XU:U<ZEKUG)XW\//\
M"S0/$?\ 95U!INK6EOIT*ZSKFJ7@N-&BT^_9[HK)=R)'$J?JMI/[#R:7_P $
M^)?V$#\37G67X2:U\+O^%I_\(:(F5]7NK^\&O?\ "$?\)3*"EM+>[3I/_"7
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M(6AN=$31C?"-(]26\A41CT?]N3]F1O ?CO\ 9DO_ /AF_P =_M%_\$^_@O\
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M?^*ZXP_^<Y^>]%?H1_PZM_;T_P"B$?\ F3_@U_\ /#H_X=6_MZ?]$(_\R?\
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M&?4AK.DE;;3O">B>*)'M;^SO)Y+>"/4FT_G/#WP D\0P>._$:_%CX6Z1\+?
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M^TO[6_MF/R/L?V/^S)OM'VJ#TJY_8M_:H\<Z!\,H?C=^Q!K/CSQ?\)O#6D>
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MQ8_\5UQA_P#.<_/>BOT(_P"'5O[>G_1"/_,G_!K_ .>'1_PZM_;T_P"B$?\
MF3_@U_\ /#H_M/+?^AC@?_"O#_\ RP/^("^.?_1E_%C_ ,5UQA_\YS\]Z*_0
MC_AU;^WI_P!$(_\ ,G_!K_YX='_#JW]O3_HA'_F3_@U_\\.C^T\M_P"AC@?_
M  KP_P#\L#_B OCG_P!&7\6/_%=<8?\ SG/SWHK]"/\ AU;^WI_T0C_S)_P:
M_P#GAT?\.K?V]/\ HA'_ )D_X-?_ #PZ/[3RW_H8X'_PKP__ ,L#_B OCG_T
M9?Q8_P#%=<8?_.<_/>BOT(_X=6_MZ?\ 1"/_ #)_P:_^>'1_PZM_;T_Z(1_Y
MD_X-?_/#H_M/+?\ H8X'_P *\/\ _+ _X@+XY_\ 1E_%C_Q77&'_ ,YS\]Z*
M_0C_ (=6_MZ?]$(_\R?\&O\ YX='_#JW]O3_ *(1_P"9/^#7_P \.C^T\M_Z
M&.!_\*\/_P#+ _X@+XY_]&7\6/\ Q77&'_SG/SWHK]"/^'5O[>G_ $0C_P R
M?\&O_GAT?\.K?V]/^B$?^9/^#7_SPZ/[3RW_ *&.!_\ "O#_ /RP/^("^.?_
M $9?Q8_\5UQA_P#.<_/>BOT(_P"'5O[>G_1"/_,G_!K_ .>'1_PZM_;T_P"B
M$?\ F3_@U_\ /#H_M/+?^AC@?_"O#_\ RP/^("^.?_1E_%C_ ,5UQA_\YS\]
MZ*_0C_AU;^WI_P!$(_\ ,G_!K_YX='_#JW]O3_HA'_F3_@U_\\.C^T\M_P"A
MC@?_  KP_P#\L#_B OCG_P!&7\6/_%=<8?\ SG/SWHK]"/\ AU;^WI_T0C_S
M)_P:_P#GAT?\.K?V]/\ HA'_ )D_X-?_ #PZ/[3RW_H8X'_PKP__ ,L#_B O
MCG_T9?Q8_P#%=<8?_.<_/>BOT(_X=6_MZ?\ 1"/_ #)_P:_^>'1_PZM_;T_Z
M(1_YD_X-?_/#H_M/+?\ H8X'_P *\/\ _+ _X@+XY_\ 1E_%C_Q77&'_ ,YS
M\]Z*_0C_ (=6_MZ?]$(_\R?\&O\ YX='_#JW]O3_ *(1_P"9/^#7_P \.C^T
M\M_Z&.!_\*\/_P#+ _X@+XY_]&7\6/\ Q77&'_SG/SWK^I3_ ((B_P#)J7Q
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ME;_SFZ_[Q6_^_;U^J5?E;_SFZ_[Q6_\ OV]?JE7I9E_S ?\ 8MPO_N0QH_\
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MC6K5JL:,)JFJE:K-14JDV_JK_AY5^W7_ -'*_$'_ +ZT3_Y44?\ #RK]NO\
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MKCJ&%^MQAEE').'<UJQ6'JXC-*]:A"EALLK>VI3E\P?\-^_MC_\ 1?\ QO\
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M\0:S);[(D?=J$_F,XV!/)_\ AOW]L?\ Z+_XW_[ZTC_Y5UY7:?\ )CG[//\
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MZ9=MIGV>X;3_  )XFU.R:3RM.CDS;W]G:W*;7'[R%-V5RI_._P#X>5?MU_\
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MXM6A\33:-97LESJ%U;6.NV&HW<WV6%-4@LXY[:X_&\Q7".5XN>#Q'#6"=2.
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M_$OQ!I\.I?![X3:_?1P&QVW.L:YX(TG4=6OY-]FY\^^OIYKF;:53S)&V(JX
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M\4_GIO\ \@5\?>"O^3G?CS_V83HO_K9/P:KL*_QB_:&\2\1\->/F%RSAS/\
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MI_/3?_D"C_AK[]I;_HK_ (I_/3?_ ) KYNHKS/\ B(OB#_T77&7_ (D^=_\
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M/3?_ ) KYNHKYC_B(OB#_P!%UQE_XD^=_P#S=Y+[CU_]5^&?^B=R+_PT9?\
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M3^>F_P#R!1_PU]^TM_T5_P 4_GIO_P @5\W45\Q_Q$7Q!_Z+KC+_ ,2?._\
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M^C0P7$F)QOU6O+#X#%87&X6A2J9E[6I+A[#8//Z+H_66\GI4,]C_ +%&-/\
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MO%=YX6U>36O#=[>7F@?%[0++2IM'O'C\F+PQINA6=Y#;PQZK:Z@6N'GWK/\
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M6IC*M+ 9_B<RP-2C7PV"C65*G1J9IA<RP]?AC!X7,:U&G3S'#/(L-1S.=..
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MQ5\'YD\<?"^+X4:[=:OX=\.Z-XFMO$_A/3;3X@_$>#Q'X-U"QU26VO;V_O\
MPWKN@:G%I]EJ?AU3JT4D'K_P@_Y,5^(__9V?PK_]4]\7*]'#QR"&59+#AVA+
M#X&GQCD]&K3JX;'87%1QE#-J%#$1Q=+,Z=+,/;TO90HIXJ//&A2HTZ;]A3HQ
M7\[?2VY?^);?%OET7^K,EJFG=9A@D[\VNFVOIL=C^SK^TCKG[-/B.[\9>#_
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MU>CQ#"E6QN#KX..6X3!XM0C@7B<)//(.DLMK*KA\/F69SDX86MFTG_A;D/\
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M=&$YP>%3Q"E%>P7M>4_TY_9GM+P=XZ;T2\2<6V]=$N%N&;[:[=M>Q]/>(?\
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M9X>K@UBY*GA\7"O+$>SHTN3!N5%_.E>__M3?\G ?$W_L-VW_ *9]-KP"O?\
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MOF_6Z\/ZQ=:5INE:?-/:&S5@8[&UG0R/'-;^6MO=7=71/^38?B)_V6OX5_\
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M2+4J]1\0_'#PGX\\.> K7XB_#.Z\1^,/AOX23P7HGB/3?'-QX?TC7]!TR/\
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M:/$=EX7TBPN]5?[99VM_-I?]K30VT>E1SPW3V9OKJ&\:V6 O9K-X>^-6CO\
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MM[B8?;M2DB>>V^T1Z;8K<WSVL<R3W2VYM[;=<2Q(WH_P-_Y /[1'_9 -9_\
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MOBYTY-\]:JY\W/3E4J1["TDU4:2?-RVT:4Y2TO+1QC*---;1C:UFDN(^.O\
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M6]5NO!H;4K;1X[;2/[6U2XU"V47D<W]H>28;?RWB9CS7_#(?_!)S_HYBU_\
M#Y>!?_E)75AO&+A+&1XHPV,X?\2(4\=Q5D^=86K@.$<3/$X2OD^5\)5\%.K&
MJJ]&G7IYCDT,1]7KT:L*N%=*52$J>(47_E_]+3PBXRXL\<L%QOPUG_ACE^&C
MX=+A?$97QSQ?0R'%8O"YMA^*LGS>,L"IX?&K!XK*\]KX?#XW#8JA5C7YYT*L
M*M!2/@KPO^TY\)=!31?ADEG\1+7X/>%/V>OC9\'M(\5CPYX8U;XCZQXM^.8>
M]\4^.M5\(?\ "::'X;TW1[34YH[?1/!]KXWU.ZT_1]*M8[SQ7K%_?W-W;<?\
M&_&G[+WP?UGQ#XNL/&/QNU7X@VEA:P?"GQC?_ GX?3:?\/M7NDNX=:\7R>"G
M_:-^SZWXMTVVDMU\"7U[XCDT;PYJ+7.O7OAW6=5@T231_P!)?^&0_P#@DY_T
M<Q:_^'R\"_\ RDH_X9#_ ."3G_1S%K_X?+P+_P#*2I?B/P J&887#Y-XP83#
MYM&/]K4:/"#J1S*J\=B<QQ5?%RQ>#Q,YO,,5C<;+,L-"=/ 8RCBL1A:V#EA:
MGL3^>X>#'BV\7E&.Q?$OT<\PQG#U23X?Q&)\18TIY+AXY7@,FP.%R^.7YC@J
M5..3X#+,LADV-J4ZN;9;B,!A,?A\QCCZ4<2?AO?OI$GCMI=!UO7_ !)I4_B"
MUN+77O%.D6N@^(M6\^[AFGO=8TBS\2>+[:SO9KEYFE2/Q+K'F'$[W9DE>-.,
M_;M_Y//_ &I/^RZ_$O\ ]2G4J_H$LOV1O^"445Y:2VW[2MK)<QW,$EO'_P +
MP\#/YDZ2HT2;%T0,^Z0*NU2"V< Y-5OCI^R'_P $F_%OQE^*'B?XJ_M,6GAO
MXE:_XY\2ZMX[T!_CEX%T1M&\57VJ7-QK>FMH]]HLUYIAL[]YH#974LD]OL\J
M1V=23VXOQRX:EQ!DV*7#WB'.G@^'\XP,_;<'XFGBZU3$8WA^I"M&A2]E3=-+
M!U/;SHTZ5*E5J481IQC4A%?V)]!7PISSPLEXK5<\SC@K-EQ)B>$JV$H\$<34
M^)Z6 6!?%$JM+&U(RJ8C"PE_:-*."EBZ]>OB8T:[G5J5*4YR_)?XB_M6_LZV
MWQR^/W[3OPLB^,?B7XK_ !<TSXA:+X'\/^/O 7@/P/X4^%+_ !0\)ZKX-\0>
M+IM>T;XH?$^_\>:UH^@ZI>V6AZ')X7\):7<3:E<7NJ:A+!9II=]Y1\5/B7^R
MW\8%^!6O>)?$?Q]TW5/AQ\&_@'\(_&G@G0_A=\.TT_6[+X<:=I.@^-K[PO\
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M-I']G2,GW#_@H3_R>W^TY_V5OQ/_ .E"5^QW_#$7_!%S_H[*R_\ $A_AW_\
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M%W#--:0_K-_PQ%_P1<_Z.RLO_$A_AW_\H*/^&(O^"+G_ $=E9?\ B0_P[_\
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MPK0MA\/&G3PN"GAHX_$SEC<Q6-S.O4QL_P";N/QII?PV_;(C^(FN6^H7>B>
M?VF5\::Q:Z3%;3ZI<Z7X6^*8US4+?38+RZL;2;4)K2PFCLXKJ^L[:2Y:-)[J
MWB+3)[-XE_:"^!G@Z;]J+Q3\')_BIXR\??M/6'BSPA-<?$GP'X1^'?A[X8^
M_'WC./QEXUAL;?PW\4OBG>>/?$VJKI^C^'M(U"Y/@:R\/VL6JZJ]KK=QJ%M8
M:;^O?C/]C#_@COJGC#Q7J?B7]J>ST_Q'J/B77;[Q!8'X_> +,V.MW>J75QJM
MF;2;0GFM3;7\D\)MI7:2 IY4C,RDGFO^&(O^"+G_ $=E9?\ B0_P[_\ E!7G
M5/%/@G,%EV(QG#WB9*5#+\NPF(P^'X4Q2P>-I8'$T,PP\*TDG7E2AC:,*K6'
MKT(8JFGA\5&OA:E2C/\ W.]M3?*W&MHDK*#L[.+UZ[VVWVU3U_+_ .,OQ@_9
M2^+7[0+?']?'W[4GA:_U";P%-+H/A7X6_#?0-=\):CX,\">'_"ECXD\+?$<?
M'S59KG4M&USP[8>*K&S;P7H,^IQ1OH</B#PO>2P^)[+RS]ISX\^$OBWX3^$7
MA?2M>^)?Q8\6> D\;W'BO]H#XVZ)HF@_%3QE;^*M5L+C0? =S;Z3XU^)FI7_
M (/^']KI=Q>:!J7BSXC>)M3_ +1\7:]I^C:;X3T.QBMM7_9/_AB+_@BY_P!'
M967_ (D/\.__ )04?\,1?\$7/^CLK+_Q(?X=_P#R@J<O\2N!LOJY)4CD?BGB
M5P[AH8/**>)X/=L)AJ6!KY=1H^UP^%P^)JPIX/$U:4HUJ\XXF7LJV,6)KX7"
MU: JM-<ONUGRI*-Z>RLDEHDWH_GOJ^4_,>T_Y,<_9Y_[+K^TO_ZCWP#KTGPU
MX_\ @3XA^!'P]^$WQ0USXM>&K[P/\4_'?C>[N/ 7P]\'>,+37-$\9:5X'TTZ
M;;ZCXA^*G@B;1-5ME\*W9%U)HFN6B&\MY3!.(9;>3]>HOV6/^"82_!#X?>%(
M_P!H>V/PNT;QS\2M6\'^(Q\9?!935/%6NZ?X"A\;::NM?V/]BU Z19Z/X2E:
MRMX8Y]._M,27+R+?0"/B?^&0_P#@DY_T<Q:_^'R\"_\ RDKLRWQAX3KY53P^
M(R/Q,P^(P?%/$N<X/&95PC7J3H5<=G&>\BYL13Q.'=2."S2MA\31J4)RH5W-
M1<:U&$U_DC](SP3XVX@\?O$KB_)<_P#"&&3\699PUE.*R+C;C:CE&/G@\#D/
M"4I0QV74:^#Q^#D\SR'#8O#2ABX?6,*J3FIX?$SIR_/_ %/]ISX8_%'2OVA-
M"^(ECXW^&FD_%-?V?-/\"VW@'PUX=^)W_"(^'/@5I&M:%9:-J_\ ;WC3X2G4
MKB]TZYTQO[5MGC$MXVH2?V?96T=I:&K\)OCE\&/A':VEM;^.OVB?'7@NRM?&
M;^(/V?/%?A3P>GP6^*NO:C;>(--\.:SXBLG^*FLZ1X5MI+5_!NK:EI]S\//B
M9JN@^(?#LE]HOBB_F71+O1OT*_X9#_X).?\ 1S%K_P"'R\"__*2C_AD/_@DY
M_P!',6O_ (?+P+_\I*F?B%X</!8K*Z7#GBSA\IQ<L'*KEE/A"M4HQ^I9+@L@
MINEB<50Q.9TJSRS 86G];ACUC:.(I?7L)B</C9/$2_+*?@_XSK,\!GN(XT^C
M[C.(<OAF,*&>5O$;#T<5-9EQ-F/%U:.(P. Q>#R3$8>.>9OCJRP%3*I9;B,'
M7_LK'X/&97&&#C^4_P"QC_R<C\/_ /KS\??^JV\85\>_LB_%[PO\!OVC/AC\
M6O&MGK]_X7\':EK%SK%IX7L].U#7Y8-2\,:WHD9TVRU;5]"TZYFCN=3AE>.Z
MU>Q0P)*5F,@1'_IJ^#7[,/\ P36\,?$?P_KGPU_: MO$'C2SAUY=(TE?B_X.
MU@W4=YX;U>QU9AIUGI$-S/\ 9M%N=1NRT<BB 0&XDW1PNI^6O^&(O^"+G_1V
M5E_XD/\ #O\ ^4%5FOC)PCF^;<24L7PWXAO+\ZX3RC)*]&GPGCJ>,C3^L\61
MQ<W#G<J,*E'-(0PU=W4ZM+$**O0=_P"[OH.>&^;>%?AMQ7D6>9MPQG>(S'C;
M$9I2Q'!^>X?B+ 4J%3(<BP:HXG%X6$(4<8IX6=1X>2<E1G1JWM5BC\G/!'Q[
M^"7P(\&WW@?X47'Q1^((^(_Q1^#_ (K^*GC'X@^!O"/P]N-&\"_!KQ?:>-=&
M\*?#_P &>'?B;\2$U'Q#KOB'S[_6O%&O^.--L(]/TS2]!L?#,4UY?>(H;?BC
MXG?LQ:C^T'X^^/'A?XQ?M<^#-;\>>.?B=XYTC5?!/PM^'W@CQ5\+M9\<:CK>
MMZ;=:=K6G?M&:K=^.+2S?5)?#.LZ1:WOPMNM2TO4;G68/$MH;%O#.L_JQ_PQ
M%_P1<_Z.RLO_ !(?X=__ "@H_P"&(O\ @BY_T=E9?^)#_#O_ .4%<'_$2."5
MB<5C8Y1XKQQN8TL32S3%_P"J"G/,UB:6#P[>*I5<'4PL%2P^78'#TZ6$P^%H
M2H8:-*O2K0J5E5_M/VM.]^6M=WN_9_%?EW5K:*RT25E9W35_Q2_:G^-/@[XR
MZQ\.YO"Z^+?$FI^#? -EX8\9?&3XDZ-X=T#XI?&KQ%'?WM]_PE7CS3O#.K^)
MK;[9H6F7-AX,T2^U;QCXS\3ZAX=\/Z9=^(?$U]?R-#;;_P"TE_R0S]A3_LW[
MQS_ZTI\;:_8[_AB+_@BY_P!'967_ (D/\.__ )05[#\1_P!D?_@E'KG@?X&:
M3XT_:4M-)\+>$O &MZ-\*]1;XX>!].7Q)X1N_B3XVUS5-42^N=%D@UL6_C75
M?$^D&_L4AMX&TXZ<\9N;.:1[_P"(O<)9?+A'"8'ASQ!AA<GS7&UW'$<)XR-:
MK'$9)GM&4</3C*%-R^L8[VL<)AJ=##87"QG#"T*&%P].C ]O!.FE"K:+>\'?
M6/3[]EHELK6/PZT[XL_LN^)_A5^RYX=^*TWQKFUO]GC0?B!INN^!?"O@#P+=
M>%/B4?$7Q=\:?$S2=)7XDZO\5[#5_".FWUKK^FZ'KVHGX5>)[JP7^TI]/T[4
MC':^?U7C/]J+X2?M"_#7XE>'?CAK'Q1^'WC#QU^UEXN_:.AO/AM\,/!OQ-T"
MTT;Q%X(TOPEI_@]E\0?&#X07L-QHJ6CPIJ)@OVN[*SM)[IY;^\NWA_3K_AB+
M_@BY_P!'967_ (D/\.__ )04?\,1?\$7/^CLK+_Q(?X=_P#R@K*7B+P)+$+%
MK)/%:&*HX_&YC@*ZX3JREEE7,<SKYQCZ>#I5</4P[HXO'UW5K_6Z.*K3C2PU
M+VRI8:A"FO:T]^6M>[:?(].:2D[:-:R:;NF]$KVM?\L?#W[0_P '/ OP=\<?
M#O3_ !W^T?\ %;P_XA^#6K>!?"?P#^*_AKP</@O\/?B=XICTN76OC!X9U<?%
M'Q;!I.I^'_$\GBSQQX*M= ^$.A>*+*ZUR'PWJ'CZX+:_XK\02_\ !-?_ )+-
M\4/^S9_C?_Z8+6OU)_X8B_X(N?\ 1V5E_P")#_#O_P"4%>\_L^?LQ?\ !+#X
M:>)O&/B3X2_M)Z=X@U9OA=X[TSQ1'-\;/!&N0:5X O\ 38U\6Z]<0V.D6SV,
M&E6,:SR:K/(;2P7,MPCJ<5Q9WXH<)0X:XIP>7\/^(CQN>TI3K8C,.$Z^'I2K
M\L*<)598>&'H1;2;JXNI1J8S%5)\^+Q.(FH. ZT.624:MY:W=-^79+OOJWU;
MNK_*GP3\;Z3\-_BIX,\<:Y;ZC=Z3X=U.2]O;?28K:?498GL;NU"VL5Y=V-L\
MGF3H2)KN!=@8ARP"MZW\$_&W@.W\.^%O#OBX-"OP]^)/BOXWWS7ESI-C8ZW8
MZ)X#TJ/0?">DRWNHPW>HZ_K_ (KT+3[!M&AM%2XL+DSK=$0W M_=?^$7_P""
M6/\ T=9X(_\ #W^!O_D2C_A%_P#@EC_T=9X(_P##W^!O_D2OR_,<^R_,?;SG
MPYQY2K5Z%"@ZU+AK,8RIQPZQ\:4J:25IQ698KWK_ !.FVG[-)PZD97]RKJDK
MJ#Z7M;S][\4?,WP]^)_@FWF\?:O\1M.EN?&'C#Q'IVOQ^+(?AWX#^)CQ6\M]
MJNH>*])A\.?$2_M?#NCW6O7=Y92P>)(K/5[RP6VEMUT^2"9U?@_C/XUTSXC?
M%3QSXYT6WO[32O$^O76JV-MJD=O%J$$$ZQA8[N.TN;RV252IR(;J9,8(?D@?
M:O\ PB__  2Q_P"CK/!'_A[_  -_\B4?\(O_ ,$L?^CK/!'_ (>_P-_\B5I0
MX@RW#YA4S*EPQQTJ]2@\,H/AG'.C2HRCA(NG2BJ:E&%L%0<:;G*G3DJCI0@Z
MM3F%4CS<W)5O:WP.UGR[?=']-SY4_: _Y#GPX_[(/\$?_5=Z'75^!_C;X3\-
MW'[,\NHZ=X@GC^#6K>,+[Q2MK::;*=0@\0^)YM:LTT%9]6@6[DCM)!'=+J)T
MM$GRD3SQ8E/V-\2_#W_!.F?4?"S>/?VC_".@7T?PY^'T'AV"Z^+GA#2VU'P-
M#X7T^/P7KL,=W;,UW:ZWX?%EJ-MJ<)%KJ44ZW=LJPR*!YS_PB_\ P2Q_Z.L\
M$?\ A[_ W_R)7%A^(<!C<FR[!XOAOC6M&AAZD5/"\.X^5.3Q& Q>7590JQBU
M.+PV-KJ$EHIN,U\-B8U(N$8N%1V72#ZIK\I?BCY;\:>(O#6B>$_@EX#L6L?%
M&BZ%8)\1OB!:Z5JKV=OKOBKQO=VE[>>'M0N].DN/LVH^'_!NFZ%X8EO4DEU#
M2;V;5X?L]C=)<V:]A\7OC'\.O%7PXO\ P/X*L-2M!=?%>+QWIUO_ ,*R^'GP
MYTK0_#D6A>(-(M/#3GP3K6J7GB?4M,_M*T1/$>N[K[4K99?M M);<?;O=/\
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M@Z]_T3_DV'XB?]EK^%?_ *AOQ4K[]_X9R_X)Z?\ 1<K?_P .MX4_^5==]9?
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M^*Y.GA</3<H</XF4&X4H1;C)3]Z+:;C);K5;J_Y!T5^OG_#.7_!/3_HN5O\
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M7JC\@Z*_7S_AG+_@GI_T7*W_ /#K>%/_ )5T?\,Y?\$]/^BY6_\ X=;PI_\
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MJS6D)2I1=_:1/Q%HK]?/^&<O^">G_1<K?_PZWA3_ .5='_#.7_!/3_HN5O\
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MYY1Q5*=#+\'1E*GD&)G3E*EAZ4)2IS4K3@VFXR6DHZK=7_(.BOU\_P"&<O\
M@GI_T7*W_P##K>%/_E71_P ,Y?\ !/3_ *+E;_\ AUO"G_RKKQ/^)<.+_P#H
MJ_##_P 3G+O_ )5_5GY7]#_B*>2?]";B[_Q'L5_\G_5GY7X/]BG_ ))7K_\
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M+_;M_P"3S_VI/^RZ_$O_ -2G4J^1S;_DLLD_[)GB3_U:\*G^L/[+O^!XV?\
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M]?I1X:_Y-(_;-_[ _P !?_5S:-7YKU\CEG_(\XW_ .REP7_K%\(G^]_T!_\
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M:V\4D\;QC;'P@^+)UJX\-CX7_$0^(K32TUNZT >"?$O]M6VBR3FUCU>XTO\
MLS[=#I;W*M;I?R0+:-.IA$ID!6O\[*.2YSB*=.K0RG,Z]*K4]E2J4<!BJE.I
M5YJL/94YPI2C.ISX>O#DBW+FHU8VO3FH_LT\?@:4I0J8W"4YPCSSC/$T82A"
MU.7/*,IIQCRU:4N9I*U2F[VG&_G=>_\ [4W_ "<!\3?^PW;?^F?3:\ KW_\
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MX.FX*IB\-3=2I*E34Z]*+J58U'1E3@I33G4C53I2A&\E43@TI*QY]7O^B?\
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M.GEN7RJ3A3B\'A4I3E&";^KP=DY-*]DW;>R;Z&%174V?@;QMJ-YK&G:?X/\
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M?G^]7OKH5_#I\=O^2W_&3_LJOQ#_ /4NUBO[BZ_AT^.W_);_ (R?]E5^(?\
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M&ZU:=O"N@:C=W5Y?6.D($B@:Y>]U77KNWEO#&]^VFW'B#Q%)I'VH:4?$6O\
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M<O<ZC+)>):3W7P^\>> _'K6UO:W-I\/?B5K%QHK:QJSK86W/?M@?\E,\&?\
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M^+O$][X@M=$TN\\._$_XC)XI@M$U.XM;C5[NW\*2,UK#+'I)%VZ6GT-\(/\
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M99+@<Q6-Q&,PE/+<9#&5,53G6Q&"Q>4PJY3B,LJ5'EE7 XS&J>$>(Q-3$/\
M0WXY?M2?#+]H/X6?V'XNNOB)X>^(5M-X9\5^?H_@3PSK/A36_&.B^"M?T6^T
M9[BZ^*&BZGX9\,7>M:O']AU>WTOQ)?:=H\6?^$=N)XH[23Y;_9M_Y.)^ ?\
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M_$I\6ZWI/BRWT:ZTKPI/KEIID'_"!^*HM2O-55+@:4ELMV^-:?\ )CG[//\
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M[#U\;BL-*%.E0K0J2E+&UI>VC-JI"4+*T5?^=#_AT+^TQ_T./P._\*[Q=_\
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MKN &/._\.0?VM/\ H>OV>O\ PMO&_P#\[2OZE[@@33DD "24DDX  9B22>
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M5+$*A4F\-5J4HU>63BI?S?\ _#H7]IC_ *''X'?^%=XN_P#G?T?\.A?VF/\
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M*49)-67\K7_#D']K3_H>OV>O_"V\;_\ SM*/^'(/[6G_ $/7[/7_ (6WC?\
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M="_M,?\ 0X_ [_PKO%W_ ,[^C_AT+^TQ_P!#C\#O_"N\7?\ SOZ_HOHKV/\
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M[^OZ+Z*]+_B9WQ5_Z"\B_P##+3\O^G_D_O\ (_.?^)&_ /\ Z%_%?_B35?\
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M  MO&_\ \[2C_AR#^UI_T/7[/7_A;>-__G:5_4G11_Q,IXH?]!62?^&>G_\
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M%B+M)+ZWM)[#2+2WDU/3+>74M;N=.TU+K4;&V-V)[F*-O1QOT7/##-\3AN;
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MA27-4E&,6S\P/^'<?QS_ .AE^%7_ (4?B+_YD*/^'<?QS_Z&7X5?^%'XB_\
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MEW/BJM*=:^ BTY4L/2HQ<5[3W5[.$4UKKKY'XN?\.X_CG_T,OPJ_\*/Q%_\
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MAG52$'6Q->=>JX16'?+%SG/EC=\J:5]#S\)XO<987"X;#4JV7*EA\/1H4E+
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MXVK252F\;44XSI4L3B&H5L7RU?8.I[:I3E",VO6XVQ%7A3*X5,AX?GFF&R7
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M_;/5_P#D*:A_U]S_ /HQJ;$B1K''&BQQQA$2-%"HB( JHBJ JJJ@!5
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M3#5<)4G"6&X)R'$I*>09%BW!5,RQE+6,,_SVE:>+LY3P. =++U4;=>*R)_\
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M%P_S26)PF)I1Q6)S*-++*="56=54_:O^"<W[./Q/^*/Q,UW_ (*.?M5QW/\
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M(.G..&Q"5*OQ=F-&6O\ :&:4FX931J)++\LFJJB\1BG667=?\?-Q_P!=YO\
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M@3Z7K'Q>\267S(B(X5CJ-W;2;H(I%DA\">'[P7=VG_"3ZS:VC_O!X,\*>&_
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M1KD(8+Z*YDM;S3/ =L_GVKA-8^(EW%>VMEH-I#[!_P %$?VI/B#\;_B1H/\
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M=0N= U>ZN8GTN:/[%>3MHEQ<10?7?[+NA_ WPK\$O!GA']G273I?A;X3M9M
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M3PY9B6YO=$\?1">Q&J>'+:V:[N;.^FNX;WPY,TUQ:W)TZ?5--U#]//[+O?\
MGG'_ .!-K_\ 'J^!_$OBJ?\ :$\;^*O"$J7.E?"/X4^*CX=\4>&-2AFT_7OB
M3X[TJ.TU(0>)]%NUAU#2_AMHPN+&_P!+TK4[:!OB)=-;ZQ-#)X,@T[_A)?EO
MI!?2BX2^B/X;9MXQ<2X_$QGE+C@\@RC+7&IF/$F?XN$U@,BPT91G0C3Q<H2>
M,KXM?4\-A(5J]?F4(TY_C>&\,Z'B?&OPOF^6T\3DV(IQJYG4Q=.<886A"<5'
M$4)Q=.M#&QJ2BL'+#U*=:-9J:J4J<:E6'I?['O@CX%?#CX!>"_!'[.][8ZK\
M/O#D5SITFLPP/;ZOKGB:%U'B'7/%45S:V-^GB/5[LKJ%R+ZTMBMA<:<NFPQZ
M$NDHOT[7PCX\N]4^$5]JWQX\'2V<1TG2UN?BMX4OM0M-)T;XA>#]$@9FNS?7
M\UOIND^/?#%@LK>%?$%Y+!;:A;(?"FOW*:3<:?J&A?;WA34$\9>&= \6:5::
MC;:9XCTBPUJPM]=L+GP_K$-IJ-M'=01ZEHFLI9:IIEXD<BB>SO;6&>)P0RXP
MQ_+/H:_30X3^F7X=XCC+"T7D/'F38F&#\0N%,3B*F)EE><8F,JU/&Y?CZT*;
MS+)\TBIU\%B6HXBDU5PN,ITZ]%N?T7%'AV^!98/ 95AW+AU48X;)W1I17U:A
MA:<(1P%:G2C&$*F&I\BA.$(TJ]*U2"A-5:-+4UC_ (_C_P!>MA_Z0VU<-XR\
M&^%?B%X5U[P1XWT#3/%'A+Q1IESH^O\ A_6+5+S3=4TZ[39-;7,$@_W9(I8R
MD]M.D5S;RQ7$44J>DZII5]-=EXXD*_9[),FXME^9+.!&&'F4X#*0#C!ZJ2""
M?E[]H'XF^(/AY)X+\!>%+.&#XA_%C4-1T3PGX@UNV:3P;X:73;"34M9UK4[W
M?'8ZQKFGZ9%/=>'O EI>C6O$MY$9'BM/#UAKFL:=_1_&/'G#/AIP?GO'O%N<
M4\DX=X1RC$Y[G&9MU)SP6#RZC]8J5:5.@I8BKB%RJ-"E0C*M4K2A"FN:2/H<
M#ED\YE0RJG0IXJ6-I?5YX>M&$Z-2E.DU7CB(5%*$J'LN?VT9QE%TU)2C).S_
M #K_ &0_^">_[,7[*7[6OCS4K/X@VOC;XA&PEU'X(^!=>#SZK\+O"&JVCS:\
MLVH2(UAJWC&1+N\MM,:.6VURV\#FXUF;3YDUJ_U"']D:^+?^%.>&?^$+_P"$
M3^V:S_:?]K_\)=_PGWVT?\)W_P +$W>=_P +&_MWRMW_  E7VKGS?*_L[^S/
M^*;_ +/_ .$8_P")/7JO[/WQ-\0_$.3QIX"\5V<,_P 0OA/J&G:)XL\0:);-
M'X-\2KJ5A%J6C:UIE[ODL='US4-,E@NO$/@2[O#K7AJ\E$B17?AZ_P!#UC4?
MXE^B7^TQX-^FEQSQOPCCLOQ_"W&&1U\7C.#\'FM>.(?%/ &!G1PV&S)U:4(X
M? Y]AIU(ULYRF+E3_P!LIXG"XG&2^NRI=]#PAR'PQR&&$X0P&'P63+$U\9F%
M"A%Q]GF&/K<U7$\TY3JU,-*4J6%P\:DYRPF'HX7"0:P].C"G]+:?_P @_5?K
M8?\ HZ6JU;%EIE['9:BCQ(&E-GL'VBV(.R60MEEF*K@$8W$;OX<X..7\5Z@G
M@WPSK_BS5;34;G3/#FD7^M7]OH5A<^(-8FM-.MI+J>/3=$T9+W5-3O'CC806
M=E:S3RN0%7&6'^@:Q.'HT\15JUZ-.E3<JM2I.I",(4X482G.4FTE&,8MRD]$
MDV]C\]SK#UZ^80C0HU:SG2I0@J=.4^:<I22BN5.\FVDEO=H_'W_@HS_P3B_9
MK^-6LZ#\?/%'C2V^!.N1^)_#6G?%#Q%INF27D7Q,\-2WMO!=61T?3X9KF7XA
M0Z9!(-%\16EAJ#_8K1SXCL+_ $O2[>]T?]6_AKX1\"^ O '@[P=\,M-TC2?A
M_P"'O#VEZ?X0LM!:&725T*.UC>QN+.Z@>5+];Z)Q?2ZFTUQ-JEQ<RZC<7-S<
M74L\GR1X#NM3^+M]I/QX\8RV<IU;2VN/A3X4L=0M=6T;X>^#]:@5ENQ?6,UQ
MINK>/?$]@\3>*O$%G+/;6%JX\*:!<OI-O?W^NS>&O%4_[/?C?PIX/B2YU7X1
M_%;Q4/#OA?PSIL,VH:]\-O'>JQW>I&#PQHMHLVHZI\-M9%O?7^J:7IEM._P[
MNUN-8@@C\%SZC_PC/^;G _[6CPN\3_I+5OHVR>84N"\)7CPWX>>(6+J5/J&?
M\;4,1B*&9Y96P4J,:V!R;$JG0P?#.:8F<O:5L/B:=6&$PF-P3/;A]'K <-83
M-N,,IR["T.+\WC'%<2T,-3BO;X?#QE4<,/*+</KM)^TQ&8J@H4\RK>_^^Q.'
MI5<7]TKU'U'\Z-7_ .0IJ'_7W/\ ^C&K0&EWN1^[CZC_ )>;7U_Z[4NIZ5?2
MZA>RQQ(4DN9F4FYM5)4N2"5:967CLP!'<5_I-4JTW4@U4@TH5$WSQW<J5EOU
ML[=SSN'J<Z?UKVD)T[^QMSQ<+V]I>W,E>W6Q^=O@']ACPYHW[4OQ&_:J^)OC
M._\ BWXRUO6I+GX5Z;K^F+;Z9\)]$=6%K8V$3WU_%J6H:)!(=(\/7Z0:=#I=
MC%-J2V<NNZB]]9?6F@_$_P  >*/%WBGP)X?\5:5JOB[P7Y'_  DNB6LLANM.
M\\A&VN\:6U]]BG9+/5O[.GN_[&U"2+3M6^Q7TL=N_CGQS^(?B9?&VC? #P7=
M7?A/Q5XJ\.7GBKQ#X\GA%O\ V!X%L[R#3=2'P^END-IXE\=WMS=0V*2Z?]OL
M/ =O<IK_ (A"WDOA_2=:XW5?A/I5OX<\,V'@"X_X07Q)\/C->?#OQ-91/>W&
MB:C< MJ46KI/,)_$FB^*V+IXXTW4[IY/$PN)M0NKN/7HK'5[/_-GZ6'[3?PR
M^C5XP<#^%68Y7C>+L55Q6"J>)N/RV;A#@+AC'86I'+ZN"H1I^SS?.G6GALQQ
M&6490C3RFEB.:K_:&*PM(_>WE_$7'>%H9OQ#FM2=3"Y3@\IX>I2I4*.%P^7Y
M93CAL+1IX3"TJ=#"8%1ISCR8:C3JUL14K8^JJM2<GBN=^&'["GAWX)_M3^(_
MV@?A/XWU'P7X(\;Z!J5IXS^"&G:4J^%]4\0WD@FM]5L[Q=3CM]/TRSO))]5L
M='71)9=)U"6[@TG4K31=3GTJ#]#;?_D#R?\ 82C_ /262O"?@%\3+KXU>#;W
M69-";1M>\,^(=7\$^+[6"8W7AI_%/ARX-EK$W@[Q+*L%CXH\/27*,UM>V4C7
M>G2F;1?$%KI?B#3M2TVV^A8=,O5TMXFC0.;]) /M%L1L%O(I.X3%<Y(&W=N[
MXQS7^B.3\593QCDN1\3Y-FN'S;)L[R[+LRRC,J,E[/&99C*-/$X/$1<HPJ-3
MH582?MHJK&_+42E%I?GO'N=<1Y[*K_K+BJN/S;+,OPF2*K6IX=XQX7+9>SPM
M+$U\/3C4Q]6C2?LUC<5/$XJK1C2C/$5*=.ERX%S;6]Y;SVEW!#=6EU#+;7-M
M<Q)/;W-O.C1303PRJT<T,T;-'+%(K)(C,CJ5)!_$OQ-_P2P_9%^!W[2]A^U9
MXFU_3O"_P-T6Z&NP_!34],GU#P];_%>ZU"V.AMHMO;1WMU?^#H<7>N?\(/#I
MET+&]TV(^:?!EK=Z38_M5XKU!/!OAG7_ !9JMIJ-SIGAS2+_ %J_M]"L+GQ!
MK$UIIUM)=3QZ;HFC)>ZIJ=X\<;""SLK6:>5R JXRP^(? =UJ?Q=OM)^/'C&6
MSE.K:6UQ\*?"ECJ%KJVC?#WP?K4"LMV+ZQFN--U;Q[XGL'B;Q5X@LY9[:PM7
M'A30+E])M[^_UW^:/I?_ $Y,A^A-X9XGB9SJYSQCQ?3Q62<'<&87$RH0S[&P
MI*5?%9GBX4ZRRW*<KIU55Q6/A'Z[^\CA< I5\0^7\URGP;RCQ1S#+ZG$F4T:
MV7<.8_#YC3QN(I6Q%#%1DJE/#83G5JOUET8RQ%"O"M@7"E"IBJ%:<,-2G]RV
M5[9ZE9VFHZ==VU_I]_;07MC?64\5U9WMG=1)/:W=I=0/)!<VUS!(DT$\+O%-
M$Z21NR,"=73O^0A8_P#7Y:_^CTKX+\->*I_V>_&_A3P?$ESJOPC^*WBH>'?"
M_AG389M0U[X;>.]5CN]2,'AC1;19M1U3X;:R+>^O]4TO3+:=_AW=K<:Q!!'X
M+GU'_A&?T"L=.O([VS=HT"I=6[,1<6[$*LR$D*LI8X Z $GL#7V7T;OI'<!_
M2?\ "7)O%'@>M5P^'Q\*F!SO(\?:&9<.<0X6G#^TLFQFD85WAZDU+#8RAS8?
M&X6='$4FN>5.'J\1<)YCPOG,,%7A+$4)SA7P6,IPE[/$X9U>53E%<WLJL)1<
M*]*3;A.+<93I2IU)\U/_ *^;_KK)_P"AM7P5^RO^PQX<_9\\;?$'XP>-/&=_
M\:?CAX_UW6;JX^)?B33%LKW2- U"Y9DTS2;)[[5!::A?P"-=<U2*Z02VZ6^B
MZ9;:?I-K+%?_ *$3:/J#2RL(8\-(Y'^E6@X+$C@S@CCL0".]?$OQ6\8:M\3/
MB-XB_9^T>?4?"WASPEIVC:E\7M6=KG1O$7BG3/$27+Z3X-\$AC;WX\+ZS%:7
M<?BWX@:=_H4L$5SX2\,W\NKOKM[X>^A\;O';@KZ._A9Q3XH<=YC4PO#N1X2D
MZF%P4(U\RSC,*TU1RS),NIK66+S+&5*>'I\\Z6&I\SKXNI##T9SC^H\*8[B2
M=#-^&LBQ\L%@>(\/A*7$#IPHQG6R[ 5I5(T:N*]G]<IX-UJZ>(P>'KTJ685%
MAZ>*A6C2I*'O/AKQ[\+_ (QZ;XOT?PYKGA_QUI.FW6H>$/&&F+&M]82"Z@FM
M;RRO+2\@$&J:)JMLUU;V^H0)>:%K4,=['97EXEO="/YB_9;_ &)]-_90^)7Q
M>U[P!\1=<N/A/\26L;[0_@[>V4C:9X+UN*X:2ZU"WUF;5;MM2:.TQI6GS#3-
M/OCI+6]GK-WJ\VE6-Z=;Q7X-OM%;1O&_PL?1_"OC?P'HZZ7H]O.HTWPGXC\&
MV0$LOPY\5PVD8C@\+RI%OT7488)+GP5JHBUG28GMSJNEZK]+_!SQU:_&GX;^
M%_B7X>TG5-+TOQ/8_:HK'7(HK*[@EBE>WN5@F>06>LZ;]HBE_LSQ%HL]]H&O
MV/D:IHNH7MA<PSM_._T'_IU<(?3"X/S^IA,O?!W'?#6(5/BS@NMB'C:%/+<5
MBZ[R/.<JS&I1I1QN$Q5&DJ.)]REBL%F%+$T9T_JU3#5\1[.;0S_@S+<WRK*\
MSK2X8XII83"9KA:U/#5J6(K8*O#&X;VU*M2J0H8JC6HRJX3'854<3"C*OAXU
ME"=:-7U4_P#()T[_ *^-1_\ ;2O@C]I;]B'2/VIOC-\)/&GQ*\?ZS=?"#X::
M==27_P #X;1X]&\5>*/M\UU;ZU>:Q%J,36\%_:S6VEZY --FO)=*TF.PTR_T
M[^U]0N8OT%.FWG]FV,7EIOCGOF<?:+; $GV;;AO-VMG:<A22N/F R,^3_&/Q
M_9?!;X;^*/B7X@TO5=4TOPQ8_:I;'0X4O;NXEEE2WMEGF1S9Z-IOVB6(ZGXB
MUJ>QT#0+'S]4UK4+.PMIIU_MV6<X3)<%B\UQ6.P^!PN P^.Q6+QE6I",,-A*
M,:U7$UY3=W"-.A&<W./O1BFXL_(\ISOBCASBJ69\(U\3@LZKT:^5X/&X7#4:
MN*IQS; _V=7^HUJ]&K]3Q<Z->I2HX["RHXS"RDZF'Q%&:YU7\6?$/X9?"*S\
M*:=XJ\0:!X)T_6;^R\*^%+"5!96?F11106]K:VME T&EZ+ID'V:&YU&X2ST+
M18I;..^O+-+BU$GR=^TK^PCX<^./Q9^&GQ\\#^.-1^"WQG\ :_HEYJ'C;PWI
M2W\_B[P]I<T:'2=6MTU/21_:<.GB;3++6)I;V*;1IY_#^M:;JNDM:1:=M>%O
M!^H:Z^M>./BH^C^*O&_CS1VTO5[:!1J7A+PWX-O5,L7PY\*0W<9CG\+Q)+OU
MK4)X$N?&NJM+K.K1) -+TO2M+X3>-M6^&?Q&\._L^:W/J/BGPYXMTW6-2^$&
MKHUSK/B+PMIGAQ+9]6\&^-PIN-0/AC1H;NTC\(_$#4<V44$MOX2\3ZA%JZ:%
M>^(?\U/H]?M2_"7QP^D7Q-X*Y7@<9D.78BO+ ^%7&6-E-T./<1@*%9YUAL=@
M9TD\FEC/8SQG#T<2YQQN"I3CC'@\PE0PU3[_  _"W&/AUA:?%W"V=5H9_1P.
M/H9_0ITL-B\/6RW,:,J6.PKPV+HXC"YK@_8SE''8;'4*]*O*,<71IQG0A;[;
MTO\ X_4_ZXW?_I'/7/UUNGZ==QW2N\:!1%<CB>W8Y:UF1?E25F^\P!., <G
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MC,JI5L/F&+JXVE-0P4<-6@XUJ4HRIU?;U&WAXT:52#Q%.K5H5VL)/$27TO\
M!K7?A5KGPZ\.)\%KC1'^'/A^RB\*^'K#0+2;3;#0[3P]%'I\&B#2KJWM+W2S
M96T=N8;:]M8)I;*6TOHQ+:WEO<3>HU\(^/+O5/A%?:M\>/!TMG$=)TM;GXK>
M%+[4+32=&^(7@_1(&9KLWU_-;Z;I/CWPQ8+*WA7Q!>2P6VH6R'PIK]RFDW&G
MZAH7V]X4U!/&7AG0/%FE6FHVVF>(](L-:L+?7;"Y\/ZQ#::C;1W4$>I:)K*6
M6J:9>)'(HGL[VUAGB<$,N,,?R7Z%_P!,K@[Z8?AM4XLR_#?ZN\;Y#6I8#C[A
M&M7J8C^R,UKPE5I8S+L=6A3>99-F<(SKX+%-+$4Y1JX;&4X8BDW4^NXQX$Q'
M".*HTL)">(R:NG#+:T*<5*E&C&*>#KTZ,(PIU:$'!0E3IPHUJ7+.E&G)5:-'
M?U'_ %\7_7E8?^D4%?-O[3'[,?PF_:P^&&I_"WXMZ$NI:9<E[S0M<M!%!XD\
M':^L,D5IXC\,:D\4K6.I6PD:.6-TEL=3LWGTW5;6\T^YGMI/J"^TZ[>:,K&A
M M+)#FXMU^9+6%&&&E!(#*0"!@XRI((-4O[+O?\ GG'_ .!-K_\ 'J_LC X^
M>"GA<5A<6\-BL/[*I1K4JJIU:52"34HR4DTT]^ZNFFFT?#YOE%'-J..R_,,O
MCC\OQL*F'Q6%Q&'=;#XBA47+.G4A*+C*+7S32DFI)-?G-_P3^_8 \%?L-^"_
M$EI%JMKXZ^)WC/5KR7Q1\17TL:=<7'AVTO[@^&?#FEVLL]Y/I>FVUEY&HZQ;
MK>3G4?$5Q=7$UQ<6EEH\5E^A-:']EWO_ #SC_P# FU_^/4?V7>_\\X__  )M
M?_CU=>99OB,WQN(S',<9'$XS$SYZU:<Z:NTE&,8PARPITX0C&%.G",80A&,8
MQ221YN1<,X'AG*<%D>299+ 99@*7LL-AJ=.M)13DYSG.I4YZM:M5J2E5K5JL
MYU:M2<IU)RE)LCC_ .0;JG^[9_\ I4M8==5'IMY]@U"/RTWRK:A!]HMB"4N
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M/WD/XD'\<=KIWW[:GL9FG/ 8F,5S2=-)1CJV^:.B2NW\C&K\2/VN_P#@EO\
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MQ+\2:8ME>Z1H&H7+,FF:39/?:H+34+^ 1KKFJ172"6W2WT73+;3])M98K_\
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MPUX>T:UCLM+T?1]+LHXK6RL;*UBCBAABC P"S%G9F/=_8+K_ )YK_P!_H/\
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M[EZQKG47L%CJZ6%RW T54Q$X*KBZD50A*M/]$9_]?-_UUD_]#:O$OBY\)O\
MA/4TKQ/X9O[?PQ\4O!RW4G@WQ7)#)+:2P71CDU'PAXKMK=DGU?P3XB,$$>K:
M>'^TV%U%9Z_HSV^LZ99S5[;/_KYO^NLG_H;5%7-Q;PAPUQ[POG7!O&.38'B'
MACB/+<1E6=9-F5".(P>.P.*ING5I5:<EHTFITJL'&K0JQA6HSA5A":_:<%B\
M1@:]#%X6K*C7HM3ISCT=K.,D[J4)Q;A.$DXSA*49)Q;1\3:3X0\;_'BZ70OB
M#X-U[X:_#;0)EM?'_AW5YHAJ7Q-\26K W/A/1[^QE*WOPBMW"7&J>)8A:O\
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MW"I"].O2E5PN*IUL+7K49]_#G$>8\,9C#,,OG>]J>*PM1OZOC,/=.5"O%/\
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M$DXSA*49)Q;1\3:3X0\;_'BZ70OB#X-U[X:_#;0)EM?'_AW5YHAJ7Q-\26K
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M;1-;@C6PURQC:>W\FZ@U"PL?J*OP8_;/_P"">/QL^'/C_7?VB_\ @G/K&H>
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M]=PK5<AX;BG_ &I4XJIW@\1Q7E&'E3H9+BH.%'B&OB,/BZ[I8K"8ZG5^D_\
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MI1^'M"UVY+KYU]>)<>*;:XMKNYC\=FY$L\[:KH5I8U_0,GWU_P!Y?YBOA/\
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M\16KI=G=I_:&^UN4W:=,J[H)5W,9[8A5RHRQ ) &3@$XX-9'VV\_Y^[G_O\
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ME^>_EYE'[!??\^5W_P" TW_Q%'V"^_Y\KO\ \!IO_B*;]MO/^?NY_P"_\O\
M\71]MO/^?NY_[_R__%TOWO\ T[^Z7^?K_3T^DU\OQ\O^#^'F.^P7W_/E=_\
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M*M&ZN?[+L&^T3[FGOPS>;)N8+]EV@G=DA<G )XR<=353[7=_\_-Q_P!_I/\
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M1]K[SC&\8MI<SC%R2;LG):M?$/B77KK]J>XFTVSDN[#]FBUF>*YN(9;BPO\
M]H&Z@<JR030M#=V?P7MI5.)8GBN/BC,@9&C\ (#XTZ#X?^/M:^".M:/\,?B5
MJU]K?PTUN^M=$^%7Q3UBYEO-0T'4+R5;?2?A?\3M4G9Y9KJ:5HM/\ ^/;Z0_
M\))FW\,>)[@>+AIFI^,.=(U7]F[5=,\%>-=3NM5^#&JW5OI'PS^)FKW#377@
MVZF98-+^&7Q-U2=LE"?+L/ /CZ_D":Z@M_#'B>X7Q8NF:GXP=H/AJX_:GNH[
MS4H9K7]FBPNXIK>VE1X+K]H&_L+A989W5@LMM\%[.[A26(X2;XHW$2NI3P!&
M#XS_ ,!N">-OVCM7]H[F^4YME'_":_88?B/AS$5\PAX-8/P:AF%=Y9F^49FJ
M$[XU\^(JY7FM'#SX@QG$$\7@<=A(X>..P.&_?,3AN%/]5(M2BLK47/#8F"@\
MP>8.%GTC*>/G*/+7P\W&E[*-G[+"4J=6E]\_8+[_ )\KO_P&F_\ B*T-6LKQ
M]3OG2TN71KF4JRP2LK L<%6"$$'L0<&LB":6U@AMK:62WMK>*."WMX':&"""
M%!'%##%&5CBBBC54CC151$4*H"@"M;5KJZ34[Y4N;A56YE"JLTBJ &.  &
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M#3[75=%UK2BUYIVIZ=>1+-;7=I<PAHY8I8V!!!RIRCA75E'96]G=KI4Z&UN
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M'V*\_P"?2Y_[\2__ !%)]KN_^?FX_P"_TG_Q5'VN[_Y^;C_O])_\57J_O?\
MIW]TO\_7^GI\!_LW_3_[Z?\ EZ_TM5^Q7G_/I<_]^)?_ (BK5C:7:WMFS6UP
MJK=6Y9C#(  )D)))7  '))X Y-5/M=W_ ,_-Q_W^D_\ BJM6-U<M>V:M<3LK
M75N&4S2$$&9 006P01P0>".#4S]KR2_A_"^DNWKZ_P!/32E]7]K3M[:_M(6U
MA:_,O+U_I:YUS8WIN)R+.Z(,TI!%O,0078@@A,$$<@CK4/V"^_Y\KO\ \!IO
M_B*DN;R[%Q< 75P )I0 )Y0  [   -@ #H*A^VWG_/W<_P#?^7_XNN>'M.6/
MP?#'I+LO/U_IZ?HBO9;;+]/^#^'F.^P7W_/E=_\ @--_\11]@OO^?*[_ / :
M;_XBF_;;S_G[N?\ O_+_ /%T?;;S_G[N?^_\O_Q=5^]_Z=_=+_/U_IZ/7R_'
MR_X/X>9M?9+O^R[-/LUQO6ZO2R>3)N4,EIM)7;D!L'!(P<''0U5^Q7G_ #Z7
M/_?B7_XBK(NKG^R[-_M$^YKJ^#-YLFXA4M-H+;LD#)P"<#)QU-5?M=W_ ,_-
MQ_W^D_\ BJNC[3D^Q\=7I+_G[+S]?P^7Q&;>Q_M#$<_M>>]/FY7#E_@T]KJ^
MW?J+]BO/^?2Y_P"_$O\ \11]BO/^?2Y_[\2__$4GVN[_ .?FX_[_ $G_ ,51
M]KN_^?FX_P"_TG_Q5:_O?^G?W2_S]?Z>GF_[-_T_^^G_ )>O]+6_IMK=)>Q,
M]M.JA9LLT,B@9@E R2H R2 /4D"L/[!??\^5W_X#3?\ Q%;FF7-RU[$K7$[*
M5GR&ED(.()2,@L1P0"/0C-8/VV\_Y^[G_O\ R_\ Q=<\_:>UE\'\.GTE_-4\
M_7\.^GUF0<GU:M[/FY?;N_/:]_9T[VY=+6VZW'?8+[_GRN__  &F_P#B*/L%
M]_SY7?\ X#3?_$4W[;>?\_=S_P!_Y?\ XNC[;>?\_=S_ -_Y?_BZ/WO_ $[^
MZ7^?K_3T]W7R_'R_X/X>8[[!??\ /E=_^ TW_P 16E>V=XUII2K:W+,EI*KJ
ML$I*,;RY8!@$RI*D$ X)!!Z&LO[;>?\ /W<_]_Y?_BZTKVZNEM-**W,ZE[24
MN1-("Q%[<@%B&RQ  &3DX '05G/VG/2^"_-+I+^25^OW$N_-';K^2O\ K;Y&
M?]@OO^?*[_\  :;_ .(H^P7W_/E=_P#@--_\13?MMY_S]W/_ '_E_P#BZ/MM
MY_S]W/\ W_E_^+K3][_T[^Z7^?K_ $]*U\OQ\O\ @_AYCOL%]_SY7?\ X#3?
M_$5HZ=97B&]WVERN[3KQ%W02KN=HP%5<H,LQZ*.3V%9GVV\_Y^[G_O\ R_\
MQ=:6FW5TQO=US<-MTV\9=TTAPPC!##+<,#T(Y':LZOM.25^3ILI=UY_U\]#W
MO+\?+_@_AYF?]@OO^?*[_P# :;_XBC[!??\ /E=_^ TW_P 13?MMY_S]W/\
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M#]EN?^?>?_OS)_\ $U+<7$XGF GF $T@ $C@ !VP -W %0_:+C_GO-_W]?\
M^*HG[+FE_$^)_P O=A'GLOAV7?L+]EN?^?>?_OS)_P#$T?9;G_GWG_[\R?\
MQ-)]HN/^>\W_ ']?_P"*H^T7'_/>;_OZ_P#\54_NO^GG_DH_?_N_B76M[C[!
M$OD3;A=3DKY3[@#%  2-N0"00#T)!]*I_9;G_GWG_P"_,G_Q-6VGF^P0MYTN
MXW4X+>8^X@10$ G.< DD#IDU3^T7'_/>;_OZ_P#\56E3V7,K^T_ATMN7;V4+
M?A:_F3'G][X?B?<7[+<_\^\__?F3_P")H^RW/_/O/_WYD_\ B:3[1<?\]YO^
M_K__ !5'VBX_Y[S?]_7_ /BJS_=?]//_ "4KW_[OXB_9;G_GWG_[\R?_ !-6
M[ZWN&NYF6"9E+##+$Y!^1>A"D&J?VBX_Y[S?]_7_ /BJMWT\ZW<P6:50&7 $
MC@#Y%Z ' K1>R]E/^)_$I_R_RU27S\\?A^&7?O J_9;G_GWG_P"_,G_Q-'V6
MY_Y]Y_\ OS)_\32?:+C_ )[S?]_7_P#BJ/M%Q_SWF_[^O_\ %5G^Z_Z>?^2E
M>_\ W?Q%^RW/_/O/_P!^9/\ XFK5M;W 2\!@F!:UVKF)QN;[1;G RO)P"<#G
M )Z U4^T7'_/>;_OZ_\ \55JVGG*7A,TI*VN1F1S@_:+<9'/!P2,CG!(Z&M*
M7LN?_EY\,_Y?Y)7_  )ES6^S\4>_\R*WV6Y_Y]Y_^_,G_P 31]EN?^?>?_OS
M)_\ $TGVBX_Y[S?]_7_^*H^T7'_/>;_OZ_\ \56?[K_IY_Y*5[_]W\1?LMS_
M ,^\_P#WYD_^)H^RW/\ S[S_ /?F3_XFD^T7'_/>;_OZ_P#\51]HN/\ GO-_
MW]?_ .*H_=?]//\ R4/?_N_B7+JWN&%KM@F.VTB5L1.<,&DRIPO!&1D'GD54
M^RW/_/O/_P!^9/\ XFK5U/,HM<32C-I$QQ(XRQ:3).#R3@9)YJI]HN/^>\W_
M ']?_P"*K2K[+G_Y>?##^7^2-OP)AS\J^'KW[L7[+<_\^\__ 'YD_P#B:/LM
MS_S[S_\ ?F3_ .)I/M%Q_P ]YO\ OZ__ ,51]HN/^>\W_?U__BJS_=?]//\
MR4KW_P"[^)=M+>X5+S=!,-UFZKF)QN;SH#M&5Y. 3@<X!/:J?V6Y_P"?>?\
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MR?\ Q-7(;>X%G>*8)@S/:[5,3@MAI<X&W)QD9QTR,U2^T7'_ #WF_P"_K_\
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M /BJJI[+VD[^TOSR_E[LF/-RQ^'X5W["_9;G_GWG_P"_,G_Q-'V6Y_Y]Y_\
MOS)_\32?:+C_ )[S?]_7_P#BJ/M%Q_SWF_[^O_\ %5'[K_IY_P"2E>__ '?Q
M-S38I4@</%(A\UCAD93C9&,X(!QD'GVHHTV65H'+22,?.899V)QLCXR2>.31
M7KT.7V-.W-;ETO:]K_GO^!QU+\\KVW[>GGZGP3^UA\./AY\5?VP_V$_!_P 4
M/ ?@SXD>$KK1?VK[RY\+^/?"^A^,/#MQ=V/@OX<SV-U/HGB&QU'3);FSF FM
M9Y+5I;>4"2%D?FOC#P_\7/$7PNT;XI_!WX&?$GXMV?P]TO\ :#_:#A_9ZTWX
M,Z9\#_&7B33_ (3_  0^$/PIO_B)IFF^//VK?$4'P?\ "WP ^#WQ9\9:WX;?
M1;.QUCQC+-%8^&/ M_HWA_PWJIO/V;^)?P0^"WQIATBW^,?PA^%_Q9M_#TE[
M-H$'Q+\ >%/'<.AS:DMLFHRZ1%XITG54TV2_2RLTO9+)8&NEM+99S(((@E#Q
M#^SW\ _%OACPAX)\5_ _X0>)O!GP^%N/ 7A'Q#\-/!FM>&/! L[9+.T'A#0-
M2T6YTKPT+6SBCM;<:-:60@MHT@BVQ(JCZ[#YC0IT</1K0J5H4J4J<J,XTZE"
M,O;XG$1K1IU).,ZC=:%*2:IM4E54:C<XN'F2HR<YSBU%RDI*2;4K<E.#BVEH
MO<<D_>U:]W1W_(KP_P#ML_M'ZQX2^$GAJ_\ &>FZ?\3_ -MKX(?LG>*?V;]6
MM?#'A5[+P1XY\1:EHG@[]I^6WTFYT&9-;TOPMHTT?QJLK778O%DFE1Z[=Z*L
M,N@Z;$EI^ZE?-NI_LV>%[OXR_L^_$K3#H'AGPC^S=X)^*'ASX=_#/PWX.T_1
M]/T_7?B38^$_#BZW9ZI97L%IH^A^&_!6AZ]X=T_PAI/ARUM[J;Q2VIW&JJFC
M6.G2?25<V/KX6O[%X:A"C=5)U8PBH\LY3]G3IW4(W4</1HU'9RBZU6O._-.2
M+I1G'FYY.6L5%MWNN52;M?1N<IKI[L8K9(KW?_'I=?\ 7O-_Z+:O)Z]8N_\
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M6^*_',?A#XA>.?#^LZ7;O\,H;RT>YTG4)/#DT<^K>))M5^SZD;>* :7I,/\
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M;>,+BWFDTKP]IJMN:.)VB:[UC4?+EBTC1[>]U"2*=X8;6X_//_@G+^RQX_\
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M[&R7)!72H4O:8BHU&"4OAN-^*<7D\,#D/#U&EC^,N(Y5,-D>#J.^'P5.$?\
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M;ZM%J%E-KVH:/X*M[1==NKQM/_5.V_Y \_\ V$K;_P!);JOSA_X)Y?L4Z?\
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M1<I1@>W45\T_LI?M5?"_]KWX3Z5\4OAI?[-WEZ?XM\)WL\+^(/ _B9(4DO-
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MHVHW5WI5S/)-9NQ_%;]GSPWKO_!4C]L"_P#VM_B1IEY;_LI_L[ZY/X<_9_\
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MV(S.K0K8BA@IXR-*6$PN(Q-.A56$ABZU!XNK#ZOAO:UY1IO] *\+_:1_:#\
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MK/*>'\AI8Z7U2APV\72IRQ&<YE4PG-FN:QCRY;A^?)\-S5JF-JK8?_D'P_\
M7W/_ .BH*I5=?_D'P_\ 7W/_ .BH*_.GP)_P4&\&ZG^UW\2?V./BQX)U'X)_
M$30-7M8?A3J'B7Q%I.K:+\9-"O[&'4-*U#2;W38DT_1-9UVQGAU+0_#<FHZI
M<W4,DVBWEUI_C'3K_P ,P^/@\GS+-HX^KEV%GBUE>74\QQT*4Z3KT<##ZO1J
MXJ.'<U7KTJ$ZU-XB6'IU5AZ<O;5_9TE*:_FC-N),DX?K930SG'T\OEGV:1R?
M*JF(IUXX;$YI5H5L10P,\9&E+"87$8JGAZRPD,76H/%UH?5\-[6O*--_H37@
M_P"TM^T/\/\ ]EGX->,/C1\1[LQZ)X7LL6&DV\T$>K>*O$5V'CT/PKH4<[JL
M^K:S=@11DYBLK1+S5;TQ:=I]Y/#[-K.L:5X=T?5?$&O:C9Z1H>A:;?:QK.K:
MC<1VFGZ7I6F6LM[J.HWUU,R0VUG96<$US=7$K+'#!$\CL%4D?SP^%--U_P#X
M+&_M9+\1/$.GZK8?L!_LUZ]-I_A;0-1^U6,/Q?\ &4(AGD>]LSY322:Y']DO
M]?5P)_#?@AM*\-*+/6?$^I7Y]KA#AW#9M6Q>:YU5G@^%LAIT\7GF+A95JRE)
MK"Y1@+N*GF6:U8O#X>/,E1A[7$U&H4;2^4\1.,L;P_A\NR'AJA2S'COBRM5R
M_A?+JMW0PSA%/'\19KRQG*EDF04)K&8V?*WB*GL,%27M,1S0_63]@WXY_&O]
MI']GK1?C+\</AYX=^&NJ^--=UG4? VB^&Y-4\C4OADZV1\*^(;^VUF^U"_M;
M[4Y&U-8W>6&WU?2[;3?$5E965EK-O:Q?;&H?\?D_^\O_ * M9EK:VUC;6]E9
M6\%I9VD$-K:6EK#';VUK;6\:Q06]O!$J10001(D4,,2+''&JHBJJ@"GXZU/6
M=%T/Q5K'ASPW<^,O$&E:)JNHZ%X1LM2TK1KSQ3K%EILUSIGAVUUC7+FST72I
M]:O8X=.BU+5KNVTVQ>Y6YO9H[:*1QX>88BAF./QV(P6!P^5X;%X]3PN IUFL
M/@J-6594:'UC$U/AI0<8SK5IP@VI5)>SA[L?K<FP>+R;),MP>9YIC,]QN799
M"GC\VKX=/&9GB:%*F\3BWA<%2^.O44Y4L-0I5*B3A2BZU1<T].BOA+]B#]O?
MX8?MJ>%]6&E:?<?#OXN^#99K;XB?!GQ#?BY\1^&GANVLO[2T^XFL=(FU_P /
MM<A;.XU%-)L+K2=4/]F:WING3S:>U_\ 3/QL^-'P\_9[^&/BSXN_%+7(M \&
M>#].:^U"Y(26]OKAV$.G:+HUFTD3:CKFM7TD&G:3I\<B-=7MQ$CR0PB6:.L;
MD.<9=F\LAQF78FCG$<13PJP')[2O4KUI1C0C05)SCB(XCG@\/4H2J4J\)PG1
MG.$XR>.6<6<-YSP[#BS+<YP.(X<G@ZV/>;.K['"T<+AHSEBIXMUU2G@YX3V=
M2.,H8N%&OA*E.I2Q-.E4ISA'Y^_;L_;/\&_L3_!>[\?ZQ;P>(/'7B&:?P_\
M"OP'YS1W'BSQ485?S+E86%S#X;T%)H-0\27T.UX[=[73;:0:KJ^EQ3>V_LO>
M+_B]X_\ @)X \:_'GP9HWP]^+/B?PF-9\7>#M!^W+INAR7NKO+H\"6VIWVIZ
MCIMY<>'SI-[JFCW^H7EYHFJ7-YI%S<2S63L?QF_8J^"_C[_@H#\?KO\ X*(_
MM4:'<6WPZT+46L_V4_A)JN9M%L-.TB_D?3O%,ME,@CO=-T.[1[JTOI8(V\5>
M.#>^(=EOH^BZ-9W?]!EK_J[W_KT_]N;:OJ>)\OR;AS#8/ABA3HX[B7#5:F,X
MES>G5E4I83%2PTX0X<P#A4="I2P"FY9EB'"<ZN8Q]E3J0IX=TW\/P#G'$G&F
M8YCQSB:N*RO@K&X>&7<$\.UJ$*-?,<!#%4ZM7C/-54I?6J5?-I4E#),'[2G3
MH9/+V]:C4K8R-55****_/S]9"BBB@"Y>=+3_ *\XO_0Y*IU<O.EI_P!><7_H
M<E?G5\1/^"@W@WX+?M@Z5^R[\;?!.H_#'PUXW\,:)K/PL^.6L^(M)NO!OC/5
MM3GELKG2M1LK2)G\'6EMK%O=^'XM0UW4UNQJEM#=:II&D>'=:T/7;_U\!D^9
M9UB,30RO"SQM?"X&IF%6A2G25=X7"TZ;Q$Z%&<XU<5.E&?M)4,-"MB/91J55
M2=.E5E#PL[XDR3AG#8'%9[CZ>6X7'YEA<HP^+KTZ[PL<?CG46$I8K$TZ4Z&
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M]_9$ZV%[XHT/39PCP-'=;8?$FB1!FT/4)4DA7^R;[3W'Z,5^&7_!73P#\/\
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M7",*>5TJS<<II5\;##M^WA*D5+JO_,/_ .P=%_Z47-15+JO_ ##_ /L'1?\
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M>1YQ%16&Q^4XF"=2G74^6-2A[U'%TKT*].I!I+\%/V9/ ?Q*_P""JOQZTO\
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M"\U&-+JRO(&>^\*ZRRZ[I )?5+#5?QO\&?\ #8O_  4T^*WPX_9$_:5T;5_
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M\(ZW"BP64%C(@&C:_JVD"UL&TZ 1CPIX3BLO"D*6LTNO6K_K]7Q-I/B_QO\
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M]<K;_P!)H:_/E_"G_P!?*7_I-8_8G\<?\,OS@5****S*"KL/_'E>_P"_:?\
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M;0DL-@,)!0I1YZE:I4WM+_X]W_Z[-_Z!'11I?_'N_P#UV;_T".BN'#_P:?\
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M9P_<A-3OC8:A(9R7C6U*'RXOEWW"JW&S!RIQR#CM@UC_ -LZE_S\G_OU#_\
M&ZP/ >@ZGX5^'.A^&-:\2ZEXTUGPYX5\)Z#JWC'64CBU?Q9J>CV=EI]_XEU6
M.)Y(H]2UVZMY=4ODC=XTNKJ54=E )N5_H#.C1C6KQBJ=2,:O+":I\JG%0IVD
MHRBI14K*24DI*^J3.G(:E2OE>'JUX3A5FI2J4ZLXU*E.3DVZ4IPE.$G3=X.4
M)R@VKPDXV;T_[9U+_GY/_?J'_P"-T?VSJ7_/R?\ OU#_ /&ZS*\C^.OQO^'W
M[.OPL\6?%WXG:Q'I'A7PGI[W,H!1M0UC4I 8]*\/:':LZ&^US6[TQ6&G6H9$
M,TIGNI;:R@NKJ#2A@WB:U+#X?#>VKUZD*-&C2I*=2K5J24*=.$8IN4YR<8QB
ME=NR1W8W&8++<'BLPQ^(H8/ X'#UL7C,7B)PI4,-AL/3E5K5ZU2;484Z5.,I
MSE)I1BFV>W_VSJ7_ #\G_OU#_P#&ZOZIJM_%J-[''<%42XD5%\N(X56( R8R
M3@>I)K\:_P#@FQXC_:J_:%\5?%+]L;XW^*_$?AOX4_%&U?P]\$?@,]S=MX4T
MOPY8:K:SVWCBPTVY:.*UFBM=/;0[/78K."\\:R7^OZ[>K'IJ^'0_[":Q_P A
M6_\ ^OJ;_P!"-=>=9/#)LTEEM2M@\57PU'EQ3PJYZ-'%N-"5?"^T<5&I4PE1
MRH59T^:G[2$E&5TTO"X0XDI\7Y%A.(:&68_+,#F,L34RVGF=.G1Q6,RR->4,
M#FGU>,Y3P]#,\/&&,PM+$*%=8>K3E."4XRDO]LZE_P _)_[]0_\ QNC^V=2_
MY^3_ -^H?_C=9E17%Q!:P375U-%;6UM%)<7%Q<2)#!!!"C233332,L<444:L
M\DCLJ(BLS,%!->?[*GTIP\O<CY6Z>2^Y'T[44FVHI)7;=DDENV^B1L?VSJ7_
M #\G_OU#_P#&ZUK?4[YM,FF,Y,BW\$8;RXN$:WN&*X"8Y95.<9XX.":_!/P3
M^T1\;OV]?V[='A_9Y\>>)O W[''[+^N6VH>-_%_A^6YL],^-FOPS[I?#M^JS
M10:_H/BE[5].T?2[E9;?3/"D&I>,YDBUG5=!LH?W=MO^0//_ -A*V_\ 26ZK
MULZR">1U,!A\8\-]=Q&'H8O$X*$6Z^7*O)NAA\9>"C#$U,/[.O.BFYTH5(1J
MJ,M'\#DG&6"XQROB#,,FPV*CE&79GB,JR[.I^RCA,_>"=*GC<?E$J<Y5*N74
M<:Z^!I8QQC2Q53#U9X>4X)\L_P#:VH?\_!_[]P__ !NC^UM0_P"?@_\ ?N'_
M .-UG45P>QI?\^J?_@$?\CD^L8C_ )_UO_!L_P#Y(T?[6U#_ )^#_P!^X?\
MXW5FRU.^DO+1'G+(]S C#RXAE6E4,.$!Y!(X(-?GW_P4$_;'T?\ 8V^!E]XJ
MM5AU3XJ^-9+KPG\'/"I@:\?5_%\]NN=7O+*,^;-H/A:.X@U+554*MY<R:5H*
M2PW>N6D@W_\ @G?X _:!\ _L^>#D_:<\?^+/'GQ=\8^(;SQ]KD7C&_EU/5O
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M]S_WQ'_\15*BOFO;5?\ G[4_\#E_F?9\D/Y8_P#@*_R+O]HWG_/<_P#?$?\
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M*U7I3JYMS8C$8>,,-AU6K?6-W?7:75RB3%56>55 2/@!V '*9/U/)ZGFJ_\
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M[IK2HMU:2/)#-&\-_IUS?:7=V5]<_BM^T#XZ\8_\%6?VCO\ ADCX(ZO=Z/\
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M$'@K31KEPECI6HZC8R&_M[M++4=0U+^RV\,Z8FFWVO0:YI?T]6EK'_(5O_\
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M0K36(RZ#IX;/\)3A0?LLPHX>M4X?_@HI^T7X_P#CC\3-"_X)N_LJ7\=UX_\
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MY9&<J'#M2TU5JUJV81J0G3A$VM+_ ./Z'_=G_P#2>6N?KH-+_P"/Z'_=G_\
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M#"8"=&2Q&5Y;2GAW5S3/5RO"4U&A@W+'8BDZ7Y"_ 'P!K?[&OQG_ &>OBO\
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M/##X;#T*<:5&AAZ$:5*C1HTH)0ITJ5.,84Z<$HPA%1BDDD5****YSH"KL/\
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M1_EU^X]W((PCBJSA/G;H--<KC9>TIZW>CMVWU.:HK3_M,?\ 0/TS_P !3_\
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MP34GR+VD-;.75=%YZ?B8=%:/]HC_ )\-._\  8__ !RC^T1_SX:=_P" Q_\
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MM,?] _3/_ 4__':KFG_S[?\ X%'^N_\ 3T=WV_'T_P W]WF6!_R";+_K[O\
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M(R<L6.>:SG*?/2_=_:EIS1_DE?[B7?FCIWZ^2O\ =KZV.;HK3_M,?] _3/\
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M/_LJSY*?_/U?^ 2_K_AGY7J\OY?_ "9%.KJ?\@^;_K[@_P#14])]L_Z=;/\
M[\?_ &56UNO]!E?[/:\7,*[?*^0YCF.XKNY88P#G@$\<UI3C3O+]ZOX=2_N2
MT7(]?E^C\KS)RM\/VH]5_,C(HJY]L_Z=;/\ [\?_ &5'VS_IUL_^_'_V59\E
M/_GZO_ )?U_PS\KU>7\O_DR*=36__'Q!_P!=HO\ T-:F^V?].MG_ -^/_LJE
M@N\SPC[-:#,L8R(<$9<#(.[@CJ#V-5"-/FC^]7Q1^Q+NOZ^3\KJ3E9^[T?VE
MV*EQ_P ?$_\ UVE_]#:H:T9[O$\P^S6AQ+(,F').'89)W<D]2>YJ+[9_TZV?
M_?C_ .RHE&GS2_>I>\_L2TU_K[GY7(N5E[O1?:78IT5<^V?].MG_ -^/_LJ/
MMG_3K9_]^/\ [*IY*?\ S]7_ (!+^O\ AGY7=Y?R_P#DR%?_ )!\/_7W/_Z*
M@JE6NUU_H,3_ &>UYN9EV^5\@Q'"=P7=PQS@G/( XXJI]L_Z=;/_ +\?_95I
M4C3YE>JE^[I:<DGI[."3^:U\MMR8N6ON_:?5%.BKGVS_ *=;/_OQ_P#94?;/
M^G6S_P"_'_V59\E/_GZO_ )?U_PS\KU>7\O_ ),BG5S4/^/R?_>7_P! 6C[9
M_P!.MG_WX_\ LJM7MULNIE^SVK88#<\.6/RKU.X9-:*-/V4_WJ_B4OL2_EJ_
MYO[GY7EN7,O=^S+JN\#)HJY]L_Z=;/\ [\?_ &5'VS_IUL_^_'_V59\E/_GZ
MO_ )?U_PS\KU>7\O_DR*=6[7_5WO_7I_[<VU+]L_Z=;/_OQ_]E5FWNMR79^S
M6HVVV[Y8<;O](@7:WS<K\V[']Y5/;!TI1I\_\6_NS^Q+^1_E^GI>9.5OA^U'
MJOYD95%7/MG_ $ZV?_?C_P"RH^V?].MG_P!^/_LJSY*?_/U?^ 2_K_AGY7J\
MOY?_ "9%.BKGVS_IUL_^_'_V5'VS_IUL_P#OQ_\ 94<E/_GZO_ )?U_PS\KE
MY?R_^3(_-O\ :P_8T^(?QN^,6I_%CPGXD\*Z>UK\"/A7X.\)>'_$VN^)X_#'
MB+QIX ^.&O\ Q,OM'^+'@VQT'5O#/B_X8:WH>HV^G_9=7M?$-U::[&FI6N@V
M\NGVU[/\O>+?^";/QP\2+^T!))XN\(W?B3XIV_Q4@T7QG<_$5-,BUBP^(?C+
MP]XGT_0/B?X=TK]F(>-_$UGX8M]!LK70KS6/CAXMT[PS=:7;R^$O">B:?JE_
MID'[GW5UM%M_H]JVZUC;YHL[<M)\J_-PHQD#L2:J_;/^G6S_ ._'_P!E7T5+
MB''X2-*E3KT.6A&BJ//AW*4%3A0Y$I)IN/[I-P;<).51RBW)6_3LE\7^,\DP
M67X'!SRZ5'+(8>&!=?!QG6P\<+]35&,:T:E.HZ?^PTY5*$I2P]:=7$3JTIRJ
M)P_![]J/]C#]HA[S]I7XPZ38?#[5;7Q'X1^.NF:3X<^#WA^RLOB+XZT3XA>(
M_!VK^"=)UOPQX&^!GA?Q)XL\2Z!+X9AU#Q%J?C7XK?%:75=:8:WX9M?"CQ:A
M;ZOUG_#OWXQZGX=DU+3?#OP'\*:KJGQ,T?XD>&OAU)XANO$/P@^&4D/PP\'>
M!->U*^^'OCW]G3Q7HGQ%\2>/;C3-6U_Q):?V)\,M:\+:W:Z9<>'?B'-<7^IR
MVW[:_;/^G6S_ ._'_P!E1]L_Z=;/_OQ_]E6D>)\;&A1HQEA8^QNE)4*BC.FX
MT4J<Z:FH2]ZES2DTW)2G1TH3J4ZGIT_&WBZCEN7Y?1PF3TEE[J4XSAA:D:5?
M!SI8&,<+7P<*\,/42KX+V]6M*,JE:G7KX!\F6U\7A,5^:G[+_P"QE\1/@Y^T
M%XX^+?C#Q+:^(UU8_%ET\6:1XZTVVU;QAI7CSQG9^(-&L/B'X&3]GS2/$6NW
MFA6T-I'8:AXB_:)\;6WAJZTY(/"VE6.C7[Z;8_H_6O:W6Y;L_9[5=MH[86+
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MPKXNK&C2>*QE=T,-1]I-J*E6K3C"/,TKN[:2;7UU7"?$_P")7@[X._#WQ?\
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M'Q3I=KK/A_7](N%NM/U33;R,207-O*N"."8YH95CN+:=);:YBAN(I8D_*O\
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M<ZRLTMEJ&K:%=">T\2W%I(YL[@Z)=E?$&OW<:S0:CXYGT_1X+J?2_!<M@O\
M0SIW2_\ ^P=<_P XZ]GB7+<!DM#!93&/M<\HIXC/,1&K*5+#5Z_LG1RBE",G
M1<\#37-BZT5*4L36G153EH\D?E^ <]SCBO&YIQ+*?U;A'%3C@^$<#/#0IXG'
M83!NO'%<2XBK.FL5&EFU:2AEN%E*$(8##4L3*C[3$^TEG45\K_M,_M@_"?\
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M &GG>8>PG+*L)"3PN7T&\1F,)XAT\(_47_Y!\/\ U]S_ /HJ"J577_Y!\/\
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MMBZF+Q$ZE7#T*,(7J***_/S]9"BBB@"Y>=+3_KSB_P#0Y*IU<O.EI_UYQ?\
MH<E4ZTJ_'_V[3_\ 3<28?"OG^;"BBBLRB[9_<OO^O)__ $?;U2J[9_<OO^O)
M_P#T?;U\C?M._MB_"7]D:7X6S_&*U\:Z?X9^*7B^7P9!X[T;PO<:KX(\%Z@E
MF+V*X\>:\L\$.C0WL(N)M.LK2/4];U"RTS7M2L])GT[0-7NK3T,%EV.S7$87
M 9;A:V-QM>%9T<+AX.I6J^RC6K5%3IKWIR5*G.2A%.4N6T4Y-)^7FN<97D.
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MP]&BMK-\V@VS1IK&M7%C$8O%&A1A)?%]A&FIZ<\'C33[>YUC]N=8_P"/X_\
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M3J0<:E*I&-2G*%2$9+^6'5_VW?VX_P!G;X>>+/\ @G/XO\'Z_P")OVIKC5-
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M^VI^TGX%T'_@F=J/@76/#?[5&M^,;KX8_&[QW<11VT=]\+M+L[6>\UK44M'
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M=.N3#*#LGL[VVAG@EC9)$9"NXH[JW:JJHJHBJB(H5$4!555 "JJ@ *J@
M   #%?<9CQH\=E-:C3P%+"YYFD:>&X@SFB^6>:8+"\LJ$?9JRH5L74M+-)4U
M&.+>&H2DY*I4IP_-N'O!Z.2<4X3%U\]Q69\$\,U*^8\!<(8M.K1X9SC,E*GC
M:KKSO+&X3*Z,90X9AB)59Y5#,L;3IJG+#T*]9U;MS_Q[:7_UX?\ MY=UA5NW
M/_'MI?\ UX?^WEW7PB_B4O67_I$C]3S[_<'_ -?*?_I2/R=_X*(?L(:O\;&T
M7]I+]G&^D\!?M=_"3[/K'A;Q#HL\6ES_ !!LM%4RVOAK5KEMMJVNVL*R6WAO
M5-05[2ZMII?"OB+S_#]Y;2Z-^8&L?M)_M$_\%9M4^#W[%47A+6/A';Z#/)K7
M[9^OVMBUM;P7/@K7&L'-MI][(+G2;**YM(+FS\):PK7,GQ$U33=-N ^E^$VU
MBZ_J4KAO#WPR^'WA+Q9XW\=^&?!^@:%XQ^),VC7/CWQ%IFGPVFJ>*[CP]9RZ
M?HT^M7$2J;N73[.::"&1@'(D=Y"\C%S^@Y/QD\OP,*.-P%+,<?E,*DN&,PK/
MFJY36K>Y*%12NL3A:"G+%X*E44UAL92I^S2ISO2_F[B;PN6<YQ5Q>5YQB,DR
M;B.K1AQ_DF%3CA^),-A6JU.K1E"TL!F&+=*&6YKB*#IO'Y7B*RJR=>FEB)?A
MU\/O"/PH\">$_AMX#T>VT#P?X)T*P\/>']*M454MM/T^!88VF<*K7-[=.'N]
M1OIMUUJ%_/<WUW)+<W$TC^BZ=TO_ /L'7/\ ..LZM'3NE_\ ]@ZY_G'7P^(J
M3JNI5JSE4JU:GM*E2<G*<YSJ*4YSDVW*4I-RE)MMMMMW9^N8&C1PWU?#X>E3
MHT*%*-&A1I0C"E2HTJ7)3I4X12C"G3A&,(0BE&,4DDDCQ7XW_!#X:_M$_#;Q
M%\*/BQX<MO$OA#Q';[)X),17^EW\2N;#7M!U *T^DZ]I4SF?3M1M_GC8R03)
M/9W%U:S_ ('Z5\=_V@/^"->M:]\$OC'H^O?';]EW6]-\3:C^S=X[M62"]T/Q
M#!:76H:9X*U&ZN)#!I5C=W[06_BCPZ\KMHXGF\7^#8KZR?4=&O?Z2:XKQ]\.
M/ ?Q3T >%?B/X1T#QMX<&J:1K8T7Q'IMOJFGKJV@ZA!JFDWZV]RCHMQ97MO'
M(C@#S(S+;3"2UN+B&7Z;(<_IY?3JY;FN$_M7A_%U(U<5ETJCIU*.(@K4\=E]
M9/FPN,@ER3E!J&)H.5"NG%PE3^ XPX,KYU6P^?<.9E_JYQGEM"IA\OSR%&-:
MCB<'4?-6RG.L*TX9AEE67[RG"I&57 XI0Q>$:FJE.M^2W_!-/]ECQ]XA\1Z[
M_P %!/VKA=ZM^T/\9TN;[P-H^K6S6\7PW\ :I:QVUA<6.F32S-H]_K6AB#3-
M$TTXN/#7@=+;3WE^W:YK5O!^SU%%>?G6<8G/,?4QV(C"E'EA1PN$HKEPV!P=
M%<F&P6&@K*%"A3M&*27/+FJ3O.<F_:X4X9P/"634,HP4ZN(FIU,5F.8XEN>.
MS?-<5+VF/S7'U6Y2JXO&5KU)N4I*G#V="G:C2IQC+K]C9:I!/IFIV=KJ.FZC
MI$%CJ&GWUO#=V5]97>FQV]W9WEI<))!=6MU!))!<6\\;PS0N\<B,C,I_GI^.
M7[/?QI_X)=_$[6OVK_V--.O?%O[-7B"ZCO/CS^SNT]W<6/AO3DD>2?6M'B07
M-Q%X?T]9;B32O$%K!<ZMX >62#48M6\$W&I06?\ 1!J/^OB_Z\K#_P!(H*S)
M8HIXI()XXYH9HWBFAE19(I8I%*21R1N"CQNA*NC JRDJP()%7P[GM?);Q=*G
MC<MQM"G1S/*L2V\+C\/9/EDEK2Q%)^_A<73M6PU5*4&XN<)Y\;\'X/BI4YK$
MU\ISW*L1/%</\18%168Y/C7%)RIMVCB<%B8I4LPRZNWAL=A[TZBC-4JM/^<C
MPJWC'_@M'^T1HOC+7M"U[P-^PC^S[J=I+%X6U>98=2^)?CJ6UBN[O3=1;3KN
M:SEU2\BE2WU>XL+FXB\*^"GBT^RGM==\73WTO]&%A86.E6-EI>EV5IINF:;:
M6UAIVG6%M#9V-A8V<*6]I965I;I';VMI:V\<<%M;01QPP0QI%$BHJJ.7\ ?#
MKP)\*_#-MX-^&_A+0?!'A2SO-5U"T\/>&].M]*TFVO-;U*ZU?5)X+.V1(8VO
M-1O;FY<(H1#((HECACBC3LZZ.(,\AFU7#X; X=X#),LIRP^59=S\[HTY2YZV
M(Q$[OVV-Q=2]7$UG=M\M-2<:<6^'@OA*KPYA\;CLVQJSGBO/J\,;Q'G?LU36
M*KTX>SPV"P5*R^K95EM"V'P&%BHQC%5*TH1J5IQC<C_Y!NJ?[MG_ .E2U\!?
MMO\ [#/PX_;/\!PZ?J[KX1^*OA2*6Z^&7Q4TVW/]L^&=25_M,6G:B8'@N-5\
M+7EVJ27NF&>.:TF/]IZ1/9ZBGFR_?L?_ "#=4_W;/_TJ6L.O"R_,,;E681Q^
M7XBIA<7AJT9TJU-V<7[*FG&2:<9TYQ;A4IS4J=2$I0G&49-/]8ED.4<3\,8G
M(L^P%#,LJS&%:CBL)B(MQG'VKE"I"<7&I1KT:D8UL/B*,Z=?#UX4ZU&I"K"$
MU_-'<_\ !2?]LK]FSP5XJ_8Y^,OPLU[Q5^V'!-I7@;X)_$:U1-7L?&>G^(KB
M31M(\77:L(Y/&>K6R^4WA35["WG7Q-J;PVOC6QL-9T?7DU7]1_\ @G9^Q%%^
MR3\.-2U[QY<P>*?VBOBO/_PD?Q=\:SS?VI>0WE[/)J0\(:?K,SS3W=CIMY<S
M7>M:DLQ/B7Q')=:K.\MI#H\-C]OZ_P##;P!XI\5>#/''B/P=X>UKQC\/+C4[
MOP/XFU'2[6YUKPM/K.GS:7JKZ-J$D9N+07UC.\-Q&C^4Y$4VP3P02Q]M7U&<
M<58?&Y=+ Y3E-#)/[2J0Q?$+PLI>SS#%TG:C2P\9-O"Y;3DGBXX*+Y(XJM))
M.-&G*?QG"'A?C\GX@IYUQ3Q3C>,_]7</5RK@!9G3@L1D64XJ"EC,5CZD(QCF
M/$->+CE<\WG'VT\LP=)MQJXNO2I%3>*=.T_5Y==TG5K&SU/2]36_T[4M-U&V
MAO=/U#3[V.2VO+&^L[E);>[L[NWEDM[FVN(Y(9X9'BE1XW93#6EK'_(5O_\
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M_P#22.LVM+4_]9:?]@W3O_22.LVLZ7\*'^%"CLO1?D%%%%:#/SAT?_E,O?\
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M%I#;P>'_ !C:*=%OX;^3Q;KTVF:QX8U2#6?Z?JXG4OAOX!UCQUX9^)NJ^$-
MO_B#X-TK6]$\*^,;K3;:7Q!H.D^(U@76[#3=29#<6]OJ"6ZQRJK92*6\BA,<
M=_>K<?<\,\;X?+<%2RKB/)J'$^59=5GF.0X;%U)0J95FL?WL(4ZJ]ZIDV.K0
MA'-<KG?#UE_M%."KQDJWY1QOX7XS.LSK9_P7Q+BN!L_SBA2R?BO&Y?1C4HY_
MD,_W%6I6P[M"CQ)E6&G4GD&>TU'%8:5\'6J2PM2$L-\G?L!_L6>&/V+/@O;^
M%8YHM>^*/C-[/Q+\8?'#%Y9_$'BQK=C_ &98W$Q-P?#?AHW-U8:(DA1[N274
M==N8(-0UN]B7[MM_^/B#_KM%_P"AK4-36_\ Q\0?]=HO_0UKX_,\UQ^=YIBL
MVS/$3Q6.QV)=?$5IZ<TY-)1A%>[3I4H*-*C2@E3I4H0I4XQA"*7Z/D.0Y3PO
MDF7</Y'A*>!RK*<)#"8+#4[M0IP3<IU)N\JM>M4E.OB:]1RJXC$5*M>K*52I
M*3R/%.OZ-X4TCQ'XH\1ZC;:1X>\-Z=J^OZ[JUXQ2TTO1M'MKC4=4U&Z<!BEM
M96-M/<SL%8K%$Q )&*_!#6M8^+G_  5Y^)TWA?PI-XA^%W[!_P .O$,0U_Q"
M\+V&M_%G6=-E2>.**&93'<Z@Z^7<:5I$RW&E^#+2:W\0>(8KSQ'/HVD1_OUK
M.G:?K%OJNDZM8V>J:5JD-]IVIZ9J-K!>Z?J.GWJ2VU[8WUE<I+;7=G=VTLEO
M=6MQ')!<02/%*CQNRG"\(^#_  IX \.:3X/\$>'-%\)>%="MOLFC^'O#VFVF
MDZ1IUN9'F=+2PLHH;>(S3RRW%PZIYEQ<S37,[R3RR2-T9;F=+*OK6(I895,T
M<E#!8JJXRHX&+YU5KTZ+B^?%_#&A.;<*5Y3Y7))/]7X)XQP7!6'S+-,#E*Q?
M&LU1H<.9UC)4JV X;HU*=58W,\+E\Z<E7SU7I4\MQ->4L/@E*IB%2E6A!2_-
MC]J'_@F7\-/'WPX\&2?LYV6G_!'XS_!73K4?"?Q7X?DN-(2_&D3OJ-IHGBS5
M+/=J=S/<ZDTNH6?C"5[O7M)UJZN-2EDO[:[U*QO)OV$OVX_$?Q6UW5_V9OVD
M=!N_ 7[5/PYANK75["^L5L;7Q[8Z/%&UWK5E';@V-IKD5JT6H:C:63MI&LZ?
M-'XE\+S3:1/<6FE?J)7'R?#WP%+XVM_B5+X*\*/\0[31IO#UMXZ;P_I1\7PZ
M#/()I=&C\1&U_M9=,:4%Q9?:_LZ&2;9&HGF\RUG3Q.7UL!FM.ICG#VE7+L7*
MI_M>"Q,Y<TXNK-2=;"5W=UJ$V[2M4IN,U<[H^(4LWX5S#ACC;"XKB25%8K'<
M)Y]4Q;_MWA[-\35]MB*4\;B(UJF/R',JCG/,,MKR;C7:Q6#J4:ZYCO7_ .0?
M#_U]S_\ HJ"OSN_X* ?L)>%OVROA]:7>D747@KX^_#P-JWPA^*%F\UC?Z;J5
MK-_:$/AO6M0L-M^WAS4+^..X@N(&>_\ #&K^5KVC?/\ VGI^K?HB_P#R#X?^
MON?_ -%052K#+,WS'(<TP>;95B9X7'8)T:M&K&S3_<PC.E5@[PJT*T'*E7HU
M%*G6I3G3G%QDT?BW$/#N3\69+F/#^?8*GC\KS*E*CB:%2ZDM5.E7H58VJ8?%
M8:K&%?"XFE*-;#XBG3K4IQG"+7\IGBS]M3]MC]I;P)H'_!,C4O FL>&OVJ]<
M\9W7PO\ CAX]N(H[:.]^%FE6=K/>ZWJ26C@:<^J:6]Q?^.M=TX2Z+K_A/3_M
M7AO[6OCE-/T[^CK]F?\ 9Y\"?LL_!;P7\%/A[ ?[&\*6&+_6)[>"#5/%7B*\
M(N-=\5:T8!MDU/6;XO,R%Y4L+-;/2;1EL-/M(H^^C^&/P]B^(]Q\7HO!V@1_
M$^Z\*1^!KKQS'I\*>([CPC%J*ZO'H$^HJHEET^/442Z2-]S*Z(@?RT5!W=?4
M<6\983.\%@LJR/)J'#F4QK3S;-,!A9N5+'<0XI..)Q:;;<,%AJ?^SY7A'[N#
MH3JP5^9<OP7A]X;9APQFF99_Q3Q+B>,^()8:EP]D6;X^G&GB,KX/P,HSP>7R
MC%*-3,\;77UO/<Q5YYCBJ="I)KDDYE7-0_X_)_\ >7_T!:IU<U#_ (_)_P#>
M7_T!:^%7\*?_ %\I?^DUC]8?QQ_PR_.!^-?[=W_!/WQAK7C6W_;*_8IU-_AM
M^UCX+D?6M4TO1I+;3=*^,-O!"5O;2]@GV:5_PEE_9![&X&JHVA^-;.1M'\3J
MLDT6JP? GC?]M[]I/_@IMHW@;]A7X6_#;5O@S\2/$C7UK^UQXFU".\M-(\,>
M'_#.H)8:_:6EI+-%K>D>&[N4+<>(]#UK[-K=[JTVF_#JUN;^WO=0O-4_J#KA
M]%^&GP^\.>,_%WQ$T#P;X=T?QUX^MM$M/&OBO3M+M;36_$]OX<CNXM$36KZ&
M-)KYM.BO;B*&28M*8C%'(\B6]LL7Z5DGB)#!8##4\[R;#9]FW#U)RX-S?%RD
MZ^4UD^6CAL?%NV9Y9@92>.R[#5^>6$Q=&G2IM8:JU0_$.*/!RIF6:XVKPQQ+
MC>$N'^+ZZCXD</9?"*PN?X:RGB,;E,DKY'G>:1I1RO.<9A/9PS'+\36KUXRQ
ME!/%<7^SO\ ?A[^S)\(O"'P:^&>F+8>'/"MBL<UY)'$-4\1ZW<!9-9\4:_<1
M(GVS6M;O UU=S$>7!'Y&GV4=OIME96L'N]K_ *N]_P"O3_VYMJJ5;M?]7>_]
M>G_MS;5^>UL5B<=C<1C<97J8G%XJIB,1B<16DYU:U>LISJ5:DWK*<YR<I-]6
M?LF"P&"RK 8/+,NPU'!9?@*&&P>"PF'@J=##87#1A2H4*4(Z1ITJ<(PBELDN
MI4HHHKC.T**** +EYTM/^O.+_P!#DJG5R\Z6G_7G%_Z')5.M*OQ_]NT__3<2
M8?"OG^;"BBBLRB[9_<OO^O)__1]O7B_QQ^!WPS_:+^&GB+X3?%KPW;>)O!_B
M2WV3P28BO]+U")7_ +/U[0=0"M/I&O:3,YGT[4K;#Q,9()DGL[BZM9_:+/[E
M]_UY/_Z/MZI5U4<3B,'5PF+PE:KAL3AIJOA\10G*E6HUJ59SIU:52#4H3A)*
M491:::33.3%X+"9CA<9E^88:AC<#C:53"XO"8JE"OA\3AJ]%4ZU"O1J*5.K2
MJTY2A.$XN,HMIJQ_-7I7QZ_:#_X(QZUK_P #_C+H^O\ QY_9:US3/$VH_LU>
M/+5D@O=#\106=WJ&E^"-2NKB0V^E6%W?F"W\4>'&E=M'6XF\8>#(KZRDU'1;
MSZN_X)F_LJ^/_$7B37O^"A7[6(NM6_:*^-27-_X%T;5K9[>+X:_#_5+2.UL+
MBQTR>69M'O\ 6]"$&F:'II_TCPSX&2UTYYOMVNZW;6_ZX>/_ (;^ ?BKX?'A
M3XD>$- \;>&QJNCZV-%\2:;;:IIZZMH&H0:II%^MO<HZ+<65[;QR(P $D9FM
M9A):W%Q#+VU?H6;>(<<?D^+IX/)\-E?$F?QCAN+<^P;5)YQ@J'+*$*&'@E#
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MWE!W^QYKG31+*#ICDB1\G[?(,G<<G'D\9/..U1_:=,_Z!;_^!\O_ ,9JC/\
MZ^;_ *ZR?^AM45>2J<;+6>R_Y>U/+^_Y?U=GZ\DK+?9=7_F:?VG3/^@6_P#X
M'R__ !FC[3IG_0+?_P #Y?\ XS697YF_#C]NSQ3\<OV[?$O[.7P6\&^'/%7P
M)^$OAW6!\9/B[+<WSWMGXQMX;NVTZS\)W5O?IHMUIP\3);^&6M+BQO+[6'L_
M$NN:7=Q:1H0EOO1P&38O,:>/K8:$G1RS!U,=C:U3$2I4J-"#C&*<ZE11E6K5
M'&EAZ$6ZM>I+EIQD^:W@9WQ-DW#V(R/"9EB*D,9Q'F]#),GPE"E6Q.)Q>-K1
ME4G*-&BISAA,'0A/$X_&5%'#8/#P=2O4AS04OU=,]C_9MBQL&,9GO@D?VQP4
M(^S;V+^42V_*X! V[>,[CBK]HT[_ *!K_P#@=)_\9J(_\@G3O^OC4?\ VTJG
M7#1IQY-ZGQU/^7M7_GY/^_\ \/N]3R,VK3AF&(BE2:3IV<J%&<OX--ZRG3E)
M_-NRT6FAH_:-._Z!K_\ @=)_\9H^T:=_T#7_ / Z3_XS6=7Q_P#MO_M=>$OV
M,O@5KWQ3UR.TU?Q1=-_8'PW\'3W7D2^+?&5Y$[6=M((V6X31=)B236/$5Y#M
M:WTNTD@@D_M&\TZ&?OP.6U\QQF&P&"IUJ^*Q=:%"A2A5JWG4J.R5W.T8KXIS
MDU&$%*<FHQ;7SN;9[@\CRS'9QFM?"X/+LNPU7%XS$U</A^6E1HQYI.RHN4YR
MLH4Z4%*I5J2C3IQE4FHO[>T^>Q:Z41V#QMY5R0YNW< "UF+#:8@#N4%<Y^7.
MX<C%8GVG3/\ H%O_ .!\O_QFO%OV4/&OQ6^)'P0^%GCWXW>#](\!?%#Q=X4G
MU[Q/X2T(7Z:;H_\ : U*?14CMM4O-0U+3KF[\/-I-_J.D:A?7=YHVHW5WI5S
M/)-9NQ]6KDQ>$>%QN)PU2:G/#S=&<J6(E5I2G2K5J<I4ZL)N-6FW"\)Q;A*+
MYHZ2U^SX2QT,TR>AF%.%6E2QL:.+I4ZV&>"Q$*6)PN'KTX8C#.%.=&O&-11J
MTJL55IS4J<TI1:6G]ITS_H%O_P"!\O\ \9H^TZ9_T"W_ / ^7_XS695>\O+3
M3[2ZO[^ZM[&QL;>>\O;V\GBMK2SM+:)IKFZNKF9DAM[>WA1Y9YY72**)&DD9
M44D8JDFTE[1MM))5:K;>EDESZM_C\V?2OEBG*3M%)MMR:225VVV[)):MO1(V
M_M.F?] M_P#P/E_^,ULW$]B+?3BU@S!K/**+QU\M/M-R-A/E'?\ ,&;<0#\V
MW&%!/Y5?L=?MP>-/VPOCQ\?++P9X#T6#]ECX7)!X>\&_%-GU.+Q+XN\<K?6J
M,GE7%X=,N=#U;1UU37K6WM-,M=2T'3O^$=;6IY+CQ%%:VGZC7/\ Q[:7_P!>
M'_MY=UWYGD^*R?'0P./@Z6*C2HUJM%8EU)T5B,-&O"E6Y*DG2KQISC[6C)J=
M.3M):Z_$X7BC*>*N'O[;R&M/%Y94Q^+P>'QE7#3A0QCR_&U<%6Q.#^LPY<3@
MJE:A4^K8NFI4:\%STY-$GVC3O^@:_P#X'2?_ !FC[1IW_0-?_P #I/\ XS6=
M17/[*/>I_P"#JO\ \F>;]8J?RT/_  FPW_RKR_/NS1^T:=_T#7_\#I/_ (S5
MZQGL3]LV6#)BQG+YNW;>@,>Y!F(;2W&&&2,=#FOB#]M_]KKPE^QE\"M>^*>N
M1VFK^*+IO[ ^&_@Z>Z\B7Q;XRO(G:SMI!&RW":+I,22:QXBO(=K6^EVDD$$G
M]HWFG0S^M_LJ>-?BM\2/@'\/O'OQN\'Z1X"^*'B[P3)KWB?PEH0OTTW1_P"T
M+R:?14CMM4O-0U+3KF[\/-I-_J.D7]]=WFC:C=7>E7,\DUF['NK9/BJ>4T\X
MG"4,%7QKP-"<\3-5*]:G!5:SHT74YZE&BG&%6M&+IPJU(4W+GE9>5A.)\NK<
M2U>&*56%7-L+ED<VQE*E@:<J.#PE:M]7PT<5BH4?8T,5BI*=3#86<UB*V'HU
ML1&'L8\TO=OM&G?] U__  .D_P#C-'VC3O\ H&O_ .!TG_QFLZBN'V4>]3_P
M=5_^3/5^L5/Y:'_A-AO_ )5Y?GW9H_:-._Z!K_\ @=)_\9H^T:=_T#7_ / Z
M3_XS6=7Y@_"C]O;Q7^T+^W'XG^ 7P-\$>'O%7[/'PET+6(OB_P#&>>YO6NT\
M7Q0WUMI$7@R[MM071+S2+GQ+!%X?@MI["]OM>M[+Q%XETJ\AT31XY+[T<#DV
M*S&ECZ^&A)T,LPD\;C:U3$SI4J-&+481<YU%&5:O4:I8>A%NK7J/EIQ=I6\3
M-^*<NR3$9/A,?5IK%Y]F5+*LJPE# 4\1B<5B9Q=2I-4:5"4X87!T(2Q&.Q<U
M'#X2A%U*U2/-%2_5N^GL5EC#V#.WV2R(87;IA3:PE%P(CG8I"[LY;&X@$XJG
M]HT[_H&O_P"!TG_QFFZC_KXO^O*P_P#2*"J%>52IQ=*F[U-:<'I5JI?"NBG9
M>BT/HL17FJ]5*-'2;WP^';Z;MTFW\W^;-'[1IW_0-?\ \#I/_C-'VC3O^@:_
M_@=)_P#&:SJ_,G]MC]N_Q5\#?BG\%_V;?V>O!GASXL_M&?%KQ'I1G\*:[<WX
MT;PQX-N+AXFO-:DTB_L+K3M1U>.*]O+&\N;@V&@Z'I&K>)-:M)[".Q@O_4RS
M)\5F^+C@L#"4ZSIU:TY5,3.E1HT*%.56O7KUJE2-.C1I4XN4ZDY**TBKRE%/
MY[B#BC+^&,MGFN;5:=+#1K8;"TH4<#2Q.*Q6+QE>&'PF#P>%HT)U\5BL16G&
M%.C1A*;7/-I4X5)1_5%)[$V&H,+!PBK:^8GVQR9 ;A0H#>4"FUOFX!W8P<"L
M?[3IG_0+?_P/E_\ C-68_P#D&ZI_NV?_ *5+6'7C^SCSU=9Z37_+VI_S[IO^
M?7Y]--C].R9N> IR=DW.JO<C&G'2;7PP48KS:5V]7=FG]ITS_H%O_P"!\O\
M\9H^TZ9_T"W_ / ^7_XS6913]G'O4_\ !M7_ .3\OS[L]6R\_O?^9I_:=,_Z
M!;_^!\O_ ,9J_JEQIZZC>K)ISR.+B4/(+V1 [!CEM@B(7/7 ) ]:YVM+6/\
MD*W_ /U]3?\ H1K-TX^U@KS_ (=1_P 2I?25+KSW]5L^MQ65UOL^K[KS%^TZ
M9_T"W_\  ^7_ .,T?:=,_P"@6_\ X'R__&:RG945G=E1$4L[N0JJJ@EF9B0%
M50"220  23BL3POXET/QGX;T#Q?X8U&WUCPYXHT;3/$.@ZK:-OMM1T?6+.'4
M-.O8&X)BN;2XBF3(# /A@&! T]DK7_>632;]I5LF]4F^>UVHMVZV?F:JC4=*
M594ZCHPJ4Z4ZJ4W3A5JQJ3I4Y3^&,ZD:-64(-J4HTJCBFH2:[#[3IG_0+?\
M\#Y?_C-:UO/8'2YF&GN(Q?P*8_MCDES;W!5]_E9 50R[<8.[.1MP>6K:MO\
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ME_\ C-)J?^LM/^P;IW_I)'6;6=*G%TX.\_A3_B5$ON4[+T6GWL22LM]EU?\
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M)4_;8/&4I.GB\!7E1J2P^(@Y+EY%*I44Z->MZGYUG_SYM_X%/_\ &Z/.L_\
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MX9\/>,?"^I6^L>&_%6B:7XBT#5;1M]MJ6C:S90:CIM[ W>.YL[B&9<@, ^&
M8$#H$^^O^\O\Q58;"8;+Y3IX7 X+!.4TJL,/@,)AFYP?+:I&E0A>4+./O*\=
M5I=EXJ6+E5E2QM3%RK4)SI3IXJK7=6C4A)QJ4Y0JS<J<XS3C.#2:DFI)-&E>
M2VHNKD-:,S">4,PN'7<0YRVW8<9/.,G'2J_G6?\ SYM_X%/_ /&Z;??\?EU_
MU\3?^C&JK754JR52>E/2<MZ-%]>[A=[==];[LY(17+'67PK[<^R_O%SSK/\
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MG'S*D:-ZCG&3?NREK)+5)*45S)7M22]VTG;E5VVG\_C]B2\\)_'/_@G+\/\
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MQ,*V,POUW"4\11EB,)[6I0>(HJ_M*:K4FJE*4HWY9Q?NRLVFKI_'<;8?'XO
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M0/#VE:?HFB:180K;V.EZ1I5I#8Z;IUG F$AM;*S@AMK>)1MCBC1!P*ZS2/\
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M:=J6G7T$EK?6%_974<MM>65Y;2RV]U:W$4D%Q!))#-&\;LI_FX^/'@SX\?\
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MRLY5:31[[Q+IT&G1VMC&P;0?!5CH.@P_96N=:LV^._V<=%^-O_!6#]HCPO\
M%+]I[PHWA;X$?LK6]CX>U+X<+%?Z=HWBOXY6$5G-XCL;O1]2@CNHI;O5[>'5
M?&NDWAF;0M LO#W@F1IWU:_U.7^D\  8 P!P .@'I7T.<1CPAE=7ANC4I5,]
MS.,*G$>*P]2-6&%P:DJN$R3#UH:256T,9F,H-1J-X?#N52G"27Q?"52?BSQ+
MA?$3%X?$T>">&IUJ'A[EF/H5,-5S/-Y0>'S7C/'8.K9P>&?MLHX?IUE*=",<
M=CE"A7JTY/9T_P#Y!^J_6P_]'2U^>_[3O[??A7]DWX[?!_X:_%?X?>(]+^%/
MQ5TJX>7]H 7B?\(CX6\3+J-Q8Q>'K[2X]/FFNH[&&.RU/Q'?G4[.;1]*UC3[
M^VTW5;>+4&M/T(T__D'ZK];#_P!'2UX?\?\ X"?#;]I?X6>)?A#\5-$CUCPO
MXBMP8YD$4>K>']9MUD_LOQ-X=OGCE;3->TB:1I;.[1626*2YT^^AN]+OKZRN
M?E<BJY72Q]\YPU;%9=.<Z6(CAZLJ.(H*K0A".+P[BU&=;"R:K0HU5*C6</9U
M%RRNOH_$7#\08C#5UPOC\-E^=T:>%Q.#GC</#$X'%O#UW5J9=C8R3J4L+F%.
M,L)5Q6&<,5A8U?;T)<]-1EZY;W]C=V,&J6E[:76F75I%?VVHV]S#-8W%C-"M
MQ#>P7<;M;RVDUNRSQ7,<C0R0LLJ.4(8_ST^++O4/^"N_[9UOX#T6[NW_ &%_
MV5=:BU7Q+K5FCQ:?\5O&ZNUL]O;788+=1^(S!>:/HDT3%]+\!0:]K]M-8ZEX
MKL[=_F'QE=_\%#/V<K/4/^"4NA?:_&=G\9-9MM$^ ?Q@$E]9W$7P<NFO6\::
M)INJ^7=KIVAV^F^4/%=I=7$FH?#?1QXCM+!KW0]8\+7EE_1?^R=^S/X'_9*^
M!_A+X,^!X_/BTB$ZEXHU^6,)>^+O&>HPP'Q#XFONI5KZX@CM]/M6:0:9HMGI
M>DQR216$;M][/!X;@;#5LTHX_"YEFF:4ZE+A?$X62E'#996ARXC/:E-WGA\9
M*,YX#"T*C4\/B8XR;]I["+/PNEFF.\7,=A>'\5D^89%P]P]6H8CQ!P&84Y0J
M8[/\-553!\(4:RY:>,RRG.G3SC,<91YJ6,P%3*Z<51>*G$^A["QLM,L[+3=-
ML[73].T^VMK&PL+&WBM+*QLK2)(+6SL[6!(X+:UMH(XX;>WAC2*&)$CC1455
M&!\3]?U+PIX>\?>*-&\,ZIXUU?PYH?B77M+\':&T*:UXKU'2-.O+^R\.:2]Q
M^Y74M;N;>/3;%I0R"YN8BRN/E/4KU'U'\Z-7_P"0IJ'_ %]S_P#HQJ_,922Q
M%&<XJJESRG"4I)5$ITG*,I1:FE-73E&2DKMIIZG]-Y!3E*ACZ5&H\-.5*G3I
M5J<*<I4).%6,*D*=2,Z4G2=I1A4A*FW%1E&4;I_"?[$W[<GPY_;1\$ZGJ>B:
M=-X$^)GA"Z?3_B-\)=9U!;S7O"=U]HE@M[VWN7L=*FUC0;UXGABU0:582VVH
M17.F:C96=W BS\__ ,%#OVS+']C_ ."TM_X?\G5OC9\19;CPI\&/"8MO[2N+
MWQ%,((;KQ'<Z6F^6[TGPNE[;7,EN(I%U36;K1-"*J-5::#Y,_;X_8^^)/PV^
M(D/[?_[%$<NA_&WP:9=6^+'@#1;-YM/^*WAU%1]=U+^P;0QKK.J7=E"4\7:#
M$HN?%5K&FN:4]OXVTZ&YU?S+]A#X>?$']OC]HC4/^"B_[1FBG3O!7A*Y30/V
M9?AV]W+=Z+I-YH-Q-#/KUDD]O;F^T[PMJ1O9[75)((WUGQ_=ZEJB)9)X8LK0
M_I-#(^&I6XOIUH/AG#1]KB<AK8CGS&EG*Y7A^'G*=ZF(P>+J7K4LPY6WEM+$
MJLHUZ4IO\9QO&OB/#_C4V(PE5>).8U/JN7<<87 NGP]B>$6I+'\?*%+EHX'-
MLLH6P>)R/FA3AQ#BLO>$=3!8FG2A]H?\$T_V-+W]F/X7:IXZ^)K2ZS^T=\<K
ME/&OQ:U[5#'=ZOH\VIRRZK;^#/[1.^:66RN[VYU/Q3<K,XU3Q5>7KM-=66FZ
M0\7ZBV__ "!Y/^PE'_Z2R5BUM6__ "!Y/^PE'_Z2R5\!F^9XO.<QKYGCIJ>)
MQ>(A4GRKEITXIQC2HTH;0HT*484:,%I"G",=;7/V/+>&LJX0X/PW#F3472R_
M*\)"A2<Y<]?$59554Q.,Q56R=;&8W$SJXK%UFDZN(K5)V2:2_/;]IW]OOPK^
MR;\=O@_\-?BO\/O$>E_"GXJZ5</+^T +Q/\ A$?"WB9=1N+&+P]?:7'I\TUU
M'8PQV6I^([\ZG9S:/I6L:??VVFZK;Q:@UI]Z6]_8W=C!JEI>VEUIEU:17]MJ
M-O<PS6-Q8S0K<0WL%W&[6\MI-;LL\5S'(T,D++*CE"&/D?Q_^ GPV_:7^%GB
M7X0_%31(]8\+^(K<&.9!%'JWA_6;=9/[+\3>';YXY6TS7M(FD:6SNT5DEBDN
M=/OH;O2[Z^LKG^:?QE=_\%#/V<K/4/\ @E+H7VOQG9_&36;;1/@'\8!)?6=Q
M%\'+IKUO&FB:;JOEW:Z=H=OIOE#Q7:75Q)J'PWT<>([2P:]T/6/"UY9?9Y/D
M.5\38+#4<!B:&4YS@+O-88W$2^JXW+5-SK9OAIU9?NZ^7T7)XW!1:A4H4U7P
M_+)58/\  ^)N,>(. ,UQV*SG!8OB3A?.6EPY4RK!1_M'*<]E1A1PO#&.IX>'
M[_"9UBHQ659K.,JM#&XB>#QG/2EAZL?I[Q9=ZA_P5W_;.M_ >BW=V_["_P"R
MKK46J^)=:LT>+3_BMXW5VMGM[:[#!;J/Q&8+S1]$FB8OI?@*#7M?MIK'4O%=
MG;O_ $1Z#8V6F/HNFZ;9VNGZ=I[:=8V%A8V\5I96-E:&&"UL[.U@2."VM;:"
M..&WMX8TBAB1(XT5%51\V_LG?LS^!_V2O@?X2^#/@>/SXM(A.I>*-?EC"7OB
M[QGJ,,!\0^)K[J5:^N(([?3[5FD&F:+9Z7I,<DD5A&[?3FG?\A"Q_P"ORU_]
M'I7D<49OA\?*E@,LC.CD63T*F$RJC-*,ZJ?O8G,<2DHIXO,:R=>L[+DBZ=%)
M*G=_2^'W#.-R:&(SG/YTL3Q?Q/C,/F/$6*IMRHX>44H8'),#)N366Y)AFL)A
MES2]K45?$R;=>T?GK]I;XLZY\"O@O\2_BYX<^'6M?%?5O FD/K</@/P_=BPU
M+6+>/4+6#4)Q>_8=3DM;'1=.GNM>U:>WTS4KJ+2M,O'MK&YF"1-R7[*7[57P
MO_:]^$^E?%+X:7^S=Y>G^+?"=[/"_B#P/XF2%)+S0-:ACV[@-WGZ7J<4:6>L
MZ<\-]:["TUO;_3<_^OF_ZZR?^AM7\_O[6?P ^)O_  3S^,=[^WA^QUH[77PN
MU6X#_M)? FP66#PX='N+HSZAKUCIUG%*NG^&Y)Y9;[[78V<DWPYUN1M6LX)O
M!M]K.DZ>N'LORK.\-6R>I)8+/ZM55LFQ]6O*.#QL_9PA_8V*C-^RP\Z\HN>"
MQ:4;XB;H5Y<DJ27VW'6?<4<&8W \6T(3SG@7#8183B[(\+@Z=3-<FH^VG57%
M^65:4/K6/HX.G-4LYRN4IJ& HQQN#IQJT\5*7U!_P4\_:[\3_"GPOX;_ &9_
M@%]IUK]J#]HF2'PQX6TS10)M7\)^%-<N)=&O?$RLKK_9^K:M-]HT?PQ>3-#'
M8/#K7B1KFW'AQ?.^E?V&/V1/#'[&?P(T+X::8UIJOC#4F3Q%\3?%L-ND<OB3
MQC>01K=)!*8TG.@Z#$%T;PY;3!3'86QOIHEU+4M2EF^&_P#@F5^SSX\^(WC#
MQ9_P48_:9AEO?B_\:&NKCX1Z3>E_(\#?#34K;[':ZCIUC*N=/&K:+Y&A>%(L
MF:T\#P?;))[F;Q9>&+]K*[>(L30R?!T^$,LJPJPPU6.(XAQU)IQS+.8)Q^KT
MYK6> RE.6'PZ?+&KB77Q#AS.$WY?A]EV.XLSBOXL<18:MAJN986IE_ .2XN+
MC4X>X0JSC4685Z#;C2SSBEPIX['37-4P^7K X"-;D5:FMP_\@G3O^OC4?_;2
MOSK\8_\ !0?P7\+?VR8/V3_B]X(UOX:Z1XGT/0+SX8_&K7]2@7P9X]U[6;>!
MY-(C@-C#'H]A#J,TWAJWUN?5[M7\36$^G:C8Z5!<V%[<_HH?^03IW_7QJ/\
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M_$J7XJPV7[8_BSQ1X-^(?PPO=8\63^)=+\)^(]96X\0_#]_$?@+0/#_ZH_\
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MK>7)CM=/TF2^O[F:&"VDD7](OVF_VC_ /[*WPDUSXM_$*2XEL+&6+2=!T.Q
M_M/Q7XJOX+N;2/#>FLRM%#/>K97=Q<7DX^SZ?IMG?:A,LB6IB?\ .\TPV)K<
M4YKA*=.=7$8NIDM;"4(ZU*F'K9%EF#I3A'_GW4QF"QU*,G:/M*%:[7+)GT.5
M9;C\ZJ9+EF4X2MC\PQ]>KEV$PN&CSU:^/JYCB)0P\$K+VG)B,/.3DU&%.I&<
MY1A=K\8OVQ_#6H?\$Q/CYX>_:H_9QUGPYIW@[XRZI?:)\0OV>]0U V.FZS=P
MPS:I>ZAH>CVQ$B>&XYI/M4%[91+-X$\17UO:6(G\/>))=%M_:/\ @FU\#?\
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M6_\ 1KC1?[^J?]^K3_X]5_5!I/\ :-[YKZB)?M$GF"..V,8?<<["TH8KGH6
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MO2Y?R?W>G^?X/L<Y16IC1?[^J?\ ?JT_^/48T7^_JG_?JT_^/5I[3^Y4_P#
M7_7_  S\KE_)_=Z?Y_@^QET5J8T7^_JG_?JT_P#CU&-%_OZI_P!^K3_X]1[3
M^Y4_\!?]?\,_*Y?R?W>G^?X/L-U/_66G_8-T[_TDCK-KH]0&D^9;>:^H@_8+
M'9Y<=L08_LR>66W2@A]F-X&5#9VDC%4,:+_?U3_OU:?_ !ZLZ4_W<%RS^%:\
MKM_7^7I=1>BT>R6WI^&OX,RZ*U,:+_?U3_OU:?\ QZC&B_W]4_[]6G_QZM/:
M?W*G_@+_ *_X9^5W?R?W>G^?X/L?EG>>'=#\7_\ !7?Q5X4\3:9:ZUX=\2?\
M$I;_ $/7=(O4,EIJ6DZI^U9;66H6-R@*L8;FUFEB<HR.H?<CJX5A](^)SX;\
M%:/I_P -?VIO#.F_$;X1:7J]CJ?@;XP>,M M/%WAS24T*66XT&#XTO>V%Q;^
M$/%7AZ$1Z?;_ !)OX5\*^+;9WGUG5=#UR_OM*O\ Q/3!8_\ #YV\\EKLV_\
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M?P7T CNT_@F%?'J6?*UL)DRDFK55G.+5FK6J*DLFNFF^;V:KW5N7VOVSMA+
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MNL_9O^>G_P"!KR_S_!]BN;^[+[BG15S&G_WKS_OF#_XNC&G_ -Z\_P"^8/\
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M *:I!1110>^%;MS_ ,>VE_\ 7A_[>7=85;MS_P >VE_]>'_MY=TE_$I>LO\
MTB1XN??[@_\ KY3_ /2D4J^:_&G[-6@>+/%MYK%IXDUCPSX1\87"7?Q<^'^C
M0P1Z1\2KJUCC2UN9;\/'?>&+C58XHM-\=3:'LD\<Z#!;Z7J;6\J27\WTI17S
M7&? /!7B+E>&R3COA?).+,IP6;Y5GV$R_/LOH9CA</G.28REC\JS&E2Q$)QA
MB<'BJ,*E.:^*//1J*=&K5IS^:RS-\RR:O4Q.5XVO@J]6A5PU2I0ERRE1K1Y9
MP=TU=:3ISMST:L85J4H5:<)QKVEI:V%K;6-C;6]E965O#:6=G:0QVUK:6MM&
ML-O;6UO"J0P6\$*)%##$B1Q1HJ(JJH V=.Z7_P#V#KG^<=9U:.G=+_\ [!US
M_..OJI)1IJ,4HQCR*,4DDDI1222T22T26B1RT&W6BVVVW)MMW;;C)MMO5MO=
MF=1116A@%%%% %_4?]?%_P!>5A_Z1050J_J/^OB_Z\K#_P!(H*H5G1_A4O\
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M_(****H9MC_D$V7_ %]W_P#Z!9U4JV/^039?]?=__P"@6=5*NC_#_P"WZO\
MZ=F?!9S_ ,C+$^M+_P!,TPHHHK4\PT-+_P"/Z'_=G_\ 2>6N?KH-+_X_H?\
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MPZDEK;?;[JRMM/U:&>71]6MX]0T.[U/33=:;?6GVL7-K/$GNE_\ \?<_^_\
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MH_P_^WZO_IV9\%G/_(RQ/K2_],TPHHHK4\PT-+_X_H?]V?\ ])Y:Y^N@TO\
MX_H?]V?_ -)Y:Y^N>?\ %E_U[I_^E53[#AW_ '2O_P!A#_\ 3=,****#Z *U
M+_\ X\](_P"O.;_TNN:RZU+_ /X\](_Z\YO_ $NN:SG\=+_%+_TW(E_%'_M[
M\C+HHHK0H*T],^]??]@R]_\ 18K,K3TS[U]_V#+W_P!%BLZO\.7R_P#2D!F4
M445H 4444 :6I_ZRT_[!NG?^DD=9M:6I_P"LM/\ L&Z=_P"DD=9M9TOX4/\
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M8_\ 04B_\!;O_P"-4?9;'_H*1?\ @+=__&JSJ*Z>27_/ZI]U+_Y4?GOM8?\
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M:II_#MT[7U>NUOK<@:EA*KC&--?6)*T')I_NZ6K]I*H[]-&EIM>[>I]CT_\
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M%N__ (U5ZQMK1?MFW4(WW6,ZMBWN5V*2F9#NC&X+@?*N6.>!UQ@5HZ=TO_\
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MO_E1\+[6'_0/1_\  L1_\O-'[+8_]!2+_P !;O\ ^-59LK:S6\M&74HW9;F
MJ@MKI2["5"%#-&%!8\ L0HSDD"L6K=A_Q_67_7W;?^CDJ9PERR_>U/A?2EV?
M_3HTI5(>UI_[/17[R&JE7NO>6NM=K[TUY"7%I8&XG)U:%29I25-I>$J2[94D
M1$$@\9!(..#BH?L>G_\ 08A_\ [W_P",U2NO^/FX_P"N\W_HQJ@K"$)<L?WL
M_ACTI]E_T[_J_I;]$2=EJ]EV_P C4^QZ?_T&(?\ P#O?_C-'V/3_ /H,0_\
M@'>__&:RZ*KDE_S]J?=2_P#E?]7?E9V?=_A_D=5]FL_[-M$_M&/8MS>%9?LU
MUAV9+7<H3R]X*8!)8 '=\N<&JWV6Q_Z"D7_@+=__ !JH1_R";+_K[O\ _P!
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M)=J?6W7N[6TM+7O1U?7MV] ^QZ?_ -!B'_P#O?\ XS1]CT__ *#$/_@'>_\
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MTGX9>&KKQ59Z1\7M.U6]TOX9Z+KNC:!;ZS#\2?CI\:-/C6VM-7G73;'P-8>
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MOJ7/(M?^?Z/_ +\7'_QNCR+7_G^C_P"_%Q_\;JG16?/'_GS3^^K_ /+2K/\
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M ):59_S2_P#)?_D?ZN_*W2Z='$L#A+A)!YK'<(Y5P=B<89 >F#GIS14&E_\
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M?^D-M676IK'_ !_'_KUL/_2&VK\-?@-^V#\<?V8_VH?$G[(_[>_B<:S8>/\
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MS6FI1;/+2[C\07%K'?ZC%(CK:_#NPTK1[VWLKSQG<O-_07;_ /('D_["4?\
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M*L],TG2[:2[O;N9@&=A'#$VR*)))YY"D$$<DTD<;?BE^P<WQ/_;=_:U\;_\
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M@?K'_P!*1MA_XT/^WO\ TF1G44459B%%%% %_4?]?%_UY6'_ *1050J_J/\
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MNU2QN#J4,723U5.M%/6XER,SW .<&64'!*GEV'!!!!]""".H(-?@,NN?$O\
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M_P#>7_T!:T7\*?\ U\I?^DUB7\<?\,OS@4Z*_#'X(?ME?'C]D[]J37_V3?\
M@H'XH37/#OQ&\07^M? +]HJ]LK'2/#NI6NK:@RV.B:K=6EM96%CH=S/-%IY6
MZ N? 'B!QI&ISS^$-0T?6--^Q_\ @HU^VG9_L=?!-[SPUY&K_'/XE33^$_@M
MX26V_M.ZN]?F\BWN_$]QI*+++>Z5X66^M;@VODRIJVN7>AZ$4":I)-!]AB>
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M?4(8O[1N$D95F.D:3&D.B>'H)0C1:186\TT8O[J^EF^T?[-?_G[T[_P.@_\
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MD.B>'H)0C1:186\TT8O[J^EF^P*T?[-?_G[T[_P.@_\ BJ/[-?\ Y^]._P#
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MQ:-'\0]+U"0;KG39M(E?3O"%W<QQ:G=3:CXFU_6K=-<N;>\K]TZT_P"RY/\
MG\TS_P &%M_\71_9<G_/YIG_ (,+;_XNO3S[B+$\0X]X_&RH4Y*C2P]##8:'
ML<)A</1BE"CAJ-VJ5-RE*JXIN]2K.5_>/$X&X)R;@#(XY'DTL7B(3Q>)Q^-S
M',JSQ6:9ICL744JF,S'%N,'B,0J2H8:$W&/+A\/1II>Y=S:?_P @_5?K8?\
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M (NC^RY/^?S3/_!A;?\ Q='M:?\ /'[_ .NZ^\]RZ[_UI_FC,K=N?^/;2_\
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M>JU3DTYLSJ*T?[-?_G[T[_P.@_\ BJ/[-?\ Y^]._P# Z#_XJM/:T_YX_?\
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M4,71K0IU:-:M7I5:56$9TZM*I3A3J4ZE.:<9TYQDX3A).,HMIIIL_F.\??\
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MC3O%W]IZ+X8_X6]87WP_L=<OIK"R_LW4?$/V.PMKJ*/[9?V]B]UO^TOL3?\
M/Q9_^!47_P 56=K7@WPYXFL=,3Q)HGAGQ"?#_B;2?%.@-K=CI>K)H7B72(KP
M:7X@TAK^"X&F:]IOVF?^SM5LO)U&T$TYMIXP\F>W+I+#8NG7K8>.(IPC5<J-
M2,)PJ7I248RC/W7'FE%M/Y:GL</YI@<ISG+\QQ^ P^;83"UG4JY=BJ5+$8?%
M?NYQITZ]&NG2J4E4G3G.,UJHOE:E9K\C/A?^W_\ $6P\&_ _P[J?PY\5_M&>
M//%7@%OB9X_U_P "^'?&,?B/3?"6J?'+Q1\-;/2HO!_@'X-:OX<E^)O@32=
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M3B:4(8J5"6(>9\08O%U*5!5,#@Z.'AB<)R1H8G'2J2^M4\MPGK%Q_P ?$_\
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MW\^QNT5T8&6SO(;O3KN]L[CXH_8"^$7[5W[..J_$CX _%R:R\8_ /P8MM>?
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M*_A?;K4E;KYHF,XWE[RU::]'&*7XE.BKGV)O^?BS_P# J+_XJC[$W_/Q9_\
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M\?J?]<;O_P!(YZY^N@TO_C]3_KC=_P#I'/7/USS_ (LO^O=/_P!*JGV/#O\
MN=;_ +"9?^FJ04444'OA6[<_\>VE_P#7A_[>7=85;MS_ ,>VE_\ 7A_[>7=)
M?Q*7K+_TB1XN??[@_P#KY3_]*12HHHKI/B0K1T[I?_\ 8.N?YQUG5HZ=TO\
M_L'7/\XZBI\#]8_^E(VP_P#&A_V]_P"DR,ZBBBK,0HHHH OZC_KXO^O*P_\
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M]&-4%3W7_'S<?]=YO_1C5!7/#X(_X8_DC]+CLO1?D%%%%4,VQ_R";+_K[O\
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M)H:T7\*?_7RE_P"DUB7\<?\ #+\X%2BBBLR@J[#_ ,>5[_OVG_H4M4JNP_\
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M2\T_]CSWMS=^(;H2R#5O%5YJ=T9[JRM]),'Z;Z1_S$O^P9-_Z46M9%:^D?\
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M]II.GZS:PZC)//H^KZWH\%OH5MHBRRIX1\.V,^BV-Y<6NKW8'[$UZW$./R[
M8&CPOD&*6,R^E5CC<US6$'2_MG,91_<V@VYQP6749^QP]&4K/$2KUI1E+DJ/
MY_@#),_SW.L7XE\=Y7+)\^Q.'J9-PQPQ5K1Q7^J'#\*B6*<JL5&E4SC/\72>
M*QV+IPYHX"&"PE.I"E[6BMG3_P#D'ZK];#_T=+7Y)?\ !1E/VPO@[XF\!?MA
M_LX>,M=\4>!OA!HDVG?%_P#9T>>Z/ACQ%X5DU"[O]8\;/I%HQ&L7,=A<1Z?J
M][]GFUOPC9:9IWB/0V^Q6_B)4_6W3_\ D'ZK];#_ -'2U4=$D1XY$62.161T
M=0R.C JR.K JRLI(92"""000:\#(LR_LK'_6Y87#8ZDISI8G!XNG&I1Q.&KT
M(4J]%MIRI3G3E)4Z].U2C/EG%NSC+O\ $7(O]8L-7RR&8X_*,1*EA<3@<SRV
MO.ABL!C\)6>(P>)BHRC#$4Z5>G!UL)74J&)I<]*HES*<?A[P1_P4(_9S\:_L
MIZS^UO!XHCTWP/X4TEW\9>'KR:W/BOPSXQ2*!(_A]=Z>LB^=XDU34KJRT_P]
MY96SUV/4=.U*SF_L^Z\^/X)_X)T?!KQS^U3\9_%'_!33]I+3$CU3Q-<WFB_L
MX^!;R"273_!_A+3S+IMMXFTZ*[B0&VT^S:ZT3PM>>5%)J5_/XH\9S0?:]5TC
M4#B?&C_@B]I/BW]I_0=?^'7B23PC^RI\0_$D/C+X[?"G3-5O-)73]=\,QZA=
M:;:^$=.M76SN=*\33:OJ6G6'F+'=?#Q=5UV?1'DT^\L=,L?WBT;1]*\/:1I6
M@:%I]II.B:'IMCH^CZ580I;6.F:5IEK%9:?I]E;QA8[>TL[2"&VMX8U"10QH
MB *H%?9YAC\@R3+<13X6Q-;$8KB.F_K-;$14,3DN3MQ]IDKDK\^*Q&)A..+Q
M$6HU<%1H<D7'$>T?XUDF3\9\69[@*_B%@,+@LOX&K1^I87!U/:8'BKB>,6Z/
M%<:;2]GEV!P-2E/+<%.+G0S7%8SVDU4P*HPTUZCZC^=<M\3]!U/Q5X>\?>&-
M$\3ZGX*UGQ'H?B70M)\8Z+'#-K'A34M6TZ\L+'Q)I45QB"34=$NKB+4K*.4K
M&]Q;1JSH#N'4KU'U'\Z-7_Y"FH?]?<__ *,:OSISE3KT*D+<T%.<>:,9QYHS
MHR5X34H25TKQE%QDM))IM']&Y#2A7HYA0J*3IUJ<*510J5*4W"I&M":C5I2A
M5IRY6^6I3G"I!VE"49)-?A;^R+^UW\7?V:OC._["'[>FN7-WXJ>\5?@9\?-=
MO[N]T[XCZ3J=W+'HNF:SXEU1VN-1;5YMUMX<UO5)SJ4&JK/X+\1M%K-M8+*O
M_!2;X[^-_CO\2O"G_!-7]FF_CG\=?$^>S/QZ\4VGGSV?@'P(RP:G-H>K7%F&
M>T@FTC'B'Q@JO'.^A?V3X:@%W<>+)[)/OC]MG]C+X>_MH_":Z\#>*!%H?C+1
M1=:G\-?B##:+/J?@[Q$\2@>8%:*:_P##NK&&"V\1:+Y\:7MM'#=6TEMJMAIM
M]:>'?\$VOV%M6_92\*>+?'OQ?U)/%W[2GQ7U&\D^('BQ]8N?$?V'0[74YY=,
MT+3M=OP+W4#JLL<7B/Q%J4RQ7&I:C/86=TDB:!92M^ET<VX7Y7QA[&E0XCPL
M537#T*,5EU?/)ZX;/:,?AA@:48U<5B,"HI0Q].C",XTJT.?\9QG"GB9SQ\)?
MK6)QOA]F51UY<?5<9*6?X'@NCIF/!&-FTJE;.\5.IALLP&<RDW6R*OBZTJ=3
M%8.LJ'VG^S[\"O O[-GPA\&?!OX=V*VOA[PAI<=J]Y)%%'J'B#6)OWVM>)M9
M>%0L^KZ[J+SW]XX_=PF5+.U6&RM;6"+Z M_^0/)_V$H__262L6MJW_Y \G_8
M2C_])9*_-<5B*V*Q$\3B:LZV(Q&)]M6K5&Y3JU:E3GJ5)R>KE*3;;[L_=J^!
MP>5Y#'+<OPU+!X# 8/#X/!X2A!0HX;"X94J-"A2@M(TZ5.$8179*]V?DC_P4
M93]L+X.^)O 7[8?[.'C+7?%'@;X0:)-IWQ?_ &='GNCX8\1>%9-0N[_6/&SZ
M1:,1K%S'87$>GZO>_9YM;\(V6F:=XCT-OL5OXB5/H'P1_P %"/V<_&O[*>L_
MM;P>*(]-\#^%-)=_&7AZ\FMSXK\,^,4B@2/X?7>GK(OG>)-4U*ZLM/\ #WEE
M;/78]1T[4K.;^S[KSX_N%T21'CD19(Y%9'1U#(Z,"K(ZL"K*RDAE((()!!!K
M\#?C1_P1>TGQ;^T_H.O_  Z\22>$?V5/B'XDA\9?';X4Z9JMYI*Z?KOAF/4+
MK3;7PCIUJZV=SI7B:;5]2TZP\Q8[KX>+JNNSZ(\FGWECIEC][DV(X<SC!X;+
MN(ZBRJME*E5PV:82A!3S#+J<Y8C$Y3BH045+&N+JO+<9).3J2^KU5.3IJI_-
MW%&#XYX8S3'9WP/1EQ%AN))0PV/X?S+&5'2R7.ZU*G@LOXCR^I5<Y4\JC*-"
M.?99!QA&C36,P[I1C6=';_X)T?!KQS^U3\9_%'_!33]I+3$CU3Q-<WFB_LX^
M!;R"273_  ?X2T\RZ;;>)M.BNXD!MM/LVNM$\+7GE12:E?S^*/&<T'VO5=(U
M _O+IW_(0L?^ORU_]'I6#HVCZ5X>TC2M T+3[32=$T/3;'1]'TJPA2VL=,TK
M3+6*RT_3[*WC"QV]I9VD$-M;PQJ$BAC1$ 50*WM._P"0A8_]?EK_ .CTKYWB
M+.:F=XRMBG2CAL+1H1PF78&F_P!U@,OP\'#"X6GLGR0]ZI.R=6M*I4:3G9?<
M<#\+T.$\LPN7JO/'YCB<7+,L\S>LK8G.<[QM2-3,,QK[M>UJ^Y0I7:P^%IT,
M/%M4TWD3_P"OF_ZZR?\ H;5%4L_^OF_ZZR?^AM45?/QV7HOR/W2.R]%^0444
M4QFX?^03IW_7QJ/_ +:53JX?^03IW_7QJ/\ [:53JZ/\/_M^K_Z=F?!9S_R,
ML3ZTO_3-,****U/,-#2_^/U/^N-W_P"D<]<_70:7_P ?J?\ 7&[_ /2.>N?K
MGG_%E_U[I_\ I54^QX=_W.M_V$R_]-4@HHHH/?"MVY_X]M+_ .O#_P!O+NL*
MMVY_X]M+_P"O#_V\NZ2_B4O67_I$CQ<^_P!P?_7RG_Z4BE11172?$A6CIW2_
M_P"P=<_SCK.K1T[I?_\ 8.N?YQU%3X'ZQ_\ 2D;8?^-#_M[_ -)D9U%%%68A
M1110!?U'_7Q?]>5A_P"D4%4*OZC_ *^+_KRL/_2*"J%9T?X5+_KW#_TE&^)_
MWBK_ (V%%%%:&!<C_P"0;JG^[9_^E2UAUN1_\@W5/]VS_P#2I:PZYO\ EY5_
MQQ_]-4S[G(_^1=2_QU?_ $Y(****9ZX5I:Q_R%;_ /Z^IO\ T(UFUI:Q_P A
M6_\ ^OJ;_P!"-9O^+#_KW5_]*HBZKT?YQ,VBBBM!A6U;?\@>?_L)6W_I+=5B
MUM6W_('G_P"PE;?^DMU4RWA_U\A_Z4CS\U_Y%^*_Z]K_ -+B5:***ZC\_"K=
MA_Q_67_7W;?^CDJI5NP_X_K+_K[MO_1R5,_@E_AE^3-*/\6E_P!?(?\ I2,N
MZ_X^;C_KO-_Z,:H*GNO^/FX_Z[S?^C&J"N>'P1_PQ_)'Z7'9>B_(****H9MC
M_D$V7_7W?_\ H%G52K8_Y!-E_P!?=_\ ^@6=5*NC_#_[?J_^G9GP6<_\C+$^
MM+_TS3"BBBM3S#0TO_C^A_W9_P#TGEKGZZ#2_P#C^A_W9_\ TGEKGZYY_P 6
M7_7NG_Z55/L.'?\ =*__ &$/_P!-TPHHHH/H K4O_P#CSTC_ *\YO_2ZYK+K
M4O\ _CSTC_KSF_\ 2ZYK.?QTO\4O_3<B7\4?^WOR,NBBBM"@K3TS[U]_V#+W
M_P!%BLRM/3/O7W_8,O?_ $6*SJ_PY?+_ -*0&91116@!1110!I:G_K+3_L&Z
M=_Z21UFUI:G_ *RT_P"P;IW_ *21UFUG2_A0_P *%'9>B_(****T&?G#H_\
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M]+^2I_X,C_\ *O7^EKJZA;3F>(B&0@6=B,A&(RMI"K#('4$$'T((JC]EN/\
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MG?5*.GE9^K+/V.Z_Y]Y?^^#1]CNO^?>7_O@U6HHM/^:/_@+_ /DSW]?+[O\
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M='_,O,B^SS_\\9/^^#_A1]GG_P">,G_?!_PJ&BL[P_EE_P"!+_Y K7NON?\
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M='_,O,@^SS_\\9/^^#_A1]GG_P">,G_?!_PJ&BL[P_EE_P"!+_Y K7NON?\
MF3?9Y_\ GC)_WP?\*<EO/N7]S)]X?P'U'M5>G)]]?]Y?YBG%PNO=ENOM+O\
MX U[K[G_ )EV]@F:[NBL3D&>4@A2007;!!Q5;[//_P \9/\ O@_X5)??\?EU
M_P!?$W_HQJJU51P]I/W9?'+[2_F?]PF%^6.J^%='V7F3?9Y_^>,G_?!_PH^S
MS_\ /&3_ +X/^%0T5%X?RR_\"7_R!6O=?<_\SHM-BD6!PT;@^<QP5/39'[>U
M%1Z7_P >[_\ 79O_ $".BO9P_+[&G9/X?YEY_P!U'%4OSRU6_;T\_7^M_@W]
MK#X<?#SXJ_MA_L)^#_BAX#\&?$CPE=:+^U?>7/A?Q[X7T/QAX=N+NQ\%_#F>
MQNI]$\0V.HZ9+<V<P$UK/):M+;R@20LC\U\8>'_BYXB^%VC?%/X._ SXD_%N
MS^'NE_M!_M!P_L]:;\&=,^!_C+Q)I_PG^"'PA^%-_P#$33--\>?M6^(H/@_X
M6^ 'P>^+/C+6_#;Z+9V.L>,99HK'PQX%O]&\/^&]5-Y^S?Q+^"'P6^-,.D6_
MQC^$/PO^+-OX>DO9M @^)?@#PIX[AT.;4EMDU&72(O%.DZJFFR7Z65FE[)9+
M UTMI;+.9!!$$H>(?V>_@'XM\,>$/!/BOX'_  @\3>#/A\+<> O"/B'X:>#-
M:\,>"!9VR6=H/"&@:EHMSI7AH6MG%':VXT:TLA!;1I!%MB15'UV'S&A3HX>C
M6A4K0I4I4Y49QIU*$9>WQ.(C6C3J2<9U&ZT*4DU3:I*JHU&YQ</,E1DYSG%J
M+E)24DVI6Y*<'%M+1>XY)^]JU[NCO^17A_\ ;9_:/UCPE\)/#5_XSTW3_B?^
MVU\$/V3O%/[-^K6OACPJ]EX(\<^(M2T3P=^T_+;Z3<Z#,FMZ7X6T::/XU65K
MKL7BR32H]=N]%6&70=-B2T_=2OFW4_V;/"]W\9?V??B5IAT#PSX1_9N\$_%#
MPY\._AGX;\':?H^GZ?KOQ)L?"?AQ=;L]4LKV"TT?0_#?@K0]>\.Z?X0TGPY:
MV]U-XI;4[C5531K'3I/I*N;'U\+7]B\-0A1NJDZL814>6<I^SIT[J$;J.'HT
M:CLY1=:K7G?FG)%THSCS<\G+6*BV[W7*I-VOHW.4UT]V,5LD5[O_ (]+K_KW
MF_\ 1;5Y/7K%W_QZ77_7O-_Z+:OSB_;K^('[2'PJ_9]UOXB_LO\ AK0?%_CO
MP=K6CZ_XB\/ZWIEUK,U_\.].%W<>*UT/2K.\L)[_ %:)4L99K>"X%\="36FT
MB.36ETY#ZO#F$GC\5#!4ZE"C4Q6(HT*=3$U51P\)U&XQ=6JTU3AS-)R::5]3
MXWC;,J638"MFM>AB\30R[!8K&5J& P\L5C*E*A%5*D</AX-2K5>2+<:<6G*S
ML?8M<3\2?B)X1^$G@'Q=\3/'NK0:'X/\$:#J'B+Q!J<Y7$%AIT#2O';QEE:Z
MO[N01V6FV,)-SJ&H7%M8VJ27-Q%&WA7['?[6_P ./VR/@]I'Q/\  ES%9:K"
ML.F>/O!,]RDVL^!?%:PA[K2;Y0L;W&G70#7GA_64B2VUC3'24+;W\&HZ?8?E
M?^VIXQ\3?\%#?VL/#/\ P3U^$&KWEG\'OAEJ\/B[]J3QUI<;/;PWWA^X N/#
M:70+6\Y\/231:/8V<PD@N_B+J<9O;40>#'O%^RRGAO$8G.<1EV:*IEN'RE5<
M3GM>K&SP&#PK3KRM9J=6M>-'"1CS*O5K4G#FA+F/S#B/CO X'A?!9WP_*CGV
M-XDEAL#P?@\/.\<XS3,4UA(-WC*EAL,E4Q.9SJ>S>#PV&Q"JNG6BH'O/_!-3
MXA?M*?M0_$/XX_MA?$OQ-XI\/_ ?QY/<>"?@/\&+V^DE\-6FE:'K,(F\766G
M[Q9PZCI4.F?\([>Z]91*WB?7M0\6-<F.VT?2H8_V'U7_ )A__8.B_P#2BYKD
M_!?@WPQ\._"/AOP)X+T:S\/>$O".BZ?X?\.Z)I\?EVFFZ3I=M':6=K$"2[E(
MHU,LTK//<2F2>XDDGDDD;K-5_P"8?_V#HO\ THN:\?B',:.:9K/%87"4L!@_
M=H8+"4H1BJ&#PU&-##0J2CK5KNE",L16DY2J5I3ES<O*E]UX89'BN'\LI9?F
M&98G.,S="OC,US+$U:E26+S/'8I8K'5*$9NV'P:Q%6=/!X:G&%.AAH4H*/,I
M2EE45^2EI^WI\2/@I^W!XP_9M_:YT+PYX+^%_P 1]8:[_9F^*NFVMQ8:#/HT
M\ZVFC:1XIU>XN[BUN)M18PZ=JVHRI82^&O%Y>'4(?^$7UG2=3T[[5_:X_:9\
M'_LD_ KQA\9/%S1W,NEV_P#9?A#P^9#'/XM\<:G!<#PYX<MRI\Q([J>"6\U6
MZC#OIVA6.JZF(I19&)]<1PYFN'Q>68-4%B*F<TL+6RNIA9JO0QL<5RQC&C6C
M:+J4:LG1Q,)<LJ%6$E42CRSE[^ \0N%\=E?$N;2QTLOH<'XO,L'Q+0S2E+!8
MW)ZF6^TG.IB\+-NHJ&+P\(XO+JT%.&.P]6FZ#E5YZ4/@O_@I3^U#\49/%_PV
M_8:_9/UG4[+]HSXT:EIESXA\2^&]2ET_4OAOX'\R6[,S:Q8.+WP]J&I6UC=:
MWJFIP/%?:)X*TF_O40-KFE7*_KS\,=#U7PQX+T+PUKGB._\ &.M^'? FBZ'K
M'B[542/5/%6JZ38Z58:AXCU*.(M''?ZY=V\VIWB1LR+<74BH2H!K\C/^"6O[
M,OC"QLO&'[;O[0L;ZI^T-^TO+<>(K0ZG:&&[\%_#_5YTO;&UL[:7<=*F\4PQ
M:?>)81871_"=AX8T.!;-H]4M&_9O2/\ F)?]@R;_ -*+6N_BF>7X*.#X<RU8
M>M#)YR_M',Z<(N>99Q7E26-E3K-<[P.#=..#PD$XPFJ53$-3=6,SY?@"CGN=
M8?/?$/B*6.P=;B[#TEP]PW7K5(T>'N$L)&M/)Z>(P:FZ*SO-57J9KFM:2E5I
M2Q-# Q=*.&G2<%%?'7[=?Q _:0^%7[/NM_$7]E_PUH/B_P =^#M:T?7_ !%X
M?UO3+K69K_X=Z<+NX\5KH>E6=Y83W^K1*EC+-;P7 OCH2:TVD1R:TNG(=K]C
MO]K?X<?MD?![2/B?X$N8K+585ATSQ]X)GN4FUGP+XK6$/=:3?*%C>XTZZ :\
M\/ZRD26VL:8Z2A;>_@U'3[#@_LC&O*5G4(TZN!6+E@J\J4U.KA*_)&=+ZW22
MYJ%/$J4EAZDKPJ2ISA=345+S?]9LJ7$CX4JU*V'S>66PS7"4\11E2P^983VE
M2EB/[.Q$G[/%UL#*$'C:$+5:%.M2J\LJ;G*'NOQ)^(GA'X2> ?%WQ,\>ZM!H
M?@_P1H.H>(O$&ISE<06&G0-*\=O&65KJ_NY!'9:;8PDW.H:A<6UC:I)<W$4;
M?EG_ ,$U/B%^TI^U#\0_CC^V%\2_$WBGP_\  ?QY/<>"?@/\&+V^DE\-6FE:
M'K,(F\766G[Q9PZCI4.F?\([>Z]91*WB?7M0\6-<F.VT?2H8_!OVU/&/B;_@
MH;^UAX9_X)Z_"#5[RS^#WPRU>'Q=^U)XZTN-GMX;[P_< 7'AM+H%K><^'I)H
MM'L;.8207?Q%U.,WMJ(/!CWB_NIX+\&^&/AWX1\-^!/!>C6?A[PEX1T73_#_
M (=T33X_+M--TG2[:.TL[6($EW*11J99I6>>XE,D]Q))/))(WT&(P]#AWAZ-
M"O1I5,^XDHTJ\HU:<9SRC(U4C6H64T_98W-:E.-522=2C@J<?X<Z]W\5@L9B
M^-^-9XO!XK$4.#N!<5B<)"IAJU2C3XEXNE1EA\6I2IR7UC*>':%:IAW!VHXK
M-JU36M3P=EU>L?\ '\?^O6P_](;:LNM36/\ C^/_ %ZV'_I#;5^0'[*?[>GQ
M(N?VA_'_ .Q]^VCH7ASX<_'"S\07]W\*]9T>UN-*\'_$7PY=SS7&E:3I$UY=
MW<5S?3Z>OVWPKJ*W"?\ "16"7&CWT%IXNTJ>UU;Y3+,GQN9X+'8G!1IUO[+P
MM'%8K#JHOK3PLFX5,30H?'6HX5J+Q4H7="%2$Y+D<I1_>\VXMR;AS&\,Y;F]
M2OA'Q-B:F6Y;CIT)?V9',J="G5P^7XS'75+"8O,E*<,LI5;+&U:%:C3E[50A
M/]:Z_$W]KG]H3XR_M#_M>_#C]A;]DCQYXB\"3>"]9LO&W[1WQ9\&7[6UQX7T
MK3)+.XN?#PU"UD426^BV=Y#'K.DS2FSU_P 6ZUH/A'4EACL=9@E^N?\ @HE^
MV+;?L@? RYU?0/+U'XR_$2:X\'?!GPX+4ZA/>>)9T@CN_$,VG*'>[TWPI;WD
M%[)!Y4J:AK%SH6ANBC5_-BY?_@FG^QS<_LN?!RX\2_$)7U/]H/XTW,7CCXNZ
M]J+&[UFQN]0,NH6'@R;4)&DFG?1'OKN[UZ?S9/[0\5:AK%P9[FTATUHOI,CP
M]#)<JK\59A1I5JM5U\OX:P6(IQJ4\5CU'DQ69U:-1.%7"95"=H*49PJX^=.F
MW%T9'PG&N/QO&7%&#\,,AQ>)PF$PT<'GOB+G& Q%3#XC+<D]JJV6<-X;%T)1
MJX;->)ZU*]5TZM*OA<DHXBO%3CBJ=OTZT_\ Y!^J_6P_]'2U6JSI_P#R#]5^
MMA_Z.EK\L/V\/VO_ ([?L:?%'X+_ !$/@/3O%W['VL1GPS\8-3TO3Y[KQKX:
M\5ZCJ=PMIJ,5X+R&WL+:+2A8S^'X+BV;3M=O[?7="U&]T^_OO#MW%\[DF5XK
M.<;+ 8)T7BJKJRH4ZU6-'V\Z6&C46'HRG[LL1647"A3;7M*CC!--GJ>(/$&7
M\+TJF<YJL3'+L.L%3Q=?#8>IB?J='$XE8=XW$PI7G3P6%=15<9749>PH1G4<
M9*-C]1J^(OV_?VO]%_8V^ .M^/!]FU#XB^)&F\)_"7PS)LFDUCQG?6LA@U&Y
MLMPFGT'PQ%_Q.=;**J3+%9Z,)X+W6;$M].:/\5OAQX@^&=O\9=&\9:'J'PNN
MO"L_C>+QO#=C^PE\+6MC+J5[J\]Q(J/:PV%I;W#ZC#=1PW>GS6US:WMO!=V\
MT"?AK^S3X?UG_@IY^V=K?[9/Q$TNZ3]F#]GC6)/"G[.W@_6;*2.S\4>(-.N/
MMUIKM[93%H9;BQN#:>,?$S,'_P")S<>$?##3:AIWAV]A3Z#AS**%2OC,TSJG
M4IY-D-JN8TIITZF+Q?.X87)J:DE)8C&5XN%563H8>%>I-P<8L_.^..)<71PF
M5\/\*5Z-;BCC)RPV28FG*-?#Y;EOLXU,QXHK2@W"6#RS"5%5PS3E'%XVK@Z%
M*-53E$_3'_@GOX&_:!\$?LU>&'_:;\>>*_'/Q;\:ZMJGQ UB+QC?S:EJ_@BP
M\3)92Z5X$-U<,TJ+I%M;_P!H7>G8CM]#U;5]2T*PC33M-M!7VWJ__(4U#_K[
MG_\ 1C4+U'U'\ZYGXF-XL70?'C> DTB3QRNB>)6\&1^(#.-!?Q8-.O#X<36S
M;,ER-(;6!9KJ1MW2<69F\IEDVD?-YCBIYIFE3%U(8?#SQM:O5<*,(X?"T/:U
M:5H0A%<M.C2345HVH1YI.4KM_JW!&7TN'\D674:F.QU+*<OPM"-7$5:F-S'&
M?5J-12J5:E23G7Q>(E%R:NE*I/D@H0Y8K5HK\N?V /V\M<^/.H^+?V??VC=%
ML_AK^UK\+;[4++Q+X1EM3HUOXQTS3Y")]:\/V,MS=1+J.EQM$=<TVQN[JTNK
M*6T\4:!)/H5]<1:1C?\ !4?]J_Q/\+_!GAK]F;X%K=ZO^TM^TK(GA+PMINC@
MOJWAOPAK=S+H6I^(X9$=#8:IK%RT^@>&[V1H4LG77/$*W=L_AH&3UH<)YN^(
M*?#M2G"GBZDHS>(YU/!+ N'MI9G'$+W*F CAE+$>WB[.G%Q2]JG!85?%+A5<
M"8CQ P^(K8C*Z%.=)8#V+I9Q+.E66#APW4R^5ZU#/:F8SIY?]2FN:->I&I=X
M=JL_++7]H3XR_MG?\%$="\ ?L\^//$7A']F+]D[5TU3XR>*O#=^T6B_%/Q);
MWLT-QX6OVMY!:>(- UV^T^;PMHFGW#SVITS3O%OC6R:>5-%\G]S+?_D#R?\
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M2J==='^'_P!OU?\ T[,^,SG_ )&6)]:7_IFF%%%%:GF&AI?_ !^I_P!<;O\
M](YZY^N@TO\ X_4_ZXW?_I'/7/USS_BR_P"O=/\ ]*JGV/#O^YUO^PF7_IJD
M%%%%![X5NW/_ ![:7_UX?^WEW6%6[<_\>VE_]>'_ +>7=)?Q*7K+_P!(D>+G
MW^X/_KY3_P#2D4J***Z3XD*T=.Z7_P#V#KG^<=9U:.G=+_\ [!US_..HJ? _
M6/\ Z4C;#_QH?]O?^DR,ZBBBK,0HHHH OZC_ *^+_KRL/_2*"J%7]1_U\7_7
ME8?^D4%4*SH_PJ7_ %[A_P"DHWQ/^\5?\;"BBBM# N1_\@W5/]VS_P#2I:PZ
MW(_^0;JG^[9_^E2UAUS?\O*O^./_ *:IGW.1_P#(NI?XZO\ Z<D%%%%,]<*T
MM8_Y"M__ -?4W_H1K-K2UC_D*W__ %]3?^A&LW_%A_U[J_\ I5$75>C_ #B9
MM%%%:#"MJV_Y \__ &$K;_TENJQ:VK;_ ) \_P#V$K;_ -);JIEO#_KY#_TI
M'GYK_P B_%?]>U_Z7$JT445U'Y^%6[#_ (_K+_K[MO\ T<E5*MV'_']9?]?=
MM_Z.2IG\$O\ #+\F:4?XM+_KY#_TI&7=?\?-Q_UWF_\ 1C5!4]U_Q\W'_7>;
M_P!&-4%<\/@C_AC^2/TN.R]%^044450S;'_()LO^ON__ /0+.JE6Q_R";+_K
M[O\ _P! LZJ5='^'_P!OU?\ T[,^"SG_ )&6)]:7_IFF%%%%:GF&AI?_ !_0
M_P"[/_Z3RUS]=!I?_']#_NS_ /I/+7/USS_BR_Z]T_\ TJJ?8<._[I7_ .PA
M_P#INF%%%%!] %:E_P#\>>D?]><W_I=<UEUJ7_\ QYZ1_P!><W_I=<UG/XZ7
M^*7_ *;D2_BC_P!O?D9=%%%:%!6GIGWK[_L&7O\ Z+%9E:>F?>OO^P9>_P#H
ML5G5_AR^7_I2 S****T **** -+4_P#66G_8-T[_ -)(ZS:TM3_UEI_V#=._
M])(ZS:SI?PH?X4*.R]%^04445H,_.'1_^4R]_P#]HNQ_ZUM8U^HU?ESH_P#R
MF7O_ /M%V/\ UK:QJ#]O7]L/X\_L8?%/X+?$4^ M-\7_ +'6L1GPS\8M3TK3
MKB[\;>&/%>HZI<)::E%>"]AMK"UCTD6$_AZ"XM6T[7=0M]>T'4;[3K^_\.7<
M7E9GD>-XBXAP&59:\.\=7R6E4PU'$5X8?ZU5H4<166$P\ZEH3Q>(4'3PM%N/
MMJSC34DY7/ SWBC*^#LDQN?YTL7'*L+F&'I8[$X3"U,7]0H8NOA\++,,73I7
MJ4\OP;JJOCL1&,_J^&C4JN$E%H_4VOA[_@H%^V'HG[&7[/\ KGCT?9M0^(WB
M1IO"7PD\,2%)9-8\:7UK(8-1N;+<)I]!\+P_\3G7"BA)UBL]&$\%[K5@6^G]
M&^+'PW\0?#&W^,^C>,]"U#X67/A2?QQ%XX@O%_L)?"MI83:E>ZQ/<N$>UAT^
MTM[E]1ANHX;O3IK:YM;VW@N[>:!/PL_9F\/:S_P5"_;2UO\ ;-^(NE7:?LN_
MLZZS)X3_ &<_!^M6+QV7BGQ!IUR;ZUUV^LIBT,MQ87!L_&7B<L'_ .)U<>$?
M"YGU#3O#E]"G/P?D&%JXG,<[XDHU:7#O"JC7S>A.,J5;,,?[1T\!P[2C)*<<
M5F.*@Z>(5D\-@Z>*K5)4G",CYGQ%XMQU#!9-PQP7B:%?C'CUSPG#V+I2AB,-
ME.4^RA5S;C&O*G*5.> R? U57PDE*4<;F%; X>C&LJDXGZ;?\$\_ O[0?@?]
MF;PP_P"T]X^\6>._B[XVU75?B#K,7C._FU+5_ ]AXG2RETKP&;JX9ID72+:V
M_M"[TTB.WT+5]8U/0=/C33=,LQ7W5?\ _'W/_O\ _LHJI5N__P"/N?\ W_\
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M?^AR53JY>=+3_KSB_P#0Y*IUI5^/_MVG_P"FXDP^%?/\V%%%%9E%VS^Y??\
M7D__ */MZI5=L_N7W_7D_P#Z/MZI5I/X*7^&7_IR1,=Y_P")?^D1"BBBLR@J
MW??\?!_ZY6W_ *30U4JW??\ 'P?^N5M_Z30UHOX4_P#KY2_])K$OXX_X9?G
MJ4445F4%78?^/*]_W[3_ -"EJE5V'_CRO?\ ?M/_ $*6M*7Q/_KW6_\ 34R9
M;+_%#_TN)2HHHK,H*<GWU_WE_F*;3D^^O^\O\Q3CNO5?F!8OO^/RZ_Z^)O\
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MNL^*/AAI_P 19M0G\"ZKI]WX]^,\WA[X9_'9O$N@Z]IW]$]?-VK>"/V0=?\
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M23H0KX"I&5&O3EA^P55151%5$50JJH"JJJ,*JJ, *      !@<5L:1_S$O\
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M/2;PYJ^JVGA^_P SZ!]IAM9O"_ANQE5+JUT.#6=2N'O)/%"W8_8[_A8GP_\
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M53KF3\1OA[_96GC_ (3OP9D7&H9'_"4:)D9^R8R/MV1G!QGK5/\ X6+\/O\
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M_)U'_"Q?A]_T/?@W_P *?1/_ ).K7DG_ "R_\!?^1YEGV?\ 7_#K[ST+2_\
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M<:AJNI3JJ?:M7UK4I[S5]7O"B&ZU*]NI]B"0(NY_PL?X>?\ 0^>#/_"HT/\
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M'3:6K^')%D_7*N,_X6/\//\ H?/!G_A4:'_\G4?\+'^'G_0^>#/_  J-#_\
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M\M7R);7/'5?#+JN\#J**XS_A8_P\_P"A\\&?^%1H?_R=1_PL?X>?]#YX,_\
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M5>JDVESO1-KL?+?_  P[^Q=_T:1^S3_X8WX9_P#S,T?\,._L7?\ 1I'[-/\
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M8:_8KDO(E?\ 9&_9G=2LV5?X&?#)E.()2,@^&2#@@$<<$ CD5A_\,0?L8_\
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M\JPP0>A%?2-:>F?>OO\ L&7O_HL5G5Q6)4)6Q%=;;5:BZK^\+V5+_GW3_P#
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M>)+V\O;K6HH-"TWPSX,\0Q75[!)'X@U'PKIK)JYX_P#;#_;%L_V5=+\(C3/
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M4[^QG,,T^D:]I%[?^'/%6DZ]X9U35=%OOC]?V1OVY=/5="TK]O7X:ZAX50+
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M2J0D[;+WHI*^E[):NRU?97:Q*:PF(OO[&HW_ . ,@HHHKTS\Y"BBB@"36/\
MC^/_ %ZV'_I#;5EUJ:Q_Q_'_ *];#_TAMJRZY*?\.G_@C_Z2C],H_P *E_U[
MA_Z2@HHHJS0V=/\ ^0?JOUL/_1TM5JLZ?_R#]5^MA_Z.EJM54?\ E[_U\7_I
MJF?%9_\ [^O^O%/_ -*F%%%%;'B"KU'U'\Z-7_Y"FH?]?<__ *,:A>H^H_G1
MJ_\ R%-0_P"ON?\ ]&-6%7^)3_P5?_2J1]1PW_S%_P#<'_W*9U%%%(^H"MJW
M_P"0/)_V$H__ $EDK%K:M_\ D#R?]A*/_P!)9*F6\/\ KY#_ -*1YV;?\B[%
M?X(_^G(%6BBBNH^ "KFG?\A"Q_Z_+7_T>E4ZN:=_R$+'_K\M?_1Z5%3^'4_P
M2_\ 26:T/X]'_K[3_P#2XF1/_KYO^NLG_H;5%4L_^OF_ZZR?^AM458QV7HOR
M/TJ.R]%^04444QFX?^03IW_7QJ/_ +:53JX?^03IW_7QJ/\ [:53JZ/\/_M^
MK_Z=F?!9S_R,L3ZTO_3-,****U/,-#2_^/U/^N-W_P"D<]<_70:7_P ?J?\
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MI:PZYO\ EY5_QQ_]-4S[G(_^1=2_QU?_ $Y(****9ZX5I:Q_R%;_ /Z^IO\
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MG9GP6<_\C+$^M+_TS3"BBBM3S#0TO_C^A_W9_P#TGEKGZZ#2_P#C^A_W9_\
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MXBM+*RLK2)Y[J[N[J=XX+:UMH(Y)KBXFD2*&)'DD=44L,?1O#V@?VSJ?BO\
ML/1_^$I'A^#P\/$O]F67]OC0#K$.I'0_[8\C^T?['.H@7YTS[3]B-Z!=>1YX
M\ROGS]L+]G?7_P!J/X-7/PAT3XHZK\*;76?$F@WOBC5M*TO^UF\0^%+&2X&K
M^$[RV&IZ2XM-1,]OJ 879BEO-)M+2]@GT^YNXS\GG\J&,SG!4L166#H1PN#P
M];$2A.LJ5.,JG/65.G%SG:+;4$KMI)R2;:]GAO!9?B\TP>$S;-(Y-EF*S*G'
M'YK+"XC&K+\)4=-5\2L)A8SQ&)G2IJ3A1II.I/EBY0BY3C^2GQJUGQ=_P5S^
M-EK\%_@Z4\.?LH?!/7CJGC#XTWNAI=W'B+Q.;6ZL%F\,+=BWG)O+.>[L_#6B
MQ75H9].EN?%GB;;$=&T>W])_8Q^._BW]BCXBVO\ P3__ &JK;2] TR.^NI?V
M?_BW:6D6F>%O%>FZ[JUU<VVFW]Z$AADCUK4[BY&EZI>N=0TO79;KPKK\K2+I
MLL7ZY_!;X+_#S]G_ .'/A[X6?##0HM"\*^';;RXD)274=5OY0IU#7M=OECB?
M4]<U:=?M&H7TB(&;9;VT-K8V]K:0>6?M<_LE_#G]L#X7W'P^\;@Z3K%A)-J/
M@;QU9V45YK/@K79(TC:]M(9)K7^T-+OTBBM]=T*2\M;?5[6.'%Q9ZA9Z;J-C
MT?V_EN(2R2MA71X:BE3PTE%3Q^%Q$7.V;SG%7JXBI*I)XG#K]TZ,G1I1O!.?
M[[_Q%#A',XQ\.<=DU3 >$%.%/"Y35A1IU^*,DS6G.NX<>5\13BY8W-,76Q->
M>;Y33;P<LMJO 8*GST(SQ'U/5N__ ./N?_?_ /917C_P.\ >(OA7\(_A_P##
MKQ9XZU+XF>(?!WANRT+4_'.KVSVFH>(9;/>L5U<0RWNHW ,%L8;&*2[U"^O9
MX;6.>^N[B[EFE?V"_P#^/N?_ '__ &45\E4C""KPIU%6A#$1C"K&,H1JPC[=
M1J*,TIQ4TE)1FE))VDDTT?@&.HT,/C\5A\+BX8_#4*^*HX?'4J5:A3QM"E6Y
M*.+IT<1"GB*,,33C&M"E7A"M3C-0JPC-22J4445@8!5U/^0?-_U]P?\ HJ>J
M574_Y!\W_7W!_P"BIZTI[R_Z]U/_ $ADRV7^*'_I<2E1116905-;_P#'Q!_U
MVB_]#6H:FM_^/B#_ *[1?^AK50^./^*/YH4MGZ/\@N/^/B?_ *[2_P#H;5#4
MUQ_Q\3_]=I?_ $-JAHG\<O\ %+\V$=EZ+\@HHHJ1EU_^0?#_ -?<_P#Z*@JE
M5U_^0?#_ -?<_P#Z*@JE6E7XE_U[H_\ IJ!,?M?XG^@4445F4%7-0_X_)_\
M>7_T!:IU<U#_ (_)_P#>7_T!:T7\*?\ U\I?^DUB7\<?\,OS@4Z***S*"K=K
M_J[W_KT_]N;:JE6[7_5WO_7I_P"W-M6E+X_^W:G_ *;D3+9?XH?^EQ*E%%%9
ME!1110!<O.EI_P!><7_H<E4ZN7G2T_Z\XO\ T.2J=:5?C_[=I_\ IN),/A7S
M_-A111691=L_N7W_ %Y/_P"C[>J57;/[E]_UY/\ ^C[>J5:3^"E_AE_Z<D3'
M>?\ B7_I$0HHHK,H*MWW_'P?^N5M_P"DT-5*MWW_ !\'_KE;?^DT-:+^%/\
MZ^4O_2:Q+^./^&7YP*E%%%9E!5V'_CRO?]^T_P#0I:I5=A_X\KW_ '[3_P!"
MEK2E\3_Z]UO_ $U,F6R_Q0_]+B4J***S*"G)]]?]Y?YBFTY/OK_O+_,4X[KU
M7Y@6+[_C\NO^OB;_ -&-56K5]_Q^77_7Q-_Z,:JM54_B5/\ '+_TIDP^"/\
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M1<T_9PG/DC_-+E3Y5YNR(?LXVYN2-]%?E5WIHK[]-O(^K_(@_P">,7_?M/\
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MTO9U%4]]-P7LVN=N23DDHMN*<MDV+VD+)\\;.]GS*VED];VT;2>N[L?6@AB
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M^(NN_"3X > ?B)X*U_3-$_8=,?QF\:?$?Q+\19M/UOXY7/Q*N_@XL7PDM/\
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MD0?\\8O^_:?X5+11=]W][ C$40R!%& >" BC(!R <#G!YY[\T>3%_P \H_\
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MA?\ "I**++LON07?=_U_PR^X9Y<> OEIM!R!M7 )ZD#&,FD\F+_GE'_WPO\
MA4E%%EV7W(5WW_K^DB/R8O\ GE'_ -\+_A1Y,7_/*/\ [X7_  J2BBR[+[D.
M[[O^O^&7W$?DQ?\ /*/_ +X7_"E,49))C0D]244D_4D4^BBR[+[D%WW?]?\
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MQF-#@8&44X'H..![4GDQ?\\H_P#OA?\ "I**5EV7W(=WW?\ 7_#+[B/R8O\
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MVNX8.ZHE3<'RS@XRLG:4>5V:33LTG9IIKNFFM&"=U=.Z[IW7]:?AY$?DQ?\
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M]3F\ ?M3_L*>%KWPE\;/$]O\ OA!\5/AC\1_'?A3]G3]H/Q5\/[3Q+X]\#_
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M?B:;7/&.A_$#4+TZ7XV\ :OXDO?!/P_\7:'X-T_QWX=/BO5]'NAK5KH_ O\
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M7+> HOV'OV@/AU=_!_X7Q_LI?&WX2^!)-'EOOA=X"3X1?$GX=>#9=0N]6O\
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MUK^P[+Q7XZ\$_#70)_[.U;4_M_C7XC>([#PEX-T7R]'L-0FM?[9\0:G8Z?\
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M5E%O$T:?U3%QK4?9^R;'&D2)%$B1QQHL<<<:A$C1 %1$10%5%4!550 H
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M:'I'AK79[VZ^#GQNT]]5T_Q9X[TCX7:5_P (G8W_ ,.;;4/'%];_ !*UW3/
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MZ#_PKKQS#\._%7ASQ_<:SX2TW5/AUXGTGQ.US::II_C72-$MO#WDZ9'XIO\
M0KSQG\/+3Q?FZ]^VY\$O 5_XDTSXD:_+IFH:1XU^*7AG3[#P#X)^-OQ7OYM+
M^$&F>"=8\<:UXAL_"WP>6?PY)X9TWQ[H&H^)3;KK_A'2M,NO[0L_'&KP6.NG
M1=?J6,<E!86NYN+FJ:I3=1Q4IQ;4$N=I2A-2LO=Y9-V2;(]I32OSPM>U^96O
M9/>]MI+KK==S[$HKXI^)'[<?PO\ "?C7P;X \&QW7Q!U?Q'XZNO!.M>(K;2?
MB%I_PK\+30?!;QG\9T9OC!I?PY\4?#CQ'XB&C>'=$^U_#_P[XBOO'-MH7B2;
MQ3'HEU:Z!>6%SU_A/]KWX2^)[338;23QIXAUX_#GPS\1/$</PN^#?[07Q4\)
MZ#;>)OA_IWQ*L-''C7P]\'8+)_$&I>%=4T_5_#7@[7-/\-?$KQ#IVK^'GB\
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MIM6?G9NST9T%%?GUXC_;0^(?P\U+Q_X7^)O[/UAHWCS3? 'PJ\;?##PEX/\
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MRLU:_P 2Y[)IM7:@Y;[1=G:U_H'PE^P;\'O!_A3Q!X3TS5/$4%IXH^!7C_\
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MRJ2H/EE*4W>,7%M4T_?CHFG%-MQBE=IK1*]U9>">-/\ @G;\;_&%[\2M2@\
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M\*V$WB#1_'6G>.-%UV6ZU.TN]._L>];2TYO3/VFKCX7>-_%VA?!C]H/P;/\
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M*+*Q\,6*:'XY\&Z;X5\;: USJ/\ 8_B"SCN5CBR+[]@[]HF^\2?$GQ9)\/\
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M*6'B:XOKJVO[KP[:7QELJ/QM_:Y^+OP0^,_[5ND:]\;O@_IGASP1X4^ >O\
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M"WCGPWX#\*ZW:^%;.+5]:@B2\GOM;OH=:U2/7-;U87;D?35?%?[$7[1?B/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7(Z!X$\)^&/$/CGQ7H>D1V?B+XDZUI.O^-=6:ZOKRZUG4="\+:'X,T< WUU
M<QZ9IVG>'O#VG6]KHND)8:-'?/JVN"P_MWQ!K^I:F44U*24DI-*2Y9)-I2BI
M1DHR2W7-&,K.ZYHQ>Z3"RTTVU7D[-77R;7HV==67KFBZ9XDT76/#NM6WVW1]
M?TO4-%U:S\ZXM_M>F:I:36-_;?:+26"Z@\^UGEB\ZVGAN(M^^&6.15<%%";3
M33:::::=FFM4TUJFGLP*WA?PUHG@OPSX=\'>&K+^S?#GA/0M(\->'].^TW=Y
M]@T30M/M]+TJR^UW\]U?W7V6PM8(/M-[=7-W/Y?FW,\TS/(V[110VVVVVVVV
MVW=MO5MMZMMZMO<-M@HHHI %%%% !1110 4444 %%%% '(Z!X$\)^&/$/CGQ
M7H>D1V?B+XDZUI.O^-=6:ZOKRZUG4="\+:'X,T< WUU<QZ9IVG>'O#VG6]KH
MND)8:-'?/JVN"P_MWQ!K^I:FS7_ 'A+Q/XF\">,=<TG[=XD^&FI:YJ_@G4?M
M^IVW]BZCXC\.:EX2UFX^QV=[;V&I?;/#VKZCI_E:O:W\%O\ :/M=I%!?107,
M115^TG?FYY\W)[/FYG?DY/9<E[WY/9_N^7;D]RW+H*RM:RM>]K*U[\U_7FUO
MO?7<[&BBBH&%%%% !1110 4444 %%%% !1110!S">#/#*>,[CXA?V3#)XRN/
M#%GX,_MR>:ZN)[7PS9ZK?:W_ &3IEO//)9:3#?ZK??;-<FTNVL[KQ$^G>'DU
MZ?4HO"_AR/2NGHHIMMVNV[))7;=DMDK[)=%L@LELK=?GW"BBBD 4444 %%%%
M !1110 4444 %<9\0_A]X2^*O@O7_A]XZTR;5_"GB>T2RU>PM=6UK0+R2.&Y
M@O;::QUSPYJ.DZ_HVH65[:VU[8:IHVJ:?J=A>6\%U97<%Q$DBE%.,I0E&<).
M,HM2C*+<91E%W4HM6:::333335T)I---)IJS3U33W375,R_AE\)_!7PATC5=
M&\%6_B$1:_KLOB;Q!JOB_P =>.OB5XL\0:])I.CZ NJ:_P"-_B3XD\6^,=<N
M;;0/#^@Z#8'5==NTTW0]%TK1]/2VT[3[2VB]'HHISG.<G.<I3G+64IR<I-[7
M<FVWIIJP225DDDMDE9+Y(****D84444 %%%% !1110 5QWC+P!X1^($7AN'Q
M=I/]KQ^$?&/ASQ_X>7[?J=A_9_B[PG>&_P##^K9TR]LFN_[/NR9?L%\;G3+K
M/EWME<Q_)113C*46I1DXR6THMIKT:LT)I-6:379ZH/\ A /"/_"P?^%I_P!D
M_P#%>?\ "&_\(!_;OV_4_P#D4?[;_P"$B_LG^R_MO]C?\AG_ $S[?_9W]I_\
MN_VW[+^XKL:**'*4K<TF[)15VW:*VBK[)=$M$"26R2N[NW5]_4****0PHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
8* "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img181012247_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_10.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *$!-L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBO'OB3^T-\ /@SJ&G:3\8/CE\
M'OA3JNL6;ZCI.F?$GXF>"_ NH:II\4[6TM_IUEXHUO2[F^LX[E'MWNK:*6!)
MU:)G$BE1<*<ZDE"G"=2;NU&$7.32U;48IO1:O303:BKMI+NVDOO9[#17S#8?
MMM_L8ZK?66EZ7^UU^S#J6IZE=VUAIVG6'Q\^%-Y?7]]>3);VEE96EOXLDN+J
M[NKB2."VMH(Y)IYI$BB1G95/:>.OVD_V=/A=X@A\)_$SX^_!7X=^*K@0-!X:
M\=?%/P-X1\03K<K ]LT.C>(-=T_49!<)<VSP%+9A*MQ T>X2QEM'A<2I*#P]
M=2DG)1=&HI.,;<S4>6[2NKM*RNK[BYX6OSQLM&^963>RO<]JHK/MM6TJ]TJW
MUVSU/3[O1+O3XM6M=9MKVVGTJYTJ>V6\@U.WU"*1[2;3YK1UNHKV.9K:2V99
MTD,1#'Q7PY^U3^S!XQ\3P^"?"/[1_P !?%/C.YNEL;?PCX<^,'P]USQ/<7K2
M+"MG#H&F>(KK59;IIG2);>.T:8R,J!"S &(TJLU)PIU)J"O-QA*2@N\FD^5:
M/>VPW**M>25]KM*_I??Y'O5%%%9C"BBB@ HHHH **^<[3]K7]GF^_:-U/]DJ
MT^(]I/\ M":/H4?B34_AVF@^+/.LM)ET33_$L<LWB0Z"/!XNWT#5=/U<:4OB
M%M5^P7<5Q]BV%B/HRM*E*K2Y/:TZE/VE.-6G[2$H<]*:O"I#F2YJ<TFXSC>,
MELV)2C*_+).S<79IVDMXNVS75/5!11168PHHHH **** "BBB@ HHHH ****
M"BBB@ HHKYSU+]K3]GG2?VC- _9+O_B/9Q?M">)]$G\1:+\.X]"\5W,]SI-M
MH>L^)II9_$5KH4_A#3KI= T#5=773-3\06>J2V-O'-%9NMY9?:-*=*K5YU2I
MU*CITYU:GLX2GR4J:O.I/E3Y:<%K.;M&*U;2$Y1C;FDHW:BKM*\GM%7W;Z):
MOH?1E%%%9C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1&C1J2JU92GS.=.UINTE&*@U2DD_M<LU:=WK9,_3>3]JRVT/_@L3\0O@7=_
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M'?B7J'BMY/%6H_$&*=M$BU'P_%XJO(-/MK<ZCH&JBPL-2O\ 6K2.XN;$]/\
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M^,WP1_X*T_LY_MR^'_@)\;/C]\(-'^&&I^&?$]A\!_ =WX\\8Z'KL_@[XJ>
MIK&31K.Y2-8X[;QIH'B&UU#5KO1-/OHSJ>F17*7.G>=<2:Q\,_C7XY_X+??L
MJ_M&_P#"C?BQX?\ A=/^ST+_ ,2^*=6\%:[_ ,(UX$UK6_@3\8;23P?XL\66
M]C)X;TSQ1I>N>(M,\/7VE2ZDMU_:US#!%$_G1%O8J2P^)P^&G-87V5/A+%0A
M.$XPFL=25;_9VE44VZ;<91I2BTY5&_>YDCG2E"<TG/F>/IMIJZ=.7)[^UM=4
MVGLNEC-^$7_!2G_@HW^TQXW_ &IOAM^SS\ OV;]=UK]GGQQXHBD\6>+9OB%I
M?A]/"6F:QXITGPKX0N/#]AXTNM8\3_$[QQ)X6U0Z/J&GZIX9\,P/I5X-0L;2
M*X@F@Q_AW_P55_;_ /VAOV6OB#^TI\#/V;_V?=)\,?L\Z!KM_P#&_P 0?$3Q
M%XVU&P\7:QX8LD\4>)M*^#_A30M:T;4K%_#/@"]TCQ9K9\8^*+B)8[R;3]+N
M]4OXK2VO_3O^"-OP6^,'PJ^//_!2G6OB=\+?B%\/-'\>?&'P=?>!]4\;>#]?
M\+Z?XRT^P\8_M 7MYJ/A6\UJPLH/$&G6]IX@T2XDU#29+NS$6JV+B<BXCW>/
M_P#!-[X#?'#P+_P1_P#V]?AAXW^#GQ2\'?$GQD?VI1X0^'_BGP#XJ\/^-?%)
M\0?LP^!O#F@?\([X6U72K36]:&N:_97>BZ.=.L;D:GJMM/861GN8GC$UXY32
MJXR,,%ETXX7$9'&A)RJ/VL<=0YL:Y\N(4:B@URI)*%)^\X\_O#@Z\HTVZE:]
M2.)<DDERNE-*FE[EU?[Y7M>Q]&>/O^"P9T[]C']E_P"./P\^$]KXE^/G[6?B
M'5?A]\.OA/>:X#H&G>.?"?BL>"?%\^K:A#-9:G<Z)#KTNEKH-C&;"_OX/$VA
M-?WVF0M<75=/\/?VZ_VO?A-^U[\(/V4_V[/AA\"-)?\ :%T&XO\ X7_$+]GJ
M_P#',FA6&O0PSL/#'B6S\;ZEK%W?7R:A:G1-1N---A:V-_J>CW=K)JVD7$E_
M'^.FH?\ !/7]I/QM_P $YOV,/$,_[/?C;Q/XF_9W^-7QNUKXB_LX>)=/\2>
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M>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7XD_M=_\ !'+_ (:J_:'^(7QZ_P"&B_\ A _^$\_X1/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_D7_ ."GW_)\OQP_
M[II_ZJ#P!7]=%?R+_P#!3[_D^7XX?]TT_P#50> *_K'Z'/\ R<W/?^R$S/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGZKXJOH)4G^!_A%J&C?MC_#K]H;XX_M$_L]?\%"_VFOVE_&_B3Q19?!_XO\
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MZ^\$V'@W0]:TFR$=SYAD\3S>'(8W4)=3VL0GN+?WG_@MC_RC'_:8_P"Z,_\
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M1+$NG3H7CSSJTU-W?*M(1<G[L9:MR245&UWJTD?W'T5_&M\?!^T]\-_V9O\
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M_P HLO@'_P!G_P#PL_\ 6=?VJJ_K]K^0+_@]6_Y19? /_L__ .%G_K.O[55
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M5:_K]K^0+_@RI_Y19?'S_L__ .*?_K.O[*M ']?M%%% !1110 4444 %%%%
M!1110 4444 ?CM\6O^"8?QCU_P#;:^(_[;_P$_;1?]G[Q[\0]!\/^')=+?\
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MZKPU*C[6K"7O1G5YY1>J:9C'#48;0O[K@N:4YV@U9QCSRERIK1J-M-#\+/\
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M,J?^467Q\_[/_P#BG_ZSK^RK0!_7[1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5^''_!<WQ!\*?$W[/_ ("^$=U^UO\ L*_
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M110 5_(%_P 'JW_*++X!_P#9_P#\+/\ UG7]JJOZ_:_D"_X/5O\ E%E\ _\
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M?U^U_(%_P94_\HLOCY_V?_\ %/\ ]9U_95H _K]HHHH **** "BBB@ HHHH
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M?R!?\'JW_*++X!_]G_\ PL_]9U_:JH _K]HHHH **** "BBB@ HHHH ****
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M<>)?#NE>++:SBOK"^M;::S/B30]#MM7-MI,][>6P!^9'_!&7_@F'^V7^RO\
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M^'?AGX;_ !,T.X\:^-K^SA\V#0-$FU73=,_M+4)'BLA>6]NC)&P4?G1^T?\
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M$_Q5\$VVJ6OBC2M-\%>-/&FB>)O!%EJNI6NAZ_=6O\YG_!T#^RM_P4G^!W[
MOPB\6?MB_P#!5K_ANCX9:C^U_P" ?#NA?"3_ (88^ O[,G_".^.[OX+_ !_U
M+3/B+_PGOPM\1:OX@U?^R/#^D>)_#/\ PB-Y;)H]_P#\)=_;-Q.M[H&GQR@'
M^AY1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH **** "BBB@ HHHH **** "OQ'_ ."TOP8_9*E^$_AW]IS]IMOVUO$-_P"
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ME\?/^S__ (I_^LZ_LJT ?U^T444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^R/7Z***^</;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\*GQ/KGCMKK0;C7M7@T32+NS;Q#_ %*U^)G_  3[\,_MH^$?C&MA\6?VW/\
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M[E1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEU$0371L- \+^'/&^I:WK-Z+:WN+@VNG6-S.(()IC'Y<3LKL^S[[=.X77?\
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M][9W7A7Q3)J]OI.DS)JFGW:)_3W7\8_[(_\ P2L^!7Q[_:!;3_B1_P $]?\
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M^'NNZ-?^$HM.\+2Z5I<GARRCTA;;1)--L'TR*U:SMS'49)7NKWT?DK6T^_\
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MXS'8K*LTR3*\P4,;A*-#ZKB)X'#T<=0]O2SC-95L3',J./\ KV'J+#QR^O\
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MI-4_9:BBI;;W[)?);#22V]0HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
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M ,HLOCY_V?\ _%/_ -9U_95H _K]HHHH **** "BBB@ HHHH **** "BBB@
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MO^467P#_ .S_ /X6?^LZ_M54 ?U^T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %?E-_P6(_9A_:4_:G_97\)>'?V3?'GP0^&'
MQG^$W[17P8_:'T/Q]^T%XK^(/A#X=>&[/X-:MJ/B>]N-1O\ X>:%XFN;Y;]U
MMM'U71O$NA7_ (4U#PMJ7B);UK#5(]'U2Q_5FOS"_P""O/['_BG]M?\ 8RUS
MX6>#_&/PA\,:QX0^)/PM^-\>A_M&0^(9_P!FKXH)\'/%EIXT3X6_M%IX3U#3
M?$R_!WQ1=V%K-XHN-$GDOK.;3-.O%M+R*"6VE /+_P#@GG\5/^"L/Q0^([ZE
M^U]\3O\ @CQ\3?V=Y_AMJ&L:-K'_  3\\8?M'>+OB??>+)O%<OACPSK=U=_$
MB^O/ $OP\NKWPA\4-"U6^T\+>R>+O#,^DZ8P?1?$%M:_L;7\M/\ P0S_ &!/
MC?\ "[XQ6G[1OQ"^)7_!/MOA_P#"7X+?M$?L[?#;P%_P3\\;^*?B9IVI:/\
MM#_M>Z[^U\VA_%/QAJ#Z;X0T?PA\!]9\2^)/"/P1\!>&/#T]_;Z+XLU/5-;U
MVSN;.:VU_P#J6H **** "OY O^#U;_E%E\ _^S__ (6?^LZ_M55_7[7\@7_!
MZM_RBR^ ?_9__P +/_6=?VJJ /ZW?$WBSPKX*TF77_&7B7P_X2T*"6""?6O$
MVLZ=H.DPSW,@BMH9=1U6YM+..6XE(C@C>8/+(0D89B!7R)^S'\>?A_\ $'QI
M\>A+XW^'\?BGQ%^T!XIT?P;X>L/&&B76J^*/!?@3P3X.\,:#XB\/Z;_:#7^L
M:9K%CX<U/Q!_:&FP75A(9M1DM9WL[;,?T]\3[CPA8> O%&L^.]"TOQ)X9\/:
M1>^(+_1]7TNRUBWO3H]O)>P00:=?V]S!<ZA--$D&G1B"2:2]EAC@5I713^-?
M[$O[5O[+?ASX^^)/V==<?P%J'Q3U?QMK7B'PM\9-'\/Z!:^#-1\<^*%2/6_A
M/X+U]8#=6<6BMYND>&M3L[BW\.>*[N;5-$\/*(CH$WBK]=X+X;PN;<!<?9A2
MRK/<?FF#PV$C&IET:4Z%/ 4*]+'XFJXRHS;HX/$4,!6S6+J*N\+4H3P<;0Q=
M2G\;FL>(,3Q7P_1RU82>58*EB\QS3VE.K*I0YX2P-&52<*L4JF(HU\='+HQA
M*+J4,7/$)PIP/W1HHHK\B/L@HHHH X+XF^$KCQMX(UO0M.N8K#7@EIK'A34Y
M@QCTGQCX=OK;7O"6JRA/G:"P\0Z=IUQ=PH1]ILTN+5LQSN#?\ ^+;?QWX-\.
M>+;>VEL3K>F0W-YIDY5KK1M6C+6NM:%>E<J+_0M7@OM'OU4E4O+*=59E 8]=
M7S&OCSPW\%?BQ/\ #SQ+=7%CIGQL\5VVO_"Q(;*[NX9?%^NI-#\0?#H-K%(E
MA;1ZU:6'C.:^O"D,NH^/K^,S*(HHQ])EF&Q&<Y9B\IPM"KBL=E\ZN=8"A0IR
MJUJN&5&%//*5.E33J59PPU#!YE)\LH8;!99F%9N"E4;\/'UZ.5X_#9CB*M.A
MA,9&GE>,JU9QITX5W5E/*:DZDVH4XSKUL5@8I-2KXK'X*DE)J"7TY1117S9[
MAX#^T#^TC\-OV<?#EAKGCN_DDOM:OHK#0/#>G&&76]8?SH4OKR&WDD18=+TB
M"876IZC.R6\*^3:QF:_O+*TN/?00P#*05(!!!!!!&001P01R"."*_#GXW?%:
M[^._Q)T/6?B+X*\!ZY\$_ACXYO@O@I6U2Q^(NK>&=4^(<WP0DNK_ %NWG6YC
MU:3Q(R>*8_"&EMIEM)9:39-?7=T]NMR?W MK:&SMK>TMT,=O:P16T"%WD*0P
M1K%$ADE9Y'*HJ@O([NV-SLS$D_J''7!.&X-X>X,5>EBEQ)F?]NUN(*OUK#XG
M+J-2C5R[ZCE.&5)PJT<;EV#K4\3F*G2JT9SS2BJ&-KJE*EA_@>$N*J_$^=<3
MNE4H/(\!_9-+)H?5Z]#&U85:>,>+S&NZBE3JX7&XFE.A@G&I3J0AE]1U<+2=
M2-2M/1117Y>??!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7YA?\ !77]EOXX?M>?L@_\*N_9
MR\/?!7Q-\8- ^.7[/WQB\(Z5^T+J&N6OPANKSX+?%7PY\27LO&^FZ'HVOOXJ
M\.ZTGAW_ (1[7O"&HZ5-I_B'0=8U2R^UZ1?M8:UIWZ>U_/\ ?\%>?CE_P59_
M9C_:0_8\^+'["OP6\;_M)?L_^*+W0_A-\??A)X)N_ WVB'Q'K/[0OP1UK3]2
MO;7Q5IFHZCHS^._A=8?$SX56/Q'M38>$OA='XGU+Q[XZUS1+3P_I U0 ^5Y/
MV9O^"_4W[8/PU_;)'[./_!'/1/'/PE^"7Q(^"7A'0?!GQ#_:'\(Z5?:3\5M=
M\ :[XFUGQMJFG^!)/$'C"XT=_A]:6/@/1+W4+;PSX1MO$?BR\32=1UW58M8L
MOZC_  W)X@E\.Z!+XL@TNU\52:+I4GB:VT.6XGT6V\0/8P-K,&CSW@6[FTN'
M43<QZ?+=*MQ):+"\X$I85^:?[)?[:7[<OQT^+L'@/X__ /!*GXL_L@_#Z7P[
MK>K2_&'QE^T7\"_B;HT&L:<ML=,\-GPQ\/;NX\0O=:X9IQ!?A%LK3[*_VEP9
M(E;]1J "BBOCRZ_;E^!J_M)^+?V3]%M/BYXU^,/P\N/A/!\2;7P!\$?BIXW\
M'?#1?C9;W5]\.KKXA?$/PWX5U#P3X0LM7TJQOM:NKS6];M(-'T6SN-5U9[.Q
MC,Q /L.OY O^#*G_ )19?'S_ +/_ /BG_P"LZ_LJU_7[7\@7_!E3_P HLOCY
M_P!G_P#Q3_\ 6=?V5: /Z_:*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "OQE_X+K? SXP_M"?L6^$_ _P:_9KUK]L'4])_:E_
M9R^(?C?]FBR^(FA?#'PW\9/A?\.?&X\7^-_!'Q"\2Z_JFDP)X/UFQTJ*V1+2
M:\O+#Q:_A3Q VC:[8:)?:/>_LU7\_P!_P53_ ."JW[1W_!-K]KK]EC1[7]G#
MXC_&O]DWX]V?@_P9XBUSX8_"#Q!\1?$NA_$RX^)M[:^+-&T&_P!!U_2&G\?:
MA\-9=+N_AYX"NK>_E\67]OK,UA:W)TN\2, _,S]G_P ._MJ?LM?MQWW[5/[-
M'_!N%XV_9I\!7'[..M_ O7_@_P#!']JW]EGPKH7Q:US7/'?@[QOI_P 1OB+H
M5CJ.F^#-/U+X>1>&M5\-^$(M"T&ZU_4+?Q9K&HZYXN^Q+8^&;7^R?3;BYN].
ML+N\LGTV\NK*UN+K3I)8YY+"YF@CDGLI)XOW4SVLK/ \L7[N1HRZ?*PK\T_V
M0/\ @J5\-_VROBK>?"7PG^RW^WM\&]4L_"&K^,G\6_M+_LI^,O@K\/)K31]0
MT;3I=&M?%_B"]GL9_$UY)K<-QINB)']IO;*RU2ZC(CL):_3F@ HHKE?'7CCP
MA\,O!/C'XD_$'Q'I/@_P%\/?"OB'QQXW\7:_>1:?H7A;PAX3TB\U[Q+XCUJ_
MF*PV.DZ)HUA>ZGJ-Y*PBMK.UFFD(5": .JK^0+_@]6_Y19? /_L__P"%G_K.
MO[55?U%_ W]I/X(_M*:'>>)?@=X]L?B#X>L8-&NI=:TS3-?LM-GM/$-I+J&B
M7NGW>M:3ID.JV.IV4$EW:7NEO>6LEOY<HF"30E_Y=/\ @]6_Y19? /\ [/\
M_A9_ZSK^U50!_7[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5^,O_!=;X&?&']H3]BWPGX'^#7[->M?M@ZGI/[4O[.7Q#\;_
M +-%E\1-"^&/AOXR?"_X<^-QXO\ &_@CXA>)=?U328$\'ZS8Z5%;(EI->7EA
MXM?PIX@;1M=L-$OM'O?V:K^?[_@JG_P56_:._P"";7[77[+&CVO[.'Q'^-?[
M)OQ[L_!_@SQ%KGPQ^$'B#XB^)=#^)EQ\3;VU\6:-H-_H.OZ0T_C[4/AK+I=W
M\// 5U;W\OBR_M]9FL+6Y.EWB1@'YF?L_P#AW]M3]EK]N.^_:I_9H_X-PO&W
M[-/@*X_9QUOX%Z_\'_@C^U;^RSX5T+XM:YKGCOP=XWT_XC?$70K'4=-\&:?J
M7P\B\-:KX;\(1:%H-UK^H6_BS6-1USQ=]B6Q\,VO]D^FW%S=Z=87=Y9/IMY=
M65K<76G22QSR6%S-!')/923Q?NIGM96>!Y8OW<C1ET^5A7YI_L@?\%2OAO\
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MQ!<:UH]W8_V3#H=_K,TWAW]#_P!AC3O!OQ>\?6_Q.\5PZ+=>,+GX0ZSX>OO
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M / Y_P#R1Z!_PFL7_0/D_P# A?\ XU1_PFL7_0/D_P# A?\ XU7G]%'LJ?\
M+^,O\P_L_"?\^W_X'/\ ^2/0/^$UB_Z!\G_@0O\ \:H_X36+_H'R?^!"_P#Q
MJO/Z*/94_P"7\9?YA_9^$_Y]O_P.?_R1Z!_PFL7_ $#Y/_ A?_C5'_":Q?\
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M_@7PGK&H7<GAR2U\.>+=8N;+Q9X>U0^&]?\ '.HZ-J-]K]]HEOHVO_9]8O\
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M  6 ^&O_  4^O_&G[,7Q*_81_:H^+_PI^$<OQ!\+?"3]IWX8_!?X(?##XO\
MC[1_"'C77KN"+]HWPOIWCK0=7OO$$/P[FN[&U\=^"[&:REG\)H->TB0WFF7\
M%T ?JC^S9^R_\&?V2? 6M?#3X&>'+WPOX/\ $'Q&^(7Q7U33K[Q!KGB2:?QQ
M\4?$MYXM\::HM_X@O]1O88=3UZ_NKR'3H9TT_3DD%KI]M;6J1PK]!5^8W[('
M[&W[;GP$^*MYXW_:&_X*D?%;]LGP'<>$-7T"W^$WC7]GKX'_  NTBR\0W^H:
M-=:?XRC\2?#JTM]>EO='M-/U+3H=+E=M-NHM;GGN$,]I:LOZ<T %%%% !7\@
M7_!ZM_RBR^ ?_9__ ,+/_6=?VJJ_K]K^0+_@]6_Y19? /_L__P"%G_K.O[55
M ']?M%%% !1110 4444 %%%% !7E7BK_ )#,_P#URM__ $4M>JUY5XJ_Y#,_
M_7*W_P#12UM0^-_X7^:/1RS_ 'F7_7J7_I4#G****ZCWPHHHH **** "BBB@
M"_I7_(4TW_K_ +/_ -*(Z]IKQ;2O^0IIO_7_ &?_ *41U[37-7WCZ/\ ,\3-
M?XE+_!+_ -*"BBBL#R@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBOPL_X+ ?#7_@I]?^-/V8OB5^PC^U1\7_ (4_".7X
M@^%OA)^T[\,?@O\ !#X8?%_Q]H_A#QKKUW!%^T;X7T[QUH.KWWB"'X=S7=C:
M^._!=C-92S^$T&O:1(;S3+^"Z /U1_9L_9?^#/[)/@+6OAI\#/#E[X7\'^(/
MB-\0OBOJFG7WB#7/$DT_CCXH^);SQ;XTU1;_ ,07^HWL,.IZ]?W5Y#IT,Z:?
MIR2"UT^VMK5(X5^@J_,;]D#]C;]MSX"?%6\\;_M#?\%2/BM^V3X#N/"&KZ!;
M_";QK^SU\#_A=I%EXAO]0T:ZT_QE'XD^'5I;Z]+>Z/::?J6G0Z7*[:;=1:W/
M/<(9[2U9?TYH **** "OYX_^#BZ62+X._P#!.IHV*,?^"HWPCB)'4QS?LP?M
M?0RK]'BD=&_V6-?T.5^!G_!P%X<N?$OPH_8#@@L7O8M)_P""BWA7Q'>/B[6W
ML(M!_8Z_;1U"VOKR>TCD:WACU.+3X86GVVMQ?7%G83MMNPK?8^'=&IB/$#@:
MA25ZE7C#AJG#?24LYP23?*FTHWO)I-I)NVA\YQ@X1X2XH=24(0_U>SI2E-I0
M2>6XE7DWHEKJ?.'[9WQM^%'[*_AGX5> - _94^&'B/QA\1/V?O GC2V^(/BB
M[UQEBU'7]+^R:GK;:/I-]9/>31W]G?+;P-J>GO\ VBK7LQ-G%#:W_P!>?\$M
M/VY-&_:T\%:K^R5\7/ /AI-8\$?"NUL[&.VM[B^\*_$/X;Z3'IG@_5K+7-'U
MF34%M=;LTU+1_M\*WMU9:]!J-[=6=AI,6ES02_S->/\ QSXQ^*VC:!XC\<^)
M;W6M4T&UU;PYHYU.[O+L6WAW1!X>GLM%T\74]Q]CM+277K^:UMH#':QCS8XX
MU8DC^C#_ ((K_L;CX;P>,?VD?%>OVE[XPUK21\.M%\)Z?#<A/"NA:U:>$?B!
M-JFM7-Y! UQJWBC0[SP9JNB0V42P:?X=OVEGNKRYUJ2TTC^XO&?A;ASASPEQ
MKXBQN.QW$5+$T<;DV:?VCGF*Q%3B%XA1HU\+3QN.QL,!0^J594\93A[#!0BW
M*A"GBG@TN;@S(\ERK+(RAEV7X'/H+'8''2PE'#4ZC^HX]4*M&G7PV#P,<7A*
M$X4(TZTZ$JGO1]M5GB)59R_5;X+_ +&?[//P#^&WC+X5?#SP'9VWA7X@7FKW
M7C$ZRR:[JWB"+4Y;O[%INI:GJ$,LUUI?AJRN_P"S/#5C,'CTVWB-XYN=:OM6
MU74=S]F;Q,TO[-/PMU/Q7J5M;WWA#P%;>%/&^L:A<1V=G;^(/A?'<>"?&^HW
MUS=2+'8V\.N^%]8N;IKN5191K(+J13%(P^B:_"?]O[POXR;]C_\ ;$\+^&?B
M/J?@72?@W^T9J'C'Q#X=L[*>>T^)/@GXUCP5\3VT&\NM.@EU73;(>//BWK5Q
M#*C/HES?^'K^W\16T-@T>LZ-_&O#6'QGB%FLLISG/*ZQV=<2</U\3G.8O%9C
M6IQQ=:MD=:KRKVE:M7KXK,LGPM.%X4WR8>-:K0PU#VE+[*"=67+*3O*<&Y.[
MLF^1OUO**Z=+M)'FGAG]FC]D[_@I#^UO^T3\1HM9U3Q#X7==2D_M[P/J]SH,
M27L'AWX1>#/!&HG3[S349+@WOA7XJ:S-]NL$3Q =4L[ZX6\MX+>XGT_V9_\
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M5?$GC#PW8^((A/+96&K'PI_PMS2-<OA=-#>1^$O"8M+O4=,?2[B/\BOVC_\
M@EQ\5?VL/B#XR^/?P9U_P?;S>*?C'^T1X=\9Z5XSU;4]-,>H_#SXY>.O NDZ
MGH]Q:Z;JL4UK>:7H*:?=V)CM#97>CF[62[_M62.P^</VJ?A9\<OV9_V,_"W[
M/NAZ'#%X)\-_$G6-;_:AUS2[J\U+5%^,>J2Q0^"+QHY[9?[)^%&O?#NW\*S>
M!_$6ES16OB;6!KNF>)K+0O$^E7&AIZ3X)\.>+\OX2RG).):=/C3$T*'"G$M+
M%XA-87 X7!XV@WBL!4G1]_*LWPN64\C]E4OCZU#*L#*4*>*CB*#]G2FJ<8S_
M 'CM"=WLDFM5M[LN7E_F:4>NG]-G@'_BY/QM\?\ Q1D_?>&OAG!J/P,^&[GY
MH+G6(K_3]6^-WB:T<9CFCG\5:7X9^&HW!;C3M5^%GBF-";;5FW^>?'/]_P"&
M]!TD<MK?Q:^$%B5_OVUK\4?"VMZG&1W$FDZ3?H>H ;)! -?//_!'W5/VA+_]
ME/2;?XS>&['2/!UE=E_@OK%R9;7Q?XG\*:E=:CJ>JZGXATLVR)_9[ZM="X\.
M^(+FX.J^)(;N_O+NU^Q1:7JNL?0WQ5_TGQ9\$M)^\M]\6[B\N$ZXMO#_ ,-?
MB/KT<K#KM35=/TJ/(Z2319X-?@N999+(?$+&9/\ 6L'BZ/"5>I3PU? 5X8C"
MU,/P[@ZV8*HI4VX0Q.(GAJF)S&A&WLLSKXVE.*J*:.;$+_8<QP]TUB5A<N33
MT_X4,1' 7\G?$7;^S*[OI<C\2_)\</A/(/O/X%^,-J0>@CEU'X57+,.AWB2R
MB ))78T@*EBK)T/Q1\"I\1O VM^%DOVT?59UL]4\,>((HQ+<>&/&/A^^MM=\
M'^)[:-N)9_#_ (DT[3-5%NQ\J[2U>SG#V]Q*C>,?M ?%/PE\&/&/P\^(7C6Z
MEM]%TKP?\5K>."TC6?4=5U2\G^'?]G:/IELSQB>^OG@D$9DDAM;>..6ZO;BV
MM(9IT^C?#>NV7BGP[H/B;3=YT[Q%HNEZ[IYD"B0V6KV,&H6OF!&= _D7$>\*
M[*&SM9A@GS,=A<TP.4\'Y_2PU>C@UA<30P>82I?[//,,%Q!G&*J4*<YIPJ5*
M$*U"I4A:24:D5)6E8[<MQV$><9_E\,31ECZ.,PF,J8533K4\-6RG*Z5&O.FM
M8TZE2C4A"3MS.$K;'*_"KQT_Q$\#:1XCO+!='U]&OM#\8^'Q(93X;\;^&[ZX
MT+Q?H'F.!)/!IGB"POX+"]9575-,%EJMN&M;Z!W]$KY[C_XMC\<I(3^Y\&?M
M 9N("?EM]*^-'A/056ZMP2=L?_"Q/ASH<=Y!$BI!%JGPTU6XD:34?$Z^;]"5
MXN:X>E2Q$*^%AR8+,*,<=@X)RDJ5.K*<*V%4IMSE]1Q=/$8'VDU&5;ZNJZ7)
M5@W[\E9W6SU7ZKY.ZOUM?J%%%9^JZMI>A:;?:SK>I6.CZ1IEM+>ZCJFIW<%A
MI]A:0*7FNKR\NI(K>VMXD!:2::1(T499@*\Z$)U)PITX2J5*DHPA"$7*<YR:
MC&$(Q3E*4I-*,4FVVDDVS.4HPC*<Y1A"$7*<Y-1C&,4W*4I-I1C%)MMM))-M
MV-"BFHZ2*KHRNCJKHZ,&5T8 JRL"0RL""K D$$$'%.J=MRM]CK_!G_(1N?\
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M66XB,^6"Q%6I7Q4H>UK5)2],HHHK\</N0HHHH **** .6\7_ /()7_K[A_\
M0):\PKT_Q?\ \@E?^ON'_P! EKS"NNC\"]6?099_NW_<2?Y1"BBBM3T HHHH
M **** "BBB@#TWP=_P @J7_K]F_]$V]=77*>#O\ D%2_]?LW_HFWKJZXJGQR
M]3YC&?[U6_QO\D%%%%0<P4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7\TO_!;KXY^)OAO^T1^S[X/_ &B?VM_VT_V!_P#@
MFGKWP+^*?B'XB?M,?L.^%_%3^.KW]IO2_''@>P\#?#;XA?%3P'\)?B]XP^%?
MA-_AW?>)_$&@-I>CZ?#XPUA-3L[L:BFC"]\.?TM5^$__  6%\4_\%6?ACXS_
M &7_ !Q^PC\8['P5\!/&?Q&\(_!']HS3]'_9>T+]I#Q]\*KGQ]K]W9:!^T0W
MAN^O++6?$/PN\/3W6EZ)\2]+T"]L]6\'Z4L7C&RL/$MM)JUKI0!\@_\ !&+X
M_7'C[]L7Q7X!_8T_;>_;L_X*+_\ !.&']FO7/%7CCX[?MSZ#XSUK5/A]^U!#
M\3_#NE^$? _PS^-?Q)^$OP>\:^,(=?\ !%QXYN_$?@R3P_JFB^'ET*QN[;6$
MF1;,?U+5^8W[('P!_P""H7PR^*MYXB_;%_X*"_"G]J#X3R^$-7TRS^''@K]D
M3PM\#-7M?&-SJ&C3:/XHD\9Z/XR\07=Q9:9IUKK5C-H1LDAOI=5@NGN8VT](
MY?TYH **** "OY O^#U;_E%E\ _^S_\ X6?^LZ_M55_7[7\@7_!ZM_RBR^ ?
M_9__ ,+/_6=?VJJ /Z_:*** "BBB@ HHHH **** "O*O%7_(9G_ZY6__ **6
MO5:\J\5?\AF?_KE;_P#HI:VH?&_\+_-'HY9_O,O^O4O_ $J!SE%%%=1[X444
M4 %%%% !1110!?TK_D*:;_U_V?\ Z41U[37BVE?\A33?^O\ L_\ THCKVFN:
MOO'T?YGB9K_$I?X)?^E!1116!Y04444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7\TO\ P6Z^.?B;X;_M$?L^^#_VB?VM_P!M
M/]@?_@FGKWP+^*?B'XB?M,?L.^%_%3^.KW]IO2_''@>P\#?#;XA?%3P'\)?B
M]XP^%?A-_AW?>)_$&@-I>CZ?#XPUA-3L[L:BFC"]\.?TM5^$_P#P6%\4_P#!
M5GX8^,_V7_''["/QCL?!7P$\9_$;PC\$?VC-/T?]E[0OVD/'WPJN?'VOW=EH
M'[1#>&[Z\LM9\0_"[P]/=:7HGQ+TO0+VSU;P?I2Q>,;*P\2VTFK6NE 'R#_P
M1B^/UQX^_;%\5^ ?V-/VWOV[/^"B_P#P3AA_9KUSQ5XX^.W[<^@^,]:U3X??
MM00_$_P[I?A'P/\ #/XU_$GX2_![QKXPAU_P1<>.;OQ'X,D\/ZIHOAY="L;N
MVUA)D6S']2U?F-^R!\ ?^"H7PR^*MYXB_;%_X*"_"G]J#X3R^$-7TRS^''@K
M]D3PM\#-7M?&-SJ&C3:/XHD\9Z/XR\07=Q9:9IUKK5C-H1LDAOI=5@NGN8VT
M](Y?TYH **** "OPQ_X+2P>$_ /AGX*?%OQ-X\TOPA:^*/B#'\&H[#Q-KMQ8
M:'K'B.?P?XZ^(WA^6RBOKI- L-3T_P ->"OB,9;QXH+W4$N+6Q$\BI$D7[G5
M_(]_P>8:!J7BO_@FM^S%X6T:RO=2U?Q)_P %&_@MH&E:=IMK-?:C?ZEK'P$_
M:BTZQLK"RMHY;B\O;JZN8H+6UMXI)KB>2.**-W=5/VGA[QAF? G%^3\2Y5AX
M8W$X*NZ<L!4<HT\PP^*A+#UL'*485'"56-2]"JJ=1T,3&C7C3G*DHOYCC+AO
M \6<.9EDF85GAJ&(IQJQQ<8QG+!UL-.->EB5"<H1G"$J=JU.4X1K4)5:,IQC
M4;7R+H7[.'C_ .*'C?PMX*O;K3(WM-"^)'B*;4?[#FTBPOK?PY\.)_B.=-TZ
MP6TLI;S4M5TC2(;.P<1(C76HZ;<R2_8)H;A_Z.?@S^U]^S5\/OB%XD0?$:UT
M[P5XO^&/POEN)9/#OB&)++XG?#6UU+X;>(6EL].TJ]58/$W@+2_AK+H<ML;B
M!;+PO=QW-U%,;>SA_%/XV_%WP1J>F:3K.N27.CGPAI_@CPUH5HZW-X=:O8?@
MU\./AEXIO[R32;Z.TDBMKOX1Z5KNA[TOG+:K.98FA^U;?"-+\;^'M:TK4M:T
MJ\-YIVE1W3WLBPS12Q?983<N3;3QQ3[)8/G@D"%9"LD?RR1N@_TPXI\-,/XK
M82C3XPQ>;9/"A@_84LLRN6"A4H2Q<\!CL55JYAB<-C(8YRG@<K]G['#X>EA:
MN%Q5"4L1[6M&G_-7_$4^+^'\ERBOPID.$S?)(T<1E^,S:KE6-I9.\WQ&?9EB
M%A\'A\ \OPV75IRQ=."H+$5EB8U,+[.E22IJI_3-XI_X*C?LX^&M8GTR#1?B
MIXFL5"2:?XD\/^&?#Z:#K=LPVO=Z2WB'Q?H&K26\-TEQ8S-=Z19NMY:7,81D
MC61_Q9_X*3_MZ'QE=^(_#WP*O_$OA+PQ\?? OP_@^)UGJC:-8>)G@\ ZK\4]
M'N]*O8-"UOQ##;Z/X]T?Q-X=@U2UGO;+4+O3/!5E!-;'1-;G74?SB\/?M#ZE
MJ\QLO&5QLT70M#U&+PM ;G4;MM/A.K:GX@DT.T^UW-Q#%%>ZEK.J7<$=O%96
MPO;B4^4&N211\6Z/X&-UK_Q+U>#4M:TC59XHM&TJ?4[F!-3OY\&5].N8Q#J%
MMHNGQ1M:Z:EU/=.+6UER]S&ME+<>/PI]'KP^X4QV"S3+\+C<5C<*VJTLRQ[Q
MV&Q$<+B*6(P=>MAI4,-3ABEBL-@LQ;HT/8T<5AW2IQ=)P<OTO)N,./\ (.*\
M1@^/\!5G@<3A<+3R' 9'D^'G+-L\Q\\&X9;@\PGCY8.^"=3$QMBLPIRG1HSQ
MN(JT\/A<7.GP?P%^.7C']G/XG^&_BY\/[/PU<^+_  K-=2Z2WBG1EUW3(S>V
MLEC=![![BW59)+*>YMX[RWDM[^S^T/<6%W:W<<%Q#_8O\+_^"EG[/?B3X4>$
M?&'Q'\1CP%X^U#0[6?Q=\/8-%\3:Y=Z+KZ2M9ZA::?>Z;I%Y87^FSW$3:AI5
MQ]O,ITBXM6OA!>K<6\7\@/PO\/?#WQM876AZCI-S:^([2*2Y_M&+4[T27EJ]
MY(PDMK<R&QB>RBDMK26.2VE,J,+E27,AB^J_#8T2RGT_P_=ZG?S6>D-I%EJL
M]M!;:MK5EIEPRPK=?8I+W1X+Z\BLT>>."XU#3Q=>4IGNX1*9Z]WQ$\%N#?$U
MX+'<0+,<+C<NC:&8Y)5HT\PQ&"BJLY9;76(P6.A6H*I.5:C"G0]O2K.?L*D5
M6K0J\GBEXU9CP]FDLBX>R1T<YR_$U*6:0XDP$EA:F Q#PT,LS?+L=E^<QPL<
MNKUJZA*>8.E4C.M1IUJ>%JTZ]*7]//["OQM\#?$'P'?^$-!NKVX\367BCXN?
M$77H5TZ_DT^QM/B/\<?B'XIT]+S6%MAIMMJUZNLF[ATBYN(=3N+$G48;5[99
MW@]9^/WP]MKR$_$JS\(67CHZ7H-QX9^*/PXO-(M=<M/BW\'IKA]0UCPU+HEW
M#-:ZUXH\(W3W'BWX>074%PT^H'Q#X/M380^/M1U&V_CF\0?%_P"+/@#Q%I&H
M_!_Q%XK\#>,-+U46\&J>%M133]6N+/5K8VUN9&M8C>R:=J-S:ZC:M;W-S'82
M6T*'4+&1=0MBG] ?[(W_  5K\ :YI_PZ^#O[4]YJW@[XY:@(-$OO'[Z'IL'P
MN\77MW?W%GX>U(ZKH]\[:#J.K0"RAUIY] TWPM9:Q)/-'?Z=8/)::;_+'BUX
M"\0\'YWBN,^"*.,S_)<3BZV)S'*J<:]7-L"L3&OB<=S+#PC/$9>^6?L\3AI0
MQV!K3HRIP=2C#&K[SPWXIS#B'A[*L1Q#B,HI<19A3Q>)AEV"Q5)8K$Y?AYTD
ML=+!1G*='FC6ISG&E*I&-.K0K)TW4E1H_LAX9U;P_KWAS0=;\)W>GW_A?5M'
MTW4?#M[I)B.EW6AWEG#/I<^G>2JQ"RDLGA:V6-41(2BA% VCY&\8?Z7\;/A-
MI_7[#X?^+/BO'7!TU?!/A<,1V./&K*&ZX+*."<>AZ+_Q9#XCIX0D_<_";XN:
MYJ5_X&E/RVG@+XJ:BUUK/B'P(S?<M?#WQ%?^TO%O@T.$MM/\7P^+/#?VE%\1
M>!M$C\\F_P!,_:$?^+_A'/A%-_VR_P"$T\;KT]/M'_" G..OV89Z"OYORW"1
MP>-Q^+I3G6R^ID.;XG"XB=E.I0QV Q>5TX5[*T<5A\;BXX7%17N?6*<W1E4H
M5*-6I^B-7ITZ*U=?,\G</-8;'0QU33NJ.%J7MM9O5(_.#]L+Q5K'Q2\4W!NO
M"7AC4/A7\#O'FIZ#K%KJ6J7VG>+?&6HZ)X<T;X@^.=,T^[BA>'P_977AS1KG
M3-*NH-U_J CO98+D-.EM;?JIX(T_0-)\&>$],\*6<VG^%]/\-Z)9^'+">6\F
MFL="M]-MHM)LY9=0N+J^=[:P6"%C=W,]QE,2RR."Q^,/VN/A+\)]%BLOCQKW
M@G4?$4VE>+?#E]XW\-:7J-]!IOCNWL]-U71M$&KZ(ERFFWNJ6U[?:?80:@\!
MGFTV6YTR]6^L;A[5O8/V3OC+K?QT^$D/CCQ%I]EIFK_\)-XCTF>RTV":WL8+
M6VO%N])AMDG>21TMM'O]/M6N&=C<R0/.VUY&1?TWB^4,Y\+N#\?D.%Q>'X?X
M;Q53*\RA5K>RH4\\S&A"M64<-]?Q?U[$2Q&&QF,JYD\/@N2AF>$HQI\M26%P
M'RW#<999Q]Q)A,WQ&&K9SG>'CF&!G3I^TK3RG!572IWK_4\.\)1C1KX7#4\#
M[?%\U7 8BK*;=-8C&>I_%7P*_P 1/ VK^'+._71]?1K'7/!WB QF4^&_&_AN
M^M]=\(:_Y:$23P:9X@L+">_LE95U33!>Z5<%K6^G1Y/A=XZ3XC>!M$\4O8-H
M^JSK>:7XG\/RR"6X\,>,?#]]<Z%XP\,7,B\2S^'_ !)IVIZ4;A1Y5VEJEY 7
MM[B)V^?_ (W_ +:_PJ^ ?C4> _%^A^.]5U@Z/8:V9_"UAX7U&PBMM0DNHX()
MVU#Q=I-[;WJ_96EDMY[&,_9YK:XC:2&XC=O$OA%^UMX%\0?%KQ#<_#WPKX\N
M]!^,L\1L_"M[:>%[+5%^-/AO0HA>R6JP>++W3-+TKQU\/=+AOIK[6+[1]/@U
M/X::[>1/J&J:[<)7S6%\/^,L5PI+,JO#^.AE*IQSG*<UJ>QIX.I1KQIT\=!U
MIU80IT:^%ITL=[?$2C3H1RVI!*,L5.1]E#C'ABIF=?(X9SA)YOAY5XU,O@ZD
M\5&IAX.=>DJ<:;<ZD80;4(.4YRBH4XRG)1?Z6U^6O[:OQ%\+_%ZQTSX5>&?$
MWC73_#^@?$C0-&^*7Q#TG0+C4?@UX<6^*0FS\8^(K)&:]UG0M1N-+FL](AN[
M72(;ZXG_ +6O$U'3[7[#]T_\(/XH\;_O_BAJT5OHTGS)\-O!]]?0: T9Y$/B
MWQ-Y>G:YXS)&5N-.A@\.>%;F&22RU/P_K<:K=R?D[\?/B3I_P<\<_%W]G6.3
M5]!^#_C3Q?9^,O$^CV/@K1GUVU@\06VAZUJ^E^ =83Q/::3!X<UW[.D-O+?:
M,;G0#&]A:VBO:W G^N\%^'\/B.+H5L%7EF?$&24:6:X>C@TG@<%1AC,-@\PQ
ME*O/!XY9IF>6T,7*M@L+#!PRRMBHT9QS/$QY*53X?Q/SBM1X;E3Q5)8#)LUJ
M3R^M5Q+MBL34GAJV)P>%JTHXG"?4,#CJN'5+%8AXF>/I8>56$L#1?/4A^TGA
M32;O0/"WAK0M0OUU6_T70-&TF]U18&MEU*[TW3K:SN;];9IKAK=;R:%[@0-/
M.T0D$9FD*[VWZ\D^"'Q4TGXS?#O2/'V@Z!K?AW0]1GO[+2;7718K=7-KI-R^
MG->P?8+V^C-FUS;W%K&9I(Y_-M9M\(01R2>MU^,9OA,=@<TS'!YG1>'S'#8W
M$T<?0:HQ='%TZTXXBE*.'E*C"5.JIPE3I2<*<DX1LHV7Z=EV(PF*R_!8G 5/
M;8*OA:%7"54ZC57#3I1E0J*591JSC.FXRC.HE*::D]7<Z_P9_P A&Y_Z\G_]
M'P5Z37FW@S_D(W/_ %Y/_P"CX*])KPZWQOT1Y>9?[T_\$/R84445D< 4444
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M6MC<3+=26<4@>,W(B\EGBG1'9H)A'TUK\2OA]?7/@VSLO&OAB\N?B)H[^(/
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M^QN=474M3TVRN_IJOPT_X*#?!W]JSX1?M\?LP_\ !3C]F']G6;]LJQ^%_P
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M?#+Z)-H.BZY/>^(-&N=3G\<V>FZM'I?ABZTKP7KC^(=:MK* 6.I?OS7\OO\
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MT,4W/"X+,*2A"3J86M/ 8B2M\%+"8OZQAIR3^U5S:A&2Z1:L_OVBOB2\T/\
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MSIU*<I0G"2E&3BTPHHHK V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *_FG_X+8>#OVD/!_P"UE^RA^U;\&_V0?C'^V/<> /V7_P!LWX(_ C3_
M (->$K/QO?\ [.?[:/QPM_AA8?!/XY^-=,N-7TF?PSX >VT;5=,\2?$F,76G
M^!K#1KC4]1FTV^.@O>?TL5_-A_P4=_X;I_X?-?L;_P##O7_ADS_A>W_#OO\
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MI_\ 9EYJMQH\W]I_:KC3Y;VRT^YM/EO]EK_@AQ_P2W_8K^*7@OXT_LS?LO\
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M*ZN3<.XK'U:N69=6G&4J%!\JE*,(KEPU.O54\12P49U88*G5CA(5JD*,9/\
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M&U?P?H?A6Z6X\*Z?IQU'QII1F\06MR+/3M5_(K_@E!_P<7_&7_@J7\>_AO\
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M*U2[M-7M[>=/LVE^,=#>2"U\4:/&24A6>6TUK2HI+C_A'-<T.>YGGD];\/\
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MF3>)O#MIX'\<^)/'/AWQ)IFI:6WAZ_\ &^D^';2SU6P\6:=8:[<Z;:I]O?\
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MV@:Q:Q7VD:YIM]I&J64PW0WFG:E:RV5]:RK_ !17%M/+#(.ZN17VG G'>?\
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M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\TO\
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MZWID,VL 'R#_ ,$8O@+<^ OVQ?%?CC]C7]B+]O#_ ()T?\$WW_9KUSPSXW^
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M5_,G_P $?=8_9!^.?[:7QG^,^L?\%>3_ ,%9/^"@?PP^$VK?!F77O^%7:/\
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M110 4444 %%%% !1110 5\9?'O\ ;J^#'[/_ .T/^R_^RKKFG_$+QO\ '?\
M:Q\0:S9?#[P/\,_!M]XNG\,^"O"B6TGC7XO_ !.O[>2"Q\$?"[PFUY96NH:]
M>RW%]=7ET[:9I-YIFC>*-4T#[-K\4_\ @H-^S5^UMX<_;*_9J_X*._L-:7\$
M?B;\9/AM\)/B3^RU\2/V=/CQXYU#X8V'QF^$WC[6],^)&E0?"?XBVMEJ>F^%
M_BEX;\5>%KV]\GQ%I5WH^M>';J[FEGM3H#V>L &K_P $TOB'^Q_\!OC3^U3_
M ,$O_@_<_M#>'/C/\'_B=\3?VF==\/?M+>&M,T/4_BAX1^.?CJ/Q+XD^+?P)
MUO0_#_AO2_&WP-T?Q]XI_P"$&TW5IM)M-8L=0AB@N9M>L;BQ\1:C^R]?@S^P
MO\"/VO?CW_P4)\?_ /!2O]MK2OV??@YXL^'W[-\G[%GP?_9A^ /Q8M?CA?\
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M1BY2G@L0XP55QC&4JE"<*6*I*$ISH>P]G7J]I1117E'HA1110 4444 %%%%
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M6\&D3ZI=":%C;>&]:AN;SPMXMF"*\IA\+:[J]Q#"C274%MM95^F*^&S' XS
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MS7]EM?QX?\&8'_*//XT_]E_O/_3)'7N93_N'$_\ V(\/_P"M+P\5':?^%?\
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M_#J6YBL-%^(1CBCA;6=*N)V2Q\-?$JWM8HX;377\G2?%EM!;^'_&K+'!X?\
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MR0'9/;3QQ7-K<QE+BTNHH;FVEBGBCD7V*&94ZU&G@LVIU,5AJ<53PV*IN/\
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M2_\ &5X@;SKW]H?QNLY+94BUL=+2+:O\.%D;=_>.#VKW,I_W#B?_ +$>'_\
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M17QE' PQ,I8;*Y>U>%PB@Z^.C*&)5:E%4:"59-QDI/\ H'HHHK\5/U(****
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MPC&*2<I2FW*3<F]V]PHHHKRB0KPN;_6R_P#71_\ T(U[I7A<W^ME_P"NC_\
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M7-4M=&M[R34;C3M&U6^AMGMM.O)8?Q@P/[7:*_D"_P"(CO\ X*F_]*Q_[?\
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M87NF0A8H#&+;PWXKU/Q+X5MEC)XCM]#BBE7;'<)-$B1KIZYX,^/&A:-J=QX
M^,=OXLUJVL;F71])^+?@CPQ=V6H7J1,]O97FL_#NW^',]E'+(%ACOOL%XT"L
M'N8;Q@TA_EWLO^#B#_@J1H,)LH?^#9[]OS4E>1K@SI=_M$P!6=50Q;!^P1<
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MA5   K\!?^(H[_@A1_T?-_YK-^V'_P#0^T?\11W_  0H_P"CYO\ S6;]L/\
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M4)UJC>#J3CA,7-4Z<IU*M#$X-R;Y*& DTD_Z<Z*_DR^%W[<6O_LP>,Y?C?\
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MOOA-\4O GQR^%?PT^-?PMUW_ (2CX9?&#P!X.^*/PZ\3?V9K.B?\)%X%\?\
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M0H_Z/F_\UF_;#_\ H?: /W^KPN;_ %LO_71__0C7XZ_\11W_  0H_P"CYO\
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M /H?:/\ B*._X(4?]'S?^:S?MA__ $/M9' ?O]17X _\11W_  0H_P"CYO\
MS6;]L/\ ^A]H_P"(H[_@A1_T?-_YK-^V'_\ 0^T ?O\ 45^ /_$4=_P0H_Z/
MF_\ -9OVP_\ Z'VC_B*._P""%'_1\W_FLW[8?_T/M '[_45^ /\ Q%'?\$*/
M^CYO_-9OVP__ *'VC_B*._X(4?\ 1\W_ )K-^V'_ /0^T ?O]17X _\ $4=_
MP0H_Z/F_\UF_;#_^A]H_XBCO^"%'_1\W_FLW[8?_ -#[0!^_U%?@#_Q%'?\
M!"C_ */F_P#-9OVP_P#Z'VC_ (BCO^"%'_1\W_FLW[8?_P!#[0!^_P!17X _
M\11W_!"C_H^;_P UF_;#_P#H?:/^(H[_ ((4?]'S?^:S?MA__0^T ?O]17X
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MH*36]S;RO%(C#E6R"& (_$O_ ((5_P#!-3]HO_@GC\!/B7HO[:7C7X._&/\
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MV3OVM_BG^S'\:OVA/A3_ ,+ ^)G[''Q D^*7[-_B7_A.OB3X4_X5SX[E\1>
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M'P6\8>+]=U"YOOB+?6O@^[\2:'X2GCT;40#Z5/[%/Q3_ .'T _X*+_V_\/\
M_A20_P""8)_8J_X1;^U?$?\ PM/_ (6F?VJ_^%Y_V_\ V)_PBG_")?\ "O\
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M^/X_BA^TAXF_X3KXD^*_^%C>.H?$7C_Q9'KG]C>-O&/B3P_X0V^(/BAXZO\
M^S/ >D^%]'/]N?96T\V6F:/;:?\ 7]%?(?[='[4@_9 _9L\;?%O2/##?$3XH
MWEQH?PW_ &??A';3-%J?QH_:*^)NJV_@[X+?"K3?*=;A%\6>.=4TJ'7M2@##
MPYX2M_$/BJ\\O3="OIX@#Y^_X++_ +%7Q3_X*(_\$V?VD/V.O@KK_P /_"_Q
M-^, ^$(\,Z[\4=5\1:)X$L?^$ ^/'PO^*.L_V[J?A/PKXV\06WVGP_X)U6ST
MS^S_  QJ?G:Q<:?;W7V*REN=0M/IS]B#X)^*OV:OV+OV1/V<_'6H>']6\;_
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M-P&4BO-.X_*'X.?\$I/^%3?\%DOVKO\ @K9_POK^W_\ AI[]G_PY\"_^&?\
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M_A'_ /A(/[6_L3^WM$_M7[)]@_M?3?M'VR%/V3?@7_PR]^RQ^S3^S1_PE/\
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M^GW'V#1],U#4[KRK*RN9XOTK_:;\=_';X?>#]$UOX'>&O@AJ 37WD^)WC?\
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M(5KXVAL-*@\-P:%>7P!^SU%%% !7SW^T!\'/B%\6;3P-<_#']HOXF?LZ>*/
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M$=EXJLCJTV]_PYN^%7A/X:_LX^&_@A\=/C-\&OBO^SAX;_:7\,:1^T!IUO\
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M/#^F>&/'WB[3?$O@O3WT'7/[5\.^#I='&HPZWXCNM+_>VOQA_;:_X+!?#/\
M9"_X*7?\$WO^">&J'P^NK_MB^(-?N?BQXHUG2?B%J6H_#OPKXLTGQC\-?V7-
M&\)V'AOP[)H>H^(/C]^U'8V/@RY\37FOZIIWPQ\*^"/$T_CKPGI6D>/?#GQ&
M\( 'ZH?!+X9VGP6^#/PC^#FGZG<ZU8?";X8^ ?AG9:Q>1107>K6G@3PKI/A:
MVU.ZA@ AAN;^'2DNIXH0(HY962,! *].HHH **** /Q.^-O[)W[7G[7GQX_9
M?T+XR_"?]GGX-?!#]E']N+Q3^U2OQ7^$?Q4\0^(/%7QC\ :)\-_B'X'^&G@B
M+P->_#/PIJ_@OQG\1;KXE3S_ ![AO/%=]X:TK3O#,9\*>*O&][J%HFG> _\
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MX8\1ZEHWA_4?$NF>"+#7]/\ #<OB6]T32G\0:GI^H:O;:;I]A>6EE;_H-10
M4444 ?C+\'_V-_VG/A%^WG_P6U_:JT3P]\'?$6E?MK>$OV(E_9=T+Q_XIU6/
MPQXE\4_LZ?LT^+/AMXLT7XQP:#X<US6O!OA6_P#&NJ:=IYU/2](\5W\F@W%W
MJ]KH=_+:KI5U\3?M.?\ !*O]K_\ ;E\;?&_]J+X@^%O@A^SU\:8?@;^P[\//
M@5\#]!^*FM^./A]XF\??LF_M'7G[3OC'Q#\2_'FB_#CP[)H^@^+KW4[_ ."O
MPOU6U\+>)=<T#P?<-XP\2^&;"ZM;/PA7].=% 'YN?L"?LT_%SX3>/?VW_P!H
M?XZ:7X9\&_$/]M']I"P^*\/PM\(^*G\=:9\-? ?@'X4^!/@UX#TK5_&+:#X=
M@USQGX@TOP/<>,/%2Z38/H&BSZ]9^'=+OM6_LBYUC4?TCHHH *_FS_9Q_8._
M;-\5?\%.?C!^WQ_P4%^#>C?%[6KSQ'XH^$O['5GX<^.?A]/AO^Q]^RYXB@U3
MPWJ&IZ3X%EB&K:K\7_%WA#5KJS\<:KH\\1EGO_$UUI=Y++XF@M_#G])E% '\
MHOPZ_P""&7[0WBOX1? C]D;XWZ[\.?"7P@_8O_8\_P""F'[*GPG^,G@WQ=JG
MBKQ)\;K[]O&:S\-> OB#K7P[N?"WAT_#Z#X5?#W2[+5_&7A^X\3ZPVL?$=FT
MK0KO5/!L;ZG=?H5_P3S_ &(?VE?AI^T9HO[2O[3FC?#?P%X@^%W_  3B_9F_
MX)R^$?"'PR^(&H_$C2_&\7P2\7>+_'GCKXTW>JZGX+\&W/A[1O%.OZ[I6G^
M_"L]O<Z[::+::G<>*5L[^2T@K]L** "BBB@#^;O]K#]AW]MW]J7_ (*I^#/V
MBOCS\)=)^.'[!?[(T'AGQ+^QS^S5X?\ CCX;\"Z?XA_:#L(M&U2]_:#^..E:
MU;O;ZQJ/AS6SKNG^#O#!%_;2:19^%S=2Z19-X]T#X@?4?[7'[+?[8/[7OQ#^
M%OPCUSX8_L[?#'X&_"K_ (*"_ ;]L6T_:)\)>/-8U;QYKGPW^ FJ67C+3/#:
M?#"\\!:7?Z'^T9XM\2:79^"=5\:Q>,;WP/H_P]O-0UFWU#6-1@B\$:C^T-%
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M$U"WU35/@CJGA3P+_P )%<:IX0TBU\76&M?$&;1]2\_2?"-AJ7],M% 'PO\
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MFEPZ%\']>^*_@/2/BEK4VN*SZ+%I/P_U#7K?Q9J,FKHK-I:6>D3-J"JS6@F
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MFTVQU>_UZ1M#TCQWX=U.3Q!_94OAS4CJ!@TO5]1O+6^MK?YQ_9_^#/[6Z/\
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MDE^*7A^QL[Z]3QGI.F^*-'U?P5KNKWUUI>F^'=:6\L+234+O4=%N[73OK_\
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M3/V1/"'BO]GO]ECXV?'+X6>/KWP;^TGJ6H?M&:YX9^ 'BN[T#QW\0/!/P/\
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MT#P\WB7581I&IVL\>=:^'_C]^T!HNB>,-:\7_'[]A2XTOQ#X@@L_A;X2U?\
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M* "BBB@ K_)%_P""UVJ?\%$OVL/^"R7B?X\^ /V7?V__ (<^(/%_Q D\._\
M!/71K_X1_M1>&_BGKW@3]DC0M%N8/B+^S1X9\5?#7X?_ !-\+^;>Z9>_M3Z]
MX1\%>%-/UCX,^(_BCJVJ>(YV\0'4_%FK_P"MU7X _P#!0_\ Y3K_ /!NK_WE
MR_\ 6//!- 'ZO_L4_&3XA?M!_LC_ +.7QF^+_@'Q!\*_C)X_^#_@?6?C/\-?
M$WPO^)GP:U'P'\94T2UL/BSX3MOAS\8;*S^(F@^']"^(EGXET[PG<ZZ^K0>(
MO"MOHWB?0/$WBWPWK.D>*-7^GZ** "OR@_X+<?&3]I7X,?\ !-']I*^_8W\
M_&#XB_M1_$7P_IOP;^#FC_ WX7_&_P")GQ"T34?B9JUKX>\;^/M E^ UE+XI
M^''B#X<?"F7Q_P".O GQ0UO5- \*^&OB9H'@BSN;W6-<UC0/!WB?]7Z* /\
M,$_X-/=4_:__ &4?^"COBW3?$7[+O[7]S^SE\7/^$U_8Z_:'\3:)\(_V@+GX
M6? +]H[P3JFA>+/!=Y\=-&\*?#7Q1X?TSX@?#_Q!%/\ "35[?XBR>";KX(>'
M/C_XI\>^+O$_A3P9;>*;;7/]/NOP!_X(%_\ .:C_ +3_ '_!1O\ ]XW7[_4
M%%%% !1110 5^0NA?\%)/C?<?![X@?M5Z_\ LC^$S^RC\*?B7\<_!_Q&\3>
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M345,YY?RO9:6=]HMV[ZMJVFJUTO;]'5_X*$?LB-^TGX=_967XX?#1OB;XO\
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MS^5W][ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHKYT_:Y^+OB3X!_LS_&OXS>#['0]2\4?#?P%K
M'BG0[#Q+;7]YH-UJ&GHC0PZK:Z7J>C:C/9L6/FQV>J6,[#&RX2JC%SE&"WE)
M15]KR:2O\V#T3?8^BZ*^$1^WSX)E^,6H_"*T^"WQ^NX+'XO^(_V>K7XI#0_A
MG9?#'6_CSX?^&OB+XMP_"S1[S5OBKIWC2;4?$'@KPY-<Z-XTN_!%E\*8-;U+
M2O"?B+X@Z!XJGN='L_%/V2_^"@7C3XB_#P^+?VB/A]K'A'7O&'PO_:&_:8^'
M_ASPUX%\'Z%;:9\ O@1XA^'7AJ\TK5-7T_\ :<^-B>,O'>I:A\1+%=*UR6U^
M%-GK+Z7KZ:EX$\&6MAHFH>*]?J]7E<N5*RBTKIRDIJ35DF^D)-WM:VNK2<\T
M>_?7IHTOS:^\_5FBOS@\3?\ !0_PGJ'AS]HV7X<^ ?B2)?V?OV8H_P!H/QK\
M2-5T3X0^)/"?P\'BSX&W_P ;OAQI?B#X3R_M'_#?XR>.;O6] MW6T7PQ8Z#\
M-_$VO:-XG\$6OQP\.ZQX=\3:EX:[R?\ ;M\!6/Q-T_X>S_#?XPZGX4B^)7PW
M^!OBW]H72M"\"+\$O!OQQ^*WA7PUXE\#_#36X)OB;)\6I]3UR?QS\/\ PS-K
M_A+X9^,OAYX9\8^/-#\,>*?'FEW^F^+'\.S[&K_*[VO:ZO:T6NN[4X\L?B=U
M9:JYS1[Z:*]GU;7Z.[V1]QU^8'[5/[%/Q3^./_!2?_@E+^V+X3U_X?Z=\,OV
M%_\ AN?_ (6WH7B+5?$=IX[\1?\ #3?P%\._"WP%_P *ZTS3?"FK^']7_LCQ
M!I%S>>+O^$F\3^$?L&CO!<:-_;]ZTFGQ>P_L^_MV> _VA_'.A>"M&^%7QO\
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M\+2U_P"'^O\ _#67_!3_ /:Q_;6^'7_" :KXCU3^Q?A9\=_^$!_X1'0/&O\
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M7PIX3_;Z^'7C_P"(_P )OA=X#^&?Q8\4>)OBM#\4]5 CN?@MX;A\#^$?@_\
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MZ1XAN="T2XUS3;"]M[+5I]&TJ6_@N)-/M&AZ>BB[6SMNODU9KYK1^0!1110
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M +0)TCP)+\&-4^.WA_PWK?B+6OAK!%;?$*?XPVEUITGAGQ)X8F\::K\(M/\
MA?)XTT6Y\+6_CJ?5;K2H=0GV%6U^7HWNKV48S^]QFFH_%:[M9!S*]K];?.[7
MX-6?0^T*_,#]JG]BGXI_''_@I/\ \$I?VQ?">O\ P_T[X9?L+_\ #<__  MO
M0O$6J^([3QWXB_X:;^ OAWX6^ O^%=:9IOA35_#^K_V1X@TBYO/%W_"3>)_"
M/V#1W@N-&_M^]:33XO9/V5OVZ/ G[5]SHMOX?^%7QN^%4?C3X+^"_P!H/X87
M?QCT'P+HT/Q4^$GC2ZETY/%?A&#P5\1?'VH:?%H&I/I%KK.G^.[+P9J=[;>)
MO#>O^$K/Q/X7U1==CW_ WQA^,FH_MC?%_P"!/CG1_AGIWPZ\._!?X>?%;X:7
M'A2?Q3JOC6ZM?%/CWXC^"KZ?QSK>L?V/H<4][_PA$5[:^%] \*O'X=\R1)O&
M_BW[6O\ 9HZ-2+G&2Y7"/-)-J]FU'2U[N[LUT::=FF@YD[-.Z;LOZ_K[CZ\H
MHHK(H**** /S _X)C?L4_%/]B[_AX3_PM+7_ (?Z_P#\-9?\%/\ ]K']M;X=
M?\(!JOB/5/[%^%GQW_X0'_A$= \:_P#"1>%/"O\ 9WQ T[_A%=0_X2/2M"_X
M2/PY9^=9_P!F>*]8\R?[/^G]?EI#_P %)D\)>';H>,O@?\6/BIXW'C'_ (*%
M:D-&_9Z\-^#)[#0_@C^P_P#M;>._@'J'C'Q-=?%3XM^#+2'6AX2T_P #ZGJE
MCIVKW=]XN\4ZAJ]MX)\-Q7%WH_A1*MQ^W_XSA_:4^).GS?#W6+7]DOX:^#/V
M6;:U\;VO@OP5KGB7XE_$+]KCXF^'/ /PSUSP]XI_X:=T/6O"7@EX?'6@:G)X
M;\0?LY:EK+:5X/\ B)JNK^,/#>JR^ /!OB[=8>J[^ZE:^[7O-35.T5NVYM1C
MIKJ]DVIYXZ>=NFUU>[^6K/U5HKX4\:_M]?#KPKXTM/AMHOPS^+'Q!^(>I?M
M^*/V<M&\(^&[GX+>&;K7?&/@OX8>$_BWXDUC1M;^+OQE^&7A&^T2R\*>,M*-
MIHT?B(?$C7+NUUR3P]X U72=!U;5;7'D_;FMM(GUGPUI?PP^+/[0OQ.D^,7[
M1O@[P]\+O@CX&^'OA3Q=#X!_9WUO0])\<^-;^;XL_M":1X)U7P]X.U'QI\._
M"=WXD_X3GPSXI\=^*?'WAA?"_P '-*2ZU*PT9*A5=O=MS*ZNTKQU?-=NRBDG
M[TFEH[-\LK',N_ZZZ:>NJV/T#HK\X9?^"G7P3N=0\+S^%_AQ\=_&_P /=;\#
M_LW_ !*\1_&+P[X2\'6OP[^&G@?]JW78?#7P@USQS%XK^(/AGQ\T]YK,DUOX
MH\.>#/ OC'Q9X+MK#4=4\2Z#I^D64U^/0/VZOBU^T-\"/A%XC^,GP7U3X'66
MB_#?PGKOB'7O#GQ6\'?$/QMXE^+7C2;4?#^C_##X*_#F#P-XV\"Q^$/$/Q/\
M0ZE+X0TGQEJ"?$BZA\7:SX2TC3_A?KJZA>7-L*A4YX0DN1U'RQYN[M9.R;3?
M-&R:VE%[.X<T;-IW2WMV[^:WUVT?9GV]15:REN9[.TGO+7[#>36L$MU8^?'=
M?8[F2)'GM?M,0$5Q]GE+0^?&!'+L\Q %8"K-8E!7-)X+\'1^,9_B&GA/PTGC
M^Z\-6G@NZ\<IH6EKXQN?!UAJE[KECX3G\3"U&M3>&K+6M2U'6+30I+UM+MM4
MO[W4(;5+NZGFDZ6BB[6SWT?FNP!7-/X+\'2>,8/B&_A/PT_C^U\-7?@NU\<O
MH6EMXQMO!U_JEEKE]X3@\3&U.M0^&KW6M-T[6+O0H[U=+N=4L++4)K5[NU@F
MCZ6BB[6SMT^78 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^6-!_9$^&WA[XH:=\6;+6
M_'$OB/3/C+\5?CC!976I:"^B/XL^+WPXTOX7^)=/FMHO#4%^WAVQT#2;:\T.
MT34H]2MM8>>XO]7U.R:/3X_.M)_X)Y_ O3/AWJ_PNN=5^(FM^$]>_9,N/V-=
M4@U77="2^N/A9=:AXHU&76(K_2/"^DSV7CX3^+=1^SZ_8FVL+(VVG7%EHEO>
MVK74OW916OMJO\\MHK?;E;<;=K.3:\VQ<L>R^[O;_)?<?G/J?_!.NPUOP7\:
M/">M?M9?M1:[J7[12>']-^-OC7Q)IG[)/BK7?B#X2\-^!]8^'=EX%U#PUXG_
M &4]8^%6C>%[GPSJEO%J@\*_#G0==U+4]'M-;NM<?5]5\5WGB/J+_P#X)^?#
M*&.6^\"?$WXV_"KQI9_&'PQ\:_!_Q&\&>(/ ^K>+O ?B;PU^RY\.?V/I-(T:
M#XF?#OXA>#_$WA;Q)\&?AKIEIXETSXG^%/B!=WGB?6=:\3V6I:=J$7AP^'OO
M"BG[>K_/TM91BDU:,>5I*TH\L(QY6G%17+:S::Y8]OO;?G>[>]W>_?7<^"O^
M'=GP/'PX^(OPS7Q%\4%TKXK?LM?$']E3QQK;>(/#D_B76?#WQ7\0?$+QA\2/
MBA)?77A">R7XN^,?&GQ1\9^+M4U8::?!,6LZFJZ=X"L=+@33:]F_:D_9SC_:
ME^%]_P#"34OC!\5_A%X8UR=/^$IN?A)!\(GUCQ5I46)H] U.Z^+?PF^+%K8:
M8E_%::F+GPS8Z!KINK*"%M9;3I+RPNOH^BI]M4<HS<FY1DY1;2=I.UW9IJ_N
MK5K=)[CY4E9*RM;331&!X5T;4?#WAK0="U?Q7K_CO5-'TFQT[4/&GBJV\+6?
MB7Q3>6EO'#<:]KUKX(\->#?!UOJVJ2(UW?0^&/"?AS0X[B61=,T73K016L>_
M116?]=OR&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y7\
M;_A%X;^/GPD^('P9\87VN:;X7^)'AN^\+:Y?^&KFPL]>M=/U!56:;2KK5-,U
MG3H+Q0H\J2\TN^@4YWV[UZI133<6I)V<6FGV:=T_DPW/EB/]D3X;1Z[:^(5U
MOQP;VS_:GU#]KN*(ZEH/V5OB3J/PXU+X83Z)(@\-"4^!TT#5;B\BTU9UUY=8
M2&X?Q+)9*^GR>/>)O^"<WPTUGP!\*_ 'ASXP?'SX9P?"WX6_%KX'#Q/X!UWX
M9P>+/'?P<^.&H^&-6^)/P^\;7OBGX4^*M,2RU>_\'>';K2_$W@G1_!?C[PE<
MV#W7A#Q=H5W?ZC/=_H116BK54T^=Z:K1-:*4=FK/24EKW9/+%]%_5O\ )?<?
MGIX]_P""<OPZ^)TUA:^.OC)\<-?\)>&?V?/B'^SC\.?!#1? ?3--^&'@_P"*
M_P &=)^"'Q"UKPIXLT7X%:;\5-3U_P 4^'=)B\1:EI?C[XA>-?AX_C9K'74\
M!I#X7\$:?X7ZL?L'?#M/BD?'\?Q,^,\?@R]^*'@3XY>(O@!_;7@.7X->*?C9
M\,_#7AKPWX)^)VK&X^'4WQ8L=6T63P/X%\3GPQX7^*OA[X;ZEXQ\&Z-XAU;P
M1?W<VLC5ON"BCV]71<[LHN*244DFU)VLM).24N;XN;WK\VH<L>W5/=]-NO;3
MTT/ECX9_LB?#;X5:M\#]9\/:WXXO+KX!>!_C?X!\'1ZSJ6@W$&I:/\?/&?@3
MQSXPN?$JV/AK3I+S4]-U;X>Z+;^&IM+ET:UL].NM4AU2SUFYFM+NR@_X9:O3
M^U);_M2R_M%_'>?4K3PIJ7@&V^$,FG_L\K\)(O NJS6.J77A0/#\ HOBV]E_
MPE.F:?XOCU27XLOXF36+1-/_ +=;PI-=>&Y_JZBE[6=Y-RNY1E%MI-VDW*5F
MT[-MMMJSU>H^5;)6U3TNMK)?@E]P4445F,**** /@CP[_P $[/@GX9^%NI_"
M.P\4?%*;PWJO[/'[*7[-%Q>W>M^$I-;3P)^Q[<>);GX9ZM#<P^"+>P7Q;KDG
MBG4!XZOWTV31]32&S&@:#X8,<[7'6>,/V)O WB72]<BT/XE?%SX<^+-0_:7N
M/VK_  ]\1_!5[\.KCQ?X!^*U[X./P^U#_A%;/QU\-?&W@6[\,:AX*N=;\.7N
MA^-?!?C#SK#Q'K#_ &M;O^S;G3?LNBM?;U;WYV[N[O9IZ1B[IIIIQC%-/1I6
M:M<E1BMDMK>BUV[;L^ -,_X)Z^!]-\._ CP*WQM^.^J_#?X!_$^R^-.A^ ]=
M_P"%%ZO;>+OBMIGQC\1?&_3?'/BWQW>_ R3XP:?K5MXK\27>CW@^'/Q(^']C
MXA\$)<^$/%5GKND^)?&T?BCGM3_X)E?":Y\.:1X.T+XP_M"^"O"=Q\&[']GG
MXM>'_"WB3X;1V7[0GP2TOQAXV\9:;\/?BM<:Y\*==U/2[2QNOB?\4=&M_$GP
M:O\ X2>.1X=^(WBG3'\4N9-*N-*_2"BG]8K7OSOXN9Z*SDVWS-6LY7;?,TW>
MSO=*QR1[=+==K)6]+))K9ZWW=_E-/V/OAA%J\NL0:MXSMY9/VH],_:T2SM[[
MP]#I]O\ $/2/AMI?PML_#UM;IX8#0^ E\.Z3:W+:2)3K@U5I9HO$D5B8]/BQ
M_B7^R+>?$/\ :%\,?M&Z?^TU^T-\.?$?A#PBO@C0/!/A"Q_9OU_X=:7H5YJT
M6K>*WTC2_BY^SO\ $_Q%X<USQ^UK8:9XW\3^&/%.B>)-9T+2=&T6/5;/3M(T
MV"V^Q**E5:B=^:[Y7'WE&2Y6DFK235FE;8=EMMK?1M:KTMV"BBBLQA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5Y7\9_A%X;^.?@"[^''BV^US3M#O?$GP^\4RW7AVY
ML+355U#X;_$+PM\2=#ACGU/3-7M!9W>N^$M-M-6C:Q>>?29[Z"SN+&\D@O[;
MU2BFFXM23LXM-/LT[I_)AN?)-I^QI\,+/4O"NJ1:]X]:X\(?'WX^?M%Z:DFJ
M>'C#/XV_:*\)_%;P=XVTN^5?"ZO+X5TO3/C!XEG\+6-O);:O97]CH4NK:YKE
MO;7]KJ?BGQ*_X)E?"GXA_"KP7\'[#XR?M#?#3POX;_9+D_8H\577P[\0_#"V
MUOXM_ 9/#VE:!I>B?$2]\7?"7QA;P:SHG]GW^J66M?#FR^'TU]<^)_$^D^(8
M=;\):FGANV_2&BM%7JQ:DIM---;/5.36C5M')M::/5:I6EPB]U_6B_))>:5C
MX0^*O[ O@;XW?$/QY\1/B?\ %[XS>);SQ?\ #/Q/\(-!T2&W^!OAO3OAG\/_
M !AXO\">-]<\/>$=;\)?!'0?'WB33Y=?^'?A^[LK#XQ>-/BGIVDSMJ&HZ596
M>LW2ZG#OZ7^Q#X"TOXP)\3D^)/QAN_"-G\9M?_:+T/\ 9^O=6\"2?!CP]\=O
M%/AO6/#GB#XE:=+#\/(/C%=W6HR>)O%7B@>"]>^+NL_##3_&OB.[\4Z3X%L-
M5TSPU-H7VA11[:KRJ//[JBXJ*44DFDG9)63:6LEJ[MWO*5SE5[VUNG>[O='R
MY\%OV2?AQ\"9?@I-X1UOQMJ+? ?]ESPK^R3X0'B/4M"NUU'X<>$&\(OINM^)
M!IGAO2#>>-ISX+TO[=J6F'1]"E%QJ'V?PW;>;;FUK>'_ -ER\T/]I[Q#^U!/
M^T1\=/$&J^(_"4'@"Z^%.LV'[/D7PJM? VEZIXGU_P ,^%[%M!^ FA_%1;7P
MIXA\8:YKFDZI=_%*[\1W]U/#9^)]:\0Z-;0Z6OU912]K.\FY7<HN,KI.\6^9
MI73MKK=6:>S'RK33:UM^B27X(****S&%%%% 'QEI?[#7PFTB\UN^MO$/Q$>7
M7_"/[:'@N\6?5O#31QZ7^W1\?T_:.^+=Q;"/PC$R7_AWQN@TKX=2RO-;Z1X5
M)L?$UKXNU?&N"CJO[!OPFU3P5\2/!2^+/B?ID?Q'\&_LZ>$G\1:;K/A6/Q'X
M.O?V6)K;4/@]XW\'377@N[TB#QAHOB&PTKQ/?OXBT;Q)X:U+6=*LTD\-1Z.U
M[I-W]MT5K[:JOMRWO\^=3O\ ^!I2]5V)Y8]O+\+?DK'YS>(/^"<'A7Q3\)_B
M+\&O$/[27[26L>$_C9\1/$7Q*^/%QJL'[-.J:Y\8=:\3>'? /AV[M-;O]3_9
MMO(? -GI2?#W2M9\(:A\#[/X4^*/ OB&\GU7P7XBT&31?!:>%>M\3?L$^#]0
MU=?%W@'XW_M ?!'XCQ^._C]XRB^)?POU?X52>*(]*_:8U3PKKOQ9^'7]G_$C
MX1_$7P3-X'U7Q!X"\ :_I$EUX0G\<>'=9\$Z!?:/XUM95U'^T?NRBG[>KI[^
MS;MRQLVTHNZY;23BE&S37*E&UM Y8]NRZ]'=?CKZZGQ!!_P3^^!&G>#O%W@#
MP]/XX\,^$/%GP^_9D^&/]C:3K>E3)X?\*_LGZY?:]\,X=#O-:\/ZOJ4NH:A<
M7\MMXSU+Q#>:_=ZY;QI-;/I>IR76H7'4_M%?LH2_M">-?A)XZC_:'^/'P;U'
MX+WVMZWX1T?X76OP"UKPI<>*]:LO[+3QKKOACXZ? ?XT:1J/C#P_I$E_I?A#
M7H[>TNO"EKK6O/H7V*[UO4KJY^MJ*7MJEU+F;:O9R2E\4(P=U)-.\(J+O>Z7
MFQ\JM:VFFVFSNMMK,HZ9:7%AINGV-UJ=]K=U96-I:7.LZG'IL6I:O<6UO'#-
MJ>H1:-I^D:/%?7\B-=7<>E:5IFFI<2R+8Z?96HBMHKU%%9#"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH _/^_\ ^"A/PZT_]M33?V(9O!7B_P#X6;JMI<-9
M 2Z3Y]Y/'INF>+8M9M(UNF\+CP./APWBCQM>:IJ/C;3?'4 \':AX;M/AIJ&O
M:MX=M=5]F^)_[6/PN^$OQP^#WP$\3V_BJ?Q7\8Y6AL-;T?2;.\\(^"9+^>[T
MSP4OQ U.?5;/4=)_X67XET[4_"7@8Z/H_B!;SQ%IUU!K1T*Q\C4)NVD_9Y^"
M$WC_ /X6A)\,/"#^-RTES)JYTJ(07&L2:]X=\3#Q5=Z("- N_'$&N>$?#-]9
M^/+K2YO&=B=$T^WL]=@M(%@K\I/B#^S7^U#^TMIO[;/Q8TC6O"WPPO?'OCNP
MT/X0^$?B#\ _'=[\63X?_9 UUM2^".O^"/&%]\9?A]%X%L/B'\2])UOQSI3Z
MK\,_$L4EIXJCUMEU#3M1@TBT]JA2RO$SIN3GA*5/#4J6(G5J2E[3&U9JG[6G
MR1J2C3A!SKQI.-KT'&I4Y:GN\TY5X)I6J2E-RBHI+EIQ5^65VDY-VC>_VKJ-
MU8_5K2?CCX3UGX\^,_V>+73_ !%'XU\#?#?P9\4=6U2XM--7PO<>'_'.N>)_
M#^DV>G7L>K2ZM-K%O>>%-1EU&WN=$M+*&VFLGMM0NY9)X;;S.;]LOX1VO@;X
MH>.[RS\:06_PR^.?B+]G"+PS#H-MJOC3XD?%[1-7T_0=.\*?"_PWH>JZI=>)
MKKQ;J^IVUMX=%V^CO!:1ZAKOBF+PUX<TC5]7L?E+P=X^\3>%/VD?"_[5WQ$^
M#'QVT;PA^T;^QA\(_#?B*U\,?!'XL^/_ !'\*_C-X#\7>+_$?B7X?>-?AKX%
M\&^)OB=X9AET_P <Q0:/KNJ>&9= N[[P]JT7]N,MWI?G^61?!7XRZ;\*_!G[
M1J?"GQU=7FA?\%%/B3^W'J?P*6"RD^++? [QIIOC_P (V@'@C[2D=Q\8]*\%
MZ]I7Q!L_AC#JD_BJ">;4? ,5O-X_E'A^*HX##*<55?)%QPL(OVL4JF)Y)_6:
M,9NZB_;4W2E)^[0YX2GI*',G5G;W5=WFVN5MQA>/))I:OW)<UMY6:3T=OU-^
M&7Q9UGQ[JNMZ#XF^"7QD^#&MZ-I^FZO%:_$W3O 6H:5KFEZI<ZA9QW&B>-/A
M'\0?BI\/Y]0M+O3;F/4O"]YXLL/&.G6TFGZM=^'8M$U;2]2O/9*\;^&7QLT;
MXLZKK=IX9\#?&31M$T/3]-N)?%OQ-^$'CWX-:5J.J:A<ZA')X=T30?BYHO@G
MX@:OJ&EVEG;:EJ6KV?@N3P<EMJVGV=IXHO-;CU32=-_'GXY_"J7Q!<_MMZ5X
M\_9U^,/Q _;&\8?$JYG_ &,OC?H7PH\;^)(?"6@SZ?X</[.]U\,_VD]&\/7?
M@C]G;3/A-XU2]\0^.H=6\;?#.:RNHM<UW5KO59]:;4)N:A@EB:]2G4_V-Q5%
MRIJ+J2A[2=.$IN-6M"4*5-3=6JYU)2I1UDN6\HZ2J.$4U^\OS6;?*G9-I7C%
MIRDURQLDF]%KH_U,NOC[XFU+]J*[_9R\"^ O#NOV/@SX<>#?B7\6O'?B#XA7
M_ABX\*Z;X_U_QAH7AG0_"7A'3_A]XL/C;Q%*G@S4=7U&'5?$?@72+'3;O3O+
MUF\O9Y+2'"^.G[65U\!O%'AGP]K7[-WQ]\9:;XY\>>%/ACX$\9^!]0_9T?PS
MXO\ '?C'3+C4M)T#3[7QE^T'X-\8Z4R-8:II]YJ?BKPGX>T2&]TRX:/4IK"?
M3KZ^^>/@9^SK;^'_ /@H3\=OBSXM^#GAE=</P#_9[N-*^,=M\,+#2],U;XL:
ME'\4M)^,>L^"O&+>'[*,>)-=LKC3+;QH^D7D6LW.B7FD67B!/L<EI!7L_P"V
MIX4\4^*KG]D!O"_AK7_$B^&?VV_@EXK\2'0=&U'6!X?\+:3I7CJ/5/$NMG3[
M:X&E:!ILEY:1ZAK-_P#9].LWNK=;BYC:>(-JZ.#AC,/14:=2E+!T9592G4BG
M7J895YR4HU]U-^S2M"*BW!T^=>T<\U1TYRNU)5&HI).T5/E2LX]O>>[OK>VA
M9U;]L^WTSQ5=> +7]F_]H_Q)\1/#7P\L_BC\3_ 7A/3_ (+>(/$?PF\(:MK&
MNZ5X?D\2_8?C:^D>,-?\2Q>&M:U;0/!_P8U;XI^+;_3[1;<:)'K=U9Z/<=_X
MV_:7TGP_X^?X5> OA?\ %7XZ_$?3?"FE>./%_A/X6VG@#39/A[X6\175U8^%
MK[QUXA^,/Q"^$_@W0M5\5W.G:M_PCO@W_A)+GQUJ5CHNLZU'X870M,N]3B^/
M_P!MS1/#I\8>*/&_PY\'_M=> OVP?"WPSM;;X+_%W]GOX:_$+Q3X4^*DLAU[
M4?"7PR^(FI^&_#GCWX(:MX&L?'T5L/&'A[]HK3O"4NBV4Z:YH>J:;H-^FOS:
M7PWUCXA_LX?M!?&3Q]\??AU\1]6L/VF/AU^SUXP3QG\$_A3\1?CAHWASXH?#
M#X::?\.OBA\,_$WASX0>&_'7C'PHW]IK9^+? ^LW&AWG@GQ!I.H:_:Q>*K?7
M](?2KVUA,/.C"O3H_O'0E*&%E*HIXBNIX;G5-*I*57#PIU:M2FZ,X5E[*5*L
MG*G*I47M)J3C*6G-9S25HQM*UVU:,VXI2YDXOFYHM)I+]&/!'BN#QSX2T#Q;
M;Z'XI\,QZ[IT-\WA[QOX>U#PIXMT2=BT=SI6OZ#J<<=S8ZC8W,<MM,8FN=/N
MQ&M]I%_J6E7-EJ%S\]_ _P#;+^#/[1/Q5^+GPI^%<OB?7+CX.VFAW>K^.9M#
M2Q^'?BV/6M;\5^&99/AUKT]\+[Q?IVC^)/!/B30]0\166CQ>%KV_TV8^&]<U
MZU22Y3KO#=_\=_'&K^$?'NG:UX2^'?PJUNPT[4]2^$/Q*^!NO2?'&SMIH)#-
M;ZAX]T+]HL>$?#.I7Q-O?PZ;>_##5[_0+>4Z3KMI_;,=W%9?$/PV\7P>)_V]
M_P!I?6/^$#_: T/PA\8?@=\%?A=X,\;>)/V7OVC?#/A.[\4^#;OXNR>*X;WQ
M!XG^%^AZ'H=CI-MX@TF:#6_$FIZ)X>UI[R"WT76+Z9F5.:AA:52&.;4ISI8>
M-6G[.4W&A/ZS2A.G43I+VTU1E4DG3GR*-.<_?M>%RG).E:R4I<KNDG-<C:<?
M>]U<UDTU>\DM.OOWA']O/X8^+]=^&"0^ /B]HWPR^-WCC7/AQ\&OCWKFB^"H
MOA1\1_&.C3Z];6NDZ7%IOC[4_B?X>7Q5-X7\0?\ "%:CX]^&GA'2_%<&FF]T
MB]N+&^TRYOG:7^WC\,=5\0^$XXO 7Q<M_A5X]^,\O[/W@;]HBZT;P6OP?\5_
M%87FLZ%:Z#I5O!X]N/BTFDZKXS\/ZMX!TCQOJ/PKL/ FI>+[:&RMO$KV&H:9
MJ5Y\'?!_PG\3O$'P0_X)\?LH7GP>^+GACXF_LT?'7X?^*?C;J_B;X;>--"^%
MGA;PK^SUJ/B^VN=:T+XO:QH6G?#;XD?\+%N6\-OX$T[X;>)O%>HW6F>(7U35
M+?3H-!UE+?*\%>!/B=K/[-7[-?[$MU\(OB]HGQ6^$_[6W@K5_B#X@U7X8^-;
M+X3:9\,OAC\=-<^+MY\4-$^,=]HUE\*?%FD:_P"&K/1K#0O#6@^-+GQK<^(]
M?BTP^'Q#I>J7MOZ4LOP*E)6MRUG2E^_OR8/VF+BLQT>_)1H.[OAY^T4HTU&M
M12P5:K9:[QO\-KU+4G['7;64U_-&UF[QE?\ 47XN_M'7WPZ^+GPT^#7@WX5>
M)OC+XS\:^%/'WQ"\0>'O!>O>%=%\0^%/A]X)AT[3(/$,*>.M2\,>#-0G\0^.
M?$'A[PKI]CXA\=^";8P3:WJMMJM_>:+#H.K>>?#_ /;BTCQL/BGJFK?L^_'W
MX;>!/@7K?Q!\._&GXE>.;C]GVY\*_#76/AEX*B\>>*K35M+^'_Q]\>>/_$*P
M:+=Z7%:7?@+P3XOL[J_U6UB6X2WM]5NM.R_V3[9?BU\8/VD_VN;IY+K2_&GB
MN/X!?!5YA+-%;?!KX!:CJV@ZOK>CW<K1J=.^(OQEN_B)XD6.&R@B?2[#P[*+
MG4"?M)Q/V>?#NL^"?"__  4(O_'OPB\9^*M$\1_M8?'/Q=IWP_D\'P76I?%O
MP#J/PO\ AA8M#X1T+QA+HNA>-=)\6+I^L:'IRO?_ -A:_=0WFDB[E=9XAQNC
MA:<:E&=&,JU"EAHU)^UJ1J2KUJD?;QBG55)2PZJ>Q5X."J47.ISQ;3UYIMJ2
MDU&3FXJR:Y(I<K?N\UIV<M'>TK)IVM[)X"_:T\-^*/!?B#XC^._A=\8/@'\/
M]#^&.G?&2'QK\8=(\$+X6UOX=7]C=:G-K-CKOPQ\?_$S3=)U72].@MKW4O!7
MC"X\,>/!:ZG9367AB^2/4CI^K\+/VD+KXGZQX;M9/V??VA_A[X7\;Z1?ZWX&
M^(GCWPKX*3PEXBL[2WAU*R&I6'@WXA^,O'GPSN->T25]7T.'XS^"OAL;KR&\
M/W!M/&-SI_AJ\_*W7/@+\3/B)X)_:)_9N_94E_:&F_99U/\ 9JMI_!'@C]J7
MPK\5/!&E>"/CKX<\9> (_A_\(O@]KW[1_@_PM\9Y/AGJOPZ\ :];:SI%]J7B
MSX;^"=2UC2?L&J^'1J]SI:?IIX)_:4U7XPV>F^%?!7PJ^.7PQ^)NM>$]6U'5
M[_XS?LZ_$G2/AU\(-?L=/B"6OB_7?%%[\)_#?Q4C'B"Y@T:QTGX)_$+Q+?>(
M4$NM6]_I7A2WU#Q/IU8G!T*<)3I4XRYY2YXN=6$L#1]C3G2G7I.4ZD*M2<JG
MM(S=:%Z3A1;=6FTH5)2:4FU9::1:JRYFI*,E:+C%6LTHO6\K*,D=)^U#^U7\
M)_V1OAS/\1OBI<:_=PNNK#0/!_@K1F\2^._%T^@Z'J/BC7HO#F@K<6<+VWA_
MPSH^J^(O$6MZOJ&D>&_#FBZ?<ZCKVM:;;"-Y#X@?M.^#_ GAGX0:M:^%/'WC
MSQ9\>KC3;7X3?"KP1I_AJ;X@>+)[OPVWC+5"&\3^*O"_@?0K#PGX4AO-=\5:
MWXE\;:-H.F6EF\$6J7>H7>F6=_X;^UMJ'Q,T']BW]H?P#\2I[_XR?%+XK?!S
MXX^ / 47[.7[,'QPET^^U?Q/\+]:T?PQH6K^&/#7B/\ :(OO#DUUK-X;=_&'
MBGQ9X>\+S_;+:W:/3VL;FYN?%=<UO6HM3_X)U?M!Z?\ ##XXZQX%^!NF?$;X
M7_%[2+7X$?&.T^)_@V\\=_![PWX6L/$B?![5? VG_%'Q-X5TSQ/X?33-6UCP
MIX2UFV6UOQJVGOJ%G9W!J:&#H3HT9N$YR]KC8NHIS5'$.EA75PM.G&5*E."J
MUX^P:NZE23E&$H2Y5$G4FI22:2Y:;M9<T.:HHS;=Y)\L&Y;626MUJ_J+_ANK
MX(V/P6\=_&?Q3#XU\%I\-?B5KOP4\8?##6_#]KJ?Q9M/C5HM_;6%O\*-%\-^
M#-7\5:1XS\6^(UU'1=5\,2^"/$?B/PWJOAW6K+Q,?$%OH%OJVHZ;[[\%OBOX
M=^.OPD^''QE\(V6M:=X8^)_@[0?&^@6'B.WL;37K/2O$6GPZE96^L6NF:CJ^
MGV^H103HEU%9:IJ%LDH98KN= )#^?OPI&L^ OAK^W%\9_&/@/XN:5IG[2_QY
M^(&M?"_P?IWP8^*OBWXE7OA4?"_PW\-?"7B/7?AGX.\(:_\ $;P?;^,;[P=J
M.LPV7C+PEX=O?#6DWNC?\)7%I%]J*VD?MW_!.74;F/\ 8Y^ 7@;6?"GQ'\%^
M+OA?\*O /@7QIX?^)/PL^)/POU+3O$VD>&-/BU&TT^'XB^%/"_\ PDME:S*T
M#:YX8;6=!>='@BU-YD=%6+PE"GAZU6C"IS4\51IN7/STXPJ8=SJTDE!:X?$+
MV4IN<V[QB[2UDZ=24I04FK2IR=K6;<9I1EO]N'O*-E;7>VGLO[/_ ,<O^%Z6
M/Q:O?^$7_P"$6_X5=\?OBY\#?*_MO^V_[=_X59XC;0/^$HW_ -D:1_9G]NX^
MU_V)LU#^R\^1_:^H_P"NKWVOYRM7^"1NS^TMI&E?LO\ QMM?VQ?%7[>WC#QS
M^SW\=&^#_P 0;;3=!\ W7[0@UBT\8^'OC^=,N/!_PS^'EOX>LO&M_KWAR^\1
M^%F\:VNM0ZO8^&/%5OXLTC6+_K?B%\!?B+XH^/7[0;?$J\U'P!\1/$/[0^D^
M(O@I\>=/_8"_:2_:5^)OA7X8Z-JOA/6_AC'\)OVG?A3\2)O ?P?\-Z>-/OO#
M?BKP1J?AGPY]F6Z\7W7C6QU;2/%,UW-TU,IPTJLG#%NA3:<HT_83KS45]77/
M"-&M5JU:#]M/]]R\RE1J1=-<K<8C7FHI.GS2V;YE!7?-HW*,8QE[J]V]FI)W
MUL?N=X<^)?@GQ;XO^(O@/P]K7]H>*_A/J7AW2/'^E?V;JUI_8&H>+/#&G>,O
M#]O]NOK"VTW5?[0\-ZK8:CYNBWFI06OVC['>RVU_%-:Q]U7X[:;^R3\%O$W[
M2G_!07X9^+OV>[;PI+^T5H6CVOPP^+>F?LYWUYX<M- \8_ 72]!^*.K:!\7]
M*\&-X+\+^)F^(W]M^(-7T+5/&GASQ%XD\7%==2UU"_O4U!_F*6U_;0U[PX_[
M1=Q\*OC!:_&SXA?#X_\ !/;6_"NK^#_&-S>Z187GP;\.:BO[1>J:/#I:W4/@
M+3?VF[?XAR6?C0+;Z7'X7\36.O7>K/I>K7PTC*.54:LDJ6+5->PPM3_:(0@I
M5,1AZ55*$U4M*+J?6(.RO2E25.3G*7,4Z\H_%3O[TU[C;LH2:=TXZ/EY&M?>
M4KJUK']$U%?S^?'?]EK4] ^+>O\ PY\4>&K6X^!NA_LU_"SX2?LV>+-4_89^
M/G[:<7PXM="\.:AX=^(-Y\.(_@'\1=&E^ ?Q8.NQZ%XI;QMK?A*77?$C6WAZ
MXT/Q5M\(W%@^S^T#\#/B1K?Q)\/6/QQN7^,?PQNOV1?AAX#^&/Q-^(7[!?[0
MW[7<^E^/[&VU;3_CCXIB^&GPB^(V@>*?V<_C7XUNKKP%XSD\8^-O"NMZSJ]E
M:67AC0/&VEZA\-_$NBWY'*L/+V+6/O&K2=73!UY2::IM0HJ$I1Q%6'M'[>E"
M?/1]G5NI*#8.O-<UZ5G%\NM2*6[5Y75XQ=KQDU:5X[7/WJK!\5>(K+PAX7\2
M>+-2BNI].\+Z#K'B+4(;%(9;V:RT33[C4KJ*SCN)[:"2ZD@MI$MTGN;>%YBB
MR3Q(6D7\DM _9#TWXK_M)^!]*_:,\-^)?VB_ NA_\$YOA1X/;XJ_%CX;>)M#
MT;Q;\3;;XA_$.TNO$.N^%?&<>H:?HWQFM?"_B"76O[-\5?VA\1/ \NOWUY))
M8ZAJ&H7-S](?LX:-\39/^";'P]\.?$+1O&X^*@_9;N/#^N>'_%NEZW%X^_X2
M&+P/J&EV^D:OI&K6Z>(#KQ*6UG]CO;8ZE-.8T='G?YN:I@J%-4Y1Q2JOVN&A
M5C[/V:4<0JLE*$I5'-J*I-352E2E!SA>-VTKC4E)M.'*N633YKN\>6Z:2Y5\
M6C4I)V9M> /VZ_!WBVU^"^O>+_@W\=/@OX#_ &B;3PBWP7^)?Q)TWX6:GX(\
M::U\0K?0[[X?>$KFZ^$7Q8^*FM>!?$GCG3M=AN_#$'Q+T/P9INHW%G>:"-4C
M\4-8:%??<-?B1H\?C'XY_L7_ +'/[''A#X/_ !OT?QYH/AK]CA?C1XK^)7P-
M^*?P?\*?!31?@!K/P>\0?$'4;7Q;\7?"O@31?&_C)M1\,3>&/"_AGX:7_BS4
MM=6XU;52]CX7T^_UV'SKXF^&_BIXF_:W\(^-?#O[/^I^"O&OA#]O[P##=^+-
M*_9?^/?B3XKZE^S[!K5IX+\2?$?4?VZ-2\7R?#*Y^"_CGPGKNI+>_ 3PKX=>
MR\!^"=<3PUJ.EVVF^#O%.OVW;/+*%6I.,9K"2A+%)TW>JO9TIPCAJLE*I[6E
M'$7FG.7/!>S51<L*M.+RC7DDKKVB?LTGI'62O.-TN63@[:*S=^75QDS]_*^=
M?BQ^T=HWPS\>>#OA/H7P[^)?QF^*_C;0M=\7Z?\ #SX56O@==6TGP-X;FM;'
M5_''B?7OB;X[^&O@3P[X=BUK4=*\/6)U+Q=#JVM:YJ=M8Z)I6H^3J$EE^:/P
M(^&GB=OVK](_8VU+3+RY^"G["OQ,\>_M,>%M49G;0[[0?C-IAO/V8/ \K6_E
M3-JGPVUOQM\=Q!%J:+"L'PR\,SZ<]W:F6"S^P/VM/#O@#0_'_@7XT?\ "2_M
M<^!/B_X;\">./"F@^(/V3_@?XD^-.I^*O!>H7>CZSJ7@'QAIL_P$^.WPPLX[
MK7]/TK4?"Q\:6?A:Y36%FOK+6XK.SU">SYOJ-&CBJ5&4WB?;4)UJ:A3GR_O(
MSG@W6C1E.JHU*:I5ZT86G2IU$N9M2DM/:RE3E)+D<9*,KM='%5%%R2BW%N4(
MMZ-QVU2.O@_;>^%^N^"_@=XG^'OA/XF?$[Q)^T-)XRM_AQ\*O"VC^%]&^(4E
MU\,8K\?%BU\2O\1_&/@/P%X2E^%^J:;=^'/%DFO^.K&VE\3?9-$\-3^(KW4M
M-CN_8?@/\=?!_P"T)X'N/&WA&P\2Z#)I'BGQ/X#\8>#O&NF6^C>,_ GCSP7J
MDNC^*?!OBO3K*_U?38-:T:]C F?2M8U?2KJWGMKS3]2O+6XBF;\FO@[\"OBG
M^R;XC_8G^+/Q,\"_$CQ!IVF:?^VGI7QJM_ OA?5?C7XP^%_B']HKQ_:?&'P
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MQ3^&GPIT#XB>(+C4;V%(-4^$?@YX%L_B!+?Z;?ZMJ6C^&K+Q#<6?F?C;X"_
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M$4:V?BC1]"MK_1[W4_.O^"@>F:[=_#KX&ZQHGA3QIXO@\#?MC?LK?$3Q/8>
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M+;CP1X$O-<USP)<:O?\ B.Y7X,>*M:^)?]@>'=:\2?#'3/$.KZ58PS>6> /
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MTN+NYE5YG[&O'DK2:5[)M*Z2>CZI-I/NDVEW>YNM4GW7]=OR04444AA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%?D]^TPGC+X8_&_P"&GCZRUG]J'P1HES^U
M'\&U\=?'OQO\:)+[]EA/AGXNGL_#5[\(++X#_#_XAZS8Z+9^(K_4M&^&.C>-
M?B+^SQX.L-&\;ZHGCSQ9\:6ODL-=\1\5^T[\9OBGX[_:.^"&I_#3QYXM\%?
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MJXU/9PA*53V;DZ:B^?E>@_;4]-7JTO@FFFVHQ33C[O,VDKVO?2Y][45\/?\
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MG\4/B'JG[5]K^R/?^'?A_P#'+1M>^%DOC#6_!/B+QUX7\;>"_C:/!5O8^,O
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MG]F[4K#X5?8?B_\ !;_@J/X8^#'BKX90>.=/O?#5_P#$7PE\,?B;J5A)X?\
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M]@[X6^#E^'DB>-_BSXCU+X=?M'>,_P!J2UUOQ/K_ (6OM6\2_%#Q_P"']?\
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M2<FX1DH.4I2<>:3;T]G!7M%).UTKI.VS:O9M65FU=))7LD?*/B+]CWX9^)O
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M^$>N:9XA\!>$="L_!WPV\*_#7PYX:T?5+"]N9[72/AW;7NKW'B#7+_6-0O\
M4YK&^T_U_P"+W[/^E_%GQE\)_B)!\0/B'\,_'7P;O?%D_A+Q-\/G\"3W$^F^
M.M*LM'\6^'];TKXC>!/B%X<U#2=9LM-T\-+%HMIK>GSVD<^DZQI\C2M)[[12
M>,Q+E&3JMN'/RIQAR152C##SBJ?+R*$J%.%+V?+R*G%044M!^SA9KE6MF][M
MQDYIMWO=2;E>][N][GS/9?LT6EQ\:/"WQM\>?%SXJ_%36?AW)X]N/A9X6\96
MGP>TKPE\,[OXBV<6BZ[=^'6^&OPD^'_B_6)8/"RW7A/3H_'OB[QE:QZ3?W-[
M>V]]XECL-?LN=^)/PJ\;P_M<?L\_M!^!M+;6-(M/!/Q2^ _QGM(;_1K:\L/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img181012247_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_11.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '_!*(# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLOXC?M0_!7X>VWQ5^&'QZA\<Q?#N7Q+XD^/7C+X9^$O!WP:^)FHIXD;3!%X
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MP1X=\7W+W\44]BEOX:U?7+/69FO8;B":T6.R8W,4T4D(=)$+?E'\*/"/AOX
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MV_PC^,GPJ^*=QHF/[9@^'/Q#\(^-YM(RR(/[3B\,ZQJ;V&7=$'VI8LLZ*.6
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MQ@HQ48NZBDDDK(?+'31:-M:+1O=KLWU?4****@84444 %%%% !1110 4444
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M;_PE+H5YJ]M:>(?$,\FKZGIVE>)=/L6O/+:V@MD@MTB_1K0M#TGPSHFC^&]
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M.DE&/)>5*A!5:=1))4Z3I0@E:R;6M[]$N5*VEY.[OH4445YQN%%%% !1110
M4444 %%%% !1110 444A(4%F(  R22  !U))X 'J: %HJJ;^Q!P;RT!'4&XA
M!'X;Z3[?8_\ /[:?^!,/_P 73L^S^YBNNZ^]%NBJGV^Q_P"?VT_\"8?_ (NC
M[?8_\_MI_P"!,/\ \719]G]S"Z[K[T6Z*J?;['_G]M/_  )A_P#BZ/M]C_S^
MVG_@3#_\719]G]S"Z[K[T6Z*J?;['_G]M/\ P)A_^+H^WV/_ #^VG_@3#_\
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M3@ 7$1)/H 'R3]*+/L_N877=?>BU1112&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<+XG
M^*/PS\$W\.E>,_B)X%\(ZI<6<>H0:;XG\7>'] OY["6:XMHKZ&SU74+2XELY
M;BTNH([E(VA>:VN(E<O#(J\N,QV"R^B\3C\9A<#AU*,'7QF(I8:BIS=HQ=6M
M.$%*3TC%RO)[)FU##XC%5%2PU"MB*K3:IT*4ZM1I;M0IQE)I=7:RZG=45Y%_
MPT#\!?\ HMOPB_\ #D^#?_EU1_PT#\!?^BV_"+_PY/@W_P"75>3_ *V<*_\
M13</_P#AYR[_ .:3M_L7./\ H4YG_P"$&*_^5>:^\]=HKR+_ (:!^ O_ $6W
MX1?^')\&_P#RZH_X:!^ O_1;?A%_X<GP;_\ +JC_ %LX5_Z*;A__ ,/.7?\
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M]%M^$7_AR?!O_P NJ/\ 6SA7_HIN'_\ P\Y=_P#-(?V+G'_0IS/_ ,(,5_\
M*O-?>>NT5Y%_PT#\!?\ HMOPB_\ #D^#?_EU1_PT#\!?^BV_"+_PY/@W_P"7
M5'^MG"O_ $4W#_\ X><N_P#FD/[%SC_H4YG_ .$&*_\ E7FOO/7:*\B_X:!^
M O\ T6WX1?\ AR?!O_RZH_X:!^ O_1;?A%_X<GP;_P#+JC_6SA7_ **;A_\
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M_P#^'G+O_FD/[%SC_H4YG_X08K_Y5YK[SUVBO(O^&@?@+_T6WX1?^')\&_\
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M_A"_[)TWXG:A_P (#_PF?_"1_:/^%<IJC>3_ ,)5_P (IH/E?VS_ &;CS/\
MA')/[.\[.R^\O$GU!\;/^2,_%S_LF/CW_P!175J_E!_8R_8<_:%^+G[!>O?&
MWP3^WS\9O@W\/['2/C#=7'P(\+0>-W\'7\/A1-8;6;29])^,OA;1?*\8"TF7
M4]_@Z90+R7[7%J?SB72$8N+;T?,E=WZ]-._?H!^S?AS_ (*G_P#"0?"C]@OX
MG_\ "B?LG_#;OQRO_@Q_8?\ PL_[1_PK'[#\5Y_AA_PDG]I?\*\A_P"$T\WR
M?[<_L?\ L_PGLW?V9_:KX_M _KC7\>EAXT\-?#?]AW_@B/\ $3QIJ7]C>#O
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#U;P?<2SZ05E<O\
M9[J6"(DY(B$4,JKD\D*TK!?1<*. !755Q_@G_D%7'_80E_\ 2:TKL*\6NDJU
M1+3WG^.I]1A&WAJ+;N^1+7RT7W)6"BBBL3H"BBB@ HHHH *Y/Q1_RX_]O/\
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M8C^>G]S\O+U_K8/C#_A]U^RE_P!$_P#VA/\ PE/AQ_\ /8H_X?=?LI?]$_\
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M)JC7Y;QAB*=6G>\&%%%%>N<05X_XI_Y#U_\ ]NO_ *1V]>P5X_XI_P"0]?\
M_;K_ .D=O79@?XLO^O;_ /2H'FYI_N\/^OT?_2*AS]%%%>H>"%%%% !1110
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M9Q<KVYHI)V5^[Z ?KS7X4_\ !<__ ))G\!/^QZ\6?^H_85^ZU?A3_P %S_\
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M +=?_2.WKV"O'_%/_(>O_P#MU_\ 2.WKLP/\67_7M_\ I4#S<T_W>'_7Z/\
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MGRMI5*<FES4JD;3ISM:=.49+1H*\?\4_\AZ__P"W7_TCMZ]@KQ_Q3_R'K_\
M[=?_ $CMZ]G _P 67_7M_P#I4#QLT_W>'_7Z/_I%0Y^BBBO4/!"BBB@ HHKP
MKXG_ +1_PG^$SR6?B3Q +[7(P2?#?AZ./5M;0@-\MU$LT-GIK$KA5U6]L6?<
MK1AERP\7/^(\@X5RZKF_$F<Y;D>646HSQN9XNC@Z'.[\M*$ZTX^UK3LU3H4E
M.K4E[M.$I:'H99E.9YUBX8'*,OQ>98RHFXX?!4*F(J\J:4IRC3C+DIQNG.I/
MEIP6LI):GNM%?$EG^T/^T%X_19_A-^S+XEN]+G.;#7_%+7UOIM[$3E9$D>UT
M/2UXQN$&OW:*2"9<8!T6\4_M\6H^U7?[/'@Z:S_YX6>L:>]]QR?DA^(M[-R"
M /\ 0>3G&<$#\N_XCUP57_>93E7B!G^!W_M3)/#KC'&9:XZ7G#$RRBBJM-73
M52C"I3FFI4Y3C)-_:KPOXDA[N-Q7#.68C_H#S#BK(:&+OLHRHQQU3DD]N2I*
M$HM-2C&2L?95%?$<?[7>N>"[^UTOX[?!;QO\,VFG^S#6Q9WMWI,TNQG\V"&_
ML-.>: !'+?V7>ZS)L1WC$A5D7ZU\(^,_"OCS18/$/@_7+#7]'N&9$O+&0MY<
MJ??M[J"18[JSNH\@R6MY#!<(K*SQ!64GZ_A+Q-X'XWK5\'P[GU#$9IA(<^,R
M/&T,9E&?82"Y>>=?),VP^"S.-&$IQA/$1PTL-SRC%5GS1OX&>\'<2<-TZ5?-
MLLJ4L'7ERT,QP]6AC\MKR=W&-/,,#5Q&#=223E&DZRJ\J;=-6=NGHHHK[P^9
M"BBB@ HHK'U[Q!H?A;2KO7/$>K:?HFD6,9DN]1U.ZBM+6%?X5,LS*&ED;"0P
MINFGD*Q0H\C*IRKUZ&%H5L3B:U+#8;#TYUJ^(KU(4:%&C3BYU*M:K4E&G3IT
MX)RG.<HQC%.4FDFRZ5*I6J4Z-&G.K5JSC3I4J4)5*E2I-J,(4X13E.<I-1C&
M*<I-I)-LV**^*-1_:TUCQEJUUX;_ &>?A5XG^*>H02>0^O/8W]IX>MF8-Y=S
M+##!]J2R?  FUF[\.9.><;"^M;^"O^"AGBM1=O<_"SX;!P"-.N'TR\:,/R 3
M#9>/""@X*O>L1T8,PK\;K>.O"6(K5:/"F4<9^(,:%2=*OC>".&<5F>44ZL).
M,J<<^QU3*\CQ+5KJ6$S'$4Y+X9MII?H5'PRX@C3A4SG&9#PNZL8SIT.(LWHX
M/'2A))J4LMPT,9F-%:V<:^%I33WBE9O[!HKY G^'G_!0SPTK74>O_"KX@F']
MX-.@.F6376.?LZO<Z#X(1<]-S7UMT_UX/)QM,_:O\0^"M9MO#'[1OPL\0?"[
M4+N8PVOB&WL+ZX\.7.R7R);A8Y_-FEL(I$E)OM%O_$,<B[2L8C!F)1\=.%</
M7HT>*\DXU\/H8FI"C0Q_&O#=7+\FG6G)1C2J9[EV(S;)L+)R:7-C<?AJ:O&\
MUS1N5O#+/ITJE7)L=D'%#I1=2IAN'LUABL?&G%7<XY;BJ6"S"LK7TP^&JR=G
M[NC/MBBL_2M5TS7=.LM8T;4+/5=*U&W2ZL-1L+B*ZL[NWD&4FM[B%GBEC;D;
MD8X(*G# @:%?LU*K2KTJ=:C4IUJ-:G"K2JTIQJ4JM*I%3IU*=2#<)TYP:E"<
M6XRBU*+::9^>3A.G.=.I"5.I3E*$X3BXSA.+<90G&24HRC)-2BTFFFFDT%%%
M%62%%%% !12$@ DD  $DDX  Y))/  '4UX7XR_:6^"/@2>2SUOQ[I4^HQ%E?
M3M"2Z\17:2K]Z&X_L6"]M[*8#DQW]Q:D=#R0#XN><2</<,83Z_Q'GN49#@FW
M&.*SG,L'EM"<U;W(5<96HPG4=U:G!RFVTE%MI/T,MRC-<XK_ %;*<MQ^9XBR
M;HX#"5\75C%NW-*%"G4E&/>4DHK5MI)GNM%?$L_[?'P4ADV1Z7\0+I=VWSH-
M"T98R,XWXNO$MM+M(^;!B#XZINXKM/#7[9?P$\1S+;R>)[SPW.Y C3Q+I%Y8
MPL3C.Z^M%O\ 38 N>6N;R!>I4D#-?"8+QR\'\PQ4<'A?$CA%XB<E"$:V<87"
M4YS>T85\7.A0G*3TC&%1N4FHQ3;2?TV(\-^/<+1>(K<)9ZJ27-)T\OK5Y1CU
M<J="-2I%*]VY022NW9)V^IJ*IZ?J.GZO96^I:5?V>IZ=>1B6TO\ 3[J"]LKJ
M(D@2V]U;/+!/&2" \4C*2",Y!JY7ZE3J4ZM.%6E.%6E5A&I3J4Y1G3J4YQ4H
M3A.+<9PG%J491;C*+33:9\7*,H2E"<90G"3C.$DXRC*+:E&46DXRBTTTTFFF
MFKA1115DA1110!ZAX)_Y!5Q_V$)?_2:TKL*X_P $_P#(*N/^PA+_ .DUI785
MXN(_C5/\7Z(^GP?^ZT?\"_-A1116)TA1110 4444 %<GXH_Y<?\ MY_]MZZR
MN3\4?\N/_;S_ .V]:4OXD?G_ .DLSJ_PY?+_ -*1R=%%%=AQA1110 4444 %
M%%>(_M+?$B7X/?L\_&_XI6LJQ7_@'X5^._%&DLP!#ZYI/AO4;G0X,' S<ZNE
ME;KN(7=*-Q R:VPV'J8K$8?"T5>KB:U+#TD]G4K5(TX)VOO*26S.3'XRAEV!
MQF88F3CAL!A,1C,1)6O&AA:,Z]62NTKJG"3U:6FZ/Q>L='_X>=_\%)?%L_B8
MRZQ^R;^Q!>#1-.\/FXED\/>-_B3%JMS;-/<0^4+6_MO$'B+0M1NM29'FM=0\
M&>#-"TV4&W\0323?T'@ # & . !T ]*_)7_@BK\+X/ 7[#?A/Q;/"?[?^,WC
M#QK\1M;NIUWWTR1:U/X+T5)[I]TLUO)I'A.VU>V1I&C236+J8*L]U<L_ZU5]
M=QUBX/.I9'@VXY5PO!Y'E]):1<\)+V>8XR27NRKX_'QKXBM52YIITHMR5.+/
MS3P@RRJN%:?%V9P4^(_$&I'B_.L3+WJBI9G#VV299";7/#!Y/DL\'@L+AF^6
MC)8B<8PE6J(****^+/U8*_G^_;U\)ZA^P+^UQ\*?^"AWPJLKJT\ ?$;Q0GP^
M_:>\*Z4\D=CK+:W%]HGUI[&"%XO-\1Z5IMWJKS2A+>+Q]X6T35)?/U#Q#<^9
M_0#7QU_P4#^%5K\9?V,OVB?!,UI'=WH^&FO>*M!C:,/(/$O@. >-?#XMWVL\
M,UQJF@VUD9(\,8+J:%B8I9%;ZK@W-(Y;GN%AB5[3*\U?]CYSAI/]WB,LS"4:
M&(4U_-AW*&+H233A7H4Y*2LS\Z\4N'JF?<'YA6P#]AQ#P]'_ %FX7QT(IU\%
MGV20GC<&Z<O^?>-5.IEV*@U*%7"8NM"4)75OK?2]3T_6],T[6=(O(-0TK5["
MTU/3+^UD$MK?:??V\=W97EM*ORR07-M+%-#(.'C=6'!J]7YV?\$HOB;=?%+]
M@KX":GJ5PUSJWA/0]6^&U^68N8H?A]K^I^&O#\1=B68CPE8^'I&W8VM(R#*J
MK-^B=>-F^7SRG-<RRNJ^:>78_%X*4MN=X6O4H\ZMI::ASJVEFK'U/#&=TN)>
M',AXAH15.CGF39;FT*=^;V2S#!T<5[%O?FI.JZ<D]5*+3LTPHHHKSCW HHHH
M **** .W\-?\>,O_ %]R?^B8*Z&N>\-?\>,O_7W)_P"B8*Z&N*I\<O4[:?P1
M] HHHJ"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^:7XK_\IP-*_P"R
ME?!C_P!4KX%K^EJOYI?BO_RG TK_ +*5\&/_ %2O@6L:W_+K_K]#]0/Z6J^>
M_P!K?_DU+]IO_LWOXT?^JW\2U]"5\]_M;_\ )J7[3?\ V;W\:/\ U6_B6M9;
M/T?Y ?E;_P $,/\ DF?Q[_['KPG_ .H_?U^ZU?A3_P $,/\ DF?Q[_['KPG_
M .H_?U^I'QR_:X_9W_9MOM$TOXT_$FS\&:GXBLY]1T?3AH7BOQ'?W5A;7 M9
M;UK/PGH.NW-I:FYW00SWD5O%<2PW"6[2FVN!%E2:C1@VTE;=M);OJP/R?_;5
M1WT/_@KFJ*SD+^P4Y"J6(2.Z\+22,0 2%1%9W;HJ*S,0 37SY^Q7'(G[*/[/
M3/&Z+-_P5I^%4D+.C*LL8^'GAB$R1D@!T$L4L1=25$D<B$[D8#V_XD?MI_ S
M2_C#\7OB1\#?V@_@!XC\/_'W0?!&E_$OP/\ M ?!C]I6_P!)\_P)H-SX8TX:
M8GA3X;W,>H:??Z1<2+J%EJJ);R27$Z/;SJL,B<CH7[7?P;\4ZU\&M#^)WQO_
M &4?AM\(?@W\4_#WQ@TOPI^SE\"OVG-&NM1\4^$DO3HED]AK_P ,K'1-/TQY
MKV47TEB(YGCD8M#</'!Y?YY4S#&T^#<[X'60YO4Q^/XQSO,Z&/A3P[RIX/,^
M,,3G&&K2Q;Q"C""P%>E4K<ZC.G-5:+INI!*7HXCPCRS,OI9^'OTJO^(D<)8;
MA[A+Z/\ PYX<8[A"L\;_ *SU<XR3@F648J5*@J+4N?,\1BL+0I1ISA5C0P^)
MCB7A\3.>'_HPK^7#_@MM!/+^U=\.5BAEE:?X >%((%CC=VFG_P"%D?%0>3$%
M!,DN98AY:;GS)&,?.N?V'_X>I?L%_P#1=_\ S&'QE_\ G>5QOB;_ (*&?\$R
M?&FHZ'K'C'QWX,\6:MX8GDNO#6J>)O@1\2M>U'P]=2E#+<Z'>ZI\+KJYTF>0
MQQF2:PEMY',:%F.Q<?K.4YI1RW&1Q4E&JE3J0Y(U(Q=YJR=W=632NNWW/^>/
MI%^#V*\<_#3%<!8//,/P]B,1G.39G',<3@JF/HQIY=BO:5Z3H4J^'GSSH5*C
MI24^7VL(0FHPG*I#].J*_/?_ (>I?L%_]%W_ /,8?&7_ .=Y1_P]2_8+_P"B
M[_\ F,/C+_\ .\KS/:4_^?D/_ H_YG[L?GY_P3]@G7_@JM^V[(T,JQH?VC%>
M1HW"*US^T7X.FM@S$;5-Q#')+ "098T=X]RJQ']!=?FAIG_!1S_@FQHGB#7?
M%NC?$GPQI/BKQ2MJGB;Q-IGP1^*%AX@\1I8ILL5UW6K7X8Q:EJZV:$I:KJ%S
M<"W0[80@XKI_^'J7[!?_ $7?_P QA\9?_G>5WYCF-+'5X5ERTU'#T*/*ZD97
M=*FHN5U;1N[2[6OJ?D/@KX8XCPGX3S+AO$YM1SFIC^,>+.)HXJAA9X2%.AQ#
MF];'8;"RI5*U:3JX?#RIQKS4^1UG-4TX1C.3O^"J"._[!GQW5%9R%^&3D*I8
MA(_C%\/9)&( )"HBL[MT5%9F( )KY\_X(CQR)^RCX\9XW19OV@?%DD+.C*LL
M8^'GPKA,D9( =!+%+$74E1)'(A.Y& ]QU;_@IW_P3UU_3+_1-=^,>G:UHVJV
MLUCJ>D:M\(_BYJ6F:E97*&.XL[^PO/AO-:WEK/&S1S6]Q%)#*C%'1E)%9OA7
M_@I'_P $W_ NBVWASP3\3_#O@[P]9ES9Z#X5^"OQ3\/:+:F0@R&VTO2/AE9V
M,!<@%S% A8@;LX%:0S2C'*:N6VBY5,8L3[7VD>515.G#DY=[WIIWO:SVTU\?
M,O![%8_Z1/#WC@L\P]/!9)X;8G@6?#[P=26*KXFKFV;YA3S"&.5=4H4/99Q4
MISHN@ZD9X:#C.4:TO8_I57\N'_!;:">7]J[X<K%#+*T_P \*00+'&[M-/_PL
MCXJ#R8@H)DES+$/+3<^9(QCYUS^P_P#P]2_8+_Z+O_YC#XR__.\KC?$W_!0S
M_@F3XTU'0]8\8^._!GBS5O#$\EUX:U3Q-\"/B5KVH^'KJ4H9;G0[W5/A==7.
MDSR&.,R36$MO(YC0LQV+@RG-*.6XR.*DHU4J=2')&I&+O-63N[JR:5UV^YGT
MB_![%>.?AIBN L'GF'X>Q&(SG)LSCF.)P53'T8T\NQ7M*])T*5?#SYYT*E1T
MI*?+[6$(3483E4A^G5%?GO\ \/4OV"_^B[_^8P^,O_SO*/\ AZE^P7_T7?\
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M/_!"#_FZC_NA_P#[U^OW.^+G_)*?B=_V3WQI_P"HWJ5?AC_P0@_YNH_[H?\
M^]?KS9_QJ'_<3_TE'Z\?T(5^%/\ P7/_ .29_ 3_ +'KQ9_ZC]A7[K5^%/\
MP7/_ .29_ 3_ +'KQ9_ZC]A3K_PI^B_- ?JE^R1_R:E^S)_V;W\%_P#U6_AJ
MOH2OGO\ 9(_Y-2_9D_[-[^"__JM_#5?0E7#X(_X8_D@"BBBJ **** "BBB@
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MX/,,'PG@:JG)Y;D>0X"EB</A:E!8[&04N9?G>?\ C-XB\<5LRX>\%<'E_"W
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MW)_Z)@KH:XJGQR]3MI_!'T"BBBH+"BBB@ HHHH **** "BBB@ HHHH ****
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M?^%7\./_ )T]?L911[&E_)'^O^&_/NP/QS_X<B_LI?\ 10/VA/\ PJ_AQ_\
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M7RKE;/4+.X:)F$5Q$Q#C]>Z*/8TOY(_U_P -^?=@>>_%S_DE/Q._[)[XT_\
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M%:17,8(D\F_AM]=\MV PZK)X5!C1R0!),%4B27/YR_\ !:#XH67QW\)?L_?
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M_/\ ])9G5_AR^7_I2.3HHHKL.,**** "BBB@ HHHH _ #]D?78_^"??_  4
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M^#:GE7 ^&Q,,/BZ-)JUL;Q)BF\FP;]]0H+,:\J=J*G'];_ _@_1/A[X+\(>
M?#4#6OASP/X7\/\ @_P_;.RN]OHGAG2;31=*@=D2-&:&PLH(V98T5BI*HH(4
M=1117PTYSJ3G4J2<ZE24ISG)WE.<VY2E)O5N4FVWU;/UVE2I4*5*A1IQI4:-
M.%*E2@E&%.E3BH4Z<(K2,81BHQ2T222"BBBI- HHHH **** .W\-?\>,O_7W
M)_Z)@KH:Y[PU_P >,O\ U]R?^B8*Z&N*I\<O4[:?P1] HHHJ"PHHHH ****
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M-TW3[:&RL-/L+*%+:SL;&SMDBM[2SM+>*."VMH(XX8(8TBB1$15'\R?PA/\
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MWS_N/"7BZV?P+XVN3A8+571M/>_O)=T82.VT^\TW5(D9F++X:N2 X'EUC_\
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M/Q+U7Q]\3KB^LM9U!+RVAN= ^"WAC4--TJZ@@BFGU2W.J3:-[^S]_P %"/\
M@JIXGM=6_:0\.P_L3_LN7D&EO?\ @S1+*.'XN_$'2-%GO-0\.Z'XDBU40^)=
M432[W6]:N]+?QWI_A[PKX<O=5O=;T?X?:IJUQ<R7'EY=X<5<CJT<7Q34RO(,
MFA[;&XF%:O"&(J8FM5EB:M&EEM*"Q698G$8BK5KUXX.,J>*FZSGCZ3JO$'NY
MMXVX+B;"XO*O#?"YWQ9Q+6G3P."E@<#.6 I8915#Z]B<[JU?[.R3"T:,:=*C
M6S6<,3@W*C/^R,5[)X27+?L&_#X?MM?MM:'\?M,M-3U']E']B/3;WP5\*?$'
MB:)H-0^+/QFU&]U7Q3X@^*6J6.U$'BKQGXZ\4Z_\</$\D9AFT6^O_ 6DWD,N
MYUC_ $;\5ZU;_M#?MH62Z=(-2\ ?L]Z8X-W%METZY\7QW3/)-!-NDC,W_"0?
M988G0!+J#P?+- 3'MG?0^('CGP+^S/X#\*?L8_L;^&]/M/%,5F_ABWM/#[K<
MCP5%<J[:MJVLZHSM)?\ CO5))+K4]5U74[B6ZL9FO->UR=)Q:PS^N_ ;X/:?
M\%O =IX:BEAO]<O)3JOBC68X]G]HZQ.BJZ0NX$QT_3XE6SL%EVEHTDNWAAN+
MRX2OYS\1>**7CIXE93PKP]3G/P_\.,UR_,N*L?)QJX7$9EDE=YCD7"#KPE]6
MQ^;8O.*W^L?%:HQJT<"J&'P%:JL155%?MWACP54\%O#S'YCG>(HU^.^.J6,J
M4U0C.ER?VIAZ6 Q^:X6E47UC"9)E>48:CP]PU"M*%7$4HSQD*48>T:]JHHHK
M]B/G HHHH ]0\$_\@JX_["$O_I-:5V%<?X)_Y!5Q_P!A"7_TFM*["O%Q'\:I
M_B_1'T^#_P!UH_X%^;"BBBL3I"BBB@ HHHH *Y/Q1_RX_P#;S_[;UUE<GXH_
MY<?^WG_VWK2E_$C\_P#TEF=7^'+Y?^E(Y.BBBNPXPHHHH **** "BBOFW]H?
M]KK]GK]EGP_<:Y\9_B5H/AJ[%C/>Z5X0@NHM3\=^)#%'(T5OX?\ "-G))J][
M]JF1;--1F@M=#L[B:$ZKJNGVS-<)TX3!XO'XBGA,#AJ^+Q-:7+2P^&I3K5JD
MGTA3IQE)^=E9+5V1PYEF>6Y/@J^8YMC\'EF PT'/$8W'XBEA<-1@NM2O7G"G
M&^R3E>3T2;:1])5^%G_!***#0_VL_P#@J+X.\)"-_AOHOQWLI=&2!@ECI.HO
MXV^,=D=/TJ&(M;R6GV2S-C]H1R6M-#TML;9N.6\0_M^?ML_MP0:KX'_8#_9T
M\1^ O >MK?:+<_M'_%"3^Q_L-A<)<VESJ'AZ_21/"_A_6K10K@Z3JGQ"\0V3
M,LMCI=G?BUN8_P!(_P!A']C/0/V+?A!/X-37I?&OQ#\9:P_B_P"*OCVX2>-O
M$GBFXB$2P6"74L]Y'HFC0%[;3S>3/=WUU/J>N7:6MUJ\UE;?>U,!/A+AKB'
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MC"$7*3=KNR5WHDV^R3;T0FU%-R:26[;LE\SVUF5%9W9415+,S$*JJHRS,QP
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M2C&*M&$(I*,(16D(04815E%)*QI&*BK15E^;ZMO=M]6[MO5ML****S&%%%%
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M8TZ5-/EITXQA!**27[=_%S_DE/Q._P"R>^-/_4;U*OPQ_P""$'_-U'_=#_\
MWK]?N=\7/^24_$[_ +)[XT_]1O4J_#'_ ((0?\W4?]T/_P#>OUW3_C4/^XG_
M *2C _H0K\*?^"Y__),_@)_V/7BS_P!1^PK]UJ_"G_@N?_R3/X"?]CUXL_\
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MV8U/Q1XIT?1H)=+UZ/2K:YO?[0O]+L].@F>']!*^9OVM/^26>%?^SF?V*_\
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M&U*:]'VG1M9TW4=,U"&/PC<RV6I6-S:W#I/"T([?]DO_ ))9XJ_[.9_;4_\
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M!WPV\-)!?>,/$Q@\R,7?V>6:&VT70$ND^SW/B#5YK:R619K>P74M1B&GR=F
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M:V%A:V]E8V5O#:65E:0QVUI:6EM&L-O:VMO"J0V]O;PHD4,,2)'%&BQQJJJ
M+%%%?&MMMMMMMW;>K;>[;ZMGZDDDDDDDDDDE9)+1)):)):)+8****0PHHHH
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M^@4445!84444 %%%% !1110 4444 %%%% !1110 4444 %(2%!9B H!))(
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M'_80E_\ 2:TKL*X_P3_R"KC_ +"$O_I-:5V%>+B/XU3_ !?HCZ?!_P"ZT?\
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MK?6?!E_>77A:?2[/6+W7A#+(_P"M?P2_X)Y?L\?#+XI_ GXU?#7Q#KVJ:/\
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M&]2K\,?^"$'_ #=1_P!T/_\ >OUX<_XU#_N)_P"DH_+#^A"OPI_X+G_\DS^
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MO_7W)_Z)@KH:\*\4?'7X(_!6QTG_ (7)\8_A5\)?^$EN]6_X1S_A9OQ"\(^
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M?1]2QG_0)B?_  15_P#D ]I3_P"?D/\ P*/^9]4T5\K?\-U?L1?]'C_LK?\
MB0OPC_\ FOH_X;J_8B_Z/'_96_\ $A?A'_\ -?1]2QG_ $"8G_P15_\ D ]I
M3_Y^0_\  H_YGU317RM_PW5^Q%_T>/\ LK?^)"_"/_YKZ/\ ANK]B+_H\?\
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MO_L>O"?_ *C]_7[K5C3A&="$9*Z:[VV; _EK_P"'(O[5O_10/V>__"K^(_\
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M\3:-'!<QO+J&@QR?#K1HI-4MX@[V<<NK:?%),%26[AC9G']-]%/ZM2[2_P#
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M1PV8SQF7TE+!8>K0K.E+-\\J8FM2=5J2PL)^[#EE]:?L&_LV^./V7/A!XB\
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M%\$? FE^$=.NI4U#Q/KFUM2\:_$'Q%M?[7XP^)/C74#<>)?'GC#4IIKBXO\
MQ%XEU'4-0EDGDBBD@M1%;Q^^5Y,I.4KWDWWEW\ELEY:^IXW&7%^/XESBCF%;
M.^(LZJ811]GC<_Q-";G6A4<_;9?E&'A+!9#@FHTHT\IP]?&TJ/L[_691FJ5/
M\U[C_@GWX\\)J-7^!?\ P4#_ &X?A_XQM2);2?XI?%*P_:A\ :A+P9+?Q/\
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MA*4))QE%N,D]TT[-/T9\\TXMJ2<6FTTTTTUHTT[--/1IJZ>C/,?C#\9?AG\
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M&HV#^%=9-UXDUJ"YU:>R\36TMM+8B+2+>6SEEO/RJ_X9D_X+0?\ 0R?M"?\
MB6^@_P#SZ*/^&9/^"T'_ $,G[0G_ (EOH/\ \^BCAOBWB#A'-(9SPYB\3E>9
MPH8C#1Q5*C0K25#%4W2KP]GB:-:D^:#?+)TW.G.,*M*4*L(SB0G*G+F@[.S5
M]'H]]TT?U*45_+7_ ,,R?\%H/^AD_:$_\2WT'_Y]%'_#,G_!:#_H9/VA/_$M
M]!_^?17@>VE_SYJ_^ O_ "]?Z>DG[)_ #]@/PK\ _P!K#X_?M3Z7X^UCQ!J/
MQP'BKR_"%[HMM96WA1O'?C33?'WB[_B=0ZE.VNI<^(-*LQHRMI.DOI.FB6TN
M)=5FD^UK^@-?RU_\,R?\%H/^AD_:$_\ $M]!_P#GT4?\,R?\%H/^AD_:$_\
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M.**SPK2J4,ERY2E+EM&AB<]4L7%<T9)2J83!U5%6NY*-K-*2^WJ*S=6UG1]
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M:+4=-L;I+=XGFM8-/368I(K8Z]KNJZFMVJ:GA+QU\:/^"8'BGPU\2_ASX_\
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M#QMH\$27&K?V8L5L]AIWBFV,>MV4"VL=K874^I:!#+<3Z%=N/M>OQ_'AR/\
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M* "N3\4?\N/_ &\_^V]=97)^*/\ EQ_[>?\ VWK2E_$C\_\ TEF=7^'+Y?\
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MPE:%T<[6@BBD FCD2/\ MFK^=/\ X+%_\$S_ (Y_$OXK^ /^"@W["]CI-_\
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MXW&<09GF&68K 8+#8'#X+$XJ=7!*IBX5\=CG!X.CA(R<JDI5(0?]05><^*/
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M-=Z4-)T\Z=J>JC5+:0W]RNF2XLE_1JOUSQHX@R?B7BO+<?DF.IYAA*/!_"F
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MX4O=8D,.GV6G:.-:UR*.#0?"ECKEW:ZKK%C\+_\ !.#]DSXV>$/%GQD_;?\
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M?SW_ /&^C_/_  QK1_QOH_S_ ,,:U_0A15^Q_P"GM;_P/_@&1_/?_P ;Z/\
M/_#&M'_&^C_/_#&M?T(44>Q_Z>UO_ _^ !_/?_QOH_S_ ,,:T?\ &^C_ #_P
MQK7]"%%'L?\ I[6_\#_X '\]_P#QOH_S_P ,:T?\;Z/\_P##&M?T(44>Q_Z>
MUO\ P/\ X '\]_\ QOH_S_PQK6_X5?\ X+JQ^)=";68=$GTG^U;)=2C\2']E
MH:!]B>=$N'U@^#98?%?]GQ1,TMT/#TG]KF)&%BDDY2-_WQHH]C_T]K?^!_\
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M_P"O^'?E8/YK?^'4'_!0/_HX[X>_^'?^-?\ \[FC_AU!_P % _\ HX[X>_\
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MK0O[U*KCL52=FF@HHHKZ,\L*\?\ %/\ R'K_ /[=?_2.WKV"O'_%/_(>O_\
MMU_]([>NS _Q9?\ 7M_^E0/-S3_=X?\ 7Z/_ *14.?HHHKU#P0HHHH ****
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M (?#?L7_ /0;^(7_ (05_P#_ "51_P /AOV+_P#H-_$+_P (*_\ _DJO0O\
MAU;^P7_T0C_S)_QE_P#GAT?\.K?V"_\ HA'_ )D_XR__ #PZG_:.]'_R?_+^
MKORL'GO_  ^&_8O_ .@W\0O_  @K_P#^2J/^'PW[%_\ T&_B%_X05_\ _)5>
MA?\ #JW]@O\ Z(1_YD_XR_\ SPZ/^'5O[!?_ $0C_P R?\9?_GAT?[1WH_\
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M#?L7_P#0;^(7_A!7_P#\E5Z%_P .K?V"_P#HA'_F3_C+_P#/#H_X=6_L%_\
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MXI\9"Z\3Z3+J8VMIUGKPTBST._F\V.*ZL=1N=,NA<V=_<65U^@E>=?%CX3^
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MO&7_ $<#\7?_  2_ 7_YR5']LYC_ -$GQ!_X4\*__1,'U#"_]#K+/_!6<?\
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MP/Q=_P#!+\!?_G)4?\*V\9?]' _%W_P2_ 7_ .<E1_;.8_\ 1)\0?^%/"O\
M]$P?4,+_ -#K+/\ P5G'_P Z?ZL_*_KM%>1?\*V\9?\ 1P/Q=_\ !+\!?_G)
M4?\ "MO&7_1P/Q=_\$OP%_\ G)4?VSF/_1)\0?\ A3PK_P#1,'U#"_\ 0ZRS
M_P %9Q_\Z?ZL_*_KM%>1?\*V\9?]' _%W_P2_ 7_ .<E1_PK;QE_T<#\7?\
MP2_ 7_YR5']LYC_T2?$'_A3PK_\ 1,'U#"_]#K+/_!6<?_.G^K/ROZ[17D7_
M  K;QE_T<#\7?_!+\!?_ )R5'_"MO&7_ $<#\7?_  2_ 7_YR5']LYC_ -$G
MQ!_X4\*__1,'U#"_]#K+/_!6<?\ SI_JS\K^NT5Y%_PK;QE_T<#\7?\ P2_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTC6=5T2Q\2W'A3PEH#:1 @N=#BDL[NXUR2SL+E[A[J__ $T_X0G5?^?C3_\
MO[<__(E'_"$ZK_S\:?\ ]_;G_P"1*UCF3C&</K',INBY.3E)M8?F]E"[O[D6
MT^7;W8VLE87U+$_\^9]>BZ_/R/S9_9A_8-^%?P7\!? D>+_"]CK7Q4^$WAGP
M_)--IOCGXCZS\*M-^)=KX7L_#WB'Q_X)^&6NZM8_#O1O$^LF"XO+KQI8?#O0
MO%>IZE>W^OZC<_V]JFI7MQ[/XJ_9+^!'C#Q5XH\8ZKX7\16&K>.XK.'XA67A
M#XG_ !6\ >$OB3'8V]Q9(OQ,\!>!/&WASP+\1C=:9=3Z+JS>-_#FO-K>@.-
MUEK_ $6..Q3Z_P#^$)U7_GXT_P#[^W/_ ,B4?\(3JO\ S\:?_P!_;G_Y$ISS
M.<ZDJKQE13ES)M5:BM&4_:.$;/2"G[R@O=3L[75P^I8BUO82MZ+_ #/D/QW^
MR9\ OB5K,NL>,/!5]?0WJ>$H]?\ ">G>.?B%X;^&?C2/P+=VUUX4C^(OPE\,
M^*]'^&'Q)325L=-TU5\?>$/$:W>@:3H_AJ_%UX>T?3-,M/4OB7\-/ OQB\"^
M(OAK\2O#MIXK\$^*[2&SUS0[R:\M4N4M;RVU*QN;:^TVYLM4TO4]+U2RLM5T
M?6-*O;+5M'U:RLM4TN]M-0M+:YB]J_X0G5?^?C3_ /O[<_\ R)1_PA.J_P#/
MQI__ ']N?_D2LWCK^SOBIOV33I7J3?LFN6SIZ^XUR1LXVMRQ[*S^IXG_ )\S
M^Y?YGQKX=_8]_9]\,:UXT\367A'Q!J?BGXB^ -7^%WCCQ7XP^*/Q9\?>+/$_
M@/6_L@OO#VK>*/'/CCQ%KUS#''8VEOIEX=1&I:):0BRT6]T^T9X6[>7X ?".
M;PC\&_ DGA+=X5_9^U;P-KOPBTK^WO$P_P"$2U7X;>'[GPMX*NOMRZR-2U[^
MQ="O+FQ\CQ->:U;:CYGVK5H;^\2.X7Z3_P"$)U7_ )^-/_[^W/\ \B4?\(3J
MO_/QI_\ W]N?_D2F\P<FG+%U)-6:;JU&TU%P33;Z1;BNT6UL["^I8G_GQ/[E
M_F?$?C?]B+]F'XC:IXWU/QC\-)-5A^)-U?ZIX[\-1>./B-I/@#Q1XBU+P_+X
M8G\::K\--%\7:=\/9_B##I<JRZ=\0U\,)XXTC6K;3_$VD^(++Q+INGZM:_2.
MC>'-%\/^'-*\):581P>'=$T2Q\.:;I<SS7T,.BZ;81:99V$LM_+=7%Y''8PQ
MV[O>S7$UPH+7,LKN[MZ7_P (3JO_ #\:?_W]N?\ Y$H_X0G5?^?C3_\ O[<_
M_(E*>.]I&,*F*G.,/@C.I.4862BN5-M1]U):):)+9(/J6)_Y\3^Y?YGQ+:?L
M4_LXV'@.U^&5GX0\4P>"-)\6Z%XZ\)Z*GQ@^,Y;X<>+/#5SJ-WHFM?"35&^(
M+:S\'[BQDU?5(UB^%^H>$;6>TU"\L+F":QGDMV6S_8H_9HL_"7Q<\$K\/+V[
MT#X]0:/#\83JWQ!^)NMZ[\0'T&>\N=.O]?\ %FL^,K_Q9-K(GO[N6^UZ#6X-
M:U9I%.K7][Y,/E_;/_"$ZK_S\:?_ -_;G_Y$H_X0G5?^?C3_ /O[<_\ R)5_
MVG4U_P!MK:R4W^^JZS4HR4W[VLE*$)*3U4HQ:=XII_4\3_SXGVV6W;<_-_\
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ML%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<(<O/-1;C#F=H\\DK1YGI&[5WHKL5TFDVDW>ROJ[;V76W6QZG1114C"BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *_E[_ &O/^'Q/_#RR#_A2G_"\O^%._P#":>#/^%:_\(I_
M;_\ PSA_P@_V;0_[3_X63]F_XHCSO/\ [7_X2O\ X3?_ (G?G_;/[ _T'^Q:
M_J$HKT<MS#^SJM6K]4PN+]K0G0Y,53]I"'.XOGBKKWER\K[QE*-U>YC6H^VC
M&/M)T^6:E>#LW:^C\M;^3284445YQL%?C?\ \$HO^2H_\%2O^TBGQS_]2+5*
M_9"OQ9^%?[+7_!2+]FOXI_M8:[\"-2_8AUKP/^T=^TE\2/CG8W/Q;UOX\3^*
M] M?&>O:A>Z987>C^#O".EZ0]QI^G7,'V^QAU^XCN;V.:.WUN&"1)H_6R]TY
M8/,\/*O1HU*]/"^R]M/V<9.EB8U)I2LU=03=NNRU,*MU4HS49247/FY5=KFA
M9:774XGQOXOL/V<?^"N_[0'C3P#I(U#1M;_X)N>(/CQ\;_#>GK'!;7WC#X:>
M)M471M5G^QQVT-AJ]WH?ASPUI8U'4Q?&1O%U_+(S3ZG;-:_&GA/XP_';XM?L
M]-\=5\>?\%;M0_:J\7:%J_Q!\$7GPB^"_P 4;G]DBVUV5[K4/!O@G1O >CZ!
M=> ?%'P[>"*PT+5/$%Q;ZI<WC3WFLK+=K#':3_L;^SI^P;<>#[KX_P#Q-_:9
M^(:_';]H#]J3PS-X&^*WBG3=+;PMX1T#X;S:0VBQ_#/X=Z*LLMUIV@06;1QW
M.J7+PW>JMI^DW#Z?875I=2W_ (=\'?V;/^"GG[,'P^M?V=O@G\6?V/\ QC\%
MO"L^L:9\,_B'\8M!^+8^,OA#PEJ>HWM]9:??>&_"4*>!?$E[X>%XRZ.;W5H+
M42!8[Q+G2(+71H/;IX[ I.,*F&JXG#4\NH.OB&Z5/%4</1JQKJ$ZF'JRG1C4
M=.FZ4X4Y8BC"G+E?(H+E=*K=-QFH3E5FH07-*$IRBXW2G%*5DWS)M1DWM>Y\
M<_M>?#KQI\>_B!_P28^)OQ5\7?M&?!KXE?';Q1X9\,?$'P!H?CKQ!\/_ /A4
MOBJR\&V=YKWB+X=^%[G3H;WX;>/]0U6\NEU'57@.J_V=#IVG7ENCV3;O9_VN
MOB3XW^"WQ@_9@_83\-_$S]MG7?AU%\,?&7Q?^*OC_P"#\?B7XS?M<_$G2QXK
MUC3?#'AA?&FBZ7/XLT72M,U:*^?Q#XJL;6WN(O#XT318KF!H(WD^T/VP/V3O
MCC\;/"/[+/B[X:_$7P!)^TE^RU\0_"7Q(T[Q!\2=)UK1OAO\2-9L-%M],\9V
MOB'3?!45_JGAO3O%5];1:DL&AVEW)86GVG1[*6R^TQZG:<+\8OV2OVL_'_BG
M]G7]K#P;X^^ W@?]MWX->'_%?@WQ=I8TWX@:E^S;\1/ GB?4M7N$\&W;7/F?
M$2RMM*MKY)DUB&VCO;K5KS4KVWMM*>WT5M/SHX["U(8!5:V'C2HT\PI0P\N9
M0P^)G+%3P53WJ,Y*C&%2G3A6<)NE/EG."E!R3E2FG6Y8S;DZ4G-)-S@E351:
M22<FTVXW5TFD[.S\I_8<^(?QSTO]K+Q/\+]/T;]O#Q1^RCXG^$DOBS2?%7[;
M7PW^(6D^*OAO\6]%UZVM+SPSI7Q(\<:-!>^)/#GB7P_<_;K+3-2U66^M=01X
M[*W^SZ=>W5[Y5_P2(\!?'3]I/X'_  G_ &GOCA^V'^TSXBNO!?C3Q7H_@WX=
MZ3\2;ZR\&^(=$T+Q3K=UJB?&N'4[;6-1^+%YJVKZQ>65C+J]_;OX=\)Z1X=T
M+2+B""QC6V_4/]GW1_VY'\8:WXC_ &JO%_[.5OX8_P"$:_L?PU\-/V>]#\=7
M=BNO/JEI=OXO\0>./B0MIK]Q=Q:?!=:7;Z'IFEV.CF'4!/.LM[8)=7?#?\$U
M_P!E;QW^QI^REX4^!7Q(USPEXB\6:)XF\;ZU>ZEX(NM8O?#KVWB/Q'>:GIT5
MK=:]HOA[4I9TL)+<WJRZ3;QPW;36\$EW#$EW/SXG'45ALP5/ZI#%5)993C*B
MHUW4IPI8^.)J*K.A"/M)*="%>I2C%3;5Y3E*;>D*4G.ES>T<$JSM*\>5N5'D
M3BIO323C&3=M=$DK?DI^R;\-?VFOVN/V=_VEOBMXN_;N_:C\%O\ "SXK_'GP
M]\)-#^'_ ,1-5T467B#PIL\51ZK\0M>GFO?$/C7PN#JFG>'])\ QZEH_A_0M
M#T^Y73ECN[Y9;2?PIH7[87QV_P"";^M_\% /%/[;/QXT'XO^$?A-XH^(WPV\
M%_"SQ#8_#_X4VOAWX)-K%OK2_$OP=9Z<+3XE>)_&D/A#Q!K>MZAJL\5C'=ZA
M86-CI<VG6CZ7=?IY^Q'^QW\1OV:OV=/CM\'O''B#P5J_B#XG_%SXU>.]!U'P
MI>Z[>:/9Z)\1M(TK3="@U>35_#^B7L&JVK6$DNK6UE97]I;JZ+9ZA?G<16^#
MW['/Q,^'O_!+[5_V*-8U[P+=_%/4/V?OCG\*H?$&F:EK\OP_3Q'\3H?B"FA7
MDFJ77AFS\1C1+-_%FGC5KI?"KWT*P7C6>FWQ2!+CKK9I05:NZ4\(XQS;!J@U
MAL/98"5.L\7RMT;^SJ5(4?;N_-.]FVISYLXT)N,%)5+O#U.?WY)^U3A[.]I;
MI.7+T5NZ5OF3XU?M'?%;Q/XS_P"")'C#2/&WBGPA9_M(W^E>+/BGX:\+Z[J>
M@^'_ !A'XJ^&?PO\1R:/XFT?3;R*PUO2;*[\1ZDUEINIQWMI:23M+ @F5)1Q
M/PW\'_'S]K/]O?\ X*'?"S5_VO?VA_A7\#O@SXT^%$EOX1^$GCN]\,^)WU#Q
M?X+UF#0M/\)>++R/5_\ A7WA333X9UG4_$6C>%=-L3XLUC4=/N]4FDDLFE;Z
M8U_]@[XK:M%_P2A2'Q/\/8F_81TKPO8?%CS=1\28\2R:'\-OA]X2N7^'A3PN
MQU-)=7\'WDD'_"2#PJQTZ[MKF18[E9;%?:?V9?V5O'GP4_:O_;O^.OB37/".
MI>$?VH?$OP8UOP%IVAWFLS>(]&M_A[X<\8Z9KT7BZSO]#T_3+&:>^\26PTC^
MQM8UY+JTMYY[QM.F,=JV#QF"H86J\-/#JO# UZ="]*$Y*K+/U4AR^TA)>T6!
M;G";]Z$$G%J459JG4E47.I\KJPE+5I.*PEG>S6CJZ26S=[IZGY]_"O\ ; ^.
MG[/G[%W_  4<D\9>.M7^-GC;]B3XV^/?A#\+?B/XY,5_XIU[3K[4]"\/>"=2
M\=33;F\0WGA[6]?.LZA->W-Q<:A8#^Q?/-O9VKM\WZS\2/VB_"?PI\(_%CX*
M:W_P6#^)/[5.F'P=XJUG2OB/\#/B_JO[,WQ3DO[_ $VX\;^&XOAX?#4WA7PI
MX2N]*N]2?PEJ/AVPCO;2"TL(XYQ/>_VA:?IUX/\ ^">.HZOX+_X**_#'XR>(
M/#\O@W]M'XW^,?B/X5O?!-[JM[KGA/1=;2RO/#EYK=MK6A:/8P^)_#VOZ?8:
MM_9MC<ZUH]R;*.&34I(II$&=\./A/_P5I\$^#?!_P8D^,G[%_P#PA7@[3]#\
M)V?QN_X1/XM:Y\:[KPAX?6TL[.ZN? VIQVGPSG\62Z3:I93WUYJ=[8RJIEN;
M>ZU.:35QT1Q>71E7G2^HNI+%4:U:-9^QHUZ$L'A_:0Y88:JITUBEB?;8>FJ<
MFZD90C)QBZ<NG6:@I>ULH.,7'WI1FJDK._/%I\G)RR;:LFKK6_Z8:AI\OC_X
M?WVEWD_BCP1/XU\'7.GW5SH6IRZ'XT\(2^(]$>WGGT;6(HC-H_BC0'O&DT[4
MXX/-T_5;2&Z2+?"$K\.?^"5O[+-K#X^_:T\?CX__ +4TLGP:_P""BG[2O@&'
MP?-\;-9D\ _$Z/PQ:>%+1?%_QE\+&Q^R_$+Q]KPU=KCQ/XHOY;>ZUF[TW2)Y
MHD:PC#?OO7YC? 7]F+]J_P#9P_:7^.>H^!?%WP$U_P#92_:$^/OBO]H3Q;IW
MBJ'XCQ?&OPOXF\=Z?YOBK2O"-CIJ'P-)#=ZS:Z1"FJZOK,Q.E::LJZ1;S2I9
MV_BX'$NG@\SP\:\*$J].E.$9Z1J*%3][3C)QE[[IR]U-IRLTGS6OTU(7J4)N
M+ERR:;6Z;2M)JZ]U25W:]NJL?G1^V1XW^'?PF\/_ !L\1I_P6$^,U]^V%X,B
M\6^+/"/P[\)?$VS\/_""#Q!HEQ<:EI_PEO/@KX*T7Q%X:ANY;"W?PG#8>*/$
M$M__ ,)!-9W^N&"!;RT;U+]K3XW?M$?%#3/^".\OPO\ C1XJ^"?B3]K;2HKC
MQ]K?A.XN[;36;XB_"GX8WVHZE?>$[2^M]&\0W?AA/%VNZKX/TS6OM.F:9XB%
MA>(T30"X3H_ O_!/W]N;X5_LO?$_]BSX?^./V1+#X5^.M(^*6@W?QMO-!^(K
M?';QIH'Q"D\175SI7CC1X]"?PFNMZC!K]QX/F\=2:WXJO?"_A&5#H>@7VJ:5
MIDJ>^:_^P=\5M6B_X)0I#XG^'L3?L(Z5X7L/BQYNH^),>)9-#^&WP^\)7+_#
MPIX78ZFDNK^#[R2#_A)!X58Z==VUS(L=RLMBON/$Y=2EAW]8P^(="IF'LZLX
M4)*=*>6U88=NA3PE*%"E/$JG[/"U)5Y4JC?-R\SOR\E9J7N3CS*C>*<])1K0
M<ESRJ2<I*'-><>7F6U['@G[2>A>)OV=/B1^QI^R9JW[9/[3'@OX!?'/QS\9_
M$_Q-_:*^)'QMMKKXM7FL>%_!_AJ7P?\ ![2OC)/INC:A\/O#6J:LSW$+R&)[
M_4/$$EEI%\CV8M8.'_9@UF^^''[4W[?_ (W\/?M0?M/_ +37P+_9'^$^F^+_
M  1%XO\ VA_%/Q)^'&I^(M5^&_B#Q/XS\!:S/J%WJGAKQ;K>@W6DM'H>K64M
MC?>&9X)+;5DU"]5[IM7_ (*927&O_M\?LG>#- LOV>(?$D?P/^+6I7=_^VG+
M#JW[+^N^&M<U2+3KOPM_PB,EB+J^^(?VK1EO1=Z9K5A<2:=/I%O=6\]K!YD/
MH?[*OQF\4:Y\8_%O_!/3QY\-/V+M;^&?BWX&^+?%NL>)OV Y=6TOX9^#].UY
MY/">K>'?B!X<F:^M?#&N>);*[-K8R1:A!?29TB]6&ZMM6C72W[_]ETZKC&I+
M$8"=;%P_<TFZ?]HSJ5L7\'-.L\/!89156#=.7NQ5E3D67UAJ]E&JHTW[SLU1
MBHTWK914VYW<7JKW>Y\)>$_C#\=OBU^STWQU7QY_P5NU#]JKQ=H6K_$'P1>?
M"+X+_%&Y_9(MM=E>ZU#P;X)T;P'H^@77@'Q1\.W@BL-"U3Q!<6^J7-XT]YK*
MRW:PQVD_I_[3?PQ\:?'SX\?\$E_B'\5O&O[2WP9^)/[0MOX@L/B%X(T+X@>(
M?A]<_!GQ9X;^%?AF?7;_ .%GAZYTV&_^%GB?Q#JDUT?%$I@?4;^S%G8ZA#')
M:MG[-^#O[-G_  4\_9@^'UK^SM\$_BS^Q_XQ^"WA6?6-,^&?Q#^,6@_%L?&7
MPAX2U/4;V^LM/OO#?A*%/ OB2]\/"\9='-[JT%J) L=XESI$%KHT'L_[7'[)
MWQ^^+MI^R-\2_A3\1?AM<?M'_LI>*H?%$>K?%'2?$&A_#CXE7>L^&=-T+QY_
M:]EX%BU'5/#4.OW>E0WUO9:38W:6EM=76G6UU9@1W)<LQPU+&P=&K@J=&<LP
MA0Q%.3<Z='$82M2P].<%A:2P]!570E[*3E*C*,VDH.I*8J,W2?-&JY+V+E%J
MRE*-6$IM/G?/+E4O>27,FNMDONCX8> H_AAX!\,^ 8O%_CSQ['X8L&T]/%_Q
M/\3W/C/Q]KH-S/<_;/$WBB[B@N=9OQY_D"ZFB1Q;0P0X(B!/XY?MC77P8\/_
M !'^)Y^,O_!6_P"+WP5^)E\;N]^%?PI^%WQ/A^&?A'X3P'25E\):;X^\$>!-
M*\3Z]XMCDO?LVI:UJ?BVYTN[\1Z5<R)8Z?9QR6\X_8_X9CXF#P'X9_X7(W@5
MOB<=/SXQ/PS3Q G@-=5:XG(C\,CQ3))X@?3XK4VT?FZH4N9[A9YO)MXY(X(_
MS!\%_LB_MI_ ;XJ?M0ZI\ /%G[*0\+?M-_&GQO\ %^3XM?$OP[X]U#XY_#-O
MB!/!->^&M-T32-,;POXZT'P:\"7/@?1M?\7Z3HMOJC75[J6GW%MJ-WII\/+J
ME.&(Q56MB:<*D5>.M&$:\G6BZCA7JX7%1IQ2O4<84'.M"].*LW%]-:+<*<8P
M;CU7O>ZN71.$:E-R?36246KON?$7Q6_:[_:/\;_\$B?V)?CYH7Q4\1^$_C7X
MV_:+\">"?$'CC1;V[T&;Q'_PC/CCXM^"6'BFU\.W.FQZSHGB";P7I.H^*=#<
MQ:;X@VSQWEFL4[0)] ?%'P1\=OV(OVC?V&O$>G?MA?M$_'"S_:$^.VE?!'XV
M>#_C+XL@UWP!K7_"469(\2>!O!-K96VD?#AM.E:[N+/3=%:<Q/!I4+:A+#%J
M0U/1O/\ @F/\:W_X)T?LP?L>VOC+X6_\)_\  W]H2V^*OB#7[C5O%B^#]4\,
M0?%+XJ^,OL>CWT?@MM:FU[^Q/'>EQ?9KWP]IVGMJMI?VW]HI:+;W\_W#^V!^
MS-XZ_:!\>_L<>*O!NK^$],L?V>?VF/"GQE\9V_B:]UBSN]4\+:);3Q7MCX87
M2M#UF&\\0.[Q_9;/59M&TZ52[3:M;E%63U:F-P$:WL:,L*L)4QN?>UC[&FT\
M/43^H+F=-SC"]G049)1DE*R<8M81I57'FFI\\:>$Y7S.ZFK>UT3LWI[UUKKO
M=GQY<Z;\6_V[/VXOVJ?AI-^T=\>OV?O@+^R+:?#7P3H7AW]GOQPOPQ\8>./B
M)X]\.W7B+6?%GBCQ+9V.KRW^E:1+87VGZ?HE\EQI]Q:1Z%=QV5A<OXBM]1H?
M\$K_  KXS\#?M0_\%.?"'Q!\?W?Q3\6^'/BE\#M)U+XA:CI=IH^J^*X+3P3X
MNCTC5=8L+#-G'K<FBC3HM:GM_P!W>ZI%=WPYN37K_CS]D_\ :Z^%?[5WQ:_:
M7_8I\;_L_P 6G?M%:)X/MOC+\,/VA;3X@P^'8O%?@72I=$T+QMX5OOAS:76I
M3WQLI)I+S3+N?2(+BYU+67GNYVO+&72^W_88_9!^,_[-7Q/_ &K_ (A?&7XJ
M>&_B[JW[17B'X5^,$\5:387>A:M+X@T#PKK-OXXAU3PP-*MM&\.Z):^(]<FT
MWP+8Z-K&N$^$M.TYM4;3=0$EG6-;%8?^SL52I8G"JC5R[+:>'PL*?+B(XFE6
MP,L;[27LE+F=6G7JR<JK59.$XIQII4ZA"?MH.4*G,JU9SJ.5X.$HU%3LKVLH
MN,4E%<KNGJ]?G;_@N%>ZKIGP/_9+U'0M$?Q+K>G_ +?GP'O='\.1ZA9Z3)K^
MJVGA'XM3Z?HD>JZBRZ?ICZK=QPV*ZA?,MG9M.+FY801N:\H_X*(?M$?MJ^+/
MV*OVA?#GQ&_X)WZY\)_!.K>"$MO$7Q%N?VH_@1XU@\*60UW1Y5U&7PKX9NWU
M[6E:XC@M?LNF*UP#<";!CB>OT(_X*!?LK^/OVL/!W[/OAWX?ZUX/T.[^%'[5
MOPG^.?B.;QC>ZU8VUYX1\"Z9XRL-9T_16T30=?EN?$<[^([.33+.^BTW3)UA
MN1=:Q8E8O-]0_;;^!_BS]I/]E3XU_ SP-J'AW2O%OQ(\)IH6AZCXLN]2L?#M
MK=KK&EZ@9-6N]'TG7=3@MO)LI5#V>D7TOFM&OD["SIG@\?A*-+(X5*6&K2H8
MZM4K3K2Q49X2$L3AY*I%4,11IN\8RG^\A57N+W;7C*JE*I)XIQE.*E2BHQBH
M6J-0DK-RA)[M1]UQWWO9K\L?VE?^2J?\$&_^QCM/_5;?".OW%^(?COPY\+O
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M@5\)DTB*+PZ=7T^XU;3M(\#:;-J5M+>:=X'AM+<7&E7#ZC8\;?\ !*KQTW[
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MA_9WM?\ @KI\2I=0^*G@_P (_'SP=^UG\)OB]KGPP\1_##Q',=.\4^,=.O\
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MPST>?Q%:^%=1\"VUCJE@NEVUEINI^([V>]AM)--MM6%E5_;5^(^H_"S]DO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ=IOA[Q5XX3Q+XZ\$Z1K+>(=7M4@U3QZ?$/AK4]<\67%CK=QJLMO?6K:_;B
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M&ERZK96UOJD".]J\T88C\?\ X5?\%2=8^%/_  2^_9]_:F_:"UCPO\5_C?\
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M,BUJVUVVO[6?1[G1Y[5;Z'5H-3BE:RFTR:R9;R*_CG:UDM66X24PD.?Y]O\
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MI;0?\2EM+>R:>UN]-N8KN\%QY[X5_P""5_P/T'XE?"OXR>)?BS^TS\6OBO\
M"'Q=HWB?PQX_^+_Q4L/'&OS:?X?LM4M=*\#7OVGPC:Z;9^"8)]6N-4GT_P -
M:?X?U;4-5BM;K4=;NUA\IOTRHKHCF>/C&I".+K*-65251<WQ.M%0JZVNE4C&
M*G%-1ERQNGRJT.A1;3=.-THI:?RN\?6SU3>JN^Y^;/Q._P""8'P@^*'B3XB:
MA>?&S]K#PEX#^+GB;5O%_P 3O@9X&^.%WHGP5\:Z]XBN?MOB6[U7PG<Z#J>H
MVT?B2\"W.M6FC:_I=I=ND48ACMX8H4]2^/?["'P<^.^A_ S2XM>^*'P5U?\
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M%MQK/3XU=V>VNP_9TTE'E5E!TTNG([7CZ:(^28_V,OA5%\:_V?/CRNK^.?\
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MO?$'_A4O_"$?\('_ ,)!_:WA[_A8?]D_VU_;OVS^U_\ A%?^$;_M3[=QYO\
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6BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img181012247_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_12.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ))!-0# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5XCQF:\/O!WX8XJ\-^'>)92Q&,S.AFF59SB,GS3,\PQE3$PQ>4X7]0?AW/\
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M+'.D=M/[?^V_^U#!\1O%VN_L"_!;XA>$/!'CCQ9H<5G^T1\:?%?B+1]"\,?
M3X8>(K>+^U-*L)=6O+)/$?Q8\;>'[J:P\.^&M-F%QI-CJ+ZU>76FF'^T-+V6
M'<I8>?U*A2FZV,A7C4IU/94L)AZF%<<1*FY7NG4K8?F:E*JXJ,5+$<LCIC@7
M5J8&JLGP6'K2Q6;4L72K4,0L-A\KP-;+I0Q]2@ZG-S0=;&8%5&JD\1*"ITX5
M,:Z<S[A_9'_: M_VIOV</A/\?;?07\+GXC>'9=2O/#[77VY=*U73-6U+P_K-
MI;WAB@:ZLEU;2+UK">2&*:6R:W>:-)2Z@_:W^/4'[,O[.GQ4^-/V.TU35_"'
MAQU\(:%>&1H/$7CO6[JWT#P1H#P07-I>746J^*=3TJUN[:PN([Y[)[EK5UE1
M77S#3_@YKMI\"_A'\,_V%_VB_ WPB\"?#'3SX6373\.?#G[0MEXDT[3;2"!+
M>>ZC\<>$K*RU\:E]KU?7=3AN;F;4M1U*X>>SMBRD_$_[6D'[1OQ'^+O[&_['
M'A7Q1\,/C9\8_AU<7O[8?QG\0>/-$U7X4?#'Q!I7PU\2MHWPFC\1^'_!$?Q*
MUC1-,O?%6JW$4FBPK>VFKZEX=TBXFNDBO;@:=Q4,-AZ^-YHSIQPZKUJL\-4=
M6%2EA*+G4Y:M2=-4H\T(QI)JM.7/.-UO;R<)E^!Q>;<].K1IX".,Q>)JX"N\
M52Q&%RS"RK5U'$UJM!8:'M*-.&'4HXNK456M3YHWYN7[;_84_:2\?_M%?##Q
MC'\:O#7A?P/\?O@U\5O&WP>^,_@WPA-.?#VE^)_#-['<Z=J&@P7VN>(]0.A:
MOX?U'3&L]1EUK4[/5-0M-7GTR]DM$6*#Y"B_;3_;?^)GP9^(O[8?P)^&'[/%
MU^S%X-O_ !_J_A#P;X\NOB$GQO\ BO\ ##X8:KJ>G>)?&^DZWI&L6?@GPC<Z
ME!H6MWV@Z!J6AZ[=2G39;19+TW&F76I<1X L_P!H;X/_ +?_ (K\/?M&:?\
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MFFTTTT[-/1IK=-=&CX=IQ;C)-23::::::=FFGJFGHT]4PHHHI"/RB\??&/\
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MPF$P^-XBS+#X+/I5,#1E''4Z>198\;A,GKQS[-JRI0PLL+A,5RSI4L52QM'
M83.)0FE%<SNHS@DG-I3ND[KEC=1?/)M)63[IV4CZN^+G[0WQTUK]HW_AF']E
MW0?A5<>+/"WP\M/B3\5?'OQB'BZ\\)>$;'6]0:Q\,>&+#0?"-]H>KZMX@U>*
M-=2:>+5OL%K87<#N&FMKR),WX+_M2_'/XF> ?V@_",_PF\'7W[6/[/'C.W\
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M_$SXH%3+>>%?"]Y-H=N(#<B\\4ZD\.B^$;!X 09(]0\4:EI%E* &81SLP1R
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M#=>"C;65]#JEG;_\(K/8/H7D6FIV\&HVT/V#RX+Z"&[B5+B-)%^<M%_;^_9
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M+*,/AL7AZF8XS#Y51EF.'^:O^"4")'X^_;=1%5$3XKZ$B(BA51%UKXH!550
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M_%M]INHZ[J&LZM!86EQ/=W6DZ1H=DZQV>EV%I (].C<0VR>;)-*6D;S[P/\
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MVSI%OJD,X!U67R)$C"*9?N/X'_ ?_A2*^)U_X7-\>_B[_P ),=&.?CA\1/\
MA/F\/_V.-5&/#)_L?2?[*&J_VIG61_I'VXZ=I7^J^Q_O*/QF_9E\!?';QO\
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M_P ,V'@OPEX7\':47.E^$_#NB>&=-,NWS#8:#IEKI=F9-@"[S;VL>_: N[.
M!@5^5<05LOI<'0PN$S"&/ACN/<_S'+W[.6'K++Z.5Y3AZF-J8.I*57"T\?B,
M1"A252TJT\KKZR5%-?OG".&S>OXD5,=F&3U,IJ95X3<)Y-G$?;0Q>&><8K/L
M^Q='+*.84:<*&/JY5@\'4Q5>5&\,/3SW"Z1EB9)]%1117YL?M84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGPUXMO/">OQ3W=Y\)?',OQ>\+_$KQ3X:M]?T5M'O/%/AF'2?#NMM9ZSHHO\
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M T,PP;KT)WG0K/#XBFZM&3YJ<^:$M8L****\X]D**** "BBB@ HHHH ****
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M?'?PJ@\9_'6]^(][KWQ_\"_ +XL? ?XD? GP-\(_'G@"7XB6FIW>C^-;'4_
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M_AV1H]1GEUA)VUEVU)M/X3_ _P#X*2?L]V.I'0]5^,7AOP4NGVHU*P\.Z/\
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M=].',,LX3X-RJ7A=@:GL<LRWAZCG>:\>5N%\CQN)R7#9;EF8XZ>99AP-4R?
MX;"U:^%JYC1I9ICGE3QN%PM:I.K5I>T_2_\ X+4>(X-/^"'PF\.6_F)K^O\
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ML#5F4445YA^\A1110 4444 %%%% !1110!^<_P#P4MTLR_!SP9KD4;/<Z/\
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M\&^$O!UB$%EX3\,Z#X:LQ$NR,6NA:5::7;B-,+M016J!%P-JX&!C%>(_'O\
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M^(_"MMJ^BW>L:'X@CL;Z_MK"2:S]#_:(U[_@GQJ/Q(O?'GQG^.]S\$?C+9_
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M^*!K6M7?]A:1+8W&B+X>$.IWJMJ]L\'S3_P2/^%W[:W[*/A*']G/XS_LE_\
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MVIV4%[ 5<<,#%.A##AAR.#7\Y.E_ [XP7VE?$*7Q'^S)^TI\2_BCXV\"^*O
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M1<W"G3BY.,(I%%%%0>B%%%% !1110 4444 %%%% 'YO?\%++]YOAA\/_  M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-;B:V:2)/A%XK29K=/!!L+R))V^-TB1S3_$C'BRVG:WD2T\$9^'TMM>Z\?\
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MRP>!;:+1];MY/B+=._LGXS>>K?\ ">_#'[,)4+1?\*C\5>>8!X&&GR1K<?\
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M67-GXTL)_#&CV,W@+4%\_P _OV_X/D!ZG17EMWI'QK<ZC]@^('PMMA*/%?\
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M6^A1P7;Z]*B?9]0N?HGX ?\ !/\ ^/4G_!'CQ[^QC\0M$TWX:?&GQ9)XXO\
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M2E\=-I7VCXZ:M_8Z^(]&ETBP\)I=_P!N'P7J=CJ6KZP_CZUU6UT31G\U^/\
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MFE_I'QMD&H_V9\0OA99F7_A+/[(^W_!WQ;J(L?MFLZ=/X&_M$6_QTTO^U/\
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M>DW7CFW\._#2X\&PZ\_B'PKX%TS4Y/"7B35O$?B.6\OY=)@\-:=8:U;V0?\
MHV.D_&;S]P\>_#$6WFS'RC\(_%1G\AO RZ?!']H'QL$?FQ?$H/XMFF^S;)_
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MR,GC[X8+;&2Z,43?"+Q6\Z1/X*CL+%)+@?&Y(Y)+?XBB7Q5=2+:Q+>>"GC\
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M,P>.PN%KX.NJZ]&HHHK@/UP**** "BBB@ HHHH **** "BBB@ HHHH ****
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M?&8VIF5;#5*N&PM>%#VFBBBO+/W\**** "BBB@ HHHH **** "BBB@#\Y_\
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MK=KC4? ^L?"OQMIR(VQDDTCXJ>#[;4)Q*.8OL^AZCJLWF+R F,J"77-_8/\
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M>+P[<ZN(@\-0EB*E6IAOKF&Q%;$4:D*%:=*?[^G^YU%%%?/'PH4444 %%%%
M!1110 4444 %%%% 'S+^VCX9'C#]D;]I;P^(3<37?P0^)=S90!=QFU/2O">J
M:OI48&#R^I6-JH(#,I.Y5) !_/S_ ();_M8_ KPS^QMX'\+_ !2^,OPH^&?B
M/PYXM^)=HNC_ ! ^(WA#PCJU_9Z[XTU7QY!JMK9^(M9TZ[OK"9?&0MX]0AA>
MWDFMYH?-:6&4#]7?BS=6%C\*_B7>ZJ4&EV?P_P#&5UJ1D(6,6%OX<U*:\+LP
M*J@MTD+%@0%R2"*_C5_8M\8_$>S\8)\*_A7:^!E\:_&6]\"Z=X>UGXG:C?:=
MX%TF#PQX=U8W\&H3:;>6MX=2O[O6-*T_2H+><R75UNL;>UOM2GL;*?\ HSPM
MX7H<;>&G&N38VI/#X;)>(<EXEI5XXBEA8QE# 9A@L?*>(KTJ]*E2P^72JXNO
M)T:DW3HJ$(\TDUK2BIR<'9)Q<V]G^[LK7>EDJDF]&]--V?UL?\-E_L@?]'6?
MLV_^'S^&'_S45^>?_!4K]JOX$^+?V,O'GA/X7_&3X4?$[Q!XF\5_#2PET7X?
M_$?PEXNU:SL='\:Z5XWN-1N;3PUK5_>V-DB^$#;/?R1QPQRW$4(E6::('\R_
M%'B/7?BVW@>\^+?PU\7^._AQ\)OC!X]^'_[17PW^!6K37UYXTNM(LO#TWA[5
M_"T,.H+>:MX?"7UP9(H=5-Q%]LD:SUG3F>U\1:;\B?M Z-XRTWX=> I=?TCQ
M5X;\.7'BOX\7GP\\(^,=0N[[7_!?PUN]#\ 6/@[PAJ?VORYX&TF6VU"RTZ&X
MM;$I9&W>#3=*BNH]-M_T'@CP4X?R[B;AG,YYIF'U_+LWHYE'"5,9E6)P<L1E
M=7&8["X:-7#TZ6+KUZT<LHXR<(X>A1A@,=@Z\,75JSEAUNZ*IQ=52O*"<TFU
M9N-Y16EGKRI[*R:>NQ_7E^Q9X;7PC^R)^S/H(A:WEMO@=\,[J\@9=C0ZEJWA
M+2]8U2-E.#N34;^Z!) 9B-S ,2!]-UY]\);S3]0^%7PSO])*'2K[X?>#+S3#
M&08SI]SX<TV:S*$  H;9X]I  *X( %>@U_(V>8FIC,ZSC%UHN-7%9IF&)JQE
M\4:E?%UJLXROK=2DT_-''9+16LM%;:RT5M7IVU?J?(GC[]L+P[\+=0%U\0_@
M]\=/"/PU/Q)B^%K?&K6?#?@NW^'T.OW.JW.@V6KW.CCX@/\ %FT\$ZGKEL=,
MTGQQ<_#&+PQJYNM,U/3-2N]"UC2M5O>A\=?M,6WA/XU#X!^&_@[\6_BMX_3X
M7:;\7[R/P%-\(--T?3_!^J>+-:\&6[W.I?%'XM_#;S=236M#G6:QL(+W;:W=
MG<)-)F[2T^??CC<W/[9OQ//[+G@2YCD^"OPF\9>#_%'[5OQ%MI2]A>>(_"VM
M6WBOPM^SGX2E4"/5O%T^K:1I/B+XE:A8R/9?#W2[?3=,O[Z/Q;?+X=;$\9^$
M/$'C'_@IOJ=CX=^*?CSX47-K^PCX/NI]8\ :=\,=1U'4H/\ AH'Q]#_9M[%\
M4OAS\2M)CLO,D2Z\S3M+L-1\^")?M_V8SV\WZ+@^'N'YX>C+'X/#Y?FM#AK-
M\[QF7XK%YM5P5'"1EE"X=QF:1P?-F5#&YA1Q.88O$83"2ITYX*>48REAL-2Q
M4H2V48V5TE)1E)IN5K>[R.5M4W=NRMIRNR3/N'X)?&;P1^T!\,O#'Q7^'UQJ
M,GASQ-!=@66MZ=+H_B#0M7TJ_N=(U_PUXBTF9G;3]>\/:U8WVD:G!%-=6,ES
M:-=:7?ZEI5Q9:C=>K5^>?_!-"Z6R^ GC'X=V<FAZQH7P7^/?Q>^$_AKQ]H4=
MPL7Q8TCP]KEOJ3_$W4IIM3UF*\UWQ-J^N:K_ &S?6&IWFFW-]92R6#I;&.*/
M]#*^(XMRO#9+Q-GN58+VWU'!9GBJ6 >(DIXAX!U7/ RQ#4*5J\L+.BZT94J4
MX5'*%2E3G&4(Q4CRSE%;)NU][;J^VMK7T6H4445\Z0%%%% !1110 4444 %%
M%% 'P)_P4TTV2?\ 9"\<>(;993J/@+Q/\-/&^EM 2L\-[I7Q \.VAN(I%YB:
MWM-2NIFD&-L:/D@$UZC^P]K6GZ[^R/\ L_W>F6T-I!9_#G1O#]S!!$(5_M?P
MIYWA?7II$ &;JYUO1]0N;R4Y,]W+/.S,TA8M_;EAT^?]D+]H>/5-OV3_ (5?
MXC?YAG_2HK=9;# X._[>EML*_.'VE,L *_('X&_$OQ'X2^"WP/\ !?@[P#?_
M !*^)GQ(\2?%FS\,^$+36+7PVES#X>\?>*K_ %^\N-8U"TN[:QCTZ.[M<0RV
MP4QR33R2VUM:3RI_0W"7#-?C7P<>4T*T<-B<L\2L1B:>)K2H0PZP-3A"IB\7
M&O5Q6*P>%P]#!QP.(QM;%8C$0IX>E.M*HU"4I1_CKQ"XWPOAC])'_6#%8:>.
MP6=^">"P5;!8:&)JXR6:4?$6AE^7RPM# X#,L?C,5F4\SPF68; 83"5:^-Q%
M/#TZ495(1A+^BJOSJ_X*D^*K;PK^R;K$IC!U;5/'_P .K;PW<HJ_;-/UG1O$
M4'C)[[3IF4_9;R/1_"VKQ?:%PPM9KF+)$I5OS\\7?&MO&>D^#SXFO_'?P.\#
M6?Q&\4^ _C[KGAF*ZU+QCX U?PU96,]OI6FWVE:?)<O;ZA_:#7":G9VL%VEQ
M;V<7]EZP1<^&-8X/]I+4_$.K_L/>%;_Q'-J]U?W'Q=M%@O\ Q'I\6D>(-4\+
M6_@#]HZV\,:QKNEP3745GK6K>$(M&U74HX[B=8M1NI"LSLP<_0\%>#6*X=XK
MX,SO,LTA6^K\59;S9?' U(QJ3P^+Q52G'^T:6)KX&LN?+95<31H5:TXX'%9=
MB)7P^94*A\=XF_25P/&7A_XE<,9+D-3#O&<!9TH9O/-*-2=&EC,OP-*O-Y-6
MP.%S7#OV.=1H8+$XJAAJ<\TP&<X.+CB\DQ5(_<']CGPY%X4_94_9YT:*,1%?
MA%X&U.>,*%*7NOZ#9Z_?A@/X_MVIW'F-R6DW,22<GV'QWXPD\$:&FK6_A'QE
MXYOKG4],T?3O#/@32+;5-<U"]U2Z2VC=Y]4U#1?#FAZ99QF6\U/7_%7B#0/#
M^G6L#_:M4CN9K.VN7_#Z&QM_ 7@B#2P@TR#PAX:ATX1JJH+&/1K)+0(J954%
MNL855.T# '&*ROBM\5/!?P7\"ZY\1/'VIG3?#^APJ66&/[3J>JZA<.(=-T+0
M[!6234]<UB[:.RTRPB93-<2!I9(+:.>XB_GS%U,1G?%N,K1P%?,\5FW$&*K0
MRVG[;V^.Q..S"I4AA%[%?6'.O5JJE)47&M+F:ISIU'&<?[!RZCA.&/#W+<-/
M-L+DF X?X0R_#3SNM]7^JY9@LKRBC1GF,OK3^J*GA:%!UX2Q*GAH\D95J56D
MI4I^8^&?VG_!>O67QH74_"_CSP3XN^ FE3Z[\0_AUXMT_P .1^+[?0QX>N?$
MFFZSHLWA_P 4>(?"&O:9KMC8WT.E7FF^+)H?M=J4U%M/@N;&XNN>\+?M>>%M
M=O/@XNO_  R^+'PZT+X^P6,GPI\7^,;7X<WOASQ+=:OHEKXBT/2YV\!?$GQO
MK7AW4]=T>[2[TNV\3Z-HRS&*ZMY98;JUGA3QS0OA[XT7X.?M??M"_%?1CX8^
M)7Q\^&?BB[3P09(;B3X<_#?PA\.M?T[P#X/U"=;2"67Q6+6^O]4\97*M'#/J
M-U9V1L+*?2)%?YTN-$\0_#GX.?\ !.'XNR?$#7_BI>6FH_ ;0_"?P4\=:=X$
M7PW'+\2?AOIV@RW'@D>#/!_A+Q%-X@\"Z5<S7'A76/&=]X_N-&,,>IW#RZ@M
MS>WOZK@>"N$,?6S'#8=T)UI8REDU!4\QQU>$<^CP3B,QQN$R3'8>-;+ZN"H\
M6T)X:GF.<5*V!>34Y5OKE:ZQLOP3-/$WQ%RC#Y-C,8L53P\,LK\2XMULGRK"
MU:G"<O%#!9-EN8\3Y5BYX?-Z&9XGP]Q=/&ULFX<HX;,X\2U8X9Y=A[2RV'[0
MT445^#']8!1110 4444 %%%% !1110 4444 %%%% 'XR_P#!3&ZM? G[0G[%
M/Q1N86:P@\9'3_$4F&^SG1_!WQ)^%/CF.WO0/EF@D\G4)UADW!3;/,J%T4K^
MS5?C)_P666Q/P]^!S$G^VU\<^,5TP"9U_P!#D\"Z@FHM]G#A)F%R=(5)3&\L
M#.%B9//</AS_ !<\=ZGI'QC\;^!/A,WC#X:? C6KK0OB!XED\;Z=H.OO=Z%#
M/=^-I?"_A*[T>Z.LVW@^SA$][+?ZYH;:H9%31DOA'</#_2<^"L1QMX7>%F+H
MXNE@:N6QXLRJO7QE3!T,/75;BG#T<KIQKX[,,#05:I6QL<'0HQG*M7=.7)3Y
M:%29_$U/Q.P?AAX[^/67XC+\1FM'.I\ 9_A<)EU+,<5B\*\+P%BL1GE:>%RK
M*,VQ3PU+#Y9/,L5B)TJ>'PJJQ=2KSXJE3/VWK\8_BW>VOCK_ (*Y?!#PC%'N
MM?!GA#0M0UD*@,)UGPGX0^+_ ([TFXN00#)<0IXPTB.VD^80K*A7#'*_(6N?
M%[Q!K.H:SX@T;Q[\1;+XL:CXHT&7X _";3O#]ROP[\:?"KQ!!9WW_"2>(YI;
M"6QU">\T2X@#377G7OA[5[ZX%M="-+F]\"_27P<73V_X*NZHU^2;A?A%IK:&
M3+)&!>CX$_!N.=0JNBSYL'ULB%ED3,<DV/,M4>/V<@\-,3X>T>,<UQ>8?7L1
M5\+..)8:A' 8C!5,/BXX?)*#Q--UZDHXS"4(YQ:GC</S8>>-P6/HPE-X&;G\
MYQ;XWX+Q@Q'AMD.7Y/\ V5A*/CUX60QN*J9MA,SI8S+YXSB;%+!58X2C">79
MAB9\.N5;+<9R8RGEN995B:U.G'-*<:?[CUXK\2_C'??#N\O[6Q^#?QA^),&C
M^$YO&6MZKX TCP:=(TS2XI=3C^PQ7WC?QQX)3Q%XC9-(O;D^%_!Z^(O$%O:M
MI\UYIUL-:T0:C[57RY^T9\7?$.@C1?@K\'5LM8_:%^+-I?VOA"PFN'CL?A_X
M6CBG@\0?&3QK<Q1S?V3X6\)J&72DE1]0\5^*39>'_#NGZQ=)J,-I_.?#& >9
M9SAL)_9^'S"-15)UH8S%8C X#"X6C%UL;F.88O#5*57#8++\'3KXK$5_:TX4
M(4_;5/:TZ<J%7^S>.<V62\-XW,?[7Q>3U*4J-+#5<NP&$S/-<?C\346&RS)L
MHR_&TJ]#&YGF^8U<)@,'A/85:N*J5_JU!T*U6&*H1Z]^UU\-]/\  WP5\?>&
M-$\:_$?3/C]XCL?"GPZT_P '6?AFUU6\UR_L]1N4M-4'CGQ5X+TK2?LTVE7V
MG7CW6JA;?4(3$V8<W [_ .%?QOT+XI:Y\0?""^&?&7@3QW\+M0T*R\:^"/'-
MGH46LZ9;>*=+DU?PQK-MJ/A+Q%XN\)ZMH^NVMMJ L;G2?$E[-'-IEY'?6UG_
M **US\'_ !Z^#%C\)/"?_!/?X*>$?$^NZ1!X4_:#\*:!9^,M.MM#?Q!'J,OA
MSQ/=:EXCM++Q%I7B;P]%>WFJW5[J,5CJ6DZQIMJ;@6S6]S#$I/JGP.L;_P"'
M/[:?Q\^'#>+[KXK/XV^%/P[^+'BSX@>)(M%C\>>'M>TN_N/!&@?#CQ!_PAUC
MH'@R+3%T,7GB_P .6=AX/\+W]I8ZW(;BWU.":#5;K]'S#A+A&IPOF.99+*M5
MJ?V=Q!G62UL55QT<QKX#*^.L-DV&JXZ'L8Y12PKX=JUIUJ5L/CZF<?5E1?LI
M/#5?Q;)_$+Q#H\<Y-DO$]/#T*"SKA#ACB;#X&AE53)L+FN?>%>+XDQM'+*GU
MJ?$5;'QXRHX>GAZZ>+RBCPV\9+$KZQ".,H_H)1117XP?TP%%%% !1110 444
M4 %%%% !1110 5^,OPENK7P'_P %<_C=X4FA9+;QOX-UO4-%,@80OK'BGPC\
M(_&^JW%HA^5)Y(O!>K6]Q,@S.MO*LCGRD4?LU7\_O[6&N:!X3_X*4#Q5/)-'
M9>'OA9:^(/&,D#27<T46B_";XJ7TYBM?,)C=-%ATZ1;:(11SR/'(09IR[_M?
M@I@I9OC./\B2J-9OX:<1T:;IP=1T\70Q&68G"5?9J4'.2J4Y48PYE[1U_9WB
MY\T?YC^D]F<.'<M\(N*VZ,7P]XW<%XBLJU148ULOQ>$SS!YAA_:RA-4HRI58
MXF55Q?LEA56M)4W"7] 5%?A8GQI^(DFG>!UU;X5P^%M0^-_PT\7>./@7<Q^,
MK#Q7;^(K[P]I5YJMMHGB>TM-+TI_#>H7.G+INL>2EQJML+348K*6]AU."]M+
M7D?V:/'6K:O\;_@U8>'OB'\1_'M[J_\ Q,/VD-$\<:%/I6B_#7Q1;3*OAW2O
M"<5UI]NNF%;M;>'4;73C8VFH_P!HK?O:&XCN-#\&]DO K,Z679IF%;/,+".6
MX3&8M*CA88^A6A@8YBL1S8_+<?C<#A:?UG*L;E=*K7KQ5;.84\KA%XB4U3\R
MG]*O):^<9%E&'X6QTYYUF&6Y??$YA4RG%X:IFTLF>#5/*,ZRC+<TQU7ZCG^6
M9[B*&%PLI8?ANI5SRI)8.%-UO9?^"9U[:^/?VAOVU?B?;Q[;%_%XT_PZ=@$,
M6C>-?B9\6/'$MO9  >5;\Z=,T> 7>59&R0 O[.5^,G_!&I+ ?#[XYL-W]MGQ
MWX074]TLA)LU\$6+:>WD,Y5/]-?6D:41H\KHT+EEMHUC_9NO&\=N6'BEQ)A:
M2E&AE]+(LOP\9;JC@^'LJHJ:U=U6G&>(O]IU7*RO9?2_11YZO@/P7F%:4*F+
MSBOQ3G.,J05D\1F/%^?8ATVK*SPU*5+"<OV5AU&[Y;OYBUW]J3P_X0U3P]_P
MG/PS^+?@3P-XJ^( ^&FB_%7Q;HOA/2_!K^)+FYUBPT:?5=%'C6?XH^&?#WB'
M4]&EL-'\3>*/ASHVAL+_ $C5-0OM/T#4[;5VD\5?M-:?H7Q6\4?!SP]\)/BW
M\2O&'@[P;I7CO7QX'B^&,=A;Z!K$D\-FUJWC;XG>#-0U34#- T+:;IFG7EW)
M(\:6T<Y<8\:^)<L_[77Q8T[X.>&+17^"/P(^)6B>)/CCX]D\T6GB?XB>#)3J
M&F?!'PG)$R+>7.EWTUK??$C4;>02: ([32?M%CJ<D5OJ?$2^#=9\;?\ !0?X
MY:7H_P 3/'GPR(_9V^'(N]2\ 1> FU74+:YUF]MS:RW/CKP-XX2P6$N;BWO-
M$ATG5(+E4D34 %"5U8#A?AF5&I5S/!T<NS/ \'X[B''97B<9FM? X.C/.<AP
MV05\S>!=3-*>98[+,QQF)Q>"PTJ5)0J93BHX7!1KU\/'BS7CKC>&*HT,ES+%
M9QD69^(^4\(95GN"RW(,+FF98B'#?%6-XMPF1K-8T<BK9+E>=Y/EV"R_,\9#
M$5Y5J7$. GF&93PN%Q<OO/X4_$_PG\9OA[X7^)O@>YO+GPSXLL9+S3SJ-E-I
MVHVLUI>7.F:IIFHV4V6M]1TC5K&^TJ_2.2>U-W9S-9W5W:-#=3>A5\0_\$^=
M7-U^SO;^%K>VT*31?A?X_P#B#\,/#?BGPW'J46C_ !(T;PGXAN(1\2K=-4OM
M3F%UXRU*YU+5-6>WOYK";67U">QBT^VDCTRR^WJ_.>+LIH9%Q3Q#D^%598/+
MLXS#"X)8F<9XGZC3Q-18+ZS*$8+ZR\+[%XB/LZ<H5N>$Z5.<90C^R^'?$&*X
MKX#X/XCQ[P\LQSGAS*,?F;P=.=+!?VI6P-%YG]2A4J59?4ECUB%@Y^VKPJ89
M4JE.O6IRC5F4445\Z?9!1110 4444 %%%% !7YJ_&W_@E]\)/C3^T1K7[4,/
MQN_:B^#OQ9UW1])T.ZUCX&?$WP]X %O8:3H%GX:5+"^;P%J_B*T&H:58V\.J
M0IKQM+PJQ-M&CLA_2JBFFUL[75OD!\'_ +-G_!.C]G7]F3QUJ7Q9\/CQ]\2_
MC'JML]I<_%WXT^,)?'OCZ*WGLFT^]6SU#[#I.FV4^HV3-:7U];:5%J$]D3IY
MNUT]FM3Y?\0?^"5/PD\:_'_XB?M*>'?V@/VN?@K\3?B>J0^*+[X&_%KP_P##
MVWEL/LVAPW&DV]U;_#^_\0G1[ZX\.Z1J=YIE[K]]9RZG9V]TL4?V:TCM_P!0
M**?-*][ZVM\NWX ?D?\ %#_@CK\%_C/:?#U/B?\ M)_MJ>-]7^&D6KQ^&_%?
MBKXS>&?$_BL-J^M#7'N+C6?$?PTU:2*YL+E+>WTZ?2X]->&SL[**7[1):PS+
M]!_!7]A;_A2_Q(T#XC_\-C?MW?%C^P8]7C_X0/XU?M"?\)W\-]:_M?1=0T;?
MK_A?_A$=*_M&33/[0_M72&^W0_8M:LM/OL2_9O*?[MHH<Y-6;T^74 HHHJ0"
MBBB@ HHHH *_/'_@J3J;P_L<^-?#5LL\FH?$'Q?\,/!&FP6N#>75W??$#P_J
MS6EHA=!+-<V>BW</E9^>-Y!QU'Z'5\B?ME_!GXB?&/P%\/'^%<_AI_''PE^-
MOP[^-FBZ#XPN;VQ\->,)O 4FJO\ \(MJVH6$,]S8V]^=36Y$RQ;)9;&.TDN+
M%+DZA:=N6SA3Q^#JU)1C"EB*51N3Y8WIR4XJ4OLQ<HI.3TBFV]$S\U\8\NS/
M.?"OQ R;*,)BL=CLYX5S?)X87 TO;XVIA\UPE3+\<\'0YH2Q&*IX#$XFKA\/
M3E[;$580HT5*K.$7_.YHW@OP[)^S-\(?&&C:['\/?B5XS\<0?"^+XBS^.KCP
M+X?\*6/B#3-4L+Z?XC:Q'9:GCPA=Z#H]Q<7\9MK6\^Q^*ID6[73-2U&QU#T?
MP3IT'Q"\$?!/PYXL\)^)=;^ /PJ^+7C?X>_&O2?@M)XDUR;QI;^1H&JZ#X\L
MM$#3^+-4T-]7UK5G\5Q6*ZCKEH;G6-2T:ST[5&T^WT;W#QW^PE^TOXFU+Q1>
M>#OV>V^$VC^-9TO?$_P\\#_M,>!C\++[4%B@#W4/@K7?AQJT<$;W5O'=QV,V
MI7=C8,!%I-OI\0 KQSP)\"/V\+YM"^#_ (6^%/QI\ S?#T:HGBC4AXETOX<>
M ]3A#S"Y3PKXOOM,OO ^J&YUZZCNM/'A&U\1+<V+W=T%2V>YU"U_0OK>%K4Y
MR6,P\=Y2_P!KPO/14U*/-[2G6FE*'.XTW=QC*TUJVC_%[%^%'B/PQG648*IX
M<\69S3>8T</@*W^HW&4\IXCJ8#$Y?BEAL3DN:9!E\Y83-(X".,SBC*C2QF*P
M,:^7U)K#X:%:/RC\</!GB#0O#>@(-#\6^'].U#Q3\4?$?PW\,>)\KXW\%_";
MPO9ZCK_A#3=?TN.21M'N)[B?Q;JEQ:,T%O;?8+F>"*.!4@A_L8\)Z_;^*_"W
MAKQ1:%#:>)/#^C:_;&-MT9M]8TZVU&$HV6W(8[E2K9.5P<GK7X+^&/V*/VI=
M-M/B UU\!=#\5?$GXF> _$/PP?XP_&W]I/3_ !Y/X \.>+M&U+P_K=YX9T7P
MWX+T22TO!IVJ7"6^H/!KNK6$!ET_3R-)OM2TN^_<?X2>"KCX:_"KX9?#F[U,
M:U=> /A]X,\%7.LB)H!JUQX5\.:;H4VIB%WD>$7\E@UT(GDD:/S=C.Q!8_-\
M1XK#XFGA(TJM*I.C4K:TZU*LYQJPI.4I.E4J**C*G&*]HXU)RYY<J6LO[O\
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MYB@\3:[XV^'VN>$/&]IX>N?!^@:7J<]E9^(-.AN[KQ!I=Z[R.J&;^J/]OO\
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MW.4E&5K*,92LXO5OE3W35D^SM>[M\/0>%]9T_P (?$GX&?#SQ&/CK\*?@_\
M%[X?7VN^-O@W#::#K'QC^'FM:9K\GCW1M%GMGU&VUO5;#5;#2C;S2R:Z]]IZ
MVK03>)_#Z:*VI>6_&7P/!-IOBM?A[\,_B'\,OA1XV^*WA+1O@Q\*?'_]H-XW
MT'2IQ9V'C#5'L;NYO;^U.N:W;^!+0--=2*U]JBZ<=6U<VAUW5?H#P_\ LF?M
MS>$+Q/V>/"?P9^./AG75\82:ROBOP[XIM=%^%2^')YA?S3#XN:=';> 5NY?#
M:+8RV@TL:B^N(C-X8;6MFBGZ^^$_[$/[6_PR\=Z=\4=3_9WT3XR_$;P_F7P3
MK7Q\_:HLO'/AOP5JW[R.#7;+POH7@?PF^HW5C'/+)9QZIJ>H1:5=[-6T&#2]
M9@M[Z/\ ;L5QCDF0U:F/CQ1PSC:E1+'8.A#B+)<'6SFJZ67SCF^*I?VI@LHH
MU<TQ^"EB)9E0PE2M@L%B<SP. PU2G4C0GU5,12@OB<FX\RY8S=VTM9<B:C)M
M7>BDDVDMC]=_V#?%,?C']C+]F36HY/-,7P9\#>'YW+;V:\\(:-;^$K_S6R<S
MB]T2X$_/^N$@XZ5]:5\N_L6_ G7_ -FC]F+X4?!+Q5KEAXB\1^"],UPZUJFE
M-=/I;:CXE\6Z_P"+KFPTV:]AMKNZL-'DU\Z/9WMQ:64M[;V$=V]C9&;[)#]1
M5_!'%=3 U>*>):N65XXK+:N?YS4R_$P4HPQ&!GF.)EA*\8R491C5P[IU(J24
MDI)-)W1YVJT;NUNTK)ONDMK[VZ'SQ?\ [(?[)VJWU[JFJ?LP?L\:EJ6I7=S?
MZCJ-_P#!7X;7E]?WUY,]Q=WM[=W'AJ2XNKNZN)))[FYGDDFGFD>65V=F8])X
MS_9V_9^^(U]INJ?$+X%_!SQYJ6C:+9^&](U'QG\,?!7BB^TKP[I\UU<6&@Z;
M=ZYHE]<6.BV-Q?7L]GI=K)%8VTUY=2PP(]Q,S^QT5S//\]<Z-1YUFSJ8>,X8
M>H\QQCG0A448SC1E[;FI1G&$(SC!Q4E"*::BK5S2T]Z6FVKT]#(T#P_H/A31
M=+\->%]$TCPWX=T.QM],T70- TVST?1='TVTC$5KI^EZ5IT-M8Z?8VT2K%;V
MEI!#!#&H2.-5 %:]%%>7.<ZDYU*DY5*E24ISG.3E.<Y-RE.<I-RE*4FW*3;;
M;;;;9(4445(!1110 4444 %%%% !1110!\$?\%,M5>R_8Y^).DV[.M_XQU;X
M>^$-.6-2[S7&K?$#PW+/;K&H+2&XTZSOH0BX)WYZ @_E7JO@K3-,_9B_9WGA
M?Q#IWQ#NG\,O\.O%7A_Q(WA;4/#WBCXK(WB^[U*[U]HWM-,TPEA?R3WILH;?
M4+'2MVLZ$4.L6GZ^?MP?#OX@>/OAW\-+[X>>$V\?WOPR^/?PQ^+'B+P%;ZEI
MVE:EXS\)>#+C5)=8T#1[O5YK?3/[2G>]L[F&*[G198;6=($N;LV]I<?FQXG\
M/?&:32-3\$>"_P!EWXSK\(M0\B;2_A7\4OA#HGQ#C\!3^:UY/9^!/B'HOQI\
M >-M-T"VORL^@Z3=W%TV@%KC^R;RRAN6M5_K3P=S;"8+@O*<#3S++L/4I\8Y
MAQ!F'UC-,'A*D8O+\)DWU"KAY8B.-G]9P3]O0IU*%+*\?AIYEA:V9X2NE2K_
M .>_TD.'\PS/Q,S_ #2MDN=8RE6\.,GX1R9X/(LRS"C.7]L8[B3^U,/BX82>
M64U@\S_V;%5Z.)KY[E&.IY-C\/D>8X64JV$\OT:WUSX4^'K?X>>*=>USPCX>
M\,_&/QQX5_::^+7PRU(>/-;GUR/PQH%_9>(M'U22R:XLK?4(]6TW2M3N5M]-
MUSP]JN@Q6,UM>:PMUH&L<_\ $2RU7XB_L]?M!0^'O$_C7QW\(_ _Q"^%&H_!
MSQYX^M9H?%'BEM9UA/AWK-O.+JW2^U6W$7CB[ET^XF+WL\-Q?_:[71[VTO/#
MFB>Q^ /B]J/@3X3>%OAI\*?A-H8_:5/C"#2_&'[/MA\)_B1J^H^ ?#>G3>*C
MXG\27>G:]K.E1W$UQ96_A74+*_U'XDWS:F=1\F6^A6&X%AW]OJO[0_BC6="U
M+XN?LV?'KQWHGA+4[7Q'X4^$/@OX<>#O@S\-K_QK9>8FD>(/'^L2?$;X@>(O
M$PT>9K;4='BN[BVTW2=2M([J>TOK9KFWF_2Z^<8O 9A+'XG"9;AL1A<VH8R#
MS',LMRW$YY#+\WPV95,RRS+L;0FJ<LX]E6R;+<SK\41X=PV15*E/#_7(X>GB
M<1^(83AS+\VR>&58+,,[QN$Q^08K+:D<FR3.LZP7"T\YX=Q62T,DSS.<KQ,)
M58<._6,-Q+G.1X;@.?&6+XJHT:V,66RQE;!X/].OV1/$D?BW]EO]GO74F-P]
MS\'OA_;74Y;<TNH:5X:T_2=2=C@$,VH6-R64_,C95B2"3Z]XR\!>!?B+I,>@
M_$'P7X3\=Z'#>PZE%HWC+PYH_B?28M1MXIX+>_CT[6[.^LTO8(+JZAANEA$\
M45S/&DBI-(&\&_8I^&'C?X-?LO?"7X;_ !&@MK3QGX=TK6VUFQM;NWOXM,.M
M>+-?\06&DM>6;RV4]QI.EZK9:;>/937-E]KM9UL[JZMA%<2_4M?Q/Q16I8/C
M+B2MDN/53#T.),ZEE>99?7E&%7#1S/%+"8O!XBDXR]G6H<E6C4IM7A.+3LS_
M $]X$PV(S'PUX*PW$^4RHXW%<%<,QSW)<WPL9U,/CIY)@7F&7YCA,1&<?;8;
M%>UH8BC6C+EJTY1DFT>4>&O@/\#O!C:N_@_X,_"CPHWB#1KOP[KS>&OAWX0T
M)M;\/Z@8S?Z%JYTO1[4ZEHUZ8HC=Z9>F:RN3'&9H'V+A/"?P%^!G@+6H/$G@
M;X,?"?P7XBMHKB"VU[PG\.O!_AS6K>"[B:"ZA@U31]'L[Z**Y@9H;B..=4FB
M9HY%9"0?6**\VIGN=U5B55SC-:BQD(TL8JF88N:Q=.,'3C3Q*E6:KPC3;A&%
M7GBH-Q2Y6T>Y2X5X7H/!2H<-Y#1EEM65?+I4LGR^F\!6G4C6E6P3AAT\+5E5
MA&K*I0]G-U(QFVY)-%%%%>4>\%%%% !1110 4444 %%%% !1110 4444 ?B;
M_P %2GMO%/QQ_9'\"W(=M/TG5;OQ'XBVRK';V^C^+OB1\+?!<=UJ3LZ""TWQ
M7MI'<'""6[9'95)=/DW]I#P5IVD^._%>F>!]=\0^#EUOP-?_ !C^+&E/\0U\
M,>"?&FB:#KEY+/9V>A7*[]<\63:PDVJ+I5A?1W#ZA=6E_HVD7&I3WVH6/ZF_
MM3_L^?%/Q9\9[/XM>"/AY\.?C=X5UWX'W?P,\<_"CX@>(KKPFPL)/'<7CNV\
M4>']86VGLX]36^@LHEN9)+>\TB338+S3H[B[FBN--^'?%?[.'[:=O8Z3>ZG\
M(;CQMX6\%ZEINN'PSXL\<?L__&CQ))HNGWUM<:_8:#<Z[\'M(\7:EKM[HD%S
M9Z;<P>)T\2S7(MVBO=3U/R8Y_P"U_#'BK)\)PUP1@*7$?#N#CD^6XZC7PN:\
M19;EJKXW-<VK9E4A5P&)Q"Q<L7@<P2E0EB,)3P<H2P>-PF.G.C*DO\Q/'+@'
MB/,>-O%'-JW!?&693XBSS*L3A,?D/!N=YS+#97D/#^$R2C5H9O@\'++H9=FF
M3\\,5'!YC6S*%2&99;C\KIT\3"O+Q?QG?^ WMM:?XEZ1X_T&WO/@U\/F_9!\
M)^&CXEETW1?%MUX<T^*XL+Y=,+!_$OAZXN;R*62,6.I3>'K:>(S7?B!? J6/
MK?A9M6\(_M\_L=>+_%#[O%.O_"7P#X<^(WE&/R+;QKXO\&?&;P3:VNHFW?RK
M>\O(/#6CW^GV[X>YMFM9HXS!Y<DGI^L:'^V;\4O$4NN?!OX7^/?!/PWTW1]$
MT1;'Q]#\+?A7XGUKQ1;_ &N]\1ZW#I'Q1^'?C?Q6NFR07VEZ797,EOING/<:
M;<W-C]KDDNX[7JO /[*W[1&N>+_A;%XL^&GACX>:9X5^._@CX_?$GXM^)OB\
MWQ8^+GQ*UKX?P:E9Z'X<FNM*T/0]+M='&EZE+HEEHMKIFB>'="L,WFF6T=R+
MRSU?OS/B?)Z&48^AF6<\/87ZWPWGF58S+Z?%N79EC\OI9MD=+ U,/++*OU;'
M82I..'CC,?@\$LZQV8<1U8XBJ\)#VOLO(R/@;B/$\0Y3BLEX:XQQRR[C7A7/
M\MS:IX>YUDN59OB.'^**F:T<9#.Z"QN59A1IU,75R[*LRS.7#.59-P9AYX/#
M_P!H5?J_UC]C:\K\7_ KX(_$'6&\0^/?@Y\*_&^OO;06;ZYXO^'OA'Q+K#6E
MJ&%M:MJ>LZ1>WK6UN'<00&<Q0AV$:KN.?5**_B/!X[&Y?6^L8#&8K U^1T_;
M8/$5<-6Y)-.4/:49PGR2<8MQYK-Q3:T1_J'F.5Y9F^'6$S;+L!FF%52-58;,
M<'A\;AU5@I*%54<33JT_:04Y*,^7FBI22:3=_)KCX"? N[\+V'@BZ^"_PFN?
M!>E:E/K.E^$+CX<^#YO"^FZQ=))%=:K8:!)HS:39ZE<QS31SWUO:1W4R2R))
M*RNP/5^"_A]X"^&^EW&A_#OP1X0\!:)=ZA+JUUH_@OPUHWA;2[G5)[>ULY]2
MN-/T.RL;2;4)K2QL;66\DA:XDM[.U@>0Q6\*IUU%;5\VS7$T)X;$YGF&(PU6
MM+$5,/7QN)JT*F(G)SG7G2J594YUI3;G*K*+G*3<G)MW.?#</Y#@L52QN#R3
M*,)C:&&A@J&+PV6X*ABJ.#ITXTJ>$I8BE1A5IX:%*,:<*$)JE&G&,(P44D%%
M%%>>>N%%%% !1110 4444 %%%% !1110 5_/=XJTS1?B;_P4<_:*OM=M!?Z!
M_P (UXA\#06US*187]QX8\'_  E\$^)-+MRDJ22S"P\2:N;^W0K+!'?O*F%W
M/%_0C7XY?$']E3]H72/%7Q;M/#7PN\'?$S1?&OQS\:?'CX=_%70OBK'\+_BW
M\-=6\>1:+;ZUX<@N=;\/:]I4VDG3]&@T6\TN73M:T/Q!IN^35[>0R6]CIW[9
MX*9OEV3YAQ3/%YG@\LQ69\-RR7"UL9C\'ED84L;F&"K8K$4L5C\1@\(ZF%EA
M,-5G0>*IXFKAGB'A(5JU-4I?S#])WAW..(\GX#IY?DF8YY@<CXTAQ-C\-EV4
MYCG<YU\LRC,L/@<)B,!E&#S',%1QT,PQU&EBE@*^"P^.6#685,-AZKQ$/A'X
M2Z<?#/BWX4_%N*YF\1> O%GCO6/A)\,?!7B+XB'Q%X^^'VJ3B[_X2K4U\-6E
MM:G2].TR#7;J;6_[1@F:)M7U;4KV227Q%X>\1Z[V7@2\AC\>?"5+%_'=[^V!
M!\9GN?B^URGB*3PM:_"R&]D?[!IHO!_9Z:%<VEW=MX=5IKBPCOK>_BMXK:R?
MX;VUO['H'PG_ &G/A'\2M.^)GQ7^ NK^*_#>I0:AI.L:K\._#OP:^*'Q+@U:
M=K&;2KZ]E^%OPR\#^/KO2Y--L-3T>^FDDU/2S+>V3ZD;%8K3S=JV^%?_  4#
M\8IJ&LW'@KQ9H/A?Q/>ZQJ6C^&].^*?P1^%OBO1/"NKZA<W.@Z%>7]C\)]>\
M9>']3LM!GM-.U5E\4)X@683BYN=-U'SH8/Z5S+B7+<54KXFIGO!KPN(RY8:.
M8/C;+Z.#Q7-/.:5/)*CG"K#.*6#I8V6*SG"2J96\TQRR[,\5B,*Z\:,OXDR/
M@K.\!2PN!I<)^),<=@\W^N5,HCX89QB<RP#A2X8K5>)J,:56A/AVOF.(RQ8+
MAO,(4<\61Y5+.,CP.$Q_U6>(AU__  3373O!_P"T=^VC\/\ 3)5GT;4?%$NO
M>%KB-P]E>Z#X.^*WQ;\%"]TF5':&ZL9%FL(S<P;X=T4<:2.%W-^SM?G)^RG^
MSQ\4?!WQCF^*OC3X>?#WX)>$_#?P+M/@/X$^%?@7Q1?>,II--C\<CQU<>*?$
M>O7$:0W6K-?27L4VH//<ZIK<^IW-[JBPWD,MYJWZ-U_)WC!FF SKC?%YI@<9
M1QOUG+,DABZU#$X;&06*P65X7+W"6*P-7$8&O7^KX3#SQ,L%B<3AH8F=6E3Q
M%5TY3?\ H)]'+(LVX9\+LOR+-<NQ.6?4<[XGJ9?A\5@L=EU26 S//<=G"J0P
M&:4,)FN$POUS,<92P-/,\%@<;4P5+#UZN#PZK0IKPB?]EK]F2ZGFNKK]G/X$
M7-S<RR3W%Q/\(OA_-///,[22S32R>'FDEEED9GDD=F=W9F9BQ)KH_%_P*^"/
MQ!UAO$/CWX.?"OQOK[VT%F^N>+_A[X1\2ZPUI:AA;6K:GK.D7MZUM;AW$$!G
M,4(=A&J[CGU2BOAWQ%Q ZM*L\\SAUJ$*E.A5>9XUU:-.M[/VM.E4=?GIPJ^Q
MH^TA!QC/V5/F3Y(V_4EP=PC&A7PT>%>'(X;%5:-?%8=9'EBH8FMAU66'K5Z2
MPOLZU6@L1B%1J5(RG25>MR./M9\U'2]+TS0],T[1=%TZQTC1](L;32])TG2[
M2WT_3-+TS3[>.TL-.TZPM(X;6RL;*UABMK2TMHHK>VMXHX88TC15%ZBBO)E*
M4Y2G.4ISG)RG.3<I2E)MRE*3;<I2;;;;;;;;=SZ"G3A2A"E2A"G3IPC3ITZ<
M5"%.$$HPA"$4HQA&*48QBDHI)))(****DL**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ K\U_P#@IO\ ME^-OV1?A/X"L_A!HFBZY\</CO\ $;2_A/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWX:U.^NO&:>+O&,>F^+-/]1HI7_JR_K^O-@>6:C\/O%MZ-2%M\=/BGI!OO\
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M7'C3PP=534WN_$NIWUKXS?Q=X.CTWPGIWJ%%._I]R \QE\ ^*I&NV3XV_$Z
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M;4_L'P?LA$?'.F7MMX0\4_V,-)6T\.Z1IUSX)7P?XMEU;Q1JGJ5%._I]R_R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV\9:Q!?VGA/PU8B9;>VO&TG4I]3OEFLK*UDFA<#\\?B<G[-=A_P1R_:RT/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M, HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#5M*GU6[TR"Z@TZ'4]/DO)(4O+9I/8+[1-&U/1KSPYJ6D:9J'A[4-,N-$O\
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M5;#8BI4665LNQ>(Q$L(JN-]A1="K<=$WRJ5E?7;>*5T]T[MZ6>EF[,_.-_\
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M_;;X_H/-OK4(\D*_]I/(GC_;1@W3C5^L^VC3?*JBW/R!_9V_:+^.0^/GP0\
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MOKNWLK.VJ?&_]B3QE\6?$?QX;0OCO:> _A]^T=/\*[OXF^%D^%4?B'Q3??\
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M2;_PG\1(?"9UJ&1+.PU&WOK35/ 7BWQWX*UW2KVRU*U>'4?#?BW6+:WO%O\
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M?'7A?QU8Z3?3P_:(++4KOPOJFJ6]C=S6_P"_BMKJ2*:2']ZB%/FK,\ ?M ?
M;XL:YJ_AGX6?&WX1_$OQ)X?MY+O7O#W@#XD^#?&6N:):PWB:?-<ZOI/AW6M2
MO]-MXK^2.QDFO;>&-+R1+9F$S*A_,GP]KFB:Q\3_ -H7]JS2_C;\!_VWM?\
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MG7XC:+X%UW6?B+\)_C=K'Q;U[X1:3\2(?#\WAKQ'\4O WB/X(?!^6U\'V?\
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M.4)5L+5GS67-*4I63;/*JI1J32:=I-MKO+W[/S2DEN]$MMD4445^'D!1110
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M^:,E5I3A4UYHR4MY)W?CV5DD[JR2>S:MH^Z=NFZVW/E;_AGKXN?]'U?M4_\
MA(?L1?\ T'%'_#/7Q<_Z/J_:I_\ "0_8B_\ H.*^J:*^7^MU?Y,-_P"$6#_^
M4$^SCWG_ .#*G_R1\K?\,]?%S_H^K]JG_P )#]B+_P"@XH_X9Z^+G_1]7[5/
M_A(?L1?_ $'%?5-%'UNK_)AO_"+!_P#R@/9Q[S_\&5/_ )(^5O\ AGKXN?\
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M3V4Z&WT:Z\1^,<;PW+\+O"'QSM=<\+^ ?A#I_P!D_:+D^"=EX"&N>/+OXHV
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MO5.Z>NMK[,****_'R0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4^,(]0\0V7BG1M7OKWQ1JUWJU]JEMJ&K:=J@I+JKMMW;ML[=+/L]N[ _)KX
M>+/'7@SQ7X)\96'QN\42:-^UC^VI^TEXL\8ZIX[TSX*6^D7?P-_9R\-?$S0I
MM:O-6T3X7Z3J&F7_ (FTKX:^ +*ZN3XDL]*T70--6X\-6'AZ.YUB_NM+PO\
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MSX*\,V?A[XDRP>!_"7AW6/ OBP>,[#PQK'B34_&O@FW\3Z9;>'_/_B9^U_\
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MXOEUJ\U7PAJMIK.O_%!/C-?>*?"_Q ^)'@CQK!\2H_!=K\.E\2Z+XX\%^+M
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M$GN^K?M)_&C3? _Q^_:5\3?%O0?#5E^SGXA^+?@#3/V;?#_AKPC/X+^+^L?
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M2OLM6MU=635M/2Z?KIY!^3MGK_Q$\-_&CX]_%CPA\7_&L.H?&O\ X*"?!?\
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MH+.RLX(;6TM+6&.WM;6UMXUAM[:VMX52*""")$BAAB18XHU5$554 3U#W?0
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH \Q^$=P;GPKJTAO);[;\3OC9;^?-K_A/Q*Z"
MT^,WCVU%F-1\%V&FZ/;1:<(1I\&@7EO)XL\*06L?A;Q[?ZKXYT?Q'JEYZ=7E
MWP@=W\)ZLSRRS,/BC\<$#S7_ (*U)PD?QJ^($<<0N/ ,<6A1Q01JL,%A?J?&
MNE0QQZ9\29)OB+9^*97]1H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%HE[XQ%V)AXFN]&TJXUK[;-IUH\+]2^"/P7UE]4DUCX1?##57UP^,&UI]2\
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MAXJL?'7BVWU#S=(?[9#XI\;Z9IOC+Q'%<^9'K?BK3['Q#J:W6KVD%Y'ZE12
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M#_A5K3R3X>T35-1TK2#9V%[<P2MTSX'_  6T3^S3HWP@^%VD'1G\'2:.=,\
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MB[$P\37>C:5<:U]MFTZT>'U*B@#S#4O@C\%]9?5)-8^$7PPU5]</C!M:?4O
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M,LO]D^8)4^&JK\/$D#!U\#*/"2D: !I](GP1^"\;PR1_"'X7I);3:7<V[IX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"._A<V@+J$2JXN;>RG\3^(M+BCNH91J5KK%U8$RV]F84E_8[_Y3N?MX?\
M9&?$W_J4_LX57)%KF76#:5]G&27W/6P'[]>,O%WA[P!X2\3^.O%VIP:-X6\'
M:!J_B?Q%JUT=MOIVB:'83ZEJ=[+C+%;>SMII-B O(5"(K.RJ?A;]C7_@I9\"
M?VX?&/C3P1\*?"?Q<\-:OX'\-Z?XJU*7XD>'?"NB65_I&IWT-C:2Z4_A_P <
M>*[F620W%M<JM]:6"26=Q%-#)+ED7YQ_X*@>/]?^-'C_ . O_!-KX8ZA-!XC
M_:.\0:=XE^-NJ:;NDN_"'P*\,ZBVJ:C),T3C[*^N/H6K7X$^U+FU\,-I,P,7
MB&'?\_\ _!-GPYH?@[_@J?\ \%#O"/AG38-'\-^%M$M/#GA[2+7S/LNE:'H?
MB;0-,TG3;;S7DE\BQL+6WMH?,D>3RXEWNS98SRKD;?Q-77DN91N_6[MZ ?T-
MT445 !1110 4444 %%%% !1110 4444 %%%% %>[N[6PM;F^OKFWLK*RMYKN
M\O+N:.VM;2UMHVFN+FYN)F2&"W@A1Y9II72.*-&=V55)'\R/B"Y^.'QJ_9D_
M:3_:P\)_L[?&S6?'WCG]I/2OVQ/@/\7].\1_ 1? OA[X=?LUW=KH?POM9M&U
M[XR:#\89;>V^&7A[QO:W-EI7PN?4M>NO$WFZ-8:E9:D([S^FC5-+TS7-,U'1
M=:TZPUC1M8L+O2]6TG5+2WU#3-4TS4+>2TO].U&PNXYK6]L+VUFEMKNTN8I;
M>YMY9(9HWC=E-/2/#?AWP_X=TSPAH.@Z+HGA/1-%LO#>C>%](TNQTWP[I'AW
M3;&+3-.T'3-$LX(=-L-%L--AATZRTNUMHK&UL8HK2"".WC2,>EE^/C@.><:$
M*U6=7#MNHYJ'L*,W5G2M3G!R]K4C2<N9N'+3LX2YM,:M+VK2<G&*C-:6OS22
M2>J=N5<VUG=[JQ^,OB.V^#_[8O\ P4 _9/\ $NO:+9>._A)\2O\ @G]XG^)D
M?@[6;E]0\)>)[6X^*7@'Q'H>B>/_  W'-_87C/3-!UF2PU:?PIXJL=4T6T\9
M^'-%UB?2UUOPYIL]EX+::,WPA^$7BOX]>$Y;VRT#_@G#_P %-?C/I/AO0(KV
M]NAH/[)_BW7_  IX-^+7PS\-Q73W(@T32/#OC63Q%I>FO-%:V%IX62.V2:YC
MMX)_WD\+_!CX/>![OP[?^"OA1\-?"%]X/\.7_@[PE>^%_ OA?P_=^%_".JZH
M-;U3PKX=N=)TNTFT3PYJ6L@:O?Z'ICVNF7FJ 7]Q:R78$M>>_&[]GS3OB-\!
MOCM\&/AI=^$O@QJ'Q[T?QCIWBKQ?IGPZTG7;>XU/XBV2:+X\\5:YX8LM3\)1
M^*?%'B+PZ]YIUQK>I:S'J!NY++4;NYOO[.CM)NZEFU*,Z%"U6.$A["BXU9.4
M(T?;UUB)2A",_>J83$3HSE3A*HUS))IJ)D\/*TIZ.H^:2Y4DW+E@XV;LM*E-
M25[+;:Q\Y?\ !/F)OB6?VDOVQ+V.1Y/VI_C7JLO@&]>2("Y^ 'P32X^%7P8D
M6TB4_8?[3MM+\4^+'C$LD5T_BDZC$TQO'OKWP[X2_ 'X%7__  50_;/GU[X+
M_"*_U"W^&'[/'Q*\+2:K\//!=Y?6GBCQ3/\ $$^//'FB&ZTB6YM/$7B37567
MQ;XEL_*U36=2:&?6+RYN)8G;]5?AO\/_  U\*/A]X(^&/@RS-AX3^'WA30/!
MOART;RC+#HWAO2[72=/%P\$-O%-=O;6D<EW<)!%]HN7EG**TA%9_B'X/_"7Q
M=XS\,_$?Q7\+OAUXG^(?@I8T\&^//$/@GPUK7C/PDD5Q-=Q)X9\4:EIESKF@
MK'=7%Q<QKI5]:!+B>:90))79N3^T$J^83@ZM.EBL/]5H^SE:=*C2J4'AHM<T
M5)1HX>%&7O*T92DD[<DM/8WC13Y7*G-3E?:4FI<[V=KRDYKS2]5_/!?V7CFU
M^&-[^QWX=O6D\6_\$V?'7[4'[16AVUS#J&GZUJOAWX ZMX!^(7[*OF&*)=MW
MXR\#_'F[MO#<6_\ L*\3P?/+=SW<NGVVHW/8_&+QJWQ*\!?M6?MD>&O$NJZ!
M\&OCG^T]^R]^S7KOQ$\.7,L&KZ!^QS\-M4T#PE\8M?TSQ5926%QX>T'Q;XZ\
M7>,[+7[W1M7M83:VT6GWNH VIOE_?N+X9?#:W\4>*?&\'P]\#P^-/'.DV>@>
M-O%\7A/08_%'C#0M/MELK#1?%.OI8+JWB#2;&S1+2STW5KN[L[:V18(84B4(
M$T/X8?#7PQX#_P"%6>&OAYX&\/?#'^S-7T7_ (5SH?A+0-)\!_V-X@DOIM>T
MG_A$+#3[?P__ &9K<VIZE+J]A_9WV74I-0OGO(IFNYS)V_VW2YH3^K2<_:0G
M5?-!*I[6O2Q>-:]QI2GBJ--X=N+5.GS1FI7L9?5I6:YTE9I:/3EBZ=+JM%3E
M)36EY6:9^;I^&_PV_9[_ ."B/[,G@/\ 9?\ !_AKX86'Q$^!_P :[G]I3X<?
M"WP[I?A[PGJ'PZ\%+HS_  7^(WCSPSH-M9Z5;^(+3XEZIXA\)^%_B#J-F_B'
M48=6\1^%X]7>QGO[.;V'_@J5_P H]OVL?^R3ZK_Z7Z=7U5\-/@A\%O@M#K%O
M\'/A#\+_ (36_B&2RFU^#X:> /"G@2'7)M-6Y33I=8B\+:3I2:E)8)>WB64E
MZL[6JW=RL!C$\H?L?%/A3PMXY\/:MX1\;>&M \8^%-?M'L-=\,>*=&T[Q!X>
MUJQD97>RU;1=6MKO3=1M'9$9[:\MIH69%)0E01P/'1^N8#$OVM58.6'<ZE5K
MV^)]CB)5W*;YIVDHR5"FG4J<M.E33E9<L=E2:IU8>['VG-:,?AA>"@DM%IIS
M.R7O2>G5_EG^VE<-X=^#_P#P3R^)_B"0VOPD^$'[3/[-OC[XOZN\$LNG>$_#
M<7@S7?#NA^-O$4L4#K9>&O#?B[Q!H<FI:A<SQ6NGW-WIU_)%,]M$]O\ H1\6
MO&?@^+P!XBT67Q7X:CUCQO\ #7XA:CX+TF37=+34_%VGZ/X2FU#5K[PQ8-="
MZU^STNPO[&]U&ZTJ*[@LK2]M+FY>*&YA=_3YM#T6YT6;PU<:/I=QX=N-+DT.
M?0)M/M)=%FT66T-A+H\VE20M8R:7)8LUE)I[P-:/:,;9H3"2E>5> ?V;OV=O
MA1-K5Q\+?@)\%OAM<>)=+?0_$4_@'X6^!O!TVOZ+(_F2:/K4OAW0M.?5=+=_
MG?3[YI[1G^8PD\U#Q5&=.BJD:BGAJE65/D4'"I"K4]JE-MIPG";E>2515(<L
M+4W'G;4)1E)IQM-1YKWO%Q7*[=&FK:>[9W=W>R_ OX#:!KGPY_9Q_P""2GQ>
M^*7Q%\0_%#]FV[^(W@+P]K'PJ\9Q^%/#_AOX+_%/Q3/K,7P-^,/AO7/ 'A+P
M5J^K:#X#\8V#Z?JEE\9O$7Q!TZRF\3V6LVAM;^SAU32?WZT76_V@I_B#=Z;X
MB^&/P<TOX4I?ZS'8>,]%^.OC;7OB#<Z9 MT?#UY=_#*^_9U\-^'+*_U1DLAK
M.G0_%O4+?05N+IK'5/$9LXDOMZ?X/_"6Z^'MO\([GX7?#JX^%%I!IEM:?#&?
MP3X:E^'MK;:+JEKKFCV]OX+DTQO#<,&DZW8V6L:9%'IJQV&J6=KJ%JL5W;Q3
M)Z+6F/S"&-DYNA%2=3%\M[PC&G7KRKTIQA1E3A[>+J3C5G*,U44:;ES-,FE1
M=)6YW:U.]M6W&"A)7DI6@^5.*333<K6T/RA^&D=K-^T__P %DH;[Q\OPILI;
M/]GN.\^*+ZE;Z.GPVM7_ &/M+6X\?/J]W?Z7:Z4O@Z$OXA;4KG4].M[$:<;J
M:_LXXFN(ZO["V@Z=^SW\;=2_9+\:_ GX2_#KXWZ)^S9X/\>7GQ;_ &?O$.H'
MP-\?? &@^-]2\"6OB_XG^"=1TKPUK.C?%V#5Y8I'U[Q7#\0=4\076I>/I])\
M>VNG+=:9?_I[:^ _ UCJGC+7++P9X4L];^(HTY?B#K%KX=T>WU3QVND:.GA[
M21XRU"*S2[\3C2] C30].&MS7PLM'1-,MO*LE$ YKX:?!#X+?!:'6+?X.?"'
MX7_":W\0R64VOP?#3P!X4\"0ZY-IJW*:=+K$7A;2=*34I+!+V\2RDO5G:U6[
MN5@,8GE#U/,*<Z.(I.%2U7#8&E&*?*O:X/"X?#^UE.$XMQ_=5)*E4A6A)3BT
MJ52"J,5%J4))J\9U9-O7W:E24^5)IZZI<R<6K?:3Y3\S/VC_ (#?!OQG_P %
M2OV3[KX@?!SX7>+-.^(GP)_:"?79/&'@'PCK]OXW\3^ 8_  T6;65UG2KL>(
MM:\'Z%>VR:-<7ZW=YH>ES"/3Y+:U#JO@.F?L]_!WXO\ Q _X+)>)OB9X'TOQ
MIK7A+Q7JB>"[O7VN=0C\#:DG[/NE:POBGP393SO8^%?&Z7^GZ:\?C?1+:R\5
MQ6VG6EA%J\=@CVLG[>?$3X/_  E^+UMI%G\6/A=\.OB?:>'[]M5T"U^(G@GP
MUXUMM#U1HQ$VI:1!XETS4XM-OVB58VO+)8+@Q@(9"H K2M/AQ\/-/D\;36'@
M/P993?$N9[GXCRVGA?0[:3Q_<2:8-%DN/&SPV*-XJF?1U727EUTW\C:8HL&8
MVH$5;4LXE3HTH1EB%4I8.GA(N-1QC!4LPAB^>$N?F7M*,51E#ECK".LHOEC,
ML.I2DVH.,JCJ:J^KI>SLU:SM*\T[O=Z)J[_(?3_B1X:^-?@O]@CX5^.O@+\.
M?VI_C7XX_8@\'?M :S-^U!\2+GPU\$]*T.?P=\/H?%WC:]L=6\!?&K3O%GQ>
MU#Q+<QQ:?JL7PMO?%>@^%M2\87$?C31/#NL^*++5_AOPAX3\!?$[]BC]A;5?
MB#X6^&OCS2?!7_!3_P .?!S1]9UJ/0/B3HNC_ .[^-_C?34^&FD>//$6B6MY
MXE^$5Q:G1-(L+*^MK31=:\/67AZWDT2TTRPTW3;#^BSQ=^SM^S]X_P##?A#P
M;X[^!?P<\:^$/A]80Z7X"\*>+OACX)\2>&_!&F6UA9Z5;Z=X0T+6=$O=+\-6
M%OI>G:?IL-IHUK96\5A8V=G'&MO;0QIK77P4^#=]X(UOX97OPE^&5Y\-_$VI
MW>M>(_A]=> _"MQX(\0:SJ&MQ^);_5M;\*2Z4^@ZKJ=[XCBBU^[O[^PN+JYU
MN./59I7OT6<;4LXP]&$(TJ->#^LQK.U635./-BU/V*=3D@Y4\4DH4Z=&*=-\
M\ZGM.:,O#SDVY2B_<Y5[J]Y_NFN9\MVDZ;NVY735E&UGUWA;PIX6\#>'M)\(
M^"?#6@>#O"F@6B6&A>&/"VC:=X?\/:+8QLSI9:3HNDVUIING6B,[LEM9VT,*
ML[$("Q)WZPO#/A?PSX*\/Z1X3\&^'="\)>%?#]E#IF@^&O#.D:?H/A_1--MQ
MMM]/TC1M*M[33M-LH%^6&TL[:&"(<)&HK=KY^3O*3YI2O)OFE\4KMOFEK+WG
MN_>EJWJ]SJ6RT2TV6R\EMI\D%%%%2,^=OC[^TUX#_9['@ZP\0:+XZ\<>,OB%
MJ5YIG@CX;?"[PV/%WC_Q.^EVZW>L7>F:(]]IENUCI%O)#+?W%QJ%OL69/(2<
MI,(O@'XY_P#!6JQ^'-D-&\,_LU?&O2OB*UW;^;H/QSTK0OAC966CRVMU*^IB
M+3_$GBC7-0NQ<K80V^FMINE6MQ:W5U>G6H9+*&RU"Y_P5A\2>)_A18_L\_'G
MP9?/I/BCP+KOQC\%:-K4)47.DWGQ5^$.N:9%?69D22(WUJV@+=V:RQNCSVR!
M@%!9?MSX>_LA_LQ^$/"FC:9IWP>^&_BIOL,%Q>>,?&'@[P[XN\7^+KV[075W
MXB\1^)]>TV^U;5]3UBYEDU"XFN+DPQO<&&S@M;2."VB]ZC3RW#8/!8O%X>KB
M7B'6]R-5Q7M*%:<)QERN"C"--T))>_*I*I.\H1@E+^4>)LX\:.-_$3Q)\/O#
M_C/)N"*?"%/AJK',<5DF"Q]:&4<2\/X'&X'&8:.+PN95,=FF)SFAQ5@\3.2P
M& RG Y7E,H4,PQ>95IX/\8/AO_P5O^*W@S7-'_X3JRUCXT^'->L?"][XQ.J^
M&?A_\-=9^'VN/>W/_"9Z/\.$\(:UJ=EXX\,6NG2VX\,WOCB;0-?U&]M/^)I+
MI4$\F/TGTW_@I7\+Y+#1?$OBGX'_ +4GPY^'&LZAIVG'XN>./A3IEI\,-);5
M;M+"RO-6\3Z%XRU\0V$U[)';?:K6SO%65U4J!DCZN/[-O[.S JWP$^"Q4@@@
M_"WP,001@@@Z%@@C@@\$5^0O_!07X9>$/A9XU^&WP8^#FEV7@;PM^V#?Z%X4
M^(GPV\,VMII7@B77O"'QA^"T_A/QII?ABTBAT_1O$%U:ZIK6C:A)HT%I;:O;
M6=O-?6TEY;-=OU4GE&:XJE0IX&IAJD[N<XS4(>S@N>K+DII4Z<X48SE!JDXS
MG%1G&\W-?!9Q@?I%> _!6;<29MXK9=QUE. GA:6#R_,\NJYAF4,VS3%4\MR7
M"3Q^;^VSC-,LS3B''8#!YG&KGU''95EV+Q&-RNK*GEU#*ZO[QT445\N?W6<E
MX^\:Z'\-O GC7XB^)GN8_#?@'PEXC\:^()+.#[5=QZ'X6T>\UW5GM;;?']HN
M4L+"X:"#S$\Z4+'O7=N'Y!>/O^"JOQD\#^"?#/Q U;]COPYX7\*?$C0(O$_P
MMU#QQ^UM\)="\3>*_#>J0)/H?B.+X9-I'_"92V-Q!<V5W<VMK$RQQW,4/]I)
MY\-RWZT?%SPJOCKX4_$[P0T9F7QC\/?&GA5H0,F5?$/AO4M(,8 SDR"\V@#K
MFOR5_P""+L.@^.OA!XW^*WB"TL-:^*.A^(_"?P:L?$MVIO=3T#X7?#SX,_"^
MP\)>%- FNFG;0]$^TW6MWFHVFE&T@U;6)+FYOTN3;6;0_K7 ^!X6H<)\3<4Y
M_P /4>)7D69Y/AJF KX[-\#>CFBQ%/"PH5\JS+ 1PKJXBA7J8C%XRAFL%3PM
M/#4<"IXB>(IW'EU<DW97MK;=*S:VO?1N]TFK7LS\J=2_X*1_M?:YXLC^)FH^
M,[O3?'VD7_AW_A%_#OA/XK^%] ^ $'A_3A./$6B^,O@O.VK3>.;[Q2;B1V\3
M77CK2M9T-TMQI$L,-M!#'^GG[/?_  5%_:3^,6DV7A[0?V2_A[\5?B+HVBRW
MOB>V\%_M6_"KPAK.KQZ<N[4-:T'X5Z_!K/BT6BQ-"9+>SOM:B%S+&D5TBW=M
M O[C5^</_!4./1_"G[,VH_'"PM+"P^+/P:\;?"SQ%\*?&:!K/7="UJ^^)OA3
M1-6T^#5K1H+]M USPUJNN6/B/1&N&TW4]-DE>ZM9I[6UDA^SI\><#<>YCDG#
M"\(L@RS%8_'8/*<JQL,WS:='!8C&3IX+!TZ^&RB?#N)JY=]8J0GB*4<QC"BZ
MF(Q\</B,4YPKVI1FU%PC&[24EI;HMN72]V[OK?=:_6G[.OQS\+_M*?!;P'\;
MO!MGJ>G:!XZTZ]N8--UB../4M+U#1M9U+PYKVEW)A=X)SINO:/J=C'>0,8+Z
M&".\@"Q3HH]JKXL_X)T^%%\&?L/_ +-.D*AC%[\,],\6;2,9;Q[=WWCEG Y^
M65O$9D3!(VN,,PY/VG7X?Q1A,#E_$W$6 RM5%EF"SW-\)ERJS]I56!PV88BC
MA%5J.SJ5%AX4^>;2YI7EU,;WULU?6SW7D_-;,*^4[S]KGP7H/Q,M/AUXY\ _
M%CX<V6N:%\6/$/@OXB>-/#F@V?@WQQ9?!*&PO/B&NC:5I?BK5_BAHIT[2KRY
MUO1[OQY\./!^E>+=%TNZU+PGJ.M6]]X?;6OIS5KVYT[2M3U"STG4-?N[#3[V
M]M="TF32H=5UJYM;:2>#2=,FUW4]%T2+4-1EC6SLI-9UG2=*CN9HVU#4["T$
MUU%^41\-?M;?$;1_C)\7O$O[/?C/P5^U/>_#?4_"OP@@\3:W^S1XG^%'PM\
MZIXG\/-XH^%OPM:T^,'CD>+OBEXO\/QW^LZI\3?B_P" _"O@OQ;XAT71=&UC
M3?!7@6QM_"5]XD4G=NUO5)W>WRZMV:M?K8#[#^#?[6/AKXQ^-]+\"P?#3XK>
M +_Q/\)K7XY>!=2\?V?P_ATWQS\+K[5](T>R\2Z7;^#OB)XSU_PY-<S:]H\Z
M>'?B)H?@GQ3';WDB7&B0WNG:M9V$WQS_ &L?AE\'KB#P?IOB3P'XW^-VH^,?
MA/X.T?X%V_Q'\-Z+\0;V;XL?$/P?X$T_5[O17.JZWI.BZ7:^+H_$USJ=[H:Z
M?-IMEY?VRW%Y!<KXI^Q%^S]JWP5\6?%_4]%^%/B7X)_"3Q)X>^$OASPIX%^*
MOB7P%\0/C!>>)/ >F^);;Q#XEE\6_#[Q?\0M*\-_"J;3-<\/:1X%^%:^/M:T
M;PQXATSQYK?A'P;\+M'\22V'BOYTTK]GO]J#7)OA1\/+_P"#UCX6F\$_M6_M
M ?M-_$;]H+7_ !7\--4L/&7Q-U*V^.$WP/\ %_@WPWH&N:SXEE\/2/XG\"Z5
MK[>*O!GA?7?#&EZ9H7AK3_ VJ^&[/5YM/=H\S[*VEUKI=]?E9-N[T8'Z7WG[
M2O[.6G:UXC\-ZA\?O@G8^(O!T]Y:^+M O/BKX%MM:\*W6G6>HZCJ%MXCTJ?7
MDOM#GL-/TC5KZ\AU."UDM;/2]1N9U2"RN7BZ/QI\9/A!\-SJR_$3XJ_#?P$V
M@Z1HOB#7%\:>.?#'A8Z+H/B36+WP[X=UO5AKFJ6)T[2->\0:;J.A:+J5YY-G
MJFL6%[IEC-/>VL\$?X[77P$^(-Q\%M!TOXY?!BP^!_PB_9P_X)^_M!^!K[Q/
MXZ\8_#'Q'K.N?'GXG>#O"6D_$?QKJ-QX-\6>.5A\(:K#8>*_$FFZ[+=V?BGQ
M)XEU'5=5\4Z3H=Y%H=AJVQ9?!']HGQE\"?#?QGUWX6?$G5?VI/BOJ7AWXT:+
MXC\ >-OA!IWBCX#^-/A5\.HO '[-GA[Q?HGQWNK+P?XL\%ZEX8\3?$+Q1\7)
M18ZSXQ\.>,?'?B#3-,\'Z]=2Z?X@\*/ECI[V[MNM[_@K:M]+I:]0_:O3-3TW
M6]-T_6=&U"QU?1]7L;34]*U73+NWO]-U/3;^WCNK'4-/OK626UO;&]M98KFT
MN[:66WN;>6.:&1XW5C>KD/A_HE_X;\"^#] U:T\,V&L:1X9T2QUJT\&:<-)\
M(PZW!IUNFLCPSI@@M38Z&^IBZDTNV:W@DBLWA66)) RCKZS *^._BM^VIX#^
M&7Q)U7X2Z/\ #/X\?&KQWX<TK2]8\8:+\"_AK)X]D\&6NN01W>BIXFD?5]'6
MQGU2QF@OK2.#[6IMKB!I9(GD6.OL2OP^^,6B3:E_P4E\0? +5M6U71OAU^U?
M;?!?Q7\2HM'U"XTF[\7>&OA1\+_B[;Q^!KG4K*6WU*TT+Q;J_A73=)UQ]*O+
M&_N; 3V"7<<5U*DOI99AJ.)J8GVZ<H8?"5,3RJ3CS*E4I>U^'WI.%"56I&"<
M.><(Q<XQ;9^+>-_&/$W!V2<)RX5JX;#YAQ/QYDW!SQ6)PU+%+#U,]R[.H9-&
M'UB3PN%AC^)Z&0Y5CLQQ%#&PRW*\?C\=2P&+Q.'H4997Q[_X*Q^*KJ\3P5\&
M_@[\6/AS%<G2;;Q+\2/'7@O2KWQWX+=]<4>(?^$;^%%Q=ZAX9UW4K'PY%YVD
M'Q1XQTVSU#5KXV=]I^FVU@FI7\?P*_X*P>,+75V\%_%KX0?%;XE:7!)KMOX<
M^(?@WP/I=A\2/%H&L!_#(\1_"^QO;#PCI6I2Z"\PUMO#'B>YM(;^U@2QL+B&
M:>Y3]6;;]DW]EJT@BMX/V;?@,L4*)&@?X1^ 99"$4*&EFFT"2::5@ 9)II))
MI7R\KN[,Q6Y_9._9:NX);>?]F[X#-%,C1OL^$?@&*0!U*EHIH= CF@E4$F.:
M&2.:)\/$Z.JL._Z]D7L?8_V95MO[3G7M>>R7/[3G]I:R=J7/[+6_)S>\_P C
M?A7]*A\2?ZS/QTR55ERTO[&65UEP_P#V?&?M?[.>4++%E3G*IK+//[,_U@:_
M=?VC]3_V,\\^%/[:?@+XF_$?2_A-K'PU^.WP4\>>(]*U36/!^A_'7X;2^ 9?
M&EIH<#W>MKX7D75M7CO[C2K&*>^NX9FM2+6WN)(3,8)57[#K\.O@[HD^F_\
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MI^A>'])TS0M$TFUBL=+T;1K"UTO2M-LH%"06>GZ?9106EG:PH D5O;0QQ1J
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M)>V0AUCQ+XXMY)9UF>(2HD\?[AT4N>6JYG9JUKNR5^FNG;TT ****D HHHH
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M6ZCI*2BTG*2<I15Y.R>\8V5U(^R/VV/VY/ _[/'P;^-.H_##XE_ WQ/^T/\
M"W3?#.H+\'?$'C+2-:\26D6K^+O!VD:A-XB^'OA[Q;HGCB"VM] \3KJD4@?3
MUA\_3KV9Y;*417'U]\7?'O\ PJOX3_$_XG_V5_;W_"N/AYXU\>_V']N_LO\
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MS>'[CP8GA^ZO=!T?5;RQO;;7H==U]UM-0UO0;N<:'+)I<EZUM=VU?H+^SO\
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MU]:6UW#LN((I$^:XCC&GFK48I48X?"*E!*R5*-&"4;>34M_1G^A/T+,=+,O
MO+\;BJL\1G.(XKXRQ'$6*J_Q<7GN)S[%8K&8JH[)2J5X5J%2<DE&<I.45RM&
M?X"\4ZYXPT!=8\0_#?QI\*M1-Y<VQ\*>/;[X=ZCKZPP>7Y6HM<_"_P >_$CP
MN;.\WM]F1?$C:@OE2?;+&US%YGXL?\%PK-M.T']E'X@64@AUOP;\5?$RZ3*"
M?.AENM&T?Q$LT2J=Q\J^\&Z:[D*Q   *E@:_=NOY]_\ @N7XAC&L?LC>%)[H
M1:5_PD?CWQ3XE3?M\G3K?4/AMX?M;@C[OS6^M:ZBNQ"QK'*V#_#][X$TJM;Q
M5X5C26TLYE45KJ5".09K[>FUK?VU+GHI/XI5%'>1_6D5*4H*+LW.&M[:<RNK
M^:TMUO;J<+X4_;W\=:O'X*TCQ'^W#X]T7QWXH\.^$-4U+0[+X;? #^P=)UGQ
M5HNE:HNCKK]Q^S?J&D6 CGU6"UM[75O$4E_#YMM;WLTEVY+XGB/]M[]K_1[3
MXA^-]-^(GQ\USX(_"7QS'\/?B)\58])_9(L5T7Q$NLQZ%=6EEX:F_9NEDU25
M+]BMM!_;-G/)%<:/)?II?_"1:"-0^._%>@:I\%OA=>_LY^)?B3\'?#WPJ^-6
MO>'?B#JSZWX2\5:[\9O#UUIMM:2ZF_AU?#7A_5TM=-L[L7EI:7&KZEI^FSQ6
M/DV4^D37'BDZKZ'\1='C\:>._CEXF^&/@'X/ZAX=^"F@>!?C+\2;[QOX[\56
M>C?$[4I]'BU+P?J/AKP)X<\5Z3X0\7^(?LWBU]-TG5]6T'Q$;RZUB[LQ<G4-
M=T;2/$7]1PX1X)IXJ&(CPSD&*RW%RG.AB,7P_D<<!+!QS#)\$JM&NLNR!87&
M8W%YC7RG"85XK._[/Q=+"U\72S"CBG"CZ?LZ6CY(-/9N,;;Q7:-FW)Q2O*SM
M>]]/KS_@E,VN>,?V[OVS_B%XQ\0W?BCQ?8:5K?A6]\0:E;:/9:EK4$WQ0.F+
M?7EIX?TS1-#MIS:_#W2A<1:/HVFZ<LK@6UE:1;(1_1%7\R/_  2(\67,O[=?
MQREFB?2]+^+7PI\1?$+3=*GD62YCN-<\4?#;XB:5:S,JH)7M="^(&H/YRHB.
M3+A0"%3^FZOYK\?\-4POB"Z<HTZ='_5OAGZI1HPITZ.'PU+*:&'5"C"DE2A2
MI5J-:,(4DJ<(VA!*,4CS:B<9R3=W?O?1ZQ7ERP<8VLMM+JS91117XF0%%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ%"%*C%S<'4GS-W;=DFVV[)I-MMMZMZMMM^>H4445\:(**** "BBB@ HHHH
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M&5Q\0?#GP2T_X6MI^IZ/K^N>)M:US1;&VRIO^"@?PY>#P-8Z+\)_CKXG\?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img181012247_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img181012247_13.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )V [8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8)=,1]W_ (I_P]X6U66X)R"RQ:U&5QM!?=N7%_X>@?M\ZSC_ (1?]C+SM_\
MJ_\ BVGQGU[.?NX_L^[T[?U'W<9[8S7[XZ!X4\+>%+;[%X6\-:!X:L\!?LF@
M:-IVC6VU?NCR-.MK:+"]ALP.U;]+^T<JAI2R2FU_-7QE>K)^;5DH^BT^\W7@
MM](;-+UN(?I5YU1J3_YA.%?#7A/(\+AX[NG3KNM7Q.(L]JU:,:EM&K(_GO\
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M4YM04\AX@;_L?-</4JRC1PLY5\%B,;4:6%PE5:GZ@T445XY_2H4444 %%%%
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M\SG7RJ'.J.(S&O2KT\+2@\12E0]G'#3P]2>)_F#^ _[-?QU_:=\5S^"O@/\
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M?$GXG?V-X:'PG@OUUC^ROAGK>AZIIV=4M;*R_M#4)YK _:/LPA^T31.OA/\
MP4X^%.M?'+X=?\$Z_CIX@\'P?L]?MH?$[]H;X*?!IUEU&;5)/ X\:CQ%J=NV
MHV4C+'?P>"O&>G^']<LXYX/MNDIK%_I-Y/-+<R,?C>&^(<ZPO$N68S'YSF4\
MOQ6=\5X"O2Q'$53,J.)6'CC)8*G5R&LW5RK"8*5)3>-PRQ+G&$(1I4E.,9_I
M_''!7"V8<!Y[EF4<,9%2SK+^$_#K.,)7P7 ]#(<5@GC995'-JV'XQPT5AN(L
MRS6.)=-95CI8!4YU:M2=?$.E4G3_ !*M_P#@C]_P4?N="_X2./\ 9CUY=/\
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MT\;5JUU4BJCA5FI-RC=TJ#FE"IT\#^'/"53!YJ^&<YS3+,@\1_"K$-XKB^6
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M #DJ/^(=K]BG_HJ'[4G_ (6OPF_^<E7[V44?\1+X\_Z*C,__  93_P#E0?\
M$!O!_P#Z(#(/_!-?_P"7^7Y]V?@G_P 0[7[%/_14/VI/_"U^$W_SDJ/^(=K]
MBG_HJ'[4G_A:_";_ .<E7[V44?\ $2^//^BHS/\ \&4__E0?\0&\'_\ H@,@
M_P#!-?\ ^7^7Y]V?@G_Q#M?L4_\ 14/VI/\ PM?A-_\ .2H_XAVOV*?^BH?M
M2?\ A:_";_YR5?O911_Q$OCS_HJ,S_\ !E/_ .5!_P 0&\'_ /H@,@_\$U__
M )?Y?GW9^"?_ !#M?L4_]%0_:D_\+7X3?_.2H_XAVOV*?^BH?M2?^%K\)O\
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M'_\ H@,@_P#!-?\ ^7^7Y]V?@G_Q#M?L4_\ 14/VI/\ PM?A-_\ .2JU9_\
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M.IC<1@L7BI:54V4445XY_2H4444 %%%% !1110 4444 %%%% !1110 4444
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M\.]?^"F__1^&M?\ A]/V@?\ Y7U^^U%'L8=Y_P#@<O\ /R7W ?@3_P .]?\
M@IO_ -'X:U_X?3]H'_Y7T?\ #O7_ (*;_P#1^&M?^'T_:!_^5]?OM11[&'>?
M_@<O\_)?<!^(W_!&KXR_&#XG6O[1V@_%3XD^,?B-%X+U/X93Z#<>-/$6J^*M
M0TRX\0+\1+37([36-=N+S5OL%V/#.D/'8277V.VE@EN+:V@GO+UY_P!N:_ #
M_@AQ_P A;]KS_L(_!S_TI^,E?O\ T4&W2A=W^+?_ !, HHHK8 HHHH ****
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M7/,=EV682G/&X[!X.D\1BZ;K8K%8?#TE.M6IPE^8_P#P_2O/^C3+G_P],O\
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M_P#P7#^N_P#2U#^?C_A^E>?]&F7/_AZ9?_G.T?\ #]*\_P"C3+G_ ,/3+_\
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M=M9.]DTKO=[*[]26N6\;^'H_%GA'Q%X9DNOL2ZYI5WIHNR ?(>YC*1R%25W
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MR;T4;;W,>+\!FN:?1_\ I799D6&QF,SO,?H[\3X')\)E\:D\?BLTQ7%W ]#
M8?!0H_O9XNMBITJ>'C2_>.K*"A[UC@?V/M9U;7M._P""1FHZWJ-[JM_]C_;F
MT_[;J%Q+=7)LM'A\0:/I5JT\S/(T.GZ7866GVJ%B(;6UAA3"1J!^[U?B_P#
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M8?8[RS\V:SF^(&M6K.M?4_PO^,O[+>A:/X9^$OPK\;>#?"\&9-#\&>$Y%O\
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M35/@CJ+%BXM=/\+?$S5_AUJOP\29F=O-\ >(?#-EY[_:-1TK4@IB;[5^"OQ
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M^[5^5.UE[D8K2]KMLQG-3::A&&EGRW]Y]VK\J=M/=45I>UVV%?SW_P#!+_\
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M/^([2RK )/!/@7Q-XEMDD8J,3WFDZ9=6ELB[E+RW,T44:L&D=5YK_0D^%_\
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M_!2[X?ZC<9@CUD^$UAD;@3'4_"U]X6BVGN)+J,VP]74BOUUK\B/V_P#/@?\
M:!_9[^*P5H8[-=,,ERJL%+>!/&5MK[@E00SI#KZ[E^9FC*J05 %?S]])#_8^
M!\AXC>E+@_Q$X(XFQ$GM"CA<V6!E*3^S%2S"%W=;[ZGZ7X5_O^(,QRM?'G?#
M'$&4TUU<ZV#>(22ZNV&EH?KO134=)$22-UDCD57CD1@Z.C@,KHRDJRLI!5@2
M""""0:=7] IIJZ=T]4ULUW/S3;<*_!C_ (+M?%;]O?PA\)?A=\.?V*? 'Q+U
MC1_BMJ/C'2?C1\1/@_X8OO%/Q"\':-I]GH<7A_P[I9T^*XN?!UEXT.K:\^H^
M.H8[>YT>/P]%;VNK:9)>NE_^\]<WXC\/P:]9R6LPRKJ01SSG/7 .>IQ_G/I9
M/F$,JS+"YA/!87,(X6<JBPF,BY8>K-TYQ@ZD8M7=*<HUH)WC[2G'FC*-XOIP
M>(6%Q-+$.C2Q"I-R5*LFZ<GRM1<DM^234XWNN:*NFM#^!7P'^Q1^T?\ L^>!
M])^,/C72=6\1_$;Q#XQL;GQ3X!T2]?Q5XD\*^'-2M]7U/7/%'CKQ7YTR>(_%
MUQJ<.G+J\M@]SHVDK?7UZTUP9Y!H_P!1Z_!\!?VT/AE_PB7Q6T1-9@T*)M2L
M/$6AW<5OXA\&32>3:3ZCHVOH+I+>.<I##=0W"7ND:JMO!)?V=ZEO:R1?IY_P
M7(@^,'P7_9$;3?@!\,/&'C'5OC'XQLOAGXV\6^"=$U/Q)JWP_P#!VLVEW-?R
M0Z3H]I<W\=WXUD@3P59:K.D6F6;ZO+9M=V^NZIX?\S\Z?V?_ -B[XH_#3]A/
MQ?HD_AK6&^/'BOX6^-O&>J>'8;:>?7;?Q9=>'=5G\$>!XK>+[9="_P!)MX='
MTV;2XEDE37[K5HHT$\[5^T9?QCB:N2X?.\YK82&+QV>+!993P<U2JT<.I05>
MK6IJI)T<+A(OV=-SO5G>$JTYQK1J2^XP>>5/J5/%XZ5'VF(QJH8:%*7+*%-.
M*J3G'F?)3I+2+E[TFU*I)\ZD_+OA!^RU^RG^R+JG_"V/"ESXO\2>*Y+;4].T
M/QG\0=<TW6I](@NH5LM731;?1-(\.Z5#=2:?++9RWDMC/J0L9KRSAN8[>YNH
MY/-/VBOVFOC'^S=XS\/^/;?P_!XU^$OB2]T^03)<-'X:UJ.]07%O!9:ZD4[^
M%/$%Q:XELGO89-+OT#R>3?P6F8O+?V77\<_M?_L>?M#^%+%;B^\7_#F_MO$?
M@35W!@CFUNY\-C7H_#T5W(?L_GR7&D:GI%T\Q\N*#Q#%-.(4,$D?T)_P23TK
M4_VG/A5\8/@=\<O &H>)_A3I%[X>M_#L_C33KR.&[MO%4.I76L>$+6XN%@N+
MA?!^L:3%J&D:I83I?Z8=5M94ETR2/388?6SW,J="AG%?,J5',Z.2YAA\MSS+
ML152K5<NQ\:$L'B\OJ*<)4Z\'63A23C[\:\E*E*G[1=68XZ,*6+=:G#$4\%B
M*>'QV'J-*<\/75-TJU%J2M43FN6*TNJFL'%27]'_ /P3)_:1^%G[2OP6\/\
MQ+^'CWUO97EQ>:+K&B:W:K9ZYX:\3:0RQ:OH.K01RSVYNK1IH9XYK6>>VN[*
MZM;J&3;/Y:?I]XP\">$?B%HS:/XJT:UU6R=&,+N#'=V<CH5%Q8WD)6XM9ER&
M5HI K%5$B.HVG\U_V-_V+OA_^RKH3^$O@OX4'@OP9?Z[>>)[G28M6\2:TLVM
M:A9:;87=^][XDU?5]0#S6FE6$)B6Z%NJVRF.)&>1G_5"R1DMHE;.Y5 .?7'O
M7\W\0Y?D.<?VIE[R^./X>QTJU)9=G6'PV+C7P-1WCA\=AY^WPU:T;1DI>TC+
ME4FV]3\]G6C1Q4JV G7H0A5<\--RY*].-[PO.G)VE':\9.]KW.1^'/@6P^&W
M@_3/!FEW=U?6&DS:L]K<WHC%V\6IZSJ&K)'.852)Y+9;X6QECCB6?R1-Y,1D
M,:^"^'-*^,'P1@N_#7AWP)I/Q*\'MJ=]?Z9J6GZO9^'_ !)%'>S&;R];%VLH
MU&YC)\H3Q6\A6-8T6Y,"16\'UE17Y]FGAUE>*PW#%+(LRS?@[%\&9=5R?AK,
M.'JF J5<OR;$8?+\+B,IJ87/<OSK+<=@:U+*<LYXXS!5L1">!H5*.)I5/:2J
M=='-:T)XR6)I4,?#'U8U\72Q2JJ-6O&=6<:ZGAJN'JTZD95JMO9U(P:J24H2
M5DODK6_"?Q1^.M[H%IXZ\):=\-/!V@ZQ#K;&/5;/6O&%[<VH*Q0V%Y!"\&FP
MS*S";S+:W8'RIV-TT"VIR/C'^Q=X&^*OPI^(GPXE\1>,(F\:>$-;T&UN+[6+
M:XL[34KRRD&DW]S FEJ\T-AJJV=Z\:,CN+<JCJQ##[,HK@RKPDX3P>;+B7.H
M8KC'BY8_ YE_K5Q*L#4S6GB<L]B\MC@Z.4X'*<JR_#X"5"$\-1P.74$JG-5K
M2K59RJ-8W-L3B\%6RR*AA,LKX;$82ME^%]HL/4H8N$J>)C4E6J5J]5UX3E&H
MZE67NOEBHQ21^*WPZT&^_;G_ &-['X#:UXB?X6?ME?L=^*/#>F17U[N76? W
MQ<^$;S:;X'\;3PHKW=[X5\;:/:-;ZAJ=G%/;RW-QJTMK'>2Z;;)/WVC_ /!0
MKX]_#+3HO!/[27["_P"T=<?%G2HAITNM? SPA!\1/AEX\OX 8EUGP]KMM?P1
MZ3:ZHRK.VG22:D^GF4I)*&'V>/WC]I7]BZZ^)/CO3?V@_@#\1;WX _M.^'[&
M/38?'NEV::AX:\>Z+ (Q%X7^)_AIU>UU_32D$%K#J$MO>7%I;16Z7%CJL>G:
M3#I_DUK\7/\ @K!X4@.A:[^R1\"OBOJ-J@MT\=>"OC7IG@C0M19!L%]+X=\6
MWC:Q'YA EEBCCL1DLL4$(P@_HR-; 9E2;A#*L1AZE:IB_P"S,QS'^Q\7E6+Q
M/(\7#!8VK4HX?%9;6J14Z=)SJ58123I4:JG5K_B\L/FV35XQJU<]PF,HX:CE
M_P#;63Y.^(L!GV7X3FC@*N9Y9AZ&(Q>"SG"TING5Q$:5&A5DY-5\3AW2P^%S
M/A3X,^,?QA^-5O\ MT_MEZ!I_P  _A[\$?"?BA?@+\%=>UJUN[[P)9:S8LGC
M#XK_ !0U/$=C9^(KG1(6L;;3S';SZ?;HCSVEC+IUM)J6_P#L%QZK\<OBI^T?
M^W/J^FWVE^'OC/J^C_#?X%V>IVTEI>GX,_#$SZ=#XC-O*!+!%XTUY&U)K=]I
MAN].NRHDAE@FDYJ7]E7]K?\ :[U339_VY/'GA'P+\%M.O[;5?^&9?@7=:D+3
MQ;<V<L-Q:0?$SQS//)>:A96\\2O)INEW^HV4[*+G3SH=_'%>+^J6BZ+I'AS1
M]+\/Z!IMCHVAZ)I]GI.CZ1IEM%9Z=IFF:?;QVMC86-I J0VUI:6T4<%O!$BQ
MQ1(J(H4 5PYKF%&CAJV&I5<)5Q>)P]' NGEOM)9;E65T:ZQ?U+#5ZC<\7B<5
MBXPKXO$J=6&E1>WKSQ-7V7IY#E&)Q.,P^-KX?,,/@<'B\1FBK9RJ,,YS[/<3
MA7@/[4QF%H*-/ 8/!8"4\+@,%*G1J>]2;PN%IX.BJ^G1117R)^A!7Y%?L#L-
M;_:-_:*\4P9FM;@:VRW(Y0C7_'<VHV_/K/'I\DB^HC8]J_4;XA>(X_!_@/QK
MXLEE6%/#7A3Q!KID8@!6TK2;N]3&<Y=G@540 L[LJ*K,P!_.3_@EYX>>#P7\
M5/%KQMG6O%.AZ"EPX)\S_A'=+N=1E5'8<X;Q.C28/)*;\E5Q_/WB*_[3\;/
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MOS'BV-"FZ60SK4:E7F]MC9PC3KQI-IQH4E%RY&TE[:K%QE4DDDHPBD_%]-^
M'PQTL*+3PIH<(4 *8M,LXR,8Z%80>WK],5Z)H/A+0O#CO)I-A;V;R1>2YAC6
M/,9=7*G: "-T:'IQBNFHKZW"9#DN!J0JX3*\#AZL'>%2EAZ4*D7WC)133\TS
MY/$YQFN,A*GBLPQ=>$U:4*M>I.,DK;Q<FGJD]MPHHHKUSS0HHHH **** /A7
M_@I-\3?^%6_L9_&748+@P:IXMT6W^'&D!7V233>.KR+0M52)\AEDA\,SZ[>@
MI\^+0[=I^9?,_P#@DA\,C\/OV-O"VLW,'D:E\4O$_B?XA7:NI\Y;66ZA\*Z(
M&8C_ %%QHOA>QU.W1&,:IJ32866685\;?\%?_'6M_%3XK?L^?L=^!I3=:OK6
MMZ9XFUJRB,DL3^)/%]^_@_P+#=+%Q"VE6,OB34KP2!REAK5G=L8(E+R_N=\/
M/!.C_#3P%X*^'?A]"FA^!O"N@>$M)WJ%D>P\/:7:Z5;338)W7$\5JLUQ(69I
M9Y))'=W9F/NU_P#9<BPM%Z5<PQ53&27VE0HQ5*E&7]V<OWD-[Z^B_D?A2?\
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ME.3G.4IRD[RE)N4F^[;;;?JQMN3;DVV]VVVWZMZF1I6EP:?:Q0*B_(H .!G
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M5OK&?Z-O#^OZ+XKT+1O$_AS4K76?#_B'2[#6M$U:QD$UGJ6E:G;17EA?6LH
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MBF74)'6*.QC\/Q>(WU:2\>1UC2U6T,[.RHJ%B ?)?^"C7P_^,'Q3_8E_:%\
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M]!M7BU)Z0J1J*3BI+EERR4DXM.RE9I]U)/T85^ '_!/?_E*'^W3_ -A'X_\
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MX^,<'0HP5ZCBZM6$9^Q<7ZS_ ,$Z_AAJ.H+XV_:*\9"6]\0>-M2U32] O[U
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M+JB6OAJZL;:72;BV\-CP]?W&C7][I,^HR:>\%O;_ )S?M,3?"7_@JY^T_P#
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M /ZT-H=?O_7X ?\ !/?_ )2A_MT_]A'X_P#_ *T-H=8U/XE'_%+_ -) _?\
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MY1P:IQJ75I2<4NNEM>Q[9117X7_\$9/VF/C;^T%J?[5$'Q@\?:WXXB\/^(/
M'B#P\NM74UV- E\93_$&+5]+T;SI)/[-T!$\-Z6-/T6U\NRL"D[01AKB0EY/
MPCCLYX8XOXIP^(PU/!\&QR&6/P]5U/K.)7$&8U,NPWU51A*F_8U:<IU_:SA[
MC7)S2ND1@Y0J335J?+==7SNRMZ=;G[H445^%Y_:9^-I_X+<#]G[_ (3W6O\
MA3@T#_A'O^%?BZF'ALQ?\,UGXL_VJ=,\W[(=?_X2\^9_;)B^V?V8!I>_[, *
M.%.$<=Q;_K)]1Q&&P_\ JQPGG'%V,^LNHO;X')?JWUC#X?V<)WQ-7ZS#V2J<
ME/W9<TXZ7(0<^>S2Y(2F[]5&UTO/4_="O@C_ (*??\F*?'S_ +!W@?\ ]6?X
M)K[WKX(_X*??\F*?'S_L'>!__5G^":^1G\$O\,OR9!G?\$K?^3"_@1_W4_\
M]7+\0Z_0BOSW_P""5O\ R87\"/\ NI__ *N7XAU^A%*G_#I_X(_^DH#\ /\
M@AQ_R%OVO/\ L(_!S_TI^,E?O_7X ?\ !#C_ )"W[7G_ &$?@Y_Z4_&2OW_J
M,/\ P8?]O?\ I4@"BBBM@"OS1_;6_9S_ &@M8^,GP(_;!_9-_P"$)UWXU_ O
M2_%W@W6/AC\1;V72O#GQ/^''C9(TU#2;#7HS%'H7B+2;A[VZL+B\N]/LIUO/
MM$VH*^E1:3K?Z745T87$U,)65:FH3?+4ISIU8\]*K2JPE3JTZD;IN$X2E%VE
M&2NI0E&2C)14@JD>5MK5-.+M*,HM2C)/6S32Z-/9IIM'X@_'#PS_ ,%(_P!O
MSP#)^S1\2_V6?A[^QW\'_&^I^%E^+_Q*UGXY^"?CEXGO?#?AW7].\3W=K\/?
M#7@JVABT[5K[4M'T[[!_;Y>.#RVBEU>T$K7L/3>+_A!^VC^R9^UA\<?C?^R=
M\"O"7[3?PX_:3^'OP5\/:]X2UWXK^&?A;XH^'?B_X%> V^'/A+59-2\5?9;'
M7O#,NCF34=4L-.:35=6N[Z>V2XT(:?;7%[^S%%=ZS><8^RA@\%#".%6$\$HX
MET*KJU,/5G.<YXJ6+=1SPF&<91Q,>3V,8Q2BY*63PZ?O.I5=1.+51N'/'E4H
MI)*"A:TYIW@V^9MN]FOPG^,_[''[<'Q+_8K\1_#?XB>+-5^,/QL_:C_:/^&_
MB[XX>&;+XAI;?#?X#_!JV\3V_B6^\%_#&W\9^)M.T^VT#P:="T=M6M/",<FK
M:]JE_<06%MXCM-)M=8NOM[_@H+^S9\2?CS\&/AO%\ [OPSH_Q<_9X^.?PN_:
M)^$FD>(T2S\(:SXH^%/]L0:7X7U0Q1B*RTZXLM;N6M%Q;V9O+.QL[JXL;":>
MZ@^^J*S>:XEU,/44*$'AL16Q,(PI*--RKQHTYTY4[\CI*CAZ=&,8QBU35G)R
MM)-8>%IIN;YX1@VY7DE!R::E:]^:3D[W7,]K:'Y;_#OQ-_P5'^-_Q5^'Q^(W
MPO\  /[$?P8\&:E::W\2(],\<_#OX^?$'XR"PB19/!N@3V^GZUHG@CPKK]WO
M?4-0>VL/%VC:>0NF:]=WJ 2^6ZM\,?VYOV0OVF_VF_B3^S'\ O!7[4WPL_:K
MUW0_B!/IFK?%OPS\)O%OPM^(MCH]SI=]+J=QXI-O8^)/",MU/+>KIND12ZK<
M636-I'J6E75K>W&H_LU13CF;C*?+@<!&A4HJA4PD:==49Q56-=3G46(^MRJ1
MJPC*,Y8EV2Y$E3;@QT+I7JU7.,N95&X\R;BX-)<GLTG%M-*&K][XM3\C?BK\
M,/\ @HCXX_8%_:7\,>/-5\._$G]I?X\V\NA>$?A1\.Y/ ?@SP-\(/ 7C#4=*
MT/Q)X*T[QIKT_AFZ\2_8/!U]XGN-9UKQ/XG\07U[*+72M&EO@);K4>O_ &S_
M -F/XMZ__P $\O#7['7[/?A^#7]3N]*^!7P:UR^MM6\.^'H_#WPU\'WWAH^+
M_%D4GB76-"M+E/[/\+)9W.FVHU'6+^VUFY2RTJXN"T]M^H=%3'-*T)T)PHX6
M'L,:\="$*/)3=51HPIQE"$HITJ2HIP2M-RG5E4G4E.Z;H1:DG*H^:G[)MRO+
MEO)MIM-\TN9W>JLDDDDD87A;PWI/@WPSX<\(:#;_ &30O"NA:1X;T6U)#&VT
MG0]/M],TZW+!5#>39VL,>0J@[<A0.!NT45YS;;;;;;;;;W;>K;\VS9*RLMEH
M@HHHI %%%<=X[^('@WX9^';OQ9XZ\06'AS0;(HDM]?.Y:6>3=Y5I96D"37FH
M7LP5S#96-O<74JI(Z0E(W9>?%XS"9?A<1CL?BL/@L%A*4Z^*Q>+K4\-A<-0I
M1<JE:O7K2A2HTJ<4Y3J5)QA&*;DTD:T*%;$UJ6'PU&KB,16G&E1H4:<ZM:K4
MF^6%.G3@I3G.3:48QBY-NR39V-%?EYXL_P""H'@/3KV:W\&_#/Q)XHM(B42_
MUK6[#PHMPRG!DAMX+#Q-.('Y:-[A;><KCS+:)B57CO\ AZC_ -4)_P#,G_\
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MCG11_8>4_P#0!0^Z7_R0?\37?2+_ .CM\6?^%&%_^93]C/\ A]U^U;_T3_\
M9[_\)3XC_P#SV*/^'W7[5O\ T3_]GO\ \)3XC_\ SV*_'.BC^P\I_P"@"A]T
MO_D@_P")KOI%_P#1V^+/_"C"_P#S*?L9_P /NOVK?^B?_L]_^$I\1_\ Y[%'
M_#[K]JW_ *)_^SW_ .$I\1__ )[%?CG11_8>4_\ 0!0^Z7_R0?\ $UWTB_\
MH[?%G_A1A?\ YE/V,_X?=?M6_P#1/_V>_P#PE/B/_P#/8H_X?=?M6_\ 1/\
M]GO_ ,)3XC__ #V*_'.BC^P\I_Z *'W2_P#D@_XFN^D7_P!';XL_\*,+_P#,
MI^QG_#[K]JW_ *)_^SW_ .$I\1__ )[%'_#[K]JW_HG_ .SW_P"$I\1__GL5
M^.=%']AY3_T 4/NE_P#)!_Q-=](O_H[?%G_A1A?_ )E/V,_X?=?M6_\ 1/\
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MO+9C+9PR2':5(K^B&OY[_P#A^_\ ]6K_ /F</_Q04?\ #]__ *M7_P#,X?\
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M#_\ %!1_P_?_ .K5_P#S.'_XH*>1\<?V)PEQOPI#"4L12XTCPY&MC9U:L*F
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M #_@AQ_R%OVO/^PC\'/_ $I^,E?O_48?^##_ +>_]*D 4445L 4444 %%%%
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M&349\K?*[+1A1117B'H!1110 4444 %.1WC=9(V9'1@Z.C%71U(975E(*LK
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M<29U[?\ LO*J/L*-7DKXSZM7]G.M[.A'V<O:5H:7^T*^"/\ @I]_R8I\?/\
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M_?'K_HB7Q=_\-MXR_P#E+1_PS]\>O^B)?%W_ ,-MXR_^4M'^J?%7_1,\0?\
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MP:_^>'7]C%%'^M^9?\^,#_X*Q'_S2'_%-CP,_P"BK\6/_#[P?_\ 0(?QS_\
M#JW]O3_HA'_F3_@U_P#/#H_X=6_MZ?\ 1"/_ #)_P:_^>'7]C%%'^M^9?\^,
M#_X*Q'_S2'_%-CP,_P"BK\6/_#[P?_\ 0(?QS_\ #JW]O3_HA'_F3_@U_P#/
M#H_X=6_MZ?\ 1"/_ #)_P:_^>'7]C%%'^M^9?\^,#_X*Q'_S2'_%-CP,_P"B
MK\6/_#[P?_\ 0(?QS_\ #JW]O3_HA'_F3_@U_P#/#H_X=6_MZ?\ 1"/_ #)_
MP:_^>'7]C%%'^M^9?\^,#_X*Q'_S2'_%-CP,_P"BK\6/_#[P?_\ 0(?QS_\
M#JW]O3_HA'_F3_@U_P#/#H_X=6_MZ?\ 1"/_ #)_P:_^>'7]C%%'^M^9?\^,
M#_X*Q'_S2'_%-CP,_P"BK\6/_#[P?_\ 0(?QS_\ #JW]O3_HA'_F3_@U_P#/
M#H_X=6_MZ?\ 1"/_ #)_P:_^>'7]C%%'^M^9?\^,#_X*Q'_S2'_%-CP,_P"B
MK\6/_#[P?_\ 0(?QS_\ #JW]O3_HA'_F3_@U_P#/#H_X=6_MZ?\ 1"/_ #)_
MP:_^>'7]C%%'^M^9?\^,#_X*Q'_S2'_%-CP,_P"BK\6/_#[P?_\ 0(?QS_\
M#JW]O3_HA'_F3_@U_P#/#H_X=6_MZ?\ 1"/_ #)_P:_^>'7]C%%'^M^9?\^,
M#_X*Q'_S2'_%-CP,_P"BK\6/_#[P?_\ 0(?QS_\ #JW]O3_HA'_F3_@U_P#/
M#H_X=6_MZ?\ 1"/_ #)_P:_^>'7]C%%'^M^9?\^,#_X*Q'_S2'_%-CP,_P"B
MK\6/_#[P?_\ 0(?QS_\ #JW]O3_HA'_F3_@U_P#/#H_X=6_MZ?\ 1"/_ #)_
MP:_^>'7]C%%'^M^9?\^,#_X*Q'_S2'_%-CP,_P"BK\6/_#[P?_\ 0(?R*^$O
M^"1/[;7B+4+>SUKP/X4\!6LL@6;5O%'Q"\)WUG:ID9EEA\$:CXOU*08R52"Q
ME=L88+G-?N/^Q/\ \$W_ (:_LF2IXVUG4E^(_P 9)K62W'B^XL6L-(\*VUY;
M&"_T[P?I+SW#PO<QRS6E[K]_+)J=]:$PVT&C6EU>V-Q^D=%<..XAS''TI4:D
MZ=&E-6G##PE!37\LI2G4FXOK%249+22:T/UOPH^AGX)>$>>8;B?*,NSGB7B'
M 5%5RO->,<PPN:5,IKQ^'$X#!8#+LIRJGC*;2E0QM7 5L9A)I3PE>A.\F444
M5X9_5H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X ?\$]_P#E
M*'^W3_V$?C__ .M#:'7[_P!?@!_P3W_Y2A_MT_\ 81^/_P#ZT-H=8U/XE'_%
M+_TD#]_Z_GX_;X_Y2O?L3?\ 7M^SS_ZT'X[K^@>OP$_X*=?#C]H2U_;+_9^^
M/_P?^#/C;XI6?@#P7X&O;%_"_@WQ/XSTI?%?P]^)_BWQ>VD>(X/"=O/J&FVM
MS!K.BLC3RV#:A!/>+IMP\UC=FW=;X+V;M*#T5WI) ?K_ /M(_LX_#_\ :E^&
ML_PM^),_B*ST"36=.U^WOO"NI6NEZU8ZKI:7<5K<VT]_IVKZ?(!#?744D%]I
MEY;NLN_RA+'%(GYW_P##D7]E+_HH'[0G_A5_#C_YT]>*_P##PK_@IO\ ]&'Z
MU_X8O]H'_P"6%'_#PK_@IO\ ]&'ZU_X8O]H'_P"6%1*=&3O*#;VNX2\K=/-?
M?Y@>U?\ #D7]E+_HH'[0G_A5_#C_ .=/1_PY%_92_P"B@?M"?^%7\./_ )T]
M>*_\/"O^"F__ $8?K7_AB_V@?_EA1_P\*_X*;_\ 1A^M?^&+_:!_^6%3?#_\
M^W_X!+R_X'W^>H>U?\.1?V4O^B@?M"?^%7\./_G3T?\ #D7]E+_HH'[0G_A5
M_#C_ .=/7BO_  \*_P""F_\ T8?K7_AB_P!H'_Y84?\ #PK_ (*;_P#1A^M?
M^&+_ &@?_EA1?#_\^W_X!+R_X'W^>H>U?\.1?V4O^B@?M"?^%7\./_G3T?\
M#D7]E+_HH'[0G_A5_#C_ .=/7BO_  \*_P""F_\ T8?K7_AB_P!H'_Y84?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWG&'NM.TI.ROKIOKUMT/O>BBBN8L**** "BBB@ HHHH **** "BBB@ HHHH
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M*,U*G)N*YGRV:N[I)582Y[/6#::NKNR4FXJ^JLUKIJ?35%?*W[*GQQT[XB?
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M.6/\L?N7]=%]P'SW_P ,D?LI?]&R?L]_^&7^''_S-T?\,D?LI?\ 1LG[/?\
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MD+CSEFLYW8[)(Z^WO^&2/V4O^C9/V>__  R_PX_^9NOR(_X-R?\ DR+XI?\
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MWMXL8A6[N[30;#3[>YN5B B6>:-Y1& @<* *[>BBJ22T2LNR **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _-#]JK_ )2%_P#!*O\ [&/]
MLS_UFN]KR?\ X*I:]HWQ$\2?L3?LN>$K^RUOXR^-/VQ?A%\18?"UG<0W>H>'
M/A[\.H]=O_%WC?Q%:6S3WVDZ)IUCJ23PW,]JAU*VMM8?3S<G2[R)?O']HO\
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M4;;S9H/M%CJ%O):7<'G6\D-Q#YUO-)'YL$L4T>[?%(CA6'A(_95^ B_L[?\
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MA\2W%E!J&IV6CVCQZ'X4TK7/$&H&74=1LX#'INE7DD2RFXF2.VAFFC_'6_\
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MS<VK>K1_1-1117SQV!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ>'[3X@:A>VEWI]WY]E;^%GNH[6(7[0BPEAN9/FCXB?\I@/V<O\ LS'XR?\
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M>\&Z?X<F^'6KS>(+2TN]!T*^?0TN[6+4C=BZ349+:?1O9/B-^VKX^^+W@O\
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MGN\N[;VYMDWJ?JY1117PIZ@4444 %%%% !1110 4444 %%%% !1110 4444
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M==)-A1117S)VA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIMOV=6,X7?+=W":G",TK*2NO2^Z?6+WB^L6GU"BBBN<L**** "BBB@ HHHH
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M&JWWTY^RS\(/B5X1^,G[;/QA^*FEIH^J_&[X\Z7'X$MDOM$U$WWP:^%?P_\
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M0=Q^WVO[1]Q^QQ\>-.^'-]^RSI?[/KF\\;_LCR:]8>*$^-%[X[G\27FEZ?\
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M4^;ZOFM+GI*G']]4K0A+&U?U/HHHKY\_"@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT[N%6KB:<,#6A2498N4\'2K2=&DXO]^J*^<OV1_CM:?M*_LY?"?XSP&V2_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ(U_Q]I/AKR!)/KUQ%I*76C79L9<F_TK2-4U/4+2R(OI(_+AODLOWG_X)?\
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M[_MM/#,VMV]QH\6O-8C2I-5@FT]+LW<3PK_.-^T!^SW\%?A-_P $+_AS\7_
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M]GIMW<W&@:TEK-#<MI>JQVE\L$L<Q@$<BL?RZ_9H^&OPL3_@I;_P4:@/@#P
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MB\;Q&;^8P".XNI8GDC?\J/VE?V)_&FM?M=>._BQXP_8LT;]N7X,ZS\+OA5X
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MGPO^SU\&O!WBCXT>,M \"Z?#K_[0]UI=Y\9YM1O=8U[3O'<NCZ)=>'+&+4=
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M&\.VF@WVMZAIT'PU\'^+;JUATZU\3:++<#5(+"0&[DC1&ELK]+7N_@+^U/\
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MR\"W?BZ&^AU)-?N/A=9^+K?X92ZA]OMXKN25_")$LZ;Y5<LV[[FKPWQS\?\
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M1SC4E)2E4C-RYHSE)*4IIJ3DDVVRN2"3BH12:2:Y59I*R35K-):)/2VA\J?
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M#S=<M=D?B&S\+6S1Q3NUTC+'')]"?%#]E?QQX\_;H^#'[2]CXCT'2OA_\/\
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M%OJWBC2K[QAJ$6D:7:Z9:64S/+?G]3IO@!XRD_;XT[]J9=3\,CX?6?[(6M?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116=K&
MKZ;H&DZIKVLWD.G:/HFG7VKZKJ%RQ6WL=-TVVEO+Z\G8!BL-K:PRSRL%)"(Q
M )XII-M))MMV26K;>R2ZM@?,?[6O[:/P#_8K\ CQY\;O%36+W[2P>%?!6A1V
M^J>//&U]"%,UIX9T"2[LQ-%;!T:_U?4KO3=!TSS($U'5;6:[LXKC^;CXG_\
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M (1'Q<_^?C7X"44?ZMY'_P!"S#?^ R_^2#ZYBO\ G]/[U_D?OW_Q$;?MN_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@>!_"_\ PK&^\1:.O@;P@/A)IX\(Z]<:'J2'PK)K>H6?A.+P98Q^(+U]=/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"5G\!/_#D[_@IQ_P!&S_\ F9OV?O\ YZU'_#D[_@IQ_P!&S_\ F9OV?O\
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MJ":IQM?>3UE+U;Z>2LEV"BBBO,-@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>img200782950_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img200782950_0.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #4 M0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH *_GB_P""O/[6-UJ'BG2?V:_ .MW5K9^$9K7Q'\3+_2KR2W-UXDN;42Z#
MX7-S:RH[PZ)IUU_:VJ0;GA?4M1T^&14O=%E1/V*_:T_:'T7]F+X'>+?BAJ/V
M>YUF"%=$\$:+.V!K_C75HIDT2P*AXV>SM3%<:SK'ENLR:)I>I26^^X6&*3^+
MKQ#K^L^*]>UKQ1XBU"XU;Q!XCU;4-<UO5;ME:ZU+5M5NYK[4;ZX**B&:ZNYY
MIY-B(@=R$55 4?9<)97[>O+,:T;TL.W"@I+2==K6=GHU2@]+K^).+3O!G]L?
M0]\*%G^>XGQ(SK"JIE'#E6>"R"E7@I4\;G]2DG6Q:A-.-2ED^%JIP;C;Z_BL
M/4I3]K@:L58_X2SQ5_T,WB#_ ,'.H_\ R31_PEGBK_H9O$'_ (.=1_\ DFN?
MHK]$Y(?RQ_\  5_D?Z4?5,)_T#8?_P $T_\ Y$Z#_A+/%7_0S>(/_!SJ/_R3
M1_PEGBK_ *&;Q!_X.=1_^2:Y^BCDA_+'_P !7^0?5,)_T#8?_P $T_\ Y$Z#
M_A+/%7_0S>(/_!SJ/_R31_PEGBK_ *&;Q!_X.=1_^2:Y^BCDA_+'_P !7^0?
M5,)_T#8?_P $T_\ Y$Z#_A+/%7_0S>(/_!SJ/_R31_PEGBK_ *&;Q!_X.=1_
M^2:Y^BCDA_+'_P !7^0?5,)_T#8?_P $T_\ Y$Z#_A+/%7_0S>(/_!SJ/_R3
M1_PEGBK_ *&;Q!_X.=1_^2:Y^BCDA_+'_P !7^0?5,)_T#8?_P $T_\ Y$Z#
M_A+/%7_0S>(/_!SJ/_R37[B?\$@_VL+J+7-8_9G\?:W/=1Z_+>^*/A=?:I<R
M3RIK$-NUQXF\*+<SL\A34+&V.OZ5 SK%%<V.MHI:XU&WB/X-UO>%_$VN^"_$
MF@^+_"^I7&C^(_#&L:=KVA:K:,%N-/U72KJ*]L+N+<&1F@N88WV2*\4@!CE1
MXV93PYEE]+,<'6PLE&+G&]*=E^[JQUIST5[*6DDM90<H]3X'Q.\.<H\2."LZ
MX4Q5'#X>MC:'M<KQRHP4LNS?#7J9?C4X0Y_9PK)4L5"#4ZV"JXG#J255L_O2
MHKYW_97_ &@-#_:8^"/@[XJZ1]GMM0U&U.E^,-%@D$A\.^--*2*'Q!I##?)*
MEOY[Q:EI)N"MQ<Z#J.E7TL<;76Q?HBOQNK2J4*M2C5BX5*4Y4YQ>\91;4E]Z
MWV>ZT/\ $_.,IS#(<US'),VPT\'F>4XW$Y?C\+4^.ABL)5G1K4VU>,DIP?+.
M+<*D>6<)2A)-E%%%9GFA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !117YT_\ !2O]J4_LZ? J[T7PSJ8M
M/BA\54OO"_A(V\JK?:+I'DHGBCQ9& 1)"^F6-U%I^F7*%9(=;U73[J'>ME.%
MZ,)AJN,Q-'"T5>I6FH1[13UE.7]V$4YR?\J9])PAPMFO&W$V2\*Y+2]KF6=8
MZE@Z#:DZ="$KSQ&,KN*<HX;!8:%;%XF:3<*%&I))M)/\5/\ @I[^U,?C]\<9
M_!7AC4OM/PQ^#]QJ/AS0VMIE>R\0>*C(D'BSQ0&A=XKNW-W:IHFASB2>!M+T
MTZE9-"-<O(V_-"BBOV?!X6E@L-1PM%6IT8**=K.4MYSE_>J2;G+^])VT/]O>
M#.$\JX&X7R7A3):?)E^2X*GA:<W&,:F)K:U,7CJZC[KQ..Q<ZV,Q#7NNM6GR
MI1LD45[?\&_V</C9^T%_PD?_  IWP%J'C?\ X1'^Q_\ A(OL.H:'8?V9_;_]
MJ?V1YO\ ;.J:;YOVW^Q=4V?9O.\O[(_G>7OB\SV[_AW!^VQ_T077_P#PH? _
M_P U%*ICL%1G*G5QF%I5(VYJ=3$4H3C=*2YHRFI*\6I*ZU336C1GF7'? ^38
MVMEN<<9<*93F.&]G]8R_,N(LHP.-P_MJ-/$4?;87%8RE7I>UH5:5:G[2G'GH
MU*=2-X3C)_$5%?;O_#N#]MC_ *(+K_\ X4/@?_YJ*/\ AW!^VQ_T077_ /PH
M? __ ,U%1_:67?\ 0?@O_"JA_P#+#A_XB?X:?]'#X&_\2W(/_G@?$5%?;O\
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ML;2XUG7+>_U_08M,TV]O;[[#I,SSR2:G=6.JI:Q.NEWKP_ ?_$2[_P $ZO\
MH"?M(?\ AL_"W_SR*_D1_P""GO[8FH?MP_ME?%;XS17TUQX"L]2;P%\'[-S.
ML-A\*_"%U>6?AN>&WN$2:TF\432ZCXWU2UE7=;:SXGU&!2(HHE7\_:_K+A[P
M-X=J9)EM7/O[3_M>MA85\="ABXT:=&M6O5^KJFZ$W&6'A.-"H^:7/4ISFFE)
M)>9/&5.>7)R\B=HW6K2ZO7KK\GW/];GX0?%?P3\=/A;X ^,?PWU4:UX%^)?A
M/1?&7A?4=JQS2Z5KEE%>P0WUNLDILM4LC(]CJVG2.9]-U.VN["X"SV\BCT>O
MY3_^#9?]M*7Q?\./B'^Q)XUU99=8^%K77Q.^#:W=QFXN/ 'B+50GCSPQ9QNR
M@6_A;QEJ-GXCM8T\ZXG7QYJV?+L](C"_U85_.7&'#M;A7B+,\DJ\TH86NY82
MK+>O@:R57"5KI*+E*C*,:O+I"O&K3W@SOI352G&?5K7RDM&OOV\K,****^9-
M HHHH **** "BBB@ KX8_;F_X*$_ ;_@GOX4\"^,OCS9^/[S2/B'XAU'PSH"
M^ /#VF^(;Q-1TO35U6Y;4(=2U_0$M[8VS 12Q37#O+E#$H^:ON>OY7_^#I[_
M )(#^RM_V6#QG_ZA<5?6<"Y-@^(>+,FR;,/:_4\=7K4Z_L*BI5>6GA,16CR5
M'&:B^>G&[Y7=776YE6FZ=.<XVO%*U]5NE^I](?\ $2[_ ,$ZO^@)^TA_X;/P
MM_\ /(K]M?@3\<_AA^TG\)_!7QL^#GB>T\7?#SQ[I$>K:%JUL&BF3YW@OM*U
M6QEQ<Z5KNC7\5SI>MZ1>)'=Z9J=K<VEP@DB.?\EJOUF_X)2?\%2/B#_P3L^+
M45MJLVM>+_V:?'>J0CXL_#*VF2>>SF>%;*'XA^!(;R:*UT_QKHL:6WVVV\VU
ML?&>B6G_  C^L36]S!X>U[PY^\\6^!>6PRFKB.$YXW^U,-S5EA,;B85J>/I1
MBW/#TI>RI>QQ+LI4)2DZ4Y7I5.1356EQTL9+F2JVY7I=*W*^[WNN]N]U?8_T
MFJ*\\^$_Q8^'7QS^'7A+XM?"7Q;I'CGX>>.=(@UOPSXFT2<S66H64Q:.2.2.
M18[JPU&PNHY]/U;2=0@M=4T?5+6\TO5+.TU"TN;:+T.OY=JTJE&I4HUJ<Z56
ME.5.K2JPE3J4ZD).,Z=2$DI0G"2<91DE*,DTTFCT4TU=.Z>J:V:[A1114 %%
M%% !7QS^V[^W'\%_V OA3X?^,?QTM?&UWX2\2_$+2?AGIT?@/0]/\0:POB/6
M?#?BSQ3:/<V>HZWH,$6FC3/!NKK-=)>22I=-9Q+;.DSRP_8U?S?_ /!T'_R8
M)\(?^SP/ '_JE_V@*^FX-RG"9[Q1DF48[VOU3'XV-"O[&?LZOLW"<GR3<9*,
MKQ6O*_0SJR<*<YQM>*NK['8?\1+O_!.K_H"?M(?^&S\+?_/(H_XB7?\ @G5_
MT!/VD/\ PV?A;_YY%?P'T5_4W_$"^!NV<?\ APC_ /,QYOURM_<_\!_X/]7?
ME;^_#_B)=_X)U?\ 0$_:0_\ #9^%O_GD45_ ?11_Q O@;MG'_APC_P#,P?7*
MW]S_ ,!_X/\ 5WY6_P!@"BBBOXS/6,W6=8TOP]I&JZ_KE_:Z5HNAZ;?:QK&J
M7TJV]EINEZ9:RWNH7]Y.Y"0VMG:037%Q*Y"QQ1N[$!37\8O[8O[1^J?M0_'7
MQ3\1YFNX/#$#CP[\/M'NF ;1_!>E33C3%DA&5AO]7FFNM?U:(/,(=3U6ZM8K
MB6UM[8K^S/\ P5^_:F_X1'P=IW[-/@[457Q%X]M;?7/B//:S?O\ 2O!4-UOT
MK0'>)PT%UXJU*T:YO86991H&FF"X@DL?$43G^<*OT3A'*_8T99E6C:I73AAT
MUK&@FN:HKZIU9*R=D_9QNFXU&?Z4_0Z\*O[&R3$^)F<X;ES+B"E/ \.0JP]_
M"Y%"JOK6/C&6L*F;8JDH49<JDL!A(U*525#,9IE%%%?:']OG[\?\$-O^;H/^
MZ*?^];K]^*_ ?_@AM_S=!_W13_WK=?OQ7Y+Q/_R/,=_W+?\ J'AS_'GZ4_\
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M0Z?!(;:T@"_RE_\ !L_^Q!)XD^(?C_\ ;>\?:*ZZ3\,GU+X6?!J+4+9D,WQ
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M !'!!):P>(-$TK6X;:5E>6WBU6P@OXX)73Y&DB2<1NR?*S*2O!%;=<#\*?\
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MU2XUSQ?XY\2Z[XO\4ZS=$&YU7Q#XDU.ZUC6=1G(P/-O-0O+BX<* JF0JH"@
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M"^L)?_"7]EY-1^&7AM;.X:73]5^($LUK+\6/$H'*&Y7Q#8VO@=)(7EM;C3_
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M%=M'<1S17.H_#OQK#X)\+KXN\&/(+":XLG\0:8EGXF6VU2'\7/VD?V;OB_\
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M:ZK<!HF\(3J4L_!7B/4KB!?",B0>&]1N9/#$VD/X6_LWK_'_ *_L;_X(7_\
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MD8$V:_ST::;35FM&GNGV9[@4444 %%%% !1110 4444 %%%% !1110 4444
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M)SK#=D,0Y49TIOWN1\DGU2M[K[RMMWM;>U_P)HHHK]T.,**** /]@"OYN?\
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M$4L7@L=AJ&,P>*H24Z.)PN)I1K8>O2FM)TJU*<*D)+249)K<****HZ0HHHH
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M.I32[?[1E]:KITO5];FRQM5;J#\VG?\ "27X'^EA_P /M/\ @EM_T=UX/_\
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M6FA>&O#6A6DE[J.IZC>R".-$CC!6"V@4O<W]_<M#8Z=8PW%_?W%O9V\\\?\
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M2KRHUJU5UXPC)5>2R4')KEY(QWYG>]]D?KGA#X$\.^#F)SS%9'G&=9I//J&
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MI+GQ&4XB%2$WI=QP>,=-TUNTGCJM]$VK7?'+ O[%1>DE;\5?_P!)/\O2BO\
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MMEN;A4TW2/B_I,UQ+\-]2(EW^2_B/[;K'@-DM5C>_P!4\1^&Y+YVM])A,/\
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MQ-+:>%_BA8Z39RW+P:_!;&+PWXM>VMHY9%BU?3[8Z#JUSMAM8K_3M$9_,O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^LX;V%?!X&?)14:3C/V%I<[M.5G8HHHKA/A0KQCQ]^T7\"/A9KB>&?B1\7/
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M80Z/-8VGF?$/2O"NJ0WO]C/J%S-LTM?%$<,L']H[KLV;NDD F58_TV_X<?\
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M+/6+>PNYXC/#;74MG+*L,TL(,J1N0S(-P&*^:/\ @H[_ ,F3_'K_ +%_0/\
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MY.VTW_LD'@W_ -/GC"OZE:_EJ_X+'?\ )VVF_P#9(/!O_I\\85]1PC_R-O\
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MBLS,> H)/ KZKA#_ )&=;2_^PU]._P"]H:?,_K;Z&32\4\Z;A[1+@'.VZ?\
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M\+--TO5?%EMH^K:3#::OI%]KEF;'5(HXKV1K#3KRQN6D1(U,<HN D9)+HP(
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M-<30P>'S3'TEF.'PW,IT</C.5P4L10ISC2J5%"'M'#VCIP<N1?T?T445X!^
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M#+Y<L917ZUA:U:61^VE5J2J_5N;VLIR=3F]G%\W.WS7OK>][G^Q?!V<YOBO
MB.;XG-<RQ&;?ZL5L1_:E?'8JKF/MU@J<U6^NU*LL3[52;DJGM>=2;:E?4_KP
M^'GP[\%?"CP=H?@#X>>'K#POX1\.6@L])T?3UD\J%"S233W%Q/)-=W]_>3O)
M=:AJ5_<7-_J%Y+-=WMS/<2R2L445^3RE*<I3G*4IR;E*4FY2E)N[E*3NVV]6
MVVV]6?X]XO$XG&8K$8O&8BOB\7BJ]7$8G%8FK4KXC$8BM.52M7KUZLIU:U:K
04E*=2K4E*<YR<I2<FV?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>25
<FILENAME>tcrx-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-04T09:44:24.2288+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.tscan.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:tcrx="http://www.tscan.com/20241231" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" namespace="http://xbrl.sec.gov/stpr/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" namespace="http://xbrl.sec.gov/cyd/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails2" id="DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails2">
        <link:definition>100020 - Disclosure - Commitments and Contingencies - Maturity of Future Payments Of Operating Lease Liabilities (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails2" id="DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails2">
        <link:definition>100030 - Disclosure - Loan and Security Agreements - Schedule of Future Principal Payments (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100040 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" id="StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100060 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" id="StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
        <link:definition>100070 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100080 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" id="DisclosureCybersecurityRiskManagementStrategyAndGovernance">
        <link:definition>995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentation" id="Role_DisclosureNatureOfBusinessAndBasisOfPresentation">
        <link:definition>995465 - Disclosure - Nature of Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>995475 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipment" id="DisclosurePropertyAndEquipment">
        <link:definition>995485 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>995495 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities">
        <link:definition>995505 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquity" id="DisclosureStockholdersEquity">
        <link:definition>995515 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>995525 - Disclosure - Stock Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>995535 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreements" id="Role_DisclosureCollaborationAndLicenseAgreements">
        <link:definition>995545 - Disclosure - Collaboration and License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>995555 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreements" id="DisclosureLoanAndSecurityAgreements">
        <link:definition>995565 - Disclosure - Loan and Security Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlan" id="DisclosureRetirementPlan">
        <link:definition>995575 - Disclosure - Retirement Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReporting" id="DisclosureSegmentReporting">
        <link:definition>995585 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>995595 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" id="Role_DisclosureRelatedPartyTransactions">
        <link:definition>995605 - Disclosure - Related-Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>995615 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995625 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995635 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentTables" id="DisclosurePropertyAndEquipmentTables">
        <link:definition>995645 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>995655 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables">
        <link:definition>995665 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityTables" id="DisclosureStockholdersEquityTables">
        <link:definition>995675 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>995685 - Disclosure - Stock Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>995695 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables">
        <link:definition>995705 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsTables" id="DisclosureLoanAndSecurityAgreementsTables">
        <link:definition>995715 - Disclosure - Loan and Security Agreements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" id="DisclosureSegmentReportingTables">
        <link:definition>995725 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>995735 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails" id="Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails">
        <link:definition>995745 - Disclosure - Nature of Business and Basis of Presentation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>995755 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi" id="DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi">
        <link:definition>995765 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" id="DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails">
        <link:definition>995775 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetails" id="DisclosurePropertyAndEquipmentAdditionalInformationDetails">
        <link:definition>995785 - Disclosure - Property and Equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails" id="DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails">
        <link:definition>995795 - Disclosure - Fair Value Measurements - Schedule of Assets Carried at Fair Value on a Hierarchy Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" id="Role_DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>995805 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
        <link:definition>995815 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" id="DisclosureStockholdersEquityAdditionalInformationDetails">
        <link:definition>995825 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
        <link:definition>995835 - Disclosure - Stock Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails">
        <link:definition>995845 - Disclosure - Stock Based Compensation - Summary of Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG" id="DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG">
        <link:definition>995855 - Disclosure - Stock Based Compensation - Summary of Weighted-average for each of the Assumptions the Company Used to Determine the Grant-date Fair Value of Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails">
        <link:definition>995865 - Disclosure - Stock Based Compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails" id="DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails">
        <link:definition>995875 - Disclosure - Stock Based Compensation - Summary of Other Information Related to Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails" id="DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails">
        <link:definition>995885 - Disclosure - Income Taxes - Reconciliation of the Federal Statutory Income Tax Rate to the Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>995895 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails" id="DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>995905 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails" id="Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails">
        <link:definition>995915 - Disclosure - Collaboration and License Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>995925 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails" id="DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails">
        <link:definition>995935 - Disclosure - Commitments and Contingencies - Summary Of Presentation Of Operating Lease In Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails" id="DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails">
        <link:definition>995945 - Disclosure - Commitment nad Contigencies - Lease Cost in the Company's Consolidated Statement of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails" id="DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails">
        <link:definition>995955 - Disclosure - Commitments and Contingencies - Maturity of Future Payments Of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails" id="DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails">
        <link:definition>995965 - Disclosure - Loan and Security Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails" id="DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails">
        <link:definition>995975 - Disclosure - Loan and Security Agreements - Schedule of Future Principal Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails" id="DisclosureRetirementPlanAdditionalInformationDetails">
        <link:definition>995985 - Disclosure - Retirement Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails" id="DisclosureSegmentReportingAdditionalInformationDetails">
        <link:definition>995995 - Disclosure - Segment Reporting - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails" id="DisclosureSegmentReportingScheduleOfSegmentInformationDetails">
        <link:definition>996005 - Disclosure - Segment Reporting - Schedule of Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails" id="Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails">
        <link:definition>996015 - Disclosure - Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails" id="DisclosureNetLossPerShareAdditionalInformationDetails">
        <link:definition>996025 - Disclosure - Net Loss Per Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails" id="Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails">
        <link:definition>996035 - Disclosure - Net Loss Per Share - Summary of Potential Common Shares Excluded from Computation of Diluted Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" id="Role_DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>996045 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="tcrx-20241231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails2" xlink:href="tcrx-20241231.xsd#DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails2" xlink:href="tcrx-20241231.xsd#DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="tcrx-20241231.xsd#StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="tcrx-20241231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:href="tcrx-20241231.xsd#DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails" xlink:href="tcrx-20241231.xsd#DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails" xlink:href="tcrx-20241231.xsd#DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="tcrx-20241231.xsd#DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails" xlink:href="tcrx-20241231.xsd#DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails" xlink:href="tcrx-20241231.xsd#DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails" xlink:href="tcrx-20241231.xsd#DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails" xlink:href="tcrx-20241231.xsd#DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="tcrx-20241231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="tcrx-20241231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="tcrx-20241231.xsd#StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:href="tcrx-20241231.xsd#StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:href="tcrx-20241231.xsd#DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi" xlink:href="tcrx-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails" xlink:href="tcrx-20241231.xsd#DisclosureSegmentReportingScheduleOfSegmentInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#DisclosureNetLossPerShareAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd#eedm1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentation" xlink:href="tcrx-20241231.xsd#Role_DisclosureNatureOfBusinessAndBasisOfPresentation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="tcrx-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipment" xlink:href="tcrx-20241231.xsd#DisclosurePropertyAndEquipment" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="tcrx-20241231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities" xlink:href="tcrx-20241231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquity" xlink:href="tcrx-20241231.xsd#DisclosureStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:href="tcrx-20241231.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="tcrx-20241231.xsd#DisclosureIncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreements" xlink:href="tcrx-20241231.xsd#Role_DisclosureCollaborationAndLicenseAgreements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="tcrx-20241231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreements" xlink:href="tcrx-20241231.xsd#DisclosureLoanAndSecurityAgreements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlan" xlink:href="tcrx-20241231.xsd#DisclosureRetirementPlan" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReporting" xlink:href="tcrx-20241231.xsd#DisclosureSegmentReporting" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:href="tcrx-20241231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:href="tcrx-20241231.xsd#Role_DisclosureRelatedPartyTransactions" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:href="tcrx-20241231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="tcrx-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="tcrx-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentTables" xlink:href="tcrx-20241231.xsd#DisclosurePropertyAndEquipmentTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="tcrx-20241231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="tcrx-20241231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityTables" xlink:href="tcrx-20241231.xsd#DisclosureStockholdersEquityTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="tcrx-20241231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="tcrx-20241231.xsd#DisclosureIncomeTaxesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="tcrx-20241231.xsd#DisclosureCommitmentsAndContingenciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsTables" xlink:href="tcrx-20241231.xsd#DisclosureLoanAndSecurityAgreementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:href="tcrx-20241231.xsd#DisclosureSegmentReportingTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:href="tcrx-20241231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG" xlink:href="tcrx-20241231.xsd#DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails" xlink:href="tcrx-20241231.xsd#DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#DisclosureRetirementPlanAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails" xlink:href="tcrx-20241231.xsd#DisclosureSegmentReportingAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails" xlink:href="tcrx-20241231.xsd#Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AmgenIncMember" xlink:label="tcrx_AmgenIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember" xlink:label="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_WarrantIssuanceCostsOfferingExpenses" xlink:label="tcrx_WarrantIssuanceCostsOfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_RevenueRecognitionMilestoneMethodMilestonePayables" xlink:label="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock" xlink:label="tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_EstimatedResearchCostsTransactionPrice" xlink:label="tcrx_EstimatedResearchCostsTransactionPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FinancingCostsNotYetPaid" xlink:label="tcrx_FinancingCostsNotYetPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ReportableSegmentMember" xlink:label="tcrx_ReportableSegmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TrancheTwoMember" xlink:label="tcrx_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:label="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DebtInstrumentExitFee" xlink:label="tcrx_DebtInstrumentExitFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PreFundedWarrantsMember" xlink:label="tcrx_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_InterestOnlyPaymentTerm" xlink:label="tcrx_InterestOnlyPaymentTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FacilityFeePaid" xlink:label="tcrx_FacilityFeePaid"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease" xlink:label="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="tcrx_DeferredTaxAssetsDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FairValueAssetLevel1ToLevel2TransfersAmount" xlink:label="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FairValueAssetLevel2ToLevel1TransfersAmount" xlink:label="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ClinicalStudiesMember" xlink:label="tcrx_ClinicalStudiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_RevenueMilestonePaymentsPolicyTextBlock" xlink:label="tcrx_RevenueMilestonePaymentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PersonnelExpensesMember" xlink:label="tcrx_PersonnelExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseAgreementsAbstract" xlink:label="tcrx_CollaborationAndLicenseAgreementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents" xlink:label="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LegalAndProfessionalFeesMember" xlink:label="tcrx_LegalAndProfessionalFeesMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NumberOfLeasesFacilities" xlink:label="tcrx_NumberOfLeasesFacilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DebtInstrumentPrepaymentFee" xlink:label="tcrx_DebtInstrumentPrepaymentFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_RevenueFromRoyaltiesPolicyTextBlock" xlink:label="tcrx_RevenueFromRoyaltiesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="us-gaap_RoyaltyAgreementTermsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccruedResearchAndDevelopment" xlink:label="tcrx_AccruedResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ReimbursementCost" xlink:label="tcrx_ReimbursementCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" xlink:label="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:label="tcrx_CollaborationAndLicenseAgreementsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfIncreaseInAnnualFixedRent" xlink:label="tcrx_PercentageOfIncreaseInAnnualFixedRent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PrepaidRentReclassedToRightOfUseAsset" xlink:label="tcrx_PrepaidRentReclassedToRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_EmployeeStockPurchasePlanMember" xlink:label="tcrx_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SiliconValleyBankMember" xlink:label="tcrx_SiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LeaseSpaceForFacility" xlink:label="tcrx_LeaseSpaceForFacility"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_StockIssuanceCostsOfferingExpenses" xlink:label="tcrx_StockIssuanceCostsOfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold" xlink:label="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AreaOfLeasedOfficeSpace" xlink:label="tcrx_AreaOfLeasedOfficeSpace"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_MA" xlink:label="stpr_MA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock" xlink:label="tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NumberOfTargetsIdentified" xlink:label="tcrx_NumberOfTargetsIdentified"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DefaultInterestRate" xlink:label="tcrx_DefaultInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription" xlink:label="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent" xlink:label="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseUpfrontPaymentReceived" xlink:label="tcrx_LicenseUpfrontPaymentReceived"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FollowOnOfferingMember" xlink:label="tcrx_FollowOnOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeInYearTwo" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ResearchFundingMember" xlink:label="tcrx_ResearchFundingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_WedbushSecuritiesIncMember" xlink:label="tcrx_WedbushSecuritiesIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:label="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsLeaseholdLiability" xlink:label="tcrx_DeferredTaxAssetsLeaseholdLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:label="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccruedLegalServicesAndLicenseFeeCurrent" xlink:label="tcrx_AccruedLegalServicesAndLicenseFeeCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ClassOfStockWarrantsExercised" xlink:label="tcrx_ClassOfStockWarrantsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PotentialMilestonePayment" xlink:label="tcrx_PotentialMilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommonStockSharesReservedForFutureIssuance" xlink:label="tcrx_CommonStockSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseLongTermDebt" xlink:label="us-gaap_InterestExpenseLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember" xlink:label="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" xlink:label="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DepreciationExpenseMember" xlink:label="tcrx_DepreciationExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PrincipalAmountIncreasePercentage" xlink:label="tcrx_PrincipalAmountIncreasePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AmgenAgreementMember" xlink:label="tcrx_AmgenAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCovenantTerms" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock" xlink:label="tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LongTermDebtFinalPaymentFee" xlink:label="tcrx_LongTermDebtFinalPaymentFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccretionOfMarketableSecurities" xlink:label="tcrx_AccretionOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FacilityRelatedAndOtherMember" xlink:label="tcrx_FacilityRelatedAndOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_K2HealthVenturesMember" xlink:label="tcrx_K2HealthVenturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OfficeAndComputerEquipmentMember" xlink:label="tcrx_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsAmortization" xlink:label="tcrx_DeferredTaxAssetsAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember" xlink:label="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LongTermAssetMember" xlink:label="tcrx_LongTermAssetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NonCashInterestExpenseOnLoanPayable" xlink:label="tcrx_NonCashInterestExpenseOnLoanPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="us-gaap_DebtInstrumentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeRange" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeRange"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock" xlink:label="tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TrancheThreeMember" xlink:label="tcrx_TrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AnnualFixedRent" xlink:label="tcrx_AnnualFixedRent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TrancheOneMember" xlink:label="tcrx_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LaboratoryEquipmentMember" xlink:label="tcrx_LaboratoryEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseDescription" xlink:label="us-gaap_LessorOperatingLeaseDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SalesAgreementMember" xlink:label="tcrx_SalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseUpfrontPaymentReceivable" xlink:label="tcrx_LicenseUpfrontPaymentReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ChangesFromStatutoryRateAbstract" xlink:label="tcrx_ChangesFromStatutoryRateAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommonStockPricePerWarrant" xlink:label="tcrx_CommonStockPricePerWarrant"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares" xlink:label="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NovartisMember" xlink:label="tcrx_NovartisMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OperatingLossCarryForwardsExpirationYear" xlink:label="tcrx_OperatingLossCarryForwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_StockBasedCompensationMember" xlink:label="tcrx_StockBasedCompensationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_InterestOnlyPaymentExtendedTerm" xlink:label="tcrx_InterestOnlyPaymentExtendedTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ExpectsResearchTerm" xlink:label="tcrx_ExpectsResearchTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TaxCreditCarryforwardExpirationYear" xlink:label="tcrx_TaxCreditCarryforwardExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseUpfrontPayment" xlink:label="tcrx_LicenseUpfrontPayment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NegotiationPeriod" xlink:label="tcrx_NegotiationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:label="tcrx_DeferredTaxLiabilitiesRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseAgreementsTable" xlink:label="tcrx_CollaborationAndLicenseAgreementsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares" xlink:label="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PatentCostsPolicyTextBlock" xlink:label="tcrx_PatentCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:label="tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseAgreementDate" xlink:label="tcrx_LicenseAgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NovartisAgreementMember" xlink:label="tcrx_NovartisAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LesseeOperatingLeaseCommencingDate" xlink:label="tcrx_LesseeOperatingLeaseCommencingDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_MilestoneMethodRevenueRecognized" xlink:label="tcrx_MilestoneMethodRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationPeriod" xlink:label="tcrx_CollaborationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" xlink:label="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FinalFeePercentage" xlink:label="tcrx_FinalFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandAndEighteenEquityIncentivePlanMember" xlink:label="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseRevenue" xlink:label="tcrx_CollaborationAndLicenseRevenue"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Amount Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock upon closing of initial public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock upon note conversion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Deferred Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AmgenIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amgen Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AmgenIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amgen Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AmgenIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amgen Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty One Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2021 employee stock purchase plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options exercisable, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Observable Inputs (Level 2)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_WarrantIssuanceCostsOfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Issuance Costs Offering Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_WarrantIssuanceCostsOfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant issuance costs offering expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_WarrantIssuanceCostsOfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognition milestone method milestone payables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Milestone Method Milestone Payables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue recognition milestone method milestone payables.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and manufacturing contract costs policy.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research and Manufacturing Contract Costs [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Research and Manufacturing Contract Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-Term Debt, Current Maturities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Current Maturities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of long-term debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Less: current portion of long-term debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: current portion of long-term debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value, assets, transfers into level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of income tax examinations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock, Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_EstimatedResearchCostsTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated research costs transaction price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_EstimatedResearchCostsTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Estimated Research Costs Transaction Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_EstimatedResearchCostsTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Estimated research costs transaction price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total principal payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument drew</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Paid, Including Capitalized Interest, Operating and Investing Activities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FinancingCostsNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing costs not yet paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FinancingCostsNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Costs Not Yet Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FinancingCostsNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing costs not yet paid.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in current assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ReportableSegmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reportable Segment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ReportableSegmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reportable segment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ReportableSegmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reportable Segment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nature of Business and Basis of Presentation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Description and Basis of Presentation [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche 2.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Equity Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty One Equity Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2021 equity incentive plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt, Fair Value Disclosures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of convertible long-term debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DebtInstrumentExitFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Exit Fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DebtInstrumentExitFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument exit fee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DebtInstrumentExitFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exit fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre-Funded warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-Funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-Funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options exercisable, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term deposit and other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deposits Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash deposit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments of debt issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments of debt issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Debt Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_InterestOnlyPaymentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest only payment term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_InterestOnlyPaymentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Only Payment Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_InterestOnlyPaymentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest Only Payment Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FacilityFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Facility fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FacilityFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Facility Fee Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FacilityFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Facility fee paid.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_VotingCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Voting Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_VotingCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Voting Common Stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_VotingCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Voting Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase in annual fixed rent through original term of lease.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase in annual fixed rent through original term of lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in annual fixed rent through original term of lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument remaining borrowing capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets, depreciation and amortization.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value, assets, level 1 to level 2 transfers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Asset Level1 To Level2 Transfers Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value asset level 1 to level 2 transfers amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value, assets, level 2 to level 1 transfers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Asset Level2 To Level1 Transfers Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value asset level 2 to level 1 transfers amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Stock Options Outstanding, Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Stock Options Outstanding, Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, Reserved for future issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock, net of offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ClinicalStudiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Clinical Studies [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ClinicalStudiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical studies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ClinicalStudiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical Studies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Original lease term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other (expense) income:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Income and Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Assets Carried at Fair Value on a Hierarchy Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayment of note payable, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Notes Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment of loan payable, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain on available-for-sale securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_RevenueMilestonePaymentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue, milestone payments policy.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_RevenueMilestonePaymentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue, Milestone Payments [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_RevenueMilestonePaymentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive loss:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issuable upon conversion of Loan Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issuable upon exercise warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PersonnelExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Personnel expenses [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PersonnelExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Personnel expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PersonnelExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Personnel Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unvested Restricted Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued employee compensation and benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Potential Common Shares Excluded from Computation of Diluted Net Loss per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseAgreementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration And License Agreements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseAgreementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration and license agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk free interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested restricted stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unvested restricted stock, Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unvested restricted stock, Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets and lease liabilities, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies Disclosure [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Common Stock, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Common Stock, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Stock Options Outstanding, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Covenant Terms, Unrestricted Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Covenant Terms, Unrestricted Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Covenant terms, unrestricted cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LegalAndProfessionalFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal and Professional Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LegalAndProfessionalFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal and Professional Fees [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LegalAndProfessionalFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Legal and professional fees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NumberOfLeasesFacilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of leases facilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NumberOfLeasesFacilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of leases facilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Fixtures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from borrowings under loan agreement, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Lines of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Lines of Credit, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DebtInstrumentPrepaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Prepayment Fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DebtInstrumentPrepaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument prepayment fee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DebtInstrumentPrepaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue, current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">cash payments for operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retirement Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: unamortized debt discount and final fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: unamortized debt discount and final fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Unamortized Discount, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_RevenueFromRoyaltiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_RevenueFromRoyaltiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Royalties [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_RevenueFromRoyaltiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue from royalties.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discount rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Discount Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payables and Accruals [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, net of offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of pre-funded warrants, net of offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Long-term deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Lease security amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of loan prepayment fee in there after year two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Loan Prepayment Fee In After Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of loan prepayment fee in after year two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balances, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balances, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary, Ownership Percentage, Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Basic and Diluted Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyAgreementTermsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyAgreementTermsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Agreement Terms [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cash, cash equivalents, and restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents, and restricted cash - beginning of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents, and restricted cash - end of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related-Party Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Tax Credit Carryforward [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">R&amp;D</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument payment, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Payment Terms</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total financial assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccruedResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccruedResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccruedResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ReimbursementCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reimbursement cost.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ReimbursementCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reimbursement cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturity of Future Payments Of Operating Lease Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of common stock and warrants net of underwriting discounts and expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock And Warrants Net Of Underwriting Discounts And Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from common stock and warrants after deducting underwriting discounts, commissions and other offering expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of awards permitted to grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseAgreementsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration And License Agreements [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseAgreementsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration And License Agreements [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseAgreementsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration and license agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average period remaining (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest and Other Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested restricted stock, Vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unvested restricted stock, Vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfIncreaseInAnnualFixedRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of increase in annual fixed rent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfIncreaseInAnnualFixedRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of increase in annual fixed rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfIncreaseInAnnualFixedRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of increase in annual fixed rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Recently Adopted Accounting Pronouncements/ Recently Issued Accounting Pronouncements Not Yet Effective</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segments [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets, Fair Value Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Principal Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Owned and Sold, Not yet Purchased Fair Value, Security Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PrepaidRentReclassedToRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid rent reclassed to right of use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PrepaidRentReclassedToRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Rent Reclassed To Right Of Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PrepaidRentReclassedToRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid Rent Reclassed To Right Of Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonvotingCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonvoting Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonvotingCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-voting Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Construction in Progress [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction-in-Progress</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock shares under the plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential shares issuable under the ESPP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest or penalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Silicon valley bank.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LeaseSpaceForFacility_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Space For Facility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LeaseSpaceForFacility_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease space for facility.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LeaseSpaceForFacility_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease space for facility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Cancelled, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock, net of offering cost/ ESPP plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, net of offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_StockIssuanceCostsOfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issuance Costs Offering Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_StockIssuanceCostsOfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issuance costs offering expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_StockIssuanceCostsOfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Government Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of aggregate royalty of net sales of any product sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Aggregate Royalty Of Net Sales Of Any Product Sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of aggregate royalty of net sales of any product sold.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease cost in the Company's consolidated statement of operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intrinsic value of options exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term debt and accrued interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Excluding Current Maturities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-term debt, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AreaOfLeasedOfficeSpace_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Area of leased office space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AreaOfLeasedOfficeSpace_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Area Of Leased Office Space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AreaOfLeasedOfficeSpace_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Area of leased office space.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Outstanding, Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MASSACHUSETTS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Massachusetts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of number of common stock issued and outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Other Information Related to Option Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Weighted-average for Each of The Assumptions The Company Used to Determine The Grant-date Fair Value of Options Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Repaid, Principal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repaid remaining principal amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration and license revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenue from Contract with Customer, Excluding Assessed Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of the Federal Statutory Income Tax Rate to the Effective Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration and License Agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative And License Arrangement Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaborative and license arrangement disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NumberOfTargetsIdentified_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of targets identified</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NumberOfTargetsIdentified_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Targets Identified</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NumberOfTargetsIdentified_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of targets identified.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Nonproduction, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization, Nonproduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DefaultInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Default interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DefaultInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Default Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DefaultInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Default Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Property plant and equipment estimated useful lives description.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Estimated Useful Lives Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease not yet commenced, Obligation for payment of base rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Lease Not Yet Commenced Obligation For Payment Of Base Rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease, lease not yet commenced obligation for payment of base rent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Effective tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseUpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment received</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseUpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Upfront Payment Received</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseUpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License upfront payment received.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment reporting, CODM, profit (loss) measure, how used, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Follow on offering.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Follow on Offering [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Follow On Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balances</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balances</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Original Debt, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible outstanding principal balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Liabilities, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Conversion Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of loan prepayment fee in year two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Loan Prepayment Fee In Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of loan prepayment fee in year two.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Loan Prepayment Fee in Twelve Months</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of loan prepayment fee in twelve months.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of loan prepayment fee in first year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-based Compensation Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution plan, employer contribution amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ResearchFundingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research funding.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ResearchFundingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Funding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ResearchFundingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research Funding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_WedbushSecuritiesIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Wedbush Securities, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_WedbushSecuritiesIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Wedbush Securities, Inc. [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_WedbushSecuritiesIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Wedbush Securities, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Security, Mortgage-Backed, Available-for-Sale, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Marketable securities, fair value disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of term loan, net of issuance costs paid to lender</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Long-Term Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Issuance of Long-Term Debt, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Conversion of convertible preferred stock to common stock upon closing of initial public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock and non-voting common stock upon closing of initial public offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsLeaseholdLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets, leasehold liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsLeaseholdLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Leasehold Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsLeaseholdLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized R&amp;D costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Capitalized Research And Development Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets capitalized research and development costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccruedLegalServicesAndLicenseFeeCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued legal services and license fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccruedLegalServicesAndLicenseFeeCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Legal Services And License Fee Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccruedLegalServicesAndLicenseFeeCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued legal services and license fee current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ClassOfStockWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of stock warrants exercised.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ClassOfStockWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock Warrants Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ClassOfStockWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Credit Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incurred costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average value of stock options, granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PotentialMilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Potential milestone payment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PotentialMilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Potential milestone payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommonStockSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Reserved For Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommonStockSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock shares reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommonStockSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, net of offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: accumulated depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Long-Term Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Long-Term Debt, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average fair value of options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand Eighteen And Two Thousand Twenty One Equity Incentive Plan Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Eighteen And Two Thousand Twenty One Equity Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2018 and 2021 Equity Incentive Plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease weighted average incremental borrowing rate percent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Incremental Borrowing Rate Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease weighted average incremental borrowing rate Percent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rcognized loss from extinguishment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Extinguishment of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Extinguishment of Debt, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Loss on extinguishment of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on extinguishment of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DepreciationExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Depreciation expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DepreciationExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DepreciationExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prime Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PrincipalAmountIncreasePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional principal amount percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PrincipalAmountIncreasePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Principal Amount Increase Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PrincipalAmountIncreasePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Principal amount increase percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, net of offering costs, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized Tax Benefits, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized Tax Benefits, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Uncertain tax positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, option to extend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Existence of Option to Extend [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AmgenAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amgen Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AmgenAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amgen Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AmgenAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amgen Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Converted instrument, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Covenant terms</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Covenant Terms</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Stock Options Outstanding, Intrinsic Value, Beginning</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Stock Options Outstanding, Intrinsic Value, Ending</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease not yet commenced, Option to extend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Lease Not yet Commenced, Option to Extend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LongTermDebtFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plus: Final payment fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LongTermDebtFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt Final Payment fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LongTermDebtFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term debt final payment fee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccretionOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accretion of marketable securities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccretionOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion of Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AccretionOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion of marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FacilityRelatedAndOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Facility-Related and Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FacilityRelatedAndOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Facility Related and Other [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FacilityRelatedAndOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Facility related and other.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_K2HealthVenturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">K2 Health Ventures [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_K2HealthVenturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">K2 Health Ventures.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_K2HealthVenturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">K2HV [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reportable segment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan maturity date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Equivalents - Money Market Funds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average common shares outstanding, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average common shares outstanding- basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under ESPP plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of common stock, net of offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturities of marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Active Markets (Level 1)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_OfficeAndComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Office and Computer Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_OfficeAndComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Office and Computer Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_OfficeAndComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office and Computer Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options vested or expected to vest, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Granted, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt issuance costs not yet paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Outstanding, Weighted Average Remaining Contractual Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxAssetsAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets, amortization.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of pre-funded warrants, net of offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of pre-funded warrants, net of offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Supplies Research Materials And Studies [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory Supplies Research Materials And Studies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Supplies, Research Materials and Studies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LongTermAssetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">long-term asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LongTermAssetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Asset [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LongTermAssetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity (deficit):</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NonCashInterestExpenseOnLoanPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non cash Interest Expense on Loan Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NonCashInterestExpenseOnLoanPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non cash interest expense on loan payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NonCashInterestExpenseOnLoanPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash interest expense related to loan payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of non-cash investing and financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease not yet commenced, Term of contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options vested or expected to vest, Weighted Average Remaining Contractual Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instruments [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash, cash equivalents and restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeRange_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment fee range</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeRange_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Loan Prepayment Fee Range</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeRange_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of Loan Prepayment Fee Range</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies Disclosure [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State taxes, net of federal benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Operating and Nonoperating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, Date of Incorporation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of incorporation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of presentation of operating lease In consolidated balance sheet</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Presentation Of Operating Lease In Consolidated Balance Sheet [TableText Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary Of presentation of operating lease In consolidated balance sheet</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche 3.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility of underlying common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockNoParValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, No Par Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockNoParValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">par value per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LetterOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Letter of Credit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LetterOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Letter of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock, vesting term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Vesting Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award restricted stock vesting term.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued consulting and professional services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AnnualFixedRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual fixed rent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AnnualFixedRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Annual fixed rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AnnualFixedRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual fixed rent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options exercisable, Weighted Average Remaining Contractual Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of convertible preferred stock, net of issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses and Other Current Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Software</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Software Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized Software</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Contract with Customer, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and 2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Stock Options Outstanding, Cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory equipment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of property and equipment in accounts payable and accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred but Not yet Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LessorOperatingLeaseDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LessorOperatingLeaseDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessor, Operating Lease, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ATM Program</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseUpfrontPaymentReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseUpfrontPaymentReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License upfront payment receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseUpfrontPaymentReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License upfront payment receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ChangesFromStatutoryRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Changes from statutory rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ChangesFromStatutoryRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Changes from statutory rate [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ChangesFromStatutoryRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes from statutory rate:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommonStockPricePerWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock price per warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommonStockPricePerWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Price Per Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CommonStockPricePerWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock price per warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriter option to purchase number of additional shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriter Option To Purchase Number Of Additional Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriter option to purchase number of additional shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NovartisMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Novartis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NovartisMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Novartis [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NovartisMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Novartis.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Taxes at U.S. statutory rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Conversion of convertible preferred stock to common stock upon closing of initial public offering, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock and non-voting common stock upon closing of initial public offering, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion of non-voting common stock to voting common stock, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_OperatingLossCarryForwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carry forwards expiration year.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_OperatingLossCarryForwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carry Forwards Expiration Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_OperatingLossCarryForwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards, expiration year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_StockBasedCompensationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_StockBasedCompensationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Based Compensation [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_StockBasedCompensationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock-based compensation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Deferred Tax Assets and Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities, current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability, current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value, assets, transfers out of level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase price of restricted common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Of Restricted Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award purchase price of restricted common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contractual interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Exercised, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Concentrations of Credit Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets and liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options to Purchase Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_InterestOnlyPaymentExtendedTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest only payment extended term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_InterestOnlyPaymentExtendedTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Only Payment Extended Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_InterestOnlyPaymentExtendedTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest only payment extended term.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options vested or expected to vest, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ExpectsResearchTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expects research term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ExpectsResearchTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Expects Research Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_ExpectsResearchTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Expects research term.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive gain:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration year.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards, expiration year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseUpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseUpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License upfront payment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseUpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Upfront Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NegotiationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Negotiation period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NegotiationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Negotiation Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NegotiationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Negotiation period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Owned and Sold, Not yet Purchased, at Fair Value [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expense and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities right of use asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred tax liabilities Right of Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred tax liabilities Right of Use Asset, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right of use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right of use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseAgreementsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration and license agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseAgreementsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration And License Agreements [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseAgreementsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration And License Agreements [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital equity component of convertible debt shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible debt, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Supplemental disclosure of cash flow information related to leases.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Disclosure of Cash Flow Information Related to Leases [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental Disclosure of Cash Flow Information Related to Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents fair value disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent costs policy.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patent Costs [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Present value of operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 10)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average common shares outstanding, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average common shares outstanding-diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Segment Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Renewal Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, renewal term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options vested or expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total future payments of operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of weighted-average remaining lease term and discount rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Weighted-Average Remaining Lease Term and Discount Rate [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Weighted-Average Remaining Lease Term and Discount Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Basis Spread on Variable Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseAgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseAgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LicenseAgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan and Security Agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NovartisAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Novartis Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NovartisAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Novartis Agreement Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_NovartisAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Novartis Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LesseeOperatingLeaseCommencingDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease commencing date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LesseeOperatingLeaseCommencingDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease commencing date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LesseeOperatingLeaseCommencingDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee operating lease commencing date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Stock Options Outstanding, Weighted Average Exercise Price, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Stock Options Outstanding, Weighted Average Exercise Price, Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses and Other Current Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_MilestoneMethodRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborations and license agreements, expected milestone receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_MilestoneMethodRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Method Revenue Recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_MilestoneMethodRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone method revenue recognized.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend-yield assumption</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability arising from obtaining right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">collaboration period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unobservable Inputs (Level 3)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Five And There After</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease liability payments due year five and there after.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2029 and thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FinalFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Final fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FinalFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Final Fee Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_FinalFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Final Fee Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total financial liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Equity Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Eighteen Equity Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2018 equity incentive plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration And License Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tcrx_CollaborationAndLicenseRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration and license revenue.</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_AmgenIncMember" xlink:to="tcrx_AmgenIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember" xlink:to="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_WarrantIssuanceCostsOfferingExpenses" xlink:to="tcrx_WarrantIssuanceCostsOfferingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables" xlink:to="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock" xlink:to="tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_EstimatedResearchCostsTransactionPrice" xlink:to="tcrx_EstimatedResearchCostsTransactionPrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_FinancingCostsNotYetPaid" xlink:to="tcrx_FinancingCostsNotYetPaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ReportableSegmentMember" xlink:to="tcrx_ReportableSegmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_TrancheTwoMember" xlink:to="tcrx_TrancheTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:to="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_DebtInstrumentExitFee" xlink:to="tcrx_DebtInstrumentExitFee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PreFundedWarrantsMember" xlink:to="tcrx_PreFundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_InterestOnlyPaymentTerm" xlink:to="tcrx_InterestOnlyPaymentTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_FacilityFeePaid" xlink:to="tcrx_FacilityFeePaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_VotingCommonStockMember" xlink:to="tcrx_VotingCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease" xlink:to="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:to="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="tcrx_DeferredTaxAssetsDepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount" xlink:to="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount" xlink:to="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ClinicalStudiesMember" xlink:to="tcrx_ClinicalStudiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_RevenueMilestonePaymentsPolicyTextBlock" xlink:to="tcrx_RevenueMilestonePaymentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PersonnelExpensesMember" xlink:to="tcrx_PersonnelExpensesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CollaborationAndLicenseAgreementsAbstract" xlink:to="tcrx_CollaborationAndLicenseAgreementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_CommitmentsAndContingenciesDisclosureLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents" xlink:to="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LegalAndProfessionalFeesMember" xlink:to="tcrx_LegalAndProfessionalFeesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_NumberOfLeasesFacilities" xlink:to="tcrx_NumberOfLeasesFacilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_DebtInstrumentPrepaymentFee" xlink:to="tcrx_DebtInstrumentPrepaymentFee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_RevenueFromRoyaltiesPolicyTextBlock" xlink:to="tcrx_RevenueFromRoyaltiesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyAgreementTermsMember" xlink:to="us-gaap_RoyaltyAgreementTermsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPaymentTerms" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_AccruedResearchAndDevelopment" xlink:to="tcrx_AccruedResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ReimbursementCost" xlink:to="tcrx_ReimbursementCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" xlink:to="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_CollaborationAndLicenseAgreementsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PercentageOfIncreaseInAnnualFixedRent" xlink:to="tcrx_PercentageOfIncreaseInAnnualFixedRent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PrepaidRentReclassedToRightOfUseAsset" xlink:to="tcrx_PrepaidRentReclassedToRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonvotingCommonStockMember" xlink:to="us-gaap_NonvotingCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_EmployeeStockPurchasePlanMember" xlink:to="tcrx_EmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_SiliconValleyBankMember" xlink:to="tcrx_SiliconValleyBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LeaseSpaceForFacility" xlink:to="tcrx_LeaseSpaceForFacility_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_StockIssuanceCostsOfferingExpenses" xlink:to="tcrx_StockIssuanceCostsOfferingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold" xlink:to="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_AreaOfLeasedOfficeSpace" xlink:to="tcrx_AreaOfLeasedOfficeSpace_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_MA" xlink:to="stpr_MA_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRepaidPrincipal" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock" xlink:to="tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_NumberOfTargetsIdentified" xlink:to="tcrx_NumberOfTargetsIdentified_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_DefaultInterestRate" xlink:to="tcrx_DefaultInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription" xlink:to="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent" xlink:to="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LicenseUpfrontPaymentReceived" xlink:to="tcrx_LicenseUpfrontPaymentReceived_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_FollowOnOfferingMember" xlink:to="tcrx_FollowOnOfferingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ResearchFundingMember" xlink:to="tcrx_ResearchFundingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_WedbushSecuritiesIncMember" xlink:to="tcrx_WedbushSecuritiesIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:to="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_DeferredTaxAssetsLeaseholdLiability" xlink:to="tcrx_DeferredTaxAssetsLeaseholdLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:to="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_AccruedLegalServicesAndLicenseFeeCurrent" xlink:to="tcrx_AccruedLegalServicesAndLicenseFeeCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ClassOfStockWarrantsExercised" xlink:to="tcrx_ClassOfStockWarrantsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PotentialMilestonePayment" xlink:to="tcrx_PotentialMilestonePayment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CommonStockSharesReservedForFutureIssuance" xlink:to="tcrx_CommonStockSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseLongTermDebt" xlink:to="us-gaap_InterestExpenseLongTermDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember" xlink:to="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" xlink:to="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_DepreciationExpenseMember" xlink:to="tcrx_DepreciationExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PrincipalAmountIncreasePercentage" xlink:to="tcrx_PrincipalAmountIncreasePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_AmgenAgreementMember" xlink:to="tcrx_AmgenAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCovenantTerms" xlink:to="us-gaap_LineOfCreditFacilityCovenantTerms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock" xlink:to="tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LongTermDebtFinalPaymentFee" xlink:to="tcrx_LongTermDebtFinalPaymentFee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_AccretionOfMarketableSecurities" xlink:to="tcrx_AccretionOfMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_FacilityRelatedAndOtherMember" xlink:to="tcrx_FacilityRelatedAndOtherMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_K2HealthVenturesMember" xlink:to="tcrx_K2HealthVenturesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_OfficeAndComputerEquipmentMember" xlink:to="tcrx_OfficeAndComputerEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_DeferredTaxAssetsAmortization" xlink:to="tcrx_DeferredTaxAssetsAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember" xlink:to="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LongTermAssetMember" xlink:to="tcrx_LongTermAssetMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_NonCashInterestExpenseOnLoanPayable" xlink:to="tcrx_NonCashInterestExpenseOnLoanPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PercentageOfLoanPrepaymentFeeRange" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeRange_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="tcrx_CommitmentsAndContingenciesDisclosureTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock" xlink:to="tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_TrancheThreeMember" xlink:to="tcrx_TrancheThreeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LetterOfCreditMember" xlink:to="us-gaap_LetterOfCreditMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm" xlink:to="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_AnnualFixedRent" xlink:to="tcrx_AnnualFixedRent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_TrancheOneMember" xlink:to="tcrx_TrancheOneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LaboratoryEquipmentMember" xlink:to="tcrx_LaboratoryEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LessorOperatingLeaseDescription" xlink:to="us-gaap_LessorOperatingLeaseDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_SalesAgreementMember" xlink:to="tcrx_SalesAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LicenseUpfrontPaymentReceivable" xlink:to="tcrx_LicenseUpfrontPaymentReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ChangesFromStatutoryRateAbstract" xlink:to="tcrx_ChangesFromStatutoryRateAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CommonStockPricePerWarrant" xlink:to="tcrx_CommonStockPricePerWarrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares" xlink:to="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_NovartisMember" xlink:to="tcrx_NovartisMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_OperatingLossCarryForwardsExpirationYear" xlink:to="tcrx_OperatingLossCarryForwardsExpirationYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_StockBasedCompensationMember" xlink:to="tcrx_StockBasedCompensationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock" xlink:to="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_InterestOnlyPaymentExtendedTerm" xlink:to="tcrx_InterestOnlyPaymentExtendedTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_ExpectsResearchTerm" xlink:to="tcrx_ExpectsResearchTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_TaxCreditCarryforwardExpirationYear" xlink:to="tcrx_TaxCreditCarryforwardExpirationYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LicenseUpfrontPayment" xlink:to="tcrx_LicenseUpfrontPayment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_NegotiationPeriod" xlink:to="tcrx_NegotiationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:to="tcrx_DeferredTaxLiabilitiesRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="tcrx_CollaborationAndLicenseAgreementsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares" xlink:to="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_PatentCostsPolicyTextBlock" xlink:to="tcrx_PatentCostsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:to="tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LicenseAgreementDate" xlink:to="tcrx_LicenseAgreementDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_NovartisAgreementMember" xlink:to="tcrx_NovartisAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LesseeOperatingLeaseCommencingDate" xlink:to="tcrx_LesseeOperatingLeaseCommencingDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_MilestoneMethodRevenueRecognized" xlink:to="tcrx_MilestoneMethodRevenueRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CollaborationPeriod" xlink:to="tcrx_CollaborationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" xlink:to="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_FinalFeePercentage" xlink:to="tcrx_FinalFeePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember" xlink:to="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tcrx_CollaborationAndLicenseRevenue" xlink:to="tcrx_CollaborationAndLicenseRevenue_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="39" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="40" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_10"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenuesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InterestExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_10" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares" xlink:label="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_16"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_17"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_16" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_17" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="tcrx_VotingCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FinancingCostsNotYetPaid" xlink:label="tcrx_FinancingCostsNotYetPaid"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccretionOfMarketableSecurities" xlink:label="tcrx_AccretionOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NonCashInterestExpenseOnLoanPayable" xlink:label="tcrx_NonCashInterestExpenseOnLoanPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="tcrx_FinancingCostsNotYetPaid" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="tcrx_AccretionOfMarketableSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="tcrx_NonCashInterestExpenseOnLoanPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipment" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseAgreementsAbstract" xlink:label="tcrx_CollaborationAndLicenseAgreementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock" xlink:label="tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsAbstract" xlink:to="tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlan" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReporting" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock" xlink:label="tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PatentCostsPolicyTextBlock" xlink:label="tcrx_PatentCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_RevenueMilestonePaymentsPolicyTextBlock" xlink:label="tcrx_RevenueMilestonePaymentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_RevenueFromRoyaltiesPolicyTextBlock" xlink:label="tcrx_RevenueFromRoyaltiesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tcrx_PatentCostsPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tcrx_RevenueMilestonePaymentsPolicyTextBlock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tcrx_RevenueFromRoyaltiesPolicyTextBlock" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock" xlink:label="tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_TemporaryEquityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:label="tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock" xlink:label="tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NetIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LetterOfCreditMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LaboratoryEquipmentMember" xlink:label="tcrx_LaboratoryEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription" xlink:label="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OfficeAndComputerEquipmentMember" xlink:label="tcrx_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tcrx_LaboratoryEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tcrx_OfficeAndComputerEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LaboratoryEquipmentMember" xlink:label="tcrx_LaboratoryEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OfficeAndComputerEquipmentMember" xlink:label="tcrx_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tcrx_LaboratoryEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tcrx_OfficeAndComputerEquipmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:label="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FairValueAssetLevel1ToLevel2TransfersAmount" xlink:label="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FairValueAssetLevel2ToLevel1TransfersAmount" xlink:label="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccruedResearchAndDevelopment" xlink:label="tcrx_AccruedResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccruedLegalServicesAndLicenseFeeCurrent" xlink:label="tcrx_AccruedLegalServicesAndLicenseFeeCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="tcrx_AccruedResearchAndDevelopment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="tcrx_AccruedLegalServicesAndLicenseFeeCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SalesAgreementMember" xlink:label="tcrx_SalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_WedbushSecuritiesIncMember" xlink:label="tcrx_WedbushSecuritiesIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PreFundedWarrantsMember" xlink:label="tcrx_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FollowOnOfferingMember" xlink:label="tcrx_FollowOnOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommonStockSharesReservedForFutureIssuance" xlink:label="tcrx_CommonStockSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommonStockPricePerWarrant" xlink:label="tcrx_CommonStockPricePerWarrant"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ClassOfStockWarrantsExercised" xlink:label="tcrx_ClassOfStockWarrantsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" xlink:label="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_12"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares" xlink:label="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_StockIssuanceCostsOfferingExpenses" xlink:label="tcrx_StockIssuanceCostsOfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_WarrantIssuanceCostsOfferingExpenses" xlink:label="tcrx_WarrantIssuanceCostsOfferingExpenses"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tcrx_SalesAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="tcrx_WedbushSecuritiesIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tcrx_PreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="tcrx_FollowOnOfferingMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_CommonStockSharesReservedForFutureIssuance" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_CommonStockPricePerWarrant" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_ClassOfStockWarrantsExercised" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_12" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockNoParValue" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_StockIssuanceCostsOfferingExpenses" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_WarrantIssuanceCostsOfferingExpenses" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandAndEighteenEquityIncentivePlanMember" xlink:label="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:label="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember" xlink:label="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember" xlink:label="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_18"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_18" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ChangesFromStatutoryRateAbstract" xlink:label="tcrx_ChangesFromStatutoryRateAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_ChangesFromStatutoryRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="tcrx_ChangesFromStatutoryRateAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_ChangesFromStatutoryRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_ChangesFromStatutoryRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_ChangesFromStatutoryRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_ChangesFromStatutoryRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_MA" xlink:label="stpr_MA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OperatingLossCarryForwardsExpirationYear" xlink:label="tcrx_OperatingLossCarryForwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TaxCreditCarryforwardExpirationYear" xlink:label="tcrx_TaxCreditCarryforwardExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_TaxCreditCarryforwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_StatementGeographicalAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="tcrx_OperatingLossCarryForwardsExpirationYear" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="tcrx_TaxCreditCarryforwardExpirationYear" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_IncomeTaxExaminationDescription" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:label="tcrx_DeferredTaxLiabilitiesRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="tcrx_DeferredTaxAssetsDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsAmortization" xlink:label="tcrx_DeferredTaxAssetsAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsLeaseholdLiability" xlink:label="tcrx_DeferredTaxAssetsLeaseholdLiability"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:label="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="tcrx_DeferredTaxLiabilitiesRightOfUseAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="tcrx_DeferredTaxAssetsDepreciationAndAmortization" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="tcrx_DeferredTaxAssetsAmortization" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="tcrx_DeferredTaxAssetsLeaseholdLiability" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ResearchFundingMember" xlink:label="tcrx_ResearchFundingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseAgreementsAbstract" xlink:label="tcrx_CollaborationAndLicenseAgreementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseAgreementsTable" xlink:label="tcrx_CollaborationAndLicenseAgreementsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:label="tcrx_CollaborationAndLicenseAgreementsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseAgreementDate" xlink:label="tcrx_LicenseAgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AmgenAgreementMember" xlink:label="tcrx_AmgenAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AmgenIncMember" xlink:label="tcrx_AmgenIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseUpfrontPaymentReceived" xlink:label="tcrx_LicenseUpfrontPaymentReceived"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NovartisAgreementMember" xlink:label="tcrx_NovartisAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NovartisMember" xlink:label="tcrx_NovartisMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseUpfrontPaymentReceivable" xlink:label="tcrx_LicenseUpfrontPaymentReceivable"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseUpfrontPayment" xlink:label="tcrx_LicenseUpfrontPayment"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PotentialMilestonePayment" xlink:label="tcrx_PotentialMilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NumberOfTargetsIdentified" xlink:label="tcrx_NumberOfTargetsIdentified"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_MilestoneMethodRevenueRecognized" xlink:label="tcrx_MilestoneMethodRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationPeriod" xlink:label="tcrx_CollaborationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NegotiationPeriod" xlink:label="tcrx_NegotiationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ExpectsResearchTerm" xlink:label="tcrx_ExpectsResearchTerm"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_RevenueRecognitionMilestoneMethodMilestonePayables" xlink:label="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_EstimatedResearchCostsTransactionPrice" xlink:label="tcrx_EstimatedResearchCostsTransactionPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ReimbursementCost" xlink:label="tcrx_ReimbursementCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tcrx_ResearchFundingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsAbstract" xlink:to="tcrx_CollaborationAndLicenseAgreementsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_LicenseAgreementDate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipDomain" xlink:to="tcrx_AmgenAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tcrx_AmgenIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_LicenseUpfrontPaymentReceived" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipDomain" xlink:to="tcrx_NovartisAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tcrx_NovartisMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_LicenseUpfrontPaymentReceivable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_LicenseUpfrontPayment" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="srt_OwnershipAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_PotentialMilestonePayment" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="tcrx_CollaborationAndLicenseAgreementsLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_NumberOfTargetsIdentified" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_MilestoneMethodRevenueRecognized" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_CollaborationPeriod" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_NegotiationPeriod" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_ExpectsResearchTerm" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_EstimatedResearchCostsTransactionPrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_DeferredRevenue" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_ReimbursementCost" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_OperatingExpenses" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_DeferredRevenueCurrent" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NumberOfLeasesFacilities" xlink:label="tcrx_NumberOfLeasesFacilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LongTermAssetMember" xlink:label="tcrx_LongTermAssetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="us-gaap_RoyaltyAgreementTermsMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseDescription" xlink:label="us-gaap_LessorOperatingLeaseDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AnnualFixedRent" xlink:label="tcrx_AnnualFixedRent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfIncreaseInAnnualFixedRent" xlink:label="tcrx_PercentageOfIncreaseInAnnualFixedRent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease" xlink:label="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold" xlink:label="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LeaseSpaceForFacility" xlink:label="tcrx_LeaseSpaceForFacility"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LesseeOperatingLeaseCommencingDate" xlink:label="tcrx_LesseeOperatingLeaseCommencingDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PrepaidRentReclassedToRightOfUseAsset" xlink:label="tcrx_PrepaidRentReclassedToRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" xlink:label="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_NumberOfLeasesFacilities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="tcrx_LongTermAssetMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LetterOfCreditMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_RoyaltyAgreementTermsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_CreditFacilityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="tcrx_CommitmentsAndContingenciesDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LessorOperatingLeaseDescription" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="tcrx_CommitmentsAndContingenciesDisclosureLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_AnnualFixedRent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_PercentageOfIncreaseInAnnualFixedRent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LeaseCost" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_LeaseSpaceForFacility" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_LesseeOperatingLeaseCommencingDate" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_PrepaidRentReclassedToRightOfUseAsset" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeasePayments" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_ShortTermLeaseCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_VariableLeaseCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" xlink:label="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TrancheOneMember" xlink:label="tcrx_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_K2HealthVenturesMember" xlink:label="tcrx_K2HealthVenturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="us-gaap_DebtInstrumentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TrancheTwoMember" xlink:label="tcrx_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SiliconValleyBankMember" xlink:label="tcrx_SiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TrancheThreeMember" xlink:label="tcrx_TrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FacilityFeePaid" xlink:label="tcrx_FacilityFeePaid"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PrincipalAmountIncreasePercentage" xlink:label="tcrx_PrincipalAmountIncreasePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_InterestOnlyPaymentTerm" xlink:label="tcrx_InterestOnlyPaymentTerm"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_InterestOnlyPaymentExtendedTerm" xlink:label="tcrx_InterestOnlyPaymentExtendedTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DebtInstrumentExitFee" xlink:label="tcrx_DebtInstrumentExitFee"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DebtInstrumentPrepaymentFee" xlink:label="tcrx_DebtInstrumentPrepaymentFee"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeRange" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeRange"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FinalFeePercentage" xlink:label="tcrx_FinalFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeInYearTwo" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCovenantTerms" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents" xlink:label="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DefaultInterestRate" xlink:label="tcrx_DefaultInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseLongTermDebt" xlink:label="us-gaap_InterestExpenseLongTermDebt"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tcrx_TrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="tcrx_K2HealthVenturesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tcrx_TrancheTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="tcrx_SiliconValleyBankMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tcrx_TrancheThreeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_FacilityFeePaid" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PrincipalAmountIncreasePercentage" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_InterestOnlyPaymentTerm" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_InterestOnlyPaymentExtendedTerm" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_DebtInstrumentExitFee" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_DebtInstrumentPrepaymentFee" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeRange" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_FinalFeePercentage" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCovenantTerms" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_DefaultInterestRate" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseLongTermDebt" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LongTermDebtFinalPaymentFee" xlink:label="tcrx_LongTermDebtFinalPaymentFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="tcrx_LongTermDebtFinalPaymentFee" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebt" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfOperatingSegments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PersonnelExpensesMember" xlink:label="tcrx_PersonnelExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ReportableSegmentMember" xlink:label="tcrx_ReportableSegmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember" xlink:label="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ClinicalStudiesMember" xlink:label="tcrx_ClinicalStudiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LegalAndProfessionalFeesMember" xlink:label="tcrx_LegalAndProfessionalFeesMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FacilityRelatedAndOtherMember" xlink:label="tcrx_FacilityRelatedAndOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_StockBasedCompensationMember" xlink:label="tcrx_StockBasedCompensationMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DepreciationExpenseMember" xlink:label="tcrx_DepreciationExpenseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_PersonnelExpensesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="tcrx_ReportableSegmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_RevenuesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InterestExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_ClinicalStudiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_LegalAndProfessionalFeesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_FacilityRelatedAndOtherMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_StockBasedCompensationMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_DepreciationExpenseMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PreFundedWarrantsMember" xlink:label="tcrx_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tcrx_PreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_EmployeeStockPurchasePlanMember" xlink:label="tcrx_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="tcrx_EmployeeStockPurchasePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AreaOfLeasedOfficeSpace" xlink:label="tcrx_AreaOfLeasedOfficeSpace"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent" xlink:label="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tcrx_AreaOfLeasedOfficeSpace" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="38" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="39" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="40" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvotingCommonStockMember" xlink:label="us-gaap_NonvotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares" xlink:label="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_NonvotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="tcrx_VotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LetterOfCreditMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfReportableSegments" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LaboratoryEquipmentMember" xlink:label="tcrx_LaboratoryEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription" xlink:label="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OfficeAndComputerEquipmentMember" xlink:label="tcrx_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tcrx_LaboratoryEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tcrx_OfficeAndComputerEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LaboratoryEquipmentMember" xlink:label="tcrx_LaboratoryEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OfficeAndComputerEquipmentMember" xlink:label="tcrx_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tcrx_LaboratoryEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tcrx_OfficeAndComputerEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:label="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FairValueAssetLevel1ToLevel2TransfersAmount" xlink:label="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FairValueAssetLevel2ToLevel1TransfersAmount" xlink:label="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SalesAgreementMember" xlink:label="tcrx_SalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_VotingCommonStockMember" xlink:label="tcrx_VotingCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_WedbushSecuritiesIncMember" xlink:label="tcrx_WedbushSecuritiesIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PreFundedWarrantsMember" xlink:label="tcrx_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FollowOnOfferingMember" xlink:label="tcrx_FollowOnOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommonStockSharesReservedForFutureIssuance" xlink:label="tcrx_CommonStockSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommonStockPricePerWarrant" xlink:label="tcrx_CommonStockPricePerWarrant"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ClassOfStockWarrantsExercised" xlink:label="tcrx_ClassOfStockWarrantsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" xlink:label="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares" xlink:label="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_StockIssuanceCostsOfferingExpenses" xlink:label="tcrx_StockIssuanceCostsOfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_WarrantIssuanceCostsOfferingExpenses" xlink:label="tcrx_WarrantIssuanceCostsOfferingExpenses"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tcrx_SalesAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="tcrx_VotingCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="tcrx_WedbushSecuritiesIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tcrx_PreFundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="tcrx_FollowOnOfferingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_CommonStockSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_CommonStockPricePerWarrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_ClassOfStockWarrantsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockNoParValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_StockIssuanceCostsOfferingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="tcrx_WarrantIssuanceCostsOfferingExpenses" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandAndEighteenEquityIncentivePlanMember" xlink:label="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:label="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember" xlink:label="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock" xlink:label="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember" xlink:label="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_MA" xlink:label="stpr_MA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OperatingLossCarryForwardsExpirationYear" xlink:label="tcrx_OperatingLossCarryForwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TaxCreditCarryforwardExpirationYear" xlink:label="tcrx_TaxCreditCarryforwardExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="tcrx_OperatingLossCarryForwardsExpirationYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="tcrx_TaxCreditCarryforwardExpirationYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_IncomeTaxExaminationDescription" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:label="tcrx_CollaborationAndLicenseAgreementsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseAgreementsTable" xlink:label="tcrx_CollaborationAndLicenseAgreementsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ResearchFundingMember" xlink:label="tcrx_ResearchFundingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseAgreementDate" xlink:label="tcrx_LicenseAgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AmgenAgreementMember" xlink:label="tcrx_AmgenAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AmgenIncMember" xlink:label="tcrx_AmgenIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseUpfrontPaymentReceived" xlink:label="tcrx_LicenseUpfrontPaymentReceived"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NovartisAgreementMember" xlink:label="tcrx_NovartisAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NovartisMember" xlink:label="tcrx_NovartisMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseUpfrontPaymentReceivable" xlink:label="tcrx_LicenseUpfrontPaymentReceivable"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LicenseUpfrontPayment" xlink:label="tcrx_LicenseUpfrontPayment"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PotentialMilestonePayment" xlink:label="tcrx_PotentialMilestonePayment"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NumberOfTargetsIdentified" xlink:label="tcrx_NumberOfTargetsIdentified"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_MilestoneMethodRevenueRecognized" xlink:label="tcrx_MilestoneMethodRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationPeriod" xlink:label="tcrx_CollaborationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NegotiationPeriod" xlink:label="tcrx_NegotiationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ExpectsResearchTerm" xlink:label="tcrx_ExpectsResearchTerm"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_RevenueRecognitionMilestoneMethodMilestonePayables" xlink:label="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_EstimatedResearchCostsTransactionPrice" xlink:label="tcrx_EstimatedResearchCostsTransactionPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ReimbursementCost" xlink:label="tcrx_ReimbursementCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_CollaborationAndLicenseAgreementsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tcrx_ResearchFundingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_LicenseAgreementDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="tcrx_AmgenAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tcrx_AmgenIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_LicenseUpfrontPaymentReceived" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="tcrx_NovartisAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tcrx_NovartisMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_LicenseUpfrontPaymentReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_LicenseUpfrontPayment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tcrx_CollaborationAndLicenseAgreementsTable" xlink:to="srt_OwnershipAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_PotentialMilestonePayment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_NumberOfTargetsIdentified" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_MilestoneMethodRevenueRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_CollaborationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_NegotiationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_ExpectsResearchTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_EstimatedResearchCostsTransactionPrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_DeferredRevenue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="tcrx_ReimbursementCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_DeferredRevenueCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CollaborationAndLicenseAgreementsLineItems" xlink:to="us-gaap_DeferredRevenueNoncurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:label="tcrx_CommitmentsAndContingenciesDisclosureTable"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NumberOfLeasesFacilities" xlink:label="tcrx_NumberOfLeasesFacilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LongTermAssetMember" xlink:label="tcrx_LongTermAssetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="us-gaap_RoyaltyAgreementTermsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseDescription" xlink:label="us-gaap_LessorOperatingLeaseDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AnnualFixedRent" xlink:label="tcrx_AnnualFixedRent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfIncreaseInAnnualFixedRent" xlink:label="tcrx_PercentageOfIncreaseInAnnualFixedRent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease" xlink:label="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold" xlink:label="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LeaseSpaceForFacility" xlink:label="tcrx_LeaseSpaceForFacility"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LesseeOperatingLeaseCommencingDate" xlink:label="tcrx_LesseeOperatingLeaseCommencingDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PrepaidRentReclassedToRightOfUseAsset" xlink:label="tcrx_PrepaidRentReclassedToRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" xlink:label="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_CommitmentsAndContingenciesDisclosureTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_NumberOfLeasesFacilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="tcrx_LongTermAssetMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LetterOfCreditMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_RoyaltyAgreementTermsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LessorOperatingLeaseDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_DepositsAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_AnnualFixedRent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_PercentageOfIncreaseInAnnualFixedRent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LeaseCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_LeaseSpaceForFacility" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_LesseeOperatingLeaseCommencingDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_PrepaidRentReclassedToRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeasePayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tcrx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TrancheOneMember" xlink:label="tcrx_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_K2HealthVenturesMember" xlink:label="tcrx_K2HealthVenturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TrancheTwoMember" xlink:label="tcrx_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_SiliconValleyBankMember" xlink:label="tcrx_SiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_TrancheThreeMember" xlink:label="tcrx_TrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FacilityFeePaid" xlink:label="tcrx_FacilityFeePaid"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PrincipalAmountIncreasePercentage" xlink:label="tcrx_PrincipalAmountIncreasePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_InterestOnlyPaymentTerm" xlink:label="tcrx_InterestOnlyPaymentTerm"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_InterestOnlyPaymentExtendedTerm" xlink:label="tcrx_InterestOnlyPaymentExtendedTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DebtInstrumentExitFee" xlink:label="tcrx_DebtInstrumentExitFee"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DebtInstrumentPrepaymentFee" xlink:label="tcrx_DebtInstrumentPrepaymentFee"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeRange" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeRange"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FinalFeePercentage" xlink:label="tcrx_FinalFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeInYearTwo" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo" xlink:label="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCovenantTerms" xlink:label="us-gaap_LineOfCreditFacilityCovenantTerms"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents" xlink:label="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DefaultInterestRate" xlink:label="tcrx_DefaultInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseLongTermDebt" xlink:label="us-gaap_InterestExpenseLongTermDebt"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tcrx_TrancheOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="tcrx_K2HealthVenturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tcrx_TrancheTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="tcrx_SiliconValleyBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tcrx_TrancheThreeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_FacilityFeePaid" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PrincipalAmountIncreasePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_InterestOnlyPaymentTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_InterestOnlyPaymentExtendedTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_DebtInstrumentExitFee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_DebtInstrumentPrepaymentFee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeRange" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_FinalFeePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCovenantTerms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tcrx_DefaultInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseLongTermDebt" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PersonnelExpensesMember" xlink:label="tcrx_PersonnelExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ReportableSegmentMember" xlink:label="tcrx_ReportableSegmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember" xlink:label="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_ClinicalStudiesMember" xlink:label="tcrx_ClinicalStudiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LegalAndProfessionalFeesMember" xlink:label="tcrx_LegalAndProfessionalFeesMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_FacilityRelatedAndOtherMember" xlink:label="tcrx_FacilityRelatedAndOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_StockBasedCompensationMember" xlink:label="tcrx_StockBasedCompensationMember"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DepreciationExpenseMember" xlink:label="tcrx_DepreciationExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InterestAndOtherIncome" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_PersonnelExpensesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="tcrx_ReportableSegmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_RevenuesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_ClinicalStudiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_LegalAndProfessionalFeesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_FacilityRelatedAndOtherMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_StockBasedCompensationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="tcrx_DepreciationExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_PreFundedWarrantsMember" xlink:label="tcrx_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tcrx_PreFundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_EmployeeStockPurchasePlanMember" xlink:label="tcrx_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="tcrx_EmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AreaOfLeasedOfficeSpace" xlink:label="tcrx_AreaOfLeasedOfficeSpace"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent" xlink:label="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tcrx_AreaOfLeasedOfficeSpace" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_CollaborationAndLicenseRevenue" xlink:label="tcrx_CollaborationAndLicenseRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:label="us-gaap_UsefulLifeDescriptionOfTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember" xlink:label="us-gaap_UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="tcrx_CollaborationAndLicenseRevenue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashNoncurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermDebtNoncurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LongTermDebtCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails2"/>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_InterestAndOtherIncome" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="tcrx_AccretionOfMarketableSecurities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="tcrx_NonCashInterestExpenseOnLoanPayable" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockPlans" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="5" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="7" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="10" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="11" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccretionOfMarketableSecurities" xlink:label="tcrx_AccretionOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_NonCashInterestExpenseOnLoanPayable" xlink:label="tcrx_NonCashInterestExpenseOnLoanPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure" xlink:label="us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tcrx_AccruedResearchAndDevelopment" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tcrx_AccruedLegalServicesAndLicenseFeeCurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccruedResearchAndDevelopment" xlink:label="tcrx_AccruedResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_AccruedLegalServicesAndLicenseFeeCurrent" xlink:label="tcrx_AccruedLegalServicesAndLicenseFeeCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="tcrx_DeferredTaxLiabilitiesRightOfUseAsset" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="tcrx_DeferredTaxAssetsDepreciationAndAmortization" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="tcrx_DeferredTaxAssetsAmortization" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="tcrx_DeferredTaxAssetsLeaseholdLiability" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsOther" order="8" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:label="tcrx_DeferredTaxLiabilitiesRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="tcrx_DeferredTaxAssetsDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsAmortization" xlink:label="tcrx_DeferredTaxAssetsAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsLeaseholdLiability" xlink:label="tcrx_DeferredTaxAssetsLeaseholdLiability"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:label="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_VariableLeaseCost" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_ShortTermLeaseCost" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" xlink:label="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="tcrx_LongTermDebtFinalPaymentFee" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="3" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
          <link:loc xlink:type="locator" xlink:href="tcrx-20241231.xsd#tcrx_LongTermDebtFinalPaymentFee" xlink:label="tcrx_LongTermDebtFinalPaymentFee"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="tcrx_WedbushSecuritiesIncMember" name="WedbushSecuritiesIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock" name="SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_OfficeAndComputerEquipmentMember" name="OfficeAndComputerEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_InterestOnlyPaymentExtendedTerm" name="InterestOnlyPaymentExtendedTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_PersonnelExpensesMember" name="PersonnelExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription" name="PropertyPlantAndEquipmentEstimatedUsefulLivesDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_CollaborationAndLicenseAgreementsTable" name="CollaborationAndLicenseAgreementsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_CommitmentsAndContingenciesDisclosureTable" name="CommitmentsAndContingenciesDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_AnnualFixedRent" name="AnnualFixedRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease" name="IncreaseInAnnualFixedRentThroughOriginalTermOfLease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_LongTermDebtFinalPaymentFee" name="LongTermDebtFinalPaymentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_MilestoneMethodRevenueRecognized" name="MilestoneMethodRevenueRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_PercentageOfLoanPrepaymentFeeInYearTwo" name="PercentageOfLoanPrepaymentFeeInYearTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock" name="AccruedResearchAndManufacturingContractCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_DebtInstrumentExitFee" name="DebtInstrumentExitFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_K2HealthVenturesMember" name="K2HealthVenturesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_LeaseSpaceForFacility" name="LeaseSpaceForFacility" type="dtr-types:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_LicenseUpfrontPayment" name="LicenseUpfrontPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_NonCashInterestExpenseOnLoanPayable" name="NonCashInterestExpenseOnLoanPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock" name="PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_DebtInstrumentPrepaymentFee" name="DebtInstrumentPrepaymentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_PotentialMilestonePayment" name="PotentialMilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_CommitmentsAndContingenciesDisclosureLineItems" name="CommitmentsAndContingenciesDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_StockBasedCompensationMember" name="StockBasedCompensationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_LesseeOperatingLeaseCommencingDate" name="LesseeOperatingLeaseCommencingDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_FollowOnOfferingMember" name="FollowOnOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_PrepaidRentReclassedToRightOfUseAsset" name="PrepaidRentReclassedToRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_TrancheThreeMember" name="TrancheThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_NumberOfTargetsIdentified" name="NumberOfTargetsIdentified" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock" name="CollaborativeAndLicenseArrangementDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_ReportableSegmentMember" name="ReportableSegmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_NegotiationPeriod" name="NegotiationPeriod" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember" name="LaboratorySuppliesResearchMaterialsAndStudiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock" name="SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_CollaborationAndLicenseAgreementsAbstract" name="CollaborationAndLicenseAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_CommonStockPricePerWarrant" name="CommonStockPricePerWarrant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_TrancheOneMember" name="TrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_DefaultInterestRate" name="DefaultInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_FinancingCostsNotYetPaid" name="FinancingCostsNotYetPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_PercentageOfLoanPrepaymentFeeRange" name="PercentageOfLoanPrepaymentFeeRange" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_InterestOnlyPaymentTerm" name="InterestOnlyPaymentTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_ChangesFromStatutoryRateAbstract" name="ChangesFromStatutoryRateAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_LicenseUpfrontPaymentReceived" name="LicenseUpfrontPaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_FairValueAssetLevel2ToLevel1TransfersAmount" name="FairValueAssetLevel2ToLevel1TransfersAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_LicenseAgreementDate" name="LicenseAgreementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_RevenueRecognitionMilestoneMethodMilestonePayables" name="RevenueRecognitionMilestoneMethodMilestonePayables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_FinalFeePercentage" name="FinalFeePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_AccruedResearchAndDevelopment" name="AccruedResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_DeferredTaxAssetsLeaseholdLiability" name="DeferredTaxAssetsLeaseholdLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_NovartisMember" name="NovartisMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_FacilityFeePaid" name="FacilityFeePaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_LicenseUpfrontPaymentReceivable" name="LicenseUpfrontPaymentReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_LongTermAssetMember" name="LongTermAssetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_WarrantIssuanceCostsOfferingExpenses" name="WarrantIssuanceCostsOfferingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_AmgenAgreementMember" name="AmgenAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_PatentCostsPolicyTextBlock" name="PatentCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_CommonStockSharesReservedForFutureIssuance" name="CommonStockSharesReservedForFutureIssuance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" name="ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember" name="TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_StockIssuanceCostsOfferingExpenses" name="StockIssuanceCostsOfferingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_NovartisAgreementMember" name="NovartisAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_RevenueFromRoyaltiesPolicyTextBlock" name="RevenueFromRoyaltiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_TwoThousandAndEighteenEquityIncentivePlanMember" name="TwoThousandAndEighteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_OperatingLossCarryForwardsExpirationYear" name="OperatingLossCarryForwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_SiliconValleyBankMember" name="SiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_ReimbursementCost" name="ReimbursementCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_AreaOfLeasedOfficeSpace" name="AreaOfLeasedOfficeSpace" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_RevenueMilestonePaymentsPolicyTextBlock" name="RevenueMilestonePaymentsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_VotingCommonStockMember" name="VotingCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember" name="TwoThousandAndTwentyOneEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo" name="PercentageOfLoanPrepaymentFeeInAfterYearTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" name="SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_SalesAgreementMember" name="SalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_LegalAndProfessionalFeesMember" name="LegalAndProfessionalFeesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" name="DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_ResearchFundingMember" name="ResearchFundingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_EstimatedResearchCostsTransactionPrice" name="EstimatedResearchCostsTransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_FairValueAssetLevel1ToLevel2TransfersAmount" name="FairValueAssetLevel1ToLevel2TransfersAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_AccretionOfMarketableSecurities" name="AccretionOfMarketableSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_CollaborationAndLicenseRevenue" name="CollaborationAndLicenseRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold" name="PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_PrincipalAmountIncreasePercentage" name="PrincipalAmountIncreasePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares" name="UnderwriterOptionToPurchaseNumberOfAdditionalShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_TaxCreditCarryforwardExpirationYear" name="TaxCreditCarryforwardExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_ClinicalStudiesMember" name="ClinicalStudiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_CollaborationPeriod" name="CollaborationPeriod" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_DepreciationExpenseMember" name="DepreciationExpenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_AmgenIncMember" name="AmgenIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_NumberOfLeasesFacilities" name="NumberOfLeasesFacilities" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_PercentageOfIncreaseInAnnualFixedRent" name="PercentageOfIncreaseInAnnualFixedRent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_ExpectsResearchTerm" name="ExpectsResearchTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent" name="LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_TrancheTwoMember" name="TrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember" name="TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_FacilityRelatedAndOtherMember" name="FacilityRelatedAndOtherMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares" name="AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_PreFundedWarrantsMember" name="PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" name="LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_DeferredTaxAssetsAmortization" name="DeferredTaxAssetsAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths" name="PercentageOfLoanPrepaymentFeeInTwelveMonths" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_ClassOfStockWarrantsExercised" name="ClassOfStockWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_DeferredTaxLiabilitiesRightOfUseAsset" name="DeferredTaxLiabilitiesRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_AccruedLegalServicesAndLicenseFeeCurrent" name="AccruedLegalServicesAndLicenseFeeCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" name="OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents" name="CovenantTermsUnrestrictedCashAndCashEquivalents" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_DeferredTaxAssetsDepreciationAndAmortization" name="DeferredTaxAssetsDepreciationAndAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tcrx_CollaborationAndLicenseAgreementsLineItems" name="CollaborationAndLicenseAgreementsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058166776704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TCRX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TScan Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001783328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-5282075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">830 Winter Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Waltham<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">399-9500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Voting Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,649,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of TScan Therapeutics, Inc. and subsidiary (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, stockholders' equity, and cash flows for the years then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember', window );">Voting Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,314,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember', window );">Non-voting Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,276,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058166385312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 178,689<span></span>
</td>
<td class="nump">$ 133,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">111,421<span></span>
</td>
<td class="nump">58,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,612<span></span>
</td>
<td class="nump">2,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">292,722<span></span>
</td>
<td class="nump">194,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,242<span></span>
</td>
<td class="nump">7,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">64,357<span></span>
</td>
<td class="nump">63,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">5,031<span></span>
</td>
<td class="nump">5,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Long-term deposit and other assets</a></td>
<td class="nump">1,766<span></span>
</td>
<td class="nump">1,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">371,118<span></span>
</td>
<td class="nump">272,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">4,278<span></span>
</td>
<td class="nump">2,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">15,410<span></span>
</td>
<td class="nump">10,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current portion</a></td>
<td class="nump">4,570<span></span>
</td>
<td class="nump">3,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue, current portion</a></td>
<td class="nump">11,698<span></span>
</td>
<td class="nump">10,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">35,956<span></span>
</td>
<td class="nump">29,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">5,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">60,739<span></span>
</td>
<td class="nump">59,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt and accrued interest</a></td>
<td class="nump">32,072<span></span>
</td>
<td class="nump">26,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long term liabilities</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">130,148<span></span>
</td>
<td class="nump">121,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and 2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">616,009<span></span>
</td>
<td class="nump">398,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(375,096)<span></span>
</td>
<td class="num">(247,597)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">240,970<span></span>
</td>
<td class="nump">150,867<span></span>
</td>
<td class="nump">$ 99,434<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">371,118<span></span>
</td>
<td class="nump">272,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember', window );">Voting Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember', window );">Non-voting Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167426656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember', window );">Voting Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">52,314,039<span></span>
</td>
<td class="nump">43,552,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">52,314,039<span></span>
</td>
<td class="nump">43,552,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember', window );">Non-voting Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">4,276,588<span></span>
</td>
<td class="nump">4,276,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">4,276,588<span></span>
</td>
<td class="nump">4,276,588<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167341696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and license revenue</a></td>
<td class="nump">$ 2,816<span></span>
</td>
<td class="nump">$ 21,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</a></td>
<td class="text">Collaboration And License Revenue<span></span>
</td>
<td class="text">Collaboration And License Revenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 107,350<span></span>
</td>
<td class="nump">$ 88,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">30,287<span></span>
</td>
<td class="nump">26,354<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">137,637<span></span>
</td>
<td class="nump">114,507<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(134,821)<span></span>
</td>
<td class="num">(93,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">12,065<span></span>
</td>
<td class="nump">7,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(3,653)<span></span>
</td>
<td class="num">(3,759)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="num">(1,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">7,322<span></span>
</td>
<td class="nump">4,240<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (127,499)<span></span>
</td>
<td class="num">$ (89,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="num">$ (1.36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="num">$ (1.36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding- basic</a></td>
<td class="nump">111,990,417<span></span>
</td>
<td class="nump">65,599,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding-diluted</a></td>
<td class="nump">111,990,417<span></span>
</td>
<td class="nump">65,599,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (127,499)<span></span>
</td>
<td class="num">$ (89,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on available-for-sale securities</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (127,448)<span></span>
</td>
<td class="num">$ (89,218)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058169122608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Voting Common Stock</div></th>
<th class="th"><div>Non-voting Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Voting Common Stock</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Non-voting Common Stock</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2022</a></td>
<td class="nump">$ 99,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 257,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (158,379)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,082,820<span></span>
</td>
<td class="nump">5,143,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of offering costs</a></td>
<td class="nump">42,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of offering costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,287,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of pre-funded warrants, net of offering costs</a></td>
<td class="nump">92,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of non-voting common stock to voting common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">866,546<span></span>
</td>
<td class="num">(866,546)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">5,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(89,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,218)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2023</a></td>
<td class="nump">150,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">398,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(247,597)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances, shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,552,941<span></span>
</td>
<td class="nump">4,276,588<span></span>
</td>
<td class="nump">43,552,941<span></span>
</td>
<td class="nump">4,276,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">586,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of offering costs</a></td>
<td class="nump">33,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of offering costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,958,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of pre-funded warrants, net of offering costs</a></td>
<td class="nump">158,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Conversion of convertible debt</a></td>
<td class="nump">14,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares', window );">Conversion of convertible debt, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,134,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">9,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(127,499)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(127,499)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on available-for-sale securities</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2024</a></td>
<td class="nump">$ 240,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 616,009<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="num">$ (375,096)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances, shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,314,039<span></span>
</td>
<td class="nump">4,276,588<span></span>
</td>
<td class="nump">52,314,039<span></span>
</td>
<td class="nump">4,276,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital equity component of convertible debt shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058268175808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (127,499)<span></span>
</td>
<td class="num">$ (89,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">4,108<span></span>
</td>
<td class="nump">5,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_AccretionOfMarketableSecurities', window );">Accretion of marketable securities</a></td>
<td class="num">(3,897)<span></span>
</td>
<td class="num">(1,072)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_NonCashInterestExpenseOnLoanPayable', window );">Non-cash interest expense related to loan payable</a></td>
<td class="nump">773<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">1,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">9,549<span></span>
</td>
<td class="nump">5,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in current assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(538)<span></span>
</td>
<td class="nump">985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Right-of-use assets and lease liabilities, net</a></td>
<td class="nump">1,881<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,994<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expense and other liabilities</a></td>
<td class="nump">4,532<span></span>
</td>
<td class="nump">3,853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(2,815)<span></span>
</td>
<td class="nump">11,885<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(110,822)<span></span>
</td>
<td class="num">(61,358)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,825)<span></span>
</td>
<td class="num">(3,146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(241,445)<span></span>
</td>
<td class="num">(77,613)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from maturities of marketable securities</a></td>
<td class="nump">192,657<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(52,613)<span></span>
</td>
<td class="num">(60,759)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of loan payable, net</a></td>
<td class="num">(17,144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from borrowings under loan agreement, net</a></td>
<td class="nump">32,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of offering costs</a></td>
<td class="nump">33,131<span></span>
</td>
<td class="nump">42,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of pre-funded warrants, net of offering costs</a></td>
<td class="nump">158,271<span></span>
</td>
<td class="nump">92,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,717<span></span>
</td>
<td class="nump">711<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">208,765<span></span>
</td>
<td class="nump">135,443<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">45,330<span></span>
</td>
<td class="nump">13,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash - beginning of year</a></td>
<td class="nump">138,390<span></span>
</td>
<td class="nump">125,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash - end of year</a></td>
<td class="nump">183,720<span></span>
</td>
<td class="nump">138,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Summary of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">178,689<span></span>
</td>
<td class="nump">133,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">5,031<span></span>
</td>
<td class="nump">5,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash</a></td>
<td class="nump">183,720<span></span>
</td>
<td class="nump">138,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">2,881<span></span>
</td>
<td class="nump">3,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Debt issuance costs not yet paid</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_FinancingCostsNotYetPaid', window );">Financing costs not yet paid</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Lease liability arising from obtaining right-of-use asset</a></td>
<td class="nump">6,133<span></span>
</td>
<td class="nump">6,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchase of property and equipment in accounts payable and accrued liabilities</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">$ 301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Issuance of common stock upon note conversion</a></td>
<td class="nump">$ 14,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_AccretionOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_AccretionOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_FinancingCostsNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing costs not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_FinancingCostsNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_NonCashInterestExpenseOnLoanPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash interest expense on loan payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_NonCashInterestExpenseOnLoanPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167875504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (127,499)<span></span>
</td>
<td class="num">$ (89,218)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058270901936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058168835488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management, Strategy, and Governance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Management and Strategy</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the importance of safeguarding the security of our computer systems, software, networks, and other technology assets. We have implemented processes for identifying, assessing, and mitigating cybersecurity risks and we have </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">implemented a cybersecurity risk management program</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that is informed by recognized industry standards and frameworks and incorporates elements of the same, including elements of the National Institute of Standards and Technology (NIST) Cybersecurity Framework.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management program incorporates a number of components, including, but not limited to, information security policies and operating procedures, periodic information security risk assessments and other vulnerability analyses, and ongoing monitoring of critical risks from cybersecurity threats using automated tools. Additionally, we have implemented a process to conduct cybersecurity awareness training for employees during onboarding and thereafter.</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain a Cybersecurity Incident Response Plan, or CIRP, which is designed to guide our response to cyber incidents, including to mitigate and contain any potential cybersecurity incidents that could affect our systems, network, or data. The CIRP identifies the individuals responsible for developing, maintaining, and following procedures related to cybersecurity incident response, including escalation protocols. We also </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">engage</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> external third-party consultants to provide services, such as penetration testing, which is conducted on an annual basis, along with ongoing vulnerability scans. These consultants also perform annual assessments of our cybersecurity program, which involve, among other things, review of our IT security measures and processes for alignment with the NIST Cybersecurity Framework and provision of threat intelligence regarding emerging risks to our information systems.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our cybersecurity risk management program, we maintain processes around third-party vendor risk management, including a framework for managing third-party information security risks.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> This framework, which applies to select third parties who have access to our systems and/or process our information, includes processes for assessing and reviewing the cybersecurity practices of such third-parties, including a review of available security audit reporting and certifications and inclusion of security requirements in contracts, as appropriate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not been materially affected by cybersecurity threats. We may, from time to time, experience threats to and security incidents related to our data systems but we do not believe they are reasonably likely to materially affect our business strategy, results of operations or financial condition.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> For more information, please see the risk factors entitled &#8220;Our internal computer systems, or those used by our third-party CROs or other contractors or consultants, may fail or suffer cybersecurity incidents, data breaches or other unauthorized or improper access, which could result in a material disruption of the development programs of our product candidates&#8221; and &#8220;Cybersecurity incidents, loss of data or modification of information, and other disruptions could compromise information related to our business or prevent us from accessing critical information, result in a significant disruption of our activities and expose us to liability, which could adversely affect our business and our reputation&#8221; in Item 1A- Risk Factors in this Annual Report on Form 10-K.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Governance</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of Information Technology and Security, or Head of IT, has primary responsibility for day-to-day management of our cybersecurity risk management program,</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> including leading a dedicated team of information technology professionals to monitor cybersecurity risks on behalf of TScan.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of IT has over 16 years&#8217; experience with information technology and cybersecurity risk management programs. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This team is responsible for assessing potential vulnerabilities and exposures to cybersecurity threats, implementing controls and measures designed to mitigate these risks, and regularly monitoring and updating these policies, to adapt to evolving threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> If an incident arises, the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head of IT notifies our Chief Legal and Compliance Officer, and Chief Financial Officer, who will raise issues to those charged with governance, as appropriate.</span></span></span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors, as a whole and through its committees, is responsible for our overall enterprise risk management program, which incorporates as an element our cybersecurity risk management program. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit committee, a subcommittee of our board of directors, has been delegated responsibility for oversight of cybersecurity risk management, which includes reviewing our cybersecurity and other information, technology risks, controls and procedures, including our plans to mitigate and respond to cybersecurity risks. The Head of IT, alongside the Chief Legal and Compliance Officer, and Chief Financial Officer, provide quarterly reports to the audit committee covering cybersecurity and other information technology risks affecting us. These reports may include reviewing our current infrastructure and the status of key cybersecurity initiatives, including the status of ongoing mitigation efforts, providing insights into the latest cybersecurity threats, and discussing any recent security incidents impacting our peer companies. </span></span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Periodically, or in the event of a critical cybersecurity incident, the Chief Legal and Compliance Officer, and Chief Financial Officer will provide our full board of directors with findings and recommendations from these reports.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the importance of safeguarding the security of our computer systems, software, networks, and other technology assets. We have implemented processes for identifying, assessing, and mitigating cybersecurity risks and we have </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">implemented a cybersecurity risk management program</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that is informed by recognized industry standards and frameworks and incorporates elements of the same, including elements of the National Institute of Standards and Technology (NIST) Cybersecurity Framework.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management program incorporates a number of components, including, but not limited to, information security policies and operating procedures, periodic information security risk assessments and other vulnerability analyses, and ongoing monitoring of critical risks from cybersecurity threats using automated tools. Additionally, we have implemented a process to conduct cybersecurity awareness training for employees during onboarding and thereafter.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our board of directors, as a whole and through its committees, is responsible for our overall enterprise risk management program, which incorporates as an element our cybersecurity risk management program. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit committee, a subcommittee of our board of directors, has been delegated responsibility for oversight of cybersecurity risk management, which includes reviewing our cybersecurity and other information, technology risks, controls and procedures, including our plans to mitigate and respond to cybersecurity risks. The Head of IT, alongside the Chief Legal and Compliance Officer, and Chief Financial Officer, provide quarterly reports to the audit committee covering cybersecurity and other information technology risks affecting us. These reports may include reviewing our current infrastructure and the status of key cybersecurity initiatives, including the status of ongoing mitigation efforts, providing insights into the latest cybersecurity threats, and discussing any recent security incidents impacting our peer companies. </span></span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Periodically, or in the event of a critical cybersecurity incident, the Chief Legal and Compliance Officer, and Chief Financial Officer will provide our full board of directors with findings and recommendations from these reports.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit committee, a subcommittee of our board of directors, has been delegated responsibility for oversight of cybersecurity risk management, which includes reviewing our cybersecurity and other information, technology risks, controls and procedures, including our plans to mitigate and respond to cybersecurity risks. The Head of IT, alongside the Chief Legal and Compliance Officer, and Chief Financial Officer, provide quarterly reports to the audit committee covering cybersecurity and other information technology risks affecting us. These reports may include reviewing our current infrastructure and the status of key cybersecurity initiatives, including the status of ongoing mitigation efforts, providing insights into the latest cybersecurity threats, and discussing any recent security incidents impacting our peer companies. </span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Periodically, or in the event of a critical cybersecurity incident, the Chief Legal and Compliance Officer, and Chief Financial Officer will provide our full board of directors with findings and recommendations from these reports.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of Information Technology and Security, or Head of IT, has primary responsibility for day-to-day management of our cybersecurity risk management program,</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> including leading a dedicated team of information technology professionals to monitor cybersecurity risks on behalf of TScan.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of IT has over 16 years&#8217; experience with information technology and cybersecurity risk management programs. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This team is responsible for assessing potential vulnerabilities and exposures to cybersecurity threats, implementing controls and measures designed to mitigate these risks, and regularly monitoring and updating these policies, to adapt to evolving threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> If an incident arises, the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head of IT notifies our Chief Legal and Compliance Officer, and Chief Financial Officer, who will raise issues to those charged with governance, as appropriate.</span></span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of Information Technology and Security, or Head of IT, has primary responsibility for day-to-day management of our cybersecurity risk management program,</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> including leading a dedicated team of information technology professionals to monitor cybersecurity risks on behalf of TScan.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Head of IT has over 16 years&#8217; experience with information technology and cybersecurity risk management programs. </span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This team is responsible for assessing potential vulnerabilities and exposures to cybersecurity threats, implementing controls and measures designed to mitigate these risks, and regularly monitoring and updating these policies, to adapt to evolving threats.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167743040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Nature of Business and Basis of Presentation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. Nature of Business and Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nature of Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TScan Therapeutics, Inc. (the Company) is a biotechnology company that was incorporated in Delaware on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">April 17, 2018</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and has a principal place of business in Waltham, Massachusetts. The Company is a biopharmaceutical company focused on developing a pipeline of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks, Uncertainties and Going Concern</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks common to companies in the biotechnology industry, including, but not limited to, successful development of technology, obtaining additional funding, protection of proprietary technology, compliance with government regulations, risks of failure of preclinical studies, clinical studies and clinical trials, the need to obtain marketing approval for its product candidates and the ability to successfully market its therapies any products that receive approval, fluctuations in operating results, economic pressure impacting therapeutic pricing, dependence on key personnel, risks associated with changes in technologies, development by competitors of technological innovations and the ability to scale manufacturing to large scale production. Product candidates currently under development will require significant additional research and development efforts, including preclinical and clinical testing and regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel and infrastructure and extensive compliance-reporting capabilities. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from therapy sales.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has primarily funded its operations with proceeds from sales of capital stock, including the IPO completed in July 2021, issuance of convertible debt in September 2022, issuance of term loan in December 2024 and with payments received under its license and collaboration agreements. Since its inception, the Company has incurred recurring losses, including net losses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024, the Company had an accumulated deficit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">375.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company expects to continue to generate operating losses in the foreseeable future. The Company expects that its cash and cash equivalents and marketable securities as of December 31, 2024 will be sufficient to fund the Company&#8217;s operations for at least the next twelve months from the date of the issuance of the financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will need to obtain substantial additional funding through equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements in order to fund its research and development and ongoing operating expenses. The Company may not be able to obtain financing on acceptable terms, when needed or at all, and the Company may not be able to enter into collaborations, strategic alliances or licensing arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company&#8217;s stockholders. Any collaborations, strategic alliances or licensing arrangements may require the Company to relinquish rights to certain of its technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to the Company. If the Company is unable to obtain funding, the Company could be forced to delay, limit, reduce or eliminate some or all of its research and development programs, pipeline expansion or future commercialization efforts or grant rights to develop and market product candidates, which could adversely affect its business prospects. Although management will continue to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations when needed or at all.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058171878688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements reflect the operations of the Company and the Company&#8217;s wholly owned subsidiary, TScan Securities Corporation. The accompanying consolidated financial statements have been prepared in conformity with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification, or ASC, and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation.</span></p></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience, known trends and other market-specific or relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash includes cash in readily available checking and money market accounts. Cash equivalents include all highly liquid investments maturing within 90 days from the date of purchase. The cash equivalents consisted of money market funds and government securities.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Cash</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Company&#8217;s facility lease agreements, the Company is required to provide letters of credit totaling of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of the landlords to serve as security deposits. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the cash securing the letter of credit was classified as restricted cash (non-current) on the consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies all of its marketable securities as available-for-sale based upon its intent with regard to such investments.  Unrealized gains on available-for-sale debt securities are reported as a component of accumulated other comprehensive loss in stockholders&#8217; equity. The amortized cost of debt securities in this category is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in interest and other income, net. Realized gains and losses and declines in value judged to be other than temporary on available-for-sale securities, are included in interest and investment income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest and other income, net. To determine whether an other-than-temporary impairment exists, the Company considers whether it has the ability and intent to hold the investment until a market price recovery, and whether evidence indicating the recoverability of the cost of the investment outweighs evidence to the contrary.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company&#8217;s cash deposits on hand at any one financial institution often exceed federally insured limits. The Company places its cash in financial institutions that management believes to be of high credit quality. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the respective assets as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:44%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:55%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated useful life</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5 </span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_397b54bf-b523-4a3d-a66b-ad04f717b80a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></span></span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of the asset's estimated useful life or the remaining lease term</span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major additions and betterments are capitalized; expenditures for repairs and maintenance, which do not improve or extend the life of the respective assets, are charged to operating expense as incurred. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Long-lived assets to be held and used, including property and equipment, are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. Evaluation of the recoverability of the asset or asset group is based on an estimate of undiscounted future cash flows resulting from the use of the asset or asset group and its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the asset or asset group, an impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. The Company did not record any impairment losses on long-lived assets during the periods presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain assets and liabilities are carried at fair value under US GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the user of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">quoted prices for similar assets and liabilities in active markets </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">quoted prices for identical or similar assets or liabilities in markets that are not active </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g., interest rate   and yield curve quotes at commonly quoted intervals) </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inputs that are derived principally from or corroborated by observable market data by correlation or other means </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Unobservable inputs for the assets or liability (i.e., supported by little or no market activity). Level 3 inputs include management&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). </span></div></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records leases under ASU No. 2016-02 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Topic 842) whereby the Company determines if an arrangement is or contains a lease at inception. For leases with a term of 12 months or less, the Company has elected to not recognize a right-of-use asset or lease liability. The Company&#8217;s operating leases are recognized on the consolidated balance sheets as other noncurrent assets, other current liabilities, and other noncurrent liabilities. The Company does not have any finance leases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the rate implicit on the Company&#8217;s leases are not readily determinable, the Company uses an estimate of its incremental borrowing rate for secured borrowings with terms similar to the lease term based on the information available at the lease commencement date in determining the present value of lease payments. Operating lease right-of-use assets also include the effect of any lease payments made, including lease payments made in advance of lease commencement and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and development costs that are paid in advance of performance (if any) are capitalized as a prepaid expense and amortized over the service period as the services are provided.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued Research and Manufacturing Contract Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has entered into various research and development and manufacturing contracts. These agreements are generally cancelable, and related payments are recorded as the corresponding expenses are incurred. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research studies or clinical trials and manufacturing activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#8217;s estimates. The Company&#8217;s historical accrual estimates have not been materially different from the actual costs</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for revenue under ASU No. 2014-19, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 606). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, certain collaboration arrangements and financial instruments. ASC 606 provides a five-step framework whereby revenue is recognized when control of promised goods or services is transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify the contract(s) with a customer; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify the performance obligations in the contract; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">determine the transaction price; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iv)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">allocate the transaction price to the performance obligations in the contract; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(v)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recognize revenue when (or as) the performance obligations are satisfied. </span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration that it is entitled to in exchange for the goods or services the Company transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined with other promised goods and services until a distinct combined performance obligation is identified.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company then allocates the transaction price (that is, the amount of consideration the Company expects to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated revenue when (or as) each performance obligation is satisfied. The allocation is based upon standalone selling price. The standalone selling price is the price at which an entity would sell a promised good or service separately to a customer. Because the Company have not sold the same goods or services in our contracts separately to any customers on a standalone basis, the Company estimated the standalone selling price of each performance obligation by taking into consideration internal estimates of research and development personnel needed to perform the research and development services, estimates of expected cash outflows to third parties for services and supplies and typical gross profit margins.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company enters into collaboration and licensing arrangements that are within the scope of ASC 606, under which the Company may exclusively license to third parties&#8217; rights to develop, manufacture and commercialize its product candidates as well as options to acquire additional rights. The terms of these arrangements typically include payment to the Company of one or more of the following: nonrefundable, upfront license fees; development, regulatory and sales milestone payments; and royalties on net sales of licensed products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is typically recognized using a cost-to-cost input model as the measure of progress. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete the Company&#8217;s performance obligations under an arrangement. The Company evaluates the measure of progress each reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">period and, if necessary, adjusts the measure of performance and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts received prior to revenue recognition are recorded as deferred revenue in the balance sheets. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue in the balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion in the balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Customer Options</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options that are not determined to be material rights are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement. To date, none of our arrangements have included any material rights. The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The observable price of a good or service sold separately provides the best evidence of standalone selling price. However, when standalone selling prices are not readily available, the Company is required to estimate the standalone selling price of each performance obligation. Key assumptions to determine the standalone selling price. Amounts allocated to a material right are not recognized as revenue until the option is exercised or terminates.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Milestone Payments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For each arrangement that includes milestone payments upon the achievement of performance-based milestones, such as development and regulatory milestones, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant reversal of revenue would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. Upfront and ongoing development milestones per the Company&#8217;s collaboration and license agreement are not subject to refund if the development activities are not successful. The Company reevaluates the probability of achievement of such milestones and any related constraint at each reporting period, and any adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. To date, the Company has not recognized any milestone revenues.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Royalties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license to the Company&#8217;s intellectual property is deemed to be the predominant item to which the royalties relate as it is the primary driver of value, the Company recognizes revenue when the related sales occur in accordance with the sales-based royalty exception. To date, the Company has not recognized any royalty revenue resulting from the Company&#8217;s collaboration and licensing agreements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided to reduce the deferred tax asset to an amount, which, more likely than not, will be realized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes the tax benefit from any uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. Interest and penalties associated with uncertain tax positions are recorded as a component of income tax expense. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t identified any uncertain tax positions for which reserves would be required.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which discrete information is available for evaluation by the chief operating decision maker, who is the CEO, in deciding how to allocate resources and in assessing performance. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. All of the Company&#8217;s assets are held in the U.S.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for stock option awards at fair value, which is measured using the Black-Scholes option-pricing model. The measurement date is generally the date of grant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes stock-based compensation expense over the requisite service period, which is generally the vesting period of the respective award. For awards that include performance-based vesting conditions, stock-based compensation expense is recognized using the accelerated attribution method when the performance condition is deemed to be probable. The Company accounts for forfeitures as they occur. The Company determines the fair value of restricted stock awards in reference to the fair value of its common stock less any applicable purchase price</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#8217;s salary and related costs are classified or in which the award recipient&#8217;s service payments are classified.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Loss</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive loss includes net loss as well as other changes in stockholders&#8217; equity that result from transactions and economic events other than those with stockholders. The Company&#8217;s only element of other comprehensive income was unrealized gains on marketable securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per share is calculated by dividing net loss by the weighted average common shares outstanding during the period.</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Diluted net loss per share is calculated by adjusting weighted average common shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, determined using the treasury-stock and if-converted methods. For purposes of the diluted net income (loss) per share calculation, convertible debt and stock options are considered to be common stock equivalents. All common stock equivalents have been excluded from the calculation of diluted net loss per share as their effect would be anti-dilutive for all periods presented. Therefore, basic and diluted net loss per share were the same for all periods presented.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, &#8220;Segment Reporting - Improvements to Reportable Segment Disclosures.&#8221; The ASU requires disclosure of incremental segment information on an annual and interim basis and also requires companies with a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b6b6acc4-5182-4b15-9f8c-8955c5b3abae;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment to provide all disclosures required by this ASU and all existing segment disclosures in Accounting Standard Codification (&#8220;ASC&#8221;) 280, &#8220;Segment Reporting.&#8221; The Company adopted this standard for this fiscal year ended December 31, 2024. The adoption of ASU 2023-07 did not have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements Not Yet Effective</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, &#8220;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#8221; This ASU updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. This ASU is effective for annual periods beginning after December 15, 2024, and is applicable to the Company&#8217;s fiscal year beginning January 1, 2025, with early application permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-04, Debt-Debt with Conversions and Other Options. ASU 2024-04 is intended to clarify requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion. This ASU is effective for all entities for annual reporting periods beginning after</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures. ASU 2024-03 is intended to improve disclosures about a public business entity&#8217;s expense and provide more detailed information to investors about the types of expenses in commonly presented expense captions. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058172272128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment consist of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,371</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,653</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,258</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,159</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,721</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,519</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,496</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,460</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Construction-in-progress</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">548</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,946</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,339</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: accumulated depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,704</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,597</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,242</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,742</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation and amortization expense for the years ended December 31, 2024 and 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167862096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables set forth by level, within the fair value hierarchy, the assets carried at fair value (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.38%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair value measurements at December 31, 2024 using:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Active <br/>Markets<br/>(Level 1)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents &#8211; money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">169,744</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">169,744</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,421</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,421</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">281,165</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">281,165</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.38%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair value measurements at December 31, 2023 using:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Active <br/>Markets<br/>(Level 1)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents &#8211; money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,299</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,299</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents &#8211; government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,483</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,483</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,685</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,685</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187,467</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187,467</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds and government securities are valued by the Company based on quoted market prices, which represent a Level 1 measurement within the fair value hierarchy. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> transfers among Level 1, Level 2, or Level 3 categories in the periods presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Assets and Liabilities Not Carried at Fair Value</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's convertible long-term debt was carried at amortized cost. The fair value of the convertible long-term debt was estimated to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million at December 31, 2023. Fair value was determined using a convertible bond model using a binomial lattice approach. We classified the fair value disclosures for the long-term debt within level 3 of the fair value hierarchy because the fair value is derived using significant unobservable inputs, which include discount rates and volatility. The Company's convertible long-term debt was extinguished on December 20, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying value of accounts payable and accrued expenses that are reported on the consolidated balance sheets approximate fair value due to the short-term nature of these liabilities. Based on the borrowing rates currently available to the Company for bank loans with similar maturities, the fair value of long-term debt is approximately equal to its carrying amount as of December 31, 2024.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058172272128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Accrued Expenses and Other Current Liabilities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued employee compensation and benefits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,845</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,478</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,735</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,537</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued consulting and professional services</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,473</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,026</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued legal services and license fee</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">281</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">425</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,410</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,716</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058173526816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Stockholders' Equity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ATM Program</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 16, 2023, the Company entered into a sales agreement (the Sales Agreement) with Wedbush Securities, Inc. (Wedbush), as sales agent, pursuant to which the Company could offer, issue and sell up to an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of shares of the Company's voting common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (Voting Common Stock), from time to time in &#8220;at-the-market&#8221; (ATM) offerings during the term of the Sales Agreement under a registration statement on Form S-3 (File No. 333-268260) filed with the SEC, which was declared effective on May 16, 2023. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Voting Common Stock has been sold under this Sales Agreement to date.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Offerings</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 1, 2023, the Company completed an underwritten public offering resulting in the issuance and sale of (a) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,287,134</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Voting Common Stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and (b) pre-funded warrants (Pre-Funded Warrants) to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,010,526</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Voting Common Stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9999</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per warrant with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The Company received aggregate net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">134.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting underwriting discounts, commissions and other offering expenses, with $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million allocated to the Voting Common Stock and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million allocated to Pre-Funded Warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 24, 2024, the Company completed an underwritten public offering resulting in the issuance and sale of (a) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,958,068</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Voting Common Stock, including the partial exercise of the underwriters&#8217; option to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,485,487</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares of Voting Common Stock, at the closing market price on April 16, 2024, of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.13</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and (b) Pre-Funded Warrants to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,577,419</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Voting Common Stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.1299</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per warrant with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The Company received aggregate net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">161.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting underwriting discounts, commissions and other offering expenses, with $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million allocated to the Voting Common Stock and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">128.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million allocated to Pre-Funded Warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 27, 2024, the Company completed a registered direct offering with an existing investor for the issuance of pre-funded warrants to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company's Voting Common Stock, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per warrant. The pre-funded warrants were issued at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per warrant, resulting in gross proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, before deducting offering expenses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pre-Funded Warrants are immediately exercisable subject to certain ownership limitations, have an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">share, may be exercised at any time and do not expire. The Pre-Funded Warrants were determined to be equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">addition, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Pre-Funded Warrants do not provide any guarantee of value or return. As such, proceeds received from the issuance from the Pre-Funded Warrants were recorded as a component of stockholders&#8217; equity within additional paid-in capital. As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Pre-Funded Warrants have been exercised.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058168180448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2021 Equity Incentive Plan</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Equity Incentive Plan (the 2021 Plan) was approved by the Company&#8217;s Board on April 22, 2021 and became effective immediately, although </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> awards were permitted to be granted under the 2021 Plan until July 15, 2021. The 2021 Plan replaced the 2018 Plan, however, awards outstanding under the 2018 Plan continue to be go</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">verned by their existing terms. In addition, shares of common stock subject to awards granted under the 2018 Plan that cease to be subject to such awards by forfeiture or otherwise after the termination of the 2018 Plan will be available for issuance under the 2021 Plan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,278,048</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock initially reserved for issuance under the 2021 Plan and as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,781,492</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> sh</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ares of common stock available for issuance. The number of shares reserved for issuance under the 2021 Plan will be increased automatically on the first business day of each fiscal year, commencing in 2022 and ending in 2031. The aggregate number of common shares that may be issued under the 2021 Plan shall automatically increase by a number equal to the least of (a) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the number of the total outstanding common shares on the last day of the preceding fiscal year, or (b) a number of shares common stock determined by the Company&#8217;s Board.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2021 Employee Stock Purchase Plan</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Employee Stock Purchase Plan (the "2021 ESPP") was approved by the Company&#8217;s Board on April 22, 2021 and became effective immediately, although </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> awards were permitted to be granted under the 2021 Plan until July 15, 2021. A total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">254,390</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock were initially reserved for issuance under the 2021 ESPP. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">228,533</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">146,380</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued under the 2021 ESPP, respectively. As of December 31, 2024, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">985,486</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock available for issuance under the 2021 ESPP.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The number of shares reserved for issuance will automatically be increased on the first business day of each fiscal year, commencing on January 1, 2022 and ending on January 1, 2041. The aggregate number of shares of common stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the least of (i) one percent (</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%) of the total number of shares of common stock actually issued and outstanding on the last day of the preceding fiscal year, or (ii) a number of shares of common stock determined by the Company&#8217;s Board.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Compensation</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense related to stock options and the stock purchase plan for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023 was classified in the consolidated statement of operations as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,846</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,876</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,703</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,332</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,549</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,208</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Options</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company typically grants stock options at exercise prices deemed by the Board to be equal to the fair value of the common stock at the time of grant, based upon the quoted price of the Company&#8217;s common stock.
</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock option grants is estimated using the Black-Scholes option-pricing model. The Company lacks sufficient company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. For options with service-based vesting conditions, the expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t expect to pay any cash dividends in the foreseeable future.
</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The weighted-average for each of the assumptions the Company used to determine the grant-date fair value of options granted were as follows</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.12%;box-sizing:content-box;"></td>
        <td style="width:1.1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk free interest rate</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.03</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.95</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.19</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.36</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility of underlying common stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the stock option a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ctivity:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.664%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.844000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.664%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stock<br/>Options</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Life <br/>(in Years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intrinsic<br/>Value<br/>(in<br/>thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding January 1, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,398,250</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.34</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.87</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,278</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,501,849</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.45</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">586,081</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.93</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Canceled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">846,236</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.52</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,467,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.29</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options vested or expected to vest as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,467,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.29</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options exercisable as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,463,893</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.20</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.32</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,116</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other information related to the option activity for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average fair value of options granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.90</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.17</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intrinsic value of options exercised (in thousands)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,954</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">152</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the unrecognized compensation cost related to outstanding options was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.66</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058270902688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, the Company did not record an income tax provision due to the losses incurred and a full valuation allowance provided on the net deferred tax assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the federal statutory income tax rate to the effective tax rate is as follows</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.96%;box-sizing:content-box;"></td>
        <td style="width:9.7%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.620000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.04%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.68%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Taxes at U.S. statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Changes from statutory rate:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State taxes, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effective income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred tax assets and liabilities reflect the net tax effects of net operating loss carryovers and temporary differences between the carrying amount of assets and liabilities for financial reporting and the amounts used for income tax purposes. </span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities were as follows (in thousands): </span></span><span style=""></span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.946%;box-sizing:content-box;"></td>
        <td style="width:10.178%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.138%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.218999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,332</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,201</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,427</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,939</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,536</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,305</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,216</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,159</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">432</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">479</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,681</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,126</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold liability</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,842</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,044</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized R&amp;D costs</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,315</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,515</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,391</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,824</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">139,172</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99,592</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right of use Asset</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,582</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,346</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,590</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net deferred tax assets and liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the need for a valuation allowance, the Company has given consideration to its cumulative book income and loss positions. The Company has assessed the available means of recovering deferred tax assets, including the ability to carryback net operating losses, the existence of reversing taxable temporary differences, the availability of tax planning strategies and forecasted future taxable income. As of December 31, 2024, the Company maintains a full valuation allowance against its net deferred tax assets. The valuation allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the years ended December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company had U.S. federal net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">113.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The U.S. federal net operating losses have an indefinite life carryforward. As of December 31, 2024, the Company had Massachusetts net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million that expire at various dates through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2043</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company had U.S. R&amp;D federal credit carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">17.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million that expire at various dates through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2043</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company had U.S. state R&amp;D tax credit carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million that expire at various dates through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2038</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under Sections 382 and 383 of the U.S. Internal Revenue Code, if a corporation undergoes an ownership change, the corporation's ability to use its pre-change net operating loss carryforwards and other pre-change attributes, such as net operating losses and research tax credits, to offset its post-change income and taxes may be limited. In general, an ownership change generally occurs if there is a cumulative change in ownership by 5% stockholders that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under U.S. state tax laws. The Company has experienced an ownership change in the past and may experience ownership changes in the future as a result of future transactions in its share capital, some of which may be outside the control of the Company. As a result, if the Company earns net taxable income, its ability to use its pre-change net operating loss carryforwards, or other pre-change tax attributes, to offset U.S. federal and state taxable income and taxes is subject to significant limitations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounted for uncertain tax positions using a more likely than not threshold for recognizing and resolving uncertain tax positions. The evaluation of uncertain tax positions is based on factors that include, but are not limited to, changes in tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, new audit activity and changes in facts or circumstances related to a tax position. The Company evaluates uncertain tax positions on an annual basis and adjusts the level of the liability to reflect any subsequent changes in the relevant facts surrounding the uncertain positions. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes. For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued interest or penalties in the consolidated statements of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to taxation for federal and Massachusetts purposes. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company is subject to examination by these taxing authorities for all years since inception. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058173379520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CollaborationAndLicenseAgreementsAbstract', window );"><strong>Collaboration And License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock', window );">Collaboration and License Agreements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. Collaboration and License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Amgen</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">May 8, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company entered into a Collaboration Agreement with Amgen Inc. (the Amgen Agreement) to identify antigens recognized by T cells in patients with Crohn&#8217;s disease in accordance with a research plan. Under the terms of the Amgen Agreement, Amgen will retain all global development and commercialization rights. The proceeds from the Amgen Agreements included an upfront payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which was collected in July 2023. In addition, the Company is eligible to earn success-based milestone payments of over $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, based upon the achievement of certain clinical development and commercial milestones, as well as tiered single-digit royalty payments on net sales of products developed from the collaboration, subject to reductions set forth in the Amgen Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that Amgen meets the definition of a customer, as the Company is delivering research and development activities and a license of intellectual property. The Company identified performance obligations for research and development activities, the license, data reporting and participation in joint steering and research committees, which were determined to be a single combined performance obligation due to the services and licenses being highly interrelated.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For a certain time period during the term of the Amgen Agreement, Amgen has an option to add targets to the collaboration for payments specified in the agreement. Pursuant to the Amgen Agreement, the option for Amgen to select additional targets and to license, develop, and commercialize targets is not a performance obligation at the outset as these are customer options that do not represent material rights.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company looked to the promises in the arrangement to determine the method of recognition that best depicted the transfer of the services and the satisfaction of the combined performance obligations. The Company concluded that the performance of the research services over the expected research term was the predominant promise within the performance obligation. The Company will recognize the revenue associated with the performance obligation using an input method. The method of measuring progress towards delivery of the services incorporates actual internal and external costs incurred, relative to total internal and external costs expected to be incurred to satisfy the performance obligation. Changes in estimates of total internal and external costs expected to be incurred are recognized in the period of change as a cumulative catch-up adjustment. As costs are incurred, the Company will recognized revenue over time. At this time, it is estimated that the research term will be approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determined the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upfront payment to be the entirety of the consideration to be included in the transaction price. The option to add additional targets was not included in the transaction price as this option was assessed to be improbable at this time. The potential milestone and royalty payments that the Company is eligible to receive were also excluded from the transaction price, as all milestone and royalty amounts were fully constrained based on the assessed probability of achievement. The Company will continue to assess the probability of the option to add additional targets and the probability of milestone achievement throughout the research term and will adjust the consideration in the contract accordingly.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024 and 2023 the Company recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, of revenue associated with the Amgen Agreement. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of deferred revenue, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is classified as long-term.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Novartis</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_cbe52327-d80a-4329-8a4a-2b886fa94469;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 2020</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company entered into a Collaboration and License Agreement (the Novartis Agreement) with Novartis Institutes For BioMedical Research, Inc. (Novartis) to collaborate on their research efforts to discover and develop novel TCR-T therapies. At the inception date of the Novartis Agreement, Novartis or its affiliates held an ownership interest of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% in the Company, and at December 31, 2024 and 2023, Novartis held less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the common shares outstanding. Under the Novartis Agreement, the Company was to identify and characterize TCRs in accordance with a research plan, and transfer data arising from the research plan. The Novartis Agreement provided for payments of an upfront fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, research funding totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and potential milestone payments contingent on clinical, regulatory and sales success.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that the performance of the research services was the predominant performance obligation and was recognizing the revenue associated with the performance obligation using the input method, according to the actual costs incurred as a percentage of total expected costs to complete the research services.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determined that the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upfront payment, together with the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of estimated research costs to be reimbursed by Novartis to be the entirety of the consideration to be included in the transaction price as of the outset of the arrangement. The potential milestone payments that the Company is eligible to receive were excluded from the transaction price, as all milestone amounts were fully constrained based on the assessed probability of achievement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 202</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3 the Company recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of revenue associated with the Novartis Agreement, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million r</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">elated to cost reimbursements under the Novartis Agreement that offset costs incurred within research and development expenses in the statements of operations. The research term ended in March 2023.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_CollaborationAndLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration and license agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_CollaborationAndLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative and license arrangement disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058173566960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> facilities at 880 Winter Street and 830 Winter Street in Waltham, Massachusetts. Each lease has specified terms and includes renewal options. Given uncertainty as to the Company's intentions with respect to these leases, the renewal options were not deemed reasonably certain.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 8, 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> entered into a lease amendment extending the expiration date of the 830 Winter Street Lease from </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 30, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 31, 2029</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and provides for one option to renew the 830 Winter Street Lease for a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period commencing on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 1, 2029</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, resulting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in an increase in the lease liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 28, 2024, the Company entered into a second lease amendment expanding the rentable space of 830 Winter Street. The amendment provides for an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,628</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of space with a commencement date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 1, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and an expiration date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">October 31, 2029</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with one option to review for a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period. This amendment resulted in an increase in the lease liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary of lease cost</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the presentation in the Company's consolidated balance sheets of its operating leases (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,357</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,492</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, current</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,570</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,246</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,739</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,140</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,309</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,386</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the effect of lease costs in the Company's consolidated statement of operations (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,564</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,626</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,408</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,120</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,972</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,790</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, the Company made cash payments for operating leases of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future payments of operating lease liabilities are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,089</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,958</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,329</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,712</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029 and thereafter</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,994</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total future payments of operating lease liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94,082</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,773</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of operating lease liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,309</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the weighted average remaining lease term was </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.3</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and the weighted average incremental borrowing rate used to determine the operating lease liability was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of December 31, 2023, the weighted average remaining lease term was </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8.6</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and the weighted average incremental borrowing rate used to determine the operating lease liability was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Brigham and Women&#8217;s License Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company obtained the worldwide exclusive license to its foundational technology from The Brigham and Women&#8217;s Hospital, Inc. (or BWH). The license, as amended, grants worldwide exclusive use to the patent underlying the TargetScan technology in exchange for fees including development milestones and various royalties on product sales should they occur in the future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Royalty Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2018, the Company amended and restated an existing royalty agreement with one of its founders. Under the amended and restated royalty agreement, the Company agreed to pay the founder an aggregate royalty of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of net sales of any product sold by the Company or by any of its direct or indirect licensees for use in the treatment of any disease or disorder covered by a pending patent application or issued patent held or controlled by the Company as of the last date that the founder was providing services to the Company as a director or consultant under a written agreement in perpetuity. Royalties are payable with respect to each applicable product for a defined period of time set forth in the royalty agreement. The founder assigned his rights and obligations under the royalty agreement to one of his affiliated entities in January 2021.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167856896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan and Security Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Loan and Security Agreements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. Loan and Security Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">K2 HealthVentures LLC</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 9, 2022 (the Closing Date), the Company entered into a Loan and Security Agreement (the Loan Agreement) with K2 HealthVentures LLC (K2HV), pursuant to which convertible term loans in an aggregate principal amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million is available to the Company in three tranches, subject to certain terms and conditions. The Company drew the first tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from K2HV on the Closing Date. The Company had the option to draw the second tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon the achievement of certain financial and clinical milestones and an uncommitted third tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million could be funded by joint agreement of the Company and K2HV. On the Closing Date, the Company paid a facility fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to K2HV and is subject to an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of any amount drawn on third tranche.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term loan was expected to mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 1, 2026</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the Maturity Date), and was subject to interest only payments for </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months, which could be extended to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months upon achievement of certain financial and clinical milestones, following which the term loans would amortize in equal monthly installments until maturity. The Company had the ability to repay the loan at any time either in cash or in shares, subject to applicable premiums as specified in the Loan Agreement. The term loans accrued interest at a per annum rate equal to the greater of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and (ii) the sum of (A) the prime rate (as last quoted in The Wall Street Journal) and (B) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, subject to a cap of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.90</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 26, 2024, K2HV confirmed to the Company that the amortization commencement date would be October 1, 2025, thereby extending the interest-only period under the Loan Agreement for </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months. This extension met the definition of an accounting debt modification in accordance with ASC 470-50 and was accounted for prospectively as a yield adjustment, with no resulting gain or loss recognized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The lenders could elect at any time following the closing prior to the payment in full of the term loans to convert any portion of the principal amount of the term loans then outstanding into shares of the Company's common stock. The first tranche of the loan was convertible at the option of K2HV at a conversion price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.785</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and future tranches could be convertible as specified in the agreement, provided that, such price shall be subject to the applicable conversion price floor and other adjustments in accordance with the Loan Agreement. The embedded conversion option met the derivative accounting scope exception since the embedded conversion option was indexed to the Company&#8217;s own common stock and qualifies for classification within stockholders&#8217; equity.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had the option to prepay all, but not less than all, of the outstanding principal balance of the term loans under the Loan Agreement subject to a prepayment fee ranging from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% depending upon when the prepayment occurs. The Company was obligated to pay a final fee equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the aggregate amount of the term loans funded (the Exit Fee), to occur upon the earliest of (i) the maturity date, (ii) the acceleration of the term loans, and (iii) the prepayment of the term loans. If, upon equity conversion, K2HV received gross proceeds in an amount equal to at least 1.5 multiplied by the principal amount converted from the sale or other disposition of such Conversion Shares (as defined in the Loan Agreement), then as to such principal amount, the Exit Fee would be reduced to zero.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 20, 2024, K2HV elected to convert $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the outstanding principal balance into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,134,796</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company's voting common stock at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.785</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in accordance with the agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 20, 2024 the Company repaid the remaining obligation of the debt agreement, which included $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in remaining principal, a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million Exit Fee, and a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million prepayment fee. The Company recognized a loss from extinguishment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in interest expense for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The effective interest rate on the Loan Agreement, including the amortization of the debt discount and issuance costs, and accretion of the Exit Fee, was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.61</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% upon extinguishment.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Silicon Valley Bank</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 20, 2024 (the effective date), the Company entered into a Loan and Security Agreement (SVB Loan Agreement) with Silicon Valley Bank, a division of First-Citizens Bank &amp; Trust Company (SVB). Under the SVB Loan Agreement, SVB will extend up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in a term loan facility, consisting of a first tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million fully funded on the Effective Date and a second tranche of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to be available to the Company at the Lender&#8217;s sole discretion on or prior to June 30, 2026.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term loans will mature on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 1, 2029</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and will be subject to monthly interest only payments until September 30, 2027, provided the Company achieves certain financial and clinical milestones, following which the term loans will amortize in equal monthly installments until maturity. If the Company does not achieve such financial and clinical milestones by June 30, 2026, the maturity date will be September 1, 2028, and the interest only period will end on September 30, 2026, following which the term loans will amortize in equal monthly installments until maturity. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term loans will accrue interest at a per annum rate equal to the greater of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and (ii) the prime rate (as last quoted in The Wall Street Journal), minus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%; provided that such interest rate shall not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum. The Company will be liable for a final payment that is due on the earliest to occur of (a) the maturity date, (b) the repayment of the term loans in full, and (c) the date upon which the term loans are accelerated by the Lender, in an amount equal to the aggregate original principal amount of the term loans extended by the Lender to the Company, multiplied by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (Exit Fee). In addition, the Company will be liable for a prepayment fee equal to (x) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of term loans prepaid during the first year of the term, (y) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of term loans prepaid during the second year of the term, and (z) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the principal amount of term loans prepaid thereafter. The term loans will automatically accelerate upon the occurrence of a bankruptcy or insolvency event involving the Company or its subsidiaries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SVB Loan Agreement contains customary representations and warranties, events of default and affirmative and negative covenants, including covenants that limit or restrict the Company&#8217;s and its subsidiaries&#8217; ability to, among other things, dispose of assets, make changes to its business, management, ownership or business locations, merge or consolidate, incur additional indebtedness, grant liens on its assets, pay dividends or other distributions, repurchase equity, make investments, and enter into certain transactions with affiliates, in each case subject to certain thresholds and exceptions. The New Loan Agreement does not require the Company to comply with a financial maintenance covenant. As collateral for its obligations under the New Loan Agreement, the Company granted the Lender a first-priority security interest on substantially all of the Company&#8217;s assets (other than intellectual property), subject to certain exceptions. The Company&#8217;s obligations under the SVB Loan Agreement will be guaranteed by each of the Company&#8217;s future direct or indirect subsidiaries, subject to certain exceptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in interest expense for the year ended December 31, 2024. The effective interest rate on the SVB Loan Agreement, including the amortization of the debt discount and issuance costs, and accretion of the Exit Fee, was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.46</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% at December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future principal payments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:74.68%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:23.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,063</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,250</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,187</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total principal payments</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Plus: Final payment fee</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,625</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: unamortized debt discount and final fee</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,053</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058173274416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Plan</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Retirement Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company initiated a defined contribution plan under Section 401(k) of the IRC (the Plan) covering all qualified employees effective January 1, 2019. Employee contributions are voluntary and are determined on an individual basis subject to the maximum allowable under federal tax regulations. The Company made contributions to the Plan of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058173379520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. Segment Reporting</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of the entity for which separate financial information is made available and that is regularly evaluated by the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_026c18d0-35e8-4519-bb36-24650b15093c;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief operating decision maker (CODM)</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in making decisions regarding resource allocation and assessing performance. The Company's CODM is its chief executive officer and the Company manages its operations as a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_5592acb1-cb7d-4895-8078-3175a9a958ae;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> segment for the purposes of assessing performance and making operating decisions. The Company is focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM assesses the Company's performance by reviewing GAAP net loss and significant expenses by function along with the annual budget. The chief operating decision maker considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources.</span></span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides information about the Company's single operating segment which includes significant expenses by function along with significant non-cash expense items.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.86%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Revenue:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration and license revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,816</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,049</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,742</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,165</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory supplies, research materials and studies</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,101</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Clinical studies</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,245</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,214</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility-related and other</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,669</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,298</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,846</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,380</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,499</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,065</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal and professional fees</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,380</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,119</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility-related and other</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,576</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,976</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,703</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,332</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation Expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">862</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">134,821</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">93,458</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other (expense) income:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,065</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,999</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,653</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,759</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,090</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Loss</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127,499</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89,218</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058274107424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14. Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net loss per share was calculated as follows (in thousands, except share and per share data):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127,499</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89,218</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,990,417</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,599,858</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.14</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.36</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,087,945</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company's common stock issuable upon exercise of the Pre-Funded Warrants described in Note 6 are included as outstanding common stock in the calculation of basic and diluted net loss per share.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has two classes of common stock, each with identical participation rights to earnings and liquidation preferences, and therefore the calculation of net loss per share as described above is identical to the calculation under the two-class method. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: </span></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,467,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,398,250</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Potential shares issuable under the ESPP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">138,133</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock issuable upon conversion of Loan Agreement</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,269,592</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,605,915</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,667,842</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167937248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements reflect the operations of the Company and the Company&#8217;s wholly owned subsidiary, TScan Securities Corporation. The accompanying consolidated financial statements have been prepared in conformity with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification, or ASC, and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience, known trends and other market-specific or relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash includes cash in readily available checking and money market accounts. Cash equivalents include all highly liquid investments maturing within 90 days from the date of purchase. The cash equivalents consisted of money market funds and government securities.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Cash</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Company&#8217;s facility lease agreements, the Company is required to provide letters of credit totaling of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of the landlords to serve as security deposits. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the cash securing the letter of credit was classified as restricted cash (non-current) on the consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies all of its marketable securities as available-for-sale based upon its intent with regard to such investments.  Unrealized gains on available-for-sale debt securities are reported as a component of accumulated other comprehensive loss in stockholders&#8217; equity. The amortized cost of debt securities in this category is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in interest and other income, net. Realized gains and losses and declines in value judged to be other than temporary on available-for-sale securities, are included in interest and investment income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest and other income, net. To determine whether an other-than-temporary impairment exists, the Company considers whether it has the ability and intent to hold the investment until a market price recovery, and whether evidence indicating the recoverability of the cost of the investment outweighs evidence to the contrary.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company&#8217;s cash deposits on hand at any one financial institution often exceed federally insured limits. The Company places its cash in financial institutions that management believes to be of high credit quality. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the respective assets as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:44%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:55%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated useful life</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5 </span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_397b54bf-b523-4a3d-a66b-ad04f717b80a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></span></span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of the asset's estimated useful life or the remaining lease term</span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major additions and betterments are capitalized; expenditures for repairs and maintenance, which do not improve or extend the life of the respective assets, are charged to operating expense as incurred. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Long-lived assets to be held and used, including property and equipment, are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. Evaluation of the recoverability of the asset or asset group is based on an estimate of undiscounted future cash flows resulting from the use of the asset or asset group and its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the asset or asset group, an impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. The Company did not record any impairment losses on long-lived assets during the periods presented.</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain assets and liabilities are carried at fair value under US GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the user of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">quoted prices for similar assets and liabilities in active markets </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">quoted prices for identical or similar assets or liabilities in markets that are not active </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g., interest rate   and yield curve quotes at commonly quoted intervals) </span></div></div><div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inputs that are derived principally from or corroborated by observable market data by correlation or other means </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;Unobservable inputs for the assets or liability (i.e., supported by little or no market activity). Level 3 inputs include management&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). </span></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records leases under ASU No. 2016-02 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Topic 842) whereby the Company determines if an arrangement is or contains a lease at inception. For leases with a term of 12 months or less, the Company has elected to not recognize a right-of-use asset or lease liability. The Company&#8217;s operating leases are recognized on the consolidated balance sheets as other noncurrent assets, other current liabilities, and other noncurrent liabilities. The Company does not have any finance leases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the rate implicit on the Company&#8217;s leases are not readily determinable, the Company uses an estimate of its incremental borrowing rate for secured borrowings with terms similar to the lease term based on the information available at the lease commencement date in determining the present value of lease payments. Operating lease right-of-use assets also include the effect of any lease payments made, including lease payments made in advance of lease commencement and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and development costs that are paid in advance of performance (if any) are capitalized as a prepaid expense and amortized over the service period as the services are provided.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock', window );">Accrued Research and Manufacturing Contract Costs</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued Research and Manufacturing Contract Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has entered into various research and development and manufacturing contracts. These agreements are generally cancelable, and related payments are recorded as the corresponding expenses are incurred. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research studies or clinical trials and manufacturing activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#8217;s estimates. The Company&#8217;s historical accrual estimates have not been materially different from the actual costs</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PatentCostsPolicyTextBlock', window );">Patent Costs</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for revenue under ASU No. 2014-19, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 606). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, certain collaboration arrangements and financial instruments. ASC 606 provides a five-step framework whereby revenue is recognized when control of promised goods or services is transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify the contract(s) with a customer; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify the performance obligations in the contract; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iii)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">determine the transaction price; </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iv)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">allocate the transaction price to the performance obligations in the contract; and </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(v)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recognize revenue when (or as) the performance obligations are satisfied. </span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration that it is entitled to in exchange for the goods or services the Company transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined with other promised goods and services until a distinct combined performance obligation is identified.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company then allocates the transaction price (that is, the amount of consideration the Company expects to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated revenue when (or as) each performance obligation is satisfied. The allocation is based upon standalone selling price. The standalone selling price is the price at which an entity would sell a promised good or service separately to a customer. Because the Company have not sold the same goods or services in our contracts separately to any customers on a standalone basis, the Company estimated the standalone selling price of each performance obligation by taking into consideration internal estimates of research and development personnel needed to perform the research and development services, estimates of expected cash outflows to third parties for services and supplies and typical gross profit margins.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company enters into collaboration and licensing arrangements that are within the scope of ASC 606, under which the Company may exclusively license to third parties&#8217; rights to develop, manufacture and commercialize its product candidates as well as options to acquire additional rights. The terms of these arrangements typically include payment to the Company of one or more of the following: nonrefundable, upfront license fees; development, regulatory and sales milestone payments; and royalties on net sales of licensed products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is typically recognized using a cost-to-cost input model as the measure of progress. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete the Company&#8217;s performance obligations under an arrangement. The Company evaluates the measure of progress each reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">period and, if necessary, adjusts the measure of performance and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts received prior to revenue recognition are recorded as deferred revenue in the balance sheets. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue in the balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion in the balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Customer Options</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Customer Options</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options that are not determined to be material rights are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement. To date, none of our arrangements have included any material rights. The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The observable price of a good or service sold separately provides the best evidence of standalone selling price. However, when standalone selling prices are not readily available, the Company is required to estimate the standalone selling price of each performance obligation. Key assumptions to determine the standalone selling price. Amounts allocated to a material right are not recognized as revenue until the option is exercised or terminates.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_RevenueMilestonePaymentsPolicyTextBlock', window );">Milestone Payments</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Milestone Payments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For each arrangement that includes milestone payments upon the achievement of performance-based milestones, such as development and regulatory milestones, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant reversal of revenue would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. Upfront and ongoing development milestones per the Company&#8217;s collaboration and license agreement are not subject to refund if the development activities are not successful. The Company reevaluates the probability of achievement of such milestones and any related constraint at each reporting period, and any adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. To date, the Company has not recognized any milestone revenues.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_RevenueFromRoyaltiesPolicyTextBlock', window );">Royalties</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Royalties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license to the Company&#8217;s intellectual property is deemed to be the predominant item to which the royalties relate as it is the primary driver of value, the Company recognizes revenue when the related sales occur in accordance with the sales-based royalty exception. To date, the Company has not recognized any royalty revenue resulting from the Company&#8217;s collaboration and licensing agreements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided to reduce the deferred tax asset to an amount, which, more likely than not, will be realized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes the tax benefit from any uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. Interest and penalties associated with uncertain tax positions are recorded as a component of income tax expense. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t identified any uncertain tax positions for which reserves would be required.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which discrete information is available for evaluation by the chief operating decision maker, who is the CEO, in deciding how to allocate resources and in assessing performance. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. All of the Company&#8217;s assets are held in the U.S.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for stock option awards at fair value, which is measured using the Black-Scholes option-pricing model. The measurement date is generally the date of grant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes stock-based compensation expense over the requisite service period, which is generally the vesting period of the respective award. For awards that include performance-based vesting conditions, stock-based compensation expense is recognized using the accelerated attribution method when the performance condition is deemed to be probable. The Company accounts for forfeitures as they occur. The Company determines the fair value of restricted stock awards in reference to the fair value of its common stock less any applicable purchase price</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#8217;s salary and related costs are classified or in which the award recipient&#8217;s service payments are classified.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Loss</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive loss includes net loss as well as other changes in stockholders&#8217; equity that result from transactions and economic events other than those with stockholders. The Company&#8217;s only element of other comprehensive income was unrealized gains on marketable securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per share is calculated by dividing net loss by the weighted average common shares outstanding during the period.</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Diluted net loss per share is calculated by adjusting weighted average common shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, determined using the treasury-stock and if-converted methods. For purposes of the diluted net income (loss) per share calculation, convertible debt and stock options are considered to be common stock equivalents. All common stock equivalents have been excluded from the calculation of diluted net loss per share as their effect would be anti-dilutive for all periods presented. Therefore, basic and diluted net loss per share were the same for all periods presented.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements/ Recently Issued Accounting Pronouncements Not Yet Effective</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, &#8220;Segment Reporting - Improvements to Reportable Segment Disclosures.&#8221; The ASU requires disclosure of incremental segment information on an annual and interim basis and also requires companies with a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b6b6acc4-5182-4b15-9f8c-8955c5b3abae;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment to provide all disclosures required by this ASU and all existing segment disclosures in Accounting Standard Codification (&#8220;ASC&#8221;) 280, &#8220;Segment Reporting.&#8221; The Company adopted this standard for this fiscal year ended December 31, 2024. The adoption of ASU 2023-07 did not have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements Not Yet Effective</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, &#8220;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#8221; This ASU updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. This ASU is effective for annual periods beginning after December 15, 2024, and is applicable to the Company&#8217;s fiscal year beginning January 1, 2025, with early application permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-04, Debt-Debt with Conversions and Other Options. ASU 2024-04 is intended to clarify requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion. This ASU is effective for all entities for annual reporting periods beginning after</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures. ASU 2024-03 is intended to improve disclosures about a public business entity&#8217;s expense and provide more detailed information to investors about the types of expenses in commonly presented expense captions. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and manufacturing contract costs policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_PatentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Patent costs policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_PatentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_RevenueFromRoyaltiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_RevenueFromRoyaltiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_RevenueMilestonePaymentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, milestone payments policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_RevenueMilestonePaymentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167754096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock', window );">Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the respective assets as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:44%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:55%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated useful life</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5 </span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_397b54bf-b523-4a3d-a66b-ad04f717b80a;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></span></span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of the asset's estimated useful life or the remaining lease term</span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058173465712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment consist of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,371</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,653</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,258</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,159</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,721</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,519</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,496</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,460</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Construction-in-progress</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">548</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,946</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,339</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: accumulated depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,704</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,597</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,242</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,742</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058270902688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets Carried at Fair Value on a Hierarchy Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables set forth by level, within the fair value hierarchy, the assets carried at fair value (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.38%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair value measurements at December 31, 2024 using:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Active <br/>Markets<br/>(Level 1)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents &#8211; money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">169,744</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">169,744</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,421</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,421</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">281,165</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">281,165</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.38%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair value measurements at December 31, 2023 using:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Active <br/>Markets<br/>(Level 1)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents &#8211; money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,299</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,299</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents &#8211; government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,483</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,483</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,685</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,685</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187,467</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187,467</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058268140880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued employee compensation and benefits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,845</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,478</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,735</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,537</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued consulting and professional services</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,473</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,026</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued legal services and license fee</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">281</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">425</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,410</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,716</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167995968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-based Compensation Expense</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense related to stock options and the stock purchase plan for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023 was classified in the consolidated statement of operations as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,846</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,876</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,703</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,332</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,549</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,208</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted-average for Each of The Assumptions The Company Used to Determine The Grant-date Fair Value of Options Granted</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The weighted-average for each of the assumptions the Company used to determine the grant-date fair value of options granted were as follows</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.12%;box-sizing:content-box;"></td>
        <td style="width:1.1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk free interest rate</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.03</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.95</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.19</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.36</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility of underlying common stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the stock option a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ctivity:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.664%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.844000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.664%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stock<br/>Options</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Life <br/>(in Years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intrinsic<br/>Value<br/>(in<br/>thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding January 1, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,398,250</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.34</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.87</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,278</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,501,849</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.45</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">586,081</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.93</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Canceled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">846,236</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.52</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,467,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.29</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options vested or expected to vest as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,467,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.29</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options exercisable as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,463,893</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.20</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.32</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,116</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of Other Information Related to Option Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other information related to the option activity for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average fair value of options granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.90</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.17</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intrinsic value of options exercised (in thousands)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,954</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">152</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058351515344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of the Federal Statutory Income Tax Rate to the Effective Tax Rate</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the federal statutory income tax rate to the effective tax rate is as follows</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.96%;box-sizing:content-box;"></td>
        <td style="width:9.7%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.620000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.04%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.68%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Taxes at U.S. statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Changes from statutory rate:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State taxes, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effective income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">&#160;%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities were as follows (in thousands): </span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.946%;box-sizing:content-box;"></td>
        <td style="width:10.178%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.138%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.218999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,332</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,201</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,427</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,939</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,536</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,305</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,216</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,159</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">432</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">479</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,681</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,126</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold liability</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,842</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,044</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized R&amp;D costs</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,315</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,515</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,391</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,824</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">139,172</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99,592</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right of use Asset</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,582</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,346</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,590</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net deferred tax assets and liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058168248960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturity of Future Payments Of Operating Lease Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future payments of operating lease liabilities are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.444%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.757%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,089</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,958</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,329</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,712</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029 and thereafter</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,994</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total future payments of operating lease liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94,082</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,773</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of operating lease liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,309</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock', window );">Summary Of presentation of operating lease In consolidated balance sheet</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the presentation in the Company's consolidated balance sheets of its operating leases (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,357</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,492</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, current</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,570</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,246</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60,739</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,140</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,309</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,386</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease cost in the Company's consolidated statement of operations</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the effect of lease costs in the Company's consolidated statement of operations (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.313%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.843%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,564</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,626</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,408</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,120</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,972</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,790</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of presentation of operating lease In consolidated balance sheet</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058268136912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan and Security Agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Principal Payments</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future principal payments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:74.68%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:23.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,063</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,250</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,187</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total principal payments</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Plus: Final payment fee</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,625</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: unamortized debt discount and final fee</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,053</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058268148816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Information</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides information about the Company's single operating segment which includes significant expenses by function along with significant non-cash expense items.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.86%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Revenue:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration and license revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,816</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,049</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,742</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,165</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory supplies, research materials and studies</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,101</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Clinical studies</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,245</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,214</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility-related and other</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,669</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,298</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,846</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,380</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,499</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,065</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal and professional fees</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,380</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,119</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility-related and other</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,576</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,976</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,703</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,332</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation Expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">862</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">134,821</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">93,458</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other (expense) income:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest and other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,065</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,999</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,653</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,759</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on extinguishment of debt</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,090</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Loss</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127,499</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89,218</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058172267568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Summary of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic and diluted net loss per share was calculated as follows (in thousands, except share and per share data):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127,499</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89,218</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,990,417</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,599,858</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.14</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.36</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Potential Common Shares Excluded from Computation of Diluted Net Loss per Share</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: </span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,467,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,398,250</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Potential shares issuable under the ESPP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">138,133</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock issuable upon conversion of Loan Agreement</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,269,592</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,605,915</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,667,842</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058269449712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Basis of Presentation - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">Apr. 17,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net losses</a></td>
<td class="nump">$ 127,499<span></span>
</td>
<td class="nump">$ 89,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 375,096<span></span>
</td>
<td class="nump">$ 247,597<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167817024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 5,031,000<span></span>
</td>
<td class="nump">$ 5,031,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segment | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167032432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_LaboratoryEquipmentMember', window );">Laboratory Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_LaboratoryEquipmentMember', window );">Laboratory Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_OfficeAndComputerEquipmentMember', window );">Office and Computer Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_OfficeAndComputerEquipmentMember', window );">Office and Computer Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration', window );">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</a></td>
<td class="text">us-gaap:UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482190/360-10-35-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_OfficeAndComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_OfficeAndComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058165826816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Summary of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 25,946<span></span>
</td>
<td class="nump">$ 22,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(18,704)<span></span>
</td>
<td class="num">(14,597)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,242<span></span>
</td>
<td class="nump">7,742<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_LaboratoryEquipmentMember', window );">Laboratory Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">19,371<span></span>
</td>
<td class="nump">15,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">3,258<span></span>
</td>
<td class="nump">3,159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">1,721<span></span>
</td>
<td class="nump">1,519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_OfficeAndComputerEquipmentMember', window );">Office and Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">1,496<span></span>
</td>
<td class="nump">1,460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 548<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_OfficeAndComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=tcrx_OfficeAndComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167742544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058168852704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Assets Carried at Fair Value on a Hierarchy Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 281,165<span></span>
</td>
<td class="nump">$ 187,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">Government Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure', window );">Marketable securities, fair value disclosure</a></td>
<td class="nump">111,421<span></span>
</td>
<td class="nump">58,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Cash Equivalents - Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents fair value disclosure</a></td>
<td class="nump">169,744<span></span>
</td>
<td class="nump">52,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Active Markets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">281,165<span></span>
</td>
<td class="nump">187,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Active Markets (Level 1) | Government Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure', window );">Marketable securities, fair value disclosure</a></td>
<td class="nump">111,421<span></span>
</td>
<td class="nump">58,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Active Markets (Level 1) | Cash Equivalents - Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents fair value disclosure</a></td>
<td class="nump">$ 169,744<span></span>
</td>
<td class="nump">$ 52,299<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of securitized, pay-through debt securities collateralized by real estate mortgage loans classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058166130048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_FairValueAssetLevel1ToLevel2TransfersAmount', window );">Fair value, assets, level 1 to level 2 transfers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_FairValueAssetLevel2ToLevel1TransfersAmount', window );">Fair value, assets, level 2 to level 1 transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Fair value, assets, transfers into level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Fair value, assets, transfers out of level 3</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of convertible long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_FairValueAssetLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value asset level 1 to level 2 transfers amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_FairValueAssetLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_FairValueAssetLevel2ToLevel1TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value asset level 2 to level 1 transfers amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_FairValueAssetLevel2ToLevel1TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167879728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee compensation and benefits</a></td>
<td class="nump">$ 6,845<span></span>
</td>
<td class="nump">$ 5,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_AccruedResearchAndDevelopment', window );">Accrued research and development</a></td>
<td class="nump">6,735<span></span>
</td>
<td class="nump">3,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued consulting and professional services</a></td>
<td class="nump">1,473<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_AccruedLegalServicesAndLicenseFeeCurrent', window );">Accrued legal services and license fee</a></td>
<td class="nump">281<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">425<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 15,410<span></span>
</td>
<td class="nump">$ 10,716<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_AccruedLegalServicesAndLicenseFeeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued legal services and license fee current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_AccruedLegalServicesAndLicenseFeeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_AccruedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_AccruedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058171705664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">20 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 27, 2024</div></th>
<th class="th"><div>Apr. 24, 2024</div></th>
<th class="th"><div>Jun. 01, 2023</div></th>
<th class="th"><div>May 16, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,131<span></span>
</td>
<td class="nump">$ 42,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses', window );">Net proceeds from common stock and warrants after deducting underwriting discounts, commissions and other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161,400<span></span>
</td>
<td class="nump">$ 134,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of pre-funded warrants, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,300<span></span>
</td>
<td class="nump">92,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,271<span></span>
</td>
<td class="nump">92,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,100<span></span>
</td>
<td class="nump">42,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,131<span></span>
</td>
<td class="nump">42,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of pre-funded warrants, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,300<span></span>
</td>
<td class="nump">$ 92,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158,271<span></span>
</td>
<td class="nump">$ 92,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember', window );">Voting Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember', window );">Voting Common Stock | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,958,068<span></span>
</td>
<td class="nump">23,287,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember', window );">Voting Common Stock | Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember', window );">Voting Common Stock | Follow On Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,958,068<span></span>
</td>
<td class="nump">23,287,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares', window );">Underwriter option to purchase number of additional shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,485,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember', window );">Voting Common Stock | ATM Program | Wedbush Securities, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CommonStockSharesReservedForFutureIssuance', window );">Issuance of common stock, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tcrx_PreFundedWarrantsMember', window );">Pre-Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock issuable upon exercise warrants</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,087,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,087,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_ClassOfStockWarrantsExercised', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of pre-funded warrants, net of offering costs</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of pre-funded warrants, net of offering costs</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_WarrantIssuanceCostsOfferingExpenses', window );">Offering expenses</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tcrx_PreFundedWarrantsMember', window );">Pre-Funded Warrants [Member] | Voting Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock issuable upon exercise warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,577,419<span></span>
</td>
<td class="nump">47,010,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CommonStockPricePerWarrant', window );">Common stock price per warrant</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 7.1299<span></span>
</td>
<td class="nump">$ 1.9999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_ClassOfStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of stock warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_ClassOfStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_CommonStockPricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock price per warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_CommonStockPricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_CommonStockSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_CommonStockSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock and warrants net of underwriting discounts and expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriter option to purchase number of additional shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_WarrantIssuanceCostsOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant issuance costs offering expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_WarrantIssuanceCostsOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tcrx_VotingCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=tcrx_FollowOnOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=tcrx_FollowOnOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tcrx_SalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tcrx_SalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tcrx_WedbushSecuritiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tcrx_WedbushSecuritiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tcrx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tcrx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167519424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 15, 2021</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jul. 14, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period remaining (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments', window );">Expected dividend-yield assumption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Issuance of common stock shares under the plan</a></td>
<td class="nump">3,278,048<span></span>
</td>
<td class="nump">5,781,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of awards permitted to grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of number of common stock issued and outstanding</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember', window );">2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Issuance of common stock shares under the plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">985,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of awards permitted to grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of number of common stock issued and outstanding</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, Reserved for future issuance</a></td>
<td class="nump">254,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember', window );">2021 Employee Stock Purchase Plan | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,533<span></span>
</td>
<td class="nump">146,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167872544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation - Summary of Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 9,549<span></span>
</td>
<td class="nump">$ 5,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">4,846<span></span>
</td>
<td class="nump">2,876<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 4,703<span></span>
</td>
<td class="nump">$ 2,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058270965056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation - Summary of Weighted-average for each of the Assumptions the Company Used to Determine the Grant-date Fair Value of Options Granted (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">4.03%<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 2 months 8 days<span></span>
</td>
<td class="text">6 years 4 months 9 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility of underlying common stock</a></td>
<td class="nump">89.00%<span></span>
</td>
<td class="nump">87.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167610880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation - Summary of Stock Option Activity (Details) - Stock Options - 2018 and 2021 Equity Incentive Plans - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock Options Outstanding, Beginning balance</a></td>
<td class="nump">10,398,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock Options Outstanding, Granted</a></td>
<td class="nump">3,501,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock Options Outstanding, Exercised</a></td>
<td class="num">(586,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Stock Options Outstanding, Cancelled</a></td>
<td class="num">(846,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock Options Outstanding, Ending balance</a></td>
<td class="nump">12,467,782<span></span>
</td>
<td class="nump">10,398,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Stock Options vested or expected to vest</a></td>
<td class="nump">12,467,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable</a></td>
<td class="nump">3,463,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock Options Outstanding, Weighted Average Exercise Price, Beginning Balance</a></td>
<td class="nump">$ 3.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Stock Options Granted, Weighted Average Exercise Price</a></td>
<td class="nump">6.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Stock Options Exercised, Weighted Average Exercise Price</a></td>
<td class="nump">2.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Stock Options Cancelled, Weighted Average Exercise Price</a></td>
<td class="nump">3.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock Options Outstanding, Weighted Average Exercise Price, Ending balance</a></td>
<td class="nump">4.22<span></span>
</td>
<td class="nump">$ 3.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Stock Options vested or expected to vest, Weighted Average Exercise Price</a></td>
<td class="nump">4.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Stock options exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Stock Options Outstanding, Weighted Average Remaining Contractual Life</a></td>
<td class="text">8 years 3 months 14 days<span></span>
</td>
<td class="text">8 years 10 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Stock Options vested or expected to vest, Weighted Average Remaining Contractual Life</a></td>
<td class="text">8 years 3 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Stock options exercisable, Weighted Average Remaining Contractual Life</a></td>
<td class="text">7 years 3 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock Options Outstanding, Intrinsic Value, Beginning</a></td>
<td class="nump">$ 28,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock Options Outstanding, Intrinsic Value, Ending</a></td>
<td class="nump">3,912<span></span>
</td>
<td class="nump">$ 28,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Stock Options vested or expected to vest, Intrinsic Value</a></td>
<td class="nump">3,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock options exercisable, Intrinsic Value</a></td>
<td class="nump">$ 1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058166216960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation - Summary of Other Information Related to Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of options granted</a></td>
<td class="nump">$ 4.90<span></span>
</td>
<td class="nump">$ 2.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="nump">$ 1,954<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058352925984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of the Federal Statutory Income Tax Rate to the Effective Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Taxes at U.S. statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_ChangesFromStatutoryRateAbstract', window );"><strong>Changes from statutory rate:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Share-based compensation</a></td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(30.90%)<span></span>
</td>
<td class="num">(34.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(1.70%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_ChangesFromStatutoryRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes from statutory rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_ChangesFromStatutoryRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -SubTopic 740<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479176/718-740-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058171659472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Taxes at U.S. statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 39,300,000<span></span>
</td>
<td class="nump">$ 30,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest or penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Description of income tax examinations</a></td>
<td class="text">the Company is subject to examination by these taxing authorities for all years since inception. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MA', window );">Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 118,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_OperatingLossCarryForwardsExpirationYear', window );">Net operating loss carryforwards, expiration year</a></td>
<td class="text">2043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">U.S. Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 113,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">U.S. Federal | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_TaxCreditCarryforwardExpirationYear', window );">Tax credit carryforwards, expiration year</a></td>
<td class="text">2043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_TaxCreditCarryforwardExpirationYear', window );">Tax credit carryforwards, expiration year</a></td>
<td class="text">2038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_OperatingLossCarryForwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carry forwards expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_OperatingLossCarryForwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_TaxCreditCarryforwardExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_TaxCreditCarryforwardExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058172699920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 31,332<span></span>
</td>
<td class="nump">$ 23,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">25,427<span></span>
</td>
<td class="nump">16,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">3,536<span></span>
</td>
<td class="nump">4,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_DeferredTaxAssetsDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,216<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_DeferredTaxAssetsAmortization', window );">Amortization</a></td>
<td class="nump">432<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">1,681<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_DeferredTaxAssetsLeaseholdLiability', window );">Leasehold liability</a></td>
<td class="nump">17,842<span></span>
</td>
<td class="nump">17,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts', window );">Capitalized R&amp;D costs</a></td>
<td class="nump">48,315<span></span>
</td>
<td class="nump">31,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">9,391<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">139,172<span></span>
</td>
<td class="nump">99,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_DeferredTaxLiabilitiesRightOfUseAsset', window );">Right of use Asset</a></td>
<td class="num">(17,582)<span></span>
</td>
<td class="num">(17,346)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">$ (121,590)<span></span>
</td>
<td class="num">$ (82,246)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_DeferredTaxAssetsAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_DeferredTaxAssetsAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets capitalized research and development costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_DeferredTaxAssetsDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_DeferredTaxAssetsDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_DeferredTaxAssetsLeaseholdLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, leasehold liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_DeferredTaxAssetsLeaseholdLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_DeferredTaxLiabilitiesRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities right of use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_DeferredTaxLiabilitiesRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167829600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 08, 2023</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CollaborationAndLicenseAgreementsLineItems', window );"><strong>Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and license revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,816<span></span>
</td>
<td class="nump">$ 21,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Incurred costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,637<span></span>
</td>
<td class="nump">114,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,698<span></span>
</td>
<td class="nump">10,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Long-term deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,246<span></span>
</td>
<td class="nump">$ 5,622<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Novartis Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CollaborationAndLicenseAgreementsLineItems', window );"><strong>Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Novartis Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CollaborationAndLicenseAgreementsLineItems', window );"><strong>Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tcrx_AmgenIncMember', window );">Amgen Inc. | Amgen Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CollaborationAndLicenseAgreementsLineItems', window );"><strong>Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_LicenseAgreementDate', window );">License agreement date</a></td>
<td class="text">May  08,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_LicenseUpfrontPaymentReceivable', window );">Upfront payment receivable</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PotentialMilestonePayment', window );">Potential milestone payment</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_ExpectsResearchTerm', window );">Expects research term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and license revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">$ 14,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Long-term deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tcrx_NovartisMember', window );">Novartis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CollaborationAndLicenseAgreementsLineItems', window );"><strong>Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_LicenseAgreementDate', window );">License agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_LicenseUpfrontPaymentReceivable', window );">Upfront payment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and license revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_ReimbursementCost', window );">Reimbursement cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tcrx_NovartisMember', window );">Novartis | Research Funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CollaborationAndLicenseAgreementsLineItems', window );"><strong>Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_LicenseUpfrontPaymentReceived', window );">Upfront payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_CollaborationAndLicenseAgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration and license agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_CollaborationAndLicenseAgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_ExpectsResearchTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expects research term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_ExpectsResearchTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_LicenseAgreementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License agreement date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_LicenseAgreementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_LicenseUpfrontPaymentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License upfront payment receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_LicenseUpfrontPaymentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_LicenseUpfrontPaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License upfront payment received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_LicenseUpfrontPaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_PotentialMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential milestone payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_PotentialMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_ReimbursementCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reimbursement cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_ReimbursementCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=tcrx_NovartisAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=tcrx_NovartisAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tcrx_AmgenIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tcrx_AmgenIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=tcrx_AmgenAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=tcrx_AmgenAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tcrx_NovartisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tcrx_NovartisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tcrx_ResearchFundingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tcrx_ResearchFundingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058270915312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 28, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Nov. 08, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Facility</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_NumberOfLeasesFacilities', window );">Number of leases facilities | Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseDescription', window );">Operating lease, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On November 8, 2023, the Company entered into a lease amendment extending the expiration date of the 830 Winter Street Lease from September 30, 2024 to October 31, 2029 and provides for one option to renew the 830 Winter Street Lease for a five-year period commencing on November 1, 2029, resulting in an increase in the lease liability of $6.2 million.On October 28, 2024, the Company entered into a second lease amendment expanding the rentable space of 830 Winter Street. The amendment provides for an additional 25,628 square feet of space with a commencement date of December 1, 2024 and an expiration date of October 31, 2029 with one option to review for a five-year period. This amendment resulted in an increase in the lease liability of $6.1 million. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Oct. 31,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Lease security amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,031<span></span>
</td>
<td class="nump">$ 5,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Cash deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,766<span></span>
</td>
<td class="nump">1,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,972<span></span>
</td>
<td class="nump">15,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,357<span></span>
</td>
<td class="nump">63,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Increase in lease liability</a></td>
<td class="nump">$ 6,100<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,309<span></span>
</td>
<td class="nump">62,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_LeaseSpaceForFacility', window );">Lease space for facility | ft&#178;</a></td>
<td class="nump">25,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_LesseeOperatingLeaseCommencingDate', window );">Operating lease commencing date</a></td>
<td class="text">Dec.  01,  2024<span></span>
</td>
<td class="text">Nov.  01,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">cash payments for operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="nump">$ 9,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 3 months 18 days<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent', window );">Operating lease weighted average incremental borrowing rate percent.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember', window );">Royalty Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold', window );">Percentage of aggregate royalty of net sales of any product sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 31,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Lease security amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_CommitmentsAndContingenciesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_CommitmentsAndContingenciesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_LeaseSpaceForFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease space for facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_LeaseSpaceForFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_LesseeOperatingLeaseCommencingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease commencing date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_LesseeOperatingLeaseCommencingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_NumberOfLeasesFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of leases facilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_NumberOfLeasesFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease weighted average incremental borrowing rate Percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of aggregate royalty of net sales of any product sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of lessor's operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058165837472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Summary Of Presentation Of Operating Lease In Consolidated Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Oct. 28, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 64,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">4,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">60,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 65,309<span></span>
</td>
<td class="nump">$ 6,100<span></span>
</td>
<td class="nump">$ 62,386<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058166213632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment nad Contigencies - Lease Cost in the Company's Consolidated Statement of Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 11,564<span></span>
</td>
<td class="nump">$ 10,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">3,408<span></span>
</td>
<td class="nump">5,120<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">$ 14,972<span></span>
</td>
<td class="nump">$ 15,790<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167746800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Maturity of Future Payments Of Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Oct. 28, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 10,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">12,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">13,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">13,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter', window );">2029 and thereafter</a></td>
<td class="nump">43,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future payments of operating lease liabilities</a></td>
<td class="nump">94,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(28,773)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of operating lease liabilities</a></td>
<td class="nump">$ 65,309<span></span>
</td>
<td class="nump">$ 6,100<span></span>
</td>
<td class="nump">$ 62,386<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease liability payments due year five and there after.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058162328176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan and Security Agreements - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 20, 2024</div></th>
<th class="th"><div>Nov. 20, 2024</div></th>
<th class="th"><div>Sep. 26, 2024</div></th>
<th class="th"><div>Sep. 09, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument drew</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Rcognized loss from extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,090,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=tcrx_K2HealthVenturesMember', window );">K2HV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_FacilityFeePaid', window );">Facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PrincipalAmountIncreasePercentage', window );">Additional principal amount percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Term loan maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_InterestOnlyPaymentTerm', window );">Interest only payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_InterestOnlyPaymentExtendedTerm', window );">Interest only payment extended term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Prime rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="nump">12.61%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepaidPrincipal', window );">Repaid remaining principal amount</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_DebtInstrumentExitFee', window );">Exit fee</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_DebtInstrumentPrepaymentFee', window );">Prepayment fee</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Rcognized loss from extinguishment</a></td>
<td class="num">(1,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_FinalFeePercentage', window );">Final fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Convertible outstanding principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Converted instrument, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,134,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseLongTermDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=tcrx_SiliconValleyBankMember', window );">Silicon Valley Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Principal amount</a></td>
<td class="nump">$ 52,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Term loan maturity date</a></td>
<td class="text">Sep.  01,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual interest rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Prime rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_FinalFeePercentage', window );">Final fee</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths', window );">Percentage of loan prepayment fee in first year</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PercentageOfLoanPrepaymentFeeInYearTwo', window );">Percentage of loan prepayment fee in year two</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo', window );">Percentage of loan prepayment fee in there after year two</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Debt instrument payment, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The term loans will mature on September 1, 2029, and will be subject to monthly interest only payments until September 30, 2027, provided the Company achieves certain financial and clinical milestones, following which the term loans will amortize in equal monthly installments until maturity. If the Company does not achieve such financial and clinical milestones by June 30, 2026, the maturity date will be September 1, 2028, and the interest only period will end on September 30, 2026, following which the term loans will amortize in equal monthly installments until maturity. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseLongTermDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tcrx_TrancheOneMember', window );">Tranche One [Member] | K2HV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument drew</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tcrx_TrancheOneMember', window );">Tranche One [Member] | Silicon Valley Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument drew</a></td>
<td class="nump">$ 32,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tcrx_TrancheTwoMember', window );">Tranche Two [Member] | K2HV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Debt instrument remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tcrx_TrancheTwoMember', window );">Tranche Two [Member] | Silicon Valley Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Debt instrument remaining borrowing capacity</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tcrx_TrancheThreeMember', window );">Tranche Three [Member] | K2HV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Debt instrument remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | K2HV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PercentageOfLoanPrepaymentFeeRange', window );">Prepayment fee range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Silicon Valley Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Contractual interest rate</a></td>
<td class="nump">9.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | K2HV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_PercentageOfLoanPrepaymentFeeRange', window );">Prepayment fee range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_DebtInstrumentExitFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument exit fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_DebtInstrumentExitFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_DebtInstrumentPrepaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument prepayment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_DebtInstrumentPrepaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_FacilityFeePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Facility fee paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_FacilityFeePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_FinalFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_FinalFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_InterestOnlyPaymentExtendedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest only payment extended term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_InterestOnlyPaymentExtendedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_InterestOnlyPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Only Payment Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_InterestOnlyPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of loan prepayment fee in after year two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of loan prepayment fee in twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_PercentageOfLoanPrepaymentFeeInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of loan prepayment fee in year two.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_PercentageOfLoanPrepaymentFeeInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_PercentageOfLoanPrepaymentFeeRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Loan Prepayment Fee Range</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_PercentageOfLoanPrepaymentFeeRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_PrincipalAmountIncreasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount increase percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_PrincipalAmountIncreasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepaidPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt repaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepaidPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest paid or due on all long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph b<br> -Subparagraph (1)<br> -Publisher SEC<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=tcrx_K2HealthVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=tcrx_K2HealthVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=tcrx_SiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=tcrx_SiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tcrx_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tcrx_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tcrx_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tcrx_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tcrx_TrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tcrx_TrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058268130000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loan and Security Agreements - Schedule of Future Principal Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2027</a></td>
<td class="nump">$ 4,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2028</a></td>
<td class="nump">16,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2029</a></td>
<td class="nump">12,187<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal payments</a></td>
<td class="nump">32,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tcrx_LongTermDebtFinalPaymentFee', window );">Plus: Final payment fee</a></td>
<td class="nump">1,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: unamortized debt discount and final fee</a></td>
<td class="num">(2,053)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 32,072<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tcrx_LongTermDebtFinalPaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt final payment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tcrx_LongTermDebtFinalPaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tcrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058172141744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined contribution plan, employer contribution amount</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058172691472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">srt:ChiefExecutiveOfficerMember<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Segment reporting, CODM, profit (loss) measure, how used, description</a></td>
<td class="text">The CODM assesses the Company's performance by reviewing GAAP net loss and significant expenses by function along with the annual budget. The chief operating decision maker considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058165796640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and license revenue</a></td>
<td class="nump">$ 2,816<span></span>
</td>
<td class="nump">$ 21,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">107,350<span></span>
</td>
<td class="nump">88,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">30,287<span></span>
</td>
<td class="nump">26,354<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(134,821)<span></span>
</td>
<td class="num">(93,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">12,065<span></span>
</td>
<td class="nump">7,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">3,653<span></span>
</td>
<td class="nump">3,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="num">(1,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(127,499)<span></span>
</td>
<td class="num">(89,218)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration and license revenue</a></td>
<td class="nump">2,816<span></span>
</td>
<td class="nump">21,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(134,821)<span></span>
</td>
<td class="num">(93,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">12,065<span></span>
</td>
<td class="nump">7,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(3,653)<span></span>
</td>
<td class="num">(3,759)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="num">(1,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(127,499)<span></span>
</td>
<td class="num">(89,218)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember', window );">Reportable Segment | Personnel Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">31,742<span></span>
</td>
<td class="nump">24,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">10,900<span></span>
</td>
<td class="nump">9,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember', window );">Reportable Segment | Laboratory Supplies, Research Materials and Studies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">31,468<span></span>
</td>
<td class="nump">30,101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember', window );">Reportable Segment | Clinical Studies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">19,245<span></span>
</td>
<td class="nump">10,214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember', window );">Reportable Segment | Legal and Professional Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">7,380<span></span>
</td>
<td class="nump">7,119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember', window );">Reportable Segment | Facility-Related and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">16,669<span></span>
</td>
<td class="nump">16,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,576<span></span>
</td>
<td class="nump">6,976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember', window );">Reportable Segment | Stock-Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,846<span></span>
</td>
<td class="nump">2,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">4,703<span></span>
</td>
<td class="nump">2,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember', window );">Reportable Segment | Depreciation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">3,380<span></span>
</td>
<td class="nump">4,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">$ 728<span></span>
</td>
<td class="nump">$ 862<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=tcrx_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=tcrx_PersonnelExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=tcrx_PersonnelExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=tcrx_ClinicalStudiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=tcrx_ClinicalStudiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=tcrx_LegalAndProfessionalFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=tcrx_LegalAndProfessionalFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=tcrx_FacilityRelatedAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=tcrx_FacilityRelatedAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=tcrx_StockBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=tcrx_StockBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=tcrx_DepreciationExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=tcrx_DepreciationExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058171534384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (127,499)<span></span>
</td>
<td class="num">$ (89,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic</a></td>
<td class="nump">111,990,417<span></span>
</td>
<td class="nump">65,599,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted</a></td>
<td class="nump">111,990,417<span></span>
</td>
<td class="nump">65,599,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="num">$ (1.36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="num">$ (1.36)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058167874752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Net Loss Per Share - Additional Information (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 27, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tcrx_PreFundedWarrantsMember', window );">Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock issuable upon exercise warrants</a></td>
<td class="nump">73,087,945<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tcrx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tcrx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46058166107936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Summary of Potential Common Shares Excluded from Computation of Diluted Net Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">12,605,915<span></span>
</td>
<td class="nump">16,667,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=tcrx_EmployeeStockPurchasePlanMember', window );">Potential shares issuable under the ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">138,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Common stock issuable upon conversion of Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,269,592<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Options to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">12,467,782<span></span>
</td>
<td class="nump">10,398,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=tcrx_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=tcrx_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>91
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MX:'K'?JN%IO57-^66AM;D^V[YG2]ZFQ7<4(8F@*K)\KTHYI9YX9FAS@,"<B
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MPK !O01-VWUF9#H6(HFN2#G-?OU(6;%LDJ%=3?[0QI?#([ZOR,.'E*\>6?7
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M+BF1 T@%R.\73.[RVS?JUW_;GX=._P-02P,$%     @ UCME6F^1$:8H P
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M^-Y\W#$*.W,M +]O.02O_:)OT+TSM_X_4$L#!!0    ( -8[95H>,@&$3 (
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MJ=YDH5^GZ#I?-U&\MMUFSY7N7798ZI\%"!.@G^><J^/$;##\?I(W4$L#!!0
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M%8L'78,X!7G=4Q;#T%W-ZXU"KB6FS&&Q+ /KX*-K8(EPPD*G*-5#8*EB\2N
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M):T23[U!8Z1ZA:K#_.7A_$2A5M;C)"%]OQCFG0D>V5^]RXAT&EAV-<RQ65.
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M)[.W;R8YA?U#\HU\J5OYE'PM/S>$$W?@"7A?>5QQNP?>8/AT>_D?4$L#!!0
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M:F= ][52]G1P <X_N/6_4$L#!!0    ( -8[95IB;/'^'@4  +X,   9
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M5^<3TN&[1[BQJO'?&C;*6E7YRX(%^' 3\'RK\,K=W;@-AH]/5_\#4$L#!!0
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MCL$B_O_PC.-/#4C;SJ7G 2[ IWX07SP'OJ_( ,VN_?G2L!B-FW(ZGL?-;'?
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M%!TLZ%,:\SX]:G&JVP+05A;"3B4!!<%V-(&**B(>6)7(;%L(R4@?RR>W+!!
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M2@2_9;:E+.X%!"BK,J$+;X1\2&T0Q0>:]T9H"[\Y8L_I=[.OWT-=65E720B
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MUIBP7'./TH2I^6H]!UD3EO:L:L9$PS$;^DF.RV&RN1S%27^4/-;+;R2<:7B
M"RK2[X&<\[I8\]>6& 8\28ZPRC[9-E:O@ZM_O$0W5W0]/7N@ENPQ5>(G7XC3
MAJ^C%]L+S?YH&DS$WK;2N''Z<02R,'GX.K1C?!D95X;$Q%D>Y@ QB:ZS2-?]
M2,S^GN@X&0YE<W9_'X$=_77Y?!4E5_CD2,M6WJ#R"+3H>J<IC'8QXD*U*FZ/
M$ARY^&"KTJ?WX182H^<.GX(EW(4+F3N\4?M4IXE.>K[P=3K3TJ(+@CV'DYM&
M+Z&_B]\M2LO,E[X1POO\;42\JK*8H5[3%&#53-#CMYUAV*[H@B]>"^!U0>5+
M+U)L#X!M8EDM4VO>#)V;ZRVJ#W831H#.^\&K "9N>X[5FWU[L9M0CHA)\$9%
M5P%KJ Z;58BJ<XJLV<H/L XK_5KQGD2BEY7#6N7XTT*N([LQNP(;V$:79&)]
M!(D-%PYT6-DUKW'$9$RN ZK W<IVOQN@JXXE<"!H6%-$X3JQ+V)'WC6FT4I.
M7"U# [O>>HCH+*NH%8FJ+!QP*NZST2=4A8I7/Z&>F5(&0ME\[P3E3J8APTP9
M*8%H;*\X48!/NOPGV4/?6FV0*+I;"4EI;GUBG?V@=OMUU@QT2Z9:U;\$I@5R
M6^;WT9+.H*=ER5.II&TEC<5+NG'+<QIG=&D1"[[=SKHW+8?&]$&-TQ#)403,
MR$ ?,Z6CJG(U]^X0 RY#3TT1NKF]%SVH6\ZJ.*TK4H:U*:?UN6)D-YA\_GXT
M^ WA?G /+L@&O1YH]1J]UY5DEP/\<YZ/&!YO.3/D*_4!@.+?W1;\*U9W=\M)
MNW_^X29Y;)'\4POCT,+R?UH:K\;G"R)9?LCT-R&\[7!IN+QD>!U8FRW?*@>F
MB8KB5C25@R5N]/01T7VZ!4DFBSF]N!+313*[F#SBQ6(Z2Z97EX]^-K[')AJE
M\UER,9D\>I=7[BFVPRZ]HL$^31:SBT=O 5U/46<UD<T&XM1>)9Z*63*YF(M1
MU,IGH6=R.1-#/XDXZ_QPA3&5?I[#M^N%#[]A:=YM?@'T,OSPI3T>?C[TO;1K
MFFNY6N%1HJ8GPH:?Y(07WI3\,YBE\1A\_.=&2?0/'<#G*P/>&U^0@N9W4=?_
M 5!+ P04    " #6.V5:7ET0L>@"  !I!@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6R-5=MNVS ,_17"*X8.*'Q+VG5=$J!I.ZP#"@3I+@_#'I28
M3K3JXDIRTOS]*-GQTB+-]F+KPG-X2(G48*W-@UTB.GB20MEAM'2NND@2.U^B
M9#;6%2K:*;61S-'4+!);&61% $F1Y&EZEDC&530:A+6)&0UT[017.#%@:RF9
MV8Q1Z/4PRJ+MPI0OELXO)*-!Q19XC^Y;-3$T2SJ6@DM4EFL%!LMA=)E=C/O>
M/AA\Y[BV.V/PD<RT?O"3VV(8I5X0"IP[S\#HM\(K%,(3D8S'EC/J7'K@[GC+
M_BG$3K',F,4K+7[PPBV'T7D$!9:L%FZJUY^QC>?4\\VUL.$+Z\:V1Q[GM75:
MMF":2ZZ:/WMJ\[ #.$]? >0M( ^Z&T=!Y35S;#0P>@W&6Q.;'X10 YK$<>4/
MY=X9VN6$<Z,I.FZ0LNQ@(I@:)(Y(_58R;PG&#4'^"D&6PYU6;FGA1A58/"=(
M2$TG*=]*&N<'&:]Q'D,O.X$\S?L'^'I=B+W U_MWB&-46')GX>?ES#I#5^+7
MOH@;OOY^/E\F%[9B<QQ&5 <6S0JCT=LWV5GZ\8#:?J>V?XC]?P[D(,%^>5D>
MPPMF^+I$N-*R8FH#7'''F<,"F+_31%G G([5\%D=JJ?RB)I.V,!]6U#]-#M^
M> >Z!$=,M],K./8#S_V.P"LT7"V "0&/-1.\Y,2)LA)Z@V@!RQ)#1<(7IFKJ
M!Q!.//L0PTUK]$R!!6805EK4RGEKIHJP4J!#(X-@7^2*0BGXBA?DTI<KM]1O
M9K_)%3@=A%+Q<%E++TROV4Q@&U:)]"608T_4;1:U8,%M_"Q/DA4O9;6T(:64
MBR/(XI0J58C0=$CE$:3Q^VZ%^FBPWR SE 5?,T W'N6,-&QO?<#1H <GI,56
M3:;$)H9]-RS9*7^)9A&:G"69E*JF$W2K71^];-K'7_.F"=\QL^ 4E,"2H*3[
M- +3-+9FXG05FLE,.VI-8;BDMP"--Z#]4FNWG7@'W>LR^@-02P,$%     @
MUCME6H81"W-N!0  _PL  !D   !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL
ME5;;;N,V$'W75Q NT": '.OFB](D0"Z[VP4VW2!)6Q1%'VAI;!&A2"U)V<G?
M=X:2+^EFW>V++8F<,^<<#H<\6VOS9"L QYYKJ>SYH'*N.1V-;%%!S>V);D#A
MR$*;FCM\-<N1;0SPT@?5<I1$T614<Z$&%V?^VYVY.-.MDT+!G6&VK6MN7JY
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M%D :!7S/A="[@W'0_6CF_P!02P,$%     @ UCME6CBG]&XT P  X <  !D
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M-1X&H.O[I%Y8M?/?\+6R="-XLZ K&+4+H/V-4O:X< >TE_KB'U!+ P04
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MM'ET=8VH.E9M_*][H2Q=!'QS33<OU,Z YG.E['/'!6CN<M-_ %!+ P04
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M<VAE971S+W-H965T,S,N>&ULC5;;;N,V$'W75Q!:H$T )98H6;9<VT NNVV
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M]#I]$"6KQE]-M"AL[UP*#9W8#C-X*XDT";"^$D+O)F:#YO6-?P-02P,$%
M  @ UCME6I!]2)*X @  ZP<  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N
M>&ULK55IC],P$/TK5D!H5X+-U0,M::0>(%9B4;75PF<WF236.G:PW0.)'X^/
M-K2E#8N@'QH?,V_>\]@SR8:+)UD!*+2M*9,CKU*JN?5]F5508WG#&V!ZI^"B
MQDI/1>G+1@#.K5--_2@(!GZ-"?/2Q*[-19KPE:*$P5P@N:IK++Y/@/+-R N]
M_<(#*2ME%OPT:7 )"U"/S5SHF=^BY*0&)@EG2$ Q\L;A[71H[*W!%P(;>3!&
M1LF2\R<SN<M'7F ( 85,&02L/VN8 J4&2-/XML/TVI#&\7"\1_]@M6LM2RQA
MRNE7DJMJY+WU4 X%7E'UP#<?8:>G;_ R3J7]1QMG.]3&V4HJ7N^<-8.:,/?%
MV]TY'#C$P06':.<0G3A$T06'>.<06Z&.F94UPPJGB> ;)(RU1C,#>S;66ZLA
MS&1QH83>)=I/I0N7/<0+M" E(P7),%-HG&5\Q11A)9IS2C("$KU!XSPGYO Q
M17?,W2"3BJL9*$RHO$Y\I2D98#_;A9^X\-&%\&&$[CE3E43O60[Y,8"OM;2"
MHKV@2=2).(/L!L7A:Q0%40\]+F;HZN4U6D"IKYXZ0W#Z?+AX#]=!,V[//;:X
MO0NX#R"5()F"'&585N=.S@'T+8!YC.NT'\1A$ 2)OSX4\&>[(X:]EF&OD^$C
MRT#HO#*D\!8U7-K4RW-,>[\Q..7897'$KM^RZW>R^[RJER#,M170<,US20%)
MEV7THR/?$X<[.* 2GI#MC&S*ZJUL< 8C3]=-"6(-7OKJ13@(WG7<BT&K:]"I
MZQ,HY71-!>C7=DY!)\+S^3FQ_PGL2.RP%3O\UT<P/'.Y[>\D9YV!_E:&?U!/
M:Q"E;3,2V9+H2FN[VG:RL2W@_B]SUP;OL2@)DXA"H5V#FZ&6(EQK<1/%&UN=
MEUSI6F^'E>[&((R!WB\X5_N)"=#V]_0G4$L#!!0    ( -8[95H49YS<% 0
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M\.,<7A6(<ROB=YFI2/22&F/P?_][04Y,'''V17"-JI,ZC(QL;;;\NZVC53^
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MZ/2<6;Y2<NV>9-/E1@$I5]K(I@-C!0T3_DT?.Q]V /'Y 4#2 9*7@.P (.T
MJ1/J*W.RIM30(E=R0Y3-1C:[<-XX-*IAPO[%6Z/PE"'.%#.%%T*9)T)%12X?
M5JS%7V3(.S*J*F:-IIQ<"7];K.W'4S"4<7V"*7>W4W)\=$*."!/DFG&."3H/
M#99ER<.R*V'L2T@.E! GY%H*4VMR*2JHGA.$J*<7E6Q%C9-7&:=0#D@:GY(D
M2K(]!4W^'9Z^4D[:>YPZOO0O'I^2&:=H[G.KOX_FVBB\SC_V6>>9L_W,ML4O
M=$M+& ;8PQK4&H+B[9OX//JT3_9_(GMF0M:;D+W&CJ8B:<G\+;(.T$8JPW[Z
M #SB6-*PSP%/^]'1VIFT+K)!G(?K76%_YIP-LC['UQON-$D#:NEFAR:E7 GC
MKU8?[<?3R'7EB_@8QY:?,K]I_,R[IFK)A"8<%D@9#=Z?!43Y.>(W1K:N%>?2
M8&.[98VC%Y1-P/.%E&:[L1_HAWGQ"U!+ P04    " #6.V5:/+XQ+>T#   3
M%0  &0   'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6RU6&UOHS@0_BL6MSIM
MI6[!!$C22Y#:Y+I[TE6J-KM['T[WP8%)8Q5PUC;)5KH??S907K:$)B?X$FR8
M>3SSS-AYY-F!\2>Q!9#H1QPE8FYLI=Q=FZ8(MA 3<<5VD*@O&\9C(M64/YIB
MQX&$F5,<F;9E>69,:&+XL^S= _=G+)413>"!(Y'&,>'/MQ"QP]S QLN+S_1Q
M*_4+TY_MR".L0'[=/7 U,TN4D,:0",H2Q&$S-V[P]<*VM$-F\8W"0=3&2*>R
M9NQ)3_X(YX:E(X(( JDAB'KL80%1I)%4'-\+4*-<4SO6QR_H=UGR*IDU$;!@
MT5\TE-NY,3%0"!N21O(S.WR"(B%7XP4L$MDO.A2VEH&"5$@6%\XJ@I@F^9/\
M*(BH.6#GB(-=.-BG.HP*AU&6:!Y9EM:22.+/.#L@KJT5FAYDW&3>*AN:Z#*N
M)%=?J?*3_AVA''TC40KH'HA(.:@:28$^H)7JF#"- +$-NA$"U,L%X9Q"B(A$
M-3]=#/2) B<\V#ZC6R*H0.^7( F-Q(5"^KI:HO?O+M [1!/T9<M209)0S$RI
MXM=1F$$1ZVT>JWTDUB4$5VB$+Y%MV4Z+^^)T]U'3W52LE=39)75VAC<Z@I>3
M<EFG8DE%$#'-(OK[9BTD5UWZ3UNB.;+3CJRW[K78D0#FAMJ; O@>#/_77[!G
M_=:6=D]@#1)&)0FC+G3_"Y,D0AN:D"2@:D0R4MI2SG'<#$<?+GO?GF#LN3-S
M7T_FM1F>C!UO7)HUPG3*,)W.,#^R/?!$MS9:09!R*BFT1MD)<VYA>@)K9.R6
M&;N#=:?;)PD]@35(\$H2O,ZR+XC8(G78H$ /X'M*]R3*SK>-IF6?T1*6M+1Q
MT;G N5SD8%ZMN<>>,QFU]_:X3'+<F>0]X4_JL%VKHUJ4O7UY>H;C5T%AC!T;
M_[0Q7YNY$V_BML<^*6.?O%V@WVMU^8#N60+/*$\*W:5'_BDZ8<\M2T]@#0:F
M)0/3P?;IM$\2>@)KD("M2H980^_48H5&(WO3L>/\U,@M=JYM3Z?MG8QK2@IW
MIG"3*=*B<Y4"^A/V$"%\T1IK)]2YI>L+K9EXI8/P<$((]ZJ$^D)K$E%I(=R7
M&"J O+?44(M=EQS"E1["W8+H6+.B?]')6JE[B;-K-X1:PI5<PL/I)=RK8.H+
MK4E$)9GPX)JI>X6S^3A+->%*-N%A=1,^43BUV'4H)UQ))]RMG3JV\/^65=U+
MGEVY(805KI05'DY:X5ZU55]HS7N*2ES9@XNK8@7W+7'58M<FKLS:C96^+E1]
M^4@3@2+8*#_K:JP >'X#ET\DVV676&LF)8NSX19("%P;J.\;QN3+1-^+E?>@
M_G]02P,$%     @ UCME6H1>%R\X P  1@L  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#$N>&ULS99=3]LP%(;_BI6A"20@7_V"M97:,C0DF! ,=C'MPDU.
M6PO'[FRG9?]^QTX:6E0";+W836,[/J^?\]9V3G<IU8.> 1CRF'&A>][,F/FI
M[^MD!AG5QW(. M],I,JHP:Z:^GJN@*8N*.-^% 0M/Z-,>/VN&[M6_:[,#6<"
MKA71>991]7L(7"Y[7NBM!F[8=&;L@-_OSND4;L'<S:\5]OQ*)649",VD( HF
M/6\0GH["P :X&?<,EGJM36PJ8RD?;.<B[7F!)0(.B;$2%!\+& 'G5@DY?I6B
M7K6F#5QOK]3/7?*8S)AJ&$G^G:5FUO,Z'DEA0G-N;N3R"Y0)-:U>(KEVOV19
MS@T\DN3:R*P,1H*,B>))'TLCU@+"U@L!41D0/0]HO! 0EP&Q2[0@<VF=44/[
M72671-G9J&8;SAL7C=DP8?_&6Z/P+<,XTS^G3)%[RG,@5T!UK@#_(Z/)$1FD
M*;-.4TXN1+%?K._[9V HX_H I]S=GI']O0.R1Y@@WV8RUU2DNNL;!+/R?E)"
M# N(Z 6(,")74IB9)I]%"NFF@(\956E%J[2&4:WB&23') X/211$C2U H[>'
MQS4X<>5R[/3B5UT^) .M 0U&I\@EHV/&T670*_=3@A[?0)(KQ<34S?HJA:H&
MAE0S37Y<X@+DPD"F?VZSNZ!I;*>Q-\.IGM,$>AX>?0UJ 5[_XX>P%7S:9M6.
MQ#:,:U3&->K4"^,6A7'4&7=(."R DY 8638C8A05>@)JZ]XK5FBZ%>RMMN@'
M77^QGF'=C WL9H7=_$OLZ D[K,<N5FC58-?-V,!N5=BM=V-7C'C&*_1X&W#K
M5>"Z&1O [0JX_0_ ^-4B<E*'W'YU:[3?BMRID#NUR'="CNTIH6..)UC,<[P+
M]B\+Q(-MC+5R[SW+.Q+;R/RDROSDO[H$3W9IW([$-HP+@Z>/=/#&?6XW="+%
M I1A=@=Q*:9'!E2&M<O8;/WTUDJ_UX=2;?W(Q)U&\/Q0^&L5209JZ@HUC>2Y
M,,57O!JMBL&!*X&>C0]MD>@JG2>9HL*\HFK*A,;C/4')X+B-3*HHVHJ.D7-7
M]XREP2K*-6=8Z(*R$_#]1$JSZM@%JM*Y_P=02P,$%     @ UCME6LHV?.P+
M P  V @  !D   !X;"]W;W)K<VAE971S+W-H965T-#(N>&ULK99O;],P$,:_
MBA40 @F6_TDUVDJC X$$8MH8O$"\<)-+8\V)@^VVV[?G[&2A:[VI2+QI[>2>
M)[^[V.=,MT+>J!I D]N&MVKFU5IWI[ZOBAH:JDY$!RW>J81LJ,:I7/FJDT!+
M*VJX'P5!YC>4M=Y\:J]=R/E4K#5G+5Q(HM9-0^7=.^!B._-"[_[")5O5VESP
MY]..KN *]'5W(7'FCRXE:Z!53+1$0C7SSL+3Q<3$VX#O#+9J9TQ,)DLA;LSD
M4SGS @,$' IM'"C^;6 !G!LCQ/@]>'KC(XUP=WSO_L'FCKDLJ8*%X#]8J>N9
M-_%("15=<WTIMA]AR"<U?H7@ROZ2[1 ;>*18*RV:08P$#6O[?WH[U&%'$":/
M"*)!$!TKB =!;!/MR6Q:YU33^52*+9$F&MW,P-;&JC$;UIJW>*4EWF6HT_.S
MHI!K*,G[6UP7"A2A;4F^ZAHD6:REA%:3SXPN&6>:X=TWY K74;GF0$1%_E'\
M\APT95R]0IOKJW/R\ODK\IRPEGRKQ5JA5DU]C3D9,K\8^-_U_-$C_.=0G) X
M?$VB($H<\L7Q\OBAW,=*CN6,QG)&UB]^Q.^"WM$E'RIART.Y(C_/EDI+7+&_
M7 GVCHG;T>SB4]71 F8>;E,%<@/>_,6S, O>NM+]3V8/DH_'Y..GW,>U!$W'
MQ1T *41C%@;M-RQ69 DM5$P[WW/OG5IOTWLV\VR2I%-_LYO>85":Y),QZ %V
M,F(G1V&;@E!9U):TA UVN [[E7;!]H[9+FP>[\,>!L5IG+MATQ$V/0JV$*W"
M3L7:E<7MI*A F=9*.3'OE17@K')ZP!0F>;P'[@@*HLP-GHW@V5'@'%8[B!:>
MXPC;!ZD 7,C9 4TT"?>('3%IX ;.1^#\26#;QUP\^<&S\FP/YS DB5(WSF3$
MF3R)\TUHK!N]WV*['5?8CEL,'9?_[;@N^LG!#@K3) SV$G!$!7FXOP3\G7/'
MG/E?J%RQ5N$[KE 7G.1H(/MSM)]HT=FC:"DT'FQV6..G!T@3@/<K(?3]Q)QN
MX\?,_ ]02P,$%     @ UCME6DJT= QN"0  NF(  !D   !X;"]W;W)K<VAE
M971S+W-H965T-#,N>&ULQ9U=;]LX&H7_"N$=[,X ;:PO6TXW,9!$HI3%9AI,
MIM.+P5XH-AT+E26/*"<M,#]^J8]8ID2S5N<4<]-:,M^'E'1"4N>5Z(N7+/_$
MUXP5Y/,F2?GE:%T4VW?C,5^LV2;B9]F6I>*;599OHD)LYD]COLU9M*R"-LG8
M,HSI>!/%Z6A^4>V[S^<7V:Y(XI3=YX3O-ILH_W+-DNSE<F2.7G?\$C^MBW+'
M>'ZQC9[8 RL^;.]SL37>4Y;QAJ4\SE*2L]7EZ,I\%SI50%7BMYB]\(//I#R4
MQRS[5&[<+B]'1MDBEK!%42(B\=\SNV%)4I)$._YHH*-]G67@X>=7.JT.7AS,
M8\39399\C)?%^G(T&Y$E6T6[I/@E>PE9<T"3DK?($E[]2UZ:LL:(+':\R#9-
ML&C!)D[K_Z//S8DX"#"=(P%6$V"=&F W ?:I 4X3X'0#[",!DR9@T@V8'@F8
M-@'34YOD-@'NJ37,FH!9=77KRU%=2R\JHOE%GKV0O"PM:.6'2A!5M+B$<5IJ
M]Z'(Q;>QB"OF#T6V^+3.DB7+^;^(_\<N+KZ0M^1JN8Q+;44)N4WKOY!2:3]Z
MK(CBA/\DBGQX\,B//_Q$?B!CPM=1SCB)4_(AC0O^1NP4GW]=9SL>I4M^,2Y$
M4\L*QXNF6;1NEG6D6:9%[K*T6'/BITNV5 !"/< R-("Q.$G[,V6]GJEK2TOT
MV.*,6.X;8AF6HVC0C3[\:IN+<.=HN*</_\\N/2.&687;BG!?'WX7?2'F]&@T
M/>'0;?-HVX/3PU6UA]]<NW0A[;WD[8IG'^'=)!'G)%N12OOD]_^*[\EMP3;\
M?XK&7=<P1PTKAY9W?!LMV.5(C!V<Y<]L-/_G/\RI\6^51I P#PGSD3"*A 5(
M6 B"2<)S]L)S=/3Y+>>[*%VP4GN+;+,1'2HO)?B&I&*2(G9FJQ7+X_1)?,L+
M5:]YK:U@J!B1, \)\Y$P6L,F%:R<RCW/;=NTS8OQ\Z'*^J4<RS$=N50(:I@D
MG\E>/A.M?'X6(MGFV8*Q)2>K/-M((B)BH"4O49Y':<%)M"I8+N9PRYV8&PI!
M[<0@F+_D<;6QC/DBVZ7E.%T28EY.1'D%R(JUB-OKD'T6<V3.E%+4-G:H%">]
MLV].3<<PY-/O*8K9CMLMYB.;1I&P  D+03!)C-.]&*=:,=Y+0HP/>C91V=M5
MJ;=6C@,Z.&VM0U55PZ:'<K%F=D]5_6+G5J^4CVP95;1L,K/<;J>D;)DYZW1*
MH)9).G#W.G"_40??.,)IJQLJ +=W_D37W[O^_5*BZ^]=?V3#J+)AO3%)V;#>
MF 1JF'3Y9_O+/_M;N@%MK4-5,.N/&JINH%],U0T@6T85+5-U \J6];H!4,LD
M'9SO=7"NU<%O636SN*G_YJL;*]5EU4*&7E8DS$/"?"2,(F$!$A:"8)+@3*,U
MK@SD;7Q# VD/2O.@-!]*HU!: *6%*)JLP /KU-1V>C?2#&<;Y>0Y2G9,J3XM
M:;#ZD#0/2O.A--K0W(.ASS@S#*,[0IY8+OQZ.5D+5JL%:^@ 2/[\ZGBHAPZ6
M!9+F06D^E$:AM !*"U$T68BMN6U"W6T3:F]#:1Z4YD-I%$H+H+0019,5V+K<
MIM[F_GFW>:Q,Q'U:4-P6*G-XUWK28/5!#6THS8?2:$.3G('SR<R8SKKC8K^@
M95LSU[2[+@*J@;)H6F_;U)O;@-R(OH;!8D+2/"C-A]*HJ7#5NS+J%[&Z^OD>
M;K39VM&FWH]6S[_N=X])O"#O&^TH50-UG*$T#TKSH30*I0506HBBR5IL+7'3
MA4[!H)8WE.9!:3Z41J&T $H+4319@:TK;^IM^8<HJ4;2.C.\S6,QL&[%G*R:
MD"DU"#7<H33/[-O?G<''AU9(H;0 2@M1-%E8K<UO#O;YQ3!+LR01I/>I?J2%
MNO]0F@>E^5 :A=("*"U$T>0G,ML<@ 7- 5C0' "4YD%I/I1&H;0 2@M1-%F!
M;0[ TN< !I@=>M)@]9FG60">HJ#: O"A#:106@"EA2B:+)HV66#IDP6#IV=Z
MWF#IU+39@2+<,]/NZ@;J_T-I%$H+H+0019.UU?K_EM;=G7]X?=*S[)6VU5L;
M14:VNWRQCC@CZ;Z_BMI7/.JN2RD\:'J@H4E=D3.;.#.WJSVH\P^E42@M@-)"
M%$W67NO\6WKG7WUW</7K';G/LZ<\VHBMCVSYN.-K\L 6N_)Y9,;?D-MT<:94
M'S0] *5Y4)H/I5$H+8#20A1-EFB;9[ FT#L&:$X!2O.@-!]*HU!: *6%*)JL
MP#938>DS%4/N&*"Y"2C-@])\*(U":0&4%EK]9_H-]<-'5IMPL/0/X0.2I_H:
M!DL-FH2 TOR&=F@GNQ.C^YPWA58:0&DABB;+K<TN6/KLPH#G'O6DP;*"YA6@
M-+^A?>T)1 JM-8#20A1-UE6;7+#TR87[G+VE]2LC'U]?9/S]CI7#I7IR!DTH
M0&D>E.9#:11*"Z"T$$635P9H$PHV-*%@0Q,*4)H'I?E0&H72 B@M1-%D!;8)
M!?OTEPKJ%^H>$T9V6[&/?6;Y(N9L_T*=4I)]N[^:WG0G.#?Z=@Q6&_0E BB-
MJDZ);<S<<V?2><X-6F]X2KVR2MH,@JW/(.S'QU=-*.\?]9#!W1/T]0(HS8?2
M:$-3WZ,U2H'F#+05RA(Y6.5&GPAH)-+V&E6>22D3[!(WV#5N[).FU3ZT5@JE
M!5!:B*+)LFH]?EOO\7^O-[Z;:J5E6E2C%M3$A])\*(U":0&4%J)HL@9;$]_6
MORSPW30XZ77#2@U";7PHS8?2*)060&DABB9KL+7Q;;V-__Z4-9(:AO3H:E].
M4%\>2O.A- JE!5!:B*+)<FHM?/MKZ^@<][[(G^3$]37TE0R>R4%=?"C-A](H
ME!9 :2&*)@NS-?OM&=01@QK^4)H'I?E0&H72 B@M1-%D!;9I 5N?%OC+CA@T
M3=#0I*7;9A/7=<SSSD-LBI*.:YC&Q)IV;UZA]CZ4%D!I(8HFK[_:VON.UKR5
MI=0^=]NH1R6>!BBM"]J9OS5%#BT*]\RTSKMZ4)0SS\[/N^5\_3$,50.4%D!I
M(8HFJZ&UVAV]U7ZZ0^:<MKS,S8GEO!/+^?H#&"P%Z!/Y4%J(HM52&!\LB+]A
M^5/UXPB<5*O>UBN^[_?N?X#AJOK9@<Y^:KX+ZI]1:#'UKSK<1?E3G'*2L)5
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MG;LX@=(\4)H/16NJ5CMR;'_P9@Q#^NLY*,T#I?E0M*:4M??'9N__<%!S6H4
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M0MT@ P  = @  !D   !X;"]W;W)K<VAE971S+W-H965T-#8N>&ULK5;;;MI
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MBN"0,%5 _KZ@5+S<J ;*_TS&_P-02P,$%     @ UCME6HB)/1C, @  S08
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M![G^AG4]3F B<^V>L*YSVQXD2VUD48-)0<%%]68O=1^V ,'% 4!8 \)=0'0
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M<![7G,=&SI=AR#<0(64).*\D89S@3D,3&8/0,1Y_0^0E55-$A^.DYC@Q<ER
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MEVN@N,.K /Q^R9A\OE$#U*?BP?]02P,$%     @ UCME6JE_X.[) P  )@T
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M,C\VC@!]90>41D!I%)3F5;3]GO!P?'*XT?@RV.S+/+ H>5R+K$R5^0N)6M%
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M"H IW<YK-\(-H(1QE[,UX#I:L>D+H[Y!*[TPU7TREEP]Q0HGXSY+4RR5\5(
M2*>@SZC$=(YH@I$ G\$X[Q]P/P,CCH2*@\9@-;[/$(<Z&-PA916XI1HM&,%3
M*-$4W$ ":8+ V/3[^0!)B(GXI$B?Q@-P?O8)G %,P>."+85*+;JV5 7I:=E)
M,?F;?/+N@<D/4-("7OL"N([K5\#[]?#[1+: VSD('QR?W:N #^OA/]BJ!9Q.
M%=Q6)I9.NJ63KN'S#O!="X&4B;^O)T)R]?[]J=(SI_"K*?2:="4RF*">E6FS
M^0I9\<</[=#Y4J5NDV2#)LF&#9%M^>"5/GAU[/'[:T',:P&-+U5FY#R!X='K
M^2H.?2^(NO9J4^7:;*>J7)'2\R_=[93#AE)NR>>7\OFU;7R'X003+/7R4]_+
M?I.]W"39H$FR84-D6V8$I1G!2;U,WLVY4+L3YVH_J+(F9PTWVLP/(F>GL6M3
MGRKY?D;/]<.=OFXHXY:482EE^%]2OEX JK9'-GO3$V2,ZRVV2M=PK\K0B;S+
M'6%K)W*JL/LI@\NVO^/EL*&46\I&I;)1K;*/3$("V.%6K5(RVE\( \_95;(B
MJNWLU#ZH"'*]SF[O545M4.65VQL'.7U,_P[Y'%.A2IHIF-.*%)[G1]]\(%EF
MSG83)M5)T5PNU-<"XCI /9\Q)M\&^KA8?G_$_P!02P,$%     @ UCME6E:]
MTR;; @  ] <  !D   !X;"]W;W)K<VAE971S+W-H965T-34N>&ULK55M3]LP
M$/XK5H:V(0%Y;0JLC43+IDT:&J+ /DS[X";7QL(OF>VV\.]G.VE62EHV:5]J
M^W+W^'GNW+O!2L@'50)H],@H5T.OU+HZ]WV5E\"P.A$5</-E)B3#VASEW%>5
M!%RX($;]* A2GV'"O6S@;-<R&XB%IH3#M41JP1B63R.@8C7T0F]MN"'S4EN#
MGPTJ/(<)Z+OJ6IJ3WZ(4A %71' D83;T+L+S<=_Z.X=[ BNUL4=6R52(!WOX
M4@R]P!(""KFV"-@L2Q@#I1;(T/C58'KME39P<[]&_^2T&RU3K& LZ'=2Z'+H
MG7JH@!E>4'TC5I^AT=.S>+F@ROVB5>,;>"A?*"U8$VP8,,+K%3\V>=@("-,=
M 5$3$&T')#L"XB8@=D)K9D[6)=8X&TBQ0M)Z&S2[<;EQT48-X;:*$RW-5V+B
M=#86C!%MRJ(1QP4:"Z[)''A.0*%C]!5,AHQ1:40XTJ7=LPKSIW?*NBI!28$U
M%&BBS>)0Q Q]JT!B6R2%WE^"QH2J0P-V-[E$[P\.T8'%NBW%0F%>J(&OC0Q+
MQL\;RJ.:<K2#<ABA*T.S5.@C+Z!X#N ;_6T2HG421M%>Q$O(3U <'J$HB)(.
M0N._#X_WT(G;FL0.+]Z!Y[)^5*?]Q\54:6D>^\^N1-4X23>.;0#GJL(Y##WS
M#U<@E^!E;]^$:?"A2^1_ GLF.6DE)_O0L^;)\#FB[LGE1GOGTZAA>@[&=JAE
M%H:]U!1MN2FEPRM(H[3U>L:QUW+L[>4X*874QQHD>XWD7IQ_+4L-EFYH29)N
M(6DK)-TKY!Y+@J<47I.1OK@Y3H+3K52_=.J%4=!-L-\2[.\E>"LTIJ^QZ[^L
M<7+6C[;H=7CU^F?;_/R-!LI SMU<4>;N!==U&VFM[>BZ<!U[RSXR(ZV>0']@
MZGEXA>6<F(Y(868@@Y.^X23K&5,?M*A<FYX*;9J^VY9F+(.T#N;[3 B]/M@+
MVD&?_0902P,$%     @ UCME6J[S4XVS P  ^A   !D   !X;"]W;W)K<VAE
M971S+W-H965T-38N>&ULK9CO;YLX&,?_%8N;3IN4!<*O0"]!VA*J.ZE;HW7;
MZ72Z%PX\)-8 <[9)UO_^;* TI)0V)]XT&)[OUX\_CT,?9W&D[ ?? PCT,TMS
MOM3V0A17NLZC/6283VD!N7R24)9A(8=LI_." 8XK49;JIF&X>H9)K@6+ZMZ&
M!0M:BI3DL&&(EUF&V?U'2.EQJ<VTAQM?R&XOU T]6!1X!W<@OA4;)D=ZZQ*3
M#').:(X8)$OMP^PJG!E*4$5\)W#D)]=(+65+Z0\U^"->:H;*"%*(A++ \N,
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M,!4@GR>4BH>!.IRV/W<$_P%02P,$%     @ UCME6FWKA:\A#   LX8  !D
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M85C1JXF6#]!^88Q_GK"#X1U>_@-02P,$%     @ UCME6B!OCK2M!@  NRD
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M.IBWLNB9Q42+I6T[,Z&QB=EABI\9($T [L^%T-N)>4#UX3+X U!+ P04
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ UCME6A0V1Z8O!0  PRH   \
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MX-[F3>&G+XKNK0/@HABZ(PT7W$71@O-!3N'8EKJ 7R_$F2RER95H@^L18$P
MQA\&* YF$D$F!&3RCI#S!J)YP N[%-<;Y1!D2D"F'P8Y#S9'D!D!F7T8Y%3Z
M-8(<$Y!C7LB9?!8/7LR4:Q]O6N2Y]GEI?>T40OQ$('[B1;PP7A?*B5LG"^@
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M<04_X>%\+LM\YD3SI]O%D6;-.NNR+LLIG+LVT-\4VSV8V_VC)_\!4$L#!!0
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M&?7.WZEW'3\/I5Y[OM;X_.^D>CS?6ZZ/ORR_3D[>W@O.Z;:B/O\%4$L#!!0
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M460M4&0M4&0M4&0M4&0M_E/69VN7?QP_///6U-TAGPU_NYJ] 5!+ 0(4 Q0
M   ( -8[95H'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ UCME6@,UM?;N    *P(  !$
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M970R+GAM;%!+ 0(4 Q0    ( -8[95IOD1&F* ,  ),-   8
M  " @<$9  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #6
M.V5:JZ7>/$H%  #Y%0  &               @($?'0  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ UCME6K!@? O>!P  \T8  !@
M         ("!GR(  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( -8[95JM"WY55@@  #\G   8              " @;,J  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #6.V5:'C(!A$P"  "E!0
M&               @($_,P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ UCME6BQU:+Y# @  B@8  !@              ("!P34  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( -8[95H!Y527\ L
M (DY   8              " @3HX  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " #6.V5:'/<U6KL(  #&%0  &0              @(%@
M1   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( -8[95I'
M6!VW B   /1E   9              " @5)-  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ UCME6@F1/*,G P  [ 8  !D
M     ("!BVT  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -8[95KIA;(<0@D  (08   9              "
M@1>*  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ UCME
M6I!H#?!D"0  FAL  !D              ("!D),  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " #6.V5:LIJ*W_P'  !U%   &0
M        @($KG0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( -8[95J*>N9UUPP  ",E   9              " @5ZE  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ UCME6EY=$+'H @  :08
M !D              ("!;+(  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " #6.V5:AA$+<VX%  #_"P  &0              @(&+M0
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( -8[95J7^4LS
M400  +<)   9              " @3"[  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ UCME6M\I'*.?(0  57,  !D
M ("!N+\  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #6
M.V5:%ZV-PO0"  "X!@  &0              @(&.X0  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( -8[95KD6A,X_ (  '0&   9
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M970S,"YX;6Q02P$"% ,4    " #6.V5:4\&MYOH#  "E"@  &0
M    @($L^   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M -8[95J>F3FLL (  ,8%   9              " @5W\  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ UCME6B:+<JH+!   <0@  !D
M             ("!1/\  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " #6.V5:D=&XPLT#  "@"   &0              @(&& P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( -8[95J&])#@X0(
M (D'   9              " @8H' 0!X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ UCME6I!]2)*X @  ZP<  !D              ("!
MH@H! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #6.V5:
M%&><W!0$  #&%0  &0              @(&1#0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( -8[95I8A*RXZ ,  .,3   9
M      " @=P1 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ UCME6@??HN]P @  V 4  !D              ("!^Q4! 'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " #6.V5:/+XQ+>T#   3%0
M&0              @(&B& $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( -8[95J$7A<O. ,  $8+   9              " @<8< 0!X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ UCME6LHV?.P+
M P  V @  !D              ("!-2 ! 'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " #6.V5:2K1T#&X)  "Z8@  &0
M@(%W(P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( -8[
M95HS L7/AP4  (HD   9              " @1PM 0!X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ UCME6K$NLJX@ P  Q@L  !D
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M=#0Y+GAM;%!+ 0(4 Q0    ( -8[95KU4KQ'G@0  "$7   9
M  " @5U% 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
MUCME6JE_X.[) P  )@T  !D              ("!,DH! 'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    " #6.V5:Q>A'?80&   J.0  &0
M            @($R3@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( -8[95HU"2IR* @  *4X   9              " @>U4 0!X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ UCME6IJ4Y70X P
MBPP  !D              ("!3%T! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    " #6.V5:5KW3)ML"  #T!P  &0              @(&[
M8 $ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( -8[95JN
M\U.-LP,  /H0   9              " @<UC 0!X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ UCME6FWKA:\A#   LX8  !D
M     ("!MV<! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -8[95K#:RCX^P(  ,0(   9              "
M@1"$ 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ UCME
M6A%XU!-W @  3 8  !D              ("!0H<! 'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    " #6.V5:GT5PR)$#  #L#@  &0
M        @('PB0$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( -8[95H"@&OP2 ,  / 4   -              "  ;B- 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ UCME6I>*NQS     $P(   L
M ( !*Y$! %]R96QS+RYR96QS4$L! A0#%     @ UCME6A0V1Z8O!0  PRH
M  \              ( !%)(! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M -8[95K22;QM$0(  !<F   :              "  7"7 0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -8[95K B&UTZ0$  'XE   3
M              "  ;F9 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !(
- $@ KQ,  -.; 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>166</ContextCount>
  <ElementCount>360</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>55</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100080 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance</Role>
      <ShortName>Cybersecurity Risk Management, Strategy, and Governance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Nature of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentation</Role>
      <ShortName>Nature of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995485 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995495 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995505 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995515 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995525 - Disclosure - Stock Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation</Role>
      <ShortName>Stock Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995535 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995545 - Disclosure - Collaboration and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreements</Role>
      <ShortName>Collaboration and License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995555 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995565 - Disclosure - Loan and Security Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreements</Role>
      <ShortName>Loan and Security Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995575 - Disclosure - Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlan</Role>
      <ShortName>Retirement Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995585 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995595 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995645 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipment</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995655 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995665 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995685 - Disclosure - Stock Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995695 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995705 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995715 - Disclosure - Loan and Security Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsTables</Role>
      <ShortName>Loan and Security Agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995725 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReporting</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995735 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995745 - Disclosure - Nature of Business and Basis of Presentation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails</Role>
      <ShortName>Nature of Business and Basis of Presentation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995755 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995765 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi</Role>
      <ShortName>Summary of Significant Accounting Policies - Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995775 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995785 - Disclosure - Property and Equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995795 - Disclosure - Fair Value Measurements - Schedule of Assets Carried at Fair Value on a Hierarchy Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Assets Carried at Fair Value on a Hierarchy Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995805 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995815 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995825 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995835 - Disclosure - Stock Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995845 - Disclosure - Stock Based Compensation - Summary of Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock Based Compensation - Summary of Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995855 - Disclosure - Stock Based Compensation - Summary of Weighted-average for each of the Assumptions the Company Used to Determine the Grant-date Fair Value of Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG</Role>
      <ShortName>Stock Based Compensation - Summary of Weighted-average for each of the Assumptions the Company Used to Determine the Grant-date Fair Value of Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995865 - Disclosure - Stock Based Compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails</Role>
      <ShortName>Stock Based Compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995875 - Disclosure - Stock Based Compensation - Summary of Other Information Related to Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails</Role>
      <ShortName>Stock Based Compensation - Summary of Other Information Related to Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995885 - Disclosure - Income Taxes - Reconciliation of the Federal Statutory Income Tax Rate to the Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation of the Federal Statutory Income Tax Rate to the Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995895 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995905 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Summary of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995915 - Disclosure - Collaboration and License Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails</Role>
      <ShortName>Collaboration and License Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995925 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995935 - Disclosure - Commitments and Contingencies - Summary Of Presentation Of Operating Lease In Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails</Role>
      <ShortName>Commitments and Contingencies - Summary Of Presentation Of Operating Lease In Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995945 - Disclosure - Commitment nad Contigencies - Lease Cost in the Company's Consolidated Statement of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails</Role>
      <ShortName>Commitment nad Contigencies - Lease Cost in the Company's Consolidated Statement of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995955 - Disclosure - Commitments and Contingencies - Maturity of Future Payments Of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Maturity of Future Payments Of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995965 - Disclosure - Loan and Security Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails</Role>
      <ShortName>Loan and Security Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995975 - Disclosure - Loan and Security Agreements - Schedule of Future Principal Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails</Role>
      <ShortName>Loan and Security Agreements - Schedule of Future Principal Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995985 - Disclosure - Retirement Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails</Role>
      <ShortName>Retirement Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995995 - Disclosure - Segment Reporting - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails</Role>
      <ShortName>Segment Reporting - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Segment Reporting - Schedule of Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails</Role>
      <ShortName>Segment Reporting - Schedule of Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Net Loss Per Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails</Role>
      <ShortName>Net Loss Per Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="tcrx-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Net Loss Per Share - Summary of Potential Common Shares Excluded from Computation of Diluted Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Summary of Potential Common Shares Excluded from Computation of Diluted Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="tcrx-20241231.htm">tcrx-20241231.htm</File>
    <File>tcrx-20241231.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img181012247_0.jpg</File>
    <File>img181012247_1.jpg</File>
    <File>img181012247_10.jpg</File>
    <File>img181012247_11.jpg</File>
    <File>img181012247_12.jpg</File>
    <File>img181012247_13.jpg</File>
    <File>img181012247_2.jpg</File>
    <File>img181012247_3.jpg</File>
    <File>img181012247_4.jpg</File>
    <File>img181012247_5.jpg</File>
    <File>img181012247_6.jpg</File>
    <File>img181012247_7.jpg</File>
    <File>img181012247_8.jpg</File>
    <File>img181012247_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="575">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="42">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tcrx-20241231.htm": {
   "nsprefix": "tcrx",
   "nsuri": "http://www.tscan.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "tcrx-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "tcrx-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 308,
   "keyCustom": 52,
   "axisStandard": 24,
   "axisCustom": 0,
   "memberStandard": 26,
   "memberCustom": 29,
   "hidden": {
    "total": 12,
    "http://fasb.org/us-gaap/2024": 8,
    "http://www.tscan.com/20241231": 1,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 166,
   "entityCount": 1,
   "segmentCount": 55,
   "elementCount": 702,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 575,
    "http://xbrl.sec.gov/dei/2024": 42,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "longName": "100040 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "longName": "100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
     "longName": "100060 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_67b999bc-f4c8-49b5-89ed-d7a3accc676d",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9a6fdb37-0d38-4efb-bcdc-bcac4dfcba88",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "longName": "100080 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_8a2e7250-3d27-46fd-80fc-d497b85993ad",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8a2e7250-3d27-46fd-80fc-d497b85993ad",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance",
     "longName": "995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance",
     "shortName": "Cybersecurity Risk Management, Strategy, and Governance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentation",
     "longName": "995465 - Disclosure - Nature of Business and Basis of Presentation",
     "shortName": "Nature of Business and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "longName": "995475 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipment",
     "longName": "995485 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "longName": "995495 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities",
     "longName": "995505 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquity",
     "longName": "995515 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation",
     "longName": "995525 - Disclosure - Stock Based Compensation",
     "shortName": "Stock Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxes",
     "longName": "995535 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreements",
     "longName": "995545 - Disclosure - Collaboration and License Agreements",
     "shortName": "Collaboration and License Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "tcrx:CollaborativeAndLicenseArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "tcrx:CollaborativeAndLicenseArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "longName": "995555 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreements",
     "longName": "995565 - Disclosure - Loan and Security Agreements",
     "shortName": "Loan and Security Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlan",
     "longName": "995575 - Disclosure - Retirement Plan",
     "shortName": "Retirement Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReporting",
     "longName": "995585 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare",
     "longName": "995595 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995625 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "longName": "995635 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "tcrx:PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "tcrx:PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentTables",
     "longName": "995645 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "longName": "995655 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables",
     "longName": "995665 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
     "longName": "995685 - Disclosure - Stock Based Compensation (Tables)",
     "shortName": "Stock Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables",
     "longName": "995695 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables",
     "longName": "995705 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsTables",
     "longName": "995715 - Disclosure - Loan and Security Agreements (Tables)",
     "shortName": "Loan and Security Agreements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingTables",
     "longName": "995725 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables",
     "longName": "995735 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
     "longName": "995745 - Disclosure - Nature of Business and Basis of Presentation - Additional Information (Details)",
     "shortName": "Nature of Business and Basis of Presentation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "995755 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:UnrecognizedTaxBenefits",
       "span",
       "ix:continuation",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi",
     "longName": "995765 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives (Details)",
     "shortName": "Summary of Significant Accounting Policies - Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_8e328758-f2ae-4a01-a2b8-6f6ee7b7ece5",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tcrx:PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8e328758-f2ae-4a01-a2b8-6f6ee7b7ece5",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tcrx:PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
     "longName": "995775 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)",
     "shortName": "Property and Equipment - Summary of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetails",
     "longName": "995785 - Disclosure - Property and Equipment - Additional Information (Details)",
     "shortName": "Property and Equipment - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "ix:continuation",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "ix:continuation",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails",
     "longName": "995795 - Disclosure - Fair Value Measurements - Schedule of Assets Carried at Fair Value on a Hierarchy Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Assets Carried at Fair Value on a Hierarchy Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
     "longName": "995805 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "tcrx:FairValueAssetLevel1ToLevel2TransfersAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "tcrx:FairValueAssetLevel1ToLevel2TransfersAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
     "longName": "995815 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
     "longName": "995825 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a40cc202-27f4-4dcd-b6c9-0784f4fc3205",
      "name": "tcrx:ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
     "longName": "995835 - Disclosure - Stock Based Compensation - Additional Information (Details)",
     "shortName": "Stock Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails",
     "longName": "995845 - Disclosure - Stock Based Compensation - Summary of Stock-based Compensation Expense (Details)",
     "shortName": "Stock Based Compensation - Summary of Stock-based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG",
     "longName": "995855 - Disclosure - Stock Based Compensation - Summary of Weighted-average for each of the Assumptions the Company Used to Determine the Grant-date Fair Value of Options Granted (Details)",
     "shortName": "Stock Based Compensation - Summary of Weighted-average for each of the Assumptions the Company Used to Determine the Grant-date Fair Value of Options Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails",
     "longName": "995865 - Disclosure - Stock Based Compensation - Summary of Stock Option Activity (Details)",
     "shortName": "Stock Based Compensation - Summary of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_66e41251-c3d9-4ef4-96d0-e6b667f2d454",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails",
     "longName": "995875 - Disclosure - Stock Based Compensation - Summary of Other Information Related to Option Activity (Details)",
     "shortName": "Stock Based Compensation - Summary of Other Information Related to Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails",
     "longName": "995885 - Disclosure - Income Taxes - Reconciliation of the Federal Statutory Income Tax Rate to the Effective Tax Rate (Details)",
     "shortName": "Income Taxes - Reconciliation of the Federal Statutory Income Tax Rate to the Effective Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "longName": "995895 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails",
     "longName": "995905 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Summary of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails",
     "longName": "995915 - Disclosure - Collaboration and License Agreements - Additional Information (Details)",
     "shortName": "Collaboration and License Agreements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_ed36ab97-8daf-4e07-80c2-c1cddcb96e73",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "tcrx:CollaborativeAndLicenseArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "longName": "995925 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "tcrx:NumberOfLeasesFacilities",
      "unitRef": "U_Facility",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "tcrx:NumberOfLeasesFacilities",
      "unitRef": "U_Facility",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails",
     "longName": "995935 - Disclosure - Commitments and Contingencies - Summary Of Presentation Of Operating Lease In Consolidated Balance Sheet (Details)",
     "shortName": "Commitments and Contingencies - Summary Of Presentation Of Operating Lease In Consolidated Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R55": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails",
     "longName": "995945 - Disclosure - Commitment nad Contigencies - Lease Cost in the Company's Consolidated Statement of Operations (Details)",
     "shortName": "Commitment nad Contigencies - Lease Cost in the Company's Consolidated Statement of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails",
     "longName": "995955 - Disclosure - Commitments and Contingencies - Maturity of Future Payments Of Operating Lease Liabilities (Details)",
     "shortName": "Commitments and Contingencies - Maturity of Future Payments Of Operating Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails",
     "longName": "995965 - Disclosure - Loan and Security Agreements - Additional Information (Details)",
     "shortName": "Loan and Security Agreements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails",
     "longName": "995975 - Disclosure - Loan and Security Agreements - Schedule of Future Principal Payments (Details)",
     "shortName": "Loan and Security Agreements - Schedule of Future Principal Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_818e4bd0-25da-4c16-803e-b15c22766a34",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails",
     "longName": "995985 - Disclosure - Retirement Plan - Additional Information (Details)",
     "shortName": "Retirement Plan - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails",
     "longName": "995995 - Disclosure - Segment Reporting - Additional Information (Details)",
     "shortName": "Segment Reporting - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
     "longName": "996005 - Disclosure - Segment Reporting - Schedule of Segment Information (Details)",
     "shortName": "Segment Reporting - Schedule of Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails",
     "longName": "996015 - Disclosure - Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share - Summary of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R63": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails",
     "longName": "996025 - Disclosure - Net Loss Per Share - Additional Information (Details)",
     "shortName": "Net Loss Per Share - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_6c96b539-1a31-47e8-94ff-6a44016523a3",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R64": {
     "role": "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails",
     "longName": "996035 - Disclosure - Net Loss Per Share - Summary of Potential Common Shares Excluded from Computation of Diluted Net Loss per Share (Details)",
     "shortName": "Net Loss Per Share - Summary of Potential Common Shares Excluded from Computation of Diluted Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tcrx-20241231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses and Other Current Liabilities",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts Payable, Current, Total",
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r798"
     ]
    },
    "tcrx_AccretionOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "AccretionOfMarketableSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion of marketable securities.",
        "label": "Accretion of Marketable Securities",
        "terseLabel": "Accretion of marketable securities"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_AccruedLegalServicesAndLicenseFeeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "AccruedLegalServicesAndLicenseFeeCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued legal services and license fee",
        "label": "Accrued Legal Services And License Fee Current",
        "documentation": "Accrued legal services and license fee current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities",
        "totalLabel": "Total accrued expenses and other current liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued consulting and professional services",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "tcrx_AccruedResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "AccruedResearchAndDevelopment",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development",
        "label": "Accrued research and development",
        "terseLabel": "Accrued research and development"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_AccruedResearchAndManufacturingContractCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "AccruedResearchAndManufacturingContractCostsPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and manufacturing contract costs policy.",
        "label": "Accrued Research and Manufacturing Contract Costs [Policy Text Block]",
        "terseLabel": "Accrued Research and Manufacturing Contract Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation and amortization",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r141",
      "r597"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total",
        "terseLabel": "Accumulated other comprehensive income",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r83",
      "r149",
      "r592",
      "r624",
      "r625"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r10",
      "r18",
      "r475",
      "r478",
      "r531",
      "r620",
      "r621",
      "r944",
      "r945",
      "r946",
      "r954",
      "r955",
      "r956",
      "r957"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance",
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r639",
      "r954",
      "r955",
      "r956",
      "r957",
      "r1016",
      "r1077"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Conversion of convertible debt",
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "tcrx_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Shares",
        "documentation": "Adjustments to additional paid in capital equity component of convertible debt shares.",
        "terseLabel": "Conversion of convertible debt, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total",
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r377"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Issuance of common stock, net of offering costs",
        "verboseLabel": "Issuance of pre-funded warrants, net of offering costs",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r39",
      "r105"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r853",
      "r863",
      "r896"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r845",
      "r856",
      "r866",
      "r899"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r857",
      "r867",
      "r891",
      "r900",
      "r904",
      "r912"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation expense",
        "terseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r418"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_AmgenAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "AmgenAgreementMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amgen Agreement.",
        "label": "Amgen Agreement [Member]",
        "terseLabel": "Amgen Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_AmgenIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "AmgenIncMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amgen Inc.",
        "documentation": "Amgen Inc.",
        "label": "Amgen Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_AnnualFixedRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "AnnualFixedRent",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual fixed rent.",
        "label": "Annual fixed rent",
        "terseLabel": "Annual fixed rent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "tcrx_AreaOfLeasedOfficeSpace": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "AreaOfLeasedOfficeSpace",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of leased office space",
        "label": "Area Of Leased Office Space",
        "documentation": "Area of leased office space."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r121",
      "r142",
      "r173",
      "r206",
      "r215",
      "r241",
      "r245",
      "r256",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r468",
      "r472",
      "r503",
      "r587",
      "r676",
      "r760",
      "r761",
      "r798",
      "r820",
      "r976",
      "r977",
      "r1032"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r150",
      "r173",
      "r256",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r468",
      "r472",
      "r503",
      "r798",
      "r976",
      "r977",
      "r1032"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total financial assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r486",
      "r788"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets, Fair Value Disclosure [Abstract]",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r849"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r849"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r849"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r908"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r1045",
      "r1046"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57",
      "r277",
      "r1045",
      "r1046"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Business and Basis of Presentation",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r92",
      "r93"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of property and equipment in accounts payable and accrued liabilities",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r139",
      "r745"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents fair value disclosure",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1017",
      "r1018"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r110"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cash, cash equivalents, and restricted cash",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash - beginning of year",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash - end of year",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r89",
      "r169"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Summary of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r89"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "tcrx_ChangesFromStatutoryRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ChangesFromStatutoryRateAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes from statutory rate.",
        "label": "Changes from statutory rate [Abstract]",
        "terseLabel": "Changes from statutory rate:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r146",
      "r147",
      "r148",
      "r173",
      "r195",
      "r196",
      "r198",
      "r200",
      "r208",
      "r209",
      "r256",
      "r289",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r328",
      "r329",
      "r332",
      "r335",
      "r342",
      "r503",
      "r629",
      "r630",
      "r631",
      "r632",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r664",
      "r685",
      "r705",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r936",
      "r950",
      "r958"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r208",
      "r328",
      "r329",
      "r330",
      "r332",
      "r335",
      "r340",
      "r342",
      "r629",
      "r630",
      "r631",
      "r632",
      "r775",
      "r936",
      "r950"
     ]
    },
    "tcrx_ClassOfStockWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ClassOfStockWarrantsExercised",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of stock warrants exercised.",
        "label": "Class Of Stock Warrants Exercised",
        "terseLabel": "Warrants exercised"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r343"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issuable upon exercise warrants",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r343"
     ]
    },
    "tcrx_ClinicalStudiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ClinicalStudiesMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Clinical Studies [Member]",
        "documentation": "Clinical studies.",
        "terseLabel": "Clinical Studies"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "tcrx_CollaborationAndLicenseAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CollaborationAndLicenseAgreementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaboration And License Agreements [Abstract]",
        "documentation": "Collaboration and license agreements."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_CollaborationAndLicenseAgreementsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CollaborationAndLicenseAgreementsLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration And License Agreements [Line Items]",
        "label": "Collaboration And License Agreements [Line Items]",
        "documentation": "Collaboration and license agreements."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_CollaborationAndLicenseAgreementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CollaborationAndLicenseAgreementsTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration and license agreements.",
        "terseLabel": "Collaboration And License Agreements [Table]",
        "label": "Collaboration And License Agreements [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_CollaborationPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CollaborationPeriod",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration period",
        "label": "Collaboration Period",
        "documentation": "collaboration period."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_CollaborativeAndLicenseArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CollaborativeAndLicenseArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and License Agreements",
        "label": "Collaborative And License Arrangement Disclosure [Text Block]",
        "documentation": "Collaborative and license arrangement disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r114",
      "r589",
      "r663"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_CommitmentsAndContingenciesDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CommitmentsAndContingenciesDisclosureLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments And Contingencies Disclosure [Line Items]",
        "label": "Commitments And Contingencies Disclosure [Line Items]",
        "documentation": "Commitments and contingencies disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_CommitmentsAndContingenciesDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CommitmentsAndContingenciesDisclosureTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments And Contingencies Disclosure [Table]",
        "label": "Commitments And Contingencies Disclosure [Table]",
        "documentation": "Commitments and contingencies disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r281",
      "r282",
      "r730",
      "r968",
      "r973"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, Reserved for future issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "verboseLabel": "Issuance of common stock, net of offering costs",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options to Purchase Common Stock",
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r811",
      "r812",
      "r814",
      "r815",
      "r816",
      "r817",
      "r954",
      "r955",
      "r957",
      "r1016",
      "r1076",
      "r1077"
     ]
    },
    "us-gaap_CommonStockNoParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockNoParValue",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, No Par Value",
        "terseLabel": "par value per share",
        "documentation": "Face amount per share of no-par value common stock."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "tcrx_CommonStockPricePerWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CommonStockPricePerWarrant",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock price per warrant.",
        "label": "Common Stock Price Per Warrant",
        "terseLabel": "Common stock price per warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r664"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Common Stock, Shares, Issued, Total",
        "terseLabel": "Common stock, shares issued",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding",
        "periodStartLabel": "Balances, shares",
        "periodEndLabel": "Balances, shares",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r77",
      "r664",
      "r682",
      "r1077",
      "r1078"
     ]
    },
    "tcrx_CommonStockSharesReservedForFutureIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CommonStockSharesReservedForFutureIssuance",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Shares Reserved For Future Issuance",
        "documentation": "Common stock shares reserved for future issuance.",
        "terseLabel": "Issuance of common stock, net of offering costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "totalLabel": "Common Stock, Value, Issued, Total",
        "terseLabel": "Common stock",
        "verboseLabel": "Common stock",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r591",
      "r798"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r154",
      "r156",
      "r161",
      "r582",
      "r602",
      "r603"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive loss:",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "verboseLabel": "Concentrations of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r125"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r749"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction-in-Progress",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of convertible preferred stock to common stock upon closing of initial public offering",
        "verboseLabel": "Issuance of common stock upon note conversion",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27"
     ]
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Fair value of convertible long-term debt",
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtSecuritiesMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issuable upon conversion of Loan Agreement",
        "label": "Convertible Debt Securities [Member]",
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock",
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r329",
      "r332",
      "r814",
      "r815",
      "r816",
      "r817"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r302",
      "r330",
      "r537",
      "r547",
      "r586",
      "r746",
      "r748"
     ]
    },
    "tcrx_CovenantTermsUnrestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "CovenantTermsUnrestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Covenant Terms, Unrestricted Cash and Cash Equivalents",
        "label": "Covenant Terms, Unrestricted Cash and Cash Equivalents",
        "documentation": "Covenant terms, unrestricted cash and cash equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r974"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r974",
      "r975"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r834",
      "r923"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r834",
      "r923"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r836",
      "r925"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r836",
      "r925"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r838",
      "r927"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r836",
      "r925"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r829",
      "r918"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r830",
      "r919"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r830",
      "r919"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r917"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r917"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r917"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r831",
      "r920"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r833",
      "r922"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r833",
      "r922"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r834",
      "r923"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r837",
      "r926"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r835",
      "r924"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r832",
      "r921"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Converted instrument, shares issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r27"
     ]
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionOriginalDebtAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Original Debt, Amount",
        "terseLabel": "Convertible outstanding principal balance",
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r27"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Loan and Security Agreements",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r171",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r287",
      "r288",
      "r298",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r314",
      "r321",
      "r322",
      "r324",
      "r512"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r65",
      "r66",
      "r112",
      "r113",
      "r177",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r795",
      "r951",
      "r969",
      "r970",
      "r971",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prime rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total principal payments",
        "terseLabel": "Debt instrument drew",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r113",
      "r325"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r301"
     ]
    },
    "tcrx_DebtInstrumentExitFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "DebtInstrumentExitFee",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Exit Fee",
        "documentation": "Debt instrument exit fee.",
        "terseLabel": "Exit fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r317",
      "r1025"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r300"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r795",
      "r951",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term loan maturity date",
        "label": "Debt Instrument, Maturity Date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r770",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDateDescription",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Maturity Date, Description",
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r177",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r795",
      "r951",
      "r969",
      "r970",
      "r971",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_DebtInstrumentPaymentTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPaymentTerms",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument payment, description",
        "label": "Debt Instrument, Payment Terms",
        "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r70"
     ]
    },
    "tcrx_DebtInstrumentPrepaymentFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "DebtInstrumentPrepaymentFee",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Prepayment Fee",
        "documentation": "Debt instrument prepayment fee.",
        "terseLabel": "Prepayment fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRepaidPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRepaidPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Repaid, Principal",
        "terseLabel": "Repaid remaining principal amount",
        "documentation": "Amount of principal of debt repaid."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r46",
      "r49",
      "r59",
      "r103",
      "r104",
      "r177",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r795",
      "r951",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: unamortized debt discount and final fee",
        "terseLabel": "Less: unamortized debt discount and final fee",
        "label": "Debt Instrument, Unamortized Discount",
        "totalLabel": "Debt Instrument, Unamortized Discount, Total",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r979",
      "r1024",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument remaining borrowing capacity",
        "label": "Debt Instrument, Unused Borrowing Capacity, Amount",
        "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r287"
     ]
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction",
        "terseLabel": "Debt issuance costs not yet paid",
        "documentation": "The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27"
     ]
    },
    "tcrx_DefaultInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "DefaultInterestRate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Default interest rate",
        "label": "Default Interest Rate",
        "documentation": "Default Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Assets, Net",
        "totalLabel": "Net deferred tax assets and liabilities",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r429"
     ]
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "totalLabel": "Deferred Revenue, Total",
        "label": "Deferred Revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Revenue, Current, Total",
        "terseLabel": "Deferred revenue, current portion",
        "label": "Deferred Revenue, Current",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Long-term deferred revenue",
        "totalLabel": "Deferred Revenue, Noncurrent, Total",
        "terseLabel": "Deferred revenue, net of current portion",
        "label": "Deferred Revenue, Noncurrent",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "tcrx_DeferredTaxAssetsAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "DeferredTaxAssetsAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Amortization",
        "terseLabel": "Amortization",
        "documentation": "Deferred tax assets, amortization."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized R&amp;D costs",
        "label": "Deferred Tax Assets Capitalized Research And Development Costs",
        "documentation": "Deferred tax assets capitalized research and development costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "tcrx_DeferredTaxAssetsDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "DeferredTaxAssetsDepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, depreciation and amortization.",
        "label": "Deferred Tax Assets, Depreciation and amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_DeferredTaxAssetsLeaseholdLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "DeferredTaxAssetsLeaseholdLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, leasehold liability.",
        "label": "Deferred Tax Assets, Leasehold Liability",
        "terseLabel": "Leasehold liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Valuation Allowance",
        "totalLabel": "Valuation allowance",
        "negatedLabel": "Valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_DeferredTaxLiabilitiesRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "DeferredTaxLiabilitiesRightOfUseAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities right of use asset.",
        "label": "Deferred tax liabilities Right of Use Asset",
        "totalLabel": "Deferred tax liabilities Right of Use Asset, Total",
        "terseLabel": "Right of use Asset",
        "negatedLabel": "Right of use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Defined contribution plan, employer contribution amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term deposit and other assets",
        "label": "Deposits Assets, Noncurrent",
        "verboseLabel": "Cash deposit",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Depreciation, Total",
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r37"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization expense",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r37"
     ]
    },
    "tcrx_DepreciationExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "DepreciationExpenseMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation expense.",
        "label": "Depreciation Expense [Member]",
        "terseLabel": "Depreciation Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r379",
      "r410",
      "r411",
      "r413",
      "r782"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r849"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r849",
      "r892"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "terseLabel": "U.S. Federal",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, basic",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Earnings Per Share, Basic, Total",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r193",
      "r195",
      "r198",
      "r199",
      "r200",
      "r205",
      "r462",
      "r465",
      "r482",
      "r483",
      "r583",
      "r604",
      "r751"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, diluted",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r195",
      "r198",
      "r199",
      "r200",
      "r205",
      "r462",
      "r465",
      "r482",
      "r483",
      "r583",
      "r604",
      "r751"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r202"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r201",
      "r203",
      "r204"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate",
        "verboseLabel": "Effective tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r785"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Taxes at U.S. statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r430",
      "r454",
      "r785"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r785",
      "r953",
      "r1010"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r785",
      "r953",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
        "terseLabel": "Share-based compensation",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r937",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State taxes, net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r785",
      "r953",
      "r1010"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfTheFederalStatutoryIncomeTaxRateToTheEffectiveTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "terseLabel": "Tax credits",
        "negatedLabel": "Tax credits",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r436",
      "r953",
      "r1010"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Employee-related Liabilities, Current, Total",
        "terseLabel": "Accrued employee compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average period remaining (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Stock Options",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential shares issuable under the ESPP",
        "label": "Employee Stock Purchase Plan [Member]",
        "documentation": "Employee stock purchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "terseLabel": "Date of incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r134",
      "r158",
      "r159",
      "r160",
      "r178",
      "r179",
      "r180",
      "r182",
      "r187",
      "r189",
      "r191",
      "r207",
      "r257",
      "r258",
      "r269",
      "r344",
      "r452",
      "r453",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r513",
      "r514",
      "r531",
      "r601",
      "r620",
      "r621",
      "r622",
      "r639",
      "r705"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r853",
      "r863",
      "r896"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r850",
      "r860",
      "r893"
     ]
    },
    "tcrx_EstimatedResearchCostsTransactionPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "EstimatedResearchCostsTransactionPrice",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated research costs transaction price",
        "label": "Estimated Research Costs Transaction Price",
        "documentation": "Estimated research costs transaction price."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "tcrx_ExpectsResearchTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ExpectsResearchTerm",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expects research term",
        "label": "Expects Research Term",
        "documentation": "Expects research term."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_FacilityFeePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "FacilityFeePaid",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facility fee",
        "label": "Facility Fee Paid",
        "documentation": "Facility fee paid."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_FacilityRelatedAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "FacilityRelatedAndOtherMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facility-Related and Other",
        "label": "Facility Related and Other [Member]",
        "documentation": "Facility related and other."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_FairValueAssetLevel1ToLevel2TransfersAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "FairValueAssetLevel1ToLevel2TransfersAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, assets, level 1 to level 2 transfers",
        "label": "Fair Value Asset Level1 To Level2 Transfers Amount",
        "documentation": "Fair value asset level 1 to level 2 transfers amount."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_FairValueAssetLevel2ToLevel1TransfersAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "FairValueAssetLevel2ToLevel1TransfersAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, assets, level 2 to level 1 transfers",
        "label": "Fair Value Asset Level2 To Level1 Transfers Amount",
        "documentation": "Fair value asset level 2 to level 1 transfers amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r486",
      "r496",
      "r788"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r486",
      "r496",
      "r788"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r484",
      "r486",
      "r487",
      "r488",
      "r489",
      "r495",
      "r496",
      "r498",
      "r542",
      "r543",
      "r544",
      "r771",
      "r772",
      "r778",
      "r779",
      "r780",
      "r788",
      "r791"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r493",
      "r494",
      "r495",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r581",
      "r788",
      "r792"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Active Markets (Level 1)",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r358",
      "r363",
      "r486",
      "r496",
      "r542",
      "r778",
      "r779",
      "r780",
      "r788"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Observable Inputs (Level 2)",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r358",
      "r363",
      "r486",
      "r487",
      "r496",
      "r543",
      "r771",
      "r772",
      "r778",
      "r779",
      "r780",
      "r788"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Unobservable Inputs (Level 3)",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r486",
      "r487",
      "r488",
      "r489",
      "r496",
      "r544",
      "r771",
      "r772",
      "r778",
      "r779",
      "r780",
      "r788",
      "r791"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, assets, transfers into level 3",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r497",
      "r789"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, assets, transfers out of level 3",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r497",
      "r789"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r484",
      "r486",
      "r487",
      "r488",
      "r489",
      "r495",
      "r496",
      "r498",
      "r542",
      "r543",
      "r544",
      "r771",
      "r772",
      "r778",
      "r779",
      "r780",
      "r788",
      "r791"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "tcrx_FinalFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "FinalFeePercentage",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Final fee",
        "label": "Final Fee Percentage",
        "documentation": "Final Fee Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_FinancingCostsNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "FinancingCostsNotYetPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing costs not yet paid",
        "label": "Financing Costs Not Yet Paid",
        "documentation": "Financing costs not yet paid."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_FollowOnOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "FollowOnOfferingMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow on offering.",
        "label": "Follow on Offering [Member]",
        "terseLabel": "Follow On Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r857",
      "r867",
      "r900"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r857",
      "r867",
      "r900"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r857",
      "r867",
      "r900"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r857",
      "r867",
      "r900"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r857",
      "r867",
      "r900"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rcognized loss from extinguishment",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "totalLabel": "Gain (Loss) on Extinguishment of Debt, Total",
        "verboseLabel": "Loss on extinguishment of debt",
        "negatedLabel": "Loss on extinguishment of debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r41",
      "r42"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "General and Administrative Expense, Total",
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r687"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and Administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Public Offering",
        "label": "IPO [Member]",
        "verboseLabel": "Public Offering",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r849"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r97"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r277",
      "r278",
      "r490",
      "r492",
      "r497",
      "r617",
      "r619",
      "r690",
      "r742",
      "r790",
      "r1047"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r490",
      "r492",
      "r497",
      "r617",
      "r619",
      "r690",
      "r742",
      "r790",
      "r1047"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r430",
      "r431",
      "r441",
      "r449",
      "r785",
      "r1014"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r430",
      "r431",
      "r441",
      "r449",
      "r785",
      "r1014"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r424",
      "r430",
      "r437",
      "r438",
      "r439",
      "r443",
      "r448",
      "r455",
      "r456",
      "r457",
      "r458",
      "r634",
      "r785"
     ]
    },
    "us-gaap_IncomeTaxExaminationDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationDescription",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Examination, Description",
        "terseLabel": "Description of income tax examinations",
        "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings."
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r426",
      "r427",
      "r443",
      "r444",
      "r447",
      "r451",
      "r628"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total",
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expense and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r947"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in current assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets and lease liabilities, net",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r938",
      "r947"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total",
        "negatedLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "tcrx_IncreaseInAnnualFixedRentThroughOriginalTermOfLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "IncreaseInAnnualFixedRentThroughOriginalTermOfLease",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in annual fixed rent through original term of lease.",
        "label": "Increase in annual fixed rent through original term of lease",
        "terseLabel": "Increase in annual fixed rent through original term of lease"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r857",
      "r867",
      "r891",
      "r900",
      "r904",
      "r912"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r916"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r916"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r916"
     ]
    },
    "us-gaap_InterestAndOtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestAndOtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and other income, net",
        "label": "Interest and Other Income",
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense",
        "label": "Interest Expense, Operating and Nonoperating",
        "totalLabel": "Interest Expense, Total",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r215",
      "r219",
      "r225",
      "r245",
      "r511",
      "r760",
      "r761"
     ]
    },
    "us-gaap_InterestExpenseLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense, Long-Term Debt",
        "totalLabel": "Interest Expense, Long-Term Debt, Total",
        "documentation": "Aggregate amount of interest paid or due on all long-term debt."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r132",
      "r133"
     ]
    },
    "tcrx_InterestOnlyPaymentExtendedTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "InterestOnlyPaymentExtendedTerm",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest only payment extended term",
        "label": "Interest Only Payment Extended Term",
        "documentation": "Interest only payment extended term."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_InterestOnlyPaymentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "InterestOnlyPaymentTerm",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest only payment term",
        "label": "Interest Only Payment Term",
        "documentation": "Interest Only Payment Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "totalLabel": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities, Total",
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r166",
      "r167"
     ]
    },
    "tcrx_K2HealthVenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "K2HealthVenturesMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "K2 Health Ventures [Member]",
        "documentation": "K2 Health Ventures.",
        "terseLabel": "K2HV [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_LaboratorySuppliesResearchMaterialsAndStudiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LaboratorySuppliesResearchMaterialsAndStudiesMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Laboratory Supplies Research Materials And Studies [Member]",
        "documentation": "Laboratory Supplies Research Materials And Studies.",
        "terseLabel": "Laboratory Supplies, Research Materials and Studies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease costs",
        "label": "Lease, Cost",
        "terseLabel": "Lease costs",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r797"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease cost in the Company's consolidated statement of operations",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "us-gaap_LeaseExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseExpirationDate1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expiration date",
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_LeaseSpaceForFacility": {
     "xbrltype": "areaItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LeaseSpaceForFacility",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Space For Facility",
        "documentation": "Lease space for facility.",
        "terseLabel": "Lease space for facility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r529"
     ]
    },
    "tcrx_LegalAndProfessionalFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LegalAndProfessionalFeesMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal and Professional Fees",
        "label": "Legal and Professional Fees [Member]",
        "documentation": "Legal and professional fees."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "tcrx_LesseeOperatingLeaseCommencingDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LesseeOperatingLeaseCommencingDate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease commencing date",
        "documentation": "Lessee operating lease commencing date.",
        "label": "Lessee operating lease commencing date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseDescription",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Description",
        "terseLabel": "Lease term",
        "documentation": "Description of lessee's operating lease."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseDiscountRate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Lessee, Operating Lease, Discount Rate",
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments."
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, option to extend",
        "label": "Lessee, Operating Lease, Existence of Option to Extend [true false]",
        "documentation": "Indicates (true false) whether lessee has option to extend operating lease."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "tcrx_LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedObligationForPaymentOfBaseRent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease not yet commenced, Obligation for payment of base rent",
        "label": "Lessee Operating Lease Lease Not Yet Commenced Obligation For Payment Of Base Rent",
        "documentation": "Lessee operating lease, lease not yet commenced obligation for payment of base rent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease not yet commenced, Option to extend",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Option to Extend",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease that has not yet commenced. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease not yet commenced, Term of contract",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity of Future Payments Of Operating Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future payments of operating lease liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "tcrx_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Operating Lease Liability Payments Due Year Five And There After",
        "documentation": "Lessee operating lease liability payments due year five and there after.",
        "terseLabel": "2029 and thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Original lease term",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "us-gaap_LessorOperatingLeaseDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeaseDescription",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, description",
        "label": "Lessor, Operating Lease, Description",
        "documentation": "Description of lessor's operating lease."
       }
      }
     },
     "auth_ref": [
      "r530"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r65",
      "r66",
      "r67",
      "r72",
      "r73",
      "r74",
      "r75",
      "r173",
      "r256",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r469",
      "r472",
      "r473",
      "r503",
      "r662",
      "r752",
      "r820",
      "r976",
      "r1032",
      "r1033"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders' equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r115",
      "r594",
      "r798",
      "r952",
      "r966",
      "r1023"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and Stockholders' Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r138",
      "r173",
      "r256",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r469",
      "r472",
      "r473",
      "r503",
      "r798",
      "r976",
      "r1032",
      "r1033"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total financial liabilities",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r1017"
     ]
    },
    "tcrx_LicenseAgreementDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LicenseAgreementDate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement date",
        "label": "License Agreement Date",
        "documentation": "License agreement date."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_LicenseUpfrontPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LicenseUpfrontPayment",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront payment",
        "documentation": "License upfront payment.",
        "label": "License Upfront Payment"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_LicenseUpfrontPaymentReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LicenseUpfrontPaymentReceivable",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront payment receivable",
        "label": "License upfront payment receivable",
        "documentation": "License upfront payment receivable."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_LicenseUpfrontPaymentReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LicenseUpfrontPaymentReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront payment received",
        "label": "License Upfront Payment Received",
        "documentation": "License upfront payment received."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityCovenantTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityCovenantTerms",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Covenant terms",
        "label": "Line of Credit Facility, Covenant Terms",
        "documentation": "Description of the conditions for borrowing under the credit facility including the nature of any restrictions."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r71"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r71"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_LongTermAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LongTermAssetMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "long-term asset.",
        "label": "Long-Term Asset [Member]",
        "terseLabel": "Long-term Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt",
        "totalLabel": "Total debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r113",
      "r311",
      "r326",
      "r771",
      "r772",
      "r795",
      "r1043"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Long-Term Debt, Current Maturities, Total",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt",
        "verboseLabel": "Less: current portion of long-term debt",
        "negatedLabel": "Less: current portion of long-term debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "tcrx_LongTermDebtFinalPaymentFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "LongTermDebtFinalPaymentFee",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plus: Final payment fee",
        "label": "Long-Term Debt Final Payment fee",
        "documentation": "Long term debt final payment fee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Long-Term Debt, Maturity, Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r177",
      "r316"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2028",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r177",
      "r316"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsScheduleOfFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2027",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r177",
      "r316"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt and accrued interest",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "totalLabel": "Long-term debt, net",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "stpr_MA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "MA",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "terseLabel": "Massachusetts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities",
        "label": "Marketable Securities, Current",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r374",
      "r419",
      "r489",
      "r548",
      "r616",
      "r618",
      "r626",
      "r654",
      "r655",
      "r714",
      "r716",
      "r718",
      "r719",
      "r721",
      "r740",
      "r741",
      "r768",
      "r775",
      "r781",
      "r791",
      "r792",
      "r793",
      "r794",
      "r807",
      "r978",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "tcrx_MilestoneMethodRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "MilestoneMethodRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborations and license agreements, expected milestone receivable",
        "label": "Milestone Method Revenue Recognized",
        "documentation": "Milestone method revenue recognized."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r374",
      "r419",
      "r489",
      "r548",
      "r616",
      "r618",
      "r626",
      "r654",
      "r655",
      "r714",
      "r716",
      "r718",
      "r719",
      "r721",
      "r740",
      "r741",
      "r768",
      "r775",
      "r781",
      "r791",
      "r792",
      "r793",
      "r807",
      "r978",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership Interest",
        "label": "Subsidiary, Ownership Percentage, Parent",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Equivalents - Money Market Funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Security, Mortgage-Backed, Available-for-Sale, Fair Value Disclosure",
        "verboseLabel": "Marketable securities, fair value disclosure",
        "documentation": "Fair value of securitized, pay-through debt securities collateralized by real estate mortgage loans classified as available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r486"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "tcrx_NegotiationPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "NegotiationPeriod",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Negotiation period",
        "label": "Negotiation Period",
        "documentation": "Negotiation period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90",
      "r91"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "negatedLabel": "Net losses",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r91",
      "r116",
      "r136",
      "r153",
      "r155",
      "r160",
      "r173",
      "r181",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r190",
      "r191",
      "r197",
      "r256",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r462",
      "r465",
      "r483",
      "r503",
      "r600",
      "r684",
      "r703",
      "r704",
      "r818",
      "r976"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Recently Adopted Accounting Pronouncements/ Recently Issued Accounting Pronouncements Not Yet Effective",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_NonCashInterestExpenseOnLoanPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "NonCashInterestExpenseOnLoanPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non cash Interest Expense on Loan Payable",
        "documentation": "Non cash interest expense on loan payable.",
        "terseLabel": "Non-cash interest expense related to loan payable"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r857",
      "r867",
      "r891",
      "r900"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "us-gaap_NonvotingCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonvotingCommonStockMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonvoting Common Stock [Member]",
        "terseLabel": "Non-voting Common Stock",
        "documentation": "Common stock securities that do not empower a holder to vote on corporate resolutions or the election of directors."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_NovartisAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "NovartisAgreementMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Novartis Agreement",
        "label": "Novartis Agreement Member",
        "documentation": "Novartis Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_NovartisMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "NovartisMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Novartis",
        "label": "Novartis [Member]",
        "documentation": "Novartis."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_NumberOfLeasesFacilities": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "NumberOfLeasesFacilities",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of leases facilities.",
        "label": "Number of leases facilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r960"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segment",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r754",
      "r766",
      "r960"
     ]
    },
    "tcrx_NumberOfTargetsIdentified": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "NumberOfTargetsIdentified",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of targets identified",
        "label": "Number Of Targets Identified",
        "documentation": "Number of targets identified."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_OfficeAndComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "OfficeAndComputerEquipmentMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office and Computer Equipment [Member]",
        "label": "Office and Computer Equipment [Member]",
        "terseLabel": "Office and Computer Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "terseLabel": "Incurred costs",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r753",
      "r959",
      "r961",
      "r962",
      "r963",
      "r964"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r797"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesMaturityOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating lease liabilities",
        "label": "Operating Lease, Liability",
        "terseLabel": "Increase in lease liability",
        "verboseLabel": "Present value of operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liabilities, current",
        "terseLabel": "Operating lease liability, current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, net of current portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "cash payments for operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r525"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease assets",
        "terseLabel": "Right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r515"
     ]
    },
    "tcrx_OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease weighted average incremental borrowing rate percent.",
        "label": "Operating Lease Weighted Average Incremental Borrowing Rate Percent",
        "documentation": "Operating lease weighted average incremental borrowing rate Percent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r797"
     ]
    },
    "tcrx_OperatingLossCarryForwardsExpirationYear": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "OperatingLossCarryForwardsExpirationYear",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carry forwards expiration year.",
        "label": "Operating Loss Carry Forwards Expiration Year",
        "terseLabel": "Net operating loss carryforwards, expiration year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating Loss Carryforwards, Total",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive gain:",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain on available-for-sale securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152",
      "r255"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncomeAndExpensesAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (expense) income:",
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Liabilities, Noncurrent, Total",
        "terseLabel": "Other long term liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r855",
      "r865",
      "r898"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r847",
      "r858",
      "r868",
      "r901"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r847",
      "r858",
      "r868",
      "r901"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_PatentCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PatentCostsPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent costs policy.",
        "label": "Patent Costs [Policy Text Block]",
        "terseLabel": "Patent Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of debt issuance costs",
        "terseLabel": "Payments of debt issuance costs",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock issuance costs",
        "terseLabel": "Net issuance costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total",
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureRetirementPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Retirement Plan",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r780"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "tcrx_PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of aggregate royalty of net sales of any product sold",
        "label": "Percentage Of Aggregate Royalty Of Net Sales Of Any Product Sold",
        "documentation": "Percentage of aggregate royalty of net sales of any product sold."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_PercentageOfIncreaseInAnnualFixedRent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PercentageOfIncreaseInAnnualFixedRent",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase in annual fixed rent.",
        "label": "Percentage of increase in annual fixed rent",
        "terseLabel": "Percentage of increase in annual fixed rent"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_PercentageOfLoanPrepaymentFeeInAfterYearTwo": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PercentageOfLoanPrepaymentFeeInAfterYearTwo",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of loan prepayment fee in there after year two",
        "label": "Percentage Of Loan Prepayment Fee In After Year Two",
        "documentation": "Percentage of loan prepayment fee in after year two"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_PercentageOfLoanPrepaymentFeeInTwelveMonths": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PercentageOfLoanPrepaymentFeeInTwelveMonths",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Loan Prepayment Fee in Twelve Months",
        "documentation": "Percentage of loan prepayment fee in twelve months.",
        "terseLabel": "Percentage of loan prepayment fee in first year"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_PercentageOfLoanPrepaymentFeeInYearTwo": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PercentageOfLoanPrepaymentFeeInYearTwo",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of loan prepayment fee in year two",
        "label": "Percentage Of Loan Prepayment Fee In Year Two",
        "documentation": "Percentage of loan prepayment fee in year two."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_PercentageOfLoanPrepaymentFeeRange": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PercentageOfLoanPrepaymentFeeRange",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment fee range",
        "label": "Percentage of Loan Prepayment Fee Range",
        "documentation": "Percentage of Loan Prepayment Fee Range"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_PersonnelExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PersonnelExpensesMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Personnel expenses [Member]",
        "documentation": "Personnel expenses.",
        "terseLabel": "Personnel Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "tcrx_PotentialMilestonePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PotentialMilestonePayment",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential milestone payment.",
        "label": "Potential milestone payment"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-Funded warrants.",
        "label": "Pre-Funded Warrants [Member]",
        "terseLabel": "Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r328"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r664"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Preferred Stock, Shares Issued, Total",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r328"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r664",
      "r682",
      "r1077",
      "r1078"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred Stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and 2023",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r590",
      "r798"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "tcrx_PrepaidRentReclassedToRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PrepaidRentReclassedToRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid rent reclassed to right of use asset",
        "label": "Prepaid Rent Reclassed To Right Of Use Asset",
        "documentation": "Prepaid Rent Reclassed To Right Of Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrimeRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrimeRateMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prime Rate [Member]",
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_PrincipalAmountIncreasePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PrincipalAmountIncreasePercentage",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional principal amount percentage",
        "label": "Principal Amount Increase Percentage",
        "documentation": "Principal amount increase percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under ESPP plan",
        "label": "Proceeds from Issuance of Common Stock",
        "verboseLabel": "Proceeds from issuance of common stock, net of offering costs",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "tcrx_ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of common stock and warrants net of underwriting discounts and expenses",
        "label": "Proceeds From Issuance Of Common Stock And Warrants Net Of Underwriting Discounts And Expenses",
        "terseLabel": "Net proceeds from common stock and warrants after deducting underwriting discounts, commissions and other offering expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of convertible preferred stock, net of issuance costs",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of term loan, net of issuance costs paid to lender",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "totalLabel": "Proceeds from Issuance of Long-Term Debt, Total",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r629"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of pre-funded warrants, net of offering costs",
        "label": "Proceeds from Issuance of Warrants",
        "verboseLabel": "Proceeds from issuance of pre-funded warrants, net of offering costs",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from borrowings under loan agreement, net",
        "label": "Proceeds from Lines of Credit",
        "totalLabel": "Proceeds from Lines of Credit, Total",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r951"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from maturities of marketable securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r14"
     ]
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Issuance of common stock under employee stock purchase plan",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r153",
      "r155",
      "r164",
      "r173",
      "r181",
      "r187",
      "r190",
      "r191",
      "r256",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r462",
      "r465",
      "r467",
      "r470",
      "r471",
      "r483",
      "r503",
      "r584",
      "r599",
      "r638",
      "r684",
      "r703",
      "r704",
      "r786",
      "r787",
      "r819",
      "r946",
      "r976"
     ]
    },
    "tcrx_PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives [Table Text Block]",
        "label": "Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives [Table Text Block]",
        "terseLabel": "Property and Equipment Stated at Cost and Depreciated Using Straight-line Method Over Estimated Useful Lives"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r529"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r126",
      "r129",
      "r130"
     ]
    },
    "tcrx_PropertyPlantAndEquipmentEstimatedUsefulLivesDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLivesDescription",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property plant and equipment estimated useful lives description.",
        "label": "Property Plant And Equipment Estimated Useful Lives Description",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property, Plant and Equipment, Gross, Total",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r140",
      "r598"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r529",
      "r585",
      "r598",
      "r798"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r126",
      "r129",
      "r596"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property and Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r529"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]",
        "documentation": "Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value."
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r356",
      "r374",
      "r405",
      "r406",
      "r407",
      "r419",
      "r489",
      "r545",
      "r546",
      "r548",
      "r616",
      "r618",
      "r626",
      "r654",
      "r655",
      "r714",
      "r716",
      "r718",
      "r719",
      "r721",
      "r740",
      "r741",
      "r768",
      "r775",
      "r781",
      "r791",
      "r792",
      "r793",
      "r794",
      "r807",
      "r812",
      "r972",
      "r978",
      "r1020",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r356",
      "r374",
      "r405",
      "r406",
      "r407",
      "r419",
      "r489",
      "r545",
      "r546",
      "r548",
      "r616",
      "r618",
      "r626",
      "r654",
      "r655",
      "r714",
      "r716",
      "r718",
      "r719",
      "r721",
      "r740",
      "r741",
      "r768",
      "r775",
      "r781",
      "r791",
      "r792",
      "r793",
      "r794",
      "r807",
      "r812",
      "r972",
      "r978",
      "r1020",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r850",
      "r860",
      "r893"
     ]
    },
    "tcrx_ReimbursementCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ReimbursementCost",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reimbursement cost.",
        "label": "Reimbursement cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r365",
      "r535",
      "r536",
      "r588",
      "r595",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r681",
      "r683",
      "r713"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r365",
      "r535",
      "r536",
      "r588",
      "r595",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r681",
      "r683",
      "r713",
      "r1031"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureRelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related-Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r533",
      "r534",
      "r536",
      "r538",
      "r635",
      "r636",
      "r637",
      "r688",
      "r689",
      "r690",
      "r710",
      "r712"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayment of note payable, net",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of loan payable, net",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "tcrx_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable segment.",
        "terseLabel": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r302",
      "r330",
      "r537",
      "r547",
      "r586",
      "r747",
      "r748"
     ]
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "documentation": "Information by form of arrangement related to research and development."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r1009"
     ]
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r1009"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Research and Development Expense, Total",
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r742",
      "r760",
      "r1040"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "tcrx_ResearchFundingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ResearchFundingMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research funding.",
        "label": "Research Funding [Member]",
        "terseLabel": "Research Funding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "R&amp;D",
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r840",
      "r851",
      "r861",
      "r894"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r852",
      "r862",
      "r895"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r848",
      "r859",
      "r869",
      "r902"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Noncurrent",
        "verboseLabel": "Lease security amount",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r939",
      "r949"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "verboseLabel": "Unvested Restricted Common Stock",
        "terseLabel": "Restricted Common Stock",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r105",
      "r593",
      "r623",
      "r625",
      "r633",
      "r665",
      "r798"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r178",
      "r179",
      "r180",
      "r182",
      "r187",
      "r189",
      "r191",
      "r257",
      "r258",
      "r269",
      "r452",
      "r453",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r474",
      "r476",
      "r477",
      "r479",
      "r481",
      "r513",
      "r514",
      "r620",
      "r622",
      "r639",
      "r1077"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration and license revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r206",
      "r216",
      "r217",
      "r239",
      "r245",
      "r249",
      "r251",
      "r253",
      "r353",
      "r354",
      "r550"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Customer Options",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r743"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer."
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "tcrx_RevenueFromRoyaltiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "RevenueFromRoyaltiesPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalties",
        "label": "Revenue From Royalties [Policy Text Block]",
        "documentation": "Revenue from royalties."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_RevenueMilestonePaymentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "RevenueMilestonePaymentsPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, milestone payments policy.",
        "label": "Revenue, Milestone Payments [Policy Text Block]",
        "terseLabel": "Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_RevenueRecognitionMilestoneMethodMilestonePayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "RevenueRecognitionMilestoneMethodMilestonePayables",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition milestone method milestone payables",
        "label": "Revenue Recognition Milestone Method Milestone Payables",
        "documentation": "Revenue recognition milestone method milestone payables."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r686",
      "r743",
      "r750"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability arising from obtaining right-of-use asset",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r797"
     ]
    },
    "us-gaap_RoyaltyAgreementTermsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RoyaltyAgreementTermsMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty Agreement",
        "label": "Royalty Agreement Terms [Member]",
        "documentation": "Terms of the royalty agreement under research and development arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock price per share",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_SalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "SalesAgreementMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ATM Program",
        "documentation": "Sales Agreement.",
        "label": "Sales Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Potential Common Shares Excluded from Computation of Diluted Net Loss per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Summary of Deferred Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of the Federal Statutory Income Tax Rate to the Effective Tax Rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r785",
      "r1010"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Stock-based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets Carried at Fair Value on a Hierarchy Basis",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1017",
      "r1018"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Principal Payments",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r529"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r36"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r36"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Summary of Other Information Related to Option Activity",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r107"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r378",
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r106"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Weighted-average for Each of The Assumptions The Company Used to Determine The Grant-date Fair Value of Options Granted",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r101",
      "r103",
      "r104",
      "r105",
      "r146",
      "r147",
      "r148",
      "r208",
      "r328",
      "r329",
      "r330",
      "r332",
      "r335",
      "r340",
      "r342",
      "r629",
      "r630",
      "r631",
      "r632",
      "r775",
      "r936",
      "r950"
     ]
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Owned and Sold, Not yet Purchased, at Fair Value [Axis]",
        "documentation": "Information by financial instrument held by broker-dealer for its own account for trading or investment purposes and carried at fair value. Includes, but is not limited to, security sold, not yet purchased."
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Owned and Sold, Not yet Purchased Fair Value, Security Name [Domain]",
        "documentation": "Type of financial instrument held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes that are carried at fair value including securities sold, not yet purchased."
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r121",
      "r206",
      "r211",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r253",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r279",
      "r280",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r756",
      "r760",
      "r761",
      "r769",
      "r809",
      "r1044",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r651",
      "r652",
      "r653",
      "r715",
      "r717",
      "r720",
      "r722",
      "r729",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r744",
      "r777",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r808",
      "r812",
      "r980",
      "r1044",
      "r1048",
      "r1049",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r759",
      "r767"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "terseLabel": "Segment reporting, CODM, profit (loss) measure, how used, description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r756",
      "r764"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r206",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r228",
      "r230",
      "r231",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r250",
      "r253",
      "r754",
      "r757",
      "r758",
      "r760",
      "r762",
      "r765",
      "r766"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r248",
      "r251",
      "r755",
      "r756",
      "r763"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total",
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period of stock options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested restricted stock",
        "periodStartLabel": "Unvested restricted stock, Beginning balance",
        "periodEndLabel": "Unvested restricted stock, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested restricted stock, Vested",
        "negatedLabel": "Unvested restricted stock, Vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend-yield assumption",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments",
        "documentation": "The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility of underlying common stock",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r378",
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock shares under the plan",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r783"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of awards permitted to grant",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options exercisable, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total",
        "negatedLabel": "Stock Options Outstanding, Cancelled",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options Cancelled, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options Outstanding, Granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value of options granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Stock Options Outstanding, Intrinsic Value, Beginning",
        "periodEndLabel": "Stock Options Outstanding, Intrinsic Value, Ending",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "verboseLabel": "Stock Options Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Stock Options Outstanding, Beginning balance",
        "periodEndLabel": "Stock Options Outstanding, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r385"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Stock Options Outstanding, Weighted Average Exercise Price, Beginning Balance",
        "periodEndLabel": "Stock Options Outstanding, Weighted Average Exercise Price, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r385"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options vested or expected to vest, Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options vested or expected to vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options vested or expected to vest, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum",
        "terseLabel": "Percentage of number of common stock issued and outstanding",
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfRestrictedCommonStock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price of restricted common stock",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Of Restricted Common Stock",
        "documentation": "Share based compensation arrangement by share based payment award purchase price of restricted common stock."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestingTerm",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock, vesting term",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Vesting Term",
        "documentation": "Share based compensation arrangement by share based payment award restricted stock vesting term."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options Exercised, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options Granted, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r383",
      "r402",
      "r403",
      "r404",
      "r405",
      "r408",
      "r414",
      "r415",
      "r416",
      "r417"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfWeightedaverageForEachOfTheAssumptionsTheCompanyUsedToDetermineTheGrantdateFairValueOfOptionsG"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options exercisable, Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options exercisable, Weighted Average Remaining Contractual Life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options Outstanding, Weighted Average Remaining Contractual Life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options vested or expected to vest, Weighted Average Remaining Contractual Life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average value of stock options, granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term lease costs",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r797"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r170"
     ]
    },
    "tcrx_SiliconValleyBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "SiliconValleyBankMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Silicon Valley Bank [Member]",
        "documentation": "Silicon valley bank."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightlineMethodOverEstimatedUsefulLi"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Software",
        "label": "Software Development [Member]",
        "terseLabel": "Capitalized Software",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r121",
      "r135",
      "r206",
      "r211",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r253",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r271",
      "r279",
      "r280",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r756",
      "r760",
      "r761",
      "r769",
      "r809",
      "r1044",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r146",
      "r147",
      "r148",
      "r173",
      "r195",
      "r196",
      "r198",
      "r200",
      "r208",
      "r209",
      "r256",
      "r289",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r328",
      "r329",
      "r332",
      "r335",
      "r342",
      "r503",
      "r629",
      "r630",
      "r631",
      "r632",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r664",
      "r685",
      "r705",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r936",
      "r950",
      "r958"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfPotentialCommonSharesExcludedFromComputationOfDilutedNetLossPerShareDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r77",
      "r80",
      "r81",
      "r134",
      "r158",
      "r159",
      "r160",
      "r178",
      "r179",
      "r180",
      "r182",
      "r187",
      "r189",
      "r191",
      "r207",
      "r257",
      "r258",
      "r269",
      "r344",
      "r452",
      "r453",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r513",
      "r514",
      "r531",
      "r601",
      "r620",
      "r621",
      "r622",
      "r639",
      "r705"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r651",
      "r652",
      "r653",
      "r715",
      "r717",
      "r720",
      "r722",
      "r729",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r744",
      "r777",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r808",
      "r812",
      "r980",
      "r1044",
      "r1048",
      "r1049",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r207",
      "r514",
      "r550",
      "r627",
      "r650",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r664",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r683",
      "r686",
      "r687",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r705",
      "r813"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r207",
      "r254",
      "r514",
      "r550",
      "r627",
      "r650",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r664",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r683",
      "r686",
      "r687",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r705",
      "r813"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r854",
      "r864",
      "r897"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_StockBasedCompensationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "StockBasedCompensationMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Stock Based Compensation [Member]",
        "documentation": "Stock-based compensation."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_StockIssuanceCostsOfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "StockIssuanceCostsOfferingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issuance Costs Offering Expenses",
        "documentation": "Stock issuance costs offering expenses.",
        "terseLabel": "Offering expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "negatedLabel": "Conversion of convertible preferred stock to common stock upon closing of initial public offering, shares",
        "terseLabel": "Conversion of convertible preferred stock to common stock and non-voting common stock upon closing of initial public offering, shares",
        "verboseLabel": "Conversion of non-voting common stock to voting common stock, shares",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r46",
      "r77",
      "r80",
      "r105",
      "r315"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under employee stock purchase plan, shares",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r76",
      "r77",
      "r105"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock issued",
        "label": "Number of shares issued",
        "terseLabel": "Issuance of common stock, net of offering costs, shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r76",
      "r77",
      "r105",
      "r629",
      "r705",
      "r724"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Stock Options Outstanding, Exercised",
        "terseLabel": "Exercise of stock options, shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r76",
      "r77",
      "r105",
      "r389"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "negatedLabel": "Conversion of convertible preferred stock to common stock upon closing of initial public offering",
        "terseLabel": "Conversion of convertible preferred stock to common stock and non-voting common stock upon closing of initial public offering",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r77",
      "r80",
      "r81",
      "r105"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under employee stock purchase plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r76",
      "r77",
      "r105"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, New Issues",
        "verboseLabel": "Issuance of common stock, net of offering cost/ ESPP plan",
        "terseLabel": "Issuance of common stock, net of offering costs",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r76",
      "r77",
      "r105",
      "r639",
      "r705",
      "r724",
      "r819"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r77",
      "r80",
      "r81",
      "r105"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "periodStartLabel": "Balances",
        "periodEndLabel": "Balances",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r80",
      "r81",
      "r94",
      "r666",
      "r682",
      "r706",
      "r707",
      "r798",
      "r820",
      "r952",
      "r966",
      "r1023",
      "r1077"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity (deficit):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "Stockholders' Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r172",
      "r327",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r344",
      "r480",
      "r708",
      "r711",
      "r728"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "terseLabel": "Convertible Preferred Stock",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r709"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r540"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r540"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r540"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r540"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r540"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r539",
      "r541"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary Of presentation of operating lease In consolidated balance sheet",
        "label": "Summary Of Presentation Of Operating Lease In Consolidated Balance Sheet [TableText Block]",
        "documentation": "Summary Of presentation of operating lease In consolidated balance sheet"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "SummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of weighted-average remaining lease term and discount rate.",
        "label": "Summary of Weighted-Average Remaining Lease Term and Discount Rate [Table Text Block]",
        "terseLabel": "Summary of Weighted-Average Remaining Lease Term and Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "SupplementalDisclosureOfCashFlowInformationRelatedToLeasesTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental disclosure of cash flow information related to leases.",
        "label": "Supplemental Disclosure of Cash Flow Information Related to Leases [Table Text Block]",
        "terseLabel": "Supplemental Disclosure of Cash Flow Information Related to Leases"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "tcrx_TaxCreditCarryforwardExpirationYear": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "TaxCreditCarryforwardExpirationYear",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration year.",
        "label": "Tax Credit Carryforward Expiration Year",
        "terseLabel": "Tax credit carryforwards, expiration year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardLineItems",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardTable",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Table]",
        "documentation": "Disclosure of information about tax credit carryforward available to reduce future taxable income. Includes, but is not limited to, description, amount, expiration date, limitation on use, and related deferred tax asset and valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityTableTextBlock",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Preferred Stock",
        "label": "Temporary Equity [Table Text Block]",
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r43"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_TrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "TrancheOneMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche One [Member]",
        "documentation": "Tranche One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_TrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "TrancheThreeMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche Three [Member]",
        "documentation": "Tranche 3."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_TrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "TrancheTwoMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche Two [Member]",
        "documentation": "Tranche 2."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r915"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "tcrx_TwoThousandAndEighteenEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "TwoThousandAndEighteenEquityIncentivePlanMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018 Equity Incentive Plan",
        "label": "Two Thousand And Eighteen Equity Incentive Plan [Member]",
        "documentation": "2018 equity incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Employee Stock Purchase Plan",
        "label": "Two Thousand And Twenty One Employee Stock Purchase Plan [Member]",
        "documentation": "2021 employee stock purchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_TwoThousandAndTwentyOneEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "TwoThousandAndTwentyOneEquityIncentivePlanMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Equity Incentive Plan",
        "label": "Two Thousand And Twenty One Equity Incentive Plan [Member]",
        "documentation": "2021 equity incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Eighteen And Two Thousand Twenty One Equity Incentive Plan Member",
        "label": "Two Thousand Eighteen And Two Thousand Twenty One Equity Incentive Plan [Member]",
        "verboseLabel": "2018 and 2021 Equity Incentive Plans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentDebtSecuritiesMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsCarriedAtFairValueOnAHierarchyBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Securities",
        "label": "US Government Debt Securities [Member]",
        "documentation": "Debt securities issued by the United States government."
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "tcrx_UnderwriterOptionToPurchaseNumberOfAdditionalShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "UnderwriterOptionToPurchaseNumberOfAdditionalShares",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriter option to purchase number of additional shares",
        "label": "Underwriter Option To Purchase Number Of Additional Shares",
        "documentation": "Underwriter option to purchase number of additional shares."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance",
        "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Uncertain tax positions",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r442",
      "r784"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest or penalties",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r784"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r123",
      "r124",
      "r127",
      "r128"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase in valuation allowance",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureCommitmentNadContigenciesLeaseCostInTheCompanysConsolidatedStatementOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease costs",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r524",
      "r797"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureLoanAndSecurityAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_VotingCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "VotingCommonStockMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.tscan.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting Common Stock [Member]",
        "documentation": "Voting Common Stock.",
        "terseLabel": "Voting Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "tcrx_WarrantIssuanceCostsOfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "WarrantIssuanceCostsOfferingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Issuance Costs Offering Expenses",
        "documentation": "Warrant issuance costs offering expenses.",
        "terseLabel": "Offering expenses"
       }
      }
     },
     "auth_ref": []
    },
    "tcrx_WedbushSecuritiesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.tscan.com/20241231",
     "localname": "WedbushSecuritiesIncMember",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wedbush Securities, Inc.",
        "label": "Wedbush Securities, Inc. [Member]",
        "terseLabel": "Wedbush Securities, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average common shares outstanding, diluted",
        "terseLabel": "Weighted average common shares outstanding-diluted",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r200"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.tscan.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.tscan.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average common shares outstanding, basic",
        "terseLabel": "Weighted average common shares outstanding- basic",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r200"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-22"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480126/715-20-S99-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "SubTopic": "740",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479176/718-740-35-2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482190/360-10-35-3"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0000950170-25-033077-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-033077-xbrl.zip
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M<V6I-;1;4PTK:2SLV*UI6U/='3H_GRP[VJ4O8_UN65?#F:O1?;K:+.!GA>Y
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M#Q&Z'M5&ZF#\9:/Q0LWTDFJ8G,<KU&,\JYDO1A(QF:70Y\&]DH09^@8)D;'
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MI<UE/% "E%DI_&6SZGW+=QJ'B^N3S'$.V9ZNU9^P5S%(>=5Q/[\RZQQ50[7
MC&Z>R.Z13^X1EL+,& :R1?D03?7+NL-O3$^3ZDM#[5ME@BW?#K]Y4:A7%TY2
M*I12+NQ7+U-(9.5YWG;_=$'14N'31+D*^\=B:WHM92[I8H4&5GC+MC"SL'GZ
M%1(T$LGK1GK1]N/I93:=(J3:&/UH93.%OZU@:H(:"'0P ]<]0AEV G!H$Q(U
M/7]W/3B@(;]H O"2U:" "2:M(LD>-F/RQ-[+4T;+0U!7XB/RS4W^F_U\&C>!
M>5ZW8UV B,^-)PVG>%F.Q5:)H9V59[%OE!.R&_=C1)XTUCKHB,[6/XHW3#^0
MB?0P__E6LFN #03!]][6NDM]PE MJ/13O=^KSP%(78.N1U4P?OVCAN4YI5T%
M60B)GMQ6^YT[+R6ZS"+.KUE*Z.78?LI,4+<DO4(*2ETQUE,B;>5'-15N+/9L
MNEV@J#]\F8Y9MGL;]GM>K'3TS-\>Q"(-M1Z5>:PE;3&&N9;0D)6_>I!9].;A
MY737XXEH;]'9F?8+''9?%1SPPM_O=(O4>D_S::19O+G+TPG[+LH <4 W;I"C
MZ/E3"7[W;5\O?-O \QK<L'KX3L9:+-M+C" Y\,:\_/R(&Z_:-5U)B4^R984B
M>XX7#,VJ8O%WLE(B'NCRF?MY&N@5WFHWD2UZF>+36U35!-?IW41YR8<'CC6,
M-UA0K[?4MCSG+S-JAKU \6S)^E3X"-M5;'E77B(I=FIR=JS**-[<%*BI;5*4
M_LF= 8I\!3C0YF,@@%N8 @.T<\KQH-WWNRB*#;J!!E09(+->E=:?L#9R40*N
MCZAG5>[JM.]^C6LC^)F'(Z!*?N$UYR]9M<N2,5-Q60:M]C;N53$9X($.HH1,
MG6I*OE.%J'CN+\,IQ69M*NG7[TTES,._PPG<\_4H/']S5L@M&Z)X3H"F-3D(
M=P(K[]"Y9'RY&_):D\Z2>-)U!H\<-A PJW32MS3'SZ[D89-D\G/,$MRR[_/>
M=Y94"W7\.JDG+FF9][(UKTS )"!;?<N[K:W=-L!8S]"P6/WACD+ %<[']/S(
M3D**^7X<5T)AO+]O1EK;T(=?0C,3"C\7O/5WM.M.VV$NS<%1%_[C88^_^[-6
MC:;JYB'T\8?+L52C4@>/.4'26'(I_'"_*GA)0TM>;TAF"3>RQUIL==\H1$,C
MJ%+LE_*;?C6G35GNOX5-V'HUJ#8YE;IYEGIF)E1T)KXIADWK!+FB7 ,YVP+<
M0SP?ICC,VL^TB?PZX] O\&LO9\LC86$NJ;LS5>DS8\B6C^]V'(P*AKTH!<,-
MGTL>^7=/2:KYZ^=<+U1EK73C$1E*M?GJK9239>R!9&. P%8,T',$ S0XCF3.
M(^YPF0&2+*L!4IF=*Q<M1OO<',+!%(BBZ"&._HPCHZ-VY;F L%[1T;VLLB0V
M(+-/D(EPELIW(N.MP9O5*2S:CVTOH:^IR<O4_?+=TF\FA]3VK(7 -C.FM$X,
MZ20 )373SUE0^%'>Z..H=AP)3;VL;T^?;S'=]"?T;R1M^+]]8&7:F 7%;!Y!
MSH"D.??3 &6*/@/4!F6 /"%3+/O3@!$)3O#=O$11H)J3*I]!.K<C#SNX^=SC
MPO@0JNW!)NCBN4E$&&^%Z//Q]B<J#: V6D(1(M6X<?"&_3J6LZ%^H$(YXA#Q
M];M28=J.=2?AS6NWB9G0:\0:-:_'C@_D7!-[)-R&.VAV^%.:CK>Y#,G=UN&D
M75>N&X6JYO52^@D]/)L*NZ46D9<;SC8X7C<KY WQ*H,\ZU&4)'K>L(*&[AE>
M.#!8^&41QF617B@U0C!YB-Y<[DB:LEB M(,CFV!=D!@8=PLG03XR<[,R)X2P
MS>.E/MJ\BA5]85/GJ&^DS6NDZ!]$-,"P:470"ANBO%'^6K^&E! \A(-X5!?
MFQ843?I(IEY-!?4(4$% QUAK"[UKP(SG#<X=]EL-NK7:Y7:L37%CW(K@F4C5
M=6__?=:L5G5I^##\<4/MY['A:":O5<8)(B_2ZG +A6B2";\QK'U,9;Y.I9 B
M?Y>J!YB1,CKL37+<"6J:-ERX#HF^9]#(-SJ$Z:@!#/2XI[W-OG<YQVJ@ F#>
M/G52M#KY<L8^A1CVAB2\KS9(-2 /WP(X*SZ^!1H6V['GR(9A_>A3*,)E<B[N
M^(MU3@_.M4.6".=:U2=\"LTCKJ$NF\B>>TT-]2F!21N_%EV8J0-G#!:?L52H
M^:PP$=^>SGFF\#J>188[*/:C)*&FU@QEUVE=]:Q#'6>3=AH1: 'NV0M?TI6Y
M25:\@S=,N#70]O55BZX[7W*DF!JU*1)NCO#R?OLJ^/S#5Z_4 Z1# ITJU$?<
M^#1KL[48(*)\1U44D\JV7"H#F"-4/%)C 7I\Y4X,QI<#R+?$#"F5_;S\0$&Y
M=R:YO-'FJ@N_AL2QQHS&,^G[OQIK%'C'%5 ? $855(FHQ:(<,@L>3 I#@4V)
M'4"<?ZEN,6"'5(4OT?)MT>8C83V"F)=BIZR^O&<_MV+A\^T\_4'8%)\\LTF?
MMMAG!Y(H.H@D JJ#U:@J G=*6W-]_@P52@[!TT5(9^L(55QMA*Q-6:II*7!B
M:U_#:)JB-V2^V#Z56'7B#==+_X\EGF5LG_-L&2 5J$<.S'(8MS#/;/Y?F-2]
MSQTW(.N5D;+P=&F$8+Z=IH9XG*;QVQXVO)R"SV%1:F'=M@9O,ONSF>-Z/&*(
M3+GX90OP:VUA0DO"<-E)FGV$]J6*5X0W3OGQ.?88":/CIX?"0^-#LV=%)3]2
M;!^'>(3<%5FD?!:]BXNNP10:XWPE2309'+MUPH5WWW2M"N/2)/I\O,<39M7:
M(5C:-X"-XA?V<;Y^"5<.6"S NIA>9[J\8XJM(#,R_S<[N9H"KT63R'O/0TVZ
M3<E"&?FS7H=N+4-XP;[\@NY0-Y_AZ>\[W?O1@0M (/TT+^4\T$B<0K*2EC=Y
M23O6P!N5&O&H"DTM[Z"2T*0[X\2TBKZ80D2>L3;TY-I4?8;46/IA6%:5H^.L
M$[C605>V[W(5'@=(5D50-2C0L)'YVLKW%'6$OPX)$CV_#Z45/Z:\HIXJLO=(
M@D8A54GPSL4;V.8H_<BC3\94#M0+&AH;?S*8+'?1#E&N=]-4),[C89%8+F;A
ME SK8(#.(_D):+95-)<+,+TPZV]"KLPHLG5 X.^0G8J)5=%&93HJK;ZGO<83
MDXKLN[S=WB>[.(*-I_E^'#GT/0S+>;%'P:^GQJ_LE<[15TN3]W5.FR,"$XH3
M/[][H?61^^J3@E*:R<NK;C'[I\]B#%_%$$81-,>QTN61+A?G_NOZX+W2>Q/9
MAPEZRWNWG*],<K.H(NP3C'(KQ0KO/GBX5B]J^%("OW[V978:%^V9F=4#)T^9
M\B_OC]W5JFCN.SEULY>#][I3QS7GQ%FI4>2#_!Y)W?H9ASC/60T-1^W2W= D
MO31=ZS3U4D.I0C5+L\RO*1:Q*>:.(JEUCH(#S$4NX<=1"6>B61D@[[6+.3:_
M5 ^?CAG4BS^5<8>-AK[X/1,@H.JMWMEB/]AL\XV7QSWJ=A@92=#PJ!GZ],KM
M_NC5>R.JH5B.:1?,0NBST>MI]*D+:)DC528.U'P&J*!J?6?$;'I9GB;) ,'2
MGS%;TO]8;MV]#KM2"31I\W$,S<)D8%>+NWW;:DPYQVE_VGBH/N=J^RFY*HR@
MD5EK.JL&/ZNT1^&[YI:F3.D0#^$4SX);@Z^.&C2D&#<,&4@WS,7\>.L^.5]7
MQ]?/-\CW^&P!:=9^5H>K$]/;4JK5VMFR4HO7Y+S9*S#0RR^3;,1_]59\9;SE
M<S=KFSN?VM(B=22/W]H[=H]]2[)^V+,HTUMI-!.NEQE<E)N@%6-L(*E;_..D
MMF%C1Z6Q!.6W<+V(O&0[VQ/69XKS)8]!WO">B'2[PWJU1$1"YN?CKR*LCBVF
MBX#44WX6R-3A_H\S*,Z*&Y-%<RKJ'#YG;M1VAI0*8TNYJEM^'ZFDFW,'0-RO
MA]=\BE21?G#7IQ?& (77F3! N:JX@RTPW:#J+!G:"8LXY(D.R!%W )(79"%6
MM2-R+JW#RK +B!#3$5D1SS-Q@J-I<_ELO<VO9D5.R7AT"MJRE9]J9X BQDEP
M>NP\7IXJCY1F@'KLR=)^4+:A,NLTGXN_KXP5FS]>&RS-7) <*33G\,M1_S7]
MDB%G>!7O#0/#J]:>6F</@_3@4@]?7IUI?_A26,+D@LSM?+6/XKQZAEGF\:DF
MLBJ9GD7#^H/SI'3/^9VN SJ-V0]\5$*UVQ6C^OGG*0<L#)#(>!^4U$1G0PTZ
M &Y,>[8C4-_A^E0YW O8KC6=%T4((<#H]F.H=1MFX T:_(HB+,HQ0$M)R@<9
MM*0L!FB@["H#U"Y@PP!)[<""=@.IHIF!5'(KD]L\1'TSAOQ!L_).TM\*'F2
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M$0S02L'O4!(Y [6CGTG!4R#,[O*--7,&PM6JZ%9+V)V5;<!(:?O[8@@#%+;
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MQ0(L=U[<?:^J/O:Z9,7F.$9+: IO/31X<41&+EA^(HZ ?D8_%S:")MT!1S%
M9^M946R Q4TR9&-N/QBI..?4+SN73WJX9E]96KJ6F=.[55:^KMY5'!A8NLXW
M5A$2\M:K*6&T<Y,VV_EYZ-9<# 74; O ][-)WF4,4*<6Z6!_E):'5"1H!(C_
M7CVP)PB_1?[<%/#;2GJ#_4%\P.^78Q[6'%=X>OK<M6TIM0=.K*RQE:2=3[4F
MEPPM5P<?[5=)5<Z\=+,O4%!#WO</+WU>:L0.*;L1*3V?7</^9=*RE-X3EWWY
M[9W/95]?;JJ*&RJ3)A,OF<B6Z)GER#0\KK&<O2:UA1$/.*/\-FA[8YL98G7
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M0IE$V>.>OX.R^3Q]-HF>$I/83[5@@(9>?Q<E0&-QO)KL%%_ZG#H*7S6YW<4
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M)YRK0';/8K( 2+2,ZBQ6?L]7'891FGN@'_(@05%?#N)@53$V_RX2)_AOKK3
M[B_E5&TL;K+V?W=E@)Y!Y;>":3W-C>_-G/@+PGJA/ST^LD#(_Z$E5QL"],.
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MCO(?WW*<;?T42YJ%,J.%LS )G  EH*.\]2/"1+S0/%3-R\S"F88T&CM@@+R
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M_W6@7,JL<]S,/(3J,$!'-G% +X24#(?L[$))0M,,4/S "=BD#VIY#D79$6>
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M[$N_K)!CE;FP5+CIJ&:1$LFIE-I%<.ZW2+8JR2-(/4X!DC[9:9]$Q^.FFU:
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MAF%VLJEA6$#*!J9C$F3_9)#!SK[XZ>]80#+&-L0.3N*BK#& RQCR/%OTGUE
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M?+Z1A*U?<YF':8Q(=N+LS<B#D[^ P>SRC$NO^"F;^#2[7HO ,ED Q".:!;Q
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MF03_T,V,P$Z(L"'6"V7':V7HS\9^>$#O6#:_)BQ@/O+''L._E5AN#D$$3NS
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MCRG,-=44S$M_.G?TU$+2UI"M^>9<7$U#38/+=E;H?WQVM/SL;S\Y;?]O;2T
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MG.T?2B%]I&T2PMR>802H3>V=J.^6+TA?2X] 8L"B"54NRT_#S"T+8=<-F2?
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MWZKK3XNKWEH6>L1HM*&8) +43;T:9$-D(&$62EWU=T(>!#K9]QO,SF#D" X
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M^(4E^?UQ I5_8SESJ\$S(SU/![C^+!P;UKZXW4K^3B[?G(J-R,F^GG5 )/M
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MJD3Z$5SMQ:;>TS4)32]O1*8+K9V0TGC.5@!)OCS>>OPGZ_E0\5TD5YN/K-A
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M_FL.=;#0^8\=D.0E!Q VN9(&, 'D@7ZD '*%*KS/G70.\O]EK[PQ8_[?9%7
M!OC69@((1[R'L+P3_T_:9YM<PL<J_;^S,(Y8'?*06OD?*3EX:6(*7J]Q0@!!
M2T[G,/1S(RMP5WE/$-<IZ6KZ#4/53DE?NRF)=RAT1*)PC'R';'VYQG<' MW]
MJP_P[E*ND9K!D)%'HVO>;47:K?+::CG]%R)-."M9>?<7(IYF42^6^XBG^^M^
MLH<<S,'PS?KI)P?\Y0N>19KY!H5'E9>\=RR;(!^P4O*\4^F8&?FRQSTSZ*UV
M8VG>TE1T>5>8Z3D*5UO7X8"K:V5 %:/"E209]M8Y_R<+</_*]F)AU@(XQ[ )
M3.*ZHNE:*<L'F;^XD<.'X*YB9)?G)6*RU$;=P89%699< 88;<FUN#\LDOWK*
M-W2 B4RYP_'U0]^ZW!L1<46JZ?,=A#@>@>TW2*/5Y:PG<=Q0RVS:@<^ Q_HI
MX#>^N2UCAB(*[FNRV(!^PP MB_JT%[,Z/CC8,-P(:]\59156X6\;\I=Z]S L
M5L[<L31$";\9KA1<6/6[7HP?O,^E6;KO9/.8GM[&'S(78JU.)B^=.2;=^ZGO
ML-^WV\[BGL73<RMS/O:%V.MZP5DE!=/8TKPY3[];C<[THXTWK?OM&J^3O+"'
MLW7&^!_+JB8I*L>G*S+>K8R4>$CM_[,KH,$7'G2_QX7NME.MX]R-_.VI*UG[
M 7%<>_$(KR3MS15U;3.<@>[+^B(%IPHWDPK&>/CF<EL,VK6+J17XK8+D-)JG
M=*98+4_GXP=IROY3.\50^7.RD6Z1T(>TYNUU'4"&*=\YG^Q_!D#T$$1 RAN"
MF  209P*1ZF PM@T+N,$B*2)YV=7;]VUCF&];Z,E&?O<U7&$AHY_-_)#.:5<
M_/3GRDWO#\LR5[@V/%+'/_SPDP)(@\>ZSPN<.V"320OF*;]!*=)"!!!IKA?
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M-[!8B^1AQ?W*>X4_.@?.]!$;/-X@4O"_L43[RHUSE(DYA$-<*6#1%[PM44(
M!A8>\XDQS[WFYG&_LXCQW,-&[2',"?)"22PFCJE IM8/Q?B@?>S?NC%4D&M.
M+)E%Y/T.96XHKPBF!Q@?!?,Y")Q?:VX75)1OP'4&MN\;-!*F.,SUWHK%^113
M>7\C\#8)%PE\6>M0\ZD)Z<J[56 8;H)!/S^/B2Q?WLX;F=+WQ+5/#%1=^:)O
MMU)5E4S6?E2ROS5&Q>U @TQ:^$VW(,2ZKSV]IU<[62T/E5.35IG[HJ3HSMR
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MF2CF*V0X$*1>D-!1+SKR6B9^^I ;L;'=2H@,&*($2Z8+]4&HFOKPYGO"^;'
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M,2!1,?XE/K%D*TDIH_@9:6>P*A15CUD+6R!(X;SANT!+0+2S6'[XK]$8(7\
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M_#: (2?P)M6W8T)'#8!WQ((JY.;\./&S^W >I&Y/WH7(+H>4)&T8FA'Y 64
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M[<\<24#YL""GEM\#F@_R> $*79TYPV[F;XW4T1 XD#$#SFSJB'[AU^&-_;D
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MDC\9J9UYF!+_$*'"J2XGK(4KPRZC3X*<G?-\C.(V+63<FK_QHF^2#@<(QSF
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M'B[$XFN?R='AV.K]VT"RMMZ90$PL[J5]ABJR*>U*MIP3P&L]?R:/1^5S+4]
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M\89=6+.Q.!".P19F.S8NM8WL-:?L^3B:QZA6CU2^K!_SJ,L17(]D?H\YHF6
M)D 8X1H)SXV$DM%?H7$PX:<M?L7K\I_JO@,-"1$75YN$5S.#U'C6! [Y:TI
M(N7!T=.(D.R_:MZ.H"\;JLU>R3+B_HI)C!8XZR)J_FE]E-#EKGY?WQ7.):%E
MF?3Y"ZH2&\V!L,P35G85[%-*2'A+4*;Z!WA(MZA*6/V4LH"[=+F^Z%//"FHI
M*9OX]LDR%^FRM]$X^(RK86$&!0%AWHOX^ 6H0+NJFM@9L+\27.C$\]!O?5KP
M%JY(2:C#Q4VS(%&#.W^OAR;/THS+4YLWLZPF^#7#3OC($+O2[^V:6-*N,?(4
M4:>!(M*/5!*:!REE! JX!Y;0?Y_4$4<9LL<,)X8\9CIVR=''TG2X[=*JF$P-
MM?PPHNI9_+D:5ZQW5GI>657'3\#)Q-?W*MQFV.E-YZ/?WT:'?C=>GS#'JA?O
MR_ ]G]*2N(J?OCZ^P19\N^1HKUK$B]%2]?Y@P?J_*4*J5(MGYB:-;F5W*C5-
MU^8H,B,8VPOS7Q+2U@8;M OXVURI4ILO ;,N/%3["D!QJ05?HA&+XCQ.R*'V
M")5L,@O29:^C 'IT"Z2@)N<E1R*N]U-.ZUQM+UM0P*!/3.M(AAF65YKF3>0_
MC)DGBL+.,'M9D-^T+TG&^F.08LY&1[<!@Y0V4<(G$->EHT0MIE60S!)"MV+C
MVRY/(TLH77F_3Y@E_J"[5JYE9,54E2-S WT>Z=O[?&A[U;>\3(07KF+D;"2-
M/KK'E5-LK#$V"N4'7L;<,7E0[FL&60.3'5:ET16!1[/:2W=08Q_)*].C+@,[
M^GNY:B;3+N<RI#;2<ES6K:J"NRPR]J@*UHL4&XOL R@I<S.=E!*]((B"4?!<
M\[.(MF.@*\#6^.!-@*J2<L$;07(6<:)J4.')@:)P!ZII7857*';.:8TI_)U^
MK41EN IHB-VS?UK^QZL?\Y,FASL)TA7QN+CG@>N#V%=E1==Z^VQQ\;ADW#53
MDT'_BL2N1TI\'AI&EEB'%[Z.ER^4CJ8MG=(_AZE:,3=2\H9&%[PJ3'/S[++L
M('F:)R0D+)5DFYI:N/M'W)CT;5$D02^ F?>!'UCREC&!*3I1UPP]X_E(=:+%
M.*QX;5*MONG</ZO?\'J%MGR7B([[YZ::&O=)BLJ(N=..2=?' T>3:U>S$[T-
M/ (V]VMLPDT>4H2Z+1)RW*0;;S?JF5XK(2_Q?TQ+'_7S,OII<A-894':W5 1
M^ L"BP4LR*L YBB%/(/T9?*> (-7UL2!C(9H^G(#<UY8C08G#F:N7#&@M>;9
M[%_1ML5MB .6^8)L!X*Z#20N&FRZ4F,IZ-=,(:1B>YX<N%;D@,2UYYW.)[FS
M((E[WB:/P>M2<6((;5ORW 5GPY*%-8<7]@,Z%>YHQ,,&60]_91<3&!W3-\K\
MQL[R02+$@VP:<SCB'RAUL("Z0>MEO,7[FIV+&(+7X?X\WN3;A8^\B<3=]63*
M(A,[GD\[H#N461"HRGN?_61=F[&1P8GKX@3F#2"HYA.1\$)>N7'&?&)R S'<
MYR&79WV#!7$W$T];%CQ,+=(F\ FK-PE-P*0ZY$S.6+M(+/FN?\^0*1'J$3AK
M_509,335]U&B2YKL[-2=+#.<[J0J>ZWCNS4C73BP**7O1?D"M^"D'RV NBZ8
M8Z(M4-_&/1SME;[6%T"29A8Q1U@0P!Q^C#FHPP_*BO9TX!(BU,&5H]N()N=M
M GRZ^>XPI0[,>Z:X)8=IKJ;Z?(S91"+VPOK;B^!ECEX-.&Q[\(G<Z/'6&$R@
MV^I"=>:6.26%>)(%Z8G@!PN.;J#L&>];PA:UT.?6@QV@G9=\RE9=+@UK/R#6
M.@05D6 "4T0$S6%FQLFS8>*PM3Q(">UAY),ZE&>0I^7;D7IT=ST+O45A08Z/
M,!K0WK<T1TD+KYB*$7TW/07$KHWY*+!M[$G0LJ?AGZ@[HYBQW.WC\1\0AV5@
M)F'^]P5_I42CX1;[$TM=0U/EE0I%C%XJ>LM L<N'L_,0NLE-P4WW4+:[%4_.
M(AW-J:K)Y73=EC9 (85DQJV#.S,WB\20]D+'BS9>#!17$Q'F"R%5^C4FX1=_
MJ^ G*QTX71<,-%EB0>S8X1/2+<Z=4!S7:78ZS:;_2R1?6@^7J=]/"6.H[FEC
M[L1.M]:BW(L!LGJN%$$C.XNN\$=6!TKGH@7=#Q1NI!L!Q6<:H_PO-G.]QEH4
MHIL2L;;<VG@NW=,R_C$W8N5R@]5'\AJV+(],019DD1<T-@#A1PJH1XR2%CAY
MQB3,TN0F:8R_R3>&KE6"#%CK#51+:'%%G]BO3PW[9%QV6RRVQ*!DWMFK>_ZH
M;X<X9^'[+N("NMVY[1B2!:$] /%'YDA,AXLR&(#_Q_XJZ@H;YIC0N.IQ[0?:
MSJ6]OKZD 2BAX>%:4%9Y%F/KKU%2!I.+QUGSQZBE9D5%<7$FL80,>ZH(2J=T
MY4^QGX<$GB12T02V@*]-F=&EZ"W$*4-_ SW:F=*MV22IJ,U42Y,;,V2U!&U[
MRMT1BQ[][Q6^>QN)6&=]Y,.6":$"M>MK_$W%2YE+'-TL2"1[P)G"[(B7I+L5
MHGZM.*)(U"6KIE*/2+#N?&)S%XR+;H9!ELV+&G<&9]6G''_1A>F7&,#%!&RL
MN5:-_*@[Y3-8&L)?6M[/531W*[>P_T;.+=1%2C)&T+(B9TG(1D2+8)/K&7;_
M"3JRXXFUJV#O(K,H8^E+O'F>3*T3NLY9QJA"OTK]J9JUP\"CZU[<6:6;2F#?
M=/B](PT;@NN-ED G.:_!XK+1SB<AN=IRUY6?[R0;?9%R*"ONW?033&&#\1(&
M6/T-1E.?$!9[NO'3P>Q9:I-"\16DJTSHR**D1NG&MS )5\%L4CBOX9C*1J+S
M92);7>/DM0V#/ZX%[ZXU*36T\L[:SR)^JF4$=X]PMIF9L7->H\LJ3$0'2K\.
M;A^)H((8>:AKU&V7>N!GQ[8X_4[3R-L-B]8Q%4XNA?;];0Y==Z[N5_%AV#5N
M;_[>RO70C&2Q(E__6U'U ROB[YFJJ!!0B4IAGH&SD:91,]L7XMIXJ;AHG=,H
M4;"4"B=/)J*N8!V\B08O4>?:N%O'\F 77-:@04TF6^FM:=\75AMBY,W,\JUK
MZIIK8L@TP8\[^6<C1M$0V&+!0OW"*QT8W1^< S"+VYM+1PI@H:/9= ])+9GN
M3YKC)2MVP<5[/ZTU^+$YW9DE.O^A(50A7A6#\;2=R+ ]+=0H[/*FZ&O#<63,
MCID99]I#[*.=]?1JK['/X]</<IT6CF/=).*_DIYK= =F/*Q2?UR\A7TBU'5?
M%0J-(@P816%=J[[$?;>#([35WL,%' 2UGQ8E1);NRU56'N,I,)L>&[@IASV1
MC,WL-0S31-ZO,BU1%+6IV/C>0?X,8!U4\H0%\>LG$S3W"MO.T_[;Y]-GO1''
MO)O*X8AJ?]'7;[LGI%7A[<LZ'X\W! LR]G@WNSZ&Z!CKOGBN/1_D+4Q\2/R!
MY2!N/5:R6U-X2JF_%NRSW%OZFTK7Q*P9WV1F(K)!O"8[Y#5';FJ-M?PDZ,J"
M?#3HC7#8#FY^]Y2M9&"_WN,:F;%_>L'VK[R3#$QYH"]1@)8+:E&2+;]&< \S
MS\S3KS8 R0QFW;F4<F0,5!SD9/*T/G&^YW581IQ%/X&GU=7ZW)@8OU+_AG_3
M1(DG_P)@NU5!0?,A96EWJ99(W_9HO">.B*9PM(NB-Z5LW_8; PV$;6Z4_XBR
MLS^A6M3!@EA?Y TTW_W2FD5SW-*T'0N4K*U]I2%_ G?_NEU\/Y=@NUHB<X!V
MCI:4YZV?BQ)^ 5JF:[ZAQ3>/9BI[>/"K7?WTB,K%W#YAQFN#W]47-!),,D'H
MPRXT(ES+ZMRW52Y4+HDP4\WA\A&3,!$Z C F5;Y1ZT@YYZES QRFBO>X"((>
M0$J'BV3&H2B''=6FU4]EB]%=?^C<55F8I19+ERI&)G8ZI-5GGO_KGXBP^W'B
M>0LT7[#?[>@VZBSH3HWI&P[H1?F2O.5U[8=OOY@7H^J5IMZG^L8L[1JF/P%^
MQI?7^0B[I[V_FR&/7^XM)\5@+4\[B@IB8@L2,2]+I:Y^K.)[OLU[JOO<2-JM
MMRUE79I^J5:SC=M\-TN% S\]2*V[KW?F79:?8=TF8H)V<=?[7IA1%598*=6B
M=!]UMS '89@WIX<R.7H6,0+_M787VT<BC886,U\%0./%A5"!9<@,-!>HUFFQ
M[K<V"AJ3AB(#\7'BY_=#8-4*/HI)-*)D\LGX(I_<W]&\R)0[,23W!)L84P$:
MEE'>$D+*G]K08["ESY.MTRBX'V7A'V;D"C'W$94*(U\H$FT-^E0B*Q4%T)Y$
M9%BGSKGO)8#EC.-&\ K9:*V-9]S2J FH;8INPV$1X/..R=+;CUR/KVD[R_'-
M%GXL(U]HPVE(3LJ?V2U.*#;CEC4/?&XW9>2']*H?ODI51\EZJ2BI>X%E)G/M
M(QUCR=IW7B2DEXWX%UTS;ZA[CKOS/"K=+K\PP';Y/JSN9X]]Q GZ^4885/OF
M!^9POCA321<(;I\7I+9E4Q(53X/W"1_7VR3&Z:[D7=5,$B<+(CSEF<<-,#'8
M@3" 9JQX!HE]T%C= .2U*1,D-L,S"?AD?)U:G+;9T6WFX.%<YE?O%*(4B0_/
MMN@\H&,WC>B;0M<"(KORH3K2.H6_4_G8:7(!3H4G/:T;.HN/U39V#2'U^PK?
MRF@HO5WR,>+2L+S"<G-D68EU0K'<_<>KNZYE?8E&M3[VHX<I];FGM>X4"RM]
M>UXGY9BE7*PW66%D?>TA]45!K[&0?H7<+>NA4[9%QN=G%T<+]-ND>%\5:-])
M49.J[W:5);F>VAVGK>=J=-SH=&7@5B7X#BA "JV&.AG;8G;D#%ZA%6>3=J'3
M:F: 0$+=4 +L9(L4I1_-M>'"2]V.KH/R&GC[ <Q=.S"9W SE R.X5%X7E*R%
M3N!I1XX;LHF.R).H#:8*>'#T!]T('*) HV#5<:!&"0%H)L%?1EP!1[MAPBT:
ME-:(&>>)"&F#"B^=?P#BL7M03A#SM2DV=F P^L- &1C;>3C0C55(R\J-_JC#
M_Z4QP=]NZ(1-3EV:Z(F8HJ0\!;$1.R^DDSX7Y=-$J80949?XP&QZ.(!995/W
M>:_4M+;(U%&_W"%?96V0SUG<P[S[9JYU7(=KX[6C03Z!NI[%V16A)JMKY$N.
MW)K*:2M0_"JN#QZ';YCLUO*=BFW'U]EVX%X**^#0I4@M&ZI4IWV+*WFUO 4*
M#+(=OXY,;+N.]/>NRGPY%R5J">X3,D_4IJ=CPL&])!,3GM =;@FGGLQP;?@\
MAK>2\_#&RFIAK&T;ZQIRT_WK'#S?ZEOW2GG*_=$K)6JH_.BY>I),=GDISB.I
MZ^'C H=<?>SB<H'C/2,3RY6@8FLB7V&ND6G [)-EE0*UVR_&DK D9LVIP9S"
M,9Z/2Z?G'/@^8$=H:8ZTM(.1G$=[\N9Z?-U/0R2+69!+(BS((:.)!1G>L9:A
M1X#I+,B)=L8;[=^H(CW,XQ,MXM2=<(]V%Q6J;50=HG:; Q0+U_$Q(X1N,9/1
M\E&3XCQ;"I+5;]?[;.LRPAP1'__LWIGI6"IRD66*SQT)H;^G']U%D_@6Q9FA
M@;0TNB8EH99DDW]V.15CP5UJZI7D(VTJ8_[V)RW-P;LW/WV"BN]PNN55*^NW
M#1VMN/-Q=1PC9S56.HZ1.MUA/(V0'E!O&]#YQJ@OQ/.@28R%JDS&:7BM 9/;
MY3<69 5C0(<UT]C6HD"6%L?&7O8KC+ZWSH*01?P6&#P'..;I%!9$DFV%N"<[
MH(?J%[58D&A+%F3)!9W_)&+&'!X/ YC;4_W,*!SQ"@MR"@=A079'B_Z';@2@
M.U4I^$.)73B=5YQY'T;6!']MW',L%@V4H>G8H=W-H1DO6:K4ORA(.,*[*1[R
MX#U3Z)=;CK$@0Z8I8,QL, MRM\W[UR)4+$AO+-T ?@JVNOA\F\G'5D;I(<SP
M]T<^>A%769!_51H=O,GNT!W;+792CK+]$WVP-LR"G)]YS8*L9@Z@@?OH@^LL
M2-P&B8-Q\9PH&Y-2%F0'!QNJ@?E\PG7F_^OBT!^,)/RJ$:,0!B0 4!;DEB;L
MOX=0G"J*^K7-T4L"'K2&,:U7#F@>6W5\8.J_+/NOQDGW&1O\0K@*6P<KL2!_
M$YA7<%'B>\_5V5"<P; @?2TLR/^S869[Z#B?'O2>\3(>E(31WZ$[ X%(YFN.
M<RP(R8H%.;#-7YG.KQ]_Q#&5>65PIZ4_/!O5RD1O%_A*P7;Z?QRT>3!N3-,#
MP<A_U8,L15 Q<]-#>) C$N_Y<==UYR^QDR"*^7#W47B2(_F#4N4#V+OL?&E>
M$>>X_PA0T?\' #5F2S;[UX5C?T9TP_<D(H;%03TD!PN2ERM.Y?JRS8Q'3;+U
M=@\+D@H%7[>=1P]_)2W09?)9$)E=^M%-&C&!;O@O"__+D+O4P.;JL&(6VQF^
M8Q/6]3]#]O^?D+5+_ZGKU1;\?JGG\H&+RU#-<@C\(?K &Q^<VPRBAA1!62K'
M_YC%E?,!.&QJ@-*@N[A-O!8EO5Z&X@(.CH>5O+U3MD%]4%N0N"U',JJY "DK
ME?H/\O?S?_+W/_G[O\64TU+ODWD>EOWWTRS)W?J0/--)R^4#],YH?S<COR>Y
M=5U5XXG&7(94D%)>**4^E%(7(<D>AQ-41E)AEI!!)-KSW;<7/;^_04$!IOZ=
MUX+JR4P9&0T+M>./^.*(G?\PT5\ 7%B0J;^J8$ T<YCC:D[^<1#"FSKVDGK_
M9?X?SZ7_0]2N_4]J_]<\5$?:!A6&-@TK-OB%78I*Z,^ ]-R_U\XR+U&A+Y5/
M[X4KB50,T%T$J WQ@1,O84D(HCR=OO3PX6E>Q7/JZ]QI^9Q/MO0T5"[>S,DR
MVLXXGX:1(BHEIH9>G8\>I?9WR*1&JX.1!"_+-%<!;=_J5R\0"J'IKF<"*$&-
M& U];ML7;PWKCC3T'H'^G:$<2<I< ETN_!/*V^=!WTX']XR: N\LO5DUHDM%
ML9<J=<YNG5\@8Q.8)<XY]E_\W"_"]_BA/[$>2Y$0NF,119$VY?'+N9KC+J17
M)]TG+R6D5Y*%4!XU<6*8YMZSCI(9R9&Q*#TUAK'(22-9\!H]R)'BIT@;R1O=
M2/0R+,F^+UV8\/:__9W#>0JLRX)I/5M[Z%MS$+(;)$?XMHN.[%U(SM\9'1@"
MK$,_IR3:CPYR-GF*_+6SXSY5DW)SH*?W[Q_M]]DG0UHRK?_+O05_':'0*';L
MB*HQ(GK9P22/Q52Z=:!WSF4S\8_9K. ?'_W^F]Z%!_]VN(10@[N:,O^,N( R
MH\ZGG$@?Q"WB8O-4J,_2?4I[M(D^W<6D(:[UT*XDX2C5!M5@BVGC0(\+P7XS
M+@ZF@'(BUS<>OO1;YUHL:6P_DNH/,EB0QY9D#/-#TW[@0U?A=[,2&EU&?$IV
M2%-%A+ZUJY#>@3+1(S][O%17YMO&<#;&YC4\&6OD!Q98Y F7D]0/N@U5EE^G
M+FXG[L/BX*>8_,@CAU?=DW;4'D+*,1!O4S]"_A)[OV&,;DS*573 1YK&_%BF
MK<L*5N+<7X_(9O<WQVU-*&<MAQPS8J:XB!XIH7OKF$-PFFX;+WK]Q ?;+Z,]
M'1>JIOH"R$5GD"UW+_'5NIX937K4\M90\?;C?2_;OA=-^R7KUA69#[W&2^7=
M-=.OCV$T^@<MGID-1%\P=XHM_ 4NWX$6H$:^BZ\*CL=[#D7!!9A"J&<M#52/
M+4ZJ&@76OBU$5P$5J8KDE=@V*="7W%W$$?\0V&_# A2"CD3D'>I0;)V];ZV)
MK3$U*D^LX7J7&_K$[MINR-IAEUZ *[:,I]/_]EAQ0H?9"0>ES)JL8CD;J&"9
M^2>*A?)&1_W)A*0RBPK#D71/HT0VT7+&$DI-SX=JJC?9$2W&BUTR1(2BC#Y:
MF@:XZXK')Y&$+$H'V6[9]2]VLWSCF,+4.W0D [O=)H^LH6%!-> G[1.03Y =
M.KN6S\[([@,"E$X=)<"GIR-1_/0&_@S*Y),G"W*2J;:>QTD=BE+)F/1YIJW$
MWUR$>'8XR@Z=@;%=IW6IC>U7^<?A'?GU,2ED,_!NBWL9TKA=_#.TW2R:R0EF
M4O!GYW1+ZXLPR(UNV?+53.(LT3TW&O?:X_N'85^48Y$#(_M!O7%<\GAZ:T6'
M+#-]V+E?)0TQ'*VI5%+J:G-F."W$RW7M,4A//;WU9"W\2867H'9'3;K1EZRT
M=>M "6%E-P>_ZZ6QM+*R4C5%KS4KGY+67/?W?Q]47K9R%=)/ED'FZ)O$)I5V
M9RI?V]&S3O.T-*9ZD[:_HA-H^77%L9MSI>"Q+GY\=4\[.B7O%J.:+D3I3Q9C
M*O[F?0,<,JAN P0ZPJ_8(_7?^V.1O.3M).8E9'4XSS5BF"P7[YUFI(5:]% .
MZ@;0DQQQ@CU/5_=TPQ/8$U6$C!DP2=KNPH'2"OED1Y\K)-_7VFYD6&S62A<N
M67B^%)@D.R_\J:WVP8MYLQ'X&8=20Y0BFH(3E-'0]?,S4^#K[A\:^OGEQ9WX
MUC3+XAP;S-F+M]*$":[N,9\./N8I6#]7>5$&]M&"D(>-3S\]0*;A4R([R)@S
MJ1AIDPG"G>9._\8(%D3DK%>-D56.BUO\8<O5T7IA^PSOUSV:J@V2ERM/HVN,
MTR/NT1'@ /6*'366T*]X G2DH#</ ,>>A5,M?E@[,+(#5FU&EU-,;+L.QOM3
M$K%:OM%9V[$JOB>1VT:@)0:),0C1#O-A04ZOQ-0Z)B/J,C)=QE!JX:Y8QYF#
M[4T$L$LV(/CXTT2H')V*OR%7.K+,"(I3O)246.WP4F0F0;CDC<_B%A)E"L*Q
MTTC_SH9@F_K#H-B*V=4LU2(T9DT@D[]Z%D'TF1M(,W-'R%4QIVS$X^DW/X!#
MA*:5J!;+$D=O%Q&J0GIXP0;QUF)0S7A LNF\L8FN:<O= (2\HH][QORR?+M[
MC$'RSNNO7=J])&!<VO7YWMJ@?[>A31G%QL>V'\0H$([L90+6)S*$4RY,FF65
M%:N\ZBBS>KY3FI ;FG["I9AZ,[58??&*S07;&N/U+TSQGLD MVM]2H==IN+%
MOIYEUA@YFRM9K0[F!(N";KH@6/$!]0*T731+G.<?U38H8D>_>.PFW:0 P90;
M?3B"NLV?_LG76RA05(?XT[SASWG'\N",;LZ-3QXU7QJ^O'YBJ!<::%-=73-:
MOJ7,T)F8[^[H(')JR<K><VNHJZVMBW]87U??$&\A+;\8S2/MFFRC3M&[^Z ,
M4N.D'F^>'KKS7]A[\Z@DV[9OE.X&*TLR4TM3&K72-,NA'. N;S4U)>=9,C.G
MG%*3%*%R'KG-U-*43(T<$$UQ5E)$2S-S3DT13"T5A52\$H1-[[?W?M_G?=O/
M]ZVUO[7VM_;W_ '+B^5U3.?Q^QW'P;HX3XI5KK)NJ77&;AM%YAFKEW.*)L_G
M3TI>:A-3>S+HWG-BQB-"TL#&NOC,C^C2,X$V1687!S)L))DG=]:,1>5^L?)[
M79U39V$@F?#BOVTV>O[/V4M_'+YDN#/R</$89FOBL_<=YQ\GI2<[/W$O*^P/
MR%1J'+U?670O@WDO8[+[ ^\S&\,,YE[D0?OXBOS/\N<!A534=G;8]<TLU 6V
M>VL+F-6;!#V+Y'<;#-+[UJC]H;L(ZF?].UOOR>M$M3<HAY\'<):/?C;I08D!
M=VZW/*)&0%*A?VP^\D>)!'-]>#: +"N.(9F"CPF!R#D 2XA8Z$&V49(NPKM,
M_Y6PMY+;FVR7::J8J,'TB=0W&M#5\"TQ57_%6>KJ/TWX>P=V1?@O]SY-8EKU
M,.YZ$*M:IUR3 0Z/)1\W[6OZM+U\\F04IYQ-)2;>&'P9.%Z4^7,).IA>[FS*
M?:L?3&(U4N0UA]'*WVDL> K&:*BWC?:YMI-_#E@(8XB^^QJI1*7MECG!!B^F
M3/7=FWF\X2+2CCXSE'.]^I9X.W2OO:&HQ+'.52O*E5CI0[:QQPC*KA8I'9_P
M"46NUU.NY1SO.N]\.R+IQ8Q7IW0B\5GWA;=T;_-<97UB0L'!#O5OM,PBTYM/
M/+9;B<87],93S(*MD4WW0O-FZA7$&ATIX#@'J.S)CIL^'87?&$$'35).,O=S
M1QA:'9A1)P9YT06/_H21A!XR8HM,B=73"5NIVEH4 4@:I<<2@!)XQA&A93[G
MD&%M&_+8J<;Q)*8Z\N.R/;FFK]HI$F9EE/IC7ITT>#,E^65 -%KAUW['GK31
MU%^'#&A%-6UA.4UADWAG7R GURU8^(>KFZ).PUDVXN/?'*&$5\"]CW..;)%D
M::M!HSAE]2T*A->OZG6S#?.(Q_^F/1,6%!(B@2S.WXEIO0#S%("B^%(L1$HH
MY@^>=LUF*?HX@&%()Y-H(,#$3/IM>,]Z#%_*WH=_E+7^$'UL7JT[@BWAD$65
M06?KJNF&K<O_(>_14QA43=G!IS!&'NA*3,,>N>H PF7N78SB>J,.;[X)0!_D
MJ0R%TN(W/.86F]E@:OAZLH:OZA]??%S%6?<:IT7AL>@+=6R7Q1K%-FW4<.6W
M2H=QIUZ.SOTEG06/$.^;5<I[U#("Z\)Y!MKGGE0&QL 6=14BC8Y2&4K]Q:>Z
M)9(*7.W+G$N'\(=5("*/;=MMBM]KG4'-5V_&BA6^WO0OEU5*"7]RU&REJ5,R
M\V;P83&IG&0?9>4@E4R[:$K';IM*^[R3;0,%)L$O\IU62^#[>=*;Q;K>4Y&R
MT[T\B3G&M;[Y>V-E\B#V,O,X5Y=WE$V,4U^X5YGNV/"FOH'$-FK'[D>=YW^.
M,Z-)UJ:LJHIT1F+D\G!!57;98^_8B"I\N^JH)Y5 0,*GC!9%&-B=/#4 1_2E
M@5$>TS@PNA>V31?"PE KD#K"!8L)U9_6_-1D(Y9?#@3 A\Z&=N^TLF$U<U\T
MU%L/]/GCK3JH7'LG)(U#V<Q1)X]R.7V?6K10ZL![!N0P^=>V0PAS0(TXSKO(
MPL3Q)7RS6S**Y\/+'](/ "2Z)ZXC4SLL!Y*"TO<+45VZU2^_14QY@ *;RL'L
M:Q'Y%@@$4[)Q3!+Q.UG2GZ^*BNPC8#SD3(7#T-YCK/PA4D 23/QH/T&B]>Q4
M'?I(,Y/9Q.$KU-3*JSMX#N*=XCL_WS(5[SU\>#HN,%-6W$3RG%7)FW>]YY[,
MJ!*&4TSLGVL7F77O6^BW+K$NZ,EJZ/EH%3V13D!DKM@4#S[WG9+I.&DZ:H&W
MVOO,1,/+^LEXP4'3+>8$;62C79%11D>HNR-.<9[V@'Q;=10S99LR;0C<9\'H
MTI1<Z?8-O4TR%J+/@L>%-+J$45Y.A@VJT\1-:HXS^?).MO47O*53%![_+1Q9
MOR6^,6Z<08SZOL6PS(ACN-81\G[^/O0[""BD&[$7^<;E#Z2N&?<"ZB2K,V&5
M:?ZQTX0MABVE>H#CRF>CS$?4]=P-V*JQH>IUJ:8]JM>KFJQKLU 6*S32,(EK
M^QWQA^YE5@157AE09- 2$"1(4I,J%\H[7 UX3_7&0T2MKB5U>-KB&(8$!M.W
M71X&-(<TW,MBT<R&EW=4YG^SZ,DWWE:;@I_OU2 4HB5%T4/D*JPP\K+?9"!M
MQ$>3(FPMI@M7#Q;#%Z[P6YQDT^5I^!_$3LSH "7P>PND?D0#>PBE##C(QX5%
ML JLP/)/:V1B:DC2E!POCT%"DG9K;S0^OA1^KGTSG.!L5:#M$&IB__[3$_8E
M6[%#->=SO6^ZG"$5=ZJ650 G+YN<ZS0I\SBY_4,M428(>4<[YDQ@1FA\QYGJ
MP>]-4EJ2>\I3%<0+7Q6W,MR3J.[L@S&[]+=GF ]^+3$T7<UI%8!(Y#8<A/^)
M+$Z^C=B!W>=#V\<_"#A.MV?S7X_=LIW\(]M7B2E];;!)!X_,]9_+7G?YM ;>
M]]TV>ZVY)>UD34;066IAEJ6/E)VM!8=<U=N1 \'2=E?#XX?'3O E!\LU(/L!
M7RH:W$C&6C6Q,"DH28:>51M:A=4SG"])2$1H9I1_6Z]H12F743?32"U.3B'U
M]ED_PCA.GUK.\LYLUK=(\BX.D3V+=67EGW%E@2A3MBL)PTYJ:SD_K.%6PO.N
M86LE\L\MU(ZYIMW1(.\#B)UA$BE.^O&$G_7#'H/3]2[03Y<1/ORWT69%_.%:
MS@,!Z,8\HM:(*1U$[W3UFWE32V8M/2OM\3)Z]\F8P82U%^7!TI;0GWA5:J_;
M/0 ?>R3W4D<U^8V2>YY*;GBH]S#Q </GF:218>XEDF$L-/58YEG+LOEA2O?.
MBB_\X8LCISAK<H[+CZW=]HRHM%GEVXIIN,5\J+OIT)7BK=2&;-)4W*OM;_W<
MZV.&]U"RHN&KW2^YLXFGB'L6?^V_KD; @\OG:P0@_UBKO;'I1P>&![JS/Y@I
M%&YOK\TQ&K-<Z5(ZH(,=-2M+J8XL4+Q=22C?NM! JN4D?KA1V>^A?>/-C^QV
M9VCA]FZ$'\17FF\^]$ G,GW1(QY1G3*N86D;X321-#9.U6'*K3>3)G^0+SQ=
M%("H*K5<^$=$Z"H3$H,.0SIQM%EA260?\M@R(ZL3]P C"CV"1'2NT[9AZ%9
M% ,2C99'_5F?U]DF)!F[*^SH<+]R8@!A05XV5N[NJ;-+1UI(_>3JR8/EA(+&
MVA1%B):W %05)\1%#.(/S,T<L"A*I)E]KYFKBQZ!'(8J EAZ0!0*P4JGK-?
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M!6# QUU8(M0U:0?++\SQ[&K'"[&*C&L_H0&I[N.,^S"LM;ICW,JP -0:N"(
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MR"M<U:\XG@'(]I\RYIE>SFRI  1[PS?^-U?_@Y M3O\4,J7_T3JC_RCE^O:
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MM!3[.%>I4C\\=I1[GD^+K@TJ]_CM=3HPU)!;R& :_)!=>-SB$UGDZ7E^=
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MV?I^.#$%C:F%\HF?*<JZ7$^#%4O.H>X)&XNA%ZVVEG97/6@+'9Q%V?/3^&V
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M3;\DM:V[1-8G'GOG(3C2UVCR5T*SN.5U81+?4X(ZC-^UN!7,"196LYM,I5:
MV%<!%*]&OW96%H80DD\AZ*WXSQ!^QC&:7D0T:9-E;BY>]Q1\:_CB,25"1&G"
M F)G7_/FZ+!X#^8V=W']HK1EY]@>E#A=.U1+@$[J7?[5'=1AY&X=&&8$824[
MJU>YA<>4,)FOOT4*#:^?U"'MY:^8EBGA4W*WU\DAQ2H$>H4)F&UOKH9U)1_=
MM$9HL[Z'T305EK!O/I-OX]6(R]5\VB+0K%>Z_D/QP,IWO"\%DNZ.?-D'S0J
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M(R?KH,>.X>XI&@>S.PP3<<? MC5WXC#A8WDKMH8^+V1[<9H(':/2?7HC)H@
MSST#.F'^X3BQ.<74YU-G>VNT 5/>A[SQ8//VZX1P2ORUNMQ-B9&R<^:L97&%
M927+]=8[#ZN?N1C0$Q; /?"'QF?EP[[EG "K)RK?/NPDMU=XNQVE%<DX2'GN
MRO8Q&W'ILV>RGZ;:ZH6X!()OG7,L9$PE'.W*#[Y5_G1O)<.NF%63[7 O*<I&
M>)3PR[QABS6"2SR?5U&<SU,)M7N1+:[:(D0-1J*36D4Z<.N7@6&^T.;T"&_
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M']T$P_?N#U_8];/DPHX]:^HRA#]E[+_C*_'U[_C^QX7\XO]* /\7U7]MDZD
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M\NZEAIQKJSJ:^?*%Y;OP1^']=2$/_O$!^]J_O%3@\N>GY^00L@R/B/O\D8_
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MXA 7ZS];_CVPQ&607R"W84[_%O=4M:*0\8>&LL+Y'?NECI@,(+GR;]EO]Q.
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M_T37#QQ3G-:,CE+5KBOO>'7LE(X+SHA%\08!R,NI>)U\\=,X:?D;KS#,[:,
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M-;+$84!NQ#CC&8ADBB3PJ1B(,!^NAHJB4\:^S+;R]6M>,7$IL#!Z>FSK9M?
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MA1P?J+J7,QW453W*%8!PK66X, %HTX@J)P!-KKZF<8?LA,*M_+Z?P=P8UT,
MBN_9BEMU0O6"N8A&]A$!J$"'_7W'')W7".[:G "4M('M0*UI8/L@@#E:1 #*
MSQ,F9[*:\,*^+?'"ZV"MPN\HU/Z1;@'HMO6:IP!4^/:A $3O.2 <(+9G=:EG
MEO,C6/% %'[Y^X_:%B,,&E<-K2P Y93RK^/H/%IE-D\456W)E_3>(@#-%EO^
M>&+>,#\!Z,E6X91N12<)0*9Q.&*) +0[>^ZE &29+0QNK?DV E#O!F%VE-"S
MP37I9'\?K3"$%<8'P\0%H/=.$.8B9%P XJ>3VZD C&DL !DZ\837_)DH/("[
MMB0<[I3+LJ1P/)?KN&_S??PF]%L!Z/1VL "T8Q7,C]D4@*P=^'NA?1%\O'Z
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M<[#8ONGIH)]&8LX5?/6][ ZJ&D781;:Z8=R^'Q"*_<.=T +!YT#C:_(\V'G
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MSCU-4+(=ZNA.%=19+L+H QS0]RH,\!2EQ!)^C64:.7!'!/VWD]*M:J#;^A?
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M6(Q>I_@$AWX>@"F%W1P3AW^M+U:&AE_D28#ZD7[/.TG-P,Z )5%"@!F%L"O
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M&DT=;5Z1;L\P]D!;8U!CD*Z"\,P:QI :6@ R^73M2R\'1!W-0*\?CG+)C"
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M*YC[PC_+\5T8.GIBNM0/4<YN) _$#"2KV.CUU^A_,38X<!NB7I3T.&ZLYMR
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M:26"2YYX=3B@@Q>6QL:D!,J7["=(0=#+HV$:06[9CK7W/ UGK1N;GDRBK\$
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M9I,ZW(]\K&_=.]%Q>F$KJ5ICR7!>YYQQT,"&Y",G S=V"N3%[$ID2WEN-.P
M.?9[BRKSE35[@O&2W!6NT#JSK=[A.'F"(3KU *>(@7>.AB<G+1M:TK=ENT)E
MR ];;!6*=#[+NGRL7_:<<R$XJ(?$+WZ742]*.BU^4?-06:.M3ZEMG9OJ9/W>
MU53SNPG19CV8\).I9EVVJ7ON.=A@?*Q2VM)WO^4:IT]_FQWSZT%J%%Q\*2,=
M['O8U6K70.=0%^7@PG7F(37:PDCG)2WR#>3-,MLTM2(!"1?-5._[Z<.C[QQA
MM8)$.C@*!C$$TZ<>ZCKBSF[G_TA8QG?AM/M;()K9M&T%'D(,X]$N8YD>BY4/
MIF=?9/O(0&*X1PJ<GH<G)U2A?\C6MPQ50:_K6?B@1]ASTRO)$#J!V 6-<C_+
M:(CBNH5.R\)B<C0&N&'3!-LNGB03$AMT#VW-%(HA3K_\V(*<MD1<V7GW>C%\
MXXF![V@SKK!X44I7SV$_1;ZH +T>?6CR]/Y9*U>F>Y=8JKY:T+"^#>;*]7./
MB_*ZET;$LE1,-'3V=)V*U;A<!-\:SVGJIHA?K#S3*ZU*0WJ.![L>*D@J2+VQ
MV)^VM^B@DV-,](EDE21QT:76F)^NX62*!'-D*LY,M?MPQ"\V0^-1Q]A *4-D
MKTR3EP\P9KK<%9L8*;M_)$OC^G$:C(U$0V.FH+SN1*?D1Q^6C/SWF*!MR)L
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MG@Y<?B?I$V5L9PYYCZCUS)*$GTANWO=L\3WBS]ZTZ[VU&XQ[-#R9RZKA@TA
M4;&J _E?D:%=]?_P7 CD\N#70932@Y"XS]\5KM_T]J3VM_]V<%[Z\],/)GO>
MR,W]XO>WC,#_+X?@K9\0RZCS]9\&+J*TF?)/C&7>^-)6L./T9TZ]BI\%9'H>
MJSB];?$ZA24+6,6K]N)3\.NIVV'??QP*V02*)G/\:%KO^?QXU7U_QS#T_]/!
M'_\/4$L#!!0    ( -8[95J:5( $WF\! *Z) 0 2    :6UG,3@Q,#$R,C0W
M7S$N:G!G[+MW5%/=MS8:142:2.]$I7=I4B6O!1 0D-Z)@ $" @(B 0)1>D>I
M2GUI1H2 =*0%"$5 >I,B(8F(]$01(X3DYOW=>\Z]OW._;XPSON_^>9.Q]AAK
M[[5G]MQKSOD\S]XKM,^T=< E$T-C0\"9LV< #^A? &T%<!MPYG_S\X^1_UT;
M9VB] ,X+9[G/&C&<N0HXRWF&@?,,;0  ! #.,/Z? P#_U^?,689SC.>9+C"S
ML-('M%P"G#W#P'#V' ,CX[ES]*-1].. <YR,7%=4;I[GMG1GNAK$H_K\9=D%
M\5L-?;Q6TT0)-8_@&&86/GX!02%)*6D963EUC>N:6MHZM^\8&!K=-3:QMK&U
MLW=P=/)\"/'R]H'ZACP)?1H&"X^(C8M/2$Q*3LG*SLG-RW_UNJ"\HK+J#?)M
M];O&IN:6UK;V#QW]F('!H>&/(Z,SLW/S"XN?EY9Q>,+7C6^;W[>V23]^'OXZ
M^DW^<_R/7V< #/_I^O_0+TZZ7V?/G6,XQ_2/7V?.AOTS@/,<XQ65\UPW+9G<
M@[BOJCZ_P'/K95E#'[.XFA61UR-XFH5/0ATG2?K'M7]Y]M]S+.9_R;/_=.S_
M]FL9P,9PACYY#)P $(!*E5<]<7@_F[&2C([XZZI 7Y:+R'JNB(R6EI*-V%)U
MBW!]@Z/+%T\I@9'[$?P>7->B4ALW5S0(/\8D9O0:/X1+>.SO!CN^^II-/A*Y
M^.R,TRQR\NF1$W3^M6WUR$-4&+:<!HB=G3I4PY^J46%88! /<.$K<":3;'J(
M_8.+H@&B433 'ZFN;RDKGS&3!RI'LS].,@UI@#BT&0U0PH_]O8VE ;)\_NL.
MOPF?BG_&<_B#E-L/ _^+-?25'F5$WQ/T0QH@II0''D7,'@*QH:':< OBSJ#3
M9%Q+8;IX/Y M0#UU95SHA[/AG'IJZD&:4.CNL=W?2?G+CQ8+HN+G6NTO&0=!
M_-3T.*FO%TE &H QAJ@+4S[Z0^[3>TIR=H M#_>N:<UF2>3>KJM>_\)O-K\O
M\M%!KTU?<OK76++;=17^%_&<N3[9A_6L9/NK^**?@GG>-B3NN.#15Y\TWP^8
MQ'6C1,R%BO"KUM^^5;E9;;2FL']Q!O?JO]2_0DI,% 'FDCB8%_JL:ZR39""O
M$Q>OW1^ZO?VY]KQ^M]S+M U>LV'.V'A-B?TO/D,3O\%K3'%=%I7DE?XU85)&
MK)J+3[3\U)-2SN\_V__Z"8WX$B>4&U=[-<L!8^P7PGTMP_$2U].[.PDW&.$J
M-,"Y*7(,EAOASK&4.#!C'A"@V,/O4\+9]0'*-N,")@,FU_VV-G-?+^U#.HF'
M,RY-*B&ZQEWG/P)#%C>UW[ X/O5^M?$#?9U)-+5O]+@3U\ KT_GGI.!/Z8?'
M1WYL/R]__-D1H"0X9)'G]2+(+C7#/:8L-5.NL[$% @F#5'VV-.#MC3P#S@8V
M'U#XG(^L3W.CU<CYZ^ TB@:I8DA?A9CF9'1TNHG)9(<![:<40MF]S5KGRZ;3
M#Y)ZQ,EVQ_Y6"T-'HZ;DOV<E6MOR-OP-YO(M73!,.S<0C*7\@<T@5D2?!]RV
MAN)RO6;]5/[H1ZPSR:5C=6GV 5&&/ Q]9Q!:;1Q^=4@]%<QR S4^8*VS5%?,
M??.YS]G%K1+!QW6V ^3=+:]#DE:*H)N%O:@I4VSM=_N!Q70G7Q5;'F_YX.H^
M R.G7&CKGIAC])G#9R3A),J-42US%S5GY3X/<F+*XR5]:;5/Q!K!N-[US424
M7':NH'F1=M$7G;I*Y/XT9B'%OE0/U.H*(BA511(-=PCWZ &FKP:U=B8[$0:G
MX9?GU>O/#I*R?IK'C(?R-"1B\M9 '<0]=%* 0JHI?\(O$-]G/VB0\%:8W?7E
MD4QS1!+Z82!9OGYWY 1"<4M<1V(0;/"'Q+;4?8HFBIQM7HK73(1S5WY?+G)B
M6I)$S^S6P=5(W(.+XS6G"7B"=8)@\V>%Y>%[<Z('%26ZD9&ETZ5)P$MZ5XB=
MO6NRY&P"*G@8L\9&#(A'X$&7_/)GAWFK2O*1*RT#C4Q/+=5_/GOOZ#3@%+DS
M@MI3M').QJ?3 ,FE9'&IUV$$$%EV$9/)\UTG9,GGF+U^:%)HV\X20IAI9@?C
M-M.ZU""!X@D,HVWS7>!R1_GW#V;4_V+_5-OQ.)]M0Y &8">M!:;WVV$LQ'LM
MA',]9/!RM7I!'.SI=>_5TNTUDC;R@!P\J\5W&H!=8<7R[GCO)#VS/GCD.I9M
M0SN/^UK5D."@0DT2T:&(3\AA^97&*XB MM<A)-%F(^;HQ1#AS4SF_.I[NPJ>
M:@_ETT_T6/P3?LH& ^U)DW[?.7VMSTG.)&@F4SA)W,/1 L2DMG827S%QS)1(
M;<(KJAGG?@K3.6P5$R>!XG:_SJAC&EID'\Q!.MI2#(K])6.TOR;^L,)2+XJ=
M)G\KN?"0''ABX62D,#TL.3\<H\^OSO=Q_]TB-ZI^R*\P+X%7RIAO>1D?G-(O
M()G]R/^D_NW6@M!0*:)RN_7I<L+K=XZNT.7T^*^R0= H]\AS>8MY8??O"FGO
MU?EO9 GB7CI*)"\)\'K(D^DE,P85W1N1O^M(ZC'S['<*': ! %0Y5[ O#7!1
MPP'WM(VX5HF<7.@1]<UFJ^0_5C,^&F?'CJ7:$;\2C:'?7+<BYOB *!CXY6-O
M'H\&0>5+5H/6XUY58,5Z(V$='M*3"IX=]^Y2A8I?!7)*S8H(/X/Y+NN*<!I
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MW]\.J52G#DCO%K@TI+-L*2=@&0Y#2-(#!SPD^,V2((U[C9DL$/2NEIR60IT
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M]1MR ,5#Q$6?]Y]^:/3D5BPIV.4]EIH:,'Z\L[EJ,KZ%;@W<JR(ACE;)E33
M):KTVJ!WU99LU!LR:V^'3;9RHAX';J=F2VEA:$C:_>B+TX;^IX[-I#IQT],
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MZ@'U+3L$"Q$ZPHN@UXM+=/+P^XBEX\G^X_@^KQ/OYUW>!"S+(+-GEN*AF>Y
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MC&7Q<DWVUXS*H-<3<C956CA2>_)\6OEIKLM"NK8!:*2>+&5/X00[+2HW9V:
M6\'QD.FN&WXZ;F30>G3K<PU_V(!G%M:>'.O!>OUUQ=V-GG%<ZIM4FVZ'U[_\
MG$V-_\Y ;(\N+Z]-K+&:WKW2TMR2(._GY^>3Q1KI!^/T2+AP)=E.RSU!PP&?
MHF&3SFO)(P,P,T!HD\#\WB+NK[JB_1R#9[\E<#,:%6C=XY557Y6QSJG\4^73
MT?)FPZXFY5N^@KL #1!*#L3ELY)=7PY+X3XI=%=YL[PN\4LY"OG4].@>MTFK
M4O.5<]6SW[(P[E!# ;BZI*2YR"^YN;>6!KP_-K^[&_#</_-OC3>_SO=I@5)J
MS8Y0_,#3/"&[UXBW:U],[J8L+XPN.!<F?[W,Q253$?;H[-/J7ND4J+8&3V$P
M5")WQ7])(@_5-LUBE28N._)V2';4*MM$)<UVQ?][EG'K6K(OHABQMXG7HMB?
M0*ESRZMJX40STB+>-KUKZ46R8C.8QU='LE.YX&4[6-P\32[WC WCK8^\F;^A
MQ,*;^KQD>^(DAO&<-Z:4@R+X]ZMY6SZU"G*(V>RHG*Q<F?YDLUS6N_-G+C.
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MH4I0G>YU;QG\QEABIAY^!3&&51C-"4F'_#M8JXR+K[W??^'K^_<]*T_K^6N
M8K'E^ U[5RO^A<QG&M;5L3@N^T*/?+VQ$O&,91D6>K'N&- +3"*^C]V1PR(.
MC#ZT48X!J2AQ1)0MA9C"X*D64_::U"R#FV"600!$#B ]FD 4KCZ#^=P8J>1
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MG.?;/ZO]?U%-\LNGC@&P!7XJ/ 8904H^T=/&/1DV*(" =.M99C63%L_Y3X;
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M*DN'X78,D-]GTX$<],R-O46F1770X2&=_?)R/VF0&5? =PP80T.PNF4S\\<
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M_M^&M6"\[;3\ 9F6?S 7D)UD(%T:O=U:M=FFDGJ'^F-';@D7@S*@WJ"BD]H
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M06!^AFW.S.,C0]RR2?T_S.R;?UQJ'&F1.%\[:Z0]RWP$-;5.Z5 ![>@J/==
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M6Q27QKB-[!Y*N'YR IM/G\]C!\NN]Z_8L9JPX_,SB&3^L86FX.1&9L19NN6
MB02#=]$B=0S%6DW8K#1NI^P?G(\?=<0&W/T^MIF@E71#3#&OB=_=,*R1_&/
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M_@MO%:=G,WD.!Q(^5N=V*[Z,<$XZ/T8V*3_3?FL-G+TO<_RB;;)M0@^ Z]E
MV^%4K+UB8_XAS4P1*H7!68WX?;Y%*"3NF'7"MK.YY\D]5WDN0N\V$4 ^]N,Z
M^!]BXA&;AF @JL4'MG922.7',K=H?*5M85#O,<-9"D/[0Z@ <HT)7;"//T;^
MA-P^^_^V< -QD#K3'&8WU<^5EI^EQP75Z51R#<<H^_!7!F(_K/WBZK"HC.5&
M6RRDCF#]++#T8^N%(P'[9:IAE5GP<G35@I)]8PGUI4<%NL&H\ODKPMK0]?KX
M7^/@43SP*:GM2*ZH+/";*RO?C@"RA:TS0OA'[+TT_Q&V/,ERH=TS2^I3'WO"
MU7J#ZQDXXBHUF)VSY]"^QVFGWK<\<Z_D2(/-?&D!Y"N=;<UZE_DYK9-:ZR-T
M/<EO5UP"(\CVH \C>Y+V]^;Z[:8LWV*1]'15Y,'155=MQ*^Q,BI@%.0\QO]&
MC*6,E7%)7)F(\ZA8-75>"]'?5+X-)LTW0><J\#+KB=$H<2H6J\#OVB:V]_*,
MF92866JLLSYUY<(;0K^[+*MUOI-#E,%%"FF?6+VQ<@ZJ78(IH0%](M0&*\%O
M]$A"AF/=!'"SIE_.6.UD\RG'AXD>T*?.I':2(A=&HA&EI#O<S_'*R$3,BO.V
M*JI#K&J2>Y4"<CPXE_KR%L9T9K9.'@+.@I/(&,N4:^^&3FVR&/89G2W7MILU
MWL8GEG;RUTY8]"@Y\U?HI@VU&"NEB"STZ9"%<=ZV"Q^ZB']7R9\F*E-V0"<]
MVZA"9?*4) <_2O@T?8"79>(#K%\'+1BK2EPEH)$FA"?]2B2#'M5RB*DMWP77
M ^E$AB5) G]]8'3(CA5!CJ]W<4.VYQX<VCS6HEWDOJ"4WMJ-9.V<-5_1%0JL
M<D"$_6J8(,*]5,O+)WJ3)J H0"09OHMKPAIK)X$7X(>XRH!;0^TL<1?8VX&0
MA.O@/3*[U!18YM$F#GN*9OK5?H;U/R775=JV&S4D,6%_?+O$3-*R&X"GL.:7
MSP.&3&*B .+[KQS8ALGBTA%^B"BZ.$4:;P[T==7[>S X$B(,[=_Q]4B1);7]
M)//!#;H,CMB9D=68<$K?LPHF13<M+BW\Z;"M3TD/]#R9>1.OR9'!A2/'L%P4
M"S$;TDV<T.PJ!3)I]%U<6:8 DC@1TTY<049-[V31'L;-#@.G2 "9 6M?%2?)
M@ MU1'%A)5:[E$026C"EDR#2; C1F#?PN;+$KZGT2\U#B_'SG*9WX4;H!RY7
MUD9L7]7'/W=+]1L00_2NCP$#85CZNMD,=26')<88:X.!FB7+_<!;<T;K91BH
M$;)<S^H7.JUD .*.SD0)>\A@VR&6*U^($VLC2 W!Y0F]F;ER(T&*P59F;=.G
M1^J1RF!'MX&1UW,CZYS\!8+**%G_Y>H&Z@U7A./)%P9[53+1.^6INP3HQ4@9
M[YZETNB1PLEMQ/5IX;V&*W*M6/ H8+Z=*@8_^!4/:QQLT04(ZT(WZJ=-V5X'
M2V?=,%8LGZA5O <3)M+/T(E>P@:7"V67,^6=>)A#HPOA?>XNX',.(,&7YGJ
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M 3L$?GST5H.\/.J5 "(,O7Y6(;,.-"2H3E^Q8F&LOP3Y6Z_.4+DRJS2^]C_
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MD6-Q>>F7<\\_?VJ\77+;:V%<_ZKJMW/74R.:(YR;>\+)@T4 [*Q,].T)4;Z
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M$^@(IC>W=:5KHO\.5(L60-8268Y2=HB<8H&?7,*][X0.&9T<!+[>R[:ZBZP
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M1Y#K3^T9Y=6K&Z]6>:UCWHOI?5L9#+_5E'JTV+X#1B!2T(DV^U @H@W_2M#
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MWC/T%=TD4G(;D$+0L''7CAQ\(F52@QLUN9B ]:SXMKKA&8\,>J!4253M<9"
M4M8QHNL:@H1H]E.X/)NH^JFD[SF90]@!)AUCD':.1#8NFLUAHIR/?K]11YY
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MUDFMZ_Z>L_>%\]248^\B>GF32#:P[\ID=JF$;HDS%+* 7-P0OFXZI87U:U%
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M-AEQR.FTVI4VU#U\;</"62[YWN^<+49 @^N(K),0#W(,2*$ SP6U!D1[4AH
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M*K5$%8HCHWEOC_+A6VTT!B0P% MN[Y _!O-3@0@Z/-$)W]#QARL<B<%_P/'
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M?*7X&#UN2;FZW0F2T"^$= +NITB3#C6JWY!W1W>[V!I/@4^ F2WXL_OY'?5
MG#&ULA/XMS]LK?D\S[,1\$?OTU=-AM2G?R[R1R:_ ?!HNIQ/(Y4FSDO5MSJL
M<N3HWL@3/6=U*X59&2NOO?IB(* UT3RW5Z:BT"(_4P/@)BW7^\?@WP#UR5]
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M4R9*'3IG(D<+3Q\S><!9E%)TF&EW27^ZV$_8"?C-&7Y\//';^"O>=AQ$OI
MS9KMB2D+?5S7-"E?[?I*3EOL7L\!I8_.JG.=WH=I =.X6@A.N62 P:3:+OLW
M^X5^_EBZ&DVQHZV#Y(3R$EZ[UY3*:]_OZ]SHJ*?7^)UZIU?+?KWM74;GZ;"N
M:_UB] -XYRW,$NK?2DF[VU?SXY6V)2\DD(J)[$0[CS9 TI7<+3@[+>)IL]O
M+U^_4O'.2%'TQQ>T?,6#%9]+#PI6SD<HF<5NV 17[-=(D=HZN$]2HU\&D @I
MPAFN9I/85LM>O"A'ZMQ8\0Y!W)@.,4V6F7H_<=3!E?QPA7[,A#MF*M'A5ADD
M=CI)_=B#W2+FA,C@IP#7$':".FYVI:2.\OBN#ACO_3O'3$^+$ROMV1/,2^I"
M4V21[F,0].\'+.)7?HC<%F;9>X^1!"*C.L2.:HZ9'K?+$;,0&DG:<NPUV60#
MO?KTK>P3? +:MA[>J1)A4E5K[RYUL-F9(A7M9O6-O>(..0< OJ,0E6Z:Z*N
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MWU,0!]<W3S0-ZHZ9)?CX52F)Y4SM+)AUO7+0DS#5=!5K<O^0FV2>%)!A%\"
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MTH.1DH)@K+75M=84JVV/&_K<<3]9&<&LXY@IJF<3?K:F"3!S2*F=0BD\PUN
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M,:(F2_!^W=A>F\E-,^$O#$T9_SRKS';'OSYL$A(JQ!44)-8'OA,_7G0K,NG
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MSJ"G=)#@OW^MW+<R$N<@(J#BR\237"6TR8)7UQ $@V0L+3JA3:CST;M(L?7
M;O$?7@UC*MF.M2R!-Z_N^H16D%/>HYZVI,_ZZ&36?S8T$PJUPVK,TQ]6;5I=
M2*1B<<B/"C%J3!=T*X5M Q2J++G,TY-0NM&#^&=L_<#BK](J\&Y[W:Q8U<TE
MQ_<OD,?03Y?5Z:[:$?C(QJ=58@PYIS3#-];=#C:]=DD[#S4EZWK&+0>-(WK5
MHU7]9$-&(X'DH5;KQ008[NZ1[E,.#E,#PL^[=*^YRKVO[O$ZV?MARH]?;)P
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M"K5O)^=I?*0'Q+;"RU#:>[-5<38F/)U[Y;NN"S?70[N(@'JXGKWYHV87N>%
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MJI"#K6G1]MEP/4O&X6J"RUQY3<2R=GW,G6WNIFF$T@*>$L;, IH6U*87F?S
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MA%4%591 0D5P_C  7>$)S (P)F#0@P ,O*2?4=3OQU/ MZS/72SGP=+ME,!
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M$=I= A__LN$*-AL31=;BG;- (%>FCXB' 9ZE*$Y<'S,=H6"&T\)<!&(W[V[
M-= P!$ A<(WM:(,PTO;53Y7LP)'(OF&%O<@I?MG/8R9')LT>FJST!S1G9?S]
M#!^'EV*E)64KY@_ 5*@H[:L-\"(7ET20JC&>[J 3OUIK+XCC$"!@(TULSG/F
MR:S06-%[(J! +ACH,]YLWA.!*A85S&=5EEH-?HB,;R;Q51T3_BH[;L[-'V_,
MSC[F'\--Z;]\O5S7 ,\8TK0O45]XE>Y1]WC:P%G/$_L-#^L^9?4UQV+)M^=7
M3M #YQM=7B[%(1_IXN\ATZWKX7BIWPIW%V7CPB207)B"G1(#+.(NK(9S-/W8
MFS1B\F8QRVI'*9<@"S:A=0>^+3&23_I'QED=L5KO"OAL<;Q$3@#:N)6;B_@/
MY8*"_># )G]91,0J8:>I.V%A4JO.3GN1HR,U=\$[I+C QO6;SBQ)($,G(GS5
MUX^]H=&T=-IXE.JF8";B:'EDC)LCU\U"M=WR1QD^#G6TN2K(&0?EUI1+47M#
M5"6,DKY^$F7;V,-6-KG12F )/PZD\YX'@%F"4^@B.$_W#O80>H@]U"_MK;-?
M5XW-'G+&A,%7._X$]\C;G:DD$S.TQS&.L:O[Y)*?6AY+_"[0$H]2G[K7"W[%
M')RR4Y$629LJU01WNM)2B$0;KQ8A4O2XVXD7]T)\$+S(D9>AQ5,:*T?9:_(@
ME8/(-+;3TY!N^]E%K8-/_,U6C5GJG3SYP8<'K6SXJQ>R]SBGT2Z)2O4XRI$+
M>Q_5NR0O7?SHTNQPUZ7GZF!R?9]RI<OU[&/O'E[JK-48OG9,.9(39H49_Z/[
MCR\&04LG/;,3F[GJ)SRON3MWG+H1P7<CC#DH>R!VQ-]U4#Z_Y3]IR&SG^;&G
M4GA)TB;")U/T"%YDJ?B%;D'3V-/I+:3 +%3PE=FSO(XT,E0^\MNBI5]A?$IU
M>^T>0OU[YXO78R\F1LF/#QSAQQTW/"OV$>AB7^'V2(T8_EZ7V@M""H.01<;+
M1JB741MGET).3\:4^O47^95ITZ^9HS[U/'^[;BJ_&'7PYOO]QJ'DL>9MM\8<
M=4["/XWJCGO[#O>$G;T0YBFML".I'O&^X(+C^6S&VOYAY]LG;H>^K@U[7<&I
MICN0&.M1/U=D&NZ[EZGW^*?_BO^*_ZB@_@D%#9Q6CPN<A':BYW:G0?L7")+"
MX-HV-/Q7J40($^6Q<3LQOCQF:K=U32*5M49;=1<(8.?&R,O&%J]6NPI6/Y7'
M\5$1E(G$N)MQ%H*,C_<E$.*2^(C4^K0PO_ZYQE 2+\+$=1)(:H'(<MWS!:M-
M8>^WXE-"+35-1QNUO^@Y1E>T<H_F1P[9L/\>K$).)7,:'$\^\A[W]'CTX%8>
MG+@MK_'(.&JFARZ>M"982""T,/&T!+(>2R 5B:&P# E$..FW+/VK".=*F0.7
M227#\-VV/'LN8H":H;Z=L"*!<)JOC-KSUOKQ^T&:$WG*6'Q8:-#:06\FC>Y=
MMLK)5\]7#<@M#Y=?/Z\SZ=LQ7;AH,!!K!?LVAVAG F>BOUM+!:N4E:,HQR00
M.@&(IS;;7/G[A)%I2G=4.NURI[M6CU%A5;UO>2'K\U2M:=29FU[U[MGALH&N
M@\ZS]AV*^QO,U;.]/L[IS-V&3EETQC;X1W0-?$JK=FA!W2H.*8^M_)P7J5]E
MWQ19R,]SK5WTBAR?G1NH'J@+KK)X$'DB(%CGP6_70N;#T@>9^92?1=W4JVN[
M,9'@;6"KK^@.1E&MGY"II<;#90EU:AT$X1%MB]-6NG<''DY_>D[/8QUO:RT[
ME*#8WO&PO\CZ\KLMNZ ;751CK+D$,NP/NV0JL*0RPB40!Q!+?6W3>OX1;R\Q
MI3+=H^\2;V^L;D92-@!&DG\OHO.4O;)K5=Y453%\LRMOH56^CV?E.)_=T._]
M6F==/YF-&)*-S+M%)L^=K.19KG;R1N%2(P:;V>R#/G4@YN BC4/9URIY>9QH
MVBE<A*G<9S$$=&-%"$,36:)=4?:<U:%[)D/I&T3%X(#9X,"(0KL=K<_(21[M
MMZL2/'0X/Q:RJ:C;XFWB$77BZE:!M]"0;B>W'&!7P=#&Z -K6=)*W^S7.C1-
MW$"L$&0C*')3F%-=OJ4<>:>!;S9>R*EIBQ\V/V+KGW5.'YZ(:HH^FC:*0Z[-
M6/9)("3X0-1)#KXWFB'G!VX77!2J 8_L5-MYU#MD6[7^N$*QW/27EF[7"K0E
M9Y,6.%OC%MI;G%I]'=>T:!''=5&+3HB[-72A/7>> 1U&9,%(A &%;$+;YLI'
M7C@_-ZFOR JQ(I5,V\.!CKXUAFZ_>$=J-.A79CQAIQ;D5!N "6_-9?O.F^[J
MK0<?FLUPOUV:,-=T63K]^U/2O2^V%K0QVN]/_OJ8PC?3/VM0;9Y34YV5:W*R
M<;7!J]J!WNBE8+6_8/\X;?AXV6%Y&N-;\&1]_M)DU<+(:>O:E1+O.8O*EP=<
M@EJ]O)*N>;K5F1&,VQ'-3 4J$CZK%,*3N8OO-WVW-1#$ 8+!XC=9M<%HPF^B
M<LP6;K0:J 2?KLG5B$H8PLE/T"@'NR=68M;L9+OM4>4H\>%)TBF[R4W?L*:%
M,YND!T[*T48M]QWVF3UPUC9P.AA173KW+N6<P_:'?Z7X;'L :>)/K5]^^F1R
MUF]"S8U^>>+2^,8.*BG0V"7XRJ^7Q@\_>7XBW?0(/>Q91Y:;Z^TCJ$7=%.-S
MS08[OF>QR&NKH[#LRWA^!C"]4EJ-@8D'>R):Q')H+G<'E:O(V6).X%^]@12?
M!A/8S<J?1Z]%BV=/+%WBZZ<0[F^KFXCB+>E=4E[RJDSI<WRP63](OKP4W/'%
M226D>^%4-5+/^<BC:(WGE/1Y>5W]R4\SSP;'-O[(]H173\PLH:=71-**[7Z+
MBUACX#Q -18QF7)BG*()!ZQ#P#D6-%?+M RWYPS/]<Q;J9(,9"\O:2F "76?
M_U@F "F17?CT:!,STP/+5BT/[1J*C?IF:8[C7PS!38JQ^!US;PPU5_RSZ!'L
M"GYF:IG_)U@$2 5EO$RNG1$\43HB"&/ATRQ"3!)J@-2[=6!M(+"9>602<Y%C
MK>'5="'"-]YJ, 992;6ZF\OT"K9.+CXEE<OW^B,4SV4H>^!Z3V+@!Z\/-MP?
M4L=.8O=XGW/8XJ'XBX_/%I]?(!##?%'NAQ*IS[N7C>OU%!ISW-P/8#R(*$(;
M-#?&^O:5AU]B83_!^D;LX1-?FM27],*Z6@%VYQ/@(WCW,GF<6*BQ_R/Z<GMA
MM/L%C#K_6?I%KUHG?1J'FUH?T#VY-#GHT3<<&^E5JO[ (\7/TR6_SIZA]ZQ/
M>6VKBD'9RL&-@MMG1ASUJ^J'D0[F>HWDL)'7WZ,;XTL3BX3*K]@KA#;5#A[3
M&PSG]AAR+-,HQ_$SC1ZB$H:;W3+'53SV%:7:9=O1ER57]75]N;&1T'ZT595X
MQ&*)<5"M0W'Q:Z0%UZ6H&D0*D,+?HO'SVT6E."1SYL$F_SHO;4 "V8,NZ8?*
MF/? .--IV&-HZ\%-.[FGP5X#94J=TS&(/6!P#&Q_1)<]+M*UJDF=3)I*/7!H
M\D+P3 F^7Q3V :8>B\ _0?E>%VZ#@R9K=QX_FPHM?@O>2K1W 'K$:8G<O]:,
M7D]UQ,O7-,89)U.T.TN-#I><]X]9;-%:"T#!Z,S9&-,,V#4<J#.=9 .[ODU\
M?,+. ',)S*CSGY5 PD=QU>!6&G4/6\R<)'(Z'UZ>6._QJ8PR&?](WRY:[0:0
MJ5R?ULSYYX8?WZG[:#N:*5UX9'<Q@S_>&$C8;F0GS[EXUJ*NGGRVZC;*"FCT
M/%_LE_P@;]B\8=CFS36@=/^-NCZZ]Y+>Z1Z31Q/=M]4S(_F1B]@6#P>5KVEH
M#P=ER'_%OPX_#GPU3FH@;TAU2H.H7'P($R]]ER6!)"N(E4;!<U(1D2^50PX2
MB*P3WT]X6"P#3"?!/DBU@1R,1KTFB!-J4QF(KS)M LM9NR'Q?3Z.#!=$.23"
M=_*(2G\<#4-8LG\;%1@>[V=%?B2W0KU>\=Z#!N^R+0RJH6$/+Q[/UQY!R*02
M2"EZ])#10G-E7<\3S[Q++3[*##/:;L%=:Z.\ JMP4O'#4X@3!4^+?X=)()KF
M?.:*U)5N(TDG>DCJ.>&93* 'Q@[']9T!9B^ ":(D"637D'@O]2D.A:[LG3\B
MGA9/2G-(X8R2$@EB15@K3DK^X?:?I/8[L7*U553T=Z<HJH)"L^:]&K#3'KX^
MHW5S !HT_,U 03Y'2IB7_O@"G?7(K]15B$X>UKND/^^1]:DRX-%ZAWF)6>%A
M$H>K/V_LWW+!D.BCW-?=$0@: J/]"%6,(N^5/S ]:Z>/.05L9G0;LD:5<5?!
M>TR!QB^\] XM[2?B?C+]=^!+I:C"^'=H)#TF:WD69BKZB3-]\\N&@>'7]#=_
M1/7=2,H/DSWU<N"9N\G))&3CX/5K)[+&/:+,)EK?C"=4K4SX^=&M:XG>X\CU
M^,H/$D@.\\G"2IO@'-@^/415Q:KT-J,YT\[X7Z3EI-+$)KPU&G7??,2?W0_L
MJR)_,&DX%;2KQ[39.W7_;:KQ(P.B;KW!4Y6_ I7C-M8"*\PNH+9W6D2(44BQ
MV_4$-+;(NUT1C+$4][<_!P;+:Y=.F#'N+17&-=Y@--,W:.9SGZKK7L76!S$O
M_4CH>.[S5X*#2N/ I6KW4OU+J"[OH#"7DF:/B6H]9J$WZ^,K&0V*GW+Q\_85
M0OBV]_D_5Q^9K!XF'MET8ZQ:&]9V DS:*'AT>L4/( [,'^ -W</*->/3;50:
M:42TI0#!41N(5OT<LF\JZ@HJR]:5IK6/A\N-9<I^MKQULJ/THDE!18#& 4]=
MTM> _9F)+QV4&R\=W_]0_Y+A%%&OT=&GX4W3@YZ51Q^/%LS><I^>O)[\<W&R
M]K:-R.,>;INW?A5^0H!'%E9^+N[&_HQ(T;)47[%P^BW+7]II?XIJ<^N*D5VY
M&Z2/5-@!M[=/4']7=J%,+5=&KJO_-G9 ^=BF:2ZAU6EE0.",+OJ51Q@T30'
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M)%3"]W7%Y5[J CMB;[.AZ8@#&(TZH=*TV PI/O0<#*U#NVBBV&;8H^,QUN&
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MI>@N^=^"$;8&*J8,^)2OW+0Y:I%\NY'UA&Y;I>\HM:]&D7KN5>'?-S.T5/^
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MVW0,%PX%]1;Z1O&P T08^PB EUH"MCSHP:;^A'$8(Q-51(0!=7%&' ?:&AG
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MZQ,UW:2X"]EM7O>K;8]Z>88MT*)' V0*PQ31MN6ZQ *G\F_'.'2A,IU?#9&
MJV)UB^Z?S$892YP-;F=]C\NZ;Z4A<,(>ZUE?;0Q413=.SC=!-QERC6SUF?Y*
M^^#C):CEFGC/C!WU_O]05 O7,8*]XK=P:60X)J&)J-*Y<]&+$JRU7&"29F54
MU[4E/ZU=D7MN3]*GV[ ><_-)B[QN.UHSO6-T50[Q=>W\6"W9/CR"%?*%Q\-+
M2.S=G1M2+RT1VAM2;T6@UX:4NRQ+>$:R3&L]C ;"<R(DX>$]65/];F-6R,>+
M\$;I;L9FH29H79'WQB3)U$05YPZ])_FC?;>SNHR+51B86=EB[9F1^?/F&:2
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M:)3-.RC>#SK NG>_//2UT?$:FRI;!R^O&7$\,0<IV:J/Q-:B"OPNR/"4J(*
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MN8^Y=6#TH7O:#?L77WO-<QX^#-93([=]O$\*CAW8;9T3_/)@6<6E_Y/ !0:
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M$=*\&.H'H&$N<A?6V.17Z-8\=+US"VI;2,.2.6NBY<,Q:*6O3WP[\/8QN]1
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M6GNM+W#7\/>  ,HUG3&3Q@VI=W'"GY.!2O$#A,;D?I?4SE]!ER[J6PVQC(+
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M[N(COD\VJLZ]'AMKYRI3N2__427YOODWY)<^V2EE$WH#>? :E4=;1W3Q@'(
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M"C2EE^E<6E6RNG[UUMO.IY"]>I .F,<Q0-4-\;K38+$Z0.WPUJ^'DH"9 .
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M.&%66:7WCA)!0460=2$A!6B6G>O!7$ F"8W<D/+M"C0T!R;LAUZ"TZSUBFV
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MZN2\A<;7.9P_!7L.7?_#_5C&=Z6_I)OS0D-BF8+6BJ3KH%%?A/JD^$>1Y,T
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MU"U!)8'OH1P>RP(:N2HZ^76.IDLZV,]T<,F*ZTH\(/E^#/3HBG#I\W&9JW"
MKW6C'EH8DC3 FA)MX ,>X(O[Z6I3K*U=<*UQ+A,7NL6V@JQ\)ENCFG1VP9N8
M(13WMS3T3EPF6MAYN#DN9-4%-=V+#BQ%;P=:90AEDDJ-*#T %0+^,DOE+946
MR0N03'B)9]+P&NSS,TD4I.)2L45]:= 7'"=LS!:@)SD6)G@'^O_:/V=B?"S
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M[C/@PLN0LE(EK (#'WUIN3JXM24/]ZS/;7]D*;'<ISE\UMO.2954A=] C/<
MXZES[+7038Z[[R^@Z=W$AY&X"W587?^%H/(H\\*Y1[='O#5YX9>B;&_M;'<\
M]OAL\*V-JTUKCN9+ZJH\//?K^6M2^<=2U79FN_[,L_4[91MDH)?&&>3T5^XK
MLLX^= ^WLT@_[LM^[:D!Z[MGCER^]?G\*3+JYY)5 <@C+RZ8>YT%UL>9>XC!
M'NY0L:?V(>:V@2+3JBUIE1O/;CE4]>5[RY_ENSNMOM%3Z)MB:1E%-E"FV$9S
M!>Y=(RJU%D*[7W,/VZOW&L?(L&T,GW$,CSH3[E; 1@9]&<J/^P?LCBF?6&?&
M[HV><1R>KODTOU;!ZV$'TU/8Z]CA]Y@>%0H7@*.P!D-F4AMF4LYJ1O+J)M!(
MZ*[XC8YJP\$:AG[ /R=MY[H*D4$'-:>_EJP:K,K7NW.1:S<1X+,0C_?FWP_5
M"($4=>PUTNWOJRH=7^Y@MN\W3B[9/_$L771Q]E*_^PM;J=/="X=CK'<M(AAG
M)FS=+L-&?NK9U;, 6)I.IW(VJC9W_@[./LO13.9^,B1'TMJ?BR_I151Y;)14
MGN ,RD[L^,!R?.R]PE]]#O<NKF@'3>X1DEIM?6>S/W *QHEFB$N1GR:/8)H^
MI[@9P%C_@=*PCEZ+G^H3,?X0UJMUL(>]95<&63M(: @I#^>#*/',-!8TEOC?
M5$0%5X9W [UR;!\)!<A%LN;'80OQ:4Z3% T!)/GDKN_M7)?CKYJ=3 )<.-VI
M* UAYS&2(W1)A*'>)GF K%;01;*N:#5 I3*WJO9 MR0YT6,64)+4XIWCM#L3
M*Z5H.Y561K)L!]_(7E061,8\QG_8&#P"@'DV+VH6KNZIIF#OSV4'XF0SX\HX
MS&V*/GF,O9J\F=*^GR(2,J!M\9T84VBG:*AMAH:OI4QCQ-4)$F2VT[U8!VJ1
M!C2 21+W*,)%>"WBT&\9?5S<2E=+GN;Y20X8(?BHRBN_*COF==4\.<2%=!3L
MDJ R63^3-L'>II$207]?WS&$TB*C%$= ERG8"*\F^4.^B8EQ9<02#GUME+&G
MLL*8LZ L95ZY]NEZ"<D:O,+*_UI:@N\.31";[)LY]?1Y2R\CMJ#05WZ*+G-4
M_FG/TAXF=\_CZ^A3(S& \>$!1MRTBP@NVA7HC3X #3ODM*=R<MK[5!T499DR
MTMZ4WU2<6#'AG]>2960;GQ>/2YGC??=R^C!C^5B!AKR!2K'##5N6(<D:"H6E
M+9V;N$.08+='/,^=64V,:2]:TS?UU;?K>4,=0*<ZCKKL;6AZEG7O\PV--9*[
MZX>U\S)J8AN]9OT2+E=L<RA*QQ18WGTA]$QT;<A3F-(_0HU+DV9HJC5N;OYR
M# JRC%2]<I#O\Y0[3=SZP@ 2&U(@V2)B;;[#<I0Q9EH;E;J/F,X\&7=/81UW
M'IK6 K.NB9\'ZA[HC3@DS,0#,;;X>AE;0J'U?(D7 M[;2*%B-I6^BB(N:YBY
M:6H..J2P115#5(^!6881,9)+J;6HEBA1/ RR0;@TMBCD+2TDH0+6ZBVO"141
M159UH%-9R;60OJTJ'GF#ZA6<NVUV\;PB*TA'OHNT"K*1X TKL!N)F6*']D4$
ME;W>2:A7<KI4ZI#N1% CQA]@#QT?[<SSB//.?!!]U-+LS6_M[ WL$,QPO-0E
M2^$"HJ1J4R, 4L+F858?V )0:&ASD@ET5<HPA(YML?K+0\S6)99P6\J>%Q^P
M/''/(B\QXN&)#<'$U7?.W;G3>.7KW"("=O?4_Z?(I2 QL/;,)KLKBUGZQ "N
MREZ9R18]N$*O]6_'0Y9Y7&PFJIZ?UH"]CK8"41P;K"!22N/BUYT>)LIEE1 7
MS7A 3. VH>H)7)-PIEI4Z;" 2/>K@QHKB=U'!WL'NZ:N&*#ZA%/Q\@C(92],
MP[^KWK2\31)3M$;)/2UJ"IV:(4DW%_^^M6-'F&J3LD*U?5RX3*7O_8#K\(=*
M,V"BA9T-?^%(Q4$0F31=#!BD-?B8^38.QG;K04'?SQGD/PRO555#DVU!JZ$2
M,5(+-@[W16QUQ:\ ,K-A>):@!Z'X028]BD Q4N?+_!YRWR.(RL4IBXH?3N*B
M.@>^3\79V!2<NL*XK_.[OUVY0AW:\@ABP\ZS@9U$6=L@1)%< 4N%M9 ZMJM/
M94H\T-VA6@F%R!E0,UH3M&/=,FT4TY:3)4CHD:/W" JI^N0 Y:FFG6]Z=5H/
M?F1W>_QHC(=6%8ZPE$.E<[,X5-MGA0Z2'V37!^N5YZ@Z>C8E##GL*9L&YJ<]
MY%A5-Q[%6$1$%L!\O4)V<9!LXI#&VJ;P!X/8;JSM "&9Y"NI]CT*_W'P(B*Y
M:$TO#/OQ!\ C)80SYE5HH^QHA66P?;$]/53N+M]%?H6I\Y]> :-K-U@.^^WS
MF&&*C QM6VK)VV[NADP A+Z@P9(]$*Y'ZXVS]2C1M"SG>"THGW^\GXSZ8FI$
MT!<HED.))F-)ETHFO9[05Y$.7)V9[NV27WDKF5S O8!\ ,8QZ.Y#16@_V5"!
M84-<,7M=A*DZ,-.1(%Q-O#PI\;LN>H.;FC!B),?B3;!E+R79#ERCPA\N+:G7
M@Y^TEP:-YL3$A&\5NGL",V(U#B%9"ZH1BETX<(Y2-*855Z4^,1+,S=^A>!%=
MDVB!,E3L![<WH[>",QD28/!^F64:,URR(CPBKEMW4N-J342GX(-0>'ICL&"W
M\-R M(L-AW$D<2RW7S?J<V@BDZU),?O6+(,C=\-&L4J9QXZFI>&;"2EH,Y+'
MH.HGHF#TUH7&$SW29_WFH":--LW:O%<Z\N5!#O>:+*<J$$95 Y56(Y0@PB=?
M:TX^!Q%* R:-YF_:*3PDCP8P(8\?EC;-3^6]O.!X>Z3?ZF'&_O^<'J^#5_52
M]3J7W4B8LI32J?.+B 8^=Q'Q_AN7@]X-^8(/)V4TJ.#AN!$_A6S@TBXT#1O;
M4SL4C0\"79(="W\*?C*NKY]>*8S,E8$>E]S_ H+V)YI7L2L:?U3\:]BQ,9 G
M%4XY@39<H1$F#*5.[BK2 CS3T1L5P760%#38!\1GH0V)-IVP]]X"Q72.J>5(
M\-R9-)T1XDY)Z/5&BFXX[CRUAK0;7-<5*MTXM[&!>#MR)/.D.0*2J]3301U9
M.70?=.%<FUFRM/6+B'HUA:Z.V*\:*.E F_>13136RGNL30H46)Y5-8O7/TUR
MRI,TYJ6[.4A:"PJZD40"7["^62S47D3\#IT?X4Y*U,5/K_0="W052.?KV+<6
M$= 6 @=_':.-B?")EXXMS7G8K;R[B+B ,548+0TS.\!2@W-[AT*G'M*.$54B
M1]2D4YA-Z.T0N\-99?D"HZ,( 1:Z^ 87P_":3+M52:3M4%!^";]8J$G ]YL/
ML&O6_ELOL!_+88*UIGS4QZ,PL+-4;5M$3+JJ7C4JR4/_O7N:82L6E/_9F]K_
MPS>_7Q$@6\\IKOP0N7\14<=.9NZ16T#?150N$C8?ZNPP1A*J 4V5S@@T.BA:
MI"W )/<*975CE"=OOMDH>Q'!?:/!&W+I(D]&E4RTN*3'PJYL;82I?C_SU^;J
M,T\\2R9R,95./V"?O>JJDJ;PE4>J.G&?.=UJ$%^,3'6BK2%Y00$@RQTIRZ+R
M=JK>X'5U1)\S[=S"Z!J4L :@J+@,ND]>#SW\RADDZ)X.RWF9&.I\OSS(KO2?
MW[RCK-3REEJ=J*PI[2?)5B3/1&\9"RJ$R9L(%<CW= ,COPTZ1@6KU'](D8(]
M'4*=&>8IEXR/ #\UKK62G6XP5(3($W\<F$E&6X7AJF5%^C*L ?%\HN7AWQ<<
MTNRJ*<&1/\+ALC%4M=&-50:DLPW*$O(6TB'XI<1FN'22V:O88;3A$7'S'VP1
MO<@%Q/+>[#G6LX@(HPCF Y6,@OU0N51S[ZQP39A*"T)607F\(FW(3.2PCG@M
M09YHT)%?5%$]V13O'!,0N8CH;_SW?=GKE/8)X;=,AS\H2]WI-#!SA92()RIV
MY+_R9H -YPT"5L9PXNA3X+P9.+Y,2>[YW]5)X:.+0M],=D99BHF@#.,Y02;*
M'-)58+^8VDE)%C;XM],$J/W@_/0J"3L-K07%B5LQ2;BF$DG"2/8!V#M^2I%$
M%GQDQS7US 4:\UKT%A$I3DB-B*"? @:?#ICUS'FC!O(5,!;?8*KXJFU*F(2#
M[6+$H4F*8("Z]"@V>JO"#A*:4N4']DL,87YA9*@#,1VY18[8%'8#CHC]K8]T
MF*U&.AI_)M(EP][1ZQ]6?<'A/H9^[S<K\Z8[*[J6+#M%#R.JPNBBS5BE<CQI
M:9_8C>2C+/P,13V.-'*NA7-% 5*G320SZ?-CM@4=EZ%@KNOH@)"7.=F-\ :^
M3<QS4+J.=GYRK$:"929S)SJG[.=$ Y[^(+NV4;$T#W0=C"=8N PT6-MQY!ZV
M%LN<THX>@8TE!W]#V. Y-0V,M.$!;+<Q5"XY7U@1!L,N9CJA1C7TIECA"Z8^
M6" D.U+6D-0&2=X2[!J%-F"0ZN;NKF1E2MY@CP_.C>PIV%T-!V8"]W\U-?R/
M^_O_WM3P/Z8-0M5,\I%TKX5LO/+P8%XZ"2.V6ZO^^XW$2)[@;>&#\9^[8S9G
M" SC3/P^];[='6W^TRZSJTE=6]0WGM_L_S>]'L6G4Q<16J1P\(NWE$(%H7(>
MOD$M(Y:R&KK&[30R'ZR4T%9!.NWH]4!GDL0!.<X6:%*JPO,[:%0GC!8E+/QI
MX,F#Y_O/-19.3=?#$DWGJ]N6,R('W4CTGG<-[ W$4*[ 8R;-8381[UTW:#=S
MA$8PG]+:6XX?^= >\]C'T6MUX<8;7H]>Y&X4^=WMP4KQ4]YR/U47>1,DEV"'
MATY3ED6@=.<HQI%!6X#F3A\4=V$5(\D)M0DJ/N9.$&-NS,W],7JJXV%SP2-B
MI&_]LV;@<\;73P..6*15VA<=8N7<F(:8:1_5=CKQWK%7]1_(X4G<,V9&]V/#
MCZ2XK5H[6POEU^PH<?XB G5_UJL_V9+1RNDO=ML4M2[P$,4XGY^VW<V?.WMY
M(+GHQ(W2S-<QV/ C54]^^YS\U#'DV,5*W2=GK8;XGO999ZQ:[FR/X5FNO8B)
M#7N8H4B3;X91=\4-J$!L0S,FF@6\:YB\5^4DRLWGISCM3MHX2]\(75D8"0)R
M*ZVPA0^>@NL+RT\'<I(3R][8VP5L?RL2PK(S2A$O$JXG-HT) G2JQ__\,!:>
M<S>RVM@OJ[&FL3CH[JM,I8;_#;DG^X3YL6^OXOQ"EM$"\=L9-#<7P%_"@Z6N
MFW?<I> RT@4PL(D-U&ZI:VU-Q1M,5CABM$BNFE7'S%,:K@V44K,^L9C;UK70
M: SI3JL,*WYOR+T+!V)RSW[[RV[MLZHK>-?G@\M3UEZNQ-48'DUQ^W;7]7A?
MA=]%[F_MGXZ1ZE*-5^6>URNX<?> PBWQVNX@C.8]B75?<7+G@2+_K$J_2^5'
M]$9/8;=5N.9$Z$I=YVI/;GS47RFIA:R]O!Z;SW[4/8IW3J#^H7J'::!Q"<-\
M;J[1YYLS_]R6XU@9W%^ L;_.Y 4,HMZF.#"V--_^]63LBY_44P;+'[]]25C[
MP[GV/F/&MMK>?5:K;<>?Q__8NU)KK^%*[?:5E]>(,A2[H5$0-R-E\PJ1IZ!,
M$6/9)'VE:B/T"7*X<;?1&Y76TIP:ATV+(6G=GEA$!#071@<// +-+#."@=1<
M04A#+LXG!Q\XZM[R@?Y!(S+LPG3UM-T[/B%RI=^[+?%_/OKY0.VOJ5ZG_KG\
M^(G&WU^GL]^^YN4L4$TN'C%.(B8DZ5T[6<J[3Y=-1V^NG*M"6]J7',L^W3JQ
M^X@AG#*>QGF_3_KR/EG'/NGYZ_LAZU3GEE+KDY3K8GMK!N_'D$[+"2LWVC)E
MCK<%=6#R7>= "H[(SWP=V9)Q?$)\Z5F^;_&-2Q5''FW)ZX^[V%!XL+_:'8YA
M'IWTO_0H^[]X.TZ9J]I%'J+7(176,\-=7.$JD@^8] OT48XAG05NWI7OFS#Z
MR. 85W;?$.K! LY\BDDH^W+-F:6R!KXV%)G 3)D0!*26E/J40]2]@T[>#HWC
M!M-GJL.%Y8V*102E/8B\F]+N1SF/$>R7N4&U\K4*?9 ];2['0 _G]T,^X+S8
M\D:T0E.61O*L4KUCKXRKQAQ[T0CZW7\\X;H3FA''47G=*7X8[6D?:C++P%.2
MZ,UGN0XY>F.1XRN.(WX$88<+5!IS+M-)P)#L):J>IM#N_A7LA@$:OP&M3O3<
M"X3R, (4Q_6$+ <," 16MTJB_@_VWC2HJ:U=%XTM(D) !*2-#8V"$)5.,29+
M68" $.E[LA21)F)41"*$9 G2=TM1<*$0D;Z-=((0"! :%1%I(Z"D050ZF:$)
M4TASX][GU-G?=\ZN>[[:]]ZJ6_?^H"IC5@9SUL@8S_L\[QSC>0.ZQXO(+&O$
MF2FI5'4AS-,=A/[>,JQ/-62KXN3 &JY1CI7/R*71([02$43Z#4>2<.J9+>>U
M43-&P?KYC",^>\(\DQ.E.-$)]=N"/1JX/+FM^8EMO(/IL9FES[J?K -?4%DV
M[FY?R?-9&T'$3S1UI$$["R4FMH -.1E5 Z7/$$Y5S@[R+W*S%I0 ..=:ZO;J
M8OWJ(80)X1C ^S'5"0^K4BZ6Q=SSTD/7T,:]E0^X"BR?;4[2F^JE3&2Q@H6#
M1'U!QHH7.CG7&*0#2U-L!&QW"&$38,4I3N6K P-$$Z_/&()9$QC+A=*)"L,(
M>;:4/L:FNG6TBF+<<FU0&F91VS@2%E!;G?+N-R3]/]U0Q_AW3\S_I:7]_ZT&
MY<HD5A-S"_*H\ .Y&G>/#P6P/.PH[:HZVEI02@J )Q!-!=E'6@\$8G813+D9
M;!*=K)JN!#+;8;)46\IL]GE)EN!*CTW2V.Y!;&\O5)$6B_AMW*3YXG-,X!JM
MUN7?9J7S+]=!9ETX7Q[+:Q)D&D5BQN@<5#=MS'3J,SF&K\P1<Y7T#J@LP8)K
M$,\]/L4)6: D&X5L%T'.,%;BR#WC\72/6\VT^-S-30VTK*XLWOJ[4<4&'5OJ
MN3:4X2_//AGA.+F&L= 3M>$L[(,!UY12:5?(F[R)[\V8;2TDEIA<P,8;>!Y
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MWT*/J"#NRFK[$.R:JYG&(^V>D2-=J >8;>G@(:5Y*+=\JK@3/6;*(PB>(V7
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ME+J(FP2IJ)#%B5KA3KCX.CN>AV4@7*;2TY@-R)BITUAG,&KC@CD716_"W"-
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M9X'IHLDLWE5>B+T(S;]09,+6<K)6>1_I'1!X'^F4MIW[I#@$63[7W#7TY8F
MZ_4$J_J78=Q>V%'P=MIQO$?2SK3C6/J  =-VR7^)#_A6?D[3;!>,3RCKIGWL
MG6X-_RT2+3V17E6\;."GGU[#T9#@$K''J],SY4+*'))B%]S[Z8(@#$JKH+A)
M4' !M6TDYLJJ!BM',*4FZ<OCRN Z1^U/U7>1U."%0="Y$?X<O#,3:B%NU7\/
M:9%:T3U1S.//'.$%<%>ITM(#]9(W$@<4@D4\+463XMUC>FV<JBW@"067Z\>[
MC1\72/M-X?3Z7E<::VZ.5A?HV-CYL?]!^3K0V%V4H;.NM((E+(82Y6I"#@/S
M+6W(R90N^H5G/QHI'<%%*-9S*R@7BK0X3?)?O%(DQ%O\->@"II3U$##'[3-!
M"6QEH$[J4>@DS3*.R#^SVE==U+'2D,[97_2=0+]O)(-[<?EPI"<H)7>M%+."
ML!Q$K$"2<U/<D487:3(Z"\VTWR1']C@]*/;&BY9C @U*@>HP7L/Y41(W,T;D
MCCCN'A:! 0)%$KBE<]APQ/&"W+=%)N^ :<_R5^MFXY]RL8,&'[WL7@T&.FP+
M'N++;N11'[4ES5J4\CPY*9I%CHM4,A%.Z*.NQO7>BL0ZX72,[:_8%3O@OJ=Y
M%.@K.<(U/B] IR2D>,+,#2IU77):IH+L,H9!\]R]+OV]$*$%B3I.E+<5X$@S
MZ,\MC*UVV70I9110E\7\]>43-(,2C?3(FLRV(A0:YA-&&1)?OSM>^VX14WYN
MUR?FJ^9&0,!!Q4H:[*]QM!C%4*,G.P3!%B6S=-X[ X][(H+D<ONOMY(#WH\_
M_)9CU=:!#V_YX'31.SS$L,]68% FIG\5-+=*@?1$B2A!,L1_QX2!^<U+4:W$
MG"4=VE1.^?*U,N#'THCY9&C >?^#2VYE>9&5KA[+",9Y?]")P@!MUP+U_:#J
M0.G)KEB&!3!8PPH%3$'IT%NX640N@75Y26;<MX%\+W>IC]L5V?MQW+/%=,E4
M2J4I\M!HLE9L9N'SR>%Y#^-;ASHIWWC6>WZ ^K_JNGF $X @85NE+T4.K0U%
MEM O?M>;?21UIND8#Y(9?WR?M^*:)2CF:]%;RI4^K(JIYR.P"C$XV[E_P?3%
M$/V"_^QP>$*ZY_,"_>CQII_YPHYW"K8.+?EHK[V-\:*\EB=WZ.C)1Q>2&_)"
MIV3$-C'":*XC#GXH;Q7P>/@P-"I*O-^-%I[(\\"60I   @^6W6GQA&]% I9G
MWE*YN3EWM[.RPLRO>FPXGJX)PAUG@O#T3*K.\R9+H:Y8OX/JK8A2 $O\^8]L
M&ZT_%0V+"BE"$8FBZA"!$<H1AP!BKO!UH%"$(\(_YV_1UK:D^?4CCF._;B'T
MU#V+UI(^28].6.UR=-(WC&_QI34GQ.U+G*MIYE0MCN&<MZ(_R8P,>DKP0=QO
M+>S38$34U,H@+K:ES9/P_-%32Z>/@TS=^066(:TN0W4/G-I(>LA2BD10(E6L
MHS6!H.N)'I_]/Z :?M\=WZN30AN.4_"Y3"?\V!Z@!8O/W?EJ6>Z?N]/C..2)
MAJTJ.W*9J5<1@>\^BODA^3BMBFW$RJ9UG7@H?30,YW >9XP7*5 .;R7=T?QN
MHE)QJEC9[FO4:]W^>,4'83]U?75-UX (Q[2[>+X2NG5%0FS!TSOYB%;]ER\D
MK&)?KU\IMTW%R8H>N,*S"2UU)#@WRZ.>;"2,\B4M:9%9L'?HVZ.:0<GP\WL%
M?ZQ: UJ47KP"9R,](['Z9>YOY]%FB315I.$EB8_NER2VDHXXFNL$K<D[T<3?
MEJP_V5?HA%WV%?\QU^_CZ,^T^>[?TZ-^O&)?;U"7!2.>/FE?53=V6+6(!_&A
M'-;$+C=,L& U?57A\E]W^T>2]#'=(Y(L]\,"[TS'T6@00.YE1*O3C3*\5VK$
M]N>=H-<"BK9<\#DK4IY02T1)-V4H?'N#M[-U3JU]E"?($^E7AWPD?[![&L"
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M9?\\+#ED_L\]Q!.$%0HX05H8J*(),@QIA!3SH2Y\%C,4)=/O(4UHFM+J$CD
MB:/,5G1V^-#J!Y?G^%)J+2.IO.+KMMA^[:>!-=(YE)0:I>ZGJT""2TO#,Z=-
M.$&+A3_&N:%&LM]AS80$H_/L(>PI(WE_-B=]>7N2B0"XJ=-]0X%(R_-^3^_C
MN6E!Q-T4]EEZ M'5H"K\ ^;\(@H/2CP_/W(V[QA9DPY4\)6Y6?_F;#,<826
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ML;[!R,J-.;_V"=]7W(L"U/[A\?"M''U( NN6;^4F^3JMMECU;=4<L0R98Q1
MV@CA8; Q2:CO0<]4VQ] -.>CGOSDU1_OMV<*,W!190ONIN\V<WDG^BW;YVMF
M+_=$R1WHADGXE7$C+G2V.M6R]QUJ7'1S^<O*O602 K/E2A2I'PJ7$'V5@7ON
MMRGUDJU%BDTXAU>I%;JW="Q)E 12Q). +,_"H)2>>[B4 3K&KN>!WA.P-LH^
MOBYQ8/.> C1 ;[P&*A1\OL8ART7IY'YJ(#<8SNMXM>J&Q"&&I4@7C<$@0#&B
MT2?II_1[R]HI.P;F- AIA&<S_!*QC\U%[T_P:O+3LNMJGI<MJ_&MV7B$*N[&
MJY*O7R$T-$XVK;=,-/V[4XWG3&#4T0C=L%0P/PO&O.:Q>8,JDDG)2(CFRK.F
M_8B57<)2"R#$' ^]Z2:"Y/S\?*<5 D&=!TNX>BQMJ(E=&ML'M(;^$*O=:7*"
MU':1&7S 22H,%#UPQ,'9::[:3@TZ]DAAJ&^1&ZJ_-_B[^ OQJ;C*_KHM\;(*
MRKE.TY5=89.Z[Z91B)4J @C14;SQA"U-UX0$R*9-52 B'PZ>70?O*%%@8NBP
M+J#F[#&+HV"3L/R=HJNN(^((#RV:1;/ONT4@H7M)D@9_SI)8A? @P*"P !/G
MB; "1>2.CF5G@NTXVKSJLI&J4TTH;08_7D<8-KI 2>?Y@EI/ YY&I+DL\)M)
M)1Y'HJ@'V8ZI \'G1]19AG>?2(#3G%)KO@)?++CG;$HEB8*Y7@U?5 7L_29(
M*^O'>>6!_7 ;3I7":BE43^<,]FU*<Y.62\4T_:Q^H"X6[0WV443IW!!:]XAS
M\J3KEK[H^89"N_M1*2ZZ3N1BB!OPDGF+Q758!@T#O>CTI(/[\-S "1P@0/VQ
MOZ,2!N*K[:+KFR/6/I#W-ZCDL/(?.YJ+9XC,(&*VJ)4$LB!P.(++S+"YJWFD
MB04!ZNDF%/GM7[2M/CPTOK]W29I0.-A3>('6^/TW6P+ 17J&U'CXX4\TCBHW
MS0?8FM M*FI0C\EW)Y2;S+9 W NEQ99A$52#637Q?W6V4RB(;?:I(8KE*:".
MTE)'A26Y.!37 'D]3ZO9\H OW9$8_GLJ9..\>2DJ/3(*:16)Y;EVGCW\"G+"
M:0YA))MB]U-K/NMM[7O L:<^>A0L;*3K!S[53$CST)3^<QP:7CX_[Y^[3H+S
M(^<P"6''"\2D2N5'^WO+PS:Z>97S[-SFWQNB^O:3S9.K"Q*N9C,B]$+"+5PW
M"U)XPXB"YI/A?4;A.]D[^B5XXM=<+1XBF/4-<)O2*_1Y5AS_^>?VM&+56Z]E
M;=]<XUH5[T>ST8[[8I-%8IZK]$D@(?'QG5F'L RB5["D=:]=U;<)$>=;E.\4
M#:B%DJH3]*,4U-@W]9-W\;-B41X1=T44XM[6JL;IU#C%(8<HE?[M?^G<J_A&
M^J]>]@7W2!NZ21S44W:I:.6(X\*;$N#OC2IDCD.N<5X%]/$<@KZ94M);N>QO
M-?]I+N##Z+OQO8KU-M_FYL.;8P1O)3 O2_0#32>^,X3:Q=WG8I^6D10Z9$QV
M3(?PSJ%=R9XIUO5T:+;VG$\7:^H\$'^!^O+6UZ?Y>$E0"??7M)^Z789H'QJ,
M9'2)AHN1I4WWPN=<J1Y82DK>CAS13%H(@-,^4G['JN#(39"=VSG6.N)1)80Y
M'8<.OX\37I/0&Y7PN1%HY"OMR>@BFDZO&%Z394AW\Q#H"$K ".VEJ#@2Q7\D
M40W5#1UM ,3JVH="";U]=S[3;;+[>$!=ZM/"'/VATPF)RA?5DNX5! 4$&(%)
MT0:K;OTGL\T4>^]]8$GD>/VL-C[3)6XZ@;-P]G!^7IS<OZ)D=<"DS*PU:;CH
M:7LF#BITAOHZY&5A$,\9RYZ4(PXNVK#S6\=L[8+P7MUR;P6OZ$:]3AA40_*!
M:HWBA4J!0G'GU@DEG\G&U#,2HLZ4UUZK%I)MY>2?=2\Z$GHP*6K]Q1L$X6B9
M>;3I^)Y2@&4_EA?4;RDZ1!WY8_/EINA3OJ[BK0Z?,GS-J0-0TM[.C5MXE*<K
MZIN9Q+/ZV<VYNSG1&DQG=J\H5D 5>J(6==**KEI#%::?3HACV4921X0V\?*%
M@]US643=J;B11"V]P.S!GM\!82':!9XRYB$B52'*YZ$?*(23F41L$VZ[B^F\
M60@!,E>ED)3I9);\:HV2%?"<GKPVQ^QU,<:5H58=/LJ[Q<^6-F&I4JVIR@'[
MB\9@'M*J_91R4]WYE"U7P2+D. (S"?\$F[-=V=U1H^S 2=BS+*="N7H:HSQ7
M^Z-01V!IL;]XV%Y+_9)K<U].E>N\ATK!-M^.-SI)I>!+]N^6T87/(9Z10F)T
M!^YC"X8>>VA0^/ZL(SG+R9RI%^SM29>7>'W/W_N[;=D'IR]V,OOZ,V[V4!_Q
M67@SR4145EQ+:30U6[I69H]]:<5#:OCGW&P@Y*3E9EOIG<=5"<DXC]0-^S@G
MBZQHY\=W+!1U@%(+VQ>U93^6^5CZP$O:]+4QEA;MB*-?G(] R>#;F'IJ\=_(
MA$0/T9AYZQ3+#W%_-C>G]++/1)U9 JE>F;S\D4 S;H]Z3%IP=[-\3#8S&F$I
M8RY\QT+2\ *HPO'+1QRNU2Q85R.0521G]#L'X<L71_]C%=H4;4E<6\"B^A7X
MP9[O":>J"J.>U-R9;7'-61.NLK"M2L;=<7Z@UO$JI$H+VN#D)NNR+[>PB'["
M+:&CO=">B=@G#^"KSMD.TF<6I!2M4A&4=1O=;76K.YHKJ^EIZ%OZ:LG6=H_:
MJI7M;*R_(4Q]6$I (VVU5YQU8)&QRBO63+X?CD+:%.Q!A'OQU/,QJST=VT^#
M$FM2U#NNM)$O#?9?]EY/FXQ.K4OOM*7+,X+(06LT7!_H/$MS,DBN*6\;?VJZ
M:+S3DXK<@,YC-)B03U:N2*/+$P_L9\!,@YMM66;&?-Q_0F%S6A^/./[5WHU;
M;CKB2! FK)*=Z=(?$;0J2EK[$4>VFAMPEA%_Q/$BK[?C5LG"6]$>[!]3U_X8
M\&EK[-0V#GQ#6Q-42PT6RD:\'*\1W@[6^P95^NPS9E$6I?<-$;)9; +*\JI<
M=#$:<^__]*6T8+17!ZK*?;6DB%/_C0OYD]?E&II-CQ>[/CX_DVD?XL__:D.D
MFGWX'G^Y<_2((RAOD:]'HNX"^O38NDG0SGV:><O'D%69 .QKA!&$WAH'@8+"
MR]]GYA  TV(GMP'^SH_G)E<S"XYM%:44AS!OHR(9K^CN_68?L:E/:^OI)RE9
M(ZR]PM]$\*G P.BS&U/JE+R=:%F:3L*=WA0$I4F])L_<"!1K83VBOCT^_EI$
M,-YE.,3YCGH3CJ=1T%&AQB$&*/#7J&P/D!65^!QQQ#&OJ^_BO9H\\!6ODTZT
MN. ?#MC]4K2HM8V(>M,/5M#Y,6MV(_Z_6:&8[EM0$/,*2Z>SF7:FCI(AA?:?
M+NT8:P*!$ =];ZN[5]JG9'^AS593)+@_US9M(>&:O."[^/39_4-CO7N)S:7Q
M9304CB6 9'.=IG,S2L=9MVAY5'9:%3+:$,"4U#:#>@,,;O-_-_IS%->5/K5L
M1G^1??4&[CL;TAJ1./[C4KH21@CAD/-X2!A?5^KNCB24B+ Y#G/QJBQYNFA/
M'>@[C*O3G)9#>OJPPZB= C]UB_(/R^COS\_%S.#<_RH4^\^%?5%SVYANZ1FT
M'VLV,X@<5*B!;%.R(9EX7I;UX7.8)X$/SAYA\].[EN/KT+(UFR*%5W-<:"8D
M*=M>\?5DE3(D\M"2Y+*6M:+;M..UQ7]9)%S?2RY56:95_";R_E@C.^ZU%>7+
MR+,0-M]G]%5JYR^2N'.VJ*CD-.AYKS<=@%YV3>Z;+LY964\<O#I1K+"RGFF'
M@X.2*U)PR149%1Y9L"I$.M5(8H"F&>R<'?SZ&X"VM[BKJ@-^>TS@'MZ<<%OP
M\U*:PEE4OQ;*PUG8!BH,[> VLH1[T09 TG%&36:?'T='KD@Y[X]P;A$"V .3
M\+N3>Y@67@.KCO$?L\IA\[P:-FF7" T=SSV0NN-!5SYSFW)?3IN;I@#5JDHG
MDTCWZMO\ >@#@2XW;0AG<K$M**F'ZF>7I0B@;W'5Q[EH?9],K9@LM>&OL"CQ
MX>PUU>R@ <D7.H2"G5SV@G7=S!51J4;R(!OA<J\K#C$5=YK%)[XIAB'L<5>&
M"^X\?BW/J6!LH7+U?;+2R?_K/-"Z-2R;VW-E=^[&,1-LSMDN8CJP) [_CE9C
MS_R6YCC,.>)XN!P#^T/SB"/60Z"1WG7$L;W.]&,]:@4\/6F6J]BTT,$TN"F6
M:,01&2!A3X::TN74PG" .-&X;6)?K&E^]5W7^EX]?"B!)13.EL"QP5I,B2,.
M8A>&D@FC1&*(^",.?\L="/!P!'"#T2HP% ],#PT0/ 9=9V<(E-M''+W>Q^=8
M!H$E@YEA8UC'5QHQK4;S["P&%P<-!LB.L 2Q??!&"$OHX\H7#"_!^]"$\03P
M9(I@NK5#8;-(1M$A;HTVG+,"XF4O$IIV,VJB^5E_3>\?<7!L9!O4X>51&.+<
M?F%%A3]!!%*[#P>PWZ>E3T[\>(CMD;Z08<5NV/J9QX =Q[C_1.2I"6R)7;:4
MV1$'SQ''$<>YJ79&!G!L(( D &YPVAO,>TR/UM?C&[\?KQ$E-G_UX4=F"(9E
M#ELE;X-_SA$<_L?DA)/];"WV*(&#\(# M<'6/RPVTF6!@9,K!:XD$;S@.,N;
M7D>%Q["% 4<;NCVCH')+Q$B,S+JQ6H.\-@Z!7HLH\7-9JT 6NRZ9EB\@YK2K
MHG@;YQ'3KX@L"*:[1+QU>Y=N^XE1R \PJ1EQ2PH F5*7<LQMFD:>2W,?L]R4
MO9-TSJ;=TRRCPP)HR H3?!*X83/I.:VU!>>908#%H.;OK_F4;JK-^!V<S0BB
M6)>AD/91&LSKA\V$>W6S!FPN65KC7X "TXMU3"_BNFF#/4<<YS7KDEU$XS$4
M?2#S.+UN&QF,0?6H!,Z-W%W&2,_R!4">) I[</Q+6J<E[IB4>/BWBD.7YS#^
M;>1O70WD'P%&KH?9A)4$,,T,,U-'S8EA:[*_+#<<<;"4X$E8D%97)"D:1(>P
M5 ES,GWP6?&1)#88J*($MD<<IJT>OU*T(HU=Q-C] S5/.A"=W3=79$S-,RV9
M%L/<45Z#EA,JA@L)T-ZO(5]\7_2M7=#)&*AO1R^=%'0$*6*=<(,66HN*$Q'?
MC9^\?K^P@^P3\"O_W,<(<-<J;EV*RF-ZH<7I\CLGF1HL.'"# N)W![Q);#5:
M=<N!=!$R]&%QY\3>_*#Y S+QH&"NP1"?0$UJ^DK[\5%=;;;$/R=-6><1Y\,?
ML P%C ]H#L)PHK<^1SO2,WOP2H#17'8QJI";SIM=Y>5PQ$$2?_CH]L&=+;;$
M9)"M26?NW-90:_P:$M'LY-V18HEPX8X5_6WBX4Q/6,'VC&0L\6$XT/=H@7FK
M&9S:%;BMX V7U%9&&J(:$7#QP\3>H8EI)WG?7?O@5.':\HY+U'[3^*S[DM.7
MG\Y+[M=TMHSX@/ET6O?$@)JSAZ@VQ6U0PVE[+N9=(=(2RRTIB[BG.,A_@]=Z
M6.C#>+:$E/CK!^4#^?+Q89OVT.WULZY:GS4>YJ9KM[@JCYQ,ZJZ.%A?:]+I:
MQW_'KN#.H^I2"_^AOF!TXZ/'=I5C59\=P/]XX$"):$2U&S#BFM/KH3:Q9R@W
M>+V=?J8NN!;U"@9"Z!S45E4X;624+W7MX!."JI Z<T-[(C5:[R;#.+6X$\>I
M%%6I* .JX_-H;?2)42CGZHBT'UN'%I_G0T%BA %1._5-F#]M*059_>_4(V>S
M((U!"I)IZ&K7]-%=P#ETZU Q(,3\%75\V/SZZ:#-$ K\$^8%YA1+"T,!Q4=S
MD5EZE$-;>_;\Q'9)QV381K.4M7=SLM+'0Q-2SD%?Q9.IL5F7TOQPT88;]R_"
M&TPXE2V/(3<7$-YO=&&:)4;=N43VH!&20]-N7)O>0^[[-DWL%=C,F9EMZ?6H
MWZG2ZJQ][W0_&>54_<%,Z)]7D)T+NZ4,<;U"Z7C;3ZB@_<!XB"#7WWU4A,V7
MJF^3-%I95SH8=*?V[(ED!IDT2;)AM,WI5JKCXAA-KE5).;^F1+_O[R=:56#I
M+1%II$J]FTI]+THV;GV;7%LW3KMK[CR9Q>4D]Z'=K53\\2?[,#6/X6JY#W^S
M+3 /CJ.30NN.7AD02Y7,9-E/X2]M="R_^*&LZ<Y-O=52$!Z^$O# E?F W&E?
M9':B/<\Q0'UFV<DL !/,5Q"B781;0(JX9,ZZ],IO.V[?8H:;K];Q^AOQ ^MA
MAK4U% D_Z65J7&]^5=&6B,9M[Q9RIV-DP(FFXS0@<+G!9=GLZ_Q61U3IPF]C
M*3/+MO9)_$N:/$MPE:$+^()3BVDFGW9!?LNT0L"7S0\2[)PCI&A]AFB>B.(K
M;\D.H*I@',4U-RKF9OV5ROUZB%;,P((RM[QBU3ROT<C^GJ!8& C/!?"-4*:?
M:]ZN9AD&298=UIURS$U(A 06.]4U6YY??./M;L$^%/8N*+RP4]QZN_KA3DTH
M,Q)Y.QJ4P;*AV2:K\ZQROD;Y) TVI@9Z9DT2'S@]C7 P22HUX4WX6I><YL;U
MI<(J2[/RWG'*B8I[**<M7)11H^]4Z:]),"'1^B6(:32]%O<^#;1*W.=OL1$>
MB'BGCLP:X7.*3KE.B'L;J_(._KI9^79UD@/8>I1+>K/>0"D\*0P,*.3T<$/2
M&4<<?.]N[T:+70D 6P-5IX</C2 "70.7/)S_>E[<20M[QQL07EU\MBT\ZDZW
M/%G%*].VGND1O<3F!UQ74$V[,>P_1SN#5T>$^\.0I:B,6VW-TRQYBJO3I,V6
M<Z9MLXZ^46-UG\^M\5"_0-5[Z0\WQ<>CDKFC#)R^3&!6WL*X(4:&+JP;,?2'
M;!$-TYI-#,^E^+\R42]595ZI: _0SF<7@CZJR$Y^R\6VN$:8F)'GE%S_^1%*
M:#-28@D!D?1,RN(Z$7SA^Y,12KO*2H:IN]$%Y=I.M0CO0,:< X[R64!&Y&U$
MZ<TU)?MD&7]&FG9!6$ PSFUASISJ_0M4S+ F24NO_LS')FEL5X&>=4]2%T24
M1+DTV<UB! PXKNY%Q6%I1JGU<(OGLT]>'YR-Y-*4M;B$2RU:+LDGQ7:C/K^]
MO^ ;^Z51.>/*%Z07W0X(%[X!4FQTBKAFY"9]*?T2]^G8?#W$/3KJBQ%$H\BA
M]&ESA7%H^3__RC!,#ZN", C+N-]3T0ID597H/P&15=,FNG8% F<FFM!Y@W?;
M,0FW)4(F7F@@-R.+$'J3FN9C?[X5/^(PS=@6&/0I.818T!)Z("=9( !>S#*B
MG<G6W!$T:T]W7G^;'6#I,BF?%,=HKUE2- X*<V6D\9 ?II^[F+[4U[=$MFAJ
M;&P-B';MTV5+#ND60[_HFBE593[ZH01VJ'7.<<CW410"*[XN/E?KIJ6_;T<7
M^F!=X'2O8C)=0+CR>NK](PZ_%67I\&<4-]Q9$NH@HC \X5W%*KWIW:IXLXVY
MO(*1_Z]2\YZTNW;%%D[MY.Q+=A4#5<E7WB?_6[S]OX[A!IG3PEDQI4<<=;.$
M/?.NL+ !E '[FLT1Q_3V\H'<4D<'M8(^./%OJB]S,HA.^'Q:R-HJY/3_LB']
M?STP*LLT5_!\$ E;/[W32]/H,](%6ND2E!$B.&&99KD[#U[5V:Z@+?=TM-3[
MK(S,9;*YY'TJ4"841R+H!?P\VO ]XJ *]8-,9(L".4%4<Y#IQ/9JT^A^P9UY
MY];VO[M^%$0=WI[^U<T,8\]AF^"?P(#22/=('(&/\& D%=PR0CR&8?*X5"-5
M["R!8L)2LL/3L+WN,HQ<6D9\*';N8B#^TB+BZLPBX$IL=$>=4 VM\=2ZL-RO
M'7 ZKR]'1WL%#,9T_UD3+8>6/&9@-:@ZAC<-MZ/%-&>/ZYO$'7&LY!>>H(^P
MA#I&5N&IZ"#ZR4\8'LS*>[8\O2YV_YP,+;UT]0HTXS2 )16*3G3>M^TQ$IL,
M,U3<)3)RFPOV#EIP*P^D!=EM2C]_,;0.&]E0- JHJT6)4L$L@2W&Z\-4ED'4
M.V2TSL2QESE,1(,L*0&87NV<7)$"D;@PT6=0\ZHMQ\(KT\J[<IVM$Y":NV<&
MK[4GK]'OB[PT/4CXOTUD>X0)@@-:3,;I_WKQHZ=@PH2'\#2,* 9YQ,'-,@>Z
M_X>BZ.4YT9YE,%IT#,IY#&JYCC@HK;%XD>_+,RZ^*48<Q^!*9!EQ#.)B0JN&
M+)DW2 ?8@FHW?U$1@E=#]KQE$T<I$QE-=OGQD>GH=@S.<A)EQRQ[)"+09RE!
M @B>BA"5R:*)(OJM@R^#FCKG1RK].X9SD,K1 :53+T\WD\SR*L(= !_:1T;,
M8783EI<]H^\S$@-!"W6X9WWO3^D\SF)WFC!B_=*%N3?GW-1,(D+0N^@<=6=S
M"<L2?_%(N,<UH5R[(= &G"7XD<WIR=0_AO_L<T#"B@D1S(^V!V8I(_QHLTF\
M/"R)@*B!?R((0$-*X)ML?IIE;%[/@4@CY;\IZZ<_D%G"N!F4J.6$YM#Y[[^&
MD%6;'8>S$[+Q!Q*NL(##\B,.'ZW#$JC"RN[)6=0^6QRP[.G(6JO33B@&+ ;M
MZB>#EF95--^FRMB/95JZBRP%N*M06T&2ZXX%I5:C)"3S; (+0['/>=3Z1ZW$
M)]HRUXT3\13VU2&-7/NVF%H$$?5053&,-E:<=>\#\-U;K:W30FVTO#B)2 G6
M*Y/AWU;H'2[!Y#9BSZ*>KZ(24CPB4D9TDU$=LR,\W_[UN1.A!25 ZQ*)?>D7
M)[ZHA7UX1?1\M'=UH$FBR)4_8?#[&(/\Z@6X_VDX2VC98AQ_\IC'\^$.\ZC@
M%)U"C0;:,FF'9\ZPJ1Y WLS58YE0:[27_IEQFE_>FC/O>ZT9=HE73NH!TS%=
M ID2=<;5&9K1!Z;91';), KID%3HU3"0 $N"W"E:A9(ALL%@9'WKU+Y2)&)?
M!=*[XQD5_+ E$XYJO]><S8[4W=>%BLK\%?JK_$J+=C,<N&R2FFG5[@Y:E8\/
MU'PWR-!KAO-NMN3&%J5QY^4AS>:W_-Z8K2DFUI;Q7C"6=7XK.M-I>,1QJH0&
M/>( -1T*]GE<;6NB'V8W1P7KI*(E>,<:)C7U)LW+"LJ_X_\L7#L1B50R:SAV
MX*$;?Q EIWZK)ZF"-[R3#^2_9@B_L>VW&YIZ\BM?1/[L#<B7_,<LT?->"JO>
M^BB7-Y*R=V6AKPK%=7GP*#U+L7A<4F7IG::\BAM$%*;$PN\#H$=!?!M1='X@
MEZ[8HG,"':@D5ZJL%'?WIMJ;-UZ^N1:=]6TS5&])[4LHE.[PJV2<X\],*F@G
MA&F".N*X2>LMZ.^%\?NQ_Z3=]] XXG@1WN<BO'!@DG2O@YX?P+LXN52$,_,/
M]/G0%$X.;;F]$@6[^\K,P/%FUF<:-@[;U+^3Y%-.2 P[XIA#KH*2SL36;60B
M#MP(@E"_ X?B8,JAET07_.[DP_V OQ><-B^-?L^Q]MB8GHI?HNYUE78[]4:O
MFA]_P5@ $<8SU0H6,[K4S4/7###**D,%#EK%M:%*FC^V-T]XQ67[I [FF?)\
MB&BA%/^ZF_3/%H%VVU#F#FVX8XD'Z*K=/#@LS*@:H:3ID/3Y\H+X:FI-?$.T
M7_K6;CV9>_939D+K1! ?KM)UX]G-1LLPWF=<+:N[?D#_'J+JPK>QGF^A5X>%
M*VQ#5A;,H89:&;U>:A>2K7(82)1?E*]H(FFHU").;[K@MJE1F%2#AQA]5^:?
M7^).:#<UL7C?/)^P;SP>P3$DKP][/W-U[>HAHB[5Q3;9^MFB9[.GWM6C)Z^V
MW1DE617HT\K9:@EL+BWF3<";"B,%)2\)CD%!F J661"O\Q(*TEM'E7+MP4N1
M0P5:7'P9T-PG592A:[5-!=J1(_I1C+_]R6[+'N9E-3M?+HECA6 K[S%-=7V\
M?\!/ C'D3X4"H]M:(SQ \@C)XW0S722'&N7!O-8>8#.^;!6Y*^"?+?+DB?B$
M>'2%^*SSM1 M1A[N2\[Y6SPT]Q 71Y8@F,&.=9P(V@_B8AETUK>G:]:/[>#E
M_!B,%KX_.$M_E8RM=;8AN$2NR7ZZG=KP+!5OE2+8MTRS@ !7[B[[D=%JM+QK
M,4C#F]4>%\?92BQ=K,7$-E6@;R0 4;>XT9'LNI I.2JQ:&#9E>&55+/ZY>_6
M4<K6H9B#]_,AQ -IJ7[U@0V?"9IN;GLMET:QI7S/^">?>@N\BG7^AQE_.P4R
M(W]??AMA5S&B?R>XFY:3\:K8-0Z7_ G:J.^TV<9:9IJ<*[^W&7Q&GC/WP=4*
MW2FG'VA5N6P9;OFX;B]/"]WM85T]+P7'8A=8.>PL;*5<B7Z2&M2SS U,$XVD
M@4A*0;C%U)ZEA/]O_;UI1DNT\JN-][3:^J"*A8VGAOBWQ7 Y[#E\PT?3=^/8
M7@'9J<80T82X'7;.#O.(XS0/;7T[3X=8X$@LY!XWTIIC&6,$;C#20-1;Z7$^
M[^OBE5EJ^AI+3@"RSWK9J*Q0QCC&L.7ZE>VO?T.I5C+_YE#D60+_J? D=8IY
M5Z,MZ18YM+K>G? ('C:_V@R*BG0U<V952?S+ND99?""EB&@^-[WS8&DZN,7D
M9M8K+_JME&,+N(^3WU.T-5VD@&9!9GC1RK"1U+2S=Z8#C%0W#X)2,GO. RG6
M;>,LR8[ \@Y,"MK^LI)O>(4S*G=#<]YUL.X#]V2\M_J%K^#GZWIGQQI:P;1A
M";F1JR.R9GJ??&>CH [Z\3<KK8K?K#YZLV#)3PUV$B\<+KO4I2PM@C]YM9=<
M^P'%8[!6ZE*#B"93I&5Z%;Q^^4N&9*U0)RJF/AV[T+:*HCWBT"-=O$5<6'UN
M]D6YL2#QAD@^[95]%94.F;MVQ382TPAG"<\; W0ZS(0&2L2?74#KC&LE[81^
MH[_ ",C0 YK3&RO=B3[OY^ ;#2C!GAYNI:V$+-\)XQ)J[T5$27,VOTQO%1W&
MYJ+3?E-:^T 2+.DCCCBUU>7S_Y65%=:LY*7=&7$>50G0XCX$VT0I4G^<N_RK
M-&; K'SQ?<2,;NOLY<^"(FDPW4YY)E_T9*$@>8[H#IA371?1;K</"G[DAT9=
MG_WF>.G"3K.A]L[.[OMXE;;V](BQ-42)Z6TT'RJ:M-R" )[7 -GP6"/8%!2&
M^K6(8"207$[7L\<ZSDM4I0Q*(4E3(18V#A,B>C]>.;XL-7LS&ZL<^T,)L-Z+
MBBB0?#K2("YFZ-9E%1&J^UG?3'*KIUDY5"VKL:/MXV3/0*D8Y9M-Z=G/7!_L
MO@V-[+WQT*,^# SH>\.C<VX2RS"6#M.-LH](EX[W=N3^'$NZGJ[!GV-5G,H
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M^-Q"^4-H7/LQ,*HS,BE%%^''A$&1CZK \G[;1M9FZXTLAI:=GD/;2,F(-L7
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M?JJ>+TWNF4VDLM(%6,;,D4%'0D->.KX6SS@EX#84/&,(K.#^P;K7[2,YAF_
MJ3!)0BX"264O: [5S!/PL]760M):#O6W^1UB%W(U%+Q'[8#MCQE$BH-EF'E8
M' %*@?N_ $UIM5QUEO^#B M;A(:VQ63<;68&GB9E,)%&0<]K+=5$.$@%1:8?
MY-6[O&UYFW(TG8:!SL&X2J1=B'H=*/0_7!E9];L0]PGVJQ?0[QRV!J\-?WT=
M5,_K',#/HU<C $^^K! -+L+]FQXCL]*N^MMA@.E VX6\!M?/LQ83<.Z5W]&?
M9@]1%.<(![UX!32^(:NGF$?T+_,*V, '\G)G+^6R^R\U->SP_X^/M;4FVDVX
M$BP2NZP<2YB'=5+%@SS,%GH*JY9VMKO@^[]O3[D48U["I+S=@ESR$\FAMWWO
MAS!>X\[>QD0<<:*]W//JO[1_Q+HCR_#[\*Q+[KC9:0R[*/JM((1TU_J>V84X
MX:Y^>0YM6_C1@_2:5Y-#U6%/,>[*=B/6#?MJ[[<KJQ-S%VQ/9@0;RN1J1OAK
M>XN>+E.G5UE;:AKX&:E\F$[UT-FF#5\I4W]C/&74ZKJ<MXR_&PE-YIHQ"_;2
M<:?( 3/*(U.N"1$Z0LZU]%7Y@,Z&?TG?"&;=;W(-PN&'LR.3+K_;)S=)[G8
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MYTW?<=)"\Q;H&U__PW!(X_H1HX=8;E^;R=:\-;WL7([)X<B;94%T0'K1/N&
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M[&+,;:O):_[I/?3"H)\9'CX3LFF+<<4@.?YPZ$'U,69OS^2'C0OFACLUDM)
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MS- 8UTJ'#>N_T?%_#E#<2D(LY0'9HM"J>94C@ZMK/B%VE+,;+9FYE>.] ;B
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MR[URAH.=B0Y<\HV1!*W!@EN5>]\9IFF^:,[H_+^R%"E @KJ,M_U2F O\%XC
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M6]D_I]4Y\N%$CJ NOI-[L88U[]SM%^BMC(2>N;O?W;@8OJ_(TWOBND1PV>+
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M?-C(!P6-/*G&MX*C_(K(0  1;V[/\6=6X(EH]_&1=:@,.IXELPU)CDQ7@AX
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M0%'0[P7OUD5TRJ7#.H<'*1[*;U"*-[9>%U5>-6]\Q_K\O5WM,S^SLWN!C),
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MMP5PM,^K1F[YYW8ZY\)Y9I7C/E.0N&BN(G827V>RPIVAIDY+""^!A&6EMD-
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M\6<$N5FFE4'=I/'%FR4;]V>:1A)+TEV..OZ-FP9\L1O0/^A:@)7=T-Z<"%K
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M4Q"XW<TX3J7M:D-#@0' L[0]8SYG-R?F*50?0UD@MW=!V '+Y_K)5[/!#+.
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M5F&.R=B*W: 033US18:5A\R6?)WDZ:;?F)?:0X"QX[:>)@L8!M#R)(F90W8
MNKNRIN/,"'$"T%75'K4NJE<(3&& ^C;3-Z73Y5V?EI.IX@<G:0)/EI/OS5X%
MIG2X$V6/\J+BAC"/$..]7''MT3[/2X-\D8GYALM[/KMA!Q<M=E:_KBX;R'59
M=#Q.'QFY57$O2GUR.&SGB%@F[U[4!&- #OY%G4]L7HCYY9+*V51@-%8I[UDZ
MNI_'8/-)NCDY@BPDLB7:-ES7JJQKWCKJ71B/C"#>BI/%-F0[EK<QX?CQTF/%
MCKEKEAA)IO1U[4Z?7(=<%SZQ46/_X57%B22; R=M3LLG7+L+D>WD5935I):(
MP?'V191\CC402)FS6XDPHX;_<P#ETO3SNJO0SY749X)2&%IYTJ"LHL[392Q5
M,MJB?:Y=FUI M)U_6PAW9*,X#-4!"50-*]@%0'GS0=H9IK[?DO.F&2[%D=XZ
MBB(684S3Z_,B47*CF[:938A"I)>N75[8L-@>F!&P>D!1B6JYL[C-.I,CRT#@
MOQ,=@[%KJ=;\ZH*UT_5DMO_^S3;D\]=,J/K. >E'4VMS*J+BO5@^7*@U&T(I
MR!PCMBH$Y7HL4A!PTR\2:RN\=?CB_3+8C4+5W=$*@V/'Q#$W(Q9,B=V&#.8'
M_O-OF@Q]?C,$_1\Q<!559AT+.TQ9]';74]"P\O[X9-\8L+R.JK]]LMX +/P(
MC[_^0>V_ A\;H1"4,@7;E:0U,-CU,O!2:/%<GC%!6&)X6W*XQ6;Q!/'-W<SV
MWW836UD#[3'-K!!$=6W_P1TKH\P-W0F<DBSWT;%1T_9UW$<@'K =H_)ZC%^W
M*OE=-HY1NU<B8"0WDF HI=WXU?-Z Y\D]R@<_RLO>STE5_2_NK\C/NEB:#Z-
M"7845?\( ^"P=(T*G_%,=PF_[TDMN/<QT08IO"=E(M\E)"4">)8]JATLMT,I
M!^%Q[*>@U4;7>/+U*MGE9*1DDD2TNX-+O#OF,;67,]9&+/F!B[__TZJ26ZF,
MBI]T!8=;3(L,.#\,?Q6,KQ9\VYSA[__$8G@LP^6)1?J;NQ?;_'-(DPGT*[UR
M.,HMWCHT Y_P3RO@4OFZ"?Q(3'_S67,SH%$%X_!<%+*9E 6_KN,K!!S*YV[X
MVIY)TN;FM@F46<#Z*>CC2OL>.&/%N+HIYEO-:"B=W\9(Q'3CU[+ISUD9C,Y^
M?NH6SZ'V&4;+GX+$)S=+0H6T?;1 0 8)%L>M,JDEW-P48SHLEV9(-8ZJJU##
MHWF04&OWR(4INA3E9-%@2YI:)$(>L-)3W'K:01K':VP9ZS;CQ^0TUG=J>(,!
MVU$"V7VLT#%''R/],5V2>R2UY5D:OFBLZ"#]&8:;//IBU*XB.(K3Q/K5_RT_
MS?(NA1X>\(-J,JP808[=B].$0N(NYSP+^#'DVII@DO/ \ GAY._F!\V15V!?
M2W%?/H5,/6UV?T0MB7#\[S?FS,X6M%5+"64*G,F/\^LG>5JB- @ULV(1S;NV
MT#!(D'FX[W![<Y08Z.1WK!DVEOI]+;C^_0>[>;CZ1)JO;!U^=RVX-6DK,DNY
M/DO6^R#!+N@IO4+F]Y]GOSK>OLP- YV"-D]!=&[TACI]W&(XDDC^R)O-^_VR
M)%M$MY-'9YL 3Q3.#!Q'F,"*2P=\L"J^;H&Q9/]WIH5)[K.TA$<];-&$I>N6
MG>15$Z)3#>>R?AN$39_K@R5&<4D] &Z>6#:&5:W'7")VZ^%'=;<EH]HX@7.+
M[9LGQU: WQ=AH;IAI=7]@CBMBUG6<"_O@ HB5?@MPH]R-+!^=!3TZT);6A&P
M\5=]35TDP5/*K$R/I3FZ,"0HX("G6_YR51GE/AD=52FZ0Y^DM'>K*V?'7EX5
M]V;VX&X.T4Y^D+G+*"QRT6+)5(UK$<)VMEE1@531CG/+6E @Z5@<V>%,%\@)
MU>WA=N2CBGQ8W4%W*E%LD:Z"[XI3)_0RBIY9'4)2H/PH!HH ::)LJ3KVUL#1
MW<P[PKUZGQXNC]'NEZ^S&3T9QD^Y9L]+YB/<Y7YA@USC-4($##YG/;W&> HJ
M_\FUN[FA2D(Y0+98=F-K<T]!X)QAK'2&[[O-,'F>MQ17B2A5HTJLVB@V_FB"
M/SP]0YUSS>B2&>9B\>\#.]WKWW:^GSUAMAYD:9#Y;'_G6UJBE-/'1DUE 65R
ML)+;]=%$9[XQPHECJVO13]L 495!T^#?#9MYE3V!132'H:)K3D-T961Q%[>"
MW'GT] +_'I@I;/A*__/B9>7!(&K@XQ@4^C-/YN3'<+%P<^.*BAT!^J6U8QVD
M6P^$35-O,>YJ#N&HJI 2N#B0@;7QX'ESIKRINIUW1+O:V*FN39YB)G8Z<@$P
M!C#(H32?W:!Q]/[DNZ_BR3GG<4>[CI!X0:7W/M7\KN\=X1&X\"[]?&8^CW+E
MKA,$@TX U=_CGAG6,L/^*5%2W2_7PMJB=.&.&F9?\':7C3?GCT;!)9END^[A
M:IUTQ$ "NJF[.T,EGC >N<2?7F%:(=G/]"8QU^424=TO$D,=W!KU)"=Y+YH[
M,E,4.\$"P 8YI5.(H].XC7$7YWZF?_; 0KH">B\LIT6R)SL.?>WK.J[@*@8&
MAE^O8'?O%J,TJ?6M2PCC&'7O:*4RFF<@#MVIU<:/X,/M(P-<\G _\9_KFJV%
MOQGH)CL''Y;.RZB2\A%-UZ+YGAFO&R]9T1[1;X1]$Q:$W)(G+O  ,W2Y$?@\
M&\!'->W\DW!<3Y>DPJ+E7O>P=USY9VY@H0.G83RVGY)0P,8:E>;A* W4DEOE
M9BV4/PJ02E :#2-:G,R,U2QHN-T?Y0"S>8N=K^2;295 E8<EWWF\)VGBU!@V
MDCR#ZQC\F;7]!!_N0B[)ETOA5N=8M%]LGZ^-!,^EN/3KXYFB#/N:Q5S)!PH9
M?!TDQ+V\!]34LON[!9PTQ6+R99?.M_G>L;W+D9E/:C@+[ZF^,Y!++33C<$QT
ML<PNC+-8(]W,'S&I,#+@T/&+.&K&6HUJ7B+9R9]#2G8*,X\66U>BQ$E)S(27
ML2EBK^X6K64V^S_KE;K]:*">- ]/,+Q=:R"CF-P7W'R]>L5>.WBJ4AME*?*B
M L9ABPL>%YO-T!\_JWM)B5DOLUR,Q*QG_:S;)J?[*&$8$U-\P2B)R7QU)-*B
MF,F_J)!16Y8]\6FJP;/PE@HB;(>O@-YD=T9)F&J+:FFJ%2W:[11497D*.I)R
M+Z2V4]K[A>MMZ+OR1_OR)](,@V@.*-F8C([,5X2EWKG=?0JB1*_O[)V"XB2[
M\K2\+\_,_MJ4H/X(^_.%@#1=YXMF=US6%&) 2WXU,%\$<%ER4#%PF!EQM[*M
MCGEHV@WE %"E[:2X\.J^;O 5>/;S+]<N/T*+RI!B'$C]+P:[Z,)#* /LS5!H
ME[IR5I6UZA-2Y3Z"5W[+6GWQIKO<E5_G6'.364/E9$Z*1;_5" Q>B.U9MN!\
MB8WQBW8+]W.0=&S34#)!>_ B0F/"6J"__.P[DX>))IVN5[R#)AYGGN,L//EF
M[O,^)/7X5C6Z#N/@W*W%1MD_R"L]TVU:@D/[LDY=P48%E8ALU_>AY6IOKUW"
MVCK.W?5%K<#9K]8/?WN4_';)#Q2L3H=!X7/.7<&'/>UQ,_GM'WK+OZHD[J_B
M!?;R-2KX:"INY?;3P'/W+.5-BB'F/N8N_$+$EU]T^[M>UO,)\2>?3K+#I.<!
MJ\5 0JC\$I8FUL8^N3CT#XP3V?.PN8Y"/(A1+@Q2B2IIHF8TVP/H1_D0EM[B
M60-O<LB)@!7<*0-3]WX$$7T2F-S"UN63<LFGY\IB;4:^\VY=C'5+,6LD@LW(
M.I&SIJK>@=&B(K:;=-.^@C7QPVJG3YXMUW>I>R5E([2%R!;SXJY<[8)G4Y4U
MR]:/RB:0J&]MXNJWS15,.J6MI_7SU%7M=:2^3A+NSWQC3U+'I_]4U;'0&BZJ
ML)F?7E?^"(,?OIR<L#*Y,=&0Z4?T0_@Q)Y9\M/]KFW-8=?E9TK3UBTOE9H@C
MKOH*ST)[A.TC_N5->5^W8L,R&V+Y7 =?5]HL?/#6W""3L/##0G^SPW=6)-]B
M6[,\U9$RJ5&SC(<Z['Z1\-)U?5]]JOF(EY?>=;'?..?]+--<9[YO)9RN)%Z]
M >G;&3KIG'8OTW+@=R6^Y^@YKM2A?B^!%AA0#D%4TSY.P(_<5(FCW[*^*@)F
M];CR5_;+M]3X.9[E^)F1"1DP&&7H!KN.=!S5IOIG<3\&9*P-_5;5H\GSS(V2
M=<WA CEV[YXU--4W)DF$DR^]+<Z^1'IKJ^:4J>S^(UG[V5N^C/0RD68?U?9R
MBRP\=NMC8[PW.)&P^^(8I;C,IZ^0DYBA/O:3T8I@X9-='(?1+RD;2W10<\_+
M;\86.TS^WG>$\V?KL9;!$TMNU>V_M3Q_Y6YC;#CC8KC:>1_M$ N4 N73&?.V
MJ0^W,6_<[I>/#F!."Z'HVGY^NPQ7%%+YUCRNQ>W!DUH#WU_XT[8R*XPGZ)^6
M22TAW<MVYN.:7.2MI^BFC2RE3DTAI,[M@ZG@L4S12W$FR\F2S*:FB=(?YO5O
M)Q:J*ZU)]0\13:MCTG/7'E)ONWBD?WZA7!#0?R(Y7=K\[X<BIQ__/6M*V(]<
M'9,Y,U#2)DU9P4(C-$.\/84JA:5'G]B]VY=1Y9MGA1"/!'J]G<E;?_#K1;X,
MW+E?!G^Z\@O-LJ$%&?."/.;$@V,#'WM,A(&!I-*[) BOX^>.8OO[OK(+$;3G
MPSH[^'RV2;=HD))$N)27EZ90I2PV;M,Y^A<"X8G0J7,(VQC;@#A2Z''D/(G=
M>U3N#&><^^%J62#60YGZ?=9@^9^T^Q)?_YB^@Z?^6XA\!@D&'PJ;ZC.ER,G:
M!]==S3=,L.']96-$IS*B&>%I6>,IR'UY:$U02:].T(C]\@B]GV@PA69759\.
M>*[]W&!7>M%-OX1JXT^*J593SZ#LMH_5U(9\:[F:4QB;?1C6>D]K<A&9;3WC
M#R=-$+G(KX!)$HSUI($J0^K[RZFSOX)F2/%LW*1VEVZ0H3$XYW.L_%^IET=4
MOSRC+H^/ZCG_0^,[*=<2I/D <50#TG;$+TM$08P*?XCU.MI#[RHU[*WBS5F/
MF8&,YT,$7];2.#)#J/#RPF X629)\G%#DZ@) F%4USG=)GKNO>NTJ[!-E4&&
M4]F2PN_2R[)#'4.X>,)B6:6G6N-$)SFL-@YSR<F#,-/L42H7T]"[UN+\$W4W
M<YCXY,5FJ/OR=*FS(_*YQ#GV+2L.VWSA*FEO9E/!L1K..U%,J<DB' <>J'<>
M;;U\2M%:[XOB97Z"G_\?&TZN NB[ZCO(#ZO9=ZD/@A_D0U*Z8@P_J>^XWW8D
M?N@ODOCH1!]R$'&XQRC_8]1RT>;.IH*#H@1RY&[U?[_RTX/N<*<ACO7<H5?"
MF.WJWY(W3D$7OX<-T7F&]CR9.[F5)^?_: +$R9"(!0'%% Y@EJB>M_P9IKL$
M9:$]:P:D_,KM9F?MZE-(NP'>%\::+V)#RN;01DJT*72'#]2]]1RQ31E@.)8"
M#"RICAGDA6@HOR8;]3/Y8BOIQ%960S]_U(S"T&7\)[S]4L#<+01S7-V&8<@#
M(,][J=7T06-MW8CK2(OPA/$'CT 5;]+@+#WE;;\TD)$^].U3V0J7FS27KW7?
M'7U.A??"YRZ]>^)K73D*CB5*D=9&TN&Z<GW7OPF/WNKU!5JP8-,,%$I:/G'I
M>SCV"N67"M@(H^%TG>P[?A-9[;&SV9DA*"S!07!E*U2WF%.5+K#I-,>: O;?
MHL$\FQN:ZACYJ>VIZ$-RWG:'D R=^P:'$-.,GR>EV'3B=41W=@]!M<B",O<S
M85,4C/!^>:/+!)ZEIS[GH6YJY^ XW;FBT:_[FT"MWOQ)M2/.BP))%!'8]'&/
MH]A)M2(L]B;-C?JS1^-X><0_D/)JK$WL.V+F(&\IJS5GJTV VHK)>NT5!IFI
M2W"<02;W=+WD]RP)/@7%_#0T..RA7QH_]@'0!\. 7:6^IKHFA HFV>=#**>@
M%$TUSSO]]$2J1[U* FF!PYT_D:*S,.UX39V[/J[$P="OW#W0UF$<L]Q_4K'6
MW%T&"4<OYK8STMB.K386\"L%(55?E7Y8SDQ$D;ZB#,AK.7K ZZ *9/XIB.AX
MK:6YD7I^(K@JH6)F@V*[-L_5.!J=4=CK)DY,])@4,%O;:5.J(/T40!9KB?1*
M^0P$Q9;I0K)^3&D*B[0)K0"/'M2HL@@]TF%0^J)CX^@<U2>L(L#;M'C[^D"^
MW!6L?I+@99FUQL _-&.N?W&QJ$$F>CZZR R.05::_:QV]"_"#5[_:IMMG)GK
M(O75-$EU &=#'$ KGX(Z%&D:U%/0(NR++O":>HXD3Q/+5B$*V8YVMTF.^^>9
M65 EMSB".(_D"EC"9*D2615$KI^)BL>Z!AN^BS)G^[XGVBD\J$7#C?KG81=D
MVM:[#\;=_EP^8>%*VTT:VTG9DT^ LR=%A00A@F.5Z>R42A[;D_:N.HH=RA:
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M&,\L*F1TBR;%77@,7=M5HCF* >.4[7LG?VORD#3R!(@PE_B9GZ24.'](<IL
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M+3O2H(#[D?%!P2NZY*J6_&?*24QL-4V*@7 *XMYX49KV08/@1F85^=6C ZY
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M]3+'O^VJFW^8S.?'Z7.E%<?&W)'&5Y \)@E66"7D[C#.5*&,*;UDR3+OH?8
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M^M]9D[+Y6/U/0^"ME,NS+_T=%C7SK>.L!H7B\<!5/L1OX&"/H4(;NP*+H@G
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MH;HA^E&-OK]FBFG%V@=85M/X4(>_XLZ!,_106DL/D7?-7;ESHLG-LY^DAT_
MAC,%ON@9K2:H:Z;PN4ZIA@7>?Z<EG:)O/(4N;+X?I/?="2^I@6BB_,>;U@FI
M7-AB.7&["O\?\Q$-IZA Y'\P[5^;Y;=_#_J9J"K-$22R&PU,Z-F]!0T%\<1%
MZ",4O!O[)>L E8D6QZPO6J9 +6LNIV=WX\3:HTDZ#CA%NB^)#_XA&"^-"27M
M.LQ#<K>WN:'*[^Z], #30+I@=&=LG8)TN\_#NAH!Q84%%U;JQ86AN3"6)&<,
MQ89I[F/CQE#]$DF(Q14\>$;I0;L*#2V+6><(-+);6!*+!0= O#/=-QGK11OY
M5;1M-1:K1$4)^L_H]2=@+6CH(^OP.OO\)R]!_.7QLUM:%K[.4^JJ89OJEDVM
MG9VMCRB'O=WQ5#1+5HD9A0T!%&,AXH5RHXF)8MT O6EIFPC0&'>2I0K&TXMI
M/ \-C-B/JP+D9*?Q=>UN5,0'<T> 4\M^0A.0MQ]M@FS7Y:4-J;[GK_RSW>TW
M,]\+P_">^>I<V-]F$!%\1.S]WK0BQFJ9QW>3$8!=REUX/=3;@\.<A9P[/,Z<
MT5U\X[6NQANOTCS8#S?[G"[JMP]K+_D/FV1BDCB"INRW!B>6B/$HOE_?*?]^
M@%W-4J?K+/&P%!: <D-93%(?_EB8E2S+&E)@^.)NFKK<KUT+@-12I@@2$]VW
M ,2 N)4Y-WH$2UX/1X#D\7Q:R$%"%3MQP&DUN$+U=,#T5OFWY:D3,I=*=8V8
MIOIFIOHN>K,->P5@*5#013R&50E9W()_&5O;N]K0&Q&\MK)P?4)]4>D=<7RK
M6"X\DZ)B<):>ES%G?JGT?:C+B*;Z-'B?1%&*V;:X0,))3ZAJ!O$9-R;V7YLX
MZWF$0G'IT7B5>/[]^]Z2'/]C*V^>?\Z//)5C>@J]/,+Y!3P'(+PK#2:B\:P/
M>,Y#,P25 P=L(>9P6&?L<F%#\5S8%]%:L\A\P[+?4NT-<,J1/G 1Y+$KZEDG
M2^K"0L*IO.'UFL P;D"LPI9PR++D1@FM.LIM)Q6N&G>^QH-75W>I<I005YV<
M?+K*PO72,<NP5W8UV8V9RJ$OEB4OZI9M!8D1*UQ^+O47O%[H)D*Z5,1 A^[8
M:W@L]0<9!X=_=?CBF69"MYTK,2\QI0WNWU]3LW<BC<W__ 33[J2T (II;M[4
M7)_TLQ#@8<ED,.]B';FPF!F.&)IU1(+1 F9R8;PS-)X$C@CKUR,<^Z%IPT+Q
M?DBH%\$3E<8YNA67#R% 3 1#<1)/%0,?4E&;L@C.4<3!=>(-NEP\@XG8O*0]
MLWD=O2T$XN-9HA @9K:Q.[BP'Q[0"!U0N56I-W3'P.B:N]5SS^_O+5S5Y \X
M=/*)V HYE$E(6(R3KS_]:J8Z42YQ-W?75](^7M7L]HO0]QK.EH'&DM@1@8?]
MHP3W5&71D.O%[B_.2496/ WHT[J8_N)4"TI4YNM@SHO58[@N"*#L@MM#7N(&
M<E:3#67\+^![3*AL]+6F2:QW28!.CE6B <]BP9%CFD31 !>Q^5RMCL^,MCE9
M)9+<B8EKZ1\&BP)F]#*G*@TS@B(]P PHF-^-LQSI),:KT3"$S(< A"A+I-3O
MU^ZB-[#(:M2:PSR\873SVRG@V\N1J%#-F=L6M,K-"V;9?[RGX,KE*O77Q._,
MS5WJK3'I0X"Z"XPYT *8Z,7ILU]"\(2FU%(+NC^I#<]8T?N3.\^!!-INM*&4
M_[2<TN1&NXJ7%XTHC)ECG)S JOKZTF2]D!/M.H%!E?,F@M7E:PP7@S,AX?@#
M[6V=0I"T&,<MP(4$?D+3*O6#>0,CN5;T(2"^FR,*3E$SROD0NA2^'T6<KF9C
MP"4W-_J6FL&(_$CNP-Q*Y]:T+J)W#:O0=6SW,/5[Q-FE\WO;YSG'"U/RY9H/
M9GE<SCS\J9]=EG=-WIXN:1];:YQ4:VU6JJ#C7HU[?^W.>QQOS7X-THWZ#_<R
M8C[)V)V>*3YC4\[;6*IL;[=TQJ;RT&0993PDJ6EJ8:=9['(,;^%OL;PP7E'^
M [RZO#RP?0]TO[J'5F/AH"U-Y6%D-587L."\;#T7D [Z_F7A?O!4.J.M7?O)
MVMT:<^V;S6V/__$YD.##\\NXQH/X;BLN["NR=@[">&TXQ TV[7ACB"CR\+?4
MA5G>=-^-5>H6>,)Q4[V&,XK[#6"W)!F$ TK&X'.ZK1TXN$CDG?^3FEN)$,$T
M4&/3-MP0*>T7J<Q*M!1&CS;G/*VI?TD/8^!,?5[4ZK>SJ5I#E.M9HC^32JWA
MDW[</14P7"8AXBAD71T66JQK6HURK^H7-M^7](B02(@F3UBN22985_^^/65<
M]-1V+"#;Z .GK5T!T"%E[=U,QP3V%H@92!]O?WK2#R72[G&_[++X:7[/.1).
M99)E3D5Z)^?+MXS2$NWG9'LLCIX*)-1@+BSUQ18'1,C!P'XT;2B TK?B!C<%
M6Q;3^-UF R3*12YU9*XT -\6J.\9UH/'G;PZF0>6_JB26Y'N$SC!<=L@+M*$
M0&7CZ,.OXSD"^6RBED*DU.)P-H3F^YRGKO?6X;HE8)G"!S^U^^*TDV\N8QHX
M@KY0/*5C^'HZ%>DSJ<3%.:LY?#?N,("*WRD0Q_3W&9ZE._87"&(<>W!BP$I>
M:!4FGCRO2!>L9QYP_BHE%+^M>G+XA]UT>)[-]QG+\>UU9.[Z^C/5EUGV7UTM
M<I7'\A7+1+08X?(JOLZX_;I/E\1S2^C'XN#"B;%G2M\IF B;F>E=OAZ@BG77
MEQ_T11VI&ZM]8'O'=-GIH[O;[\O2RHFIO$TRFFM&S+%,,RT)'7+)BPPF<M&P
M@WD3/L?G(&43H+,@6;NC_ZI3\0-F9K,.8Z\I*:7[K81^8Z*GUX,:I'VP44XN
M2$'[2LK)F1[ U5P[SQ_Q;766Z/>NTZL**SH1TI\-X=U":A/Q0B<7IL\Y2A3Z
MJ<N$M.+JL,Y/DC[/=WV@@",8Q6[%:8(NI"54UPBH(\VH!1L6:V7GAOS+L$C0
M:@F=Q-$'6I*K#12J ]WA;YKKZ%O17-B-34=3NA@Q#GLEB*9ZU"]H!_G/MEO
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MP;K11CZ8_P5PGK"K:0)(L]'MD4V!RPN;>WT$PM>LSJ#-S<:C>,>"U^A^%!@
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M(8K6[C"#:P8)]4[0[E&W<&"0UT9=B#>('@F(E']9C7 '&ROX; KOY>G,2-*
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M^W<]]U9:1=[?DEO]O#@Y.1^/?=88L,--L!H^+ (A:#&<07'#O<SR4M(-I#Z
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MUU#M#H>*$6PWK'>V?5"/NXP\Q*QR=*HL@O\^@$REDB)R%=XD48M$S) ^P2S
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M;[/,HS&QS50%E:&FF?BT1\T%9BO8VN3.(CW;#YO=U^RW^X[4/S"TO"%&)E=
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M.!J>W5@4B3M-6#%:MO2) J/!UB^TT:_M]W-L$R^Q[U4-)S1=SGI3<0MZ'^"
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MVD9Q!-YJE24]J5CJA7A4(#:3\MB-BFECC%L(2'XPRE[%<$AZ?42SKT?2P@]
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MQ58NO/$A)1E$W>)N)W\^#I>#I ZN$6A_.YYY$[F%HD]N/ I7$J!U/276D++
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M:5A,<;<6I$6XM#=!M%2V_ZPA(@Q1+0[SM>]8IG<(1,E210\^C6NW4DBQ!!)
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M%19W#[DW"+XFR8WJ75;<<G4Z%%%T%&2D28<Q,:3TY5X^W9A@Q4V[(IVX*KX
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MY?[^47@ACS^I,Q)?K!LR$GOYGY66>E;6(MV00-V,WJ?IYYE4P-VJX[ '7VS
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M<N)SM$T;:U2QB!EK^H34&9OV Y=.C@+?5@.(1OBTC/8UG/XI);2#LJ/_YP'
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M'MV4'#,JE\1EJ%RU$\)/=9C<>&8EG8*FB"X#W['[.4>JR8DRPRE^IN8KM<]
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M_L9'SUBI-<+XPT&"K0.$N:Z^*%%83><ON]U6Z\D%&V;N?M X@*3LA5G'%7Q
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MA>X:1R-K=3_[3WJJ"7!C\.ABD;[C#!N"[TJ!6<[:B-/EC!#>LS)PX7IDUK2
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M3\.J9:,$Y%NMC-\MS66U7"J_*.OP7S:2^"@7/G.TD?H1FO=0I/QSD;<X1^]
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M*A^NL8)+0/&)>^H<_F V(',YU@(B?!?'1-CD["NUR6BS6_GXWXNN3SM=OGK
M7Q#<I6L*,SADPOT#8:^R2%5KWA&ML*"_%TO65*HI.: 4*CN5D_^^IB#1S:S?
M5(LBX\A7XI!C9)P<>5>EAE7N\^,*\?-!UINH8VWL2]X<##:TP\*VWIQ_O;SE
M\5._>PN^;>&S%ZX%1FKT>F*_/@A\]%'84J R?_Z+3S>*T4L=N'CIY%-AZQI.
MYY^5&N4'?7'V"G>O2'$3LE/OVM! ;90H(N2_0:D!0'EW).@52)%$_Q&_G*.(
MD@P>^+*I!MR&CO@ XNX%K<'N2?V7:>I=*D0OE5C**P<\1[W!3Q_TD^J4-#)/
MS"SO=0-1G<B=Q#,;%*+!5(.J7A,ZT:='$5M;*L%1/_!B=B]Z#W03WBU'JA'Q
M09"Y9 5*2&J PF/)V%&2H1?XQH?/1,+F;CQW?3IN7936^.;-\]@%0>:]*$04
M1DMFUK6WWL''LZ$0%;W=,]"ELN3QHW_^0:>O#B^/S/(A$]5T]MC*%K_9%W?0
MTZS3%ER)JI'^81UZ#LIDP?/3$@Q<D?P<B)P5L2N@(86_A*(ST##+,<M&@?1\
M1EP?:)-)4^Y3. ";:NE'ATJ\!,LT$ROU"^#EN=7C]O1Z[YI83:M[DU92"F2&
MZ=[X'IEK9"Y 1N40W0&>I'S!%3E/?3+70CFX[.W4AS &.\2%5L0=D@Y,%T)]
MQ%D=_]#KH7A.),X\MM('8KI1VP<?#C8-F%17'^4OYW<$SD2]K+]L*7E0'U"?
MW3#_6'BX -O:VG;M0I7GO>$/M8V/.I87Z_8S^"Y,N^T#K<:GOEEV>8\='<>:
MQIDVC#_%Q9+J?#'5B",;['C$/NC(*E5(<B(>XRM^E"''L$I=>U40:$LSZ87$
M/3(OS)W=,S<PNTR&5(0YVBG>;OPN=*V'-8HP !.@YLXV1)7D_-4LKA&U"5L.
M;_T6!H,LR+S"DZH8AS-A!\:)AT=7;&Z)82I:L3 0C[%6<P%QWU+6I V?F" =
M KZYOOL(E:9)X)DW)G> .,J=:/[RTNX9A-6[JXW+M"WA?.? ;;0G,_P)URNR
MTBO:/A=XK3T^]VUVWOOM?H/%WL</9+[?OKEKGPW./N'Y"%=;=VFTEI'0W)Q2
M;VG6:IIFVYQ1UI+\Z\;%1]R#Q B5<,-!<@%I#TE8@>SZ'S*ZE6-/--HH)P:#
M2[S)8Y"=_%=5Z3+4>89'>,)0FUQ<DK</:I^(J,MBJ822!LP%"8ZMY&,R2:;
M"<B_]]IDS%UO68,AW'<8G[@T1,F<-(5&I+!;;:9Y1/\I5:;M *,O *6/ZQ\3
M4GV@*JF&^(>YT7)'5YKP[K4FPD?%@7<KF%TMS&.<>*96"<#MOD!(JB4P>L!=
MUWZ\22^__.Q=P5QOE8/%T^)TFE?U8I7C\ZI[HM5XNR/R'M/]C.$/H=N%&1./
MQM=NTM]8Q@O"(IQH%>TS"1,JC%H:FUME0S+8/!)HE@WVI:+^D'4;G2@Z^T)
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MMP)12]T\,#MX*'YE4#N"GHLX@NPVAAIL<M@1Y 2:5SW$&P0_!JU/O+TKS9_
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MM@/37<Z?3>D647.6"WU..\=)7=Q$&@EDJ8;*_F+]"=SP=L:+%E:;,-[Z$U-
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MF#82.<9CO5V<?;ON-&FQ+K*RPMP@8NJ5/48Z^-LB]_DYE0VH1.F TD"QCP7
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M^C,Y.[EM*7=EKKU]7[Z'4L0 G=>,C@TO&/@IQXM[G8XR=L\<C^@Q_B ^-Q0
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MS78U%]+B4=CM7L4?.+.%K8EZ+ZAQURVQD&L/,LR>SF%]@(HN;F2H%CBK"W.
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MF;1G]D+ 4>#)BP)%_MI[^F[L=;Y)SMR:HLB&-]9-EQ5%#HO@',3^C[GMFO4
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M'SIDI+30<ED7C]\Y^D0G+">/39QHD,B?%2)Q(W'ALVD2S6U0AV54/'%7*/+
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M?(/MI&_;6=YF0_./96+0^F:]!^[Z \@^WD]&LIA+;/_V= XNL2D"_)@B 3E
M QJ9L@6$Q6F=L67*.T&_1P#3TL%DL E&7 Q/MT_87=$0%6Y,ZF2Z$#J_NR%Z
M'H8&L.D=HB')M?;+8BR )([I6[P\S@<Z,>D M+]T14%D@Z 3<ZR];+&HEF,H
MO8X\&T>.[-,P!O7@\LA&2.JBF]5WDX8AS_HWU!&_M:S039N>+5-C]8L?[/9E
MJ ^2U!^2<#XL/^>LU#R"Q$7MDG1FKJ_""=:]-'%KXL6N"_&I*>T14TXNIA$K
M1>-V1?5K9V"O(6]]U;@W.6K+O@Q)B#U;K0TJ ]@XLFMK'C(2MN' KZN0CI]U
MZYD)U(-+-+]&%2)SRCJ FT!R<1JN.;5VM":F3U-_Z/W[R7E\+';O$%8! V-#
MVR-_BKPZ=Q6(G%G=CSYN7#]:4O=FU$\;+SZ?J7\@QX@8@$1YH(P*-/.B+KA;
M^GIZ^6OVWF#3)KMZ#X=HV]IV.)0KF)"<,Z3+K9KJOWR9=4::!-^=FLQ-M_:M
MBY NV#O1==I9?=_[L?A1XQ"+UYS5%;UM&=Y%/I%GR>[NIG4G8\]CC@-X]F/X
M0>(C[&G,/DZ3RD[.]',"4-5W&7QH_H)/5C8D[O[<X$:$8Y3<+=W<.M2NNLP!
M]VNHEXL'W;Q=!-V( X7\%UBP8*@.JP'DD# W@/-L>_BC[/W9FT^#/GK .9"8
M.1?&0R94"1[!6,"8DM'3:Y;F:\Q-5_@A1Y?IJ0^;#LYWAZL;(SV-O5^_>3F<
M)./NDWMZK&CO_ ^D [6F),?A9DYZ3M)R;O&0E;6?F[J?E6O\6OI=>MC5SU58
MG_?]D8?G,:L$[ ?!3X-"D ]$6C"6V4!,4&+"$EH.+<#VZ%@JHOA'>3*0&&W_
M@ZU,%S>3?DNW?8:!T(.&*TWVWS_W,B^MCU?O/CYTY\W)KRTW1V!_/2<4\S6P
M9!FB&(AN&(W%1;/'.S1#MCM:S@$.;# K*O\G %&.TB_W&R4?8R\!*(?FP1SK
MWNX E2<5R #3^\SW@YH5MVMK8]>GX\O"8BZD-1L8WYC.T-=TN]@09%=JW&;6
MN0W]$4(+?-*88/G:/.FTAODA[/<,;FA6Q[<*_K<R;H06"RXM:!."=F-L4-MJ
MCF9AK(\GV[FZG) D%BQ:MP'W]+=F7[B-J)<7M4^ZPT6D* _GP)$D=&1'-J^L
M9S8D/RO][/:#Q"_^X_V 2@(W@__,2$4PG!W;#CX,Q';BI 1*F&O ^7+@B2-P
MFV,QLYF@R3O*ZM]KR>R54(9VZF;*T6)21)&.9<61S2OY-.'#=<Y\&B$S2J!.
M)']2:TC&E7F7.GYV]3(O)-ODI]38?IGZ;!=ZR<&9^*%</\.P,&-D9%9!37:
MGZ%+4+E!<ZTTI^GMEA'[PBQ2L2>A3M:8MM-WXGY+B<;_A-5?I%*2GW-VLG =
M\(3I$\#MESP-CE<\5A/8&N\:=S\]N &61J,ZELH7_00JP]_.;$1J Q;7!B@H
M"/BS=\O!(1[,9ZPV7R:9BPS>P_M3"'J,Q;6>-4V!>?G+3O$0'.C*D^US0&\G
M5:I%=5X%QG9X9("LX$&J ,+,11U*UB]&NFQ<O(%F60FIQ,UY:E%7UGDLR[_$
MK,R[VNQ^W:9]M#S.3-K!S6 .8I6'+AL*UFB"KN:X#L1(34;HWTJJOR1%"I93
MNM)V0!;IHA==."OV/OWVBN%TTLB7KVFAS2M*AL&-+7/O5'3XT;![U"."CT:*
M_+0:\,Y> N]G]M4%/97=E &="+Y>1_Z^\74S?[\@NCSZ84>719+Y>.?KJ<5P
MTE1?=>!FH(^-#ZUL\=GTY*+#'Y;=(@S^"*/&3F/"HHS4EF 4^$H89]P=B-A3
M#?Y]G9Z".U+9Y,OPWV=&1H?_]1E,TDILK';SSG;]2"X!&KMAP;\4+!FF$T&P
M>/3 $]4889& :SI5:9?2I1Y\^HREP[[*BC(3ZZ]?,X)]^K,=4H,S,UR=@V73
MZHFO">C>5+WX^ 3SL9MCZKVFO5S_B"#8)<$I7.N%EGT8,Z"5)00E-B Z^FEZ
M,X+7'&Q7MQ4PR/!_C)"9?*LB#C0C/9#\O%E@[M?87T9TG 231.TQ_4<#&\W@
ME9O3/H=K)YO-!5_GQ@3[L'^MGK3LQ$@!]=N7 2V+<3\!F'>/ ^W@AW8(#HYO
M>%?ZKD]I,%N>@6-Y5V92#DPO9"J:%'DRE&&_U"68#!11&T8-C%'W).CH!.MF
M&(I,]B[+]T@N-9?V>EJN_H#K^CIP,$(Z0RZX/.-$.K*G[I3QJ<Z7\ZI7T^]^
M+>TT=QT/H>.=?CC#G52+PIOA?61Q7*M.BQS:A1L*U&U#IW@H/K')GUW$K(LQ
M,)SIC82*L(+4.D[*DEW>)I!O&#F[3I)C[&X2['MRE9WQ9\0\HTDN^V2]*K\D
MH]!IJJF69IQ^*Q0B)P3]!GLD!"E@E7B2[ .ORW@6[,R:;3VDODH:VX4I@@!D
M^92]F#OL"][.>[(8'8W#!@Y(PD=BS1C!HW#AX>+3@!>]MPWYZ7+V7'N2XJGM
MD'@5C^1@0_*8CWI\1?G#DX7\B@63Q*\CUI9]Z7:72K)S_8KSIOIO6V1E371G
M99A,;I>Y]J!(Z<VS$XNUIKVP:O_E D;_1-5F-VT*WYF2@E-H<N&<QFB XPV0
M(AC'_!5_"&/"-9)0.:JB/+1>?VPH2!-J,GP?'A^<J4OSR_!30\5]6/FY[G>U
M!MYUMDD:1X\A!"6W*"U]7Y2ER75 Q-#X5L71OC2=YI9R_V*@^GK+0/#I]=Z$
M1I<E1YV]%:M?4_M0.1J]Z$I[O>PQIHXW_G7AJ](XDGW=F+IM( EM%'%BN*1(
M,<3L%&%OUWD1,2],M3?N.I08=HRD;%>S.!FQ^&W2M]G%*TG0C]_)4]W6Y<D#
MD6RMMW6"HZ,&JNS):X*W QM@F:F%<<&Q1LJV"#U:EKLMZ-O'EO0'#4];9E4/
MW3^Z]Y#];G4+C$L9KE7#2'P"Z.["G@$,.6G<,OZ?R]ACB_X5P-Q;1#6^Z[D1
MA&?(42$^(/C[GV2OS,4:_+)U=Q/K.4A_05_0))(V1IS/#__F79BP3HL?RX<I
MF!!\*!R9XP;7 BN_99>KZ=ED%Y_(/3$RF>Z2Q#KY^7Y/AJ)UXK&9[)+46%/I
M5/L$9\+=-+-%2JC1P1'J3!ZD.J-;%#;PN^=#IL^S0YYL:_+N#U"]P;M,&2O8
M(=9-#J(C4LY>?Z6/P($Z<4Q2F):(3B33\+>:S3B_8\U#-3E/JL;:[8?O_UQ+
MB1VE>I,G;!CT%<V7&-EQ#*("/=S6<DH$_1VN _7LU4[LCE'M)#6WZG%MW 9-
ME=<P_81Y6:-_W])7#2FFY/DSOM]6QW^MBM<T']L1+-,_K&V]Q=7LRS.-*UNT
M#LY5._W03/^;5;6?0R"W,I";._[U*W+JLEA525I\E*UG;U!&VI>ZLPD_[I/\
MWO$&@&@A:%<-<)X#Z8 =/!L,3X+4Q"2QZ4QR4C ]#G8(Y[4JB0EH'C;:@Z[N
MF#X][LF!Q9_UYZF>C0XKGW1&QW9H]90OAH=D,-V,.LD&M;6/)WZNNT$UH6B"
MS=A]3XL _U]>U0U1H. %9VQLX4((<I:&;+!*0TK&Y-Q&J5CU1ER^C/:=^37O
MM4EY6N(824;G-3KW.K*M&3D2K;%F K].2W3--GMHV74H(9>L)]^I=S?UJ'F>
M[N>?"V<;W3)HSLMIOA-.;G6_%<9KY [\RT:_7Z"38MQ+;+V52 94'+E%?VI@
MPV8QU=K!TB[ '$.L<_4G-\VL)",EH&%BI=C-U/SY>\W.O,^9]N"7"X+@\OZS
M>.+G2?<)]T^T*>.-%1G2OHT'H[?=HZ;T*73MDZ2@Y6%+[9&B$Y\]%=04C-_T
M7*S-[3N4ZWJ7+-> "Y^T'1[5*0LGP?O N[%=,(I(KXDM$!2.0ER98_WE@ <
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MAUSUR[I9.CKRK<5YJ?%1=AE%):53=&8OXA/W%,P'09/@IN<P]Z<2NU,>"8X
M4+7'=]A5;P5R"5?KM@U:CL$/U\5Y*7[(*I)4R<08$D@%NW3XGPPP 4S87Y^L
M;$ _97$?\A,I8%ITD"%DQJ%#.91YH)'I9CJ31WP:!(T/#15<XOBG!!FJ=2#
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M1PA:6TP!O"&_4]==L(=PC!ZV"..??2D$N5QT$,3[082@]CXW(>CC47Y"+FZ
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M\Q\U**A]0.9+?X:)6L]M%(*RK_W3ROYI9?^TLO_-5M:']N\R.L3)H&2U'.3
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M^3V:'VTD!X33VV"21CM%2"F486'VK9*$.3_C'RT$B36I,I90Y0O93.Y7NO&
MD>K"UGVM:5<M>+!V2*]JQX>A#WU?7B_#&)N(JBR^E(C^B(HX/!;"XVHL"T'
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MU#9("'KRM84-(Y1I_"#\_9T"62I/;J?@$>XPE?T!(RL$?95-\:/.3?GS=@K
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MS7C("0K+#G86IZ(_WQ)_?[CS$S\)#YSXH);B(W.CA9)7B0!<'_.B:21D/:O
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M?TC:CZ:+MA=-3RGO7SRX/4:?:A.^-E C4&H0MU@S KH\U\MBG"B NF@LBA^
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M-;LJY5OYI(]>XPC"@B#:K"F6\!/& +"6^!J#[P:4N_$.V88MPG\]&)@&/0U
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MC%\3&3Z")N<+M*-.UGHYU#DAQQ CC-C),<_-%].&P,[=]KB14:2SNQI!VV<
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M%QLLIU2WWH;?N2TYJ0'+P*M8(<O^N[>.:R1P>\KQ2]2A)7MJ+WB&< (1<QF
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MBK_>K&J$G ^^MJQX1N\>. 4$RH6\AN^$T:XGE H#LRSK^]^0ZE-',K;O\O>
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MU>5GH*H0KO+2O??$B?L8,B1,;KWI-'J5^7FLYTLT]3:L%&+::'"E<?!JO8O
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MGV2E)">N.F8UZ#IOF*SNKY"Q\GS6,T0_\*JZR[62Z['?"6HP-@M+GTY"0)M
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MH[[A4 W5N<X?IP\ON.9,&'5"^>F"M0[*?IB+ 0R.U:D>).[6JHT]P(M( ._
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M?OU8@S'8M-FYQAZ>XX)F^9R9_$'GFII,08KREZM/##3??D2*U5,0;8:GH.R
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MMSP%.5XG]@8MU_=3X[3HS:AN_=@,M66$=*A&EZVLLQ/@#S?6EI2!Q,1!TLR
MFAV^;DY0M'MFH,%#T.F3]SJ?*:O%4&AU3$*>DZ:3IKV>A?E;D8SL(LN>#UB6
MUZ[^,ZRL'RUBKK-%]!,P\;VXD7T-JTU7J=6&HNT:M85QA(F]OH#JH V7*Y^V
MUG9Z&DJ+RGZ"#C*-8W>BV@*]!!D4(3NI$@(GG^EJOHQ(6S/*8Q+2QV-[P)S
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M 9/K?B QUFE3K7_!4KUS[4T^,PN#0T43CV*11D":U;K ]1G"KB#/11+--3]
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MU <N.S$GQM8 8) .1X9QAE>!RYB_P7&L,%<=\*$UI^7=WFW)N1RP]; ZM#S
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M,J08P5ILU9/=J,O;I6MP94)_T*T-I8467\3[['2[[D]5XQX:JKT66- \7-1
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MT+M"KL^PMG/W).,;K%J:HP!=X@\M7IB!X8&RM_XTV>L1E@=YH+__P;(/./-
MS\#_'\T-01)HW;[+%JDWEF/&MF+&T2SHT%W2"2JIY01PG@[#D'>I!4,374VV
M_);4[I#N<@]CW1A*R>M'/.]QA8<S9^%[)K[Z;Z6\F,X3FZ7^,&<J1=W-WWE0
MOS3"@ZA?E5YN6RGC\:GH>UFM@H]OF<7G1+_>JT_34T/\BB8-KS>JF)"-- B!
M2[4/^_5N\4"7Y@B[.7ED/TPDK!;Z.(L.:<7(S.>K#*BO>/=O+ J'+^O^<&%@
MX]0?Z^5#F))U+R+*7-TF6Y\K-G]+9A6\"G#2W%--^^9VK5]3K585&U;EG[Y@
M6V;@Z'DRY(C2P;:@H/1;]5;G^!J?UI.4GIKNZH<OKO/E<^(GT1+.[9/U6<ME
M?+#X8DD#QQIK(-+>4?O:A2$'V)?[N8=,"GW#:C.30P-#\8!7I\()C'WJ I>Z
M<%"=%MLF3B4)RW8/3% .WZLVJ#&O2QUN?LR]5@1Y;4JFJUM3:,YL\7 6%LBB
M$9;0THB>-M31:F!^6DZ5+(W49=QNCJ!]@W>QPN0QD;4\D.:EP5IU@Y^CSN'J
M]DZ19DWU;XG-))=E'[ZUVL(85]9H!]$WP4^R4#N 1T$,?*MK'C:EEB ,B*YT
M7:0[3B2^"L"*LP/Q\ZL3B(_G_:FXB=K="P&C3JM4:M^KOG+SEU_=W/J*S860
MMI7HUF/<8TA#!I]!S?(WA/]R.*T>8RR%Z)L^#+A5 5D4+1@AFBO$]JOIQSH!
M)HK#N)FET&,48Z7$#NZISR1;^,NQOA.$Z3RGH&(_:F5,5M4X]Q_4>VA-+68)
MNZW'5N=@*PPO!M$;N KS!A5ZJ*-O:Z6L\/[<8\P3M71.V,+$>ZM[=XAKE4#D
M58QE37AB?&#P4.W3@/B9Y)D(?XO3"37PZSEI82>J5DK@.:A0<-'B)@[@HX7*
MNP'R$@XIPP,-JTZY<C/Q?VJ>YMNX!GEQ'7H5BBO_8Q'1",$_G4FJ]*Y91S^#
M9) 9%\&;)] *_#^$,;#<PE\;2UB&;=\7Z6G8<O@T#(3 TDK:87O\9#5C#%5#
M:!RS-@7#(;8-SN^9OU7%]06S=M=+^1#&KX1CC<W#E3^7B<L6YYKDC99IGX.[
M$A88UDP78/)/P4UMVL'/4;>JLE<"<W9N\IEM[%'N,'G]*M2'S#[)Y4//6DDA
M]U#B-A]U^O_^EUR(>("/([WYY#(+E0C7++\('FAT?3(C\O_PO\I;M1H#VSP0
M89ZL*K ZR@.)FG#PZ+F7J#XTX,CFH]L/&S.VOC2+/ZFOGFP;\?>.,Y,/57E&
M:+MTVPW_Z[A??)$]B'("SQ#^> L,<%]SF8]P)CM_9]EK(]"A/)!!&!>G7+@P
MU&2YPB47LRL@/; _W@+"^ ZCUG,3!);X-XF&M:.YP1L<"UNSX;*'69,<M-7F
M-6@F^8_]0VGOR;5PC@3X=^X[(3+?3;+G%[?27V'P=LN:Y"UNSNIKM#KZ?^Y^
M'4UYCO:?W%*&U$QR)='\;;<Y.+JA8@)QPE%AZ V.WLP-KBM_@'_H'<?P81\(
M957QMU2BH7XE)I$L8'A*N]G'IAF]'[#L@!ZXQ=1-/B2M16J,B3R$%27Z%@VK
MTT5903UX/Z;Y*8?,GS)CN6BK=?O?Z\%W'<U0 A87V8?20']0^9T&Z-:O3NQ6
M\H(CX,7W,H=YH)Q2'JB1/TO-*/*#EO_]C_AJ/?DBEXZ>5_[_P;$01Z.+5]\,
MW-&LM3*EJQI!K6K>#FG^G U\31US:?LE[2Q6?^[FT[W?,TV[A(J&NS=_3?<6
M<*H#:>1HIX^N-A"8>0@]Y(JX *5O7X]/./W6/W]94.ARX\G2K;U5.;>)S#TO
MF8T? M\BOT[*&Y(UVV_Z#B0C[5G7D'L4[()25+4ZG4HB>UZ_R;89HQQ((5Q(
M6B _3%(Z61,4I:C8'U4HM$$3J@F>,[&N.U'N'/R:>.0DD%T.]7<HM2\[VQJ@
M;W)!I=O<6/@=Y,YP90@6XO_9"E[!-A^>[+A/_<H#=75F%9@'[HZ-)*KLX($<
MMIRC*]:)+4^<M+E4K--;K>.C]E(K<_,#"5O[L.HQMIDW5N<<,GQB<?Y?7G28
M%I^1=K*K3.YR,J]=9GYIS& B8G*L:_TQ9:L(]BTF\-%4(\B!4VM*LU!ON%HH
M47 1;-4$]8XMD U6.4$LL5;]?3)[_I"GB>2+RH PO5AM_')HNT'+BY=SV;=$
M0LH"9(<Y55DX/U;IW^$YRQ>VKJFK'[[P3GM4W$PV=8?G<VNM]!F9"QIV:;9)
M-W-Q*N9CIBK7Z\;-C^<$C@D2TP*+4@/KEE)=Z\;[C]<&+B&4EN&,T'8T!.U#
MB(,)(A5+?1N=XY#7\J4- G_%_1?BWCNJJ>SO&\V,%1!1J8*244 Z*%($@8SC
M($V(@'1(1*4;4 &)$)(1I+>1.H* ""&T$*6%$H@0R@@BTH(&)"0(2D\HX4@*
M-[[/?>Z]Z[V_M>Y[_WK_."MK[95U5O;.WI]RSK=4=#:/E,8<ZBL^Q=9?CC$O
MQ"T11Y0Y;?H<MEEG2;@+TXW8IS2S#$0R2@ 5B?YUR0!Y[$S1'#UV_C9;I^%5
MGS*5ATS:38PE63!U#P>S!]99B\HI:MO>)BONMJ>,Q"*/!)XYII4RL0--A\R6
MSV@!)6R]G5D"3W)S-K=_%3IG)C]"X%G/N1O<9.U0Q.5GC$_0KAPD8!Z4>2RY
M=*\AM<G-Z]M"@/M.E*SO?_4EN,ID6-:H]"?&Q7:@CH_JA)KZ<,5X)D RPX@-
M3D6Y5B[2CZ PN"'F5BN;G-)$EE_RB,'6E<P-GUYR_77085+WWNK=URQT]0F:
MPMW<M8JAWO[O_YA+,:\?E2_2 %[$J?;>YA=KBN?Z/^= <Q<F%B=B.6&["9"3
MUSH.>&85E)WRNK]1]8CYPGMX?EV:=)A%[H-=&&S!I3SL5!FBNE.0=:<(_WPU
M"'.[M6@I_L_PR?Q1QRZ?I8^UB[9&PQJW@QTC/+*ZN]$KQK[;N!4%KB$PQ_$2
M:C5=D% <NK JWM0N@T\89,I-30/F.Z[D,:6Q"(DCP-4_8V<"M_$2O[?+#H8Q
MEEM]T[6*#\0&W\[7LQKMEYTR8,FN#.Z!#L@ 8*X%D !-:$LG)J'%>/??_$T+
M@AQ&J]/JX@E#5=?J=@P53[>WR(P$YQN.X IV[S;37)-(Z3O:+U4:+UXO04_^
M^^VQ7VBNG_3]'U31SD,*RM5M$54;?5ACPL,FD=Z!W"A)VYV([_98^60CD4&G
M'9U?&()3#)WC_P+PITLWBZ_\?6LNWW>I\ZQ;K9W)39PQU]3.XUFZ*TRO2B?"
MY=B+D.R4CT+)MB'Q^O]*6_@1R8D#+K(P/041):FF%BP<HYG,++)DPM]V7+S!
MUFF:A8LMM?$%A1'L:,;:DPC<S+(1S6LW?2+]0[P^3;NW?$?/<ZA\4*=(&>&O
M],>#/5 @>6J0\R<_4W^PD$Z3G2,^01VJONJ7W]PI8O+/)%HYZ*.]PDK](O@H
MR;0 ET; A]P5.[$46*;S+.1#%CQ(YN^0YQAY_5":KD!T0KB8"!)9^'%K^!>D
M*L>(_ZQ1XL3W ER\N:E@A"85V7D1**T"G'H,S95'#+P/6;6Q)GO$Y3<^3-X<
MV2KDC)E>9-CY4Q[)Q^,7,O$H>^J1AD"9-;GXQ!=!Q@.B>IE&FD'V&M8MWR>$
MDJ'AS58]Z[(Y^^+3AN2YA[Q$-<;SV0?AE0^@X-[92QYYOLG=M\]_4GU*</TE
ML]=/;D)CU 'WS/='GF&Z\8>0G#.:@SMYH9]QG(<MK4;9/!"@:C9E\N^D$TJ#
MI96O??; X87(CQZ.WZ7_>(,8D+Y_[:!9/7G?MN[G=L'1/P"%8VS7IYB@T,]&
MG)[FL=PO AE@N"M*XJ\(,Y_89!=-,R@4P+#JC8^D989XW@ (I<JP>]>?7U7.
MZWS&5<-TW38UFBM)U4,/E! /=6M'<^3XM2MCT)2Q+KJD3GDC2Z)'+/W*C.8A
M%C1E.SKFDL=TL!VXJ#2PK<8KL(!I=X 0;^K);!_]6*ME0[B[-("XAU75A$W6
MARQ>UDG9!?_.V]]S]]*18:-9_[<DI]@RZ]N;_8QY*TR@S^LMKQ\/6HLM4@:$
M9%<G$U?C/*QPA"@=WUTU4>2Q5:K^3C NQ%/+;_]W1**2WJN&=HVS57Y^9YR=
MK[D_SP#=^$4Y"[1/-84WRB^%S&+-02S5E,8]4!R\(3-!%Q(T3).$M7(//I^%
M)T26T#H51T+<"]15V$8IX<$QL$]07,MCPA9"6T?U=0+UF^"$G67WZ\/KGM1W
M&Z:3YCVD<\YQ-2E5<FVY%2_4?5XWWB[,4SJ9BM= >BDJBAB9  6-5=>H8>W6
M&W<N -<[LVI2\?(..3GJ?:-%'A,*-OJ5#K&Y'MMW:0XX&\G"T#]1_0Q=0,6B
MY"^T$4JOO[^PR-%6/4(BN9GZC7%7YIT!@0*704%.?)^41;!EOBKOE@'U0X[;
MX8NE\=HZWBO3[TXY3_/."Q'2ZBIKBIE(64\:9.]Z^X%_0:YWSQBD7@V-'_31
MJ3#5);@M_[V8%53&/+U$*VRXG3<Z4Y</R3M=86OXFZ6S+D]HB \0LKU&S-4&
MN?*\0X\^D@R8Z2>FNJF=>B-T+WG=E";PH663G/S[0@D'A)G79LX.7= 'M#YZ
M=9\;_ZUM5$>GO#ECJ@7P%=[&B35$R%Q!'Q5,D@^2PKAG4#:=!:.C'^;Z7S'A
MH)F.;@NIR!W8V?$M\M$99+0=N1U%"W*-\BMC!-M:>J9?[3O>I3 -KL=33KDZ
MQ@=]]H.H,'5]_@@];9EX,2W?N/<CUFZX(*SK5O6PK$F07F35'^ENY4)&U#3B
M87-BY#HSC6$FDGW(!VGO%N=Y%K9&C*#6O ?,@R=R-4;?W@V)4/&4+HD6S7Y<
M[&VL96@85K[8G>.L8ST@L9V5DD!;F-F8F=GXP%2HL:V\W=K4UIQGO+J&^&:1
M)Y;ZF.F?$N"7G&>%32\P/IX[DO+W]8D?%#O#@D"<7W&Z05MPF>5V'_> E(/5
M_Y:&/\,4,*!9\IPI09,4B*2RUD:R5XM5^66T[_G7<K7+FMF975_4=523E9-I
MQPQJGKN[N U:!E\Z<>:7Q+4(]$GT%)CMANGR(,^^F/EU#R14ZH<7LO&H/S:B
M?J"OE3$1_L-3'RX(530=O;[K\X)'0B],3CW074-&_L4*F1X\]YZ]X8WXQ_]S
MHA+:OEA>'1._ SDWJ\NI,V9G7G2]7R)]]Z2I8C-497;ZF7/*8H3G:4<HH:,N
M[V=4C3+_[G]/^'^^-%F#G!@Z(Q30@:SFE]H[:Y-\6 J_3Z[(57UY<+_-]:TF
M]:;*6[&3)9ZN/]S:/0\> &E@PH)9@[T8ML4>J LID =O*S'I*R-H$>ZK;UPC
M"AJRS\QHEJ<'BE@ 01+WK;9<I./ZY!""-UV/>[($'-'.?1?(U0DG,.>^U&7#
MLY%5W *!W!UJB1/;,T%=J)W##+O]3X(U-W*O#V1M$PLPK8T.%BCKW7?_OW-.
M?NGA71,ZF1342;PEZQ^D/NKWHGL($N0!^U>$'T0DL&_9J9XX89#N(B%!^Q)$
MJPDHT&_+(."0:)J=NJEM]6<W +W>@Y9I&%\SM<8^(!\6B" QC%O4B.5TRQOL
MX5Y=>07/3*'7D2%!3]< [7WYS;%7 P-<J)=J30T8XI+#!?1N]#[65QE%6=90
M=MMG=^O*+TL%Q66K4BXIM7/V-U^-WS&&(31M A]N=#_\,I::J9=(&5[7IZ6F
MM>!45&ML;5=(HS2^;D>C9[O@!GI04O4)9O8EO1E#^7(U(IV>;I'?HZTSX_,F
M0@&S*M?45_QE<W[H3%Q_'\-!S.J.9Y^&^>!#)3Z<\(X\56@W:0Y"10&J7 32
MK]ONZI\?59N!"+;G]<8;#=!70?N<B$VD^[;*64'RYC4U@>>_V*>&^M0L=LI.
MW\UB_E92!3O%EDEDKNZ[QK9,:+IL%TP1_#9V;SM&P>5-CEU@9> D2Z47.W[B
MB*]*B@6B5OKCO/*?S]PM72Y$6S'8FFX39:)A4=RF2@O'%_#@O@L%:UCJY$7L
M6EO.3,;%G*QU$:*RP*Z%K(^VXJDE4F *P -F":#:WV.FL21QVHMWJVE$!Z%=
MIS(*9N*Z=66!]\AA9_80=BLO_ZK'6$F7":RI%%EHES5CI3QVIO%CD[%SR/JK
MQJ\1>R#93U_0 _2F]14?=GM_002Y!_R9V.UB!-M/GC2]ZL^ GT".=<\<'YD%
MLED)&Q\$@5O-XZ%S$Z8B_B>63;0F/8H2XJ(9STE7SP*OEQR]8GYP;_!^8>OV
MN*-.LL-F5SF)#*$,FEV=[\//GO;T; Y="95:W.AZ6)!)69?Q]OB'D$_9'9WV
MLI!:UMP#^1NL84^![]K=WN7HOA./9KBNAC%*%!9+) 4J@G<P';8I_%CX\!$:
M#Z&HR/:/$UR I)OK+LXH=7:RX#TETBA]EB^_:A)U06BBK=FNR:;J+Y&B:\A.
MA>\N>8JBXRCKZ*I Q6-I7M%RHCG!F\X156.5U8X]W3G58_%N"U+5W>75#IRL
MS+7JC]A+:EW-RS=QA\J55'9#$]U>Z(@MY[(_$R:J??^I)1HQ7D@;""W>8XYM
M1K?_14(BSJ31]P\\JE#K?7V4I'-@_^F"N8TTTPGWL?+OT3)O9L^C%9"33#Z]
M%YY.ES>59%VUW0,]I70)SK&AO= 4QT"8WAC)^5 B@G25X0W;I,R8LE SY]CD
MIUM.S"]GO_(N="2^A1\KFVR$B\^<RXU6)#)6X4W\/($,$NS&[T3%L&7?"L2
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MZ-*UT>#H*GVNPO"QKDK8%&UZRNN+!VT0<6"HL;Z<_4.5)YG*(;%=5\M8$LY
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M56"DE=4UYH4<UE;5S?1)KJ)A6N>Y%'T'BY@NMH^%](;J*IW=MP?B/.+GF%]
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M=#4O]J?^F([^?QN+Y\\YL0_ZVZ:+'2&U#QKV-EF3ZR"CQ8H XE]ANOSL\21
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M\*S6456QZ>;03Z-7)P9(SG'G+X]N9<$$/(=]5&6ZM*G."\JYTF&^],D2V8W
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M[]AX"=E=%FD6M;8J5N.VSM>LCKCLWR5!3XJ:.NIZE89<B;KU]U#'(EU5F=>
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M+/J+#GH?Y$O\9>3GVN8*H6)^\A\H= ;/>3,S,;&(CE/ZM;L/VOX 5LY -Q_
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MGQD^WW G+;#7M>VD2\-GVE:L-,T!,=0AS7_WK+F^XDO4.>#;12=P#%,9+8B
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M#U8PX(DMOQ:T3WZ^5-R$DC?1LNA5'J/(R0P<-;)*@&FAB!S0*:8[K8"$2=2
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M8D2[/>W]=./>SIH34X!<KOJL70;@A3B4]RH7#7Q!G]B,=/Z("6R*L1W5<"F
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M/A@__FLJNQ]#S^: 1-$K#CW.K&@ QM" =JY SF%GD(\!#H@\_RL3ZG26"B7
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MU'UA[4FX _"G>@(.C,CJ6JMD.J?=JJ/Q(2(Z8TC*V7J%8;)-[&'82?99I"Q
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ML=M5$W@OM71_>*+H!'U6H-$H"$Y]RRCZD*O/S73..%A\,@_@<]&B7;0VE )
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MQS-W@+UP3'_% C"<B5PN=J$51 N,( H_?5RY@XM-JT]/\E+@=$_TR?$,2;?
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MD->$H^)TZ"I*%[X!"I"H[R?N8NIIH5&'T#N&.K=-6XQX\6[N!_X SV40[ZQ
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MVC(!2.SA-FTL=P'6<[1L&MT,T8O<+=,/#U:?E%/6AT5M)J1]C/YB=YS&@G;
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M'YH)B C^=<S.6:2J.4 (K47+@E;+FUP"7-8Z[,5;Y??GB#LI_@VL$>D,R[D
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M1@@*=J'"&@&BG_+/#\BR6ZSX!M8%0Y)9;2JD$05K>UI2[ )PA_A4]:$^ZP(
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M1OLXGBV_NU6N,";>SD!;_FB<Y5 IZ-5]'@Z__G]=-O;1% _!*KL*"UJ%NA<
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MW)KXX_=(%2Z6F(%CM?6U 8,1XZ--%Z3]8S)CW._#N)U&O?8A?.@_%I1T-?_
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M\Q'6)X-8,*AI]YRF4P8UN,;*2)O(%BO%- C22 >,)VX_&8D-PCH5%!<VN?A
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M\M2;B8V"STB.DR!"<25*XW/R9_79ZQK0P7UU3SN>T-XA0./Y+M5T5A-QN0R
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M9/Q 9#*W2OX \P$XG]PE=;@*Q@M(@3]KV\02M!:*^KN23'IT$$3&Z>^LO>!
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MQH2X[-741)\,(2\QK_;\EXF)+P/R;>16-V?C5"4CD&J6H&BKZ!Y#=)H-4(+
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MK2_TFW;1GRSH_I7A</D&+8'5"#;(J-&7->X*US4(<3%ZXMZJ3D.\PR^TW!*
M%<5T"@FV%,DSXQ3T9(T3Q<<WNF%_MO R'_-@D@5]^_$I_[++J C.]8UV#F6(
M-&K54@OK&F0^5D4TJV\BOF7M%_?3SEAYO/+S7JB_C+_I]!\+[2-A*'*0W_'7
M0!MG96Q<X,/7BF?I.<?X;I5@U%!XCC&6E)3%?N9GF2Z4\$_S^E><M,B!FZ%U
M;74&";HY/FY 0*=6SKL/OG)2R?FY(E)P^:$F$S3U&M^5)=>MT=L)2Z(T9G48
MRHENI-EFKCC%_U%?Y%9,7$?HSHQV_ABU-AV_14]@OO?I8E6]?N3O[#$*^=PR
M&&A/)\40#R\H-13YO[@Y7[]HUCPSLTZHRPHL8['(ZQ\)D55#NMX^\PV"JQLY
M4\X6T.Z0C##U&MD"I1O%2A>L-/46+D 9YQAAJ@S'HS=*3QA5.%Z(/EOAIMKO
MYCQ:8R(<LW@]D^N&IN56N/TER$FK./:@I2[8W,_EP0/(,\TF-WB!76$L6-M&
M4SQ":9A-HR!!J;"WH"4J7MR_>:^ QYUF)K3K3J+BN1\3^1(4&%'T;1Y>0M8N
MUXG54%271G?YT;8 @5-PA+KT;O)(?<CY/O6SAD1Q-Y8\U0UY0I'%!F''J(),
M241AU,2??O7AJV+OYCN*+C!,VKS8&T_0)ES"*>= ZJ0FKXG)1?B[/%[J+OZ0
M#R5_9;IYPRV<W]\T.%3J?_OG3RXH>>H$1@O;X8\-5C$3H+?*[FX]1WL@A*=%
ME@Q-?EYCY]1.M,2;D"K;>+<.!WDI&68J.-M\[/=UG(4P[C(B1IVO].*WLH_O
M4@Q76MF6FGX&;:!(N)32J)EC2)V(XNY=ED#T"F=K$+_\V^T:M!-M:1V6R2I^
MN;"3C6EY ;1TGYUO/\'#Q1/76K)D>]D#3HM7R^BGD[XY5:';["$D\O>N:1YE
M;+"SY C#&^/A=J"P^(SS :#*U;V+4^,A0$4EOGH^WT^OZ?,D*(+_;)O-U;TA
M& W%&S9T:<4XRB8:+^^S,RM\'@&_.JGK$-X&8D(R@X5_.$Q[P<8J9Z>7B5U#
MR[$7>@U[+0V5I@"YH,M#XE&O1IZ,N(A8[)LU1JDO#DTL%(N^E'T["U9'*_\/
M+GB(X,(;HMM;V6L 91JGT&X&G)O&[05F87SYV01L$)OMZ^[,+R[)BKD=7#:P
MM\N!_+"=G 5M<.INHQ%^!\F)K_UX]:1OTU9H@[Z]58G1@#>+<?PA@14#?&]0
MT85VLFW8ZC*6SV1[=2?P%5YM/.TPR% MX(D?$4D-<</E[68;;(3ZD:WB_<^8
M:C*B'=M2N73Q)%B !.\ KU&G=3GONUWQS]P(R>^9)<H[SWB83R;IZV8=C2^G
MQ%XB.(:G)7K7V6H-:%6[V9%A1F7:'VOE%EXYQ(RLJ#I0DL+<7/C0,;5J57E&
MJP=[*@GJTL*GWP1B*E#UEWC_,L3:<+%\D>LG\?'@@N: ^$D@QY,6VGH[QJ"B
M N72<R'4H)N9@OPP^O"(U<:&[IO_N-RI,9CX@!%/45#$5^N&[+W,S4HH ?&1
M\90@9(I$T[8KH[PQ)H!15_MI8(H-WG6QXM8<1;%5IK0\6A./95.4+S^J<B[W
MF3.=U*%?4=+_.EJBQ7 -%&I-;I8\JUR$AI:6P2UB,PGE(:-FT?=J*D(>_@.;
M;RXIPN[*;V1A2OTC3S0T-I@UO!U 1 6'R_USZZ+Z/X/*/4MX?KUX/XP7/]T/
MI MXS)> +Z\;[<U;%1\($+K-J>X?]>=!$NU36F78OM9H%?B+N1*%$:]K8AIO
M*'G)S1<Z?I4>\:R6M!B0XYKT40[T %\@X[3?:^\S+Z(+OJ%B2<-V..1PY<)(
M+N*_M9G0OLKB,AX46F#F9J+=H_]@X)E3D>>(6Q0EQO=GVYJEVN?+@EF(G,AJ
MZZ7(0WA+A 8"V=Y61D($^B_ G$>_#L031&: Q]V2 [S0ISR!T)97DOT#)#V.
MBHM5@,E.*+:W(KRZW'MC0TV<'5<4/H"]],D$U57[^"[/PH9GD6PAX;Q^R+AO
M X6,LV\:GB7[S$4&F5RH@.N0^FJ?(4]1,A^2LQGY;(VS_\S^%/PZ%L#TJ=4G
M]R 4!5P@D1_.!L6)-0&<^Q;)QD9T1M'/?)A@Y8 L!RSZZ9T68PV\Y4J\2I?J
M"8:A"4@^Y#P,%6_KH_\@HI'&48K3?!9R].L1+EAI?HIW!9P@WD,G3T> Y#"?
M[:?O-:,=:D,*0W-MY ?YD)[HVA(E)MJIHCNL-JA$[MV(,<&BU[N]/ND;9^J/
MDE5G<D/^_I-O;7H,=3HY;QBEB56ZLDF6.Q,)>R\]U[YTH=E$:_"2\>S#^9C]
MD^>O>P08T_&$G^R48HNP2-G"B.J1=+><G(A9^6#3=J8% Y8_%20N:=W[/^<2
M^#H8RO]7P67\MM01D4-%KSH+E]RZEV_4@3%D&L_=QAH$(TDXT&)TQE9YF,,/
M!XWN5KBRJ/9RF!-GB'5T6NWO"OXM50N S8OO"$?)KE(MHC)/\@.[*'M0#V![
M%E1-7K<PT,JW.>_6,T(&1=:/.!,&G4(WWF!=W9E99NV9NA7C\I;&QL(KHF0^
M>$E#Z(\B]DCP.RHM0BU1C>="&?LA0=&]W;C=J/[>'LH.$THZ"_9DEJ>9^:VW
M&PLJ&9V=[BFH6&2II1KK0(^OM87\T,:_(R>=Q@;L_EZA_E--VF:'Z"3 D"38
M,\FJIOB);O% 26)U**#VGE*?R$QNM>3Z&@QUE<C&N_/W=ACNF(^*'IQ-)*-"
MUZPAGF3ZJ:;7-&2DLMXSXYI8+P_32\>)2AYL[]#?A-'IQ\UIU&E\6I5+>AF4
M%'CPGJ*,4FA88<6 YX6\"P.<2JXZVT1N%M] ^-Y-=W2OKL(;!'7C7<)#AR9;
M;^DCR@GWB/BE7XW8@HAC&^SL.6?^:2ZQ8RAY@),N[>M%U>=B4R?W\PJ!]&OM
MA^Z3]?<MLB;^9BP9[GJ@[#,(7E;8V&%V[JK01\6NA>_$+D@4&94#]*ZI(^C]
M[*F]\(U".UPIJMZ7'Y6\EG5PT4O\^],[G^Y'%,=<']%?:[-;]<G+MS[%^K@0
M3-8Y[M:G>6<WQ@Y]B8&]9W@,\PFK:O4;SU"\GZBVG,@'4YW8D-VB&'[L<E8G
M3!J0[N!>Y1D4L)'2P,[.$EU@F#@>S++:M$\TAJM8K'1.@4A$F?G# W<*_\UQ
M8PPR6!@75-*&*TZ\+[X<%7@CQX-V!BTCC'2>)LCVK'H+_?!LYP,#O18?RU2S
M36K@SPBB+:55KY$=L&"Z_K_/G >K=*\0&]1.5Z1D*JS#AXMON>S)N.FQ65^(
MSTQTZ"G7IA,L1D:L"P6AK;^_D?M6;7OIXS.C;L=#\/SSCO(:BJH8'WJ8L_F%
M5_TBU@^S_YAZ[;/K8:6B&$"1DZ4"$QGRF#U9"9.G@&<5UDO1.&H;B&,6OXY4
M":8%5Z^\ZL6RE67N<6'U,;LS[=I\,FQ,R3>_?#R]KRO2YAB0/ U2#E'5I:&/
M<R4\UW*#9]!DEF2%K 3\NU@&E%<HRZY\8>NV% A5/>38UM+$$S3MZ5TE%?M9
M6@("4V$D*PSPDD2CV58A1@HS@*M?61KD*PN0@._T5!).SD:B1;&[24.)D]J\
M@(S\/,ZVU&$;0E3-+;^@Z*G4E^ZUP%CDR&OQ2!LB>EO*O>E=/@U>B5NBAYSS
MC88\$46]%+_'\MQ@3S!F?$L5PVGL<KK0'%7$E9L=S![MLS$6?[!1&HG$*8QY
M*Z=,#BUO#OU]JI41JC#I&OD*CE&GLV."3WB7?SY3G1A]A)!0XQ=><UG>REJ)
MQ%;*"YD.N1[)#0DOG,E7(-70'1J/TXJU=-0KEYFY6@-NYQP<"Y^7:8YX>-AX
M5?NXZ(+@59K9F'FA\J]F$SOY&"*' @(@/9-'^'9MT]8N*HJ]2EK):(<R.)02
M;U+TKQ]GRH'O5U0Y^642%>5>LN]KB;*,G[)EU6W[IZ?N>MYF>GWS$LF&L^LH
M;-R8VSAW;]:?ISFXY4 N43)94X<-\(UC#^EHEQ&;<;:/;5->R7>$"?HD\N7"
MJ.GJ,4X]SF=$8=_A0>-Z<2&SX$G905/==M5B"%Q)7D7+K4_'I;C,HX=U(<;6
MQG[T!+&JS=R\TPB>UQ?N\S:ZYB>+N?0]+DV[[L[_[G+Z__%J]P?DA9JB<UNX
M=366HBN/P$P570$'8]/%YX%A_E$7/GDTL3;X+R"YUQUBVE0ZY^FIJCI,4]N/
M(]^R158N.M=-_:N)0IKX=+U7<W&%7B)#_ZIR.9I[V_NB1]I#]QM?\=+;4DG!
M#@_OONLFL9Q[!+%UM>+UTA]:2U'"HVCYK>36HYR5'2*%K*[ZX'83/GE;*M.D
MS:E'*;.@!IX5%1D8B/\\]QH6'*V9*(N*^N-M_>&@?"/H4'@HTVO#S(M9$,54
ME'V$H(B.F@EB&K<*16#AV;H6_I\HKPZ*0FC[!4"M]V'[63H)EX;9#Y0:U!/@
MGJJZO*'4"+#,?+1OGB#1@%(U-M>#!?E*QSCDU6&8L4J3S#F$_/!6:8:@GK!>
M/3E*@'HLW)A%TVOLC#)T^KY_.>T6YA3J;4R''ET*UG[UPS[_7.X=PLLGA0^<
M&-TV&UY@,%IF6VK7/.#/5LO$'=B6"C8\+%&?Y1@#T1W S@J&8*_(B_R G'*@
M?IEE]L1*A8 RP!Z:FC=M/S2\EF%TF7:FU980PO)MC*]%ZUD/I9CLCP0?\85W
MW(D#(P%%X1F1Y1;."BF\B!)V6.#35]:S6/:<6]M2\NA(!,?7_FH[/6+HR"UI
MNCX^\38]0N74 M7>\-6M__3)\,%0GJ6V4G)^G,6F2YI'V.?F?M<:OP=/JBZE
M9Z;9]!=[^<F-W,F^GNAMWJ.CH;!42]I'PRL\_S/'[0&$:)26'O6=DXTD^D*R
MVE4Q5,GX;-302L 43[Z,#\ZP419_LK$"\O@[>S=A&2;.%@N+0B=.X9@!I3*H
MH'E/.GO,>%D+@K!A(4&MZ5&$^4;M1@C!]Y;]P3?HXDC)O0*WGIL0=P>+I?C$
M'A"+PC%,MM)1?;JWLT9-%>W_FKG4?H U;W/RTWIO ^#[TBQN64)(FE7^I3Z
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MN(240\,*<VE%;NFW^L\[7*@LPN\]UM']H.=+#2PJS]L;'QE0L5(/K^(U=H(
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MA$\P_OPB37 LU+"L1>B6!F/=7!PN&*V>3#9[RXAI7=O*'?<D?9DW## ST;+
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MG,6BRAU^P3Z=X44.&K9]1&@8#UU>&)]H7YI"Q/T?OCX!VA[[7U!+ P04
M" #6.V5:6UI)X0IS P"(L@, $P   &EM9S$X,3 Q,C(T-U\Q,BYJ<&?LNGDX
ME'_\_ZM5A219(J92R9Z0;3*?%H20?3=)80@)&8R93UG&[E.*(B9)0Y:QKV/$
M&,J:/<1L'\I^W\ET9\;X^9QSKM_YY_QQKO/]]]QSO?^ZW]=]7<_[_7H]7\_'
M?<WVUVV&P!%S$S,3@5V[=PG<WOD);$\+7!/8]3^\_GO(__09N[8_"H@=V&VV
M=W3/KM,"N\5V[1';M=TI !,0V+7O_]P@\']=NW;OV;MOO^"!@X>$=C;4'1'8
MO6O/GMU[]^S;MW?OSMV8G?L">\7V'3VE>66_N(V7X.F08Q<?/RTXH'"UJEW"
M=@@XHW7GX9.#AR2EI(_+G#VG>%Y)65OGDJZ>OL&UZ\8FIC?,S.WL'1R=G%U<
MO>_>\_'U0_F'AH4_BD!'1L7&Q2?@$Y.2GV4^?Y&5_?)5SMO"=T7OB<4E'ZIK
M:NOJ&QJ;FCNHG;2N[D^?>X9'1L?&)[Y.3C%9['_GYK__6%@$?Z[_VN#\AOYL
M_J=KE\">_RW]_U&7V(ZNW7OW[MDK^)^N7;LC_ML@MG??*<W]1Z_8"'J%B)^^
M^/C L:M/"ZK:#RIHV0(2=QX.'9(\H\T\"_XG[?]0]O].V)/_3\K^M[#_6]>4
M@/">73N'MT=, "' YY]_FRSP_Z__^9K'^% NXH0"2@ .3G@:/5G[!Y_@"^95
ME$8S_>H\C08V5]XG11(71Q;8\^N%(VN!%=:R9]U/\,,4:23HO!#_2S:LYF/;
M5CH^,9 OXL+S#41#BFPGCI;?1/XE"F" VHV 7&!!,CE(Y\ML_=CEA&%C&XW7
MAYP65C P0=Z[);MM@1K1+]L"&V_(USP@)9KIT2+S-*N;E\VKPE%=@5;J!_TW
MYFJPJQ,1B!.@VZ[4TA2&/V2DP,)D<RU2JZU.=-M\6B^S<L-WSC4N1N9A3&L+
M3<#-4:+)<^]DQ])##U)/CP9C@[ZS!U<<V-9ILVI;^7P)5_Y E%,J101C *$J
M>,X@HO.&T<D9/\H9$)^N?4#'[2OE.&1W%=S_BG4 KN"E7>!F-U8GY^.A-WB/
MN!BQ>_/GZ. /^O$V/U)BVVZL#$]]F'>%*7H0O<[)@5I9%CC\K!"@^'C#PY/Z
M,8>8LCJ7W3>>ZPS*E;G6$Q@KN[LLC;CNS_Z<;C*K**SF!I9G]E>X1 JNB#.V
M!;Y^9^MFP!U([CST"'\7?Q@F**;MMBV09 0#<WAZ8#=^K^3!T@5PR36H)>3M
M-#3=P9KZ>7S?W)M\V5*DUHTJ4.+#NW&0]]@;S& 9D1@X2!&VD@'.C_K+'X>"
M05W6ML 3RDEH@&WV4[4(^-T9K<<38Y"2FRN2[@7/3[I-&Q<,8G0LHG<%Z4BK
MKC(/7JKQ$N;GJ9Y5O?Y@Q%[A0(>FPX4-)?M"QWHEQM)XH;3#_-:&\#W72S:Q
M\>;^[TX=>,>V129\GST9(GK@3N.$2FF77E\O+*.3%:(/DYZ#&S\'-40?#.ZR
M!0WCT$Z)X"N2*%D.\DXFZS)GSSZODNX;2$"]\-5+)6CWK0O?NWE3,])*:D.0
M^6U;H)Y&3.7I2]&XB,E<5V#_NZE4HS,MD"OVG!]%"2 G%2PZ-7OTE\E?)(]I
M#XJCU@.RIK IZ*&\H_SS=6=&"T>F9*-?,GYO"\@MYBL/8>18EDX?9Z52NO(O
M5 T'$0%ZO.^X*AD17!&PZ]*D\[<EU\>2.8&E?3T3NK:KFA^?19J=Z=(.AC=#
M,T AK<T;L*9N"Z0CA>DLP8Q?,P^I3+8?]B1 3P]NJ_,"ND@55-(T%& Y]G7)
M("C)^[U[0(3*95K^JTB1MU][B]O5-BHSTX"\!AKRB8%U&O8D?QA7VQU/C@:V
M!:X _S:_Z!SBG1CF2]&8C[W/-[:,^8YJDZ2@M]^=UU<>5]</L:K<<G.;WJ1_
M<O?HE2BCV+.5>K3R#+3]S^X3UJCJ[' N6I&Q$B,*2D5$/<2.9V:K%49E!V^*
MJW<S'[Z65%3M6<]79+GGM/1]\,'$&)UEE$T<_%B=X( OUYN7_C:M366SBF^%
MU6#@\J:=QRI_=GWX2K-6R9,Y1I9!3BER"B$$V,"PIM*G5*B(/>'(@_PO,O6%
MS,N"]I"^8KI:.$D073\P.S!O&/@ W6M#KI_XU22RT=I$'KE?2[P](77O%%?U
M4E1"?B&XSB% =: NVS0><8\NQ).*;=\6V!U>P B,[MP6."Z85K&*"07/C7=<
M-G4#)N++R8HE?O6;9^L3?&-ODD?KDH*_S)@%1LOH%#$L@I4APYUJ/H@=W1:
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M 8@X;952:>Q)U--9ZP\_9(CQ85L7-R, 9D1..#EMY6[\G6<A,FO)GAQVY[:
M)/8"Q@7*8ZSA$6(K%$D(P53Z\DMEQ76D0T8T)7Q0'$UUKHHQ_WDII3/DF_.D
M7[.JN6J1!;I\+2AH+-E=FA &.VJ],^8-- 1X2F,[=9 7X3ZZ+> O=PXA@+OS
M8_-2%1MYK%V]Y9&V,QP90%K(/Y/K"'">OJ'=U[D6QE%Z/VD,?S3>GI:QFKFH
M(8)>[T#4-'0CIP[WLMX7AC #82R3%N:@/%JE,R(GJ"2T<.G+X+MO5\I0C@VN
M,?&?^*,C.B* 6OH('"S4COZ4VO^'?A@T]A^K7MX?0I-.11QP&D _HD3DW^,K
M^+X:\(@GIC.P9TI-U3M#YA4DLN?_&&E(=+ZZ)"N6>[>J\S8 '6I\G2UB(>Z9
M%6V@P\_5ZCEEE:\H_J1':71@@:%E@!9ND^B8Q I*N**Q)WN\X Y&)XI,Q9]T
M?2E\X;UDV^X]HVI\\Z:2]^+ "_VYGB*C=28AT4B==P^**5W(AAW)91([D0E(
M<;(-\+TK_R1 CX?K5'R%\I<Z@&G1VND%[/E*2DUEP^BI,6WNNEJR,1=Z=T35
ML28%70D7+^?=KMQZ5T&1\\?)D,@XQN!NZ+"U!,8\QK?=:#<PUII55-%]QDAR
MZ%0KP(E'18M\K0\'5=?-8O;5+' &Q;-.L9]-?/2PA L"5#:N._@X2FI6=@0>
M"HJS1&F]*FJV!^_7/6;$!M_/ETE>[/&->/+;)KUG?GY(1OI=,W^T'CUL$1GH
MT;##/J)[_*5@0CK; K+0F&)L%ZYV?T$IM$0SMJ>%$E'84\D!P2(_.._OWKL1
M-BAJL8_V]C/J>'T./R#RU-.3MO2 9]2+ T1FG;3/:ZOU2<8BZ!B:1#@6HBZ3
MH!+_\-#8A::]6JIO]1-DE?)5DJO"?SJEHE]7.V@)2\*,\NZYEODZH/7^>#T0
M8WUXUCXGI)&&O@O)W.JYF#-V_KO^\U-N%]'N]RO'0JH*,X>(+Y7ENR4+$SKM
M>PLM.T3^6A?1Z$+6!G=FQ,LK;!60%4!%,Z B0QKT3>2) 17(O7ZN]7DED&E'
M]E2<V!24V1EQRX)U=D*G-/ <^**V9+F\H#'ZZCYRQ%&:[TI65 8-F98O!H6R
M-?#T(]KT>$]I4./)?<R54LM@IINH)+H"*>:O^?&[63V^\VGOFYU6"5ZCSO[1
M;?A=0\IZ2MUS]LL?7^9:E[4(1FTK9R/C;_[Y6)=Z:(R9IM%-V5T)1>^/+9L-
M\#PWMI%FYYY!_=TL_(CC(V)Z8S2!A-)L;6@*<S[=G"5^<>OEMS6HAE765H-H
M7XM%[#HUKDT0XEE,\,2(QB50*7(]DTH05:W86]@IPUNY/Q$:(%.4_WXS+0M/
M1/']6EKKI":$@OU.U37^(6>G/"2?L\/WK?-56<*.2+N_'[KCY*]F2_H> U_A
M$M&O1_99B_S#_$"]2!UCWJ=J=CD,7'!^G;DKZ7/E2XS1?OS$>>8#^P^.V:49
MGT->5+VX\"K((FN(9IJD"07)/?_I+OSC#OI.UN':Q7D=+U4U9U]I=YT#MP.&
MNEDH[R6'TJ22944G,3T[Y%_8/L)13""[585E\IB]-*/K"0IVT)/R3T/1NBF_
M4J1_3<,DC-]I6\N_X4@R[Y?K'."-IZ_.?O9^HI?V_HZX=G7_KQG,#%=S$;8O
MD'<((P$$=%W*UX[M2 L.9Y5[&8U.Y1>1T$EKZHH3X245Y4P4J2XW16CB)KQC
M=G9<12=$A'QR2P%)AB+@#E:'F OLT->Z1^[,'OSPY[VX%C'O2XFM7O)0EH3O
ML>\V/G47IW$^3GV^^HY=3NVCG4[8V:+KV-!.L.C$MH"6_06)AU-&,P9H\Z_Z
M]S84!,US'?+WVZ2T=TOARD<ZNI2/*4W$&^!:4J\FGR?5PH^0"$:&T]BQ" 20
MO"U O1B JYG/J.&&\L5QD"=?"LI@6=>N\KNW!>*"^6)(R(FO 1"_DO.:MP4X
MWSEMT_R1^1_; K>Y&D^C.80W/TJ)NE;^_A=RT[:FGMK%-@<X]YH&S"!],G\$
M7"TM<-1Q,'!PUV_M^<5V?-[TEKUFE]VBX@E2ALTM[#,^X2:M.?E;33L#X,@7
MG/^V0)(MOT<2N4=M&:NZ-*L)X!]C83R?6%9?,ZPC$-?M*35V"NCGE(/7/(&.
MQ:FL0D:31MBOULK6I.6*9Y-#ZM.8&/IR.=C"6=\J@BL!V>R?+MCN'-&/&4D-
MXU,SW4\"<UF<(M#M"B 4D.T:LVG*#@AT9;>[9J??O[],5+3([C#P>=E<'&AX
MBSQRIJ'IY\\VQDLC):#M\;8 XV7^7I"4MOJLMQTKVK!%Y-FQN)/:2RMW#*V%
M(-Q_'_O<D,TQBC=K1G74;-1^E5HTN5F-+&N02 XB=45Y?3^[A7B6H"WL";V:
MD&)T@!>P+?#$G_^E.;RS[821 21*E?F]C&<0$EV1.SY!./;+6L:C7[*M#!W*
M_#>JB-_""+2X89IC:6$WPG%!/PJ8]C 8IE-W'R@+HCRQ1SEVSDO[H_WM%TVE
M7!,D2ZGZ7B\,+E;DR63&;HVYF#ZS$#O?7R0:,Y+R?+ Y2THTI4^KCY* 3*!.
M%+VZ4QGYZ.S<>LG?:2=4P61GUPU4SU?WF^QE?U-9/<>0M&,?S.-U#3)^*7;1
MZQ171$!K3@J$Y^IANRA'(0MMPA[MF4/(-/IQO@%,:M%H]Q#<@942O"(BSIR(
M(^LPY"Q,QS%76-HC"CE+SI3&B3+5VE>%+;7-#>G1*C9E,6[ :2[G'X(I*)&Q
MHE: .5T%FKPJ[Q;%DZ\ 2 ?0LCN.[,1<^+7D0OO5+)7*-#H)#)3>*Y;M->P5
M2K-VJG_A>/S^6E'2S1'L?7X/70PCQKW(GX8UT-L)Z9Y*P$Y!9QS!W(9:WO._
M$ YNT&47.?+RPY33D"RMV?A+<RW :2T=1'G%(&*#3P9>C#GCGM+HXV$3>#)+
M[1+_!G86)"1C++BF+H.^7#GL!$*8?+P88P0*YSAUQ@180*',M2EQ\\:64>U<
MPRU=ZLH93P. DEOH[WBA1R/(=<1VE#@=5I^=-5Y-&Y173O4Z?RM>QKYR6\"I
M8W1S>6$\;\95^X-5V8?A-+.' V5%QE<O/#_U3M_A1H_OTU=>ITSL*\,J&^]?
MVL6H7K[:OW2KRWX^2^'@U=:;-T$]M%-N_'U+,V:A^3%?J^P6B\FN,D6'1S"8
M3O!4CBQI[P]8C48\]LB,=?FV0(=%*!N9B)#1L3[2%H\1"7S7_FZG65'CL\)
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M.Z)7]!RM(K&)BQ-U#PA8WDTJY.S47Y:'6S0UT**<5#MF4*Z<Z45S0+ !9WV
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MDTY;$EK)-G[)4-.).F9IJ(YP=@L] $DG/A_K=2FSY])73&+_&K0QJ%24E&\
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M_!VT"Z>6E[A4T*Q?J (9CMG+*@6\92FFGTG4VRDB3ZBSG%XY,Z2:?O4><KU
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MN_Q(V./F&57 5;=SQF5BKR69=4XG</+%KP>HW(-(@.)%OX@2'E-5H?@)H6R
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M.DRPODZ?.!$-<W.Z9,A3^;MB:Z/'T%!-S*O7T$ M.#0S$7())0A$5\TANB&
M 76P7W E54>DH)'"=0II36C'%-O7AP6V3 9A9 YVSKX>0%I)__N T'!.4FW>
MX:>=^$Z28JRB:KC,+G["ZYAE5L736BN\]%"U'?ZO/+;1;7PE>NOI!'/H'/8[
M\8S/CU-\F2M)S=6ZYI7JQ7FKDY"S/XBQ@'EP\B!"^'U#8E7TLV")&-O,,8)[
MQ"_E.J-S,17VM\=-CUE\JR^9%B@NY)70_UJ,F]EK1,A30SXO119R[FM,,T$,
M4<!^V<==-QUD30W![[(B/<P#\P7OO-O=<[S9MYWQ--C XNN#MT.U%V^)4@A.
M0M3=1%5C?;R3_#=5^#5D@/4K>^]%$(TWW17S,Z?LXSMQWL/D],J>(.<PE@S-
ME2L./7(N#\<.=BS%O+M-6H^:(6=[J,90SP@>[\4;5$D<8I1_HYMC#&Q AK)[
MAXPCDRG&4_OR5Y?LQP+KSDLFJ-EVWL4LK LFYF@?+92E$UJF^Q";LBPTV4U^
MLO]5\TB,G7?@>J5^01G,"^)A>*5Y=4W!H$U/ [WIY8EB0D&?.V^\*;#,MB+5
M"GZE";@'Y9)O9WU8^6MB>I22$7X_)CR+8OGPV^"'%0"^_:@]V3FN]VO^N?UY
M-:U&]+12>&_L5AW]]KKUM%UY)ET3=7XB2%Y]9_&8Q63R&>0R2KNQ^V-W8[:"
MO.*SVFW&79%>S *&X#_J%W#VW?#9L=)ZK?9J3FP?]#R$"Z4[6=-<^!9Z"2((
M;-I,F&GN;5OW0<Y1L7'[LA?)_PY>M84C7CKN3U7I2ROK?302+(UJ?]6OED2#
M48Y9<-!(+)=<MPSC$>T%@/BLE=27@G"K2^(BY'QK*X2WINX^U)T :Y=L$+_0
M'3O-#$7V]A_R//SD:?,*-4K&;N/I\HS+;=3\.L(Q2[PITC="&#"'T?JC4Z$7
M@&,6.'.*6OOAMW[%!HFA1G)TN:M96\ :977XQLX)O3UH+R6 <6;'-17)^/=-
MI07=,'F<]#+5EU7KXYMXG[8*/C.E6=4?J9[4 /!@3P$?SCU+>.TVM3_VN>9+
M6SVW_">_P=:75C0-KP5<FOKY0Y,QP15?&5MBDJ'5)6PL7,*3$.4:AS'L HL8
MC.0_Z$Z:9MP@0;F1:#@KD(9CBM N1%>T1H[[<2!>2N16(]$(^R>11**C()-(
M,4E=G-?GC^1K42)<.>M=9"VPR KX4W^3R@LA:=2USTYLU//I05!B;=/H6<!>
MAUI;&/#BU&ERF/RE/AS1Z[.[:."[IBP7C2<Y?XES!WM'J7YH0024KP:MO*[!
M/$W=J2OS1%^?K %K4XP6[.]/JLTG"02E7"0"OG[\ZQDO\^(/#NS*=EZ?S]2>
M-R?J(WTQJS'0(H7N6X#H((F Y5/HU/'BPF>!^=$W#,@9\5NS*1<B7%(N)_GX
M3,\VL]X(%T[XOEW2B%C7D5,B-@_*2=X9ZQU/::PTXC91J1X8T+2,<K.5ZG:R
MO55F*7WOU^R M"YQ6+3;EE @M-96MXTJA"XG4D0R?_@/37MDN'_B=([O>3[U
MLJW]\A"D([K.KD5(#&-_+J5$&-X<<[K,04(AY\/:_8:8UCC4R=8*VA*]%I6H
MV%B4;<5W[PS!E:24N$!C#<?&ANFF3^Q$]WHO1)6]XSV?*J_Q1B/G#_?C0CS$
M^%ISU&]-UY:5KQ-'\B-*O0]X[6K3JF8=O=K+,ROM>L(KO.V"]J[:+7Z'SSKJ
MRS>OI*\T-<PMV,WKWN*[;'#+K(_6(?VW^YCE8.@H:Z\P^J3S9VI0#M\"_6(A
MRL9F,-8-XG#LV\!\."&NQ#ND'5).5'RC)B(ZUT?\MQD[L>/BUP $PY6O</R
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M>"W'*SQ:%]5*X2+.D9:BY?8Z!A7948]I7[U%6<>Z;SI*OD9Q!55'X* D#O2
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M4,0@GF!5E?KI$>TQ1M8J6"BDJC].Z.NMQY63@8N4W)[16,=S4WZ'2W_1Y8#
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M+-_FB,<RC_#?RN+P8^AX@G.596D"X5L%FYK,HS)FTVPAM:I^M0T+M*E*G'9
MJO/?>OHJYH;,/.:V^7$\YO\P\\S=>/!Z-7O\]HI^IN&-)TE"U^1__>J5?5<I
M/]S+S)3Y#R_URLG'#M$RQE?MBAW=%:4+B#(C(% Z_="? Y"=)\R\,$@"&ZZ
M..>!_!4\43J5,^YP-#[DA/W8:V_ O#5+KWW*SR0[NR:,[ZB\2G058[BS*J)5
MY#[-^/S):D SSS7OOKA1B)51:W'P8??V,*^0E>P]] L _;+?]'*9X)XE8:K*
M"E]HG_&6+*9*2N?Q/W$>^>D:F&Y<',AKE+U!=M6/-R!XGSMIR2-[CY7!TOE9
M_\WQS+6LLKRB[3C>K,JE'XV!O7M).^'=']V>.39!:IU4T;DJ$;ND7HCXQ'9C
MQN7O@+OU&-+6O=RSZ_J$NAS<6&Y5\[DVK!Y+Q**_8^FWYA8&4+(/+=:X/T3
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MNX5O9N?:X?&V[B-L?LS/X-1_L]7&(_?42C.A0ANSDRRWGI'FU,B,Z]F-@X@
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MIBFZWI,<H=##Z2*IXB/.D^D8A:9\S:5BJ2F6V+,RKX1R.D_XDN]2X308%9I
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M31J-+08#*LR[R4T@5J3NC#KHBK>F4'$IVAAKYQ5&^?GZ?9O55'F2N^M?GGL
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M?B*DR, P&FZB@\H&Q?IO+SAZ$-])$[47&Y9W15 ]YVI^=:B3?5D<IJ+XZ**
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M/>KF,NA)MP2] O$9V6LZAN%;'4[C&>R?U8Q<9Q?4FJ&1S=C;';/&Q@M3D:2
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MTVR^M[;6*9A@M8MS%^O3F[H'^6,BO!%B04@1#A3:@<0CD,"AD;?'068;0@7
MU'XJ*HQ%BOK8;ZOVGBE5ZY&:S0BY97+K[T,Y]D6I=C3WC:3R$\DW'0PDTP\W
M:&C >^AE=\LLFH.<>@RLLH*<*PWR8"+NK*8!V4$@\WZ13+?8RX4F#,7J971A
M,ND9R53@7']=OH+;[>E4WVM3<T8L)OL=\)$0M<<S_Q)UY+&AX<UVB@PH7>XB
MTA:UC#T;.]F1U5=Z-0B['("RHZ2?ZOEX][&CE,G!&[-Z@!(3CGN?L>]_?5#\
M_M9J"#DP"A!N(];QM;_^7I^QNH70G\ HEWS,(WB>?%GTSG%9:H\G#K89,:5K
M+IG8!BA\B.YB/]I],8^,WI?\!KW5O^B63RFG669[/,<PGL"D_7O0E:E:3A#(
M?;!"FST%JK_;I_9K!;,^@>7H@.]Y.&'G'S4?:7['/R4_J>U+[5\H?$*L"^6(
MIK;/U1DVMMZC@C$A]/*YJ#R1$;A )6H&M-4Q9LW%U+W>S!?[)YEL4B(LY'JV
MH;ENHM%G>]HY]U%(^O3ZZOL,+JD7/?G\%UDWE+X5%Y;F>"?8\KC^%J13)84/
MFI!V+C(8_Y_I>,XV/[I<T"Q8#6L:WV:-=IPH?3\5O<(X;2E@IT/\L\>3B_9@
M>(6ET D0LER/C['.OV1Y(%MCWN1N,+SD+ZG?N%J0BF^BX8,<,'8>^+)G>::O
M6!H"%SJ,H99"-QV^%.2)\MDU()+>]VZ$LBU!^U(,;+<&Z2Z0B_[$506+ #S#
ML@MZTA3YTBM]CZ<;(09.!A?!BT4Z+&;%ZX _+2E>HK3P!W?3+X4:!4*,=O[V
M(^[3OO"T-'M@#!/)TFK-.SG"/<XY1:3;MSD'2J ':0:\7226,*TYV[]1"WS4
M:S=6<6^<D=%IP!>_&5%>"7>M<0!3S;V\7YJ>@_PF=*-J(M!$=A9HN6,,1G3;
MY1W/IBO1 D]@D$-D".2Y^UC=%-1N"!-:L!3^-G0833")_31X%:&=0G]\;M.W
MH 5O;'J64FTZ:##ZSVX>;IY(Y*4(HZ5V:,039"U@A;G'DQB".KF"4!KCG@*W
MZ,B8!SKQ,[8IG\Z.JC,G/5DAWXMBWM3H'3@T<>^YZY6M6Q2'4^F_;/7O8CSH
M\.L>IBFLBU7(W?OXP]_^B$O_]6K>GR:6[J$)#^W &.=<CY6'QA2EJT@(%ER\
M;LLG:'YCHMUKO)3.M!WJ>.?J "L,C9,PRZ+&Z,O@E5W^0HKH)R:PIDC'O5[?
M;!+<4F]#V[1A(+27G7=^Y41B?C,VW$X13WC_%C.3E73?."9'NQOT\DTU6MF>
M0P.I.T9@*@/"$?&@5X^NKT-LWH-I=-+3/1X1Q:=%5.);--)H,J3RC/+;^%GG
MN'HA55/@4'/BO^K?FS]^:#9)=P[U:MZ98082Z+N)"(&E9F\:80K6CA*G>IF+
MMKH=:V+9$VP8QL_@%XO\I(IKJXSHY2<G, K(6+AI!7IZP[Z)2',:[T[(KQL+
M(/V$&RW>6,X*^3JRSD'\9VV;@P!2B#O700B*I88]!VJQ%ET242-8&2<TBGMB
MA1@3RI;*(T7FNX#.G5#@A;]P4%B^L]^3!G%[$9]T4[B!871X-"0],,(C9%&J
M>[_0F.*UP CJ62BN83*)1#D,S[(VGC?TIUOB?R??E+UTA=(X]MA<!2G1S_@<
M@J[;U?CUJ3W"%3&M&JFH6]-X>U1$W_W&^\X@[^C,XDL"&6HK_-%T,RC4"^/\
MVC,S'=4%FND&IP>9RQ#$XE,.DXY>B77',QX<+XONJ\DI\Y+)U+EFG:*8IT&1
MLWZ^T@KPC4B?^<2:ZJ7G=)]GKO:VFQ%H7PHO]003!#9D H46,7SQ#,SA8XY%
MQY#E"3VLG!,,=9DGIAT7=SY%DD2LTF0LCE8=Y$^Z5<KUVRW#A)0N$V5P\UE0
M$02$ ZLE4R<0LJ!1)Y</1);X3^O%U($9]G(RXX]1!QW0L8L6M4-U_H8&T\NR
MBA.[F^7F!D?47[QLGY9];[P=XKMS:YDHC)5>@8K@_*FQ.*!/RI.8H+W'(^1[
M'-?N'<@JW_%9?G+!U=DMC"J(048$%?_,F_TUN;JE*T2H#?ME*64NTDC@N.X^
MJP^4FN/V2U%IN)0,HL!OXE1BZ[92%!Q:@>)<',&><O,3HO>Z*H[>F%A77R=?
M>^.S%";C9/UQ_.VV7;Y'L%IG]/FNYXK;4?,XVGH*XB!*E) ,K8-Q8,7CQY(P
MNG- &?DTT,(]875/![461#CJ-BL4O'/_ZQ)>C^LXBJL)\J>N;4EC+R4V)=(X
MS&A]8^$K#9:O;>G+DK&B8AD#C3*>Y/OOT7F:_5I''> 96N5I"YAC96.?6'5!
M^CE>8?@^S?<HAQ@E&XB4ML*V,1XCR]@ZAHYGB,/$\ RU KS$W5])M+^R1VF@
M:R[ZSH8,!"]YS IU@6&6$AOQ$OUVQ6KP49\%'V\ZT*6EU*OBS&?=7/@T75X,
M^F*/QX\Z8TQ_T+@C@KD-9@/>7>J,2ZB3LU\XHD,ZMX<XU]XT@Z2.]..Y?K.J
M@:*^!KKY,MNH*%*(N=?L'W6ISU^<.V5$Z]OU$^>%HZ:)[=0I2W;%[@L80AIS
M S!.TH8FX([4"<>@I.S;W0R!C/BU36I<>!]@],YU.17]B+TLI&0NIT8&J@J]
M=RM<B^M'0FRC;N48:3?,55'KYE:)OCL6Z/+YM/5XCL<QXCPL1DXCNS/O-!B!
MC$FI]V=)F2B-2&KW6][&G? =6GJBZE'BME0CO.IJ9Q(0\O&:R=__%C[=+:3.
MY^%XL=IH>3-@G48ZQH'O$CFV;]$E9BQ9(@'."Y30[+;S8[LF;S5D&S='_?T!
M".D?3QN=I:$+7!V*ZME$[T?O3<Z:$OR?ZS/;.8GXAQQ87,=BDUICXDJ0_?:D
MQ5MDO4?J_ 8<PI8S,M;NNO7IT:</'^_GY?(1Z2OW,CWS43)+I=?)*M8E&P@E
MT)E9(A:4HI7R'BTGUK=!.@9\.00>J%<A?A9EP+O/]D-.!KDIG>ZM=N2&&>'?
M?S&V$>.6W06^6.9NW&[_;E6Q/,AOEQM.-=CC:;M#%IO?U6*'174UXV(PESR9
MT!,<=T"GF,IH<96VC.K(ZL_%1Y'=_3T\RU:"9JJ*(CR] SV\9>N+.OO2AP30
M25:J&OXKR&D(+5U.>?<9XJQO5LKZF5%VP >6VC7-)C\Y0<!,[OR(<]ZS$->C
M_:\)F;=%J.?%%J'UT%4K%H%=\'Z4 V-83I<]QN$GE.D!9J FXC#:Z\]95E[4
MF_ZW?FXJEL>=T"U&DP6N#Q;V>.S&["]']&SVG_<[,'#Z47KZAD9@]U=I!JF-
M\+FD"WH4;LMR0R5312CGEL.-6_=X8L-?084W WF^N%YF'3-4:G^2=Q1O!'R?
M* E\?!]^T9_QT<+<:R$L1*!4SJ'XV,3[NCRL/:%7ZQ@4P.%__=3LK=50_+?I
MSX+.^\< Q\JBBH\WDW'A"%U&<RK]<G1OH:5"49IMWJ4,J?>@"URYEP]N>V[L
M\<?[&^<&+Z3 MJ^SGH30NX)? D@QM+E,ME"F7==#=2?)8N^7\V"#8Y*?IZ.2
M^,+%L94@'<QV#+RL5Q5-?J)1Y..E#>@L7K/?,6+C6'*%3.B^0AWBN)9_,0\M
M1Y?0H33<B>4,^POD28A!RH?YK](V'YN:LNQ?FGAE+2P[*J2;R'Y[XAWJI4"H
MLH<"&^VWP(.M<H<!A;KVA;DVMV/ 8/2;IB,>HC1ZOWBO<<*=Z)?/;]?8'S%1
M;3F4X]5RE".J5QY+RO8* :RLVB;Z@NH?OK#Z9D6[W3&>>Z14.\>ZZ)S"?[I"
MU-035MQD:<SW.<@7[L$7/RPXW">JT19$7^V^+4DI?)YO";EH\6OQ$4DJ>6 ]
ML^7K+/W:2?N<B/]>Z.:+PXXZQ4RD[NAAAYPJ4__8-WNW"2=LQ[Q]\U[SJR-:
M&/6A$5,H+_2R*SG-TYV0]JP-FD&M[THN_@$%3(A1VUZI,D%3I&B<]\S781%K
MQKKMR&:_O37E4 ^LO]1/KS%T0*S/;TOPC(#$-6@U5@>H)Z3 I1ESO'X/6$N4
M\\# 1WK E:NW?J8C3HU4;68W7KTKEAOP\YNGW2E-'I&_^C$'@7)V6 OX>T?\
M![(6M7:BA',-L,L')E&IK4ZYWY_/^#3GE0<"HTXOX/*5:'NKR4WS8-,)N#R.
M/C$2H!;B?.G2FL'/2\ZOM7?F-MU5L,/TQN.>F<=$S_17@QFF0C2W<P^[(K+=
MEQ1LQ)S5T@5D+?8#I'265D<%KYE"N,Y)C27+"_F0P ?97!\6*3J8HM:G7X[_
ME7/2GZD_TUIE0'>)DG9M=A!$A F.*E?"6R#)WW+A)VN=)%.D18VG'U5<4\N
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M<CR]/J*48SE*49K!&(V/6M>1\P3*U9T[MAI$KGN@:@AGA&'+.'X_5&/@LT7
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MB)/6=BI>ZPO?28!]K6/*IE*-%%=SGV38ZQE7J(8XXR X=]#H?%OSIE+84 4
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M934[\',Q3AE_YEHU+7K(4QWV/3^2N3-D5M]&<?)1?<BZE''SN7(8+$TC/9X
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M\3S@HB&/ZCVD*HB:.<7"RQY^J&P#UW!.MFFR:E7&Q+HX1C5?Q4R<FHX.,U"
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MGWX0<DMV\L&".&^"P81RR]?T_H#$2"VP8N\TVQHIBJL=ZM?&'-^OTH#$+DB
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M:-\YF,C%KJBBJ:_TBJ8W31WQ!B3W:(4^TU<,$3Q&=$>HZQKX/D0!T7BT')'
MU.DBB5YAF1B>3+S+<>J8P:1 Q?D?EO^XV1 U$WUNLD_.SK\HSDLB\H']DRTF
MO8<NMV2F,Y' J&O@[&7XQA4!$=;8OD(%X$8MT'I+H/)[G9@L]\_-U2D"QXX^
M%.:J&1:HTBQ+&_E$L3WGX>%Q1;>E90X2:6 LP\YCF?> $DG[@WX017F^#9R6
MYYQ?C(1>>@I(D7A!)]885-(U@XEW:M]((Y'10H XN3V[&OX:$;FB-TDN]=_T
M&"NI4+RW^6/.A=#1U+;U&#/UTO?2+7W;EXPUJ:QOJS+=7Z^\8%5X-]TA7FZ1
MCP_)H!2II9+'R#X;;^J"8B_>"C\(Y$]>ZO,;G2<+QQ5=)3!B?EY 8L_UA>RW
M2'E/:KWTW(<7V<6[EG7O)U'I4\!#OH$D&6EK?,<[FW7N[5>Z:)J#DWJY>1;S
MS5LE$(- BCOW-O=5(5@FJ=NN\A6*-2["PL1A#Z%4R_-D>K )IGN!&*747W:P
MHP"K6PG$N0>#(+7&-M:IX\U;&PU1O<UX]W+\486G@4&JVB<QP1$WT**,!I=\
MJ2>(?*531$E)JU<C/5[5#D6>>2]\1 S#8992)P=%+"5F,P@^9SK**3M"CIRW
MQP_[Q54__?@0<8>\#_K<N=O[X7H(PNU#P<W1\BK&4G>9>GZ6U\%_YF)F*P]\
MTG]A?Z?@U]\$T<KZ.'L[-C1VXT^VRFC!KV<26^1<$QJ@_POR5.N!CK%ZT\2_
MQB;AWH'''G,CY/]JRJ8=&#GCH7S#=J#^'>F9!G,5@(S/S'7C.1.C>9ZF>M $
MHH22MN'2![]H.%_B2JF8WY9KN??% '#@EK?EK?A[WW(W+#6*L^&YMU,9UR[T
M#Z=9.OK;Z#:\3 XID-]0<<++53A8.E0[OJAR+*?$66:\^)Z?YZ>D?.+?!GN<
MO53&[*7<%]6?>^T*E;6[Q@J,;:1?G/%J.#9KEUIV$'AR+DY>JGC44K?H8-BL
M[ V5[T0]X"(;S73<+J_FR##,R5"0P%)X0QJH!/@,5!2HXG]X9ZWU;T,S83RL
M8RLEZGR(\5J*__V;R(6R'-_?BA@O!ET,B.B6UTJ(YZF]GB?*L']D25XIFS=5
M'%D.\Y"Q?CJ;$1%/MJ+<;6EH2L)EN^8:(93-LEU/JWM\*:A25_\NNPFX79+_
MLNSS0%KISA>DXAWK@)=N$LTY>L>-OR_89>'T$%>U*1DDPFKM(>R9;A;G<KF"
MQL";WX47E(9D7GY^QZCTYMSN-'B?U&=?=OP&PC-+;<"I-&N!\IB@?"_Y3-W%
MX?_/CN1\)"&P% 8ZAIXIW1%JUFWO?3.J*Z;1%3$ME]$W8\UUE;%BFY/%]RZU
MQ-],EF@R9RG>.YOEHV09<%@D&7;/CQ\#9X_WDX2).@BU?I+\:="?1-T U,4Q
M@0H$)6%E^,=XH< EHC@G*$WG&?\4#1%$19IPAI[AM_TL^;3A0!9[.[^]);/B
MJ_]FK.%87CD=$>6 CY]<R2&U(132R'<O:FL6W$(I_)'Z\=*]<JO8RL0^KS>/
M8D./]^^U(VJ_:)"J^%#S,*/K,^+EW>T64UE+?#7CS9<<2P<_7OUZQ0?.!-&*
ML:'N:F.D-]"8;EC2,Q&GJ>2>]K'$*=(4\NISM\]&20SY'NQSH>GE[+-WJ[Y;
MB6<Y]#/87^[X&NUI.,;1Y:,!+QS"N=M-X&I)R2*!K$$THS^1X%/'4P?T(ECB
MR;3@Q'"H")W>UY*Y. 8^N$(P\:X$H&3#CYO4]@AN>AG3Y.JL&2FX)F#3I',H
M<1V^M W:@[S!*>&9 W!-E#Z J>0A,IE-;LC;@$%X*=V%I\O.Z5Y2M'2PMK?T
M]LTVB!@ZA(DHA]ON*]P4/:#\]JU%"665%^C<W7X:+8+2],<>09D@]V(9D#@]
M\94#.4Q?/+NZM_#PR/J.D%2_;H2AQ\M&"E&#!V&CGNN7E XQ+;1F6SZO>[AY
M7#U#L>GHB-03-L5YL^BT_KX]+'?!/XLGNPG'Z*69.[2Q(Y((*FQI,?N>5D^1
M/*<LPL7:A?$=H2.FY[XL<-O'*AD]S9TQ3F_9)_%-[82MQP6XJ:LM]N/K1%A2
M]U@!TI(_U'>7\RJ4;/]I#?DA'J11LSCVR>M0G=3<(2YBU&KI0J_?D0$E^]1>
MUILOM\B+O^_#J>1[.T*)C8<.&XE"1)X)?$DJZ<) 4R*KFDT2__;RHV=T0MHA
ML)A#9>&0Z,'\LQ#-\.F#LH>/5Q>:)S[Z2M+L]_Z)KO/+.M<<\@I=*6"H"UI:
M2.&MOU"3T(.,EYW$/):+WW"QW%'M H'C2<1*\:2,)C/^R#9Y#K.5.<2'OOBG
MS7F_[G9!_0#H"YT!2M/%8'(Q/8DH,6!I9JA[9>_,'N3IEAAF:V+88# 3W(-6
MG.;98)G2]1Q1Z-:?&0/<)2YI-,^M#?N^,?,V,65+5L$LFWQSVZ;^&TF.\_;!
M$.;\JVR0I+F4O5S6-XB<^J54)15*+^-"JJK'&>?*'.9YA%YR@:;B<3/5M./6
M:"\WPOQHM3IU$30/'L9J]M\O/.;3IGUQ;^*[D8'0:?5TCT-FXA?>5;6AP(GG
M?_<:OG23(TKJ?/1Y6I;XL>'2+6DUR:?=T:%B<;CDDJN%2OC3D:.[GZ7%MJ+T
MH4G.:%&BH@?2S&(E*+/_EY((FSJM[YZG<:"Y6B..XY#K#:\V*7\5O+\ ?H8D
MX?[EFE3^K6Q.*;PVG/WKG0&M/E%OB;X7,%V]P_%]-BW%L6D*9]1*LQPY.O'R
MRJ*(T![YU!9(9,V\ELAY?4S%8"CN95+JY(M+=<1D'M.UT$?';_"E=]GRP\]=
MMM][F:#&KI$7:E8B-AL@5?G\!4K^&3-JT9FKML]"4J!X<^7W7BMM%Y!U(->^
MT8\-Q]M0$J;T\P*WHOX[#F[K.:[@EN76O,C$#7J6&6:=-$R_F($*F<'&D [P
MY3T]%T&'4=+(2^Q]_+('V4_2?CU#BC.P!Z>A-/,SA4;NDP6B5F]R%R=4]]Q_
M%I&A\D)$ZMK?\,.KNR\%U/.NA# G5Y^BA760CA'5[YFB]9(>O/-LQZ%$[?"%
MH$]%VJTA-8/%IB7Z]2J_#1H#[.[@65.9CRAR24^XAAH^A7ZV/4Z]FBQ=EQKK
M2\,]]YR\4ER2U^]FQ*F/9@7#G/+M+,_EE\F69EB<#K6*>^OK<DM_SYW+SZWV
M/JLU-A/?IUFB@[BE>JKD4254+!X1818'>]]F4WOFZJ/ -HN68[8W(OW:_W^/
M+/I_+ZC =[/MT9,Z??1&@1'[PY5W8EC7(Y25T(].I$&[T7$+3)?IX,/SN>E5
M+SLY^KB@'/UGG/7^MY1:W<G+Y5MRHWI65H.6"E/Z?6L0PGPWHXIU_MB;9HEP
MN%6V\:"9AOE92SOTH9-29P>7_'L[3!(K+U%B<6K^O1X3'JOW,]Q;:!81?@LW
MI(!9%FF/( /-^0>00ML5QL&<%.Y[ME]?L)@KOU_ +MH$'!E]4)<48VH*0#D0
M"R"X=G%:<A0ECRAYIS]V84E:_L9H_D^Q"&C>];' <NF<Q_+WG=^4]9QEN_,/
MBC/$GV(;2,LW25)%P-S67[Q(8)R=<&,T+'@/4IL]5L*)8?FE.ULW:-4AZC;I
M=F,/M'483Y_53I=5P:TK R2U/F8/0Z,QMMGC^%D]'VN'[K&2],[PJQH'JW7I
M#95N=D&=ZA*IL+[\MJ\,V;+5M4<!?BO, IR<W:](K!%F[4S9#TM8VV6-TY/$
M;&+"<KC4[]%2=)<UZD]$#A>%Y3YE8YX231%]= A03-^')\4JR0 >^K4<"IDN
MZ=V M<-VYX[_733F).K> 9=%+OS(],#:6)RV.HF@/8/ Q$![T5VW^7N <4;K
MRDG64OT?/ 0078_ZT+X/ET340<H#V!D!(4/EPCI!MBV='13M!\8:%0A\<T<F
M6BRUYOD4D-RUW+,9%7"O2\]:[T<#?^!CH,&&Y1C.T1;;7B^?D7^V3]O@NP6U
MTN:@T[='^<X&A'K/Z;01[O-?)1\)(S;6N)8D_;%-$_$10XV?]+]VA)Z]Y0^Z
MC7>#9'@A!#9X18P1G$ [7,W^12X4I2+MV:4+:[Q''.>>&.:_ZQA1I%CR>(\,
M&UAU&?E!D*JG(1+STC1N451;TZ]3@VI59)0; +\=H7VFVP7(R&+D0RK28W<'
M*E 3OW/+&+#444): U&"N=1O8\OT*%[L&C=2;ARO(1CY5"%B XY IP?]RB=<
MS1&YS;]HV:]D*3U/TO*;+ONXOCCV]4WX".X2I:#H(W5V>02CZ9X)&RN3<S5U
M=4A5@1F).!>O!/SS*Q/NKIJUT4%9?E^WH-\,OC%?/^?,E.$=*P##=&@DODAG
M,4\:OUU!% &<>\$R&QVKDO/8H\;@&J0.>ZY?/,%PMB[.C]&)OF4MVD,C)9B>
M!DY 8;3E(PI;2:RFCE<3#[PS_,+YR97>CWAF>RX%U_1GE)_*LB2^K[;,C7O2
M'*CE%N0Y5*#+S8 X]%LVJ[?]#"@Z4Q>405#6J+>!PT?W';.]L[_H?WG.HQ00
M78F:(+%MP<FD%K45Z)8A?P!U:!OS@P#>TKV#N'<7*Q?(UW%!M/9LHDBE$S;9
M+?)#<4CW':$#7]L)M$2JM#XUK/XPK,4)<S_CZ[2%8L_/QW?9CB%UK4T%\B'D
M$<<J:KVM'>Z 8?-\^3>*<[AZM\;82FGJHF.:J7NEP>5'O6;&@QV7 Q>D^>8_
MQ*1^5V^=%*3T=>1E3LG,>-^0/.ISKFKFEB'B%]>-XXN;P=+4R)O33=_GE22I
MS6.Y!_2BQ*X^#%+J=R4U4M>C#2SH%0&A\-P'F[X%^F^"P@8$YLX.D!2$A-QV
M,AH&/190* I<Y/PB>ZIQS#!EBVY3TVF5\]/GV";4=K,T$+9ZT="+L[MHJW,8
M#R]W2R"2<LRRMP-UYX/TY'@="I$_E*O:@@Q3&XYF2Q.RI2WU%NUQZLVP-;.+
M*5D! 0XO_$3,'N;HE<F964P4F>'/GG$+L2DF**N6J/GYOO H"Z-8NRV4O^+V
M2G&&WJT"9\27([9N EL]H$.F(KQ'[+ET9#"C0.?V&-Y$:=*"XXLYU&Z6%1H,
MJUATTVYB@L7G-V62:FIF.UHC?Q@;5"X.E]5@ Z>X>I'CN6QGWK$![C$@A?-X
M?,99(&C\20>62)+A8H$\@S)_-LSS7.LPOC;23[\!9BB>MDHP@,]8/^%RYZ1I
M]PW!2<'N3F_]9RBFXYK/2ZP&.(N.I]B7>M5U1]V&$0$?'"HM#.2S).,8UJ6T
M_%KI3-@\&&XYC!HK*/U][S<+9A7DLE3=X:85;KI43%(E!0T!9U>7-]A6[[#-
MXMW8!%(S.%X71!OHHHOSS UBP\X@P16(9"WE?NE<6$?CR ^] O/NS7ZR&D>K
MX0/HX%)NS7C_;=%RCP4)S]8O>3_0$]?Z^&K JRTM_B!:PAA>*>;=!SV"$N(=
MYY!2PD/\O'!BSCU\#2"",1CE28W'EKE-P++W;#F2.MJEGP1FE<55Y/S;A&]M
MO<DT=];IO=UMW^=4IJY;[<@-*W&2.ONIF!M05;WOTIE/J24:9J7W*1DP#8W8
M@&Y'%9L+=B^\(R\UCXQ]K1O$JXSJX3&HXF2-Q,__=:;!__%5GP$.0M/B)[F7
MMW.(9Y#1@:<F>PQ)<9JZ4^!NE!(A&_$ CY4!\IP;V+\2:E>_M9Q]J-MAM7)#
M+]#G1"[M>Z"R#2E^Y+MHVXE_D()! <#\@S%,?_X!7@10N^6,/,,1CS$]T<]8
ME>']M5V0-Y,3SP/C .]WGF=&O*A,/!O3LWJ8-L@L@/1RI5M;1LK2FR5O6GW+
M$-F8NCH:,3!E]8?A2U=O-:AX0LF*FEE.:Y:CYHV ,)936$650]62[ >9 F>!
MTV6!8(]'/C@Z^%96?'K4^*+-(?! VZ-*RY_I*R:GRC145[PWJI)Y2MOQZ"!K
M\ Q]V9N#8T6L7./(,*$]^YNVFXEG>5IL1_SLCPZ.,E,X$2_Z+^&R3BQ1'B'1
M[T3U*8PXD-L[]KQ8[!ID1'?KIIY(ULI)\Z$)TB'P3#GZ3U,5?_IQU0X@?.LZ
M4H<SM+S-.,:A8TQ%><Z =2@#G6H'.(7O&7!@[PC%+&^D!9@X0+^^#_0+#*"5
MU<X7<ONL\J*BC-YJ8P-^FQJF67+BY,9Q5UL;L@(>(C.P>I>V*K<&SSKBY'3S
MO<_V6I0/G^^QRXAY9!N*N9#RI,QW8R'J1D?0R.,OV\>*2<;\/P0 98$ZRGL,
MO"]#[N\ K+<L>0> 3";F8("G/EL5(VB@"EALG"D3OUZD.]Z>$U.H<V1IA#ZI
ME55>A!8;7"$6P$(#R^FUG3TYCU<"D&LS$3RI):XOL%J"2.F35WM&\@<)(PW8
M?D^-G5GUQY%.G#FRD9%X?.%AI2.$YM9.-JJ)23H,X'JXF<"2;3.UN<#Y!IN;
MF-M&U=Q(T__BT5OS->UL:*33O<XR=A8I7-ZN( -FUE%1J4L)""BM=(B-O%Q_
MR1(D_V:[4R9XVGPZ4*,#KG Y&/\B,Z(ES01#W=18"Y[1X4E)SD#ZL<F%!X ;
M,F0!ZC+$$TW5YVE$$CO*!6"Q&Y#"#$C*IE.2MWYU="1[S3VAQXVVI,^R;,VY
MW?JVK86R4N=]=/+:Q47)+C^=[^*\8\'\@ZP93!*T"=33*<IUH8)A0WL7N:"C
M2 /&J@AJQ%.>_8DT XY7.M?)_I6D&42P%C#WGSP']J]$[S%O0OOGGIS5\B7#
MB 2H_7!,S?-_<QZZ3X5Y-6H.'$W!Q2("FN_,WK IG9DRO%UKY\"RLS:Z5'FU
M.$#KPWI5M9H-LLG84=8^_!A+XZS;V26U8WD6)@5EBJ.=\SM"%TCKO3>..:>'
M_2]?(9%: ZTD;-DBP(*$Q1I'<-;ZGH2/=?@Q+FD&A@4?<IG2BEM-YD%JZ5?*
MYI5 K:0H.)4R\I/+\"%1"S^Q8;F.G?QBS55YJMO@3^SR)">*?S")-1C!4$M'
M7=P]2':]_N\=H6.,%(=17?0>1%/?&$B>* 4$NWSV&268U *-8*DEF<*CXZ61
MOI03Q&'CB\=H(Y%K_>%^I0.'GBG17 YN/*3TKMF67;U0<,FR,R"L(.#%3)5-
M@>PG"VJ^UYE6N,:GH]:?+'4N.Z;Z5M+L,BWPLFV/>HF.9W5K,B/6&H/&K+&5
MQYQ9<\O*6U$*I"\)/:3F^I5J3N8U2FTS* U[A'>$?W&T64OAZIKNMI%]4RM[
M/"&,=!@A2>;:+;5775,9GUC131.]/1ZLI547K'VCQRG"X'QT,'N.?U!J2Y[G
M*A#<,BR=OU%&B%!W((*=39O^Q31K,,4P5T1OL^.ROF7<\(JJ1CCWF"J.(.]D
M/WGQ&;(_*_QPG!ZQ,B0X)!CW/E17\I0'LE[Q:AG"V,2M@<PTK39</^M4F1#^
M^X6RC5YTOOV+V3,55RH^V=A:&L D#Z[C9*T*SX<F&*;.2IFZZT^F32>I3CI;
M#MDO?]!@8IYBV;;H+R1NYBC2M@@I \R6 &1W=D1".%AZB:9+E.6LQNNY$ Q*
M_C2L:RA?X)]CUR?\X%V!X9+N&00R@'#S6&N1L#TNOWR1NZ=HOD2103)^'&.E
M/[:+D!>K=H2ZI=@46Z"+N51@?H5#BFM>%>.9C(0'*E\CC6T4V/<6RGQ>GQ1]
MJ><19=:L!'K; 9'X2"LH?>/_L^O"@"NAXUQ*I=S=D.=9*L*.QGIA"U58<KAD
MW S.[_U@$!SV*"O 9M"QG%K_@<I<#5RI:VGO;"'BIAR<^T%-0[QCHESC[2J>
M8S4"-*/3MR+9;ZHS7*,ZJLV[K!W# HL$4!9:*.;[1OG/82R,&!!@C?HT8E&T
MY=,7JR=;*^'O\Q91G&T0_$E\DLX_N,1.L !@%0@X]^)VN?'%",X2F2Y-V%>T
M]!!6>#3PT<A2=X0;=1.=7,SF5[-(^Z8!T=['O_4;[D !RRW7]N96WX[F]F<J
M42\FQ5_X7DJUZ]94/97E3G$TP1]DIQT8?1QGR2T[:X=3+<"=F9B@?1LZ:G:$
M6S@BD=XRF^^>Z5ZQ]=ZBKM)$?#K@3#&!<O=_>_#S?\M5C<QI=/4T+__J1@O0
M@3_,C1[=R*>E9>&7KB[!0R)QDW18*-V-?#G=*N62GI8A_*4C(WUS>"I(60A_
M(S*-F,EY98VE$:+8?7<SYH5O2PO4,,_Q0=#K%G;!-C;9N^D"\D''UJ'V_O3[
M(SSSU]:7J/9D3\DF$MNS1#AY(\V2WM]NZU/*\\5LZ6R9]Y,.!:7J,.QKHU,8
MH.3F':&5/YN&]62-@]JA6$Z3';\??01(]U!S9%=/%3Q$&%QOI"+!U?VLCFV[
MR9[V*VN\':&!S=8R,J6B7H>BBTT[C_;=$7JP>PQ!.)#$.QZ.61Z*5=(<,?V:
M?7LQA?-'&"6<0W;G?T!+0K13U&(*Y^'*[SY_"?@';LN['NTYPKH>]*H4"4\*
M&UK!)()$@VEG>"?T,LN1((YO1NO/"<]%.\3O]=YV8+96\1188F%D09IX)'T!
MW\(V64DO0]=:<0Z*.8U;#V,'4>!92CWCH8EE\L]):V66F]C%E=V:GO37EPEQ
MI!9K7->.D+2K*+>9(UT2RO(N%R%>#@!-*/<H2>18#!MKMIJ[F8ISI+)+F&FN
MA-#R@.SI(R,2BLJL@-HW;X$8=J/SS>80Q&>>(N>!J#$;0?SYJT?"79D7]E;_
M>0#JCV@PV<WX0N?2O*<.GL#I7>:?&@Y^#43CI->@F-]HI_6W3PJD9BL%O3Q2
M_)ZSEP&_<R#0R<)^9D<H13FN3K+O._^GPU/BY9L<<@B;KB2);X4GG6[FO 4?
M\6GK_ SA:9S0?\ZIZ3J%ZQ&/JW[DW7'4DB[,<V&?KF>YK"Y[6H5PWI_.-D(G
M7(4>G.IIM=5;3?,$@ZYIQ<=)(O5>_*[E\;=;>,B_-]0U!M1&3/7?$+<,>D!Q
MS^5.C>]_-2?H3^"[YD)6;W9$H7P&8,[Y-+YEIJ7V[CV:,?5((;2,E(AT#?5C
M68GPSI=\&9S1NA*TCDD+"@>]0?X%N#]04=+@_RN#%N:Y/GG@M@9]T\:^3+T%
M/EX#Q@LG(+64<"5 ;6!\.M*O?NH+(N=F\!\+M/#^.+WKPI7.WR$\*7'N92!I
MRP5Y%@BIYDE2=:UTTD%"*-4%L!3_^ 10..^&0/<XRP<$48T-(HVZ]#H[IS9Z
MRY]'E=^!ZA%SQ]W\WU"#EA_@139$P6UZ6LJL.Y558B"F</>DS$M$_Y847B>&
MKSEJ#X%/=I[E"85?QPLP6/$.PK=/,8C>=VK$^@CP?=5VI#[,"8@\G!;A54>R
M&T'I6FX6#?.BV=V]JJ;G^+T>5@R9Y UGRAB78@D1$K-=01GXDYU-Y8@)=]YR
M8MS,BS#':0&&CMG))''5X7J=C>E\5?4Z44ESJ2N]CB7:_FO]N=H+?;;Y**J:
MG*6$13F3UC[\W.YHI<A5Y]F,,9J>7QCE1ZYU)#9W\U<2^#^K$YBN8!J( >D%
M?YECT-]M&_2"&^O[H?LF(,+]P<+(OS@R/9@4E#I[?S6#OF^A\%#,]='7GPEB
MKP,,L\O.4!7Z<VNICQ_^UM))/.&0-;E&9PGS=D]0_=XQ@_DBWN=&7QYE8&EF
MP<] 3>D%;#@K>+F_&AG<#)A7M93X1-<&;***BI#V[+EDW6W9(1P4D3'_%>+-
M5#1[9UWJ?NH+_/&36)(?/U5['9MV6 _T!MABQ#6\ .JW3D_Q3G$\YAO<!_=T
M3[YCV1[A!;WA4TT5.=>?%#8PFQZ$A;!,]OPDDY]<!<1M*77&SE6:FY ^7P.Z
M+V>5+'L]8RG!6I*GS''L:G[&ZG[\&"6?#O1S&@51Z*'6?Q;--'D$#RG#)2+5
M0OUF.@X8GZ]Q&61-71LASV6Q,R"B"=U>12LJMI2RC7_+YZZ&J7:6]!I?#Y;/
MR-$S'*X4Z=/.9\A6$/SBTFYLO:?F-=X9X0;#S.!3W !QEU)*2HKUFNK4T-Q<
M'XD-$:?=YO>&(!0$%J)KAOZT]0E]!5+,NRWP@JJ(O=P<CF=U!=(6.%\"0"R'
M7[-Q*?Q+B+D^MY8,XMD\MQ2G[$T*>;,O;88Z@GZC-Q"HCY:>#\A!8KL@@)KY
MRL69U3_171;K4R"N[3!_KS^IV?F=N!C@/ /M%I-DU<<3STRZ+(TU3*NLQFD3
MHIEH^:^+38M]CP7"H [(9EFPJ;G9E:'""3].C&BM:#[8$2J1%@2JW+?[G%_D
M?2T7/&2+@V,]-2)'U-@.CZ7/JKP#OCY_KT+JL=5)KBMU=\E>ZX* _O9*[O=(
M(ZI8JF9R7M]*4\,09?7>YDZ4)ID>1=2JPL/85]X0DM2"TT9.AT(XRDJ:+06U
MWZP@?_HQUEO&VW?WFLC5OV.!<5BT_T9^[U K_S,T^\*C1W%(TU/G,PO/5M5=
M(%-B \8<0XZ6SMGH4>]#J NA9G<H=QI"+-1A<+DKG6?KW"OU63*REUW?3H$P
M('P_3W*.I=8/!M2"EZW9V"OLA 0]= JVR2#!="\=H,S0$PF.@47^_$N99)#H
M^NH!Y WV0<0D>;-46MHPM?UEEJ0GA6#MY1T*.UQMFE??'QE2-CT>AY#DBV2Q
MZF601[;KD!J,U2\Q#.RR02W/#M J0RAT2=OS*9Z7ME_S?)CT8_-$?3:]1Z=A
MR>TK_QQ'[6]C@YD"=SNV;]8]U=;A&8Y97FC$L1$/^@)[JF]'B/1F 2R759O6
MCT')?DC23@V6!L6BU)_BGHD?\'1%/#/R1:?E[!GQ@/0/X8 <LUR'3FO1;NGQ
M0N'.F!ZWT77PD>;U9L%\G:28TEFK\3*GE!G!*T]A[)3>QV;;@<9&%9.(+[#X
MX#1: M>"(YSB,Q).$E4HJA47!AX/V+*)-<3+U VK8)GYWW;,0]'JIMV'<Y-[
M!J3VER4EI\XEQJO>#BM*3%>J,:F1A+J4.(6D9,3=_/JHV^Y%6\'JOZ_78]IM
M'T)>=7W2R=I.NJ&?"</&*X$ N1VA??( G@/FB]2B.3'<.VSS;NP>?A]*93@,
M>FS13:T/DC"M/H[?,H(>]G^B5,+YT[_=J4TIKQAQ?P(!,6]M9L=CPIG!DN3*
M:<\[0IM>R0HZ\T\(Y%N"3EZG^7&'!,$%K;%#_+6D? NXP>Q4J6<V-E)+.#]A
M:>&<#C?YZX4J5)_A'X236B-+\)D4#45+LEL*\]!F;5U9B<'N0WITZ2M8$$^;
M=%XG)KYA^Q4[IC?W)C%*#F\&_$WS;P<8M6@?G:3:V>%[[$<>BO<!>;B8732,
M?TJU'A9<'.+=L-9O:$Q]N*Y\54K9IE!)SR'0"6^Y%DP;K56=<FMZ,GBZ(*/1
MK+E2_<[8BV_?F=^^L]"/U449J<[D8RTF9LD_!P1$\L#/BC^\2_GS5PNEY,>_
M$ \#K1##F(FE)VG]:9-6%WEA5%(#I<=4(<=BA*">XWW']/#8,AYT). G8I'L
MT,+^](_[ DC!P76[FBG>_3[YQFNQ:\L[0L)(]P?:N!:.S_9<\OTF"61HQ]:?
M;OU/2T=X1J^O7:9"R2C-)A*GO 2<O!YM27_GYBQ&&&?QH:.=.I6+8<XY@M0M
M/7T5(A@8V)].>WPA H&5=KH0+/\>7?E>PJ!?1%ZVWE11%JGA)?K^XL*TGH5Q
M=(AI=9$E2:P()B#]WPKF LY_-O?A921N9C7EEE(48C9<--+TD^GE).,*HGP"
M^\7G;1R2?]D'B,^<G#^ DKT<K =L;Z&[?NZESM=KYMP$:$[+5SC"C/M!G(#N
MWC+ B#F138LD0 .CBMX_3N*,[(V2+IB1ZF"/U1[2N;LYE#+7PNG-WSR< M<A
M+_5[P,#R'GA);Y8 2\86U!'Y,(UPP;SFI-W_A5)I:&=[!VB)]XL>K5)].C._
MH27:L_ @]PHG(BEH&>E:9C%3H -YR_8L)Z*QNU)J+]6_7I,:ADEK3+/:4A.,
M\(!J#E]B=3FF0J!E@BHT49,5"XV Z-9-=V38R.%J@4R>SI1N\&&N-K:D[0B)
M$$NBRQ=S#7@:6X&J2S?'H)4+8'D?0RP7C.'+N&B2V*_0WF(0AG"*GK<7]]N(
M,'EU11\/,(K3W/E'DTZ.8_N@/AXR?,EF:G/B.@1PMB[VM&+NG?N](_2/4I%
MI?,S.;G7*G:$?!&_&&FO!>T:6GZ*9F-ZW9(:MGS3<%=FH"N2P9PF*_[HCE!L
M:,_1 !HVQ?2C+AJPUH5/&5T=%DCH/9TC/Y W:E3&,CE%?#I7!X0\U[JFRE&
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M8:,>"620,J=^20E;DTRT\G:S+,N,5!'<U^N.3O812SKU[7UNWK<I]E"5;8;
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M<5G^;W;OL8<=C.U&_$3O<50WL"1A77 6:A408G&_V;G)/ L.TR%S.)+_$[P
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M<.L>?/RA"OQ@ZZX]Q)7N6GGZ?W#WID%-96' )MV**! 0V=>THNR+[(N1M-)
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M-A0(,09Y:#LIHHNKVT\.KK.<1M+BC"YAL<?<F%0/7$N7?&XDQ=(#XJE$G#7
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MFW7J#ZJ@6H&V-N4!U(@GC%D(P.B6$&^E.G+P0?@9WBP^JB:['3)L4F[KM#5
M$;WN(PW1 \T>L\S7'A7@DF359TQS_J\&$8D.Q87)/,==BVOM,_ <ZWW-M53
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M;JVKI<!44$GZ PL%<S.'IA@H4F]]P T9DBJ,/$7?79RVHVPE.*]<FDH*?19
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M;*V=G_DSVNC,VX5O9@8[Q<@>BP7O!M-HN!$^^&TP#69(3S'\-_PDV5[0J46
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M5;^#G2T ) IQL^I#@07!?$^T;%UKJL&(=EEUST3_]8GC@K$Q6AQ-@SV:R:M
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M^SAY2,_YL7>/6N7P;/BM=\89V)/ZX06,WM#BCIZ)7F/7>I@":O0Y:;V0E0G
M6M0G&E 4GAQ)0]I3,Q['QT?QE(GA=.+>7H2F *Y"*.&.CS5(]_06LW:)KX*4
M,=26*:1!H%V2UTZ,*FAWEG.U-J%X/EA.MZ&TBNA3&L#:!?07E'S+VBHT;;9W
M1J=L,43L'IUF;_H$4B]A;XPR'VD:30MDDXARH^#5JE@L?,)L('&1X-'3'U25
M)OA9?'WNXG7#,*5DLZ[SCX?N>_Y]\F2.J0.VURF($\U)MCBD9T_O?*_X]]6,
MI!J/.LV9/H[M0(C#U#M>WL?T1!##[YRMCA">$>@UPV*1ZI)';&RS$-Z(5B;X
M-6*4AYS[4+X:7J;U-=0DXPS4#NSM #5'4B_U:&"5W3/OEJ+A=Z/M9*5.93F=
M;$^[PAC.T%QB^J>PUZ$'^QSOY^WJ.-A+=USX>.1O;<G?$[XG;(]%W9FX_S@G
M:.[$QV.N23C=OIG^ D9_@7>'\6R%2UB,RG@(;1=K#W951BT(?4^-M'^!I$^@
MU->PFXLU&MF#ZC.TZX!+U$MW?_622DFU:II4@[EB5/QBD$OV\PK<$<#Y.1)1
M&=W?W7XTE%R/YII*U<C-"ER_>C80NRK3>&159MNT, P5@^&R@0<0DY ;?=B-
M7-,$,I/5)(G+A?[$G#*++R/[2BHN=0Y*.9)L!&__D3^F:VX7S7QY[O"WOJT3
M@QQL5GA?3T7W[['#Y><=MGJ,+%O:[Q'64(Z^N7'(,.)+=?J=P;SB3+;2Y/N#
MI2? ).%M_GRC'["5^)M05K2>B 8?\MG1I$VP0;.1(DFU4*ZE:\I52PN0!MF;
M.JG[B:(]D)"UX7(;.(MVZ(I95F]QNK_JI;$M'VU_O4_7"[<\ F4>;E![J-R^
MSMBF+I9K.YO[AND[]-U<*_%@P:[_//OH IO]JF=6C]T[CS.>UKCZW0B/G_N#
MP6">B^&9=S2U;;-Y?:_&RO'1IEL6&C/G)K;>?#QQL'%'TN.)DP=;CR36YATZ
M_OC*(UQ5CXU7^;#**&TK*D#A+EMCWB0"Q:<T)Q]H#EG63@L,]37,JN2O%/![
M_6JJ./.+!(1]OG\/&&?-JJZH9C+Z%S?V+B8]S3YR)FSN+;3+@P]=R#'=RIBP
M#1B(L;95<K4I:K4Q">*X>N1G??A^B_A=6V @C^#$?;]?:MZN;YOK/WX2^4?T
M!\#$US+W6U\RPGMK)='<QJG8(>]PHHE&C+7#3D:.=N+![&=+_WD"HF!)(0&U
MG4';-8G:OH2!$?3MP7NE@ZR<YP2U\T*'.+\QS4#T_8_:K![BD=MD+>:+P59<
MR9EA]T\=OVB$-ITX8L-D% ><+[5P>A)@@K6L,_&(+G3^6R7 R"FRR.:=CE/&
MWWHJ)[R-'!_C"8R[V8GZ:PWXN_^/0Q_6K+7V;QS1B[@SS:3# T'D;6"X]=WA
M@)H?\2:G##4L.89G7EZ;.-]GLGOVY?5GV[_%!CX5W#]5.-<NX\GG[22$M"P;
MT03H+=-<>(+X5-'O-X**R4TU>2F5V5-WI@\T^G&6O(Z'9VA\.EMFHYC&#=UA
MH_$<][8>Z7[K^P++<^&[^\)W#S&3*^H?J*L\*:V.7N;U(BOCEG_T2:N7X'B[
M:?(%$:MM&N,R+N*YBCJ<1.*L=JYT/B/C3$#BP=R@?PJK"JTH@.L2E1^@/E)=
M,+ELE)P[^'G*K*2TR'L(R[WVE#[8_'V8-Z7VX]$9K*]?X :\24??A[+3&ZP7
M;*<2W7P)5JTD!:$TRD] ^X50VN1]'&C-&8=L+TAI-)NC"NPWK;Q]^#QC)HR5
M'!Q.'PX]=J %_O!/Z:7$MZ#OWH 7KD&^"1<":A&'+>\7%=X.\O&X^9AO>Q'W
MMM!VQ^,<69U#ED<?V>MV!3$<+:[^3]\(__]RR"I!J^(\8(+;*IUN-KPS("0,
M";R?WL 3#X6.OHN-RQ9;";V3^3'V^U<N]NO6,M#R;EA].EALQ*\0?KU;)?Q(
MR_-WT=I?U6TLY=8R1R7/RX&LTBV<6"I;0&W39U? 8TQ6939ML5B5:67'FXXY
M2M\*#:4Y+T8T+U]*]JIUQ=W4NC?6RD*> /)BJ7R\HO^R+[W@?Q$K<4R($=5(
M,EBR!&H3:P=(%^*;O)6$:HG:09R@2<Z%WHZ7CE._3LI'"$X5*SGTSM3"(,D*
MN&1%-ZH4#&4JV81WFY1[,_I_;%'KJJ*FI<?4AMQ1<QFH2L4OE!3K)8Z/8 RY
M>@OC,5FF@_L1^,J4 <LSL4ZR=_0,/KPB7-<R5:..O7J-:#31N]LB^/.OQ%W7
M@PYV#O:G;:_SN)F7D'QHY8F.Y>WSM#>Z65'8W Q[O8I J\G/%1;*KILC_Z=/
M)166WF<S8 V\P17+L@&6$8';V5@5EI^'R\7>*9OD3L0O#3N??Y,X1[C,01SA
M>\$O"76?9<O)#4YD==JDC_3+N>?7I.T:NZ;)C(3L86F"]YX>HN<H7-F?90",
M5^>[!:I?*\KFG0G=V)I9>%J4M'M8L7;%)?W7^J'AEHT?CK89*S4I QWJ(6B#
M#P6CV&O!1\7!"*:B2]#!:TJ-5_;=*_;(S+0U+KN5_VKI<(/QA(.*SHEA+_V4
MCP,550,5E2L8GU(HS:-/_W_<:/\Y5,3U1"]0 :"+_H*L_BR!QT>WKLK(L9/%
MZT( ^IE>ORY(*/2 A8PZV"@[=LG0S'H)OC700[7L%T^>C<Z[2-[YQ)%0[=19
M15O->R]:3@T/ZD2H+.<-AT"6;%7&@FQ"4Q)KEJ[*-&A#]0L_>%V\14A+GF/[
MDKGX9B&HM/;0*+&-0-.YQ0-Y+R+P)2&P*;UR_+Z)W;,KM64,83Y%@-J*L;E3
M4\WFF"1K.++?=.D]^N@](3)/O[86+6E8R"@_2FY\*E1[^[$%%2R@#'9<^6ES
MX(>==A(,MO=AX^@QWP5LT%SUI=3*TFNI]AC+C+F!$=E%$POBEI4;Q&V2ARP]
MJ(K*"M!#,,%29R1IC[^L:_=BYR\$ZM@CHA;H.181Z&A=N5NG'_>\CVA:2$AM
M[E<G9=S4HJH^%>PRPBT.!N](>Y3@?5:< X5CZ3;E837;O>+RC5SA72;HN"W:
MULVHN]76Q.2V/H?&V( 3! V(CX^HHK=B JZVA99HRPL^S99JPX/#1[\$U@4$
M)@TR$KXHX]7TZU1$G'#/])6?GDNOR+:+CA;_2WNA@B]]R7BCWV'G5%O)8<R:
M]0M6SO?"2_8QRLO*&3%S1J5PHQ*M$X;%N&<I-B5&>@_WQ2J':@=;7(-]2*LH
M(-X&\U8.BV])2HE'5HZ+L;W2 V"&*)>S*H.'1Z'4G)M1ZW*!XTG P*A!OSJ\
M*5/N?-?2JLQ]#TS+M 2J6;OYJS*[)O5L.5)%3<]F-:G>(WU#^,6NREU![]CY
M.(QU#_%T[E3Z]KJ\2>Y(3/'D0(TE5!Q$+MRTU*))LR>,*H\4:B%VH,S>[P66
M&_,WQ\-[T*O)L+*/T=. <+(X\+R(#D*[ 1UG4*N9!Y+/<H@'\K^E0;:QUI ^
MZ:)*VL,1G_2[G.Y%BYMAG/(_P#$,LO,Z>F)Q&G=8SFUF[ZMDP_WW#/M\M-(P
ME)1UMK;1@1<RKR/R9O?TFL?LKDG-\W?8[LW-SOU")]SB5-RO9K06ZUTLZF@]
M?,Q[RG7\R:,GW#M?72M?SOUP&1#^\ !^-*"&%*1;X0"L.6M_MP'K@/B T$^L
M=-L)K'L&>C:?QM<>$,17PE*R-J0V/23,-V+\WP 322\9+XBVW$)"8'/5\D=*
M/OCF7/=2<Z5T")BCA@=^CTVZPMO$4FU;^9T0-G&^ F"*E=Y(M_JNG!:C.(L5
MP;J%6:J2%''X6/$I/KVY=-VWM&7& H*+B3%&*W[C3L2]O%9GS6@G;_%$.%"/
MWZ%6L6NE*B *H-8STW5S(%?#VUZK^8(0V!BBM0[X^B.&J,0O5?#VU]I8V[]?
M*,^+7+0K/G"N@F8+9/:S-ZA_;8LS\);7BKBRJ_+D=:[(.)/X9JQM9BR7Z"2A
M24^(MX/!M_GPJ&/$D%="B])$L6L>\41WY2>]7B+9^%?B::$#G9_A=:;QU?3(
M$2'R_G)R$2%[Q97B6ME_XWJMA6&+I)^JPAAFW/:P#?)'!>[1)I6>+BR_??]7
M*4=QV[F\S9:DI7-&ND%?)AN= Y_JZ+]X:AM=? @["S,N52G*?#9:,IN=:=R#
M,\SD]/Z<EVX9Q)HVRZN-\6;#"X?>UU!G_81T;Z%I]$365_I3TB;QT6-$8U#?
MKVSL_E"#45Q.@%2'>7K!-NN@J>/+P!.. O)&LA]\D.<"92N%W/#;#-$*.#,Z
M/-O!CF+[XM4(2/U5F3B67(25_1LA.T9J]']1]N[Q3/=_'/>ZNE1(<BZG727)
MN7(JL5TE)"&$$*LD9FD5LC);Y6SABA!B2<AAEACEL,4<+J0YR\1LNR+G[[>8
M;\S<^]WW_<?]QWW_<?_SW1][?#_?S^?]^;Q?G]=S>W\>WQ;0HMU?Y?Y G"BC
M#%?A@W'G^Q'M,;Z;0>Y1NJMY/:0RPQO88<8V2/]O*'0*NP-O"12750/UC_"Z
M7(X$+J0KV<3[AZ9R_\**M>I0[=VVIZ$K\VK!#N>*SKCKJ^X^TCY*EQ5J@RZI
M5A9BB!*++EWC?R\#CGGEB-TE/#W:I,"EH#HUE>I2,8TO%H46O%Z;"Q]&:T]H
M?6#0\P\.&B\&>%-O?_>0#3-!ZG\F1K_HWD/1PS5(R]B/=96Y%MO5:>*"&0^M
M^E/438,=+PT%Z1Y:[#*T3FNT-5.>[2GP\CGO]G1H_92_>YB/M9L_YO=(_3 >
MC06RF9R:S>()43$?"6E+K'7*/LWMDS'\-)(AB(!Z@:6UJ2M9=9]O63 2D3<G
MB#RSN":+K &7MY>/U@\N+,DF!I$<5Y:3UP>A0>[,HL:&!Y.7[W@6LMAP$4TP
MMA%@N#6>1<P2UK0Q"OL5PT4FA5.?%.B/KC#4O$U]JI*X2'6H"?J,(6CU4T6=
M$:7S':<\TT<OIG<P'@1 OD"'1F0GX@B)RWI\4!RM34NF/93).R(\P%T9)1R8
MM?3,"K<V=@2_5#7@AJQ\2]$-6N9IUP*HWT*41Q[Z:B FCRQ*QK\9$.T7GN@3
M[N!(K: 21+OZ1?O,2650J!C@"(I]8N3?5I\0\:8Q[7*?;ZMRUEX(]Z.A-G*M
MJVPVR'E#9MU_@C(D3_G<LN$?Z9BKD*IZWI]MIN=_<:W0DV9U4T\.3\W<O/<\
MY-I$;JQ2L4K4?@-3FC.ZRM?>ONBIG^7MWOF-.CYB^1+KBR)$!):GC(6*40("
M8+S0PX7O%AX?$!TDL#C[(XAL%)?<RI#^,:D(F$"G6A]6Q2)VX.U!5&R324!)
ML"4Q\3LH*.,S)(,U37/;5WO/,S=\F;I$S;S=(S7K+D(EHLAU?,.3.':2M 5S
M"_V#3H?0@,L4JR4JU(<UM=R*C$=*+IK-+MZ.Z$'%%_P!4!\;TBKR]DTG=_,]
M8UK9SIG*1=8OO53DV#VX&@>L^J]#!B3]^'F\-U=6$EIC-M3'",.X:7N@P5:?
MU7<UHU;&O%X5)Q">$)%WVB",Y.=[=L20:MIK]]5)T7V7L>'-1$?%>Z&3R?;;
M.^WG7^QV] BI5&#^&GH[0$T2G$CRNI<WG>OFFE[H=)*5E:F'[G$T;,X(GVN=
M0_2?[S*^K]YW\3U[;K9K3+_;:;SL=]I&Q&>\"7<9TAEM)RM\(QG'$'<Q0N Q
MD[I08\4W249U$[PTA" -[HQKTN(O*W9K;2CG<,E[<)U7!BJIJQ-GIJ6C-7_Y
M#][>[V^1B\%^I)^"&*WW.=+X*.X\61%WG].F>10Z#7JY UD)B/J2]DI<J5,?
M7L.ZX^-;7-B%]._8B$8-51G?\V2/QL&_&F*<$]P'_VM*5VRJ0UL_V3C;3[-6
M_<7,S7I6$J*I.63:DR*_!3M-?T=K[*?68AJ]JAL&C$T_\M([9BY\K$YW/$62
M?!7E3?%;_"^I\*;-=\3VS3Q&$#:./+X% RH)?^"5H; MF*1_%AN>C.1NAWRG
ML+N(K0ZOD3D,^]$M&!?>5[N\F&+8-!N)7D]CAZKU9AS-7WRQ/KQ_D%G^[&UI
M;+Z]T^G3K94A'H(NI[IBYSMYF?]EVKJI_W,^@_0R-[9(UY0W-(2-FC0Z]OW^
M^V'3K-1O5<N^8P19O%2_&2N>_.<6;.H940EA &W!VE#*Q)N+86V:,*!">!*L
M]5?LPR,!.-\EN3:O'MH/HEK7R4R&#$[!'=R3P:6$.0U9&1K6=^1[\0SC$^E'
M1..TCT[XV8;4G W6JWEBK4QGVO+*LH+P&'2R2&B8N@6[DN8(9L6 @QV36N#F
M= Y6^U]@8F(+QO2S$=P'J GAXYL^VC718<[U4'7Y.$1P6+K^;MCJ0EVUXX/F
M"(#(U5Y[M,*)RV:(5=,??ZP_V\$)SNT=?8(WN3MEK6LJ_:^9AF0X9Y=3"3)A
MP<MVR)!"K<VD#;Y6#?W>I.)Y?3\O9;0?<X%P;?>MCQ.[RG[QTINY^UII#[Q*
M3[0^+6..=[*=E0*/G#=31'>?=Y^^C78+'_XX09%F]];OLS.T.,31_^YT:- +
M;5J9_1^\)3'4B""&JI8;"\MT+9V6#3^;]@+8X"'HW7HQ79R'4OTTY%B%RSM2
MY]VYM8=9:=@2%M>A*F#4</GP<&W;DZA]_UD(\L[.5F_L0EO:?R(^G3RXF6'E
M#<"Y.YFR*9.*FP5-V_B& 3R7A47>J3&"FO VX)S#B_9J5=;4!Y>?4,/)NT,F
MU:&:/64',/F.[74(D]'5_^B@]G!V:I[=98-EI).!2!.WW:4)+"F\-H7=^94C
M=, %0DG10=Q\9?:OS@'?V0";^HR.[*-CAR9U<:8>?IHJHYJ_7P]\&NRCO-H[
M(LMT>4+<09 >#QDA[B3(B>?/!4UUP815^0A- 94XO&0HY<K73E-/+]5:3>6!
M\+>T_0N\#Q]21WS;<QUQ,SD';GA?,1OZC!XJ3BKANNH-'0WG2QA=*N?>@1YJ
M#MR+Y7V'3SB5>QSPD9\AG<\\%T93-3H>T[ 6Z%J/F76[EY^.'MOH"M-1KA1I
MZQM_9I XVQ%2.+%-F@ (\YVH70@E7 %2E="%E,?;O.WAL;;AD+X(/7%4\ ^F
M-$QL1I<[J,5^"!J/(06=U_>SL!M>BOM"*<(]G#"HW<B+MOS:#O^BBEW8 &)X
M=6(#+Y$%EK:Y2* GC4"+)P0MH5WV)Y\JFN'W!;(L+>74E'\"[Q1*"9*:](VO
M!8@I1%KMQ&%O8> KWZ^XK+G1<X.FC?G.?D;]!A5K)IU;L)TB>:$74;8+=.1&
M,JE);CCGS564%"--*#9B^QCQ$0Y.-0YEN.@FVY(0PR+4OR/WXY9-^:%WID>^
MUL:V*$](N\0S]MQ2Z "_0MM;S.\*G3XV-D/_9!4H]5$&>3+?1;D-9JN<E!&U
M/U%*WR:#?^1Z?%L'&%E\)]OJG,GALS8^WFUE;L7[>O:6N[?VM9:JIAS1V_?U
M^H-"(TRQVW,E79LLW7OM_JX#QX'9;J>WWD,O5[U"N\F'RT>: I=U(AEV!#OC
M-EE)?.@ XX9LO,ABDXQ0$@UR]F&15\E_B 8FCX\P0JA)7HC]D"X7NV,NEQ@3
M3MP+M9ANNG-'.PU-O*#L<MQ[A]0R'A'RS/K?SEYV,W6C,VO]/NWPLTB0$V\E
M,X5*YKS+%LIGMQ'EA#I3J"0+<W(](X&PFRR'>S]N#SV;QJO40=\W_L:IG88"
M99]:.96(,RQ1I-I3\H,@!0C(KR?LE9]5><_Z:YH$<U_1XN$_=,0L64-=V !W
MV@'8!'P4H#\UDR)$ M.?T"C96F,5X3' )2D<^P>:A"GY6I4_-6'LW6]\J^G8
M58/:4,W/WC_^N3Q.\M-WJI?[;6Y>ICPLSF=RS#J5N<&)72]M)<<W9+?VGE^:
MWH*Y0FCB%$IZ$H]DT)M $VAD2;#64J]ZI4"]H;$!?)Z.JYN>CC9W* 5-TZCG
M%\MK_/)UIU=TS[P,'J Z=2JI#M"\S9S)A\U?#A^:^VG;?>)#UYE\RV/.V0;?
M7;N<=;G_C=]VQ61D^NM[^V<X>Z9,Y)OGW<NHK:55KK-V0R@F0@H0/>,B=T"1
M9X#L.#PR<$_.*S$E6=J17_T/D4([QJ.1Y_IK*Z+^5PK^F' YU&"Q\,F!5KO7
M]1@59H$:L!RSH@%OI<OUA:.D<0%,=G35LU<X+#/7+S7IU8^''D\=);)RBGZL
MWU!N(.24CGU*DJ%D9C8ICX '.Q7/)2N&>CW6>> PT;U(1^/=&IN_5]*BFOV;
M_6?<QH*S\@RST\==TO_WUQJK5Q8Z F^S#F,B]#=?-BE%@9A.E 1B+VZ S_=L
M!L,Z4;NQSFG\'[<0*GCKF(Z'>YZ]PEP<]YOTIE,/6397UHW<'U5 ]0ILE>MO
M*M&RN50%PB<4S651G^LG[?D1B@.-6-R.8K/ZY*9C4RAVC( ,(E/Q@:'3WM^8
MA1!)#&L)!.D0@A)0]S'R=4BD ?O2P]2RRN"[(=D/$8412MV39[=@YX@MP;4G
MC<0LD$#7ICV>;NZC&[/1MO\L!M=NP51P"IVJ3EW?MB&;Z6GGZ^7XMRA'[$Z<
M\EURD19]Y=084;AI,B'KK$5)X!1SO:J:.R%]><C4&L-C/*K-1YUK' ZO<#H3
M>LIM8+GIM,02.2IX[;!:WJFWUPLF+P47VT;\%6V]VTY+,BL0>BJC9)E>H)>)
MCH*CN]PRT9>>;K;EY9^/*-RIEWJENE!"0JU;O!LV^;9:*?!44@@&0'8RWC&Q
MY]X%9=^6_9/V,92VH]U'ID\2(O_A_OSF[Z6:D^+ G?T^9H=AGOCV99_!^P+5
MRTW,I%_JSFBK2\%3A3;@R!9,)&FV<3DD>U)^V Q.HLL-F;G T.S#SZ:<[-;X
MV+8*TK+$+&(?>=%?=:!)-\JB9;\1_E0)1/A/.D6Y\UR4HY_>K9Z W;)=V;RX
MSLZTL3 '\$^Z%C2_X8I&U=H_R6A!'(,>%.%*^9\Y:HP@5JJ_\I#H .3[2:3]
MI(-U"3".B?!ULC_[$30X-C>I#&H\]VGSI :6SV[!T#5#;FO.FX5;L/CZS>>,
M'__['98AM(;O0?Y^0^W:@HW7\X*8K#0RC;R@,45,*# "R&W8/>/"OP>U1R*H
MVZ&,<Z#GLS]P1;P$)HU>2W;MPU(K?>8&G0&EX<\C\I\//=%]_2%'[D;\^=E/
M_&KHFX?>Y0533U6Y,L][ZS5/4BR/9J);?I7NE.K.*S[19:UWWK5VX!FH>0CR
MY<+C7ZKESM"5P *]*P$YTR=WV#]NY>*^Q*,3V_@U0M9.YHD+7W)[RFU,F=/J
M%NK=)Y>\GS*]2G==O_<2H:"A;N?M*Q=/7M96=$5I$HMT<O%HD%X$]$S-M).3
M5!$Y.V@5> 04Q&>HS3ZT[CF?Q:XKXB*E0QI6LW+N .\O_(/Z]M46HW^V1Z]3
M?]_8E3^04BM;,!(1N,@AY<(3# E2HJ$" Z@85&LG[VY2 ?4[1']"Z USX;9^
M*PG OY-'3 BU<N$N[X1(?&0;?!_NIB-6*5_:/7G&:=!@$2L\'[KXO?F?UBZ)
MSULP1L$Q0*AI"*0E-^G?VSN.RV/FSB0L_1ES[(49Y?B\T_,3+=T/(@T_7/U^
M[^A#+WZ:<&]/6]TZ>>$[B/K[64EHT-\02XVC5F)X/TM>: C=Y2X:29*F7?0&
M7"1#/#T3'5+U?8-?D1)?D,<^[%2(Z3ZA]?1#S@UOS8@7_^TOE;4?"\HQ]\[C
M!MJ<R#*63D@)GMYWP2ED7XC'NZ_)F<K>OD;MO&/RK7H?.-=L^RKN]EMT%P=&
MWY_4];,>;'SH/7MS@?7%0LSR.+%:G]-)<+,0*8'.5$I(PTQ\DSTRU:PW3! ^
MBM#QP2!D+Q:H-?6)].:V8/NH!"TH-+RVVP;-75:<O>]FQ])H;_KW<^D\,0$K
M=@&JD#-#5J2"QVZ6B0Z)6(*'"P!DP2TET?\22FV2Z:;0=A]0_PV%NRP!-?)$
MST"5]@+=/MH6;.^_:8&%#!+E9L9%Y9_LRYQ>*W//>G@?C7"+V.)KY83A4K\&
M\&ZELPR+ETIYV-@1'[.)1L7&FJ$%@BYDTT;$5#\C/E!:K"*_XK P!F<=%/LK
M'RUZ[IS[R=AG(F[<Y'-"G EAWY2WZY>PIWO\')7LX^Y<_NSIAX);G@PWV6UF
ML+P1M$TGMF2VFW)RJECOJX^LM-2'J$'*^6&'2^FQZ2%.AE4CW7-KX[3*53_*
M,O+=6L>R,J&?\;Z^%?ZTP')P9=&BG6X\0/NZ^C7\Q9OZP26LE1E/_%C(?L.'
M/6+_K'+P2L)ID@]&.S+YB]/IQ:LWX_=UK3?0739CF\S@L5NP )>QC'.IQ^2R
MIQB/5F>+I"X5<TBF^BY*_DG;9GHW;M8@7SH<ZFG*NAX)K]0'E@Q3I=0]VOIZ
M[@"M@7V\W=,G=AOJ;QB82YU,U;YV9V5I_+^BT^ZETG6_KU>-I8P/O\D;+BYW
M>1_M]E6?Q]I+&"XX"LAV1*MQ&6W4)UV%N* .?TGH.S_MSWE-%2@EB)^6R'HC
MW)U@2Q_"6H4!(ZS67/\8KI-^1\/M4@.1U) I/!EA^2'C8O;??4V.)3CLY1$L
MQ13^;A5M=CF<XAPJU>,R%/&A=F/,-!3I.;04[J>W!?-(9=L-+M"L;[(<1I=6
M\A%S"S822Z680HR7N?* 0\2.C+<]\F.]OS-+""QXG7/S%"?5,BWUMD@6%RGX
M!RKF[C*MD$TC_ GQ02-!M&JG$XC(*/<6[H.BN3/0MJEFWREDJWZS#/[T#2M'
M+G$_M,PSS^,YV2'5YTV@^?9Y+&5V<K=;9#.E3O!PEF@;U:PYLM07M7.A?P,U
MSZG=F1K:9!P!\%L:$$F5>#F VNEDW"9>OD>1[6F0W0I6/<2\#V??@E)>O"K.
M3!GX)[A<Q**1DZ/78+BA6MODJ8'576*,'RS!C HLK1YF_A3>WZQM.C#5V&.<
M0)2*V(5W!Q,N0WR@:,HS?[-B"IGT,+N5)!835B="\3V8G1"!36(;/0N8TFW"
M3+$2+,F)PH"W.#4GL&GRV,#@V5R^.P#6#*Y>YO9O9A*#TA2%JJ!7NXOBG.8^
M*! (:Q59U@#F^45X"4B;1Y:#QKD3J32NOJ&_(9&O^9&'5<(I<(N'U]I=$OM#
MV%X)5NY&&5-^^_Q_$&7QQF5011O"$I3@78'"9E+@ HO--U6LUN6$@D-@0BM%
M@>O5RDIAP$4F+#Y6!C-I/B(R$IX#L]M&H=$R_"E05'VM#+(Y_0Y(2,3+4/'.
M@ZL:V#,TD$7Z#NXH#%[OS4XS?1!N;>$TE%_4.V:,U)]OWO"._'DUVHQ"F"2_
MKT^XP5!EM87Z=W=T<SJSZT0'Q/BN,@T0$VN7XP2Y^3-M?NZ?1&;U@.*D'!3S
M!F=D>/"GL=S<Y(X1H6W);"0EH&3"[W!A^:QG/?TQN%/P&H(#S+:']3%"7][B
M65R]K<L?FS5,S7V 19LL'/<$PTG*]C]2!YC'O?DQ^0= 38K0B&KW$?I+@?[4
MG;&FIZ+MV\WI^_NH0M^W:.6"?2D1D<+_0)5/QDDH:9&D3)#@Q3!B#\YW:FUA
M<T-2:+.99P7G$N,:1I\V!42_A7YU3FH"QH\.@QL:09\0V_(NC2(.^ 3/<^%[
M\%;U-4.E S3*O5-J,D'M#=3D0/J >3CJ*X<O*MLP@<(NC)J2XWV6.SF)<XB#
MPO-@4"+B,-X-0HI5(X:CM$+<#A$_,?Z(8,41]R*4?VCJ@M*V@,4GG^BU.-KR
M]NYU9S*?$ND%[J%B^-$['<21*8)R?G8Z/1R/F(].?^^[7.'Y 5Y9H PBXO@H
MF1_^1D#'JUQJ0I-C\>5Y'_-7_WQC;U8X#X7R/]*R'!V_AE(K2W^^\?A0S:BK
MH[_/OT%KKJMOB+_L_O C59H]&6RY,Z[)A KEB>2)"FB1ZN!BA,;]);704ZZ@
MTS0IL&1V?32)[/ $[3:^R(X%)OV9(;]\+[N4M83.R!W:X9Q50P0X(X^4H"W8
MAJVH'Z7>V<E)*=@NSC1'SF.1&O0W6:+);"I-$@>?*HT1F> =(9!/?4K0H(,R
M!3G<39..>L^L?G_T +HA\U'\%T%KJ_ZIPXRAPZ<U/O=L;$,E,>!&%((FL<4?
M>7/Q/D]9U O%<(UEI#^J6XQI@Q*3F6 VU_,?OV/52XN'P!WIH=,'WCR:L$MV
MU8Z>['"2"J,FSY1*O2]]3/5YJN.<>6G.-5/O?9IV\*72!_UQ/O@O\G=F[B6[
M.5!GJ&\(UW(#A<=:'+>]G'Z@*6L*(N-.A%EU!GK71:1?UPW$N]B;<^=.Y.8D
M[)GV1MS=C7#/%W]&N\O$]1Z]^%G[^6 /F!GXN/UZV:7?#%["@MB325R AJD_
M)@^"*P6ZH%]]PLR 3K^IL3PN3Q#=CS]VHH^6P9,YS&]C2#4A*R>%9B/&>UX'
M9+B2_ ;Q9R+4,%%^.I[DBX,&H88'@IC$L0215 9 ;/=A/+62VX))(N,XJ(\C
M2Q$3)DS-0YL%JUA9,5!+*I<ITZJN_(!+F_5BG*'0T@G6V[^SE4&TZNW8D4]=
MZ%(6&F/5Y[!YL-\//J^L,[8!?_N=T).=/;;I=B5KT-DEM M3,9[56Q]1!K!^
M8%KN?4&.[,>1^2]KMF"5]BJ;=9 HII=.V_7S#$.0\6\!<MQ.9C %5;D1/(@O
M?_U-^'@SGQ',2+7AS[3(PB JGS+:"9<17D>E(%3!^CBKNX!ORQ9L!^$P?B<X
MVL*2&8-2?SF,KC D_/U\':/?.KQ%"V2Q41%O+_<$WF_(RKL#.F"L&-1A* >0
M%PSR=(1*?$'JB"%_"Y84R5R6A(HKN\M)P4VG ]_@52#72@?5*:7&AE!93Q43
MS1L_-;:'PBT6\\."]I9*??4_?Z=8[X6Z=4A?G&5X>IF_A_Z1#_VEY_-G^_/U
MG%U+51#.:)W#XQODHM1KN3?533H8J"]A5K]V9D+Y[5=./0L(NS5N^054.D[?
MS_RNCD0IN!SEJ?><Z)U)Z*WY7'^25<:M]BXQWX^O04\=C0AXS+SV=D#_9Y3@
MZV81W0AWBC]<VFJ\"W^_'WG3!0;Y"L*:Q#G"XR3]PAOU$XR@O'9+L3&0?PT%
MO<&? #BQ3;8&]U4L\Z=+(XOH^1(D9GF(2F[]/^GGGATR7&>BXHC I3(#O-R&
MG]C+61,.<6I*\J-!A0M]M,6/RK_0"$FH%\!TG)&QT>I)G[ K?! 5DG$[Q6AA
MY-ZVQ-L;V%W /H/!E*-?=]^4CS<;[?[5\,+G\DM-:;C3]7?>GOI'W5)E35KY
M]^:&"^"2B:4)ZP)IE81B_V++G\SAS!/M6S";%G\'GW4*(F39S]3KX<0IW[*?
M:QWPL7&15-F&8\MK?QSU(M3#AV]ON5WS@PU_6@L?JYCBA8QXJ300RDE\5JPJ
MO".QMJ(K;C+OQD^TY@G:\%)HK"'&NO:8U;LN%RYKH5B<+Y[0:7X*BJ?R^"#(
M>71X9(EF[=CV$/F(P@@,FYK/2W$>:!V_-'0+(6T#1CI"U\RI5JH>I++W@(#\
MP&RXX<KI.\9YGS/6'[^FEVLB[TH8;.\^ A 3CG;[Z0TIHT05]G-?X@_>*?-Y
M"0R!S]\=CRAU5M)_.\6UHUSNN)WL^C2 ,.+@?>3MW,?0B"#,;-2IU:@Y5CMK
MC"S(@X2,6IU/+@D%9I"0 Q<:@VWX,*#^J="8[_(8H0C)@EZ"*"@!L&G-)2;3
MK'>V6^Z,635TFW3<&!E:630_9XS%WJH*Q7:4OOG6=:MNU()8&P&Y N>^0K]$
MT@$;YT+NIY\3(/>(-.=RG^Z]=XM"^]&D *AQLR@14MN^'RZ-/C#TJO'%-H.Z
M7+S<N?^8"9NCU#PP0.8Q<_J;A;ODH]; X1I-Z7]_O>R4??)IZCC;M7W&X]A8
ML:I;:R#.BK%-]85!C4KV]_>4A)9K]+IWQSH\2U>35TN/%*33*BG*C?3@LE.+
M&'/^^P:'U0^NMDJ_KQWX_U.%DX77>.0+.7H]O=Q>>ALJ!;\0:YB%4 VSZT #
M- [N^(^C)JOJC\*HR,_%HQ9/KO:<S&@EZ!0LN<A#4BP7P)S"'9?&NE,-(<0[
MG=C5NUCUNW8$7?R]FY<I5I@;)9'0*+AMZ<U1:-TA8C3=-RO+^_;"/IR>R"MJ
M.;ZZ'9CCMU;K_+]4W:!Z=[:2H>!E]J!=_V$ *Q9%=H_'9A'^2H$9F-V.@>\1
M]:L0MQ-O<AY92M2W4=5PLBWLP([LU]#VCMQF$86W$PA<6/>*%9I@E(2Y>)5<
MRKC/^)B+P19L8).(X  NJ&34;F(0E<T421V80B45F %!3(UMB".U#Y7K^<N*
MP039 2,^L-PFYM!Y3"CF+?1D"^92C:E8M.A0C1XRUSV94UB?'AP0KM!-1 -U
M%+SQ'B@N)_!CJ'J/=1<@M'CQ_>O#%[:D_(<*G^\^L+.0/G+:X,J[;N\Z69,*
M&VG/C+;KQU\J'MM3)>=5Z,DE/NQW[F?D_RY2I#1ZAC9BPFFTP9^.LI!6PF)$
M,;'U>CCK*4%FD-7FZ-L#3]S!XE/;YF^"[5E%D=J;FV02&_[H!]X1'15MD)U]
MG]W5',^;9?-N/'CQ<6R >&V9K2\X 5Q87VZ#D\AP V30XHYUOC<X*CQNO.C*
M2Y'U@.Z^_O8>T0S^,<.E)A)V_:C3U!M8^22_T8;A3CAS?.L&"AN'G8J'5&]5
MZ"RRA.:HA<=;,'OO#?,M&/<7=&T+UFN+G]BX3OA*KM%87BC=L$4CY#8+13MP
MS#;17Y %*-VZKA(OSC3,)\2!T54GQW:$ZI#5J5#EG->SB+\:A\RD$V\,M7<]
M8;-O_GR5;H_254][]PF7S>N(?O']-P++'*!FW\PI\(OOL-^\TGGM<)%;L;KZ
MW:/M/D/']ODHH+S:/%)\+ET*4*TMYVX6[Y\K]JA]\X;'GF[ O&]>+$[G !B;
M5V)@OB=6ZDY_"\@5Q)P'J6FTM&1/E#01C2*1)0F:PK.@5F<8#[L/;P&$-^P%
MIFD\0^<3?-'7X=LWA\S^6G^9-.-X*ZNOFZ7=>(KP>'2Z4RAO<YIDMQE+4$!I
M-XX[\IH#>$%)2P<R#I\64)/\]09O>?]WJ)9R.*,8S9H^9M 2[UW=S'"8!\ER
M:.X/D*/,?5<[ZUX4PZHQD+H4/, <R+^PYR#.<K7([DF*%/$R]4SQ@S/)EYZ7
M(V]^O'5U-1JY.$%W*?\U_\&KC5P[TX%-0^T0>@ =:RWOA'^-X WY+!)#&J$8
M3-Q-L]9O7R>WHQ+7-(\-_PO640MQ5:-M(C6 P1P&C.,/#./M^D(T9:&TTF_!
M=,VAU>: *X#PGGUQBV "?_J5J!>I9DBP@C+X]B3$":$I^&YD:96B\G>"&Z3
M]S56PQM![I729L0$I)25>^C&.>23I@,1!KG15:54'"A2F!.[(D)MF7'2]-"*
MDTXK'0YP.NVZ%\=M:[P86>R'@G%736\NA[W,AY.0(6II,>LRV4S2VUK9-,0Q
M",LG/V:V^)]$[K-2 ():)_>FN;_??"/T /WY'76(7<!:7%/@V_D"R5$K26X>
M(\Y"DA^MUBX'^;86'!O!VQ3C,MR!+1A5-+@%JSN<!&B=@\@!KR X#]Z&DA>:
M0>Y$4*?S8>GC6K(T"A<P)<HLLRGS@70\(=(#'ED%Y^G[C,J9?5A7+!N/EP[B
M$_>Q(2QSG9P8D2:#9AM.QD55_B3^P;A.WBO4'T%L0Y(0>I!O^^3^S1>UQ,3[
M<*E:SDZA5B,4Q@L-\(#RK[*]DH5.8%1[;D*[;.)1W++WR%\?AU8G0H6GN*R$
M/EQ"9^[+29,1+KVQ_GU-71G($!P2"QE93H@+E>8WESX2P0G]@T+]1BB/>P/R
M@"?BW:.W8%(]%P:$2*/'I;AI%_@/09VF#$A,J/VP:#9Q"(?P(^C/!GY\!]Y0
M]6L7)43[\S&7TL^O6_LM"$8QM)DB[!T%)KPN37B@X$]@3S8_[0_\3:B1A]R#
M)FXC[!>&0(U3LE)"JRU8K/&%S4+Z$31==D"EQ8N-+S %LBK$@[)O1Q@ XYB[
M>&O F39%E43A6+; JHCZ9JZ?\R,7Y?2_2K?3! DHX!-=!HJAH+=@>PW#B2J0
M.S\M):B:=+I_F<;9"44*\,U-_591T7P-8Q=0>_"K/JY.358BN*?$H3*ZM&U]
M.AO]5L.HR\S/YL+W)>+U+9B2#]2'B22J:V%CV,A%IW+"* 5@.$#V5@6'1ZW\
M(L+">%K<97G<E\%.U5B1]D"XK"+)B=A2EZOR:"7TS.1T]\B@5TQ[=M:Z]63.
M#+DF;:&>7[$L(0R&2LSR&/&BHQ ?E.8I%P*,%HX*8=]77.,Y"+MQ$L?D6SQ%
MZ/OA#T,Q0(S;1R!_P9[70>&G[<-PY,(=L8I06!O;GTS!F;3^G#>W*/@C??+'
M&MRCH;FJOG\\NGZ\N-EFQ87+2:$9:P37/TRM 68Z.=)FH:<\\AP8 +GM'/YP
MQ-L;CJ=D[";7!R\!*B1\Y!0E\GSS^R&*OX8]DV X8DA95MZ"G1W*9:(&S*+U
MF,W4YX0]N/_YJ4" W(*4L0H%;5K6KQ!T(!)O'BOK-W<4C906*D7PL8FY,R3"
M(0OF<IQH]X<1FH9)2X'*X%41FP8@']V*:+XPRT9D95WTGU-Y.N"R&G'A]8#;
M]Y#C#(-<]/DOK,SFA97[MUGV;ZNJAH='YLOIHZM2(AS>G8<B;<$T""?P]X#H
M^@X6FR8RA[.QO-%6EQB&A&B'$!TSY=*Z+"G4@+Q*H>N_14?P%T897 7PAN?#
M<&6$[D![;YME8&=BDVME[X[L(M\0E8>/0D^M:U)GMF"M!4@@8>&WV"3F;[XZ
M!(XTO\)IM6B>@,(BM7#4]MR1/"YG#WK-7P] BB%#[=NW.=4Z:EA@";HGLA*/
M'%KYH?.AP;;QX\_%Q^C)$Z,"V5V77D*3=6K;'35RON/AR:SCZR:%JH-4@QJU
M&(^C=VK]#YN"\NVN!7H%.\*/O7AIKEFBFG4PN4+OV8#:CXS^Y<;WH4?F[W]+
M=S*\\J!I>=I>)*FU@8$G#N!1+FD^AY!*AY[EBT.[N!\,F>$I.FXFXHV2\6'B
MK%0>;3O> *&P"?Z7/M3+!X_7LG0-9,=.3\$A;8O%%,#(C]A&^!/*?H#5+,;L
M%AT$.C^QV#4=Q%WX:WSB0EW#A\&5'_C39016!3<)Z[H<(3&8U[:,+?5A19N^
M1_F\R<A!WA;OK^^W8#=DURU98_5;,%DR4U84HG>.<0L[IOP@(![.+A+<R46_
M.?<ZV3@5OOM-EO>-J\\ZU=&\>\M:'Z427]4<DWJ5+A%M)?0!GQ3OOU:M?E+J
MJ\,UX.OY#SXO]5_8I5Q0WN.,NW)H0M>M0AVAZ?;\'5CJF<?LOE>6D*F7/F-<
M4'^YJT([:+]/]XC? J6DP6\-:46\BDTN.,#8+%ZEQA?LA[K &5Y]RT28 )W&
M*ZAX(QIHZ(9*>:6MK*<-%NWSC'C$ 4!&U'#+X%"=TZD-+93O)N*$;=P0P/9'
M3T?AXC;7%KX39(DM!ZG7H*2-,R(.9[]M1;ML$N+@UYXBY\@7T^]!:IOQ4\T3
M3>?JTP]<BN?;W-V-ESOX[]2IV\1)58B\_^C04:O(E$]N15)F1Q_<ME=W?WKD
M3,2QRR]+)=->5LO*GD_1^YI["0Q_1P.E,D^.%F@,5RAYNMO=@PK8YIGY*T[%
MD9$/?'GL+W-L"4575);\_^_#A?]G)3$(E J"_J]*8EY]QQ9,$?G$:AL:*+49
M+!WE,$4ZH!2I.6"*$;\R87EBA2,5W+!4;7D%9:]=7<!QR9J4U,I8E&^32Q21
M?Y0_36\>'O3L'R^/)M_^1!2[*WF\R__TU0<92AQ[.#-%CFF*"-HX0OA,T$KH
M+-"#F+RT/2$%BOU-+F43(2(-T*@X\!41S=9N[^TH#9V:4& 6P.MPJ<5_LN,I
ME9-CE]$';@?^<ME.&.!((&]P($/[11HH+7@"/B?+-AVHPEL/X[6*0W[B CHT
MM2T(?PW3X(]]1/G7&R)CFI \#<\32[5ILAB5:DYO@.9+Y;ZS:QCKWC?N6S"W
M<(\P2N7O!U?<Z VUX\T%E*JNZ$^$<WA_<4CBQ9TW%VGA,)\>,CK@4KT@=LJ?
M85Y=AO/EC:8B;V(5H%_<'1F\B1T_9_X>J;79F=RD%,7ST^_PW.NB<"&T2?EZ
MM(YW3;"90_H<[KIP1=Q@Y ]S?W%<GKP2GH.Z-E1P.AT%VS;CT^*6%U;7LAU&
M\#I3LGM#5#1W50\N+M2FP+URSRT=:H32%* BVX$#EQA]*R^"<BI-U22]SE-G
MYY(5!YP.K3IA]"G^@O>C7P3TNA]BZ/"\^O\YW<#.A8"-.Y Q?U2L2C'L[/:T
M)/AV(1S<@O'RH)^.\-B'R*>F9%DHP;,:X+0M)R*D^ZN$QZ;@\E#]99 BM&"[
M/'GSL8"WWVS?;>RB61)EMW*?&:64LRH<PYUJU53JVX)-)2(DP9LIW F5\Z!U
M_2)\BIKD"L6X#%)NK29 C^&+OXMPRL;[)T+VVFH,+R<= "[=P=G)^/]T6+X*
M#.?')^PN*T$+/$=$=:BXPJ1"-Z5+F>=SXGWCBCR5FRV2XQ&&78X/\4.S7^YZ
M/O\H[Y9:.4,Y><:AX\NQ(I\WKY>I6F]6ZKY\<;!X3?^\"8K'M+A-#*Z(CV]P
M03QR!R>6*&/EP)/&+:W 9?]W^-HE!J]6A;E?XX\@RWQY]@8B^0QB5_4?8/GI
M'2<K*=,IRUI1@0''W^_A.X'9L694.5Q>JRHRN<FB E?3XO@:^;3)N&0^-W +
MEMATJ$"[AGP1X$-Y9VD-V6Y]7FW*RJ,6;*V0NI$8CYKZ@NE/WVP44QE)J+KE
M194_<SN%BMNG0D5%&Q;X'<F=4ZP$T]A^^F'\D5'" 7S89O4,6-_*V6L6WP@,
M&$OCG2%,)")[JB<&,P67G5>F[X>&C6-H%"WO4>%9*Y. URSN!L&^$[77RG[C
M(.0E<-JL:-(MF0BIY\#%<T$F:&SF&O%H@W%M#6F+<H5"DP'$04+/:&Y^6_6$
MSYQ/:3*M2Q@TE6,4D8@,*R69YJ]>OEK[_OV/^ MSKJ^&2M7M#L,_QC(2W.XQ
M!]I;AT]J2>R_F&D;?*ER:#,WK]1"3\__\$!64H?Q),9>L62VV6ABB-*03&,W
MG'<1Y'F*\0D6C-B5P+OY$>R9$J0 DS/^#0"%T:;ARPMZ4KO\YQ7<ZXX9U_?-
MP#>$?M,(MR]PM'+9-,5G8-[>43!DN!3>;"=)&?#5?T[JMS+AI>V&1IGK]B0K
M-9ZA=#M="91X;ED0PT/MGELG-',WL4X?U"BK,EK> U5&*XOGNR-^%S;6?,R5
MM-?5DA+J@SM;D7M%'2AUY'5#8T^H!B!R=5HY<<CW]FD(-<B13U[<.464Q]M"
M-M<V+F!$1P;PI\$KQ& ?_!5(JU1H(5Y)[:A=6[#0.8(*:$$2>@3!DZVLWT"=
M+>MV^>4AQ;SWFS*;C_&2A3A]+K8-LP63QOL C ZDC- .6@,M>/<S><@$QNY5
M3AQ9JK83O-2 %$P^!O+L1YH"^!NA8=P5_\/O1E93M-H+5,'['[G1-Y=]AK(=
M&8U1CGDY'T'<;C/UXVVN5+?RE]3SSIG.#H,1%>ZN89>:G^MU*/)/ZGC7ZSKG
MEJHX.4<X5WY'.-@=0T?UY/B9[3,?P.:T?S1M'C^4,8T?0=GB$OC+G\B[H#5[
MR(O'2$%)XH^!R#83M/+Z3F;:7J$]<)_$G[@73?CQ]<?18)'L$"T/NW<N#!/Y
M:FQ6;@P]2"\.EVG.[3VBZZ^R<4(TD"N."5R>\%7 D/-J\5<!.A?&-_Z&BK@%
M*57>I GE";P,ER6VU.TF\R+S(=I$U,7!D?6^N?78AM2*X ;E9SOR0Q6:8W?L
M7]+^+2NX#V5NG!(:@9&+I0!5D#N"ERD6^D//-C!BX+U"XG+:#%5'O<"9]BT8
M#-?9QE9$U;PLV 4X=61&\X@D!)S6CWQO2I5F0[[VX"&"^M#*IJVROL*?V;)@
M:9O8<4",-K@,<NIUT>D:)YN6!KA0R?V3IA[$1T=PG;"=ZTCA$8Z,-UYON"GZ
M+:Z4.Q,?0=X#D3KITGWIXTZ@;$J3;A&FP6RZB&NMX_W/O*I9<W,')7#,7K](
MU[/0S$V]OZ5C7_D_S2>C;MDI.5?MU]8,_C!\Y^F#DNF7\.,1)P->5G3=<[C7
M'&+QY^J5=_G/UV@OW6]WLRO0D9L[\&90+T#DFZ46E^/A$ 48Y=%SBOS:KU6&
M(&7P$5RBQN59BT&F(-& IL^0GLLM;D[Y-K(%8R2SY\Z5I,,G7RO^KC#Y!*_=
M^0E+4IVF<LEQ9#6"G- 1U$E8_*]QM,EZ2NQ"9,"LCZ]]F+A<_*@E/8,[@7%C
M#(;R&.FG]A]NKH\W;7IFF!/[^2WQ.-ZZ*CBW4QPMMHJ@<D!D+MRY64_;@NT2
MM8M. *ADNI2HF[&#%JW?0I:K7(CXMRF &ZW22=XK*[;4%JT^]2G+UP:LG*;$
MP<;)KVJ#@3-Q0O<*U*RFRO""P?3[H283KDK'OR)S AL).*7),4&,( 2*NT^6
MI%N8;<'B&#?)\83# #T?>,@4=V'[@AG))0YA"M)&Q3.>Y*-<'UDX^:/&%TV0
MR3X#1? TMF](\:\P@/LY6,J8#SMP,T/2X )7[]OS.ZMZDY?F2ITI!H87+I1=
M>@JLS!QAC;UMK>7'E_P>C*DPTPMI;KR2]';2W?7]W4BWLGVZATL&ZDUNZ^?/
M!G63CVVXOB+T(;<U>?'RC3]-*D/C *F-;CZRL)IB;PL0'H,Z+0VLY(AH))-=
M4E,XO\9&):PLALQX,FKZ5JE[< GG1HQ"#;5C+@R;:@2Y-..,5AI_7,W^A-*D
M[\![C)JQ=@N-H7Z S+-/LC)13X<RF)-_0"1QQ/9A"N#)^LS2GL,?WT!1EX>P
M*R_XC!T=]HSZ^DM-.\82\_ZCMC'&EKDLTJH+I*VS6!\*:#%K&!VR24AY(L8C
MC/M6 ^_%FZ]P@6,0FF27]UF<3<3&Y8P63Q4?>,+*AMVO[XWI^J&6QO7^-4[S
MR!I*VA.Z$=YS,RF"(4D8(=?H)$7(CJVU^!_*9J)V(H-<QECM!>I@1\R4K#Q>
M'[4;0]\.]4;K+&J -X0'^TV3JL+-/PS2#T 6K49;,+G::)._DW?A;XYX7O2X
M52'C%.!#]=K,HCS46YEQ_=57N/A\KB-E?WGX?&^YXK<9YZ/?*WP\#KV:U59=
MU5YH_E?T\VC!+/KDD9^ENOK=>C_O.Z\]O47]+*K>K$7>1FT7_@'9@/?%\.#5
MQGA<8+CYBK#?:<JE%G]@I"GP#692:Y""MP7U/_G+C2Q9V4_)[L$UVH&TW,O!
M!4<MWG4O7].@?&/[]7+(:)VQ*GH=- BJB!3%1HY%0BHSJO_WEA+QLO,#6)UD
M.2(7+NH3=8F^;<%B=5K9U"2B^'L:@5FV!;M)1(LOT:0-FPV+BQLJ9 'YW<1O
M_[/DS\MM6#6AW"!C*MUA X'[*:.Y+&@"@CI.$?<*_X;NL V_%(.^+7 5"B,8
M>@.FB1>QF&<DFTYS\U6\ ?O$JMH\X^2"P^:YRF)CPK(!0K.JK2<;KQ4B5PPW
MQ _L>DD8(0IN;<$TD:N>4/E33Y2]S*HJXDO13.^Q%P^&RS]J'DXQ7H#.%%NH
M$7CXU2"'4OVP+KV,^J.SPYDN:/W.\Z;_%6D\T#8.^19(K*4H&=N^'H:?=-RX
M*W0'9%N7XSBUQIUI8^-,3?G-?()6,%UB-(*<R) 466#@RJO+L3XN;8EXI$5\
MDSWH^&E2"SH $'Q1.\?$N'OZ3X3^B%"."DUOP9B_SO0JQY3[.&H,1RMPJ6P+
MD3R</<B+7/@HU@SL5W& KP@/ /!V%.1,Y![8L!>PA(?7)VN*B%?%#9EL)NP4
M1 J"!"YL(@W)/4#?P+*MR OS+OJ]V;]4.L6\+E(2BL?_) 1OO9E!_Q/';T&I
M;<&"R21.39K8M<;Z6+1RXNF'!JS"JG NG@U _9-PE *4P;N%V-\P;,^$2PD1
M24NK< 4HNX/SM8&0&7DU%YVY^H"R\&;!2@-4FUI;&!53NP'47(2_"O4 ,]S)
M_* -1=$7S;W]3;:@38=(!2+N3%K&GZ+B<D>XE<6@74V Q+#P'U_*ZG ^9?C;
MR*S1S,T+Y]@LHR*]$R7OTHN32G=CJPMW)M[+MSSQ<G<PS\,R4\=UPJO-K?%V
MIJUTAU1XJ8Y>;4;"LN+K"2.TF6+&\Y"39V:/;+Y@3*>LWD?#'XCZX*K$8%2<
M)W*OE0>P)K@#=+81$[9@,E9[\8&5\X3#T#(6F&FC&YB;^Y10>8;ZW/K8%48\
M2O[JL#8@>%;:=ML(3^0AXVW<AJM2R:];WGJW;%*-ZX4'H4)N6@I9FJ")1P$H
M02) ;F/M@*(Z1)I._OVWS(+#J?+H^VQ*<5U9D/K:Q?$0\_XKI*BOE*6JQ:QI
M75O*Q# C\Z[.=\9B]<9-O"[TC(HF5F,?(X,9L4BI%1:IX(\!H1=8(X@7NX@M
MV)]0$'-2&I+@^YD/K(\Z0ZZ5\PW?4Y_QL4DH%?RQLD\%^\CV9,\!H?74Y@VH
M=<%!:3(G(G0] ;B/C7/#&P RU$^+ :T^RZT:"JWK7G$BC3E-"5 F.UEXR,J0
MJW8#H.>4_B <&%R5\1R]5-O/'4!6LR.&L-K>"S?CYR(;DF\]^/K2HOH3M]RC
MM4%IKK?;Y'R#._.GMJ2G("/_Q%#%B2_A14[NA"\F+PL79D[GMN*';Q:9';'U
M+NUYLUR>IN?4H5M\>*EJP'G._DV_K=*T6MS_?5 3GD,&/"OF]9%C\C]/?>CI
M(8(VW,P2\E^XB[Z3G6*L#39=G.Y1.TY)29F3@Z5[_/HS9=_CP^G([BW8F'0G
M41/O!TPBQ0"Y8V4YUMQ^:C261I2#!G[QEAC1)7Z8LG(HQ@\T\!0I);,N#[R.
M9_?8--6KY):4+Y=X^YF;.>;KC55^IV]TBJ3MWW9% !9<[!-#-S36C)ID.4H2
M5ES'\TOQUE 0W\_&+6?X,G+,8-#SR=+LL&_/9=>Z B6&)?T@+HQ+Z7S$N&EM
M2900&I(Z4'+AB\Y?9L0I)M_DR*-NAY"M,D7?+OMC<HDDFHO$?,'^X: $9W '
M0[O!)2KRKG(,NCADS>&:.7/7AC!5YD8M/V*_9QM/W^Y-X>(EQ9/7=*,0#_%=
M'2FVM\.': ZU&5LPN"C[9(KJ%LQAM\=YZ(+=*8EG=\B[_\-5,G;F-I'D<CU[
MB]WWVT@ZGO3V#U6GT]1O8S-&(_2N5G10=NHI%2<P/2)FUT2'H#)0@5>5P'5)
MMC2C+F[CYA_F<_TK*O#6P%I+BA12'NV3ULG: _WR!$05A4+W7,6H(> ,&_TP
M?/V6I2AYW7"S=CUV=*^?4T#9#U6R#/!Q=1X.Z>YLT17I'*<F+>'M@1#XWO=.
M?]Y?YCO0=[!GUV-\B$'7F?^*A84^&W#YUA]?__U9WD$_VZWV:I!2"U?SQBN
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MFKOU,OFA[1AU\VMN5-"_8T8]1U\%O=75GNL[>;.*^+&3ZUK"O)_MDO#Z_IB
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M>>8S$R9D0YS?0!Q0C=*>J.=')RZX>NP?/-53Z]*$.]5'"0X&NA/%H.%@VG-
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M38BV09KR_%QJX$'('N"Z]L.3D0A<H$I#=0])&1##M:1R7RQ&*4&<#O*N5]5
M-'5&ZO^4/QS@<GVY. +0$H;D)$GU)$JH.(3BC%T ,'>B#N!PY;)UF&0#D/0-
M //$JX.>+F@5R-8_U=$5S=76>(GS:_'':AOV9]!^F>3GMEU[+AMW0?NLYJ-"
MN[<-0_MX&$@-P%^LA7#;XD1=E54 M]DFGW-GEY9F_27$!F[,LVY$PB4M+ROO
M/?:*5]5F-&_6!'^H3_CS6T8#_A\Y#]M'<$8(+\BVDR@F8B9'S(D;M88>(0^X
M J6>D,'*/O)'Y'Y0*V%>0.5LK;3$)Z%JN]M?$[K\N7XW&[726/;B!" SGA
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MMIAH&A8[*U<3%B%S4@R+P:!GLGH#HBU"^7Y"+:-6)"/4&R"\9+6AGA,"A59
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MGUD4F0E@=_P B;Z 83>/_IJN1"IYVZ1;_=OBRTC2V+>$TO=: U_JJ3)57//
MV24@DK\FT2X+ZN4FT0]B(7!!&95GJ#2=Q&UNB:F)V"Z4KM2972E%2_&)FT<0
M%I] M\XI0OD4&9+V&XXV5.K E'NZ6U=U_9V!UIG[WHX0:Y(DWM +I4Q0AJK@
MS$$BBK>R.!0NA4PLE 18:1B*E6.QG&EIR2F^MY%SBCTC*-L/W:T=R^W<J+KC
MCJ[= *^+V0-%J-O[<F%;/>P%!H&-8(9^>=QO"Y0E(>S@8V,/ \MKP*=B[(O
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MAM*T%"@GH:/XR/MNRN5G^_7TR"22L3>:.>RCV9!UEC*@9SQFRES6$T3.SJW
MQ.:-B=\%A*:+M@CW",CWH1#W,Z6@5%NA >C')<IC0UO5_*EQXM)9CCUS>C@<
M/F;(=%5>]BDHGWK)#AJN=Q6XNX^,=*F-CIY10WOC%$&S&&Y:*"][O@T9[T:4
M%MI7CLWX:($Q$5S8CL]8K7:U#T6D+K[7JI<74-+D/&E>4Q[-/_&<]6-^?M;
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MSW'WJ"[I(Y=X\K86!^:"FNFT/J>FH=G2=POXG[YB*_E]<]S_=7?B_X=#TPO
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M:"X-XLI U1^6B]P(<337UV:S*=:4!?%^./0_7]IABSN-61,^!TC\I(UX+!*
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MK6]%VY<6_)Y&NY@SA(1<FT<+X]30Z+@@\[[&^H\!4Q,V&B=$MAN>V O27DG
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M]+T"7&HYF,]L(7V$U="LH7QY#5]:^S :UU7IZ[NH3@IORE\>'\L;O['\*ME
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M]_5SK%<2*_G\^"\),UT0\I[1C.PQN'9_M1W&'>\D*6'MAV,K/_N:!K\:M[D
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MXC+DO^KJO\P(BM8AIL?>MO9KR([;[AW;-%+S+<CEL?*VC+MO#NWHH.+O@'4
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MCG5R0^)2=]N%9,5-+X2G'&MX71OG>ZCG0B/=P2FHMT9<-ZJIRTV-]J@/?OR
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MP,G'<"I5[6DT0./^%6,_A@W%V/;>'QDJ'"XP7%0TG!WJ&)+G+F?/)BW>X9Y
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MZ.7XW:.*&O^)=)AA;NC!VW W:JM;GD*T?JE>U,)?%LK=V$-QQ/R0)9/KABV
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M2#ZV6UO^?VQ2^9_X;P5UJ?]_ 5!+ P04    " #6.V5:/;X7 4Z" @##N (
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M"^3V-UH)Q[^CE>G3RY68IA!C-',4!C$C0./E9/]:JH,Z-<Y11;,F&<2%A.H
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MI'TM:.#!WA--Z(>>IPEX'0[>T$%YXZID+SCU%L#%8ZGJV68=O.(;O2]3 6<
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M6)+7GQ+[/!T,2LJ_W%PWU?A9O+5C6D7;JAO4J&X2:F)R;SGT\ZG!B1LSI\)
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M,<LLW&JY:K'@S?WVZY9@TW%S,<HN3-*)P<%&PCJ/?SQ#(_W'FKJ1@T7JSS.
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M=4*35 ]_Z EB1\ON3L5L8;ZL+ !Q8_U+%[?SKTVW)[D,7H9""?E%$UBTA^5
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MHM-30[$+>9_K?1W#M -%UFZF\ A7V./L2S*A8Z5FZJ'*EN [W:>32Y6N"]O
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M"KRQ0^6+XS73BC^N2AB[Y7OI_7!+[3(72>R*\#Z>]QVQT:_:2XS5/9K<-8%
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M073O'?2ACHVK4^G+,6VAU!%^1A#3#6;(/[F#YP._0X3?; /7&4Q.[D]\),%
M/A/^&]5RC8TM#0T-Z><F$1WU^.=MH H.H'NHE?&L>'V=O, _0/5A>E&!26%;
ML2'C8[L:\5/ HP9H@<@0?_6][W<>UH[5_SZSIE\!+UI3D6WZNG.0[P*+3>_
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M_U$/$O])@*'0R2P5V%O]=VVOGP-@^?CS=Z+7:4?9W%L<@)(1JP6](4/G #@
MY_-&5;YHP31&*0=0\N*  X",]&\>7E%R9R5TKL_N/>, )J/H<^B__ZL= 2*.
MID$_Q$JSOP^O,VX?W(<Y=[PH0W>Y[JH)6+>/A0K4L'N<G\Z&'"3X!\2DUI]X
M@?6=?(MPDG4,Y5-F_P:W_OW) AIJH);YZ@5K[M]O:U(X@)-M;O3E/B#-#ACM
M?B0-W$3O3-+B *;[#GI:GF#1_N]NE^M&[UAH](HUK(8^H<]V$V=7!3SYA@BO
MG(PBGOKDY(C2[WA!A*X4ZB,MR'5KGR^7\NMF5ICY*QKS1C5UY@ZT"_NW?T%T
M'LG[@3'A $J?.+WRJ'G]9>OR_C6Z(9="MQ>]W "EHM4;^/3HUT\>M'O8@QG*
M^H,RLR(IK4[$VF<>J=U4KCW#R5#_\$,K&&GLJS^/#:]88*7M_2"R9]^[FH<&
M^=4AD#>PJ_8X@R_;6OJH' ^O,E+Q@XOU];'"W<9O4%L.% [@T)%'NZLS^*@"
M#+FGW1K ?@]_*II[&C7S>UZ:&+)^X&]Y78N!OSUA /8*^&T?9 Z_'+E@;ZX4
MX/\]>]AEUJ6NKJGH*B%N+S+Y8\A:H&["E5+%SYF,><TR12VRHB$_F=]!M"ZP
M89+_]*='N?^>E%G!9GN_]GO$JS_8D?KM\HLAVK-H99M^<K"!AEA@[RD4\+QE
MXY9'$C8QQAD1/\&B5)XK/Y@"'45[@,49K?:'K_D.17(V+*>XP>Z-N<-3 W7R
MG[W_]LUQ@Q;7-\+G(R7&"U--X4'?7\FP*(5ZG7$>ZX;Z/U 1KL8=+$'2@1_3
M-H+I.63@YN8!&(FDIZ0F^=.H%%ZF54Y77E91O6=$. X8OR!4!Y:8D8':;[>S
M\UFORJ"_1<.POH^= SHOJQ=I^!=6>[+@^,;ABM'*I#)EH;*KJE*":D1HKZ76
M@U+1R8+1,4V7WFJ'1U6=A:BD7#%AVN^X&39OTL>-!=4OE8A\BKQ'7,^R+5VX
MQDYSX^GI*5Q,GW6LPN_T;D^7RH0>^[2?-?<J=RLTRRWK?,&TX+U=>EKB3AI#
M:7E#KP2*DIX,8:EL@DY<*7-:$]/9L^  N+W[!4XC@@FE..PKC^!J'YW)?>,2
M)P%2U<54TMV^8MCOU$[Y3AADAI<*/ SH6?R>'6-S<0YDTLQX2B/!8[>H;F9;
MSL0-O)87 TTW<J0OS;BI__#9VM78] =9)?9;L <C::7[IGMT;S]1<J>3SQ??
MT2(AI10E8N;J_67QT2C+>_DXW4&M>NNG0;4394-U&6$(M5=T0SN*PIB&9-'2
M3 .OVHC!G<&:;WH)7Z /E,A7##HPI[RFGU&V<R=9\S+<7#Q7G>Q[@JU3S 1X
MOE=XE%EBOCLP17,@DSN@&:/NP!520W&I?"-]I-O9N%KKH!G'CRW%1Z)DUGD]
MGMP/@>).E)= <]CFZ;%K?21KWELEJ.>HP99WV&K4EX7:ZOHJB.M:6$<-384L
M55ZQYE![O?='\?LU*0"--;>[^VU;-#T\OS6WM.A904ZZD^1T]@/8TK\[EB,;
M2W307CZK:$?@&%.6Z*>-$4&$4\KBD+[[%FQ<V4HG?*RJ[0H5Q#_7#T57NCI#
MRT./S2O4MVW__+DY:>X"*TV8IP[$0CX8'F-HV#'@-*/%A9[V9YLE4P;':97D
MY<C=7-62*TX=E63XR95]J;=[Z5DV:K7NCE^^WK$S)U@E1C[FF?!IRSEN=N7=
M>O^YA(+%O+U7R<7'2N7HBI\'Y'>0#0Y+3XK._=.$%=AY0P?%7W[V!&X><T6
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M'V" H W)133+B<V-;U__+_;Z8'V8+@W:X+;W3F A!W ,QP%D\#+.< "A( [
M08.@SSJ)'T$SY.#,UY!/:0?E',!^,^KBU,IM971/&?LD!["J*'!(WQ?[F3&=
ML)&#DTP)#F ,DYSU+S,_!]*,TO[PHJ8P>V<8>H?T!3JG\IN-%6">1<\N[-L^
M/U3,T__S"\]M 3XDDG'CT+!+Z3 DR1#)E8Z+C&+:PBWBH>>09$!,TUUFVM2\
M*N?!GIXG\!''P.]<UG"! 1P =-1PFM0>K>D\@O:"\6WFCZSO!I?I^RN_+#B?
M_"B30OFF(*)HJB3[S5NT])R:G&B>_V7YHO)WU1-$L.W&9*'-:'7:WV\3E4\(
M.URA=(HS=#_E/6Q92#5P(6-.K'PU4:WU9:M,U>'Y5U_V_A57Y 3?#6^]=H<:
M<\[9X=G-OJISGR/_+2($8O,L'P[>-L-N[WTHG&3>[:X\[M_DIDLN+6JF7_SY
M\.R7>[Y%IXG:$/[*4^2\=>>&%$<1Z%&EHV4"4;V4P@_3KL87YQ>:L=:X]F<R
M*L_F)]=NK=F4T8=/<P#"F6B=M#%]E3\M_WZ.S"6-Y!ZEI@M$00"&"HR]3=2-
M9U06O ?"M]-.T+OR=YXJYDS]^?>9?^Z;!,)*!^57-1]L?QW\,T0W9_.+L^H,
M(&I?@/P&:K0XLFC>#_!'"R_R+ =P'I%^S,_OP+B,,F1&[?EM;3(L!3KI+"/T
MB_!W;WA3P.F10%$XKX0!A$28+!/H.!VJC"_4"AJYU-VSV=SQ-0F=5(<&VARX
MO^W,Q#"D.YG"P+U7K#<<@!_F'$-@+XDQ2@'&ZQA>8>A1^(RZ\XRK\@(*2YP8
M@]T=%VF3)7%&A^2W40<7@ :!R=?21(<BY++3,[[)Q51<B2^6[JST_77%K[K#
M*FF_2#IDV6;&IG+$/)?H^Q;-6^ ACU7\K!OH %V!WVP+%&:5V)CG]HW5_\2U
MY[MH_>91?-O6<Q__#R:I\C!K04SA'')V5@AR&FDXSPT+65]"/X3FI263)9;/
MPQ]!&7VZWGCM_4W(JSS,%FBQO"5LSL,CV9GU>G>N=M$VPVCJK#SC8[+WNS#Z
MOR;B#GA^J4-TT0NG.M*W(/#X;#2;VZH<<KE2S@8;E772?=]-9@=_BO7%X>P#
MT8SNQUQ"#Z#U=*6^(E'N/M(O9^RLBRLK^-_%>P!S7&4)0HK:&V%E<P /KU_K
M_H4:0Y]K4Z*5(I^%AGN0>?T?^S[-2VU7+Y@\O18\ W66*JQ8,[$8@S@03^ J
M!Z&B6:6\!_;C&O[9#SUW[5 /T%UFH,4"R%'TXAMW(=HMH(@7O3..:4%KV7)I
MIX%3V.?7PQ[%4 IU9@GWG.3;B[^!JU8,9<>VZBS<=@KE*3](5#-8Z[,=QD,B
MO@IYL-2Z$_3:*_3**8,K>4TMY_Q*M1,J7\3H4=ZT%[#RR\0K[L%(!]K7^BQL
M@@.32]+U+U7RJM[63LYR],A'C=D*NSD>X+-Z3;4#4.[^YY=:35ME& &L]DXH
M_@AJ%B3)#*2FG63^14OKW@).,_\>WV!>IXN1'9+E)[3!0&B+^MN],$L<]4!1
M374'?V9-;-^KM!I7C+Q)RW!V)<6_)>(Q;A^:QY;'.C[13;HY !)LCT@3^(3A
M1XVQ%8D&MTN04E_;P(>R_&DBYN[X T9^N4):R )OR5Z'3FO>RFI+8=\KA9B0
M!_#LL5F;\;SS":&P(>-M^L\W$U.@Q7QW+E86VV"%+5K/:"1S /%/B(S841E:
M!'%Z=4&P3M+@$_%&,'YUWZ)WLF#O_M_8@T<NDCSAJ\OQSC,B8H(]JPL-#ILX
M"FA&H0_(WW$.<90<$$/9#.Y#B4O)Z(\D:D/KAL[9[8:WR_.)69H[^0T-OQ\J
M<S5]_&M-9U5L-B0>M[DEU^R3LQ]WW$:5X!$$WT5EPL:ZON)<5'L?L-I\%U?;
MKO50)'EFHO9VE,PRRL]UF4\W,7E,;^/'/]"[)["1B)-EELD*JM>=:\HW%;NZ
M;#"UV1>;N]7534O^^$W@2]OZ^] UWH1PD* )/0$94;6^('C_Z82VAM3:&3Q3
M]IZO3LOMCBBLK_A=DY'4!>NO=4W=B("?Y]XVC^Z>],?[_:PJJ6_(6UA9F"YC
M\USV/X2ZWS2NY#J!5&=,/R2M2':"&5J.2.I! <<,B=3PK1,K8F&H0AA_;A5B
MJB^L(0$J,*OACP\-'W237K<A^LDVZR; ^<O?PT0;.(#3R-.LADX_H!!JHI.[
M38@>T:;AL8A)),U7EHS0&F_2%N*6V/UCL^". ZFJO*RJL+)$M;>U;0AO35^4
M7*M3U4[2[\[:V&_/ML,7-J'DA:,^[AK$73XXV3B!'J;2[CXYN=!M,T@9]/>^
METBQ,]TPT!.->B;Z<BK<U,?&JJ;][\68)+F;03^: X2N=%M_^A&BY$FK3M'?
M$76PX;8,QD:76VO1ZFKL[,1#?&P*?.7?3V(M3.92["R&-0L>"0@D]AAG(8S;
MM<\V&5PI/6>F5="L9(S]GGQ1;*A$P5+)IP3[I70_Z\ 0W?5/BT(_G.1-AGR"
M 6>N$9QU8]F*B!Q+6DQ9\B*C]@TCGY G58R^+ @3[WRQ@^:-R-80@%[B:I^L
M1I/5Q43UO>KW2FJ&&^!^"V-["108WX,O"R9:T(!7N0^S3>Y0$V6M1V13A^K/
M"(L^>73$5E06 */E[SFQ,MJ.O)EQ]N4 ^-@B#*$NW5>.TK<Z1&EI,6UZ[X??
MZCUR.8]SN$NDYGEG.SUR*BM:6W)W^I%G*J=I*K.?1L"(,EWJB^#'&=6?.8"N
MENO-TAH"M]ROAIX4.J)>77^RN[I&(M$H2HB5@)Q[>_J3.%MX_R9BMJM#Z.$T
M\O?Q;J=O68C!XR\^>:P]H%_U>^0ANB3>7!3L7H@4!5O>RWQ0KD2YK/U'055>
ML"4%XKWMA+(PBJ>OQ3I9%KG<3)&E"^(30M?!\T_+S:(K]#.>0(.ZW3^KN8=*
M?\]@O1[5G@,2\OST^Z+>D]9(=H3&E[-KHM;<N  @N+V)6,U,R/F>=Q6OIGY1
MR-CY'+)65D/V;NK\E6K45W>I^DD\$D36.,7HH<B7O;N[1\I'&)F$LW2Z*:#.
MXWW%K:?64&Y?C;1.S7!?\8^HXP"\0'\NL+DY@.HB!0Y@O-$-C]&")!ZRKD8U
M#'B*>;38&>E!V\LMA[AU[Q_/KI5J+ $_"U7-$17O9<7F1GBB@^'2K[\WV>5G
M;L=\,16<)J&<>@W5'C59\M)R$@*="OE/#S(X )FN1WKS\.SOUI2V08VARW^D
M'/(6@PIR+F3+.WXQ!@K3]0HJ?]P;#)[QVOG(O*YJS*V*GGH\$36@.')IF/82
MJQKA6GO&.ELJQM5DO-P."Q:R3S%C)%M'EITSRDY,$7/@VW1S^BRB83XSLCK"
M@WQ*F^^LGD4XN'YEVBR"!-UK+*[=I:>F[S]8@S?;>1)_)GTTEZE5-JZ5Z\Q7
MD3V=J_!*!FY"[TS6THCKX*-#T@RLGJ@:Z"YV\L/<E:?P_ (S=2E'+9LGM+FS
MS-7_"$Y.VDC<CTVWJ,%_.:1V0\U)D _XW(K47XR,=S-,M3&M.<L%M_JO^*I=
M1Z85164V4-;*R7$M[UV^/\S_?(*XKF,ZR2G/UO'VQH"P*;639IT6*25  V^
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MG&@O\S44']=8M+AFS3\BDEK\W5='0R)[BE?SK1MX0W\8=R+%XSJK[XG1>3W
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M]-N;OL]Y<.3SSM%+&S+>)'<9]8P0?I'<D_TCVY.0SSUV\/S.Z(W !3W_@-+
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M,\4:< C*#OSSZM(O.'L3],I7QX6JOQU;J%&9JQW#,Z^UML$F6I_>[&-(&)I
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MRWKH5D'DD#2QCM=H-AP\=UO+B/>]4;Z8DJA]B?>A$\K4[-VF57;K+]<BKE0
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MX;_W:FMCOFI\/ ,=-] XX<]FNB!DB]U?\K 4+)6=#*57,0C$S+8"($KG"W\
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M534W-;7Q:WST89=/I+/.=#Q]/=XLL>.'H9H^+%.UM/KGG-.AO1VVTM)F59P
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M]$K9A]]HIS$^E7(0?KC_2,)/J]?[T/# )PT/'R=0K(P+ 2\VCR_C(CR-\H#
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M3+?/@4/VIL+YUN:VP'&=WBP0U=!BUGSD8.A^"ZUI2[F2*3&A9ZR6$#PZF^X
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M#E9Z\ )U.%S!M!A)]_&K8LV<=[G W:8SA"$0U;R&%]5Y&^%!1?6#<:&=# %
M7KL5!?670IC34#U@<?8XB-JA!4FD\EF<76>+3[=+DW.W3SH)G%[%GYJ8N=L\
M&0SA[U1OD#A1Y5NV;B*SMTF?K$MJG.B)\&0Y"K]?MT&V&)ANB"4TETU$]NN!
MZC*D551-9A[J7'Y<'AQR?#=A[\$_SM^M]C*O:PV<G/!EJ$$_H;4,I'U4;WYO
M!+_#JJ423^Q:1(:B&_PR:=RWIO \#^$W7&B[,STW+YCF6QM:\,+=YQ^TT$X4
MOX+29W0S?D*/FDQ6U027J7A.NT\^J=8LPN2;:S?4Y)#_<]^K,QT^Q &IOT3I
MJ=0TH(D<D1H3 N*!!GFS-9N2"VFX%'09X"H@Y!,J(YYH3)7!5,SZM 9O%,&_
M'W)UAW64M;]0J_0M]HVB$7OQ)VG$#_Z '*@/$OL*\0>K@!E1@YP'-9H 1B3I
M[<TVBJI7'^08\SH&X4V3CW*;;C^^-&QD/['E7UP[]HTJWY,O<9/??]=N?,O_
M=Z>OX9:3OCA)CYUMIK#3DD4W.!I<!]G,9P@B)*B-\<4^(%$.+!)?@/F9NHVM
M3\[X- 5Z-UFM<R ZN\HUAAA1*5ZU22#)3FOQ81/7LGM"3XW*O<]?2GAN[HJ]
MG6G2G),HF-+K]OYGB:X-Q8(_ML2DY+XM,DQ+JB.Q@J(48#-EX6DW4?)H'IZP
MT#YXQ;FA?,3'>*!E,MTRVE?+[U%U;D=+47$U<INC)G_*>UL:"'/]O[WN/JT%
MCC=B6AURC?_QJ\SWKV<V"&_#_NV,Q]HT( IP[%7R._AMV'XX?0PX4HZ<1-7+
M]UJ\<-1N\20->_1+(/\*3O:P-B::X:80:APS"\"'S%.M&*H=4^/0O6R\3&0?
M'>8$2WRMZN>9<](S2],0M15*':*@>@E1CJE1!*_M^ UJ-IF_#U>\:$1^-H4;
M%=@_N%DS9UA45/,2H>59!IN3=-5KG/GMD,NT(6N)E;KI6\=7GH^219&(:*HM
M^N#F*',6/ <^Y'K=.E=PJ?I<A\2.F[Q5C$E(^<B8CY;BB$84='7K8JZ9PQ9N
M;B<0,2/YZO&LZ_.L*9L@J5SUSL?-O./12GU9.I=[QGM)/H/Y!@HV-AMC&'F>
MWBYHX(#F'-B)X$[\2P*]V<)09RH#(E6P+'W9:82 &UD(NR'AN'#I34@%O*A/
MYCPMJU FG]X6;HIY7]]&.S6M';@P-[]@X>\K-=$M7/U1_UW-"H$MO<_!-8=#
MKJ*%0Z[A=%;1(==^8M&_KI97)52]K+(7M,OXZKCKY5CD7*Z;^7A%.ZW.>-!L
MUD&U8;HO((<2M$G4&M50>E7U>N5ZR@VM_NGD:U;)SGX>\=BD7IMD)9\K&/&9
M*BN3O N%Q_;=TXQ!'NQ/**K%Z%G$"58S&&HQ5V1-&XFK@OM3A "Z!2\0V">Y
M.Z.Y!V13OLJ33[?K_>&GXKMYWD7VP?B,V3BXOB;D:+B7>G,[0W-5UG\RY]>0
MTO^V ?B_ER9$7KO7XF3M!7G,GY:81#L^2+!9[;H265?G-]>XZ[=M9K73C$[X
MB;_RZ<I^041\K+)X[-#5A7?))L$*)(K4.=N86"$>;MXKT9Y:YE)32IK+5L68
M2^,^REL"<XGT8S2U_NUY)SJ$519<(^GM*!^'Y#5;>J-G3]JZK?K'AF,:4Q=X
M48$P^$P@R6A/BVIK2#M93H%,IV:L.B9B\C.,0Q[/:-3&$AXH_YJF&H=$==JA
M5O? /Q\=<GESXLI]]5\7:SC;T7S?X--E%7LVO>B6W/$A'K/ATJF\_'^F%AL3
M7*2S0GH=9LYX,F]D?GO]VJZ36NU@K3A0WA>C9%48B4W$)N4IF>=Y*/T,@5VK
MR)0J+N_*TQ\*9)WC &0*^Z.^' NG?P2*XFL'D9,%N@HN4?=Z4@68M\9K$"9J
M?3'P ]<X,IK_Z]I<])Q++*;,J3@'E;!]>>M;8VU>[M -;T^>8W4?T0\1X@!2
M7P@! BRIE3Z@N6X2NAOR&Q,L49@ZJ/LWU2MFAW :Y2WV7J^F$?68533T8?:;
M[X=>I!0'90G@)2QX)QR]7X=J0!URJ0>C_GO)]$JO!9_I<:5 >)B6CQU&\I:6
M545D;B"0TQ!L-LO1TUL30KT.TVJQ5T<$:N*CZU30&OW? *FKA29:BI0@I6!%
M=R^5NW]B;:*2CZU-Y.6Y*64Z$C1M4(6\S%;.._!'?I"18\5MXV^Z -G]$J))
MW+W2X=V*I-[/I$E9;5=1*J) *=NT99I-]'"_,+,]FH!QN3WX87%MNFOP7!,A
M[],&J ]-W1X%E$99,BOL)^@MT"'7)Q?0?R\)UY^RE=)7YC//RY3R>G_0XQ@5
M>-!A 3,9#^O/\FUZ7%,_3G_N)>+E8'BKIUWC14]7ED7OD+S#-QD;19L"N4</
M9[^)^]=776MM1GDDE%\?^C(H,Z5ODC=F#/H<@W1!?SG:@Z;^#&"$"$BNHJAQ
MJ#_]_;E?UW#B18XC)(O8(D< G7\$=@0V"9L"FTDP-$P734^E9SUA]]*=S2#B
M_P_M0&V)5>;9374SMSR8/E=]&C<I-WR;(-^0\ UP6K9+J[?["O.(@V-U29 M
MXJ;S_2O$#=#IQPCEW*#/)9#Y?UKZWQ^P)?2GK](UL+MASKBU'U.8H>_&+L2#
M,S61X"4,\8<[&@3>E%Y"L1S8/#7I8*_1+VULWIO40RX*Z"^F&^T&G0 1 H[>
MGE&M0=B3ZFEQ%+74TX2BNZ8N:WPDH@3<P^+S)=];W+,QR\,+5]?(=Y[[N,)?
M26Z  <4]YFM,_RB#&\ZQ@QTJ$H9^,YB7FYBX''8#I9:]X;%R:AN0\V>^AGQ(
M990?<AVT(,_/K!H@.6C3J8SZIXM]#/75XI!K:HAVFG!;<8(M#?XUP='XCU]#
MM4^#_U%EN**^&"VML#.8CVJ(!\Q?U6,IU$<G>ONOCO:=HRQ%8("3+,502]WL
M14Y2+#YB(&SW0>0;2!Q_%7&-A<9+P+'DO=Z:L_-PTP_Z_'4)>R[3U6ZMK>I\
MV+8(_:[Q\<$^R<1YEI'5I-^6)DN_;V01EH@=>NU^=S]1#3/3AV[";-9',/Y$
MCB#/ \9O@9RA+IFKC3-,-4K-D8V<WC>3"!V!)#WQBOX*J%V!XH3=XKHI\?3Z
M*U;-_<EC=C-6LZQJ5;,G(1;O\R_O(504+(1NB^6D9,F$E/=UW,,."N>EY66E
M31E^9]8W,M.:E-^T*!AW*IH9-&/J,QLL_/ ^#!<_1".!Z@#Z2R+0.^R0*X5]
M%#D'XL4+PQ.^34NK4?I[_&>_'7(9 3<#?)_K:=/GBO7/3[0;5<)$'8-'=:^:
M>I V6F9O]=8^2P;MAAM-[1#.0"5<"87KY\+^-^K>.ZC)]FL7C14!,=([4>D@
MH/0F>2V =.E2(X(@("!- X3DE5Y%J5*C0@P]TGLBA*(@(ETZ"2+2)!&!1TC"
MCK\]>\_^??-^WSE[SYQSYOSQ3"8#<\]ZGK76M:XKSWVOA4^L]I[0QJ>5K^YQ
MSGWQ"7?%^/'^0)?>GKLVQ#%8N%GR>7;&^<:@R.?^=''EM]+4>$=Z,\+^Y7?M
M^ TF?SAA2\]5@T8Q1(":DGF$"@%874Q^OF0Q5==306XS&%YQ.@2==1HL=46H
M-;=$'7RJ%WKSJM+%._BZ8@5B6K0C,5L@]!#$0;L!=!X8-=&X,W9] 305O.M"
MSX&ZPV+09_SU%($ADF=;Z2&H:W92+4!D]=(\$_?=282$UNWUO)Q8OW,4[XS;
MT;?SR#\8Y @S6_\':O*^')<5KI3_]A.<R<YXUUL@-UF6"'^Q]%;M4N:<IER]
M[W":ZGKYN/=PR)T2C/;8[VS1-W^V =JW9]G-WBW[&2%74R:Q<+%8^IZ8S?+'
M^23E.K3%C*,\-:*7P4,O@]Z!3:WLKE/MDPC> =RT($ 2BQ :4P-/S?1 >-J]
MJH'XW:<4<'<5S+29,M@N=HYJ01.?]LPO_3Y OA)AU#X:*FSF8T(*Q3BHQ3U_
MJ3:^ET_M2T$X'1@A>PAO5[K ,UY+2IN&U+X>M!C":Y')^6AJ@!,%W5VD,['%
M. $WM 4*%ZO,R4.],%Z:@JKV!($:00;'MY]W(X,3[//B$W$!FY6ZOE^_[[;R
M8=Y\=W125PT*J)3X[G[?UC:0A]+L>ML.+]5@?*GJ0_\BQF1*ME=MV5)F]'$=
MNO7-<N+7$1NLV&VML;;45[S2PG/JF(^3K=FXJLI-NJHEK&\K!>5W"(H[!!W3
MU2"A4IF?A,5*2'W IL[!#3BJ1X]G7#>,8DBVB&4H?:&Q ;A7KNMYMM@471T2
MY 200VI\0B+$#T][VPNE_N+G EX+YSY0D#)C\Y-WC=23Q3?3:P]! 81C\-'=
M3T#L@0;"B%[/D&#TH.J&WA5J&(Z&SGDMQL>W!T-[AE(6>-1.D?&3JILJ?7JL
ME(#D'S1VTM"):299N]Q:S^DC5*#R=G3G_98[FNBB%!>('REPWW31LL99666S
MB+(-W_:^%6MN*O']HKYKV-W[Y58Q6EZ#TAIFUN4D>6'C0;S-:)3)M'4@8LW,
MU<>YIC:F)>.QG9U%G@8CO13W;@&06MFL*IZE7:57XP4=D2/S5^B54"]P%(3C
M%RJ5 ,:KT\Q'VJ][4Z^;4G:J<[6H>]$TZ\@E!>&N_85$J9%JOYAIUXK2+X[Z
M#_V4_-WRA'UWZM]2TF**CM(K&?*H3BW:XX,[B ?T%L+]H=C+JW@N8(JZ0K*(
M88C2KN*'JT4O8B8:.D ((^K3:C48#SR?V/IQ_TKUD\6M.#'1-LI>7'T 6%1J
MZ69CCA-5#'<?,+E09ESE"$^Y<8F*M3]AP%5F>+;<MD@[<VTDY7Z$FB/O>0'&
M?N'-GM&L4;^?VU8]L@:*9X/]U21&,A5XC4H_M 0'-3?2I_3Q]T8C4&:J]A]A
M-5Y/$8^I&KLWZ?F,\PBSQ^@^O#*@M@CAA.?M.\%JALH7UHK$:EJ$YGH:C?6#
MJV?:A7K>Q[HU>F^51/CZFCQ*FE;"^O96F=OXC!=+\\O92IN;*U*#8@J<DD>H
M?BXZ\L5OE/(NIP\;2>'PY?NQ/)8.*?_6\94$GGZ\*TU9Z&4-: ];%%RD!/3H
M'Z56BRL%O +>_#RM:U91U9JK.N>2I)2%FSJ?]16T9C>9XM[2>(!/^NU_>1$O
MO#2;CK_:(WA/9$"IDH[1\QWM7JRQ3"DV$?Z[Y]KX6WB_7-!NZ/=^A5YKC*5-
ML15&]D!0+#*/\DVOZ%[FW978[E'GV@:,<0??:!&$V\ >ZQIK;CMH[EU1^DE1
M39RU[Z<XR6(3384LNC9 NIC4FX@\'XQIFJJBN5V46NK.SOX[H<IS["RD#DXT
MT+G=@UMM"EH#'ZT[!'7_O'L460H8]B)YJ+NQWN2 D[[[L,00X47D4-FJAN6<
M4^Y9L/K\'>S'AK:_WYKDRY?$_9@P[0L\;76T^!@9UH6*/P3Q_V*AK'1#.+ZL
M[QX;C-!Z8WT&4S([ ,D.4(TT/R;ZHS#DY-R0G[+$VFOY%RM_UYO]SB"G?:E8
MZGN7ZKK>NU#'TFUF;_V$-0]VYD.8'P;^U.1^T_OLID>3Y^ 6O7:46,4[8PH;
M$MEV3W5<+GR[(\*0-D JP76SA>#.CU.*(&[DXKAN-Q<YI+B'@+%WT# N+L,&
M_CI+"-6&D;.ZO39B'BH=1>SB >,+X-)/(0VI#Z!'J0IV<SZVF<M=O[.\ ZP*
M;Q_\UETS_IF7!X?+&\AU.!B_VM_31YK#51ALLF3<R05L#).7HV/#\1F54YEQ
M![:?-[##H39'IJ%Z>YV,<^JDW,:M;/* ?>.3*0GU5KC=S9P?T*/(L040\@*F
MF;+5O<6A'_&PV/,YF9T &*BA5)\)S>N(1H;\5OQV_1GRG?_2P]//C22N?\1]
M;K;H17-H]E3J.?0(B(AY"T9H_^:+D'Z^ D=<0]0138[D1KJ&KHWDM%@N8I(P
M@O?+Z[X%%QTEMZ=&F+I:)N!B?/.*W'(D7RS*68?WEG>3KE1Z=_G>+E]+F3XX
MM7\TR4?[9J*$?ZWAA8J^"Y="0AX*N@@:V=E9L;V5.'OU>+0Y;FS4S$4'6^[K
MV8:&-)+^]9[Q:FBHKWN VMSF8$<AIE50NK4U3R<"+B[JD>?M()[*\NB1K>@@
M8G)I:P:\^Q@($^U:@W'6%T981@>E0CJ9T,QJ^ZM.1K+JX[1EOG%][D/;7DS9
M[=>:/^<F3!7@82O<#U=.DXJ4$NIFB\6),OW&C;XO2)<X\YZNY4SXC(9ZSC^/
ME=3Z9&9P.<@;>EVI/]ATNOQ5UO*7V:X*[Z [E/&:,PH[Z-J83'Y[V>8>!2<3
MZ]76[:U$" _M&"7CKXQNPEE=$RP0829V=QKS,7^'PXHLL<V1G?:F2^S IET^
MZDY=E%TJ.%\KZ428_;9T]T+3G[<FC[?AUYEUW[[<:=Z9DVL]QPY*R81'S0L^
MCFEG#/YIF4.BEQS=TQ[L;7 3DJC<*- -9T+F$]U(*M@IN0_5 .X6M;89\W>0
M:J9\0E=\J%Q7[JUV>: &Y3;=ONW]Z/DS=\8GRE>-QG6_<R:BYIW#UY"2250B
MI*?!9]F5[6&16R^ ][J&Y?T6<ED+<G395FE +FO[M,>E+Y6?,"<QLG<>/GQE
MU\ZOQ]<0$00E%)-VA25B+A=$%KK5LJG;GL]PDS:Y1!;Q>) 7JZO&:EL<DWIC
MY';2SS*VH)$&;=]Y9Z^T?^E*9O S6H(IN-UPRD0-"7=B0/QZU7J 5MU80'T9
MX9$7U;4IX)L#W-TPZWA^?:3>VH\#ZR-5R-&R,,)4PQYX8_) ',Z_&UEOYEP+
M%)/5EM'/RX#:'V>??REYKS>*A?L,#J \O]1\#';1T<.6G@NHM^"MJXJ!&, U
M.L6X@(B7TW#W3CW(J*[:RRG_2][3+JV=G%E=B8K^$CK8]G:T3W[RS >OMN8[
M0F%?_7W+<(^C=2]DL^O$B\(3"TV>TOX*A-GVD67*M?A/6_L<@JQ)#S 8$U:A
M('_H-*\LD=\!%\ &-QZO,6\J1 ?6=M_;BF]V!S4_CJNF-PIE&5I?&L2\WOV-
M5_\16I!NL3:<4<Q^H&5<+SN\>X_'$M8(.?K/^R?^_>*E0#?_[%2:I;] W6]1
M4JNRZ*I%7*$.#H=Y4 G$)_=>+LS/-HY^6Y_6F9H%(ER]7<XZS\VM)E9^X/M.
MFE!(#H#A9:HH0($!W^N*^"JK5/W=L@^]Z_79(VGP#YKXTM_^2HO(LTNTUV^N
M]Q9H9 :J6]NV1%IH=%KV=*7:M=B)LUL%[GZY:&-/H<*-,R^K[F'M+C(>51,6
MT5#*+<B4(L,O8/<FL !-15P1[<X1[YIP["#$5E?_]<SLFP\!3/,-*Z5I3GC<
MF'T37&Z!T@D;\'/C;/Y9]!%*L5Z80>VB\N3!T]&[=P\>H8\GLJ_GB(E1H42=
M-LI'<>\[U+,-5'!4PP78!:F1D-)S81K7OQWK1UW/$JG1U[6ZJALX>/K]L,GI
MTEK]B_X85RWQAY;#8UD>=VPSGUT]V1&PV3Q9^[&6)J6U4_F:\B47E=0@#/L@
M(_D(I87JKB0W&UBAHUQ5X,])MB>D=:$<$[U62WB6+N,]F#VI6K( *_88XV#[
M9V)#ED3F@T.0H*XXD^6WT M#+>24!&@:0!U)]NN[L/IUV&DXUI0)T)S9I% Z
MOY6<CD!(F$/;Z\F6VZA.)NMW.Q@DW <2R2[RCU1V#T'QKFH9GJ@.>D[QFD-?
M9'Y''<P):-MUI>?3PKXU)3..(R0FJZ7F\(SM=V("0J4*>RGA[=H/'$LD6VN2
M-MG/EJ3;WJ3*'X( J;X-:)G_@>$&G52ZYP6],ZGKBPEE;.W"$BMW#_QZ=:QV
MVZ]8.Y!4Y,"_[]L7VT$C/4I\FB-6T9FN3X]U6QR#MQ8@16"\#W.X/33+LT?W
M7B %JG0O:C4A4J>^UVLF+P#RX UYG[:70%O9FB%HHQ;PI:JKLQR4K.EQOC5]
M&G_&?CCA6WM?#X3B0)@"7T]\FNA-=>H-SM)S#E>*WE#]_GC[B2Y#FGHFBHH%
MU1$#@A8Y$UY\!0<SR6V4&[*KD:,5_'>X1WS@ U=@ANQ?TB)1\& ,X1N2'P0W
M:P.]8P,=[9 FPMY.;CPAR68O&=(+]7AUOU\W5&PA^2KQU)L30LEZ,D)]61?0
MN1YIOA6@SFC0_172>U\AP0:[1EL?-V_LUSGY^O;/\_:_OGR$AB:3T<4X\+5P
M$^YG7PO"\L@RBG7%AKIE(E>,%)]7_6A;=__9U(VF..+XX*U4A,X!E/%Q/[N-
M+/R2Z;D +I_IG$0ER7,Q?^$Y*'8Y'#OO9ON=B63;Y9@[]Z(G90-?,?6ZVR'(
M=S#O49/:(>@=Y.B:1'+-Q6<TL?JFJ""\7\=<=M%T?,\!(';6<D/)O;TF!'QB
M,MLKXR,C6A7,#O?JRD;?H1#B0Y0XOM (WQU//L=^WT6?.P\=KE^/N(_\JUOI
MP\^HOWK-_$<=&L%@!BG3S=O,SXE7:TE.&MLAAK1E?=0PLOFY%V4(X]+LT01:
M?J4NS9\;6%M-('TZ\NX>4LBCX7M;\)W [?YL%?Z\.VN2/OAQTKJ9CFR7D2G-
M#1!FHHD[H$%BG['@0H10LSNH.3 '_$SPR^G*>5Z*35.:3)'%)N>)N84D-7+=
MZ=R2B5_)OI^WV>E2'CD#%I,$5@#:573L\P-=A44TQW<D%V4^YVR\Q>=V'<S4
M_7W;$C?;P!.I,9><BB_=\LCPRI7G^*G2<C%<6_Y3SS>!CR&9-;<3QYN(?&/>
M?335Q>)3NZU) 15>FTA1X H)&RM@1-)DB5$NB+)=?)7\4=:Z+/E3(-7N4=\*
M?/]%Y:3@F=!-7CG@PW#,+,:X0+$K2:9:Y=?;?^CE L+%0[W1@/3"._0TJA<O
M I15^\"XD3P(+PHFR=M1NC?MB9A6,Q! E>.0$\S[-FG>/.%6,WXQ@/RV]1':
MO!D_4JWTZ^<01^%7OA&C8_0^?;_KG#!V2UOB>*%0HK'NYPRS7N.1E%9C94=C
M97.E<H]/9\O$''J,-<R'6L?5IJI3?1 G*.(,UC[*]<6<[H. U.F^%+P6\C,3
M2>K;V N5B 3N0Y W.G$/S=MN3S)A?V]6]=%5.$QU3MAXU"O]/?U)*"=FH&SF
MB^I$=L[;JX_#<_2\J! &*_^!"D*?NI6FZURD2G^%AP!.9$(2.(5QD<8->%']
ME[K0QQE20)Y7NLMU6^KC:'M]?%LSVKHHHNQ';VZU=R!1<N[]:'J7EJ,VW>AU
MJYWWB][*BCY!%]M,<:,/%OKF7-]BQ"%1G#$=@$Q/D%F+P8C?L^^6@98A2_WY
M656[1:E-;7[W9\)+,H8A<C!&'Y3E!U*!,0CCJQ2?I%V1WB@D087@.HLKQ+F3
M*P;U@&_Q*EZ;,D>(:7"JZ#BS=+5MO&1L,T3'1,=%>XW8+>0C[C!C%GF"]ES>
M%C5=L7L)@!ZXK#+8(6>KVX-)3(15'?_1L, 4VCP,7G@Y[#C-E"*&0?%PP@9(
M0YR8HN+CLA&[.H)OHO;,\#'.7QQ<KCUW_JO6?B+$[G(O^955ZNW),J$7\'X>
MSY+?KP0_88QZ],J#J^RLK0@Z97J^;X;-"S4$]7N"!K&2P_6O,W[6IE@U5/57
MU5 #-GH.6!#<].QV0S(A04QXC"%!LP#:EB*"W<BX5*@(PA?:#4O2QF=Z16W^
MRD5<5WB:X^?G=F6S72/'V_V-XR JF$<)=>5]8\-M))P:3^/<VO6@6B32?,N\
MD7I,N24"L),M$OUU7:CLBU B-"7'E1<075((WYG:89_SZDQ\->^*>I,K:1!'
M=*Z)^\3*49V=S5?&<YE1.>QDJ/KQO!T&3EXO;W 7,$=LMA@4%JIYP7%> 7-!
MF U&GZQB+#\OO[GB93^,7_Z"R\YZ=8<_XOF2TA?L8EIRVD:'N^^]2D"^"U:K
MD5J_!4'(4%BB/(=5ATY^J/Z>;>3]$LWMX"-T!E>V=NE[M>28@N1H@Q_$JGE<
M<4MIQ^SZK2+2AW6&).,CXQA00VU;9.D+X%LKDL_IAM2%]J4%,"" ZZ?M&\F=
M]N%]W0ILD\3]HA:R+WL:>,XW+QM;XC#E. L/W*!=QTROYE"2L0VM7EFP[TGR
M)Y*[L?R;Y:YG<>;*0>V9E^5>=\MW!-C:EF*E?J-UQG!>'/9R=8%^(>U:8:HS
M<\NIZ:-_O4Z2+WC[_]D4SU^6L-.H3F.\%+"PN+=A2!TE@XF%X=M=#.41528W
M6)TV3%"=<N4P,;;@H1E3 F(:=#JTOTD9/=@Y/J(VLU/3$3OA*_\F:8V/JRNN
MHSU>!M<M^,/D&<G'JCCQT_:#-AGB>-7@AK?]QYK,AS8^=E]3L!NOK.KO6:<K
MYUQ U/B_+^WIMTP:[C>6[:B>:]!;>8UGTL$H'X0IE= +_I*V".L&)TS3MY)T
MW2N^P"<MQFE7R_KWA+++\?Q SA*4=37',76L\N?<0N/S5U\4-K]^&G5UKFQ2
MKDFWP[7*#-4FT:!%*PYGY#!R7PHRU#\&I>@[ZL[W5B&:!)U..&(4X;W(_E"9
M?IO?2X)!:H,\/Z(L S-?[P1F)/OZ8N^\)K"A[H*G@Y=0W6F [,IF+B6CMTAO
MHF$K7DPP9TD"*4")W?PX>A\O"(M#"2"N+%IPH,%?/HA?+:G[+A0[LGYR4)PQ
MV7&OHVU.618WY[/3/!!S>98WSRVHDL@9USW1X_';/)CMA:'E:*K().MI&YF!
MZ:Z"#@R_K%6^4:^Y7."CK(PR%G-CA3>S[@K0=IQ?Q E>P.\@!#E"$&((,>NS
M">$N-%:,E?JCZ25"AWIOJ,N6"HNI5%R)-J#^!:12<UPI_ F&"1>+GY\;CT%"
M1C<S;CIU9X54+.Y-O/(*&C_(,$F &XH26^S9/+]4&@@UB"GTRWT#M$-$+;SC
M,":"3J=6[X:1!%K3;4BVVD&9?I:=;9TM7-$Q;E*CUFG*#;_L&UM/\/[68D9'
M.C!)-5P,V"@C5460-%(:"$> Z.Y#D!!->I%NV*TG@F\>V7E?+]M^GGJLNXEO
M&HGUEK"W P>7 NXF)HE^7^VSWSM/:_RH]N#=(VP,DS<?DUDVE@Z@P'8/_[6#
M;KPZ($FIZ)F_T''J G_>5J(NZ\MU[8;/B4:W>WKHF]V=1\X?VV0YFN)U:NDM
M0C2#6FAJ('3[](K&QY_A K=;T8X8>P7,M9)UVW9>)2_[Z4^7+/,S(_."[/*6
M182P0CEVF056ZYB&C8A[//8D%(TS8_<%,'-PU0?5< ,BH!M9!9"5P$#T.[%S
ME)_K]M8NJ4=A@A;4DPHPD^'V50G&X&=.70U,*E2_X>=&)9OY9P,A\C57BR[-
MC94X34+20R!%31=RLN]\-A1L.[;_23+PI+NU(C'2UH#K#3W5,:@0Y:L9D1H4
M;+S*&9TI9Z;F@VAR@>G4-F&=T*U,\12[LIL+3*,6FX[M(@]!,7N.AZ!8354P
M8$@@P9++XN,^PBB#7N2AW;)1W85:412#:_L;ZL$+_!3]Q<D<PL8[-DWKF,!9
M)T9MI"%G'#/)*T2D"P(?J:PKOMX%1'+6%FX32?0":809K)(X)5>029\*-M=V
MCA'YO3'R->;-UKC!I,F0]=XU_*E_ZEV,W_NG=TS/T9U*E(&?'H(+_S"0D;;W
MS\>=K; T;=1B&B/][__L5<^_]D5H'H*>-6V&_>E]$8W>MZ:F$U!KEY@9$$_O
M. 1A;AY-DJGZ6W[;<'>"7L"4XPKN2]+OTF98=LV8#T[:!9BD*)DP"4-H6AR4
M,^#>2+L6%4KJ2TU7'5/-YPA7X0GG3ZC/C^]H?=O<WC:Z@74:JC<KE5^U]-9>
M6 WE'8[M'NNRLRTK-?LYAM4.=1\RKI)[FZ5=OV:PVFS.E>F"$90ONV:9GI)I
M$U4F9C<]KDK>E.E7,%:V<%(=^3XZ]2;?D SN Y_^[^/) H9 'PY4$2;T;*08
MHP_%0@LH QR02C3C":06(+V4D[B%T"#-H<RI5^9PQ 4.N-RT0/VFXX'5\*^M
MMZB G*=@A=<Y]O5<#1M7-)(99Y'3T%JO33=JWQ)JHY#"K'_U"\2T:0O25B<,
M[#O/-8F4![Q( 4EZH@!AT?[O&=)03(.#FA)O9':?*^5CJU:&Y?A%U6\9MN/5
M6]A&D]13WKN3_(0Z'OOPP16! YD[E%M=FK8Q%&/-G&L5%=9@N^""E:1LA;'@
M+K>">R*F85=2W'E>?\5D$+%;VEDN-\CC!J0A,5N9DO2HV"HM+%S]=[[_KB\%
MO03="#QXR+SC))HA98$LG:P&2X$*0WV@TU 2(1FO"?<<( LY(30 ,,5GIGN7
M(8FGP(C"*$$@WWQTLQY\LI#=T,]QM.ORAPK?:0R]FX]O7KQ^Q"\T&==$6'Q)
MJ//J1J=!3^H)]U#.;!&UH3U#4TM+Z*ZM:6F2U'.RJ@GTE*^>#&!-KSF90XJ\
MU2.0-&#>7#OQPW$X,, SX.+&@Q_5%Q](%:V!\:65\[Z)H9=V>&2NDFIX:RZE
MR,J,!N&$5%?,;;;>K\IIAH>X"_0J6-L%!=5GW(8[>K?@X08<+:Y&5S^\P?@N
MY)F;[SD/^=Y'.M%TJ!HT7L@2J@<6WT?^TW0,Q.A&G=05+'/T17&)C^H&4[:6
M5KHA*5%=$@ZZPB\M K#KCM)1NO*XN:W(Z[<B?,'\]Z?#V-_X3CXN/8YWJD!<
MIK<0/)2F W;S@8R#R[2C%/M-,TK=;L5D"#2!>S6OJ8=PFB9%#>A:2&C4OO(I
M)U(1&TC."' G6YP:"-5MJGBSRFE2/NN@EEH2GIT5ZAL16,H8M#37RD_!#CQY
M9Q!K+!=K*N$]:>/%:Z<VMF)Y5Z])[GG%J7Z5;,DIQ1M9ZHM]UU9=J^PU!W)M
M_'4_-#>KYDC7&?74C\3AYH$&J#A2CL;,P:@$8&GW!!U#N[PT:$\D<*&\46GJ
M/[^[<@*6E!\61P"5=PNG=$\L<1@:?Z89+5;I].;]8@BV4I6^Z(I&DB-2O1RI
MT$3:U<@(F8:1>N^ O[/7+=</00\.05-IY'D",_5_4B8W0@^N $@.E'7;"/X$
M0FA2J:HAX P0#@4CU"B1>W%IR30'GB+)"55YDTS&$*7687:UL=AR0FFS(3^S
M=J1:D=W";S]>WS38^',A:]=3/C&B$/5SC,Q/ZU";^UT%]TX9RXZ4E&*/5VG(
MCF<9C67^R'_%5U)0KN>#_- D/Y#]T^_-*&+DV^/P"HET(PDWN!,QW"(:H4(:
M.G5?_1#D\;E=_I6WF/"PG]%IO_I"L$73J.IZ4*>-1H:7[^DPMI>;[V]I"M=;
MN@;_:W+%3,"C^2J"^F!Z;>W4_:@DF9(C^KQ]\"TR2S12$'BTU5.D33T1'Z\J
M?"%186>[Q=LKXW&6]SWOHV9AI:X?>3^JVZGO\5N5WUQEO3F7@^9/Z;H'.!OH
M0)*(BV]O&UOCDGK(Z]9$MX=CLOK]&)^==6.>TA$LS[)VEK2 @6R+ZO,J-MX:
MM3(WRI@/^3(O5LCFOB56NZ%\+'\Y5CMD$:/UR0PCT*MHUB8Q]648EE-TD>G8
MEW"P>4?>0B<SQ(S(R3<3;Q F&MK ; I$V<YT8?A%73/-)[_OSY/\5N33E*>E
M).V?'H+B2P]!XZQ_1A(<@L@_">">2*EVCL[)LKBJOA=A8QAI01/V]$!U[6CO
MJ59XY1F3A*Z)-.^1*DVU\@S#[SP(*2I;A^9X_!G;%,_,]*JT_H?C7.$'8X$"
M^[8O#WH?IF0/2B%;+6'/490=R/XKZ.^,0Q#-U?(0!&9>Y=Q_IG4<@GJ6@P]!
MW2-PYE?]28:OB/LAZ#,51[L&YH1^+V+:U6AX"!I2V1E)HB7_1VO3@/ T^BWT
MGTD%#"690U!B"46:D8RC36@R*?BKQ4-0PE6R-)U[X7?V^T/0[V__-TR!4%6+
MCA^"AD,/07E] H>@7[H0ZBG=&X>@UQ&'(.4IR"%(=V@,S0]P=R*AH\*&U*;8
M>@BO=XG>@$NP:?T8U\G(-DQ]1$*1DTY:EO&L8[M*L5SMS<J7:4F( &9>D  P
M646M+[8:8;LHW*<XK/_&)]II>+@@'3' $:D4,,6#3M>)]!RW010O3_,3H:0U
MZ,XUU+;T(0AH+V:(%1^";*3_3&@Y!"7W WA9*NH[NG> H5R)-"FTO;4;V$,&
ME)+MW,SYFB1%^M/ 5GW#J>E[WG?OU#NZR$=,08_#!Y]! 4.B.^7LMV\A,BM3
M\EW]]@152I:*%JE<9Z=0]HKC5 V:\@Y2#WXR (F%UE^8ZF-7<3)0@PK".9-^
M7#QB=G0%%BOZY'=.8&IN@B>;$5:)J 3(/OI;;PB+^$O[XT/1FH_S%RF-;SR/
M%8?A96N2UOZ*]+]&*,7\ETZ3WU;:A+Y^"C87H<*ZS<&8W8<TE1= 6FPQ+Z98
M8*D9=2G=LK8V^%'M1J37&,T#5^W=67"Y<*C*=(:]:_S-@MT\1)DHM6#O_XJ>
MRR2U9AETW@:P(N?(RB;J:,XC^"'(Y;0GL 2B]6M3/ZB.4I(9;";D!XYK!&XG
M(F5@[X=A:OV@>/^0\^#BH+;O<J\1O:OQ<M\Y:\)_]>"A$^#B!MACT5_)U":5
MDE]9IY&/^WAE^B';/RR+.\<D%B>R5SI:XW>]$BF38!(*Y";=6A8W "!5K$;G
MS<.6]0<Q6[XP3#T?4R]Z]2P(#)U>X-.#BNK?B'**_1O([\VH.YU]=@Z><6LX
MZF9W%C_XP;(&_R6"S((^P,]@73FX C?:_!%: 3X+W]_G<V 'T/;W0Y:4]URD
MKR7?C+JI,C35(*@F,/-<-@L.89)\XAAJ+>80],WB$$0-,Z1=,6246OR9K'((
MXL_:^-I^_9?"AT!VH9H7#U8@@X(FPMU3$ A5U*%??3FS]-MO/?F3&+Z6S%>Q
MT1:N2;.:M+J^@DCI^!"YQ8<3WFX_"_KB?C;K7Q&R[G0OG?2N$LKREK^/K 10
M1%=12E'NR612)/M-RH_G#RZ?S'VU.I'G$@.3*_-HJ(T[=;VV/"XR?P%4QSWH
M-_D5]F]&9:+^S6)8S?"^!9PE#F,!CE\RMI&QC/$>*3:,A>.SY&S(50+6V#.B
M*>=/E62Z"Y1B7AM!.*R[++CD/MG*?54ILPH**C3.[35B0N1<OU7V_659C0J_
MQOD->LAKPH5#T'_EWTF&5,8[]+XB8?OV$H01G_#_$(9,&LO_5/J/H?7O=OV;
M'=&,\RP)Z%\6J&].XH>@E=S]57WDS4YFS-]J\K9QIG'D"5@LI(,360/E#D%M
M/$7'&PQHGL;[A$7L9AW%:TFOV)OT7G$'?!*.W\D6AH*!*H7-I7'%VY</])(K
M'8?T"B,NG[<2=L*.-LBW"$A6Q<S<3GM)&H(@SI';>^.LTP/Q+O:7NL=2+ZH+
MB\8,!CG<]34K'7T57_0X9WFL8K)"ZI5QK%Q&A9W?M0))J>??/(N$J7BSV++4
MCYHHWM-J,BWC%?%5T7WEMY[6EMEIGC:7"UGM]-7.2(JY4("1R/":_&6ICWR'
M^.O/3NL_UP>)IP)?LQVX9%X;I#MXW+NYE,I3]T&\ABTAB5WE,ELYJP3(#*G)
M&$51;J<Q0X5UI\.B$W925^T0Q)[?'>X\ZN C)JW=]9WIDXL!K\^+7=&P;&P<
M4P/S"X?=>#:K5\B74])_S0B[/OG>R9OY]!+H6#7"GV5H:A3W3L>":5@"0P7U
M ,+CPV<M@'N %/V^[N=7NEK3>B)[%FB[-79AM(@L>"3G3R<QO1NR"$%4#MN!
M&(2TK]DJ+YQJ5:C5;QQ[0OJ$VDGRFDV@C]TW,P/97EJUE9]JVK;T:NJO7G+:
MF>;7A-@B/ONNY99O3K%==N1JN:H8HJ= "H'SA5O9TL,I/8NXWM'N.^*NFJ<-
MA+F?]MU]^"77*EM*P/GB):#@BD_?!F:2QK>]^SILKA(O@CC6U 1=([=2]KIU
M/HRAF@+YNV<$%IKD_2"C(P2:WOIN%3/H4 =7F"$O2V7&75$/4FL89DN/SV36
MV!/@5HOMYXQ(DU78KY3, G0RPJX@W\^@\0QGVZ8 25R@NE]6<AC"+ D'N.DF
M1N(A:(,I"&.PW2A&! ^*^(/@L[#/C-2Z!087FI.9&1OV2X4\*+=EZ*\CUW_D
M'((DE("\K1(8713/)"9=*4K,*$?_GR\&H:HMW"3LZR <F)I: ,:X!W6'DO9@
M#0%T9MI-;3$]:,%,5=KNG^E@<\AQPB\FA'@1:))ZS&S9_H+KTY9A$/M1WX_&
MSRDQ;D+)OOCGJ%^/@+I#$-LE JT?V?M/-OQ)[%9Z!;/,,H90@#&"R4-6:F!/
M0RS_Y_.#T9ZANB<CF9#R?9/JQ>!Q0_W.I*?\HPG%#$CH 5--#T/I3%)#R032
MF*SF+D'D>_$!6/80])(-$D+X?8Y)8:KW]9G_-4,>HLDPM<BV[('@/YEA^)]Y
MUW!7C"GA_^+16T7]O'H(XG;YQ61-Q4T]:, REHFLUKLJ_VA(&A YN>ET"&*B
MU"X3I;JLR4PHNY)$"WZ=MJ&+9?PM$SER"/H:S9!J6^4_!!D&)$,IQ>S,BH[=
M\/I'2R#_X&A>8$4?\B7,@@ZZ=<!D!1]8:&:/1Y083Q?X4"0#YJJY%E^&_MF,
M?W2U//53$O3M3_0^Z-6>R2$H'?S_HWB;@ULPV%.IO:.WFC+Z8"Q('GBT,5=:
M@R-@CN('H+?2N0ST.Q@UU0!Y6O:O3T)FVO?<GS08JAT8'<@R9@@GH+ZI8B0:
M:YGS=U?5D:HE=#?T#,)THA$O/?KZ/)^9H<5MZ;P9V.>8S:_556]N#AZYSV]7
MQ]1459MHX!7N.F!-->E%G6"<ASN1'Q/ICG["/4BN\?-C]>NE P+^G%>?;IN.
MG3MAMVT\_F ^4L>F-O,%[J*_UY->B%IG&JG@Y(441H616R"KAOFM3'I!26/J
M3:,/,ATM+XLE(PX^!!&^Z)[??PSO[&PW_-L953BY](,#EX@QT>STU#0]'ES)
MQU>R) 1LY*L0W2@O$I<N4>@;EQQB'QBP\+R28[VS-KF_"=EZE+2=%GT(XJI'
MI:#8]2 TZ\_6'T9H$20%[FZ*H^"-$>^1M>S+%F$E0W*O+^8XZF\[K^8\*"WW
M]Y.<5B=WB!'4"B19^[G-56(PK/I;@OH-$K11,Q7ZYX&ZTV)^.8O!IFV<%OPY
MWV[KJKL]Z;'R&^E>I&:Z)72191LS0M9OE;$]\Y,>D PI>J+/8U/XY+_H.'#D
M?[.]Z^TQAB2$R@Q3HV-[# (Z;6:)8=5QP(V:;/IS\*Z*9:F5\63]-T#'0Y?E
M%VHTZ!'((>C^9Z0.UFD1MA3/R/R;^>?M(09;'8D>T'T(>@O>9"T!(DPZ)D(O
M8X%CM@<GT<=FYT1UB M\NBQD#I]-MQ1^>/T<O\F8FGSZRUHG1U/2[6IP$V,2
M5I^)JD5W5AF29XN.CS/.T],<1NH]/H>T,3,DH3C#YL!\[KK]Q-/<2@YQHR;U
M>=,F]%1.S-SLU,Q%K>9Y]',TA<Z\T084[1.$(2,_3=K8>3C)Z:'UR]N0V_["
MIZ#V;T5\086:=Z6SW4O=W:Z%NK&V!E;)L16\*98^(2W)-UYXS3DCI0KI8&"W
MU3_:M(A\<@CJE WA\"5"WX(W]C#P:)..X1UQ-^HQFX,SKX[-S'% 84#=TER$
M0>M]CR,C"H8&8QMJPG[O5)Q<KBU??0#^//VO$S$'AZ ='V82%T!IM_Y@]L(A
MJ,*>B4TDIMJ(PB8 42+ZW5I[9VVP(@JF>UJ#*DDO[FMGG8\O\GJ*2\TZ99-Y
M7NYYL=R/ L\E?C5>:9ZYYUK!GZP:6C"R3DTJ_@N)A4SA1@<BER+9&6PS!R'K
MK7VQ#1T:^D9XW9NA3@."K][*+A&>(@6H]M%3BH4WK,!G@4<3*_:C[8WN"@7*
M-Q]E72"\%OJ_-K.C6GL)O;.@T>4Y3LFL_>VFK)LO:>-M6Y&0,F$='2=(=EXQ
MSD_N-C,OQ_334R2%S#%>+':A5MCZ]*RJ^[WJ'0Q>WU\+E!D79FA$Q<'9>\.W
M:+S!N\<G55&GU[6S4_SQK%XV=;5YOCQ,$!1?ZDN@V9,7E)=Y>C@_([0>^U6N
M'36P%LW\(!?_B>67.&P(18.B&%6P0Y!*_"$HB0WZ;Z9;D?TU#T$.RDB.?CDW
M6=+Y+D&%!T6%<-L*N]O+3J)._#N)738OW_ZX5*CMVJ]<$78M-/*UK;CQ<^VG
M@5AAIW3=IJVJK:\1331^*%'O'!6R$482#!$5MIS@)BY $,+5OJBIB=JYQOP2
MZ!.\U'WYTMD^MOI$7WI-M;=0V#-9]D"4?]7?/?'?%S;0K]?PPO1LE"<.[-O(
MKVW7\I(& C1>KVO?^^HIWZ%C.\(0A0?U6;YM3?C:%^SU^/C$=J^1[,4''174
M-@:$< BRPS$+#I%)UT] _M>8ENFE]DW"A<47<]UD1XO3O<*J@T4Z;2OD7L3G
M#K\R<UN.#\GT+C]3Z*!=7DDO+S/7^Y2!D;43-1E-U4$H9^(B?V1G_]PY!$73
M3]EO#S(#1X("3D4(5C"^@,D$]G57,7TJ"Q'*GCU>Z5G'TBTFT SD,<Z-//M8
M@5\W-G,W\6TPZT^.]+]^Z9DM&F!""=V1P/ "'X)XF"6+6;[6QIFU11,%O,0^
MI_;M2K,&$MBNLYIPFJ2*$Y]7I18ZOBW[^Q!D7Z?=DJ5AG(21F=P?*V^U7BFS
MF)+ BCW^$>,3-%K&#IL.\HUL$=U=#]X_BUMY 1SK)3+8 5T[A%)E&H<Z,Q]9
M;TXB>Y1V'2A[-.4P"GBWM+TO8S< ,.VD?'N\Q1@Y*?KB=_G0?Q4?EIWM@0PL
M$]-<^UA-1!GU#SW#.L<CJQSKD5A#G7V<GC9:0:YHHAJR5I&>TB)N73A?\J#:
MNFSC]R_"%2WK^8EOC?A'C7V_SL..HSHM"%][]/107W3>,1U41^.&22&'T)3;
MMQG:B+L4Z2YOJ"<=QG0AI<#WT?X%WSR-[C3 5'K$]>NB#W_X.2",-)%A4G\$
M.U:=8YTRY6BH,)1U*>75/A-$(P]!4K+4;4;G/,LA:!R]F ?,PS]Q!SXV5K8P
M:&C*,_#\?WNRHS[OVQ,\EG_]9]?I])NDIT;WGE](DO"6S#:P>:HY;**;KG.V
M-.%EG<K9\I?I?QV?W'8XN$6+G-"[0C,95XMKS=45?CT[MXID&5&F=OJ^)NJ4
MA!?L'N2B&AK>)D>B5 +2+U&^2,1-],_9[Q\'EB/4\RG62R=?/>A1O*C'1_NK
MH^FA<5;>9%=X._72/:*L@[C5J7-1REJXY3>$*&2^LU.>VT/:^<X7IOJF>@ZY
MHWTK#@W:P9EVVG#C+P@]IVM-"BW?W<IU[2[8>"R;8Q['E9.Q<1CQ?9UW(CFL
MCM6/T798MA?M$F^!TSP8GGE1.ZQ5M5R)4H1-!:]!>EY]L9EME+^:1U22#&Y[
MC)'')E/!E]W$/VDW8?=<=>]QSMGIF;]>+*CU=">?OBQU4[CD^3B_Q.GGZ2<T
M>ZTSW4ZU&)L97$X*RL1(WQ/ /)KQDTCW:_*0&C%K3#=JG*DU\ID)N)$^WE3C
MFK1/^C,+J>I6"V W8VOR#*\&/!KZ6_FO5(2SAV??#5M%BWZ>)MYM6#("0DX[
MLCXYST]]&EL*!,-&G26_Y98[-71TN\7=S5,.%AVL7$U4P"F4Y$VL7:AS&KQH
M6HW,T5FL5B:5\]0X&W8YFSUS\QW;50W4FK^>MVPC;[<<O&M3X?XV4W:L[(.@
MR527N7--4$.&5U;.RF\^/ZN0H/9UV8\5UO'U929*'Q_"^Y]A0\7"B&#'DN(S
MGCFJZ:G3]FV&&OH\]A^+WOYWO:RG^37[1I)$V+VL"<VE5(>OZ89W2IE*6:?M
M;'DYN\I9D,3G##^)?+\IR0J_C?2U+W[-_?*OJ1HQN@Z+%4 (3A .ZW;E&OMQ
M<6GLW&B[V6L?1P[:+K?)E7:-SU-KC1,Y7 X#5ZH^7IXM\6,?"-#U628]MR^L
MJA% &' UF*K+Q3Y0OY#2(O>YVZI0: SK\=O'JDS@$U>=1;:E^>!]?>WZ=>M4
M1[7S=IF3JG+6!3[6!1&]@?[*KM[U/)9V#RIQ:O(#9CKF]2V$,:4?=VIK:FJC
MG"H&9@;*K-A]34SN<QG]4/27?GX^ZI3E<I[]S26#1Z 5@?Z@E/."YL'I*>=Y
MEF6-S8=3[F8$9>8;_;D_^<SII* ,8UGU&6^)]#:_#BX3N_E$WE)<*5,'N(.G
M TR'_76OAE&PUF;J(R-.ZVGR3A3,1+%H_=GVGTV["M4$O?H1B9O=[_(BG/F.
M'#>XQD,CN'X*)>H:$8.(UQ.:4;KOI5.P<E\TO1S,H7+9BIDB-FNDXJ?$SZ&K
MG9_8K$NP BT]ZBU9P"7!1MN\\MK^;5V"<BJKC'WV,>&X7CF5K%DW6]*:C<VR
MI*":X,^F_HUZ-Z8/$\+_)YDT-X3/>:3FB@IH:U^V-[02='&X*=?_[M*=J\>/
MGO&NOY5OOCI59>V$G=689?R-<@.G3>?T0N,FY\6HME,=5#0Q5Y6NO'TKJRZX
M"D#NL\;%EL_I:$6D&JBX1V)]K&.EK'V](X+%YWRXA Z*"&=0BR]RZJ1["<+>
M:]U.<PB%L8![I@6J$V(7*3%\&_8_TFO6[,]Q*;]Z+W!ZBMZ+VY7_/M>3BQ8
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M)S,3(C7U0O8];2N@$HBRX!:]C]G8MUK=4JR#J#9GQ\B.%E#&+ZQ=J_*WAW%
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MVZ\3163S/.LO(:[_-_;>-*C)K5L7C<NE2&=$I!&0J$@O8$,G798B(" @($1
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M</+9W.WH9I:QSI.+_H^^S12@Q#][7WS79SX\5'OQL^VA@3=+'Q$;ZTRG+?W
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M\Y/C@_QXF]]9"N\C>< "5_XI<8TF-$62/(PG$R]T#0_QG89F$D(#IW02>18
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MS,1)\[";^=@P(&"JJI(E@"3BI('(Y,/P('.7E9.#/Q47O&\O6+)GVU^)+L9
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M?M%OQW;D7"U1DO5\+XLX;D'"5G?THJZKK(NS?O'V')^*;$,S:E_#:XU26OP
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M-(K>?K=HH2++,[PKO*$1I;>?LZG(>;!98&;%/-,2Q11 B,AM:Y-;^U@+>@0
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M)M\7U&-,K+'FJ]^:E_QQEG;,6$_[96^>)>[[;,AR(W$6L9W89B3<"Z%97^B
M$9O804DA2?']0$L[J"SK_KBG:J<.XNDJ8=_4%':2WGD2,3SN73-B4%8/&CT-
M>3FYB,W-:+@K4!YO1\J*JG>+T%&P!W1]QH%)\<49008(&/20V>4#'Z;@,2#"
M"[!XQ-8ZUSFBO1$CRZ(U<\QL6%_2(_UBE+P]D"16]'7_4XC;-0JW!=,^]S$I
MY4EAF1K.&1KO6L;K7U1\T&TIUE!'D&_,.;E/-Y[4]5=7PKRS7;F07E(:EAZH
M9?5&RUR?UJ7?2$V+\EPSOY%PDG+RT_\^]ONEY3H')<XW [Z4<^!P'*7#1QQ(
M2?C+YB54W:VTFLVB[,><GO:>^NC96[F4,SJ:]?R/;*/Q^PU7S49'; RF^UOK
M_<IR](.SZ*JHV08593"KAK>-?V/,U Q4O@JDQN/UKA?ZX,;;%0J4@+$:+(BP
MIX'S#U_JM\*OCH7G*I/].PY\S2EYAGWF@_-A=W.%V/#7M!P;"=6GK5J<G<1Z
M>Q%*U/Z%!K@_H"!6=S.4]ATWQ<V"UH >5F,<E;07MW^MHT)_;1=>%Q!_O(PW
M -8Z9PR:P-WI!OV/:=H/A0OK K1'6.THTWIX?6.]<@ZLCFT?2U%+(S_MNG%G
MIOMJI[75U?*X'.S$]<50F\W-C!MS&AJ.R2<_%%?N\=5\I9=W[01GSP5\;YOZ
M^R_D-5N/Z";#--?T=.M^X5]#Z*?PFH$5,H?^A"XJ<B#IL2&]GAFW)8:U%\<;
M08J^8"B+WA-DQ!J/(Z@L<97ZVP-S[M>P8 =PT1U1=IFLF,L+2AFN;@U&-H5>
MS9Y/QH 9'<8).>+-U"14(Z&.]YNWD D_3$-!(=T$^4&4_T BZ8!^Z@3C$H2:
M)9^%)NW%<%Z=$4VPA!8'$'ZQ<8A*5N[\*7S#6DI\SC=B>>NBI+R^IB]P:9>B
M7FZ2KD^6V3PI7HDAWS8SLG,/O),DK),8KTPJU1S18)1KG\E3/=ENC79/WF5G
MS;AK>\9536:N_M9JV?0;I21,KX5CD&U9]AGLLUYJ;<C%384$852+/2@NW"M9
MBO/B;H?242MKM\:8#91.8AQ-9IPO/KLE]B==;!*UW9/O!F0RDY;#$=NFL3-[
MQS<&9*"0MX->9<_8N:U1O!6RP4PN8HJ,OKJ;:<G>$N/+7>!UT>L;5R2 =O14
MXUOF:Q&K;8?RD4J0S\S\[&:<4 >:8E.2ZJ<PHAB   V;\'YEHGN:."N >4P4
M+TSZ/-V?7[DDN:_N2&!_T;.2H9MGG]=7NG6,)<1Z9JI;'%RD]3IT6N[E:-YM
M,V%D5!L6+V-<4K7]C:U/76O_.2+34GRVN4M5W=KH2[P)IBFO\N0D?SB%?"+W
M/BK"%,U)W<5'#COY@&N)?,1L\EYO&]NAXK$6-%M*O</S2@ZM+D*%5+Q@5;%D
M=-\UI#)P_/M%O[*/+[L7?ZZZKY!O9&'D80[H]XB5X^ X>VTE5^0^^B$O\)$3
ME(]E!5FVT>OI\00Y_ 4J@'J,1Q!GF4F$$\,$7<CH$N#6%:2YU.D9(VQDY<8H
M[8$])>OK*+'[+H^%QX0XU(\NSPW=KF_>@RH*>438!R7/HG9UO, [0CW5_##0
M,]!M\QZTZ0GX/VS9%6.6W-<]YND@\F]_ZK<>[QCJ*BMJLKR?=6-U_OVMILQW
M93/X6UX;VJ;JKJVHES%8Q=CJ>.OJNSA_JU +0J\3AF>N'O7TVP>2YCUN3;GS
M4K0']2#-WM^NQ!\W\?U[P+A>Q&90PZ(;([-O5&L J8-W!-!M\+B"LU C*.L4
M=+P-!<,;5^**.[-!K[[(NPKY9;\/M[C>O[/#8$7PJ<"[@.1WX'OP6K#.2KK4
M28,?E<5\*\%+U&WT))R;!XB\W^3>'JX/9,P[!4V.SZXKI20"Y6_1<OP@$,[V
M+GWD ]5='8OOQ)I=O#)D>KK(_L1]5X4H W+I:A'-N=S15?$<05M00D,(!^EP
M^FP>L8'YB*"!-Z<"/9U;8A.R[)!$FBS_5BN ?L WV!+;0UJ18$VK;8E=2.\P
MJFFC3,XL$G8]<K:U&_!H3F_G6-._A_7=C'._'7XN43D&^*$_CX;9-1Q[Z%C]
MP+WJ:G@K32G+H&/"FKB\FIXQ>OGBIE/U\J+SPZH7;_)NX3(*C0[:3AI<.S$2
M>6NA/#IZL[8NJN*[!2)KM5<X1>C?$JOWIJRHLFSH!T6A49QFC#\^G!D6W:J$
M2I[9-XP_&L&>5O9AB#ZU/G  YQT6(H>K&K\ZK-9PT@^S^G)MQ<=]5_]C&U.$
M^E#X=__EW-F!)S1Q2)5E=HZ-[K;UY=PB5RQ,JC460X^\1' PE0YE,:5\(+>.
M(4R!Y"-[0"6]>"$GLRS9@+PRXOFE-,2P,4:M7#NB\<SY(,QA=#ZS@;AR"(2Q
M[#L13UUSYOERQ;/VRZUWBS&]T4#T;&H\[2#N(ML_*9P7!GQ2*DT>[YZB*WM@
M<YCQMT!D$^/CPMB, F-="HG8GVMF,>Y!IQ?<;/P2)^%[FOH:\G!Z?&,JMCB)
MK)!1# N_*.4DJ^-W?\Y"4\.J(<VMW&V"\;A*;8JZ)18O:9@[]OVJ=YICQ,)]
MPK #.I9V5E!/#-P2>X*N(_)E]7J8N_E6LZ1XIIR(@>%/32(>\,,,2/O<EV9V
M-4=3]N/2/GS[-F]/KQ\QZ#NB.^4Z;/F4]1K@DDL#Z_2E ^(]%=)MCT>Y4#KA
M4\HL^Q47(N\(U,%-KX5Z*_A1@DRA*O\\=!JT%O&.8@<]7O@;=!$D=J@[#J^#
M@D>L5K6U=IH:\%B[!GM_$/=JP*L%^_$/QL;NYIJ&-\*IT<\;G$.AX^WM):Z:
M=DGE'B.?V\;R#U]9VRM34FS+R+<-5#>Y&YR3P?B35B>.O1"$NO6&K.Q3XOR"
MFI,Y/3SD83;I2:J1GR<J(+4@V"RQ@RF#=X;R7W["1;^E23?6B:2N!EN(B^]L
M5+@:J)2?E1H ?B7(#5,'#@3N]K9TJ/NSIVS!+>U2;>[3M',!MW)0/5Y;8M!)
M\6Z2S)98FR%2%M?3;M)?D,G#\IV@&I;]A,RGQOAUY:?U(9-[84=0<:8>U4S(
M<<EFQ/34=UM6D.A+7743DPMZN!#[-^/K4'%=7</E]:_$X'6O<P*4Y?!M V_/
M(*)3#4-;>T/G_I?A=^T<3WH#-4&YWS/ZB*%RC,F[( O6B9:LX?8922W_YX74
MN),R^CZW+7:7272Q,ZZY:M)4G"O[NTO&%)Q'/=KOE9ZUR/OTX^3HW?RY0_1;
MG"/!\BXNO.8E.SW'M!8WDV"-TA.?,BDGIST\0M4&^D4@>=A-;#/)F5O.YG0W
MC#^[E"TSB7AK/_G[IYZ=2;V'!\2@BU]*[!;?I9W9><O5Y<9Y^76C3N94+M<!
M,A*Q(FN@D_F4='#=7@+GQIZ/7T?+XPU3>):@=T\B'OT"]\BV9K2^W](*"B\/
M4"0=R%?I<V+T?]*#?)3)NHO?F':CO]6-G/#R_)'+8O++=G"3M\3J3D-&6V+5
M.]PI9P5I8<EZ'!A?CB/<>QR,9N]^KD#AP!X8T<4)$OCCWJX'5]F XL,0O!$E
M4*E_(/ZWYK0?]<T#\HN>OX^IC=PNH?Z=C/9.D6MH'%M;SAZN?-"7EG^9T=V=
M!4=T^"ZI)Q0ZEJ+)+68FSAK4!Z5*=@9W)3[4%[N8W,FLJ-2_434VK,.XE^DQ
MG.@\)Z]BKJ[Q;N/F'*YK4J/'M75)+29V]A<<_)=#.6NQ=#F:'LZ2XYK[$F\&
M:6#*T'B7D?3V E3]6(LTEGS-QW-!9@DI.6*J@>&$"1EO&&NL&AOB_D]6X:K)
M[/:4(/\)\?9?C64OAX/Q/9ZP#M1./MH/'$@8<V*A83@&:ZW+/O;7,54W]*R"
M6+FI3X7B0$SJ$T36T1;,3_/1N>^[4_V:#QV7^H(&7.QA 0KPUXB5>+;6$9AE
M'2C^!'GPZU@.MQE;YN&U9#)=%LNV/1UF$X1VCMO9.D)>#Q^AR@\7MA8$K&_0
M6Q42]S3E6?WX :(XNZMY-_GV(F!$"]^=XA^$2#Q#[,P!<+.#-*DRQ4[M$2 N
M CXU;!W9V90_QZ/&XX7;?CVLQ88I$MMMR+BX&5Q(#K!DXH7)&G-URTE) 1XW
MU>.N-.Y**C2]=#2QW'Z2732O[:J$=BF/:QND:%*/;KC;R[666F<GPWT1MUZ\
M+%M3=:1:AUX-SLW6,?*S([9D+%HK)'*3+UXB]_=71]43+XTXF./!CW(.YF+_
M?R]Y_DY13[Y-G%.'U_<(AD@"_[58 P'OOZ\=F+H#YZ><1G%UR%MBE>YZ_?VH
M:=:6&+IX2ZS$&4409?)/I!]G$ EH;CA2A-U12\"$3E@"9/\?)O7M3FR)/5OU
MWQ*[?F9+;/A&F A+TP%;8@\(MT6Q MS_U__!!/7_N%[Y=]-. 9L= [NAQAZA
M+BW]"D!ZT*)'P75T_LPP(917VY9#T1TF+C-4,MJ\-* A*J6FLA=3-G'MDQJI
M9&%S,G_)0N>E]FIP28+X0D49.?Q];O+X&5MS:HQCNJ,5M>YNFKV7V8.9#U/K
M34WTG"9ZZ7CEC[^8@/L I.[XJ30=CQL;^^9>P-:R@"1XER6?_Y:<>>+Y;Z@]
M^/&G1S)]S"\DO*]Z+[&=]GA\2RPX=0+53MS9HLZ[!%5SU)ZR4A\7G,OBPG9C
MA<>'6CP*L4CU-PRJY+3N3\8E0*V2Q;-_HA2[4CI#BIB?\((\5HNI3]#UQ]K=
M@V_^*&:K_^*,>__AC-Y?G&%).3ND+Z(,=;Y".OLZE%QF3ID0]I%J-Q\$T_8N
M1+UT&"B!(CH)Y\;TD]$^X&KVC6]6DKC,W>280O.75GL'=IZ>VG7^;DG >,,,
MK\VO-DGS0H%)_MFYM3.O2A,+71T?DK7U[ZR3'Q05&H^%Y5(0 86V YNR:6Z?
MN=1,1EAN>.;!R3PVY5W9ERVQ:*U2E9!PC\:0R,"8?""4RQ,\(R [.)4BM^K[
M&A357\I4A\@).8PQ*I 'UV+QYB]P]C9/;]''OP ]2:9:+W ):[8-5D>9R/S2
MF=W1N6<Y,-6Y*MLVW#GAWF<\"6C) W@57X2_AU5./>PSL4"3&<'[ AT<]0[Z
M/NQD7)%#V-*Y_\Q 1[-2]_2&$KP)7;+8@,T_TH-/[.V,D>29XZ)_1XD3C'$O
MOT89@Y>(VT3L$H62.7+FWZ6%%R*Y0CMF7[3]HTU0U&3:E'2 V5LF^>SFYNNN
ML,%#'"OQ[]&5^#LC- -BVUGB3=A'%=0#U &:2B 1ODR#\4\!C2M'P!Z+0;P9
MH#+@.+0A.-[Y>FEF&ZB63('2W4'8DPVLM]K\%6 L-:(,9^/2RL,+/0<:@I"!
M;_T^'H[*O^S4?2&M<[!8BPU\< ]T+/8LQ5_Z]/JOG^]**HVKG LM[CV\8_MN
M.) <6)^3F&FD:V7EF2?XH6%Q^B'5LO?]7##&^,1D-'QT11Z:Y]W$$Z%&()6;
M#)T&]*X**LH$?Q%V+FV)[6 XU0I*-K;$8I%R4!KR-_QM!MX^_,4TWP043R <
M^Q@XLP](G(2LIZZ F:N5%5-3MM&A5<H8@SW"\9 3\,HM,<D7XV3:84@3(8<_
MSR!H8YE \H+C(DI6/P9F \QD<M[X4ZTXH 6I\&O$S[+D<H^E U;RGP]@/&-G
M"GPS;]9EO 4??!YOLX==A#W)O&Q]-F/.^G0R(?C2Y[R\.?/K4[:>5V,Q(X\P
M=J<C&B]I:GRXXX#IL#+D8"?.>>627B5WF4],M"*^-[3R G%P.T&)[I;8+?@^
M/ ): "]VTY3?0!$AX+DNN%2+9#F6#D-*(;KT#L_L?P/ELY6WQ&0#-B=M2[EI
M:VR14PE21/-4'F")%>\+]7F?&WE*].W(;3A?#KJ=,F4OW.L-JG>1J"&)5('X
M[!62&)\(IK4AI?GPFG0.*7Y=% &:.%V3KLF55OXL:O;;\G;D$:K*H=?-@,;P
MZD;%'ZF.8R5-(Y^S6$T#DM"X<"\*].):C8AZ/P4F9""E .\OQ;,D.7X@8+_<
MC 5LWM*.0I%&'8+M9O:>PRUP,OX\K2&;'=3S=&--:N$]<S)+J3^_18G<GUD\
MY6G)[7L28VKA9).34/BTG5&^? _ZT.K!7O&23VGOD#UX4N *V!K;(=+T%X;"
M1J/^>OGIRG4?GTU]3:-^EXI2^^E8C6^&S/JZL=[J-\:A]\KEGO.RS0EJ^&N"
ME_1 8G(3B2][K(_K &8] .X1IVQ8Y=T46=RF4(8I@0OISHF(]07HCY"*V.]8
MKFM3:VF7L+02VF9 .G@-9V]=-UI/UNLRR9MT]M%I;&+(KZP0O6BR.&R/$";J
MB'0IO@/T-_-@2V3I^1@%.JC!/U((;4?+]1I6QH1>#S5ZC#?0;MJ?:I:5:9:2
M:;(0=PX[<1OMH,"EX+A#D?_D25U1U330<BFJ<@T/BDNLU 22#YOC]>>=-@G=
MIUU>;QQ+(VOTGNTU?^5_Y+J+<T:&KY9EUG=\"_G=@1R;F2\A61AZN.JK9O10
M &6^CDL3U-%.X7<3$X7'2<*]-CRSK\R#ICO(N$=7@=3EF%G[6!49L#S.0 =V
M:>Q*E-L#TTA.?N#,EA@;F0_"W(!O$M3/CUR!C*B0)ZJ_EK.;X._.]&^XK2B"
M2]Q2T*B+ JG#.T3XF.H1RD%7F%21]4ZFG83B[[))NQ=\3(?6HU%2^'.0"\=&
MQZ>]FSO#]*"-\8]CV'"126X_7>JQ]'-_\JNE[)PPPJEHLL+T\/[R-+9CH;KK
M8PS[Z-.\P ]GJ\)F7__MEE@U51F75&4YH=[K!%,:F5=]5SZ2^K)CYEI=L.[>
M7D904[HSNSZW[DO@(K[6IOSB1ED"7Q4,Z1Z8JF9M/J4'PR;L[2!>$&C/@;4S
M)\K;253QM\2D4/Q)",,BR:NF9+,EU<#&CM;HMB9BO!H47MW/EK2Q:16_0(N1
MTEVY,9+\L<G6P@:S'G(32N8%0CSVYL-?0_-*B&4FNP^]!W])0#7U9M'EH&IG
M1OT1V<Y4%NPQ;3LPP#]!K]^5W/",/8WPKHG;M*:'LG)M>!4>61S[$47[$<\_
MLA-*TV\XE7'<8";A!BZ^FC,?Y&AE->]:S35/5^YU?%'USXP*(Q?FHYLSE_AW
MS8'1L_U6,5G%$0C,\AN7$O;<>TX=M?Q(.(90N_B3ELX2J#N/4U><[(;T=63M
M6D<WR%BWU@9&6/YQ*T90:>M(N*V30VN6LAG*CK',REGE<E<#R.2@PJS(N923
MTQWZ9J'F(#*Q&,KN\.S.9L/W0_$VC(W^'>C!#4E;+_-Q?6_/866!EOO0AI?$
M*^UP,X13S3\/-^U'M,L+AK\-XX*#RM(.24_-P:>6.@AG0-3R ][OGI 6V[ 0
M&-ZT@QQ Y6MCX6;G.GR40%/:,: [<]9>YMK2S)Z<J2X%(VZ.7WD">1MC-7S:
MY"2U7^U,L'YN=73>9:2A(">,.*G',N++IK)(*=<%% +<PPMZQ(T1_+U!W VE
M<A\"\ =\+6"<>PN*OCO;+RF4.:A-X1_!LII%F=<D/SN>2C:R 3KX5N,^9C;7
M &Y"3D&I]%AXI&YM\8/8V\<ZM6U/NF2=.>@^E(=M^,'.R5P8S MK3K\V?B<I
MS:[\A+IC%<<I.\U.,S<W[<[P0- M4M84-5J+RE,T)R@+WZ$:Z DM%T6 0'&C
MAXE!, GAE$CKD<?PI\'Y)U2XC"=?!R!VA!S@(T#*@\\-S7'MD\3M"R9JF:^@
MZ$XEW_=!L1L-Q6%I+]/,J_3O<U:\YY<KV90INDC$.+SS4*J+H*3%;)8TL27&
M)0JH-'V\YE +# -$OU4Y!J*ZX'MPRCU?M%*W+\T<C_9666O[J1C?HBK(+L)%
M=RE9S^ &'$8-;)U<P-V%U6JYOE(?J/>BULVJ*6B8A5R%8V?HJ'N%<7O]HF/Y
M0<<L^1OREHYYQ7V.23*NE42_J 3?)TD_(GV-C6W;A\*F\YQO3J7EQFLFI3>E
MCT\W&J0+DHKHN7 E(0/>V). NF&F)]R[@S4PN25F!6'+< SVJ_QB#+$N.QZY
MCZ\\RA[DPU_R_=)9!I38>I0"Q&E':H"NS:#6E21BNV556Z5$D%1RP2M?ZE-M
M5/0JJ;YQI9\=LITPG,6LM7O#"X"\N)[#2!A>!="E@BCN0U"Q/54"Q^C9$CN$
M5(/2KS!>_<$P-9J=MC0?0<(A2]O<RR&0-?[\77\6[TE0B(%>,>:4QY2D6^,4
M;X?<?._>CX&U2>!5LI)#MW.FQ.STGO$DUN'C^99*?R?HLP'P5;G&C$[[F1P2
MF=&HE\3.*6-_7BA5=;!J*UOT\+:P9]X-' M<4>=%LT/D</YM/O!1O@<'(1W@
M(P-0XI?+1C;69*!<-\8Z'/8U)^B?Z;L5@3\_5-_%E&,:KB+Z#:;GWI^Z9!PI
MYYI%JG /'%/P+,N.QE1B<C)+&PK+ TUBWAME*<7&?M8(]8_VB[S]S6O:T]NK
M]S!W_)35";V.8S:R36=JA,'XNSQKOI. _(M]B(VD^!,0KP370)RHOC:N+\)>
M"G*;2'R"],P%Y;0#@2JPD0TSN.68J4[U!',2CQQ%K%+()> 14=++MAW17S U
M*W?'1 0@#'(3F1\'/D:\)<F9R@.PMS!0G9/5"!8A#N!VL+JK62?#2=MQXFT7
MWRKM+-@W_!XI7YO^=A*9)CS:^, O%D7E7PC>\$"^?_G]BT>$;^*[ DDIS<QJ
MA@LKH>#(H ,YTMRA8^SQ[)R%AO&%I@J."R/CCY%K+BZ:@97CW'3KT_B4PY_&
M4U)S'#"3=@MG_YDQ&EMCU9,^UCN81ZK_[F N)_:_7=N^,5?(/&0@BNJV3 43
M9W>G4B9P:'<HD36E=>2X]\B+ HYMS6@8\4" 4(U!K"^F6NG&D<*CB]K\8W1>
M.EUKP][5!LZ;UI0@0%)WZH03=U3P F_&,\%;0$^K"*)4 0RBZ]RZI=RZ?\(>
M%!(33,:7-T!81U3Y8SZJ^#G>-[(*=X_9Y>F??-M@ZHB_^U#P.ET"C<G15\RZ
MSRVR^7LU1$UPIZCY]43<<<D]%])*1DVH56T?<C**0#G?B])RJZWO1J[OL0U^
MX_0HB7HF_Z!MPX],SL%FJY(?J@/BP6!Z$,HP?^B'O\C&.@BJML18A334KP%9
MO!>@R?. QGF&GGP5!MX((+?<#2F!M#P8X=/!04:V/+>GZW(T4#R>/1Q\F_**
M[WV'J]0_4U,1Z(GWV5_'J.]3[A,Z]:#VM]CRE(EMRO@(H+GG9_Y8,7L@#EY'
M3&HY6KW(%*<J3US*H3QY1;4U>??]XBAU1?P*/=Z\,;O3]9[(*C0/Z@1KUY\-
M3WSR!W.G(VD\BA*!P1*QH;XQ02'1?M$A!J5S^9].?YJ<GOS4/?C)Z]K4>\H^
M[O?V-;G!=ZF':YJ/5VL="!>.D$TR\@.<,I7"@?!\I;O.Z2E[94JM\[Q+W[5F
ME.Z>3 ^JM%[!(MLUK,Q[K=I+(DM^Y"_6?YX<7LO16&VBV,])LL(,T36ZB3P4
M86C2)W5+;.<*-,Z63$R-FY$9Y.\ BMEN/>1HSK-<]IF%_XN[]PYJ:G__![G7
M:P'$2!<0HM*[2I-B^*@7$!"0KB#DTJ1$1 0D0$BN(B U5ZJ"$"DAM!#I B&1
M+G !Z1)*2"(H31+1<"0A;-R9+;/SG=GO[.SN;W8S\_QSYIS,.>^GO5[O]S//
MXW&D-8)9UK.D#C2RQ&DMV0S#-.=V(NO.DB@_XWL:.[!KZZ_];JV 4=W4XO-)
MW:TPICAC=@"5:MX >F8>B#X)%V9GL0Q?LD #J!/F03(D1> 1H^M 0'0KDKS9
M"8,R U-("L$**J%./7U:-54A[=ZMV+GFSO%,8>&W/BT7O>)?TL!S<>Q YM&4
M[/[B0_M%I,. :O\%6ZUQ>&.W^3'N;S2RN)5^5^^D2F<9'#GL8GU7[+KR\_L)
M[^5[LF0:O^;.9HP6GT,P*]9-<C[;GF19VQM4F31M.&(WIPJ>]$PEO-*8S-&P
M'K5Q0[?OX)(^N3U<:71*Q>&T:AGJ$9[>D1/!%;D=6S_'.9;(86J3^Y8V1VX=
M+,B-8:G2;NV7.&00+[/ 5BRI!!I&- AZ;#,*<PQQI86%2N*J&F3T+9'I<T33
MP')*W^NQNL'/L&BG\MBBOO0)P9*WG$/+O9C36*:+$_+##%E("ZD(P2("FX +
M*/J^<]?-(,:@UP7?*41XQ9>]K9GR90?M'5)^( S\\KC4FF[.KEYLI^3*5-]4
MC=5'&XD<R=BWSQY.ILL;N]UT573(&]+_5.6\JS45(ZWIGKOK,A7P[RO"T.MM
ME9\Y88&:ZY356&K5SW"CS1Z.%_=WX =KAQZ]&4<WGYOW9H*V-.GRYG35#"08
M^0'-DKZ*Z0)+G'T3;WJ;)9WP@Y"T9_AV[VL^'5&'K5DS63#Q'XQ\X_F1.J],
M;'4G+AX(<,4'Z-+<\P<"6XY,5](9P+F/VD38"J.;BR%L@$*6].UD-^9 SQSI
M++S,8SRL?+(I35OO!NL$H130[:&X_5-P%WW:PVYK<T>F[E-C_9.O?'"U#RMM
MEX*E>8_@K.W%NT==7=6J<TFXX1]!,UDSX;A!8>SPUFD_C;J(='_<1^?=[-7@
M*JRTRE0\]N=/=\NO/V9F@V\;9OIUF6C/)G%E:. 35.LP[:^/:1F'+(AYXY^R
M9CSQNC9-]6^SYE93!8L75Q]3I/..^0<-Y:<:*A]=T<?4)V_%,V<9H"V_.L1A
M5O+FF-$3<]B8] )0UHLYB=0*!I_41>HC+C3/1E(W1\)Z2'(337(R1"-&Z%&K
M)[8I9F>Q&TA-YF)&SJI4V]_]61:ZFX<ED\!RGL<W3$)>Y<*Q;I)G<((/IS."
M(.XSDF=EE+:E878VVCAGK$PE]>4ET[Z^N1J<-*$@-'KK+O)/0)-]&.BCC250
MF7:ZR;-+2D"P3B-'ENO:RAKKY=38^?7I5L#:;QAZJ[?"4+^-&"7\U3%M(+:W
M4G(+<2V %N?[?$'\D="?C?&JC+&Y_ &(^CZ)=(@W[28[\)3&/-J]_80L2CH-
MV]->67U3?)XX:^85'6'X,JK\5D_)6.D8]IK\( >QV[Z?N*#S.'3S_O0N82'2
MK?%?EJNJ1M:#U5RS *,@I;;PR1JSJ\V[#_$0*_;]O!;EFQ59UJ:J=OC8"<>;
MW'.$!1Z2!$*./J+L<J4"&42>_,PHGNFP;%].;>JOI]TJS0L5[Z$V\6WG,)-S
ME=FWZ3YA>3AGZ0QQLFDQ8N!1P_4;E,B4P^W]LX\F%RSV?Y]5IFT+ .+=)JVI
MS=N"@&:W]ZE9LZAJBSHX]39S-UD_7MJ-E=?\API%WJ_/([,P,#2&+N\D]RCH
MW)1!#$&'\?1%UE]/\5%-]<":'RXY[*45Z&D/S6?D?N!F%=;IX8JUL4OUNOW7
M;\%]UD/6+6M.+CE9S9^-[2AL]UAE9*JZKN='8* ;TTC(:-*=[Z$/;%V+KH9[
M. C M]E()JB[2/%Z2^<TIE]JZ1R3D*K[H_/JKM/DR@?:N,_XW:;V3%/3-.A)
M;ZCU@[KLM1E68B[1G&&TB>+\"3BS?S70@&U_+*0;=6\+ WS'3.2:T\"94"&(
M<7"QVEO@-DM#5^C:X?PDKE,[^8EO!TOE,3U#U::Y9:(D;\P^]T:P]KN.ZX3F
M(G.W?4AICM[Q/S4TTN:&]PN*3T2N.Z>ON?9,IBO*1IU5FL)OKHT56FO\D\Y0
M&U(O=?%1#HM!LJ;LK*LL0ULHL%!*RXAAT:2Y%D0-.4IM)6S)</1XDP<"0DA3
MQ-7]EZ%<!U9$%^0TD]Q-%42<GR"=64.!S*0K@_<&V'GD6GCA $1IX@?J=,@V
MOD<^M[WK:%)%<T/<'WD3,Q^]%M2V^9^(F0/3=?NA":C&=:[B+$*4AJ$8L?U9
MG[OY/ -UG.A)[RCRG>].<&(6=>;E,D"@=8^\?-HBRATJ F!L,BV+YWFB-1]_
MF!;I76^=NO>Z-1C;NG^RM-HX[YPXUB2\Q,X1;\+$V:?[.11@95TTKM[TL"FR
M<?&3?9Z[\+-B156]1=52Q-I(=412:J$POT-5K6EI(KV<$C+SJ&'\L(2C=\R;
M_P(J_;?EO]X%GR$SO0ESV;WD0ZB@3ET^T;);;?/A$ZVD3/KG6\GV)'*"'?-
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MKO#/PKY8:.)JXPS"M1J8'XA=RO K^;+7E_FR:OTJ?49N*^Q#\>^.+FL<5[,
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M0\Q'S1Q3[DD6:("01 :C@AHY5EX(?Z8@X.R#1X2QOI8L4^6!QGZRZ/=.4P=
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M_FAR*68%[>-*R8;DY4*(#JL5S95A-?9_@ \,*%S:?TF\PB+T9B/?%Y\%:O
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MNS60Y@!:@\@WSY@Y$FZTFGQ.,;"-/S<QJGT-.G-?,G"Z.:VIT''JKFO>M]7
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M,N.Z^OA0#M[F25Y]%;J@<[%V^G D.RLK.]=\3>@TN MY?/G!RX&4CR9WW >
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MDTFM,?F8;G^NZ=6Z&]XM="CB56%HZZ?:K"L6$BZG?2PD;O[V?Q0H7Y],YS!
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M5[\X+\UZF&GA%NKH#1:WBY5DGEO [,ZK "1V;-O9N@>RES$'H0H_IZM3;$I
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MN[&,$GU8P&'B[5PUJQYBD_2[W00VO:$5F<JTC"?E$P:GZ'ENP!,J- DL#;\
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MM\B*'-.G3(J"?5FHU[U\N<- F_T$,\'_O%1>&.MB?CZ XX&$_X 5,1H?T5>
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MTB;D#UFIMN/F5?!'[8GZ(5K<32&FJES@_P_EJV\2KX*B+3%I&/1C&YO\$\R
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MN<2Q_]Y^K3(2]<K_!,TQ__]@.T53_PM02P,$%     @ UCME6K,3JN.:L0,
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M@(+LSUG/#Y<_0?$-L_8>5_*;]7@$.>.'Z7'#W! _M[" R#+;U @Z/$T\PC>
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M'+6*,J5N.\O:Q%W\@UQD[F3;U/+YZSNS/; < :B5_Y@%H7HQ-CG'^)\Z)'O
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M^JA<S+F8VRM*HR$&PY2K(?FG*95G<0>]'D"+#<4+?#4H7UV\B-M3L&(,TT,
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M9^873"<Z;?!(\_X.]424E_8CJVMU0)#_1*<1/372S[@O FG>9_$D-SJH%&@
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MJ7[^@Q=9+OG5*&, 3R5*K2V(3VY27Y.M/(M5K4\T*:>.;RN5-;]]TTKH+)Z
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MS7/?LT-U194F-3J.H<5>CB,:4W.>4V63H@.P.5GV.5XCY#8V 4/ #O+VL8L
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MF[JT=WZ*MFH@,? [YA+G%F]V]P $YKL>OK:]C06A3$$:?=9?TC8$>O'"QI<
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M(<#H,)#LQ!]%<VA**:V7"-?*D2]PL4'XR+WNJ9BM5D/&L>K"L:#*G+6@<<U
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MQ_[Q8*24E1)3+WP?^A(/Q@3388GSRJ,8TTH/'!+8$R*J]G8>@$YPY0@=(01
M$M[(A$<36.)T7X.8>!WQ=]E?J1HND_QHE(H[;GP!$*4/;[#HB-/808/=]?>T
ME#C8*6,)= YMF%*Y<'SVF['TF)&><0S#&JA/$?+PW7/.HEV]X>N<W9Z%H@LA
MA(HSL9#):I^1ZBZ]QM&>_[&BF[QIA!@/A.UJUHORWD\B^^*3FH6_DEE"+H %
M _875@PE^RW_W&0@YEH8J@R T:VI VQ2]+,5GES49W3FYK#C6*"1?IEIF$3N
MU(L';U?#QBG7K*_D'Q)^6>Z<ATD:8=<S=9"F:U?4;6XZ^O949HJ73TP&K6P[
M)-Y?/MIM%[G2G],HXY3GF/O$Z'-MN<1GU6NF.9EC(X_F<@*'N(.PNQ/DQ:*%
M!CXJW87'P!HUHYZ5^,JJ\6$"N0&CP3>R%CT$*//2$T%@"!IF-1&4I(9([0_W
MLIW<P1W]O'  ZC1;K'W '"HH&? .H=O8K\ZO(S.S'ZGMPC8&.#88RU$=U'3+
MXL)Z'2-'0Y)NL8%DX4Q2*3T2S7HQ&/M,Q.]&L&)3.CP6J]@PBK$I]*>&QMN(
M.H]"B:2'8]<'2F?]HH=N!\IIN;/P;Y?7#>GA9]B_\1."!?OOVI0;K*D-1#7&
M TA@N9@E4LJ'%P?]Z?,Y7H4SG4K6,Y-K'I^TYT1-)N?(]?*9O9XN]9*CEO<U
M%V@X0(X<C57'/ 0XE< V@U GA >4ICH V'WR(3.-\>TNGL:K;JQF0I=!E>ID
MV2L'YE;$NH:15'EH$U@^.W@S0?5G06O+T3SU1C@DO@A^?.4+D.OX7NR\*KKL
M/JTO(KF\XD>9%T,^]_U6=*X<4^&>53/[5AI>]X+83DNKC&Z>2]!^GU6:N_N"
MS=:S/=?">#7&\/7_M;,1$\836N4_%Q%L/_GXH\_530PR]=6?!JY_J2$.>=.2
MPBBC5XL?59\E+B36K[\22U@^$^QM&-&T%85IX%S#]BX(_"JSEL& @%<L YC(
MYS5(74SR0]8!Z*_UH#QGZK#I>'#H%M^D^KSI&Y?7;,@>_C?T>**?JML'CC=C
M-MBN 9X;55 241.;\ZKND:)9UYM 5!*;!/XK4[7%\6Z%8X9W1!=%2%S*2BCS
M=KE=XFQ6BTV_<Q94#8"( JC+=-[A8;2_ZEYSCX_(P-O<Z8K:(O/3%CEW51]J
M9=SH+$Y?6?K!<B@2/[+JG&00DJ*G_8C7<P"JC\0U]*XO,!GLR(2.C44%_KUR
M%58Q\O/GX&)Y%^#'T-O=LD?>F+=G&_^5'>\Y0,L:]_H;*8%U#/%_Y.QP+!_Q
M@0RH03?T"_S)S%N0&25:Y)X\U1[;1Y;EB:U1>V,U&^PT8A+<Z>'+G23(:N9*
M29+F+.<"[+#OO QS=1 =/# Y 4XH&<S,;7[PS!-GL7"X70BCO9^/E4;[+^YV
M; GC.L\SESLALS!F,A#"\>F2/<<;/@!%ONJ2)L7KX( <H,AI<F>6W+#6/%\:
MSLLKGPN%^'%TFM)\A-M:$8J\<03S9LH,C-TP_H6EU)5R')UCQB).)6EP4>7H
MY0_SZN/:J%-^4RRTRX=V@?>C6SUEV9O106H+OT ],(-MZ"$Q&:[P8V##G1*2
MK=A"AXGY94^U=+[9$GKPV>N?A^\2%>]9R^<^R];75B:X2&;9]_:70(34S?3I
MU.H5[^!*FK_Y[<2;&58550K.Q>>=,%FQK7)TB!CZ7BJ3+7"Y[\E9=W.,1@(]
M_ET)\V=@:%Q?@87,/Y3#GIGNDI&W$_GY)/+CQ;IH@4,"UB>8.TC:-^?R&-R_
M&3_/\"GVVOZ_/#W U&T_!_<0-C/;U?L!)T)&;IWMHY5S,37#XL/1];[!*&'?
M6T(:]D>AFO49S>,8*VA#N(M5S?M)[7TY\W<2PG],Q3[8=V"YQ+?J+.).^!M#
M6<EM!+17Y[S,V*:.1TB7]-).>T[QBD%P!2I_<V]OA1$Q+W;Z3%Z'CW?2H1NK
MI3]+]UO(?M 3O+D%4=Y1M#5;D@GMAL4>@*2Q1]$[K7#:0J*Q[,C22*M>@=FS
MX-*/I]U7W?S]3&]*+\34V]R'B:(+X<=\]_X<4[P>XY+BF+?.\X]YFTI**74+
M$K^I<70BPVVB,/]4%/R>PS1<1(6*EU<S>/8XH-_2T-RY9K]N44^0KM6N]^'K
M=&MJOF%TK95^B9S68-T=':G'[?!D5]VK7Z9;=T62@IA@H>A!3R%QEV/V594N
M!"O;?-GF! *,8/P;,, NXB<$%/YWOM.>Q<+0">P,X EK^<.NL1*S-('K(=L4
M2OKF-EB20P^]]_W+5 -)Q*_YF@>\(SL_K6SE(I#@,>(S%FP#Z3+4GC-Q7PN#
MSQOP'N-\4;&>E_>SR(NEUAQ'WL2"4/MY-&61';>8)]D)$<"@F+P^*%=\<68'
M+KBRYUFI[E]I)MRZ[>JW=P#J4E'\A&K($[UCD%\?3-31.6/VM@F_Z[ (WQ!A
MHMB9S/OH[<6F9&VRM.^QRZZK%\;ON*Y23Q0S"1VC7-."U9/4U6;=?R\\N6 :
MCCQUAY*0HZ(9X*D_O]UZU9+R6TK2:2MQYI60^&Y:>><5)/W+UR_%903;#-^Q
M()K]">W9<BDWZ3N;K*P+'Y^@-8\RLO6-):K!5Q:KXEA*HH\W#QV.H7WT$7<J
M3RR/)3A+F1F@C[?H%$64_]7AQ=Q1ONMQY[DT^6UG67>_YP3B#[XU-)%>D>]#
MA-&2&[)'6)!N<CQ>0J>/>Y591X-%:4H/.+$\=A+W;DJGIZY>0F9O#":UBOJ_
M<$K*?6YPHJE\M;F]]%[I-#*U<F[.-7RLW,_M>4*IGW1/39DKTL \S3NXW"^[
MA!!\.#JO9&7RHF5P>)F?Y)2]68"/MT^ 6).DB\OEWL.M(GW:H_*^'V$9D%D+
M=D,,^^M^-<X[SX%W;)NY10_I)L=!:@] R<$R]Y=[6,"]#:R,7Z,+=3<:M9[]
M!6&J\S6+5@"+ADJ@1-$E4,%9G1+"L\,-A!];/D\"UAY#3IC"AAQKIJTR:HT.
MG[55TB89?.^XZ_ON+DOGHN.3F23&CL&55F\#1Q^#IVQ>OY.,&$'R"DX<3>G5
M0>M%+1TONEP41?_,$,]:1.,$X,?.SNIUFS<B_Z)\G:XJDG]2MFWD[)%Y_]+I
M"L?5,;29IYA7W--$AA5I$[ZNPGF!5F//,Y>3>93%%%&,,E# Q-]I9.YV0Z.,
MH6D;TN2H8*&?P;<?R:HMOQW5A 8\?#>B$VZ\!*VWD70<"_;0W.N]-;K121T.
MV<W *>-J?#;\)=>U.![8"8-2KMB9#XA3/%&,Q7X9Y@G!_R2Z@RN[S34:"5#7
MV1)?E<R2V)6PU]BLH264<QV0XHUM-'_P*7<WZK>_%89F2EI38:MDF_'Z#1_;
MMY/:81P-%\N)1\1@#2@?G?YM'VO0,-@[NEE%6H<&/,BD?N__3KU=K1%(7$H5
MBI5/]GV GKN=&TKY^S^M-]:'(LLMY'I'.NE/6Z_[6Y]Y2519?#OQ9/RQ?L+3
MO;FSBI>);A?S+,-P#\K[*[*T_6XRPY+]6%E"/5+MWJ:BW6^,H1<_L(X(EDA(
M>:*BDLZ.06+ZG[@VWDCW=(W_^+3_-,;)S;%@!X$R8/[+6%\VSZ JDW[?+X/Y
M#A_B]>%_YP9SKF%NC&'L*@$H;0]XTI!GV/'<P)- ]R^BITCZR@J-.5C73C:0
MP,AGEU=Y<F]3O\VMZ5J*I][YF*)>TXN"=H\2[!NL@I!F0T37SHPK%O0\JU2[
M2)?<XE'/1_OW[>T2TO.*Q+[,SLA7S_ZP:!]!'$:#>8("BY!37%<FK ,72SX,
M0R)F*#UXT9YR28HB< !B,JXS>V-:PRM\&]="RK_)GF5!HHR0C'"%G35W<_>L
M,1VU)(/[J=0+F7B[L?NMG,EZ4C0I.MW++>=5;NCB)D&J<]/H4^Z=@BOEYG:!
MEY%6EQ/J;!2D>I#OZM?7][37\[*?(V=**V9*ZP35^HW/8YP/0%'A])2H_-._
MWC7P11[_!NHQ3K H'.T\$+:X!5ABH,RU_VKTR,S77(<)<OTC,DV$637-D9?N
MG=D!7P82<'6)6R27*L(Q\XMISDG7EP2"-M-SS]2&.*>[30Y;;SPT+*&N-OVL
MY/UJ,ID(K-%"UM/QPN1'4"J.72MK'([D0Y/P(9HQ7T\<E>1>8-C"CX"C94^.
M8I2G$,PT/NJ:8C#7@T>*>[%O^3]@!0<@[S?YXP/E >[Q'(EX-;>)5;J"U$26
M48%5TM'VVSWC;W\4F"<&B(O]5#&Y]!79[_PU+3TGT.MTAX[X@R65J^Z[I4K\
M\[Q-RZ-&RW.%\;VL$VW%@,N?4T9VI'EAF ES/J5\C3K!,7WRN-' -L7;N*C<
M\TS8C6K-98G)Y]LW[S5&^,>9/(I6D?<V'U2D6NK.6O(G]L6O_0G89@'O:\PP
M/\MYHYZ"6>R0%/8_P!/:<!SB;.NQ<K2/)0L5A8$Q<1^:&]M8<CU[NG5EKK?=
M8%&MQZKYP]*JNC/7TQ1SJZ5FW,6ZN7$L !KH'7O:J&DWW&";8P%_.VX\$.;%
M7E-S'WZ[>C$\ZU8=Q_$8; :UT42>V0K8_:EW"X53#$J]NM&DN&Q%T GMO-5@
M.>IGG6E7#L\8CRS<4.XW8C6GNK4$9ML3)-:SL:N9V:628=ILY,SZ0+J=V<-;
M=F9BH/\Y$-I<K?U"BRX$U8*-W\\GTTX:&&(']T(^$/\$6C@8OT,]I@Q$%,::
M[AWK"YMNM*#T4BPHQ/MWU@P6)P]/-PL1?AZ91Q JK>HK[%*C;GSO=_PV8<4*
M*?5,5QO-H%-W5QPCB5C?A4Q+2^WT!\75>:-/4YRJ'C 42$C%%D,/C\/_CSYB
M56#Q-3PS$>W>U:[ @<Z2:;*?=)*>K7OB9MIG]M-*[RSL9VT8V_3.\$;8.+7A
M[TK?FW[FW\QYKO<?XH\#T*,=H(T9QG8&*LB'L.I>;'PV?7:=#*XO8,GQ1:D
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MY2<2*:CZ 2@0/V-MB<8U<0,"%&A SF*>B.=IPH1.DOVF%,:A%"ZM-JBS$*\
MO*+=*M"HQM@5W)FO8H6)T!)?&:?>4< _9?BYVM,VY9.,R!?+[6943ZL/Y80Z
M&U=]_8ETR&7J^!2R[PSU?H2G  .OZ MQ9\\N9]PZ *$9GD?R'BTK%%GZJS_T
M_]O%CJZ.%[:2S%=L4 UMETTJWF\IE=39EQCQU. 88S_!A,C(K2AC*:"/CQ72
M!Z!7K3;'7QI]BRHA%?HU)EZ8,-*G7[W8IY[M3"Z^ [FP-UB<*27^+WELDU1?
M.2O$(2%)T5WWUFB7Q-^^J]"Y".1>=1TAF=0KV!*EZ[_0[/-N6*J8/$Y]DNYF
MH_,0^_YE[]UM(UG)BP,LQTOOS@;*9JH))%"<HAX9*PE["A*D?_B-/8VR<CJO
M/"2:X&>'+!&S0X Q3_:;,6I,=T9[#N?*R@'H=S[(+20MB.E (C,/0&<0UH ,
M/T7\ 63/VC#%>Q.#8;^'D^W3N@Y (ERI$#$F.N:F>UAD4\W[QN2KUC?O/1_]
M;'G\\/&KCVY^5J;D6UW.<4ETO >)MT__?#^UN24@,,CJ241K7L;HZN9\G\+S
MF5UA\2^XP^VJ\]S[S*!\#3)@S7JVV,5:TVO^DQG3DW>(PCO+2GP]T^%S>4UD
M9?X,RR51>[O(,Z<QHI_6X/T^,\RP.W5(+%E%<:=_Z'&&?K^HI95&N3Q#(9AJ
M%PB=T&WMR4ZU>;3C3NI8Y:<'AS"6RSI"Z@?B%8))Y*GQJ?01('2+CQX:_E"!
MGP>@(]KX]7TOCASOY*!_+XRJPH;(SA^ _G. ,[?8=\C(D0/0&'8:OUJ6J&#L
M+8Z]W8]R))ZN[%N=''#70%SOJ"=BB0JK[*MN\<KEI_^/P@W%4<!Q_$Q6AZ/=
M.P!UMP)%S%V>^%8W1(++3UP)>!H4N,Z'YRM\'0;GP'B:$,HP\ ^"+]"MF2U=
M9-0!*-ZZF_P-,0N[/PZC(P+8J/Q?/4\5T)V?A]9L?;P)FYL<I:]JE82)^06-
M Y#6N/(OB!6/HWL\A)] /^N2/9]@-LFUU'Q5Z-?\$2O#G&AHV(K=^:G=<FPK
MS8RYG[?T%8\,(:X2036CQ&K2>D I.?]H:6MC'/4!=Y*OCB(*?=F0D_6XR%UR
MC=[&4@!+J4M6>KS5JQ!]&14-.>K@.<Z%%LU?*UU],4=X [":W8749F,#EM//
M5B4_+I;+6*$LLDX3]$RRR__+P6^I=/>HZ.OKZ'=_[U9<DB>*-?C&C4<9/NN?
MFC7?(A(+7S05>KR E*6[B#*7>QRXUY@6,1B?X$7R&8SANZGU[.^(PQCS,>TY
M2 ]/UOM=_L*ZYX4Q[20OQ%@ ]$;D'?7G+WH*1)JRC_W!R7MMZ+><?L=;><#2
M[%U]MM_*S&H.W*DYP#BY6S';YM&H?TE*']\4$-I<Q_U""PJ4*LG7[,<QYX*+
M.#9^,*GZ'=:MJ9Y<(S&L"$8WBP[)#H*MNV\!-WIC)21&=841)@9V%SC/B[4>
M:F:H9A33;(U&DPPFW%J=RC\1#':\0[7;^AV7U1#9SDOQ3Y$Z*LJ5?3/ZYH9Z
M55\*Q F[Z:GM_;O/77Q&)UA3ZW(<!:5U:XX!.F11$/V3IY D@& ]?(>YS9.4
M!>OY=.W-#54W%IG(GF=9S'3'VV:6>%7!V:5)U7\X=UY#01 <;>R('#N^ 5A^
M:G0.(XL5PHX>@$X?@'P>)JXQ$++RL&/!"39JO%/, ]!T,Y3])^OW.6(O^S>;
MFRMFQV&S;G]?N/>CP5___N-/I(B<+XFK=N6>69M++]*]7*;;@S].J3\1UXX<
M1\!:<Q)#[6_E))E5VJ4F-KA9]KYQM_DLU]S<F-/RU=]YC_ UI=+--SO=0+,A
MN 0QNR+=/93?W-:>5@'W5W>63M]S\+A=72H<-6L6K)D_U>C_XK5.37/3J9_E
MWTO781P%Y$)-RH?_C$^9,=R'X[ 7QKG>] -0K+$1D(0K3#DQCY[J,8:.1TZY
M?=Q38@_'NG7>" J[*FEQ3_%]N6504%VX_+<I\WDPJ:PLZ45-D0-8BIKDEK[J
M&)&(TA]Q$M==#L3>KJCS._LYJ4%)4KF[A"&IH-OVK=S,L$TL^^DHNV7)C<H>
M,=1[&O^=STBN!R#6"QSM)JZ3[Y\'(/D6G@2.JY$"7"?3!W#_S?"592E7;1BP
M)=?#OI0=@#[V\:]DL5VX\3C6%=ZG U"6WY<?"*H>;9C/USX+)[$C"\=V+K&$
M/KCY1/'DT3'FS1+9RU'FY&?,GJTNJG%;R=%6BP*JO_1=A C@X#P2M3\4(V][
MGC=:&W/K;>:D>\:ZFHZ4ZM,G::7B\J03?I\WT[UAT9?+RL>?)&8'F 2HF=N<
M9;7<Z5^Q;)@<:=*R?IZE'3@QVNQ>'[8D3B/7P7JB]@MY(*X\\+7]#$H@)1Y[
M= 1S'Z-)?3<U%$FME_5?(<^:WAR)+FL<DI+8Y2C9:I6=>+0HWW.UOX2@/UIN
MGV$V8)^^9/ND&5,7F?N )$'?D)\80V[FF-I8JB@%RV>'C[G /9YOBMF9_=GY
M_UJ,H#;8VP./U&#L K?(XM@S3=WRL;8'(&&+9,Q%#/;OAJ999Q_FXPD8[<+M
M)/S>[;]7.H2;MCJ^M[\8S9-N>+_/=ZCP#'VG\G6:"L?@5I..Y??2/EN].V,9
MA=75$Q_5^$2"\M[)Y=MO$_'X53#*.0\:$%N.\S')JD\/)R"_#Z2FZY>J&=]N
MT?H^P!,JJIQ'DFO,<[S]0S3J9<\!LXLV<G;1ND[6G"O:4&E_%M56:KS5LLPW
M4[+#[L&]J^F:MRX8O>;E<T6!>XNP2+PP1H4&CFD_RO>?O^I_U:N'UB/ *XV3
M(CF[;U]6;P8?NQ>MLG/5%DFU:)O0.9+-8S]/#2O/1\JD?.GE2N1:,I(,V5K[
M>&)A* E[$3LJC6Q(!'W;(LQ.H]7-68?:S4.-E;N;_/X6NR&5WAS-J6.+L?!=
M4 A7A85+P."@<=4T%JR;)(F>I;%+Z8@-E;1; (*E9\O<ZH8?L:!5[IL1;"PZ
MW81+DY68)9%[=T:1!@^,(6D4=H(?U:A1MWWS0NX!:.)SLY7?Q;W)RPU6(?Y4
MU0P5VHIUAJ%-CZ-J90.Z<H80=@"ZYO/^N:8QZ+'PB]O_W:+@JG(]<KP>&T\&
MS1N<7G^.2/6>+C6_[,C2HKC\MVU@EW?;BJB*X?7U"!)X/>-!<X:WW[:,[H0)
M:;C<)$=8NV\8VC5$['6RJ4ZS&FUS>1^?SG[NN)!::ZJ-.E-.41$''#BGT%[7
M 2<^NSW:?X<5!PZ9UC)=*-/MIU>D-YI>:=]>?/MI QK5VYED-?2UURKY7./D
M2!\#)@*_=SCGVKV2V;53;J9^Y\(<F_9C^!J&/GL  F$$@!E&F^J*>C#L,$8.
M>$V?,V [AGK5D9D+KX+S[@^MWF#D3UJ>FJ?WZ^?)O6\*<52MZ^JZ07ZY4+/9
M1H<=P778MQYIUQ\/MD'PU;(4S+O-FI;?1O37RS)(;JH&ZA:MYC 760\KZ<(F
MF_X) QL/.5VPVMY831WWEI6E%KS]]H/WF:XSQ2%IH^7J1X(U<7/#OSD+9BRT
M.4>6T?-L/>1>!"''_=SZ//CI#2OJ_<^ZQ2$T!;&FL@2T'_G(K/^^8EN9A!E0
M[%HRLE3WF=@LLRH14/O@Y6/;8D^TR+^3^S9]G,PGAL6"%Q\-)->A'/<%N%Q7
M&G9X02PH$KWDZ[XA>XZ93_C737'G7$;JFD.T7LJ5-U(%CRI?(R"X#A%,,$T&
MSE9CDCH'E2S?C[;Z, L=@ADSQ:-!@[K#76"6V[8C\(8&%D$V.4ON9AE,M*"M
M/<8P>F'EJTSD7L2:I]1$T%*]KH2$B];^-N<.=O@Q;P)71^I:F.$Q>B1YOR70
MC7.*;^LE!,U=UO!;LS2PB M"G#IO<'.*^N!%$F'[6V7)J@2>J@O5Q8<&O?:X
MIF(I^6;_[P.05TH4N89,(1IV0,!?)QL&[P AIGP'B\<$T(72/5RZGZ!QKJQH
M<G%;3TJ) CY&^[\?.0LR0/RP39CPI> W]<ZCZQC+:G3FME73^'!IS.#E>,RA
M?QY,5+ID/HFC&QG?BZ8X$.P<HL[J"N8=I3\1GROKSRV([1U)ECT1W$:NJ50V
MSW7$LQ[JQ;S+;DI\#Q6[]WCZQN,>@9<U[S5A,@@1J]OQ[UJQ2!=)]1-" I+J
MU]4ZJ\'*W7 I>VWF@N/>I*RXDEM12?NOOAPTC#53\37G'#IFL:>MV&-5UA!H
M*%E Y]"&_@VZJN<PPC5:.-+JP!]8%^_2^(ZP[=X>=?G/]E;F)$DOYH<U496Z
MM[>YY9[9QTCN<>^%^?_JV!8<&SP\C6#?:(]P5;Q!]EF(:K;N4R_QX9B_I%W5
M,FE."5U^Y.(6-&(!X=8F2:CGO2F#^<.GTVCDC3!HY [D+#JAFWJB9A'Z&R:<
M:1$Y]$HS03&2Q.)S)1UC/!F\<'+%+?KUDW*_IGRQIJ:Z2>ZE(VETL#!EO_R/
MU_[0BI6F4[>3E]E_[N<+K!=QKF N[>,MDE#8"[C.=V,-E1#@)NI'Y">?B:$&
M>EY(UQ>+PM[R-;425V2ONX%MSL/@@&O_%VWO_LCT____[_GLH)(4H8A5*B'6
MP2&'MF=Y(CQ9""'VE,0L]BJGQ6S/#LPQSU(\(Y8<EN/"4 Y;C'F6I\0<,H?9
M5CGG\2CFD1U\UON'[W_P_>'QZ[;'?;?;[7JYWA_WQ^TFX%9%>+B\+MGQ!;Q5
MYHJ$O?MV_4S\TNFBPI'_P%?QC^::7:^\$!VO+]1K,JC-M+YT7<^K%UW@YE5K
M'K*E85N-54@KJLM,H?UZAAS!\<KD$T\/)/U[LRID&Q03X&+:^?E6DA'A/TO&
MVG^5PA.CU%TO?"X66!,N;]8N<'X0<QRD#L3\\%>4E-IUV*-@.1>^ZD!>>4;:
M/3+WF*"U>%9B!<'%]=!>4=:H1.A0*LS4;R>A%*0=*@EU!P+$N650#E^^"[.'
M0.;PXL017QN>0Y0_*+U#K9;!FZ9YT0E])SO\7P1)SG0J8OC;K9AXPG7V+ZD5
MO%(*)P@W>./RP,59GR0G1C/S4HLIW6XEO#^JU'L71'.[X=,?Z(X-6*O_EGN9
M2PX[$R7?9B79#WF*(5"KXX>9B:4SE XJBWVRQ80/YGP5(A(TX&!4PH9[A!'J
M0H4;V+E2D,#):1[.%(S<O0R(J24XC[#XMK<#U?_F)+1YNC;]N$].9S5@%M$B
M/"^!$^](04T563^FWI5;2ETA%^ ZJ8>L)54&: (RNP=-B3,NG1'+38'&(J'N
MD=5NYK'"KRZN.(Y2YW#3&O'OP".YI6]W;VK-FF3Q-HBO :J+>PTZ;/A:<Z1C
MP)<VP%'8ETPZ 6WHE&\9C&XS#N1*7054QL'97$MK9BK=;X(0&G!GB@>E.TGV
M>83O9%^_TMJ0-VGHTT%$*^PB"-U*!/6%\$Y6,DMG'89=AXTJ"$\X^4IN!%$%
M]+_X&L=L]:>6M*%&H?Z.8F&/3,</R$H[,F#K4EED4H'3TV1]0)A^W=IVTF1I
MS3Z!0!S97.3FA1U((@0%GSLA5E]KV&NGY<&8./WA:2B\VJ-<R[T[;\5P,&.D
MKOIKE%N2"]/'0,NS@!G3=VB68^CTUDSV]/D/S\:'K@G]$=(($3^=W^!6R <<
M$_#I:TT9R#U$+^@N^/![QSJ,H7HO.B VXM<^CF?8VD&LW"=CF;H]G/YL7C/O
MTP5[H>_R+5)_,8\_]U#'%?G&7J.ZJ1_UDM()AT-L\4-%>7@4IG<<I*43T<\)
MJN+L_F74AK#)@^!F>A6V<,>',F!HO+<8\D$/1GXU(:)*_@/M_\<C96N4/GUX
M^W]!V(""UGJ13T<OII/:D"M5GY[RZ5A*(N_#O"'7(3)7$'J$/L4*9MBBA+@^
M"EHP0]+U=2VRPX/DSH>!;!%=<Z[Y0Y;K</6!YM=#Q4.\'Z;,]P]: =D)4$>^
ME0\4=Z_#-)D'I'Y<IH'\ VO;5]+)T9E&C+94%2 +HTE*$!F,-U%VEK<S<CGQ
ME_7@;</%+=3?3\[&)RTEM=H)*EOF<=5G:XXD%'AZ%'[%#;4G^IE5' V:1"AY
M1W]VOA>Z<*L^[9\\]VB1^_N\0DU3,^&<LWLZ;:_+:$_!40>ZS:-;M(4Y!Q-G
MURC_'46(6R4%%39O2Z]]'6BN_9$%K(KBNA$;Y)W\EUJ+U372 (@F1*D2S61%
M<A,()<Z_ZP_2TFSM0D2J=]9A:N0P3 I+^3EHD+D8X^HMY';FDI4+>SK$D\K-
M([:CC(W-R2HGQ9PM.?H3/SU1 Z5;=?O/63QFL@JY-H'=.<S\199C:P!\%SM
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M,Y:W\21-[$ 53B1@N!%YO)&8I^5;[+ZRMJ%"\1N)>HHJO23$)\>@=F,4(LU
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M/7-71&6C>+^8H[7('<% \=1P.8!B^_D.1M\5I&=MG1OAQ<@X196CZ[ @,BZ
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M D>L0[6]"\_&*]^YK0 =?-J@QQ"=9_Q$\G(Z/7HP+Z'+O#[M2V.MXQ>MA1%
M(GX%-J6BPLAW)D]0Q7Q(7V(-2:;\^)"6,*N;E<%#I<O-I480GT;(&]Z<^X:J
M;FL@G"5ZRW7:/BP%C7SJ7TG\P_]?(JHB[/N$[VS39_,=P?*M7(DS,4S62+*
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MV)-F0->;MFSA(_E!"GNM9#6/G]F@\X,Q'^'H\&&YTL95GYV^F?9U'=: 63P
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MXJ;0NZ"HR\=QC7]#WC812)>C?"><<?[9PPK,F)U\+-E)/)PM4.W"WR6K29U
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M[J9XI ?T+=9ZUAI?#*NHGZD?^?4]3=@*R&U=Q+'@C2J]\,<!(![SX;94"/H
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M5.5Z54[[9)-DZ$4O(S-'(D[?SO@<7)!>D.;F=MJ;6@ /"1B_>Q=F*LA/$U*
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MT9FTC=VB"GP8_N&V%$A\4'A(5&IKLF5JE,>U8V]+/?H%[22K"77A:2IJ(??
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ML4+4*K82^O'+IU,Y__Z&#1G@#[YN-UAFK-%G=,76-8@=7PCMT74JX/@7D<L
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M85,E?W^&D=&Z#2X4Y:>49TX'?X0SNI^*D+G:WJA0!C(FY9.@RZ@Y=Z8+YM\
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MS0J ;#BIK?:\-<JCM"O$RS,@W'-/Z]; .V3#S,I3KF@=.R(4\A2#) BZ(4J
MGS];RG(,(\:>L:@'J@*X=ICS+-NGC-[P,!N4A.LGG\/ XX$>FQ(J!(\+\V%6
MZ$NZ69<B^R1?> ]WL+ M0PB'#P$R[/2 Y4FRC6^#=G-*3+LSP=+>H41FU(4\
MTZ*J<8$D;YYO?#J("=MX9*%UOHT=-P=K>>Q:8;*4!=TC0@/%E)_ #.)J+E<5
M+?56<"H5-H;S73NX/+,7ZHT_N-@X;YV+XSP&;)C)>S!^E G4*5+&3\76GI#,
M"N#QC'-;\)O1VV/25T:\O#U&=57YJD 5UP0H[,8WX%8\V51J9I[,,$^":_05
M6?_X!2-7<LG?8N 6&2QG*CT[( %8@?<M-BKH]B<;YF4&T*>ZQ^7LQH(N>]X=
M-[L68Q^2H8@J?F"Z?S:>(N\S<_@!3Y'N2GQN;"'"8U7J/2XJ*L-J[(Q,>B\W
MG4QA"7(9H3I3KK5#^@_&'E1O5OA]K=1[X.25)9:VM[J\ONSE6-!#Q[+%K5MZ
M^E*:-N8;Y+N^0Q6Z1QXG'0WZZO#H@9UCP4BMG7VI9581GD<NLWUB5%(;D.;2
M'_#(Q_M[RV=*A"[E+E%V!CM*:5CK6@U#LKZ I:#>:W_@I0227Q]G.?67!3*5
M5=8N#V',"]'Q#F.;W"J5 8N(T>*Z \UG:B>"-:O?6^G_/M+X2^;\06F.#K^6
M2)G%@Z6%H-L4%2"&XYME H^BZ5.A$>YG68U5;./]#3<,UHZT%:H1V+!@J!A,
M+H:7>V3"JJZA@97WDA&2![C;! :]^(N$[;5S.# B*PFG6T\.[+'/3C?X?''V
ME[+!-+?QMKY'CJVC(T_4[V7GB^%BW9SL8;2EBODLK,O8X\U!((3SE/\2$R Z
M!'$USK'T/H^.C$!!WTP]Y>U 0MOY;%?RV&K!&$^?16UO.\/BD#SHJ-=?LU*G
M_;8GIG^I2;5J&,LT'R$T)'VS;G7N]\Z/8"ZT6G/.\PO;#O&"@0VV'.=!/3]5
M< HMQHEGIU-^W(&.=N#D#)OZ>#'T8RB'OE7MR8S]AE%F@'<!?IU#RP(E]JX>
ME0J]U$K$UPW:I^PP$[^_VWI"R_SPE:..PQ]J#/)7)NK2(; .T0G$U.BO#Y#D
M^,*Z*STTWI^-MV*W)!1EIQ^#S4S;+A;G9OF:9OGX>Q3:0+BTF6R<RK_@OC3C
M1]D%U]A'!<SV:C\&]49.;G B6?JKBIXG 0\DR_)M7T@GY$@;N[YJ]N]-G-1E
M!EC:>_J8L5?"#,S-]AC*L.]R/;/"_5);2>F @3*VC"7!G.F$)L^\[NE9BS6B
M[ OZC.)@6-NKAE[LD-]8D#*F2:+>AB/02\=+ "$=AW@7_,.H92&5-WSLO ]@
M8.&,,/R!6_+BGQ:S_#L^*2KJMWH7U8DO:6G:CRS[GG4<3KN=1+!/.I$3>C_=
M2*$N[23JT>. 6F<I#XGI=2$H\\&GOHKA-,^]:U5KLB'ASEQ\RLQ^RCWXU 3'
M?=C4C@7EH-EK*[UEV(%,Z&%3-\9 ]+0Z\)HBH]>F*S+G1!+/,I"1Z-'Q$(V\
M/*S*@L8E)9?[(AKZDTO=_79^"Z%%YX>4+CGOE^U8S*#@!,,X2<.!!.2/%/E(
MK'SS<"4&QH;_2)&/45%IG?!J:1A<V1I00BNZL?I3@RL_+7*,"?RV=!2NW+6O
M=,"C>,DH '%JV/7&YP]E*/4&.P<7942#+SJV.XYH6U"A55-<:#R&DC=.SP*^
M?))^;)=\+B?%/B<[@'"LJ_WB(\/W!5]H"?<G=%#E,),'F[#[+UB670,?F^&)
ME-=0$;6_JR^#SJ/^RD;&"&1%9/ ;GAFN-NR&NCK4=IRG,<([<SZ[&G%CZ;!/
MZM(TN&F<9SQ.<I[(&#=RR=J;'Q0M83(!5\<#1JQLSG@]F_1'"4 IP'9@Y5C)
M47KCVUV0$X#^+$7)EW*8C.8\L1FK*E+ J&B)4$*T@53,%:YSRI3SZ)K!%$7:
MS;52##[<5Z^W#MO1-[?_<$8\W>JL8XEXNK;3K<W17.._GG<;$FP6'P3O"ZN=
M3_#<UW\F8>)T:\+%0M4/.8X>15GS"<H,PO3$DXKSV38-^=^U?S0K1?);*/>,
M "*KAX-D#ZQTX5A&/;@C9!$.>INUT.V-5>]EGZ,?$.VAI K&0<D>*E9NN!JC
MR0R'_C8VE[=,3:X 4BW"7M*LJ^Y=+&A.M4EVZ<'73/0(03]C1_#R.&^IR?(I
MT8/[GW'-:&B];0:4BJ,A86S/<@#5G;=OZ$<Y9R,;^@?9=7;M(-#,7:%Q_G+W
M#[PRNCD5%C+Z):Q4CR.!KJ(X>5?A&@+T'I728QY5V(QT0N^D=JEK.<Q7C]CT
MV489QSU\Z.MKCQ@M^] :J5.0,QQOJ[*QK9-5CZJMS_+YC/B<3CDH"CP%*F)
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MX^^=*9]^(4@V-VMS?-EL?8(^L!+*_17MZLXG"B2!9%= M^I'>[8&8B>29L*
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M?(P:6P=B/"8X#!3^.L&#$6@^L6Q+ZO815_>O[HJC#8H5'F6-I2^$(&\?8]1
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M/6R0@%*3/C^-51&P@$V4U*9C_T*?IBFJGD.927&NWO(QT :R*]=8)\D$BP4
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M?,@6+V22NL6#DWZ&QB]5(5U_L;2!5/I/*B:E\ J0O3A_FJD[<JT]Y:/ZL#B
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M^:.\X?GOH?.=/UI"<08(&O'$1RH/8 .C&WTUN-7R-]BK0IV8E([:13L^D>1
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M S6T)B(S^M>?>C=E&PHEL3PJA, 3_V9/ISI*PRPL',;9H 6\CM?++:;JH2)
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M]9\(TXU5PY:.T>7.V#M32HI+^+;6!A4+RJ^(;W*4DK.^6A;IXD@Y++MM8<5
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MN1)S%-8_7,@NB-<Z"Z9\"!&.?1=B_UO> _OY?3AE3YTA\A<[>A124?=E_I]
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M2;'Z76J1MX_11[?X/O\J(V>UF)-6T^QC]U1'<+GJ>AJ88;XZ%T2%R:",QMR
M2L[T'!.25MY)>2;"]Q9? QKFD@=];NX3^8E!RX+:1%/7V06>UNV/5F&?WQ$\
MO.G&IN1QR6?6IO(4A7VQH TWIBB/G@<,%G_;%P/MBRV6@4Z3/9A0W-GO%AP2
MSW^&[,,:2TX]M)FD)_!DLT#]T/,KKJ&H0JIG(C&P$M[AFDQD  DA33Y2?1JA
M9KGJP?K9MHO=8@*BT RU+\9S$10)Y;&]'[B,1), ;B1O?!I[/]:?K=V)#*E
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MY_J!,/F0!/YFUE;Z,M0]R3'<WS6T@N9=6>WIZ!C:55>Z)*,J_=,[*Y=4>7>
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MR2Z!&S1*<\<R$*7YK8:&:V/1'--9-+LR-O@TABH\,XVVJT Q;(#A/0L -.@
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MO2_ )Y ^>?GHC>+U\56^ FE4Y)FD?Y6P?U$=!YUZIXHTV8<L;[B_+S'*N/G
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M@^VTATX_E?&3N\)?8DM\E&!:I9I=X=\"$H)%O)*!.5P/4"(K8.@_ #CG!\N
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M0.IJ?J;C1:B@>2WB6'2F8H7*\*M\T_<$,8P.*YK)^^.AGLY"0.8\,I8$P7E
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M-=*_;JH&ID0;/3=9#]*G:5(O[\.9:%9!(#Z2<#  $8<58F7KF&>C5UNEU4E
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M&OYL$Z5T1LHI(V,KVA Z\,G7"*U\YTO1A\<[S)^G6WVK.3Q6JA#J[&9P'[M
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MC[/[CF%^&V0?0W>:T"!M^&/3& \:(3S0!'STB[V=\\H0VK=%8B9B+^I#-FK
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MXV/8%]#XUA#]R/(*4NZTQ[B]<R8X_.NH["B4J"[W3BP$8[$"2=]!"G!)BP>
MW_=&]W_$"@!XNLP<\<F/<4)/G"7H@X#=O@U:AA%,@[8)@IOM;9[E>F:)CF..
ME3.5Z*:=3Z0[;T1Y7W:@IV90^ODF@2_.,Y*-QNL\&3=AJY2-\! $U<5E7P8[
MP0'QXNX2!3%^ ,*5YG 3T"MC]\SHT.6CF:?*/+(@ ]L)SCVM>Z0('2.*Y ?,
MV2!_LN##3JNA%L_:=,Q>5GQZ\!_7]FJV)GF^]WSO-@%+C!3E/;=64KZ1W-C
M)=]>)H+QEITMPFX.QR3>QMW_V)GZ/+JZ,+AHWQH0:WWU+LO01+W[;4A \7#A
MR4[U_#:-1B)CVH<WRR7M_I*(H4CG)1U5\UANLX*A8O-67- 7,[+3+)I[SGW\
M0"D>WM?[2*KUH$-;X9.%;=)R@$W3,:!T7PZ V-+'$V#B=LSK SJHU^AP8\3/
MJS.7:.6=44WRZ"#C)$3]<(,);W2@H/;B%MIOO0$>$$Y-=VO+]R9$#Y+F7G-
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ME2[G\7I3IZA+GZ=A+4Q976%NZ<K-B$*ST>*6.J)#EOHW39NR94JE<+*GF64
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MQ!&VW1=P=W(:?/^Z!?PO*OPP$_Q/(_]IY#^-_*>1_]5&TA'L0U<X($TN% J
M<T A+-Q5$>8,%V\)->B'ON: 6F^$)2K9P<8Y(#[W3_O&QOL8/& _=3'8LC5^
MM[?^X1K9+_XD>P/7TCI&6AHWX8!(8CAFAO/L,<ODJE>N-E5[).?/]OQ;\%18
MI/CZ =ZM.[1^06=K:WO<*N%"@KS"/OM7/^OK$X7$>@ULW^HXU^,9VX2$NJQ,
M)?NI6RA;6P7C;OO+;5&B\PNRSJ(IG8;Z"D=IR/MN)R> 30KS%:I)LO/>I.>=
M^2\<T#T!UGU8RE?E,W>)=X@SU]G/B12PH,N*<7+EB9B^(\-6M.'T^%3Z U/]
MZBU/E8F"S'2/O:'872A;K#^. _HF228Q#XS"=_T,F5""& <TH-F* WA+<-\I
MA)'5AWCV+_$XB@RMG\GJP)%EN3&06356^DH"D##H#] <Q0'1P-PVN] .H35A
MD#\ ,1<FSDD7<T ]L;!"AVH<319"/P:XL['S<-IS'//9=K[(=^1?M\+_!_(L
MRR?AP'$P\(2IQH7L?@3 ",Z^_H]ICB\>HT*8AWF9U[#B7*+POI\I2^" 9,-0
M^AAN*O$OM7- 6X*T6?9/*P3F^]R_B?M7N\/9I^$"7(;RQ9U]',%%V[#JG"9N
ME",W*1S0'@_@RP&!MA%L1_._"UP)K#?D@'[FYM8Q2!1N:9VK_V%Y+GB&V)LC
MSW! +;MT'.L ALM5_@@IY(!4%?X#H=O:T[D<T*-?.: G^%;XY@[7C(@D;F+C
MRQ6(S[D%A@%([$=-W!K]J&O) :4)X_XF="_39Y#[[Z>X-D,R87<_GKNO$9??
M&(XEVW;A_AXK^-]$AIG5<@MP[CK\G^'_9_C_&?[_(^&_\&U6>B.R18Z4,]'E
MN29JM!65=?BU1? S[_6E.I/GO,RJ??UW")B[)&(P_6Z^6]DM^Y60@%5_M]"C
MZ3-W?N&Y:ORT^Z/. X.5P1ZADB[A(OJ?)2L?W2P2C&V6$I(F"M)Q&N-=$[N0
M*TE^TN8$1<+$9R+*XOEBZ=4\>8.&T]/)K%=#2Y&39@%?R&(*'186*+&BG-@_
M=W[^\>";V*O=^5=^Y\\L.@RJ.NBN^)I%$;%[<^%AJ?0?3ZO_92C/?U^X2W"Q
M&B=_,H0I7,HH9%4$[#<:;4$F5BF^:ZYDWUC[P*9E;WPS))'PBSN-D!AH]&OH
MB]]3D>#5D*!(#2?M21>INI7C84T.]1HUSQ:V'JSQ,B+HZJ-NQE;W^VK4R?W4
M4N,FB* A^+_1]9Y13:1O_#>[=A!0:1I*5NDUHG0A664! 0&IH6<1:8DT 0T0
M@M*KK%2E9:FAA4@O4H0$6$"DA")!@22"5$E4P@@A_/G]7SW/><[S<N:<>7'/
MW-_K^GSN,W,/%OU=;R;X0DKUSN.W[@)[B,AW$OQJMP:"3_/F^IQO$\H.VOJ!
M.:5+DU+T_E7Q:$>:QJF53LN5%]PU>UWI54R[_I.5_L >]$+)$9D2<)^;444<
MC@84O=LB64_F^F"-^+BP$YJ)R?KBC PJC*$YB--DD/R9GLNK&<&UP).A^_FC
MHCL5F+^ %YUJZ9Y!WNB!Q?3<ZZ_]'V;!EL6V#2%]D(^;;$$@B@9.S)\;S$B/
M!D$EUO>M2,0$JF4W'NT?\$A?N4)V)PEC2+<21KY96@!\^KE2E(=MJ'1C"ZV#
MBPEW_=]KY=VX7?<XG](W0>Y'VM?.9#M(5I$R8^+##Q]4^$VG*0Y^=/Z>F9_F
M8:946STJ$V&G#QE3+Y3/9)T6% +]JG_Z>I8T]9^\6<)%CQL1COJ;HDWOGP2F
M#7DP7RE)%-XJ="">]U(Q.*_EDEB1;S]XZ')1!#R7HDS#)<!:H6^K,9:LC#Y8
MQM+)L,!G1SPB^C>9(WL,T8QR)V#!!*B@C4MB8%,[,F]F C&R=']I,^;/O/W5
M@M#G:AB=4+N>LWFVTAH.F=U_8\X>UO<8<"?<P6^ Y.7>^1LCL+A%9>9.FF;T
M;^BI'7824R._&%^U%N%-E$]HCA9#FXV3;!?1M[OLZ?Q:<Z0\V_D-*:6WS#IJ
MRM(&U67!Z7,YYOMH<)"]K()-FF+-XS#9E/[![!S?#Z&'.7 GV_JOH! _ZQP3
M]+!&OB]+&8@:T$$Z?C*6Y\NE,5^!''EGU#^^D*'5Z#Z1NU()%DL9/>)I_ %Z
MW16D^YYE=UUG>*HB^X'ZC O)H7*YQC9;;$U5Y)?B$<_)"6#TP!)C.-45[L6"
MO(.#=F*R&$\'VR%892"645@,F=-7K/6C3J/\F4-FS  \K:1J$1U(^H';^BSO
MT#37O"UW2_L'0>.63E\+L0Z&'*>6;K*]<<LS18G]Q L8YVGN#31WD[;X\E_
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MV$O:?\O&;[B),'?Z=ZBC=#D"ZZO983'6@#N>R>%C$5,Y? 3T,;1OLPM85G<
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M,-/]1-TO^\XK?EZVK<VN^,D#)>^"N]ZF=2>SXLT=,G%SHN7\@:>,0]K[J>3
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MJF_ZY3*W+WD[<A):4<\L;-JM=*W59SN(EXO3:LIF5IW2.0*LAZ  T]V#,T:
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MD,NJHAQ"GL1P_M7/)>%KW5C238Y36N9:=9:F9$9>OY5!S\Q!=F/!"Y].0(9
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MCJPYGW<4-78RL,I+S")KC4O/N#5!^/4:O_&%"[F*=_D#,A4S%84,GOW-DF?
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M8NXC087I%)JSYBB/AS\>2.RAI=G1 [+<UCWX.PJI: $,RG%:2R+,O P=:!)
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M%!%X<.V5[J@2<8UR*D0/^P"9)%7'NTHM\,'R,S6"]Q26*=SKX'. 4<N,X)?
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MW%AB HF\-Y1UX]4VC^_F3P=2B-*9BFWGLNP;_K)3FY_&=[!'6=P4X%0;U>-
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M&XGUB7GO:^OK7KF=6?L1.:.0ER9YS3W(R,[NCU]:$5C/W"<0WNT?=.@3TF_
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M*AXU4I\V].#Z\L')]E?,51<I*[=QG"KN6G0E%):OK(;(TWB,XI^<[THJQCY
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MQ4)C:F?]U3;;2X>3AJ#D DJ2AGR)D4O("/>AT6OD<Y%OPT3+1M+<;R2CWMB
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M$_5=+B!7=YRJ19R3KM[E'+)X'Q)F -FN/HXQBC?S"Q-:P&[H#.R6D*1[%CD
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M[=LAS67_]$_DGD=KO:]A8JY-7U_?,2S5:-\(GN6T%ZK>-U/4^]5.42TU23!
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M:Z! J"6>T=T>'DVC_-[ZSM?O68=>6?7<G"FV,";^VFAZ",'YPX3OJW4DD6?
M*/*6Y!;C0[<3#)%5R@G=(@A+IG!;Z@*%,&UXLI8&>4$1Z[+"P$5I&DUDC2I?
MOYKY@8.?MVD4D6++4:EVZP?TOKYOUK'J:[QJE^=($NAX"#X '4_&$G2910NG
MQA&V=?!@CE<<K$SAP8X;HR2S?F;=L"UA4S8J7<KZLA?BF\>,1=V@,<G='=<7
M7.4]&,9TC@S/]GI\J8;@^$ORJMYEY/A0-B.EZ/V>_3LYF_"B%8L%RW(26B=;
MVB3?9^>T4>-UV>DJ0^2HSK6_.[HG1Q/NG0ZT%7+7[#5[B9'+ZK6N4G(/G+!_
M4UE$ ;]&]BB*3K5LO]#F.#+3:STX-[GE1OXT:"92P^VMV)S;(+VP43^^Q3'Z
MS@</8;6>*3)HYNI# 1&T\?RN,_-"IU%^[N)1VAS!1;Q\SA: 1XIG_ 9IX4\Y
M=7SW>,(E$>#Z"FSKAKR\L=;0F#5I\UWS>])F\,;CQYOC#]IPS2T)?[2VOM#]
MS3?QE._=4M/?[,0<3POB/'_VMSOW.X4=\L4D6 :IS#BD+4D?;XE.O]Y_2Y-T
M!^=LH)01T><+ZX!Q&XJ#[%[DY,@X9BM<'YR/3I>YI4-7,)[ .4,$.9!W*\PC
M7#T3REJ5BWRT3>7A&[PD&EO3&Z*2D6#O&+F//:[98]6E;C/)V^7J3RZVMMEI
M_%,FQ'98-+A<^(EW.G=I*9<&%80_M7JE[!]3GK^;JI>S'"/P>BGZZA%*;GS/
MO93EY27!=!U\Y03F%T&$J$G7_=K<R[&(A23J?W?L-C; ,@;(4_K7X/W.NT7&
ME;[I@^L.Z+SUE!06]'CHQJ0D>\1@Z^,_/]>!0<;MF^-51\ ,14Z!35Y7=09)
M05H5FV,NNOU'D>WPE3*@%7"0,_'BVKY+@2?9K)@ECRFP"+8I#GAMJ-YB6>+#
ME!JT8V#[0K_1:3\R3-0Y=P!11NLA'TN.H?]?G>VT$E'&*)J6&BK*L4ROB^):
MW6'JCM:^!=Z 3\_":WOU<X<5WS_^LPO?020.W'A76=G%0.Z->X6/% 5-5:_,
M.]<G8ZZT#]AH8BT<PE,Q9N4&I:5H'<R0EE4.J7'V-'.@]4)M;X2Y6'*_<[:"
MJP5!ID U*U[!T]@=\=4NU:%8=L#BB:'S)/+"/ "C?D$UA7(DY&GFO=MIT+-(
M0_V^T&.!27V4,QP850UU&D"Y32&TJ;'LNX\8"9-524:Z_MBN9\YEOC":@MD0
M$08UF;8Y(HZ"-2O,PSU*9HD(HPM_"K^8KZ<%P,QB;T#)$%8 \0():M5BB'#W
MKF6L]^V3<<])]R"^;/6EA3S?B"BAV9R8X+-FLJ=MUS8E1;7SC"YA/O]T+G8:
ML5?Y.2Q@*W0*XF^6+=V<KD-*NU" 2-%LTQ[YH<7ZJZ!"_[-WA>N.\XN\J^\=
M&?<KN;F*.;H;5.OK'^SC8Z 7XNV74?EX*81Q[3JZS26SQ98_OH7IGXI:+$"?
MC4R_O"Q[H?E-Z)DQ9J@MR<@@//S)ML0M#[7.):O8VGP)]X$-HV\T?E Q1+0%
ME5"BQ"TQTF6;()RY]9  \"F@A$@8(W1?X6;K4!(,'R]<(AJYE,'655<*I-*E
M>]MU8UORH&TOG1JG1IN&QL+\IW0#-$@.=U'E*:HKRZ/IUTDL#4:& B&L6$G7
M0:3FRNA>V"0QE95GJ:K],K/3F1BX +H1J7(K[SVJ(T.2A!',EKP[2:@9$E_&
MQO=52-6LRIA)_G&DPI?(?^ 2ZNOK-\FTV,JV%S+N:ZMEL,+<%-VT.4\=NUYQ
M6TVHUJ,,F3(M;8ETB03Q<5/XC_C_?;:WY&[2QJ]#/NUH[B?(OBY4?YH(:O[!
M&:'L'T'BW&0$#3^_AII%'WC:OE\$_5+30K/1AWR3(=<.;J5<P9[C_?5O<[D6
M;B3"C#&07@.D]KDWH-^M&"JBHVO6#4=KHT]D%%:LME[[.++$Y2X-#YZHKZ\3
MZR*-:9>'#Z1]^23(BT/^@?@/T';(=P()M*$8+HOUO';&.DL!B&KP$$T!29QH
MF8JFG-VN6[;Z^^K5/]I-/3!;.?8_>A5EVLW;B/4+E($2G398Y1$F)]&YZMQ.
M_$-L,J15.9$GS]'[RKLVQNBEQK6E^DWPM%:FI,[.!948,#A65</E,X'38AVS
M]5,Y$3 $BV78-%+Z.;9Z9MTE=[I-$=34V'%0194F@)/POW<K J'4:,*V\ S<
MHZ=$JLG#6M^ZQ9YH=1&DM>,PL7UI/@*S+E<\;!%;L];69!6#BKG:)C[T92[6
MU<A&6J.WSDO_G!G,;E3GXA5]*XTTO^&]5Q%*<A\P:RNF$0[E]?;1Q:7(CP3/
MF[TFH.\2'\I^L\^(H3WR,7(ZER4*%3!8*CJ65&8?"6D+U^PCNB)(R4P+PW8E
M.6_*B1QB^""MPLB]+ &:B#_+$^ X':G378YI'BN)FQ^,N,D48MUD7NKPJQH4
M??DLL2(*LZ9XYBZG\PY3\N,N+?#.W5%B0+?&&_W"NYW%' @-A0MH:YW60LYS
M_G_J.OHUPC;@?8J&-&$WM>ECR?B3R,OS :!F;)^UX%H<;%%X)&?T7; OW:7]
M50N[7MZN9*,GL#Q0K+ ]LK-9:-UY*D^4VO[](RG%F^#<3]VYJK.4CF[ZPM@E
M5:4L967XV.A99BB_MJASE&8T"E^92/E>1[++KPSN=P,E=QF\ZF,F:K-O]"%!
M/3<7K^=0UYTK!F.>@F:(55G,WWOM,88(BY<5?KG^D^<WFD_K0C#+>S[..:=A
MW$NE*6K]$(7_.5T!^P\[- DDA@J@S()9JPR-*O8]WE>T<+<B1[T=$"P19J )
MF<GNV/B+)*.;=.SS!<6)JLEW$V\+8+7&%X;VK;LG*AFY;PI"TAO6W>=9V :A
MV9;DC*[+<M<SZRRCRFZ5R+W VH>(5\]Y7TA4,+N6V& #3_[XN*Z8/'> E*5N
MF,1QVSWD"\<_AYV#9-TV'*"M435=5RW3[^TH_1/X]5TB0=D^ZD?**&,G4SM!
M23#*8.VFN]4>(87WM"X4$O QE"<PHK\YTH"<HBB"Z.#GZN M(Y6W*\B+N*.0
M(E00>;(()S0U<DI1AZ&!?M"*.JL+DB3#8^VG]N91_1%C429E->0!]7C#..H4
MLHU;B]1$F$QU!3-Z>SM^]$-G;_/$(6<XE\:[_(+91KR^:^O^_6*WZZS#XZ+H
M**EU$ZGFE]#VUFL;I);ZRUY/!A:F2*9=D\HD#7&G]-EN-QVZRXQ9%^S)=#^U
MUE "9CLSU5-C4V-IEZ1[PSG%Z>$J@8G6MGH]ML54/$._LOQZ..S7_.E)ZDZ#
M"G5CH<$A>_D;QF\&*V _7/LH/$%NXEI#MU">]CO!F)S Q??A&'.)6L<J"Q]5
MNLDLMQ82X,/6Y%QM _Y>.&.BY\:)7H2<:$W1I5()+P<6+C9_%:G4/58&>S?Z
MMP9OZFKZ&R$Z:(8WXX\?LS4E=E\^Y M"N#!="%C A2*^NPV8=NF6P;-X4F:U
M5$@CYPH3Q.I+!;'X$Q ^K%\0',>J(H12MPJ=F3KD\TEWZ_H5GL(YR]3O!RDB
M_BUL#@5*0<ERVYE=%AB.#K>SRYB!-9_DJ:T.6@ 8<*(1F'F;D.>N@.TK-KRM
M-().W_U'-XED=-L_-B(FUB_.7REG9*DO=^#V?G2:R56.)0._F<=^\&UE07.R
MT!Q L4\''D$X0IYJ'0'M"/UM94&?M#R]]9;)SU(L0Y0HDJK:<Z<6U*$.U\@M
MK"OV!RNS@]D+E?<QX\5J#KD7<NY%*KF4E/OJFE6Z":J;KM0U.CP-MR$A1CZ8
M+;3J$X9<3]>*YPU=5YUA>:73/?4N:AU,F63(B]NJ#@(Q\4,UQ#+P$_0E>):T
MP:U*Q>PB32>39M6<:]^B1"?(:K^J@$":)A/KQ4W;S4R@M.IOEC&5Z?H97594
MK@.KGJ&+[[=-0<HRII]S5**HJ<6A P<5D^E)++.D13CB!K:^H9BJ8-*/$Q;M
MEX,9.)<HXPR3OO%^!X*9VJQ\;@4D)//T.AZGO*G 8/?@A9#**P7F_T5H,_ T
MDUJJ:Z2U0]_"<5((JD7^?H9'ZJJ.NJJ7WHU4T>,S%I7 $ROVO,O][A=K-&Y:
MS-1G9X6QV0>3NI9IM4ZLOX.^%CUHO$\PSRW<_U[C6%ALH"LS5+#\<3:%-FH$
MJOIK6&HG1"7Q]Q*/[*F1'7!#&"LTL=^'P: ]!@M2B\]UE[H.[>Z<?GK9M4[D
M<N3[7;6E77JR@T-AA2W++(5CS]C?5#X27D Y<V/VB.?(_/0? YDG@,$!$VVF
M\LL0,.\WMQ:\?+>N)\>$F=<'Y7,#_/_SH8D8=8.KM>V8:7H4N*\X3MB9^ASN
M[&I$8&IM3QSM"IG^AEO(TT?\)VF TMI&&('T07'%5<\Y^FQ-6Z;MIZ<@')YS
M20XU*/H[4&JLYDF*$BI6<YYJ\&.>_ZJKAOEC4@<V$YHYHW'U@C7DG]C Y1)(
MHUKU@PJ5<@:NAIBWM:8:99RA*N.>D>-V!8,SV'%7&<S151FH>/MDN.?+EHS-
M1:R#O(TD'*;_Y4G7[=QCH--X>6Y.GZNW_*#S<+/J1#6QW[($+%%;XXBQ+.@E
M8FQ:+V<87)7GDDOQ):O!W3?@0BP!P( =I;SIP;X)%-)R7X$^4<[ %,69TAG;
M&B:2\"R"X7:&D1ICRY8?9G+R%.M9_]( NFZ& NO6GMK"@27@+YV3'"=#MLLZ
M)B:#34:8NGD9D"#(K L]L\?:A8[JA\9#A2#^D"2H8,,N_C1'G+FWW0N2 NC]
M%,D-<!1[3!)6<I[X1URHTU>.@4_5Y<3(ZJW-W6'YV>++U#_%*6MF7,<A27U[
MJ$>5JH122N*%ND"G+E4?59] QWB5SRJ.RR7:(N_4".J6-C:JIP<5J _#M 9I
M((FEO9^(7.Q9:L3<:(97ONK?YZ*%EHT,<GP9WQZ?<'=<]YU$A$I]O]8SY=!+
M*C:RN5 ?G91Q%D%!P0MI8,Y%Z!FD+ )RR!<O3C/!'_()@8^4%JCOTJ5F;D*3
M_NU@HPJ/_W&D,;1E(&OS*XJ@<L@G $5S7R^.[:H=\FV.A,BGBNY"P2.A9MB1
M4!E3IA"5?U/ID.\X&;A%D>$IP2EW)_<@Y#9;9F4MS0L)QXDF'R!?,;(<F*"7
M))I"Y9O'D2A)"MS>HB[+9D)7P7@.ZJK1+.$\O2^NBPQW13AQ,8=\@5E,+,TF
M]1URWN6@''+6Y#S<@:J#;_[1'\J/, $@BZ>,E"(/0A-W@V-[\I[ATL?2H]1B
M_ZX/Z?*/H*E90!U2:!YQ.C,MB4LU&79[R0Z8TZ:"D7$OBFIM; 3+2F[()I9/
M! VAP3IA387II/LI^W[V-N!:54;%CV^>>(6$,:W'>!7>0**^6!%=\VROPX#3
M0'B5-&/9R_DZ@MCPFP^W%92X3@NR9[TO/B>EJ,V2;-SS3\S;33=%@CD/.[E8
MW)@@\HNW,3!9@2092O?&VL8;ON&->\MP7R.L_AU?N/"2F7%1W@/H]"9UW4")
MM#< <G2+Q@^=[4?!%X]32KW3W?XFYH^_*AI2,;P<Y)=N)08DE7<<H<>4[@U]
MI7@-:%\L-K_S]PKT3/<?T!$,,-LGYKY6D)#^@Z.D/VWH_"I*KZU\36^Z0 'H
M)*F'T-#6 2&<]>2E#WE9XO_-E8M78P=%9=>,9L^++MA771^J<U1R!^>1+>RC
M+O++M!.S@VZ.ZL.^ TDO5+_+7A:]SIOZM#S>]^AZ4;/XU7PCI-OS?A^F;,XI
MZOKR;N6*N7QRHH>#;"+!J<(,7M>!._=4!%X$P16;M/6@I;L5.#>9T#[T<3BD
M[[8K$T)0C[C'^-%GK!E9']('CW6?TNF?TED'MP6Y!Y<4U\KN+HNW'"@L5 2'
MS+Q8#@AQ>J>8!4U"-9GW"*L1\"V#F]-T4< =U*+WUN0XQX6Q@ DNPP^@I$;\
MF0I_ E$F+5\1#JTE,:5,SMHXKCBM8^U+<+VLNI/[\;M]D--=PLPL^H^-0"R2
M_&Q_,Y;]'\"%MIV,4&;>H&$36D*/(6ZC;P)JBW CA6B:T]<N^7#&U((H8([;
MO#P%$N$60MLGZ;!5O_8/9__9^<8M76]J=;BE"VH>>/(5.K/[:XU86-CG^WZH
MZT*9-62^>J!\Z3+6QNB]9=T6Y=LCGLQ#.(* G?C0X/JX(!LN_=O>%Y):OW/?
M&(1NH^BV("\L9X!0?GP\X.O @_4'GD[WI!1=$><"EUUQALW<H0:KP7];BN/E
M/R'UF&W?(#@(5821^<K(@9O/PC:B HXL%J3,>XWR)SMT9HOWF85OBD-O0A]V
ML"'YR]R2N!*'&,A&(=/!&YAGZR+$ "RM\$XS4S\#J0"/<&<*FI[M"0VO__C&
M8ZT@IZ+#5-#]V]ITZ\Y:KEYU@OKC[3_:+/Q=^XA(.X0QXT>_+9G$>L@M106A
MQ7A$M**1*%T A\[4A+M0*4E&GE.4DUWJB^AC/36N;H"X%^ 4<;P G.Q@1]P,
MK=.M][#/CTKTF(6M-/A.//[>\7&Y=XDS":LS=;6K2N@C]CH'VU3I!N%4;UVS
M+'CR/2C=135E2U5U/+O\]4Z[Z&^&OW*C;"%?WN?;""5>3U6C?IEZ4I$V4/.K
MP>]O7T9V6&3N[R(=A%$#,S]#8.7R"K&,WS(G:!+C@,*BFP?[)X%?# @U:<"/
M\8M1#;RF*H#[E7O3:X0?KXQ4#[C507 #Q>6H@&19RWH*R^]Y?MC U%E+T5O,
MO-2N&__:5T4UYG;JGE@YW+9'47[:R(N6[DI>H B#>[OEB5NXXE [/?=@W'(9
M_&K+K%IA%LPG,"HV[,+/^N"J8OHKO!@'P@1]4I3B)N/_S!0 FNG\F\I488]^
ME+#%5Z0X[W-N6Q/B3Z Y"N;G<^Z"L95IXX?IW8^BO2,Z0U/DI^]*37#5:ZQ/
MWD,=]QK!)ZC8,W \G7_C\Q'FZ@,>M$Q%Y)2>HC@@1)5'@SC77](3Z[$ B#[9
M6HCE"#*Q*1I(182KMJ=M/9#YJ6V_(TS]'9#X<XO4CY3^V-Q=(A^@>[PMM=M-
M-<=]TF#)7/CT8\S/6,,\U^B_KYZ-K)GHJ+T^&@8-4M%;TK\^*K2I!D!LQ?(?
MS:2%1_WL5B"$QR'P:V._94:I?'>@%R 4+&,>^:3;5^33PH B9RFM0-J5 <7)
MR2.]I(:[7D=R 9>^ U Z0I,Z)@M_P&;;]B+5OT:BQ(%8>[;N4AXK,0D;R#IH
MR(IC&=]:(/)(FT^EG^YP"PZFR#]%M8?:VQ(?PJ>?X04045%,498K]R7$7Q[]
M$G*FVQB.'L#C0,EX/W2BP20B)IP^C_K46J+/N/RNEK(*.E9GY!_6P?]"8^]2
MDXD<@UN5?S+?3W<J,W]3W@;7U;H+G7D"(6-[42V4Y^IE#/W-O K.2:9^DE&P
M#_-/Y"3^WU* !R33Z<>1SI-=PC31$VM/R?.LYE+;N-IOG]^ND1^+%1O>F=BL
M2!EW&2D8+JF\GW/5[$*)1DJ%C6N.F6Z%8%30H&!6=9$G:3GK297%+6U6SA\D
MQPDJ2OK(.U_QR]^*>4%+JY1]Q"_6%S84L#SY?@;I4V!'K0G#I"=-KM'>.3VH
MG8P*D_4ST@!)<M^EOZ7;7S]%N[9 8CFG7,%*<.#_U[&"_^O@Q1[R+78>\NT$
M'?+M>T+V_W+9/0_]OPULGQL\Y/LG[X]#OHXJ7L4GGBTCB6>?N8HZY'OV[W:A
M#3O:1J'_YS8%KQ]]D%_"[H=\WS1$N6H?&T0^J'#$=B&>H_COL/1#/NS8(9]%
MLIVII'\N8HSMC!Q"GX; L D=2;VAR2P3ZSYDU"'?RRY?W^-@FN@Q(+EWJ:<N
M\.P_#J-M>8_#8(9&Q(I<W)_"+<ORR1O8QX=\>H=\#_'D6AIJHX)I-LP2YW[
M(E*'0YN_(4X /^*,ZJF'?++ 4XOTW.=E:\^6EL=,1G\,>P@?<^V._$C$TD,%
MX/E_=K6V9",77(;QN+:-?,8PZQ/@%LM8IPF_;9ZH-QFOALL/L)S'K;" ?)_M
MJ0QC6QO_@)&IXNBEWE#LBH.U0@GN07(&BYQ0F8]9/4*LO_P_W*7Z]W:9ROV=
MH=CO%*4R6=G.S!?1@^4\BHG:"^N$>O= 9VBKEXE.;YX (BK4-$3C!- 97V4N
MT/^WG&IZD&3YZA+'+I>$&+L\\BO2P4(_=UDO*DQWSB&K=\@2O83>M*"C) [Y
M>BP@@<.0;R\71]O4,S?8C%K'5J;RIBP3;#YO7(+!!+25>'8(IW]+W]3(L^AV
M&>\R"-A4;\72P6VP-[-S*PMG7M['SMD>@RL3*,)=("KV-[BR63-C/[[K8MFW
M%?>3Z3XR&>1!:Q+5]<^TJ)C*L$I8+:; JG 8<[FS(]<COR*'%\1]!7F8*<@;
MA!QOR4R2NY-;@$_%*5NC:+9I%UI=*YF05(WSID4W+YHJ# &HVZER+DE7?PCZ
M-+[:]G\596SKD(O"KL'+KA,>F&!>/\RPH\YED1UZANR^8_+IRGYIHXWAXQW
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M#!SR\<Z@DR$B*.I%7'O[D:M2HU4E'H'.&>#Y6V[A_2X2;XQF*Q+79L<;[OC
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MX_"SEQBJ,2UH>!2*0C@0KL]$]?I?9"T<N)U_@K_\;A@F "C>R!TW?]L\3%4
M_/^@C*BN:0:Q)9J"Q?MC:I6##4<*\GKJ'>U=9E7D%X/*5\<4XN9KLE/0FHB*
M)9XV@6SYZ]X]""N;"U4E"KY9%E^>/_7K1E:NVFJ#$6;9BV<&?<N11<:!Z*$
MTF")KC$BO=;FO$19<I%X/&+I^=-?6P8&AUG.U_A[:P>=')T,SF[OG#1,O@85
M.I<DGY]V9?"C</7;)K^+5_0NNTL;:BJ'R$;\YXUB_SO[?["!['\R=O\ASDE6
MWA.\$NX1T$%$ 1%+!S@*\8%)N0"='Q'OAXL'-I=AXE@]^.&O\O1R1V>%OE]]
MBCD*:O[E_.:(,2FFY?VT(1,)[[K8U0";SD*Z^*L7V6Y(WIR;==DBQH'6J"22
M<?:>:T(3[*KH"V(BC5X^0KRMWG;CT&NKY\8Z%=+0(+XKX;SU9IO,Q(]O[ M3
M\R@TJ^"W:$ZXUZX(1ZEV+UE3=6)..>Q 1K$J-$W@@I-.7N0R  NP+[+-$RGP
MJ,986AF8#PRNJ/;*K.REY!-.&+Y">YT0[-(?:E[-0)V$WUW_#3O<F7FLW0>,
MLP38+/^N4#BM5Y1^OXB1^#P7.@R5+P5HK2Z0E[U%Z%RE1 L6M?ENB&9%>Z]4
M?O$D6IO]+L[ ]^PCQT(4VM)9K8MY4;[75:8(482I:5&T(D5]WAY*0?JFUVX_
M\C/5F3L5U'A[P)*9H$1CJ.F4.7Q1L^UD;CP8/K.X6G9#-*'?5F(7=2J&B,C^
MRI#27WB31.8=63(:H5F2SMPJTNG&7?3XIV8 %TLX@N/4WY% ).,URR.*JNG
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MI [NQ2]G;8[=2N--L+G>K&2CU&.]LN<ED675_D5':4SG 4U"0</#\="3SD4
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M'\FWS2Z1X8J,MBSDS?.J-$%8$!K^[ %A=[9$XB_L93<I$Q;Z(^'"5 BV_]8
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MBV2J%I-^#J=\B : 8SMZ1W__21^:Y"1?:MH6$[EGP7D'AR[5[=#H3/A5>&I
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M9"BF3&R0/F+.*-1?"%/B -N,^%5<]%_N(UU1#RU)R])HA1P\[H%13,GRDWW
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M@M&L^PHZ !P^Y0[#'(?15&CWM(*=H'_0S0 @\PRX*'1'WD/K@=YX<L@>R@[
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M?;)]?0O-._CCCHZ-+P>G@>*<">/XBP.6\P;BPR_0,ZC+WIJ/-888I1FRC66
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MI\S/_>I5:L+3+2C44<YD?1HYT/Y?FOX=Q%=+'(<9>PE^4]X".R"UO> (4)9
MW"T\]9/GU!Z'WTQN^QS?.GH ;M17QS5R>P'Z^0^82WPL7ZS3A>_JLU@R<\&6
MMC!\ YD#T:IYI<<44XZ!*B'BW9(3TOM7HGM2=,@;&+O ?J3!7$PRWV']MXY<
MAWG"& MM%^_:NSRF2*X)7SGD,BJ,I,TY$& [G5$=]F,V_'I.;LM0T:&Y@^>>
MGDMOJ(T?F<5%HKYW5;_'O% P]%%,K=,MYB7*YV^=I%V@$XTP=D:!*F0]XG8
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M,K^^QB3(QK^O6GAY\WD#M[A0.JLL$0/>"WK>*G5-M;[Z)),\$\3?9\!29>>
MB 583%[Z0XPX';83_<%M_]R(U]G.*K#J U0<G6_&NAD;.M.QG9WS[]B[E]]"
M_YVWUHP?LO)2?G^_V]^@/TB\7!C4YP60>_@X?*-YK X^&B]1VU2@=XWEW9<L
M@,A.8TP>FD:6^MHCC14!?,*! H;8^<-6' -Y%&@FO;;JH&JWD_K+4=^_H/-Y
M[MAF!'GM'$>.N[L>^!##N<$?FU?ZR%<&HX=FV-8R;YZXG,57)+>@GWPA*HJP
M/M1+IRJ\U]/]%YWKBA"_Y>?O&Z@=RC93JZ7]RF0/\IY@H!QC7_X^UE0O+&D;
MWH=+0!QL5MBGGGK9/+=?M]ZZ(M5LV!8Z?;ZLCO3"3_J=UF"=D^]VL'104U/<
M1&O&RDQD^D!5H'>:JT;,P-TC\\>'?QQ5^;-.7J80X+F&7G[J^(9W]P;=BF.N
MT?-@X?[I!\$O^&5VV9:^\ZSR*AW>:^Z![2/HU$&G ^$/@87S0^@ER8R[AAK=
MBDK7A]%3*O$>V?2RM/[;KYQT46G59W(O5MB@:[ JZGK=C.4/(4JTN?#K\.T7
M8TUN>JX4;1[2C$2<T$YU'IJUI>BH[UUH:R"]ZH@[JZ&I<=;#.RDR\K&2A4>.
M[ITGLDX6NTFYA-_?_@M0O[_]ZY'VX5;>@O6(?WXO9</Y%#BO7F>)KS$949;(
MX2/![7AIC)'> VW"/V?*XPQ-Z)R[IZ\V9:@_W8R\JGCIE7S4WY>JY7<I#G,P
MN.X+& 0'P;T+XECJO;A#AGIT(_6KP-UG-,W#R]MS\97&10>>E8&9??SCUIZ]
M7WMDF4WROP00NFKA"''.S.W$O&:#Z7T=6<S4(U@-1G7A7DO2@\^D1*E7]VO-
M)1,&/+XLVM+/_?27 \-.F;;VM]\HT3O2^K':\D&*EZH4WXH_NE&R 1VE894
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M\UC/!>]'FY'P&!Q@EI[NO)7,UT;OH%7TX*>W3("I?M1CZDX-6BNKI4<$3.;
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M- 7"^'N%1H=(?H.:H=JR9'I1B;E0(KY?,TE1;JJN8\>"=2AY@13;X:];H)>
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M5KSXD6"HQT"2Q#_QW[NKC :+'W+U"6/U1WEZ+"BH6C>R[L9(?;:=,XZK76Z
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M%/&9*\N:!1/Z(E:ZE?0GB/K939]OBYT?,%)4'W:[)(^;X$ _Y3.6TOBGN<?
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M/GG*](;Q,^N[EN**B5HS[DH//E\\WU.8SPD3VGZNT,RT0H49"XM9?4NB/15
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MN..1IIO=D"L_&G0MXDOG]6+;Q[^:.7M8A^UJ=GWU.M&6X_+$P(5RMO"A]]1
MS).]\$!;<+*5O/4'2N%8Y^[FX13\1&"D!EY<>#36XNSN3-?$7(\K@,GC)Y*4
MP(N%7DI)!27.IH"IP>LP@UYAV#4G&Y+A'6W=043 FAQX,'Y>7N17))GSW2@@
MS5-Q(@0!KW3[EG 'P0CLYCU=DBBW>);#;]EJYXS#5*8R+5_>TM\6\JUWGE"6
MT&MX4_@HS:QWU)!J$4KY\>YGOL39"?T,+7#*O7T1_ N^0=H"W]:O1P>@\W[
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M@F_Y)=ZLDEPO8N4. 2W+,[C?"<,^I/O/=TVW@M'RVA'7<$I-XWP4C/Y>LJ>
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M4!>O.PGW,NBF5V#7QB]_!:I789!E0_;.'H^6Z8@1] 0TF6%"N 8&B,R('0Y
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M,&KX<2NS9K%%9B=;&5H"7 )15?J16\UEL0'9VVU1X4W9U=-UBRU8ZB84#_>
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MH5-::=-I.GI)WU7FQJ[/Z;HR#8/!.VPB4_=^!+!4O)XR@=J\$C-KDK6-AWV
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M"1+84"TP=9S4;F^N\&:=O/WQ?[Q('A>!9C/Q <(I%KQ=QH5_2U2!#!.@B?O
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M- U-AQ2X!':M>YCZ!C(NZ(T@<(V,QRNWXG0%BS4?##C+KZ1:LM:*HH2:+_R
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MOZ K?SPCC]#:27H26!3N%=%9H-3B*<IDFI$$8MD;X_.SRFA6<I- ;WAIEY+
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M>):W(X'KH49(B6R9M$M%Z+&SM%J8_H"OM_[YG_:LG1&;SG^=OJSI0'Q<V'+
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M=;#J)5_\>5&0EBG^+(%%[X#(9+.H#LW;#0BW46*H_M1MJ_?+L:V8-<+#8)7
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M+7%X[AT;Y2;[B+)Q,-'UP.=,] 1R-+G<X]BK(O"^36R KT%%PK)^M#=MZ=>
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M:.Z9HUPI"<Q 00@QYA:6Z TP)0?\(8'Q_B3M!W[U)O_;N%SJ6Y][L5P4@,M
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M+K !Z9DK-!X2'PL@5T:F26"RAG#I*;$^F9:.H:&5"-36&N<5(";TMIQU8^W
MX&*+RL(?1C6)#KC05"MGS!KA-5"TFC?907E E49?<R?OU)N=\2S%>>SA4N,
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M.^ZL/=.<F%IL&?1=IXYU\4.@< *8(9;&"TZ1I$TDW%A.%WH,<L[4U$+$<ER
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M@\!T$S8J!5E(EN(/5LU*V@QM6Z,J%9B=G&TAQM67 5?F<Z0@_"1V>Z"KZ:C
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MO@2^KFF-]S,I>FAP8^K\';Z*O-FP+;@^28^A!C#O,RPAG:FH)>IYH*C5:V]
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M9_4'I>=&'[3O8%28/BFQ3"6A%]#%0]/ '5.NS2L28"K3*$]1"\ HH'=!PPX
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MR$-NF"59-0&;R[ I=6SOZT?2][Z+R=_58KEYM^.LJJ!IRJ.;2XR4J<LT@'_
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MLG(.#W]J*,]7=D0Y!@T'QNC,,N4NRD!@7$:?:"G1]LVKLA5[IAB..0R\*:5
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MX6B=+C]KZNA1&-'U-MXR**<0_@7 7>6Z;F&FV&-74K(%]V/]'^:RFD.NJZA
M/87@RJFNSCO<']P+[WLL<=W<VHJ:MLU<],8<5^;Z)M!*^?9>GIO*8ZA>['&U
M!SCV$K.>WACG>NL-T<#W[A[Q5A\5!4I^=NS3A^V5K8\R3GJB9#]AZ/1&W+H\
ME;[F;OK.4_A5E+U[3[F*JD..7XS??O69XU+4*M12JH[T]Z>6/R"VG[ENGJA=
M7[E\]^X3-1,@J']W:]N??J<SKZY[6[=&L#A!K/+0,#FD3,R+SHF3EX+5/VN[
M2#K"GR#,(\&6G-<+*%-H7Y.J8(.V)[&?,@G_4F -Z&84-[RJ=/\U-UC4&6S\
MW= 0.>WR@T#C:G\QDKUZ+NB,98O(J@%HIWH+E"T+3:;9"A3!\6"R4*X'[2 N
MIYR&2I1Q+(&:M,I-NRYJ=],7ZMY+<JQ9A"7VW0Q!=S!L?G?9USNRK54=PTG%
MC59/=M(6T89(JVA.,!'4;72EZH!5TNR6(5W!+>@M@4'"P$MU!1(C"J,)Z]Q0
MABR^=_^\BA_U+!SHO&1\J?5<^>SRRO,?V]^^;(BG)_*C2*O#%E OVY1(B"QY
M*H1#2ZE^4,=CZO<UFJK-H&'*K+L>*85@S/'8_4F6G:AD48.?BRATEZZ-_029
M?DUO7O-\LVAW*CDF1"8Q& H<&#@Q/-AFK,;K0*4R0S%)NS(2B%3X3(QKJN2L
MZ_2JG->2E%Q<,R;](A3<C)"!5HZ<CJEX7#12@.J>='(I"9OSSRHIJGZLJ;75
M_[6R]45$1?&^,[=U[ET<*@%J.KK'/+9$QG1%2MY<FV%FT*4EF&4S6&,D& 3#
M.I"+^C"5UDTSCLB9QS1WIM 7\59CS.$?@,-5A67XFN(QGE4#:'H5:]UU*DT>
MY>:QLM.'DZP7_LD]]>2QV!D"FMZX=P%UAK5$V_E5TH2K^6LCYML:R>D%/P U
MU^RS3</BW+X>6?JP@$JUZH^:Y!"_"<_-G'Q0&N[O<^,,H*W$I)]Z6=T7(UYA
M&Y).['+P<]M$.TMK)E7K-I(']*39J4CP243E7#] K! *,"ET(^PD>Q>@;LW]
MR );"6LHV9Y"F"!'D&[,T2J_;"1H [-Y-^XRVB*I9RSW0$&_RC^JHQD<L)^O
MIW8J.AD%/T*;$'LU:_(<L"F6BX7V4:06.G!D:BDUI$=K'# Z')H>S=2G, /!
M^Z6R*5T+@^B7B8358W$A=W<-COQ6[2OVK:IL<+>178F*.G&KSCO\TN9\K4/H
M9;Y]__W+PZ]I;V$<$B<WJ1;@7 MY,;REGX:F=6%T8[#I:X9< 7H+R9QFW"XU
M7$KU5=M5\GQAD[(3D;'":>*54_USWJLC<P\P'$2DT1>MS,C>L^6?YG%(@E+J
M2UDI"RAS?ACV:IQEGCR>](VVHT3V$]C_^-E@^!$*^1CF&^J&6 5Q%69ED"C2
M1W0/>-D]45PC)'!F,E>)QLPW5J+O59E7?MD%MJGN("PE@1JON:XUU_YYGE+8
M&K0!\E1[4#"J1*B&):%@6H-,B#?PJZ!8_3XM7T8P&Z:D>W1-G'5@K<%K'&:@
M$'Z6XECWC-@FH/:OTA"#PFZ6<AVB4FR126=IA^*$2C-""O?KV7V7)F85)HVF
M3[F/U87*FN-(61@90:#'7PHQ!74[@;^RRSHOR'=5C-T6B\*U1\LL\"$%89OK
M>KHG3^"Z2MIC+(:^W!8G'!]B5KR.SU'&@E--A/7\DT1H:[3EZA[8O=@5.$S*
MP"QR\A[>P.ZQ%1X!8Q/9!(,Q=.MCV731.+H^$(H8$S>K/'T#Q_:Y]GZZO:>Y
MKDNYZ6"0XIV3D=H-\I%:3]2JS4=S<Z[3MB-@T-9,O(J(0 40*F!>YRVO!]LR
M'2"G74!G8ZSEEKZ,BX&CCLMN%8Y$/@]3'.USVB_7W]C_HT, <8?KL1/VF#R\
M'GA:LIH@?<@'?#'FA&0G=ZD*C%7N5!^&[E%M%/H.;*9IF.E\C8!_ WW7,39E
MYGYH M:/S7FPK*3DCTD5SL:!F^5O%3%#S&!::K]%9 $)\="_H=CG5!+H,\%7
MV\/[-0]A*XD)PL%)RRC>PB#0($_N;"1CW@@!.J^=$I*Y!'D8'F-QYG+227#E
MZ/>!0ZY7; \V"0[W[3Q16F3Y4#E5QC::$--<(ZOS'FGT(+KZ,L5(3F+@OS]!
M"949*G41J4N0'M*:7V]#LF5UF=3.S T:74FIEKH\"AS1KJ\'$RG!OB_X[(!R
M/VPY]714\IT0!_%!?%>)2\)T)VQ$4 V#2":D#U8)+*TUC[C;P,,6I%\ 'X3&
MK(?$JM] W'7J(IGA-;Q5C],6T#JPQ[1-,,]*XI1M\SH.S"7]:5IW]RBD]_-+
M?:G$>.@$Z7UGE,EPV;0$>; 7,%RCIM!$=9W7\5NH@5";5.,BRVXT!20MV,R;
MR^%(1:2>H=)CH^*X:]L->&T=@_%M7[32Q0WH?U)@7NG>8'VX)CJ^:/$8V59S
MRVEO,?4XXJA^,(+8B5<@@E>_+>&L(8.)Z.&P,K(I;,T#/J5&)W@=?J#%0DS?
MZJY)AR&7_=E-X]BTDR M2::.Q/4?57WT\%:?W>D?'E<TFW;!;6SH5W$_>-B.
ME^/J[!#(>J8SX]:F79D-[([WT&E%ES1-B;R:)#I.7BR_$;2N$BMGW6 B;$4'
M^W>?@^>3D3IN[M\%&^^TU(4R',KW%C*(0@YSZ:CHPEJ;0(](Q@HEB1VJ+ %Z
M5!= >B(-38((<DG+5#II-5NS+P!H:R)=HZT@6E*TGP1Q7NV6C^61^=]_\GUW
MUC9Z3[@=RWAH*.+6&^R @V[BBN#*.@K?@/LM/7@JE5E5DDC3I9[6U!+(?S@%
MQ$OY2RAZK9*7#@T-]SI3V!(S"LW9M)&K^X2*SU;%]'%T'H\&;>Y6/@%Z>\;F
MO+WG8ZKSK J?N]CC#F!?:K=!<XVD%U.P,?,0U G^I2 !<Z^)J83*X52 V,@W
MQ>SMAST**9=:+?7 XKPRHHQD?"(,O7]H,O]"6;CHD&-:>V3H!9,.56G)6Z#H
M16]%=/ M4GB4C5W"N']_CT_9.9&?C;\TFE!);&6N@!,0JZ72!B2KX0TE$.N7
MEZ\@:\!L7Y\33L'7EU!<6@O,0#/&).Q:-$ZS! F,&%1H3TS4[L_+7 M=ST45
M9<I?<>I>)?K^31Y,@X,UJ;SO(+*B$S8.4'5 CZ5#.BVYV!O<O0!):DQ;SP5S
MDLG<3<\@EFLW,["['#X9^23B5F/9WL>14:&;1G:-]??')0W?65K>T7+OUJVH
MDYJ'I<P63L/ J'C('^6YWP1E[+G_/S836+2 :EQ%^+N8&K^ JC1KHL_?) EG
M[I$Z6/!J@=8MM(VO7D.U7D"5+M6<](+8SE\W (QNYZ&1Z2?2WO*V:EBT9:-\
M Z=U<@\=0= 68 '5K&_4%G=::XU."XM+'ZTS2X6=\0\2KA3Y1<3.7WP3)4]E
MG>+6=,]N^C30<E;5;M'^7JQIWQ^UM=3:[%G$GX8?S9 X!0XQQ3DRAH!I%)E;
MTL;2>0_IO*89"CG*X,9YPQ9,^O3^!!G98-0LM[C\T6@0YA5@P'SRGJ/-B[P4
M$E4TY!%:$NCJ*'[?L62MZT81H L;9:L^@U/7J.L4]*7:+NV:+NX&)$6O'+&T
M GB9N%;#C-SH>0)CMF.[\&BW?7KF'E? X6-.R?O1^V;?^;[W#1?&[O;V"G@3
M&7G!?N?F3,W.,?^8Y,H2TBBZZ*G9_)G2D)B2B-VXK9NKN2]XB>Z1]>XIXM1O
M7]7</QBR3] Z47*=I!LF>8EM(R57DX T>*7FI=-Q8%K6\'#N>PJ]L6 [Y"HE
MIU51+O=_O++C0$XQE-T<6^TS7AS@:E\6'O'KXJUI-NR7S^^T@P^*S3!7.X$O
M?QEN;?WD&_%@_XF7/'-L2\C=G:_B*EN/MAQY7ICW<=T9TPK+YQ9AQS^T/.LM
M64EE1[0^+7*?.9M<[9)WGK8K:7K'IO97)'.7U.^^: W-'TJG)[S],@2=MN4Y
M\A<5)08?UDV>9+1Z/CS?%_;L0?2+OM'CSTM2'Q_-V$#Z/*6U(".TYIL%5.%C
M@*RUY&<QX:G2K_=YU"&ND-::O9G)P20JLAQ";[M 8K!CS9I%9V+/0%23X\?6
M_GD0M=@5Y3/V"=Y*% =HLZ<74 XD&<)-=D0DEZJ_T_9J=_1,(9$C$;.:XVIN
M.*1?L770[&IB+L:OI^B=X/?L.":X$AHJS]_D6<?K[NBH:M=I-^$*SC*Y:<?T
MS6M#_>HS[NU8(F>&]1S3\((;[XY,BX=4G&T7SFU\ODVBN.=H4O)-M<SMHMN.
M#8W<'26ZI):*I:KMGC&\LKL0,\!HHJ*AI&_TE-.>QG=E ?>U;_//!J'O?FI'
MWQO=7W<+)D&;U#HT$7,=SPPBR7V:LK.&S0'B5:=#=0*(+G#,09PUW=*\H<?+
M33@;:.@9'DW2AW#'NL[V+Z!\>ASTW9:]Y+\R.Q*T_\J/66-R2O L"8KAP\;!
MVBQ&(Q^*TSK2IWFL$1?9W%5X%R!HQ'\#)4C',1-3JR#W@YPN=KKWS8[OJJM)
MN?&E \MJ&[CY15Q>W7G+L<]7)M>3;PJ#@Y@&IS^_@>(WO+U@=-SFPY7=/CD^
MI6Y'55[EB:_?"8[GXT\737QP/'IWQYT/$:/.9HS6P6%,ZJO.]%?9*PZ7K\>N
MOH"GY\M*?3R/EYZ</B$TRRX\_"RCR,3;&%R3N7^=V_9PD8<?LV,*=I1H5^Y<
M0+GLDTI@9[H%X8L$R5D&7V_7R:!WO8,00QJ2VHC:V#[-!L^@SC[9,!TR0OB:
MY![O5RVBJ9&U #RSYQTQRQ90LG%H= 'UUWSV/ZS#Z,HT/,L <8[7S%GD^?!S
MS/_BV"[_9>CK7QH64(R KY<E$T9&J.;(#Y:B9 &U9XSPCR_$?[I]ZSQW#R(;
M%M.%\)[/+^@X/C!.A[:V:2P,K].!63AZ ?4IP>4?7LAG)FD_QH=Q90$E)<XC
MX]"\#3_._5.X_/X?WDA[\_?",6"* *]80)& J;>-""]&?RVV2 C#)A(XNDEX
M AP,Y0#3+=]!IX0M.6L74$W.<JPYA=DLFF3),<LC+0VN1N""M@&QC%Y_L2CR
MSM";RZ+,OJYXF\ACU6%%5TYJ.I^D=:_.M.\EGYF<G!1WD0"=OS'_<S6 !R4U
M$O@!4VFV@#HM]%E ==WO [/A-69:#W>YKN:A==H":C8 MOZ=WI:MB<_1WM6=
M"/FZ,=5SO_%_:%=<!%.9",?[^MU,GIT(+Y5?8U%RI/Q4)6P.8CW0N!3[+AEK
M[9#_FWB#/-50L&O/C.97#OOHP7,S>@W>K=\7_[CC]HD-!(_7LW'_Y>S\U_8=
M3'S2+B?J0PS!B_'<3\E60K9SP/[TYH)O:ME5()91U&>[PS98Z.0<2P\N'1"-
MY[K_A9W)RQO"'6$G:H>' _+,7QV7WDF%M@'DU_2JN2;),A@#A1?Q[DDE2\*W
M%8??.N%6@\Z<Z;3-B2NH>3YL>T1/$QO4MP/KD!FQ@'IS(W LML;KZ7<'1E?1
MBDAVM'?T:N9$C]IV'&\,S+414VHL]?NYY)//QFAF/6=A/1#3FN-8E)7NP$;G
MOR8MHKBT+.Z("N'6'*U11FY^G"]U/;HN=W?%C"NOVFT!E4-NFGJ%.=I%V@,O
MTCPGA#)%:9U!7,@(Q+F"8HI_?"1];7AJ2:1V/6AP8Z[@/#LAH$EKUVUON&9
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M#4NRT(,GHUS"ES2)<I2_3?L7R_YKAD7\O[+LWPS[O^R:!9P]<8R]>"?X &
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M/.I;ED?@,Q'TD0<+T*W/ KC[TQ2F$I9=T-0.VF09_;=QIMQF]A1FV7Z5C"$
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M4%3=T^ZU3K4;G,Q4]TF#/3^QGT ]9 '2V*-&VJ.WGS*>HP\@]+/8G?@N3A8
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M3KY6ALT3Q1.D?6';:%53L\[WXT'/#GBT=MU;QLO>ZWI@9X+#>/0A*1+;%$C
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M2((G<)?7H ;7P_.)9.F+I'H?Y$TK=6P>4=DP&JYT+12'\.)XWK-R-:-J1.;
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MQ.:S&DB_VO46=6];"[V2J^],.>%*2\/;'IYO2H7O<3EL9E]HG2# .&I?DUS
M^$P^J,]=OQ*@7L7*+[JI5G+[>']A:4:8=NZI&H]?:Z,L0&+5?<3BM;L&)N\_
MTFVX6CQUY >>S'R=,32.[];GC"O(>?#D5S_/\RB?%$0[J-SM\FA5-%XI+6OJ
M:K#R[:YQ1%K*..'A.=RUOBA0WKU>-\H7NG7 E_EPI?T:DUJN3#G=]Z]O\UA4
M5MI67+.I&A2LL$B4,_W1%W\9NQ?XZR\EB82$,--GN[5ET;-3LV)^:GY^<G?^
M[85V0WM2].7)XDP',4M-VY#[;U.T/+:RU3)(+B+VY-TV]U-EA?!#UX+"+5W?
MO]Q]RV&.-<53NDE)'VQMK[C,0C3YHSS<)1-/G(@0QTWNP:MF7.9JTF ZOAG3
M%;E>#A:59$J9[N:;A3.V;RI&,SQ$ME=LBQ79@/TD7^D-T:2X2'A5/!!FL(8P
M[7/EI^S&^)+\3R)R;E%"8OP?OH\?=R8O5GG4P.SX9\VITQ8&Z+*A@$?[<\Y&
MEP3ZZD7BK1^FV+P0&IOF)O\DCD1UBGJK(T)Z'OO O (J7+9$?F8OMM4@<IPF
M@YTFHV\DZ=M.M^NC*WP.DT9F=FI4"L+:!@QP4;FY2?6]</A)XP4;2%J>Z]#
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MX+:NZD:WS$$+W&."").'ZB"!8M2S)#=;F6K] !'C(W5PJZD?T'W[:.HGI,8
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M2+B2U$BXJ&B^%'[R]M'F:-P3 :E_^;.@9@P-M_W=Q97_=P?MXP$?3G\3M:_
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M[,<!W_^'OXQ!J;U,(&KV%PV0A<.F@^1-)0[]BE7\TN4R*Q9FJK;J] N)\L#
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MFNX^$;/ID"3JGF> ]Y6#[!N$UTQL&[Q^YOEZ4F>W"*,5D.>E8/L\T/7IY'%
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MWGG#'/FE+H.O83[!T]>FGON+/]!5-WX#4X<O9U6FYM0[(+RJ["?+?4R5T(K
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M(5K+-J\WK3)[..1A:IKQ+Z6^P/%&_FT*5J2$%NDH:@15,;:7CMIA7'G=XWK
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M Y8S0XX\+PLD<LZTC2$0N*Q-![IR1;DGD..> 6^9CE@WEVZ?:,H^"9<N59U
M+#6.M>M0/S5YOV,YXGW?O[2O6H>%U;=!MPSV_=@YK"-,522&8BY'/]9"VP[L
MIT3O%[2(TMJ&SL30I""WSE/J'I4%WROPXL;VX!&%_<9HN'95'!Q1 7_BHUWP
M8EW*#=:OT@T1 'Y22-(<$-*96E&'K0)^>C$0*=LLDX"T>(NKQ(EC94*/_4+2
M0X]^(>TK%YSIK=ET)]UL2W=H'*]HUTX/O8-CGF4_;3=CNB"CR7[G6M@UX"CZ
M:C]:M77Z3#%9>D%$<Z5QO+;IB/\?]J&OSLV+T$/--D,TP.]ZAK=B1!*VU:US
M.R%2 R^39/HECX_GZC@+JG7&XEU2E*XX.T8TP0QR[F2E.X1Z8NPXP^U24&\]
MFA#:X'[DU<"(A ]**>^!_63ORYY!HCUUSH\X$P,&X-E*D^2SFZ<R^?W/)I.O
M=2W!^USEJ^-M7;_8DJYR]9R><C#_/QG;?K4=\AR-91>"XYD!F&YC4@AA)H>*
MKE\LX>TG28/%7P2;<[W)V= 6\U-TU\SE[&R4$F%()]5HSE['Z\TXWFO0^DV:
MFO_8CL*WKRT)@W\XGT$_=J<5L.1]#WE47=@DR%8!TON0QVV$/,L#\.X/LI]!
M%JF$.?=];:"0*060J>ZLD[@>/WZ@9A$KR/70C(*D3@/.F+&B<OT8ZV(=$.J;
M]<,NVX6N,/4?0@>:<KI%WV?VLS>EQ>GJ:[MZL<X5 $+3 2X8VS"D>W:$4;:
M].]9QXV =V6H'_\H"U.+M%@2W5:)7PJ%\7C"X/F*ZA,L'=Q&Z8GFCSM@9[Z4
M&Z2W'S7W3FWO#F9ZAC]O+])P?SP]@A+CMD@A,'UCD73<TYI;X#6N*K0N] =1
MX_^8,MV$/(0)S0_O:>W67,G_-OD5(,IGAM]YI?R@U/#>HXD&C9-EDQS%0YYN
MOTY]+F;,\]'M#WE88OT<@:I%#9 ,0"+[274P1C+-A5D77].C'VZ#+?"><&-S
M34; 'K;7=+--1PBX(]<R9;39YJTQ6!RN/;P1K'5+R?)1%R0L^']G6R&,M"T
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MY5CC9QMU^MCZ6&(U](E^B.NY%Z?,/=0,\[[DXX9O3PL$MGMZZY&7=8YLW_F
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MLMW/,.XI/0Z\J42F+^X3%B$)YF<8;H]JN6IH0S0EG6A)OBOZ!^#=)S4;O_*
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ML.Y=3?\=)E_T=-HR&22%HJ7!2L0^RQ&60Z9E5?G2X>J*?2^*IUPZMD>1/+D
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M:Z^"/ZER3$3BNH:H(++YGE?_4C7";_3;Z K_MF;X %X4?AR)S6?05HZ4XQ!
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M@QG[L5Q-R]Q4O4 7(?]-Q;_8=9Y>3L,=Q:88>,PH)7A0E*PJ@(T&X@1>EHK
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M%]]Q&#R_ [E%9*QR7^L9XO*W@]F'.,5XK]7=2]!]X2+>4$@@,1)^MA]FP'M
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MC(6-$E5EK=<%Q:S=+W!._ N\(I5_G1Y X5LNWMX/0IMS11 ^Z 0J%%2>QDN
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MCK[;.E;U^K>Y&5/1@5:[(HN7E!DUQ<MF0N'@/EM8'\V"+" /M#RM03CFNJG
M#]14!)U%.<^?&DU!V"D+:0JKT4OLRH=+BX0SY6S1F@JR_5G\4@NG4&9 -L?"
M-9QVT?-?*RWQ8^4F#1$O$FF#><)JXJ^6/W(A@P,LDR^)N%K99]PKD3SX:8!2
M@ #O&5>8H&%[:B83%#.9"/GI8T130B5#=FT9DBAB*"F- ;7?'J)9<'&AAH_G
MH8C+;$S0IWS<Z.@>$T3-_CK*2-1A9YPC07X&T2TL8?U<?_NR)1/$@5[@HO.C
M$F!4%W@1R](9* ( [-//.4XRQ!Y":!_7Z+I<?T']!?47U/\(9<<$)>B$'1K
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MLQZLXSQ6.RA+$7R E>FQ]DL@(T=GW&O"OPGW65$T'M[M!VC/+,VOAHH$+YE
M^F'_<"/@OV?1/;J)I3/L7RAS[[\\A_\7PT&J(3OF %,<-_(3FL]Z0;,[[0+<
MB8"4'U;#.)D"J;_/AXQ7[_IK+[C49IN.-532 V$C]=?7DIX5.\_Y-#:>GU9O
M]55>>I=U8)80,%>[:^FJIRD2_TF^U5#*-U3+AK^P2+!+TU<E<5AB47J\<<;_
M*^,%@.MJYP B8\H!U%&/AJM?\]R#M/)"X[M)*E]: ]R38H3AR8]5^1->+=NU
M_B"^'>-)+#/)X]05MBF_>>ZV_,X6A4!/4T>G:0^F+<".^QZ$IB56J?VHO]ZO
M&^!X<30PY(/'^W<-;J&!@4&Z58UU7P?A3Q8]G%ZJ"%\]R@2]SK#'DW''@/UX
M9]U$8JI4UUBW![PBPT_]9CWP)5$P68U>PFDHUJJ[&NK3MZ)1<NJF=9D5[]-%
M@0/*#?020O7E\$!MSG!14I%PQFBYN;J/38EM\%B)W:OZ#"E,:*C$2(:'D,3D
M_!SMNA/E*6LQ-!Y&DU7',CS^#&H_Y&?T+B_5CV4HJ08FZ%,;<ML2]H0)(N13
M6?ZM1T4S05Q)K-C&5>+DD2E,$#<^%86698+P*"8H#'*"%0+3<_72]&,,8=:O
MQAC4CK+1WZVSMI^>""%9(,28(#3"@K5H-VLAV/A<9AHU]<(CVD\+A@@3=/B>
MJLD$G9V@%T!^2 .3+.8Q8VWJ)2OE_NT"L-8,2R:()W)^GW9(0M'TE!GW&-6T
M*A3AX0)ZN0\%S#%!WX8Z<=3'31NGF* ;D%@<U<H/1NL?_D?P].^%:=3G<^RX
MY3E>U@)DU([ 7MBB.^-RW 66^-9,4"P3Q-A$GF%)W(#SMC@X15-GE0//62RY
MY)KV=TM,;DGRH?Z1ZL#D"]>6?VZC:2P9]Q\!@0Q1S.%-U&<+(I;!E\/:S556
M@/P=/BY<IH@AL=^Y]7.?P 11$3!:-]WEIP,3%$_LA0QEL+:+8X):T-$H8"-P
MFI?Q!'4&!11/X'YF%_T=_-[A1P,P6;J="S74+LV2A<3"5U[=ZNNE&9W58B#*
MF""6A/2O-)%_Y!+@O\7'SIK(,$$)ND D(XH,88!9M9\*RAYI!R%="QK:6810
M YF@S>7_@,<9T8RWHN=VMA)8)1\5]S/IH&6[YO]47T/IZAVC/VU7H1D.*[?>
M(*9X$7</ O(6E.-GV=Y'MOFYU&4B]($ZDD "0Y#:S)<(XPR(]$/Q4_6A3;7-
MX);VND2.+[C0AYE3_\BA[D+<MWY*S"HR077%]/>0/=8,858=_4BY !OMX-P+
MCBFQ2-3-$A%)++#(U4W*KBMR#2%^8A1CE1PJ6^0;OV5E;6]#P-<.53Y>1>"Y
M=5[:]WHX(J_BZOJ=?0X?V/&D1+QZ!D^XAL\/7DS*R$EY'O@?</1JY;_73*#U
M7V'X5QC^1?E_[VM_0(XP0?/YKMI $P'&1:TC>381NT=:5=Y U[(>NPJU-X])
MMX_M'L97*YSWV0I9XZKM/MZEV!_^\,Z(H'NRZ7F*!QU9F$C/QF,YKYEV?<4*
M9 #Y KR&J9#S->^^&FKRZW@J\[NJC<NYCM07G:P(\:F&VI2//KT\H.4X6+RH
M'$-*51Q\AQ,R$GDU46)5*I;V%C]:8*@F,URZ.*1W6UIJ4>MP]%6)['4#%T.5
MVX6)\KN7E_ZM?WK_+Q^MRR0,CO"Q52@J"(B[^UD1$5[RS6>ZYWDIM>($Z@RU
M^LS5;7F,:6=$-TW%(HJXAN)?&?[ZXS,<:][8U@(TT,=+V^C/JYT<G+TCLHLL
MH5;EZ[ZC%07F976OO-;7;MB4Z-FA)6_K2IZ"CJ1FFTV5E<=*/2$0U]R^07?Y
M?:U+-MZ.>QAQF^8KR94(UTSD.6@.G'(LD:@NKD9_SU[?(1_VP(3TE)%C8N>H
MRD04#U69("9.+T5<(N&2Q"Z366[G.H4\!??#P^H$UK'S.#ZJ'J5K4VLWC1MA
M/4ESF<<)PWGQ$<C<R#?PB(F96Y-(<;V2<BH2CV^<5:3[5WR><IPQ"P\*]/$/
M#'IC(3I  SKYK&'.W?[',^P%TGL2]U5[O?S\?"[4J7[(FOC\2Y5XK)J3^HKG
M5"SX"L;0P9GOH9HWJZCE$[6/QUK97*F_,AA:<S5&RRSX\U/OT;LQVC8DM$+E
M&,$>0P1F35,^OGWWQE.K?@?A*@].Z^ZK>KC&]K3(0N"%N\KGHM@.PP:X5;;>
MU2JR^J(=YH&!3\,0I^0%,=[3E@;\W]&&?)8&H'_/0/JB.HUTPA:V8L%URQNJ
M41@HFA=QAIIVJ$9SH"*;M/72)/+%J<9D32@U<N&,"#XB_YU"EF/#7!R8.U31
MXC;0/5'JYK05-ZLD;##.!%'BGB(L*E9=CQ^DS6>GME^D.8TA;I"U*3VP4S3A
M<8QB_=!3/?[Q^N<^+$KF6VG,;DIW13B3I:?G65ZD-B=X:\)G'G:RN61,[WQ3
M'&'Z9Y(U64);.@[Y6TM] Z[A?4U[8U-;;5M3SLCVX*;@IG_ 1H"[=X!BM?^2
M?6QD.#$LT=O#*-7AV[/QS'C5"M;UQO8NO^TOIRM.''TC^.<70G >Z<!ZEOK<
M++76!]4>J'1;5;KT7RA^[V%8?\72_!K,L\!"Z &_=JA*$'I+9G;73KP$80;+
M*L!3^YR-DP9=0Q/S7>+QORYPEG169) =H.]+#,M>1'K9-3HB1AI\M1[\8"SS
M^MW+/Y$JP!8'E2EL=5_]M^,1J[M84JTWRNI3GCU;'N+3$BOZY/&A C>C#:$?
M#YFCG66EBH6&C,KAZ,4\7\OTV:OE)QNV_?4JMQ2MRR5#3]53?*_ZT$;4WE3-
M;>2!&4^: QGL+%XC3T,:0U 'IU=P5%$6!??Z(NM8'/LZ$4S58#&FY%([^5 .
MM[-9QCBBO+T#"R\Q\&2"'K"2U"[_* K09G%EZC"]KH@)^FQOQ@1UK,$8UXTF
M'L[M<NLS02=&F:#OK9.S8GU8VI_G9GXSI;'N?"P=__66ZU%_@[?W2I-^["X3
MU%G/:D65U??C:BM9!+Z*FN=A@EBW.39V@93!-!;1N[#HFPV#HFZ _S5@E!<K
M0=S@@P#^$(;I0!1QO8()&FI&4X_A^@>BEC+Y<_]VQW\+YXA'?3;@HHFPLF/Z
M#@P>^9<&_A=KP#Z9YCO&D*?ZW1RA^0&5YG'=M52(=12L!\:IU^]'KR-+=Z+<
MWL?9#2,$JIQ-CWHS(*,<>"S<4'[*_A99HZ!,,[KAY:X?ZIP!"<T54?8_U45#
M(U@TI@B:YVAQRE4%21<>?5IN^S1;@:CDV!.TE)QC*]O'[_.QIT0X8[6'-TU)
M];B30 PF+N:.*T^H>%N^/ ?<'C^>7*1M6[YC:+/\T>I*QIN)&&<-<8&"A"(G
M+JL26<8]))X)$J19DBMO^W%%OW5=@9VJYYK6I#22EPEI\8S+P#=*/D,JNA?<
MH-R+$H"K$NV?U*<@>T:V=3V7;Y*YXA P,AM!0 / 1=>WY$EW35!VX+FN8_>!
MLE7_>]!9:G"/EGAMR[ "*6MIE>*PX?6V*=6I?^UEH'+U]]LN_)N!2DLYJZN/
M3S@EO2S)]PJ__U@#]:_"V:_EVN 5H2R]=ODSG'JG4Z -%5U)A!&L4TZ;S^2K
M2A*?S&%$:JBSNZ1)QB5CZ[+3?IGOPR^H/'/?UD&S9R_4C#^Z8P<^$X,?(_2>
ML3X58]GEYDV4&>W\U<.)?\_D=*:@R=TL\39HP[)=@\E(Z&7!_T?'GLS^6\]&
MZ_]7<\V_@O-_/PV, ; O7QMG_&9,8[]O/"$).;&5$P)Z4_<LL3?]#=7+32P\
MA/_P/Y"8B<2VFN?=JB:JM;S[J-Q6^(W/$OK'O[<F^H\.-VJT<_2-T=E-6QZ3
M[[U^)Q[_'#UW^UAR9LHOWRZ#;E\X>QM[;&R/[F27F;^Y?2_F9?JLIO?&PC&@
MG.>/,N]YU<U@[1J)G'4]*?.-"A\*(>^90_CJ=?9W[W(T+W]-NL^>^IM]KOVX
MAP/4!@"J225VA<%+OILJ+9;)@8V)&Y4:WW)K#6L2:_U]]W8W&&X&?/95#I8&
M?"!+ R0*/L0XG7EXDJ9'CDNDL;$JKE3TE)@"8)00.G<27F3,:DD]R*FL_E"9
MX"H\KE3O$FA^^#@;H.R;M1V>+_%XY$]IT][>[%GNV\$H>37!%Z-DAS&.#8:9
M)M5R&]9ELO7Y"0U\T_:K'_),0D9"Y6[F1$AK]<BV][^LI*5]%I8?:#]'<Z6&
MD9?_/$LA3Y,A<]$D74%D>TH3Y02.5?U[HP(9^$EUR)E5'%F>+/6R:,T.YS%1
M'V783]<T;]IA#%!R [5'O*6S1WPEA0RMD@L79)J$#(W+#8VG>HRG2G-\2JOS
MDXO'TC.@03YJHV9JXZ-FWJ/0TGIOF<)$_=,R6%;%XPV;UN_ U9FG %O.Y*5<
M4I[Y$,FK&W<2(?S9NBM+V);>799 \_''N*QD'S3[-D\D7! ^4Z_-OS*F5+6(
M&[OGV>3DH@2T_ P]:5*<<4E UM2 OV7D /'L:H:;@*RZ(&9FRF5FQ^LSRP&,
M;Q@$ZZFP>HO?&*)3/LUH I<(W*BC.: &XP@/O#VFXTXR$\&?AV+C&V0V/4?K
M136VG-IJGAQ"<8F#FTZ*2A/&@=5%#>_A%Y_]FH%U,1^0F'X<5M>8.C.UUS!^
MZ&QO[[NZ.FD_#O.KSO[!6NQ2#)_E+[R=H8]\UR0;"!/;LE^QG&DB1Z\OGH20
MKNG85\,U>U1A?3EV%<1-!VZ?QP^%@X]("?UVY$ZNH?L?O[:??JL8JZ=E/6-.
MF=385TD7F_4NNZD=FS ^EOKJ25%;, G((-N4G#)X-+5M4[OTM-EQRY,A,SL0
M7CSBH_Y3KW=<O1=>1(@SL?3RJI\SR<TQ!"5Y?SF'K0=&:A;9CE:<6.*\4E:#
M/3&YY+.'L?R:;D>!&Z): I:.@7]Y)B/683_D(0B%5YE2RDWX"@;G*:_>IR=F
MPS>GIZ:DB[P^D<_J5;,?Y[]ISA_$KYOSIC[C8N&BEL%N[OX]M('4J)5Q1D"@
MTM:%CZ&/U/'YVQ^&TCR.$7]9KP")QM@5)A[*]*B8J"0FV_7)2K3QU!HM\V24
M2<OV63T?[S/K,]OW;YS[Q'*+^S%\]JH+%H+P1\3EZ%;'!5:N]X5\87 #FK&A
M6X+P,KM#248!/9LXQ+D2%C'1](8>;=K0-K:%["YU='&F/S>O;<&]WV[--75*
MBDN5]M$8,6Z<-I9\/#,LD85IJCV6ZR,Q$_!1T2GP?K;=8$XB;9@)BNMD$:LV
MY <)LL.#"&&"ECU@)>,E)NIO9J9'*DUS:.TCKPH&_%R_?G2=M&^<M/\FH&WK
M,S-M76Z10VL%,I3_^8E+5Z),5?P_'0"77V[3IV0 4KF'YC]0M8@#K\09D@8.
M2$2EG(>VV@F;PE5TE-GC]P(YU6,&BZ>G_8RQ#924<&UH+W$E9*OFYU6-BJ:S
M_MD_3,IOWEU<2G(>MDXYZ)X=<37_%)Q<%'!_4LTF\Z![G2YH:1 L #Z'..ZS
MX,<5VX34!&*P!'_K6\\)S5Z_*>F8%NDO^!OAGUF$^2O'*^C(2ZZN->5(V&L(
M3&S[-E)X'"0H]D%J)-/P3!ZSV8\M4M\RU[,V?BI5&6O6!O1M?A- Z6,+$V5!
M?]*4[8RNX4'G_M0WLR,+ERZL_ZK-GKRD*?:IV%9.SD-P4$DUV4.@*)D5X^NC
M9I"7=U^M?#1_M6@>-&["$Y0>-58X"I.*](I37YS O+A=*;KQSE);^>M#N&/1
ML73^>+RLM/O#4\>$5^1[=$14C;!.XNG'"?97VJ]7=.S\%M74$;=Z/%(78><3
M&RL@(&-M5W;-L.HR3NYYAK-]>H9'P,<23#439/:A9ER%>G*LZF?%2+D<+WKG
MG2&/-6HVZ%4XIO5YA.N':OUNUXM14GR-]1X"37+.6D=:XX-M/M:3V[Y<[7WU
M>T/NL=]=HN!-R2YH@D"BL;A$@P'%VH_SA5AT2'+DMO'6[]N(&\F53_I+Y*X^
M+(=6R1CZ3-^U2EZ6-=C-5M0R4*\(;JXS1EMF6\8@3*SMDR^N7MM];JYB_-/5
MN&%B(D+C47J_PN;(P.7^RZ_JTU6OU^PI$)Y3<U(3Y7<T9OP;9P(VFA[//9[%
MH*W233XZ*O(X27YA1< O_Y]DP$5/0\[DOK[@JN+*H]KG#$]>'A/VY_-_*U9$
M!'.;PN>FLD?"G\N=;\A+&Y+K>0\OEEC\;GM\O)UL&T68%]Y:ZU23%=;U,O60
MX$7Y"77V]BM\Y.4JL+^8.O^L%[K?3 ?'DC.#X$*&]:^6X\K7B[2N]]E\M7E=
M/(OIG4V9K9;3;#'#O1R0N9D"[\NQ3''8N8;A27^<F7UK]_'T?F..>*(,MD#G
M\S_ZZH7_Y& C("51'QZ/,CJOH%8\Z.$;$0($[,^STZ@O4EQT!1Q6%UO?SP1]
M?<L$[6T@'\Q>5S;X>9S/TB7ZGX*8]I0)>I**^CB&ZE2"K'_?XZ)?1US!3C9O
M*\?/'6'P(:!D^ZXM8=H-H) :36""CM-,I9,8PKY>4/+Y+(0Z2?;^J.=SR_,1
M2M@R!S^1XN'=Y4.I-K\*A^@'+?YQ+S5?#L=4"JL76?F:R_&[>Q=_6S9YF)K2
M[91C<O"C>B30*%7\5<7(PR3C]]:9WS:\;9_.?FRS@4(#W;?GK(#E;FSJ'& -
MFQ8AWD+5]_:B8N8X&!?@'/-S!!$8.TV3W%Y4[#CG)U] M??,XPN[.NO@/0L>
MVU37-5_KS@G(+)M!\_6KXRC)AYAT$]K@&,X'-:T]XPB -R2!%A)LPSH,J"2@
MZQMP3]100@@;>F$K?Q2PU?-8L=I4<?^I(LXC25'!KUGG\IWT(QHUTO'J;=)W
MZJ0^1*$M\P>WN5;9;E$O 3@\^CS-CSQI"+RKHY:3>6\.ZZ@O@/E1#ZA/OJ\>
M2,?]6M<XO&Z8%%9I0?QV#:KOYAF[8#*B$%!]Y]+F\KO'CP-?E+)4?P_9]1R.
MMB3_1D>'7 \\YQNQB$V0:AFEV9.Y[C363RCL7=M+BLP3,!EMA?D5PR.X43S&
MDK'1[J4K^^=.U+YKR/HX^ZU-6"A66&P#>C6#GU-7'>QA=OBYK-^EQ:9TYM5[
M#Z%!ZQ&-S.OU"[WVIZ#0T9SD/&C=<\ISU_72$F/E8+]O*:/)-J%AR1O(P$\P
M04=$)+5R@8LJ%Y?H#_%+FY8FSB8<RL*H13VXLSJ\\S#1U6;7%"E,"=6(P)!.
M,AT+R-DTN\G%'I74F>[C0U0\[Z]LEKAOJSWK:NJX'BIF0=KJ29O.)8&[(%-A
M"U'[!%S*PCSCY:&* Q6[D(E=[R6;=J&YVJ]ZNZHVDL%)]<;M5ZB]7=N$Z;@$
MI)CO6WC U!VP9PWP/2?U.<G4<P*A?OU\"WVNEOZB_<3*&GG17^=LC?*&UAD:
M^,(-UNL>3-!3DJB%T?BNR(^9P<EBUFV0UTCH!G24(:N\SBLP_0EXL>G6E*,L
M3/:B\:(HLN2>9\"./MFBXYNJW6@[/SP8?)(J!.MF@K@5 W;1G$Z^T_DM@06S
MOH_UE!O&:/IE^I5KV@VTQPS)UO%QJ3'L8Z*2A^'#3U?Z[BZ7*$&#RS[Z\A4O
M'(]-D2N'EF@.R)4/7@U^/&+AU)G>95?_WE?B>^GBX72"EC8-" !RZGT.,3*5
M;?SMDC^'2"AA>#_E"1T+\83$S(K0:]K5$#I4>U9U>A2 I:@K\\)5">[$B196
M.Y_%D"?7?5UK%#Y#WRPJHEXGL<>?30H,Q?AJ&U07D3C,P+?'$%K^;P:*7P:X
M_]18(&T1L ESM4U=NEPDY930H<0@FA3+X^II&M1'\UN)R(MCGA.A$ &JO1F
M3JI>;Y_!F =(3E1OB&UL,4$-4F.!7CEXZ"CF^Z]9-1:A!\/D:,:I[GET"KK!
M_G=$Y +V-$UO N>)/L'H;X9U]%O$XJ9=Y89US$K69D7):?'JZ#/?J*$(79_2
M[N(?4/.X2B>?B4F*F/+HGG=K9>Z1,F,W55/E,6Y&]UP='_A,NQA-O(%J4>)
MTZ$ZD3F,J9AY-)?/]&3B[G 90G]8P,KL>K=V:J4;UFD-*3UV.<VN/9&(L"[W
MLVL"6L_-S7PS\KB?1:GY8A)4Y-WG;_@*(QR279L>FH'6?IA187+UJ:280Z>!
MBVYA 3&(7]2T3\4^(V#9>C^APLXYQ=B0.\-#IF_3W'P@4)H*.?2E/:2NO*%9
MTC$(?T"3!-YP_Z?C\7,"/V;!DS3]$N3P+!?5# @C5K?6.?[8*L #KE%2AP0P
M_X,]>;JR7>S'*IT;Q7,NKE%%=]^/;*ZW?JC60Y.5,.1>RG,ZE@GR1,6L'!K3
M/*B:1&PB!##?BH.<9UPR I((Z7"?O4#>.7@VH3FV\LV/Q[<&"JGVKF-; F:Q
M@;PK4'M*GW=$&.URS:!:2_D]V.>M!!1@CON"8[52:3HWR*R==F#87<A-B07Y
MRN?\SE&C>Z;Y(HJ;-&!3.ZO6*V*B9(WGA4KO)4"W$3?.YIY_I_S;V.1=X3\$
MW+^$<$W5S6-C]2Y254GY<?,U'@M#<;A3(4._([DFT^(1]B$AJ)@<=<(D-#!F
M\D[;9(!:Y(*_+F&(_K[<9S]?XN5]E:]^/(2CG"5I>#F;(O.,3),0N1O&(Z4;
M5C;EAHKO;7+24VZ;A-U]8HS]]G['!&IT"I8?$,K[=-4P0*YXG%1A8C5\4P?3
M^6:J+ZS.F8:1I+71["<8EQ%^]*1V/G@<*:T'FY0O-XGD0W7JJW--U?9M'W;'
M^(=&G5CN'(4WXGNA7Q]!O[FNHGETE"4F([QB$+#R5?NP9HV4*C^HD^1B6W>+
M$\H>S-$J((#'@:B!'0!UIF>.VQJO\7S%?\$B04P")@!?<\WB6"L*"B(%<I=@
MXL?5KX=/FPI):F1M\$!['Y#C8NKF=Y!=J-J4H2X</XWO'=7((P@8ZL%Q*^LI
M4-/P86*RY+&!4/)9QDA?UQJ!$O&]70;%_7_1]J9!365?NWAZ4 3$B,P@1$5$
MYE89%)"T(B#0$!ED%-*(" $!%9  (6D996X96Z;(3!A5 @B$1 A#*PT1PB S
M211D,HE".)+IGZY_O6_5^ZNZ]\.M>S_L#]EUZM3).FL]ZWG6WGN=H,Z'G@A.
M1UIH9?#^(ZS4B^)#NHSL+]N!^V(T4=HXP%,7$7VB"LKL/8.UG( Z6:>?1UL\
MHC-J<\/!M$^C\ %XOCUNU-*EYVXQ(B"7OL]97?4\?3<W4-,HVT3)7MKQ:'7=
M 8FIN\]ICN<^X=Y1"7?G<G,+Z)7TR=;12NN_[EVVNY!?R]#4=EWY6&.B'Q0T
M59W[('@Z#_6VT6NNK%W6R1<Q]U^$*=[/]Z<F(>AO_YM"T(N"/4&!O2__/V?@
ME__$0*2%(-\J(:BFBHX4@;"8$ 1OP*P?&JU,U]F )?]WRRHUB\.8=T%"4(A(
MRAOGI$+W[5F/B,<!%7IXNIOH=D+0,&S>C+ZVG<'U>&<.;D9= 0)IK>* _[!,
M<.&C<R$6!BR14HDT^Z[.UEB<G,.F>P\(M!(H]FPKP?.JOF[9)[JZ^G3JR?:\
M?8EQXH^H,Z*KAS *@O?%T*1""D,L!W6A%H .EO\BF&<?WVY$1ESWT3#<OOC9
MW71@2>DEU_2SUPV3V+"L0,PO;7"\C_TJ;/5KN0H_EQ2($4<ILZ%;W$K>!:K[
M"C.SM;W,?H H/A45?@Q(H;A.&FTVQO&MOSK8#)A.XYKG%THVS>PWE9IVS:(G
M#$+UPO!Y_@_"#Z>MZP9HA/2'+[[IAQ66H/Y"VAE-WBIMID0^WVX NA[%OQR@
MNA'N[/1;^VZI?*I24&[0=Y@=<70K;*1W4%@ZG!B S'4#?N(\9H/).2J *"6,
M$RZPP1Q3H(9MX\!:&VJ=\R;#\= T>E<'R[J';G ($(+(W<RDR!RP/8NX&DW=
M_D3E73"J5M[.E+H\^&GQ8[1I9,=?^YJ9)$1X,O;5WI8)]YXO>F89KYEM;L,V
MX#QF=9(-9%$7V#:9^E$&*47H'['.[$_8#ZV1.KBZ4,R C!?P(T?/96"?/RBH
MJ1>"PLF7>Q"Q*6GR%?'<*-:\*!EP%5 GI[QO 5$L1PK9:Z!<A1V>='>R@MTY
MT'SURR:9>(D*MV$;E\08MS+TKC#EN0Z%WMXA)55&J]FYU_?UAK Z;>7,&_P,
MTMTL=YH".?R//2%(ZAB#9M,/D?^ 7*.M)8,S"#&*K+UT_%O>E8B !B$H=)#^
MA&?3J%C'=B1L![0$[Y=C+TXJZ>MIV,=9)<8P6"VV0QEMD5/PA0G'^YDZU@@M
MUWIJ7ID)>WDQ.O<5#.%_-L+7<%GGO@M_RFCT@'*#;81CE4.7Y7;GER]-3[^+
MM_(<@$\L,F=;Q!U*&*(0SYF#]\,5!9,C*^$)1 W@)EN&;&'(_RN0M:5VEC"!
M72D:A"9[W7FQ &"&C3GRS33*T4UW!3901([]1SF[*YKFXZ.;W6B2C>P96%8V
M]Z21 *W607%,&#A;" +O0F;#.<\ _+*DA?)GJ&S@Q$[.*\T<_2W#>(AGP@8G
M])%(K\_@ D)H\(. \40\M'_.K2HDAJ,CN48DOH"^/BIX@WTE11J:A0;5$\4_
MZ[!3X'+VC"*V=XBO0>ZR0$9K5Z;)GI[/PI>?PHC9M!JW>+L))G/(ZX^Z2XR?
MO\KH0.2\A4IA5O+AAXQRGI#PX0/@N;PW<+! "\ZSX=<03_%^!^#1E<B<X6F3
M.4@"S[\9UC0;I/:+@SE@.G^#D!Z3650L]99MD_K\68OR]-<',0]ZR4K)$X_N
M1ZZ/9]@E*_Q#<S8?KQ-W:+03'WH8X=Z3CQCZ(D66N^+E</&U2W6Q*XX[9G3J
M8X62G;V'II+MVZ"%?/F7&'T PCC33H?.&W"B 29;W\?FRC03NI)C2;?)W'4P
M[M.<]"^?]P426X(%9R8B<<X3"D5.V>(HR^KU3+?ET,7VXH710PKG46]9,HR9
M;6@%+XZ?SHL0R\$$:Z'E!.^%(/G;K-P-J"H& 3^(<A$)#)C$XF8'47&JQ1#^
MN-LXU:\>I1^OM]:;N:&<7457M&XH;*[:>/1M]BTG9UUYDQ,.G(QC7W  2%&L
M;]>+AHMM^G$6AQ S0XR;/A+SM&N=17N4E0*67;#D2HQA;8D+,0=%/)Z[X[&@
M:NB3=>E4.PS$<N?)F'". U$,*;'A)4E JC;(0I]%RMC!J@(8KPXV=N!9[03*
MOH*B-_8L(C \AJ%3<A:_&9>62:$QVR!'%FWE&GW674K,8&?\L_OG@ET#F$Y9
M&FK7';4TO!?AA%3MC%+E/)?N#-^Q\Y]R_Z*S.%@CK;C)*@=]C[<ZVL4&:&/;
M=WIFMF8H\3E[]LC0C!"$#\\PEQ%)NO/ 8@#73T1LCL)F(SCUP,LZU"\L< HJ
M#C>'O&T69'&2'!S9&XQHN3O))&@&5)3XZ)#+)3J[7K%F4@,Z"K].]]^9-)+4
MR>B._F,7G+7,<LJ9E1DB:@%K[!FRZ? 0Y0.,5K<M1P=+ W"Z:FOR+E1R(WH.
MDK:K!W]#!'<G6H48'$9I3>D;FC6[>[,BY;_..\31P7(+PW&A1VK5V_ES0E#*
M57X9B28#+*^$ ^[!*#VN#=#CS5X>BO\%:!P: "B#:'5BCO.TD0L*=3W* !S?
ML&_XVAXBL104&UKU8X?;(W;;R554"/<0^BU)6JP?#/Q&/(K8I_(.LI93"!!6
M0R#;)%NW!76!EB/67 F$7RO?=&!?+J.DZ4:VOOR5-4COBB+KUM)#"HN]1SI+
ML_ULM324AE@XQ_-9VNZ9FE?SY4O'5_E;&L8E4V:+'>]U PR+/^6'*_6?SS*-
MS@RP*WVTFF/"//&1J>?:&K<(N35N)<<H#_K_R^*R/TP@;036JE#!DA"TD[+:
M^XH ZX=^_65=".*(L+#:Q&B[X*OG'O>3 ?=@JJ"L"9W8C_FJWRP$^;5#=X84
M=09X/D*0^I$*(2@,NV\9ZCOKJTEG?E>, G,CA: )E6#>7@;THX^-@(P0@M8S
M;?>>0;FCL'VV ?_2]=7/E>D\8/^7_P?EB/\N2]A;"T%_#A6('E<'PM=.[]TG
MB/WG#)&91%I\B=D50/;OL2Y@Z3>$H)]%IJ@649-X!.. K-.O_[>'FCI;1V#9
M@>6()PI!]@:;E)#WQ/]9/8FOA0L^B3A_:\BWN^S96(._SU:F;RG^^\;<=1@D
MF9R? <B0[X40=9Q!$DJ+#I'I*-4_4$%2/O@TIJ'DY*/?N^1K/WO%_+@ROW#H
MM_+ I_K+>MT-WS4Y1'Z>A0QZ"@H.NX<^B3R$7!M$'V:M9>NCY2K8[FF$7PQ)
M"IO=I^_/V<&OLA52=[CC$3A$[%DMNGI,;;_>MU-6/W=:.VAIAU7+>=H9+A09
M5LF=*:HJ,[J[$U[FZ;,Q5>H:<2.O-K^VJ+MZP07=<"':;EO?/3J@,MJG;JN5
MO0A%M/X!/6)QJ2YYOL^??K"L 8Z5[,";7XM,G>!9-2'C:<KO)_#GZG5;JXTF
M'/AY=VX&>F1>&Q(YUSDA:.6YA1'_-300>QQE/$/X@7LG/K$/HT8T14"E4"8K
M!D!@:Y([G-44V8L)GUT5)<XZ+_ST;K@RYBYON8>4:O.:L/AMF?P8?D64SHQ%
M+QY^"#TB!(D(.0,KA_H%?@!-W:<D[#(E4"Y314-SG6E60V7Q#.OI9D.JOQ]]
M-)JVHWO/$"9AMX<^_BK[9IQQ6LL(I5YW#[-2!6UC#I)RX*QW0A"K :5-/"L$
M)3\0(8/E,-IPL14982D89!66"4&0_3[14V6X3V#P;C/AHW[5?-+-HOM<HZ1E
MX\L2!E+VY_)_7X=)K+F9M#IF/J_,7W -<+Y9I)V;GFREH9T^8_]L@%'?2!%3
MLG4TFD3T.)=='^U\5_U)43O4N+0+-^>4.-MSAFC)KR2:"V8@;:0A2 *DS60
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M$+-_FU/RKO"K!3("BD #>,:%(GO>E(OA6<:I3<C$8=.])Y$'123Z+ZN8YQY
MH!U+/P?GZ0M<U!/QYA:!^I0Y3&H>P9GN?H@P#=B:B7:>_1A$E 3><N]^%J@#
M\=P(]%OB4<"'%;PT8SEEF"/AQ0OO8N=D$"P9H\8L\]A&9"+-K>OY_+K%\5?X
MD&F'\_1'O84;J^.GR[\JGO%?Q;1W;JTS<E))KWR86QE<:<$(B?47 *$[EM&Y
M/K%,@<+=IS0F<',F=[-<>>;>+EB=OM05UPC,"X[UX-I?<KRAQSY856#NH'>3
MHCE_9ML%@Q6LI@M5)SDO.'\Z]>M"7GYR?!CE=]-IS8GT&O>URVLB(M@@IBO>
MMS*AJ6+KTUL3;:;,ML&7X:?4J$OAG-(O5>,V2Y[+*I@04A91FI^#N:V"!07/
M79[9UN#^[B6@H"6I!+]6A+(.HC@P#7T*,"%WYZ3Q[LS]?,,3P&R?#^GNS93?
M1TY0R1QUC\*( -7>K/;\I9.- A$%: =OI=*7YQ@TD^T?&*V'!>^]9OKAL]PK
MP!2KDR[.TD]C?5@.5M-DYSP6J*QW6_<\1[IL==^;LR)E6)Q8IQ@1=*/L_\+;
M?ZZ<5C<M%?>+&\2T%6UGL&&<&_RB9K$WS1 :?/L'[F%@?F5JCXR1#,'*\<08
M.@89^U R1 (98M\]S9C":XIP)*YO+[:PL](#KIEJM'T;Z=]!U5\I<N\RD7]H
M;S,(?VFS;<GU"2&U[PTRL]5^9E'>P&11'@"81DF$'Q(HFN080I^T_BXXQB8E
M$,]X+B.+!LOEI*HE?2P'H>#(O]V^JD3U=*;Z$I[NU%/MTL*Y6L,'9!F>-%6#
M$)?YA^\R-R/,'13L9^V.%=C8;WQQY\!F6Y>T"W.OKY8,O!LK'M N_9,3?5/=
M<:D_&#UN>U:[?&YYX!9S\<&>8Q5M9KAU/G"%,M3ZH668DP3TTG*R(&#,/;X\
MZQ8R[C<@A ;[>9%WAFV^+Y_3O#YWMZ %>#@]O3GPB)-##Y6XM"MUZSS<V[+%
MF^Q_>+HCMIFRW8L^BSH'2'(1* 0PPE7:@./=^Z&'4<> .*X"$+N=W5SW;Y.4
M["B#C*5SB=?&4="ZC6+? EI(8Q=*+^ A"EH5?&R]NR>IK<,G)'1W='0WI2R
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MQ>-JZV3G:_,NE]##M\6X-P3OESNPV:0[D%DX'9XL^!$9OI*:A"<=%=FJKP$
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M"&''RNZ9O. \>)2J%T1MN=2TY#M27JM3-'>CT>4#64J\ST;.K71]:'*B5/6
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M,+0G 3<?*4>B=:F8SB]R>D1*%/(KPINW^>ISM3L5WKDW9/#'D@Y0QSTM&,5
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MVR;%=M? 2:.2K_CEW6V[6LPM=A;V#C$>W%2;OX*-7Q*!^6 E-EH)J;<I<&D
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MWL2Q_OS")'84X%BG.1)<T-\(CO4FC)5K]J^''CYBD2A)+NBJ?CKKE!T7E"E
MV-WU4^:"CL)BB9]Y%YZWIG-!BJ/_?F+:Q03LUL,%?;!6X(+X[+F@3\]VVY@S
M_3RN*DQ![1_FG?A2P@7UAV+_]3ALRL9LBH[])LJ+I9V3L)^GV[YP& ^PM&C
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MSS#-7J"]_\L7]^#$=,!QLYZ)=*\K1CT$:!MPFR*<+,DYX@:+\52G#Y?V=)0
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M$6Y'5OW,_?OW0TH1MV]:,ITY'W!-DFE$7]@<G"+9DR[(DJ*MIT /H1L8F#=
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M6,"]-KSQ5*=ZWL7[M?%,]\PLOMP&5__KZ$8_6O"6WZ8/G60Y@0\87#KMC#V
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M\!7(A1CM0,QP8X0LP>,B\D406?FS  Y7Q)B .5Z [YQ*CC<@\796"A@H>/:
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M:ER&CV# Q%<"2\HHF_.8&J[7B61&SI\19^N%^I5[0] =2)RNZ,KN=>?78@^
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M:>/#M),6OYW59::I[DF7-;,P>)AXBW#F1H47P]JP4-3KY>;MXI'<4E>'_/E
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MY'N,/@@/LP_2!EE"*=:+)C!A>Q;S]>O/>;6I##B=@6<=-32\:3+Q*=16W->
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MPR H[/%G+%C"K$R\*9N_E1+<:'V&:KCU<>6A3;F2RZB^AW37PYK28JJ7SIT
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M8C>B'PCCFBF[3G'O3IH'1D5W36*[< T-A'VK.Y!;SUVWYERQ[^4(#;J4KN\
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MB+9^M6YDM5:OL5U]8<726L-AO)A@B=9HR^Y9*ZG#,P=CH"\'UV2Y9T%MSN\
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M)WW73K')TE'5#C5F(D.DYV>N,#M*GUDH=2"(D4I+QD<??5%+SBD*0X12/9*
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MB;*A/P\O!! +IP\2*>V=GQHP,UN+WL3P;PTSJIA[$<T!#?8,M1[\V=O&1MC
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M7EO76*OO:BF8;JEAPJU#'QCL.>2J%R$JP01\8_^<5*Z&!%(PDFQ3AMJSO06
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M^9+A_$X'QB'7(.LN^N/6P584ML$-?\!FB&ST&QE"EZ:AL=/@7#%H,O[^"*"
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MN^S+"A2!*G?%]HY\$;5!>OTA5T1B'W6-E2%_128M[_%.872A>X?:A+,2< 7
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MCB..^D_@?2W+R$=\^2X6]7+*>'&)>ZLFPR52]MXQ/0]-W.V*3PT\J'I;\Z7
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M9-U)CN$/O2/V=X&81@]54"8]J6+\>8$89-37)FE-H:'=AKT#[UWX@PH9T?P
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M]]GJF':0;XB]DR/'?=MTA:%GPL6#N[$D7*W.L@P]AY_U:*2)WX=!ZM)=Z7"
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M-:6@RR."?8;!F0!F"]3T_*\1AE1C0*(&6(62]W;ZX#5WYRT'(JH1&W?C^G_
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M SN;1U#ZA"X[],SHT5FD%V![=)L^@3K9=0$Q#WN>[7(9SZRC<D(5 GHDPUS
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M(TCOA\,\4@)>^5WRZON*+3=]M7\,-C,2LG'</DJI,V#EZA;,^DHL;&S.MV.
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MR .;)&+V )C=1UP5T(<'2>&?ZTH"'M+M?KK]]G/$B;4CWS%'W%G),SIL=.J
MQ;C:Z)D<Q;H2J<3^AYK\AON/2.S]O.2?*4KG6IHYLJ?*\Z<.^SU:H G??L03
M/@BM&:N4.L2:YKD&\HJ#E=](Z;&F$$PX$Z@JWOTM'O:IKJ1\QYB,+:)GWT\%
MI[L2V80Y5_&0#%)GYITAI12C_KR[3WYIU*JHX;YA+4?<JL"U;K#</;:I 9-@
MR;B].#PGS7W5S^9A[!#!16Q*U5"Q&[FYTIB^8Q/X]91JW_%WQ]D%:<Z<P$#>
M^]Q3W\5&:;R<5-<H4_4Q!-ZAHXTK6UBG.:K#.#?]VKW?;CN.Z$[<^<XJ=<O/
M2K_5S/U<X^N-:ANFG=S8W:O^<FB61UR$$=$[$\5;TVU9U97>?7],(^%43?53
MS=]^.&P)G+8K3BE.ZQA3<:P^S"HH]U:?GH_(/6[F!H8(?(]4;V X@YSPJ<",
M&F&2\%E(G>-!V3JY.!$+=H=>^Q#X2M.F>TW(!J:5UKNZO;I-_.0UD7%)R.JE
MR<:WFM,C!?&QZ@FUB'RQ/Q^%N-K>&/"8]'R>\64B6YL\*RP88]:E+I20["RO
M(Z^JU?PFHVC2$O\GC WBJI2,$J"QO$7J?51%@[[,*\6?_K[9U"4]I6WD7JG3
MF5H04JHZF34?&GW@$]S<FCMN+[^\FSRQ(/A53=8XIE/@GXI!]>AIP9=<VUB<
MLPQAGB]#RS^I8',ZS"RS=.%YK3W\,*+C25/6V"_VB7JG[CS+RUD0R<M)<*N$
MO5F#Z2VS?5E[&B*ZE!^2,@*__RCCN[8+6 ,;1R UG+U7*NHAP:DW%[D>XW2[
M7$OEM7^>I@'W8WCS@>"HJ$9_B1*?-F\M[[6@7ILL[A@G#JU&+V*>D19OQ>3&
M\=H=B[44HVHI7;ADNM%_S@5?4+T%"%4&Z%<G9MG&_35=L6SC_P,Z((;2;DJL
MSAQSX,_BR1&K2O3[7LS+/T2&,4 %S40!.N=?8X"&.2*_C!G^C:RBZ!(!8JB/
M!O8,4.P6BH8Y"%T+Z-G[>VAC#-#Y/X$#!D@OH$>)!D8,,4"OA(_'WJ*!#*4S
M^"_GXB'DOP8W9;+0#/Z:2OM'<@,#Q#') /V$;.T-+L<L_Q-7%_X+ !3J@RE7
M7#A0'P4NH(B'> 9(EA-(Z?AK#)Z0)UVDG 'ZAII:SL2?PQ/GP.+X+WZ /@,4
MM2>$^G[2\._1^_PP2(20[G4(,^]%\2(S40<HNA68(H+8IC^_,4I3MV2 /C-
ME7BY_WAE>?]Y82$D-<K,\2EW#.!?R@"]9X!L(VUHBO\J[^!_U:O^^I?:;;(/
M_?>6* :(<XJ9K'NH7K]5[.'9(0AY$<H I=-K:-6 \[]*/9'F?J2 M#S.".&,
MPPLB864(9:>/^^ $<>Y<<Z+);KAE2T/KQ!X#U.SWN:MI2ENGX&+]&SCW NN#
MEL?^1<W-KB).!@.'K#5*))G?D9H4O>[(BV1PDH+N7 $BM:_J:^99H]UB6Z.=
MQG.:9UTYJ*_#.3J/,XJ=+;:6I%]J2BR+/,T9'0,3!H5<U'EZSJF]"S3CCZY#
M0I(&/ [J!&7MN_BJ#%BV@_.4PCDLN<QX*XUD9(,W9%\D%Y_M.[B/]"&%O>K0
MD=]=J=/4]TY,]33D?%9JW$&VSJ[O/1(JW[11*;XZ83:6,9Z<F]2VI;)K,& [
ML:/J=V-+9%'=LJ%Q,OAHX0GGZ<64'=8@>,C)5'&1>*E4N]E'?VZ%3PW2*LB8
M7FPRN'8?3\;J7D/X. !Q9#.1+-@9I![YD\%Z!%L_?+;D]?76X*;?3B>@"6V-
MU+P0-Z5Y2!WV0.RJGRL4Q5R[YY'#L#F\/P,4W>QT9'M\ D_DI("IV4L+].8=
M\.RQ+NHGV_&2+G.Y866?N]3(IDXR4P!![1V9DW<%?L6S0[D/46&OJWPR^7EC
M0-G4@'$F^_()!Z.I(4IKB-/=ZPC[\;(,6<WQN#]7@9.0F "?M)4Z4:-TDO22
M\^N'DYZIA?$%,F$HNU@QLQ(6GK.-[&9@/C:+ FLSI5PVY>PYA]1"MR+XC\.F
MTA".K-<E]HO>6C&[A%//Q_L'65K;V_)&63DZN(SDDQ%6!CJ59)9N?/U,'V2^
MB=EA!/K!9[W%V<=4=,))ADD>273N]MWPNZT=K9-*3(SX2]4UC=-NUA3:_ZJ*
MJ$ZN_V2@/QG*OR7I\U0PPH<TF@ 3A/@+H8@N2#!YNI'\?>7-S"6D)X6S-TT$
M?K @Z&EQZ"L]MS3W,?,,]/RF^GS*U#[>DSZ'G\"5M,4P0'<BQ1$L!,PYF@"1
M 3H!F$WLA G$R=M\F'**RU^W"<W_<:_CQ6D>F+=M@Q-L:9"/[VN-E-=JJDX:
M]MW&W!F3??3HM^6 F.$U8B@KL4'X%?(KV'X0(Q H_9",NW0<OST>$S8G;1)#
MF+%N@'BRV0T_D=@"8'ZW,[8QAEGK=@S0N1N?;!LJHYU@>=8]_26_N P)UCN5
MGMOUAF"/- ??7 <.I^#?7$77M 3#7,:;&\HU)B""_V_9!?(?<A6,G7:+K(@G
MC_9W29$%$DBQ"D$]AT6'SM\=<./VGUY1W_NA7*5Z^9NY-^<SB[(.8S$JU.D)
M4_>@4R\7WNV,*1T$P%@B9U%UA\C0Q(7^I;/Y \9 9I%]1*)=P"\+F_1K$ZY#
M#K/+SF5,OICR?;Q9LF51]>+]*<S<C_6;P;BV"09(D1+Z)2UMI<6LQIWXY)P*
MME?HR67!9 /KI&&IE'R?K&]F&HF"@E,I*G7[DILDKPF++ND\K=DP\WSI$G'N
MPZ]LE,IKV#<$UKX#<O"W86MUX_P;J7SW[+1M59QE7\6QR!$KI+2LI8:\+=_(
M#IH7LZ5$GC)WWDBF"R#U@5"4;MXJZC0BG6![3?GY?$EF*,>;(1$_>-4!7\K^
MT9$ON?F)NBW_*(U'U1^I#8A0W$@EQ0&E"(EW2Q>GLN!NJ<[6^S]W<.<N -+.
MALX==X+;-:987\@W7WZ:=J<Y%L[6CWKN1=ZX0%+6?VG^9T-BZU!%&>KAQ%#@
MR^'.!F37^Q5K<%7Y=R_2IG3^)GAL8N3&($+]E=7PHVOOKH1#:X8$;KGJY&%'
M#^(LYS067-QO<M%$ !W27JJ+9@.9,^K\Z_/E06YEWD%;PI,S6?.Z.:XE"SGN
M[9,U\O*J-UM<<T,;)W;G142>__@Q':B1>E7<BT[XE^WW!7T0UG F\T@+</B^
MFVW3MH?N,+Z8WCM_T"&?-?WQMKHC@#)0OM(B[%Q4]=TT2):@6X[HV4)<3!21
M,X%4R1VSD(>^Q/0<:!B>3*3(<>1T7>W_4*/$$_7. \MA(D>POF?GU(:=6K7(
M]+6^<FNZSSIY3="V%\K):A5S=A+S'<(/++P>N-EK3G1H@>X@M5T-,I$&'-;Y
M-ZI$\WRM(@JC-\?>Y)8:G+_:%KQJ7398F(SZ3QOM\<F_213#$0;H/^UDD'\N
MD#85<P:(.V9EYOA$( L=7,DLIC_^JZ'^JZ'^%VNH_R+OO\C[+_+^CT8>+"BR
M'U9?FL  ><*U0RL0RY;D+FP-(D_%D>,&C-UYJ[F)JF7V9N:'0-J(8O5;KW3Y
MF1_9:E64 79*],1*P'7[')^O;7*;@/H7(O%_L/>>44UN:]MHUG(I B+2!90L
M"UW(4D"*D&QU(0L00D= R%860D"(- D0DJ72B]E2E1:IH4>E24N$!-B"B'0)
M-8D@51*%\ @I)[[?G[/W.[[W>\=WSAGGQSECY/F59R1SSON^KS+GD]Q)/X>J
M>?=Z*(H9>;2X<2!BYO>#W)62B.9NLF2)"JLK]]+533[07%V6-/?;7H_C*8>;
M/_F3M3DH&3]T'>$\[>_SDLH;.6@&^UZ)4VB99^YI&=<SFEJ]XQ5BAF2M>>FY
M8' AK$5LXQDGB9L$/"@-FE?BB%'Y!CT",/N="I3@RSR)H.6VIXQK4+K($ZCR
M1W;L2E) VCV-5RWI%2R#WEMRYJ$O3Y.O_T]B>Y/GN.W/IJ:C'QDQ[WY-C$T>
M"D^W[?75&7M?ZUB^%G8E^Y1--M+(/D?'976TXA=Z@LDUX_MM#8[,?J4_HT.D
MM0?7_,;9:!6;C,/PG\2'\YZ]=RJ<'2O\;&H3GM687:%)_^_'$?WO@;2 _#<C
M>7,W#;=8A#C!.\7 R: ;UKV!H!HZ@+(<WYGINF0YB7$-K9WW7'4+]YFE5L[,
M 1?ZYID[SQ_"&V?>1HD1?KV1L]M>S?]:[N?N9N4P\*96%S0P0#UXX\3#PV>/
M7?[EA$J_S#:,_;!2K<O<XHBHVI.+5%Z4)$=/! XD(*\X5GB,YABIU&3/WEE]
M6S6<E]-4-%C!PJGV59BZ5N=.$)5[7+7K?OEU[;*U*;7(^G5XK\FWL[/1#3FC
MT  ^'N-_BX6:'F8D3.30+@PSMH[2T0;.B:>:-T@\3=F ==2]@J=U8T@N5VGQ
M\^X+'ZJ)B\<5R)C"]S@F',2[P<^ _AHDJFK!$>#^YW["SQCW:*X0I,B[^"+H
M&:KSO/;L5CBQ^Q<E]XNYDY<J5+"-04&Q!\G/,@QH%_MTO:3^V/O1;GZQA- 8
M0KK=JD)N8\(.SQ]V7!HS(DFL*S76??HM<UZ;9XQJ\/S#UZ_G[=D/NK5GCF4L
M6X$GV8B4[YI'ECRB#J+SGBZB==->HPXD#9R7AM*L] 9,'DGECB3*2=&4#X5F
M<(\?P8H9E%U36+(Q8J1U,RN\Q).ISA$,G6+]N!X3WHQRRO!KN&3R\*OK4S+N
MJM9^X\6ZJKD3O7:3];EW;IR -=$8+X_;9.68#(U%Z(ZXK#O5JFMK\7L1:92F
M)"I>3C ):R:E8I383!&BC;QE3[W)]\FJ6=O;?%_F7SIC6[DFZXWX^#:J<K6]
ME]:>'4-)U7AQ0_$=AJLTT.LV8*TZU^FW'PC@F3.V['4NG U+Q5QE#OD8-1'Z
M]AH*3C[.8P3H-\JM.7:?R^H.X9R"NM4RM9N&H.\9K@F5E7TF!:N(Z21N;!,@
MMCC3$7=M1T0NR5"]#F_?_F+-;YI%S2?_ICP_WT-GKNB-T[&%(0W/]/5=0U D
M$F1'?-(@\F0S):%WXA6J_"A$9['N 3/<'C08_L?GF\C>C[#@I,'S1K^98%S/
M=22&'>F)&#<XASVCG%*1]B[4!(9,&&2CT9 ZN)RW([XL\RJ847'B#NYIS0W[
ML[T,M0.GWNKNF[UN=Z2YEIF[!3^[5:9Y3D.M2,*I+*$,D=FBT^P!\U=QF;/Z
MGO;?IB5WR+\!?P;E_R?._\\3Y__-DNWU<#+B!:07D:@F-=49R5PX@3G;^*'3
MXL_=O&#%#N9N^^NP087FA/@+@(K\ZW'(ES]31P=F!X_G+@>,E&=(BJ;_MYRO
MX'[*M!#42VE")6_'': 5:T&/ J:,%-_QLV.&"/VM7JC!5'EZ75ZX]07RL]+5
M]N"F>F3%VWOY13,WWU;!H3DJUGX7,*W*<0KF9H,F.%7W!).@Y,;W9TG@FC]?
M:X<>65ED/*9I7RLV,*!-N@0POLX><>&@B68OBM"C-\R-+^K*79'=^0HY#I0I
M/6,P"I>G[R!RG+$SX&2//P/=<]6*"JMN:3N'%]UT.T7/4#AN8SAGY4/24W'.
MQA5[@Z]-\"Y7>P;0C^95K7MV\4HE3T)L7KT>-Y)\6U#N-GG_R6"H>?S/]_M5
M3_P<^I<=]C%&X4<K,/1Z+^S/23)DC<#^:R7S;H% 9LBH/A)\W+OGWHR^.E_P
MY'ET<G=.I5GSQG4UU7I]^N4G>[WLQD5<S]8C,Q071]T27Z4;OOK])2+H:.(N
M3>6YZHTB*Z^."PNSUT:EC8(5 S9^O8]Z1?];_*\[J8OLF144M0TV\0TBTRB]
MD_<;7@^^8=X2R7XF)5X+O6ZONVOZ&#EX-G_)(^3D_OCZ+8[AW )< ;V:[]M5
M*9? 7I@V\4<+00&WR^S)ODZ7PIW*]M_IRZZM(^I=/&T4D-8>T?X]E(<+4EC)
ME:\!"T=Y!OZE5O=?X (#U<L[)YN?Z<477V]OJ8\8G??^;F>X=;#MR;DZ.C/4
M+RCX1%W2^$HIY=6K=R2]MR],[I*TWOS]:V>K&'SZUF_'CQB=T)"3LO]R,_O>
M]BG['),V&^?,='?#)6V;KUDH=IT/1 %/<^UEA1IQT#5?/]>GT":* G?\_FRK
M<:W6MK<[6]HP5YKI9OUK::KNZ\\26J5__6]?B<SY^2_BP2'/$Y?I:+KVYI?3
MUL_S-0_ZF-Y^XFEZYMX??T;Z_?V/7U/S4^VT-975M=X::37E(VL-QT8JFY K
M'\:0E05VAF/V0T8UR'IG^)UH&E@,*N,YGV$_PT!0T^+^N& R_BL;EGBJ2UH5
ME9$P&^/Y7AF\?.W;A?IOVF+YVWZNKA+/=:HD:IX?=#T  IF CH)._/2FHO0U
M._H^(J\F[:>_NO_NZA'N>L-<[\B%:KVXM=0,$^U!][J&G9BU8(1":J])I[T&
M^51W6/=4O5-C?,2H?GG%0).GKMXQ1TL%^M__<[^N_WQ=N%%6;'HJWS!?^0DS
M5]OQS\<W/CEE6IT-D6@WRVQ(EWB5>?C7)S[A0I!$$$-L!M:$8[CP+@H^O-]J
MQ?5(,? M(7.4*#KN%6_CR_=&RB5R2.=4^<C-&YVM^N].:N('V3>F+-L<T9UZ
M1VS+-.\L64\2C>U:LD(48_3_N5*2UGNK32"*["U^:1,_(3"[;0JY;VKU+/I2
M>JK6XF.36QFG$N7_*/W102W59/QL:+\*J"KYN<[IOVJ>@T @YY72#MG_T=#9
MYJUZJ;6>K.V?X2TSP1VMM:C[^R]*4[7_^G^C=XB[6#U&%[C%M)T:YUFR66\\
M!65G'R*-I(*Z!6H3$!_'4?<.\ABQJ/QD4?DYBZ#.TK;S3X\<O67MV+_(?KJF
M8Q.8:R!M)6=M%ZQNWZ2IH!Z%5(^,&ZJZ'7K<H_UIX,Z+;T$Y[Q,\1@O2YO5=
MEA3'-F.5\Z^EE:&Q Q8&ET<CAN3L4YZ5CFVG27I?'+AX-R1@\QPS\9<[;V;=
M?K,_%/[ ,\+16[[:N<Q>/F L0<>%66*?HW6MR.Q>:M.MPY>U^LY[:O6>S4U1
M?A\N*K"P[,\:2]KO[9VRB[\X!;<LN,W<U2I-?77E?];VYG_WHOP$6V2AOE^
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M^7YW*"6O_VC0?1>11&E*^JN))(6$O21MS.Q; *U7.!OM7XI8A+^@"FEO,A'
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MQ/.;%,@,LA!2/$5.\9/0(";NJ/2QF9F5=L5TLL:X41SJ*L<]C:==!?S\N=^
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M?.ZC!M56/BI#5YH:SME>'>]47Q2"Y-?<S5SV+E)B2P+O/UD1_,I>+JDND,S
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M7;<125._K7CVIYJ?@N8P[<YX<N1WY\]GLJCMD(1ZC$EKZTLD/;=6H^QN;D;
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M\!G6=7XA5DKP(1_52Y@)D[JR+B)*@!B]6%TG(H'^_.4.R.,(XZ8/G;=J".+
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MA1_*(7?:@8%AH!.5DX[2>"<\BFD3>=:].4+) 1$N^"&;NA0UA)/?02'AZ<Q
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MS1V]L^4$OD6,%/IT()NP$D9\GKMZ?4\ ;'[@S]U/]/M'/S)O79MSJ/$U1<P
M1V1FDT2FY(SM :+&9DU&Z#,MDR&7TXFR"CLR$9H:OU55+QCUR'ZB4BM=HR,H
M+1*)ID=$3M9*Y$RHDH%PLFQK&'V8B>M@'.'O%1 H1B!^MBRK!J4WLJ9FJHDT
M<AWA7RX+\E$<_E@/B"6O;4$DCJ",$$S<;NL2BP-U]TL7,N;'#;4^9[!@$G "
MB=@U#I4600-\IW"$41?PR'0W7Q^<8J[^"A5#.<[H2*,N48#/I<P!&5006%@!
MNG;.=D2G?^I,"V#9J#(IZ=S\L[U6G$^)>87>\]E6:;&5/LWCDF8[,"3HGU%V
MPJFY!+6>ZHJ;;JEWB&)RF7[[NJ_?#5=*C##)&?UF@G_Y0"GR6=B1WIRG*A5,
M8,C>H7C/!6JDS>!G2VM<3EX!O[F/LDF*.8]]LSI9S$T:@@6MTKMF85VBEB[0
MIS.8J\D>PAQ8TMKJ80O_ RV(YV!,VZ;L@WHW4J#NU&7GX9D6N9N_!@U[3BRZ
MCKT[\^5&X].#!M_._L78Y$IAQS&]I&(+"6O%44.IBL&R MEC] 0UM8OG.732
MD5)TV=U6/U5U6R>BNF4W)=JSNT'(B(1RG :^7=+A2^8)V1);$'<EEC1&,T+
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MH<]#TQCB_-A9G133G6-\I7LS>=!$0T9:\^5[L]8ALHY ?V$%W!M9\7T"9+[
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M].UUD*W&8.05Q&?[EHHN]WL>:R$E)KGIK]E_/'_RB51O,9.3\GV6GC[K#28
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M[A"BXWGE79$A<0)3=T^Q%J4MU<79H*V"&HI)0)-/&K-#E,Y-\)T(C'0S%%!
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MANU'$ME#F" P[=H6Q+UJ ?=3_+(]?QK5HED%J":'8T3JQ > )X?MRA?EZ;[
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MS0$2J>$F/WR!26@7^FJT[NS(6(@W']$+MAX8A_T/59$XQPT"O0/"3*88:;!
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MGIQ1CRR=1E\E]BMJ,^>FN'@+E](8_(!X<!JIO8Q.+1!N 28?V9U, (Z.3F1
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M].>US_\Q]N/:US"KKZC6.PQMWAC5FL\<CQWLO\'*(. F6%O\IGV(IT!2LLP
M4S][#[&OWX+@19M&&#*&[9QJ*C@MN-3E&CJV]=***NY*-F_!Q<"DOY+5ZN*7
MRF \_M<3ZMA)#G/_\.+*F-E%_K(K^BK0OJR'3F\:.WGM%8L%+%1%!N)J1C&"
M^>*Z[Y\QNGR]L*^5I5LK2PW:.<W6WJL1G7WN6H_N?OC\N>&K'&L;PHN;+\/$
M-3$"6Q;"^AWN"C5 _D/BKQ@^JNN^+%"$UL><0A4+,V-?X!TY-H[IEK.NM][=
MQ,Z;S*Q>;&MO9@S.#8NWM;XLN-K"\!6=O/#PPK$Z09@)KR'\X_O6$>N&]F):
M>W&S"I56.Q+3/.GE$$OG=^(2I3;H1]&MXQGCJG>6<:EQ'?AX\39:M(2F,CI-
MW,K_RLITSCD/9LE:GJ/PP=?SKI:H6EGVA/OI\UED,ZO[GR\]+I)OA<J 7G%6
MA;Q4<8$KS.43)N;XR$P,<RL8DRKSQU3Y]^A2M*D;O:DKJN?T7?Z^N;'\YPV[
MNVWHMFM'>KRJ/!S>#Y ?H3SSDIYX82R+Z'FA'AC[ ?<7VD/ST0GST?$QMB_,
M>MMT09S(G5/4$^P.18/6HL4<FLRFCY9VC* K<5>%*I?.8=/#?V7XWQX]/TC[
M-J 76[<@2@HHW^8;%F[DVOM+:<*V)V6'$;X7/7+I@WF90_XA<RLHVJ^N5E$#
M_L/5AY]G/$[^7P35_U<AV((TN3Y)KE<TX2X[@H8<D:)_$[+@<ET?::KL #)L
MB<58P4%.B($-^J:2=B5)I"/OVE1*<I'OIHUM*G6<E]*@2RRQ;\9Z1L9P%CK0
M%![L3!6=OCN<:N=C=R.6U](D(H8XR^=R[_WQP>X#_TFT&W@OSG:T?XY_+4J1
M/_^XXO/MD.%..J2\?I:5R3PI,^V7W:7L18;,CHXGH^FF22NONSB]V['H/27=
M;.+/T$D0[LK,<P#O Q8YY=V*]G,QCUUR$"R\_P60%XO6[2/?Q1G=QB/=9CLL
M%;&I:D+XMSC+EEL@-QB>;.TG>%3C1W_OBT:FH356:*G,_6!*S:F:B&@Q;I?,
M;-C.+P'H9<>)Q[!D[M>"BE*\BWO+ #S:97WLE(M+;4TEL<XJA"=]$4Z@_RJ6
M_#)84<98U'8.WREM'[KDA"8_K7NLF5EHYA1@,=U>4%MEQI([\YW,/O^XU2UM
MAA[4$/Z (B<23'VA!!KD)U[,8![&JYP?BH(_9.UGB?8#]]I%<#6HUA-8H%<1
MPL!3-!$NA0*+HLVC55P5M -[>\]0]75.;XL_[,;K1*<\C_8?ZQ.FG9M*&:SM
MQ)]ENX"AXL4DNBM:@N-L*@FV2=SXRZS[%%WFKS>@<^QWK#V$V!?0XE6^W0X%
MS*^M9A)-L43CH7KS0G9-!>O^'8)YN9,9E.C%SW.,'UWL=U66ND/JHAQ-",<5
MF"9985V]WA$/\65^$T7[$ <(SDR \F"%I57)@*6AWR&VL, $_@,9K'*F6VSN
M,Q^GG"*SK9A2X_FV3&>LN>4.HR*)_QW?&@0$)Q.VJB?1HGJ4WPKD;\0Y6S]/
M(4Z _%2"K\@^GM-2TEB+3_0 )G.689H8H5U_^7"X[&Q=?9D.1>P7'U^K,AWU
M]\VP(P<;<FBSU[6UW2Q??+=V'6RWV=\SD&U^T<5'1SS3UU_KZD6NZ>DQ]8('
M^\08_Y>&=;[7&%7?.MN-= L*:X)(')@N"T-+TYN<ZS8NH"EWZ,^R!%YB4[;?
M*S$N$;V78%PN<Q^P1*8$(/@R*\GZ8JKA8>CQ!$S'<<(@_D**T!WR(1YH:6_A
MM47<-*Q1SEK1)ZE7%)3-DB?GSX+GSPW+(H"4!-C; 4)DT\8SHI[L%!2OP://
MXG9B*;N8AWW5M:<INU=4#0@>L?4WWHLVE;9"6'&J= VSQJ7G8DM4\CZ,:+X/
M1#O,PAJK.L9W0WYLH0;_7^"WQD 14I/QJ.TX=8:T5WY<"*VSY8>PMO-V,S:.
M7)4<P_>@R5M2\(R/%!G8#-ZX]_/'&>S-T -AB3E%$UM"T712*A$Y\S+$<TK^
M$V1DRD9OU1FD%Y_G?L?G^(#:&]]H5"PN_G;S(J8""A=/7NR;S$,-+=),0)^,
M^NB]O^;734:O/#)V"'8ZS*OROI)9M3W@.77^B.EAIP^AH6[%E^P/Z'^P,3/M
M]DBH;187M4(W O=AL"9U7RI:1P2K]E7OT$!#VZ*>0B44335)_S^*KTF?_YG@
MM]U'NJE4O*FTDS]GXR-5EYFP1EFF,E.D #U*$6PJ?4*#OZZK2WT^;2KQ$"/H
MOTMT(#B0RB6I(L-):26' $JJ)0T&H:4/-RJCBY4E%G\'8IX1K@#F_$3>*,=&
MC2'J3;>YY8MGG,6IAWJ77<FPM;^MLN_F>E!**2ZZ8GQ&)P9=2=P)*6PS-1(_
M3%(.&?_T778!_$@#C3KA&V6UH;!10TO^G2BJ];7A>S.%_.ZJC1?=%W@B^4?>
M<)=3XAPSB/[H1$_$(:9CPOI!V98A*_@>=&B)#FA8$RB![?7'KW*%JH/R(S+?
M080N5,4M;*EHIL>\P.>(#":S;T-H*K6S-B@HP8)2@S\WZ8*IJWO?,(K]N2MK
MEX.-5_6/F7=._:%72_=VK][U?'(CH<')N3< 8[(2X=-0<[:[\-*'#TXUI^3F
MQ3_\Y5_PP1V]69M*3>Z=U)._ _S[<*(NY,65JVX4,[?)?H>*:82K "ZM[:J=
M#WA28OJPB!-W+[$4(KTS/ W%E:@!TL*-K!<N8G6-L>[ZS^ZDVG>54\Q=S71
MMDKN-"Z<)X&ZG#7EM^/IGB@\>H+VCI5.48V":V+'=\O\@2Z%">PC6%5 ZU?
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MF13--OMJEXDOY-[+0\MC:@L_GKT9G*ML'YP+YW9FZCJM7R3V7I%Y _PLN,P
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M%_'R8SQ<Q._(XD'K?H5^P'>5PU:+6V:9,& QJ?C6@)Y"<U'PE%OTAP.77C8
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MF]2%53@@F(^5%OT!Y%=<Z6=?$(=4$O%8^SRR!Z ]ZPH>%+T4B4Y"ZLZL/G:
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M9;M;\ SO!D[I7)YJUJ@*M\0!HD3J5:K)E(D)=  \>>8?!_DT][G+RYZ4$'M
MG[GZBR)^[=&\C5/@2^4^MPR++XV2NV+,/8G KF!(>7C(ICBT@V(!K-5<CQ%'
M.Y3DUKQ9&:H/A35"F*4XJ ! "BY!Y4L)0%>'(_XDG[N9O0G@80#M;#)5WCE
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M1^F3""Y#G],E%X;F%-IRZVW70VQH9X5A>6=PC/=?#- ^#2Y1.F,$5NMELIF
M^KR [Q2R*E].L\%37]T>.P+ZS^H"A*54Z(Q^M54#L=08,Z[,&K_ (#N!!X_:
M7&>RUAQ#A'"+ZLO=,=+815RW5;^R*_!.W=RS3[T3?*AMU5IQ YH/!4?X8\=S
MI6%WV5'@IG%)LE(#,N@8,P9C,N !4G?'7_K@T6-(H2K#S1M-(;78IL^"PPNS
MJV,BK] GXS!_NE=E70DS*EH[/^'?AC,>A6\)\(XHIYL$.9V^Y9$7B]_Y4U&D
MCT_-10_BAZGFN3>:;R;/G\R;/KPVTO:ZMFK^V4SNY^<7>R\ZE12C5VDO0Y"
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MC)E# : _CV,,?,Z1,ERDHL0;\-TRC!C)CWOF4#E6.<[=KO""4J\ $R^_?7F
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M![<C665/0/.S[M^^NI\=R$,7#>(=;]%QM2%B'W="^W=;O\;!N=SVG.&BI1(
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M3=;51?E).4C9^P(R6CT;SMU&]JS[@ME#V:?0$U$.?\D?LX((JD&U!;<;^S4
MMPNB=A8:I"J/0_:_)'::['7@Y#K5#T6WVX< 7UK=X@,G$T/$+I'^TIQ7$C%&
M6O!JDK*!%,:':< =2TG>KZB[%8[CVIEVRR5'10I"0G6XR)!'MA<2K5.6$7J]
MBA_'5R7:6>B12^"1IQQ[*!=7,V6X-UW$NSDR_=6MC+2/5H_J<HH;D(UVMM1
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M_0/PT]*B>,R,IBOBP'$3/. M[^I<\Y8NSV2!\4'0NIHV/_B_JGAO4<EC-E#
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MV]7R4>HJ:/KG6[]![NUE+^[QSN>1B=AOKN?^>/;)=&L_N^[!!/K-F]&0@K7
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M1RAW8C$]4FHS(#T#?0N XO5;(18J41"0*L*D]CY$[,<MW";"$ GAV!/MB?;
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M*/[AVB6:]VOL<7_-2Q1G=.BGZ24T$B,XA.SH;Z_0;^E-4,93VHAG*:+.O[^
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MSJY:[<NXE1W=(^@I%4PKKM]6-[C9([<L,-AP2KGVKN@[-R?OVL@W7(S$I7M
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M?>++8EON[GZ\!C9&1"P3-=H&>D)^X"F^>+$5&]+9WG!LD(79DMF'7QUI'3M
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M&SO5T+>B="#'&#[K!$BHVLG7EW#Q1#.")T_BNW%W6HVK)#67>/*;K$'/J]6
M,,G&4KR8()<OL:F&R4K4HQLL<K$@;$+V8<3F<4W#V53R?G-NO)EFCVT0-^/K
MH"\;'<K@[\7[>GD^U;C\^$J^5;*'EW*%:Z;C>Z<C'[+L_GU:5$5U]7&9^EK
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MM4Z8(L$;BA/E6KZ!:] ZSVZSQ"&";!&>9%\+13!"QO95]S,9\V:]:O@Q7F<
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M[#!_-</I\M<$-NOS9!@F^_%DS[M,QPITA=>)^W93_?5>_!J>U=@@LLOPVD9
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M[LQ3^I[:_$/UTS>9^42>A<NHOR7&$F.6*W#1R7%:J_,G<VXQ'Y%$KR1NNQ^
M49WJPMU'$]_"%#C&$'<<D:C+@M(I8V>@3-#M$O2<MH]@>+T0^A.OIZ#Y&\!-
MCK#N.;V".( G=WA'C6DV9KJSXUHYQ_F5E2O-WCAMXA#Q-&2' Z/^V.Y@TGF^
M! U,C.=.=N*4T)R]4-E]<>\>2-A"O=F0IS' F@1=V4#W6ZO)A)5Y2]]Z?@9>
M%S!A7M?-+MPURLDW2C4N-W_85O<N7]TD]$H6TK@^0*XHR[D.AE:,(>SUR<K
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M_M4%:Z9[!T:L8RB*Z<A -8CR036)9PKRJ#_!"?H3F.IF;0/HZ;(##R-$/["
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M?$3ON=<!"\:5UYCWIVL&-I1JK/PF^SIAHRI2%)<J-.2(2X[A3Z^)<3RX*G%
M9WP;ZZ"(8$)^-4#"$-3!^JR)]TP30(9FDKEL ]DI@%==1ZJ=#I"5'8*BUVR"
ML#IZL?=KQ1ER7IT+MFI]T]HUV24PK ,]$L85EI9519/ >%X<4@_RG)AW?$54
M T.'EJ9X:ADZOL'J9"Y1%; E3X'T;-TV!V-YG91FR['1$9D*M+O_91?$7&ZN
M30]>.?FKN:.&XZX/!K\XWKN7]:#)P<6;,)M_PB[VP(F+*;DEQCN";1H483%E
MBO:P="'TA;?OT/B?5I(AOKL_-<0+?2]AA0?+,$2M_QN."EO8(KL&K4Q0,N3;
MUAOE!C*5=ZQ#T(0,#86!76OB,!Y.R[U>I@^2[DO!+W^(/=,34BABBH8_%!U8
MR$TX&%=FU088UI)B*X,Q>GG'+B]@44P_[H:2T+Q[_$53!L&R'M\JCLL":J1A
MKZBI;(9?,N$D#2O780ZQPQ?2B8>&8JB9J&UMGC7"&9I)LW@AQ0YW%RYEOT.X
MTK:*H4+QF]/GF#MHE]_';BA='5XIKMNZS^/I]4E=I\YC*:9IQ<DKM,QHKWNN
MBR+FD2++U;_L[9GZ!_FM47R7^83$WHK (&KSH%\/^CDL ^$DZ?LMYRE4$SS<
MYE:G8,-OZT\7*?-H]8A"X=NJ]7PQ6\B6HLD(A^JD5J^R3[-KJ%/ <G[5YP"+
MPN+E2/A9_@VKUGT/GS<TW4.01C=+J5Q2BB][]R(J>>"S8$-I#R$^47J2,:Z"
MA:E:L0TX3_#1KUA:5*[(3'"42=<B\DDOZ/<0JA7XJV,W*H>MD^*[5YGKPHB"
M9Y_+M <1.6=GNI-G'N";)P;%?3N9M2VYGRX(GD=/E11EE_R:M[^DB!'RM,B%
M26<$O[F &>DZWEBX0KO&=&EEY,XL!E"O]Z-+43^P,;@<-J.^"1A6VS:#4I;K
M3O>L61)[20P=GBJ<1]P"XKB*E5JTL)PZ(#M%GS$T@&X+_7A4\GF\(T>DRY?!
MHZN$4!_7QM"A8"5X>(LF%+$/87\ U/(D*YQ8(18[O[F>*O\>@,X1V:P_))Q:
M0T/!,XET-3SY,K_-(1[8N:$DV9TJ+KW>W?D'P?'=4J1WG]NP#"5^*3^ N8W/
M'79;:6L=B%E'=P@2\E/'TE[T/E>/SBZU/ARW_/S3@Y@'C]":.B8/I0<_7YFY
M$/S6!Q-P=(!0>_A='%-(4FG,^79:C394=:(FIH494T_\O1^=A=JE@(P^H<!Q
MG;JA].N&TB:\JX61E,)CWV<WT&IX?[81$3LJ9U>>0:@.PTV0$S91'$1R@9AK
M83*U+ F.UUL:+=D^3(@%#;NEAI3$(PG(BB2=#K,K0[%!(9VP6)D?Q ;[.D@O
M%)D1^5, I--1MAM:E] UB'\A=PS)-DE+/:3<LAT )8=E(PN#?( :GM!:WCP1
M%/1IR&I\M[N4%K)F'MR/6_!V?O%LZ"!_Z43*JD-O7:%OE7<^"GO:@WGG?'7^
MA4HAS6YG96W/X=\K9WQ*[E09G$0?=SU_VXNF:_+]>O.O-19'F=EAKROK2_*N
ME3X87KTQOS2F]3U,C!.&+3]_!@Y,*QSW*#LL)Z2C16<>@UDSFHV<6"!3]Q#L
M)3C-"-%/P WYD7ZB*<:=)@L"D?D3[?:G2>J0D?L0$C960SE*.%N /,QB@"MI
MJJ(_0K&=Z VECC/(8QBV6MNMITV<\2T195;K5*0.]B9Q0.]LZ;8*7$WXAA)#
MNP*<9/T :7*"]0LO@K3\M*R)89P*X13TO ZF 3TXGQ2H2!JR ]3K((Y\A'F'
M<&GX1<F%RCP#O4R/7.\<M[-+Q1?JI_99]QT]%U198<>0FNK:E+.>NYL20Z^-
M%0WW,Q?=13U-H75>#UR'V7,.6M_-)#A#XD""C-V0HOAW<N<=A$XM%+\\#"!8
MN]E\*^H6?,):=\#>\4UR*Q'ZK.+B-=?.$/D%+=MJ*V;5QZ9_=XD%KP+0??UB
ME9<Q.1H#GT0OF+A136F^H!.MAI_B?I7I"!"F:R[RURA&7]<"6:X-W=I04K'L
M1-I"2*JJ7']:?J+?2FVO[%R__!"K%MR9: [7&(',NX,M >T'@/)E ,?=?J,:
M6!B)8@8>["]Z_:3W02Y-K^1-';\D;-M G;U/490EL2LG@.;"G[P90UVX\VL?
MS@"G>_:ML,X:H-]Q\&L_P0LL6OD$Q:)^/43GTN^C#9!'"!X LK7<L8Y@!-1T
M+J2.,_SF5('N0 "7.8_ /%9D0'8ZPE/2-](@50<+TV0AM;+31:_YC@53/&%<
MX</PEI5DV95ZB.,*D"D$YSO21/W>& 9YFC3J*"F4'=I0RB9MDQ\G==HF2=6@
MB]0&\CP'W"S7B+2;FO-+6)']1-2![&F*2*AXC5BKS;VOE_,F@R)((ZODY<C:
MHK4Y'7;8FE5M:.R=QSY3677IE\C;G8+?%F@7'"X)-7,]YDW3>Y;5<*LFYD/E
M]PK-T:Z!N#A*0VM2C>VV 9?6LV]6XI@%.7**%[I :#OOO/8KWO-5G/PX- 34
M=1KN?V?MF85^ 4]E>*;;%IG>;;,5TYP[T?OE-N$D598I(T%!O\*5Y>)S/P&D
MM*7YS6C%X--"NHL,L^HCD*;:3:+-;IZ[_FR[.#7.*)SWE[A;^O43DC!B%9@A
M=80NWZD!PL7L% 9ZJS/I2%%^P1\;2EL$D$!BO^[6U60C"/Z1I2W:#:(H"(5D
M=J]T%AG+6ROPYAR]S'##'T!4MA6CW_JKKN]/5<[;W^:<R0\.R'O26772H]0N
M^KQ/V]62*M\2X[_XU1]*)"5ZRL$[@FKA:3->MS"VV%&_\M:!E:8BU-7']-=H
M=>+0>./6/FX=.@V]30%%2&CE"5Y-C.O 9;!0@K;-E7CS7P _'M8S<Z7LI[8]
M! =0C8L6KKU*H'/@VUP>05=GNCE(Y'.@9MX65SLCB+==O7^WVK%"&"XRI?)@
MC*GY6%O*4I;GUJ8Y<0U>@= W'JT9A6L3#P'.W+$P7L$[$71TEOL&=+LTM$C-
M6-U-28*G11GV*'.*+50\T?LYN-A-4!8 +OS4^@P]$ONED,D)XB\7+/>\/A:Q
MAXS8>WEBIO-6*1)?QVL5GB^YNMYF9]9^AVB@'V!O,T"HGQ[YPFC!L(?LS+_Z
M7%I_UA;X< 1OWD7:"Y?!Q6,AKPSU_G[T[C1*7791G&,IX0E^XU]>+R2$E4/F
M+F!4,1#]"]14+<1SS@[3YG\53 +T'&9D-#?!@/?F"WFB#X:_)(HH,QY*HBZC
MH?DU%\)U-B0 UB0F^1/C:8H-&+D;/ROV;VD6(/<)W_>0)N"&>$]7,.G+W:>$
M$X#SO#]8U-LI/U[H&?1+.,L8ER,<C&ML$24_GB7MDA3^TC+ 9"(:V^U\ZLQ\
MLLW&2WMZ,/O=.E]?F->U^SW5,ZSO=9[D2<?+VSTN?]!WN#B9C#)SFRZ952Z]
MB P6CGQE)M;!'N;Y3<;+]MIWP_8A5$#'Y1!0K=-3 WHM)&T))QG*?X8*7QGN
M![<]K_G,UD+8 W\0-:!DGJ$Z:$N.F5VSAVOW)@'RV6Y?0\WG@^6M=O&9U@[V
M7OR)W"\'<+<D"=1N]GZ9_WHY7^KW&]$,_VE\0N>^?#-Q!+D/LA2OZW 31)0)
M]MYIM!+!#'A)ZOQ"=FP8O/J\&32D@X%=XWNLT*KXS$^]:Q[P;1"\TZZ,>NN:
ML.I-I9W7ZR>^%6=;ZK9W,O<[.<7"XV),O0X?%48/I1[.-V,]K_%SGOMHYI<=
M>NAVH_20<_63".37KUFYV:VVL$_.\_-:4.G$&S27JF(U_KYKK8/-('$M-+E4
MA5-52.E:A/!F:!S,ZH;IM9E.++UCAQF!:A[KE?6,\1S#G\$+,+7%\6T$S\)S
M_"5!/[W-<L(=ZPZ:?Q9VE1YXSK_V;+5[^5"S@*!?3W"#=H!:\D/P+C@Y6!-R
MDY ,33.)2*ANN1"*?<J1ZI-T/R=X4HAZ,B>(;$EP!_AXT>RKHC?=F4A=O/0<
M<)%-MC8XK#*^!?*>_==@#4C)O,H*FL-<J-,3]9\^?(O2\+'X'M=3Q=L[JY@1
MXJOM4?RT)$S99^0DSW;GA[=F78*!E9;6E.NY<6-=07=B/0N+_EI7*F<=7Z]2
M.'0\0.>.I\)V(94_$ X.U,NB@;[E>U R'4J6-*420J0J2;;RO3.RPTE[NL\I
M0$Y*W^02N\Z.E_:6FE^T;7G#7HYM>X9/&PCLB3F)."8AY3,\1RV7:;!="P3<
MT[_;2*=;LS6)_RG;M<X@J(DIVR!<]^^V:3+E2,GZGBF),Z>4.'L)NGN$K=YV
M)0EHNIRVTE%FU&^!A(U@D">8+7QZFYED_=B<:,8L=&C6N\9W3T7$?<2S/&%I
ME6^5L5EBVW.*]>$7D;WG.AH?Y%O;'GZ771*0+TUDU#,R\YO:US]75=.^VQ-;
MO="Y(I/U%N()?/T:YYE,"= AMX4^DH5"HZ#C*]0FA%.(.,>(%Z^W\IM\&Z3L
M/HB(E4PO4O;+^]$-\6D(OSL22OK/>.DOP)LJ"I>M[/(0C^JP2VNP)F<OV;[D
MWSC)UB?@(38P*K%"[Y,?D)T 5N[*K4WG B?8:K/!JH*E617J5LB/)[=9KXN!
MI<41S4##&K$[B6?S##)RIG)MJ.J$4Y73P?"A+XSQ7:<2Q=^DNKCY:^#VX9,>
M/P'9DZY:A^&W*8QDVIN_IJOLHEPO2)YT59GUU,S-^.1=RY^8A&MLC<LK"NS-
M_RK\(/!X8_MZ,+>?\:4Q;CVGG V7.:U=)+XK4P4+TUF;(IK&-UN/9[*!M@VE
ML(54I"'478W7[UJ%<U15/"'I!%T//Q,&UG3,4K,"%M(_@F'D.?G^B"*;PO+W
MLEO\'T$G 1=.MJOP?,A=T0NNFT#O0$6P]\G?!.\#Q[/EQG1.WSX9$E2;W[P6
MBR%:"F1;(VF8YVA9(I08:4J1:55"=BM>H%IZ)&-,15)=.D'*(.KTMVG4!D)9
MW *D [5#M(\O"Y4DG?;!U?_Q^I9F<EZHAT]$R6-^5N1PC7=QG2ZOQ\G)564L
M9=ZKY\1K];B7LQT./FX7S>P#CA[WPLPL7%^*F!%6]XT*S;\%2Y=3UY\0#:#Z
MOG/0MVK9,<"AL0YX,K/RZMEG] Y"F"1ILV2J"[9+WB=D\W#I<KT!^:'/5 -F
M%BQ59:)/'8KGI7$Z-I0T9$K?9/\";%-P3-0F@J. Z<)\C]#]VLUC"T.DRESZ
MB+2K3!NJB >PW(#X+L_W@@X28R5Y@;7[L^C0@!&PE=FG ,@?PNT*[\I\:O%9
MW4B;Y.ZZ6M,L1BW!4NIPE"/^>'L,[]D55VBH^7*;,/)$59Z@SN[6Q4,O+^3O
M?>+SX'%)1&^!Q^[^5&<7L^8JJ[Q'=@B1\'AU,7TOM=6\RD+/3>PR6Q>QXH*A
M#=)Z:]>H3D1T@/S]N.X7-M;=4HPB+Z)4\%,3&TH9K(,R'.3\"-L [12(2]]#
M&4"BV(,-*E\ A@NE]@M"YVX1'+SY3N;XL.ENFY_$;6$D6;R0S!)$F]#$X^HS
MC<^FU2'*?V0NX/@R#>SZ T"=8D-U$["4\?TQ.&&#..SO&QX1A<MWH$?B+-RV
MRWC!*Z+%T")\!Y0VZ[%>%TM1)5P'/![9_)E86_U\@F+H(J;H"]W%<Z1.<]IG
MNX+BFQ7Y?E$[8P]U>.29!R\=%.]H>=Y^[G1)C6=NE:EK1<G5"N\+$\5YDJ)8
M:5BHR6 )\;5[O5]E25[08%Y^<9M/H@GQ;3^Z4 2#UD'R>:BBCJ !;*L"5CKE
MQT#JO-F:8_@M_#?)13(/G<G2?09,=?212;NLU]Y8GH&2'A-N )\J</7X0B_P
MJ>9TBW+JW\_X^P'O=^J=S*GV$F2S<+[L*Y9>S<; # AWH%! T*GW=PLK^"ZL
MWW#"9#9)[^_VJSOY:.ANR 3ZAQ'(+Y@-PKE!FR>(%##Z%=$*3$UM2I^SPD<A
M3,6X#$-C4/1 O.[Q998CUX?RZS"]U4%2A-:Y"Q7N;TM"@Z)]O",3RQ;OC.7E
M5YWP4$^Y_.2MEXM/VT15Q),(;Q>F@4'KYSEZ6#FF<2#3TZ^B:7#1[U,^9?X!
MJ.,%_?%0MN^=!(J6L/<1O,#"N04)Y1[K* ,8ST18*CA&B_@7:H_<8!:FSCI(
M\&@%KC.E;K0[3,^=CD"A='?RM7[\_:[><\-M/D!4-]?N\FI!94M8%AZ]G3A*
MA5F1=N(])72%DM5D9J!G,O$ 8?]ZG?Q@N()'(\5L72BD*V!;S9KE]@7&O-U*
M%^L V)>]2-?F@+"S+P9%6#>X$MY;VA' ^U):<RI)FNAFGN.QH>0YUW:Q$!BL
MVN>J'CU9ZF1WT=RIZ[A; 5 1(._OY%?81?$GLVM&^>W,F6+F0(17ECMMJ22N
M??"!7XYP/:R<O6N)1!F'R6&R,] CL"90@ JCIU/W1K*OX.Z660))U&0KF![>
M[]5P HE+R:'A0A]"#>=:(;)T7"/("1==%\&?+K,?D#G6G)(X',>:OVQ3K>JI
M_-!!2[(&L<OD]6JY@8@0_,X"$;IF54U?LY3W!81ULS/LV#E(/<*_@$8J>!^N
M@47M^<2/P9'M#J(-ENRIJ8;[^F/@9#5Q.UIBTDXGA 0Y=K=P>,HI5G4./[Z/
M2' S>UJUO8NF&_UXYH.D?DAEY/;)V[62<!_O"(O75=\O'/"^Z::A77PKMZF"
M+VH*FM>UCZ 9?!D@55_P^SB5P\;BA%U37$.[0:2^@EV5&.CM4+34=HX)!#H!
M;"YI%\%E$!$:2R/RV6K(W3.]M?ADKE#MOE60I7,CA/N[*Z2V95!  ![NTPH6
M)&]=SM3I2*C^8W>[9"^H,U^XYO;>64Q*$>D!\&19+"CU67\H/TG8UPXZ)Q,T
M?Y6K#S'&DUE[^?(#CD\_PW8B38G\<>5<OM^PS$QB<52TXC2(P@3V,'H0MA*V
M!J9.HN_;^.Y&:.BE@H>#@'SQPL?2"^UY#MFW-$M=3CQ^S*\ZX4IX\:"M^6K5
MH3=.+8![G:=SZ!>99W'^H=FX#_7Y\V,CUJ1A5_-O/2P'N0+P0>6YE6CPP2ND
M%J0S =?WER&!)BXM8.I5(57O(.X^TAIZ$#_A8"[.4W %['XYZMYRL/5=F?D=
MA>O!9EN4NW#D '0Z(@PWT:<%=?4%\6,NR6[-4QGP'!9<!EO/)R()CGRZE9J.
MS!OPY- S1&9 JB"5H%G[N26TI,#&KGTE]:@I4%8K(<'&9N.)>_@LWAWZX9GG
M0H@UZ]*>V^<"C#76:!?7?&LS<+*S6J_2=6UW<BU.^3#=W%+V1KYZ+"8@ZU9>
M<X1+EV4RUC?_<$:MO<NA^K"_FH-HI%2AZVI5#-,]BO(XG-ZS!E-'=6XH:4+Q
M3I#!4SF?JHD\)'-;+T7^A.=/%/(H66A]MCB&V,MFB-@/9?8 )>>A($JF' V.
M^PG:MJT4?6IZY!)BRX$I"&*+U9'9(E:Q&(-#[&S4-LV&4M>N$'R@23%NL\P1
M4M'.JL%O0H53WI,ZY)KWT+H0M2.!G"/_D7"&[ J1P4#Q%$6&%2N<HK%PPEWG
M-"C@])%%IOWS"L/*_-+-$Y*X!O:7DR^P![X0C!_%=!^N\_:*F=)Q=84++TQ6
M2_M\1IR+$%^]/CVNSLT;K)A[LG:)GW^RZ^=9GFG,0E+^9.+!L=(6D^*!OB)$
MO:L+>\3.'-27.%-82*S\Q/I#F1%H>7E(KO?ALIR/!GXA;:+N(F@KU'@X(@%Y
M=X*:2=4BH,0+!N_Q*(EJ8:I<&6KE:.)73K%:&D$_F5& ,CFJ=%+JRRXX0=>9
MAX\(/VTH*39QAF#>'C#BR.U!-A>62E63&0!J778$M#KBEH2=0?P1\@&-),8U
MW!.R(*"_C00J^X.V%(136!W>IY.MQC(;Q;!^ FWH\)0-)3$B5W]SR,/9(NU2
MC/7M:>\*N_M/0T_XI(9MKSID=_O^CE;?E$D=XR.15D^;#SZR>1)]XK2'=5YE
MH;E+3]?\R)A=,:]R8'V4U>3G%\A<<=#ZOJ&T%BX?0.LB5?$/Q.-W6=L_MUQG
M2BC[9/;0B+3GI\()'*]/:'2A99"E1R4'D)()!K"[+%4\O=-N(66Q#S8K0A2Z
MMT(-DARG-M6)V1R3X5[_U!K!TT]-TB\D#$IHVME"[P[LRT0:0083J"W$OT@-
MX_>(/\DN#AYAJ1-.@]2,6$]#:%1,SK)>>]F&JI@F&3R-F3?O%&U7!+_RMF(7
MO>XL)DKO<Q\J=1[A+C8OS.K&[/TZLW2(_[3*_:RB<*?FEEPO^O[C#",/#X_8
MJ9VWO#[%Y][VHK39!AQ[D.7=%N ^XA^,6&T<RLV,;*J^+XCHGD[54@RWI=1V
MWGCME.QG<+P#E9D XWANP6=UDIC=<\X3=&V,H1UT+"2Q"FIZA=[7E@CTH0<0
M%E)VBEQ]G4;\>5K;]]UL%]\+3,M'=96ZR;5-.=CO",U:?-@KVP#:\,OQ2"+O
MG2SX!=@]CQ;3=: -I5=V*YQQ,LJ0+0[&&W4@]T"W)"1ESD2@N^T$^54DUJD?
M\:.0RMM0VA].U(+BJR!28-HP7SS\ASCQW"/0:G4JBV8]&PA7-TU='#,/K4_=
MF1^67C[E*5J^Z5,2YN&V<_JMUH4[,,:EQSVFK_.\VYJ+LR]@HUV<3E^F>UP?
MB' KFNY:X>?7S=+F:'5K7S-EK_I)6+;0O%NO+TNNH4 %6X[:'OD[DC*#)"22
MLD2:+93@?H:) +&U#A/@-\>O@GP7?,#02CLLX28?@18O[!^US8KM=4=.G08V
ME#)C>FEA':<WE-Q X\)0B5JF'9M'>F^Y_&2HS5/B;LDUM 06.M%"S0Z1+8//
M4L>S)U)$ZJ O!>CUI7H#OL\G2+H$1Z@V)I:N5OT(I[J0'@,WQ%,ZY$9[.$\@
M'Q]V?QB3U9(1.O1P^DENRH49?DUXD[=7CO_+TT_S_(Y@WAC;>9<\K#OM%5-2
M:)EUL7P!VVJR],*]LMAEW)>..4@U=W<=(SDJS&W,?KD< H'H#N'X;S(,K*,4
MQUVF[F"'T+!BSTRK]LU=P9J VMT'"A;.E\#O/H-E?YT1G0!W/Y)$:HH]F ^G
MB0<'92[B9I:A6GK1C28[U_#Q75^^S"^I((L5G$Z>OR+^3H3C38:[Q?"LV+[?
M%"XJVUPM\X&Z)R@I+!O0)$-,5[Q#)V/!HVL\M35K4N<J7Q;[%/^@(Z'U<T)\
M.L)V8ERQ'X!QCR;>D'X!Z:F$K1+5LS.H;3OEO?0[QM[)F1'\Z%SOY L.T%H3
M!N&^_;;Y4-[,;7X-TM\_,7RZLGZ1R?04Q24LIY3*]^:/^OFM(\K9=@K"@AL0
M@J#D-5_"C2&U+M(VO&"BC;V-';JAI ^1.$4D#M7P<UJB6KI<!_KC\6?1CT#\
M\H92E_OU[E?CH[9ZUX3TC-R5#KNR1Q+L9O'\3W']UFHJEV<2NM,))*@/=):@
M<U O4$RD)CY:[-E)A0Z-SV4!9_"FWOVR,QM*N@CG^O>$TY %J"/7-$=KD3HQ
MRFGS1V)UK3GK?TS@(#_;PD+Y;GXL;-^&4B=.)7!#Z>KQ^X$GKSJ0F?>81QPB
M'DP^;B_BGLVK\,SU2BEUFK]:-. P9>!M<*WB+\G0Y"%>\%$9K6[,AE:1)/MS
M3=F)Z,=9.R,+!3RRQ-0]/.V,B86[;N"&TO(+((P'SRHS 6IX="$RZ(>55QM*
MS)7[Q+^5/[B*H!HR<.EEF_@(_X=X8BAI__M+LG-0Z$2?1O"EZ:P)4AI2B;\X
M:L($QI=;UZL(\5*X/C2@<&%DJ1@U$MU99K)>B3"7X RQ2#T@IFE#:<>\?.ME
M:,V) <:G3[W;4(J(C)>0N*IN/@*9<B1. D_59C?H<%0#'9'PKS$+^V=;_%)_
M!)WO*Q?X>=5:VQW>.^FM^KH\*];L[:UE#9$EU^6T3\X^U^C)F^YF%ZMT,]NB
M\JOBRA?]7D3 _UPZ?[GGI%4^?UK7>C7'B7B6<'2=3KI!2A?I0M/5T[!=!--Z
MV1E%G-I0"AW/8/V0+D, 4VFQ-#<QO9NN#BW#U&<+J=L9Z%&4@H-IV.#] /JW
M>EF0F*T\2V68=L)T\/?-EUZTO(NIJP)DR*/6N%'T<@'8R%8D>65Y+_&'=TAD
M1!&\PT)3(LB0N>AP+%#BLGS0T@<TS9$?P)OT<NQ@R40[XC!ZFRP1L'7J7V*G
MK@XG2RC:'S#CC(*Z1UB[C^9/($WW!Z?X5@OI-E]+7/,D,U=R%=NWE\"K:OO;
M?#O&E'=E;NJ)H8M7=D9$6>9]GS<,N!BZ=5Y\;=XA[G+]?.T)1L$\[^_["6BT
MR;T;2I<_U^/.9O&HPJ+U3\VUX;F?==Y4O!$[[.SCQ">@TPFV.S'G39K#)'1U
MZCZ([ *&C@TW+&>U(Z?.O&LSQ59.SQOF6Q%_+-.LORS?*W]#TF"9B+!RS58J
MC\I03HN%[Y&=7&]E*B@&(BNR;%>?%E[ZBFKP5*8,*I]_A]"(!#0Y>A0N/3T!
M_9O,!\C].%UHQ_7"_]TN30H,Y<]W_5&!'^?XV=73RJ5IK]I^,7]K?;6=TC @
M\(ZN"J@+>-G[(6<'[^OIJD_\@=S\2X,SCT^8ZBR@/^8]TI=]X _1K"":SMJ2
M$]%6WJ?3TCUOR-H)Q'?UY<!TV\RJ()WEK>NY2&/H(N( 2.\>W\X<U\.R]Q)T
MZ1\(%Z%O$JH>WHUK: !Z<K/Z5&<-]RL\FURFIHDMVE"Z2[!]/!810,V,477T
M!W/R_T+RUR[+PB'JE35K@C-N$^0I8:7:DJLA&/PN.]QMP9  ZT<8@=<BJ'I$
MK?#9Z(=8ZC;6CQ"EN\6A\#XC*?AKI*M\5@Q+7?2/46D//A1#,?G4?9H]X']#
MFEF5LOQLN:'6M:2$MO/6Q4EW[SQCLYJ+7P<]*HVT#ED-3'GEE>=?$Q\NH>>?
M=8\:_>C>8U78^J2_D=^2$&2ZZNE$-">^@QFR(]";H&_+?[+!4 %9OGL<PBU?
M6"]E6I@(Q!0>3D.Q^-%W8TAZ<C[Q!("BL*R/&#I #@#;:4!V14S?\J9N)B"[
MT'#+\)'R_C;=\K&9A,G)$L_J:=*_9#<AU0G89F(?FV$\E<RR)_)U1,8 ZI4J
M3A*7C($K\.3T3, *V7H,UH':4Z6@G;C!>=:A;JE^CGW7:MH?"._/>J+G)(#J
MTP81_S^:SCV>Z?[__SJJI%624':58SE=E<,5LUWEDE@LA$SL*LEAS2[GQ6Q=
MB3DDGXOPC5!.<YH5FX798@Y7N;08EHG9='#V7CF\8^:G/WY_[W9[O]][[_5Z
M/._W]U[OYXNEHP'<SJOVW:1S'[S9IZM^H5/Q=]OW+_^:$?7T.>7I4ZK6RXI2
M];2RQZ7G3EI:SK_JO+S,VN25]@(B/V?XG/XM02X[J[6_L6!T9+$D#< ,%[1;
M;?*"X>:O-ALGS"2>CY22]X"8+JVA*IG&9K)DIJW.O6NI [WMLSVR(/N)5V28
M]*5>V\NYU[8O*W0$EBH(R+7KO7<CJ5,Q#6+_-^'?#3NYHO0);Q[],.G#F*Y@
MD4[)9[63A[4E7ND3#>.@W%1:P$W%'&1F'I";RB#ITOJ\;N.)5MMV\3[Y.4D&
MUEFP$$V+02D1IN,WE%3\L*<+$;\WO7\^R"P*)3AYT;QR-$_&VQ4B/2+#F#;[
MTYQZ3[K2KCGX7Z^6"Q[_6:[O6O(PX*1Q9!1Z9#0R;JKDH6^<G^B-]2U26A\F
M-X;+^#J7\XQPX1TB%;$7=F!\+DCJW86Z5[Q'H2IWESDFLW7+"6;!"O-0K25Z
MJF5&K(3<GBG:#/B'+4-S\N.XYU,8X-'/)K@]K[$RB"_X][-)+R_1T;AC"GK-
M-TR#<A<FQ5\59!KR_")6)-Q4,](9TJB824Z$'R?D\=#^+&I(P[1X+V='\)@)
M,Z_-!O<UW?()['1"?#7!G3PG5IF)8ST*BSJ"6Z+ML<.[O^HO[G!?9-?54]&D
MH0?KCX-^6SNY=FD@:3/PRDI_J[OZ?+L@G:CH-SOXX(ZH&*_=&?$FTJ+XS.>0
MQM)#@L%1QCRCP<6*Q.[#/($J(T*YCS",V^4 [^>R[6C^WYR=@S![H*7[9R]P
M!RF-_)ID#CXI(63R\J'=N'B)83*#O(6 _0/L ::E/0I]]!$AS'%">T$#S.\,
M6TK8(T8!GV)$Q05XZ_N;Y8<N*NXNUF83BHZ VZQ:U^R(MJ! 9CZ^DH9GS%E+
M5@D%*"88A*N:6E&<>2D+_#IGK?&0V1OD(U-]5'"WC'@V<]E+L$-(83O]N4P^
M8*[HW4>M^:/^XQ]^U]Y%'3]U^C%5*^>JR<#G7>>=0W]]//T*-=QU!O>-";\H
M+3O5%VIZ$>=4EI^Q\G,7B7+MNMO]8F1QA87WIX79$5F E-I%%WDO^X %,L,.
M\G:F-B*U^ 5E;HO,MVU,'72C@H]Z?(%]/W>;2>.^;/TJU_7_C2-D!TDKV;[P
MPL/%@64B@A#9+U<)J25D7I)Q"C:4=L4\;3[D_C$&;@'*9)0+X*!,[354A2O9
M^5((\UB[130!U; TN1,^K<@6F$^2%,8N&[! 014AN:?-C>C6QZ!9>PJ8M*,F
M_L< DV((VUJ:XM ST]<F78_U!.^?\L%=&XAJ+3LJH13&97KN,KJI?R$\(B;;
M[7-$Q,-CXI8C;^%KZL$C^>_>A:JTL ]E-[Y=::3W,E^N!CB07"?%AS>40HI3
MH9J(@%1MJ34/O^--O)0^XBWA=B+V3L&W@W]7$FR[T5]G)V08#Q C50VZW,_O
MZMU-FY/;5Q#@?MZO#W-.9'9Z%^^SM+-W'U@((P;A;4.N!,KMUAD;2EB^-O$<
M^(]L&G6OV>P)X"J4*,]M^;E-STPS+?.^Q1IY-R%1DI"98@;3+,6*ZI+6W @C
MW9A#QX>8D'VA6I#T6O$X_O4Q1Y[H:=CVI!/_,[[K>:NN6C+?.GSRZG),U9S,
M0M=Y7]G-:E>\"CK\2MBT*3'L0+[G1'P$_TVEV/62TQO1,E+D8+L4.VS%]:ND
M_S>"$D&6NZP0!V'Z@1+\ ^@!DHF(>&R]@&,#'N2_UMDG7&Q1-6Y''&'?G<#O
M)?X!+)=+^,?D?[W'*?0)!9+&U/$$>S_@/X!X";0.DAU_.HP,&6^186\D?"^>
M4UMS(EZ28=JY*6/'05]9K#/%D[)L/B1/,.S$J;0C&)#V=/P<695(; &LTTRC
MS.\K]$$AM0?HZ8@Q+Q=/?NWP/T[Q O\N$0_[C?C-:(P=_8=HJUV>XU7E_NOR
MXZP<YZ@?TJ^_=8O:GTK.B8QS#SX4FUM2K5VKJ;M/>1YU\D[S_IPS.UJ8'8.S
MJ%L*%8FF#.J$%OBU! =2J/S">B7'CJ@+/N4V\%.Y$@\";T*YHY*T$S&[1I_T
MWR;+? "#2F_)O#.B-[]S3*O,.RD:DL;Y5:B;*=&@+#K)R::/$J5/1MEVM<%_
M\1.B(]=+3:EL^54P3Q;Q?4*8R U:2!2M\"#;L%K4=G--8L"0'"-#O/8W )_O
M&"N0<#4)QFU>1=K UT28N<QC?*G_OS"VCQF53BA:Z,S+7;U@_SS$C1"SC#K0
M6%XZ#EC>G&IRSD]"1];LR2M(+'4]\+1Z^/S IY6GZL\^S]UP+TA[K(]=?BET
M\C=UZ$96.0T[QF."6INN^\WV+66H_V@*7_.4W\9H(:4%9-"C5**:-U=()76S
M$"K4/J+G9O[F?_FRH801R/=N*.VG<4Y0'RDGFR[@F!GNYJG;)(QBY?E;KT!D
MH%4),1X7'<-:O@Y)).,PF:NW,R6H5(Q:%.3!F!Y@V('801I2_ ((_R8=)41V
M<71D[U(K2?_QJS%3NNZRXA087CH*[:B:6(?RT(/,H7]NC)M#4)($_PTEIW@<
MMF.Y41A^?;*>C<P\$U7LH!/O-+ <?>IM%MO]:Y*-Q],R4=E<CU96@5ODG"0>
M.X,S)70BXX??.IF:#Y;E\(>TC('(+JX&YU<TH:9K$_DXOQ#R)(YI<H_J#:4V
M6X6VW!600W<Y=F*28D1FJ1/B1VB+(9'IG.)O6;:;;&[Q<$,YV$_2!8.Z2<KI
M77\EU+>Q-9_[3J[P_)??<'Z1WP44Q6O!,R03,'N3I;5 7QZ"A7A-3^9H .\*
MJ41_P(HK\45I$O*6;5A6S=Z/8-:;%K-FCP3*,Y.(9-OK(,2I?Y&FW<$Y\TH&
M32%>6LV[S\;5RL_:PBJP>2M F.L!KX=S)]]6:!4\U&9^]#=0;4Y[[,?(;OF<
MXV>[EOG'V,RM<M.$J_X?AQ!^D_1>C(IB</,JF'A-HH7,00:>-6_'IT.9AAT+
MP\7.H%M("5C?/4&__PE,B)<9.L!-9-"'%;)W5 DMR/_^C"1C0RF%& ",C4B"
M* 7M\*-"FD"AEH!VV8.S1\OFK)=9ZZ5+_.$-I2LR;@<(AUSWD?MM*-TG*/HV
M%0QR/XJ?;!/4R:>L"A,M%QYH.?*0R&+(#,FB 6PR3\7/P5R4.^>TKPF6Q%O\
MY58R_'V\Q:B]2S_1GDP.J2"\O9/KF1+Q.:*LV.+/_IS/[T8#;4(L#WUVNC'C
MC'KB$:KSV>G<Q:6YYR)?3""KZ?92')P@$H:NE@?A/S0;?S>86,Y;?VXA/@HR
M&?\J()F)Q2IP.T5W\=8EG)HGL-)ABI'FI<XB0C*@RT2!.7,$<?2C_)*?AM,
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MA#K-4GR0-*2U69+5RT.L=&#%'?"#@&KQ[)2,2.#RBHXT4ES!8H,&Z4P/>4L
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M*YF)4):?[2/I7Y-?7?\?^_CXFE@+W 4ZNNIHK%<QCUW8))I.SE8P\N?.$;3
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M.Y!Y[XX$W'22"\'B[73VN0G$7C^Y*TBA]1QA- \0-V-::XIT^H5+6/_), ,
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M6UYC]=-JF_K0,D&.U_RTK=WM,?:FIJ]2].[DF=S).]47HC-6Y*MSND;Q#M'
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MF@;K[NAQB]9>KS0/-=R5J#2%:9%5_4)%A5WI^H]9*RAC#TDL[S?V@K%$_'?
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MZ77'Y_S6]3W[<[I7>,98*DW+RR6XJU0]WL&8,9HU2"N8%]JWRQ%KYJ1>G8.
M,%VN*<$,B\<QR42H;*<J?*2;HP9L5B644O"8EJRU,5N_H]F3F[YH:LM;%F%2
M_Q3HLUNR4>D^S-9';Y$UE,9KHKO(:']U\"Q ?IV+AA>,9R9!58G:5$(L!FX"
MK%.2B"H2,L0GV/\D7KD76&(C2T536GY/M6YSB-LBP\<C:X<==Y80H>'6R2[\
M99-Z'^MR-\]32U][^>C:IM'/O>X17XC5&CDC7XA5%^<5T\C &T:=Z+ZTQB&D
M"[XB'TNOHS[ 0NN%L]U28_(>$2%Q.1(\4"<"#VJGD[?[8J&[2-#0&(4JJV7@
MTU#=,Z#6FJ-3A(#81];VF-'"#_^O,<2*JI?WS=C/UCE!6Z$NYFTH6?,WAX]&
MVUBLW  !O(0M@!<M4-:*P\K#B(8-)8G-=SB/JU"#OB _^WF/BN>X]>32A)8W
M/XQ?EF33T$XG/:OTFFH+G2R:"C_?&LT[.^0U.CW/RS4.[B3^\QH)E$KN2-VL
M>1BERX:;9YGA'P1M>?6[N9+@496%U*+@A-]^% ,O\;^WR(;DFX?WB]K1G8)@
MZ&O/O#5'W((.?PSVUP'H29S#!$-)\0,&(M5_)UB5(,$G%>T#R/>BS#7 ;$DC
M-5(*V=$VH6(. 4D#T\T74Z55)D0/];*#'_B1U5-6,4)6K);Z6%/IIL(@W3R/
M.A"(ZM7=GJ:&QI$&HAQZ6'#3.8<%36L]P<#1FRL/,6_N&L?YZ D]*[KT%Y+9
MYRIGX@Q3F1#(9)Y"#_A/JY65+#\?7W[-#TN"-@HG&!0_5I]ER'C6AI)SHF\Z
MZD6Z=UJ[=,S.V=;X#[9/KFC_T\9B(%%BE4TEX!W[.1IR6X%%YDZ0[ _D/;!H
M1;3!M>H%;&,)1MTQ2"-5?E;2HHT[8XN#\!2ZZ:Z""2'#[XRQG_6U1^V]EBK8
M).8]PQ*W*]4NQB=[]4N<7?1:E["&N&K4AM*VXN^V+8;-F(AO&TKZ*V;_ROA;
M2.^X#0OME3!'+, =]V[C)R^/G7Z1Z2R+YM[C' $-VP "]7*2N2[%1784KM-G
M,;G4LZMTP+S?ULXEC#:!G.F\UO[Q/VA:R_K_$$$/WL-L)=#=Q%^!H/:%G9/%
MZD0-6;H'0&G/5":<?:US3,9*5^A\)(> ]@HU7]5MO-QN+\%BYG[1)%QW-]:L
MD'RWDH!Q$"RI7ICAH6HG;;B"0U[I:BGND9XSD4Y=[ME55A^?T79;C;"?<7;;
MW2A-=SD><6'H4T;.XF>_6-\[JW6ME^WLVQ5:@TP_A-\@S/9Y*/I+=@4VSBRG
M=EK+)>E+347PF '.E.U4-K6:T<G.RT4'I6C_T5?@^Z(QW];/AY%A(N[\ZXXI
MK(Y / -8%CZP*CH&<)/ENM%4PAY4LO^Q(9BU!+]'- W_V>1M5RW;7/+O@H7M
M^BD^+^YJ;JX&FIQ49]'#WU.[&IWU<3+6Z[U*Y%B?S\E>GY/./8&Q6+\6GRGL
M6S2:_V0EH'Z6B_%=Z<-^(BY)N,.^XP9)@*%D859<0]P,B@[$ ZYJE,NVBYM!
MDTPR(F!X_K;U11.\H0BT+R'34[#4JH/3FNE8R?J(F=9896OYE;ZI#(U[.-2'
M[HYZ_VB:-\YM&S5VV)Q!^,N;:"UP 5;DQS6*-PWQQ1W8;@G63D.ASBDU^3[]
MLZUE_=QBY2Q9LHN;/SV-Y>^Y"_U@[?Z1K[>\[_LEW_[)FIRX;U^^T#R_NWK>
M>OHYR-WU6X$W"U94Y]62\,=S=>S%4V\<@AG(P,EFW6Y31!!^> T%1E83=5Z
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M=PWYFP#F27+'D EEH" ,J $K1J[U+QR7;0,#4_&0QMJ\H(L!A;^-Z&"3A.1
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M:.:5EE<ND*OO%Q/L+Q]FQ04^?A$7J.[:>OMC86@=ZJY--FY&HZ9U[$6BL#9
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MJ](QUJ2?NQ4E&.^T5*2BMDI22LFPY8_RQW;V6[:;?JVDWYI=CR#PG^SW\ _
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MCAX_?NPXUW]P'3GZY#\+^(^?N'CMY+D;EESN0><OJ3X[=>'FB\+ZGM-2:E:
MP(/@<6[!R^HT:>9_H/T/R/[/ 7O^?PO9?P7V/^.:A_ >.W*X><?X(7 (AR-;
ME CYWX_NA^ J4Y>5 2BW%'UB0_<SMP\@:4Y*WS.D%QMK%K$8(*O7>VS'L"-3
M>#M]HO,6K3J88>.H=$Z!7'Y#_6QAUD;_)69CGL]X7OB[P-#B*SD61%]MC$_-
MEEV7:>CD1NYDP.V<L>W@SMKSN1X7G_7:#I7/5HB^2OYYERKW#X"RCLI-_RF^
M)9;U=;MDPC=7GEZHTTC4L<S]MXB34T12)7G!%I"LG'V".CR6Q!\*_91C,6[
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M8]3MJ!Y6/%]<_R&-#2*XXGML^NDR""VR\8(E!3-=0$%P@RL<[J0]>>R]&?^
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MT#B H6UPW@=_3N.0GWUU$']=9L[D"3ZK]CWKNR@)P&,[0Q@I3G >I=&8C;"
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MWJ)DIQ:$E6"*3<8U*G63\ :G-;^LCB6\S>>)%W6XDFK$EIO!\7,F=B/3-C\
MQN3\$V '0P+-*MVOYDA@N*$)' W B$BKAMF"UDHU%>68/3HROM-S"1&GX_V\
M"7_ZB\.G!=#>89:M3[,F5$E*Y^P)D7_]NJ?'OQ]T.#Z.L4I M3U3W!B,5P^^
M5'",+0;(]*<H]"+%L=":3Y@G=.2F '"^IUMI?-._\S1C]"3^T:<%SC ? 3/0
M;Z?CE4'7WM1P;)IMJAO;=$_BG.,/\6'N3O_(E= 1*$4("=E=+75*T_=]=*ZH
MG"8='TP0]>W,J8BOEG?YV^("D''12K5"MG'G[J_>D?/O'_[NECG2I^[Y>JSW
MJV.-]4[5@G)E#,7SZF"K4TV$70T7W[/4)_&5B@/ZP^N>!Q#;'B.,'BF&"6(?
MP_A3*+3ER#DFFM6R7\#A\M7*#J!0Q;_X*)5\H(%8XXI/H R=*[%38^D#VSY(
MHB76GXVG4T]A[-T $GD]+[PL,?(*M7^^/TI_/[E^S6[\ Z']"ZRH,%OL]8/6
MEFR%I(CXXNS3M!?2L3Z>-RY;&RIZOKQ38F2?>MO+V(BWY#D?[A9G3G24DI;\
MM"4.[T%*D!0%\_R!8/HD65)AO]1 GZVT_QIG@$FZ#49)IE6ANN7'NP78 N-L
M*.T DJ)2B*2NV>DHC29B36I TKTF8+^K>B=9ZVE-<4 8K0NQ\XI<,%< I/G
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MJ_#9<TZQNC +=#Z/_"#:ACQ3M=Z#;YRB3)&K$'K2SPBIO]Z2W$D^::#2Z,8
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M->L#OG*?"7CU].NK$17+D]CH?#JNKXHUFE:M%GG,=A,/ B]5HQKS/YZ.J0I
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MZ;_HPJVMF$/0+7I24FNLPX._/$[X8_?(E+H3P&:IDY/ ]CU=?"=0AX0SX8#
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M&I\DKQE+#"G5*%W[7434&/!M/6J[WE(SN.U0V5!M;\44A%5..'WJ]E.2T[.
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MKO5<G"[PB.F+ACX8:]E[#XSDU&VX88/Q$:H\KUJ>41K\$LX%0-.@8D@)!#=
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MX8N,]7!T)II/QOJW#B6C&?<+'=^V'KS[8)FK-U%E[@JZTR3JJ^ZH&RV@/([
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M-D5]E)/4A.@RJLC\^%!C2.,N02^@?Z1E<;A'Y@OBPC$;3R1(DFEYDOK<F5>
M::)2D).*/A.N;WP2F=)F'7-,'FTV%!NA7N"Y]GAT+._LW(V&])?24-SK4\YM
M.J:_[/]I:U=;9'!1VZH!X]ZV10DCWA,;'@!)'K-YS_%816!24=S(2U*6S@SR
MX?5>2?T(_@ 6:%(KJI DOA.'4/!3*2H8?1'Y6NOLN(%J&_(JT%!;ZQ\]F_<!
M]F<>FB^"O "@/]K,00D]HD#^G$W\,9O_5ZT,7BJ(V%4,,C<Z8Z74UW.!D48%
M\594?,!?L8^]<9(AN9@0X9'#6YDJ L3%"UH>9\GV^"]SIE\,P)KJCTF$>H5Q
MS ^*/JO?L=:IS.GEY6(7;(AB<VFR;5JNLHG"K9\'BJ9VB*9M*N9\.)2W^;SX
MZ/43G6)7?%WIDP.T=.1P$!'J!*99EM_O!HV-#])&CRF/SM_,IT>??:"A;&6@
MQO?8%Y7X.383JK<B9JK&BR[E]A78I5E,1@R'WR5'=HO8-DWN!CT@C#J.1WIH
M;TALWW @:W'!?VQI<7'-^64O_!S<G_)O" JN_YXMD2R;Z5),B_1&]EP\>KXC
M1V8),([9*,8VX3&5K%%H"WN_S?,2\8F0AJN=^!X@/QYAH07F2OMT-?L6MM*_
MY'+3EWIJ>G)IXWC]Y7]NA82T;P[TC>T+;8S9K]@6VN76#_-0KC9L+0N73\X7
MMAO_L7G1D>KN2GC"SG>/:'8F>3CLL]$5J><)9A!1R4'U?;V2LT+?O/92X<J$
M/#DN[EOIWIZ"N?X-KF_>IBH);'!O0\W&#6Y60OT+]O.K I]J5P?)EE25!^QK
MS^:]?C?SN<NWM>=]=VJ@91?,>3F;*[D\U83R;RJ3^W_\/+F$AX[=QZ+Q#VOG
M0$DLA<<'^2B.UJ'J@6=[KT-EFM&<F_Q'-8<$D8/S=^(LNP]#$L6=4Q=F;;B^
MWAX!O[%0^C+4?#?*V6WN?NU@85 X&;DG7AU1:W[8-+YN:=Z_DVWW%!/YL40F
M%)WXNV!8UU(7^^SE,F_#?;]#)O9Z%7N%,E'MW5%"Y."RJ).%: UG6)X$WZV0
M(I8EZB&6H8#?/GTH !\[9O/#SOXB+FC1U9[O2EFK2/]9)-WZ:9,*YJ*D/^$;
M*IT/L,^B+IZKLQ3<?VHR_/U?HX*+.""S7>I9FO4$OAJ<"!9D23'] ,\L.B_%
M+VT7*@G7\,A8M)INN8$QFOF>TN;N.F]\F?2D<L/)WE?*V&*BOE[+T&A)JWN[
M K<QAB[!!RY^12TE;;^FR.^&I$!N%X2DM<18OL*)T97^N1/$=*/ *EP]=0U6
MH4INP*_Y.WX]P%3MBHN[AJ5ASGI!:=R]=I:O@10-=8*&YV8.S3P8SB1Q1(D,
M(Y :F!5=O689&@EZUJ/*<)KU:;,1A)O9YBDXWZ)GYOZ=U?]+U,U^K*%$1:U/
M&)*8$1G<CK$RT/8@"6XX?;PEROWC0J32_0\O'S/F$.%OYE_Z3F$I+<4UE85]
MH#'1$M"237D4NT3A8VM>CEZC:U[7FOM7<)>V8;;_=>!GY)2MU:Y6&]VQ[1]6
M@^E!<A)<=5<B:@CES:U'N6.>$H<&R#$H%S@ E/C4AF03WPE,:?+<S*@L]0Y+
M"VQ@^+DERE?T #LIFF,R]54!^Y?]7]/XK0*C0U1Z2BOG/=?;H]K#8W(1/A!'
M^8D3JL[5;_E.T0]/2Z?(;-'DNS2G7S-S7BU_959)I0UI&$A?.?7JOM($@7;-
MI=.A-(7X0/X3H4)\HD9^1" ^Q\I<=6.]4M#.Y&;__]NNRCT\OG&\+B32T'J?
M;$V.V+1,.S*VQ7<DCO03^D=$.KJZN[LZX-O;02I!M.R8M)3OF:*7,I9S)X5>
MH2X=L[6AMAWI:2S.T,-;:ZAFOZW-J@!G/&?+CL"HS]+P^5GS(!4F#%6E^07*
M=*)W]W_)DY8F;_5,QI0-($N<GI<:Y.<0M+HMJ+/@QI.4VX)O%RY]=,P&D$Y,
M[2'&<?K^> -2(^"I,MGR79UXCEGX&Z9*2R;Y>F&QKYAR)$; ^,(3U8BY;HG;
MT@_U,UM]D;,GEN#,ZFT[9FN"$K)H6&E8H9$1PF&\;I4>]BUY(>0T'%9A>:1&
M.2J[HF\6*5'?4T%=+[VOVCK13AYRGV6@;#KSMWX.:H9Q=^JM7"]2]*:;#\@3
M)@X5ZD/#,W:"G>%=2C=)"@K.Z:5'090?SKEPV8\1.!\J[KR$5'^1B74EB- C
MU3_PVC9^'1M($NU4M'M7K:AUQ2F=^F:=(I>4H0A@BVQK$_ZH[5\\2L.=.A1&
M7&T#G).X]7<RM<8"JYF6=&;>$,]!ZAZ#>O\]I-;7C9?;OR=BOT1J7"<KY/1H
M;!1Y8S:S+#IT/U;0^=,#=:'&R),H*"3KU K[,%%4TI3#%+2W4$\].>Q2[<S5
MEID'AL,=A;J?-;8.I-RN#S??O4MW^>9[V7RBUBG*7)XD;U]AS:GYSK9"U([X
M)4%?$$;(U;TEBPQD3:O/(+^ I5FBR &CBQ,[FOBX3A1Q.&8?<U19VHK'C_G0
MHXDHCD" X4<Y9GMV94J3<*!0'MACE/G+E9Y;A)II_[EF))KI(0!IG"ASAHZG
M,M\S2)6;$/QV\^$MN(B)VVL#<[H9BP-=,PN79IP1<-W45^O#@-;L_6?O7+*'
MR4P8^+W=^&G*>EA]XZSL_8O.OD[X6<5[-GD1C_<4'8JWUD?H5=LYZ_I\U8I
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M6+]FHGK$45:4_++HP?(/@D;VH>>%_ZY_WD#S.0W$1HND#H9]5M50_G3]FZ^
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M5:T WS;R3OF%/?P6N$I,)C2VK;8!24=A.T"U!:G3W\4>Z <ZC^;TP_ZT?_Z
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M<9H:4V!,221E\,,@"B$Q,1VP#&*H>7^BTITN3N*./B>^UF<W"N#(CNG#IQ,
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M'[U3) ?: +W?-^?M]+<+XMA()[P.G8_@1MX.-4])@AJTFJH8MYB32W=S\N'
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M+B3Z[ HLGT?RO' ?-U-6H[@R%X4- G?^%<$189DQ/%G%M+]=)+N=R)/D! 8
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MC.)W$G*F/(Z8+.H([?AZ[P="&4R@PO2VS34;UV,(=6%Q=J#V@T0JI1E!DSF
M)O1NF+3EF:JK<J6;@0$U:Z\1K:8)',L_V 1?[?-I>8S.P%5X=[VVC.+_BOT.
M7RA$_'#?GIH5<!Z&<0#^Z_'^S9S^+;&F#I#(*Q$^AR.UP(3XPY3FM?O8H^ )
M$'%E)&!BK?,&)O[?AA0A"<=Z2HHWL3C^TT'XA?/)"40YX5V+[1O)>?_FM?--
ML>]M^!;HU[Q\KA<XT^F#"R%F8_\$1Z;TF:,E,N);8C=G^V0$&G]_#BOHF1:]
MXV[[](VG1@@+7PW1N\2!:P_O9&2X3S_6H7^OF$7<@KBYLY<$BG*\]Y!F2O<
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ML$WK$E027%H[W&>,V+@)JVV::MJ.6<SB)B,TN(,[>:9K$=MPGME.@5R?*0L
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MD%%[X4MJ+M8/]-$AZ;HV/;=S0'7RU'@&CS5W(1+BRRN].!4?A]H(5I1%CC+
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M:I#),,SZ=<CUH"9T<5EA<;7GLNK1%J#DWT+U_!7X] DB=[8(>+X5\!8EBV#
MV<:%B?.GU;1KT( _Z^<!MGCW\**A+YQU8NAG##3QD\?IYX2TH:P?!X.Y. ]
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M.PV&_W.#QDT4!I8DZ9EXD<(),5?=)?N8UI$$5P>G=PZ..0W/6K]]TGI-N2E
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M?B*6HU6.*H[W5%3H)3K;%/H$$DJ)V.1)9N$B^20QIDHF4<^)%)C4'L5[]Y;
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M+DRR+@1:Y3Q6Z0J@>G^*Z2VX!K99VXC5F)L&]8)7$^#7Z0)K>RX,L!A"9[7
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MPX+L.^#19BAJ%]:M @<_H\$N;KM<VBB>_W3L04QC3EG!<G:,N6I/Q2I-<]*
M@A.U1I,=DYI])Q*"=4BZMB$^HB^9D%/:WYY'&EQD!88-^E;E"4@B(N.UV'9:
MM&\!1/S=1*=$V=?C2IF&$O?^50_M+.3ZPMR?_;L/4&EK;+.$9J,%6H/2#3>V
M]>Z%A<C@D(D* 6I37DYH;BOV2 DNQ/)L")^V(ET]A(DL^YDA'PIY:C(7>T%^
ML#7#X)PEM+PIU2[W]_*;/*+_]7T=VS0/"Y Z8F:IJ0,Q@3T9K"]1#DND](!X
M.V7(5SG)D3TAR7E9.NU %"VN1]TJDKC$G_QFL=7AUF_M#N56J%+7&.IUH&ZU
M2Y_DFSV]5\A/H/1B T"#'!M-9,X2T'@T( /Z^Q^!BTD</(I2=!2WGY\,]D,1
MI =P^3.1NAZ8US!,<\@9F"N^6W+"=UQ?KV9--+&A!F G9STN:YN RR[*39=0
M5]]#5J5+\F3K+^2=(F?Z2V>0"T2L[Z4ZE=H\,U8,%KF4><,K,Y.C\5GMR4N.
M#J;X7/7J![B9$I<N#BWYZ=ZI7C*4I/;">7;/LDO6#N^I<5KRXO'D8A"/0S>G
MV&/\Y-[4>0B7HE*4?8WM'T@J<#;KS&Q51J_7@S9]#_E$$-<+ZV'U_?E,YQ>V
MO;&>=VD"_L0FQ7S-GI4V>:?A8+%3!3Y1_2?>]Y+726K48=5_<:15I.;$)_II
M #L@&(U.9^HQ?%D1SF/83.KKE0'(WJ7C!L<9*K3CU!E-"QG<GB[_ U@)ON!V
M9'1Y#>G;9'CLY>U^W<@TA#J.%!N\I[#$!XSA)*5GT%J<GY#6!L<0HT@!YGFX
MTV=P (@P:4S=CF,84>FWI_2OTC41PQYGIC67SK H[4/J7I5/8$5 !Q-#YE*>
M63"EY??5^5DVI]V,M;J1H:] JCM[\41BJ_I7* V [-Z<&9WH/89IP+0VM:0W
MF,<X76A]PMD0*<<OGUT5Z?OH_,T5KX%+SQT4FC0IHL"@).Z4">_USJNW+^(I
M:N%J6JN>@<:V>,]&@H[X"?M\GV:U\(F*]-S3QQK:4AUQ4P/Z6F93 7\*KY(2
M^13[8D/4\7=# W0(5YY]6'[Y2.5(?+^OCC/=31!\M<]W?H#7[^6>@F+MU_N-
MQ1HZB?9/\0^]_9?5!L9Q7N^6X;GT8'@0S>H#:GX''\W"05B=BH$:L.1.S>HY
M9'NR[TY,F+0&6FFN> =);FI:J9!#?HMCTK7G-AVT\/W872YHY3SLT7J_=]KC
MNE]UB >';#VWO"X35#;]R&GEJ1+L/2#J'=1\"-Y#MJL]5VES=T1PPXDFE,!G
MV]7^;ZW#3)[H6$ISVLORW#PMWL>;K[_!&-I);U+''@[J%(36&9/?7"&MH$];
M-=C4B2M.3S[HLRQ\L&-:I3,5H&1:WHW*;&CKQ,:',2Q/8&XKRU^)-=-LR($H
MW?^GSTS8Y66"B'/E]-":0_'EG#(10XTW(I;J3Y\A1;%/#*1A[ -_^_W AVR>
M7[TH.(1VD/KDP"%;"VH+3;:X:#<-A];!EIP;,#3-[/5%*>F?/C3?)BC90@\B
M>J-@8R/;GWEY7)/GV'JWY%.P*$!G<4USQO6_3?L )SZ_ )FJ+T0;HRP]U8_U
M+''I,WB/I*D,%*MC9O4A(5$QE6X Q7GZ%TC8">[9.AT!K9\8LWE''>B'<*V!
MYP4%'5QBRQ)P 8Z$7.0\WX#'.>KW+18N'^< +E*4/$XF)3,"B>AT,$]XX*O8
MRYP'9G, 7V^'8QIFPWP\1+*N"IH-<W4"M$CO8TPZNR8UAY9.;V@X+ZS]GNU8
M(B = M<U%L^/_BP,YB[FX7_W2WZY_9%/\L!$ANYT6.'-H,<X[T O6D2@]<$O
M79MJZ@LWA33<7;G/N>+ZCMM2X+$V\-,VVQ3UPM$6Z&,805/CR\:%#]_F4F9P
M=TCWA;C]A!DU7*P456VKOR\%OZVZH3ZL(3R5"+Y2DYZH('%%Q=L219'&4K']
MDCK(L\@>?3"4)WE?&[^=7##6(VQP%3&X)%'O$AB2@N2&QY D;*[*D[1 9Z]5
MX+_;4D$9DS=GX!(4X'PC326SDXTI]UG?-K0V0-?AO73);]2F">V]R\%;%NL#
M/T4*,:R.7B?_W=QCL;LDKG#]^.OG ]V<,UK@?V#KZWH*3DIUM>>Z:)&)$37O
M8PU.VBB<E,D<T58\LO"-YPSJ'V"6R9%%#$DUX (R2$J1IH Y70<VQ!0R6IO=
M]YQ@BJ@\P8RE2IYMM!($<B,<&EJF],VK&-:S#N[2/Q9'OU]K 4QJOZ[S?7']
M(K\FR9HXQUK,Z5ES^21D,GJ7WB4%CR&'9(#.AM<I[PDEQJAP,XR KS2^?DG1
M/Z4G9\] _'7[4=6$K\EO,U<(3#DOAY1GI@K)GJ*%5\RZ;MW4^@I/$M&1YSPE
MKJQWN9=V3,/%[D&JJMW%M$2K7')UY4W-:DO>/D.U1.6B'6)!KFSHJ S[S=)U
MSXMQE-/U15!OJ9=VPP^+Q8=UI-$\7FI1.=7VL,&7/I8R9/'W//(8F902L[K;
MQZ&#]>ZN^;N2J0H[&F3LEAPMGP+.Z)9B7#S(U1KC9)RC@GHD$!9']U(.,,Q+
M"_XNK4^9XH$=_((=%2E,"882M?B][&<&E++%38!YTNH;R&NU# GBK;/, ?LL
M.L2:>K %]W7.)6N88<[?M/.W?G/<42"MS]*.VN9B4\5A7>1L*" _:ENE8UN2
MA+-&I^'M<Z">[WY5:['OE\?BA95!N/&:E(K4/G)HA$_2T,_A[AR%%9%,:?YJ
MQR)%?7F[-TEE''9R=NC4?DJ#SNWW1PW/XKT;7@3P1@BM%0DP2+!7^$.VAA\O
MW_;1V,D0/(I%VK=,B5L/?].O&&@&HO@[+:A)Q%%,[;7\?%%,Q6-P"R.*K@,\
MBCUQA8*%7:#6Y6'>N@[<GR$@T#'R%EIC;?"S,YVN,7Y1%!5 9FS+@A9".=%.
M/-"!/>\'-4"V6LE7#?>_]TD>:VOYN2MK( 1;ZHN^BDIG\'+U#TQV\E!J0L["
M)DD&Z+JQ,A<@"2^X;YQ+;=NO-3EF5Y*8&U+OY?]S:'ZPVSN'K'KE?J"[R;Q#
M?PS<&'ZLS+K:NJJ ^'!?M4I'T=B%]WLN>)2*4!S'4SP3G#V."FR=J['M^=9I
M^G2DB?#"MW!1AC-/7YGSU*M>?OX&]1)<>W=$:HUAKF,<CKPN;[>!6!GW$*!K
MP^%4[)82-0D'$6"H^53Z6U6UE)3 :GH*R'\,I(%8"I9K:>PM,/ !(=<(([8U
MSC"TZEW<G0=;'?)"8GWV)+P6O][74M!&1J!3\:0:(DV ^J+:IB0%9U]EV"4W
M;U;D8O.@ZI0S!O9)*YP04SYY^\#U2%;/R@MQ:9]\LASYG0Y#2]R#C\^TU;);
MC-=2RW\Z2=W&+'Q9Q,4ZO23&3-ZTU-I8X,G,WY-^:3%[KP^*$$<TSS#\@'GJ
M) GS:TKMR_PJ4XX6G%T!>[HWXPB;^#& JWM(V-I"O10K<2>L[;CV?^PU=13H
M!G&F]-MGG):6[);OW/YDPF-6%MW8PFA>NVF;VT%0_#;@317Q%84-#XG%#U%S
MZK;4G#8MQ*5%B[[F7XW>J3 3BE:&*G1E1;[M-@>@=!BS'R7TRVI3)0G;W-HK
M$>8>LQ"K.VG81DM\]3JPH&[Y\_"9U6APRJ4)+25D%-[70G"&>>EEWBD)Z0BC
M7V4>*D<S/MCMZ3 D%8X[UU0[=5Z]KW6S.?);W4FS&>CBS'2DVE!8>H7N:YJS
M 33?=\Y'V3%Y*+3M?NQQJ7 6"0J8+B\+GRY$ETS>Y+<V?EB<PLB 5?)PL,I8
M>-V#8X8;>[G44&+0)UI6TJZZU?7A ;=+*+*RI>D5\*P2\B*R&;)OPA"RPBW-
M(Z67"+9[KCLQWS<7)0'C _0D:$._9GS3M9 8=_#0<89VLQD6'4(N-DU8<;<O
M$4*/6OT 5QID'[)U#<(Y^JW,YE#L0 BACV&>SV58O>)^E6%LO%[*L@B>S>CF
M=_P.SD3Z60&R#N\I$*$-!$LS/<U<*SY&#4:38V-LJ?E/Q?; @#G9CXI,#,&8
MU]1QXGC(%K;N63:T8P7<^4KU^=*M2'''@AH"YA=>S5SO9B>:H6'%X/_.?.9#
M0C*,5!+ C.[J_X\4_<[00#,$N!">K#(I B#/>]QXB/B(XLD6SS34D\9T66<-
M#J-4C^5^XP"3KB-[;"A_6#!_A%K^2.(":L^.6FAM -,KEO ><7^=Y][E?"TD
MI^"O6#MDDS[P8E^7^(^HYM!F<I2B=!%?(<=E/"?D#ME\KTK*HO0EQKCK[_V]
MK"2/#913 ";=9L7"@?SG^=[X 2K8E#@02K\RP'%D%A88>Z?]P;4[%<OG7Q0;
MC@]B"\!9^?DH(OW(?X0G*AY%=;B%G6;.@INNCO[ 0@'VRIXFB<NQ*.N@A<;(
MD/ZO-:TU=PR$D#TN9#H*H[)9%?$>34"<!%(E7JPU;?X^9+N\6;2P'^3>Y<*2
MM.,,>&?G(1O[W/\M[05F&0*C*KE@_Z6Y_6^2M_-!)^$AG'&3=UUCR EL1^)
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M0VS%N=7UEM$Y681 X8OQ9+IN<H@Y9#J>]5(QDLWU@3BZ(OH1XB 0<'K[#>5
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M]%_97E_O3.G@8H@]EF(VH,+GV9LU=A>&^.!2+&";<M0H5P)3[:CN!,Q*,!I
MA)\<D!U$H[H3:$)?YF,/<H>P_N'O43[&-)\4" ^*ZR8?UF-^VD\T-*[%BLXR
M \FLP.W^:U;L)S7]"7:>>O2*854-G^,]RFX#8<9@'["="0V.ZV@0N8 7;9I-
M@;:#!!FWC.*L:H?1'H4G9HF;J8B2(LU=F:@OYY]&J?[JS.>C<];<7POQ*%K%
MN-+F,#W,H?F3J1$)TP3R8!)MA[R9Y@D7R,R,1# OFNM:?)A$>^*<G3KANO':
MO[4.PU$EGU][\CA-DQ+*?,/\G'_FJ#2DOO#P\>'*9LY(_@6$5J+/ H23,.$&
M6(G.\_$;$ EW.#=0LHX+/F8161&UW)],J2IN9DW:\!<CB89,1N%6G"V3=LVN
M7:N/A/&CP@WSWFE>O_#B('C'V4ZI2EE2?23OMG41%&%NT_+F7@FX8<PIO/C'
MM\PSIH(Q;Y<'GA:\]=#;NMSMO1;[(1C(+W5*Z28_7B_39(YWC!&;,U>MB%V-
MFL\5%\CM07V*E#+PS<?Q]QYAAMA6/"KN,S]44&6VI@OV(^D$$A<WXS8@2Y_O
MF).@@3;X:'YNHDB!E7P>0FL+#92&%J/X>N>>*'Q^C*A9E=3&:[1296O#1&Q1
M*<Q@LXSL9B^L-<3MZKP:6EDV>Q0.2X5QM,FL,N6!WR=\5PM,/(F?TSLJQGK-
M)Q=<P"C[!1F?,JF:1FE^87(!-?[*?^N]4!%C"I[-KO(+K+K$YKPZYKQH]<")
MX(GHZ?^P&N,7H)8BZYS^IOQZ$UL(W $?7?WVQ^S^8Y)'Q6"._\>QC/NS@5!-
M:G).OF6N50I86YRORP,Q05I0&RNWX8CJUUB?U2*O3^8+AI3HI[&Z:/4$OFH1
MEU,PC>7C,^90& ]V,Q&@0S>4Z'648"PWX\RA"G-@^^>3 HFV*[ZBA!3P=6H:
M'UQC+5\,$*$%F>7X"QY2,$7OJH9+"10#8Q)2*(XI 6!6?(;WH+PNW[CXM:O3
MV;JQ^YT8>31LJ@'&B:ICLFU1-^1L/]?2@T6-UXDT!#$G\[-S7E![OAC=APCB
M</PV[[M=@TBY,ACA0C&JH:@_3K\NWN3\T&&YMWE,\#9"L5!T;QG5\;C$@C-#
M4=7/&@<3B&T?#;F_FZ%@R5]IRDDO7S]ZDYZ<$R$I]:-^IVH5=W6,.%496QAY
MD'G!"XJ(+'^U])MI1G1D^SBCX]<F]%?BD,)2R*.ZY!5/^S/WZ-R9%V[9 I:Q
MDMR & 4;S]2D(=>_TX0ZYAO+.H]9+L!#^= N1U4$ORUNA/Z)+]4>XIN!O:AT
M1#WQ=R!*ZHU)N;Q<W0B.^+O[>@--\D6YTW7T##:^Q:0,%40Z^)KNVCB"I!:<
MZ*Q&5@;OU)<9XTC**+(A#]8%.P/F4Z,CGX.5BB]E.TX>L]2W2?Z<TADJ_EDW
MA-"I:.,!1N 4JH_FJKYE9,A[7)DOU@WKO<6*OD+S:8?&-<Z?!BN"I6CS)$G1
M$0:<_/VR?9:_V3I&=<Q?NP_>D/0YQ=#^8_-X3-YW7-%Y;3- 647%7RM%X\&H
MU@9DCLN9?F'*_N#L)X-DM6_N[46K04ZSWV;,L4B#\2<VK2V:7V=[.#I_:/2_
M?SES7<O&55I+_7;J*K&Y%/GP)E54>U&XYX9 I:>Z+?W#&X,YU&"*EU&4>7@]
MW#H8+E,H(%^ZN(_:XE6SU>RW%XWC\J0+APE<>MZQ]!K/2S][*HFV1QM$/;U/
M3N[=T5MTNKEHM=,M_\4KO9?&$ZU6[^&<X6=*6#;^PB4)3"WH=L'B8'6AR4RY
M5:@XDXV!I4%:J?AI(2IK_);_'E0*1X@*S@7QH8K(::G:+K=Y6F (UJ@0?VCG
M' ]]@^$<O//5./1=S_[1OKV[Q)$J?CF=7%U7S35MS#R_$Q*"U$FK!.28;*%D
M;-R<*->I]G)X&_=$RU.ZX<TIL-2%NK>?] ->%ZTVXV,VJRC;;\VX.%W:E>6U
M&AP)A<U+@[Z*=D6@H+PAOAOUA<(=VGYDQ&!!TX_(NU&5MT9"^(,SO>RQ 7W+
M:,L>^*+(;+*;".52\I!&<C>/48JX-KA;XL6R<(MXD"/YT8H';:Q[\66?GZ?"
MB&OZP*57#O8ASK=LQT'KNY7L&S96GQ*'+,<>;B*W-I>N>334U<5LJE9[/92H
MN7X:J1S'RE9,P4TM#3$$XJCS#/F"KT2*^M@6IH="2.R0BG87WE[:KK8%FN?6
M4>^V)>*&DD]@?XBDPC%^S;RQ2#7O\&MQUF64FB.<&HAZ* M-XW'.DSEFR<XW
MN0J5O[(H-W)E*).L*M%)1_+]$-=\;KGFM.G_O$^A1ZE"22 ^1O]C L[?C./6
M.,DN:Z3$]''8%8P8MEVS"H3U2P,43VA.'R&X_<W)-R>[,RWU5XWK>[79@>KY
M;RAL1\Y3SPZ38AAJZ,[G,7_JO9\YYQ1%YR8]8%,1&#9L^]FVTX08R'G&+>!W
MQ4S&.$0%E0-B!^Z;")PPTSGL,YF6QM:6QOL"-_SR5<>UD]A+Q)A8]EF)WE 5
MS-[4Y\Y7K^P'%:V*CUF"GA69G3*7*XY(=BD76!:M>R,%"W)+F\:D3S/Y=.DV
M$AF+M;!I5X',Q3<2S\I8#RM@T[9E#F)&ZA:]C@^)0HGMYM,F1_8**\)?WR4J
M+5DN__LN49[E_SGP+PD!T)E0DZ,74&]D DP4Z3YI'FXZ.IA .V8Q;59T< /B
M*&=>$D\^-OK?*9W&J9B]5F_YH9PVJ5%M1/02V\%DHN#!:C.NFI4<Q^#>VA^?
M(/A"H]R5 06Z+FG*^9BE$Q\U4S+9Y%6QYC 0@@.:R-U)>V:Y:Q$WX-752RWC
MJBVR%$3E$:M5UC64<G KGS7-(#$@RQO_[>!/4=M(=6RO]@E2'%9!#]J8"@ZK
M JX;0TI*2@U(<ZC$%_EWB<_^=_;(_QK0?Y'3"KG[X)-G":M0]F7O#[2E2CJT
M>Y[U<DI"3'6+.O57_B_ROUX/GR%#A&@<Y/AL:Y<'CZ]N_X!.#6#E8307J;@3
M7&PGS.R00S=4R+8Z<=UAT+B0)',[C\>-QRR\$&[WE<;W.SUB\K+!9VAW&@N+
M$YUB2B@DTYDZ_"Z9!J/$)M#Q9!"Q(,E=W$L?2@*Q^D(4&V)@_0@1;9=S :#@
M3[,L1Y6WVQ!Y&O3;9U0WKACVYAQL7H&Y=#QX38K8PMWSC"69/*S1\_[]NV#'
MU+I28*+"LA9:WO;O"-J!".%&X0U_]27H0=*XEE_%(X0#SUZ_6G4'8<;$3)(F
M^W^.(><RP9]V9/_#KS3\ECBT1+1Q K\.35#SY.7.P]F@PXO,]GGV8.@,WWXR
M[7M'51:,ITT)568^M7?,$NO.2;?(\3)I,5R89P7$_ID /SDX;3$3&H\V?^\[
M XJO;[6>WAVWG!)E\ ''+%X5[JAT)OO3M]/3+4TI"T/38A2;61>7^H/8N@45
ML87]/*EDE;=-WMD;3XK, "RE4N2T?=7EE]MVF:6:MWCA[;:7'-2Z;$-D;S1<
MD.350]\13;DCLZ-\S"+3HT1YWU/6$U_X?$ ]1&TBLR2.I.CX2EM?'0%(=Z+=
M[D#,,N_NJW5Z!#XM];01>U8N8I'J8W9Y84Z9TB_I%A_MO/\1[.Y/G Y1?B+J
M4);:#C;ZNR)3V99RA%\(;8>EP1K-NTKHEOLXI!#Z(G FM-3\+5KRZ&6+- Y8
M)MOXA@5DR@CF@!+ 05S1>_,<0Q4#9?$-PO?&T":"G\GS?,TKHLMQ]9:<*'WB
MG2:Z/TZ)>;Z2;KB0W^I#04X'[3< :>3P652(6"X.2K$= Z)N3X:XN.GLN_T]
M2W(7HM6W"0,N%"Y.O["W#:,M=A++'3_!2,'LIU<^DY%2/YOS$_Q+3J0_&M-+
MX-MLT\ ,0L\P9?S"&MJ:*% >A@%MBW&E.:8"3C>:YZ[/%=ZUC'^".YLIKN]?
M=8!-V?V.M?Q47Q/)[N*2!/=?:(K4FY39Q<;/R=.,HUND*U:EN%M@9.@IP.^(
MCSB&F-.>U,KC^L=LBT=O9+?O_.9>Y89^1WB>Z?ZFF)+!U6IJKO6GG&M*C\;N
M) :3Z#H1<?TUKY^(ZJ&OB&HO9[>\C.7,T@1%^UJ@0DT\ K7\S 3L'[=43E4*
M)71--MPQ3+^;K/;ED1 K];$X'MQM*?;:<S&J)*\[D?ZZ5%IYL,)2R#1+1R\N
M[<O]]X8@XFB<LAKJCL&MY[VT3=L/?CR9IIE8"<8E.NQV'%5HW?,P!.#MFO\2
MQKH114%L37/M?Z1QOM#B*%Z5$JT:2GX($4-%PQNS5CB+\"@DI2FZQ8G,2F=6
M1NB48Q=4'/YIK&E,Y?#>_899<-C!TK+;=<.DUO_4PEP"_$OG>R@&H10\@[^(
M2!!M.2.>53N#@%P$5&A%) R('EM&O[ERQ:6'/*:-_!L%,Z+C?H>_MLCUI[9J
M5V_*>&49,?]5<K]*)/^\_RBP4$[V1FE@]MTWGUI+[GQ6&: [HEO',[:L*XG7
M)_K@$^]G]T4B%$U[$\T*.I2]=86>]R\G1<.'A QC@UJ\%-&),>([8'(502S/
M*%E^ENNZ9X4R)!S&9:2H))1W7UUUN_.J1J(\/AIZ[W]FQWT%&@ZOH?V 6W1-
MBD_7_+0E$?,74$[F2C61Z-ZX="C%N-4R]N>Z7T+8*GSR0'8JC2F"RJ&:?Z)M
M13,OH]*,XU?:P+7TF#=,+OI1RY1S=T+^&DEGQG6$F3[BGNKR>JI/<;S<E!\Q
MBC?[>O_#J_>FI6)"AC,W*LJ<M99-JUR5K,N<,Q\:^ F_,?![A(O#FYX83?+R
MI[-<4*)544)E8L=]M1!F4[:W(UO&3^KVNDN1 X<B )\LB2?:VCV:6"/7Z-T)
M$!-ZUD6NM"-Z/GJ5*"!GSF31C6:>[@Z'QETZ06O7$]0UUG+S6Y49 [6) )Y=
M<XHC!)^$O7/FXS2XX=WA8Q9XWC6R,Z#!GE1N?QZG)8;E,.2K2;IYU@2W>&!Y
MHDEK"[K39J"WAM&L])UV A?V >SK#M$AQVT@;MV+=LVQ?A)L16>;O9-Z152J
M:RC1G==<J&/2G5NT\^7J&EDJUEY%LLFGO*$L/F2LRM<YX)/NFI? KEZJ5K=M
MLKMD5%%\U%))<J>W2#4"QFK_K;K:[4*?2'S'PIK\M'5GE8$KD:M/Q*.FOO13
M 6D!K=0K;U$<^+$AX<N$^Q!?EM=O.4[:)I<FL5RAFR-O_+_:%D&H1L>G,L7?
MR*E'OU5U\XO5I]VO9&1(&YN-[@[PW1FK=Q.RJ!G5BKC<-68V&IRG.CI'O#.Z
MV\>.VE#6.HG543W<PZJ'N/N),Z.C,_*X#1PE5=CS]HBM^[M$8.E_Y=%\]E^=
M1=K/3C1].DCV%#92B[;UY"\2[I3O4D^L3;:N_1^-]U[6_NE;/]1MF0;E9%PE
M;\TL4Y$=A(2PZ#E1X/HQRQDH8$"&GD6%4F[U#QL+11'\D%$YLEO1#"7R=]4@
MK)=_&<)Y.>H*;2@1S">)D]&%*-+G8W#@:^2I3Y^%=!I>T+CVN[/WU6ARSPC>
M:;-2Q+:+-&0B6(0B V#? M\W6JZ1\3%9,#;EA5$<6H52B91$K76%G?W3D)@=
MS@4I*OIY 'N62YKGUH*=!;!F'^C(Z/MTN_HQQ/Q[@GC;&;3:41%&'(%E8ZJB
MO&=)<WR3+9\F1'*F[(;WDJY?&F68D?/<)9J:N1*TGGH]K1]P[[B]>6E>NZ4M
M)'/B.ZZ[>Q)VZIAEH1!VKM"?G<RUX40KHV*CK.'^NV:@F5_DT 1MJ"3*TSB^
M\FM[!%V7K)N$5@^GB]G)H4-SAA(8!AZAES?2-2 3:;NN@D&92Z_=E G:Y;$V
M)1=DE#QJ,NF.PO:5V1Z";L^Z%W^GBIUZ1>1R\OJW,*J;K)ZA8(7?NZ!Z.571
MIM*!C< ]@(+%H[#Q-2)37-;=IIEATYFN.E#ECL7?#:ZJ8N#^K- W#WX/&K_R
M_B1[)T#0B7$"HU:O%U']1J#S1W6O[M5<1<L/%Z9A]5#9^^E'[PD!&]Y3Y*GU
M$C)!$,T-J&I_#J)RS< ;9!*7ABS&\+C- ,Z4ZNE<&*=?]OE[DP>IN6_1"G08
MZ=;4WOEUK2U)(+<=(]! OQ)'P=3MPVFA41@=-!9PP]*\1)?WM4X"%(V"=4(Y
M(5Q OY^FG^"\.,$7)OCS7Q2LVUUS;.M'[2%K"EB=MD-\N7;@U9WB'X-K)-"5
M2 ?Y!'*$I=LH>&6C%6E[E(311V-"HO8'C\H;0&+HJ\V^ 7N6TU/[6%H2@QNP
MJ;S39*9UP)7,< XYD5H,.R"!?/Y^JBSSOS8Z5^Q7UUL</?_VB>."#KC(,#:4
MSY<Y\1&TU,+ *6,:/@:M6^8"%V6-"^: 3)F.U$=H#*H+-*3FE3G=XL"5U,NK
MO3 4K3:YSZ[))Y(?GKGP2./+@^&.<HN4,.[8OSSEHCN.'D=_^+KNK23UZFZ'
MIR9ZLI&W6@[TCED6U[>]+BG-34OC<VY!6(U=7&!>&M@)>]HM8-LO:Y$/.I.,
M<]#+<C%3[Y=T2"Q)ZWW<3Y#M"7R:ZD!T-8CI__!5>8T_RR=E<*=_Z$RDTYM'
M>@]E/GS-._B=O3\ X(Y9V(SW[8 ]NOZUM-I527$ 23E7+Y;"A&52"KA=TBX
M)DV<3^DZ=<7)"IS3,]'JIR.T89%8FCLR]5\ ME! Q#\+\^_%/D3;T$WH/O'W
MC.[3@&M?8J^J7/[X3R]/"%)@5=2M\TU:RU7:Q(%BP-V5[:NJ'-0Z5TX1XQQ-
MDDVF'8*YE+N?F;MQ^-$$,5&,=02,.^JHEKPHW3@[(1A7\I!:R(ZP\]JA'*A@
M/];OQ[[9(90]/MFU/BA#NO*E9<=)],P38OROE!]>1P=\CJYPAC-% (>WKOZR
MWOXWR P7RD^S1_RS*9KM&HK/%CO'!+<[0+E':@[+K S>J(62H7;HUW2R?WZY
MWT/&=;KTH2%EL_7438\74EV424NN\R/TR]_*(H-/D,#X\<L*$X$.DU.7?]\@
M&*]AI#NK D+2<((EYR;W^6="DV(E%1,#MW.C"@HT$4;A&$C@3=3GSD'M ?D)
MNP_!FL;I]WR$!DS(C_6UMM^/OSL8)4UTV'5VF9F #7-J7]X^,40DJ.3_RT#\
M5MJG'I4%%TSS[7L#F?32O8T'4_4XY9\%7+N5[TI"YN,Q%YV4P0IEKTPX@A#^
M*)C+Y/WDWY7D(VG[CQ;W\#C?0F1U9<7, D88V\YYS.)O[K(?!6A3AB(+^-#F
M(7B&,V!0X89XXES=@)YRGD_"B*,(MI_:FL:OY*QN(@9NK'6X7VDF#(>(>#9%
M=IN-:(-.?2U=\?8[&OK3LT1:B%'DL!]PS-)\PG656Y1,3*'=X+?MVMK/]KMC
M]&]_)\J__[\]'5$* .EV--(MUZ=HRY2\XK.(^1@H;VQ!Q!7.6=@%],TQB]SW
M%HZG(N=DAUO$_ 0B*R.*FUZ)",@<#>)SH0]!48\QP] ZKJZA:)T:F1E\$H.]
MO"SN?J:A$5-E1)2+%_6/R4N=,H:L*.1?]W]";[[M+7S]=X&97&<5)_Q9IVX?
MFV,.9M3M_<"A_I__2A8^/]WYZ&"4+BGU L4TTTY<QZW@7A:D\HGM=O_#.5A.
M+]/IB9) T<CZC'G=$A:0P78B 6?LAZ:.D(\?#XUPM.F]H1C]3_.$GF.6:%-&
M#WD6@WFPC>:K0+D]X>MZ_"KYK51)".-D2=I/8W2Q'J@IJN[Z;/5__Q=A[QW5
M5/J]BS/C6) 2D28UHR!(ER:=C"(@(""]$P'I(B(@ 4(R([V/5*5%A!"IH2,U
MD@(C1:1CJ$D$I$FB$(\0PH_YW+5^ZZ[/_=YU_WB3_'ERSM[/?I[SOL_>(=*,
MJ_E8(O8\V8-3:37;DSYI3-D5"1R0NVZYOY0?^6KIW'E314>VV)3(CT0B=)(4
M&2;#L])2%ZDI=@OME(H.39PD(GXLLK?]Y2:W2T1=I;[T("F!CPO3X;Y_9JKX
MQX^HZS#.N$^TR;]0_(D,5/$:GR!0@ZF/S<DF,!>2A['6-ZV=7D8'"7?*D"/8
M%4>0;NX$QAAGB7T\@"I=%W]T/S86EPX6[#'RI:AP+;0Z/>TH$)8BU,8AJ1L/
M]\6B%57J60::^1.M3J?=OM^':P/E*]A+H#DIIO"4BKX4-I#9%9H!"8',AT+'
M(T.@I*)E(D_LW622R9@3P_O?D</THJWVHM7L%)0Q\H)R'UDE_:$^9"7$B2"D
MZY_!"J;@&I$KE>>89/]M.ZJ.ZY*$&!Y"OW?,\2G6E2&Q2JN[X?HT&XFD8CDS
M3;Y1/B<IN,4:.!&[W$?#]=-_XZZ6[GYNKL5U* G[#J7_V)G_ST@ ,9J2XR7>
M#MKR>98W@*SPN%G5CZQU6P","$51Z:R;_H^5J--M/,J3>->Q=\<</"3^)>A&
MNW",9"6S_<!W=:::N8O]9[+_<2_\J6B6&+]M/C?A1GTRT=@>DT*DM(A7*/0/
M]4G@(QBM3\RUR3_SQ94BMWV@8HJ6OK8:@?W("XSPK-!!P+T"G#[HNZ=Z::$X
MB?YV06#Q_)P^+T2*JGQY9&.%45,O_]-3(8VAX\@O15R[I!,7Y'RWH>P4]Y<Q
M?L^Z.OB_,Q,<6(8,GM7D5!8GHYLV^"<K"K,AU'2C \E0&$1HM,_ 74(CH^+"
M:"&A;E/Z4 S<+]MANJK+(L1JF  586FB2]6&/DQ:MS;F+2\&2?I351+9ZHQQ
MABF+?YB9"F16L"R TC=PWK:C5Y 'QQS93B&:A<3LY#)]>E8M[_.(HNRTD/)0
M?N5J^C''X/M7067"C*/\7DR:?B1]<Y<8HY5V=6K?4MT]SHCY%">]WPD_38,
M\BH)?<HP/:I3PO[B*8KL]C!-E5$5IWO,81DB3'E.-TU%2,.L1N%V5(WI!TT=
MT_H62-I)34U?--Q<&J#=:@0,HL+B-*=[QH\Y_)X\Z&2&O:AS#YLCOTW,]P5*
MAI6)4P2[VA2\'\Q8=.XJ]Y/*+1OGHL:#GNJ9F@UOBDK-M2&TJUF,NU/_@NKS
MGO9H$Z?D_KXK'[ZQTO6'O]!J*'27+*.7YLYW9R*?I%(-Z],*3H'<MAKKDP@#
M?1ZV*&9>C4D2^,(J$[)MR< Y'%4@?:V?02_!C?B220@Y>LPGV#1BC*>H(UO_
M<O6F(2=C8=S%C<0M=..'Y'7Z6D=8B(] L$1I3Q.Y@2)$VU="Q)WDOI+WU-BV
M.CW4:5ICN%>DQZ>:Y0FD5@46-NG;S9\P6-.!Y12V/IT8/W*'[*S",J JJ=NV
M=9YK6ICW).CKE<,6<3<55H&T1&Z5"_XO'FI(6? D?U#7O13S..@>QB3K1J^N
M_<I,UG7,I0&E@ G+ ,1?_9=&/'WZX5(O?#:GB#Y-"ZI_^ZBV;9+P:+BGK#S>
MD>A8+1([7NHZ66IFXKGG*U/YGUU$3YW]_^RVCT#;P-N?_ ]O T[XW0J@YCNE
MD'3,D8A0: %2Z:94=C8ZD-S>1#\<U'UH>RL[K&K3I@V;TB-!Y7+2=<KL$4%>
MV9"\-M'S)O3O,5\O@XXU''$>='$Y&#P/;;=F\;?00E,1*OW!_I2UHW+D2AE;
M?7IW!W'5Y0N5/QA9,P^84IWPV6EEX(GRS(O+YA_9TJY 2B!%6M1WNEG#[.Q7
M)<&]:*>+WLU#]O3OE4T: 5THQY(P[1%>K;.BW^RP%EQ9[YS*7;RV/LA'/GZ1
MGXJ/-=6=^F*'M8U$TQ=,W[U$Q*749V!2"T[QI]D+&>;113Q#\]9R\?T3_51U
M[@KM?MKUB8&5+T/VCW\6G''F?F]CWSC=E$^/D/,J!VKI.#Q45+9GRO\H"^(M
M8<T,G(8'![0;7CZJ1SY""G=D(M0V;F2+5=4400GI8V+P>T!%_>9'@SUR1[(B
MW)(6<I:R,]/$CPP)5)MW7S("?>G8'CY4A>DQ ^A5;;Y5F^39;$-IV*&3I"+P
MGE$\8'MU/1NA")NYLPAVGGU$N*.HX:&LX]=(STYX*"VJE1A1"%-RW++OF]DO
MA6Z8RX=;20_XV6]Z35U.),SFRWGG*7@SG.O"R]F[^RP$A"]MP/NRR9!]XWBM
MQ2FK2H<@9_-(VZ(^R15W[&6LD8C\=+CX(R%!RI_Y[LINA:L_S4E8YMAV!DJV
MW_?GH_,-*DM)4F!]0RDM["U;@K>Z_%RT[L,37K*>W7X>@++/B]&7!SQO'*%"
M6,'T0:-.!H24_6F8&D7()OM0"I.4?MS1MZ!"$F*^;<9@DM'-:3>ZI\7<Z,:[
MZ1'S/ K6L$@>(Z?.R?IZ2;,'0I-'X\91OF\W7_IYQ8_(W1*432#:8;=KH)]F
M,J1+S06C77/1GBA-T6J-19WW,@W1.E]MC S?M^@7\]FB15T*>/N$MP2BX_J$
MT'<T3863PVV?$2D*L?I6DK89%:)3Y;)"^=F$8!4A([H3[010GJ7 A5MFX7&'
MDHC9LM,3/98,7WTN2CPU))9@J#*IKS;C"*(J*5A.H;O&E;UG(_2"P3O=G9?I
M@\_TO; LNX\(:?<OC9M%6BFM8&>&-4LPJI\M0]]-BEC^5$BI:F)@:*",UIU[
M\RS=2?A-BK7 )H)SNCZ2J_<&>9AT@,3S(*GVF9$&O75E5]N_MT%X85<L^7S:
M&"K$W5-!M@M5Q=NNN]MF-.B_S?YDB9"Y"EK;V/8J)*,M?9<?V%K!I>@+^S 4
MF)&,[-2&^IT)FELC76$3(3%M*+)U\'G&,9 *X8.)N24LN[J229)I91;I1:'T
M0?;Y4!H@,\[R.31CCX!_C1@P?$ ^YMC>IZL/&%YG%+QIT0^,]I,!QFF]1H2#
M4\5A<FTS(1$ACDRN9-Z0A4IKX2^:JG#5%SW**L)VRJ0CVR0PCWET@=Z-X:;'
M_93 #UE<7,4KWU@HL2.T$X_91+FBITOZ$Y(7_:V_K;:9[M0R->_)[@4U[36=
M1VZF>L-"/AD#?H(;#W2L>=:C(]V'KV--^8O6Q#5?KKM;YM6E\[QPRI(5ME8:
M^S8WJ#*PIGW,X:/_017OF$WJZNT8!"=V&6(IR\*P$X(_>$(D[,#SP82N9/QR
M4A\?"FKI.<_T!21JM@Y6?Z3T(.L6 <O=""PG$(RWVW0=S-",L_[#HI?W.^D
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M67,FX^\'^,)TJ,$V^?"A]HOY@3;X+RQ.>M9?-!29@!<5_G/G4:CAV6..DW_
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M&Q7,.[_H!NNV2AX:)=:&KRP:N?>D#5PMWNEJ*$;__M=Z%N>5G\+L<V:'=]P
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M4;+'@&3Y$5CY_:WJ^XR7!9;YGS]%-%VO3^JWZFG<#Y-=/N;X#1< BH>VAB9
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M:3+!9"+3<2!*:VO7A(I&*<2QO:LSEZC TSM0B,1^<=3-4.LR\XVN#[PQJR!
MSBRR'(<%TSK>'7.( $D$O"<(>$^O)94I3&LXP\VJ8/X$Z 665 .0;$/?(=5%
M?0R>$54NK/,(<BI2G+$E1?-6AX9<S2AH-GV<VZK<@#38PWZRH IB=TZ?/*QM
MACZ*.R*@3P+^VU$IW&,%E5JG K\0L7P.-N8,A$EFAGH))115=TZO=L]^[DZS
MM":X/JV_+U,4/)S^^9G?6V21(8A-0K4)$XXY$O_=BU/2LP8<**6R@[A3)Z%
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MB$08OEUU 9HZ2^+4_-K;58EWX(2D]46Q)D[L$VWW5T?/;>QG-V^_R C/]??
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M!\(L)':%7\% 9M@G0%-FRUI7_]%>N0-%]:D1W^,;Z'DQ]\"GXHJL)NI^P'[
M8^*+;.F:HDC"9$%4@4XCK+?3K#N'HV7*3V87@NV6#-($X63-1KGASW^L/GA%
MTR%I))U.O_)/EU)?87MA;%WR-&6@+@[Q<YS?[Y-R[IDA[^MG'D[+%08\T=E/
M8 T:A37D]L,OVM)$9S <R["OO%2+G]6R4#W ?7D1GX\FK"![W2]/^[@)Z. I
M[ 3U5\W!-$'2*/><SH#=)$U9LWGECMN"LA!SKY5*1E"CSPN8E21.*Z#3A2M/
MGR,9\7Q5_>MG_0+1RB*M5 5.^V0Q2*V:5I&^YTC6\M1H0S\Z+8OL^K"(14[
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MI*@S)&K:_SE11*: ^VIZQ6^IHPC8<A&>$^]PS'!I@?XYMQ$93K/# K]ZB"W
M']O-2X.80,">)*Z=,;W8O_T[YRI@JBV]J)U_SUNBKNXY'LCNVTE^XSJS-*7R
MNNLJ6H*<$-J %*)I4'1B5A0NHL/'-18@O0+G]E3^O)J_)2F;\\30?O''PJ=@
M:L_&U:Z)'XFV&EON@:5.8=#/<V)]J]RFY2F/E(V\OPZ^',.=3\Z?,-;G7$6U
MZ"WY7U!%>/W:Y<*(D+V8ZR7-/CM<&8JH9PPTAI KS[XJ-LLB2=^US).T*%&O
M(3Q>X)>:ZK8H72TL)Y4_KHE/E<8Y:'-9O0FRQ)P[M*'WJ&-W_J&P?R V][+'
MV"M]H?.@=7O^3&?""'!F;2>4W&B,PN+OIS27$O>,"&I\KE.9]KF=!EZ94K2+
M-:M7/@)AJW3)[>5;7!8&#LRM0,*>XYA!=FKVT1M9F/LN(^UF@Q&$M+LC=*CB
MKG[A==#-C9S+S;^4JIAU.T!OZ%W@H&\10F&R&>#N;X80O*Y SLLJSM8Q*BAM
M[(H?Q>1W2JL57T]1-W^29YG"-<77]5(Q?RXI><.28!SG.O)HV&CP69SVT(Z#
MY@/?[Q_>78DAS!\S1*-SKWV\P:RY @UBOT5F^5$MH5*2,]/W]PV.0<#@0NYR
M/53<+W79N^6<:=B5I'/Q16]T+"H>2Z3 .6!N>*X=S<M@2?\7=(0V^._%G^^U
MP/T@58!>0C*"KV!W%BC<'=J5KAF/FGY/[C4""/0H^7O?;X]=FXYL'CM(+U$\
M28XFX+&ZT'N;>I7X2N:0Z42$PY1&O[:;@5'51I3S$^07K2NO%'O^B.742KRN
MQ$AAWV\(B+A9_:F*JYK;6I283!U 3C?RX3R5*EX9+W9C:_=:<9RF7>&"F?"Q
ME](5:V#YI!N)/*6NG&SA^FL*9]HL6B"IGE*K+&-N+"^C;UIDM(5V\^A7NA6D
M3*X66GDZ*DHP)5?S]JRILM1'NJX]NH?4J$AS;O$/[UL-J'9Y]UUUWM(]:9#5
MJNCMB@0T@?6=5JI[^)#KVO.RQ\N?1.)=%Z5,Q*+-7;_%:UO%/UC0;U._(;V^
MJ5]7(SWXX&J(/<H1,%M>2R,?*D0*('MR(]21\7M3G;80?E0.$["62XZQF/20
MJ.FR;MRZHRYD9/EC<'-MW.]0[[+M/)SS=-(#P8E2W&W%+/-D%\DR"7[)3T62
MG0*)1G;*!7"= +"C7FY@E-D*DK;LTWC#.MJZDMO0_G*X.-K0@K^_ZHHQCU_9
MB#5&6_I-F+Y%F:IYB6J_=V*R&3*B#4;8C;R)N=0.\@+MII-*2\1,ZAFPF9P=
MV/U2KJE(/*4<HW?"7W>0B&D,K'J#NA7@R+T60LZ]B,X7M 2^SH@V32K#F'"A
M&/B=HHBHT,OTF),\'@!9R5ZGT,_Z3NA^+G#033S:20G#QT"%RM#%@G9>W9JR
M[F=S$4!_9^'6;:)*Y//V;)Z#D8GOF39?]AH#$KF9!#:_&N$H<U3OB2!YMQQ^
MRC%#&!192;L*KBRK?FL&X'TG7!*!6-Q\T68T_*&M$TB+:6">O3;>$;#LOO7:
MLP1H:CMF< FFE.3"V^J,[EE'F/TV&T"RP%QQEP*00#O>T6L60FV8?CJN82<S
M@)"(>0_ZX 0OB@3Z^E7!R)#7&"-1WH.A<YU3?<4A9.TQ#R<?H0;#M_URG:WF
M!$<2N[MD?TE#F:4[<3S/DK-RLJ(4?HD441%19KE?UC=58AE:8IDKN[PBA95U
M\#56!;"0^"("R&*O*!N@:?5F]6ONMO!5\J+@YY\Y5TKVV;AZG=7\+]Q37#$,
MB;UE+&P=Q#?BHZ2*5?V(QIU+_=;:X3-KJ9ZC<2JT_E [:$9 MS?0%OD/OIZG
MPG\%%TU7Z*R/GFK L0Y@WS?E:$ZS)&VJ[S0-(=EMW***-NVE*9WQF<_R737Y
M&J;S)FA&)>A-+*OU_#;F-K"8&7!HC1$''4F!D],TD4,6^M"GY5>.C^J=M!O!
M)(H\A!'M;@",%%8:P)\OL0<)#9%E2JN^M<3 <_Z,,)<E_M2[IF_/!AH=FAD5
MSH/N)&Q/PFP2]1(0WGEFSOT/+M@AA%S2U\*DE2F_5[K'SH;F).W-I+%4>1P5
M52/=>5\^]17,M'9I:PZV/(0OCW8GG,<P 2C *P36Y'7Y1/5#3<A>G.@"BTPD
M)2$>ZEC]Z<K)9L9V..'F19^YVXM-%X7S='6YOH_4/==85-18E5+5V&""J!9D
MO3O^GOQMQ?)FK%M/HZ[T%_/RZ5Z+(HB#ZYB?E$F!OA_"ST5M6(QO=(P4#UD)
MTB!7JG!0[&2=9%FA0=KO''VLLY*424_+<YC#;XZ/^FH*D(ROD*$&Y&8D1Q^7
M;]!5<KPH6;9"I, ^7B]U5<W2QI;#2C!NJ/-QM"2.BU[(!,Y11XZ:-+F"^B%L
M113=.-SC*9I[E:U]'_"+U!?VV1V';K<(OI-OP_G]E0SA-N>G4S-0;1^.YKJH
M:>*XQ@YBC6#43O&:JZ<S>0 15+6:%J#XG9RF.,:GH^%MPU+$'\N"2[4 P8@Y
M\XX56;S$<[PKQJ5E "IPEFE19(KD&OL0U>;W94;NI";P3MA93NH_)PRT&.,Z
M=<S@"B=R]KX\2NLIGJ*BD_K'M:EJM'O"N= <*P(NE,HY(!:>6[3Q3V%MZZ3<
M<IHN,-Y)^)B!BQ3+&%_9^)D5S9G_ZQ$9SI@\KH\:I%3%^A^@'B8,#-VN&DE3
MVG6S.BB!_Y$A0,Y[MW24!XF"95$5/8O\3K7AXK>JAN\ID0>;/</MDDA[O1V:
MTB;?T.4/J2VES09R:YY-*F?,J&9'&72E$Z"W/'G&DW;L!_ZJ<JNER4\HEXI2
MEJ+D>ILL#V[:IK2,:UZBW0[[7(OZ@OAJ<,5?46M"(>)Y5*[EI',GA0?G[.>U
M1>C1Y !&7W?<? \J=&<(9Y-P3&A'@_JQYZP7])H-[#3TQ[>O6<MYR#G V][V
M%SQK#7!^TS&A)SJNT00C(,.#SH*PY>PSI!D"G 45= EP"7\Z/:#[9>^=H26@
MPQC@DF.%DO=J9/Z4_J-12/^/>\R1SD\;G(*G2VN&GFU;M>R66EG&=*@#>\7R
MC3%SP/K!K%:*4K)Y8<&/MD0]>Z+6[5#/I.0N>-\2-Z5+;*T%H0J5_MBB$+&A
M>ZH'HQ!AON%0-\\JJ1-[DWOC82.CX]9XR3D5-C=KA#0?%%IDG+4Y(YD?38%_
MU/J_^=/\OZ+CWLK!]G< 2\T$Q)8(H[$Y[#44XRB);,TT-&&;>!"NK/=W('I_
ME'G+1V'NN0?BG*?8/T3BSZM/&S5LC]1M8]0ZNZ+;+-Q,RI@:7-0M4)_TN:])
M\/<8N/!K%V?\2)]-6U.EE0B&?:[K\)21_WS#HB"RQ]';8M.AUMKMBW\8@GM]
MD%MJY(X8HX3SQ%@#]MHQ P2VG(5OXJ5Q'O1?ICT[>D=S)./YT2IW42X1_4&G
M@FVQPJ"C00I1;QOCOUSA\(JME022HLY7E!)MW87YVX)YVV?VJMB^%M4<1E!U
M3Y)[#2W2F]J&#,&[&UT"17I?$YSQ7+1KQ0M(4,&,+&FZV]MUI2EPV(O@[WOS
MEMW\>LT6 EJGE%25$^(<<_J8X>[^[[1#,VRW)-XI@>BP#[M$!%]UL6,,\"A/
MR "$S<-#UL-/9H,IM94""['6)AUY#Y+6.MH;$N[/[!:_+6R9>9?(/CTQZDN;
MSO*FZ8;YEG'E&2CUZ-SH[<9.K(NA^MR69%U8GQ-^:3K^"3FW C\#IKTF/+&_
M VQ35+?OJ)+JCADNJSX.NR)QZ6]274 .3YRFH06?FG%AJG"X!*L_^DEB]6HD
M-D^8D?(]N$L,[06G1!!V>="!_5T\4XZ74?2K0#_.L0JE\E>YQG7[C5_PBSE7
M-YMY1H9\O*[=A'/YG@ZIQ'WC[8/4Z-*XZJDL%)Y_O2AG=Q]1_*-I-P7YOU,4
M/NP8K_W>-S#P%@N&\6+$VE'[<I8/4@3T/ 0)=+FQ*H3L,0-*[28O%1F\!-CA
M8[O.MVOR'!4'<:!R5%ZI6];B9S#2=9@[E+YD8-F0.!..6^X J 68.IE^:NI#
M]"W5YK*_$>)Z^3BF*=P%I%@_Z1E"L+2G4.KQWSGERE(C^M)ZKI,EC,W'#/)3
MXZKUL (=ITR2NXL]!\6?#9V>*%JNRQHR0*K[<;U'RSU#R6<V2+K2>W+++*8A
MSY8[I&\RL</WCV]&,;X,(?/S.TF7QB-"%0!SJ;8>NF2V1J#"JO4BKP%80,K<
M$>9ZLZR:U/N2$TSHL:047&%4\#LTVOIUCL\;CT$KKGAUYT;2X329I1@D"^VY
MR]PW7 C-GX2]W!'6=C9!9TKA2NU&L^>R[\6S',@[44.UH,ZTS(6H/,]&R<E8
M9);SRB>Q[_S*:T'\N=X0 :!3;X(LST5FR>XY*$L8]&FX\=,@8+Q//V&JP@P.
M1^E4;BP9NQ=,E.9'KV@:2N:W(KG06]W"%YMXNY0H"6&8:\X//\K33,A"(G\U
MW2R[E@6OL$?<-WEPM>GH?4A2=PG?H)'.3=^D6>W;2_E63Z?C!+Y&ORV(*+#L
M1+5KI0@\JS#U:G X)Z7W6W1VR@1YBF9V4AOOZ00L8^*3J:X[:&0?,=FAHTJ$
M%+Q TVUI?7M7G'NR0^I\ 6G(1H<I=^>.;S?W,<.+$<@J;F@T#@\@.\4U;#LU
MJ"] ,:P?IM^\D8+L.P1EMZNHP662@%6H'W-[S.K;R!26+N4) 5%M&[E"5/K?
MU!M9=[)6$%15)DK(,4-:RLK^RQ=T)_7Y:#WLL_0]O4[V*57D!SR/:M=S?!U:
M0JTHO'*JGF6)_2CJM?GB?D'4L/UEU6@?!+Y<]OZJ"Y_6LP/X^AJ9O#B^&-C>
M2FIL; RWC<G,C#(5# Q$FQ1F!*R]357-"U=&B:7JF,=Q9W^5% W2"YI" M:C
ML[G+L@A<.%T0J3"0&W7[DX\'6^[RUM>(UWM5=\_6XJ@'\<'##OY<BE=O$4%3
MH2!_:8]J\0F[#O"8@6?IWLFRX4Z:D3X3JQ$TZ)B!13E@)8TNWF75HQ!<:Y/%
MYVD&_[GWCH;R0G5<_"'W%(.JTGGR8NG:KW2L.=9I%#S!MP]+X;!9NOA1GE^Z
MIBK8 Y%?H7-D.G5\">)#-<NT=C37Q5LW[O+\5JBI)'9.IQ?9O7?=A2I>O\F]
M+9LK-GB'MG4C7I%#4#EU=33[EXR*P#Z.EWNL'\ZVU^$BES!5!EJ0V,,JMG(4
M?/HAT?6#;)1EMM.5%#._/.=UY]G,5(%J87EJMO3XQ[76@%*RC]ZARF^-$K07
MG>G",<.Y0,KF)K&J;SBW9T?&TB7&I#/A(=#\ <\@T]+<&D)HXF_+[+,7;7K=
MX%O5#B;U.8G&*<<9#Q@FJI'H,<<,CW&@1$(WY"M!*WJ+0/4!Y\A3^UE-BR)@
M,P[UA5 U?^]9S3Q*D[_F%^X:D!;QKK]]6];3!3]YN\ =45WVC2B'F\\0#LD#
M'1],=-PA50GJ ]1_"A$#3H7K+X6S70HW!.R213@0**)'Z&VJI67MZ?LOJ%^T
M+[-QGW.;R4VGL(D(Z?U=TU"V.OM4*9R=)=F<W$3]%1U3.C?5)]G]:=$D:SP=
MZ+H.[N3ZQ-L*<Y+F\1<^Y$ <K.IZO*NU"K14,S@\^K[SM2FM&PA)?6IKO+&W
M\:5[I"(.L>>CFN'.-2B9WX6F2?ZG>03_+V83_*\PF5+J5+2=\-I[Y6Y<.[47
M9SI.)IB--QH8!!ZIF-2T1[UOJ\/7ML?;VK8;O+,CM32U1#]PCB*J<;R-A WO
M[HR>:.LG4\\[];=6)+:-N#_SWIZI<R>6=#=.!75C"^WF'LQLE&.DIW]X7GWN
M'A@Y[8YE0MH/^+O?*@6FBZ0.V4(N[.5IO[1Q]H@;= ]\*F8@96-1H#$8YEI!
M5$8MV,]@ZF)B5_R'1#/A>Q VFC%YE^69?X9W/RPQ)<C:V49'#LZ1M+8G\CGE
M"N'\"4_AEBI7S3 KB"'\&C;!79PLXS]F.&D<=1$T'A?R3+>'/2P4UI06CC$B
M#\/N=P@H?X^3&'<:#U( -9^D2F8L]6><+VSS!?-9U34]G^0(*?91WF<$5B1P
M+"K=GCH2H8F"LT#F"C[L/:6D^X0[@.[D"Q'B'(P*&%BI6.\?S(2,NLT6XE&^
MD.U?D_H%BJB,A?C<4IWW#:F#:K@+1Q58!_;9%>J'L<](S@[)$X[)C[!M4)?H
M76)BMH,,((RO_UP.?@7?GN@FLTI#EL<PNN[EJ"^>J087*SV_'2*.&:"Y//CE
MM*5FWFTS<@!=ACZT>),BT2LD^$ 1SAX9Q#GO)L#>6\%ZDR6QLR02<^;<5._B
M]=I$L0>>E<\%$[@1FQ>?J/S1KJI7NK=N)P\9W5'GOO;6V10LM:C_8)5YS)#[
M[-';XF\[3SHSVU$FI4??#ZL>-7]8$JR*&KP)>IW':/4NS7V;#8X%%53[#>R?
M\HC+L$9\,.Z8=^ ;_Y.BK39X8]!G'X:%;25&TVV#SIUDX8LN>;0P&B-Q^! C
M54^90-5EP\PH\%!'^&GT3Z(UOR79PZO'OR:7>3,CHR55I6$B[4/3V-J-,9F^
M:[E4]^4!&M<250I<\')5@L4%"0'.S<\M;P/X/C5',*"RVWNS,C7F&6Z8/<)/
M(V*>1_E+XPY"3>SSS8_CP2$# ]X_O%ZW5X2462:V6P!+.UR/L.EMJ$$._[&I
ML-N'D!1*VNLN*>!>MN%H6&UZO)U@BPL4QN\2X*1OX/:S+#B4HJI^:R+1)I[W
M@I0=0KWBB*)M7C,IJVRK\4K7H+-ALN'P8ZJ[P1;S.R_9'WE/=U(7-Q>^!:,S
M+SQ]JR'5W5WA1_9H!?<*)#_UZ_6;>-Z*33*-3:HWNF,&U\DI6__?;KW>PIH@
M#L"3++/\L%%X#@P[<&#T<]&\DU(2_1S.>O=6L:]<IG5G_:%Y6'*ACVV44ZJA
MM@ T5(K6"%).D+/N*+&+1VXQ$YBC7X8EV(N%^(K:<S4E$7+8]*8, OQS;E&X
M"[U$=25YM@A=$(I8K2SA,TMLXT+HD"(+)MD;K;__8V?XHK+1\X/RH=1DWJSB
MMU2H'&E7D%+E:D+RY!UY5AW@>^3('%):P[6P0Q]+MS2OHREY[@Q']H['[;4>
M<B(9Z-/'#( I;+:9^J!V4FGW$CJ579CV,.0&$2,)W-E/S2.K5G?Y08#D)9E/
MQ>A;([Q,,Q*(9'?6,[^)EA$5W*X1OWZOC(*2"C0N RIM1EZ3#W,.&.DDR9TQ
MD?/P(R&#>1#97?G3O!<WV@=@7%XN\5N&-8DJ&<0??I,T7E+%5U&#5SH]_DP[
M^S/;K2>X(R8<E+L"(6[U'S-XOOUFL$'GIFE.2LQJM$,3/,AX2%W?LVMOZJKV
M<\,\\I*"J/44QR=J?U2]Z6=D3*IZ5=?-$O5-AKQ]+7PL>#:5Q2#!MV9;B*P>
MD2&P5SV@8+?]%;."3/1._SLH-[I?-5H3 E3YI?OPW!$M85+]K,W35:)?89R\
M^3#V1ETLCF675=D/.&:(I2L$+9ZLCQ5<&/8/1O#]HUG,K9I)N>K<;CHD<?<>
MJ+L\YFF <*/#*'Z;M3-^7TEOYKN%"Y07CCZ7^4B$T&3<AL6*L'_A:T9IG%;+
MW[?=BVW1B?=#R!+]6W/G(A!@4H6-SO6Q6$I*QWC'J6*CM6.&'HVB&O_FEDF#
M3[@M#OYS^]L\BKJ%B%>D94A$T#G0BF2GT UA@XJ]1TOT(&1ESF>^1WL9-HWO
MK3/<U\TF-<6Q#N^,]"4>/&Q#[>[^8)Y?G)]_].!GL],CM=Q+DWT/_X0CM?@]
M;;C&"28OLIV*%J_GU^<JXR2K1)=VQ2R*Q"A=U\"->#(TVQM^]LE7)#M-(V_8
MF)_-=/)F>H-04D7.2IFOP>4MW_*4FB\=TE-)J3".=/,P:<I)!_M- /Z#I^;_
M-J#^;_RJ_YNKEF4TWV,&+OSM4]I<YJ__TQ5-"OM.^N%9S.6C!HQ\4XY2[3%#
MJ"U9.,5S##0C-T=4>K!'*V$P8QO$.KUO ^0$5J5T15?U[)X 8:=>HAP]YI6/
M&(7^-&CX$'.";) @D04C=ZYF+'/C@H=A,\REE0+I5HCZ,L?!W9%F;ZO]C 3C
M''4N_0?AQ8;NXEO^F6BDJQ,IF+M=5],!)V%9P9F_ICJD5EC/Z%#@X<I;:DI'
M[H3%JQ-/]U_Q6M9F"CL5%Q0O$>YD+[2G6-Z$,Y?Z63'<*H/<3:&<>\HJ$=QG
M$NZ0:CZ.5J=BHMI;'V;"9QN.5GFRU#K72XU:<UM!KY5XK^Y6/WL.LF$]XX"]
ML"/>/X[TZ,>48VAHR:CZK+QXI?21?J4;HL/[5YBA0G-,E1:?X:/%6[ LV,F*
MT+BMJ+Y'97)*2^SNB,:2[M&8)+'.SH'7-/=RHNT&<23O^AO"![I,[O9+;&3!
MVYE+&\TF*$T1>1M.G9;@FP$*&PO8.\<,C5ZT2_7=.=*Y5I2$[0KR1]JIBGFE
M@Q*2?YQ8QR24&[J[-CB]*$B!ZOE7@VXJ'E$>#A4(,'YT^$T^<H-'\FW?[R,2
MDCA#9SH1TV<G9N0TA6DV8\H[CMVW?QXE& "XOKG 72Y0Z^<XYZT5TD&OQZVC
MXF@^LHT]<4B'(D1-<-9J7'L]$L?Z\M;'NL\+ZO.P^%"WQF%9G*""BSV[OX"%
M8%(9W^(G^D_F':NNF%T?819T !DCO99SGA(O$.YD>KG7$EB)J8"R^81B.O8E
M5]\1ZRIDG:0-%F(R!QP*_'9^%1Y-'46.(:.1#,<,RRU+];R]V%H4C.\YDI-V
MD<+5([F&[XKV$@!9?USQ8.:-A,(>9^R_2W3XI5E!TM!@?O MKEK93,!(%EN!
M9Z7?I@F!A"?*[&%(+LP9"MO<X.5/QPP7(Z+WC%Z2IUYRO'(I61P-<)#FC/H?
MM+UG5%-;N.^-VZTH141ZS58$I$9*: +9BHB $.F=B$@)$0$!#1#)EA(ZV5(%
MA$CO($( *8D0R@:D-^DDD0Z:6'!)0KCL<\=XO[SG?>\Y=]S[87Y9(VN-D37G
M\W]^_SGGFL\?G5'+OGEK:9!'2AL-.?:>V0/]8M'UQN"6*[K6&$KM.3_K(XX6
M[[TIED0B2XLV<J;6.EN07A><<2.OL<^NV[+9R6IYY=UP('%%I;Z.W2]D/>M
M&-\^9KZPC9[_N:9I%U'=[B*!^ *N\]_=W2L*JWM45Y:Z/+\LVK>1%;;^(/'*
MB^O@RZE5KQ_\?67%H^33U/V\=,3E=/_FW31S^X5QV6JO1"4*)IE$MP[XV+X:
M2_C"NDR21"M0+?Q&K^@KT>?7(B^BHI"E UJJ!6+()26S=QQJ <!MB)OTLOIO
MYGJFEV\?:R9&&KK:@3_/LI+MQV*\P3$SQ//BT;78/.H11[PT/)'EJ3RK'K]7
M,H$6*[F&"K:<FIO7*8R^.Z6/0&JTR\])):/VZ?H&>>N\>CIZ?Y<=<:RQ+T9P
M*6#4,V^6:K8QKTQ%FNPL2JR:)**#%(,'40Y2T4/KDUE!!=U.J@Y<CV9KN3YN
M3M8FEPM^ >_N&JH7S2X^><+&&2J@/0 WNGGW3T--@$ ;Y0%.DK4*NZ98II5=
M]U7+C'GW#53'<^H)*<9=TI8Y)?/+VR*_QT;-W_H#M'%RO_F8SB?0MX#R*@MZ
M]KXB_3.)LJ!R?RT$&1"?OOFE@F7!L.@E&[QKHH-C[R7=A9_K#W?QS_S.\#-4
MRK^<B+P&Y_%3\Z\7 UR.@V#VL /ZJ%Y@GF5W6,J"4V$G (SMUW5#1:!=EEU.
M<TE1]^3!^]#CR'##/G_AGI[!_>;P'/JCY(;8K&ZEC-^TV#%'' ]&/Y[<#SW$
MA0 ;P%-*UJS^,TBUR_:*(.M><WA]2OT%5-JU(0NM/17_/7V-XD6AB]]K?YL?
M4+W/KUIK6!UTIBW XRZ%%;W2,XT-RS&BD*W>OA^K(&WLKFCZ?>T43\O;4M8'
M=9 <2M,!J=5,AB[;$\M([^%1M\1>SWK<'ZV>_"#TB".6QW7F$M;0UD_A1E!-
M0W";69UY;.60.RAUY<T*B[^\QUUQNI:HR5XPLHG;<\Z9W27RN6Y[?^N1OM+>
M_N)+V311$3GFMNCF;!(6JCU?A]9&H$*7;CQ-9U]0,;JC\+0$CC$3UTHJ!H)-
M)YM ? @][]C"+>&_'1%Z6BD>R-(M/:_8MV?V:IKV]/JN*._6JM#L4KF1OO>Q
MET_(&-\]A1B'0W.]@<7Y%D+OE&M#6_&-W*#"&^#=R=CENJ'<QX]?U:2GF\H"
M ?'+5QA/$\5J@E7E^N7CR,%&2@-OK+) \H-7S 8FWJ\N;B &U1*K$^OU/K9M
M7TTQ^UINF:GG)6CE[O'KXW^2D/Y;S2$&?>_P)=2G'C=^"NBE1[PO,&AS[(@/
MS?>\T0P3<+[>Z//"DUI]PH?J<L8L]H.]<PU_NN0=AQ"KC)_A2F9V?N.YE;=*
MS>QDZ",9:Y;("2L_\T\CBR3U#X]?V>D_L</U'<N<=DA#3J0BD5O(M'-)_Y9X
MJ=Y89^8O[[K(RRS[XY$L$#E(!&N+8'@Z'!@RE%.L6%;2E5 EC#3*>5%-]OHD
M^DXU%9'L<\(<-?XXYYS8/W^CP30HH/V3IO+\)4L?.*1/]E[4%N5,UM>EXGXS
MO2)9$50,BC<5*(B^</OUCT!=T-0/H2\>0+4A65:45FZOM$M5F*A;J37[.Q3/
MYH$B_R&FL34_:5)N9(M1@_7U59@U/T]E;PC)!_SZE=KGX>?]>-*$O52[$#Y7
M_\D+NIJ%I]NNG+[21,>G/$ B84L+?&<BQ\3+4OP;^ ;][T^!T?KCM\*+.JY>
M_9R(P%"22*O-S5 &N)$![S?RDA_<\V*Z(ZXZ[DEI+PPQPF>\X7^JN.*NPV=5
MA&;9[[S5V7)\BE7,J:[A]I\3':&&Q6PY<NKV3@H%S-.H\'G;L]5%R/I1Q+<6
M<]VB=PL_ZY%P%] _*ZQK$6PN&O61_G4:5*CO,O.8#%^P)QJWC0J(/A_15C6?
M?_:QF+/&% SPQ\:>*34BO1)]&R#1L\F/EW72MLW]C?H,=6:CSY^$S ^_]K77
MN,/Q7FVGA>L]AY?[RHR08&E?6)N%%9:3-[+I:B7D:Z7>"^:D1O7W1H:9YAI,
ML9ONP_>NSL%!CE(5LE[4C%.])H(KF0@O5;1V@)XP%#UFF1.1/)O9YY?0SL *
M[4N\M)/3N9S50\Y;0&BYV:)P2WONP9?^\/Q>XN/2W7K-O 2.<_6GS1RVLKM6
M /F5W6"Z8H2*$>6(XSWF5%G[/7MSN !0M;S3[WZYI4U4)<*K&AC<<'TW\6@Q
MFCDLNC4@?HW\>]"??3+[%D*?[G_[L"*>V[,NFM!;;?9*KF(BC?U#D2M?^UL2
M%$P-$$-;4X&I4CR#&)% MK>$!#JZWGG\JJW&N3'%M?T*EO.DG1/![V68[\J3
M?[.8R;K'?_$8[_\CE5'^4UC=P*7\6^EU=X-Y:]XT@)%-$8GN0*#&)'S1QD'E
M&&]47Q](^5;#UK+Z.-R289QL)JRNLD?PW<LIBAG@B;K,#?Q@1+#/\-')3KD_
M[P*RC/K>R--IMQ"UZ&NTX0O]?0<W&CV% Y'.;J-82 2WL:[::!B2*D&X>\$F
ML&<0^GI0::K+QZG,-2/PY?S4:G.I7-6X>T95Y:3#-DV0-3H.&/6N7-"Y<+6T
MF^66=^]J(#);I=JZP#/3V'W/2/E#)96N^6HF+5]<<!L2\ PB3'KA@@=D?[*$
M!/;]2>]: 0'JPI[U:,3(SR..DT0M=Y3LYTN_\^\?@GK:LLG,ZG?Y5UN$[RYL
M-[0K]>!"A6=?0"F%QV#4C/GM#)P? 9(FJ"A.)B6@;>@^%D!*\56CB8W>9C;_
MC/>-+D=L4D]@1Y486<>:?+!3U(G_T5SKK\%3K=A/;*S&6E6#M>6VC:$ZW88F
M.W"&IEC!PPP4C0SC <:_5DSWTH!(S6#Q&?OU KG:.Z%G;-E.=[LF[C+5H"](
M %J;)1A =D5%OW?G21_ZCW!#2S#L\R:C2;O.ZRDM!:T+J1^+V:!L9J#?N[>3
MD5(L7I=6TM.+D\>D:=36L1P>]O<BVHR8\."3A_';<W@PY/"QE<E!5[J!5_='
MN8/'5$F1$26NR>^_DM@R<3'??NX\DP!NV3ET;_I\)5N3?E88Q7F)@>6^?\;(
M\!T[]6.TB:I +3Y+ZC;D+IC_3(\A8$Y'CK9E$5!2;VV=C:H=405BKW!M;UU<
M'_"U65K<#,$ JO#^PF:?P]+OOO586?,4F,DA_H^OGR@S$3:A](]&_-8WL_9^
MP][P5+OJ'W>P6Q3; _CIK0(1"H6&Z96F]FG?,SQNF:]=K"]QX//"=U#@OZ'!
M PU*CM2&7R'!B6-(2E"U.7?F_0OV%GT0:M[/)I^O<:L@X")^SXX!MCJV1#@:
MJ7?E%"#L;W8SW3K7W\@%:* 5;9RV)][,OCU6]^!$8LD+8'ZWO?K+F>?2L$G<
M<Q+]YA''G #EX?Y\"RZ]%RX%V7EB:H=&1+9!8^[G<)R@T/'8X>SY8OF@"-CY
M'>D_&@,'Q5>NG#V,*6IEH&WRJ9/1O1T&<K6[;_Y.E9(E9-"8.R[F>K6.OPSE
M#FX#G3U3/C%X@=&+0^5\WF_9(F2K 06;\D=P+Y@8%J9E^\LZKC'+\\IC=ZW&
MS%_U9U$:76R.L1H6>!7.!01W18I/SOKCXE@*10BB]/C#6;^+PFWNZ?X(K]-V
M_*:IIY3YK\O_UN9\I1[_;U6E=Z;_L5=TJ?F'_X^'++U:O]9$@M)LM37!KS'3
MC% U8J<X7:FU6&Y=LEBN.]"\IJ#];Q6F8^V1^?]SL/\77.Q_-/M;[91#SEX]
MB\_15'^!VPSIN,J;]Z9"W)Y:-$Y_SP/._DZ.*/<[O^BT=//V[_WZZA?_D QR
M_FYC49;KKSEI<4USIK*,8&&0$UBI9Q-K9I.OE[$F-EEY5L=2(,DZF:)#N#*H
M;MIGA2A+M]",M$0?DUN4QK]'^8I\>C>-5GJ]@S_98:*+L%@A*VUZT!>_-3Q\
M5M\5OD2L+')QKFH^58\UP=[ZE))<<E88/@1/ -%O\,W+=XF4NP%BC+PN=]UT
MRY=+B/'M@5HTF(&V?'<U12_""6U1+-'Z[<WB*%5%#)1C:]P^ -]N3OQ)1\/R
M[TW$!*75FR)V&ZQ2+ZE@E%Y-UA3[JX@WV(^'0/TI 24^28L*9@4BO+VH9!JX
M7!JVR[Y<:*)?K(=PLD;5//#*F2PJ1BG:JGU_7?BYHJ0XX),Q^M^8[ 5.5V79
ML"?$:_.CGB//Y5.7)&B=45TB_+)U&6VDGE..6E>^[@Y'J<O)('W_44N89',%
M']_E1C^CATG1EZAV<Y^7:H'1ZN?FOUTG+7+\[G:]V)<H$"7\S^68INC?"S@X
M^'8*$O>..)SH/PA]@6RK^&RGR9(*TR..A8D4!/I=RQ13Y'OR@(;Y:!*:E]ZN
MW]/IE=CE]6)0[4(Z\*IZIC"/*IY56^__"&D>@ON$9(-PS,>^I,WY%O)H%&_@
M$4>[40WZ&A#M%7A9G_?% MID\N^!OP/+A'_?N!)^[ +)--)J48$<C<P^05<,
MPV\?<5 D 2AUZ?:WR2%FP#$O+J&62 ;?X+.R@IB 3T..]&;NO(X&U>/(?^\N
MO!)/HNJ@8'R1V>.D&#N?ZLR';+O-E2$^5:GD2QT9-:.?[K(G\73GT=22?LHS
M 5IJ?JEK6@,TFLB)8)^9D/'YYQ)49 FEU[=U6Y0:<(&4Q1%X/NO)?4P7!+I:
MA6\B+#4 %*I_ &SB4YIN40= 8Q #!.?F^]O#D+!S0+ #8XV-O^P3E#C\/47S
MK!I>5F(8-!LJB*G-O(+YAZ0P& @NH6#7JT$0G393XN>[3W<=6'?VKUVQ"(3&
MLL4"'Z;Y98$Y_U:^Y6F\8$H6NA7V3,%N>P/.[9*W9]P)VTBG@%CG^=Z+/\AZ
M>L0A::B+RNY-3DUW!8(I(]&>%"FH0I2_+$.X$YP0RKWCY'@?X=_D=GJW>UCR
M@LM0\QK&@W@ZLI_4Z+"[%,"%E@*,*&"N[:#N-Z;4'.45%T;IQ*Z"_#S:H]Z\
M$I50_+())UL2GFRO.*&#G;E"3_I>*T2C!7?,JEGJ=/C[92Q_+YI65'D24GG%
M)K--]Q9L9 ^?SHA+-I1E+,J;)+2V0_I6J^!X9?)(@5.F*7PIY4Z+<GE,U^PG
MYUNH1$B5[)/UQ9(Y8T&'C$B__Z]5G/]:<X]@N%#KGQN>14,9H%YP0NX'-HBN
M'?.Z\=WLCR1_OA[IRP6#$H>60R9-J.\PKBWG95*DUU2HA X78MYM\85R&=4K
M=5ZA#&=F6T55G"B\D6DVO6,;JZB)N'&LD]769H);UN6G%*8JK1_?C?GC5:E<
ML>#"[7Z!!/(J_0<#U?8]L/6.BGCK*WLE 7O!J\!#@S-FM7X_=NPR$./%MUYY
M6=<ZIR4K=*N_^E24YQYK'.G+!RB+L 2ZZG)[(Z_MR/VXZ)+=^&]-LL:0K%VF
M\),6T%GT6BS^DY/9[^"OV%&A'7?-8\E*8/>1^/0%Z#M4ON1(B*/OLC306+:X
M ^7SS^LZXN '=\"I!I=&#IYI;=@F4=;S*-RC\>*1>*'#VN%J=[]ET3<MZ@LC
MU3)AUD+[58'U A/YXJ&H8,-2&WYM&)]E&>SEC=#URI'J6%'S<Z7V?AGR=GU<
M%C8QZ[/*+G EDQY#CIZ)7@<R8Y1SMOAYJ?C'^2E4GFRU.><MNTI*L8.0M>B<
M$9^98^*4[ZU2AS-MTX@)6$')??9T40=N=;0?%P-MDO_K-8"G(_O#M5,[N VF
M]Z*1;8$=C>8J1I:W2TF3!'^H V&2X"9B]19+78[(ASHT-'1@EZG+U-O"8M2G
MOXR<C_]_S3'9&WX'7?"3%B8=EG3HJNQG5AJ^P%0AI(6 %"K?Z865DKV'XZ!X
M9\YH O3$@%AF8(L5*LW<)*4X1][7*]5DG?S):5F5*,\=._#-U5+^E*JK-X@O
MF[KCT&V>TY\M<"M?S+90U7=0JUK4T)?0YONEC_'T[-K'.Z<]7@9!^>Y=%:L)
M^_KAB;;>T'%7#YY3RRTX*0 7L$Q55Q6(^?7F6\4[+S'W"0MV[+BM9JV-Q:QF
MI[;S^)?:4 ,9QS>-TYJU9H,/6ANG-)=N+%]KE]@QCQ\R,:A=JAF'!6@^'%"V
MEJE4?#^+8X4?EA!/LS\8GH-)HU% 2B%+C_[A)]+#,[BRK+C"SYG X!KV*40]
MO=$PC3:I=S.2./OYWGA(WB]__Q8WUQK[[8E4<5%7>R5^V%DLV:&'NCVU;_NF
MZ<I4;7RE_5Z$7@BBST[>>JON=N_@UF9XZP?RB>S5:F]'UA.^D]D>FX>>_+B^
M^[Z4-[97G* !+D+.@85F*;F1$Z$RW)J_""8MXZX$4@I+-FCUI:$,_CPBR_UW
M?/<X:A&H=F@5E\,A* HAF;.X>,BUVGN.=2_*KA>W[*?L]54I]^']T@;0*CW6
MN[\X*7B68/V^-$!F<!L#3O2?M/WH&F"AIZ41012;K$=#:"L\6T39*0_URDF6
M+A4CA+*Y2:_KC- <(]3FUZ77NL,PX>..<R9!8?I732>Q@\&N7OIVKG).+^]7
MWK/)TJJ3.)50#^,4K1R$">G9KDGJ695K+?G\GB&W_.()I3\(Q.>5^797RPO_
MX%VDC':&9\98O_=+2=F'(S:9.C=T0Q5_;(U**%@2KO1Z%-L-VB%ZY38$V1M%
M'4A:]AXWW67?[]A_GR?JHF^,L:51E@HS,TJ'+GLM3W-3:+S=_3?'FB(LS'ND
M_YC2[QB<$9?.KG!75OS6])O@4[@Q'9\8 I($',CN$#H!F$:KT?CX-I<5Z.L5
M*G6[?:6O@6C+YNFF) :BPF4>/I\T;/AY>=7%?7[![?WEKW7^E!QWR$:6@! /
M1/\!_6/\ZHY=Y:TL15L_$UY[@JR87;%E>V*I7A--QZQ49V"$R^JQJ2F\62P5
M;B,%5RK'==E^H'\,=ZRQ=..Q.^OY!G"]6<XEF@O<GD(E.H9/ENM8UUJ_0DQE
MR(N:6:JH1B7^^K*//:R*/!DY&"Z"99DR=OK542 3QI..95'Z)SH*UK<,;IV&
M]#;@K;3.;RV?IJ\D$*Z\=%JP ..#?'@KO1QOKH?=3V$MK+:P!)7V(8>O6?=(
M?$0A5O 8)$!R2"QMJ-OPTAC+B[[3H]? ]58T1$6):H)ER8;5+\4[+N:I""LQ
M&Q"2LUB^MUV:X_O6 QI5@()WR./DB6:74]8V'Q3NJ85>M4I1>#R=T1!8LFEL
MDQ94L72S4$76.ZPU59GR4,Z?)TZHY]UI"?U*Q:OEZ?<U7K6E^ENCXA4S+O*T
ME<GI#)AUB.>+]B6%WIMZ79+K,]?D@&,A@6,;Y;D?3,>QY.$2[$M  *4_=G[K
MH3^!-W+[NF%IY#\/A,6U,KUXE^MK5^(S-Y JE[KWM_XPE4=EB2[-=K-YCO7H
MV"AX@N=/]F61SA&%64'C/P*D_-0TYQUB.XPI>"F6_DPHP3'WB<5ODU3MV ZY
M@\/^%Y*-26X2>[-R9U1]SK^L+4>MIUKD40-#@WD,[7+NJQ\H/FK62^44<N T
MM3&="@W2W#)+@5AH;@Q#!G/7&QR)5RBO3OL87>X/$C:.&@FR3.M>$^U8 9/7
M4=E.!..[[^U[C(2<9A!59OD*>BD0[J9GE<;H+0;??M-A0:0@V@L(8D+1-X 7
M/A1\$EY$YDTZ92/F\W>PD"LX'EM=O;2IYXJD<O-R?>D^\.HKK75<W,H2;AMI
M*7===K]D%,"#T__-?9+JT,\7NW(F%(=UYNN!"Y;'A08D1UZ;9(NCM1O]9>#3
M$CT%6M,R:2Z\@A9%".=,8IK\[06VG/.G-N\7 H*I$<"G-,A#4F.P!,5A2JWE
MWW-,N\!5LT0PG_E\A#, 7SKB:+(JWZUBFC6]H_#YV.2:I]EOLI<&5'"8!5V[
MMS5VDN=\CW\2F#44U(J[_P;0C]B?Z:)6=UA*69&I!OG.Q&7<9=D]C^'M[P[/
M61&'%42.R _B<CE4/AQ(4/\:_6N_2UO6J%'SU*W"RIVVM1[^7]E*A0"<O*]'
M2@B-(=@G/%J?#,FK\+_<VH2EWB[M()BVPOXZXF@)V,UAF@-9S"[,:4/U3>(5
M1D&^[\]O -1V7-]M-4!HR%,0J?PS2UH2>$[YPHW4JZUM DO^#-YZXO#"^;JR
MQF*3E84 \<U 8WBKV'K(UYK!,A<+T]&K6$XA?1Y!V0%M?5>$OKZM[.>!MJ0L
MYVL&Y\(7K<B.Z/F"Z_#XMXIB>SZ6FH^=YXAPF%:UXIM0!<6P$ 9_G\545'!9
ML?&[+MU;.S8[X4HT4"J(?A<S)[(?!$0=<7"QU="V'?1^7/%8R!>! <H.'Q8O
MW.&E["Q=J_)!_!FKY3A^Y1-"*K*H+KJS_Z3]>E0TGZ+)7S/65#!*!^_' 4I,
M<]15UI^ "(/;"$BBZ'Q9GZ@C2/T!=UY$M)7P&^OG/FDHWMX/?])2#.>.B%>U
MGK2;K-G(FD&IWD]9S=45K4WW!M!"RD/\F=ZVZMN#><6XVN>]UEUV=C8A^<JV
M6[=BC>WDMEIM_1#:$J^[&28\M&#76\;15.4DD7R*FR_U+5HU()NJX:KY9L^$
M7_(6W)Q?WTWDAG5B39554LF\S9J_].@Q,.9&%/X?FA6#L>=)DA#,7/^^,S#$
MB",_,;%B^&#1&@%E@-SD@'D&1AHUZSJ!/KOJ)-^4IFN]/[_2NRPW_DBUQDDM
MPE^PN9WVK:-GM_O>SKHH2^LD3T:#SJZ7I+2T>K:R%US 61.A8+HEN&VI,+!+
MT-%P'>).]PK+"DK-*(P:#!3],"2F<WTDL'LU\(>:8\(-KI''_Q9PCYJQN-RB
M@TN!-Z?FK-;'%Z_*OR=A"RX>5F!\IR=67*?9HBA../U+W'=H7*[Z7_1MC&BD
M' H;1,%@&[85^G!E?F<K4#B;K&<0C[$9*>2M5A*#UX2JS1+\=W).=HJTFD,Z
M]X/7ZG6>!1!& TFP@A@B*9J-%3>SM0Q!TP2#RT P;!H23\NZ%E%K9#3N FM]
M:="7$Q#F.]9$@KJBSP-#K\%8TCW,'+YGUEUB]K,FB(_U;[W$O]@SXVZG&<OO
MJ"M)(@6R4]ZMXC^6"XM0D\[3K*<5*)^^R;S\<[\ZG$I\GQJ>&?N#P8D-&2*=
M!]+-#R(<CF^_$]DG_C,&#7[MA^?C9UE0CCC.&1?YX04N$NC?@(5^\<*6)I%E
M-<;'Z1!>EVZV N,XA%T,W_X,K\=^]E<!JY83WKPE3,3HH>&1E8%U%C!NKJ]D
M6]1+,ZMZ!]7*5]Z0P*\68Q_4')USLCA/9'JH9:6@3Y_.Y['T^:'8Q-!Y94MS
MSN#KE9;IL52H?6G?;00RON=W(_^.',B@D"PF!Q(3$4H:>+S;C35ZY2-IE..5
M72"B,Z)$I>MR#?O>ORK*<TJ7TB#$:W!M?PZ(I@?WALM'81[AHYKA)XZQ7< O
M'(/M #&-4!)],(;(?@##)*'.J_6OK>5+#*'U!,HH/UH,;QM*R";;'W&<;^I[
M.U5[NC884X>PVOPF1KJ%9'R[ < *(X?QYPTE(WN.."ZP_VCI!\]M[+?0\3VC
MI[3)]1(=_!;TGWWAFM*7&77IP90472\BD?XS2C]X=8'7P5C/+8O@4^I+$NP
M^U/YL+FPF(>A");NZV<"1QR_+S&>QH="YT:^4'R2"=7X"\#DOBO0P##?=V*
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MF+C3]S;(8/XM::D.]LR4@.5-8CO>GKX2G] V,9(GF6L\G?9QR7$@"#5P+0R
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M0Q2H#WK*\#?MW5XO>AX53G:IYP*&'('.6I;=!/L2XF"_%%-I\@R,%>@J$&&
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MB][WM[]*:+3(PKF<,&%"D/P^O$ ESP%G.743%NIS)L#CL/.XY^I3X2!5C'>
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M!OI[9I>5W(R<)_AY=^66N?-F/)X^'/Z1'0?UQDMNKM#OPN-)A-B^>HIII!1
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MY>7&@W?<N<L2Z/,I0XT/,#S* RLC@RN,1H >"G.W]<"G8OX >.@MS\$)T O
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M,-J1Y?R^5JG/;?D)&UD):(&E4?U4&/?.YAF@<VD[%40.BCQ9"M48@:BH%S/
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M"L]G%G.9!Q[E<5%9#2\"=^K;>O45J?3O9@)1NO7!EE-&I(IA@ET!JGN\;+W
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MA:(S:$\6+JX3[._%12M:*(6JC>QT)1@]3M1_ E',6)N[,*:3JF>E?V-8=[I
M_WJAYW4&HL#/O% EFGIPYG4C3F@YM#)G/-N(Y/;RP:OOUB2++,^;PSU#,CA"
MTG*>2Y7+ T^W\?KMM<K>_*JQ)&O!)4]'-(QND1E6 ]'*UY.-CY%LZ+4C#Q?'
MITK<?;AJ:*W7XK5BF]*X![#?@>+)BPAO7^MP.JY$<=%.>G,+M@AF"VW:)+#/
MLOK61^M0)3< XOY5M@/3)AD-$NO%3H%W_P;B%D28?&DZ,# :TC3"#EC42-S%
M"->SS&(5C (]  1%="+UX"4AX-0>Q:)P972;G*2"D\GSV5(V<'-AF]QR[S[P
MODU,R%^[ZP@QN4DKD)BHO&3]J-A]RK'LU,;9K+4/L#F=C@>$^)\/DH5>,!ZB
M17A;# EC9<GD.Y5VE#N>#_BXO2OO!M OVA,LLA7+Q;YX5X\G=;@90.0EO7KT
MF;+53./=%,#J"+AB@0_[!BYL?E9:SKZY/_1,%TLL'GH9Z.^#\Q^EQ!, @;E)
M7NZ.TDAZE(P_SM8'GH-3VK49:GP/ZB#.]'>E3*^:O?+LC!7.Q>1]TQ\WV69]
MX :EC>.O, /88UWW;.)D%8#(Q<VG4R<Y356<T5_0*\"31?A3+T/@%S^1,6O6
M]W;HR78!LAO&VWGYPX+-?U!;O9+?B!&L,P&_!(%J>^8[LX4"?:JHJ%%\6U4@
MMM9Q"6H(L)@P>D(>1]2FUR8."QKHW+R*1K!.DS&BJ*1E9=9:%"D9]\][JW?)
MZ%>"?Q+AIZF&U"JZ7#SY<\\$I5UX)$VTUNU+4IO7J3KW+.?J]4#EY\1L;Q4'
M0FQU_%[[HF.?D.-XCWV9&U@_-\2&EP)Z,23SXN[/=44MPUJE2]\,'D#%CN,8
MO/.@HE!901RMXF,*\R7'[UF)NP[%A]-F42ZK>UD<1?^Y-\XD05[OP:880PN]
MQ25H+0"Q?PFM!A2]\D2YFP"A]+S-A"XAZ!]L<1(36J"7AZAR#P31#[EBX2?;
MC>G3M5>NQ6_9,%MPK[Z[I3T_0=L+>-/QM'^@*?F3+OPIN-F/C,3/-X-[;2;)
M?0L1*8^ZIBRO,4W^_=A>DX7K]3("(@ZYSBCUP' 8,2C/,-J^U ,%IG=1$]B^
M]"(!?X1O**.+;U;IZ8[?N$YSD0WK!GQ*_Z'I@0_G+/Z(!?8_EV6KS$\1Z,\V
M>$3"2F97YRXD)NUH6M$/E.SCZ3&RW/*F'%'=;ILCL_W[J'H\F/90:RYJ'LP=
MT7SO#Y5D^[UM/8&-^C%-_T2KN#KG>[J!:,R3Q4*+A,<M?/I8#A8[6]]CZRH:
MYE6H&.?V1=HAP*E6'>U0.=QSYS)0Q7?78=&19I?_G5:@Q+@O?8V>/\>WR+;[
MIV)1:^I%5-MC90\X^8O1%UY'7CU$SI! /)DRZ;N]=O<G>UDBA_&:J55F]RQD
M)$X9E:^KS)I[=Y"-44>K'>!R=J\ ZO,@C)(7*ID>T0OF0@TQG'OP,D >_<;?
M:_.BBRQ=3M-B@<:_[Y/=63G[_G.HDMZY\S0%YOBWUE=8OZGI+U^4$DCFP83.
MYNVA9T5-K6QY['^@$FCP01WF%&:PT/"0*^XJ'7L2L"0WQ!P171^.I &8H&7*
M 2^L6 R>@>S&<AURD<$UJS"? FR3SC3L7*2>]F\;AD0KQ''YK1];));#/5\=
MM*^Q8;[@TNH#GHI"ICSR\-N?GX9*U$]N=@5?873&,_4W(O95V+=^.K^'-2.[
MP2(S \V*125L:V;X8%T-,)7A/S_-4S7]SZ24SYNFQ"%?W33#T'!)D<(K<I^8
MX=7W=;<")PMNO=/MOCL'._=U;6+Y"*=R($K*P<+,[95>?E927EB,H3%S0BB%
MW'>1,1.K3:8_A"CQ>VM)&BZ#[D\^>H@6#E!5%/KRAA$*X'V=4HU8U7 )M^:J
M:NO22K?T+>)93/]/0&R7V@A,+G1HTS>?07F_'W(UZN+7?[\"0&2:%7U_5HPJ
M6B0>#DXP]=0@[]G@UMDJ!-3- /W79^:&').V \M=#KD:G+X<D#BP?Q\I/P"(
M]D ,_2M+'GP2^@<P09_?R&$1=].8RW]!L*<J&:!8N$"G+/HN2[UTKXM"!'^H
M!)3LWC%_)2@P!TM.?BMB6-J<0&U:,XG)S<D2KX?1-KYR Z!UAX=F.J']PHFJ
M=J\_"#<TMC\T79603QW+>A1^/BLSR_>/I]=.%7EAP$E-^:KC%HZ,*F64FU;%
MPJQ%)C.SX9$<]]@W1ZE:2YDD@E>@;;6N?:[VLT4)#:04?9GGFS#!3" VO\*B
MQ3LQ3GS,(D[R=RJ:**:<6?'3Z))W@R$4[G[:PF'Y>F;%PR/[LR\PQ,AR)N:/
MV].)ZPA6'6UK ;1^I#[3:'O@R3X,,'-*WD4P6RK#Z3!>%,\MH(R>ZMSC97CP
M&GH)A3U*%-U#8H&'7'S-:YK5,X%.7N> 2'HJG*QWD4;#7!XK8SG22NB#Q[L[
M18YL&B_$^3S?%+$^S:JFB_74^BSFK&^';TIPIHI.MENRNGJ,ALA8$52TFY$8
MY9 K?EX0HX0V.R!T!5IY'7+9L'I?Y([C<! 5.C'!2Y8%BF\.9<R+3 )R+J.O
MW[V#?>836:4#TR)FQR&J]76U?LG5J2G+2>&7\0(?LLQ.0TS!0L8"23TQIJZ.
M9YOI]IH.#;K"T'<V0M9"!.?ET$ZA):!]+ALJ#M"9P_TADXX6CQIWC#5==)T3
ME.\[U+O,\&N<S%DZXFPF0_6^+.D6U'(GA8_;P=41S1>8N>9]R*7$.8:A=!H!
MH?MV[,O .O0<YI\BKG:)!60L1A> UZ"D=E%O6::$6J#(=0+T;'FTW:\.5>0(
MV#)G4,\)&;?&U@>+ZK[TUZ(>SDU)?4##%Y.)@G-F]$_N\"^QN[&'7+@81%?]
M+/60ZY2:'[,H 0K6(,\GM'1"6 .SK<EL-7K1%+2/\:TX='&(9P:MU%)$_]&&
MH//)4BSK1[?!Y]#6#;1VD_"(W0)GREY0L[,SC.C@S&>M.;#J5.R%!"F_\#"U
M3Z88]G8X6PJD,T*_Y/,YV[5<*'/[F?PIM+GJX'Y9N%,6,C+:[5$5Y>AFXG@_
MDQ<O9]+TA)ND00)+;Y8LRD6?A1JH*[]?,N"=>UH2WSU,\?:Q,Q1U](I]?YO<
M#X+S[+?4[S0(*W,0G/&N!J44J!$ZE%F4!I%B@$Y_Q_*W1]/AW&C-@^IV6*U5
MC<M:H3Z 9&XQ)N(PJH"=QIE4.=,QG0-CJABQ'""\SUWOE'LW>L'F%)#KCG!O
M8Y>UI.%[\%]B]RUW,X$LUKX% -J_B!EU DNBKRQ4PT10L-VBN&TU=_I0$E3J
M.ZU3;#B\*YZCG;S0U_<"^0@L#@2D_CN#$708GXUO#0IY;7R]W:S:I,(K("IB
MA202QZ\\>'F[_@O**;DXOIOV/EIWX^+'%LF.!VH1DN/,<?^[;7354_"SX0'.
M978Z(08/KF16]#Y:GDAA;L:'OLG':)6+(L3P R$OAUIRZJD4[C2R=Q.OO%]<
M]R(3:.^:="3D+>NJ?*;2-77\D@98 .G,78)%+?@C:.KT^W2ST*,2N'Z0_HC(
M@U8=T9T\Y/)'\K%#6=CX3B'450B(V42!_N>@,/N0BZ&1JLC\%<LW5[H'Q54"
M?1[,P3@_M8W>V3#'\3K9:']U7?,'&S#G[Z_?:/..H/;$E;4)_S"[/"K=T#^0
M0LE]/LH,!,,C\FZE5P;%>UQ^F;.Y(;UI2Y;MM:1L/WS@%91$<)^JZ5YZ='FL
M([V\7B+8-HO.%+]U-J<YCVHPD79%0O5&EA(:6>^0Z:^<=?;BZ_:F[]>3+K[Z
MSW\Q0/WS@)P8N\1Y-_B0Z^U1C%=O,K(PQ<[_Y0&\5016/]N._>6DL*W=_YEO
M)O\;3;% !1P#SL"< # 11A\2+F]EV,0?V2F$;[>5"3JZ"O?K\1X\%:V_^T;]
MPIN18*7"N6\35%FA,<RH,@(J.D[/)7-HT5_.IY/=IY.S?SHR<6QA.=.?CRS!
MR4>%:C-U&[A]O1/**B+;R +8/E6E/W/$D'3B&=17E([G%+YP4FUN:F1CW.23
MP(U;X;]$1(9Y/5VNZTR5.>5K?)#<#AC?C8@(S">(&9BT?*5+* =;?>CY, -
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MS?O+V.K,47+F!R)C<L:TRUNB>QSKR.J&7?)O*_  BYCS?@V 43QB]/>:B<7
M8M4I?-.A20IV;51A;O!A^/7?>)E[ $I;8W*8PK5?I8_2BO7TJPBP^J&Z$3V*
M$?)7M,8P6<(V])(S4>2L-%*7'9M9RAC<\T7Y@O63F!J6>&,B,)Y20/GR=$L#
M<ZQ2G]<4]L9Y<+JT^PKB4(WTYVP[$<&<^^%&$?K_GBR'F\<9\JKXB-ZY7:&'
M7"DFB% #/WLFW4R]Q+:DB%7V3-"AB?G8,R_JK!D+^U40TYL.XWM']Q'C];4U
MR3,O6[9Y+])Y)3.OH76)ZZ1RW&MDPT\R[!$'$/36;UFQ<H$"E8K2]$HS("0M
M'KU$['+&!%B&1X7Z1BQA\%9M"[GO([TTS@CG/=SB16$2J;I,+/]%78I^PY4J
MZ&R,JF+^4JG=G@3<B$')OD JLU#&*=LQ7N9\;(A]*ISV._=LGE!8R %_6TR&
M)E.#M"8LRZKNP3K?HJE 0[2T/<;O%%U:&GL);+2_-="U4TA-2:N/."<PF?W0
M.N@(\1'6FNTX2&OXFL<4<+JWYGNXS,Z5__CJ'8A/EFM%'<)ZU:RI0G>%XD.
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MXG#P_<8B6BB@^C"J\^SFYR^(+6X>ON\V/N  /D %Q0F;F.$\Y)7SSW[$5-N
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MT$V><GW#)S,XM.YTWGB'QN8:ZA:\D4$[O?HT8'!H]D*R^#2-\^HH]$>27@E
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M1*;G:@D>AOF00_^ T2LP<?\J3'IQ)5A>W(VHLV*<V1L8I/+S%CE-XQA4P ]
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MO'X;R[ N(P3!JX#LA&?)=+IJ?%JQNSK:)@"_=<3YM8?(UF)G_VN/GBZ?<)_
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M?3M?F,JTM6\[W_&M(?*QW1&]SBLO'ARZ2<VBKWEZR1<SSGL3\BA2OT@_]VP
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ML3^Y$A^X0AJ;T)6\AA&CP,[9)RN.,C@Z1CH,"?_RPVVQI;3E#$F.>#:&IX.
M;)X[I/9#.HRZI.N-HNY8:[P1193$5S_4'2 S/<U^P\=;,>T4BW,N.V-V D7;
M=Q![I?^7\KXKJLDMW#9[;Q$5$.E-B%M$D*H4J9*M" A([S4B2@M%F@2)9"N]
M;[I2-R"$8@@E=$@D!810I M(21!4ZA\4_)4 !\\9X[R?ASON&?<^?.^K?=]<
M<ZPUYR<P!+\QX([V2J[@;Z]AW/OPB29&F^O2ES#?*^2%932^ODU(EY"TI[-(
M47TD&$^(:-N':*@Z+88N(5E55KO2EI3FTH;B<J@);5^38HM)X^#;1+\/<2R9
M:19P&]X9M\ W$^L[6@CUA);G.P-[P\@Z?R4%Q?N.V#IL@+M7'&.6(61TKU@:
M69$X=6<FX]EU.: WWU]UW&SHAB@B=-H@?3U[W*@RWT=UO,-G+1]AD#^IUF;_
M*8_%OS(2C_8LDEX^0PUZC/8R/R;T37E][:'@Q>*'Q'$6&S.=I.=LTK;Y-F_C
MNI9@;?6Z4$#[3MFXDTO=F_6?8BY]J5WB])&$8DYF^#$U%/:AU8(F?6["TUWB
MC"*I3^TMIM;D8NFQNF^F@6:( DW_K<VI[W<)'2T^FUYQJW]>R3SMD6,[/=K/
MK*>%N'1"[7AK#4^GDJ=QQEP&8?5 K5!"N<B-B^N6>]D3'9IN:],Z9M(#-9^Z
MM(L^@D_JR8R0\SBQF!Z&;Z\5)JYWDCRL(6]#ASX)(M_O3HVX"7]IO>*#\?IA
M"4SW$@$,;*EF$<\=HV-=:_)P:7&V]LTB%T$2I3ZYM5L_>[:;<4.EQ^TL<#WC
MU:RA?*U/T-/'"[\S6:*N\TUW+]PL];X[^@&93)[Z&;\^,:X7R-DJQ-MWXIS!
M5W.=X08]SFM7(J1R#64S^D3EM#OK;2P<$R#YK-^945D5*-[1+FZ >V]]6L<?
M>!\UDC]<Y+\O@.ZYC>*F1X0%<O73O3%-!6\(9\#F<.EX'5.Z*5_?+ ]0%]>Q
M'=<57HHF76-D+!TH4:9$4W$)JER2?4\^*2RWZT+T@!S=\ZB@XT/<RA(&GP&7
ME83?KW\GB ,G1..IQ)2%/_?],7L7/W,%,9322_"5&%C<\9Y^RO^-OA\8.XN+
M^>8\5\[@TM9[%V:BH+S3]TV>%O?%2TVYXQV%<6'Y.6V'FM#S8*82$3=4=4^F
M[W1\W\IN,.N&MX[^7<ZK%KB\^U[Q5'I#\2)W8NQI*ZMJL%B_#UDL5%I"1SP$
M19,J$85>8V]6NRS)+,U4^FO/D,3<AVG]35VZ8:FDJ30^[@*[(5^Z2A>7O"<\
MG:9;G?+&AOI:+Q9:NUMR'G7VH!0= (]=/*\K!M9\<@;2-_* [PQX<I0.RR2S
M=]T,]*<7*&B3H>=85X#OMQN8 @OQB(/.*L04G$_W(NHV8E/%:0*EJ?2L2ZY\
MO2,"X?I$K,A\_AAZ\D7M,"'[U^$HMZG0;KV_)HX@/D>05*@8VF<*."P/\"\P
M&"4HH?2FPM#LAIXX^48:QI=PJ@683GB-R6FE">+//OBKL7_'BVS^W(FXJ;GT
M%+JD=$S(HP\U#EX2EXI;HOYL9L(H_N&,]+VME_LWH]ZW^H15^G[UB3:?VI9B
M8F(.Q<&6M=[A;2KQG(Y)M2%C1 0,4H5Q@U;B['KIMN-8F&_HD(KI:.@\S& 4
MOR\N?6?,SU]U2,YX7.%"_7CHT'72J4V_T /=WBD-K-]K/^S]I-FQL5F9I=;G
M&O0XU50!PQP*.*C(]YNY%-D,7V.XEBT@K^\KG&+'+D];\]1(T85"K;E0\B&<
MGNJJN 1<=.G@SJ NWQ^Q6*=*18<V\N<N&"V$DZ:)HSJL.7A;5!]4I.1*LL=2
MEW98<[#AJ@<OY#U5+I>^D'IA?GE@ITZ"=*_^9:7<#!G6NQI!\(@EC=)*<X<K
MUF3*")"#%[\>HN3H1Y"$7\TH9I08T)1FI40.X+L-&,2$VH?F63-'>N 2R/6E
MU?:J#QR8KK;NB24P@B'^A]YDF,F/BHQF+B^;T>VPR,:>%:)R'W_&3^Y>XIS0
MDOK&=LW,%YC0+CQA0<C?Q/;=-RXY!SS(SMRG%O-,Z>@Q[JQDW0(6DI?33Z*N
M,;FCPTIXUVZ='ELD=[AUAV-_O#,-E'INSI^!ZT*J4V?MTUAJE4C<;3SS1EI>
MK<*XTRQ(Z]%5 4,8#K$5FT,QY=: %T7A#[+$U5''3\VY)C93H7+LW8V1_L;]
M :KK-.WJ@Q2=)E9NC@Z-XP";0V<FSUCUCCET24!%^',,C=48U6,44K_IV&JU
M8'.0]X\4/PWUI""U1AWTSU:*\(<:! ]<ED)3&&2^?&C284DQ9U=WYOF[IB!T
MV76\7$V:)H(IW8&3%T%IKXUDX"MU"LTC1 \M.4>0=(A!!$JPO)GH5%U59.;"
MFE@53J%9FQW,PX$%)J-AD4;W6@7S6V(K?9ZD=MPJT\[Q>EFQ'Y#T@WTY?;,6
M:%KBIKPE""#[_@*?52/C I_!^8\@WFI=P' .?6Y(&*E"%TQ]C2B^-"ZZ;,.T
M2T7IF#_U*7/M*YWATOABK\[K7''87$G9,>49*0Z2D+U:Y!<5F%1QZ_52+4.6
MX6M%'DVNMK0.JS&9&<.<6.EG%Z8J2);IV;29/]OY,5D1VP\B%'')Y/%:^<MG
MXDZF28HG5XORBS^,+1=RYG-[O<R-L#5[M2(W[-\R@JO"J8 J3'ORXGD"'TL;
MI-+E;GB9 2.4D5/>;FKO_%#Z@1X^=;,^;A?JXRT:6R<W0^<-[<>7)B[&A3I7
MO=XUV7^0K4P-5X9\&I>C80WJ))I=;GAKA5795!M@-5$V:V-9L7>,I^U3&(R-
MA:KO0%NAKCI7?*^[;R]!2.A6FC27&U>;'7D:(XKW[<$7I!J'I#!FS89<+[RZ
M!#&Z #E]J1#"?BD3"3E;F4LL@H(*YBQ^LAF(H,//1;V%_\XRD619,_4;OQSC
M'\J^=/[R8OPA#Z%5(6*I /'>1!G91[7+,CR)^ZA%HV]S?7"YM9'?TN!_.6?K
M41_7JHY]H7LPJJ4@3*[?N#M<Q#B-@T-$WX[*$&U5D+7T'?@R644W*%JS>8Z6
MZF.%98!A9)%XOD_-Y:+"Q@'"=\][_?(I(3W*(JVT:= <IRG&BCN6V=X6J7ZV
M 4[\LL:P(C1@ YTMH4(!RY'9<?KW#>R^AI%2TB_A/G41B$5>43!*OLM<I(I;
MK9JJ4 @Z^5NP:V(D+:X4<_?R=;[>J19=:",3FG3QA4_'>L(1I!8^H[[G#P0>
MUV7NXSQ_,\)V*7@6:6YL/]U,E+K8P;1/WKVHI&/)2&;P:YO6^C;>W?MG8*RE
MJ$(?XW/NK7_H>AA\  U>Q+'X<(<BB_0-*)Y(Q8IX@)-,^%\QH/7MB8T6..HJ
M&%[-UAXG<K$CT:N>&9Y2NJ^VUTIR]=&"[D7]?01YT%E">9P5M3,]"Z921((Q
M>0",:YAU@ZQH49V0DG4X.=2]DM0[D6V5JF_V:MU X&*VK%UM8K79-PEQW "+
M>VEPR[:I1+!M+=_%OZ]&H,I=^K0^\)WK<,N!LR[E\HH6+\X@5S#,>Z@#_^B]
M'Y<HJZUMF3])IHPH"RO[_=<OQ__?@B@!6ZJ% G>+V/>&@1M]E)&X7$%1]4VE
M)?\_>^.1)P0?$_E5Q00BXI^A3()[-<:M4T2XHYOW<^<P"YJCNU?X#(C[GNG[
MW/I/?DA$O'RTY14[M//Z=CTX*#]1MANZ;OUX[P7J-I]QG03^Z0!^SMZ,&53H
MH<%:%'J4:]C[XZ0[V44_.DU%?O"*AIF6 4$4'_#9XVI8?A9Y^6JS@EVL-\9'
M6J0W%&-5> 3)" 2E ED")A8'+\-.H1]PSQ[Z!]X&%).Q-'K)2>0(A>E*KD&)
M3%[LS!Q>[Y%0;^Y.\15<.-4Z\8>^5X3L#\*)O"%\YW'*^F<B$3_I^$[\A()"
MX(8B=MLOT)_>V=B-S]<N,.DT>3&%B*QU3G"DM[6VQ8XY>"8N:'J$95Y_>,]\
M^0C"XE\^/&VYE#ZG?I,(%@"]BW< PTVELO>"35-)4FFQ3(.Q 4C+H2B3=KO@
M_B2OS-@<^?#:SL)6SVTGST:ET =-_F),ZSWQ7R8?K/!?PB;P.$4\]O" >7*S
M4NR"T!2L45'5__'L*G<B_"3#*\Q'1[:U4:$UD75NP^[GW$UUJ$=FK_ZDC@A6
MJC#:;)+H/ 2B99E*[/ D#>4<'6E>:[-6GD>O:T@J.,O:B;Z5.I>,JK7AG9QL
M]\1LG,QH[U=KRA'D^J-%$:;0WS/%W'_K6%%L!]L$.QT"3C//\LL.Y_+&N%8_
M^+$6WUPD3/\R>W4UQ[CME,&[8CG9C]B\(XAGJ'T1Z@K8"HPOIS_#PQ/AIW5\
M2L'O;PXO)'X<8^G]Z_JT;,HPL<5E9E[OHGYDI6^N\BJ7X9V)S=>[IM=7G&8/
MAQ="O?O*IAEJ59/DR>I;W;+9",O"ZLER)UZ,7<X==9'Q:C-?E9CE2\LR_5?T
M*_--H5/"?F9B(O&ER3T,F?OU;?DVZ_0&#5_\.IW)+TLUR_$5J#8.71NK/HDQ
MJ] TYDNV2O:IU-<Y]X&LUCQXS<7Y@_Y_?C;-).LHEZ8Y>";]-4KCKQK,-%A[
M^YGJ<.X.[CK0V@.+=CLY]8 )?1[%B[H&A"<\=!QSC20M_ [@XG=?\JX_:C=2
M,Y4VQA/"VLXRPGS>%D1&/&L]_S.,G^[6K&&#,6MV"EVK<ZJ/-2()W&])O4.M
M&I+KOI0_8?OHA=.NS!0VCCR%C<_*E< ZJ:[9E%X>#RZW"@JNN#SFWT.=5PB]
MJ<]O9_C7?YL8IQY!V,P![K3#/UG2!\6AVQ"D')6@,:%J/J>T!$U2*^!F!T,<
MF&I;&?0BT64*MA9,MFX>]=OVJG^'KRC^H]KWNR45\SZQ3-V>YS1?>!FZYRY*
MC)G51VQHI<*Y4#Q-3,4&AG8I?;V$'^G<8V\]"X[T$CGEPPYTMQGPZ"[%EN#9
M-='B:@;W*?WJ&6+<M\[U&];4V4@XTMI,-&>A63"QYNFZ_M.3? ER]Z:Y9>CU
MN[#)C5Z"QTW;U>QK*K@$TGUQ6::I$T\N[S4S+K-Q?S49:HG0RT=V0LIYHATO
M6/[<NW-2/1_;VMV[B[3:SCC<%?1XGHJ2,J@8LGLTZ*5I\%K*[-NRD,@M*W.
M8R\-U'.O \E[?E.'?QR.%%\ XC?"7Z$<P(8(I@D=DXSV@*8<ZH+^ZI1Y<SIW
M#![W!\ML$N8^]/M7>@FE8/MW4H=;,]T59A--(DB\PP<FGD/&]PFYB4ZDIW@P
ME=*ZV!T/<J.40!,;T.M?T&QZV;X/=@)$'Y[^LA\"\I%UU8@'A01%EGS![0ZF
M6QY3:_$-^M1#P#Z-/H7R^=?W>M/"3?HQZD.9=N72"6KSG)]/_^OL\OFK]X+7
MM^_Z3P6%*/)1?-SQ)#+7IC>]BN$MPT",8677.@:S@QR.*R)"Q/HJYOQPL[I3
M[N4T4>PI*XP\[Z.4:8H'2Z#_Z_D [:NU:0XH.VV!O&4IG;.\!-YBKJ6*?P8B
MHN#/X[SD&]-,W2)."G8]:DLYJP2-ITY1[.,04G:AF)WP#4GZR#E0;T_Y((^E
MP)AG=P2(B5TPP)"^FH5#AE"<7/<2ZS[G8_/B_>YUCZL]E;1Z/F<Q'L9AE$'O
M:.IJC5M=L/5>216_ W68C.SL-.%P+MC?+XB4$Y.+J-M64EQ-FYTZ)B+7\QFK
MJPS/._=:G_-'>.;;WV&DBLSGV&2P1M$]^L2E-CLM$P3Z#_1][7TX[_KT.],R
MQ!$$*C]ETJUMU-$AYR\53W*^*3$4Z<#V\9D.XE'FY[VF^^:<3@@K4Z^Z]S\B
M8-Q>A>'%]Y>SEW Z=HHM*B)N9I9O5@#*=)&C.4]"IN_5=-7N0MZ<)Q]2K2JL
MC"J^Z9CW=DDM'4%.K8PQY,=S<UWSW(,'F]C9SKPDA-DKD<;(I&(.-A%IJU<_
MKG3L.F-B2!T-N9>[18-32L9A@"T4E#.,0S^<EZ3 ?CL\L=92?/'@E9KIC8VP
MI[Y#V.U0^/.I[\"SO4W+&<]F(G/=Z:WG*$KU=L;G32E",T/-X63)*P2:^Y>V
M![:4]WWQW*ZK^M[D0<VWVH/[PU]MT0(HJ>-J/L7XN=^;OT(=7^-B(OI,:D0"
MFKDT<?,XEM+#JA^-8):E!R/U-B%'\(7:/!&4&F'Q?+*>WA57WWMUT-(%0T>$
MH)$HTR5TM*YR&N.IO>-$P*KZ^C(Z1; C([+?*?(EUT'Z\UV+@%T.C-#"M92;
M1#W"87EYFH;'G;+;23(9'FD:DU8:R_IG$A+^E;TH<Z;F7]DJ"(3MZ>*Y($'3
M'DT#N>>@]#FFQH:]@NYE1KZ_[(N:C.34NV?A&IK!ENFJ7]JM"C"W"FNL,5KO
M\YN9UUCQT1K223H.#!<B%28 ('[+6MFR!3G(LPW952O?O#1L2@N\5-<,)*;Y
M+&\5A9GS&*LUA)4:8)\XN)R%<OQ=\+DLB>5P6/4_$2?\/Q=@P=[8P3/"[U$?
MHKB2;X/EY485R/';31WQ;Q;YN[3^<0;[2"J#C?WB[473 ],LU>_!!<E'$ [?
MPX"21R-JU)A\L[IWOE.+?J.N[5$>:0-!V2J<K0+.;*ED\^(T26[U,_\\;K)W
M,N9-#CK&3XMJ=ADSY9C\*+>PS(?G#7/O[_A]5R2MMKMIE312[S5DESO%.LP;
M*^6LG\E>+;=*]0T0J+)-D1TME+VE#*<()4?Q')]K@R/(4DHQK)W9%QU60#N"
MQ'S_6<CS =E)!A;!@J7XU+%P1"07C &-#7"2I.-XS'_'8CO7C"K6]G:Z *0>
MU;ZJT96X-;+A<PQH^(.71.]:5VD245C)#^V5GFQ_DN.*ZA%$P->9<!Z,VXVQ
M/,W27.Y\@7T=BFLQ6RD?[7()K2WP#&ULG-C];M")GC%U-AIKWE0^@NA/JP[!
M'$>;G8TVU&Y(VS6V3(0.&?>N7D]:'3@D[6AB Q44+WJF148FO(ISF,F\_? 2
MM"=P=OGPU)^ $(.\1E \R&^> MF7$97Y&Z#!EAPVG*Z(>;SB0&7[.T+GYE).
MOIXD/E^A%U<V\^>=X_&=GJ/\RSWM066)]]F4QBU_X.C_VM:K^IGI:6HPT)R9
M8N<5$R.K*5<U7^.0<.EC5=<)Q<6OMUFJ3!A)7M\E/+J]@Q'%E_T)SD?OX[]?
MN!*WFE5D^,^JFJQ%S*7QDDNN*'%[*?;$M"#;"NBB=F1R) VIN"D=MS:U)ERG
M4.>_8K2YI?!)/U=D*?^R]VJ<]\R#I/^<4.C]5WQJ:)[<)\>74(&FP]/JX;I9
M"B4I\213Y<?N$J650TS$7F1W"]MY(_=:2I/TL\.YY@>1B!N&;P@7VQP^"CTN
M]<@Q_!*^\?4(PL[#4F#^[O3Y"((?(2F@Z:M5MAY9O7#.RN.MII%"AF*50B+I
M6"M_&%64#?>3<B=T?U',)8]'4#;SSKL(1TP,2L\X>E CG.=OQD:9?<YY-].$
M"AV]6-S^H%C5Q[5U+Q,.>R&IO7;7L9^*T)]&@)LD?Z.;1H^7A%B0E+8>7R[3
M@(/'Y&3-PLA[SZ!RX=>ZJ7T\+^@[L\%&.YIUCB8_]<L(6B#LE\WV03)!^R 3
M&E>"#R3?,+?I/KT'/XOH> \8)GT*G^6T0-KW,I&1%"%ER:M&NC2,60W%?: Q
M=Y_'T=5V-&<T6[GQGX$!LNP ^4+UB7,W+T1G4*/\4VG,'V'V>E=[[@,"D]N&
M(G'8V!HL<6N=Q,?BGF_L6I<>N4H3R5QM#PB,R<$F#3#?NT2)?Y6KM2--UIK;
MUGQOOC6J+]#[Y+_Z^R+-J;A9]%X8R,/9R'('9X 1^H=1S O5$3XD6;]A>LO>
M!^6 #-D,Q*TI\[/%V(GZ#U88+,6$P+-^<2TBL5&:3#.AP:*=I--T=<%,%?G'
MP8X^K7!NG7,/4AU#(AE*0@Y*"9.BKF67Q[NXJ\DZ"+F#2JES(H?)TG2)RR,5
M;-D/(M*4!40M*7I<6DA]]*?>*1L@>[IP71_*0UFX! BQWZIEN,GW*W?@LX)[
M)OJLL"]56_<BW 2F!Q%J%9/R\K/^KK[I\TD@]U[S,0W)C1J -:P45[@?,QR)
M63"/<0/;A?4"\MX$.X/QO5_G8_[I"7Q-/D$V!5"\;_]6FT["X5NNYF8.S![:
M.D? \M-%T3V&Q*6J1< BU=P*#-^'(9TIAT) ;_F5!@*PO?&#WNTVNSHUS% 1
ME4Z)DE_H#ZKV?F3"CQ7??,]DCPZ5H[[T:&\\Q32$NQT.P(# W-(J4Z_EP#D8
MXWP#+41F0C&*GZ4VD;MMV59LG^ESGQE/B7Q1&6-RZ17:VQ&T&]C]Q*L]BR2)
M1 7]E%(Z&RPAE!)4?)$I(79:->?.HRT32P\5%X.A6_AEH0U)Z:T!B\K/^*V&
MB8<U+!.>Y7AA\)E5A-=S'>ZTP2O&5N7.J6!--$TCG*TVI8;N/5R&["?!NF)D
MI])DE5,KLN^[(XG)OX2X,, "!LIATG$$3A8?D-M./X+$[HR(N;*4 :Y=:DD<
M?O/,5EAKM TXR12DA[Y5B[SZ=N3C6I\1L$D=/-.A%%LQ.2J*_K -2@>R>+;I
MYAOQ!XE,$T;3%Y@@VKO69=X)X79W'.2C#Y']O,??/'$K]P]4VVKWL_G4.SOT
M2JN,]V0L!AEA.N<+K4:?TCV#D@'9EK P^F(/\3<PDKX='3J(%U6/WV#%%M/_
MYET3K?@VHHO!KK7^9K_I1&B*1->XYEB'A%^Q,*RRSZ!$24Y2EZ3(75?RQND!
M(B[O<L7.;+[P/(?(M!H,"@H(WALUF;-*63,N"Q!.,9.]KIOWK(N3O-).U;W.
M%-/",;BA1KVO@WXDK?8W^C;DX3&<>8K5I\:C24/$VOO2QJE:7 9U[+_E370/
MR)01K\+0_]=Q^'])B,A;CIS_9TC4E/,MTX2_JM%0/OB*D62F.INKN)&] 9NC
MT8EC=CJ,3B\!C(X@[YWWXMH[)UDF /PN8)^$$UD(%&1=;L^BKU;+CT6O?ECP
M>:*,)DG6N@WL/\S<=P*&*Y[LU"T')4KS'J:.NJ4Y%ZR^O(%^O>*8IJZ(JUA;
M8JH]VLF$>T8-!-G^N<!GE3Q3F<YW@TZ ,E#2$\CD2P-?!\7GTJ"J;^@-^"_]
MM5K9N1<+YT7SY6Q?T:T4I$4N9[ Z4? C2'200L&F.A%"]/["Z$$W(@,9QQFP
M7'+A*W06A5AJ\L?C3C&4(-<W?B192UBC\A>!.R.@G/T;.Q]=3O#]PD%J\ARQ
MAWM6TA;0ODYRN%&#+/M*STXP4Y=MI'P$^!NH:*]0^\]M,!'D;*R4GIBS_' 5
M5EQG3J'4UAA&TW1WXPW3VA_/KMQ^_1),>_C-%< ()2(':SE*'M5=F:_YH%[,
MJ-_B#6!-E+Z0'R@2M\++D(JD'GI+@OU&Z*4E\]^J&O_8JR0(PCK. F X0UN7
M/+'8@2S=Y3R"C'B$A'2AQ3BMCB!DD^-[T)N.<)8)C'[^H/K!5UVXRJ&(.OE)
MY;7%?>=#_LG%G,,CR!P?;$'M('_4%<84J&\.HX(1;]XG;JT<9)FZP8?VWTY'
MKC/5/TT<(R[#5853:X76Y<<,9#/U+CULF,ZWF,O[+G U8\YDI^)@SALM@@8*
MT3UO"/)'D#REV<SIP2-(320=Q[8<?D!SXLXY@J3Y[]4<08!M'*B0M_G;5Y89
MTYS*H:#XO8SE</!J.<LD35/W)RX6'R@,9FZ;Q0A*;<;'8V]*);VA%!Y!O+(M
MNN"][LT#;;#G.QU%<A8#T.9X+W:S[E.5G0/*\'GV;YZT:PO;/,@"1C%:G^7@
M!^>E6E3]W+\S1;K_2::YHMR*]_"[W@\YT/X(<G*%Y3RIN-P)+N_K@>RDJ=>,
MR +NN'RA!%1$M:L<:^2/-8),\IOK'4_[Y5&TG/'=MIR>.7%2?2;1AG#Z>$W/
M$MVY8T+>KQ7_">0E$:ZOMS@_=,8E'4JJY\MTGA *HD,Y9D /<EY+281D/9,M
MK?M,[R(!D3@J#:VWL7]6@"SO<Z0\-",\322]RUP)57X[3ONW;++0]:[\%8:7
M(-ZW(J(2/Z>W@0S\_(,NQ&E<Y"?-OA3":7O]54/$M_5/8><9XRF3G*0*/ZXK
MU%?+LL+&IFI#3-][2 ]2L2!@EOB0CCN)1/P%I,>KOF=AM?\">E,QWJ)2,2Y1
M6S3C,2Q6WM]C"?7/35% @]'ZN8QP,J3(R#@D&Z/9>L4L.#C[U?R'BLMS68%V
M<_[=COL*6J&?QV-E+6)E;9:%K3%FUV*U'B59IOQYJD*X]XJ4,/67/>SS))EJ
M^?]3/:C^-\71S'\ 4$L#!!0    ( -8[95K(#"=86)0# /D(!  2    :6UG
M,3@Q,#$R,C0W7S<N:G!G[+P'5)-;NRX:144%19HT(8KT*M($@2Q%0$! .H22
MA4@7$ 0)$)*U1'I;(D5!B'0I(=*5%B !% 2D"RB0("#]"R5$2+E9^YZS]]G_
M_^]S][[[W#'V/6=]C#D&7[[Y/7.^[7G?%^8(\PMS'G3.Q-#8$'3DZ!'0KZP?
M$',&I \Z\I^\_@3YSV(<87: N$\>=3SVA.V(..@H]Q$V[B-, @@, ATY_G]/
M /VWZ\A1MF/'3["?/'6:@S6AX1SHZ!$VMJ/'V(X?/W:,]32*]1QTC/LXSR65
M&R=X+=W8Q8/XKO[^K.#DY9LUG?Q6PX"$ZKW@)Z=.GQ<0%!*6E)*6D9534]?0
MO*:EK7_+P-#HMK&)M8VMG;V#(]3]OH>GE[>/[Z.0T,=A\/"(Z*<QL7'Q"8GI
MSS,RL[)?O,PI+"HN*2U[4UY16U??T-CT[GUS%Y[0W=/[X6/?R.C8^,3DEZEI
M(FGA^^+2\H^55?+VSNX>99_Z\^!/N8Z V/Y9]'\H%S=+KJ/'CK$=8_]3KB-'
MP_Z<P'WL^"65$SPW+-G=@GC%K_Y^DN_FLX*:SE.75:T _GO!PZ?/2Z@1)<E_
MBO9/DOW[!'OR_TJR?Q;L7^2:!G&R'6$9CXT;! $Q&#*%B:!_]\ NBS XW,E8
MTHD\LC1QKF/C,@':F#;OR!"!PID@YY'Z_I5U?YI!Y9JK+-GU]T"Q^L8!7E^-
M'!=LC)VIO&E9ULCUI)7-\T>N&0L ]]JQRL3PA8<9-=8]AG&-YI:E;[0Q-S>D
M92-][0(F:\TD_0-#<$-<0NWH]V$QKI>#!.)^HF*OY<LB5!-*?NOUI*8JQ7%U
M5>L2WTP2K/"_%N&UOI?%X?MJ"VOX@]1*H,5R)M?@H]]?,4&?GR0R0;H'\DWT
M.TQ0>3;#D0G:'_X91K-A@AA5*$8(C@F27CXX9PE;QAF 5[WH=W#;0TQ0>S1#
M#L4$V4&8(&T8$_1\AWY2!KLS5YBVI\HHA?WT8H+F;C!!_*S'E6 F*$^9"?KX
MD_&4S_[GUK#1P4LFR%J95L<$;;UF@A+13-!X&A,TF,T$?:<Q03=/R]/V?Q3]
M#[OYC.JV8()6>YF@95,F:!N)*CC.SXC<M624HL;ZF2 %)NCP!X14Q@3MN3-!
M.R5,T$\(Y+])M=[*#:R1N C?H LWJ('S,"'$C4E%M970R#:13C'!"9I])71%
M8U\CZ]%JF/#C:'=4^-F\,XOTE.*FVIN-PU]GIW_9KFJZ4E3^,.375R4OWW3[
M+BJ(&RMMM$)-ET+<(#ZERN"$HN@.*D=\#XG,:P-0G:7C,X.NY>P)^]],.:TG
M-HAQK,^U?.HA+[510-^WA'7E8P^5&2,,\$BH;J0K/8^A[9TCEE#FNGHP6%=)
MDR S<HM7A,US_167BLI7(U*6XXAU;T>K%(@YFQ3*IC<&XU^8%;Z8*O.M-V8,
M_U1VS&QTP,U2VI,8DYP>E9NJ.)47CMZ0& PVR2CW@A@E#\E4NO*4&^9[];ZH
M.FXRMJ#D:)ZAXBIJE7G;T'6]Y!BII"CLOVM)C@D:&SIXB5IDF2)*S.N_N.EI
M9YNZTA*-YV]1BYF@,ZT('&?)']U@@AT0%I_=D6ZB;O\YV8>T4,;%U1KME&IV
MH7#U>&Q%6MG"AN_GU!.E.J)"L&RUY/?W%Y2<Q1&U3MTSYS<DQW7M;4+OX7Q2
MK[/MH:JI[(F=]$<<1J)/#R;C0]\R0= .$E\^6"B.,BN&GR'ZO?DX3+!:*K(U
M='Z>F8?[[RK$_8L&+^#(UDS000W+$4>8(!H:_>.& 2J?SH<J1^]=98+Z(8P#
M+FHY$T1W8#U=03$LAG8O%N*&D(F0?\%@_R]NA']G_,FP5H*L>C!!62CZ+O@?
MJ$4& MQ&I>A!@*$->R+7T\9V\?$E@)W0)M_S&(J+V50N0]^*O@OL1X=N"?HT
MCV?EJ7X,]"KOUHQ+27*9EN =\(K2X6U]YF_+P%8NU3UH#+>3=2NQ4\\H-ZR7
MDWGGRI-!W+K1YUQK52;I(2OO..>DO(DKZDUU#!MA_TTNJ)%-G !\<Q:+3"5^
M'94AN)<O!>$]KRE(N;S0C/GD%M-!?W3&_GC.?(5A%7#-N*>JTC($6EQA(U.(
MN\@$S1?@Q/3$J=:]4 &\Q2EXG"70DZ6CZ4%R.OQV=C,*8MV.OMLZ5O7ZM[D9
M4]&!5KLBBY>4&37%RV9"X> ^6U@?S8(L( ^T/*U!..:ZJ< /U%0$G44YSY\:
M34'8*0MI"JO12^S*ATN+A#/E;-&:"K+]6?Q2"Z=09D VQ\(UG';1\U\K+?%C
MY28-$2\2:8-YPFKBKY8_<B&# RR3+XFX6MEGW"N1//AI@%*  .\95YB@87MJ
M)A,4,YD(^>EC1%-")4-V;1F2*&(H*8T!M=\>HEEP<:&&C^>AB,ML3-"G?-SH
MZ!X31,W^.LI(U&%GG"-!?@;1+2QA_5Q_^[(E$\2!7N"B\Z,28%07>!'+TADH
M @#LT\\Y3C+$'D)H']?HNEQ_0?T%]1?4_PAEQP0EZ(0=&L U[[I(=S.N4D>)
M+K8;A6UFJH1\<?)@W!O=5QOB-QXW0O,6,?U.=X"^9^;B*K>';[_Y7G2D'IGK
MJ/!CG*"/;V7 (WA*3N\MY+A)&B:O[1P*VE:\#>!;=)JRI5B^*ER-E-V6[E=R
M0(*6N%_)FB9L?QE_4R87,LM3FW=[=)&2_E04Z2/S")_7K2X&WW%Z"3M %>*R
MP%1G)D@0]:.29L($=:UU@VGU10P!2 _XSSJ!!P<TDXV8($5Y,#5?3(P)*N30
M9H+P@^Q,T$M=5!F+_ GM2^A=RWD($,?-RG5IJQ&)# <4\1'-C3472Y9G:1#+
MA]H>2?M'JTC'Q>%^/!G$ 3N_,T%+%K"5'ZB_X/Z"^]\3[C$3Y+DU;4K:C]-3
MHDKU[??,2I UGI$">;QGA<=V<;Q^VEGO P"_G)3J5\^[#F+&=J#]?FKDK_).
M'Q+[THTD@JN2RPXDL#_0[*UN'VEN'^L41N7[5:8,'A2)6AQ/[5CPM:HFK0U3
MJ!%C07SA;G9Y#K+=Y3?S3$)E/YJ<5>)%+UT(ZJ!NLO>Z77G1Z@H6L1")R[K,
M%8_O"1FU65Y?[0JI<+V;(4$:M<KP$)+*^UG$DRB#G4Q+."U3^-O_Z@')PE$5
M)VEY@7A6(:F).XU:_4"M@:6&'@HQ0<>;6;4MALJJ=#WWB19T1_!Y>?(@SND#
MJU2U_HT)PG(P02;/F*!K*).MG[=QYYF@]2H":E6)C]6,[UDLORU,E '][:CN
M[P1S(R_2KHY7JV_%,K3)V?B-X"WS[-LM$PAN4E1@5T[#Q/.@1S[A>B^#WOS0
MG!!X[C/JZN#PK=]#8L!?<B"S>(O7U)^C3,1 UE#5_&IBAFOJ5>/2%K5-]*<?
M7>XJ<$ZS"Y[L_/&=]X =VRO4*LF(=P_,3B>HE1FV"=W$R!9/6STMDM? EM.Y
MF*!.0YVPA9]Z:HQ>&.=K:@R9W13@ZD:?@.OCYWAHT@7PY6[HB:2%O,O=2(51
M&H0D;\'KZ#W=D Q]-Z'F=#B@07'J5-B!.IOR&C?$8Y7HA2P=@:=X^BFY &K=
M$4#/;^*(@6#J/@QPQ:+(P:@$I *N#K"(Q4+-W EZ8I]U)*MGU[*@Z^E4B&G[
MNX:QAOZXECC7]MOIAK4)]])(:=.7*0NY"\O=7%-;)&O$U;0N#  V!S#9E*O4
M[H8&LLVL,/E,?OL.$^0-YO21UD^E36$JG.A)#GY7-E3>M70DOM739$S/RE,+
M#NU_S#6@GNHH^@%;A';AW,XF;:ZX:O5RA),/7SM/?>P4<5R=;U1'1:K$#?-[
MZ(D"GS.IK^:FFH(=JC8N:J;M7'-N 9MD\;P*!S:SN,XO%;C<S.UI[G.P=U7S
M13+D%)M"K=!R#_-&%U'?VB_")XE@;J_\RY[O^EX&"HT.M9H"(T(NSG-/UY;"
MVY0YWM+4K3E(_$KG>\A2E@-=7YJIJVK>UOEB[;8YK1X.GEK^9:9K8Q!71"@3
M=&R0>KW*!R:,X'[-^)2O0#7@>D+C0E4AY.@E6(:V$[P''"\F,:SHUARIS$U3
M$Y,:6P(&8LL@+V(#J89_./]H/"CI0''XL=VN:P6VOC!!%"VJ!=FH WTB@(7]
MQ8N$3E$#"ZU4:A*4T]HUJ7/L^$C_\TN+ ?>3H(  WHRKNSF@DL0$L>NT.T/]
M:0<>,>L']V9\SY76>_HH(?6I^,, VFEJ#9@ X\.M&\R+*B_8$["<?L(G:LCZ
M5M1G)&7>E8/')1B?JRN\\!9]:F08\5"4S9SL\N1VTX'A>_XA2EX^)C 0I;[X
MM?QB=@L IO'UXZ%<,1"O%F51QB=A,,$"S!C0/AX7VRX"_T&S(2O'JAV*0LQ'
MUT.N1WZD<7F]]M56WVQ54[S:-Z4>9;5LI1&1.%3AT]@HM>IGV+OZGM1U#<8K
M5_<J(/]23XFL@LZ"W!_E%\;[2K0S7TDLR %/A1^EGK!$$@[0K![C1XD]04'/
M0TZ'*_N[%M(E.47["_)DP0L/QTT.WIZ7KJH<&9XO-51_D/79GR_]M.? J^-'
M"?-P:XV!1]KJWAX.6#[@79]?/'@&7=?[E'&6,:3-3N-C@H@7F*#37N347"#[
MQM@>%^^J)OH<XD:)*^TNU:D*'M83,1>C)SK+P1$N#L0LQ10J%92YPOM_.5/A
M)Z#]-;O.85KCI4> GBE5$L!1KI&-U@L.C9$32 B5#=N8!NPLW+=#GJ-&$><2
M\U4T&\4$QS<88BOY8.!X;\+F'L>UK1"6 804FB<3-W>-:9;GLRDO'W!.GG-R
M^+C8+LP$/4GJ+J'YTLO:+U'3Y@.R65:.@S7HQ;B_AB\3/>;2U,\H;4_TFP\7
M?U8DU9&7T,2:A_=RS7 3I+9M'4WWT,MSTT,>X64#I579>OYAA_>IR#G*(WHA
MQ)/E+#3>.B LIOT:[>X(XZ+WHRGXYJ%E$S6T9$4;^YNZ?""'?MFJV(7((=Z\
M]F.I[!/5H0.2_:O!0_2\I/NQ_FZ_?^);->[E%7Z1,^5BLE>^$"Y0%Z.CHP+4
M!YTJ+S>L-#_75%<O,Y2=Q3[HZ:H(5W=2[+LR%O2*(ZWOFGP< MD'MXA]%,A1
ME(JYL* R> VO"J2IV))U^*W/Q/?57'O@><."-_;3SNTQQG0>8C0AF$IJ;\KI
MW]7O 1]%S>>WGVRCI]%@H8<Z\!W;M_3Z2T# 2^(6B)5.9\C^37%($:,*-$>>
M/6'4MV9U#LA<._@4ACI'T_HUI#+MG$'AK,-*4]C$L/?^;<I!]G6@GW&J&T#;
MT#&X!V#V63BJFV4VU*'VRBSG.$T$*,1WGV\7&Z<%5B*L@)BAY%85HA-.V&45
MJN^P<O# +COGED"3=OO+((5TG^SFGMH$_S=&;Q J"]B94)I?&1)_@*+)JXT:
MK7NJF:6SMG<OD(O@.;RI)S*494$UP*"(W*RF?H_7&\4K:%XUU&QYGV=M! .9
M+X%6@>LM>K>2!7 G6B%8Q#5ZL8XJ$74:84A5Q,)SG-;\!E2[\D^_!3RB]1=.
MMFKYDL(5"\?OOS(E9C=$F@5O?L3DD&:'K&.B++1BA"I"@_1&X+[D@&K5:>C#
M3[*'QRURFK^7Z[39N([PE'XM.9Q^6^FCB$Y &=[IC]_.F9K5[[SR\>J@!I$S
M5/"^JPA>@O+>#M*9O'K!!:;A8,Z;_JD6@>WQ_6D0?I]*PVD4<9X0]KM,I/5?
MML;;'QA18NDQ>@)4\U[*;6J"=,>&$P7YGOK\T(C*-=_;;?&[)IH_0$_6P;0$
M7N30GB-J<8>\E]KV!B8]4^]R]$ ^[NW8@[*$T"0WT>KLR#*U)M<6OT,I1J>8
M/+VR71'9G0/IV!+QUI/_W'I<.LD?J:#<K7S>V8@X8&WWF::*^?*#(00,+&'>
M.,PY^ A;)-57?FB ": >.+NL4J:ST&&EIF4E)8N]BVF)*%](M"4\>GZB"'"G
MW $".]ODB;!N92Z$Y=@GI,XD+7P!*_0-'F9=.Z9(TPHB"Q":;_I.P^*DSSD'
MCL[B[9^(3-:T/Y'ICG9R.6B*98+FBWC@*,HTF0G:2&%Q2)324"I"VH\82+6'
M >B&=R,3HUWMG$"?*\O\+DS02>>>O5S&N=VV2!35T)_](-+I5-S4TYWTSJ7M
MX@U[@2%.)24;^XE,(053@E66<-ZMFG=IWD6FTR5RXVN]Z<.5EGT?7T!XD2E4
M\TME5M4WB(2W0MGQ>J)NU[+JWYU%&#W!=,"1IX>N.(>]NE]+@#MVHKXTU#@>
M?*BX=^7K]<Y6E63&<"CYYWEKB[.KDW$38#:&.()]!#6?T:X[T6IZJ,5U'FZ-
MQPGO0LY0]SO10!/"O0"<(*;C(D^,!L?W$B*BDG/03X^8Z1O=F*<+R^YZ,+J4
MI <KP^J K:Y\H0D='U+:&>IU_,2<_R3-$<NRQ^?U_7C&9)7?=$I[=JE3>,IV
M&3HR])C33,S<.T!^@VMJE-(/#'6!?V=<I^<C96C'A]NU$:ID=*H:$Q1?LQ*&
MU)I ' ]U(T4*ZNB>C.RG@V^/;ZJ[*.">[IYZ;AY3_WK6O,@/I5=4MAH\;4"$
MU4GWN( I4=1O\ZCDB*'?<41W@WD_C+[U6Z"2^@3"B0^MLBB&K4R[T*:K\L%D
MV;3#\]L4W7L3U^KG5+;6_06=;\83Z0I*8NW<2[4IPL_SH'LJ@@$/C.ICD+[R
MZ=RV\A /=:NK*<;F:AF%*]7A7:^BT"2QBT%A)ZDQIC]V?N\EZQED+X:#3WGH
M@'O!4U^%=+#7B-(Q).&:@4<*CR_+$A]<)5UH;S1-P"]L.XO9I@V5Q/:XU56,
M]-=^[=?J'M)@O)"DAI.XSLW2?J'_)M*AIV;Q6X3]>C01<H(*(^5CYA6#P2=0
M77.?.9^W8WQ(E6U7P5Q^VIB.280*B2<G:K?<CZ1\TM>N?W'N1BA_TW?<NLNA
M&N+H))*-,0'AQOD$QHE=G@S%3>TXUV<MF(T@3+'P2->:M"Y*3FP1R>*48B.Z
MZHO/&;V&\%*]Z#<NJW;[ M 07C.-[+"R;[VB([3#UZC.6S@?19&%=8A0=;L$
MS60"H<IJ9WB8H!X!%'L@0XI:;7'$XL](;&YN 13;,]7VA?GS<P.+74V+O?>-
MB1_=AA=C^ZT;1Z:=KF'6/C? J#*/L_7B#N__$&;OR(6=_8*<% CR#>[F(AP)
MSC\V7DV[IH;F]56\@#Q1"^,W(XGZ^AL1:E$?&B<F(Y(;M]O(UJ'2F::* U?&
M5H?+&B^OJE?8X2<IUBD1H2N]Y[^67+/(;^ 8RXTA*GN2L+(R0P=L.N2Z#C'U
MP6TQZ4&K3'-6!Q!?B0]7/DLN.S44'TR#G5ZBR>;>HVF6Z)^)[5>]P]9/=4_T
M^=Q_=54HST0K]JSC@(+_;>M.-SG2%;%1H)+8M&Z\P#7E1TFA8V@6AUK4]%X\
M^FR[ CSR#M"$C^(B+:<HA7+H7CW$XSCJK]%$-1.W&J[;M RK*XO!:P_MQVA&
MH84#)*<S/*L.]1W;CE"?K76]*U1>5@&Y!QALK:-(A]BIA=X<3-Q& 5=TR! 7
MG)UQ?B[)O_4Z,*UK0W5>;9?*M4VS8X*>8F$3[BW4.&(_6XDS_(GB^>U>LY;V
MQB2C9J.F,9QR*^^A+20:YSZ7#*M]"(BORI.]>K6YDF=ZRP@]P_5'"GV11\92
M7^@HJ7$\JQ I!>0,**,D4<@'X5S(E)3&[P'7TT21,]@%E^L4\"BK.G(LS8&X
MJQ0^R&;P\L*1ES72@H!91"VJ2]&/16GQ[V%Q;W+UJ2^Z0CVC1I(N9KOP=GB>
MK<?8"[]I-1=7:72S1=4:L7%50O930Z634TJ4%ZY_'$,.FELLU,X)Z%S /^R!
M73#B@L-@\>4 Y+A[33"!JOML(J/U5C>\+@T1>C- 1_PM;P>1IM)=\<Z94^"@
MR0!_1E^Z1&&&/19O>6C$,HC1H2H4.0-NT.Q@@LY#<4E%U-#7/R+F.N:>NHI3
MXR+G;<B+3% B3=%MX?SG@%:/DHQ)$VJ HO6=$<QB8];R7<9@ZW.'<45U^]'J
M3MHNO4%/E!I)3.OA8/$@:MXK!>7E^;Q3##S.:O[:KY!M]*XWUI#/+ Y694_.
M<I!;M:MKF*!37M%*EYKJ&VLF)%M,8\?7&_J-U]?OUVL\BYA,0/GC8M#<[==I
M#ZDMY$>4NT O(8]]00)RMKV?J*A/DJHLI.9V:**Y=%3*X+XB6 Z:Q>=69:]J
MQ^KV+(XP3&>93X3%- VC-^)3&HO7U+MQ^"MR0IN5;/P7-MBZ(^)BJA!GB%OL
M<'-\YRPWP"K3PTA"(1M7)\(W-Y4:(-RPZ2F7->V\C?%.1Z6<P4&)NH::N/6M
M4-%%.H4JIY6A$B(=3QDI!6PNNXP1#$9CQ:]%F/AF:L,3#(/S KU73>"1Y4;Y
M^5)WL^M@LJ0P;JK("_BC;BW8"=/8*R\7E?G@1> NF]J <]V?!W?,S_:2T\Y-
M]BWF+VM-GI@/>JG'H4!$KWM_?Z=3EB(_C(WM5FBY-M]ZUN/W_ "&:6&B_#=(
M^LU$F=='_\'@^IQ&E0RDH<LZT@[+F:"#TO9+DQ056"^$QM/$L!B=-Z*/,4%T
M:]BYM4-![" <QS"T@:R?R&84W[.@+% >H#XFDW"'UX6V&#6TD_Q4+2;HN"P3
M]#QZA-7MY\ ?,4$62%GLK#:-5?,_R6""/G:NH"AF.JQI93B^23)JE(-Q9P-V
M*%L+Z1=$8<3863,><1WR+8'SV'96$V6PVQF,#__3/U'0A>A_("#$K6,T >K<
MH>FLMS LH=5I7G#Y,XW7!^.4U'(&?-=%HV<IRF)]0#Q:?>Q@-O=8MLI/S;<^
ME&Q*H_W=%).UL&7U*+=#3>2PMF:7OW(OFJO]$MSSL =R&BFY,N1%TKU\Y[VI
MOVL7L:KZP?WV$:A3DLRTZ8SQ0E,S.*#F7<*&VN',]2_2M2I?D>AY1N"S^XB@
M)[W+7Y(UCJ;W/_JD9Y_K_G"[>[[6_%*WA^ G/?U7]][<3)4*+OGMTZK;FEP-
MWAYNPNI4;NA =/1,4P"M6#?\.# 5*O?N9:N=B[W0$_QXR@5#B$)1:H&]2J=E
MN5Q&85E"EV&5EBC4MS[\C1;$KU_>FN9*'3IT6F6<HJJ2Z/KXG#9*T\* WHX)
M^3K<W70TM.TTKT>YXQP4TY.8<U] #-PPNA40ZM0OA/' M:!-:B[?/7/VH^[V
M*,6,GHNP(+/W@(_0+I-Y21DPP5;YHJ_.I>58*-R9RF$S7H7Q7VJKJ6NH>YOD
M[.XE^0GV(-;TRYTKF$]9V=I_-&2@3Z 2875#^#.!'0PE*AL1G"@@I@(,I:XC
M3*,J:5;C:C)%:/R5+ZN/<[*CUQ5:54)#[_VQVG/ N;K_.'CU\2F?P_>;Q[9[
MH@8@?EQ3_5T,77)V+^PH38]:H-D#.^^C:3>\PI!N 3X Y],J5KF=NJ/>3)FY
MHQY5JYK[#V_JS'@*</^<:*SQL?S6MW8P=^;>.S"OW#C-G%3-OZ!WT9'A)"8^
M^*BU-WXG8G1>\/X7G%\LL:HK"\SE)$"H?W3B]5*):X,Z'6V2B7+CO.-.=FP0
MNU1</DI40&M]")[,(I5D_?I0T+F2[23Y0LVNEN_2.Y_Q<O-86^O3[]]#RTZA
M&LQ#QHVM@HDT\*$FXGPM':TVQ"I/!6BF9.E;Z7,]PG.QB!N%< ,=793BV(1V
M=5&1X\JTFOVT>[=[%"7I1E#8FU7AO*7\8:<ASKM&$L#M_.YYW%3E?!,>-HTF
M9L>I&R-ND-DZY[AI I#$]@LKTXQ<8HI=YQY;B>_(G"/M9AUN]'7]6/V+W<IP
M=5VQ*'FSQF8S3Q<]D5S;V!Z_%G3V7MHT+SZB:;W '=#SX^*Q6'BVL(8[[PL=
MHQS<HT;X^;7![,8]O#='K?U-3']*M">XL@_/-W%Z!H7<%#?]P1"G5]-$@UA<
M&D1-*X0'$NJF$!<!CZ88FFG9:GG)EV^P_J!2%^_IDIZGE)S\$G["XXGL.A>?
MY;M16M6;XJD<\55%C_.TKR*V.JN:Z#;5;W543D]I@#MI,[RIF+C>>X\X#;WL
M-?-%TE8\U=HPSDHJ\\&9%D).ITQ/OAGML4Z52I:W"[;J%\TF3R@NV^1?U@PA
M[\'GV$VYS*O%LLYG\0C*A<(#'!RW;S8<3^C5SK@$#6TK?J-E]:I\M,[EQ.\
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MM!+_F<'5/T25\:+Q#FY1NEJ [%0=;A+]<A>,1T>RR(P8#4[ ;('Q2'%@;55
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M*UD$OHJ:YV&"6+<Y-G:!E,$T%M&[L.B;#8.B;H#_-6"4%RM!W."# /X0ANE
M%'&]@@D::D93C^'Z!Z*6,OES_W;'?POGB$=]-N"BB;"R8_H.#![YEP;^%VO
M/IGF.\:0I_K='*'Y 97F<=VU5(AU%*P'QJG7[T>O(TMWHMS>Q]D-(P2JG$V/
M>C,@HQQX+-Q0?LK^%EFCH$PSNN'EKA_JG $)S151]C_514,C6#2F")KG:''*
M505)%QY]6F[[-%N!J.38$[24G&,KV\?O\[&G1#ACM8<W34GUN)- #"8NYHXK
M3ZAX6[X\!]P>/YY<I&U;OF-HL_S1ZDK&FXD89PUQ@8*$(B<NJQ)9QCTDG@D2
MI%F2*V_[<46_=5V!G:KGFM:D-)*7"6GQC,O -TH^0RJZ%]R@W(L2@*L2[9_4
MIR![1K9U/9=ODKGB$# R&T%  \!%U[?D27=-4';@N:YC]X&R5?][T%EJ<(^6
M>&W+L (I:VF5XK#A];8IU:E_[66@<O7WVR[\FX%*2SFKJX]/."6]+,GW"K__
M6 /UK\+9K^7:X!6A++UV^3.<>J=3H T574F$$:Q33IO/Y*M*$I_,841JJ+.[
MI$G&)6/KLM-^F>_#+Z@\<]_60;-G+]2,/[IC!SX3@Q\C])ZQ/A5CV>7F3909
M[?S5PXE_S^1TIJ#)W2SQ-FC#LEV#R4CH9<'_1\>>S/Y;ST;K_U=SS;^"\W\_
M#8P!L"]?&V?\9DQCOV\\(0DYL943 GI3]RRQ-_T-U<M-+#R$__ _D)B)Q+::
MY]VJ)JJUO/NHW%;XC<\2^L>_MR;ZCPXW:K1S](W1V4U;'I/OO7XG'O\</7?[
M6')FRB_?+H-N7SA[&WML;(_N9)>9O[E]+^9E^JRF]\;",:"<YX\R[WG5S6#M
M&HF<=3TI\XT*'PHA[YE#^.IU]G?O<C0O?TVZSY[ZFWVN_;B' ]0& *I))7:%
MP4N^FRHMELF!C8D;E1K?<FL-:Q)K_7WW=C<8;@9\]E4.E@9\($L#) H^Q#B=
M>7B2ID>.2Z2QL2JN5/24F )@E! Z=Q)>9,QJ23W(J:S^4)G@*CRN5.\2:'[X
M.!N@[)NU'9XO\7CD3VG3WM[L6>[;P2AY-<$7HV2',8X-AIDFU7(;UF6R]?D)
M#7S3]JL?\DQ"1D+E;N9$2&OUR+;WOZRDI7T6EA]H/T=SI8:1E_\\2R%/DR%S
MT21=061[2A/E!(Y5_7NC AGX277(F54<69XL];)HS0[G,5$?9=A/US1OVF$,
M4'(#M4>\I;-'?"6%#*V2"Q=DFH0,C<L-C:=ZC*=*<WQ*J_.3B\?2,Z!!/FJC
M9FKCHV;>H]#2>F^9PD3]TS)85L7C#9O6[\#5F:< 6\[DI5Q2GOD0R:L;=Q(A
M_-FZ*TO8EMY=ED#S\<>XK&0?-/LV3R1<$#Y3K\V_,J94M8@;N^?9Y.2B!+3\
M##UI4IQQ24#6U("_9>0 \>QJAIN K+H@9F;*96;'ZS/+ 8QO& 3KJ;!ZB]\8
MHE,^S6@"EPC<J*,YH ;C" ^\/:;C3C(3P9^'8N,;9#8]1^M%-;:<VFJ>'$)Q
MB8.;3HI*$\:!U44-[^$7G_V:@74Q'Y"8?AQ6UY@Z,[77,'[H;&_ON[HZ:3\.
M\ZO._L%:[%(,G^4OO)VACWS7)!L($]NR7[&<:2)'KR^>A)"NZ=A7PS5[5&%]
M.785Q$T';I_'#X6#CT@)_7;D3JZA^Q^_MI]^JQBKIV4]8TZ9U-A721>;]2Z[
MJ1V;,#Z6^NI)45LP"<@@VY2<,G@TM6U3N_2TV7'+DR$S.Q!>/.*C_E.O=UR]
M%UY$B#.Q]/*JGS/)S3$$)7E_.8>M!T9J%MF.5IQ8XKQ25H,],;GDLX>Q_)IN
M1X$;HEH"EHZ!?WDF(]9A/^0A"(57F5+*3?@*!N<IK]ZG)V;#-Z>GIJ2+O#Z1
MS^I5LQ_GOVG.'\2OF_.F/N-BX:*6P6[N_CVT@=2HE7%&0*#2UH6/H8_4\?G;
M'X;2/(X1?UFO (G&V!4F'LKTJ)BH)";;]<E*M/'4&BWS9)1)R_99/1_O,^LS
MV_=OG/O$<HO[,7SVJ@L6@O!'Q.7H5L<%5J[WA7QA< .:L:%;@O RNT-)1@$]
MFSC$N1(6,='TAAYMVM VMH7L+G5T<:8_-Z]MP;W?;LTU=4J*2Y7VT1@Q;IPV
MEGP\,RR1A6FJ/9;K(S$3\%'1*?!^MMU@3B)MF F*ZV01JS;D!PFRPX,(88*6
M/6 EXR4FZF]FID<J37-H[2.O"@;\7+]^=)VT;YRT_R:@;>LS,VU=;I%#:P4R
ME/_YB4M7HDQ5_#\= )=?;M.G9 !2N8?F/U"UB .OQ!F2!@Y(1*6<A[;:"9O"
M5724V>/W CG58P:+IZ?]C+$-E)1P;6@O<25DJ^;G58V*IK/^V3],RF_>75Q*
M<AZV3CGHGAUQ-?\4G%P4<']2S2;SH'N=+FAI$"P /H<X[K/@QQ7;A-0$8K $
M?^M;SPG-7K\IZ9@6Z2_X&^&?683Y*\<KZ,A+KJXUY4C8:PA,;/LV4G@<)"CV
M06HDT_!,'K/9CRU2WS+7LS9^*E49:]8&]&U^$T#I8PL394%_TI3MC*[A0>?^
MU#>S(PN7+JS_JLV>O*0I]JG85D[.0W!023790Z HF17CZZ-FD)=W7ZU\-'^U
M:!XT;L(3E!XU5C@*DXKTBE-?G,"\N%TINO'.4EOYZT.X8]&Q=/YXO*RT^\-3
MQX17Y'MT1%2-L$[BZ<<)]E?:KU=T[/P6U=01MWH\4A=AYQ,;*R @8VU7=LVP
MZC).[GF&LWUZAD? QQ),-1-D]J%F7(5Z<JSJ9\5(N1PO>N>=(8\U:C;H53BF
M]7F$ZX=J_6[7BU%2?(WU'@)-<LY:1UKC@VT^UI/;OESM??5[0^ZQWUVBX$W)
M+FB"0**QN$2# <7:C_.%6'1(<N2V\=;OVX@;R95/^DODKCXLAU;)&/I,W[5*
M7I8UV,U6U#)0KPANKC-&6V9;QB!,K.V3+ZY>VWUNKF+\T]6X86(B0N-1>K_"
MYLC Y?[+K^K35:_7["D0GE-S4A/E=S1F_!MG C::'L\]GL6@K=)-/CHJ\CA)
M?F%%P"__GV3 14]#SN2^ON"JXLJCVN<,3UX>$_;G\W\K5D0$<YO"YZ:R1\*?
MRYUOR$L;DNMY#R^66/QN>WR\G6P;19@7WEKK5),5UO4R]9#@1?D)=?;V*WSD
MY2JPOY@Z_ZP7NM],!\>2,X/@0H;UKY;CRM>+M*[WV7RU>5T\B^F=39FMEM-L
M,<.]')"YF0+OR[%,<=BYAN%)?YR9?6OW\?1^8XYXH@RV0.?S/_KJA?_D8",@
M)5$?'H\R.J^@5CSHX1L1 @3LS[/3J"]27'0%'%876]_/!'U]RP3M;2 ?S%Y7
M-OAYG,_2)?J?@ICVE EZDHKZ.(;J5(*L?]_CHE]'7,%.-F\KQ\\=8? AH&3[
MKBUAV@V@D!I-8(*.TTREDQC"OEY0\ODLA#I)]OZHYW/+\Q%*V#('/Y'BX=WE
M0ZDVOPJ'Z <M_G$O-5\.QU0*JQ=9^9K+\;M[%W];-GF8FM+ME&-R\*-Z)- H
M5?Q5Q<C#)./WUIG?-KQMG\Y^;+.!0@/=M^>L@.5N;.H<8 V;%B'>0M7W]J)B
MYC@8%^ <\W,$$1@[39/<7E3L..<G7T"U]\SC"[LZZ^ ]"Q[;5-<U7^O."<@L
MFT'S]:OC*,F'F'03VN 8S@<UK3WC"( W)($6$FS#.@RH)*#K&W!/U%!""!MZ
M82M_%+#5\UBQVE1Q_ZDBSB-)4<&O6>?RG?0C&C72\>IMTG?JI#Y$H2WS![>Y
M5MEN42\!.#SZ/,V//&D(O*NCEI-Y;P[KJ"^ ^5$/J$^^KQY(Q_U:USB\;I@4
M5FE!_'8-JN_F&;M@,J(04'WGTN;RN\>/ U^4LE1_#]GU'(ZV)/]&1X=<#SSG
M&[&(39!J&:79D[GN--9/*.Q=VTN*S!,P&6V%^17#([A1/,:2L='NI2O[YT[4
MOFO(^CC[K4U8*%98; -Z-8.?4U<=[&%V^+FLWZ7%IG3FU7L/H4'K$8W,Z_4+
MO?:GH-#1G.0\:-USRG/7]=(28^5@OV\IH\DVH6')&\C 3S!!1T0DM7*!BRH7
ME^@/\4N;EB;.)AS*PJA%/;BS.KSS,-'59M<4*4P)U8C D$XR'0O(V32[R<4>
ME=29[N-#5#SOKVR6N&^K/>MJZK@>*F9!VNI)F\XE@;L@4V$+4?L$7,K"/./E
MH8H#%;N0B5WO)9MVH;G:KWJ[JC:2P4GUQNU7J+U=VX3IN 2DF.];>,#4';!G
M#? ])_4YR=1S J%^_7P+?:Z6_J+]Q,H:>=%?YVR-\H;6&1KXP@W6ZQY,T%.2
MJ(71^*[(CYG!R6+6;9#72.@&=)0AJ[S.*S#]"7BQZ=:4HRQ,]J+QHBBRY)YG
MP(X^V:+CFZK=:#L_/!A\DBH$ZV:"N!4#=M&<3K[3^2V!!;.^C_64&\9H^F7Z
ME6O:#;3'#,G6\7&I,>QCHI*'X<-/5_KN+I<H08/+/OKR%2\<CTV1*X>6: [(
ME0]>#7X\8N'4F=YE5__>5^)[Z>+A=(*6-@T( '+J?0XQ,I5M_.V2/X=(*&%X
M/^4)'0OQA,3,BM!KVM40.E1[5G5Z%("EJ"OSPE4)[L2)%E8[G\60)]=]76L4
M/D/?+"JB7B>QQY]-"@S%^&H;5!>1.,S M\<06OYO!HI?!KC_U%@@;1&P"7.U
M35VZ7"3EE-"AQ"":%,OCZFD:U$?S6XG(BV.>$Z$0 :J]&8!.JEYOG\&8!TA.
M5&^(;6PQ00U28X%>.7CH*.;[KUDU%J$'P^1HQJGN>70*NL'^=T3D O8T36\"
MYXD^P>AOAG7T6\3BIEWEAG7,2M9F1<EI\>KH,]^HH0A=G]+NXA]0\[A*)Y^)
M28J8\NB>=VME[I$R8S=54^4Q;D;W7!T?^$R[&$V\@6I1XD#3H3J1.8RIF'DT
ME\_T9.+N<!E"?UC RNQZMW9JI1O6:0TI/78YS:X]D8BP+O>S:P):S\W-?#/R
MN)]%J?EB$E3DW>=O^ HC'))=FQZ:@=9^F%%A<O6II)A#IX&+;F$!,8A?U+1/
MQ3XC8-EZ/Z'"SCG%V) [PT.F;]/<?"!0F@HY]*4]I*Z\H5G2,0A_0),$WG#_
MI^/Q<P(_9L&3-/T2Y/ L%]4,""-6M]8Y_M@JP .N45*'!##_@SUYNK)=[,<J
MG1O%<RZN445WWX]LKK=^J-9#DY4PY%[*<SJ6"?)$Q:P<&M,\J)I$;"($,-^*
M@YQG7#("D@CI<)^]0-XY>#:A.;;RS8_'MP8*J?:N8UL"9K&!O"M0>TJ?=T08
M[7+-H%I+^3W8YZT$%&".^X)CM5)I.C?(K)UV8-A=R$V)!?G*Y_S.4:-[IODB
MBILT8%,[J]8K8J)DC>>%2N\E0+<1-\[FGG^G_-O8Y%WA/P3<OX1P3=7-8V/U
M+E)52?EQ\S4>"T-QN%,A0[\CN2;3XA'V(2&HF!QUPB0T,&;R3MMD@%KD@K\N
M88C^OMQG/U_BY7V5KWX\A*.<)6EX.9LB\XQ,DQ"Y&\8CI1M6-N6&BN]M<M)3
M;IN$W7UBC/WV?L<$:G0*EA\0ROMTU3! KGB<5&%B-7Q3!]/Y9JHOK,Z9AI&D
MM='L)QB7$7[TI'8^>!PIK0>;E"\WB>1#=>JK<TW5]FT?=L?XAT:=6.X<A3?B
M>Z%?'T&_N:ZB>724)28CO&(0L/)5^[!FC90J/ZB3Y&);=XL3RA[,T2H@@,>!
MJ($= '6F9X[;&J_Q?,5_P2)!3 (F %]SS>)8*PH*(@5REV#BQ]6OAT^;"DEJ
M9&WP0'L?D.-BZN9WD%VHVI2A+AP_C>\=U<@C"!CJP7$KZRE0T_!A8K+DL8%0
M\EG&2%_7&H$2\;U=!L7]?]'VID%-95^[>'I0!,2(S"!$143F5AD4D+0B(- 0
M&604TH@( 0$5D  A:1EE;AE;ILA,&%4""(1$"$,K#1'"(#-)%&0RB4(XDNF?
MKG^];]7[J[KWPZU[/^P/V77JU,DZ:SWK>=;>>YV@SH>>"$Y'6FAE\/XCK-2+
MXD.ZC.POVX'[8C11VCC 4Q<1?:(*RNP]@[6<@#I9IY]'6SRB,VISP\&T3Z/P
M 7B^/6[4TJ7G;C$B()>^SUE=]3Q]-S=0TRC;1,E>VO%H==T!B:F[SVF.YS[A
MWE$)=^=R<POHE?3)UM%*Z[_N7;:[D%_+T-1V7?E88Z(?%#15G?L@>#H/];;1
M:ZZL7=;)%S'W7X0IWL_WIR8AZ&__FT+0BX(]08&]+_\_9^"7_\1 I(4@WRHA
MJ*:*CA2!L)@0!&_ K!\:K4S7V8 E_W?+*C6+PYAW04)0B$C*&^>D0O?M68^(
MQP$5>GBZF^AV0M P;-Z,OK:=P?5X9PYN1ET! FFMXH#_L$QPX:-S(18&+)%2
MB33[KL[66)R<PZ9[#PBT$BCV;"O!\ZJ^;MDGNKKZ=.K)]KQ]B7'BCZ@SHJN'
M, J"]\70I$(*0RP'=:$6@ Z6_R*89Q_?;D1&7/?1,-R^^-G==&!)Z277]+/7
M#9/8L*Q S"]M<+R/_2IL]6NY"C^7%(@11RFSH5O<2MX%JOL*,[.UO<Q^@"@^
M%15^#$BAN$X:;3;&\:V_.M@,F$[CFN<72C;-[#>5FG;-HB<,0O7"\'G^#\(/
MIZWK!FB$](<OONF'%9:@_D+:&4W>*FVF1#[?;@"Z'L6_'*"Z$>[L]%O[;JE\
MJE)0;M!WF!UQ="MLI'=06#J<&(#,=0-^XCQF@\DY*H H)8P3+K#!'%.@AFWC
MP%H;:IWS)L/QT#1Z5P?+NH=N< @0@LC=S*3('+ ]B[@:3=W^1.5=,*I6WLZ4
MNCSX:?%CM&EDQU_[FIDD1'@R]M7>E@GWGB]Z9AFOF6UNPS;@/&9UD@UD41?8
M-IGZ408I1>@?L<[L3]@/K9$ZN+I0S(",%_ C1\]E8)\_**BI%X+"R9=[$+$I
M:?(5\=PHUKPH&7 54">GO&\!42Q'"MEKH%R%'9YT=[*"W3G0?/7+)IEXB0JW
M81N7Q!BW,O2N,.6Y#H7>WB$E54:KV;G7]_6&L#IMY<P;_ S2W2QWF@(Y_(\]
M(4CJ&(-FTP^1_X!<HZTE@S,(,8JLO73\6]Z5B( &(2ATD/Z$9].H6,=V)&P'
MM 3OEV,O3BKIZVG8QUDEQC!8+;9#&6V14_"%"<?[F3K6""W7>FI>F0E[>3$Z
M]Q4,X7\VPM=P6>>^"W_*:/2 <H-MA&.50Y?E=N>7+TU/OXNW\AR 3RPR9UO$
M'4H8HA#/F8/WPQ4%DR,KX0E$#> F6X9L8<C_*Y"UI7:6,(%=*1J$)GO=>;$
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M):D$OU:$L@ZB.# -?0HP(7?GI/'NS/U\PQ/ ;)\/Z>[-E-]'3E#)''6/PH@
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MJ9C.+W)Z1$H4\BO"F[?YZG.U.Q7>N3=D\,>2#E#'/2T8Q4#,T2@I5G@_7,R
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MDBPL,O]?%.+^:TR,DSZ>J\%\L!-Q$;O*5G3K#_\YT4,SV+L'YV-2!27FA]>
M?&@?E*]U0-8)[H7L^]]\H^K_=(BE\>R<C1I-AM_-W;(#=_LLR:N5BL$IY;/?
MNO<HRLA8A["A2\VR1KLY?['/_'IA@/;;BP2DOIV.U>O'K\\GF)0"AD_?RN;(
MUH^_53EO:EH0&74Q(.#BB81?KGQ4WN>UX+5I6OUZ$1..,EF[;N$%\W&V1H'M
M7[I5K!;U-^N>OSM;V7LL@:1-/"X8$ESH_+<%\X'#@ N#K^Z1R GC-QM=%YP
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M=,G'MSE376(9]QS-EB )9J&/%AU-N2#DL<Q+_)^F.L1*DWJL],FB"5F>].R
M3/BD@<Y W,&#UA:A-.<;UIJ;-TDV*<^_E$HIX4IXH>C=R*^4"+^U,Q[F.C.M
M:CIZC_#A#MG=>BQ\T>VW2IY Y\WWV[%Q+.W(-!>4ZI@MGE5ND[]6*&/[?-$6
MSZ^WAR0D?]&PKQ#W,7C5;&%KCGFNC:UOQ.X?1A*!@X%<4&\YIY?G=3Z+E_%F
M)UC'!<G4J*E%U?PJ]_08#*CAN""%3P0*TY6X]Q7/X=/:^XJXG\]._56(0_U7
M(0Y9!$?7C'&9YZI^K]'C@D!!6& 2:6,V^9J'OS$7=)CG%#YA<N?EI^I8K HN
MZ.D@BY4[[_OOH[;YMQY=[6V^W]5C'_S <UX\G_<3K/B#KXGWZ&!JV.4'O _%
M']+$C[,P]F^-2ZP#OXJ'V&/_'0:Q2#=!WJ"^P6@.,(Y9?V3G3@ 71![  7)$
M<G]D+^K?Q@S^E^X<2DW CB3LARO"+'$X%Y3Q%7$OXC\(_ >!_R#P'P3^]R)@
M3W-VGKN\%:AN^?!3\+-%J7R^\B%_?-'WX*3R#\5'2F5T2A0;4O65.F3,:W+G
ME6U+'$/R/0I>3<]_Y!&EBO_IMX3_WYKX&DP:$QY)FZ;4);8C7B$9><T=?O(O
M2M'>%L2BP A!> ]!9:IQZ1@ AQ/R%N37C(S()P-=/3I&F^WNW<HTB185.UO,
M;U]PYI2/@:F(U:N"5V-.*),JUPZ1GA>^4NYXS;ZUMQL#10+G.[T:COO<Z KS
M@0L\*[8332A CMM6V-J46C^X&>-CT%@B]FGL,L:;KDXAD]I"VX"G*US0(4!B
MZOHELY 5L+B_IU0+FB1^Z=SL COE[M.L"A^OXJ?2_YQM)W%DEABV7%!)/KN(
M"Z)]P^AS06N9+5!IU@E:W9.SZ:Z38N@M:N2^,2R)HPY43LW9T'$)NHK'ATY/
M**>YA(*%G2&9;D!(5QXDIU4YOI%RJB:[/FM^P9UI<I=3)3D8,!G$F*"8:K$N
M9*N]:=KU4U6:S$_QH!(>)*U4AZEX%4;)4G8#Q76SO=Y4DQ+H:/_!Q92+C])$
M$Q[(*?2H-,F9'->4%(DK<;$6NPALVL2=Q9.QM"DNZ$TN6VYIF\=/XTLH?5R0
M3A:6Y,890'P+P38L<>33X\&L,:</6;9K)"PYCPL";'B+]X45%-\'^V9S#\<Y
M\X+W';,BXMCT.A$(Q,Y8<M)0C @NB#1*XX&69P&CU'!!/EK[!L2972Y(V(R4
MSD&J?[90^9?NC#<Q(5R0B20_%T25+L!^>[3%UHCB=1+7PLXB?N:Q(C\BZPI8
M"/;S5<E_BS AYF7:73W63Q[EB!7CV7;6?X;WWPZOMJT+(0_E0W, 9-$A8)A6
MTMOZW+"W%1M#.(LV[LX=5EBYXS5N.J7EISDC:V_V[LT%P<=-]SUU@?O+L(3]
MP VH(2TGFIJL=/.L3',AZGZ8]UG]'-D.=9N/K7$9Y:[6%6'>%<APQ\>QL?/W
M/6;<.T/$'I07B7^F>$HR+6H,<_8^,73>=5QYA5HXYAQE5"+I:-#"[WOI6="M
M4M+/7BLY8TL+E+:[55&[S//%-P/W1]0Y[G_L^-?AHO@WHTZ/ZN(2L$<P-K4!
MGNKM@$<898X+$D2W>79D<D'=' 7@T4I5D#63)(HNV[SQ82FP51[_$L!UZ<F\
M/[__O2[^_/?DA=::M9?JG]62_F2$W&O-;/21UBCE[[$^V3 9<LT&4SNBUV!>
MEHXX-WR[T*=1^^B'JMB"2B_:7^VG_/@G.WVE@[5%<M;0JA-EJZ8-G6M2?UC+
M;HDI0J!G;!UHW]5L*JP?J+Q,&OK^[/^O0L?_IS5"!)O'^#_E X&<$5'&#2YH
MJ@;00EQS(F-YP>\Y5A [TQ75#]Z?)![>PF@Q1\ <(D\EC&= [=)AG^)78$Q%
M_60NR$&*Q%O8+U]#JUDQ[&3L\BNH.C"WDI[H*070B]$"[_-,$Y?))S'&-"B1
M$H$0<2%%4'"_!<JDX5;<(ETUG-SIZIMY.2]\CAN6<P8]+J&KO^U8/QRK]6IM
M#$3R3 @!J.PF1BD&@.7:C9G&2/G#@!.MC3(=W7Z&+OS[9&BJ>@^YQAFPZ]W?
M&8Z/AR<=RL,GI#6$5R!_N!YB9 +8Z^,YC[1B1F>EOHP)P*0G8,O9.*E@PE&T
M:.=^>#I'[C-8M/T*W8C:.,L%)31V&'=7E?*8P1&H%C+'U2^!!0DSI05LYK9.
MMAM&G?_FQCX5JLOY./DIV:6I<"@7RN,&NQ\MJ4QT.B-K BJ(7G^_"!KCG,-H
M P=H/#UHL6!5 R__W(SCTX!H>X=[4Q7XXGS3?V]N;:3M7RT)])3#N4X&(?YI
MM0R"ALHC)AW33 P<[5<MY)=FNC0,>O51MQ-++$+*?OK5*L6LNKWH"H .1'VI
M@>VMQ-W'6::T'>@*:RB0/+$6AK8VJ/5)Q2<4YWC=E[MOEX062&@8.N)6=/MV
MVL!\Q3T]R57G8#EG?U\#=WH59&#^?D67^&LN" Z$,/;8F2PW&K,/(=8.HT=U
M\>@+%W1\G38D;SB9W[5H]*:5MH?N<XTG+<KD;5TETCKJ$O -D[HOQ@:,F*>4
M-GN/N)2UO6UI:7Z;IRXORF[%^H!Y<(JPX!18\FQPTTN,XI@0<66K"BN$GC)H
M#!+QN]SGV#3^!:-[I)0J"'$_P-]&6RBK$WYQ3IVH32+NY6$!)2YHQX */APU
MV5RD0<=U]F.0S&M ($4I_]5PT,I2FKSJ6&.A&87G.-*%T"4V5G[=2Z*-N[)H
MSI=>N/#GLW.6;6U3NLPR(OJNS/0?8Y0T-.$54,441N=2^7K(LPH]KIIURRA^
M0(&ZNUWE0U,F77YX8:FLYB60^\=$:&"-X0_;40T=2X^S6L==9_P?/KYKA=_2
MDZ2[] @VRMRUN7K"TX#RP'G )DVSP1K9ZSE5D*5:OERP<N[UQF1^]EWWV_H/
M3"(]HKX\WHO*S49'?ROIO7WAKP)XO+N6:<WYUM+SOD?*C(MN5:T]:E8_1<T^
M?L3HH)-H;[;JIW?!HOPD3S"U0:[N0IQW4A6G92(FY*[P%T[%-T0*%W0W?6;\
M_<4-ONXH:.;B2C>8_PZP\K?+'-JI5R]7IH]TO:'HIRXS//KW0$NDW[-9A/*-
MB2_5NJF#B7>];@[!H+ [,$"%"XIQHCQLH>LQ&MFEW\R_:XFCBP(%)=\[@H]B
MC/'FM*X5:\+T<8Y\\T2[-$7])R3P=N5G4;0;HF72-_):I+3F2';%IG"Y!@GF
M0B,QU-B5IX%26A\O^$EA?&A*##(E?7N#FCZS9?H:B%HTC-MB2K=K57R&GIS8
M_30=>I0R&<;O-_E%F2X^I'#]V90ZVC2_;+&QMIXZ&]5%;$J/(1R(&D((0@[2
MC2AAZ0E10E?I.>0^USN+&D G14L0_12J"!!=ID.KV))]B.-!$##]2K[9^'<5
MP<58!EG(?S:N(E#L\=]3C5EY([L!H9<"0M?CB\[J*CJ&&FQ59HWCI<RD#4QC
MS9?7-BHLBN3%S[U[5.BLK#]NF\+QNTRM>S454K3*0CQ=9CF:/Z,,527=SJ8U
M8=(A57'#]>]RU$G'&_C2J7=+-.CJ*J6%CIT4[5J=H4L%&DAJQ2I@#1[:M!F@
M2Z\I'$@9A%+IRCO#3!6T)67]&4%MBPN2UC&"_\:Z'FD-.Q+P 2FO-E&GVS>*
MPC8T90C'-W8<^='=3)S1 QHGACGI >>5?=(^=X_\_3,HGB46LBQ?Q?P#\&9@
MQK[G6UE:TG.?0D[5 "BJ;C0ZYRO9'HA=8>[(K'0A!,]^"&H_I=8UBXL.V]'N
M>8XF["):1G5>X+'' T6<MW):7L^RTI=A@++>C@8MWA00IQ+C/?4 $2P]G'*D
MA.[:NVY%_^1Y:1HJ'4"0!J++YQ<^+KD,2L9-=S\L4JB/8WPU^F=J3.MBT:CW
M])VDD; ):.X'K,^O#:6X1LGWJ!2.+!W;J5X.@=$D24N_0?4V]H 0>UJC7IX<
M0@0%/0WD;%$0<>VJQ9U_(_?Z=8<)A<7-)9JI02<_YN</0SI8]7.KYS6MK.Q7
MNP=/+$!L7ZTF,!PK^,D?]<1C X'[T6MA<FHCI5EG_AG=70;V-HP*X I%1L]>
MMY\YYM(2_WUO'BH<HXAC>RL//9C'L^^66H*35K;/_RPI]#7(5KUU;\9*+EQH
M=>;XYO3PGLN:F!K8#(EK%MY>K_9'"&&L\!A3RU11*KD;"]CCA'=A%'%ZNT8=
MZQIGC/,/SU30L^[H /6%<UR0?W8+9W)JY]N"Z'H:8D?K[/7L=CNJ'DL,O"P#
M(*@/7]!R5\!/W*@M3T,U(NPN8T]@I.E)B*.?WP#>W8Z>\M.*=/LH<5KTUM?9
M64_WO\ZT?&"QK['Z#W-P@E-92JV(YRQIGC+YQBYOUZOD:8RB8AYK?.KZJ\+C
M4W"3T OZ$NF-:]_*("PA;RUS4>OUM&Z;E<NKT2\8HT"L?*&?RIA.,N+RPG?9
M?N\.NGYCW,+XK [V(XH*S6<J<2:PA\#V0 #T-.L^@%O!2:%#ND]X;A$_-K?R
M)7PG"FSF6>.H'LZ Q95@@;8;WP*YH$979Z1A4Y8H67BF%G]R^)S9Y(, NQA"
MDV'_]*M,!V1YI5VW+MG&\OANOW%FV*TLE++*HI&B$&3?VN^G)^PXZ\K 6V\1
M(;&1*B]UZB7(;)FZ2+>4D%"7E[Q'AGTGO5M"? WC9G=A\ VDM^D/>$/GARZJ
MCYFHD6/=%\_3;.*O1*9Q]_SS]'K(*3)'GJX@V\\L(TX&2L@XQ4 5%S;&ZU(;
M!2(#X1,Z1Z>[PG/W/D]G6$S;G&-^/R4_XG:CW40>]T@EL167R 6U2&[7T(+G
M.L.Q(E&:&WGG$"=8JF7H]<ZN<1+G(OW<_G2,;OFBE4*W*I*"$MIR<GSL^ZI^
MX'RMKM3=*0JE2#_:_- _.-T-+NCU;KI3+T*&95;MR=*>J(DZ$]7+D647L30;
MYK?T<O,0:3KI!S:*I-HG=Z>VNCP]<N-\)^Y" -2WG[MACS0DI'U&O0HB"V&J
MO/6S(&P)"- E*7U=L%37OM2=%9K>=N+R4LQ^/V"S I-@71SC*.72X0D8>!4:
MNM0=30GO3@><BX0F2B>FIKZ2G&GKI*T;3<[%+>]PY+&BM?6[FFXYWFI=A3)O
M\Y[?3+68V+!_N0H-L,EB)X6>?%;J\-7<BOQ"M_KN)TYX>OL#^ASI;O2%$71R
M/""K-*B^%O8F37Y$FX5+*(D>K+S=L _(B;W-+ ,G^[GI5N ^A7KZQ5;ED-30
MKHV;UJ$7*QLO3'!!9?!XF A&EA[8*2\/I-*8SCSSB.XDJ#5$L ^Z<,B3H74M
MLV9A5_('V;B:CQNM-;6:07[I@QWU+5G;BR=Z_QF><\K ')@.W17%B  V-1OR
M0M,<,%*2<(#V?JQ=G!IZ9QJB6^:ZX3CU."K[\1CX\GT4$B4\$[Q^(UCK;M[B
M5^KL%')Q5LNCKJA*_%C3K:R7Q;;W;0I*5'M,K115KZI8F*M;V%AH+/2X]C%0
M0BN!:QA8AJ]^M:FP9.+0I;L-L@D]/H"[)]^!Q+KDSIMU;B)/.WW%U;UI:,-)
M-8LR68'4&B?)^!(5F^Z)"E?1YS]W28BO8409V/8B%^0+9[N FSHB^1%7>+38
MNF7%C)V_M-W/!54I,%KJBM7HX.YT-IK'EC9U18>7R3_%O&';52MD=K!^ D],
MO-__7ZF+_^\TB'OD/BS-!L4''*2F[G8)FC$"V*^;L-*:==1";5+SHCQ@4+K4
ML\+4.KJXZ!I0I Q$'N?HO9G$.%#,3[^)=!QWK1^'X,<4G^U3C>X\J*@)YX(.
MBP &2#H( Y/_#:"'[C]L6"8+HE=Z&-CCOF]I<-[(Q- +YT?R*74)K6\VJ3^N
M3577!L_!)S6"&FO,STZ<;Y(--$#EC=BJLCQH?BFZ6H *?#M]Q<.HJTAQ B)+
MJ8M'R-S%F%#G- 3L6VDC3R,J@1#;:,N&J:;/&G?&&JMJ+!Z=E!6(V'JKV)X]
M9A2:\?$@7;@/(<QRBV?DTH63B+Z()]@F>!<\W177DZIL-<5"_FTBN+O=0@]_
M__AAB6X5FMB[G[WMF*?;Q*FZD^.:->OPR4DFJ&AK0ZLHTLLN*BI>.&9PBRG5
MZCEB]YZ)M*).(+L:Z@P1'>L_B@\?"PZ/4=,?N!\2C:]@(7HX9X#^KA JQEY[
M,O_V)9SXQKUFOO/%E%6,[_T7M"%](R6J-/P,_DDV1,@OSW&X8?]1 &G-)<<&
M#HX>N!CZ9GXD+DBU)Y)"AW&.2=,0E+IN+0F602,-VYN>9(@CE7OAJ+XMM'3*
M/C#(PU209& ^WFM8/]4X/3[\5#:,7R-(Z^^& G/O\R2;EM:&Z*TZ$8P)S2^&
M=1!+AW4;CB$)1\9UCK)L(FH[<DKUXXUS9M7?UATI#/2#UJCW'QJ5VJ:\SORY
M:!(;E-(W6#< CO>\!(PSY3">[&J(43EG "$#U79F>0%S5&(*6) 50:LB\==L
M&':AN^A?[K*,5N GKH)G(-JW2XU/#\_UA&D6E@]7910G&Y77JN\<_4:>5:<4
MO5M)3UV\ G10N: DA&#QAZ::D#_8.9B#-.WWTXO:'VI1GQI;Q]L-*&39S[--
MS1TK-7"22K#.6QG*W1*Z\'"$T35'7<C' GEYH23\H)2^75: Y4D\)+3TV*4"
MU6O9,O6D8>L'*3YNF051TBWZ%EQ0^'N"TOT<)#PQ<#UT3\[SMO&EX=<OXBSC
MEOVREB&JI%L-UF=(M[3_8%XBO\6=K>M]YX-IT^KTKM?W%.>,CM1[,M0U2:/O
M?:7\3/MX:/_*=-ZC]8PHRH'.&J_PF.H5P)R*.HEVXS&=)>/&<5U<"]K[QH>P
MY'?5.I'J3E-?SL5]A8EL-+N&U6R\GE*<&&IV,O0HJ0[2*@3X.,<LF5!@#"9[
MN>D5RPZP4WX6=:J?[K%#4 <TP<<7@!+*_G 02CB!)8VZ7;.%JIU=(D?XYMT)
MT*C5/7-/\4T<^G1;SM+><XI6-$&+]3L[DQBT-+. ]2.G$X[3B=U$,/H'XPG-
MMY0N0"FJ6%[BWW*].,T1<_\(2,RY3OFU( GG-LTI.Z:65XXLCD0:^I_)]&]Z
M!WE1\D==,HZ/ XV:X?'X)!WP$X0$5.PJ#<^ C!)DYC9PXA #O>CO6F#,U5&6
ME4_=DK^\\#CJHA(>#P^4+\O3_)M\S'W>A:>/4?$619S%L0ZIU4</JA)27=.R
M=1,^.4 ;+'^(%5SX6JJNPZZJ,\Q&+OE'&,VXX!*]"'_*Z\+/4.3ZXK^6K[\8
M48B1@(EFFCW5GGI;ERB![ '<?QP^;J4ZYG(<[:8ZH!^A[WQGU>["HZ$+FTU.
MCL\0U;B&]9U^&HZ11&_:)77PD<!B'#! T.+O7!F6-0/J*;+PHV3J[N%Y][FY
MJU34,=F@$!</.XL7M3MK+=G#U2V.J1H+K^SF9A?-40R?*!AG),^I!YR*:YKN
M(J>Z3G>"DWB<B"5-,V+<?@,X5>CU8 7=T::[/5#]=SE?!=I@@LB6T\/EZ*C)
M,+>Y? \[U37C,K?!B*"R^44W%[W<J'FP0#MOE<SZ];62>Y9F=AFQ[.(H\4TP
MWS>V.B,R>;D=>G8R% %B79>Y6^\9 %6JIRWB\5R0GSNVRW1:[\VF(7Y.P0/J
MYIAK3!>L- E"]MAIDNQ[JZ\8$IT0#JD!?ZZ7)A8$['UMO9!5^0%OH*\_A9Q,
M3I%KN6^#K?"1UZ4W6U'"@C5''O#3>>KUBT+<I8+159?=PSX?6;&K]7UV5/<E
M_IA_T%6Z Z_%0M2<O\B6))#NH ><YWNE0P*%C:7M)"U_F!+NL$NYH "-@PS$
M:"-*!,!34+U+8"#"IHE^^$M='4:)9I*;U(@Z.(/&,F6'V^AK%>5 -(D!E6GB
M!>QF,X9NS\2N^"[#M^X=A7EB#ZO.D>/\LW2"<);EP<Z$7&3"T6 JE/@W.IQQ
M?>+;KER@<"25Z2'?U]V,.,ERJT-+=BZJT8GQM4%!(PV4'?EUDIXYI:K#_Q^M
MT$BC'<?I9D:;(MN,W8R!U0%U#&O@!X4LX/^8F @QKL9 ILXWIO+]/HX*2_5S
MZ,@BK;HB6ST+#P]__S[QEY'&SJT<I\[9^"/U:(@F6#JFQ'!0\MAX4["E+5[*
MHKJ\ZV:-S/,'45N5NT<5Q0\_4B4@*KJ C+YV'UX$FS?/H75@A;4]3PWD*,>?
M>6'XCA&>,D3#Z#VC%O0=_HNVIJ4P0 -NF% _W_NN%S^D;3%)SQRJ5'-6>WL<
M<C_J+&SYU=)Q;QHN'F)5CA%B5S8F[Y[:<I2!D;0.!R#X7J;WXL05.L:.-.Y/
MDVJ@2SV2AGZ).NJRJM_&PR*%Z@4&]GO_"MV* ,KRG(W213E+X$/MRC0LA=BS
M S<'<M:I(PVU0,A[K, .1*X!XSG%,J:D/MXC>9X=]:9%;/[9*?XEM<8E7Y:L
M[>R&A>Y:)PDDOB(VF4-OLXLQDF4+G!%8/3F.<)HSPF/@^+1:E@%MCM20+ATU
MDA<YA_$%1%9PPH#D^^;FBUJQZW&SE+0.-*JFR;A\?D;PV&Y7^9WF7-O RTT_
M]XQI=3LOE@$NR+MNMH3:UT5.!,N%+<6X$GN6CJ-SW_M9M$QP+CD#PCTY=7BT
M48_>K%5]VX0N3*SS\%0-I'[>K;E8F.$9?:0*>WR_O34V/?2"=&1 Z*8*4VG+
M2V$;GQSC@?4[#J\OM;!=6W4(L,'+/*\L-@R.VBQ0&\O"GAZ&N-/SXQONCBO5
M)7'F2^"Q@)$L9%>+MG*YQSAFI<BW_>C;W 1T\N'8' F76$RT,O6/7>EL'PQD
MS_U(8/R@;WW3U^W!^(8A>6V&WK)>'TJ(\T%>;*H=_C=@1P4_7:<M)>L*'P+2
MNQ!B[><7A>A%T50-O3]&F_*3KUB:!"Y<]1+$!^Y[=-OVA:NU%(U>[B_.T=V;
MX8+NDJ-+&#FT]>T:/#[Y.RYA\31*9 Y>N<$!WV@7I;"=NA8E)C#>E?YYO1V5
MFS(^PU-EK8K/+$1)KHB$((WUB<:MR&M?!LS])%@G-Y<:B3N6% ^C'J( RXTN
MRI!J^8#QH$;*(X0Q=H#",O$4FDR%Q\M:T"(78ZD>EB2">D<S*G[P=@4Q*;0\
M=,YHV)6G<I?F/7]:^AS'JD:-P4YBD#[,*!8?4%C*&<(U.:5 ))E7D#C1=FUJ
M*JH3=_@[Z@22H_J.3HS6305;3$ .5K@ARK)KD9>G\Q;>3M1^/V5\/5.\I4-B
MZL>#K@S+?N.#IC6/:0%J"(>>$2FTEVR.3(>:U8=4UX92&=WL@%JU$R6.02&*
MCC99[C[[" ET37<[K&M>,>]VY4K ;<4^J.SJBW@I7\@IZQR^M+=.5\@7O@$M
MLJ1W$HANJ2]G*4D%L(QJ7V6=/KJ>\"T5)S1RBK)]69L_J3B-%&E$%^8<NTKC
MH[1THT18L*E0>+),#FZY3GS#DX^^U"-X\/T@EE;UGG-^,L\A^AI=*W%]ZOR7
M'=3+B(C2'",KF6\6=^L(W=//1I;[-N0UV(U08<",D42+WR;=#UJQ0E#-DL.D
M&J/#7J&CP,#U=J-*^-\NZ)>",(_IIB"XN;9'/X5M9SYY+I[T,.I,A'JDF[7,
MD\:<#05P-DX2<YC.  MP>,O@C40ZTP!C1Y>O8EIRIL+!$NTB] A3&M.2AH/3
MPI,A(<M$*6D,?,6J#SY>JY, 444&:J1\-6UN"&AMG/XA<7+C_FQ U##3'8WO
M==7;L6&>,Z?4S<PQ2H%4"F[F$K,[G4>LI "C94X5M5"VM[E(AV9&ZATKI2FU
MW'[$QM4AD&/(W(?R*C(%LX<<988D'1^.>39>>O/P?,MA59L8N^=%LI(Z4YK/
M;4-I66H4^B7''PI.HK9EIVZN)0>9[+F*VK)FZ]+D59=?8\S_6M.]![A#G7H)
M<LMJMC64+Y&F9;])3R>T.V7<KSM$4888/XI3/KWLCE-=.5;@(",U?P4"51"-
M=T8@7ZPVT<"-]@Y6T%WFM:[>7QF^<Q!!#<UM3(EBX9FZ'>CX,2N&VU8DF1$Q
M&,EQ&#):&G@A?V6X16D!,]7W0TQ9YL^4Y5WI7NWD!J>4S/L/D;JAXPWFM>7
M-"./W80!,]4#<BX7&0#&S-_1^*L=8SHU5NU8VMY[&<\6V@]XQU18I)-I/:VW
ME%KCW>-YJJ&)[D8NK2$S5)VRJYNLSOK?R=Z];O.3\XZG:.2 $,H@5G V$/P;
M+( )DP-RR-V&$V#^->#B)Y;U.$:!\NZD^I)< .<4KKO>;0ZP0#JR@\+4(ZV_
M!+6:XG47"DO;+PS?]^8<\UXF2Z'W&(B._TI2ITI%2&^1>1J\Z>OG(M$/37"1
M@!T?;ZK;H]TZ2:O1'9268$W!L7$/]Z-_.-(/GAM)$'#ZM5/2&&.DU$0_2'+-
MB:4I,_ 3'"5T"*5C>*E+:U:2X16W;MOVH=T/6PG$S<+B.; WS4P%I.?))G3H
MKTT%KFX;J#MOZ*?81;B@8Z7,A8BWYZ&_=4!D*LR9%@T]UZI+$FU:7L=*6C^(
MF0_B'VD(^=0^@6RQOM28P<K^546\K6MF*5'\ ?1LU_G\TX,8Z-"E\Q):T6HK
MIU#?\9>I%BZ+!_E>W%+QRL8,:@X"P0679M;NE>:090M&2_*\[@74"M5_6^^N
MFR,MKY.JA&-\ET@\+<A1 !I6PJ-U4 G0WP _&K%3N0<LL@M1J-V@;UZ6Z?D1
MKSRI4^\CVQU\-O!A1^9.K0[;6O_6B[N:GK!BCA#+D;;;NQL//07D4]R$19"N
M6@DC]6*&3LFA<1\PEJ6+ -9S$J)=O=$Z\N>>>[[ZEJ"?Z82&8FJP<FI[QGG;
M?K&$]:]@TD,NJ$EKFPNBDY9_[)C0L<O8;ERZY*(A^Z]&7!Q8E IX4)*UQ%C7
M:7S)U1!CB;*6D^@(\^S;K>T=8^=#43N/,H/DNR*-':>7)>L)F6<FHG[2ON-W
MM.@--P$X/?</((,*FWG>*5NS2B=N#_-L,B9*@!Z>V&YRNQCS.UTX7[-E)=4Q
M0A#;Z<2Y0H,8GK-#YGED=Q>=W.N>VEO<5(>,^25WWJZPQ6_CS4VVSGMWMTZL
MVD0$W]51^5!B6#F?<;-*Q51SP.Z^P^W!;2"<FBOG]Y,1QGZ7<_^(@JB)3>DS
MVK3@^PETB,'[3TT5M.[7F*"_Z&:B="6//\T=X_Q2NWTA>C%#])E814]GN<HX
M/6G2B[JI%JA4U R.+^H""TW'\G!9UJ%'55#AAP&X _UA*34?)UR6NQRQ927<
MG:<7TQ0A*,$%V4QH-+$M]OL\IQS[OWC39OV=!/&;03XU'D?/,,U>H+W_RQ?W
MX,1TP'&SGHETKRM&/01H&W";(IPLR3GB!HOQ5*</E_9TE #8:_3K>9T3P75W
MVMK>M%Q_?O5),>%-T<H_C6W/*!PO&N_1R.BQQ(C=8 D_]@M80)7P 321$I7/
M-')!I_&&2J@)?+5!.(M*X(AEL%#5F[M1H8&PN)LSGZ<?9W$4DVW?$=*M_5%"
M"5Z7I @8((+6MK+XCK;.<&0GAF%G=JG3L;K@)TM-_D#N"B[5R95_G".Q@%8G
M<93H4ZVSN#C,[3-!,+?)W2"(SR/Y@C\M3A2";\0-6%E'.BR/&RGD+&>OVNB;
M4%XW!#A7ND\4?*8J)E;/VC!J4UU#SVQ/>.77W*D+C$(ET\D],C@GTJKXO9D<
MM70Y^I23S$>X,#IZL]U,#I\(*&@MCTB21G,41,XGY8K>D5X76\L@7W0>NE/>
M%W_E%5WS1'<EKJ092[-%S#"8U-AX4D(H+@E9&H 3D:68YM.?K73>FV-)$X G
M+>H\ 79TE9CB.S6V4YM*^OO2Y81F^ESKYJ5A^9PN!O%W]9_D#QQA%F:"(\<R
M8B?41AW .(_IIA^-^O@ 8S%-T(53^FNBA(3CIPR+:D+8Q%? :(O;IFL*8[^T
MIZ>Y**-W3<!2Y7;>NGU;Y*7Q7<2O5SG/(+=7!-)G%@-Q<3AQSB4.>99G:38A
M]%T*MK/BNP0]-S'H2VCD9=C!D5;'U'!D54"K;W:$1(?N-XD6";4M0Q=LD+]D
M+L.PHU:JH.UHO92K6 !3T6E+;CP,Z12"MX!,J)N$V,;X)3466V=M7@WYRARU
M??<=PK<"3SRYG :ACIRGM,XL*IS./0)1<C..WR.(IWD4W)=7D])4H0SY(+99
M/\#) RQHD0)_^D@(BZ@R?-%2';U9W^E]4<I_-'=CX1&VAPM*7**58T3#5Q"
M$U$,JLS.8<+K>49K2?E5_X.B2V\B,V*HPDVS_K!9&;]";Q^<T<VW3%=V'NC.
M1[8ZS9@CO;)RN91I$ "5'>6(L![0TKN63G#FEP3;S6DE%,=Z'VH5[QXX(:AX
M3RF0,^Y)%RKV"VXMZZ (0@]$EL9/H+0>;LP6%OP8FW^A;&5GQWE"D,)<HB$Z
MR;]]A@D23FU<\O<\3NL.IWUVO=Y:5%5])44FK2*RVMV875JSN&E8,Q;99M.*
M7F3LK]U)S='2>:DB]U?UJ>/@AMP6Y[(M"\TL;RF3<;S,@]PKSH[E%)L!?,.]
M&+]?_Q&M6G5?>@E$4A&2  Y^N<LL>A.-M4@76+X_H<UZ")/,\RHN]),:(O,_
M37/)\'77RAP;>I.'OEO9'"37!TX9I(?=^]C^LO!N7'*?ESP?5?@PMM,J2A@]
M2(JZ0!_B@OAA2 0?!D*[_+QF4_XTD,QS@K%3$IRCT?:CFM4Z/VB/ V<ED\,
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MTB^Z=.COLBWNE:WL4&RX('-[)RKV635!E_6 71(%PD#H\!UCNI;9F"+[&42
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M3)@\;<4HUZ<G@^@)!MNVC]P]QIYOS\839R9I%GMYZ^&Y61R2?L9^FG:"W;5
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M$9C.YHSYU>$UM;'P&:.;0'-B^/I!MVETO!T;1XT6PM1U,)ZEBS S=(W=BL7
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M4HP<^* 29%T?"3:Y7*Z[D,J@BX#G+7-IRF&]!7#@3HTO8W /6NEB0--->4?
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M7WFTYV];F7N%O_[9)RI2&C%*7 O]7AH5Y>Y>06^^X*O$(X5]1DM^8T/W]?]
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M@6+I+2KU3-M/*ZR%9 9?C^LR1C*1UI@,GS&<M6J=^BNX$C7AO$\)G57R]^7
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MBMXDGY5() &6T/V>[AC%)O:^0M:*&U]JQ788KCX+)INSXUI+IU:<I,",2VT
M-/:NP4! 9\XV)=[9H6[(Q%DDMLTWF#'C'R!N+\3J@A-U3:^'OE(T# 9!C>!N
MBHP?H5$B;6--FH,&3P$.+(T>VTESEN^?@D,\$P":O$GY*Q>9AO-93Y#$F(YA
MG%F#RFX\#1!%\A<2ZQ\5R\9?\UCKAU'0?6OK&V@=$]TJ]VGTBD-#*YUK:AK^
ML?L&M:SB!%'S8I^UX>="^^<WNZN^O:X821XWZ9^UM#R='FH<FN<^,:2?G>UL
MH[L6-=G8WG2_Q1IKA+'C)U("$&FNT+7B:K#9D?^\;3=KG>8/_=0"_<4/>Q0P
MZB)!P<N,:42]?(^R;X_QJJ<NH$><DXAOF4@K'3=!&&232F;\!++LT[,KBJD3
MCT@Z&]JZ!V )!<<!B:F)MPBY0($,=@2IC$.MN<V)4$F)4%G<';PHMI?^"UR"
MIPGBF="C[P#Y[EQ\ES>+"Y2!,4QYZOIC[*^ ?"K&HN:?)K(,&,# [??_[K>]
M+Z?2W\CU:[-!]_L6W,8NTV#;4U6B(YF%UCWY#+4CM6;%^QF,=PKP*+/KG4,I
M^<7G7"PJ-&VLN\J[B56MUH:;ULT:[\=SB><, E1GQRU@O?14RDL1/,8:&.3D
M K-X1J T"TE%T J@(IYHZEO/$_QVQ%W*)P'5]/406<YO!R+2YL80C^Q$0$PT
M =A;W)&V8RR)@VAOLW8WNMR2Z[Z*4M/R%:QX;O]-=I<B8C*:\E88NJ3>'<CD
M(LNV)TKXN=T[%T1BA[&VDN&2:(K]*%8#W<S<E\,BQ41ZBK+E'PLD09+91XR2
MD*O_$L!!*FQ$#?X"BE%;2(^5/,$W[((=B 6@5UCM&F#DVIV)JD *$B>>@L=9
M,&IPPNPIL&8.N@_$<WV[*7LP%L5H<R8V@X\GH82:/04=WZ5R9,3$N^1GD\.Q
M\%;E,ZY<9-SF<R,[+C*>9!"@A&O@IRTO*(&^C4GPYH3\HZZ<S*7AQ^JE:QI[
M;0ZE:/;9+8;$ZU38X?6]]QKYC2XNU&/[#CC;#-^[9WVOPN/[.=6U!^JE&G=F
MFE.K:^:$L\X12IQD^EZ!EF DFS9/H$9["T=[H*D%6N#WN4%%%/P,8(*4NKN)
M5T#[,IKPT7.VTCQ8&QA>(%\_$AZU?@B='F"KM(24WXRJ<1T+-\A[NWUM8DMH
M0*2WG6G8C0JM5XOIENYUR2@#[,WR[_I3SBCU-9_H=/V4&X[9M*F^KYP=2/S$
M^Y]/H_ 5YH5Z.B^+,D44?"CN1&QWX>H&H T:PI%/;L*1;KIPI,D ^E^<\Q#Y
M778'$D[GLY[R\=S4'4BKR)@0SQ^4=?RGI+@;X\6U%/PL*>[#("CL\6<L6,*L
M3+PIF[^5$MQH?89JN/5QY:%-N9++J+Z'=-?#FM)BJI?.G0!="8=GM]%"^O_,
MZC3?P]3#.+U4&+UN!?DL>R-G]X_IF4$M54)];JVI(5]OC3"KQMX#ZSF!X";7
M'F,#!C+QM*1!AGSG8!Q];PTON!)$,)H[H D%I\'N6G""J=%E&T_6!STB63]+
M8,!$I\0C)T^9$<QN!DR._HX!/8!"2&!<]!J9'D[1 >Z 039!B(Q1CM^#X^BO
M$&O680S2)\(<OD=3F#[7M!D:JQ>9@[M!HAF(9_=VTP\;X!/H"GES.7]MKL?A
M]M^-D(@5' -]&+B#&"5K))4V#?\5S-#+ 9R9E?"*,EL&X9#;Q:* ]&57Y(JR
M[,>Z+&^5JSVYCQTK>K,:+6A%]V+NW;N7TU0^5;Y8G6%QUF$>[Z,T\\9PYO-7
M$BQNXM4KJR<NIFJ42%R_[2_8GYV8>&>X9P7OH/LC+D0R9GH3!;NPD_+0!O.D
M1C$/VRX'OQRR1!X+VH-(V&W+[A[K?5RS*4:0Q?V!N3)<[3IB-Z(?"..:*;M.
M<>].F@=&17=-8KMP#0V$?:L[D%O/7;?F7+'OY0@-NI2N[P#I&H!+<V:-[D .
M-I!H>Q&H-<3;);:_;>Q+#+P>_"N:E6R%W.7!NX9G7:-YYC&>+0)C).K*#D3*
MS931C_^D^!V93)$7*/-$0%PUSQZL84)!4XPH8X5RZ-.*XCK'YDUM=/I*-U9]
MJ$WYA2G_&:/]S,WQ(#B=>0%W=:29MO2]-X!#:?)L;WPL;W1].O3ULP]#=OF+
MR"F'I)C,;'5'M1,VN6FU_A&JA?M*Y0=\1<^[1)U0:[4PSVJ=FK;4+*.;%=5N
M//301V^M-K*-A)G!EU_J W@6,V8N8D]CQW"R\'/H/] /UQU:#56D@)[G#*4+
M&C83<:4EJ-\FNIR^?9%/+:>A%F^,'+,(3&TBW1_4HFYZR#BK6?253,\'^09,
MND15F**^/"FY593N!AN;%H;<7P1MP2>Z$'./_P=SQ7!"R!V,V#3%D+C>N'>J
M;#S_N?FJ4.[6O.%>F!B3'4%L&4,YTLD_H?@W>4!-< "W[?A[49+VTY^MGW<O
M4B9A NLP3@1T!M1@=S_8@7AWT(3@;4LM#<,UV_*>0=>$D7B'Q+V$6RX!(L()
MKY"\W!W(*@?1R@YF#./H*K(C\MO.1C^Q_]T3X8UQ_'<@#1J"2EMYYT*)'XJ]
M@A[)'<AH)B9^-^[=;F'6XEP-V8$(*D+B_Q/;BQ/_*=UI811!!28]'M> 6TL%
M8EQ',><C&"2:?#=T;P1E[Z>ER(?YVU^?H=BLN=YXLG+ $["(MGZU;F2U5J^Q
M77UAQ=):PV&\F&")UFC+[EDKJ<,S!V.@+P?79+EG06W.[P"!>B%J;CV!;"(8
MI(A@(MB[F?A';0Y,I((?0A2N@]$%=B!I#>O0_N BGOF(X"B8TRTX )@_-K%F
M\"6$I/\=7#9@G);OL#*K/!K>ZN8&-MY$F J-3TC#2O%+R6(\!+@T9WV^R]7V
M,?GXEV\K#U6>,Z>L3U.[[C<]\3=J\3:OI/EMD]O++H8$Z:A'6%WPW#XC=J7G
M^NH0L7["NXNI:5EZKIS(K71$]1D;Q!6;:!&USY-F^NPRDNT7&E@G^C2K?QQ3
M4U#?[M-%+.;[>V"&&S<:1UKN@DJ<5/ X]ZI@%%<GL2;)-N\98%_NH!S!G@(#
MNE64V&D90KT ?G<# ^:>:WT-V*\OCNC"21G@1% %)X"F0JV;,RNYO8D-@S&"
M?4WU@7?HG4V>AT9%XN:!G"3RCZ*DQ><N-I)$OQ[)"OL2;UD?>7M]EMK]J8#L
M3*G68+.IP";[))NMP$G3YHFL)D+-Y_615Q=-'Y 2R##>>3:QBQY'$8G8@1SF
MQS 1W7R-WNU%*N40[O9*#I+]]Q).K(9W+I+52EJ+TCV]>&D8][*&Y\98,DD-
MNS&B9X!8$\\U,8ZA(76;2V^<?7>B62XS1]_-6M/4TNY><E2M7Y\P:0^ES^B?
M)T;IKZ[RGF?4KZZ.;* V#_Q <H1\,[U9&!&3H^C6'<A-/*>'5*D]CZ-)"RSI
M/T/"UXZYSK^%F%)L.4GH)O!CO'&;A]X8P&4%QKCM>QH_'3),[G]7E$@)P;@*
M?-R:G]/)EPNTN:"#MN.A6/T(B0!O*ED5\*FM85Y O$5*8!50+>"I048K% J.
M.-X&8(DZ94E;U]CC,947@PU:E\5.TF(5G"L40U&>:^_6CM3,UFBWRSB@SNGG
M.;?\J-5CWH7M_WRS;5W6K$SC4Y0Q&J.FH>8@G5"C=_,2F^A:<F(8W]#MK>U0
MF% 1_U8H&!*\ *F2\L$?LVV@&["/RFGQ@[4A=/-PU%OJ18&UC=:*LW9^ K5H
M'UC!>*"UZE7$J]V>T657Q^3HO[Z^6XK[XT!?7W6UPLU]3O8'7CWYN\_LXI[#
M%T7VW-.>4];@F '-O%]I@8_)6B"2T6ZV(!U6PS.J Z'L10_P:KVM_AF]G-/^
M+?H%!N.Q^:=J&K^^B6:6C1GDO18&_K7Q%,<]E%>^J0.$Q-M@F*\J )IW80^.
M\0(9R$/MG(K*3Z"(!]LHA?YS>[L8.M)NW-/:#B..J[0J! D=KA[?GS5863O;
M#8_]T=S<W)1,&S@E=JK4)GQ^'SLD4^V(9J.:MJ>-O87IZY',4>^U8_T*LR0C
M55]>Z09VKE(@LOBFQR%O+LQ?G^?P_LL=T-T,A=1*O=8J&<>I(SZ*@\)(B07'
M)6REGS/N\9Q@2OP,?!I".>=2MJF.3OU!S]TQ#R)(CQ$-9HV17H7^KC30N9MP
MN U9A49>;FH=Q5@PH3$[$&6EB\#>P52>;NF5U$BF1=M> &$ZL8&3_$*[[>#A
M,NEO;#K2^[G!>3>.%;DF4H9>Z+\T$M@FSSP/BVL1BLM3S MA707:0P;*(FY
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M[T$0ZVF93X.W8MVP5I\9V5F5+?."=,AYBMRG)G*82G_Z?*-">DTHD2*A+\=
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M^MQ$SE+$(84XW-"NO([>X%?%2E,J^KM!>#$]<$L'QX^C?APA;K[,_S\'*G5
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M2*CZ\!S] 1Q4?)DX:@^^+H4KB-^!9%0P(4C44T'^>PA?=BMF[2M4>^5HJ/;
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M&SXI>@TU: M;GI)J'/V<3G4Y+D8Q7;TR]=YQ,L0=RTG_Z,(4?\^#$:'40HK
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M.>_I0\L<>-\]7N2I.H#EZ!J]'R6LJ[[=!MX5*0?.(E4H,FCZ-2!VF?@UDVA
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M8M'Z=-X0;I+UP&<3T@#9(?Y!,YN,5/."-?SH%A-85:L+"8VH1#J-1_("/&9
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M0_@X '%D,Y$LV!FD'OF3P7H$6S]\MN3U]=;@IM].)Z );8W4O! WI7E('?9
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MM'3B.X9RN$??A4"N_;"W]/*A5#X%$#F;7U CO*O&;TA)"\=Q=Z4/8N3YE;
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M%H+1++-NL*J9#?K95@I.NZBX5S,8'EV^%ESE'<Q[#!QD(::'NQ>:+//2H1!
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M%?\<>Z?_=C[/5S'"1.@WA$@J?/YI,U%'&(OY9 7G/^43!K^_K/"G=05=BI+
MO!-I#JTS#/Y;Z/6.+<@ D5]AO07)@&4U:FZ6_(7K+/ZG$>?X?QYP]FGBP4!:
M&U3"U AU%/P5^&%81)G[9^"IZ&T +JU^]8 [8O-12P48U3:M/K0^!;\V=&K=
MV\Y\.&!$3UY^3S7!3%CA'_2D_Z6-3O9#@D#I7^+SKSWI-,*B*%3L&<Z^,1*P
MYR(IH4LE,R.M;K/FT8#%8/I/=U+*RA=S@[Z6ABBL;PSTPR8GN6DB>@\5CA5<
M !\#7]M$YH/LD@%\[=K$T]YD%VB\ ,7$VA14KW 6.%$)>FOQ5X=( K].E<^P
M) _%"ITDD51CGN29=#W\5)OCT-(P^*DIW30>RG'!3'##0+45(L_7BV\(5N,.
MH [QSL):,;],0VTD6EU-SPRC'!JXB0Q'P#Q'Y]'S=^%:V_S'A3^Z&3>JIAA;
M8 3Y=TK?ZG[.<!S1TJ668?XL\E7=PB&F[*4C]S^[Y=97^"[YJFMDUGX)YZS/
M)CU8:*T^47__]+L'86BWGB*XPIBP"_KV<WG;V<Q9!]NS)<0+KRWU>5V$SY,-
M;.VN/[8@!Z@SHDC7AC9Q,%SU80QB-8ZAT'P/2.*>&X\PHN['[0I"2R4Q<:G^
M8\T6A? /X&Q'D@O@@F/!#X,UG1(' J?5O ]_9MB^&&\."(B5J64=+T+&7W>C
M#(*Q/ O^#P!C>5)$%##!:Z$N&, JQ;;IT(=GN^)%>%PR9 R]Q^S39WV@'C ^
M,V,B1O-15%1,<AO]S"D'% J29L79CMXOY5I6TFYOVA;C33Y7!)<^N,#X,VP<
M\#S:%J&]</-5ZH&(8@/AW)G<=-7T1%."W*'P&^4Q7M>4' LT;+5T(ETLG1"S
ML\'O'A#D=:)3FUOR2H_:36^P=\T&#%<V40=,12>+ZT(=!*& 'S>:$]:*C8<>
M"J>^[YIQ;2,J\O7A^Y9<*?)IK(UD$BY%=M.ECLBWII"'(P(X:<@"!4_SKT6D
M-*]ZSVZ4\VS,V,BR;2W"W_?C)H8O)<\] TIR5ENI==1E'*=XMC^?X]G!J(?2
M[-(P]>./**<_(#4=0"IK=1<?!LPE\+U%(,9KS84]X-L$,\W)K^HXRW):]8TU
MY.()!76=:CU-K4N\=CHY^2=>S%]HJ@8WX?ZTQB[7\2?.DHDW1Z/K%UT(=H>\
M#27H8PE!ZQJ==X?I>JJRO?*JUF<P7Q85',:P33+%LD=XPF4OWR/UI)>D]8!V
MW$'83#EFM[&9R-'LM  >)<QL05*51-1!EL%R>,P!VK8J!$62-(A2YPRT%4B%
M08(/@^,.]4"$L!B_1,<G$$/G;.0O#J.L2UM6\DL7O@2[<+]^")(!D!;"O<$<
M_3>;J_S#8_OE1?I86ALEQCL$&G5J F$7,^PX-7FJJ923J(N<V++T&C#C#?<W
M9.<FS8L\V'Q9I980F$-1PX@'N1YB3)F_0S@L1B7"7OTI<%9F^[56'L-Y5_04
M_Y%1_#L"NKR>;:;##3$XG?-0;M36(?]#0=K[S[+4.M<6H88G#QXZV;S>8JT_
MU*WUF"_Z_03ND' WWT=0A%9"70=WEO =AE!' ;%VP[E'>A>!N%7:.;!SHY-R
M#CA0RR)*3XG;[6[I3R\)O!YD.,!U35KK&%FO^C2T]EY'S\9GU;[E]9<M2,2M
M+<C,"_B+'5N0>OTDV"V;>UR,H*A,4'0+O7<"=<:MBZ\9>YFY2N,UF<#:=]U'
M;1,9P3V/TBO@W80I9.(<C4Y,(97K?F/S58]Z0]L:9',VF^5R7/_"Q;JF]+VR
MEK60,&_P3[Y#&ZQ(>E"\KU,R7ZX6+U>_V'/!GZUD[X!_FSN>W3-X-^UZ(1:O
M;J7K>[__'*)12]VLNZ-DKMBK?YH\I4+5(&U!)H-%R9 &N[$Z$<-U ;23@,O7
MJ9PNMD$U'RFH0)DIYC.K@F''$(W4U&;W.W<"9KAI'57W63:1<VUHC3-60K4&
M3M8SN;&,@&.NASU^)U8+&:+;G*EAU.ET8%)P9%,L@&-V=1T5H0:1GM>*V<V7
MGVG"0A!4B7#<PX+#@Y2CX-W%MEAQ-V_'CG$?N30K*J!"8DD<6M *(P2_F]^0
M>U1&+(&K4",.X%;^%$"DSVE+5$2=BG6:LAJ],6L!E;4EH+SW_;SHV"!]U]*%
M9G\]^.IP'#[4967T6)N10YK+0X^[):M''+-.XJB5=YX1IQHV8&HPD3QN(+9"
MZ<',C>5B3@XW$KPS&Y8 WR>Z>^A.L.X2MJU .\\F7](>4.A*9))Y!PKQ8!K\
M-0"=T&7LHVG-I>@-EBUN9A,J%\?/NIEQ4_QQ"P,3.L*]UKP3Z&[H=NTUQ@X4
M3% 1BM8,9NP.,Y:?I<8WXM-1ZD1TMZ(1F!<1L#]KKF-I:3_&E0I@DR($H497
MM4A&L/WSD='7HB4Q/YD^+6\I+7B!\_T+5G4>T&,>G5F84?[=%1D4H>I,F_CL
M->KO4+UD-VG#_%#YU>D9OD]UX*A[IWUTRO6NSI+*2ONY3*>P/HLK3U(_>6VZ
MFVGI!IOGFD9^?Z5WIY$@WBZ)ZBMQ&!4)R@*B*T./8&Y@DW)=:=0#'D@;BN(T
M2DM?S@R74%]EEW*:ONBCP>&VU(!M_=#=;DNY*D\Q,DG%"W+<BE@M=F?+O;)Y
M>@OY/M#K#,!;<>]5N:N"0E.5$MP!TU,BL6]#,43"7<"+S)  #\YTQ6S>ZL2
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M*G:]2J&[E5..W;0V^9+KD1?&-37^@X:O?%HP;17ACUKU[A?.#,?;_EBV-\P
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MRSB'JC?Q8ZUF:"$"GRJQ[E1/%/ZVT88PPD]VZNERD+\0#$%8(L4%B@T6T?9
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MN<6-.3K4)8PU8=LWE4XC=/"I8KHP9_V?@R>598X3N$3Y?A#-41<P+KT!0J%
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M2CE4:;5",JM)F)$ 3*Z4I(J*?Y5=$I5G6RY2O=N")8,5LR5J[EK:&G,U![I
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M?7B(1?LV0^DPS,X!#G7XF>P#4^KM9RVEL%TD?]EH0?KB? 9WKQ5E-[?+R-I
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M*F0'% :TCGUBVP.?5P7BI8=KCZK<I4> 66[:<'2B$8E^J6\15[1V?G(Q1R\
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M ,1X8?,H)7F\Z"J2:\_*)K& :V(C*R8+?-HT:'-/BF>$K)*F#T2^<*?Y8E+
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MY@/NSE3',@-')XLO45%IN0.Y"Y4KWL/QF<V\*&%O_\2R:2)'!FCNR(P0T79
MB-8ZI&S"R%N!ZOMX4:[ZI==]A*-#+T.,1?YZ6/B[,1?K5FPI<@15FWCSPW3"
MZIA\(6:R]4BJAU(\;1\VD)_/AL+&K6^Q8F%MVEJ\XW$MVK $6\-6J5%N*,$S
M']VEG5<16 AE?SDXT:81]#*EVS=7S=]>_IG*+PM3]'G]F&_O%Z/^75C[)EWF
M OJC\92@$H&QQ9:,[II)YUG,.'/W1T<1NI*@*\HYUZ10].F6MESVT'D>XS-
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MJ[8LN&R*VOOP1=W([F<1F(K>X/*<5%@AMU9Z+("@"WK739#W36W)*#4A.8=
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MA'#5X4;$7HX:6$>&FSCG^TO?!.R DDM]\8$3#NW<Q)X*Z.ML6YXFOZK)LRJ
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MKAKC=;B@K%M1;$0;,YZKT"3_ B*/JUBJFV[\,B:Y"F%VIX%PVPN706(<D.,
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MW/OWPQX*R-(^U7%HYS>N4)"""*6[22)#.N46S\ PA8OAC8('-(/QUD$_NTU
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M*M?C7A^]ST]ZNQOOOO/U8&[R@UL-(:L-@C'7%8^W@G8ZL^E%Z]BHC[1=V7%
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MWW'P:S_!"RQ:^03%HGX]1.?2[Z,-D$<('@"RM=RQCF $U'0NI(XS_.94@>Y
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M[OY49Q>SYBJKO$=V")'P>'4Q?2^UU;S*0L]-[#);%['B@J$-TGIKUZA.1'2
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MU61FH&<R\0!A_WJ=_&"X@D<CQ6Q=**0K8%O-FN7V!<:\W4H7ZP#8E[U(U^:
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M+BU@ZE4A5>\@[C[2&GH0/^%@+LY3< 7L?CGJWG*P]5V9^1V%Z\%F6Y2[<.0
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MTN9H=6M?,V6O^DE8MM"\6Z\O2ZZA0 5;CMH>^3N2,H,D))*R1)HME.!^AHD
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MYRC 2B>J2A:&OX\G)XX70YD%X$*;R+J=O&6*=%A6,]7_9'%%AJ?41NVR*#[
M?#A[NP%WLQ\0O;W\OT,1+J&A8B7X=NR8Y@!;HXYX"'2B$6Q]-I0>!*UAVN-8
M/+)R*%QSD"Q1Z:^U,%<FAP1;YUN(_%;D)^(,<LHG%9IKGK7<#S9>!3>H4^1
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MC-#M"6+'>^T[T5XYDIG_PUNHGG61J8ZE6]$#J).QN<LK<7:%M$^;M_&__?S
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M@-A'UO:8T<(/_Z\QQ(JJE_?-V,_6.4%;H2[F;2A9\S>'CT;;6*S<  &\A"V
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M20](R..)#Z!#BPZ^MU3!Q;_6NI-?UAS[]U*EV>*/DD$8](89B^84*"GX5.S
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M3X?.JY4E/_#JYXPX+C>B"HMU03RP^"*B:Z6>TSR,\5OZ/O/Q&Y)_?TR% Q8
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M9O*K9#N^Y%5BO[H/,DQ/M"O F=A5G?2$FH*:5#*#;I%@]F7E70&*08CS@>N
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M\]JP_GOBR]8?GLNM.7,? &/\,%5B52!3'E_)C$+L^P#>A-XKV@\F2:!).MN
MN@P)655N!\3)7?)X/=*,6*?WBWC(L/_PS)D0$E31SK@O\$[D_1/2/,0R&8.^
M&JPSM43J=$N]V_")Q9IS%JV("4@[/IFL/FMA6Y#>>WCSDWMRTXD:%YWY>;W[
MTS/(1MG%G&H>]>-'WM&_/J*"_]=CX586<?9$I<X3!VO_AL>&<Z&1 M=?\Y\^
M?E9^\MWU>A?+7IL<?</XMQ[9N,;.-]J6/=I.%8,Y!4[Z%2*C3K,AQR>;J9 +
MGMM04C%4:%C+3VV>&W@%[UU&@&@Q\#?HJSB,&D;4<U]P>C:4=@N7O>7ZT-N*
MS5F2:OW/>M5G<B"Y@XL?1D3ZQN%Y=(KH+"%\D;P5M'7&*[^ANT@."XBG2ZZQ
MDBID5[-=I'>)O^'NW+31*]+-E4K]XEQ^%36^U/L.?Q:FY6WZH<]]>B#+::#
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M[[14I**V2E)*R;#EC_+'=O9;MIM^K:3?FEV/(/"?[/?P#\!>'=1\(>!O@?\
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MA.F*V(EA34B:WF& 3-NCQZE4U<A)-/5RV)_AP3G/OI3LE 0UX N;]R 2M).
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MX6UVOO!6^"\P<&>FFZ6G:"3I'].B-W'AZ(O^+MD=V9/8;JY9]T6='K4X5S9
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M!6 F+BF2255&N?:]5E"3:, ,P<< W4R(PY/?C:-^J_[3 I[Y"/_"AQ'M"NR
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MF53<B4I01VEJPBYGTA,L_L*GW6]ND=93JC#V?,B&3:=M5)]K:]=]R@\<'20
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MU-:O[9C/C313_[55:L(>8S.;WNJ +>2]/-6BN'X8HMS+F8.=K,EL^,Y#CV,
M$3SG_"H>%D.Q(-OU"E[$E@ !B]LO],OK%AQ@GY=$;AU;L(]VU37H74DQ7/7F
M[-@.G<._Z?'+^+*BLW9#8!">[:;QHH>+N#F%>4.L_\RJ*@.Y\<[4HMR.SS9#
MPJ:/)Z=<0+.MS[)5UA%6N%9__V-P[*6$^[+7901L=7QB\RKQS[[[\5UE>C67
MF%>HSY/QL%1RZ$VI*%S/>4_BA%T/P4Q1M=MER#P]#'Z.QML"ICQ/!;PP\UA:
M(@R'H4@]@0+KX:FTGF?JU(M("3HH_J(Y@_H7>.]#&#J/P'G"Y0$%G@PR@GFJ
MZH\"AI5_8J\#S4SQ![3)9^Z+BI+,^]'G$,4/O.$8?N.)P%R3':+W$][Q9Y>C
MYS]:G+6Z2F1[E;/*/H@$)_=;]#T$,#%O$36FAI,X?/W\-SL8EW/-PKU2_619
MZVV;2K7)I"L"QJ8EZ<K5KS8"I,R:D6C58OV,!]LVU=F$K<GR<]7M8R6;@Q<2
M'-J-2K)J"VKU>.TF"^[]SR[;:K>.I7#_H/T.;093\R7Z5ZE:2W;;>BB=U0;8
MWOXIA#;" +0F5$2X# RH6W6:87!Z;+S@]QQ/4<%LAV8MY,+RTKG)!P.!YU)\
ME=38N1Z\C&#Y,%3]LM"1*_*CU*=RK6:AWN9S\G![Z\I@MXE :![%B; BL(;F
MU>$=;^O4'=$(OEYJT/]1]\&X^L!D[T,\C"?M<0;IJ-2YJ9C)LHFZX-?]Y<C@
M2%DOW)JAVKXPH'7\A UI2 ?UL6[005F\J'_LX\L^MG6C@WZ_GTJY.!Y*NV[U
M3N%$FW+F;\\S7K+05=-VZ^84B/G?</U7:W\JY7(=ZN^2??_0\W^:P?W_WLJ7
ME4J&I$BCIG*\J4B6L0/B.@K?=@IZFZX)19[#JAV$)0T+W5MPY1=U)JW*+WTC
MJKY<@P*RL;N=X,@N+?0%58R("5%ORD7T6OI=TF^5#Q?^DI50JV8'XFZ%.Q7=
M:!7]666O_Y@H%6;6L9YQ=1@O#_>O[!QP&+V=-A7\H"[@"+G@/[*EN<;K%U"/
M)O,!UYWGV./ZP]PU:<ZD#!K&CMWDLTWUWE2*&'8VK$PT)RK3^#[R;E[Q;EKV
MK@C?3T94XDRG)D(WY<A7Z:!S,FC:?8M_[&)XW\T==L041P?U/MED?/,,$ALM
MA0X"T4$$O3_HH/7R[>9_U98%-?,-ZM-%QENF^G^_I7NK)'OHYTYOGYF>:T][
M%]&@):(&$4I6W,K!AXN@>AGAV+V- GZ,Y@X<%S(E7O&O">LPE<$?EL;.I]0B
M RP$>RO.M=;]^82I%\3S3'SY\'$V-?W-\S&897]H5TMJ8[;*4GM31'/N@Y[O
M"ZTJP3UY4R=F""9A9S +'<0%BWC\EO>&S8JTP+$SZ36J:IR%R8#+;K'2"A-_
MLEAPD97'QB5ZX,.PZ <IVOL)6 J, [7&$*:-.N$7IG@(MJW$D*['UV>@S8\G
MP\$=]U4D;'NT[D4_Q'*==;K\F:7EC[L$R_DGZ8O_=%NN9[A;9!1_USI8]_'7
MY_8+"NH(LC,OBT.8EZS^<;]+7HB/,3K7B&>K]PN-L3-O0V@P$[[;"WW*QQH)
M%AB-*8QY;EH-[]=B5<E*[0=4VR*L- I_@'KK067JN8;",_G302.LT'_H0>_6
MC-#^> L&Y/+!9*6"7U 3JVM@BF$]F-+TG]@X53A^2JV$\-)FG/EGNV"DG VG
M]HDF=H]3MGMA*/UTO78&3#:6SG[^*PW^\6V(6?GH^;.[=1HUU0]OO$9H9=;/
M5%J92FCV5I0M9Z[F!GV'Q$93/$CH9'\O>TX61'0?4B_?KM2Y6[A1:DSQ]4<?
M8PVOIW5B)9*6E5+#O/!RK609?:G6(DAB4<)[,M-@I<=?.\$O1&J"%Y;K7E4^
M\#RVDE%1SRFY:&52OC!<K=JH$LSO?5Y)>NGW@0<O50PXNBJ=2LMJY0(<?H2E
M3GI-6\.MJR7'+$K- H7AO=.5XN?:-::B?*5&2SW[I _2C;S&QW6#CT_(=@D]
M4L &WG<7<ZH"%!]GHO'1TSD>J5V.S*E=NJ2YWASGQM]:ZTW+MAQH[:4[:EI=
M$:%LG8XP-1^E,(>O0Q8^%^<LZYL3:#L,MA!%4R0KI/:( KX#*XH JIHB1Y9_
MZQMRO79-Y,4QNX$-:6^@K#ST8=8/]=G9XS^=Y)8NOO52FS+P.1=J\I[CG3]Z
M0X'&<HJG@Q:J4/,HXGC_^$MH$W,D[>)]A/J LR19M!&_LQ\+$2)C$[K\,)ZB
MS)]4YPFSW\>Y[;V8<04B:)-7^$]/:VH"!3;F^)UY''$\JN__3K]%A(9/BLI0
M*[ >[& "9\J>+)Z<]8J@Z]_K+(:=JIT=QCEW3[A.[5^>DSL"B(:RHH>F,[N/
M>IJ;/1H%\[N/9N%P'Q6'L')LKMMT?=.VK(KB0<S%;EE=KXGJ^"R9!;/T[/W*
MZ76<Y'3F.KAZH,U>WQ)()6*+AY(%Z""P>SN[L]K'MB&6',3+OB6]@2Y57%M-
MXDO%%;!.N1SAO#S'DES.%[0#,>?U+IK--HM?B-;^:-/JHQ-27YDELOS2PR7:
M6L53>;D]N8V.C@(A;T=/M[;V]K;,*ZVMK=&"1N4%< '7A$O%MFGVC]T,)^R7
M(R(,\ 7-^$[88B*-U80<NM8ZN&P%ZP&D2&R]YJ%X;(P@+"Y03LAP5E7(._77
MSRNK7E.>:5MVDY#22B#FAW5G=VN!B,,YGR9=0;F[\_=EC+[0S@.^?U$@U$KL
M$_!GM6\;#N3RW;EJRN5V\K?T-2>[ 8:J8?%>X$A<\TTHX,]9.1X[T;6=/PJ[
M]66K4<^W8@%\8=Z@:,6[P;E&P05B,7R94"QKG8G 2Q)W+%-$C!5Q-IF0I\9U
M33;&I')+Y8"E*RQ0/]L5D]6AL&O*6HC6^'?/./BY^A",J-"6W@<1(<AZ\(^S
MI R19_5>CHG'A* Y70"8B$YU=./=5?%!MT]CGE_?%,"C<+A3 RY<2Z:L*JP#
M^PB],'><3<7HF-12;D6^6V5&WCA5@4,TR.H1UU/WPF5SB>S=>]DQ+F2.1*VQ
MD[P"WFF?0BUL3*WJAYCT,N,#K[1\^3'#6OFRUE,9XM  5@ I.8&$JO\1SH+8
M)V8GZ)C6)O.;D_8C"T;N3AV]:VE8'JD"6@<<<CZ4(6"&;!=:(V@G E<*CN_7
MCMP1*(5]@ %BZ%[S&(=LG (O,K2;-)Y/]L#107PZ+FLB5P=0BY#+J;L%W+GO
MT)RJ+ 'H7<GF^Q15R,ZHKU7NW@\MG84<:OF(8R^OVA;_7FHJ)01O'DUC):OW
M*PA[7^S@C*)<+7':>;%2&2Q6\LS!X3J>5_ICK7]8R(V$$=/ZR+"5THJEA:UC
M/]-@__-FC<8(+X&:31?2=D#%L(JMB'[ ]$:5Q?-H^$S58H:OA7'>5^J*X>*;
M[PBF7'(Y;QA8:466**K<[_9F@]OE1IZ18Y*7Z\%'0IE=EM%D)4S A"6'M.+X
MZHMU_9'BZP%SR=JH\><?&Q1VTC[>F*C6N0X^/%P;I_#:HBZ%3Z2>RB.? IP8
MY"] J?:H=ZG#,K!H0OZ:'E(Y5"H2M- 79F7^J8G-DSC3E)&V<6?Z:'"VJ=N(
M$B?6:=L>G=L(M)\^7P%"B6YSNUNG4 H'67WO*MG_UA1Q1L>[;'-%>H+"B8<Q
M.XQE*>EQ8(ARSCB[^HB#:].R@X7'BS[0NV\[>J:.!F?<9LK:ZQL B6-=4FHB
M'>23NNC?O]J:&H?4]L.#HU;.]Z!-@4"7@"AS@IR=,6F+E!+I]M7@^7E,(?SP
M P'&O6U[L 0G]H][%\X/Z::O7$=_13=(1$'AZ'AT,WAO(Y"4381&A9\!!A<)
MX8T22?O-,)#GZH7FT\YY2C#YVA9-A$3+)^CW-$Y2E#TJ/YMZ$$P-1GLZ&LP!
M_8'FGB)R%"3S;J="M,.!7[$17HFB>M=6M/3)W?KIMY\3JO(*I3-*[7BW)BW-
M[I5+08(O=<3[.Y+/HP>QE\@_F<^M TA<?.."Z%6@=\C>_%>_ AN<#F<4L8:!
MORG<[[>_?A8>41A6ID!NOE-11AYRQ=::L[S9T SG9#VH@:B+G"^K-8AZ3OT,
M\)#Y"?S]XV>==K \/>P[L#,Z-JX$D=NWVTC.S001Z("I:G=R"UKEQ4H^!AZD
M%9957.H\&N+G[>W'7F]TK3Y_8EF '3EQ&DB;[5&GYA4#-]:P4:)@4FLB1)'B
M0Z:V1B-5BX"6.9OI@-=-S3E#IAT=6;B;<RKLEB:+M?[.I&-T&;AUX,F.?.E5
MEH+I.XS-#UQ'[UF0;Q^GD'P'3,\0A7.>8HC8*(AR"XFZD1B0#YDR;":+HJNO
ME\G=.7%'>[B6X5#ESIXO\IX_^.QHCPMT\2L+R0GKGE;G5U_5"I]+.<%0^!*/
MKW_R=0U1&=7N<P;/[9U!5=&F&>B%)3A-!)R/1KYW(WU+EXVZX5/-S_5GRI(&
M\KQ+KEUA?+%).IL!5WPFJW^E9=*,CG:MV8V\+]L=SY]R_UA$*W3*:"]^3U$@
MVPGD4$41M^,!<'Q;A'VL*%F"Z9DM<Z(R$BLUHI%]!J9-?*#.X?'Z8] 9J3[+
M#XKM/1R7D'._K3C&I#B=?^P:WQMJ+)U1_J-\$+T@1,S&K?*,K*U&PQI\4VFZ
MSILTOB8R. [I"">P@_&I?WQ)LWE3/J6C6HV(6.U71L0ZQ,NYY_AR;,6'5BUV
M':LI)M\*357\;]4]V7I7FR4B:!([05 .B@L>+8P4G_PZVV5$&NLED%%QJHF_
M>%0L.>BMS8LU?2J=:W9<[);>-T@T:IL*R,V8*:EO0:6=2,56A,^#FWVCL(]1
M478TG=GHEDI"M_W&1+@(<+/<IHTL$9\SOVXD$>T1LX74+I9*^-'_(HI)K[EQ
MT=Y >MNA[ W[T!"69#0^'SD(9=%A)OHF8WGV/*:0@>25, 7+^D_R?ZG-Y2A$
MR8E/!YHX[MWBR[1=O4=VHC5>+[Z>JUJ?>W<J@'KYC5A[#[:A)2% $2.%2<#$
M) N^JKR5Q5'C-7O\NB,A>$#"S$8$ZG'.:\,LCU=HW3(C,_6V&B$%@J.*:3C^
MT6:7XI>GE_ZH(5QR7,<0O^M\&Y<VW*7[0=J-'/LKX=G/04XIG =ZX6?*D_5S
M:_[(?97*-R[X[Q]<%.]+58T8$-0IO)&$'[U.VGTT-6#F] +R=R"8E#OP@K"9
M!5'L M#X9)/^H*G, I2$-4D$$TOL^O1=\\F>0MUNP/B%'2UM+PO[L5EUGB'A
M-(-=M!#VJ?;X&6 $/X[#1L"8 K$+/(/H"S2>$?+@XMTI"JP48!T;P;])./ 6
M<=>];3<9F#VMRK;9U&U1.)$VMO#-Z$IC8Z/WLH%E:P,X#TJR3)8YGD:_<^:9
M@\*K?2.UL+N'^/VX'+UO[86T<<&A^ #=\-#*L?*R+7[!43JH/U_"IB/AYZXJ
MVX@0/"!7U\"PM:O=Z.GNF9_J-ZCY!.S\(FY5%*E-@AZW4@MH$"#U^!%$B)J_
M1^'SP#@!YG?)>G5H4IA*OO'^J8QEP\SW;FY='EM2OU99*]]&7/&,JN1?.;-3
M-A/KK1V3NX%OM,6C1UQ-F..KC:-<;0A;'S[5)F$BCR>BG 7S0VX%^OE5?%M7
MU?]0:VF\%>X223XS2,'%4>ZNY<7&M;6*).%WH;'V7\^P#R U\1A61%:;OTAJ
M_P0Q:36ZPEU3WQQ/4Y9*@AMP9A$TLA>G^V:2'ZAZ'?1+:R30B(5_U\QD487.
MBT(75JUB?MPD[2QX7;S=.Q>L:$H0P@A_WN9WT($P33Y.44FUF0YT,OLLHG7
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M(*P_&&XG7R[Z0RK#Q\8>5<-I,)37*[X?7\G4P;F'2@^J@KA_IOWU6Y\FFE
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M*L*XA-_98@O%57:.AO1RQ[5G#E^A5S'&'/L6!6QLZ:ZC1<ZKA<+RJP:LU\S
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MZ[X%;DM3@_]Y,\#]"# XA]O&ZZ1%S&T+=1YG1EY?"2VK\'_Z-8^VD/-:W(X
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M-,/X0W:4XRMR783N)63C/1KHY<-1?S W0PI&77Y%4F2'V1N2#Q3OCUYIKHF
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M'_]<O"-+U-4Z;(=5(C9\:;[W:;".L@L@(:83%?1B&Q;I\%I7F-&TD, &G[U
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MRHTM)9E&;-$LZA::4LB! !"N/P+>NZO?]X'MGUF/$(%"97BF0"9KJR]?11+
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M%%OU7[V%[_^Z5VU=K.6XN5-9F(42^V!Q6&V(Q<GQ9@E)WW%XF?=FM(.J![&
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M9:!T^9)Q3SMN-5E]+,I,-[#/M'FD-?U#)^LSH8JZIG6@)1U-X^*R=IVV3I-
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M%8=92(QW6M+@<B&FTVWF*KICG69-9(I*5YGW)Q*L8/A:BV<:%+AJL-&2Y7!
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MJJ>1YGT;L[6 %RH3^9:B9\);")XA2_KMNF%WR>GQ&QO?1=H]"<1T<!(GD:D
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MGLWQZ,8!!G'KCWFFCMRM7@]%[ A3!6*%CIP6'B_[B([AI.3?XR5Z-#S:_KP
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M0W!*^">0.D7FT%260/NI-@-L\H' ?'K!>YYAFE@9T&-;3]V[WDSPI2M:;/R
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MOV:"JBV$B%Y\%]GV;.](I4;_V)'20N_J4L0X\RSOM;O%@?B8!(\T:U<YT%Z
MU!VB-W%G2+_(X\G7E>ERO$=KZO"UUZG:146)(T.;J25JJ(];8ED44G *.P Q
MX1$>0531(WP$;T>J)_LA7 KCQ-/VY;7@Q9KH&0="(.%M(X+QY:&UO..WSG%T
MAD\+MQ^?;WEP)<ZNW 9R-,G5G]KQ:N*[7MAVK^ <MI_6&+[N1=6!ZE+5$!#[
M=F[!C'1J+&$=K@3 >PH/)=Q[6!_U?5,%?1+&W4PCKUN$[ O+'[#V>*7)<18^
M/L;TQHX07EFNL02F#&0SX3>(:@16*J=7J=/RH74 *I9Y$,@)05[/=[TS"?9G
M#P>&\&S*=BO-!GFH4N;)YJU!01XW&V0^YSOQ7TZGF$%D*V2F^OY2X?ZH-J/6
M'OZZ'1LY3 DYN?VNO,)=/&FB$1D36\#+16$1H[DK?9%6+$2?>PV*\;K7M+/.
M%>:W&%<41+LNP$'FP>.X:(\'S ;;7V>@Y;KYFI/P?D*3.X%#TQ%_(#1A"$WA
M;Y%M]AH;G/R1;BX"?N [Z""R=4=*^(=$B I/_3DJA+*R+#W;7U_>3AE^?@_E
M4$R+XS#3J)!QL0*N4QM[4A@%N$M(%:S()7 VNZ"[W&HCQ6#N2,;W86^6N(/[
MX"T?JP30JE9*U (SH-)+#*%-R1]M!=TE1Q*3D.?=9/IJ/E2LG33\[L2S9=7?
MIQ['0'EQ7<RT;4OA4>QNWN3#>!93-0+.L&M^+"*5P9^[MD'7S\CN2+E.FF$F
MI)+*W.EF&V6K*DOQ=? >6J,$S>LUA=H4$0$3S-V1.L^S[9RQW!^AJ]#$A;1;
M6@=#F/_C4BKR"O!1G(Z.UJ* P#DM';O>)E&XP$D0.;\R:?J)[K B>LYW@KRP
M=IM\.Y[BE$'V:NP&GW-5@.]]>=M'%1,<T%>.F#]6OE!UKMC.D[@F^GR=^\3M
MZT2TR3,?GY^04W1^R9;^J>8B_VCA>[>6F&_A8MG>&L2\+4UT'_L;&KOJ3H?\
M@;DH:A'+HT=<QGUZXV.O+J!^[V3;\N"9[1GQL*\Z]BYNT;V55-=X\\7Q1W75
M1A$!H(_IP.8":&V7X _L.XCI:]Y4)_2!%CP%' XI,$@K,:(+73G9.LA6[.-C
M%XK<1JTMTR"&/-\I_!KQD75J8M(!-[O3"TR42?L)9^VDAR'N)Q7/W;GY;]!)
MLDE P&0.*>29L4^UOZ*G"VK:FP0[EAPJ>S.=WQA5[?SUV^VZ])N%><XC>2YE
MV6UJGTK+M/7?<=1FHF@I5ZPHE*YTHWHPW?3G!P J:=@(3E?B;<II7"\HGD"Q
M>4P"QH.:>.'='@_A"EB=%:H=#X5OMZY'G^^=UR[AHS3.EJ+]>Q)<T"6K7<U;
M(5H?]%JIK]N:N2N1S-! [6"'8JO-)2K5^?^^F;I+C8=>HM0U?7LN!]3:E39H
M7"@YDLP*R4*_EYEX,:R9:.ARR[>:"GLVZ)]M]I+LRDBT*9-IC?G\J3I6QE#3
M@1@QY#O\KF.JQGDSYB<%>%H6V2J]5B2AK<N /S?'?[(]1F"%?0>BJ*_]K!&"
M&MMY[D1VF\>!97Z)92CO?*=8<\K:8 *E/X;12Z!JJ_]1'\UN:0X47;];LH&<
MZ7#B>XMEVWA%K,\=DCP: O+JT$CXJ- CBK=Z%HB7,%FRWZ12;_4(I\.U3_<$
MMX)/4,";1Y7'6_Z0<].U7X\HM__4&'7"34([_2C#)8]NYO3F0D$7(24&<Q!(
MY/9W030!CSCBJI9?Q4+@&1/C[V<BAWIL7EU!\H!44TX<-"UL<JTB\4S(9A#A
M<AN=?+&EO23"4Q%[!PC]U1J)C#^ .?M!;"0\(R(TZ>CU437HT=8X.>:*KB%P
MCUULV;5-'FH?KD:'=U'->=%M+*@"O/OFCE3DJ[;1)E?C[ZO_D3?-CC:W4IH+
M+=WC^_92$E17QGN-_[Q%TCSK:%7.R[K<Z?VDUWDB^V4UK'FO]<I$9<,!()WT
MQ/UX;D- PN/D%^IR/N7+@^OUX9L^R.DZ_V&-OK+,4 OX?;MR!N2$*/4:Z@&<
MZZ4P8[D0EU4^_GU$#=CD8T1X\'E60#C]K]0H[-1"_=LD*&LJ(Q4?N>0?X!H<
M<YEV<B@TUG(ZZGO10\P;MN!2<S#QK9S (XW)#4#-F/:7*">>\>_"[:>%@U+@
M>]O/L^6-+VS' *N^$]\)JI <BPJY#O)[4F7@TG9=$4X66HPPR+]1>?%34Q(S
M!ON!V8!;ZQ?XS@(QEX%OW#)7'K6!9?2EY1=;_)#8<?M>N^#B=ZF(IB6P[X);
M8K>N7I)Y)<)0RV>[O/5.G/*LATZ-FT0U,#'R(@)VOW@X9%\V:^0M$[]MV$V3
MKGL12W*K6-[+_YSDY-<>\.2+[V1L<<BFYY3UG'O GRW-=JF-U? 0\V(RN?!2
M<W,SMW\H\$07G1C2% I???VL3;Y@XD&*=2K^94#D[9YS-34K;O2RE&1?]7.R
MRL\JUL,'<^NLKC_30PN,_(I]-F:9)Y_EPA:=8=ZHHJ=S1VOK1D)+TTV[[.[_
M/WT-^?^OA[8;NI!+:_SR%I4)E]^1BC)E9H#V4%6$+G1MOE!4V@YI)3RB@@#O
M7EBMW9$(V@&+TC$RQ0WETD$W-_NSC6ZY:4Y>K_OK$>/KU\\;<Z%O2IP#MZBT
M$OA')(?0 _HXXB*JH1X2GA.E[TA%$S16YZU$K\2G,-[<RC+N$#^:9YL&_J,6
M".W)IQX<M3J]+@RLGH^P<PX4U,LQ@_J35'(0TFZO&Z@9GD\-KV7,#*DB%F)<
MT(A34[DO3]Q/\76)/D;R'>Y]<Y9AZ^Z7$#$]'-SK6_HYY[XO"OW-E*(=?$68
M?564W51-NT8 C/S7O05*0LM@N!>@7"64&96D&2J9)K])62U:PH)61\A 7!?5
M@!N'CS5/6*0U-C%5D"5ZB1EW6DL2$UW/V%]$SO2W95QNZY@%%@4!N$Y7VG54
M:LZO#=6:D'W8P5N8_=R-%M: A*#^X,9E4/603-UV;19("2CL[_YG%OHHDX<Y
M-F6=9/'%=_PJO>C\A_HF;K2\\$_$!Z;K5:+@C%!15(/QY9WDOQ6UBP^CCPRQ
M%/IQ&4QI"[&*^!U4.O9,H./D#RA>K,X5IQ?B4^K 29AY;(IN(YN@N32O-FFM
M8_'9>^_36[HO"RLH9'(O)87PB=B;?6_>$L@3: '$LU.T:U# :*378Z9URX72
M!CSFG61G?>F;XEKDU"#$AYMH4^7<Z"+US&M<A9YA7?;[OBC+3H@RM_Y>NVN2
M5B2/&12$X"Y?#NI<]RQ+[N6\,+OT\M\,LWKY[*);]5ZQQ:J'@GT#5_]-N%SY
M)MXT],]5>OX1XW'OV]CQ?*]J][SG-><VFI;-_\KUJ7<'4]_?CMK4\L@SLB&8
M%UAN3G4K,&A]"5/K([P<OA=/3%@8PDD42E<I5Z$?-4WL;=V3WU 1B;4'<*1]
M3?7:3G5#-4!&P#AEW?4BS^$C92P:8QM6ZLCPRR:%S"^_#Q1)2QPCG.N3G0Y1
MYVZMA_+TNN=_!Q U0@L@7N -R/'/BPA"5](<.L-U-%;AD!LJ'LGS8"OTXC0Z
M2?/+4X0#0OOJ;D1LF3-+1\XI!I&TMSB6-/]??T!(H%@V7OJ1Q)@R4W>D&K;6
MF=PI]T!X.JXQ-A<J!_8F!D\_+_+DQO5NXAO1WFMV[]3]ICQGL_<#/3 #0N4<
M[-2#RSS51?IU^RH]PYEV:>XKW+2Z6*:;&\KRSZ2%U:MC)]5"#.QN,)NFNE&R
M$9.ZAKRF$\*+^!Y=**\E4_J^-3 \TN,&[\+:H!2 $'/9^4WG2=;YL/J/S.F6
MU,FYU\LLKF)92A_XC-VJJK?\_>V6IBS#]9NQVOT^F<13YTZ0'4L..+]Q/)EO
M4ZMN:AU3LV@7>1M_I-@]\70B1<DG_V%S;H5G+,([8XHHL?2-]!TI"KD;60!J
M>D02G #P9SO&[[CN2/VV2FB<(/1T&->5+ 6[5M>](0+?_'G6Q>^+]$G++5H&
MY#+DISD9BY2^XD.X\*=")['L24&P\+PHBWH(H\B;ZL[>%0%5I$#3X$W,;M2#
M5F8RI;+C_I:?1.Q:@0XAM?(*DBFF47#GQM'V,-PM5J+.R;.3L?2)[_)VR.5P
M^G>W<_J>H"$0UPV42K7AHM:E!?]#PO=#%,0?F(TM:^?):/MN9ZY@86M=$U6S
ME+#8TCNR;E74 _MR'ZS.CH('\PQ3P$96K)JS8'^MC//5;HG$2[ +S:]>CEZ3
MN%S.W&H^Z/<=J6N"S?W+QY#BHZ]$5.SN.0!W[@TMV[5YDC*$DA8&%CF/15N?
MSGLQ_IR.&IM_'_C3MZSIT?77L:::JBF'=&3"/V*L'<YU:-45Y9WJLSJ<RQ6*
M!VN-?9\9321W,$:)5_JL50H+XRAV3P*NN,7TN?"CWIPQ1/:^)AI1:E':3>NA
M#1,X)&TFFQ\/T 3V'[$?X7([4N&FT/NTII:>8&V6;DZM4'62>G@.35S8ZD&I
M7_B&=NW>D3KX@Z8>!$T17K(H-FQJI7$G"16(]X7^:=:!@=V(RL"SU3^HQT2U
MN,C-3'A3?>_F-(=_E.OQ%K<V,LV '@C P(%>P?E@0+S5U8@>Z;6[45A,O"<$
ML4;P,<MV[=N/'JMV3% ;JH)73LXXQ$<E[L^?1.PEV%"^9?>-*&,0DI[+$%X6
M/<8J7?DU:=KD_Y:&)TA3(6@]/A[XR8$_$DO^0K+VV<8W0 R"!)L!]%A\:LO6
M,6"=$D-&)F 2^E(;"@([M'W4[C8WK%A>_8!&>0$-$MTD$-71D*)$7]%3+%2(
M 30%/L#466!@8407^QZ[^S5 J ?@O=F5D0]ZJ0J\[ =1UJKT&T?L.H2K%2M]
M&W)_A*-"P9<OME)Z"?@$+!G_R0M]0VE83;:<<S_K(AA<WM#$DGDMB)/Y2TUQ
MXEE$:S;#.]/TM;O[UY33\[,_=!0B<JK&O5VG;3C8"_0S1)/;SC"WOM70EQ*Z
M6*C$'6Q7YH;R)PHX$J\T+.<DJH3^98J3'^982J'5@^GZ7&AV$S/MW&X@B0.2
M6=%ZYP\YW, M7@T.7-$2S'96!T=L[]_&EG_5)L-T3LS,0>310V)9$ _TUJG_
MVRKSY?664F"5=6?^*!"<M-"&>J0<@(!83^B-;PAM$>RV%IY:(X*]([5O9F:H
M:AJ=NM7=@E6?>")F['U)N1:_@/\,?8#5$3TW^P&?(?%%0); &$V _SI38(I*
MT=W+E5Y+K Y>.H:Y.('=!VC>$,JS5S<UEA@5):2R ;9;>%?+U+P1_JU=<M8M
MLG-I)%4][/YXCYW^=OR.U%HX=\I70G/14:;]N%?U:Z,"#[%DN%]5?.G&J2MD
MS^\&?K#(_JS^!^ K/-EU6<#. P\] #Y?M_IU>L5/G7PUI@JI"TH,-C$UM1=!
M!K7E3M<Y-OMU+TR8W:@:[?(JUA@GVSTI-G,$S73O2:U.>^O]N2<19G&*"#N5
M\$]*Q%^&QI>_W"K]G/:>:&UM[!/IUGNT0N9KZY/+)-.S??YXTV?7V M/\NI-
M3TF&)\-8 +/].W89M4D+CX>&E_&V.%-"@W\"EVE*_7U/,0DHT'H..E(<%2Q4
M!"7/].#=T7],-/VD/"X5M9Z.UA)V&FT7B.4DNMVH7S*N&YD[4JO_$QK7GY:$
M>00<XRHJL:Y/!S5L]>Q(3:]R/A?4# G.8Z)Y4WBL32 &'$\+GPM\V[HQ<C!"
MJYVIQ/1S-:*X(=8J7S9]J+WQP_1C-$7^"./;?\]6ELL%V4+5U;?84X#$ NW>
M$+W *'(YG?/&O!VIS!\ON,^7YA6Y_O@?*!6 X*<5WJ^06MA7)GKZ?.EN :/B
MY\NQ.P*1^QH,]BYJS:RN;E%NM])_C;!2C/<#LN556>]W+ZT1]/*%:OH+,Q]]
MK?'<:YR[]</&5F/9[7GX/>)N+].G Y[5ZNIWZ1U%[L9G$B/J29!$GI-0-5PL
M(\ )+(",MS:$)AS^,R]V\^T9>">?<8R;W9.7#U><Q8!?CUX=WS,.'+_AYVQM
M&^AI/V?^//2S]5O\"?_^UH(>RT,?<9U'H0O/<(W,;H)R)%:&)[V>P3O)ZE_[
M4@/T7WJ-U,Y2Z-2UXA$>1F'<_Z";]TQ--D9F6^14!)N3R[M6_]<V1:Z\>=05
M.3)OJ;YD-\M\Y9$./K[W<?4L^A%J>CSPP]4/4;71T=8/?[R!: 4M\Y8/(E[V
M;>6LW&;FO4KO,PKY'%@9B.8@ HR%:="&@GYH.HCK8OGQRP6N!SX6];N8SFP\
MT,)2R*(I"(TY@=H[4M+( ?:F-#JGI\"-Y>8W%6@G<?P_Y 1GSDWYOA*/N]H$
M>UP:*RU,-++0?Y-]21[3>IQHU'7G<.,S<#D/71CP;XS(7ZMJLNG8ZS!9*Y++
MLYK3)H\7&Z..TO,N3MY.J+9-?>+^3%\:A7 >M'L?EUM:,72]+9Y0ZL_D7F)^
M3%UE08JYC_H7I.^UVQ,CFFTN+^G:<9L?ATN\:L:V&J5R=XX;+[^8%^C>DM%'
M[.7'\7JK=Z20(2M3#Q-CE;IK8$P$63^9((/KO(V5Q6AQ-]>L>>?9AGBQ$N;$
M!^KA2)P2^+>D:O2J(U<]Y0Y-8T6]=2LKZLN4I66[1UC%6?+<'/)DD(<-^=:9
M[SF1)T:L"K)/_K=(O2?)[X7GS"9HAO!X.,MRKP3>['"1<Z;\='H4:XS@ 10L
ME'/CUGBLD8/O2'OZVFHPT1WTTJ9)L&;%T)$52$A.A4,=TN;E4"6C(FN(_/6L
MQ-P_!5 \6S9M;0_'4EH(YH+2(4?0&YN]3+EZA12(#A 7Q,,VWC1K]R8.UXQ4
M+FV?29EOB+OZ%WC@\VNU*RVO'%O;#O8?JGT&:%[7P#!-MODF0?7'*ID0&]6F
MO$C(9/E/I#M]A6%3;?#"__'K-[?M?>%AX#.X\#VXOR9S9^]F+#YJ"/F.XI)#
M8V=%*ES;3M#]'2FY'W+#@2QBEV4J2,$Z^-R(P&Y'RIMK^S?&F&5^3N#QC?U&
ML&=QXU[Y\I:M#0YQ7R[[U;!IYY=NE3;P?Z-XXJ@#YM.7TP.#MW,_K<>[NWO=
M'0UNGL\(;3B:]\3YKLO0QED'%9],H])TJ?\W/:9XX '/EM72!5>02.HK/'^V
M^CVQ)N"_/LD(%QZE'<1<>0Z<E*@(AC_)],KRCM0,1(\V?F>S);A6F4(A,C _
M)S4O>;[.XLWZ<VA"M<;N5H\,B2C)GI:\+$'4,G/'4@7+8#;N2.%C25";B]BI
M\E4DQ]S6J_G;BVN%EI#WGR/:/Q8?S<9^"OMSW]H0]T-?Z,V/D3FY?\!*D[_L
MKCC5-]RB:I!S%V8P1OT<6[D\_FS,K3?88*VH%48A4Z"!=6!GUHS'@1&V@)SH
MT,PM;LXP?&B!\;Q5$]#-FL$=Z/Z+\8SQ?7LVIZY(+4.MD%PU4.-\N_GX1U)P
M$WM6TQALS4;) R/_&P/[+TAD4D2)*;<ES<S\1[!T3XG61*WUW*[ <8L/KLAJ
MA%9?P:U88J2?^O''^AV+>>\FO_VA<"BS7$NH"TAS-I6%!J)"*(H &(+Z=&!L
M =MPC<0UY#B,=+GAO#(#W7B6_!L\Z>Y-I5FT=LCX!^-'\1B#EKN%%B25$^UV
MOG45+Y9N-GU;8A1U3V/D1)686 $4VT_C7K24!6PO<DN(H8+SZ!:696>]YBRZ
M<"B@O6U,:$Y>+C@QST1?;2+'.*:.].Q;!DVCK -BB^WT#S0B;/=,E&U6Y_BD
M5U73??5__-N53-7RY39V3O2-]_2V448<"R/MIEND-PWR/7L,!Q=U SO?D!=E
M:AY7+DSEED\(3-=&9FM,64Q&(+^0U]])8#CQ_P#L66105R$^E89 Z6)<N2V/
M4#^&SH1P@L?,P#HL<\N@L4INQ7!J"Q'!]\]A1AYH?;"J=?W-_LG'M38?8)?Z
M/F&>*JP_%<0*0T2UT$@).S[@1P/^ GOKEK4=*;:'=*=T+SQCBG#0K-V<M:X
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MU"CK:\-VPMVSN85;UI(W^!^W*\6RT0+6+@Z6](L%+-/*Z=M.X16$_0^94.'
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MB8FIABMF2RO'?]EW8</Q7U51$LC;NH [SI:6HE<OI#"4PCPN+6F^<V4"(T*
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M:)Y[LPY5WY'I_AL(JR)CY[O-;,P!A)2W!.<9^G/.CA*V+_#UL[\_BL-*--%
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MV=8,[8ML#)^.,R#00HVO]Q>])U_+]XG(S8CPJ/&J+ OU6'1W#6/,?W)++BW
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M4]4#+[QMQVANCRUF"@X@[3_1U)[E8TGY3YG56DT&K%%^^DSZR1X=>'OKM]8
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MDS[Q8L4S%N?3 K%[<'9;K.L]%5/JM(Y&:OL#BVZ+\$!LB)+;GX_'4<GU-0C
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MM)217?M6I,/@:3RN6%0F)''R[4?7"_>+.O6< LYX>F(:.J-@7P_T!DGVT+5
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M$'D\;A%\R#5Y '<.J@M0E6U.TS.>^*-^[$Y\MNPBZX[+.<\%Y8;)F&W&LJO
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M_\G8;D/XL^--UY8% F^0S/%^6(;7'A9* HS_@$JS2O#=GCJ.U@Y/]!#@O'4
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MSJ!WOMQG#B:!UP8T$_!.[ESC)$YZ8ECJ_D%7/;@=[RUA\JE/A-7IFDL?P50
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M-1QV;I>%7N&E6^^JM(UJV)0NOWV4_4JT[_V42!:12I2](S2H%@8S@-)F<W'
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MW&]EK1F?*GYWQB\]^TYF=)A/;O;PG::1H,]COCK?8/61_\?9Z/^W#2^%M1\
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M-JS]BNNH=6"5"Y^BY3 G;S_CQ604=7U>!C1U5TD\E" ZU59EL51IK(YYBC@
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M4D><Y#ILM9H-:LR(S4::^F=45KR#;*4HMBWC#02.ISR&*,CAR+3UJ7/.?U:
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M"S,M<@D;*,-/1,EK.8/52_\X9N&$QKS0#XG6R/6.6PAEHCK>8P[.1L (.N!
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M(+^9BU"\0C?V>SH3I+,##[*_$1_>%CPAP'"8^(IEH@4#NA?*D4+RDD(J%;A
M_#$?S1_F],H+?#W.WS0^):K8>A1%AQQ8S[9E0EGW+%O$VM.G*/R^)$2CK12C
M6=LRB12!9HL(QB/(\M<:H&24D*XVN2W3A>2S$%W?<+RHOUG\(T/B?F7)^-/-
M"T8V,=IZ(]6GFRBFO\S7<?+K]2N^>F"M3!EHA4*+QFQD(]I&R!VH7'G\<=3G
MH</FO\2[BOKR*7)'H4D@'96VL=%:6G0%$"#2;.5)6D'+EH8S?767_?!GH\H%
M&D53.BZ&GF0/1HIKS"K,A>7_1("QNG>X&:;%W!7&/ JV))H.9L'VK,-4Q*8<
M1B!*8)&T:GL4LOW<'20S$JFOJ(GS!)O3<'6.U9"/Z_"'_-,,_ZF[O*Y)9/8%
MYQ=70BYY//;%V==L>*Y3$??Z\Y"XI/XI]XG^"Q\/#TM"U[#CHHX.+*TM++9'
M^;U4^&P"NKWCTZ<[@)!>>B+3I!&Z%@9G:@=*=1XB@;&"2VFVE_=>#,(+X@U]
MVS*Z[E9-GAO_N+.7^8V@(P_S^A-10)UJLMW!ITP6\*.S;(_AV5W$W2\ :C=\
MYZ)ZR^H:?TM.0/J#:$(P&&LW$V Q<QNIS*-0(%98'[6F!/F?:_V^VL0;(FG3
M1!E\A8/XR;YIG=;1XR-B^"SVO#^'>Y'YG'_BE"C+K= S5]-!^^^_:IP.)+W[
MZO5^^6POXF#&0LO1W.R(^RWM'?.C-]?BI-Q6U,@*J5J85))B]+7O&$W6P#/:
M=\P.9E'V6 ?.-35TC,YT!AV2 O04J:>V:JD >:TZ3)X_(/VX<95^9(=#8T>;
M^54YYXJXF/</@O4,\,=$65NE3!U\S>9+EKS$FJ &)<QA3TY+OD^RW[?5PQ_K
M(1IP:)&U3VY&.1>M*81:?I#0T;BJZ7?^$S,#MT,.WXWV8.-N#?<;'#O_.# B
M*,OKE?*9Z6*ND7:<DT_0:F!)Q6I)26G"_(/2+U%W_6BHX'JZUT;I@%W,3S--
MNB^ML-'=$M7G$!^X+[7-,;;D&!B296UET<W:95</.70Q%9X_;P)Q:01DA6U3
M:_(]_K:,7.#$U"2>[#N&%9H*%07C DW7^?'?M+T^;<OL)W)A^]ZT;)Z>%)N,
MB55!2A>I"=:S%<T_KF4%*'3;* 0":\FX2(5DR1GH7AQ)>2,%*[:K@I*7U:P/
MM6J/IQ=6/30K6K[_S;]K_&KOQ_*D;F28F:V:TZ>,Q)@KKE'^\P5&I)0]KPRG
MG>!Y%M=U3QN_;W%VB+X[ZIV^=C='&'^37+M(UQQ!2!GZMDRWBN1TVY#M&;$F
MU]CVT-0$6BHUZIO(:<R]HS2)ULRR7]+''*HO7H Q#L>+=:.?A!6&EU=-^&.$
MU(&H)^B-YEO'"U0:^S2=X3R4Z/9HNYJ DOHM6O@#X+0MPU^[MVYHH]'+M&Z
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M(>9H0?SM*K"BKR.1;TKV6PU_ J85$6Z!IO"M,Z[LE+*D-YU ^*M*"2,I2E5
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M&!\B 4\@F@7<B(FY<?3 ]V'MVNX- 7;E-[RSYU]7G[*-.L?:VGGQ"?"X^FS
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M:@O*:<"2GQ$F1W5*X!"C<X2*@-Z40LL"\2).1XF7YMA)^2\]]+H[,![UJ3<
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M1]/IQP@QS@16P@=&G_@;RA%%K/(!V?G)(E5+94<^<'\F#AX"J'D,8_>]BE]
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M1M:/_[WF^#4@QVQF6)"/_^]1L$$.SQ5N0.55L@?!\I[Y3Y$7S\;VV7?S4_P
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M4AL6LA&(#4D54:/D7>S^!IAU>H3;3]2HSY!$7*2*$F(@_5S,_ .-J]#RT(?
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M\AT,L_Z/_:+_STM?/?T_4$L#!!0    ( -8[95IZ 7#-"=\' )!_"  2
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MYZAKC.^]III>(9;?;3!3JAD>UT;KO7I7V36^QN).9ZN@@0<W=5^V?:OC51'
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M-CODG4<;>V!?>Z3F$6,Z)#BEWXD@^^6^G=%X&.SX1#15UW#]"A;,O1NL A[
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M]J\MC5PM\&KOBC,98\3&FB0>NV6#D,(^X">:*\4R,ARZ:<>$H%M;XFL0T^E
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M(2P:/2[_1?E*ZX)&TW<J@TM14<AO"BN?I<)]@F4O:Z7CK7G[V%D;2%86)P"
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M"F,63:C?>%0$63KQ8_,L+AE/J<-'(+</P'[D"V7P7R@50@UO7AQ^=+<(\H8
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M,B;)3U.O%TR+K4"S]%]L'*)NORUF.9J< =[F!->NQK:N6L'+]P,_D!)V\WU
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MUL_36_CN3U]\1$<-<]8T-]Z!YZAW\L)GENJI>PLE#'F64180RXW*8B*2^!<
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MKF1T)K^&6S/GY>L>+9*D[E_['[1]5U03>1MW=JV($)%>LXJ(U"@=C.155EA
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M1U?<WKDB@DA+,48UH\%DQHGQ-:^/03I3'B<';4:-&T&;7868 04E +FRO6N
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M1WY@W*(35K;5?TS1"06Y_C&AH!VKM//MVI03"TK-)<MCM,'Y__"I)&K1U9C
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MR3__W%KH_VVM-7;Z5@&X7;W @\A6Z^(3N2?)N13BP7#4L84[5V[J!]!&%8Q
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ML;;,\\/20+G>$OCNI=1[;R[<U%/4Z6%C.;1B"QYDTH[I7N)<.<75.MK6LC
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MH=0)DE-YVT467,;[K+ODLTLNJ7++1A5$1LVF@F7*>T!Z-NB)S<"2=Y:DCSV
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M\?RVPB _$MT5/$3Q%";83-QDOFV&'IW(;/)4 Q3G1NG"7!G<0?!A2+5Y= A
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M#C*Y.K3NYL6_6/%!'-4X/F,F(2;7+WKK^61,HQH(OQ(FOKX<I0)\H3E-I*/
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M,($ HR0QK7'!*OV46/X=4AURGJ6RL7N@>5^0E(&TA:(X*1MWX 5X6#0PPZU
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MPR<G#_9YOWWRW--;\P^J5W:07R9#M<5(1S9C1R8:G2O9\PZO5AN!5(3"DM*
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MGAT[ZJE]KTP7[^!D%[M=C/JW^Q-F0P\?O2,SH@-J,JT1AI0%A@ZXMZIY2?<
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MQ1,!>/0S:76.<LFULO><R:"?$>#,[MZ[.%H2T#DI6XS?"YVKQ0>,T FP7'Q
M V1[%DH"FC@S*HEISN> .FH!+6H U7LHXNR2"[_=?U459SRP:BX<?K R]WQL
MY?J%PSZ/?@BU=%Q&_K1]+X&0[S?3L\3+02FMTC#9&!5\$D5\G D&,F=_!+X1
M)7!HZ^R@ 6A5 <\5RV%% ?$7ALW6BQ6US.)9D\P<!*'))V 2G1K5>.'ADE]
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M!ZE9O_*MT^#L=-T1^OF2Z04_0H%8%L( 9.'MUGJ(P-V14:6C9]$'<"0N4@&
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MH#F=<&WG/$0L?I^PRIDS+1NUQ=PGC@;J2VM(<I$I)8YA_\TD+A24#B]3HF^
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MPZC_ :0!/!T3$O*IWFRU\DG4;WB]VD!<+;=K/?>7KJ>#-U\6S:#Y8<]H]+:
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M4OOKEL0K8'6#[4^W]%\6A8;7&K>:;*Y@QP_O00]Z]XIVGE"H2#=YO#7P%\F
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M0BJ&4T.F'LJ;%DH^K?S@TQ]9->,(SP;VL$I3J9 LF#)0P82+>&D\8"9:S22
M19>5NL?K?LH=?U(JM[$6PPZ_YDU32C[P*8Q0[[4H5VQ?F-8DO%#"++%7FYFF
M<F/^F30.I[('4N.MJ;K25*^%W$<>Z&T:4HH X2'9M[@_TR)B9O],;*YJ:Q[-
MH_K))%T<NI>(0)"Z6E#BVXW6SMU*V>^ E_(WD*A\%@^>NB>J46+*,]!!GQ[
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M\&M9DK:S;L,UQ0>#VN(>3QM7?40=:R5WM'463'V?.=FP"E7NZ_I)+7568'+
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M:@2>+HYOI9"3)AP![\A* $'M#YW[!'88L:IB(651X,99#@W).3^P9:$-X5W
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M&4.0?SU7LU.)'6@4(%#[O4\8T<0$UDFCR/UANM$$/R#6<^SRT-&A72$;'%-
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MD?L>RHQ"UYA.Y8MA'9X]T_=\(\8:]7FV50"RD?MXOIS9WMG]7[>^T,K3^5I
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M].1.C6D3@B58HST'2&0,L-*3A>R9FOJJHS?# _<\]E^C'QPYPX?]P(/Q$NE
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MO49[O6GB/7)G&:X]$#GH_$_>] <$^F'7 1./&V!(DZ:/]GID;[[C*%$4TKF
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MS=(,%_ HD'X.\W*CMC<73YN[TUZ(?S(67B3^&F-%[WNU&(R4NT+']P@=#X3
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M>=%Z_>:"<K^ULCM]"AD.><8%B(6-_@8?/;3B_'8D8,<*7130].M%?)A\,Q_
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M;F693RI,:&O\SF0*H0*L(BY:^X1=.-BGT;-GTF[;R)W6602#PC&]?=E4KXH
M@JH29E#BSNU%_:T6[_4!O2I*".<$.F]QW?P*ZFF?<^JZK9"D(\FET#<)[2@
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MAA11 [NK_^^!'NQZ?&X)._?C_%'F)T4N !ND!YR6_\@3ATJNJ5S QLH7Q,$
M'6[ON95!Q]*0297T!"*2(\W:\VQA)<!JYUC'!>6[..<I7QB])0E+E/,,S?GX
M"_5D-.+L#/PQ3-DYQ;/$S.-#XZNP8=-K>\W1ZB]D/<6I_3W L_[U\"Q2YR^,
M8B+U \%J^*PGPHS>^;;:OVX=C$#J B4@JV<#FO2N?JC$^%!Y_F%8+\79:&VV
M&U:L17T:4WKE'1XN'E/'DOCVUN?2"Z>BZM![*O@'L^"=LT7+6\#@Q)ZQ1MSA
MI^M1"%FU9. *82J<IPT\7_6YKI;T;N]?E*\+/BKX&;'&9%$AKW(._!C1'$N^
M#0\>?KTK.>CH-' M2.>9"1E'W(#F(]8-"^5Y#FM4Y]@/7>55<7P"<?<*YMN2
M:%TY/*)'3B'+/H4T+5:'MZKP/RA)(OCOP*[L.659T3G/_YC*'VFK0J4*$W(S
M*J;5/0.BBOY.'NS^"([&T'@NW:8?]M=]@IN,V_X*[[R&3[)ZP/FI"2$8J!ZR
M&$\)=KU-GN^B$_[*ZL$B,$90)JP,M]+:$=[X9_N& M#/43(>93^.328Y5F=E
MH1TZ5)SLG9;=FT]:6BJ:YX!PTX-%AL.';[(@"TL:;9?PEJZE?_:YE'TNPSIT
M3V$L!YTQWN6B#K]ERZ"2\*;/+&<G<:#,.[OG)1^)[MIN-'.PS$R>-'-A\>0*
MJE@47TC8/@7/ZIZZY,XJ(4TO([6UO(N_3).]QH-W4@I2HCVM[,9J_9X)FL[-
MN7LW3^H4.8**W<8R-:VL*1KW?5L;WB8#RQ&^Q%U(8]Y1?G,OXDB#CHM9EG!&
M>R0P=E4H">!'Q;_D\A3RPYR&VQ=BZE-"'D/1#S;('N6;QD:E'H+][M8R9E*-
MZJ:2Z.MJE&50C6'][6[[+VA=27-&9F:K:XJU/]G$I2QYTY7:W.,:J6 +8$T4
M:Q\3>GZEC.7JZ9=!'4O0LLBHL+\+@JO,#,@L]MX^'N_]0O$PML\%:.TAC"1]
M/8S:\0]5-3@,X"FV,EK%XJC*K-F(FDM'85GQ&A=P!MGE<[EPWJG[7LB==#6$
M:ZD+42$_ZUE>/4^O491H1879BH%?VT*<7"%\I&VY67BDL6?@0H;X)Y:#%0S\
M%2C<1<4]"!:Z7ODTQ!M:.ZM$D,V"XF!ELVNMOK4XHT\O&V?2S+NE^Q*MAL*S
M_D);G3%MJZIR+7<?PQCI.JO]5;7JC%:6',<,* \XG$U)I:J#KECKY/N[I2II
M\U>UNXB?271+UF%(1"25.R3CD=@3%)17"D;B$*SKK3)2Y!9J^C#;5U*'C'#B
M?)#_ZF@LR0OPW4,=Q%HR730&!_G1U<\Q5VDWJ(V,%W1FB_%YI;?*B3X,]_'@
M_L3YGK\^F%4/43]/"1*9'H$OH*$DC&5%2GELKK 9?)(V]_M?[-'CSFBK.);'
MM%,"$)KE&X;Y-G*)F:,87[EH(S,<:F.I+V'^%7I-4W)/3O$]#M+C=2W,?Z*F
MBB$6X=5<CS8J'DR]/"&R[O39]N-X7+93->A]2K8CM-%[S NG_ Z1?FF5HSA1
MR=)E@#75NU(46"3'+.I\"MF67G:SS!V>Z\K07/>GS9BZM1MB5N?.O2!8:IKZ
MYR?D5O>X>789%S8GQ?RT2#RQZB4Y%>.^@!=C^?S.0*6L%9^>C+E)[? S&V]W
MK[0XED!>,Y&DZ*JK!UI']6H2K*]0MW;>UN(F!<V['<^E?YVMV%/Y\M%+J4+5
M^YM&9P<XBQFV.M;GO4;! +UW:V^9BBJJCJX1-XWKK ^%YCT^'O8/W8,C3+H<
ML!#)S <LD(CJ(7BBSC#H2H*:3F?3&[EQ'*C1FS^,TSXI5 RS6(=Y;V^6G%^-
ME>+1X5M'#8@-(;HX%^"JEP;)WSVPI^+W=3)F]#GON("?$+NA_A/[>(A"+N+O
M;VD\C$9U(=;%NY4/YW?XN(#L^PNCA](A2 Y!\K6])Q-#+Z?E\LCLR5>3G=+P
M0POYT\*F633)B>]O_0!R?M-AW)Z<Y$@B)(_P-DC.F3"&:.]2A91P8(FW5/N4
MRQCT"W7Y.5A].U'^[ [QU Q\RH$5N5ATK:NY]4DZSH\VLWTRD%DLV39.L#9=
MOT76O0:+6K3- )784L(]U(>O]#'5FYO:*)I:-;BES"]S;EGCZ=Y_9E8NIG5;
M.F- :<HRUF+5SGA0[H4T-9@UAH(S)4A12J4'46J-U3<,G%)+F-8\W,8K[^MP
M_*G8#01+Q99=//]]D],WN(<+.+#+8?0^R> "CIWDF6SF" W<P+%X=0MTMOTV
MA)WK+G249<R#=*P7/Z^LG04N8'AHYFAB4-:,BU&GI6R?7IO3KJ?/$2.IUX]S
M ;?'"?,BX)6#M'YDF*<MV ,]MK/IX9$\NS-KQ 6X6$E/DC6VM;Q;B![7*@GI
M]L&J-LG;5&#O-:'?6-AN_7E!DW/N</R[5L6]Y^W!U!3B<5;R3(_):?I<GE]@
MU9K7.89+BEY^?AZRT?J:;4=]9^=$>'3@-0&K:VT>V)2DA9;G\[.Y^GPG;81[
MJ:5& 4$5BE[9OL=LUSAC(UK0WIOK<*]HU-!N(5"W@V 2T+K5R078?H-$;44>
MQ2:PS_%N793%,X*?'YT'UTY[O8,L<==QW6"A@.G*I_C5J'1D[4I4VM8+G']K
M1\Y( 18JU500JIE;CEK+#]^P\X(>I)=$_CJ9U^3ZD!0:&'KJC:W(H[X5DP,6
MC_8IJ3/D.2.C5 @'LYV2L[A<G[KZ.32^W,#V.?R172&8!RT/G&1\)94HY1?)
MUGKY$3;]WTK&%SGVQ%[BH1+/YAB6PH *]K&8^#1N-S</]=%S#9R+B@CV1D,G
MQ<A>$,B\U^U<9JZ+2^ZJ8N_$[$3/BZY@V*^/K(W'+]HK7%,K1MK1A=(;B_3!
MD[J08ZR&V^/&^C3W&$F:IJL=_4N=7^6*R:6G#Z#MJCC(G8_]@2A6KFA3"S1,
M??7NA(*;DG; K[;-6VOW'E+0_,XA(JI.530,CQL6*NL;5C^TBZ] *1NE.6:H
MQ9 #U+Y"Y;^E61Q+ZW' >"4*BWJEB=I/X"R$7%!JH!Q],!;#JY/G,&.IU91'
M4-/".TO^E2,V'6@FCU1E/6?Q\LT73?7CH(U$'T[OD>;EX:XVC9/&M@L("7BH
M)5$*6C>ANWUJ'6Q2%*5;9$A(DYF&!(BY,*=^<1D_LVNM0U)/V30$'TP--SFJ
M;"$>S.\;E/R)8()CQ1!KH:6N:<7W5.[!@Z]C$_$69RP_[]<X@T3/N\@,_>*U
M7ER(DL9BL;,0QQ66!U_*.P:>WZZ/&B)AM)[T5=+(H%KTX:Z3;[YWY/W5B53E
MP8V-33\_OU)&1E_&O@9$#+B!^E];ID4N[>,=VHL6[%SM%'FF SN"YS(;K!OX
MOSK#!UJX_^H,Y]%LQ2T6A$ZO@5T3=XLL;*?8D3IZXI?ARF;M#?7Y\TZ,L*:#
MVKP0^<2-^R7N\'#UDRY_]T<&C4>^Y*?X^T:&89W1YMK'XI-SP"_0XHJ)J=,V
M,"6*@BIX;RD550]#3)R%*D; Q#A(!;.(Z>#NDF2C82X@::=#@=J<0?"T[9J>
MS*,2Q:'3P3R6_01!#3X36'PAHUM**XYVS<K3R"--"#S!=M?Q$A_?Z;"YYK%Y
ML\>AOPQ\0Z]B_0^X>VG^'!2V=2%3(.EBIN1"OEZR_X/GR58B=0:NZ;=FW2^F
M4:Y<4GOWF]ECAQ[J^N##<J\T*-DN7 %4HP;*Q]KH0M_VG0U20ZEV5QAF+J,-
M1O13LX)6-\A <]C__R1C#W;F7]<&VX'4^=_@#>YDMB'54\"-H9\4#N4,H_Q-
MY,G:X45^CF\_?#TJL1W?6=$*QBM_7<RT59L^>?%#^N%C[)F!+H+JV-]U$P$C
M(A@'FHD.Q@%E:2ZR2D:*+C\J7#;4E3 ]8^.0G9]ZKP!V$3%J2TY.^\-B'-T3
M8R*7 ]I='WKF_[[4_"P63 AH/]G]'@W*,5"U08&RLKU/F&HY9MDGPRI\QCSV
M3$08UGG(L%'Q.7@@I)%>W!P=7>D_I_)VC"!A? V[!@XB5ZT>/&C6K(<V[S7]
ME#TW#?XT=+UVZ=MBAH*^L>,"4(8EA6B 3W45J].?#'1VCO<2DV.N85FQB,WK
M5^:MVRB-V^HN#8U9F]-/:AO*/\V#88=FJ$YLY7"(3,@\N)%H+_/@K/-Y<X,:
MG>J)X@M%:O9X2PK&^&+VY8?Q(F_1QCKYZ1<N6X]EV5>5S68LJ?J^3569Z+']
M*2U1+L%8%KR[E("7TH$^^"W\DFC 1!A%E=Q_PW!AV5"%=K>PZBTJ=)8+\)'?
M-Y3_WE!:7MP^<IF[A!^</G(X2D5\_APKSP5,E600=SW@W<3+.H*_>#%<""A6
M</>!$IYF>R8P;_+@P?/7_E*P+W6X0*F<SRF"E26H57"8OOATPBZEILYC&GQ#
MM^?KE0K[AM^$^B8+51G%3QPJ%FV*3$2HEB.AF:GG3WQIYU6(1UGVJ3XBGRJF
M+95F+.4WM;_WPK.N]P.9C^H0!T/T@1=FX1Q]UI/%^<2H1;@/S>*9,81^V(.!
M!L=RY!C$1$()?V"*3P1Q(R^M8GW217P=&KXTP(R."SI?,(30G GT/N "2/@D
M$Y&\GDOP\G?%5^B?.&<ZQG3F14EXEH_'V!*]KYP6J(ZS(N7*G<^PKVMZ(K;7
M(Q6>L\EY'HC1;#S Y: F)N(C?O,8NA!EU[>P9AZ_2J-/G']>64U%\^^@9,R4
MC71R0&=3I['6$SUVE6CK0:WPE6[VQ%T4)WT66CWE7+MN[3K7N1-"8 (W>6A_
M\2I3A*<:8AFCG$9TW_3^-<_WNO,":WL<>89>"A8>X37^Y5 /71;8&O[E!79U
M2EK,MF%^M35>;R\W](\PA!I-XO.'M9F'[TIJ$%#M_?,E;]!'!7OIB%V4B=[4
MT\(1T:M>_!B;$(Q-961JH?))5=.'>?PA(N4&(,T^^VQP2"9,AVQ=>;M3+;:>
M"QAW9_2*OH=RSC*\\-^GUL ;0/31I'"@ -S46DI>C)5G.Q:N/B_$\H*<^?3I
M(RM*^TR@WN3XZO3%_-W9HMG:U/RBX8: /+WF2V[/EYXY0\SHRQM+AZ:LWE+;
M$^P3K&$:^BU]"TD[#*<O=W,!TNMIP'BVM1:*+Y%MS[^:+SN61^H\5V ^>?[]
M;J-@Y=KX*CC[L;B^D$_8!29#,M<S/LV25L?2T/$?=L!JF*LE2(Q744%E:'L*
M1O1D:_B*DUV6PT,<R&4)PZ<&TYSVPFFOA^\5ZT)\.'TE7T6.*A ;(T#_^:.;
MXYVP#E8@0]J:KO>" ;2G\Z6%<0&)G><G%,=TA)(B.D6G8#&"M8%V>E594"F+
M%+\W&?^A$&Y!;DYF>@AHFD:WS-R:$*7QV;;]=J1X*(7XVY'Y@N<[@Z-RQ*X0
MB ZO[^!G7RUL%<6X.&66VH]C^).+H@Q:+V'-@P2KG%$ZBPZ%. -+@P'EUQ7D
ME :B;1&31ZN2M\M9]@R0@YAVXIS)BXP_'[!JQ8!\\.<#+(^@S*$0QL5CY.<F
M/SU34<H,ELA@H>_=\HV@./L\,LEM4A!"+GUOLZ&&!]>=$TR"/ P??1O47[(V
M] C$;CE"@\9W#:34W]:SO!G:#O2WC,XB^K=^(^2S2<V QXPG>?&$0[Q C8F,
M&(PFF4X\7J*4?>&]>>G=<(S@W+ &Q+U@$? 6B1"TR8D2+3(S)ZC5IBZ!JE$.
MHK)J+X*NH.U-K;M#LL'9BE"E?*C.NT-Y)H4+>$%<<#UZU;_!,TFU?K?H=Y)Y
M&(#X>YZNSOEGD7F+"YB0IO+O>YC3\<G&9E#\FIP\CT;6?H [6AKM)6N'P>3M
M)S2-]4M3VF#&Z^"CX9QV^LK!+6)'0[U1>AES\M[6UO3,R#?T<_EE W.4T1W5
M%S8U5!OYCRRW;Y1L;SDHX81%OK7ZR*/4"_A(D'UR&U18Z!F0FO$Y54K]O29'
MF.W8RN!+:%<.I)-IQT:3VT-??X!CN[PDF^G!294,OE3CR]4?[JSE^R6Q-<LM
M*IO*:8)\#F0-O*ZTH(]E4QMY6T-3*UASZV+S,W?AOR9TTCQNODT> H_ORE[X
M^N3:K0EJXX1&;=CAJ\:2WU;UP)RGU6;'/MD-*175^H-SBW!0\:K$&8?Q< %-
M\T'WC:W7^;:OT2G=D_EH"V$DUG[<F:(ZB78(2BG$J U>SLJJ6#,-F[!Z9-AM
M9YNOJ=:ZE5&+N(O85P,VXH_R9>0/)B -14\Z(+]]ES1?G1!0R*&. 7"WFNAG
M=$BT'->%(1P:QAHUM>TG"4_,PYO(.SBEP65["GX+<DUS8^,/6O[:6D37C,@9
MX[2X! /\?OA1M<B:RX';/8Q#_-H$MNNMJ%'8:I\CQJ'B6^=%'B*;&=J$\O#X
M7B%**=.Z$6'%$E(AQ7_[.&(??[XW,A7-JZE]EP?K755!UBB)7J49V,4LV(>1
MLM8B[7=S>E/*%,U&"!\+[?9V/%Q:4-ZY>9P-Q 8(K^9W8J.UBE"K4?$NN5F6
MOE5KX'CA#VYNGVI<]?/># 4&BV3U,=+JZ'&T@<E:8ST3<?;O)A<:Q\D>K>_Y
MGL58'1%@90.&A S7EG%>[IG,GL[=4YM<15P4\"=CXD'WCP6R-\HSEPV2P];>
M#X8:[513F$[5]N_N53MB7/-KKN<8=F>7&Q6RHNB?4QY]*7?1ZS"LX@P;QQ[/
M1O&__*1HV&W\+96AXZUB2ED:51F$]AD3H%:O*G .!1UHZ?W9:"Y@TYH+4/Z)
MH<\A/9X_\",'OE.?YP("@O<-A)X3F=)-7 #9I,"K3XAS*_;"]Z97''#7OA\I
MB-A7>40\%/:;/R@B(?^T]W" !_?8NZU$%;:>)L@5T )3AB"":V>A$0,^-&F<
M$4W@NNG,S3;_7Z4(O6FSPP3<9[VS=RP#0T)^%:ZVT@B8O;[=#4G.#\K#K.=G
MD(!)1K'/RX9"CM?5>+&N]CQN]<JZ7M$]O25K:U=BG3[>[>&1^-L=BW =VU,]
M9A>P?Q%H#H.A( 96S3#(&ZRC0A+V<GH#SW]1CL3>N(>YI];B&% D]1)J<8:_
M80EM).B26J17$27<M[#:HO:R75??H0+CZ(@'::'<*&&^-OR.-N$*SD8.\<&*
M]@8Z%361N]&<YSP!1&((<X8@W<2CF[%JKIFLO*[8R_3[32Z<2_22YS&J)N4P
MYJR)_-D5<&6"YE'Q9DE@?883@1"-Y6D#Y9*?!\2V\V+A>/"_SAT=R$F0[EV*
MK U)[*6N>X>(M+BF.(,DDIU57"J72.ZI-#2HQL= _Z2Y)4B-D9DY5AGIW@MV
MIL/Y&P,<<:#(R5M4AVP> F<.O\&TC CV6>J0&QY#<6,+(BY-SU\'=BH2/=5)
M^5HXFJ ]]>U;:_W?R<&Z'GO-]<^LL$,)#6\2HQ,3QR=5@X)\S[Q<>&:HE).I
M\T J7_RI<3 M":=,'XV+<::I:.^Z-ZI+-FH+!1RTN[;.=K[2(H24@RW1'S\I
M]F&/9_QZT#@=H[A%(Y_//:)ZN,TY[Q>:0#)ZHQ43NNXQM-J70<](5*P+<T*U
M50UEY#5REIE5R9 (-S#]FH(WLU1VD9GKO6TCE0%LZK%#;2Q*4I@Y4%+F66<9
M7Q.HEMN 0_6BJKNN#:K@<\Y;\#9'F L8<& %\@@=%Q"'V+U #CAI(L$&)4.$
MN[1)\S)FP&<PV':[WZEBX:EQR(F/GA^M,> Y>+$>F;0BUFP4WK['W).JGC;3
MS1;V--_\U?;"*+V$ \HC00[EV=+?SPH5>-4Z/NU;:/B4YG,)7J-0'!*?*J8L
MY!)7^.9C]J4/2:3I;IEQ$DV54NJNWNJ,&<FF^)TT"UF\+**^M!]7ZI7F*R/J
MI^WK(&KH?$<=:SF4Z5"/ 3W$6G<HV]@7!DLJC:;(?W7J5$1\^#XKYN@606U!
MG<BJ^W[&BN9ZE,&Y\OV,E4/MX_YNCA)E8V-75I_4NE6*7C/:D!,G;]>$I9EN
MC7 !/5/V%M>;D7]LW6W.%, ]IITLRQ>\P/?$U V5?FOSHZQEOT$IY$R)GUVI
M.2ZRAGPY*T$J%*,H7TO)N)HJDI^A4RX]/97IT>CR,\HH,@BBEI5@T"XGJFIC
M_RQXC?[8QEK]HSYLHV#%V][3NN1I.ZQJ+E#J<<GWW:OY #FY=J0-XUA""7(W
ML&!8R*Z%,F767#>I>;<Q<F=H8#?14TG:@_(L,ES/XU?SU@L*PZ._,AN&8:&G
MFO;TO@X<ZVUGM%_M,M;RR94L^TOCA95(\L#%H.J5-><_[YI%$AZ^K#$^[] I
M?<:\R-(IS2C'GR?4,U$.8=5]9PM])$%%X%"TO5DS_U^%%[/+QM<3 G1]5<@X
M4,7KLB4)I_@E48.^AX_L82@#T-44J*JY?68KE!@UR07P,DV6"^"E&N9[JG6W
MTOGWCH(YUDCJ_%$N,;GD()&MCN=K:GK;\;:YH:&Y>.OK%AR'@\'*,J,+"EY]
M=GO=W/Q,,?)!,=13(5EEHB+3W,GLP5VA<4:,KT:_:JIC-JK[_V/L3<.2S/OW
M?V::LEPR<U]I,O>M4G))9=)14U-R5U08-7/+R)0B)9ER(?<IMW)CS! 1D7(M
M<TE0'+4R%S0U13 SMX1<NDK$'W,_^A_?^W[P?\1Q\(#ELYSOUWE=U_EYEZDK
M,?5>N,#2O_8\</6='M:B)&H.]*OX7XF)/=&8O=8R\\#5M#>X9=,9?4G.SRE^
M;ETQ +Y2/%&AP%<G%J=#0OX&BKXNVH_--?.VGU\N>A\YM=#30CZ<3U&]=_G/
MJ(EUU*U%!T.$.S!ICS8YA*$YCJZA8Y$,VU]'FBB?S2@4(YBG"%W5;;].![>T
M=PP;&Z&,J8];GJ<$-(XV2W3H1S[!;$G$2/2OJ412(Q*^+X4#@-X 1NV2IGLI
MQ=P0$EGCZ45Q9I5><S%CN<@OO7CIX)[C;_[&/2HQ1C8]W\4B\^CU!ZF>%+<7
M;DS9B\XN7]SE]?H=8@8]CS:3%+XO?]L#394*747+L6M'<@JW5'R!!OKO'-4W
M'NZK/5]QMQ"K+**G7&OK*5%UO[B V]8>ZMHZBY<&/6ZBF@6'"AF^K"L)Y2[?
M7-^%-A&"QJB&QO57S"+1$O]L[AQJCODG-.FVE<'T]\IG30^^GO?\]-5_K=+$
MM%8]7V0[<ZXR&$XBUZFAR3*4]1FUMA6YSAR4Q\C'AE)/-Q>&RPYX^LLJV+WE
M>9?K(.9$:XRN=MM1I>.W%!?)<Z=882ZB(M'VC*I_LDH?DSB:$\ U\&&\R]%1
M@GCZ/%-*W-1E&K45UK"(^_5&R\*6!F7Q*27EB2<3QA8\7.J.<U02.+Y5)=?=
M]<OU"Y;=!@;DENVN-T4H?'<1C<U=W%?]Y&'VMKVVB ^)/'J[^<51M+KVQ\GH
M(L6VV+F[;S]/12LT3G[("K9[*V5'_]@=IW;]N^*XHN_$>/R5KU^N?#GV(JU"
MN>K&-Y/_^TF=>2DA5EB'U64[[V6O@>>/95.Y\Q;NUI RQXMEEPJJ=/LANDTE
M4=7Y3L45 Z<'Y:JT= ?5\UU.9[F?SGK#DW(Q"A99([/5\1J>N&Y])59FWBDT
M@R,M9RHMT9HS4'^'8BJ]_\GE"/ZMG]\1 (<1^:A 9-^V"[/:_H:<+-+422*C
M9^,V4AK199!9_(SH23,H_R[W0M/ \OI@X=GX@*GM"*HG5=]WNSEJM&-J.S_;
MN"JF^35K#9T4B[[]%I&Y9-2N/"_Q1@G(':57G&CC\=SL[&F!D? G/T[FG3^B
M[FM?ZQ ]_JM9-SH:+6:ZUJ!X4C7_2(G-AQG]]U<<U3U%R%[#[+ 8?[SB60Z!
M%XP4Z(_$9_NX7,^NTGVKF)WO=J;DH _1XXT7V;V*I".>*9O]04=AK!*B\/U2
M2133-ZJZQ$:DNO\5J>KX'V_"+@Q#RB/9.:KGQ[;"B%'%B;,U9H,2E(WJSU,8
MQR[6NG!0KBMLU+#H_)N9W;[BF"OJDB-_AP^-Q17J%SXG*+KG6++(AF>\!MW+
MM"P')HU_ZO3OM3Q[8KKAAG/'_?F/LJFGL=:+NG3]ZM-?RPI":;D]6C>F7-:(
ME)GWKQ^W^?"0V4B/=V:I(J1 ^O*#<RK(G-M&"48>S>"C424I0^KI57\'2'C%
MU_FSG6/BU<MGR^7?= Q.NS_]9TWR3GQSK"S\743Z1- (Q$WA$W?<X+-1<ZSM
MNGM%DMY@G>)?C%N2IUUC3N6>DZ<;./R:0S\K?P4[<^'PF4)+7TI*KU>5>&;!
M\AB#E6;A4_"KI]F"Y3E'B+I5T[+NF2<<SZ.N17&H\=SCJ9_(] [EMQ[QV9J>
M1\O^)NI:UI#/<(G*#OT&>HXNW]Q,8OY70$L$F*_8WT'"8?#V;Q#";@!8TN"5
MP>?XH>\ZSPV$O8^ZA$T!E9_"1=I@.K0'6C79+Q*+=B6/8'L,F)D%67B)L>^5
MB",!<=8AN'T8G*^L/^!R?HV8UVM^7]5M>U;M@<&TI5?@(Z\+F"]KY5<SAV02
MWW!@<L8YTO=*&8D_@.1/4U^WV<$B(Z9BMIUX@TR*3$S[8%79HN Y[;\"[\RO
MFG7/;_)MJR:3HC;:@F>G[4WN&+X\F=?TZ=6\YBJ91?4KE0A.TO?6=RR,;C;9
MW^^>$T O#!@8)GG&I4X5/$A^T!M"T'HF![:N/ AO-A^RNA]/.@A';)(.#ES+
M?%D0NB W<N45+7F7!/WX=+EK6UN@*=K'Y^9<>"K?UJ?BA:Z'*7N@4!0=NNNM
M\0L-)[8'.@&5P4WZ=1-^U,PSWM!$<'!8!(JA5W;V0%[/K_%4#!!(Z15>9%&%
M%L&>Q>$M[*[^",_M,BY-TLA((L/_+EJ$-;$0^Y^^Z&B]EZ'3E'ZS0N[7CSG>
M*<'A?71HYG:1U5LRFM?'56]YQ&&<!O >SWG(C%^?O2N9?<N^^#SX\A<W2.QF
MX_XT%G63_N.\I._-,]],6D0ZQ/N\8%G]J]N[P7CQY7(53&9NKK2,AU<EO-!E
MDS+TH.Q%)*O2A1J-UHIT+[0JU-0YZ$RSP[Q6-_;QDD^O7K3TRBQ/O/B)?(A9
ML-17$KV1YDPO^YNF^S8NQ<73^?N":''\*:K5[*Y(\,YA@8+(:K1FK_1#V >
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M!ZZG:UTD^III65TE_E[E6<#QE-U&<^!R2XZ$G?-+S$!VTN>IB4X"="(<U2I
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MW46KVZ_!J2K&IX@#GVZ<8&ENAT#GJG!B?GUM$3U0X#?!#6L_$K&8\1,7/9J
M9DFO+G<JCEK;)W$*FV#J?9=F3<&JACI%TQ?+%T:G.5>)28]O%4TT.D?O@7X2
MCMG: C!^(+.%("/46($>61A'#TD#)LY\OW1LQ!Q4"D!=X.WVI22#,4[=-?_>
M \_@FS/]$/IXK[9W*)1R,U@"L%F-_=A\3GWU@<NQ[[F9;,TYPRR\J7A D2?_
M?2)/I.67WYKVU#GH \9HGXMD-0?]!ZD^&'H;)HKSL=:^T'72G:I/.*?BD>)N
M[F8<O(ZNSEW>E?VPL[(=N ?*O[S;T+4ROQTO0F!V+WJ5T AF=AT2'&\&*J.X
M,1V!KL_Y%??G=F+% D:%L@);8#BB.EI#D5]=S"W.]^)!>PAR&+]S+P+OF6VW
M/AL+[8QU/=_Y0!T&.XF =UMAV*NM>R#M-SOAN(F^U<4]$+DK<^5-S+O!!JS&
M[</6 _P!F!0RZ_I HT>.>!Y!C*$FG_/WC+6/FJ-*G3P6HN.9>SPM6OYOHCO5
MDNZ9M0<Z*B2H.3WD$49BM(:ND_;GTC%1A>^J%ZU]M%8;]3\@BT(+8OZ(L[".
M%7] #S-@%FD>RF*$7ML*,KA(=:=:]-_> \VQI_HXX!1;'<'OP#,B5F6\"7ID
M&7&L O4+]$Y[//5SR9?*)\L$F3KL+?+R'N@(UH<O[0'TABG>&QED6$%32:,"
MQ;ER'2>^QIUY,)A!#O(?*%&CO(CEKV\C&_D$1I=\E"GV,F^[D/=U<#XB?9-V
M8%)@S#.NC!)+MS7$Y''KJ42CEA:VRB8SD' PJDMF+6'XCP2SUG%5NRC?/9"+
MZU;NT,:#S*G6] ]07[2^O4RY!R508DM_"]K\3&ERHKN.)IO/D(:N.>1EIADJ
MG#V9HSR:;>!9 96U0H<EZA=_U59DUILP1JL<JV73X\Q.OE]?L]:29P#6#16*
MIV]]D;BW'!9EF+9P%&WPZ1;"PTO6O:F6\TRNH4S>:DSGRN_/U--FNM)CL5$H
MU-PN,G@":ZY!(4J9^O)-\ E[H$,KQ?>8PU]4]D",'\A,ZX@0DIE?3MPO>BAN
M[$58K)SYU>V1M]LW/MQ<F_[W=M:.)VX2#13_^X@8$5YB(DA/(.P<>H];\O8I
MWA'5DOY%X1AA.SA92P2*7F3?R0(M6-9U\7B*U5>\1)R<%KRVNG:\(-Y6SIWJ
MX%BNHH]6B2\ANA1"M%E6UW)$K@$YF>8IW\6U8)'LBA3*@_Q 8^DJ*31])0QL
M]T9!I$>1=HNFK+YW*,L*)7./%DS78U%]268+7W '_FUE_2=8RE8\LFL_Y-\
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M'$HK'/Y1<:!EGX3?_BUL2[E5PM,7/H9&UO:O/ 9Y<DMV10<*U;2L'B;*I*M
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M<<7FK9LW;[Y<OTEE!Z/9\:NX:2^AR"C=06Y'@!N<A#7L@W[!.T;"$=R^9#%
MUI^'SQ51/(SI!Y45>%&61&#]!:LY'RS;/66'U6L';G)A>(5$R42;+SE<U;Q[
MYGJQ?/,^H8F564DKO:F!C\-WJK&G,0TQ.38FF\9._S,B?TO9W?D.5^- ?\/K
MP143L<!]:>7^(7&8;'GG@0?Q58E P A-WK&-F'$W[3P-99=/L('HQ[OH>\\K
M)EGT79YP8-U:3JX'H-M;0#@G.&F.G1E(GSW;R;_9/8V<7.20\.U!(LTW0JM*
MWT'(\DBO@$[(9X4;#)^23\%7-WJ1$LG' K!GG[V8\'/MX)'6]O/U@V]Z\+:K
M-!Y=2M8!%KE=:;:V6=T(0UYZ!_^0(%:,@;L[NX^/2A4XBQS8YUF%D6H@D!?6
MC91<WS(Y#,Q?  A<F\">9\MMI!1F940L60#EE=J'U'"C<GH)A>@-EOQ, <_7
M[?Y\44AA.T+U"(]/][G:;,6GI69W4!C>_IF0</<"OKM_OZ%9C8M%22')_6+N
M\79]B/NIFW[NXTNU:[7K-.I.XRKM/5CHDK=F())CO)BPV6]U$?F$?1 ;1L)"
M@4*1^U=>YK$_1'5JL(J$7]2-+;3&-""M%<>,PEZT-=PA2A__2ZOMSF^_K/\#
M$E[Y'QGZQ*Y/^=N5\WQEY C_,L9)B=OP18%3EZSBE5FF>:^;+R83JONB>])=
MGVCQPF%)*^$;E(B59HPPKT4<#3'0_LQ]7@IAL#RP#0F4C]]M]#-<JZ[E-W[>
MLOW!6U\+F),R_J1<S9O(2.!3HY,/\8=RI\\WCBP(WP.%$5S"H>AD"Q8U-H*_
MG_ABY.KF^J$L]F'[4W<_&<4@)HZU[4 Z/I2DMN/2A:<$VN\$EIPAO-\/4H^T
M+-9R^$"C;4<U!L\AI:+8S!6NC>?9:>KAM^^PGND;G%1;M<"#*!&FY$D"!/AX
M:8_M,?YADE%A867^!58GY'$7GL@=DO<I/,0-*>1&X!G<DU%#$O#4Z+EG#]N-
MH:IW::[[,^GOJ&E]8=<LK( IB)X%=]X1XR( U*Z&I3&3\S4D^N=J]6&*SCX4
MUR-C,795Z<?3Q)]?L3U>MC),]2R_8JO1D8BYQ8P:1FO""<;'TQ6:Q?X).VV9
M$7S<F&EV?SS@Z.F^T/8L-5?-VCG3.@^#IX::O]W(P_Z;CIRSU=X#O;\ZO0>Z
M\"/V/\&H_YN\7SR9*Y#N@;EA&E,0&5KU'GVE6I>*'S@;X\E(]V,#(NYPJ_B^
M!WJ-.HQ.+!]*@49*'\3<Y/2EM&O68I+@+'0>:#+&5HM7/AD(6YTQX)9I'.<C
M*CE2WCK;=::POQD1W,HDFDF^?.];"F=787K5O.5IWZW864S^]E] 0#V0Y\A_
MXL2%=%(Y'P%2A!@^G->%#Q\6G OG'Y_ZT7N@F6J2-_)I=AJ6N;,&K\@M.4!4
M:&E9(TJYN@4.K05"[WZF)4EP6^4Y)Y6PSUR-J:GTD*]PI4B?[NMC1&.-(H5J
MCWOH&I]*WV:LUH7#1Z-"=>!I/G9F!N_(Z84NIAN4:S?< F7]%,;UY5>\^\9J
M.??:(]3>^.2>>4#RE!>5KT@_JNI(CM53M)9G^7D?CYJ.TGEPED!^_NR:IB^/
MQVJ&R05)P3?Z*LQ8[5J/,3^C%*-;6P>UT@8!$X:&+A^6OKDSJ'HB<DL]S(7@
MFM]3[-5215FZ'H.;LIIM;GR,ZW\J^%UD+2?^O9!RD9U9.">__D-'4"J:B1TC
MG+C(T$@!Y*" ,Q%(RZ&-U2%9]S1]H%Z>^\(G5P,BIV5QK<6J@.)=GMC,M\AV
M_W5T&WA]V;A34SFW=XR6S0PUX%)8%)M&22WKPX%%'#V7)TO#;Z_[B'GT]CL&
M,#6B97(LO(@NA;:H"+LTE82:D,_,<G$Y\C#IH%,A8,E7%,I'9!M;ARA.>WFT
M\&C9";N'DY1B%Q^,]L"[TK?4S_[647&V-"M2V!M!"8('(1K:&[6:KC>=F3B=
MEB;,(&RG SZ0G/64S3?[>F>/\B1;DT\47V@<-:-*^[8-]^4F*PG"15L7Y74A
MOZ=$JW#F;3D7F:D2G)X3V9:6?;-3G%==84Q+V+7370WDJAA(XO.>X_$GY;Z^
M[JR6F2//1\]W%.E(J+SUZG&24O,!7R&*CSU]WWKW%4P>)NV931E[]0?)LC6=
M.%@?QKAU.2JCPD16947&VOJD8)-B<8)LE9L#NSQ&?DO=CY11.4U6KKW6PSU>
M%3W:-?$-I]2IB,!88&1].H$[7)HXD/0*Q4$=7M(XSG-**_5@"1RBK=WJ(C4@
M^-ZG@# 6R4E[>Z<>\^2S0J)"3NQ\A_9&=S)X]$HS:[RJ7?C/2"?NOQJ9UO_\
M<@^4^J],=JK\Y[GY.?;N^:8IVE:^>D_ ND0[VM (NBJX$9S*L)*I7W8ZI(90
M4<(:4#-[0BGM9XX6ZGK1.2P?QWPT__!19MBIYV7G&^IL_8H_L?W*HV['2&=0
M?;P3"H(C["CD *\JEQQH#.)ZP8K/M?AR\HBGMV[(DJ>M(:[?$RC\SSD&V5U;
MQ\<H2RA\%U@H [C2D\5YB"I.WCU%A62E#IY)CC&D-(8F'B02=1GLJ?E\[ALG
M[Z>\LO$;?C)OT(^756A_SO'59JTVJGEC5JA23E9@49OF)\)_G32@S_O@5WHM
M3Y9_V%SG1PDMJ_?30[7?GV&L+/X9VN^G;CG!8$+F3<+6B.[YA8D:@XIB+K8,
M&9>-Q<P79R3.]G]MMST[W9:@^P??K%!\2]=B@H3/)/FTQ2:Y.^@1W4DVRGJ#
M4UZ$EX/?;J3M> %@MQ=6J;-J?#.5XHR\M&9DAF++TRC%>$Q63Z<8'_4GF'%S
M>\V8? E+ '['GN+F^.[6GX&9Y%A'D>UF;_^I\O2[*E=J*'5=X%,;G7R896U?
MNP1O9GVB&%9H\SZ5<LKMQK>%PB^?8N0:1@1^W)V8TD!,!7MP3-6SI8CK]$C5
MK<7?TQFH-2#<PZR<Y68K@/>5U2D<M[#*K5=H-K1^RJKQIN@7QC5K2MK ,0&P
M4STL2G:?2[W*D]IY ]^>[E$*HKTVINC:%V1!J#[WI+2,\_C=M.CX6HK=DV.5
MXC(%M71TP;4F,CU=W:[.6]>N7%F/7@Z1QOV/LP:X0AD,B:$AQM_.FC>1CYIJ
M>1;!R6M>L;J<7]51WOQF#Y1Q94T;)W4(?7;\@9'&^!#\3&+9U%^CD,E?=\1[
MS%P7RE-O5__[9"V#MRX<1/;"=NV3Y2?^]/TNM.WT(_ ^1:1Y5^B8<+X<9'(Z
M.G3]'C]30H '*!<+X?*R1,01RD$7[VAF0C2QWU=>;^!B0?CS1,SKEV9TWWCO
M9Y85.#M:8QEY+(%RV:(-+:?O0![-3WU2,#=O8?[FD*.S\^UY\S4C7IY/ \N,
M&D9'V!#L@=19)60F/'QM M]<NL/@=(DM)ZOC?4::5R)X/>9MJVWCQ7,PA<$;
M0@W>IN=R'"93E]N(?/8F?@#K!*S-@;-FI8K/\R\(S7BS'7L@N7JJZN<*N6%K
M^ZI.&N<;4(NT3T4".XQOB1'X*GQ?B4]U<>+]:$6%&R57MD5;<^=XRT:RY>,.
M0[\L-;\\1NBUAUN%H;SW4TKMME8%#4!(9RM,67\KNK;Y&N1D(4<IE/\HW2K-
MT 9NIAMF:LVDZGOD&M>!U34D^Y^RHOP8MZ^G!=FX0*YM^)-]MD__3;93^ZO'
ML=G2TH/!N;:EXRFO[UV9RK"+OYI](O/_WPD'WP5@P5\"ASU0./( ;KDJ3]J]
M2U!@B=S-:%S?=><PB "4G\(A,=;W+2.D^8IXZ]BZ_GG*[G5I#?9G>$7:DZES
MG)<T238FPJZA910MH8Y R7^('*I?J=!M\JH%)%;;>*._QDSO^)\H^+% 6@N?
MT[4^5PD4"DRY8?619,X>2(Q!=8JI=KH-ID\':S+:*AJ?.*G$?'X08S3_1M53
MP<B,'4:@VVJRC'0>C-Q,<MX#03_3;AKP_;(:KG3]5!2^=7W*PKIQ>0_DA=]&
MR+PM8;SPN5MXU0'^_UA[[Z@FL_=?-/-U+ B(TCNC]"Y-$".,,H $2:3W1$!:
M$")- @0R2N]*51082H30(ATAD(%0I$M7>A(!Z0D@1@CAQG//N>>>,_[6G;/6
M7?P3=K*2]]U[/Y_R[.?=NP+9_R*Y>[ADV4)GTT:F2GXL!N*!9WB>?="\:2,K
ME!"K$DR+')\=V,B:>+!>UFEFN?(YI>QV-I^1VCUDF&:A3E_OR\-OW81+=(D>
MW>R79 0G7$\QPI5"7. <;1@2<*;V/,>LM02U\U$A<0Q5J1F;5A>*<L"&0^K!
MAE'V,O\>\9#]%D+3!=_'E]TB\8^-%'X\L;]4P$@LJ \Y?M9'^.J-NEJM(C$(
M]V# X@<WS L-+J4.-%?P)*0*V5B5N_H\6O"WO.1LU!:V&UW#A]$=CY85OOAZ
M69BW;.Q>J=B>DM)5>VE1:=TL!0LB>==!,P_FL2JLN??P5WE+OSQ=."A/2]#(
M(@DKUZV;\7KN#4,?).P(SX5O!,"(10W'+R:7QPJ;FB>OC UUN3+-KBULASN:
M[(R-#_GH^%7[;BTW7RH9[Q;13/J63&@H(#;OG !(<J-X(8JR8M>,3 89S8[T
MZS6?0&GCO+Y%<DT"74AH 2^H &%"*6CGO/.:N-"'69/I($<8%]J=_E<WQN>;
MFI./[LOT^XL%^[82'+2>B$Y-__T T L0NWJV.+(\ZZT=RBP$*)IWE^/+=!6;
M-='T+-029[H^7E(.!NM@XHOAIJC9N-VY;63HRL4J<Y*UW6BRX@3&S*C%O,LH
M:&E"H7R?(AQX4/,JV2+(67X!L4T[^H,A@6:#GP XE8,(XBROCBVF-Q'%>=('
M;G]H.+8%C>)-2Y!P$UR#XHU%D;5+/PZJ4&ZD@7$1Y^$?B'QOBETX! +J XRY
MB"%K;F)?-\.<A^977HG-]WM/AQS<6VN:ME'4J,(,;><AT.6S'YU'_"2S5_HY
M+2UBISR05PCX.U-D4*8-RJQ'J)1?B>N@2O0_^<YFI+>6':35:#O4^>3+!JJ8
MN%+']2"JW1W+&*"T+M(+'"-W.QH>+GC[M8_\>VJH1E<$&)DC:I7E0,-9VP:K
M<399\NG6Q37EA8UE8AP"*Z0M K),C&= %I$G !J%"6S_E87? "J,68"'.4H
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MW"&?K"MB4V4_3>:Q62'A#;^5&ZG[)S$#T/^<_#^)!V;2%YPG4R:D&W;(_IY
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MT_ABU],0J#6LQ#AA8@\%U<.@B@1GZ!RMOSA#9**YBW/(&B Z\DC>!LS'=W>
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M#7W(N]-9E(SA12OJ_X0&BW^2]#(9=2Z@J>?+H3_8F)P 8L/0#/SRX1"4=D3
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MGC)]<S6I=3:M"]_=)KA_-;0/AJ5E[_A\-PLY^(PA5HG[;H@;QDD2UFA%_.+
MT4D8?;A8FY2;'GH*"L5]8O*=A&M ;PQ7P6Z1X%DATQ^I-I/>?T:[MDS=O5E>
M66/J(Z1/%!$(I\O.3-W;RP?S?'2UQ$1XR#-6N1WPZ<?]I@W6Z]5C6]E%8"7Z
M1TO7NF4()LYN.UN]<'FO8$AD]7+H4SZ/:=_V[M:LWI8IZ7$B0V:H_"$[F%O;
M"Z$D[C><^ &N%'/2M=_G5_1X8;[DJN%RJAP0&23>T3V'-?["&Q'\"%N6I]8
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MF;7(UIS,_K<JG:FM,Q?_4_,.\*#E.#1W894A=-8JP$T!"3C?9,;X"&9H\>C
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M.\9N+&@+FBQE.TIJCQ8-\9-=65F2[;>-#]%KKE3 +/PZ6<^D<I>OKQO%ZXK
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M[H%54XO/N6.2$S25SFR1777;$N#J][A6V9?C$>8HW;^I82#KQ_+P0())RF[
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M6]C'$=IP-0$'C<]+392W9RKI"PDU\IT472" +$1G83TQ^:<M]@_::^4B_5N
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MN4%8YV]OL82!^8&-3X/L\_T! +]U,9]4Z1];]XLYN[QLZN8]&W/WMLA"%"R
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MCLOURTRFWGRH;%X+*/5']+WT^*HY>W-]*Q-:8(E+YYUQF/GRC#[#+&/ -\V
MV\N_<+L''#0>'1C<S_-&O[]Z^V90^*"!?9E-6NG>')/%A1LE%OD_(5-EW*4F
M%W\^E)W)^87Z7B>ZZ6:='V$1YIE6XLG1SQT1?#[MG?U_]61_4*[P>Z5]#1$3
M]^[NMJ%R?93DRLO7)>H6:"V,GO#_)XB&J\+. +OKIR#@^L3 >X8,5UBL<T/9
MT5!'Y5W= #.YXYM0YAZ-S^3[L+F,S=^/2VI^B",#]Z/=;PRK##V-KB2^8)^(
M4TF5NSWZ$TZAC)HU=LY&"W6ZZUG.[-]3"#L\O'>UN;&QL3EYJZ.SLZ-H_=GB
M_.(?7_*)1 BGI+?12R,[&_RO7\!<-=!)9]DB-RZLX7JGBX5IV;K,NT-VY,3!
M@F5V^0-M V)D</3=)JC7O?_&RGL'-;5&?[\YQX* @$BO41&1+D@3(CG* 02$
M2(?01 0," $$B1")TCM*5>I!2FBA]RHD@(+44$--(B ]08@10KCXF_?.O.^=
MN7_=^T]FGIDD>_:SU[/6Y[OV6JNW_?NB[4B@.Q'#+UNNHYTC/Q(',FZ4*'A&
M8_9?7.+1!X9^NXS4+@7I:7?8:LBUML8E OG"\JX3^B8R+9SO7TJM\?%#:Q@J
MM:.,*4'F0Q118VR[Y05(3QGBSNJ\\4>RS$"\AI%RA/3X0%U[&/>6[^4H[B<U
M;()L0F[B$;"U5$ES=B<N:(* #/3_F[\_ZEX>84/ /[<*1('$EH\%()2U"(:J
MJW/!#ZAXFG=Z:\C'XEF9/^W4;#XET?_5U<!<W[7C0<E?=I9BG6J2^E'\S%X@
MMQ=J.>\$T&#9F/$?[/V2@]$1F&%77Q_WD-(4N[\0:-7:THB'[][7N?A^$YK3
M^V7\P&A:,S*C<C" Z!!B]=Y_]LGQT*F,2XH&;]8['0I/^,I6Z?.$=YNAV>[(
M"^H5FY1 ",Y4"QE5I'\907M.P&$S.G4\1XBYHJ<4ZT>D%A>[O.U?L;_S%NM,
M$1=;H?/%+0NZIBW*R@[7?K.P!E^>Z@_6="+<67556?0RZ]"P_FP-4;18QQ<6
MV32?7O/4[VW6=QV*6!,#MQTH7"3%+54J=)>V>ORNOH/)UI8Z>*2+Y*FW?4+9
MWHE3_=(\";KGC";TD4;NY^HETVA&6K ;%+7:?IPF4AGA0;;&JYP %D22Z/0\
M9IO1"2"_(<0E9"FOL:B_>] 83 NF7RU*BD8U 'N;"T;;E8CRVN,<,*0$>K.$
M5EJU24"&&MDVL']Q-"<>"SPRA5WW5.NH_!W$\2[,:I5(^+"2^=J)54^PS*8S
MR(8A^<J/*/O8>^'5DV)\@K"_2U -SBXS?,*5T^VW%!D!CB,]\'6]6'YMD/)[
MB@6$'3F#^RWN:CK^I8Y3U.!/&M>2D ;J8L\8,^LS&\)LUQ(H$5#Q<;_##E1N
MB!:JVUA!6^T4#+NZNV:L\-94J?ZJI"![WQ%_KX2BM>XV]@)?SPK=TGDC9AB,
M- 3>FM[KQ*Q]+4"\T&V \S>0L;Z?C,"GX0B\Y;R\-,M"W&]%"G CJDA-<8P<
M(U(2+BX\V6CWDL>6([%^2"VX&N[%4"V:-P;/7/F8OO:H)?FUB[EI\$OG1H;O
M*,JMBR#"9-4*_E-*A<;GCVLK(HPL*/N.0L=%[?*?UGV*^L/D SJ@BSLV_O*6
MXW;A?]*XADVU5(=6&P*J1Q=]G&%;8\QNUQ"!RD\*!PL@_Z).$W>C3K7M[6D,
M0X<(Y)F-RY)MKLY0R[B ;%N0LJJ3&U]O'<[PNUXWL;].E<=\\_Z?/"X&IU3P
M=K"$N,<J\_&\3(=^=#\^J]1.(+'(S%O#_OF\]$ :2(77-1S;7!;P'[,^QZ#I
MYNL30.R$WXX(T9[3FNA/C*6T:7[S550C/5>[AJC WB6!.&^TESYMUW<@5C?X
MV#S/NUAJ_:6V90P=T4_< .TH]Y)D#!$H&]1O%NP)P.G%">!'B>Q*%:&)9D/W
M/;)#RDYTBB)HDUY5GW@VQ-FH"9AV,\\05JI4LMF2%3YG0"1.FE;4V%)@(/>R
M=3BO52 X^,MS579@J1/SWNE&_D\_F0P;&>1*5F1'@BB5'624B&<K*A(I14Q0
M6[.>;EBP\CV7F(4F%*^[I5&&=_J?6]%&KS=9!RKKP& 7?]W6Y6'D",]D:RMR
MV;%HIE(M%L5M7IFVE94=:7K(L-[X_GU)43(STUM!7BUO^0ZG<]:*;9_#A^]\
M5,3S3=;$ FLYS%OS= 6-$9C@6,*%^\IIL,GL-"F=9%^<GG?\^D2$P7VGV*XZ
MR/97$GQ6Q(J*VLHZ"O90#])KH*#_:9_4%F98)HML0[G$Z;*&]<U91N/\*U<]
M,=Y[M+ZA3Q3'"@L'CV1=]?"#WGJJ]H>8$A+C*AU&%6"R?:0&#=*2Z2> (@]Q
M@>-D;>#&]#LD'_UN@.PGQ YI_+N^;ZDGJXA<8/IM8R]!ZLO&-[WE]I\[.4>+
MO!1-)A6N[,'YD>KT4^UY[CT]IXKQSUBXTX53VPQO=8I%RE*B<)U71B^OV5$S
M8A7(";@F/:G8'4_/;9.1AYU4F3F'^?5%WG%BXYC*CP @M_U&T-LC6=K9XPJ&
M+G';#SQC3OMO;%M;G/&*;N[J14PZ,U_/W^H=107VM-Z-O9%P/ITVUHV&8.Y]
MPG),?0QX'.=)VN8P-V\T+YO;,/(]O*&9ZH.P]P;+88FEISK5+#<P"CNQE@LQ
MK)<ZJ##Y.[:XP*3!$[M96V166+L+NWFO[W::Y?$K7+.F[7EC',BT>];*_"TU
M8450AGEMY96>$DF6<I[E5H'CG6$X5@CI\\<:5]D0 ;BT6X@*5^_+-H3Z6SL)
MF@=*[X[]&AL;:QN;ZNJ:0L>'QR]@,%Y>GQ+9/3V?2=C\U]04*OD@/U3PO43L
MS4F71%4+7<M'Y],_W5^8OWVIK)#_R3^ LV8&4F\ WU,^\YFU%YP^%EEB%T&1
M*(#;#0V1;YO8W^8B 2-W]J7_[Y*O.%*-PP_"-Q:3+GQA)[-_RJM"U4#%<RYR
MK&$& ]2;QBCNVVT>B20-5[_#3I8;YBJT4V:@']KEE#0R_4/JS+GN^Y646T<"
M"::'N'5SOU)A;4)&0ZK%W<([+1G4&\YV0D;L\55OL>;]J[P41&LS2 QI/;'N
MXOL./1*%M>IKU<@KPW+;WD][:(Z=IG%GE?V87/F>48[_7W5:I/^W.JUEZRW\
MD1/#X3A,6VK=J0:X?0) _J3KTFR1?Q\753YMSL >5D469&K)*QI1;]0%9F3<
M:^3R>IJ9FR\]!6()N [5C[VX*))A-%7?>4HB$D=FR'OT):K$O=,8[Q?2#ZV
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M/(UOIZ9L1 "'41X[7UZ")7NBFH#E*#B0?K,R:AD2UL7%D#^2\;R%-*/_/+*
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M1KQ57SK:\]@"-@SZX*&R,86SP"25E4UDY\KFT)V/V!"!RWG;$!*8P$($)QP
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M/'7>K]*(NE<EXQVOAM5(96UM8+DTDQJC+1GSZ:5Q:#X]@]*4JHE(0G"W&YZ
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MIB0!%8+E\A?W=C,ETE=B7!86=+]LJ"6&F_T\;?UOHY(?!9<9J]+3H02!>H^
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M!E>(QI"Z1?K3W(T!0JLXCOAZQM%4+T/S= I=Z<+?/.$FI+^*M=@*,F;">L\
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M0J_K&A4$']DW-5G??DJZR-T6]&CWP;Q7TLV<45':P*$2?>#$B/D9@6M*/0-
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M^0^B4-(;8[^+SFL>_BL)'EY>@ISN<D"XI*TT,1IE!Z$!9R"1%0IZG,LQ_"4
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M>C3)[?0Y:QLW 9G.2G>9GF)WJ2+PC5QWK;+BXB*M'N.;)K+?E9^IYMWK1)F
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MW<BAP?-)$'8E76D/S#SC;SKL25;5+T7U4#^@_:AOJP9M\" FAQ2A%SPSX^N
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MT=:;/M<-+ZI/E 5PAN5CR]0*@F>.V?X5MS@\;W3,5EQKJ^CK])]CNY6I%)!
MUJ*/I^#:2-<C*BS=L<UA2[;?]&YZFIL@BOUIPH,_W[ VN6&,&+@CT4_WB2[]
M1UOI4OY9N?YJZZ<P!47Y[=$B\X )L&\_RK'N684KSD@.MSY6YEB)!A<7'[,)
MZ$LB9D!B^$>ITSNN%/RF=U$WI%:Z1^^9+).3\?!/FMG8#:([K3@2KN7S36!V
MH>H<&+\9PHZQ>FJ<>4U(,#G9?'!8-^2#4Z];<.#"H<487@3N08?^\7+3QU'Q
M7?E*PV0ZI)#^$-:YV#VA^=K;T>57M-H-,[3SXWW^9Z;\6*GZ??Z,%E%^9;5L
MW.9F.NIUMD^I96H2Y*R^*!Q.#R$K1Q?PM:JZD_&GZ=EC,_.KQ 2P3^BHHE?Y
MJEU->LM(,$8EHM'1L\)=03/#3J;VSN73Z?B"FQ9T28M-%K#PMRH>2L$JR"L)
M#&,6Y.U\8QA'4/TF&-X-&41##BCY!5R_N3I9?P9-;U\+)]HCON I,833<\V+
M>5=[9ES",?R@UHX'I)2KA;&8E&XWNK]8AB7ZJ(S=.NWZU 0DNB2M1BA81I)=
M>Y9TVKR*S\"R>RR[&YSD66&%''1H4$ZE2PBD$):T$:HIM4G';'Q.1RYE<5TF
M):#HNLJ>3T$4[66IRCQGN_.C%;;!E*E7.=T>];*ZG[BUP3"3]5&6JCAFBT%H
MLF9"'F)$]C (\4WG5(O1QB)EU.K3,-YS*,JQ$S.>TAQ0-!\CO%P!O?)VZ$%U
MS1AF%$PU^)GB9,$#:YF;_SO& :Y)TJ[O84;O;OT^9W_,1ES",E--?C"D219<
M= &"#N"5+O#C*E.4@HW>S1'C($Q?2/?+:'G^KAC:L.KC[N[UU]/7,QW"5W_4
M-9_^$?(F*]4!C?SW=B\3KXC<#;/[2A4/5EC&K5K:Z]:=C,T R Y\V+(X'1D)
MK_';FGXD?W.BFWQM=IV85CPO%^6^[\S1^9KT1+)&J\PSB^F;'./5E?7='N6D
M_K5\VQ!UKT+9[27!0$'#*3(R64'J4NZ5<[+]E2O4WLWZ@OI9T$E=TRI$G\Y2
M2AXUO#.[/9,<[LN^11 &Q7M25V+K*T98B=XV6WT@JF8$)V;8<P?I_SS#,:6P
M#.G1&!/4->J/^ZG^57D(Z98Z@_Y<T& 7J10YC8[45Z-+J=72RRCH!Z$/QW85
M#<\;)/?@/G:$UQX<=A)#UKY=>W<%_PT[<RC@;/^KO3>X+&()=/ ;OUY9<"!B
MM]BX.7-X%C9WV&.)F$+6F*- A*'I@H[VYQ6859US];A:.LY#[),1_*W];,^!
MV5"BWY-7TRX.:PT[4''-6NG[$R2?1?\0:7,#A1S5#MU8-?LGC0+@^@H/W;\7
M"H6ULJO19U\,2I[;L1GP:3(8[<+)-0=#3=!M,7GV1JM-@Z(00A9*28N4Y2EZ
M)_U;AV5G@,6)\E&,KB<D-L^QXB9))]AK@])J$!D-K31T.6O!54"2[7Q%<X@6
MU?/.!3%XK6B)?QJCP/AL 09/",T:G[+>>\S&3?6EKO=D*.HV  &Z (6 6>]\
M\3'_RN&O"<;%(%IF<DERU_ JSRJ3&^?4YM2UK\&/+X74@38V%X!3[@LK44PN
MN$Z#6S$L[#MZ7#WQ_<=4&RHDWM]6<X)AA5&[\R0[!1,@_$;0*]&B.J;7N$[6
M#3UM !P 4<Q!D_D64W:D">PB(&Y?GNP_#5I4_TR%= _QN][+3F;F!99^E2K7
M%8%6W!,/?[^!K5K!4Q4/[J^3 ;RF@6$[SI/V/_&>1Y<Q6JFJ'2.$;Z3<M]CZ
MONWIJBII(;[^G=:IWK?M[I;^>V'>='C+NV<TF,>F*$IG< H60<AJEP<F4X')
MUW_%\E,O"&L]^223VU:LI1R=;@ Y31@3&5X6C'_F3G_%6V1&_")538V2(5U%
M-QSB:Q4T7HL,C3W/.)VF>2!U_D&__<F^$VEO/KM-X"\Q!9AS0$&0)W;:H@M?
M2V3P2C&[H$QYJD8%DB)!>]M F<A:F#\+RR%DMA01/MJO'R#>*?:D?EP%$R0Q
M+:X-A:7>XASC_^@H)ZLKF@S>@]N<W2P[9GMMGG?,!A%.94[;?6&1&<!&(R6'
MUD1W*6,HT;%%$>6#$)4= N):M?TCJF8D_.\KCS'P.R3,;7O4H?H/[?/!4!4S
MM/>$IQG(&M=2ETZN$A?M6;(6ESB?]S!#0JEW!UR14'0.^7@)=\6U")7\V>:M
M;XN?Q;J@@[JI@,FWTMQ"X]X!*E".K."IDN_5V5Q<[;!LYD"^_ALAAX%LZ!Y$
M.ZN?(ZM4+@+.7TN'C::.U0D:D)_-&JQ9OD7;MGJ%T#*/BO7%F .@,W +*IHL
MN:HC%>\OJJ.?[J$ FLY7IHHQGN5Q$(3/O6EMQG&YVN=%]0:S8OPT#0NSLAC]
M59*Z362>WSG48A@<?=177(-0P 73@YU"NI!%&Q[F$.3"+_);%\W/^EQ_/:ZW
MN#0].9<E/"*CMIH/^*M;17'4*+ 4MKTQZR-,RRF=H:=V .A2FINJB\HI^8)T
MKT-/V!:8GGXH@QBXJ+C5*:^])[CRK5VJI"Y$85HCH8%S>ZTA^WGZF0)>\>NC
MC%MZWR?22Z97VSDH1[-,T3'WL0_,I ^1'/97&AIBY,-]8$61<W/G1@0O1_)R
M=W/>,.37^IB@;IVB9G/7@/V#S%_M[ZYC,RD-D+C^[?N]@.QEAS;IHZ(\-]XB
M4\"[<6\8O.[\D'?:^J+LH<[OHN=![U+.[ 142/[N,8T:9-P9K(;?Z<Z24HU]
M)B[4)?WV:<DCDJZA:GSUZFA/P!GWC2W#=H!"Y;J;5JBT#%E2.*LE6=T*<+8"
MQ9K=:TBB"/Y((A\O UKX !1%^@"FW+L*N$"/+6)T@M%=V*DBPO/,:8O>K6B-
M.='1(J+:)+HM?A,>#DPZ.;=.<5)/'YB<R;DI8L;123RXJXFXE@JIILH* ]:8
MF<=L0%94.OL=L^VFA"W]VE3TW_1[XH_!;#W!^B[7M]9]BKF9X_3)Z?VT2*)/
M3F@Z*7\.YD+.%K)<S-#\)]CC$:#' [8FA(!:\"1\=JO3E4-MU&B)6MM)AO&E
MA]GPZ93IO']R5T(9&M,-QIGP+;(G9LG>AC235>Y[77S:XY;IT;SL3@C-Z1[I
M6IJ:<+ LGU1X?L'^B;FX#>679>'[AW*#V87O/9I0"OHWSX)QY[?-'U18_*M_
M@H&D.QR:,C2&$7)P">HU_<N4P:I(;=+3C -B+.[Q8O)6ZTVRKX*I0HOAIY+Z
MTD;;M[JOOXH0D&CG>6C(<SLB*&&^'I#2ZG[,=MKAJ A/>JM_;FT_#+110/%R
MK9MHUV?8C%[[[K-H9F'>]KAP- A*4"\I]!%;PBSG+80;\CAYA[4*9Z;X?< /
MPT'%K4$@Z!9=*G63FX+LF;LV@5_(=U4:9URA$&F)^3.?00),?GN?&]#LD,@-
M72-$QG[^Y5'QG_?L/D^\F?V.&QXA,B\-G8'NA^6EO%0DQ@9K;ZCA)Y%3JC1'
M>O#A%8;H-P0/'(1SR/]N946-34!':N&0(O1V\IS@'H3;.RDG0:'D&FZD_IA-
MP[X^67QNP"S!H7UPG^>H)?/"TS99ZAGC][WJO8MIA82F^P;J>Y61YK*/:K)P
MRB13L5<K-*$0N73V420DR4/P]G7&=%#K;:HRC^F+IH$K900A<5.Y8!AKOY_M
M"FC^8E8VHK6MZ.@ G4?0?YKKH;K^%P^-./TN1#*[\DR"Y<;R(-X4@9>ZDA1"
M1[X0/7Q![T(OP15 B4GU*H0A[XY^Y':<7*59QBVZ;NEU?6U?IFV3EC[AV[+)
MM&WHKU]264=R6P'UHW]=K S:J:_->##O\ZG#@S/ZA9;DG3*)%P.Y23K?FX_9
M4GV5F:T@VO8OO%:>\7B7(<:X'V62+F==!GX6F+NB_N?SF#G/THIG4;(:/V9\
M&X:F=\)XGT[9Z&J(I^L(PG7^N\L@9_UXQ!+-^MM3RVB=())@Y\5(RZA'1;QO
M[S$>T.\<!L,?'N4CH04\S+YC-LH#19,.NVY7F;$MYE^(84MZH"G%[E6K$^FK
MD76VXEGSB<J@YBHU7P'SEF3,IJ_2/'A,&2Y=J=LN2LVH*+W\JLMGOV SY] !
M)D+3IDN0@0GM"AD3ATXW!HKA>I3 V=\"[1K4O"^7-'**;]6X/O[39BB#_6DS
MJ/V/-H,MLQ_(CGP"B Y+)0 3A+TD!MLIJ8F55Z-@[S[/7;W^?G/O*_N:C>[_
M;C-X_U>;@7]GAGF+^05(,=N:-NT&U2O'*A^S^8$$3*E DO1&Q.G&Z/83T.GD
M[G;,1X9A\B]D8[W>@YE9(\G9=N%OCR*4#Q_-=R$0%2'(8CJR(] 90@_LW''$
MKFH]?IH1*!PZH8-2R*]R,E=7;4WE.FV2'[BQ*.BV]L\;-!^G&A5WE">*$)(A
MG!=^UVT9@!9R^OU*S*FKBC_/C[=?YA&L )!/S!/G(6\$&\5C.OM;EZR$3!.]
M',%ER:@TDAC<U3+U79F=2IZPPW,I=?E!S0,1YOG"0VGZ*BZ5&S&'Q$DX^P#K
M,WOCT./U7#=MZC2&*,3/!U^X4<6VTT'K>(,)]38A107%^C$.Z1A=H0L%I'&-
M?8'IO?=''T9;('^:5"N_>QW&B]!!^&.VZN"AG93VFWI?J=IS&@V@2X46.5.6
M!+<R)>?_J\%@;%486Y)VA3=3=;E,?BSWQS$;>&%.Z//3#+NH/LH%E)^Q;==B
M#3U>>S'0>8COJQTPVWVMK]^FYOWT+QOO?O#;J%"9T:4BDUR)WRPY>/H<M6#3
MGU)$FH_25V4.**-A*:.DV/@E(N(&7*:)DI?1B*2>))%J/3\UU8\O-46XFS50
M9F9NK@G[1^_N$?U]<9Y$M_%-7X:B?CKFX)CM_W.+U=)NH7>S@"6@J/0IRDKO
MP=:F &NP,J$.. %K)$=@MEZV7X<K4KYOYB>6>#\7UWX-U8E-;%7GFW11MDB8
M7OX=G.?Y1>$2W>_@.QQ*,DW6/^A\/#K75_AVQ5XG5/S_8.V]@YI:P[W1N.T4
M$1&0&AO203HBD*UL04"(@/02$1%"*"(@04*B(KTI54!@(R6T$.F="*$H""B=
M("6)B" E$0B1M!OW.><;]YUO[LP]Y\SDG\PD:[WO4W^_];S/L]SU+UAD6Y=?
M6LI>6RPG5E;4+9<_'O8\@I:;>[]('?4/EG!XE#+]0(;:;F,3WVRCB>UM458:
MC'^@9"&NN<4^7F)M2Z6;NJ]4W-)(%HDRU>U#5 @.J<?^L.XM4?([7^,V^:";
MA>F4H8^P><P9YL[(MPMU'$#LA3=T7@K#JF$*!5U($%=H&(KZO">UE\V\[ D_
M/C,_ZYV3:&3QR5?<5)EI2JX/7SGG=[B;O\*4D4$9)#9%(@7H^[LA?$CI;Y-L
M(,7K:;"SQ>$_1S%]?XD\K#"W")3_P[SCZAYQ&3>^N:P<5+:J8V\_96T:%*B4
MM)6U=HDA3;],4Z$#BQ&:'_/''*G^Q=3O"R>8,*D*?"!I1!3\1_$Z;SLT!!A3
M[[!50O<"OXJ$W4YU'0'22M$5+BZL%(= $;\HK*2V:5J0T9D!ETEQZQ09EQ&Q
M\T5QPVJ!M?Z=,OV9SV10E>ZV>A=O=OS%T 5&;_&=IWYV[.7)LU0G71_-U#N>
MU5#X?"EXP7!_M/K*O)6#2X?IB)A=7B?NY4"C0E5%B3%L$ 0UD"4?:J*$DD1R
M*?M[G4*?LM7-%WMSB1NX2N^<>S@/T5C?-4R 7_V,;TCYZU'E68AYF.:1!HRE
MLO$@OG85BATI^FY:FJ>PM9@RK<'F.8&35FT SFS2HCYQ $0;]E2!@/3R=:I]
MI%:X^^M9^OIV;/^LU@@OX<;5*Y7%O+3U /Q%_3)E%W@D_@$$_@@Z9LQR'$=-
M]7( ;G; O6L'D7>1"T *&"6 G&C\K_J"*^,FPO"?^@).:/N?^H)I?;;A3"D\
MO#>K];8S!U!K%%RQ)QJ+00QY=#<EJBCUSK_:)5S;D+P,D<%&AFF'6IYR<D!;
M-@H8E)B:"V?>F9.S,3_QNH7JZ&I[JH(>OG4S2_N<@$\R6@<B>9N./9QM34H6
MPMISD=UHOH3F(M/RPLU!>J2*K:<36#7]R[>E]BLQ#\HH+R<$O!(3H@4D1HQ/
MAIWE,OEDY&=18.UNI"8H&L=3!>S%U>_V<<WQR&8WZN@T=Y%0-V\.@) %F2XG
M.\^I[>]X'VF5Q0!UY_C6M#_:C!/RP >50O5&3=!<Y_O&BGG->L&6]$&>IJY_
M,)1G%1DJC7  1V6Y8A(? =$P7T2SQMZ7"QQ>V?LPI-7+9<YA05KS3>55:P@+
MDJE* [0X<Y1?6@*8CUK,A]0 >]L@L6XRK%J4_R5LNRW#8G5WJA-(\<\ER==7
M;BTJ\QJ;ME^Z@/M7A8'T'Q6&4MBTN#D'<,*55X# LUU7Y2\D^]8\JM;70NF6
MEUY(<XPVWCPG$YI8_+/\-B5#)],^JW'BDM-_5A@4"G2>=(>Y>?:*]>A?)54=
M.Z>2IV?[YK,PWN&;'$DW7+''6*WG7G82OP<XMNYE;S@<+>\Y?1!\H,(L"#/X
M /3ST&K!Q@P'L&(]14Y91S%LV:.X&IUU"2('$"^M,08D>:TID_,TKE"^UGD1
M1WB@#]W.TG5(G\YG9C5A,49!VFBLF\\#$^DF#]E8E>"A_4Z-N(*N/;_2%U7?
MWL (_6O!O\VRJ>;M[3Q!&4G1UZB&Z_0]$LDBH7CH618MHUKK^YWJXQGF$\&S
M[SZ$BF1EUE6:G/='GU[4?Z!@+G2^+!FGEDJFA"'=[4K=LSY]H B3E50T>*WD
M)FC"T$\/,)%8+R45[81$+R-!7LWQ<LOMBO$$5I;6NRU?1E3YS7=!3"_^Y9=*
MOD%*:'7\0%!WN[](2-C%[+ZC9II;^KEB/&F%R6\GK9\5R=V!RL3CW9>E [I1
MHH;B\&4BIJ /R .?Q>_UXR46!#[32T'B5R(D'YT7%XZJGW+*HQ4&!GUIS&*]
M$&[X..G7<+ZA;52VH:UQ_.^&EL9\N5]E"4: $ ?0Y8&"3H<POON!K[*>X+P$
M3K3KA62,$*H\Z;VD;X]#U7L[Y0].MGA_,M@"R%)BGOC?'GL.99^C^@T-4CD
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M[^_I?%[P0R"7W;G( 7RRF2+;=X%G%&G/6;_>)W697X.&? 7?I&G0,57@$'(
M+SRMQTYM@2GS<G:  R"(U*R&4E:=,M9?QDOXR=I_PH1()*%N7-\&B<ZJ%'H6
MT^/!,[<X@.>(A9W=P^SX_$[8Q6[W^R]S%P/3J<WZEM+P1/WQUS4G"V4TOWEX
MHQ_I5E@G)(ZY-)P;M"MHT<PBN02^N)M]P?,J0J='U__L.PU?+<D1Q9Z*='+.
MXC<[K-Z#07C,?I&EQ\,70^2'\Q[YA4M:@#R3\"#WV&?N/V<X@(/\5/1Z**6
M.!7)UF0/8-'PU"EB:-S25*<Z0K:9DI'<@J(>)L[4W&O/'[//).[D:<_B WPW
MRU8Z1<:FW#H;)Y+;CF&A 43';4S0-.IN .$[$;2>0:GH)WGAI8S>MT:NT:2U
M*9:%^LHDR#YX\O4;J=_V/@BN;V&\9C0)TBT'8.COC6KU-+;%1&>AN\>.,O(P
MFX"B6(YPT<<QP].PA?H IE""X[C^?M)FO'93YT%Z+P6+MV]\I))= 65?3F,
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M17R?>T ";5OT.XP#>&<(_*<9\]H52#SJ.,YO(;F@QGX]!4O7H+6E@DX@WW$
MXB'-_L@C3(]/^F<\"PE,E2T_3&+GR:FSGY;&_4/"00)@S1Q4W(7) '^F15B
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M:5GIR <073&@AP-XL@=:XP!4NU6EZ'[(,TQ[>I:^%4*"8IG\@:TXJ@]>UBY
MTVDSF#,M7%UO#[Z?!3\ER$F#3\VY6! =E#=\ER=+N2'A,FJQ(/-1Z!J$<:N?
M")PU>IL3$\E60G!=,4JY\QCB%O4A1@1;!$>.;MU(N('BX;]2TC:V/=OV'?(&
MKNUZA__*+#Y4_#+\:DC=IQW[EK3MRS0E5CS[M&R/%(2&9]5^2>"NLQZ=H/*U
MA3(5[?^U=CRXX%FKG31AR)=<V]PQZCYEC1?),2C-#0ST)!J<*A8$:[>$H612
MIA<:LM8J*=]IS73;,N8EZD2MD\]#4H3)6[9&8U.R*ZS+4.9'HU'YM(:F7R!Z
M[F#RE.NGX@SED C0EWM-N,:Q!EZ!EI+<I18W$1?U[[:]BVH*Q4$N8_QV)>5W
M8.'*#][)R]WJ<B\Q4Q0<$F7]W4(PDQX"[Z$.]R. 78Y:D$/++SV"AD\-GTDH
MZI?T2B/76-S>>A7458T\AN\N]K[3'"Y?'ED"UK"%XG:J@8ZOW/G4N\>PV^O.
M_YHK3#]'._01!!/X@ZE!%< +$%X/=__8(N)B/2@C>+#4%:P#+"<F&2$0 ,UU
M7K_J;#Y8B8ZQ[.VHSHK X$MAN]STG5^'OE!4\MEU/F(S@@, 'F:W.*-6-+6H
M] _J71.][D6QA?%)"MOI:KK0BG3%*V/E<I:OLN#O@ZXQ/F9IRFQ>*QC^?"W=
MZ,Q(X,]K2F/*P]\6*P9.:O@6"/&YN;YT7Q;7*KMS?^+O+QCKI.MZZ7=9U>)-
M]7@[,XQ\B76\7+50/T^; #/,C0/ <0-KH?FMBC40=2F<S4*SHY2AYB34SD83
M.R=;?085#]QS,;.E<W]U\"G5BYN\8S,7CH'NH7C@Z@%QN 9D"\G@ H/(E!;-
ML'>CA[B7@0]D652Z7A78:'?V"&C0!Z&4.THZ"_P[M29DQY2WDZ0W=G<*:,\F
M#56]00?99U87]NGKH.EM)%;ITP5*I+=>R41>2=YPN<$<IG[WQE[21$92SYY=
MKM8&UA/M.N?<53$_/;N2>KTR-.?G8=IQ5LPR_>"A&BJ:?*^$"_EVUZVH1NOB
MV&2$:[GKA3=L(0O7WKGE:$V#O[+/Y?\PY<'&:;5I'X> 3T!SS%'N#EW*',#'
MNUKW6SPRPV.K2R"'[6>6?D8H5 M3=9L.JD)CO_@$U^Y9Y= P*W%^1'+(NA K
M'*_D;]XUC(YS+(7R9"=?2<J4B*+;[$_.X!N[-+P4;2NBJ'5+5IQN*-SUJ;JS
MPZI!<KXHWQ:<#W**I(>RCT(KZ2!:$'V"&D2[S_H;(1.XB"(L](IO-V7.ZU,M
MB[7 =$<GON\B)<"8>N6'7UI_3DW%!9)R80FPMI?,A_Y_U0T3JJ.@'I"/ZA$[
M'$ 8ZB7V&3?;!TQ7X@L:L$^4_>MS7[:?H>+?7FD 1T$$U]U@BG.@FXU9ZY_@
MX?:XVMX5"HNU'3C"WR.SV7ZI(K:A0_8K^U/-A($.[7([JZ@:>1A^;XI6_M&W
M'IQ 4-XH^GO5QLGGD7:Y3FQ]TEFBLB9*:#7UFR@A^84(IO)M\NZ@1_#M-GC6
M+>=PP;*(IX2M"KHO26U$?BI*R<\IO>S>I1 SS+!PD84"_-4?KUXM/RD7?YBA
MV')[5<;R1XF>7P#)V"N-2A,IB-.],9 L$!N80<F&B% R527DI_ >Y8N?+[;T
M\YD(6H=0)77BBY[=+W]BG7<C4OA]5,<-*80F\1NJ/C.-FN!,-Z*:6[ *VNU+
MZ8IDS=9#:!T\[K@/03J+Q'ND_9KGZ8Z&L0LUDU]33)H,3YN'(4 B#>7XLAGX
M0U<++4:2A).%YHI]P0'VVU]=H4OT'509>P14;YS" ?!DT=[2'^Z*@^+;1:N<
M^4\L]*<4_V4X6TUW&KU3?JCZC>QL X[OSQ]_-P22!/C?1Q!GT!:B.SX,-D@%
M]YWTS\G-% :22[/TVPT8#M ]KYZ1&+UFNB/#BFGP3^]3P<G@_^I]XO^:35P0
M@4"?!+#?\X]6Y?QGZU/6/ZU/>3+L%Q'?*%\5HZFW:EY=[JF'WO8FUUAVNO:>
M0NCE7Y;I;ZZP<I@X4$'^H;=ZT:'J7%J^B,MTNZRRH^TRVX+L>UC\MAK\F/KB
M*PO$B%#&(KO\U7T5#5&%,'LA3[.J&J%,AU73CP/P(IYEJ\6@@P)>R3$7]E]<
M+K2,J4MA\Q@Q'KBP!Y&\'SO%$7)O4*+(<9#$2W@04?59/0.UKC@'9-A]^U9.
MAOU'^Y/U?[8_U3_:C!/]C_8GPC_M3R16]&O6<[;$*O(,=6?<4)%5Q%;^I_VI
M3T#"!<RJ##^XM/W#QZB+\+!!PR(PS*-T_O-0:+4/[#)0B)YJCG$*NU ?:1S=
MOQQ EPU8,Z ^G"(!XW"^"[/YL$UA]ABA=V<WIEVLE![OI\ !L(_S\UXS;=>1
MC3V;8&)3Z+Q*F"NI;^R4=!6VQIM2JH;"]Z5R #U95_&TUQW'9#X\8$L-E+QE
M7DHL3$Y<M>X)]$=%9FGQ;:F]_ESF.<U#, N3MKTP(:\EG-S'N.&,/G4U12>A
MZY)V0-^E;7UKLGZ3<,;XKREK^(T3'VX7QA-]<T^DJX7UP6(F3S:C08EGOW==
M&E08-$AVJQ@NIDKF$B#,<!SK80#K#SVY40Z /,<!?*]#?1/\!#D7P^8'4=A5
MK ?H?E6;BM?QBI.7_HB7^_N(RA/MIM-_F#Z]#1 [_W(: /B2"@>$8%49PLO,
M/1<.8"$.18_?X7U]#?/^P-/3+Y\>.W)6^_332P>DH]O;UD-16[]>,(LJY@!(
ME=,#/W_"'OQ@WL2I1^1/(G&3"SKY#%5H#"U_;+'<WQ+R-6ESB,Y+4QSYN=W"
MS08G. #JR8CX+7:$"FJS!\>\)DO8X "6OY+9'( I!]!K16O#_?S9S/WE*(IJ
MN\K>9>>QN%L"0596%CF .A07;G06_'S$ 9C;_FNM639U[:@WO@TM?HV"E7Y/
M[0CS$5V$::-H_/[(R*?'+EXS^M=U+Z!#@G&W9X/T-L;(]V8U(X/"=O<'XA_<
M![Q?!ASK?E.Y?JD<(=K>:OXS9#6\Y7#=WD2 UPCJ]N8PV1\"M:0MV7<P5CPN
MKXDN;"V%<@"/QU#<+3UEL!'57%\7#V"?S:7-COQD_-KN#^YV@R,:M]C(#=0F
M$\=T59WG ,9PK9#E[RP#PSJ(:O\@6X#X]5_7$JXLF9E#TZ(9SNESZ!N5K4?M
M@\368VT'$FL SP]9[M-=G#29#0 M;RQS1<;E]+V3U1DA#S@ @D2UK%]K\(>V
MTN?K[@9O^%H\H@'/CW1UG=//R0XWCTB)EY+!:2(8'(#32K0BBX#3GN\K6<=U
MC>Z%,O7?=?:&<0"&6:!=$H1]-J7&#352,L*B9W&S<3'#=8')_(Q:6 '1*PRG
MN&L$Z0!W]\!LA58<-]I8LE=0!=CM;>8N*Y==P-KF+FEJSPD[C04MCRZSF>9<
MG[#ZM_(+8&T<0$%N"H,ERP$(F_R_U,]8V O=-6>R4.A"]A ' &;OH9:^LY0]
M)ZJPTI1:)Y=65DZ/OX.,>T9MDYW8$6/;)W921G\(G)X,F%;%+0]L<@#[2KE6
MJ6ADU]IJWET>I*<Z4V4I CWI6849E#RT_WRJZ8:I;)HCSJ^=NX:V JXT5#D
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MD=YRNO+ K_@A*7XE-.0%.RUP'#4(-4#-%]FVM5J8L:R_$FW]2WDJ->,K#L0
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M-?[W;_?+R@*./4W])\J$#Q;C7BR4DY<1.&OD6&X6P8:N'#&U!>U@VRG\CE:
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MOZB^^M<_HA^N/AN2^7T/+^>T-7;E#&FB+X!Y46.6R23A5+?GO=-Q[SE00,<
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MTQ6>XWC#XND-3DOIRTDB6%QY;1SCNMH!8S3CH:OK!'0V?L$YV2'?<52R.T]
M_U1LDIXEPM21(1$%?KE0I.V>_OV'16S-$,]*AE4_K%)(W#AF9G/44/B;U_MA
M1P(<$:3J_%Y#D"ZJ;0$K-IS]"AW:9FPF^[F=H4'<LW5V">FH;L=@&7.+[[YS
M*,8\4YP]1Z *+UOO?1@(+[(^_APL2&W+JD"^V&&)U+D[I#6R+C4O91Q(1A\!
M25V5PQV8\1_*XT''J$2-*Z26XD:LF*\E33)GL=I!@^FK*FS=7<<D%8"SN<@J
M7!T)I-5[ G!&CNU*UX,.K8X\;HQSA?@8G+V.P8+.0'D&^Z$SI.3).YV/JH<]
MKEJMJPMSS.J[E KAR)P?EO-^@&@*!A/\!5(.BL [9(7.M1\3R2RM&$%&-^2\
M8+SCFTWW7;=@T(T%'^:;#SY#L/@(!%!JJO,&1B)@')=S(P<S5>R]HN\*W?G,
M5WTF\3M687(CI-F\$VI!\-PP,^H6M'P;C;96:[FNQQY'=_;[?%@4=([L5V%:
MH.>QO;;ZJB)3;)Z'C[7Q\_*L+.)6U)=%N\M>&@(7"X^UTT7Y#%E>;GTS0X-C
MMHNG[B@IZ"7$Y"0M2.OIP8M-KQ-V%)%?KW50<9LG@!U&M0+SMJ.0)_C5C1/
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M?KMGI18S_<9%,5(R(7]M[FT,6>9&+M@D[UV4O\G[L<GDA[H&+[6-8:ENJ[0
M]=PAU8.Y7A=>4@!<IO)U5Q9&8VV:07K":06-A0;9#XO,E$J!+Z08$53@7@:U
ME@8^J3D\98E;:Y[I<%O;7:'&N7=TTH6H#B93_JICDI^$483S]NY *NM*7I/-
MJE$)5A==D%0R5](Y&](YWTK5K>ZEM/QU(^K0$">N3DE]S;A>23_&N=^8#M%G
M_>H,ZF!6DEQV_DXS;9HB1;N*D$-BIGW1R6F[E8%?1L)NU6%]T\94K3"92+P^
M:P\/(XRN1@;^SGAB+AMX ?7$;<<&GKD=X2*2>FYEBS]+0(D^83D;,/@6[>9K
M%?;SSO(X<E#MCZ[ZF:*"!YU=K5F_+.D0*H\+?8DT$8VJAYSI%8(V$T\SH&SB
M=%'&E%.6E,LYD1\)])$'4Z6)3.[(R_Y@J^0O^(/CF$AM("<!GN!T<,K" N1?
M6H94T;*1<7P%"QN_C 'QSZ9PTZFTT*<-5V*#1/7$B\M(S]++QA_B'I5;1W]L
M9.]+C'FJ_K;:JNJ>=??]D2.5&#H@CN$QM.7S7D9_.T4_ZAG=#X0RD1D.4J,(
MC9M&?2+)3([37[)%%=GGPDNYXT:V/:B_=(O,@0GIP7XR7*0MVY/YDS1]/PCA
M)@U[4MCE0.7I[;!HC=+W!+,Y;:_R37M2+\?Y@DRI(CCE0G[GV90RBEZ1/\I?
M-1Y5X;BP6A/S<4O>Y^.J83GLIXJ?$K.^E!'UY4R8M^D?V![BX)*]>CST(*(B
M@"[PB7"Y@)AZD>[RH'5:58S3/&ZH ;\KGQZ=?$YE1'6Z/2*Q<^2#1%=/5W;$
MTE)B8F=\25HS^!?;V"D+Y!GJ:_G.E_J%*G5%/JUU2CK%T<SQI2' F%T[)4/3
MU+A&XN-<BTSU<J5=1$LA\#FW/B\9M",UH1('B?LNJGCY,UQ;T+559N3KP!W<
M!%MT6C(H("@AI8VQ*;@IL\!XO!3P/)G#?ZKP/MH(&8&X=X8(47"-]=:]*#1R
M!"."X"EC*%/FDQG*'V'ZG'I:,+T;TP%=(F1=%YM\%]D\6:N&IOB"WKE, JY[
M+8YT1BLM @;*_;GFRHNAXF)S3;HOSM281*9'VA<G.[F>'AU.;5X55S$05J&F
MU*SZDCM_2>Y!I56>F64(.AR><!G&'5.1)V<A8\<3_^N+5?\'B4B(1M^&XQ&\
MRO[N!_MAE=R;I1! P@CU()3FF*0ND2&\G>&KYL*6F*SEH;SPHEY0YO"KVD,2
M\A;B'N7E&3;0&TF0?JZ >6S/)8I]?$0M/<ZQZUF]\X*3L6NQ:=Y/A];G[ZN:
M=BZ>6]G6CL%5Q^3:N+EB>1@N9Y5R[Z2Z1P&YF ^D?Z!ZG<4UIVIJG/Y%MM2B
M*>3O$$/='_ TG+LX?F/F&O424S)E\V%W0T?'=,#':7_]%E5-.558GG5DL''+
MZS"$;E!8\*]!ZA)N5?KLCVUFSO*O-:SUZ3I8XS%>J%?NUUKFD+H(X^D 85E%
MX,Z<PTO^J:TC7<*%UIX$I[W  \CO_8ACEWCR?,\U4_["TBWG&R8GO],%>E<%
MZ!'$"4ZZ2*^V> &QEAT.ML2K B]_U;:]P<DE:XHO2B",CQ- C7PIMT0V,C[G
MAW%.!,DU#MU*/OQ58Y5)J05X4(0RA053E"=Z2E/S9-YE(^33I =ZA#/,GN5Z
M-B:10,TPJUJA+G%7,KL-&L(]B@S%+IOD4O>%/(.?IHG9L!$Q'""L-/I-$8=U
MG'C0K4(Y!?5NX5EI2W"<YG/WZ5@@=TR>YA>M43_;F'"ZJTC4ED+PYO*C5XC%
M9_?_9HMX]"?'N]^V?Q/:>CN' 2+/(0GZ@DQNYI3PS]V\8_B*+RU?ABK1JE!(
M@9 OYZ$=Z1&]^4IXM8BA&U--W#19F,[%JD W)(ZX8DPT1L,J38*)$%ZP0E/+
M_%5F[S)JL/^4Y9  .>&J) +I4N!/X-?Z(BB?0 $WAL^\ZMIO6,KQ PQ5/U9/
M>KGO=B=%KZ;>A-?CAD&K=DM.[;)\?EH9_,E*\D"W7,O#K;*.76&C,<SH!M^S
M._VSGYX(!L+B1B4Y.'F,LYH&UF$_AA[V>X39Y)(GU$2-A:5////>619?*S@4
MB(./B^;K<&-!=NF@%W8X<[9,_%B=H$8"24%T=-;)1&'LCIWEG=KXDDJ2;KY/
MN@WXV(&#?'$ GJ0G?/7(BZPX (Y;8V&*G4G5K/Z]%V+G^I BS2JN#Y:\>V8"
M;UUJ$99(?.RNI28?:-?&"2MUO->+SDAZ-\1:Y2!PA0$^OL (.BG#0+L#2>!!
M\)LCXP_K@8N#_3WN!1393S9;]O$D8Q=.(B]30IOD?+?<+]L?EWO'!;*ZS6/J
M4;[S;IPITH /Z=;*W*?>I%E1D>7'+Q#!=  E@O8WO3LRC+))'(SUR2%BH@X]
MPDH,J:DNTX?2555-U>9NN+:9P\IC6$2>S+YK=RY,>^ #<225:RL82]*UL>II
M8S;+R9W1<1%Y1?.&)GS(F/HT 6N)KY(O;*ROJV^,D=^3JZJ6G]:)<#%W@9//
M^-[%_XS\,S*R$\\/SB3280!00[,,?'1)A$_[_9!-&O81):CB)%=);UIY$^<0
MLO^F_[;?E>=8FZX\)V 0"7!Q(Q^P <^_/*H$M[Q&3KF.%C56U*N.JOJ>#_P;
MZH4^-!-5IX:4CW#G?K%3REVL@0E^WVA#(@JXQIQ+U"L64+_8L&> &WS*\K5,
M)L/MOS_*_BC]5$!Y&'AA&]6\UE^P0"8-O@X%OD9QJW*YSP%CM./B$4;%VP3%
M 0L.YH"8H=F,:LZ*^BW\@86/6WV^F+DA93D[I3PX]%*:;VN6,RHI9.>4Y1*6
MO/X=,:*>HE?C%I,O[QT6"AH4X[ IWIGZA-T^\",5Q07;[4P7:L^LWG ,#[47
MS^UN1OF8FL%^%:F3'J3%[7BKJN1&@GJ<:%#1 IGR-Z7NFD\MH?8Q3XTN7:*^
M1<M)"' GE,95U?V)F_N+&EIXB-!HKI7"HPK5UD]9FEKW &<5FN9T1@  R4#N
M;Z/ADC&[]1[%2V/GPUL3NHQ>B.L"^CIX@SNJCEH:7YRW2GM?57WUAUVW,I00
M^9ERK-Y8!747FSJ$7($1DO/?%GYU]J?55VT3DOM?9".ST-#,AM5M[>3#F=$_
MEYP6G7K5QF;[SX33^?\()Y >+_Y,+M+E O<>8[A!AJ7;+< ZX.Y\K44IW>5?
M,\A9+\ 9Z H97,\WZ6[4LS&5: <N*AX>/I.DK+T6,:-,)^KZ]!]E_**U&<8]
M6VQ^Z@[+L\L'Q#0(AU##OBCPVU5*FU8I6+WJ3,CWSIY-Q!+)HQF"$:X6QH7&
MT[_ W)HC(E@ZHO,ZL8*W45R'-#S[G"DP4K$RB=4T J&XGW35YY8__L#*7O5$
M'5'];_UT>T]9=/+D\4D44HL!.Y.;/M4"9,5!0%R^&!U60<>[S84"S_GVB*39
M?E=3C+5L,>GKN8YIF0MLYCQVV;,TGIG3"/-HG3WH]-?HMS][.8]U5T&>_M<@
MR"?.A"7')9=%)Y=>J _TO'I+9F;=8* _S#]0&/=/-ZZ,T?DK]^)YE?H318,J
M/LI4O)*F[]C,A;@!<,Z#<2"-8++B%:BS1&795W?NAIFF:N$?.&U<9H[:^ ?B
MDIN7:WOC5$CY8>4"$?]QIAG6Z:^.^V;_A>:[]_'M8-Q[3ZDGFHP7-UG_P&[
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M.AA--U^NCL/"!&0P3OTSY:*6'G8GSQUEA/Q%[WE8YB[W)+@7;>OG"6,8,6J
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M18G-3E,5O]91_TM?4"\#*7["CU : _V+ZL4378E=O&VB)_C)/BE(:^YF@NP
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M\&E-YCDV, $LL+<_$3MHU>"H30^AJE1+/2SEJ"F&8M"D?:X"\9D1V./WRPX
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ME-94[S5!'"*LUE)A$XQYE [J"%U<%%1T(S?HYI":^/29.IK2@(:W#6X64EJ
M-!I%Q6>!(L "QO6Q+LJ^RG;E;OR;5KY!=YCW]/[_ENL\-[XV(CC7GVK%=>I7
MS'K/LL4WHD&&7_=3#01:ZL;V4V7&Q+BU(/7/ +?]E6J6XV87I<4\DJ1N?,3\
MTR1$*Z%4.Q<0,3%-'\#+87E("_\JN,+8<'S@N292X<V^*6=.D"@\9,PK;LER
M GZ]>CU7*%_P&7F6^ -G_15^M=IURRG[1Q[)9S\Y\'24*=F/I-S2.^AO?V.Z
ML61Y*:F(6_ ][-='ZX4HU+;HUI S#R_M">,=BS;$I'\LDKSVBX\6V/O2&;_Z
MV]X)@O8KIR6#)_>3@6N0$X?AM!/[J93K*?!+Y.G$^D]K;N)VA;J.$($J'7L^
MG9O9D$LCVB8".G)>K^^<\U>8B5: A3#1\3B"KWOVH_:0.ENUSWJ<(W2-SYN4
M,^&OB:T%6L.;5FF!;TA613ZYRX\1VVUG;--2=$H@.<!_H70/4 .6Z +BU>RK
MD,*G^S[8Z+%C .D0^(M%?L<B_(IK7_SI(:XC%HJ/ :8KM='8J&**YS' ;>,8
ML&%KT4)8^F7&BMKY8\#^@CJ9D]I .T'18K*O4=)^4<F,M,:P=IIKU3P;HZSK
MU#>E][#'Z[^$C*,,W>K&:XC9(:R%\%FO?BFJMF_8M$M\Z\DUM->I1>ZNJ9!"
MT 1B.0_:,))N( G#X8O)ENFS#T4"HU7IWG[5Z3%/S3<0DA^7N#45 ^MF-W5#
M4ZH+]7QG55^Q:*)2'EJ/AVU.JF@U4-!-&.L3@/;'^-<J8?R7.QHZGCL[=X K
M2UN;VYM;4]\5+1+9;8GY[._"TQS*C--NS[R:S$Y0]/?W]_0/_*\Q-F6\SDZS
M<T;B@E-37XWK;@0&GC)[97CJZN5^?LNJ?G'?RB1^@,$85I04)"+U<_;U4]!L
MZ+K58)#CH?]#X<Z,Y+7R'/M"#&A1KJ=6>G#V_I7&#?=J^4H=\-X7GA<1!M"^
M$%A<G'N*B]:+/J)VO-*RW;N?XI@42O(WHG;R:3-J63:;5:V0J@TCCDVM]WXP
MEU3E0%4Y>[45*[OU]M,/]PJ. >!:/Y4F55:T1FZSE*P.=K]]M4L"<5&5PHJ8
M^2=&+-WR&-""E21AY\2HAK3 (T^XY(2!&&WS[#[#=W!'M/@?O6!_/_'9Z6?T
M.U_/$B>49E("0\N63B5-]SJ)C0@TU]U+X)S;O/;4K=2=SG!S/09TWV#J^+KQ
M'P.>@^FFSD-J>SV+4NG6M$Q*S$AD<# 1.K-[,]?"_Z35A*;IV]MT(T*U?';Y
M6*AQD;()/G\,9MWS]'#&3]<-J_SKP,\&VZ"QM*.ZD[Y]I+J#J$,\1/@R,GAV
M5+='==I%$7.=V*:H!%>^8*J%UJ>]SP6#>P:^1VY $A?$-+;H0BT/=]Y8B0[I
M26"M2GCFPQ_GSO<3 LIACD=FK8Y.V6;[Z],NV?(MH,^PW1X7;,J>KDZMF-87
M6#!?:JF)+$OR;^=%RE$0''TUOI.?]@P<;_0U+5>Z-VAK)>*6JTE7S&U+W,Z7
M]\*E:?;+F.<@[LZ+Y%+"5%:[Z@L][G=SZ_D7TXX!NL%<1JMM7=BVV=2(JLV6
M<5??_*:]JL]1J$77A4\GO_1\@-XYFEZB<GTX!HS>;U"T^(]'7=>%[-#A3A]\
M,ZN=FDQMJ^W*WFS:5%LA]<TRLPJRD#HM\J;-*S)SX5Z;K2XJP--QN&5RB+S[
M^]=F_(];733/&F=S&0!Y(!J5=TLA[#<+%6Q*1$,(_*5GC8SEI5[E&?'?#>"W
M- +X^"*VE$';8DC$AE0H&;3S^8B+#F(TP-E.H[]O+.\F+_*D@9=BEP0T:(6:
MT'.;0=A9PEB3H_^=\/SX6$P@KW1[@ZG15%YH*M0D@W/].QC;I?F? \AJWR"O
M]'DZI,BXYQ)EX_"$-UYF:*VJL,92N4:2U1OBO,)8?K9NUHH<1"TE/_I:Y$M/
M<<M,DIK2KY,F5P?V1"7Z!6)KBY5R,F+-@I-3S823!"1%O\'-17JZ)#KEITJM
M!"Z)J*Y@72E8.K\A%=-%;J'SL1$?)D8L'P,$8?9.1]"=$Y1"Z=97G:YDZ.U<
M")1GJ_W#1-BHHV][U)>BD+K-'*&D:*DM$#EYXS#EJ>>\A'R!)?.E 1=<G,SV
M$1@7S4<#D_N-TF^2 U\T3HSO;]VS G=\SIN-,G28_#&FG5:"WM+Z.>_[M.LM
MI=1U:7Y(+DUNX%914K.@8I1*9;-=,FK$YW3,;-+<3=6*NJ;\5>+L@//[YT0P
MV"]YL&VY.8+KRE!HL)(W1J]F:FM=G2D3,<2EPLF>Z_[D45?,6@KZV<<V)0-9
MS5Y5:B><I&Q[#(B->3M?^@*GZF[F@BX6^%@DAHNY.E,4E._UNUAHC39@\^2-
M1'AA57"_9Z=J;H=GA( (SE0;2WTS+B9@5AOX&KS56AGI@,<,7P0RK541QP#O
M#N#AU)3F_MI.]I'Y3/1G["G-P"15P@=#_.'.(AI) W6[7:R/"V^9Z/3$W(B2
M296H"WK$U>RD86C1UOHA_RHU.9/?R36=?D>3T^QWNLDQ(&MPZ1@PJ]+/;&I*
MC2X!<ZE7FA+3'CA>RK.R<>0W#U1S<1X0Z/[7;=DD'<)C+2,-G\L"(7; UT&:
M9OP-;YHK9%[T$C96OK%/X:IJD]$0M:H5B]G*H6YS[Q7AYLPPGQG,C+:'0.Z]
MACO7U+4&/=]XOGXT)D"9L0G*'%QTCZO8@%3PDGS&,-;<HAM/(.6Z3RK??G]+
MD$$"/^]^"Z2J41H-KF 9]5B_&4^*_8XJZ6>H*YOAU&7C%AJX=-$YX=%.R?@G
M/W^MWL_E]3[-LU'U4@9<H\_7<][I&[O>Z?^.:(K?/J"(415IR/"C$&9_OD_@
MN4&I7&"C2;?BK1P0S^8A__2_MNPH G&%WNG?U_?:,H[LP&"O5G) C1!>U.7)
M>OV6H"[B![? &BXQ:&E6\VI3J5F71)-T#"9'\_.S'->+EYXA364JQTHO>D/D
M)\HM(YT'GA2#-C7TH$2+ PQ?KTZLN(1']D-AN0>.Z6QFY^*Y[0EF?AGQW(3W
M=ZWCV-B>E>]ZMB9=@;V1N!H5681^^CH>.AC-#G?\&JU+ER$+X7>Y''WS ^))
MNSQ.?E3=L)8 Y5#P"9T,L63%3Z-%0I'.K5[/ M!E.<-4*?"@3D53D8C8=""K
M2OQ _&)5:DL;CS1MC]OO;B7)O6+=F[32)AEQ)"2\5;@LQ\'2[I4 P&FW_QRF
M!<N6AIAUHFZ,E2O=\H2\0>Y(0PJH/\YG0QSV6HU'@U?2U5WFJZC07%*5NR^)
M8OM8VV>9;.M'K+I'S@[B$;#FC"T,>&0@6B$__HZB7F+:DT4YERKK9!FJ_T:G
MS9X0OB-&Q*0"R7>QLVQX:%UQS]5:N@ZC*)J7EJJQ.PLBNN++FELD_IK4J*;R
M$.:D,GT79@H&Y3-[#D6"@0F!:"C^Z;O"DV;UGD<8HOWVR2,]^ U&_O[N3/YT
MS]2B(!D;6_,]]Z/!Y7%_0G%OUP6*]:TY.I0Z T>%IH+MVQ[FXN\N#K^B98@@
M62GL8]>WV;\3$B><[Y4F1XI,/#5]+J%R_,M[?$#]EX$3.3=.G?_[XN"5..%2
MM@?>[\P._+Q:L[FZTES*<PCU:Y FT1!?'4B%SHT___-U<XCTG?0<$D89SHR]
MG3QKDEDXLJ^$Z^V<Y=>&JA)T@Y?IR)B5N"]J=!G7Y$(78\5$@;.&5XAWID4W
M+"/2/%(JJZQ+.2:BT<\&/<4;>$R^Z?[ DGYM RESI'0<3])A+NMKWMUX6HLA
M(4ZOV[=C>P*3SDL/,0N)N_'MNHA2?*6OM<)0N =W$@_-)'2CO^C=XEI/UU_.
MYN%W6L!+W[X? U["EPY^L3&3BAJ^!.4)6B5XWH*-W:QZ<'O%>_:6?=^*J:AP
MWL3YVE%CAPO)J:?^X^5M%-JL8YP*K!UF!M.9Q+4D(HWM2ZT%/JOZ)Y1;Y!CT
M:!96K".U>P(@ZKZFJD4DR.7N(+O'>U]4C&(_716>%79<$W8Y;:^$%2J4!V%6
M7RLIEIM[-@:SM]KGN++;(^-KM\P*O3A>Q8*R07Z@&54":">97&U)<Z>8W/EC
M=F6A_W^Y7;M.4<0,5[IKO>W_[78]AR[[LC1SN)!4 .X]E]-R#3N"3#&X]&=<
MLH&P=S%Y$UPHLX5WTZ$]JYR%^1%D=]A\(BOQ!B5D]DO_;40=_+<1->R];_[*
MS@ M_:.;N'DXK@%7"=:*W0W9W:RH,G5WU]RI+=?,+FM/3=$*F[+_Z7SS5W/8
MKYU'TU/4ECMQD;! IX&A6F+<K;05M'+*P.K9I"@+#LIDM 0.K-J_ E.Y/"@W
M%9%C^VQ(I]Q"?D1>Y9&*1TQ6U('IY-U#Y@EM F4_,Q7B>+3[FY5S<(4>2O0U
MD2[KHE7XQ2+BX]'/P=O3DM]C _XB^/Z\V_]])D;VJ,W>(<+&T=B7I.1FG9"!
M,BG*IX)7,3.<5%M:Y)$$G9^\UJ-ZXK_=LM-XJ[]?^49K4= +_W;+'EQXV_Y?
M;EED8T;MJW=./H>^@]>=/P>#)J:. 10*&R.,I<P,G>(J6"HE/0&TU0@]%)WN
M)UVE?1F_TOM0)^YRA:)8:N\@7U*O7:ZF65/52'YPYHQKA_%5LRM)EDDI5N!]
M>+7\8+T2YF2FI["9-E>#4H]5][W',-A/*QRATOHN$J)H-YO4B925GRC(-LO(
M6I%7(S$-9(\!M2S5L>X/?29DM\0'6D9C17\\JBVAJ.(PW\#+V&3IIO;GMJVC
M!R/)!BICKN_R17B?MTZ6QQF;&/, _VD4ZSD+Y?=S0"Q%IM-HQ<P.\)^37&V3
MA.]9O302EQLS5Y>Z78?*)WJUMF95 ;@R1Y0ROWP/R/&1,%'Z\>5I_?;($6M5
M[S\F%QD$46%Z#U80E<$Z59,HRZ"@HLN/@V)%ZS.H$O2LA]_;$,;+76K' *L<
MO]<KOUTYZ!8)/58]CYE1"=5#S)I(J!]7/_#YQX&4C>FA:O<U2-Q),:L:4 ,(
MX52H,*G0/48#4AL9SPR$F%^+V>C7EY?.^,Q">XX!$G"9,4+R<G@R'.0;\HDN
M=7A?JEE"M--?3WH.YD0E+IY4_WL,NG[X3WJO:'AAI,!D;3GK3=WZQP#?P"3L
MA0K*VO;<D0D,ZCB*\(;^<XT:MB@['>!O\@WN0?BM(HB[,ZWRHV2H?FN,230-
M0 _Z=,F/_U"&FY8.*5A4WO \]+_#VR?E<_.O[%')B']5OB(EEGF/%HOE2?J4
M/[ R*P5?NLO9[#2T9JV,SB'Y1#U1".CZUP>S#%NR<.*$5>W&4%] .=>="$:S
MA+G19!!&Q#@(SKA"ZC16?$&A7^K55MTYO-H[>)7P9D0@&<4U$KNG9RQ3Z#(,
M<[F#LD<E#ZH_-<-,_\P?CV4G>8+5RJUR% I-[;[^CWE-RQ9S&"HO:UG[PLYP
M.L^,=Q<+P\7$<[$<3,4-BJ[OHO@$*7/G\89N8W/%]2'#GI:6RHP%Q[)W6^!V
M28?1LN=,':O=W3^&5CCHX!>(F?0<9>,YT^SQ:A5V9UH!;]--(D?WH3GV\]NC
M^WBS9$5D.1I]NP<*?34E%6Q19B&;-^]FO3L&R(RT(F2);XJO? JFGQ8?5/CB
M,Y"FR.YJX*B(^F-QZ2OG,F+!UJ-K,JRPXZ9C=2=\;]9(2M/1?HLZ+)V4PIQJ
M8?X13,YPBZ^[<#'B$H<?U(]18J!IHMR+)O$\?WJK_0DM$CJE\JXY:=!V_,>#
MO?)TV_'=N_0[4UB"X'BH\'Y'JY[MM7*&/%R IDX^HD;1/ BJ,5#.QMO[P#,P
M+7-SD'G3::G.SKP%Y(1FH=N.9,*FZ&H30KD/6>/+(ZJYP)CXF4!,*3/=X'2_
MU_)S,]G3N_T--8?*MZGH?Q:;WS/E5Y#L+!_0PYFHK%RKJBK;\I\DEKJUWEJ=
MLM*K[7+.]=G 8SW]+$*533]1[4M#D;9+0$0R=&>F_/:@[5 YUSF1-IQ*CW1<
MB8J))+&5$W?[<=AU]>%@R%]?:+B$JXV5*\)Z>WHV:^F#,&?5^H&?"NK/5S*3
MH4Y#0:.I"FU]]Y@=R2^JSVK8#ADR02PLB$#LGZX*#;[+@J#/QX!%*..$'TF(
MC&2M"WG$AF;Z>'$_D#RX]XPV=P1CI8(!W)$(%7%B?BNN"ZM<XCH&^(%.#816
M'RE+.$>IFM$^G&XT4D&KDEZKY!0I=]1?</@L@Q);CU:K?[6O*E QLSQ9TR5
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M>]T/X)H6O%#VQ-RIZGMD[4<%ITJ@FD2]8X"0K>&)C!6;-YG5.W[EEEH#!(C
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MM&P9X3%GO%&@_". Z^U@4N;M!EGE.A%^_^N?1ZZLN'6!O#AC0JB!!.OJ)PP
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M+U,OD&E(LAL64X_Z^*M=CZXD>NZ9Q3B,D^B(6T[:K2XF\/>GQ>;H-2$JMH5
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MY?DB4A61KZT(NMJ;PT%*(XS@_JQOBK3)7-G[8UM6B'?JT/"*&ZI[ZDNM5Z=
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MP Q%+434+L@5CQ:@ FE)<($;:*H>V9NPEH,?U"<WE2W:+\Q45^$5_EJ(3F4
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M-*WV&XKO<5UEOW;1INHHA>F>SD[O[UK;1%A?OT,^,7-BX"'-3*ILO8+IF_\
M64LES.K^-KU3D@$83;&&?"FS*2]3*[=J G8NM&%4<:YG@_L7T[H[!W;:_Q-4
M6\O*ZOZWK,_\7R%\,Y12MA8S9ZC!)2<M<2^0ZYRF^4*.+,=_%QO@W;F7D2?D
M-V#2O#7OAWGK>?'OC+6'61T=H,_1_?DP!UJ^'C_,;Y+*@Q<3M2</@[A@6@S
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M[*+#F;%&'M8>4*5:!QP]*A'GDGU-YQNN$]H=_[CQ.J<V+,A)RK3*?AKK<2Z
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M9/'%E3]A,(B_3-\HSX&8MSP')KT@AU/DJ8)$4%]!?';Q]QR)]L#OQ]89'Q@
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M3SH8A#R:-C &DXV!@JC%K4?:IYI<+DYL?!AC %P9@(<CLQ#<]$X<(>0&V81
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MF^/FGPGJ!6S;4\2!5G "52?B2G!TG/W8M\PYF6OM_(_&%KU;GVLX^.VN53(
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M?]=.W_C5;S]9A IE/OM#V,A!:J<2<*C&?DF'YS5^P=KHX&F,+"0K59C3I$\
MIB@J?#-6-,/-*-?VSH'1?D8Q V"-.R<R2+:4'=P'-IA:!;XHDYW)&2G@3>NS
MV:A(_A+4 .YP%$SI&2ZYW*%/U]J_H9_K>I;^B,F*;@(]*8Y4:7(XCC.9"3&#
MFTOB]617?$38<C*851$HY5ZU3+U.AOJ^J?ZAH![A+V8W[M=^C31\'/L6%ZT;
M-C_O9]\P$Q;EB& S0T+@&,H5^N]ZD0C?@)@L$'>GX):HR828YP<B^FD#"RZ
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M6[>]03C0PR$J][N0*2@"7Y2V'JEMA\+-R&^1IWY<Z\2*!HA3D6_IQHQWNM?
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M'TT4G[IB]=D [?1$U'JYTY9^30E#&#LQC&F]*RK$U\GO*][>S]6J[?]J!-Y
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M1FA;!\H$9.%RP-$/GGG4C<+H5BJ4S$G@1#'4$5EC&"S1JQ7@/]-Q<)1=&5@
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MLI'R+2J]@5T!XK"[;C8.!PW(]E*F)F+E-MT;> R! WX]SF-QQZ*YB.WMC2S
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M$'=J&GL^R[:GJLPS6( @7[N(RW5"P/W8QR(3,IW&&(UC NDH=UH=66_#\*"
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MB*R+;K[0&5U= .[1C.^E-IPNIN_$V/"5D>*"9YB4I91*5%+N0I$<(T\=Z.Z
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M8C4U.9I.^SO^!F)L!M(/0+&450:;FO5/_*0!N]2P2959U^>/R[]>7IG53LW
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M;__M XC1W-\P--__>L#W_UN3T?^ER,LHYL<A9FM#$#/5\&[-@+=@S%>YV/&
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M0VI.L,9Z4M_<2,!T>28JI>IS^6VH*;&TS<Y5]VJNR5&'L>47X*(';9BBO>U
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M%CI,#]!X.N]CGOBD4B\J0L+6:]2#+>L!L8\9T5W[,!C"HV_AG)U[)SK!>Z-
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MG]M/'F:Z43.:N )@+T\K)1*,&_VO9+O,H1/-W=27[]S)^&G5,;6WM3)T#%@
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M3HWM0DR?^^$"-:QO>V\@C"'5.-=.7/'YOIKERU,K"5L@3#X_XG]G_'9\C9V
M+0:+9,.8(_FJ4>5Z>8Q)3K&=:J<'#OX I S'--8VKO727-J3Z2%DR$@=PAS<
M;2!-KXU0 ,P\Z*1N*7K\FHC8Q?'35QST,1-N2O,KPV\KPCCLKE=N*2N6+W".
M=?0IEF>*B,VU%"5&"6*MIUH-#>Q/#"FZ>OPU^CA;#:QD24$UP&T@62.MP9F:
MZVG9,H1PP7;/=\#>P1\.S#O#$>K,^V-H;\)O$?U@?G\VR%.<&-T .QT$F9+K
MFCM16P=4T/>H3-VY6-85@[8C]W"&-=KLF5W)?#!!T+NL9_S&";[;C'J*S1A&
M/)7,52DH\M]?@LFN8=Y+Q:#,:.:Z+F$T0H\OE*J:N:!V$OF]?]>7.*$G](1N
MIW8&I5\]+-+QR _SX1K*Z9>B.XEUF3[^;.$ '%M$>P>@6-=&YIN;Z6T]R2JS
ML0$[V$!WA-MJ.6^2PBW+DD)9HW0L[U^=>? #5X\!:Z'- 9JBG&)@>E)92Q,V
MJ$A[6T%'?8:<T90_[6=7GR#^6$E!-FA?:/-HZ8ZLL=J^L4'#OC!]8.M# 1^0
M/[_%SP0SV*#8VCDAI%9WL\M@,DV*;_7SSUW=+$S0&SVK$P^R1-\&I] &=\<=
MU((.)GVW*OU4""KS!>!"U7]?T17BTJ2^9#*(U>G+-PU6L,C_RZ3S49Z:O,79
M1*ND(AFLJ"%..-U<'35T=@3K8E7HFJ\[BKA+,*T3>Y=L:@NW,152&,5IR-O@
MK'AZ'J4%9$"3TLV+?N+:&+T]&. 2N@O-#QAMWYE@76=UHP4YXH/]HP8"@BI*
M 6D:QV[P;"$.Z;=@^:@^QV-CX,L5)R#GLXQFA,QG$C!-VOU8!7_*B@9/2M'-
MB%/9O5I[++7#=B(\[MLHVAM"D=H0P\2LUYD)_@V(4+^57- 46!E_7#OBO6<@
M.[+QX\!7]>,Y\T* =\AXY.Q?TS;C>(XUCBY(3 $(:*!"YXXQ[]!3HA?0IU:U
MQ,)GEF*9AF["A25#P5C7CM*5B<NB-Z?U\S=JM<Z8B1K;W6I)N%$1TE>>4'K$
M3 M_A:)M08KE?_]>_C?HUW':?N5UJJA>B*U3LMX)9=70'*,"<?"@/.7Z)[J#
MG^/=V)KD3*[&IMIM8W,C[8:80H5 Q<R+?!W?P=SN&0'"X@)0[2Y/";D7-H24
M^4&1+IQ5-M^W5RSO^ZNZ(WX.K9HN)J828*[O9<K-YYC.%_L5U1&VP6;E;- G
M,*MC&+UB.&!HM4K<YF.#W@7!]BT#8;]!%[!KX$.9PZU8].P:&S1Y@PTB9PQ]
M) #R7NL*%4P?7:V-BP<Z<R;S:I0EJMK43BHW,M:P0$45'2?LI/A:I56CXDO]
MM-V$BMM9*-+?9E38S*P"[D$GQ*'8(+Y9:']1Q'T?-J@V=>/HEB?NCQGPL;K?
M 68.@(GOF\']H8U<PK1#6UVKE@'W.*5[H!V#I"V9O$_Y-L*="^9$G)K@8PA8
MDX/6_MZ'14T[-+/>KL7\"GS%L@087LFMP50,Q[*N2)*!C'F1,W*[R\D3PU.%
MH[6D\DWUXY;):UK\BKE-#Y67<LX]N"<1?[Y835J$T/2Q<6 1.&79,Z_@J1-C
MS95&1?74?*O(L,=OF@H)5E5KFW(][KE79F/MX.RKB'II\VU&+9*VQ3$>7C#>
M\V!J4RGVO:HB_A8F/@_\W.*<GU('50)AA8_-4%%N4>]I%OR>MR04FRGW^@&0
ML]HZ\]3D?@D03&>#.F%<*&XJ)(9U?'BC5HH#4+K]CKX7^Z/"QM;,%PR)=C-Z
MW5GA/#NC'=9FM.\[H1O-W-.:>&P6&*"<NN+TOP5YQ@T1*U+;9X]F[L'<OB4"
MQN-4O#H8[#-HJVA37FY3IJ-C$9AOJ##XV+?)U,K/*MVW?MIO_3 2RW7.N=G!
M64,,B=(4YUR_<D07U9<_%QIEUV"-,K5EN8)6R$ENIPSE.Z]:)IC(!!3<H,L]
M9\DA;W2A^9AHZH96MRL/PR\[L @92]JO-0A/P>)FY/D$GSG*QGCGNS?6M-5E
M<<\8[(J'K8DG(OJ1<JD_R?__[>,?U<[@_P\[,-R+SXO>-X/B]8AFD?^YSL&W
M(5%O_<CO$4M8B\-JA<J81%=;74NHX!XN_RDK>IO.JS&_^N6VQ&7?EY[@53;H
MW-?RHH_7EZUL[Y?9L4&A?36FO-=2M.1["+3/96*I?(ZW16ZI%LM9-'QE@YAG
MMW8]& -'M.D( _L3*/=UZJ0H KNQ!T8X:HN*5?<%@Q- :%D<3]1^<!Y>/4=_
M*#ZH)=Q@VNR]D8!WQ+&:X1]1:9IC&A4W#ZZ:V]K8_FG[IR%7W!O%\M+?;&U
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M\E2.9A.YJM,80>/A=4PC.Y%CLP9\2YU6<K(P@'@%:YK8(+6^0=_NQM MT"(
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M^39(J)R+6/LM=IK'(O@2X5,36F>^_7@/G>66.HB,->@*L A6UM=+E_]4G;'
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MF(92A;Z:>9U5R=+=UOKG3SFY";2MCM0H-H@?/8^;$ZD]<KWINR^&"7HZ!RJ
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M08"4&ALD6K2AZW7X^]R1MU]D@Q8T7AN&L@;U5]'S%"(3D[TT@WD[%7JXQ1P
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M#Y 8)!M*5^1M0A/2 U_VN5T/J?A4ZL2;A'4/FDN .E]B.O/\#3(.ZWY#9=N
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M FD-?Z]6#<T>+S;ALF+/6KMA7^Y&#"&]^X!$]*X'U>+L>O[TL;:OG#/FK;=
M[OZ.5 S>9\C8S1$,49I1 )=$_A'URA"[>(('+HO&7$P'#/U==T[,;)9!9"$Z
MX/CJ9C[#N>CZ,QC?G%%]MNTEFI1ZSN7^ZI'*1% (#*OAT$8'A@]$[*?&BW)I
M"Q-?O8^6(V>1SC@U$_>>:_.^==VA79E1%)*S;;EDD25]T2MJFK!8)BNOV0,X
MBD@I"O)U\^*9M;O>1P=PTMX#6\S[5G #W85\T>K4.V1($4R&S%<"[8'JLNXD
M!\-41L*Z<;_ZI.*73/KQ._>[&@I,?T&%?"V=^:$NIPP^$% AB."8-XB$_HVQ
M>L10HYR!17;0KZ6QR/0-&V(VS%8!,^UM8)_G/%&*Z)5YF52O'C=IV3>#U#>V
MOEY7<+550DL#]DTMOL&/C^OSHH05EV,9O& MF.TQZR\(QBP,%9R11X[$#:PC
MC<SXV82JC LX.4&\,H'][I63/6ZGI:X,F@3%P;G^WL'Q3A<)F!R S2C5CQ1.
MDKQ1[N.8657I\F'+H_BKHTB&5U3U#FZYZ*KFG'>[?/(A$CJ$7YZY)9CQ_1H5
M3-K!#BET"A(;>^!L(=(.N$EK\B">W=R>%+KXR^L_"\P1R^>Y','W7:XF9K^R
M)6> 44Z]<O>W744G]VR_S"P7]D2QT 'X\Z6BA'/K2QJO^G2OMF+@,:Z"4U>O
M%;+1!+;31B3CZG'WDB524V%!Q49@%/765,FM"H?FC=:GZ])ET)!3S 9P/OCP
M.TDQ.5J)O'X(.JV \;V%\9V^"9%_=-HI5KK5"%*,Z82L?;_\K6?R#F:Z%N)*
M<3)5\BSV"(>$'G)>VE((U;DZ@S7Q1>GH0IB>CY 3.9,^!AZX\LGW3B*NJM^3
MEY/0'N!Z5B7E]_AJJ/<8MW'2FR(U0R86_B1>#2STHWD32DZ7[T ;&:,D-ZPP
M5C]O<#[3UPIQO>G&_!(0)8T/G--LEC*H43R7>;O)UYT8'FI_[4OV7"]7; ^V
M^7*&M%5O<WS%P<H\W,=42TV4^%?TF*LB#M9= N]A)RFMC>4P 3UTK](!,5DD
M\P]22 9SK%UJ6SC"-#I]LR&<64?EB8A/4%E)[N\=:WO@ KZSIAYK6>@9,9+H
M$VTPM+X$,=PC>J&)(FO"W&R[_*"5N)*H/,8$;;T/1689$P].\PQV3PR3.MW7
M(+'H2[.=D'7_,'/B[ OJC;+%[9/#CLI1^=V0)=UQM6'M,428I]:#UM88B;:.
MMC19)WO/MIQKA?N;A_:G99WF%.B.J.#Z#)IE2Q7>(-^.1'2>PYM?[(U BY.P
MC;[AOV&<*$:U$I,E*>IB+CX:34Z^1E31<CK 8RX99#V=9M+!9R(V4ORBWU/
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M_JNR(B+'W=$'?7WJM;8^2:V_;J'D$?D55NTO@U:CLV7*>0PA?"L$PN%TCV?
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MFPW:+Z<FA9H,AIS>KRE$&IUK*11Z,.)6:#/=] &BV+0@K:"X2C$TH0-2I^B
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M+L(2A=/P=! _!1QS;U&2@ G5>)@VVH,;YMA(%5RI;TJ:*9SXA_-'J@ V?.=
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MM]#R!Z95O'%1<W95F7&AVR2J=M%=;N!4(WG(KC*- 6":G9Y:R=/&R*0V8KV
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MSN4H24W;3^543#] *9\RN(Y3K"SV2@5;Z^[;2UGB5$9Q!BX8HYP J9GG@=*
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MVI[7,X9+S;UB54#EU?$:P^E@[]Q 0':)34JQ5W:^>F6DBR/H]R,^FK/\@N"
MKS!2D#NPW'2MIYMU!S%NZIXT_O5 D+&39"HR>SRO*?C;F+2"]6Q+D5YWO-$A
MN?R([SF$R.AH2PL-:)3HT.L?J\D.D*K=N8K*)QLJ&!63U-RKOU_QNSI=L?JB
MGQ)\0V6<..F$=;+?"#B)!3BF,D>O4.SPS[\]=(M\U9&-L9A")1+\*.O^.NJ(
MR\$9@AI_3KCGPA_HBUQQ1 %4T".JN>>O\#@4-QFN]@/VX"%TX;Y,0;8*CY[
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M+N$R]O:O([Y//K;L2.3>IZ<I5ZIBR4#@(#L!>L2WL0[EG)P) 4/DOXGC>:?
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MF1RZ\L P_7222&K_9[%P7?!=.FQN*E%!7"8B4* = RA6&<A5MX"1<$GH*W%
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M!43^"XIWOO#3?O]&DQ-VG2^:"A\3'IS/.\QPO3DP-U^@M5"Q&QH@*6WH\"^
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M#=$R?\C2F;=#2YZ(F]E[1@,CE8FX%O;(5/M5869B8S1LO+&8AQWVA&5BJKD
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M8>FUF*34!)CBH+&2?T'&36WT\E"HNT6!2:XX4[OAN=!:ERLFUTRNQ7P83X3
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MJI)'4'>&.-W-$ETKI\7'2C\)RW(62+I\G^CM4CYZX_RKDS?_.@RCPQ%TT+Q
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MCRYXQM-!$BD,XJUPC*?"X?Q4/6P*?NS*' '6HB1"LF:?2DM],U)*20@-7OI
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MIL@Z5R)OF-^3\^[X"R_)*(H9$;<.(VZ3+E K_:GG2(6CGAHV9!%:G_"%FCK
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M-'9\W*-R5OCA 4_8!?"W V5\@<_"U.IE7B^EM&&OW,_9IP6ZQ-MYW^K^0"Q
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M*O[X,9GM:S'A&S#D8Q<@FW7)S8C'7# IOV4@]JD59_Y7--HKN8489F&OWHM
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MZ M/%0^ISVG,"=+U9L)QW/&/-Q,.$[T"BKXW-*Y=^M@M<,U H*B(Z_PP&04
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MAIK5MR<'_BI&&.4'N+DB29L,92?'#-*C4J*2JH2)T+.T9)64KA[P3I(+89A
MRO>,Z,\_@T\($0-_5#4G1*8^#7@SIB'61D29J^&$ JW0:YZN+R0,0F8SYJY[
M7CMM?>[A9:&4%%YD(X8\7[DT5'C<=F4D2F^KR)H-^J.T\#\U7A>6!Z6EM^^8
M/X+H_2[*L!1'H31SDE>?K)C<W56X;BN''23*&I\7(DB?C+G]7E-X+SS3DVX
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M- <D.$!1JM$T4^Q@L9%W'28J]LH6-E#6S6?:(]7IL*KN(7>.6'GKLE_/W4M
M'R >E>H9Y6KBK[91A@T&_M""N![= .(4I.?+AN&VCKK4?S\R]]5RQ&6&9@MC
MT)[*<MW=1^1(COY4S%1T(!M9X7R$UDN=;I;/Q7$'"+_>LRY/?TX;2\@T<06'
MK)AE^\VAV: >.?Q(@<>6WA3T1-.N?\-\:AK>&S&N0O);2Z:D6])LJ;*]/7_L
M-<4]C71Q]3M1<(%R-7[L=,JPXV!Q!BI7Z'W#F&*\>,J W3#$3CHNUJ3&$0(W
M9K6+4DR@$X=%)W2WR-UK;\@WM;MG=RQ2#6FV=%59-$8+5[+"L[C36^%1H#;$
MH*6%1:J1UN3LZI"$9+2TUT)G-C"?7DJ5J)G,!K]%E?\^Q[?62,QJ7>ZIOC80
M]SK3F:*6K/X'2OVU>:=K*N\2062S13N2IO.2E-X^6\@=6">Y)78<W<<*[= Z
MXQ_'2W74ZQ**%7[5%^@UXC6*NE53\GA J[C$7"(E(MIP?%[N2E?_&49Y"13!
MY:B9%B*A9*"X_'.#%^C/2V+;4.MJ6+4PD3_V!6[WXIGHTBEE.ZY-7&]R=W*G
M->;XGKI%N>1T)D-AC9$ZT!>UL)B6 ;'R)B?N!>FPC(0L+ =^_E^B/_.B@7$+
MEAXM+&SOU9M91N\&\&E%\U>54?'X!?( D+1?_5#+=#[$0">2Q:'SX[>9?V+C
M4U#W7C:0,#Q^*B&JJ\0*Q31L8'6_V!#GW\0'Q:9G]@:B-*_/;"UZX7Z>U<H2
MJ91P'<9UJ-)1N;Y7+A+C$;T;6P"I3@C^"U-37<WW1$ES"_,)"ZE;<OAAQJ<#
MY4C$NCI7NZH%2/Y8$EZFPZ=!X5:H,O>'EGM5,[Q'S*10/W^^-E,JA3];F@;U
MK1/S;?5XT:^2W5+GB=,[4T++6,0@_ULZBZQ&,U(IFUM;.O\</.I >5/V0<_P
M71-"71VH$VU^Y%3I;+[9QKOPZ\(1(?/)VY>?0J0L;V8PB5@#!WP6#IE#[YE/
M58R:H_3B -+I\>&O%L *_@&U"2;T#O0)#(C.0Q&HO5?Y#G$L31QB&E!>GTJ*
M?W[9LA%K W% Y7N%*E5]E;TLU0PQ%GK<GH[,$'W[-"6VML0 I; +I2SOK!A8
ML4%#V5-W2DYGM[1*A+"^(_J$^/^7L$%=G8;N9N\EU!T(0BB9W,/F.XG@%G4'
MG0+\AKE%N4,$+N1+[W\ :-MOZ_?0 [=JH<,\^D("IZ+*UPNL"/8=%?*K_A_L
MI/3\PXX\[;,^,#:+$M,1@+OG-8=DXW+$Y1.2+$?WG!LVH?/_.Q0-EASLRU+A
M.39WP=^UX<&';DEY5?JSZP9I"MW&C6T;.A%G8/JFI3D([A4VZ,A^C>K\<%Z.
MM_6/F\L4:75T;88L30Q#NTJ8TFRAYA5<HB6S0<<N4J!QFAP4)'F@<YK'&TWB
M=%#>[:CY[4_&%8I>\G:$MX_(L/7PNFPEKF+-AX%Y,MA[(18A74ZSH[J0IKMP
M1SQ96C0H&0ONG#H]XOJFSFY%L;FF>7A;0T@SW^06]7!\N9V-=^L9JG)R4.[-
MT!\=M8)QIQ:M>\12<*6VCGI7.#=%UW3*'6AR.Z7,I%8)* Q,CGO6PCTS>77G
MQ3##NB)2D:9--9S]=>I\,]4]NH7#B50[IN@7S>*FEC:[B%2%N8=R9'[<=[:[
M/=9PY2/&3_KJ0G>G' BV"WE-12:$3(_GFH]$<M -&7#:'!5YBP(LBNAX,YFX
M=M6/LM-K1).FY)+PA#"&-OT&XSI5+_ILV_1IEJI7$SBQQ;0X\A:M\&8&\K /
MQTXF&=9RDYS*YS6ZW1C9%'LIY7Q3IJ<Q5M)HU#??P#< %Q]=-ES8:^P;4*BK
ME(\QAKK^]@%[)2P-J]KO-1B0E%9?;N5?.I)7.60_'# FZ=F:YOZ=2P>A#A$D
MR"4I*X.K]=XA!&!!7==1:W0*WTXP!;4F>"0^LQ;'0[.S9SZO:+E9$6F#['B]
MPN6)M0'(*>!TA34T'[0A&N(E*+C;)%!L/;:U+*@5B1CT"9Q];=K6Y*7ZS'JG
MLB@QVLP^HQBMMJ2V2#W589;PT%=10*?D]R(@MI4PB2)VCAMV/4%BU?23O/!
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M3SQ4^+)YS>T2[/;@VV.6V=HZ_-8Y88__[T&WY<<ZYDT9F)7KD#O%,/]1RLZ
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M#,HZ5S<=&A]TO#+38ZAMQF+I4_NG')3FP'6LX:$XS#'U.DGX#I[QE 0DDC=
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M6[.O[7S.TA\&= *@G<C(3RYJ8PCWLL@N;.-U+K@:I9IZ\RL 4)45;W@ [R\
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MO',)0"[=MM9X&38\PL00 ?7]7!9<!$MF?@+2QV+B%1W>3?H'()O+TI^$O(P
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M08M?X=K0IOWF_=+HA4>HEQ93M>8T\PT6&$F2)M=+)V4RJ7ZDPK4F\&8GC$;
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M?)"-T"Y3^67(#8Z/<W:IG:BZI@?;.>?$Z\B&L<JKR4T./DV-EGS1C@G"#[R
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MVJP/T,.]D-N$/5!39E F^=R=OCW0Y2?$Q9DO',QVRWWV6^-XJ:I4XJ7ZH"]
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M#KVQ_JDD,8O.M;_W7,++D%J/7?T,V7KN_@G9V]_+"/V+;T_7\J<K)Q)5G"G
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ML4<NJ9%[2%P$/T#!0HY97PU<6-"&5"I9O(3BOM6%2#\CL)JFT"]PI'QUCLM
M?EW<D%D[_^/?E,Y5=W6==4VB-VJI\-F?WWO08-N:OCVK"2SL&*3,R4(? TE,
M<_I(.!X[B+J-^P6O\6(,* P:"2I*.'FR/5"-K0TF4QN\@57X7]K5"0(#W_N5
M6@-W@+BW72+ UDK5T=[U#\I1V>P318PN"FYM;58550SO:Y^#MZ!B(Y8,B?1G
MQSDQY;OIHH/((+*S5>6^+WC^SLI5W>"ZWH'!D)"Y' '#-[EL,R[BGJ)^66%Y
M):@M2N$+<[O:HLW6*!@K+77>HOM2>TV![9"$.;IP["2?<2KV@KS"1\L'M<;W
MHE,56BU*7^B:N!3A@I]=,[9XCIKKD#L1I=L67/)U07I:]W#NZ='LQ.=9OJXY
M>YI[=KIWIS/E*XI+R@LXT61'_3+]UWO>%)46@_OH=?ZNSYR'K,Z_+DE$"92;
M'%<SS-=6NM+2L%,Q67A70@Z**<$)NP1]FL5< GI>,)U;WSV#UK%5W1[N+3D[
M3N1/R%Y]@/_ KS*K&TC-TR',UL!JI 1:9%1J';ES%^<A^3)FQRAN;6XEOVY&
M0'+50(%37;-HO]T7MC*#5,7:.1]3+D8OH?G>CP>"^@^ V!=VUJ#.*<9 :*"$
M7_+;0*E/QD/UC\:!PEX==@UY0DP#BK;N]"K8-#^:45?A5W2XSHC9H4Q4\R(?
M+'7I]+'H[;6T?&*RE..34:5^*JTEU/GEL83RF$J=]\054E<-H&R&:@?FG)$%
M6&C'0## _M#5'FV1//\<RUEC 7-:$681);N 3/347TQ=((\GL0BQ7 0U!+@X
MO:1&Z(&%)K\[!0,Y7EX)8*0,^>3QP\2E#7#"WG4!9F!\;G8&U"H7X/;48P;*
M^@,T_<($)@Q :5R!U:%V<">]2=2SY^U4-X[_=JRCHWW'DTC=O07 "JD_[O:W
MDYL=NF2U#.5ZJC@7*Q:EN0B4BP^N?P;GL:2M8,J)0?51P&O &M^OUA-XF$3X
MC[-VP$U]*M0$@/:0.#"KKL-663]AST6<BF.IP\810%BZ?>@(T-;&=7I@YK;B
MN(AU[;"4*8_[XCR1 327 N :H+$AH/ZC#^;5P(0E4S.*/$%@J:G672DO=K]-
MYN^)PN>O[\8&Z]J^1737_5I%@Q7,<C=WE +LN_.XG!#H86R6F5$-#;@!M>#T
M0@<J,M*G1BN.38W4C51^.R+OG]5MXD,H)34=NY)=BGKS'Y)9\=)'.>B.(A<Q
MV$MDQT6R"*+QN"94!1=A*_H%_YK\:GK"]C$7L0.FK7GD[,E L24NHKO@5 8+
M'F[+F$9+/4LFL$G^@??!)+FW \$NF4DG?LDD\-_*7(] ("16A2X]ODEX"7G!
M>GQF>SMF? K@[.@(.F,HUPOW+)=)=%B'QA5IZL54=ADF$-*H[>GSE5[I[O97
M+Z6ZT]S\/SLL*-<W$.DUR#P"1QPWT<6;+TZ%4TK5%*!L":S#S#D#!3@(#E8P
MD=UDT6YJ_+,M:4Q3\D@?AOT+YNMPY=#7 ?"B8'<]%(%BNL(.1]+A-'^:V767
MN9,3MCE&)H2IPXGGOWLV8DW(H!-E#U6@,/RL"OWC9.HM6<_P6Q[Q2\K%.7]?
ML*Y@)[?M^?[[N>0;@HO^)HMQ"X2CZND;OH)/3VT)CY9V3(JR8XM$*.:HM;V8
M(; /P'Z$$PAV(YQ $: 3G$!-R)5*Q;RL<,?/X-K8A/H6U\]%Y(9-K1S<+!\D
M+]$6.F&8Y6M,?/S>Y3/V?F U6NQ@?N$[,2ML\&F%X[ON;-@UR,"=Z6@Z"IT0
MP<POPCY(;DU*DQ.:&('S:C".79'QF0U#\%2AK)QUJ%OA6)O!H<FK?J.@]+ 5
M^0(<]K<&\LA\BXEV1.2O"%"2_@FQ>@MB-<42L?D.[(_@79QPX'LK%^%(9JMP
M$0*8Q7A2Q@@7@=/@>$?!S:Y+:)[E<X,XEG8 [T%?.=.P7<D*IA-D7X&X;D(<
M+UIQ*\#XY<IW?ODR_2<G"?88<Q%$+RZ"O@%.*OAN"80)#98(X&BI"]\K@J6Z
M2#@&^L+M@QB]T?\>2_EM$Q>QX>,WOC?%=T[;UN]HR%R)_=3G;__XF;WT\'.L
M'*L6>)@.&]&:G<.$,4\(:N)\J1?:P<HS3(CVTE]0ZW]@M=][_C^#8='/J:OQ
M-QBVI0=2<'DV<2XDEG3@AZDTQ>2BRG7X@P[O>S^\OX8_>,KLUH7OOTH_M@16
M@(H94V39 :-^S[%%<"0 :AL/?YCX] 78C#*D+8413H^Q&1)3OQ]IJ*N;DM&:
M7V;P^=VB+[3C+A/V?+(^)Q[V;ST;SN%O+H25P+04&HHN>,!%_![*18"'X.?+
MPKCK_P<H['W-">8B+M:6M.E![P8*#J,<*MZ!8O1WHD"13>Z(-.6(8V_FFXN&
MVS??LFCY<06R[(,:EAXP*;S RZO6S0.N,/%&))[8\K9D0QVJUZ13Q0C8-A;I
MU##PSZL;]F=:QSNID>-Q_E IZO6B^TH1)'5#<(3.<4J "3C5BAOY0@QX\#O4
MM4Y+<X0BQW_P&N5QHD" HK6F+]S<L=;;<!&'QQ0N>FB1.$F5C#^C@.%5I**-
MNAUWW(JFG7W9)#:<6Y'D?UY+LW[*H? ;_[TL7=EZHY^ M?Z_3$_B(ICBG+!M
MEZL#X1AIKG:^5(-ZVQRLQW<L16GB5_J[G4\?.![3WV:HFXE;$4R)R5 E:FGF
M%<R>\@I!3OI"#YBF YV*?6UWW7O;R_ 9 [3^I6>T<V9C*;TVT[_U3N!+8)./
MLD2!EI3 )@QH'RC&1<RJZJQ(I@&ZVLX_C7S'?VF2I\E_I!<E?4P9N.3>\[QT
M?UH]!@[058.N33EY9*K8^RF[G6LN7?/+=E\QK7^<2. 9X"34; %'+BJ"[&^"
M[6L#FKZPKL1NB<7IOE>)&LG*3GK6FER<HY$:4[%U9GI%\8!<":KSPMNA9>CI
M_ ?H^=0!7!CH+CVFQSS,15PB]*2IZ3\UVXJ&]:>I&?^US"SJH^V;WR+6!LA:
M6]>S@]RYB/$Q=\Z&3G?A!\Q7.$N2NY/1Y][VHO8,*[:MIH]H?KHWZ_45J,:_
M_MTBZC_"?MM/:@Z9S]O]=Q3.R*VPZ((9'\;-\LIM7D'F4?6A&+4(EC34M.[X
MRW._/V+S@Y=LI,_9Y/U:3SEZ)]9,]GC5KFT'UP:(GC,?F%E/A*K-!Y;TO8T9
MAZ.I5[2]6>^ QE[B!W+YC<74PSJK'D1?V%!DH-9N[#RK8]I:NHB47T%@M:R4
M7#AC(UN<50T7\4D;8.^$54HD#$HZOA5R#IA>^@[[GPS"GBZ#(J29<!PI.^G-
ML.GQ10XL :B6<.,R@6< /\G[:G8.797ZU-P\9K7B:NKS+<=WW:V2L&@SNTJ!
M,-GD\:G/7(2.[!G&X41=H- "Q/VK]*JE[M,L;'-+-]Z8UI?SH9 -<_]C3Y9@
M8.VXAR9I(H:EOE9(#X%<72F.0/@@$%JJMQ"#J]X*"ZXL3TV\8=[70,[WN\.B
M:ZTG1>C!5P),^L&8&6:ZPY_U-_-_7W\S?R*;D!^5;S)/5&$*E(;AZW4X3]EU
MI17F &A$Y"_)3[*.-G<'3_D*&W\P%;IE.7C=A;0RHNU^/CGY0<T,4&X!CL&Q
M3E!XSV/Z=Z!-W^MOA^_7SM1J^ABUH+ZTW92]5-1E6$K<_Q]$W)KC),1%'!>&
M$]P-"^G#XW_V-\7EW 9<('7GZK^+@;'EWI/0GMUC 9>FAFC:QM/OT&*[!F_I
M2&S9,&R.7#D,0;RWD7.8*3A14F:Z,#:S-;2 ;'*O(N]('#CN[ Y,Q7#EU^ZE
M?F2X4U#V"*Q$)N5D4EI-1PMSVWRP+_Y#_@CXV1+R#W%I)*]T7:H_K]/*<$W-
MAQJ0!2<*8R,+P\FK \6"?43C-HF]H[]3JC(S%6G8A/B.(*4H_GR&!,U#:PZV
MAVW\AY@_8<Z"$UFV-;T)V4<A=1,<AO%1_U%/]3.+"_\# Y)A@43,\WS6!\M?
MG8E6EMIXB>T ;$!QEV65A0UXB1H]DWW@^'?M &GKFT[]E5S$*X=I*$PXP<9<
M]H1YC<4Y-_.D,7(YRD$?"H"I[*TT!)N UELQ]9-7),3*I*3"_Q80*X[[_]#&
M+*O /[/HH3$,W)?91)Y;PXG$.$8+I'<?7<OKC$\>_7SJXXB4F)C31:LG,S61
MNNK$E5R/LW;Y\>@+.".?(SL5!V)X),H;>Y"X:3;9%^O E/XZ_!^VQ#^';YDN
MK[-59)IPGLAP$7?R[-B'HIA>X$XY2B%OW1-!4NXVDHJ]?:ZJ<<@==&9A!(%J
MNTIQMPW?&VG A(B;$,O+*L*$)?O,D&71L_$>YRXC;M"7+:3/Q--K0\(AE<!F
M9#[Y-ELUTR_L##TU..,E?A5==MA7G)D;9V)EF2V.O3//E[JNLWJ).38Z>.XH
MWT[%LL_C8?Z6,C'X\9^.$0^@,DB#)$IS+Q^5?+]2!(_]1.O2VD]3='NX[EW1
M?FFC!S:CO=!=?,N[)<<W*1_A9O95183D\=G]N=325V_*"EXO?MQ3]S'6(TYG
M:]B'?8/]JW]A**Z_'Z/9_]$X8U).5[?T:DZD:^)^W91GUNKCUVHE0JW2A#T$
MM-R9TDV[)5JMC*NSW^\0&568?5MNJ_#:]W[ZNA%#X=]'F^H?O_;TK&^X0K[H
MWNUO7%#8[C7=<Y)I2VZ;GOR](J\R'Y2EYX]]9'X<DTGLG&H=$Q1H6-M4]&&;
MS"<L7[G);Z,R5]^]3?2O1^83V$(+5-*](EA&^\TR+W%B\/NI@GRC;2ZES(I,
M]E;002"6Z+#13/DK7GFF2:NUW+S3QZ?%P!_P/U81$5%1^[5FB^YB,UUPB$3@
MK8[&B$IS'I%=*JX'F#"!SOB9A4&YNO%W5S$%<[:*S;)J.7K'F<$EGV*MDHLZ
MO"@R75)K.]-#?]- ;^E4*N)3&LU%[X:3Q:[RX+&(YXF[Z*(3PO20FOONRK\2
M]3O1*+_(QF^__78MVWMGF;/&\>UA,N@U=,Y@61D6U)U_=DZGR>%(@M)O6335
MYZ;7Q;U>A$$]Z?=S1VD'BF0Z%"PO:\;%HK-IWSE&_5XN=8:^Z<+[H [DFLKT
M^*X/GE>ZUF.KV<J;@OVYB*VK^4X<K'9\NG=O2L8@_8:AE//[].WVKL:).$Z(
M\3S]\)BWPX/P5X4OC,G?%RBD'E]HXR3#M0HM!4;0IYGVG#@\=I LW',H^7?7
M8O(J--*: KC$"5F?'G!HQR.= %<E4?,N$?C?XM@%\X4MC?ST^CT''T(+3%%.
MZ+8Q!UR/(-/!3/!6%EV1>A]Q_AJ"_G8UG11 3P_2TAC$"5P.W$P/#$L'/:LA
M\;;]:@%\)UMS6KNP;6J?Y6-WNIZ[;!+TF_;:A#!]I:!O3X=C=7S&IKF(H2F
M-Y/*"*=AHE(+<3[5.VXBE!#RS#R\;<WT%_J;3*-E=[R9>3G[^I3*=8M0O89
MQ8CDV/) V:_M"A24-P.UFM_EA8F8!+(89_90V6M?VPNM,Y?]U>V\G-M2%3(-
MG^]>OX,4!5"#@8ND)35<#UP&^'$4%.0(BZQ@,4XH^7L+X.C.5@'XR8M/2!G?
M<X%)"0ITET$&S>"6*O8&ZC6E&Z[$1%,RW>9/;D32*9@\"XXX:@)NRH-15+AA
M517V "X W<D3JACV0>1$0[GMB1=DZF_L U^VUZLH[(2VAM_2N_/K81G^.5+:
MV!CP#NV^Q+K+16ACK4T^>/(U<LK$V)K$66'<(G(!;J/.O&S)YW2@0I$S4Y@F
MI/0P+.*(W5E0A"C3$98)HO1&6,2%8I9;I#AV4Q'S\^A)]CI0 $QJ51Y_LK$2
M0.&':G%SE\D%&M .<C"._<'T52 %F:>;N 6XA.V)OJMT_BX<W =K1,\>7T_9
ML>OAAF.N8PKQ Q!Z%ZPP6H#OKF;\]0>^$5B!JC0"N]9BBDP>KJ1JJEWA(KSU
M82FD//2Y#7;3^UD(ONGIQ/,8WDU7*=U:]4?&K#^/6$W9@=B,D%1 K6364O$0
MQ#M7.A<N8]_=SK9HP8^*XST*@-U#!F'OW#9*=F!E^J,6?9&H_X-!1K!'5%G"
M0$L2] 'N0" Q8%8%9])BPDE^ GP*Y$TFS>(B9IIANO\QM!\B6'Q0+?("W-10
M'\%EU.#;F .LS#;)48-I28=/&P_0PR_=LGRT\:W,4([)2NF3@X2.T[F(/]:D
M*6Q*M3;]X+E6]HJ/2N!4'.RI<3T!3B4)9ZL;(8Y>F,I@8R';^L9WB_;0#B>F
M ERCM3E/R?1:]D&X1%\DK.B<Q-!FELX!N.5BNT/"<-7ZFJ@_I?A/TM.%]1=^
ML7_@E__ '_A=K9!^2TOE=L,DSO#OTUMR1.R?^.\CD^Q1D_N #V; URP.W-PM
M*->PQ+5:.!V88-S,U#'J,/[I"FZ&V]WF"3.XTH:Q5 %J& @KX@^U 5AMIV6^
M%YZXS)OW@ .5_VP55[2XR(T7D;4HOL!W0(&T<-&7%/9&\+Q>2>_^KNM1U+N%
MDXYB.P[+^)+27?I(2V4#2W-<Q.=G+JVQ]D]XL^[LT;!FA@T8CN/!ZD&,^"%(
M^%^P0LG@G_W?'__**)6'6CY@OF-X<Z/A1RTZ1;+N_I2(%KA7Y(FS25WN$R&L
M@[GCECUYO'A]J4UIE/"SC[QV$'L8X9-)7BG2\PDC^MBEV3 NXF1D1F>,IT05
M]HR/BO\K+N)))A?1(,KF-$2(:V4MF"YQ$8VO%^;@AG&F?B6C5\RC^6/"1.;#
M"[!H!P?8"G#?U:@5]\4B+QE6?!G X.L_-=.32>"">_>+R%E?WN@/?=9Q:'Y+
M"I9SW?C[JCCT#NJKT^^JJJ1?J)NLE/>5A3_N%_/!<[,>;K*[.1@'XS_EJWO)
M<"7-_E3$""L3MPU^F@=DN?@?,( 5+'V^(>>0$5Q$->P-=D%#0*V_.&9V+ [B
M(RS";+DR&'/L JNYB+P3'T] <!KN(2A_H0:NQ:L8Q98\>#+H=YX_5H9HK*L5
MO^23,P#45\'D!7?[!@*7"R0H/08<?S' 61^Z"&?-?MST(NJ-CUQWRS<"#/^#
MO/%/"TH/#_Q?YG>SU[SB]'M/OPIO$;'CB??,*DOV)O"BU4FULCM$\-1!C?-.
M:YQ6'U,<??_#;!]K8]C[3E!?."2)6PPEM4;WL@+$S>=L>4#"E:8S3L+\M9C,
M2_[_ZR7*)(H)DVT)BGU1;N)#X(6N01QEF^;#9&CK0]<QZW]-"4HKD*@>YY#%
M2GFYSNGB81X%WQH/EY*J:W_>&M7_9R3[OF3R0JF0V2QOAKN-XS_Q<O-;Q/I@
M!%R8)#;EK)0\EG!HOW9Q>!.$DL4S.V!F%W3&,-E.]2C8->R!H1G<]>WR+5]Y
M@57A!7:BG/<F-N\_H!B=_Q%8:-"7A<:O _V3;"]7_@(JTI.K-(]U9J S/%/]
ML-3I>^QCZ38N)M:6O08O#1Q21@_%MO8WNCHXN<FVU;65B\2VJ#X9C# EX7CK
MW>#><[P ^+ZUQ2Y!0OM&Z[UTN\)4^;[W9G+[-/I*]GZ>/R*W85^#O+;,G-X^
MV>(&E(P?9M*9==(OBND$7D#55 A1I9(9^MBV(DEEY-;WB0?I"W<*L7S.-Q^6
M)7W7#<C"X>IS_"*9,\QQZU !/@-Z\UVMD\(=$]MT: (ZU:6N>W/]8)X69-86
M<&*\R!LB5-^JLDT83@^\]8\FZ%!$ N7N5H]2,2'V-792](<%#&E<^S-MAF2-
MI@$AE&T_.+UIU-S(67!O&0TC9&FUOR\HH3@CP]*.\QHM@G<&O]*/VH(8NJ<V
MB+OA,>2L]I@T/K -DO8CO?T$7D=N]LNB2.UK(YYN8^^GQ]$\P40#LSG_)C13
M\3-Y4^ZC'+<;:WJK8L^=UN)C1G-" O=!GR!1QD)X=J#2.&X3I(8W^E0IZ.=;
MBQ0L)&UC:S%&JB0UM$$SQN;ZVDYK=,@0611JI Q):.+YEZ;#<G(*H^G%,5E^
M$+2WR\MJSL0KGW-J4^PO1E6-(M^KM+3]NBJLRSOV:01'(%W%39Z/R@\(RQXV
M24O)J%.7B::>G<W4RV2&$E7QCZ\MF$573%VUD$E69(4VE7D>(KVG!=X'%RP8
MP2%46WTCNN#='+P_;?Z97F&+ELI+O\3/5?$&7Y82\RZD85^Z)LJ_;O-^H^8N
M" 9^G!FJ0>\J:]/"T-RW !='+1A^3M7]<@S^>,?;+]DOJ .?I<S "XR%6MQ6
MM,1QN)4D(@(5;/!"E:#O(%FL>8B#HNG42I[[E7ZHB-Y5C>%CN[X$-=Y&C<>3
M:IX-/$ +T-,2[+/ DY2EAR&TB%/^MBYU LK]DG;3)$9S%?:!U%8ZK@8C!'VL
M5.OR;NX]69,H7$1GAI"@3V1Q2,45V&AA5M;N)=-9CO.DEQF\8<A5$]>[ONJV
M''"]:8,4@ 1 ?VWQ;WV_#.BWX*6S79CVM6Q1EA1(.4>WH/2MKNO-3:8+UF V
MHO>X<!';YY B>!&PC(HE0+O %PQ4[<U#>6E@%HU8MW.@=S7S^">M8R_]EKZ-
MV':B"L>;CE99;'46M<XBA\C2FX()OSN+^_C=]$,Y[#./.2)KOM'@O=>XLIF8
M:5BJ>,%U2KM/ZJ;H[X:9G@E6\@IZS[_TV5U*(E9/93^W[8M)H54,D_8^;_<R
MLOG2A=.%FC [KY(O-_>PJG!BI')9Y&T4WCG=+U2_>>-)FA#MM=>Y'+Z:F]/!
M5_?3&%L_L0]Y6WZ-T_9/>:TI]?S$QST'D*BFJ%327DXX^A>_ :8SYQG^"#V*
M)OIPH+Y?YM,4VQXX]&)K"_)4JYMW\Q:7^**T,.IXA-S;_E7EI6W;CB9GV>K3
M]BMS$58&@$5GSHN.%#JG,BA]M+_ %C0[I<Y@4%Z7\@G):E<UU?=X8GMZVA=Z
MS^:7D^1<BQ> (XF>&G<]R9C\./4)HL8;_]2D3M;E[4;:OE(;?ICPTVZF#)>U
M [Q/1-I<1*JH>I#[P[AL+F(NZOMA7\X4F7.7S#ERANT=.H_>"'W!% T$:3FO
MY40C"[/ G<PL4#>C/FU@3*>N%Z"0;PULP#AAP]&;Z$7%SP2@Y&PPF9K"16PH
M7TNKL*CN]<Z.SUYRJIW<Q-)I0_6[65^N5&HK7\V@Z#!\>%O<"Y7240\=P0<T
MK)3-J)0ZN-J9^OG9M/@H+C^MN!1W;\YV$Y+ON(-;5A_>B.[.M"76Z#>A6] M
M60;>>^-N,E]UV\!%X0VY$#G11G_&C*<7/Z:2'RRAD[J@;5WKPRHE_&:KX_M3
MJ<@'N$WEGB+/@)0>OQ%J2<3<D4EO(K_?PTZ*"3GO.45MZ51%BMT Z%EK;5A!
M33 Q:W&OQ.!Z=C*_MG5X[5=DSH.N+_W,?GE;N8M1,F'EE(-W=37;%'RCW(&*
MZE6D+E2+J<>>E'[6PCJFD[;SL;OB90-^S\^VLR;>KV(4WP>)>R>'XF,6OSHI
MJ;5S*G>:1]M;&X<GG"XQWI9NT/;5Q68 :QU2Z(%ODB^1[WW?5NJ16#8S%MF3
MH3;]XANQ,#R$%E>#Z<$RK]&C+<2)$?@+K%/X39P71>/G_&3UB:O9HIRHR@/@
M^J&!,/0NO\<.6[!)E^/CPLHE!U'WS/<.5_EF@.DTNZ>IQUU]W46*8\D%I?\U
M=:?K';$@;B**_IGI^:RF7_%5NQ:6H3AD47/.=L\ K;Y^^D%I4'$) T-3N&SB
MHJ&I'..))CJD^KE756Z@SRU5IO4+@\[T:4K_-C" 6A#@[YL&>J@'8"TZU%&Y
M<X3%!T#W07>.?-%+RB>O?=8&1_129";S%Y(B*^/RK<OVXQQ\\O9E[]W#8HG#
M23#(?R=4GG2&/<S;<C?JA_-EK+PSLH%Z!A=!.B?(V5V<73J<SM8$!@E0)*%-
M'E;T<1S_$"@2OCQ+[9 7+,C7CY'A/Y3<;YZE^<.D%K@*D^<9P&BF4RW<Z$Z/
M0^6\':-YNQ!?\;M#,II'?HS 02?B0_Y8NI L'C2&3EYL@1'RSN3L7\>FVIL+
M P^P;&%@+E.G_=H NY:+^(+DO'<RTMY.>+FIMX2W'3.1N8W 1>A>RK;^\7=&
M+-Q:DA[Q]J@><1R84:X%[F"6KJ^UED\J)=S:]"8=>'>B'B+O!^9NFFG^_9>I
M*22)I>O#MW LQ!!TH$K>7LBT2]A_;[(@K/_OC>!-S<)][,)F,'I_;4=L(O8:
M&!9*![KJ8"52'&.8BUQ<,SHPSWC)14RFFF0ELS&L0!*4\)1NU<P.ST,7DN>:
M#B2%*II\4%,C@QSLTI O%Y'BV86Q7;?LLSY0"[L]':8-,W1]"/!E'.@^0Y[K
MV)44*G^,GO.9"#)AF3(.4XV[\OBFDJO T&?8 I(@I[PLA?Q OQ.W]!M!%,U%
M7 /F9XA0=*BID;87<9MP<KH7F8MXY=T\^[#@[^O4M;&WE^JY"+U3W<#02:@?
M=L EV.?"CKNUMY]=R]'AX''S7WD[0)TUV_3C)MY6+7#+N+0@R)'=20/ZX<8@
M(FB[D?4.46DX,E<SH$DB%+/_0N>/FWA_@_,D!JA'<M3/L)X3(.UV<CW<JQN>
MAA/3*5<X-1MX9\Y%0)5I7,2G",?.6%@C[CX']SM+L$H^H?X,4L*,]^$X"O=+
M23J+-4VP-X\'_;#N^6)G1PG[]@AL9DP)%-EGVN@'=+T#1D_/SN(616GD\5Y>
M>,W@ZUZRV3]LTIWQP_'HS8-QH,.BJAZF-I6+P.V& R&M/ ZAKV+&RWE[7VY*
M_/N/D9 J)+U^1F?4H^<FZAULR(MG]C\L"2[^^>O7?YL94 BG!\Z#1.N_=G-?
M0B[ @&J]X4K,O<%%B.#FIV"_FK(V2W(17K 6OB#(11BT;9)/NOO]ER(4_/?-
MI^$8'2'/E7[+7W9(.-N+7(OB:.S!U2)9_C,'OR>%?OK]AX6O'W[X]9%$_SH#
M/_N16+21]N55<#ZLBTV'\MN@JE)?*%+'JBCUYZ6G3OH@#.=-VWE @<=4*+9(
M@<'QWF$:QH2H/1=AW5M'QJ+<KQ0V*E;H&)45M<UQT)TT)@0Q:8KZBHJ*IQ/]
ML\K*,OH/[\]Q^_VA;J[RWL=[@F5NR'AK*ZG,N0M>1G[6)(;"SYL#0#V=D$$Z
MG8%B.L0QP4^;\S:G>&$F"=(L'9;$V"Y<@NHDYJ+&[[8WI/QF%4>:/_,Q?;NX
M"!?,70O,!B]LJ":I^IFM4TV\P'2HNINB/M3IO@4TKM._G04:SG2[W-0/,_BM
MV?WE.E''?>YJS_3UN^7:IJX.8>2([X-5CU09UYA;:FZM'J3/YVV[-ZY@.J3P
M?#Y&T\,S(>GS6;W)E.>1;B2G8+I5($JMBJIZI?7((:O0#QGUR/A&OOMUV>2-
M1FUF#,6-0>&,'4];TU*HI^(-4Q8O?MWPQA 3210O(HH"53;0(6NV**AI0B'F
MAU0=\QM+/ "V^;]([:N_7V[H=C5;Q)U_?W?)\V>-1Z8FV.I)M=Z7G=I2W\!-
M0G&-EYO40"M@CWP([>>$HO? ^5Z%@>W.<D/]VB9=61K'!, 29V>1IU1WX='2
MJ1QO3[>T@?Y[P6+2G45'PQZGCL7E>@N@;&/'JTO9.7M&\VN71NCG!LF49C@E
MJ<TAE2+X Y^2/I4K4C^[*\O(RK9[GUL\D7#2KLL]]C#1I$O=N6M2/&CN_NUG
M#A6%AXH/,8L?W7":]&3)LH]P7J%%O^#1C->:AGD79'H)M\N]G1R$OQ4,YOB<
M;CU441BLFP,4JI7-A2H&^)Z(G.D<L"AZ*&%C-29R\VJR?0N''$O;UJ!XP59*
M/-24WFID4D_UV.I9['ZDUBYW3TJF+NW:^()A>(*X4;D0<9K,V'Y81S4<?Z3^
M4L<!J2TF05K*)N;;G;MHX5'JZ9I3$C=P6PV5+;^TB9X3LKM1:6)0+I'?2UIU
M)[WYA&I- -;\;V_=[3#THV^E]H 6= (5;MU)(G[CQN!3&G*]W]7&$^ULSZS/
MQ])>T,2N+&1;6&QI]'_Y9?7:O."Z?<KS?.,]U**'_N-E86\<8SAW8!2B84Z"
MZ<!!>,9,>H,"/=W(_)[*UG"%NH/W7*K1?:>2PEN?F[8:&\4;Z_;JJK6 ZS0C
M^-$8X9!J&I5 .4L*30ZI-TZU#M)RVV3V1IXVVE)S(G%/N(K:D/BG5+LM.8:J
M9[,V-.DJP"@]?U[8&S.,U. $5'$12>F99G__E;-O&N9KN"Z?OM3H ,D#HQ[[
M>+L2'S>!*;:^!CG?B^((N(C_\#I;\"&&1O@6M)^8S+[SP]OG]BXD@X'A^,3Q
M9@0&/V!?ASL+\J&M?U'@XSC<#V][+7[\:6T&P@4.9H:TW\_\_ULV_W]FRV9O
M6$G<K-\%"S+$E@V[PN]6K7\A%9PT R=+HLH?8]\4&^KKZMCUP4"N%-N!6^H)
MJ+'[#3E;AV(QB52=Q^O9C#"(DPZ:%AKY]G$F;/(@2T[CTO=*&FJ/X.*0*(>%
MI:<>J/%XDGQXAYCVX=6'5TO?;ACT:,B03YHN8W6WZE^*2SH=]NXNY%?+<PU;
M_L<'*[/(%>%_^]_[?E/AI\G7G=J\]=3QL<WKI6]7#85&_O%7MT7_/12CX>-<
MA-9%WEL]2'@_/LZ-Y<9>4\I@@'9D>OG^<F_)U(<9WB]<</G Y+F4XF=4CKYU
M&7T^+JPH0L<4W.^4\KURW3/+MGD^U:$*:ZBQBB%Y]&SB_T/*F\8UD:[MOG$6
M$9!Y$F*+#((8%1"9DG8 ! R169G22B.3$!4B$4*B3&&45J86!)0IS)%9$!(A
M 5II1,9($$(2 0&!E$HH(81#O_OLM7J=O=;9[S[G0W[Y4%5/GKN>^[[N_U65
MJN 0LR#5EN>C><<L0S ^]HW>EGT(/['^QXB^X\X_W'+K?EH_,Y[[V'@ G>DU
M5TC=./T53OE[).8)B-D4].HBHI.*Y2LNWEZWP%L/XI%<J!3^K$IX/%Z3@S/'
M5H"4'JH\T-Q)VSL![N9Z@#Y@'*= 7HCBLV.$9CPTJ6(MN*.@)U]B>&5Y+ZM'
M,Y9I^N?E^5;/[-P",9K_)B26K0K#&-*V!Q+TTUP;WAM2Y$O3>.PXHCSUP((I
M)<ZHO+1YJ,V%TZ?!94>W29?C*NFRGJ^#?0'%^&ILL,J[^2 SC][Q>\M??%Z6
M7P,NNQS\?/U0^567.R6.NKF93UVLN!DFZ:XSC4O5K3)A>8_#QK,[TQ\V+4Z.
MSHW_(?BV_]*= 2M[R!M+;<@O^Q^]E]SSK/CO\0-#Z^?QR@@5SD;>-6 R+QS(
M\MKC!!S)%W]1-VJDW+!A;%7_WDC?5C_(O78HQ-SXV8+K&BI)J%^=)A'DWD5*
MF'V/MWD6U+3FW&I52_;^"%"A&[4(/Y@L.(\FY5@SC$T_O 0F,A_6EN.,>UB*
M]((#@5!Q7@XF@>472SB^0%48(LB!0RY\<X76N)XD0YH8;LA]V- C6,/S);4I
M7D+\RF/&%;R3F_-)2=V<:JQM2:9"\8A'V?A8HY@[4=PALZ!UT9/O'MH5U!OB
M"^A%OEJJ:6"[?%QS^@]9RT?%HAL5.V /<_K8))$J2'8;-DHPUR["K77V,PJD
M_GKH%R./1P"[1OJRTH ='"%;>FO][8B)ZMO;6YNOI'=3(=D,JF(*^W,JO%(&
M%W,^^#QIA!@B-39./VTZ2N81%29 +3H*'.*F/5 YDO/N$;9\$K?0[2W.Q",X
M4O+SWN+OA=!-B!@B 2NU!Q?>XWVXB:]%XZ9:VPR&;>SH.OW-/:A@;#0\PDA4
M,:JH,#.GJY06I.XQ*,#*HZ*,=WUAS8;8F!PI'$^Z,W8:%B"NW:]J-O9-+^#7
ME?:&8.V:I9[1:*7[ARR5)%+N)\<\M+(Z<>N>\IS-WRON&[F+PF)O,8D:UYA/
M9E!4V?YK7:4Q9+ 2K8)Z0#B,Z[?C(^*,@KV^Z\.ZB++FYZ?2Q,"T+4T2;],O
MFW\QX3Z&2^,>+^=$*<Q^47G*9ULT99?U!0_;K9\7*B7S7-*^?#$/)WL*?6D#
M6(LHO#QY+$@EK^MA07' FG=ME'I+5<!:,).$-ZDH3:WQ;QVA/J#,KX6\BBJ<
M7[M!\2G].-<L:':D5');G$?V6Q]Y;EI;4%?>JQLV[&6;Y-ETJ[1$T:24)\?]
M-.A_L+S93^=T3FINZE"D=6MPM<(22[WG;W'*W3M [%>B+;.(<7:6U_[2/OS?
MM$]Z\']L.AHO8W/2ZJ\3^AA5?N37G/\A5JE'FFPB]*3_.8+Z/Q35<<"2';Y:
M^^B?VV#I"J=_."R^N_O%TT_IW<D47LI*EXTGF20,GR(JS!-T!LSU>+!]N-RK
M?*NR'.U4PS0I,/GB*!:Q=\'1:LBZ&%=(MV]K>?7>R.8GZ\QC1E>JC[., A0.
M5UPL47F<,JWTSJ$TH\+FZ)DA>UOI#%9K4FC&]:<Y]DC-RHOOL/Z=8>7.Y?;R
M>F\=BNQ#4_S<+\=6O#-\KE7B>)DLYOPX.N1$2NE@BH>7\;^7WJD".6(@-+I@
M3]LYJ@Q 3A">123R^-/,%&SPGM=$":JVT'VD37MJW>;Q1!N:MP"-4Y< JC8A
MDL*CH28OTRX!L(?I=);6"Y9W^T9Z5(2Y14V>V83AHC5JU'!=PL.&5C]B6.WX
MCNDP9&1A.B^^B' 86GYFEZNW+C[NE\7Z^FZ)=:5&/Z1Z^K%XPA&;Z^&I(ZFV
M>?[G9)_J=LK+ALWJO#M1EEG#T7K\V,UM.H1YWKNO*5OC]L1Q5V902<4X!7.8
M^,_V=:!S[V&=CCV'8B^?7=FY/\;1X>K$*C$2>HR8A;CSUQ^OD_^(78G_?[1#
MMPQ_MK(05H,/!IBO/>PD" @E/)R_YSY!8\$TLZOF:;YJZWO1X7F1P4"8G=>I
MK_J.P8[!KJ,+KUD-.56*$1:9Q0JK*J$L--K&Z$_7/,54N"9.C[.X";EOV*\4
MA!Y3I,GAL4%\YNL71+] %DDPFXK!FW Q"N/^U!O9UR(EG\S@B!TBC6%$ S;1
M<$,344]]H[GF/?%AW,M_;M3Q\G3NT^<JCY+L'6]E&KG8:(;[(;^QB[%WZW?I
M-$R,I-_&^(;]<&=6?U]YOXC_1]]*^\?Y* _* <A)6TJW'33KRC\]\KSMY6";
M&J<ZO,L]CYIW4#90=DZD/KC4&/3AYN&6EPU-65\]@FP<1\V27UU1OVN9Q=W;
M:_NBI7C8*?A-<>9J\!@L]^@KK<E>US#XI0N0ZRD/'N_N>JVM?,AGQQGE'L_]
MW_^EC<S@]_#4#+C0!VW*O T%\74OU1ZX+'\Y)2PWV%$/9V069<!@6>0W7MM=
M)%$RLEAES&=-=JE]=&4VWP4^'DN4&&%<\R74D/H4N$LE"D-N8^0;!7G+=X(5
MJ].IS77,((+=TH5_CS:.KY9$@H/_*.^3^VWO'$Z!7DZ2,E?_>>E,\?_*+/]'
M!7XT7N/^]93[)[99GE'6WO%PM\T9M3=&6_0JOPGQ9T>C=V"727!EL!Z0NL"'
MUP,^'J^VH/O^XLJCB-\65#(3ZM;]"HB8 'A!X8?QWO*YK+KYUNG1W)*2R1*?
M0&9TT._OUWT]G[L>(#LZE"NY.(:1==Z<*XQ]>F3N37%IT1&>ML*/7Y]ZY=0R
M$WIK/]P\+JZ:])K[^9=Z';?*[.L+G$I'NL\<)ZA7(K$\FN(H79(4#Y45XRR\
MC9W7=>'HNAP,M.RR_ ^2Z*T/793EVZ-3M05W2=SC,;>!YV%'VVQ@]ZO[IKO)
MF)*S^R9LF6ZW6/!' 67ZZ:5%&\FA95W5IW_O+:_)']U_W&:O2WG_%YXCN3ZV
M O7X5+;FF?&<XA].T[$A+<6+\MB[-<>T/%)[-OSFS^QW-9Z_8OM!Z#=RHO$V
MPODUYT<4U5CV2T#_AVLZH>?'KP=^=2CI4[_7_5F ^EM),PP2BI1W'CR<$C-\
M4/+LDM3N.G,[KH5BA^@@L"<9;X-O]2/A]0L#J1K,1NUX+L=P0_'"BP*G$5C^
MY#O5Y);1P>[1>RQ5CWM+FM(9T<J^OE9?U?8(\D!E+N9^J&B(!4L+7A+M\?"'
M:P!')D^GGP<LDK5R.?HHYP$CD!2W_-T.K0QO]*OQ9V61%..+^-]P:9='IY :
MR$&*D6JN1\#'@-&GSIQ]=<GE*K8.*=.*K@$O'9%:>39E;[H59QXCB[^\@]TV
M@U_X,ATL.^V*'*\;,*Y[O_K/Z(K^"29Z?Q*4\7Y@%)!\:1#;3PI?$[5S%B,[
MO"7!N&=@/G$[;O5G?DT+!Z,VMUR!NSMK"5@GFAL4XX@N(\C'&";>X%JY)ZZ@
MT\!F%SDY+%AR:692+,J^]':YO;V\QAE[L^Y A\<K*57,/@D=(UQ9XT!QSMQ(
M!.SU?\+Y;YA4A+S0C*_'T6804ZC'ZT8;H?OQ)_AWVWE1!#H]2V <L3*3R9F
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M)[JW@\OZC-54')&E>56#$5<K@T8\GA/_4R;S^Y4) ^C]YHIDPGM%-Y6'Y.K
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MJ8OU[9(^Y4:S;QWTW,Q*_^?&O6%#@0=<,3:6U+9*H)ZWNY:;'$44S&=? DV
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MD^O<J/AF.<(1$OT;VI]]H'%1]@)H5\KZ>#'_]-::Q&(:I)3&P*!Y5#1"&8\
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MH*:BUV=<!>Q9[.'3+ '-E4Q2+%P'5\^9)6UA>=RD-+#:@Y;PSU<BQK(E\5Y
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M=8-2&.A6(-UV>'6U%H=Q?=$,R"_,$TM6:<VD!PW+L2)#$,#RDWD/0",.1C%
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MNF,S7YM4 ^6LTEV NV2*5N(S;W_JSM$OW_>\&E3EM%L+=,!:H!0C#9Y;%WB
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M\$J*;+UH+D<"KM5^#+H;</C1;A/_WM%'.QZ-A%:7=)ZK<?5:=XT>:<D/.L/
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M/R?%)#RV8D-R)M=XV^ PH$6PXL+<A\O>#D;V2MT>K>L4G*W .T,SB+8C;1-
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M9:'0SN'X^!+2@Q7+,R0$ Z2^#;4"TC8QP@-TX,>"J0+<K4/*?H2-HAJ)HQ=
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M%".@]#;5Y&[8M8\^?4UFKG5<CY'"RS,^'VJ;*1^SQ"@9+"[:<6)#C4]%&E2
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MD;J=MC3\9+>)0UY?/L$4&#@-!E6J)@T-Q.NT_PD,D0D^PN4LMS7R"@4"TH,
MZE\XF,=V_+5OM'-7I_^,T@SYM6Z<8SVT,RU0:A!W]N!7:4,)U4@=;L.N&ZMN
M=+'WM,=[/I39A$KCKJ%*#CZC!@ES'XW3KY=1_YDNMOG0Z$R\!HY*<>-P.SX/
MW!^31MPN_XG2S3,B^,N.AN/?3'+,C144PC$#*@?W;ODT;FJ.@]15FN,=A=",
M%=:6SY3MK2S=Z7?X=>UDZ4V S&5!P!EN21D]U^FXTZ)V4(A1RVO>+\M+""-P
M89%]TR@7'@_X<="MN"6VD)R_H=82UH-\YR!-5]PE&&& T1Z&2?-#R9[%;M+/
MQ/UQY7LEZEP_G(DQX:<F0A PQ\[#5D^T+F_J-Z^I6&"8C']LFYM7_XN%8>4A
MC6O'X%@@@6^8)X+\54+BE(4)/E+O)%'R3X%((;K CF MS);O%.&@! \0G0HL
MR'K<J+=;'72/"K527>5G)917T?LD%L7I;0,S$)T_)A$[VR60Z;:,,Z-&61^I
M$26!TOMS1V0W838)(YF&APLB?Z^YJ9?'5F%_PZEZ%:AY$8>MCYZ)#2I[']E6
M@GIP*O1R_)$/=8,PRVJQA<5%6A6I!/G$^U8K24-^2M$*(_],,)+T=2/3E(?!
MAP [^/__$Z\QP54"[5GT]_YC5+DCUBV@K1Y4Z>F^EM%E@KO@A=P?VS!$Q5]8
M&=2<8SLSG*?]US+AAZYJ#!]0VD%;)@KXN%^(H^;:P- 22]AE$XN,[R>$2\[]
M 6( /0[3: RAL@+KQ9QXT\CG8.J/>X331NE.449"1OJ=G(/%@2K?33*.,ZEY
M4U"[.+L+86HIQY105G[RO.8-:S09Q^[OEX6D!=BW?IG5=!($A%AAQ^Y7J5O[
M?.T/+F[-"W"^#DBNYE_NFDU!A.!FG:=]I3X>.R8_A"XF?)N4'@2\* )6+J_-
M*/O'GI$2]6[65"EW$KD%U</Z.8ZG#?<!D#[%JM1/;YN!Y)L[ *QNM&&LN?8D
M'%*SB$&RQ3O6E8O="%,R=WU#+0.6>NU=G'39_&GRNH&G07=.LP16%FY9FK$?
M:^4*\[J_OS>HU*^\NLK?MUIL8/W"Q\NZNCW]QIZJ.:NVXBXKRWN?BY:*/MSS
M7=I?F?OJ<67N?K7_UZ..>ENKSK+]1:9M'C:[^K9P%C\2:W7[_*&!;</'35S_
M?.!\_IY+J+>7S:OZ/365A3ZU)?ZPB^7UU YLP]GV/JZYB2*7 'U,.,88NTSP
M;,!"-W<ZD&*$]$S>S\O"VVA-O'OOAEI<B3#RH=4%EYN\=(*#DZ$;E8W:$A>(
MJL+;1C#'FN-W/YCQ F#T#.9D9>YW<PC?7!.0:97\!V^5\37 L"<F?/8"YT8[
M=-\ ,)4*9\,'%P=T_[YXNDXPWQW"$=KXA;^6WQ=I!H]9]QR* N5#T(=OBDX0
M;9IM$O?W9%B'%+VW[@ZW+WY$Z0JLI@<VS93Y^/H_H6?(762&*A'RD*2Q*08;
M:H(+J72E[H;:=*,H60Q3W-I0VYH\I9Q46?1"?F@5$*;<3A&C0%^J#"G?2\%M
MJ*47*W>@EN99;7+Z$FY)V^$?Y3BJ8S^]K2:;=C0XF/JZ,:C(IGSIPJ!&[\G[
MJ9]?1CO>Z[PT_J4$ YOSU2UZ5/0] AO:-.KO 4UD( X 5DL_?@_%06;->JCB
M($M!5;VTXFZHS6@)&=(P^1[TG\KQ#;7,)Y):FE"% % &254<I5#P-U(;LH75
MAOBQ+Z,&ZJZ4M;2L<X-UD<Q5FBM5D4:$1LF-#BJ'9[=*['-D+G)KL!1(YM,S
MX2B9VV!2U5$!,CMT6J=4NX^K1Y5?&H5!LB/>%%> 6*^WJQI.*<MJGZ=7"](=
M[;.JXUQ,:%+J>K)GXH$!XQ>L%*,W)<4PS1TCJ.T?+\>A'FRH17(L11=%(5QF
MB'[5N]'1#W%O%D;NC5^+Q&#E1W 3ULLIRBA\I%*CJNK=_+I]@9"<3=SUH[.V
M@Z%RQ$WZ@H_,0&L4"L+89<BCBBJ$^FFY[GBG 4#IT0-E?0<)]F\3W?TB62:=
MAZ/!7C-<K]N&6O;J3KO$X48W;DH?\HDZF7B0X#$&-Y*0I1G#A*#ZS\B?5E%_
MH;<2C@GHM[^!7@Y;/\_N9P'^DP6$JZ(N\T5A7\Z,T(4#V3$E=P:B2Z5=IB$@
M3N!OLA5^S+)(L'6?1(L4HRP=#E/0R',%J,LO!/:QJ'=O/Z6_F'/F*XI?#ED/
M!G]DM*:7N3T:$^NF1M_SO_9Y[<QHR[!G5 +V@@%V:?)P:QO\'!NYE238!7Z3
M)(MP\GW(2ZJ9K0?6^(Q;2,%.9;\,*87(;;3#A$JJHE'1IJ BI53564!;)_G)
MAMKY>=X4\AT"-P-#BE$. =*;^YMWCI7Y6/M_@VDFCCZ+_FASM<8_?%_7N]\/
M,;],%L:WK_IXAMO:,KX57L-%BQG?8_5/>?[6D[O_\<^J S*X#.Y'RO58W<CV
MXHP#<._'O!^]PI""E:L\N0WXHA;62TF-3Z6>(6$PL^82V)>_]0(IO[GEVKTI
MJYMNP9KKCD-EV&.'U<=::>BO;.EEQ=^L2^09D31W&,?B5SN[Y2.W(?^LMR,8
M0&\O)WYN';023G(6\4U)5^MX;*Q324Q.?%O\'K0.F-9+/#!ZUPFM]YDFH!EY
MM4>:84^7C*Y?J61.VH@Z1=:O;2\$5V71]P?2_:S^P8X&_8,G'ADX=C \U&(V
M<7=^Q5# %7\;QV+&X_FQ3W/RQNS.7P5W]@K/..A.EKMH:#[/M]R;\Q5N%N.W
M3^3Z,7ZBOX9S^I?Q71?.T(WKPZBAIW!Z7I3Q0U=IWE,RRSZ3/W+TC]_M,SEP
MM<\D_?BP6O ?GC^%&/P6$J*V7TU-C7K*DW!JO7D&:DU_Y9"M- ,714.Y2&WF
M88RY'A#6"]TN/R3!<2D_8Y%:HUSFWK$DE9DSL;_+EU$!"-FTS\2\D#_HTE>^
M"6"D=^X5#L23!#R.MN_TC!]SG+"W"3P7/F;GD$C:FJ?46/Y(, !- 9+2\,LR
M& 3]!1F+3$,#=TD]F\B@#U*0 AJ2-JM$REMQ5Y7?]<H^5<Z$#2E'E'W*T7$2
MPUE!E@5Y?Y!6K'M[7O>&YF4YV!WO*PKR:7 *+JGY_8<=[*(X?=\?4N_O^L+=
M=^U3?L3@2.URXH<9DCXMV<+E0HKM:^N7D2%3+Y4)<>@GZE(R>YEL_HLJ3-O^
M5?VH&%!!C,!!C 9_DP^!7B3!(R?_3=[*MS*(W!*C4)D\C6(I=)K8+QVT4NKR
MVFX@,9,$LG,,X<J/1Q?!!%'8':4%P7,"[L.GH<(E:,Z/A0;X7L%0#EH]436<
M.D[^D0(H>\B <'"L%04%70(E%_-4<FO;,ZNR-06P_AG_9^/RS:F"Y>V18$ID
MZSBN.7%_H&@E.O?Y)_SG@7+8^PO8J* :AKV),WA@] X$8MA^KW:THSZHS,VI
MI*5@LNGE("]UM-Z9XK4R[0R2!92E%,A?A!L M.]I-,$0J)(; 6OBGRK.X!WY
MT%?ZX&[@&^<;X=I+,/SP8BC3&)U#=$7L&H<C<4#OUB2_')A9JCS,N8[Q4R>B
M)"XR"OS2M:'VRXK$GLZW<Q#<AQHBC#T%,D@!11?A$HZ?"5*4XU9Q=Z)_ECAP
M('?<J+T:#DQU.0I5,)U4W$/2_SP1UDXT?";)1VA)[.3%SMI"P]9<:R&@H,RO
MZE<]/'?. A:>X%EO.7^JZ%%,="7&MS0"I1<EEHJ!7LV]53Z-1^:QA, (V.9A
M:3IQ\<L'I>%311Y"52VVLN1GZ(Y*7=8,M8_43I'GO$3,J*:)(3^  ]M97V'(
M*160(@7(#;6[ VL;:O$_'D.\&SHJWE#['+T(F/+I<FLS1^'E4M5G'.3[-M2
MITPW>30X/D<Z1_IS0^T<J6=<DC27RQ*8?-U0:TO"B2%+T#9%FBSFGZ?*L:_*
M<441%2=SD]48E)VY;-EJ$5 3$.M#M>CWCZKWQ9[NABW[=$$C+]VS<1(8/@HI
M"8U@U-Q;D'FFSE9XZH=9G_74/_G3_SG4Y_KD^K;2.^ XX/XJ>AN0O+0(C'*(
M'N"PA!TU!M?EET7Z#5-"ACOUDK6["M]CW6I/-86%Q+;]9)4EG#C?]E9HZ-;^
MHNE]>_'CJ*G9L\I7K"?VA;(#\Q$4#CTGHH1P7%&'V+=OG<S!94_G?XL;P1R.
M&]52'&.;&X\Y='>FA'7NB2*A[WO7@8VG\L^<L6.6XFKGV]'5B6&/6S1&7Z5Z
M91QY&W+^8S[-\,.9J.H/-@DX?I6OL^]]](&YF_=>7D<GH^Y(\.8:!(-[_"O?
M/0X,Z(;I<F\P36@^GQX%&8?=__I^BWWK_6B]_0.QSWM=+YH'9-KJ4PLX+\;J
MEP3?',11LOWR PHZTS .JHVPF%>>&?Z^-JLC*<C?SLCNU!9:9@VDA0]3"W$/
MMY6>RSH]_.GNI:1& ^?)/:Y5+9VM8(IT"Y@A"R% P0J:LF=#K74NO=-/M!^N
M+6BDD016?0I$W\DQ@FL3J'ZB?/8-VW\RZ;OHZZ>VKY\R)X\^[WIN\JGPAAX8
M%,YX6#7:O%N14EET@"!(H]VB!1S)AR^[Z9;&G3[A16%56"2;7\"/UP AJ$C8
MM6M,5Z[@",J9WS2Z*6OHVH$8A*-554%]H/$=XZ'(@I;\8KW--O<-\-:!_UQ3
M'+R1OZ_L=$]3:G7GAIJ0Q49KRR^ :(F> )KO*0"H'-XO8-6KZ#VISGYXV!$G
MDF$LH\-,,5&4D(Q-C<<T1D3.=DT4WX"5C83SV+AK\1^_MKO\LTEZ 9P4+I)O
MF9![*=-6['*/,>8OA"C A2.VZ+0%O%!J[\ <^&Z +9QD#_K ZMH@N4KW<>]\
M @;)-8:QMH,EVCBE;N1I K0&0]P%XBK/+-S\TD:2*@PR#H3</'B%NK^.8;4<
M5./J^<;\S>4=CRQL+E]IC5GZ:)Y864,,P:7=WVM9&K PXTR/24HL"1@*2133
M&#&?YK(WU/CEJA3Z;QS1<HPEN*PH5.ZP)EU^0:" OQ&'I4@P/M)!9TK\#2F
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M$5SY%GPHQ'"GV_#\AEI,JE5H*1MA 98)_=U$/A*K/HC1![E_QXA#L<F=-,%
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M#^3.T:5?>MEG>P66F@ 02T^0F$#,DR4X@'=SCK951W[)DAL<&H+,]LHV%!I
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M"6]9V6>C?])*,0UTNF9S5%(D>Q*.E[L>8H/($*"3<8Z7#&MCFTP,RGLZ[X]
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M"Q<C<A"<$%&/ QX: LK42E8'8ZC(&\I3LO4\@&+I"]T7,G(YN@!$\038N2S
MM@XQO0KT<_P-NHK=&!:3+%[(0/F X?^KMW>-2BKOX[Z=3E:FY"E34SJIF1E3
MGDH)9O(R4\=(+4U-F<8Q#PQRF9ID"%,>\,R,9EYI2GG,%*D4+0^0 GJ58YZU
M,(4-4^:!V'M*W"7B32_NM>[[6<_]YE[K>=9BO^,%_'^_W_?[^;+Y[__S%&9:
MJ.=8IWWJ*K.^&UHO0)I[K'B1WUC#4XB\SF"I#\F<G-:K/O(([I)^VVO"(0FQ
M^@1L<]!SO)[Z-4U'O5/E\6T[N#*F'7R5+\&^\99YK3(YJ;1@F "%]B2'V\)%
M#]^0(P3([9_%1N;EG@&3<K F[:]=-?0+64T7+DF_[+YU*];[G+3FX*/[?KV%
M52_\NL>*YX:K=@X6'BQWO?5;K70I(5;QT.M#Y3NC=P-)U/.--4G)M+'_TGY!
M97S?+?%)A+0%>YD(/-\_NH:#U[W=3M*ACJ@WK3Y,A![J ]];&U).PK2JZ$GF
MKZ'[;-+BDDY@UI-8 P2IW4'NB=5T[E:5]U 25A=^\JDWI*#H82P/R7G!BNP$
M!P3Z\^(6ESQ'L26Y</$-'CZS?(:;V\.U&7&<4FR::Q=6U%3O))YBRGRQO2FI
MPFE6WPVRCJSU,2A31L#]T/KG3'TB.@;L^]=J_2'T>C! AN]%&,-TZ>3-1&P:
MQ@E. ]NZN?OA$BDVJ[2NH!**$J(R>5O1P5)%CHD^3#\'E][T->^&/K2ICX-M
MZ8XQ')Z>ZL]OV+Y%@^U10(8B^Y#:3N4 M[%@NHPG/U$?3'"ETW]C8RPU]0ZZ
MT1DD*4O5&Y0,9G<FK?Q,7D?:^L'@ OEF*$,/=@'^HG%P.7N&G<*PYX=5-M>K
M8KR2I'T^.J7GZU$1.90QZ&B&B]4QGRGODI:RXOL'1A[<=S+M]8\SO!+T+O<_
MQX=R+@X%)HY>;;[XT-O6/NAH^W#-Y=OM'=A1? ;S$:];G.'.SZZ]..]:SJ,G
MXO*XEJY);3>Y&U7?#RU-.\C*V_@^*%-=&A^OQ46H=H/O)NYO9/3P]%[/F8U7
M%%UBV=?TWM_4_(!P1%BI:WYP16D WNX"4 C8KA=KCD'#H^Y@U$W*-7#A.3]X
M#&,PUZ;>#I(87"0?G%GV:!ZC[ '3^";4/0RO(2*K=K2)DF23BTJR>UV-VWD1
MKO/N&DOL&/P.+EKYC9( YBMZF9M3RR3X&RK?E1,79_H@0R'/H*9E"*W[<(K\
M24I/-U?2+!%/(5ZOIKW5>D1:+[)Y:39?%90** PH^.'?V&H;^#H._&G&!@PK
M?W6?=DFL.K_ZB"/>IG)>+>@,K5&=@TW!CM.K5<1@50!4)>/]OC2 U.A[51OL
M64_Y@3-.I)A]^WT"N8-.DLJ3?Z*?'#J4A,TW4Y=O2U'_1Q242XD-PCV#],+[
MG:[4N82@QVL""KULG]:<JK5]M=6H6M)PML&_QLDK82+];<06BNVGL\T7FX8Y
MH\,N V97DPL[\JIVMMGOE?&"HDYKL"B"LFE8A6@D;T48JOZ5ZS7IJ,@/(2Z6
M'BX'\<__$)KTT;90G$%2GM5()PJ<E"ANJKZ[[Q59J[(?0CD>:,%ISRG]""9?
ME56-(L*56'VKNF>40ZOEAL]I+<ER8VCD[SD=A#!&94Z0=.W[J8-;MK*IM[^'
M:IDFM7Z<'(%A7KI41:!M[PRKC$EV?5=1[,R*>= MD6L+2EP@@NA]5Z2VT-5&
MKH!*+HYS=TS%ZE.V@]K9E( :ZHM/(M4ZB,J0+L$\Z#V20=TW[(A'DA<D-:N*
M I53/,!>1W%Y,IY$#/ZVG0B;<^6-NX1GX"4;P'>7)KJ85=SAPQ'*]_"TC)4@
MJ:CD(;&7&;IP+$YT7;"FI<T]B(>3GUM:0LD]^5=&5B3LG,XD4,;'[(1':ZD3
MEG9@Q3.:=!K_8\EIL*N?P-2$!)QT.JJ[D-P/X#(^3X4RUZD\11=^$U7;'>1(
MI'/G\L]$';<R/2:MV7GP7 TM^D- SEVC^I?^2O1\^,B18C3ZXK6?%0,FYB$#
M-8OC;ZNYQM:BJX4^%1/-M//P=?46%NC";R_IS0]'&JK<N\:ISA^^SMQIBOWT
MAH(<Y:PB_,8QNST@GY^@_+H<RG&0X0[A"M#7 )3%U(4%]2X-O)03I+5/X@[9
M7X(VONHBS':?4&IJ?H6R!9>%W8#9<V%^QO%Q%ZP-B--G+,#PVQ/(K4D/JNF2
MC_<?S(<CN\J$W -P6),*!_[]=?55?1**D2BF8S"@2Z8JYMK^KZ\X]W%2G55<
M(/<3,PMK2HLA!B@S0!5&"_9Z"&-\F&\"9*>:FR@V, 3QO>#KQ#IN+F0(U-PN
MATQP3(D%7>ZIX43!!#CO8A:7H3OPBO'PQ[KP^9Y4_.E GQ.>LXK?\=M5+K(5
M$MTL2.ZVXD7Y!30I4*AUJ()"BM;09WP!UH#R'5L5/*I*!I.?I]3EJWRK83Q?
M]*Y918-0>>I#L1A'L$1P@A R1*$UP*C3(XL<-U_W[J"1MJSO=E[VKSLXTOM"
M.))7L]5R4/_X*=KBQ[$Y[\';W^<F'6;[GJEQ.>Y1KSOD?_;<^)?RN^P-I2W+
MM]O;?F5U%7DY+.BZJ[<P06=-'A8E_TX#[."<Q'*4)WRD,I3+J:/L@.2L<>;S
MP:V44V!R^BN.9$TK6ZR-)H%B 2NUEH*;9"=E=7I)\D->(;;/S9A!R PYQ8D5
M[9Q<]1"L6]0%%[I3&&D%&1!6AK8T!&OHB[-1-'!N"9LYVV/IQ%2>'U&Y18(1
M 5"8 +]M+W37)46O!B":"]J+V>EH/'#"'#\A+W8B'IP]6:!KL&M-ZXU-M[+"
M@*F\ R%4UE@SM&\"@,K'&ZB1'_PH/\+#*S]0$II'T!8 RZ7G*[?X4C7LT(?<
M3OFY1%3#&A>^\)$COV'J:%!.\HAA8(5;>AMV\P<L>(Z='3+8HS GOU EK3C/
M07!HKUC7?THH:LT'N3V^$<_#G4"DP/=Z4#,XV-/EIMYJ*M75[D7J?T9N)P?Q
M^^,E*R21CSN<AJ GX;:S50=S!W=\*,5EJGZJVC5HZ K>SRF^X%^\T?_\_9U>
M[:H<W?T-8:.W=LMBVO^X=6[.P\O9;>AFVBVC4/]XKYF7)EQ6[XM:1=+EEJ+'
MRE[-Q&\86*WHQ,IPF52WT=KQCTGLS%;N]N9L58 &0J:D%GW9E:!G=A+>,/IH
MK.5NF $Z"&>^!Y/^#B"8F"5^I7<K#%1'>+=?3OEVAOYG:=6Y/Y3^UYI6[.#K
M02FOCUE@:0VGD20*+;CDAZ>PEXQQ4VW*'>-%^^H J&PBVASR 8*RN1;PR,Q<
M)_;;P]GA.MERFB^S3^TX04$!;$,5&4Z3V-$,?2)DD2"U_('/*KWVJXL\;264
M/"JY^KAV3KT#<NGF92J#D!M4\5 $?W)-RY)R7-K?S\C7]//XQ)U-N>!ZH/;/
M2!D[T^0K7A 6;O>ZMB.,BX8B6THGZ(1:RJ$)Z]"A3N9SIH4J]ML?*. #+O(M
MLH&3RWWJ?2 JA^)51]:6?+P3#SGXC%).D#2R7I)!B8^2A+GQ2WD:"32%]:;.
M3L0E#=AY=DUHPO)L#\9J'.V'R%:Y-\V[+M5E.V*WP0>JT+W?%[BRHL_X5QT\
M1AZ?G2WA"/QK#M1W#_N-$+WC&F_M+K<]T%J9^:!U[I2]E97M/_^\N2)\X<QT
MB%WP>-FTNC 5))U$/N+)$=KY+8/9:D/0Y7?*>LB-OXS5LP%Y# IJA13;%L++
ME,+QX.5/DI\"=X3@<M>T)/^9.0AFUM3!O.?+C91+1"E.EU INW!S9OD'DMY4
MXVU_=P#U>KVTY&:G/I0,?,P'D9(%<H3,\SE6ASI(/=0Z1HL;S!)EC+?1T79$
M*:"=VT)88< VN6%"V71 (-3$D8;A_<?>C2=J3V+^*TK.;)$?WC3R#CC$BQ-G
M88R>:4RC9;6&NI%RUC=4P&Q.SE39RI ;X3.O/BFOCN+#X"B()%#;#CL2D'G(
M5D4W8QT%.QFBX-L2&PGM:UKR[^K"X;3@X8BA($#%M>7F>@^ER!V4G^')FF\H
M,,G V%/,P!:3-:WFNL4;$!VHZPE5I)<FO6<!U]2NO/3&S@"I6WZH4-RR_'P:
MZP^3[BU\'9]-H_A*%9:PHAMC.*3RE:(V3'M)%0A<=1C91HI-K"JU>GG;[.6Q
M"]7O[IR*&^5[IQM=6ZW*WUI\J^JOPEI9>&#ZK!6ZZ#Z/QW83Y?IXV3K+"2^/
M!''>EAP<MR+]&V(^QXH4?>%;X"V +^DY;?/DQ=6[J@2 E(59!Y=$KOP2[BYK
M*$_NJ;" M#/L?X&V&:QI=1_YB-YXK38V1#M+T>ATW<+EN>CD6\<=)JTCP?/.
M\=/,(O0)S60\AHL!(72: ^/!]\G0KS.;2_S::5.N]F[^?VA2WQ*SEV6\="+J
M!XU=7?@@&LSC$)@[@G/MHX1B?2?$3EAV#GS;4#4H_=EQU4SVTTK F=4GZ-2'
MU%[L5EJT3H<XPU)[DG(=LJ4BR6W2Y-S$-R3U9I7],)%Z &Y^GHPW5)VOT03Y
M<7D:G."'VW8AYK;S!!YI#78QLU61E2UX0XY<3^0V$'6G3#D'&6'<Z!)YB68P
MWG0(9C 05L!\,]4CUN&LZOPT5CV*L:*XPFW@##\8PO9BMY -)F7.[(<PO?LK
M/G\J\,E(TV><^<R'B9#4NR$[ZJ1VJX'12W>>?1C_:^[AV(=A?K<_Z_SYL[<=
M;A_E2W?/.AV8B#^;$=LYKU]XZY=9)]^3OB^K'V""O0.2\RZ&GAM=EE7&")W?
M_E(L(OR+G10IJ= ,]\VK*A*4H1"PO!%:L$V/B7AGJ*R+(>AG;*5.N\XCC6$?
M93I4FP:M[\5LJ$#IT[J/4CPV%0,#=D*,98LFS2S3I2/H"-V:5_>K"6H[:,>?
M9*4/ ZLR1$G=Y['&"B)&6[5AM!+F5\(K7M!!_HH/[+HL*(T<%/"T7VB,S60A
MW!AFLS1%M^;@\T6Z[ZLVOKK?T/0G0O"&LD>O[N'\[7J "7N2ZH;,/S)>N\GH
M#.H1BC4<T:#RA;^ 05)< 8>F36Y=$%(-07KZ(94]I-<OL-PUJ4+5QGI>Y(Q2
M;0FBU%O<C<3+]B9]*:EM?/DVVF]D7K=\+^PE40] GMUK6H9<!_6X\S(-/)M+
MRRZ=S<%8J(Z!<??!P!,.0C/?5^7@R]GG$R)FOEI_3ME?"7=T\UII0HMD0-Z6
M3=TU7[%W@A/\&;$A^M]PN747%)75&0#RPC*HYK%N?H++!NS0+?+O_TBTV>S]
M3Z\:&A..\,-OQ0:FSQ\;$/;Z6E=6;7[ZR?'6?8^3AN\>C(VF'*3*[\TJK@BK
M6=<;1,MQJZE7D:_9,H&E P?JH>R&3R41<'G(9D7O?^532@GTYVB9$-^<W"T#
M<<]%UWNPDKM[_X9IY\$&"W?AU=RK[?G+64>2JV/;=Y2M:1F4=D XI3,,0)DH
MT4F4*44;-KR"C>$9J_9 O#QC+!%A$C9%CA(P-W0>!YC;X,.?ND7ASS1S)IMP
MO&;_ZQ.0E3ZS>UB55$>6>4Q&MH_)#W]6+%Z?&!DM&\7&-# R9ER@JQE@A#(-
M_&U-ZPDOAY(JR3?I87*P<CL9;:=Z"+L18T9F40W@22%RNTH?6-/*Q>R&GP'Y
M>*FCF9(-\-:%QC1(D8P(+Y"4C\;)<'HQ;6U!(B*#O^#4H6G3/(T7R1T'3LH\
M8+?ZA:_,1<X#2O"P6H]\2H32IWA,4/?,4;^#&/F_/H-.E(O[4 B5#^P#SEX8
M3M2UZU6;/IO08"6?;\;,6 I%Z(DIT2-HHA2K%[.<T'_G^NE7Y:XF^0<QKP(J
MG(M/CS(>L[P-< :R+:/EFP_^D5#RI-CX8.&YFC-).L->M>_B8A*LS/SSQ8Z1
M^[\8CP9<O7K&.S#GBB]JQSA6\A]>"[=&NJ%@\@<8"> SV^G/%48J?8AW0VVI
M2@%)?#M%5@@REVOU84U+WXF\M.H.#*H,^GNX&T<<<WF+H18[%LG[ %*ZBI9@
MS.*\@>_LBO)_-.[:%:#>4@+M6 F$NQ_$B-=QOX-C)V7N\$?:]N!H6HLX0\/1
M8:I36:B<2+!.Z!NEWO)C(R7^\2C[[^N393TI=4+[J&Z3VRFMCX'5 +XK/8-C
MQ]J*J\?L4(MHQIU!*S;J(;$%1]<&P.<ZX=)%%541 -80-@^#$QIAN_./VL"^
MC*34T#"H+Y.[63V"Y7@PTV5P/(;W8"'<?JA$YC'QN!$V]WX,;?,"4/*QW#-?
MF#^LLM76'TH5O4CDG!H#8N4NJW1HG_+>.,6"K8$+]8$8I/;2-!9 +1JO.,.*
MTT.=ZR4LE$Q;H+N.I#L@\TJ:A"PRWHF%6^PI^%09:3OE1$&?0/19^NE"T$#=
MP2&?K>5Z9-'=Q[N*[IXW&YS))P?D%98[UYWO;3QW<1]R^M41__P-E1J':UPZ
MV^[[=$W+CNAVPEBZ3#HG#@#;E-LULG%5!E"K)/A,VN;/J1& 9^_@+E7\T)(Y
M0B3&#=N3EDC9%8@1M#:TOMN%:PAJ*L0[">[(!Y<%ZITC!CV^-L\UL)')N=\U
M/3Z90?&X-^U1YW/I0\F:EA8V[HL:14F$&X!5.TD;/Y>1?Y2R8_P/U;%5EBH^
M0DK:2F8""'JG![!%45 GP[\V[^-NAAB9JD@@-;;?=ZS37+JFE1E245(;/K<=
M3CMSER [,Y981MNTIA6ML!@ Q/ !AC"4EL_4P487PUY V#XA3Z\3![[2O8*\
M$>12L0O629+&)"ITR=&4$/A>*3$;LKZKM'3*Y8L-XO0:FD)BVU#Q5;$DI\PR
MW65Y"339T^H#L+-F4*MW5.L;IN%/@'%K%;0BQ.A#=#I7FW(4Q KQ-\*=X68B
M08;;2L";+2J6D/KN4M)W7N#L#Y"36"C^CDP0?*W+I[@.UD2GR)N8 ,DT84!6
M%\B:^WE^P+]N:T%U?(%_C1_P^ FCN=YOH-<X=N16_=.#A46W]GA?_)3&6;P5
M$7,NYTI1H#+%&SU6=,7O2=R1J\5?_(.N#!]%9(J?T/L4&0'JOXK@($GR\R7L
MDZ8_(;H/>"AY3:M5(=#1Q*!X:)C51-V]$'ZL  G;9#QJ'U,X78AS*G<6]_#
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MW]H2J1P),#,.<PA(1$Q*7;;*]I*4D+O00%AAZXGPIK\]4!%7FZB'5=OAP97
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MFW75PV'.DX['G]D9-(F&X=:AK:IH$2'D-&EF+5V"%:!^-X@UF\U"N]3'CG[
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M6(/S5IB)W-'"H+,QJ"=5FY0Q3VN?72N"&UO&K["[*,@5:YC 9R)4NF"'@&9
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M?I'<(&R=,=#8SJH#/T;&G$+V8':T0<@>7K;HX[/J$&J_R:E/ON-.J^X_P;/
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M2GKJPPL$L<ZK$NF61<=G!0C')_%"]]OGJ\*OT$^,>X_;UOB]/!=AZK5R_GS
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M8TQV%V#6#]MW[F.3:?XC28CM[HVJ/VD:[]&"AXDQP/H$V@H:)@FWDPG=D^Y
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M4AD0$\M(69:V<&3$PP_(;50KRBFPCN_K*:7S!S?,\T@!$H0.>99/70\VM1&
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M^?I#^.;6W!Y;5#KR8L'E5LB"6?>!^613K;A96XA\T]>+-PY?Q>R=)A<2$1=
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M:GK+8 \,..UJ[4Z*Q>B3R/1^OB?&V42,ULI;=(6\%?$XCF(PYT3",#TC(-R
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MZI>K[B^=F?QAM)Q69_.TH?L+'E9B8"&\8?702HX51#@B$L3/3< FC9,D ;V
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M*<;U##X;=,QW9#'2]6.T46A<@E#;0?\<7C\W7E6,,OU&9]5X)*Y MN.71([
M-WQS[1WO>BWWVY_&:>*='-3U&UAW\CG3D[,=FTV(DRPYOMXQIA-XA?7VZJ]@
M _'E8*$%_-]X<<';5QX+K6'D>GVWHRQ_\V^2P2M<[I#0/>FL?M?ZMW%1.8!E
MV-*1:[_V1A:7^"(X.;"OX=5A RYQK9]C/[M[=_MNK7J=__.[(/;?S!:WN["S
MEV[6 M\RV([&$T\74]B=-]WE#MH9;7QQTO6MS<*JK.%M\4S-E-??M\/(OO]
M1NY,+E[9>OS^<?_XW5OOZ'CW^-W1L"SMLAR]V_O]</]X_]V1M_OQK??NO_?^
M:_?CK^^\O8,/'_:/CO8//K[TM5J=N/E#5&=PT:3(M[RWVWO;'O4CQF];G^8]
M40CL,/\O,X'3O/@J9<Y,WK<C-QJON:YTZX)SN'>M[Q%/X<;%TWTS>&[J6IW
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MZNS7-A&[1<&ZF<Q>E\)4#>(!#M;A.&VL:"O;8'ZD6_<$YNG\D6B>9I/IC-=
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MI5.CD&+HJ[K[_0[<A^RRN*SVZ4W$BWG .73;)(6;3S)W6<TO36J9[;Q*%S!
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MP@DX9?]@!*I(3D9%[P4V+-])FMT'FNFI\2-O?\^L$A-K?A([<,HN&S/U)GS
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M=P8GBA)"VX^7KK*4<,A]<,*)4]2V?G!'_W+\A(M[+4(EJ(W&;JAE$22SYMF
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M;'W*WOI<<<&=+HYB0;%\/?ZO/]$_CIX>'1X='Y\^^=^C@W\M+_Z$MH[N/R3
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MUXLT^5'4J M6""BV= 2R-S?9%X,"J9$9M#,8 36%#VN,<4PQ1L9C=A&QJ'Z
M0YN@52E<=R@5I&YA( 6,5"<P*$T^L>D"WZI:(?$.!=TTET_*!&%6!NP"%1-1
MS!,EL&5>^$+G#NLG5PDL4NE<9#I#VP^]UPF-OCAYWXJ3IWUQLB].]L7)>\1O
MM/^=[3<.X?X*Y)R]>O7+BS.:F$<GSY E?<VB"N07>3?M'7MGK)*][7/!G7J[
M'D%\(:Z^T54EE'_]_&VOI_/E8K='NV*W1S?IZ9P\.>UCMY[R(M'2RL?OP0I<
M<K"TA>'HL1O[4-/Y4G[WB_-W*A_I.Y:0U)XPUQL(WFL)$!?H2^\H'?QSQIH^
M/E,/4^(KY9JAI:'1;93TB7UVQ+20O"XN);6 / .[=_BQ=A?T.%Q8Y*SE!(B
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M_8%O8NV2*I'<D"+2$AJB)+87X'CT.&DB8;<H<HH=0'21XDD\SN*66;,V'",
MX)+E.A"TR6ACA'QR$4D\8$QQ&8$,Z:):>:29U7O(H_W!V8'<,6#:G+:RDQX
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M/$0S U'7I"#.=<TR42P-;6591S^4G$[K35/X@F &B1LL?ML3LA52$79?359
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M_Y!BL_=!"7-6<0/ *G\/3'Y<FN9H#XT1TZ*FN1"P>Q$+0WI!CR 9+!(EW%(
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MB/M!RH142+P:-87"N<E$82ZNC"N@T%\ \N52F+7U#6!@<MV;)?@D\Y.]+P'
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MT_131[L^=1[=T3YU[N^XM<BVKW>$ZR6@CH[\[DL^]7[(R_<X.86$-<QBA/[
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M&:W67_Q,+O+WLKPE+YRO5K5V407V29&I\272-I'8[D2AW/^F3?+]+>@%;Y]
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MMWCB+U=IN_O"&D#,XV(IS'IT7<0#>V\;^KK973K,#5>WI'MG=RWH2BBW9>T
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ME"&:Q8J2:3RM(EK/![LR8QR0)>DY$(T_](+9%_T8VV.X]OZKRG+)(7^O5C#
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MRR$_(QB+-!81/Q^%),VXQ7Z1(@D"QDJUHP$0BS&AO,2X,>0J59EAWZ.^"ZR
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MOQUV$2K /B61HF=(HB7]!&'9D(857=4B-956V2)@0[9R90=B"FE@N;L]M'M
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M829<O*B]*EXG@Q<E!MD6B59 ((1.'B"P]-?=7GLTXXT7*HP0@I3>E'UO 92
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MXI H]KR](OL009/^,+KTO[X4R<3P>7_S<*P$ &F4/Y02\ME?R"VR]L>H/S<
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M=<@>.+NT]3,"GKOE>6SXY3C;/])*/DH;+(M[/A366-R_MJJ.BRM3;$B3\."
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MN9@<G\E75<]*8.^H#7FK4^\@B><R<$ZFE.CGO,'ISA]K+#'W'A05 0@LB:A
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M3@2MK'/A2?)3D5&V):_&(U6ZX_P%RX]PQ@BLL!:JQ"C;[OE9;+9:M+[IZII
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MFX5"+P85)V$]DKW%.#<&%8!<@>L2GKJA&WQ70^OZH8U]57KU*NCX3>W822S
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M5Z[>G36;#0K38M005P@]30?J9XD3MN6^4]BP#N\MLMX50*=C:B=[%R69^KI
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MJX*+8IW8CM&T0;"H% I,!4JUJ=?15,)RMQOJQL\K/,]>;\8"KB=D--_8Q\\
MJ:4+P:>9R:IBSN6ZYOMT,I&LV94<9BMW<10)KLIV->Q81:\TSHT:^L(9.[VC
M.'8\9!E_HI=\"F,D"Y=OSM*VO%>+Y\<7:E2DTL&()*U)M.O;LH,6Y;<']H:R
M#[$]OW,S7E-GR$<NVGPEW!<-IFEW71RQ<X.:Y%>6>.51JU7M,"R\DWB&SL)1
M"M#F+-JLISFQ0[;)D(GQ1.^T8R#W.9KH$R9SR*=<L$ZRV[ 2;"^+6C)U</WZ
M@D1:_:!7LKAHFC@/+911G&TAO/":7P&G*6LD^%2JQRS8L)P=:^M2\F!*=<=L
M):QT]W%2+)H$>JJ1E#X9=['.P3FU+1-K'8]31QN:L-O35FBOI:% XQX_^FC'
M.+FRVX[!1C)7UYR]N9!$7DQRD:)MF;=6.@ZUO9.,F(/3+8PE$5HZ\2<Y=J'X
M@*.V:_>;=)_F_D)LF0ZNCSMSC[)^(W]?\+3Z!$"QL$@?#Z\7>^LCBH?L%2Y-
MG(^MB?//2Q/GTL2Y-''>X<REWX]OYK&:>6*ZO<5*N!;.NA63+9C-Y!JK6&X!
M>C(16KL.\WC69!X;RTQ?N&U1;7*Y8!U(&/(8.(KIX&1IRXM!>.N\GT2A'MM9
MCKS5$;!HT5OP*!>#4WS.9ZAC=E'.J^7"QB&58N$L\^S8&G#X2*4-L4?".=/Y
MHK,2!AXT@41_E.HO*G@9#\QV[83K^I#M_)+]B;,_P((<FH%>7B#$N[Z#,K>4
M/P0OD12\I3&8V?T&U#<D\RNA"OFB=:?4CKT0M^\;IM=%?J@8QU*S6(%-LQK@
MMH>OP*$7$Z1 5[CY(5L>SJ2O^T^F<."K%]%2%^E_R-(?NM"A$8^I'T5FO4HS
M'LA1S_JF8J T:\@HE6CLG#H;FS]G_P31HROP._Q7TX9%=E5PJO4047+"1!W"
MB (I71P:C?-Y&6U3C08/ -,1."OY O_Q0US0G@#>3B$B\-,)5*);'B.\EN)Z
MT<4ULP@B$O:$_@'FV'KUZ]C%'B:[W<>5^O045"BVG:"4DC8 32?<F.N_!7!H
MBJDJ(O$RZ%GE?/$_/6J&"E)O!IGZ>@!+!1\ 1L$M&=7'K:R_2R5H7C*@N6X$
MJKTU'K0X\W4;D3_9VP7W@&( OE@@./%W3ZG5Y.I#7:D#3OY567D\Y7QOV!$/
MVWRMM]G8 '=7GZC3Y^Q2\4297K &\X]WSYE'QO_-)AYG>O-/W&N<@\QF0L'B
M. #DZ3,K\#3_)B'@J(?J-D'?4;"'LI-@@\6C]7)VF@-00!ESY7JX&+1)[(LP
MN#DP(L8Y]I$,RN@U\GYSH_!.9!T.<66#5T$660@6N6G?P?597V%:B4Y&FL#T
M  "413E^6I5RI9\P*Q%4+#8(WKGR-/9<Y>@A@Z$Z\K!8@19:H*4UY,ZD:V0N
M;V"*\*?PF#(BAAX)H&^U=3O.;XU14;D6VA# =-F35]^^>CIEPY8NTN4$W,,)
M4%R/>A4Z65P'[DT3!8T+G&&&X,4X$]!5S;5KQ0D@'VLG"$IZZ.L8!1E&>(2.
M"#%@(^HZ#WR/@F_I^2%'Y$P<$1PL,7/+ 5H.T+V;D#A!YEWUU__Z^@P>JXRC
M"8=I](7$T5=6.?IN9RB#HI5AOA%P9!'R1<CO7LBOMTXGA"),T@:!]0C/;XAP
M+I30JYQ#]HO0RQ3&B:X""V=;/^16SHNF?V7L$R!94B QC@Y>2,*$?QPXSO<]
M*'G-+)?=<LR68_8!PI$P)D(3 1T)<L>QA(JSG3YI8+G=\=O:1(E<@(8K_@=/
MW-5)86'PA(RWX*1C[6BE-H%B.4?+.7K0YP@Q0LO0= 8.Y]EZ$+"7'!.N\I12
M;0Q 6QXYJ;W6L>V1R2OH2XK39J$[&R/Y<B2]VU)@RM*_-'L^9L]&+MS<A^6,
M+&?D?LZ(!O\4Z;MRC_:?D(6?Y/B3N9OO:W(6@5X$^GX$FG-'],%:FY#VVT-7
M4@# :"R!;C"[B&]VUUFFUEO''6Q]*1W6Y,:LFWU_ Z/E*6TNV"U7]-F6Y)F.
M$TL. VWD>P ;2Z/=<CZ6\W'/P84-H;:?5<1G$JGC9A\_LBYA HCGM V<H7(G
M:M(W!@HYW[1U3&[(5=G+ID&;5@WO"Q[63'BC:37/>T2&J_3-AYXK<6(\WG3S
MNHNF0PN^DPN[6(!UVF-MXR]SB+9RV9/5W[[]_NERP)<#?N_9@VDF@^28(K5P
MZ=4!;1UW^]R.;>2F VSS)7\\_^%<6Q+IVK6"(1BN2=%.,NC1>YS,'5+N+@8*
ML(35P\]]3#H&#'@,A';KS[YK21,T+1#9EK<L*N42P=&/>APU6.,/+69X.:7W
M<$K5W>3D'J:GS+)(2S+NM(V,CM#"I[I(\ >Q,[Z]VW"&@9(Z]WS4Z /G#AK,
M")_BI5;V:D^ZTC+R6"#-M1^N^POLT"RMZ]+L_,B:G3][MC0[+\W.2[/S,K'V
M%^[-MYK-PSQ536VP)\2 ^XOFRLUTF6EV@WO%A =;4.>AY)-@OK7K4R>GLZ<W
M:.(\$'U-P3W3]FMED9[I1H@XJ,&VHXS5MXG;$BZN28IK4@U<*4,DJ,!RS8?$
MG=S*G V&L2.^[M#X$4@8#9INQ)M2AOY5Q63_+!?QS<.HST &Q%$>=X#;WYB2
M&:FDI7?O\??N 3!J[=**PH[Y02.0D;[U!)S'@CAN+4)W].WA0U*YQ4EF7LZI
M(\',47RO,NYT41HID-'C"=P:,NV9!N P:SZ3U HG1NC6R&0X;MBH08H9K6F"
M9E,:TT>/8K2FOM(=#LO2,/BXK=P/QP/60[>9-'N[8[8TU<K*)<^ !Z5N'/9D
MO%B:BH.0=L&'5/L8LX5I%C'0*J_=16_=Y?6ETO7' DKG:7HT1$J8::>$X\:Z
M*Z_<:/!YPM8_/_A\+:EYT%_3R\LVM+>8,"\#WJ=-$ (@40F^54N>\/;X^%A#
MG=!+YE18V[!=*(_<A9P;VGT%9WX6).F@F.%"7(79+L";9_?E\9SYJ6GU$QK&
MWHAGN&[B#*\GA!EWTL0IWO/LFZ%E]<2= Z,U'(_,B,&D3=<?SR$)W?M3XU\>
MA2?PL;KN+U%+_)HL)WH9/WF>9R^>O?@T-R*>/[SX\[/SY]F.Z_]2&E@5G)'B
M_X=2 Q:LC_M/89D[MQK:P'!RP2005TY*?J)72!SE=+W?Y>3,)VVJ?,@3BNZ(
M3:)B]NM:09Z;LNUZ3YM!STV/^OF(Z^(W6)RG<O$^.NN!:*TWC?,413@1S.2F
MH1/73%R@&0UH2OXFS^Q]0-TCH]9L-N"]!#5/8II.$U/%C)6!S&=,E:G%-%(H
M9&U*&$]A3T=^_HCZ,D ,:?&KB&"';$8SVK(C0\$1&K,P0ZVOM@TCXNG3^Z%E
M_O3HXS&+R8E*@RWFFN^F)@C-6DPCO<:T!&G:VC.]T*AI:U&<#UEQ&K>)\&1+
MG[FC%>[DQ3/733?L]N8%ZMPE1#*"_&;CVK2M$Q(X&PU1K/DYY50&$G]X=&%<
MS:KLY&RH-I"PQF.LV&1?%64%Y63GGRXD!\*$_+A?4'P :8+7W$#X-I8G1RQN
M)&QJ(10Z[H!_6-WN2[/[4K>[2X!DMR*G(_>3SY B -^=>LS"7&T,6HCBVB'B
MMLZ3N"?NB4\,=<1YK4:2W8/>==[$3K&F+-.4E\/Q(0^'$J4 V,[G)!Z+Y;-I
M;(O8M*TCEVL1T45$[U%_:R#4B9).4RCS\=(XUQ*HER:(ZH3\B>ZXRX8]XH.A
M7Z1\D?+[D7)Z12R_)(="+L+5E)4$'L!PGBGH[0295YV.U%MD=Y'=^Y%=ULNY
MC:86S=J#LI%4=90JT^F(ITJ*OMD4[:R^4W73S,Y,1,N$G!.$\HBYA6D!Z9R$
M>D3\;H37PJG@OS**M!/"!FT<\=9G3_\X"]DSNP.OD9O'=3R4]=[N:)V7\J/E
MRZS!PM<\8W*)I9]P.<P?#*CM3]QJRWE;W]$0":6KK\JVJ;VWI1!7_-P.U2*J
MBZC>I]T1]2RFAW1S,GAKBGXU+AD;^\")>@KZQ*_<1 5Y$?-%S.]/S(V5=U\(
MH::.U=,. BYS2E%U:LR>M2;@BQZ1Z1L5[#JBR V#^5X="S)X8^,$:3;YU3-/
M$EH5Y6XQ$LOI^8!M.YBLFS1'>UQ!J%TWHX+W<55<.'>DG& @ZS@9Y1&'FX@X
M7+ (_9;G&N_"S!V&/0 -(8-EHELM1V4Y*O=C:&P\O#A%BA7;NJ+BSG^*;2/8
M!/)5+>,MZ'':08OIQH3O1TK%A36/O,Q3R&Y5T#>?1#Q3]4'8% X>1[<K>KI;
M]Q2G+@SOL>Z7Y80L)^1^C(EI=(QCV H9L\DU@V(/';_TJ>H"23 39.39%E@2
M%)UA>8!NW? <)KI0U]2UJ^)$F/_EF/=SA"I>"LG+R7A0::/]MFAW=&\*3*26
M7*XLTDBH+NBSF[;H^G8 T\YM)';I77X4O<O/E][EI7=YZ5W^I;W+BXE>3/0=
MY!'''4(7#F9YU!JT4.LLDGG?A9R18-Z.&0 U',PJGR_5S/+A?/2M$J_YB6D]
MB#2]%S\#+E) A# CW*H3E%M9"U N\Y>[88>Z@[1)6E/K4-OD2*6?%&Q$7[RC
M:Z)9-6Z0\HT5,B\\'EZK;:[6:$[K+J1]0U)0'F,1.N:G)"5I(KU%ZWL^Q2P1
M#7],*"Z,H'!Z=BB:5I!YDRMT*65G:!S!M,A"_X$>#^R3K*OG9JQ1Y]RX+>UV
MC $@#JQKB9P"Q;MVH>)(A@[Z[*4QI,97LG:S>(YZ> YF'Y:&G#!_@3QZ;M_G
M[EP\2:YY>C!>2((R#&$A3[EN=FRU*G3W1+7>,-F[.\5.,$%'@!QG;0D;%E-=
M$X98SK$48);D/%G![(QZC[$.Q,HGJ0OHPPRTD+I;-+\O>O+)MD#!.<GZ0^,;
MG>.-3"R?N$[#(7IU==1:S<E8;I\24@FT6)YXZZ1KG::LH C06-Y#U4@G(PEP
M(:4.X8Q9%P=2LV=K;@Q, ;OH4>0,M7#+G-I6W;&TQ;!S[MU4 Z8.9=\45TVK
MM+@C$0)]M>]V9%U6KD,ZVP5N&NNF-?*!N-,4?8S6].$;8MN)0>N<$G\</88+
M3<OLGKTA!0/;<BQP+)'"J[0NJ\$&_";]S5U/L?V6ENM:J:.0157BAXC#(FI/
M'!0+21:8?M%M(QTQ7\]OIGMC:]*3X31 _8FR7HA2'K>_I]IP3A%:]WB!D=!.
M6-)W#L,$8FRN?&J^.IY;- GY*J_8"EI'^A%)2IYPL$>%P$MNOP/0\*GW24:S
MM$\UKN<R>)K<'OJOS55[WX9U946Z*&O?>2\-Q?#_R.5CZ_CWYIH]T5P(I?DD
ML8M0-V@T;I5"10TPNV$7@;\L]4*:$4L[<[HT=70(O5N$J?9QWX!>_ZA[?OQJ
M8PZR\$I(0MA*EWPGO)Y G"!><*2.LN::'.YN6^Z%WYI4DW\LJ#-VB@T>(<MF
MF9/WZFBOZ:YKV4UQ/QS>@Z\LB][B05W7KC56.?\QWZ^MXXC8,<8((]-W6@N+
M]>?D9J52B$C%'-/0O>UY!F;W50&R/)N5;\U7S07#,;J![,%54[&3?]DZE3&L
MQ?:&&T[I\WTG[J2B4$SY6Q <514Y2LHL?I(1:9W>ONB$(Z8=V2!9X:YXIVA(
M/ 5",OH(^2&='-%554AS%3E@:QZL;E[T[$Z@+["H%3N?,D7<R CA#R9K 14O
M_R1AMW@3;VGPXE:8:3OW.#RLCS8U,1NS'9-(C4A/)DQ,TTZ;K9.R.2V51SPF
M1UQV&JW&&8>Y*)'UXVE*NQ%'9A(0/@X)7F*$V3W[6]5<L/JU/(9/ABG6-F"=
M-"0E^U'THOX10" 5LF\8S[Z"->J,TS2/B_')((J,Q'KM!%S%1P!"K0F^#:T?
MB2?.$^S8NI3:2+4N.9)EQI- F50@FQ49N4 ;>V2>8V"8 &06^L7?B:K^+G5*
M4I^6'*MNN/BWYCC13,1=<@PRU(&2HUXCD_2B&ESBS9UGW[NV;-;: KYJ&W]N
MKEWQ3B:@M:@#=)VUWTG)V=5N??((V5HN71-.4Z2&[4AXHD6) OA1NCRDSN&S
M<[Y9\Z=V64E<>H#DT69MA/,O#@1&\;=020:$9K)0D$1R:LX\OX+6WO-F:7"F
M6TNW)5/3@C4H''ZR5?VU<Z/9-:^V=*IU?@S_H:DO&[B,7DG8U]X,M-T%OO3C
M.WJ>VL718MB/CI2$9<Q^!HY-V:9CY]]\7?:25R.*)LD -UU( -MJ_^@O$$W&
MN2Q8'49AI-"W*'Z5WA<2BSRR@36:^[G@$D.NCY-+RE#>>N4*L>(>ZYK'JA:/
M'HD5#^\2Q2Z:=@_X:HWA/-S;+:% 1MYV[=_HB(L GD54S2"ANY2@MBVN&0_K
MI, 2R-G*>C_T(;\XFQF-<_9)6G=&[F6!:3R>=7L7XO$)XQ(+0'R\L1W!GX].
M3G+U[="O*<JTKEW^$A<O!]_F3K')9I,F)>17(BQ"_\6RB0+)P4=IDFF=D*.Z
MY++"#WW"#3<:LZ3?KL@C["I-![1!2LE8UK>^'I;ILWJZ9]I=TTO%I>R4?HS-
MD_1>[DCU($1[KYMIB<I= F5#*DIE3O2AFGYD(UF-NG:D6^-"RLO )@_Z^)VD
M\9E<7,GEU?H?VWST&W5<Z^KRR*_Q5\]CI\#K#=5[&KA#EFVPL<'4IYR?B-5)
M8F]H_ABJSH$%A* K-;@@&[GFEW$Q1)W948E,GEY"^^A"OKH H4.601]^XXV/
MK"'LG24ZR'BD-5!HI+7K5FUY09OJJLY=(Z<$ 293BD+_LR_?L G]1K8<OWK^
M):=L0""[N.'O[="]-5/RBJR<D(/Q:WK;#KL]:4CZ&BI/6A26K"!:B)(_013@
M,\>%55-_7& J.Y ;]\7/>:2Y-VX-F\R2O"I/YKCB S7[HC]2+Y2,V8MGSS_/
M@V-@;]-G(Z=>*&WT>O:-X3+V7LQ\:[8.1$/T2%L%,ZR:=M^T5H5F&M*K<LW5
M%GK=I(LX0SBRN+-+(BFI=$)@PC@]6IB8C8>< UA VX\-M/UB 6TOH.T%M/VK
M!TY]#!976D-7!0\J*'>[\M)*P63_HG N(H^!*44X]CT99BXL]6(!V8E]_OF7
M'7NQC8RTW8GK3T:N[A2%$R<JU'#29[_BZX"G&Q<LD1#ALF,EN?<IVZX!H;<Q
M$N UJZ&3S%0PQU?6K9<^!.CS7TUY"HBO! P]2E3<[%V.YC^-_H@(PV/@#!>7
MQK;R9W(O=PV7"^%@]ENKLT?YG<LX]<RCB4^EB',*41P]57.0Z<31V\ZS6 S(
MURF"<X.;37,'\0TW59 766G!R34*M"J>774)%CSR?!@X:-%9Z%,V]I8\%.4C
M!RD-/0$0OD5B^IR"Z;ZL^+[OZN::'#[RQ/6MVL4Y<MPA7K=1R\(E-O$Q^C<Y
M<O2CO"T61/>?08C&AOW655X^:&UMK_VCDK>DN\MUO<B&3%&21T=BSWZA^5+V
M3%U?(B+G@X@/52P1?#(B0"CM+!ZTW.3X(!"7 :=0.SKQ K<#,2:))R,;0BI!
M]M#+^6Z)/G\!4,RQ#SA*( :H6$C25(R(""C/DFN/'@(<C;I Z!B$.^Y"EH(-
MQZYC8(C"E3=9MRU:%TO2#M1UY+4@&ZQCDOCO["9<T,N7,Q;E-H.D"MH#Y2C4
M/L<+NFQ)^$9I(AWIP.R778!?TD7!T!\AX)!CCYM'+>T3L'+1K>1,()7"?]&-
M76I/C]L'^2X%1$J;P6CDRHXSH9!HF1JCZ!X,UUJ/!RM) B>*NLOZRLG<AR[N
MP4_T,(MQOP5.<]_(-?W?O!&0W"R^/=2*K3+8-9](@_WG1@V JD08CJ6(X8J_
M(GQ0@3 @7E48@N<Y"DZ<&4T[1Q4LXYV5G@L43LAVV_-,,,W>/)="JS?1MO)T
MLG(#6%>$Y[9G#.,Z\*YN-=5"^S_@\_UE/@^Q=*PM'6N_3N7H0$'&)?F)0"2D
M39M ZF+Y3\IAUB)U/,IN199J8>Q81/CN13@V%W[0B=8?W8WS399A)HM$/S2)
MGHD:QO#B!/2&)O=%.!?AO&OAC,("R\R45S):$'B.I4%]=@CJJ(U9D"R2U]4C
M/XOZ1C3GI)'5NV7\96X+Y6[F&&VK6=2IM(M6Z2W@  +DALYF;NA#"CI"\4FS
M<VC@F6FG2"'M!@STTZG?LV]GLI]0,Z'<F^K2"K.U(^9^)#P'IGJ_>)BJPXIL
MOB$2T[YO)W3K&*2)/(?*<0!,?@=0B0(%Y>PFHV1T51,9)\'<C#III.,8*<>A
M&Z6_#:6I?39A6V-@86BS$7,@C<R1E)RUUKLYFA@DDN#!2PF,&5(#GLHX%W8C
MAEI[\2<::HHZ%O.0XDTS"!%5H,?2Q59PNOO=WU6;]L/N-FW\@\EQ1X_8R1$X
MB"CG8;PE_3Y-F2#59RVJ1Y!72:A8'BY*WO@MOI:IN1!/II$;)_27+//[)PY?
M*A0Y 7=*EMB2)T&P.]=>(;U,)H>>E(<@>FBQM!!SSWNO]!:L1NM.3YV0*/NL
M[]IM"J& ;4E-UF?TMAD)@P":#G"X):/WRG[PGAOJ?@*N!$QPX/J4$BCGIVHY
MED-2-.6_M3X1CD\B;V7?3:$1C\9"'C<K+ E8M="Q/,0RL ,L=4(6\B-)\)YZ
M,26EP,/I&YX6F/RDN,286&:W*D,!^(3(2\_8Z8\(]TR%Z>3126#8[K#CXEMQ
MT0P]#*D=&*M5OBO9SH<0A;:K*EKK*)!2KZQQ7^B8B^-JKP'3Q5WA]^/"AK/T
MD[K?C0JJ; C 5Y-=-&V+DA*W1Z+[FDM$]?A4TJ,X&2[<;R?^K.\@FJ%$:U0R
M)G3,C<=L5*Y>:V?OZ#WI[:%JDCLS!%9&,Y-WS\0KH$I/;Q(:[X*9TWJ7N&SL
M6/TVI_=WY&"_3JKP&'[NFUQ"ZQC;ZQ;Y> BF BL*] DSTDFEDE$#?/9][\Z>
M9WXU0\="P?YB@@N)_4D6K=&=+D@!7'MMKE7/]#.18'NXP=<\(Z,W6N2W+2#S
M=#Z_^?KU*SSC-PJW?>/X/+OLJZ9HUT:^5#<<%*R9#T^J*((,;[@)FL="TD]_
M>/$9-])4BD&O&N8O![IWTI1%WJHU:G.1E25R>B\,%C!S/3[M,E+,)=U4P?NK
M&E1IFCII]A\?*CHP]$P=O:&"&T1(:I2=9D4"VNQ(*_!+6;?%=1$WZ 3M@DB*
MKSRST V*MCNW9DZWZ'N8=_#SRKFU15Q(?/LUZL8#_<. EHZ9%"Z'@HF/G#(I
M_-JWC8J2O595$NS5TGGI\+8D"AM!:^0G*')#\J]HLT'>L]']N2CJ=UWD1!\9
M*E@5>82#\C&MN>$'[6*@2*JXND4Z[1C+O\!I'QN<]I,%3KO :1<X[:^&TWZL
M[EGBN+-9[R010E9&FN22'OXNIJ +S:.<=-S+V*Z"*321C_%&SZB5C,TB)+I6
MC+GL4UH,ME**I_')(^_\()#3]!5MQ(EPW#HQ)Z+RT'N7H$485&8S4JW9, X,
M!P6XSG@C.G))1RO#V[/'"_0RO%'QPXK-U.CN%N&B@FG1 "R1(;P8;O!.VB.U
M@RA!Z2J/8-_Y3$MPF1C5U'-GM:QQ4Y05EPUR;<3TF34-J3,*^W3F;)=!?X+/
MJ^&$XV'O4J<MMWUH8N=N?E/R=.)/F[1=WBZJ'K-:=$?1LR%,E1W5\C4(IG7J
MEK22BL?Z'E']W N1A/%\.NK4(X7[3TA9^&(3 <:2@YM'/:=H)34^*%MDR*H<
M;=U[92D>!U_,QZKKWV+0KD\Y3F18E2Q,9)4NA?;V1L*/?E[/C/C\E#Q 2CS3
M!!7OET/E;[Q?#E4/X4@;\BF(RFF60>P;U>Q-5377O(T+NF^IU=_5*013%V>
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M)PJ0!&TQEZ*HG/7Y,^6]96XNC.1@X+ZQ^' <)@\$V93+ CP"F"2F=$%6C%-
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M(_IYJFNWXK I/)2D\T8;DN2K(RTV:TB7([L<V=]T<HY9UHN#VKVTR,C'A[Y
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MTR3[MG3TG0._^9[9>O(9 EW 7J,=M-^7,K"XH\6*$N.'FF=Q>+DBQYL=V.I
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M>63L-^OR@TOV;RT<!3*W>JT9D.,2-'@$H^NN>"*Y\<&._(5UDW4-;LH##.#
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MM*)@DXR!;[3 )L(738.4HI'=DEDYT4=A</\GX4ND<VG3NJ>Y[TH(4-X$&5,
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MQCD=R5:N/2H\15Z/A#-P:.BTPB3W;TG1(_I!2WI)!G.HHQY$?OE#=PITN3@
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M5!UE;[3J+$<CYNZ2)]#-N418TWKKOW"C"M:-'_7UD#S!U<>2]1;85L.)V&J
MQD>VOQ_6VRU1IN2M2*+ZDZ^SEQ'ZPS9>A)70)=@1'D57(!DR<G,:(;R/YR<4
M+^W88IH .PVGB#F6NX_-9MS*A09LS;DXO\9W0LRHWC9$8"@]$]QOC&#MO .F
M?/FX:Z*1(^D,>UBVV 5IL_?/V%$NQA\)<&1NW,D '$AJ65;UCB+>"&&0V$*A
M:['OS6ZX0>S9[]0LW9@-',TT51D>C/BK-A1X;QP[?S:ZL,:@V-O$(H:;EA.$
M_<Q.A)Y :<_+YE@\;+<JRXH(L<*]7C!^29X<J+>$TH?VYK*^#6070D3QN#:P
MI3WMB;>G?;ZTIRWM:4M[VJ(>^?YRC3_.\5 A?X035<)04M=RZ!SB!K)MC8 5
MH37]S9%H'7GZG#RD%#6<%#GN0_&*PQA)L#//1<"9K%W:#L\),'AU4ONA U^C
M#8%36OZ8XY'&/?U,:#KW<T"I&7@M]%#1^>-AJW.R/@VO'48LQ5$.D/Q7-ES.
M8B=59D)@HK$AB;MF.!IRS>&WA3H+'\4??C;;/%AABIIFP8BPUD58"3,K:/6Q
M&,TGLA+V/36JT95P%PXDZ#O:IBE7;G6%>M]_E[.#G4MR9V(A!L9!L7%N0AM;
M^*CO=):MCEEI'=/3C!:C7FZP,)ID 2'+<=]%$Y*1$PRY@T!2&/MX,,PS$^]C
M+V.?,\ =6J23-'ECVPBM.IK6!:42#W9%RMOP)K0+M],O$R-)WQ684;YU2#8'
MEG\B&$)JKQ$"49W%F8S):JKL"2^6LI"UD!):K,D]IEE8/CBV9@N@L5E^WY"A
M2JYM 0^Z2X-QB3N.)7V_:_+](49F,OQ0LXV4>64X)\P9P1A@*X\WRPYF5@'9
M]!MPA')RGOE6'W.X]L&GFZ@,JAGOU*@36JL42,5;GUTT]6T55B)['M0O,03?
M0'^8LL%91(LS3*N50OLOKO8;UU:WPXF-3LO\$VF*EHM+PP9E5++2=HX(!-@&
M.L"I]FR4%0@>8+$!3\.@%W?\',V5D$:5DNJO:LG7*6D#H4MHB][GE3;SL"WP
MEPTAJ5K=$;*(E;E.9*N:/#Y:PLH4[?7DG3?YD6V_8'CA8&GN&^<.L324>/!<
MK$3R$=>C\WHNJVK.WW"J#  X5+0#RE=_+U"<Q;=^VAO_Y"* \67&(KF\[;V_
M=<^==M8N?\.*^)F+\^QM1Y=X1=F7FKQ&.X3!(N05 JCG@&5:((^F3"N$BT+O
M6-#1@>>C6CYV^ AF!/;#3R<&%UU.5 %'C.='.A7\2R*4K\#:4K(/?GY9CJ)!
ME:W\.O5C[AK5\6D<T&U3.X"?3N\O5FX!1#[J933:VFG%."K-8"---GH@%JB&
M/%IFX Z<6V<1&XE&<6>=,8J)&B1:^#AHW)[<I\!L6(IAF^4TY\</HK'OZEMW
M(QS>#8=5:ZSTNWE=XA.C#B925<- 9C!T)*DBRY->:^LWI3H+0MDGLS(98D/7
M,3L"<4."/P6'%%U-"Y<VCNZ/$M0KKEF#U^0DM<U9(\[; )+&6/R;ZOCE5T -
M=$WM3]T;)QK@$^O[[)T#PZ8^!XJ6^L[X AH!Q@(9S]YUOAT&W#.!F_^S]PYN
M#.#;Q_CU"ED.*["@DAZ,0M\%S)QQ.+Q1>/,E"'L(LJ>,SSST4P G+)O=*%A\
MRZU C_9PKD>KF/<KZF9F"^$23%VUU\71NKX79(DGL[F0Z (?W":_!C(ML3A1
M'_CWY:M+\ V@JR-_(N:WA';WX0H\0Y)[Y@PT_;>QV7$?G31E4(.C>R# [?'Z
MU!(ZKHI8$,!B6WB>:'Y/14-67 "739ZI,,0>%4](A@N&[27*>O([IE8J1@I6
MDK&*U;&1H13,'$WV,DI+1:<$Q'SKILZWA#>$>7)A[_U:YNK_RYN"=+5V^49$
M=*%TM"M[A(&WUPZATCE0D0Y6;X(E9G!8"\V=A?$LW<K_O=W*B>2094.*,@]G
M%I*&;0LUQ&*K[]]6[;ERW],DX$2I[DKP$.5MG"ODA/:#&.:'*R]FOICYPVS)
MT3F#$?M@T@%$#K;BH%HWEU^A_$]>(NF7&O#"Q[A8\ -1H"0E],C9 VC'O8V8
MBQX#.-9BPXL-/] N'-M;N*3M;5(P28!(4;5%&FX7HUR,\M$9):.8L8?F6VIH
M)KI9PF48T=\AUA7^1K\N"=)*;L=1^^7/7D?U$Y=]>ED2#QP4BNM0YM29R="1
M6&UI7=,I0(,KU=*G"*8-71PV5]]WUW6#>M!BOXO]OG_[!>(YMN_>YO@-\A54
M1XI)ZF#@0;$2/30PY?N8ZM(6^B3:0O^RM(4N;:%+6^B[MH4N9_-R-O^NX5;G
MSV>&+PH0HR"0';F7&A?-%A.T92U@VFXBQF-Q+A<#?J#JKDAB&'A'1+0!0[E4
M"A8#_0,-=-C-&P@G-U0#\#YBYLVU.*P)-1PED)J"(IC (R!0S&-^JJ7RNZ=?
M5_R#):A?S/I!-9"*DD)U,#HG9%4D3D']J=U%O;LX^D#$!4QPOFZ52$L-?['N
MQ;H?H75KZ$DYJAM7%:$6P8W5M(/[GQ:H^((WP)#!LC><"[GMM.NA'!7!:38E
MA47%9;'QAW), @),]W%T(\VW%RTZ*O/R](:GWB_Z:^BG2\L=H<F9.05S>5@W
MI[HB(FB_I 2P#I;A8RG@5&V,]6??C0,&/ L"*5RZ)$]RVSNEU''^$-5VV;:&
MG@+WRM%OJ'K9]DU#-)K:P&BU= 1&S\URVFB+TBEWTA*'O[!OQ[HKN#ZKTXC(
MALE2F#3'7DS9Q9420V\X_/T(3</MB:VSI5CJ11ZC&".]RKBC9+XOCC@$[@$
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M9#U [Z#<_)RU1""5L WY,VN3(RO8']6/G*<R]S$$B$_B:."RVR%E0V=<@MY
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M3)RQ&N^G24$W;IZ:?_#W/]2T?&D(7& 33#Z2])G13O//Y!_M(&48?4(:FKM
MLJ21?_3'Z'!K6KW0#FJ2]!+W6>*+LNZP,,GC@.9-2-%Q*41:,YH0,V<L+Q8S
M?8,6CN#4D(-C/9XH#Q4$T:[S;7P_)RT2J)-93(BMJ$-FM7U<1]M&*-\'OMO
M?.IWO+)TLND-MH>)+9@I6>G42"+YC%.8M"VQ0LGTWJ$!5]\5@;AA L;K#V3'
M:E+<X2-)R]9->I'H_Y-AA<X)4VY*L/4<LPB;QI'$ <<V/7\ P;P3A:6RK&^E
M&5\/.I3Z5*.T<7XZ*Z:\4LZ31[V#+M#4IP9-_=L"35V@J0LT]3=#4Q?&G;O[
MHP\V-$"74N7]O8&8"/DAT_5/2J_%BJ*(&MP."FOF0N@YX:^>(I_ (.6CF@$3
MHE\<_VCLS&J/7,6X@(;*(7AJ,:R24DEDYEI@A$\[)!H6;N?L"RJV<)=7%">L
M^Z+<2OX@F%X^5_.OA^D2BA "M(XRD=1G.>*&2S@RJ" ]>9'[WC,@=IE0),DU
M7R.5$9,.<?52G8^99B;Z"4U"U9#K,%H'.0[A=+.,!,SAZB>R=YJ3F:3GX=E!
M$UG/\DFC8' GV39*]YZKYR:Z[]X);7I120RA:'C>S#[MOJEO24TO*L1GVHL=
M:J-AOJ5$P^1%_+A:R-!;MU*[1Q36D#?L@\B-/$TWH?5G:B?W8+#;](W VNHF
MT-FM+'L%;\5&G7K.8J> <!;Q'6\:6CW7C(^[H-H 5?>)A"!D.1D19:M=L5HU
M/7%:ZP*UZJJ]KAOB=M7BUBEEF9A@-DAK8DR;VWL+ N, #IE$$9>?9\C3YAW<
M$JY0FI]<N\KMBCFXBQ+#2,?MVS0T/NK8[X//GB7Y8#*(;[^YXO_X1T]D9WZ$
M+]RVV-"K7%WMP?W\\3]>7"5\(-H);M/#W-0>ZE*:6A8AB'Y-*9,6%&>M4I=2
M\DG_4_; L#=T]9[U,$*%FYIXZPUQ/OF%=#N1#5?-<$J#."B*<J63G"&2N*!T
M,2H!B53I<!9>7,7*X5L\IS9!@R!7\<(.S*.=L#SP<$M'<O3<*AXN]Q]*;;$Z
M#R4 +U>O2F"M3/GZ7($^Q>:CA!Q*!@I-SSL9D[(6!%[%5/^]KT3VEN91BP41
MIL,O)^XVAF&@CANB!;7X(R)'Q9HY4F(.S"*9(AI;2%$AN+KZX?PUDZ(*6QJ7
M"KB;9F\0%\RPP2G9-$N;$DL&)]H0A\=&\M"D_SMT;Z]^TIRNE*!GL1?Z"A6/
M)Y62^ :(T&:$HP2RR6],;URG2LIG5)*73?L1;]K*^Y=VRX6:@'=\M7S9.-MX
M8\7?VDW!]=!-I@9U80&> ^L+OC-YUT((RP)W\[;J$H?Z-*=&&Y'EUC4<=_\I
MEP2;NC\Y"N""6=HY[O5F<Y;-&)7,QV71"PGRVT?Y4N> ]VG*1#?^,EON;)K?
M-:$6F9PP=W=E@F@IZ%D2"I4\='9U%=P4FY-FL=I++N5)[[4LZZ)9@.0%*TP_
M&W<N]]2#Z%H23$VV,4%VRH:+G==OPBBC<@A(F!;*T)$^FH4W,M(3>]VVKM"-
MEC/)4 JGGH ^!_GZE3\@_.1:5X)9Z$V2A-O!--9N>7\V!?;!)>1Y1H/AP>M.
MSL_VN';@Q:>8)P1=NQ)U72O@/8MO)IQ!Z)&<R&B-UH:IOWOK&FS? \,BK^7:
M^5_5U-UK6FIUPQY9GA&]35CE?(2RY;'#$P)MP/$Z;UW(> S1&K<N8M "'W%^
M3-'Z3*Y,3V9J]A9\'>&L+& +]NYD$3'%=U[1LMWW>>.'[63$LNR'(JV3,S)>
M@YP-]5>=;JQ*.D>FTW!)7U=*1V";8)_&ROZO\Z/>C8CEGT%HV_]5U3470I9'
M^H[?T8M[?>U64[+29M\N06$@++U3]4'9MRV RJAV).W L?]]D.R?&L/[P5DN
MKO(?OO/^;'3FJ>I \._R),E>$ 2OOO[A2@^Q;[]!9E51>09C;I'%0G&9-^IB
MG$G 7JZNZ ;9^++P7>-EL]6!SE^ATN#6B!;P.P.,3WD=B!U461.$W3,A+*]C
M"2KQ3X)UARX5Y1.Q?"$ =FZXCQH4S\I705RCFX@:Q+"1^M&QVS69"O=8/M9!
MT:L6L01MC0[,)#\[ ?%SN;,F:"OJ4.>($>@5@>0[8K@3#X]I.- @.]X-_#OS
M[A-&J@0/D_M6WEW?YJ<S&<M(*BR0WDSI,3+!/8+:F9AM>>-3FELU.Q,Y\8B?
MBF[6AQJQ2#Y(9<;UE(HG$[]_YK@HO7\]@<@&7-OR:'/KW5!BE2X8]6'^_IC-
MPJ!9_1 .%WY'ZBX<TV=C&'ZB_L^, _7LRX]2 .O@F)I$JB+N^ H6<D%W;/].
MNCL$(QS94GP&LM,O/GI4QO7YY1=_\3OTEW_]_&_/_OS%YU\\^\M'7]WZG8DA
MH7]_X]S1#[4<0B4Q3V<FAI!X7SY[]M< Q3.P1K[Q9Y]^^M'@JH]EB=%V/$3T
MQP)7H@2#T%"%:63E,1A&UQXON:^BP:; W<5P%\/]W0P7/.[P^O:-8^D <J%B
M);MSC>F>00F6_(/G+W^<:H5<D<*80 /XEY'$@SO)O)/[BW"81'>R<ONZ*XS[
MEE.YPOLU*9D'=_UHTJ@[/XAE_2SKY_VOG^BS!Q<\[S@TF3!*PLGY,7__\FM(
MZG1^88 Q$F&?6RQVL=B'V/$!@54,,7=^"NL).JG!%\S5 &3B4SM>C'0QTO=O
MI-?Y36$8%Z.?/#1'Y@-!(R6%J$<"(7>49)'N4&K"O.B/][':I:?Q*?0T?O'I
MTM.X]#0N/8WOVM.X'-/+,?V[V=E4W*W8>VHH C5Y(SP<:$( 8JJICT?&L2@K
MZN)9+B;[,";+APFHEJ:S1MY %SM<[/!]V^&PFY>PKT!*"]*U8+P= +#"T*7P
M52;PVOSSQ4^IQK8 $/])9)>O@8A;_40$GZ25^?'FGZ]_4G%JJO"?I.1]$"YC
M3LM>K$\7FJ'UME9PX8^ZA&SC_@"P/5@F2[U5Q4+G*JZ[U?'ZU/KWG5=M@H6F
M0E%)%$I(#08ZVQ$-D:N:6M0X-$(>OY^SVBBKLG ]4ZB[=M,4:[J8^[7@!JD0
M04N#[*AU6+$9CLPV)_XK168 I<&RL> Z*A.UX5'X+F"$MF^/0O\'^60E8UV?
MO/%Q.>'[EU]'( :IK19='SK\N,0 UD]Y>.(E6SM!<=#S4Y\XVJP)H7*HJT+4
M[D/ZE;5+PB6 CEF?+ 2'FQMGFAH%B)NGBA(L>!L7:6!*KW5<*2Z,9Z5 "<;O
MD+%Q9Z9;9S5LI@C=GG17+M=P _G$;:RN<S-(4]_WL1/8+E[-04,P$6K7>U[[
M6#2S@'\V(K5QYH-#TPC4N+E)FAH%XY1MW0%=XB!@U4YL=C-9-B8?6WMFFS'W
M =.)LJRB.EO+(-NP5G:^"9^4I#I##Q/Z_GL1UQG0&:3S.T&MIJ;-LY.E_0-1
MJ29\#N+)P4N;6]79D.$MM$R>0P,I<ILZ-%5(?8!_)OQTPUKBVD5ZX^B1];>!
M;F!$FCF),9G$D-.E J<_2QB RJ\E%K4M\5_8!QC")T>X3?KC+ZX^$K;K/VY"
M#)IK\ $=GY?2A!<>5AYR@38]YJ/V%23*IQ%S?/P&-0I _PEAV;9CB752IV::
MVM6Z('FA8C/7(%=M!QOK+,VT[**A=7UB!SVQQIQLM/<&<#+)JQ"+",'AV?92
M\)#HP*B_E#D"FK[B(U:/$2L3\?R;%S\.B7"+'<.=WXR@DK+'"C_PM,\1.]1#
MMXMRT.AA:&EH)LB7)P0@B7BW*;;"VA((;:?QE]3.0MSX$&4A-OEE=3_BU?W"
M**.DA"U$7(#3LW0YV0]YELQ@8(E._0ZOX@K)N3JRH0$MJ%Q46'DJ.74?#J+_
M./M"GFCSSV]KHDX88D4G<<H0SGA8'*[?H_$>1X':FY)W"\\+XI)PMUN$E_R%
M42?A'=)\42+"=+M%PF3K[XD+E"7,'<%#G.3J6%I3GO:6^]J0LF616CXY[,'+
M16E(^B]M"\C@0V="G**T&K;YD0PE.%=1K;&9P03&Z,R&HY%+:<8SDOW_WY>O
M+A.5NK[R U%- :PF&_XQII C2?ZNQ GX3_1[T$#1L$,A7"<]@D(3<][EP5A8
M%(66LKIV84R1YN@4^*T#01WB\=A\$=1>I_<3.Q-^NO&<O_B7UFZ+S6]?GXO#
M\P"K3V(!:RDS+Y@0M3@#,F56IT,CD(*=;T;:,47D::*18VG;6(HP'T81AB5;
M36+()A@E &C]$='N\B2/*FMTL ^?6:XGT3,\IY["1V&^<ZI?H;GT!1B\+(8'
MZF'RAAU5XNYEX*!C#+\A#M;02!(4,\80$&54;8Y$O*9+"Z49>#CWR_TLZV)9
M%W_T(4';>E+ZB4&'90H^O_/7?8?8ET-]+HN%PINW5<0$6]996HQ^,?JG<1B8
MY);(?;UE;G\Q]<74'\;432YSJC9 >1_0 D<A.\JND.<BNM.Q475CE 52',7]
MRWNT6D(0OZR"914\C0W?('7>NBC--R0*=L38L0QMV/>:=M4?:T5[W:*T?EJ6
MQ[(\'F9YQ"(9O)D .:I+@NZ*-+F!E+UCKJA@J$)*?<#X"J'&))H0NA<5%D>
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M^1,)DQLI2 <>PO2U& [NH[]57:T&7:'Q>11ZBH?)K><Z-S^YY5ZU:5T_4PB
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M\ <''DN,,Z8T.&4 K<+EC@(QPJTG?I \ B-U8N79)C(1 GA/A!Q#:HOOE!P
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M2K]-B%KV5&.M#H*9"-5;9;FK<H MF$(?.5;!4&:<L8H=66^%((.DUH9H)KM
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MR/9P6F>4^MQ)+4 J>B8)>[9DRME*U89/ "2F_D<5:N;^*@!-X=$>'!66B_8
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MWDK]5;MZHP@BX-^5I%]EJ82CA17D#-4+"S3(!-%7R<YD?FCY>M?(;5V4';>
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MDN2Q&L-P->D(9]^IVE>.B9'X@4FOZ%F9H'5(ACYT#V1QI&T<@5_KM3Y!J(H
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M$H;##MJS+:?)-$TXS@@*7@0YM*^98?6?_Q< BY,(/O Y/)QZD+;RY_Z;\FX
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M&4YH7T=P4RJP6H@XD'?7XB6<ZY>)!V7K6Y?\#&B@[GP_'&WUEL($9F@Y1&Q
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MH,KM(9##YJMNB<B?]I'PD[GIE]:Y#[YU[ENNUEF%PBB+R41)PF0XMC&F<WR
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M%_/TE,W3%':*HEI9E:P7VTC*A["(L;Y>[X6*R[WT)#$-T2!JXS2X"E-E90)
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MJ4^^#%OP:E^NJ_T+_.+3+U<O]U0SN;Y9V9_T(L=8JJZ)R$;XM6F_K@<&%3'
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M#3?>Q_#V.KFYKJR%BWT'6LBFHKT!$][&MGA05C#F *04G=PN!E./(PPN#+=
MK],N7$Q!&+2,Q_T+3SH/ON#BGQLN_H\++G[!Q2^X^)^,B_]079+7XQIP\"R[
MDU7^J&#/T&X!HM>S6&&5XU'08LD OK\JL!Y-:^3/,H],9=JN\ Y2H5<7 WI
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M\P^22DMV,?NG>.A\T#+.Z?9.WS$;?2O9V:G<!F= D\RF'TLQ2F7&DRW%FSP
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M:]4WWSMO_1[XG#50@7^B;CN1 '52+DCSAW5^A&H$[[O\<$^/G]0H2%-/<CK
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M&9XJC,0@]4SX7&<X1)!3DB:/N9EP)%<5+H0.-Y7 *_>:,NR-" -Y0PQ9AP2
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MA;A40F_ ?W<Y [YKXC"Z)B:^:\)W3?BNB9MV37BK[ZW^K5I],?68S:PQM<E
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M9"BJA#H3O)PE'*-WLAO$L,4")A,T)-.U"0.D!FUF3877TA,F>>[3UMTK2$$
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M#$)(V$YGG/0F?T(G^SU5SXAQ5>@*8KC*@HDXE]0Z0<=$?T>?-XD.RJ;UHRA
M!K7(<$9:)"\Q4>5V)GY_[ORYNP]OT,2M*(E9TZ8P&!+.SR4X:? -ZOJ$+VJA
MA^@4353'=Y@?$>-P"/$PR6@2W04265%LB6ECRF@[5*YR<+SP>^&_)Z"$G; C
MM,U=\KE!Y#;%R7-I"M:%^&K@B#C!#$YRUE*-2 @L!VSH]U#&H$<)#DJ_VB91
M1K-[8/H.\=@&$QU:(3RY=)R36),,D5U#JOZ\Y(-J1A?.V!(V<R>..?1&RY_;
M!SRWFH<-V6^)6/Q"F3.H91Z%&X>-(=7O\7%O],/X>YT2ENAJE5]2&0+'>.H_
MP?]G/61)P4G;E/\TD9_S33I<H?Z78?NG9#66*<#Q(]D/";.]5)*J;B:G;Y8^
M%>5P10;5120F&9GZMH) ZRS1'KG6S-3(7;YX8487$!'2#+_$HSB"FA@@9@D-
M%-<9=Z3%7L*;]J@8KPSNQX/%N;HSG$I889;%(:VG3"8+_R:%G<S)K9 R;XG%
M&.5"?*7LL25"S,5*TDB'2BSJE.PD'(5ZE;//V[BKD%IKI\(]E;;:1#,Y,'6$
MAMB@*,W9I&A2)F502!G( 33V&VNGB7("9%,=@>\;7NW\$MY:*OJDZ6B@XKI,
MX,GD'.M6:"82T)4B^%J]'4CDFYP/KLGYR#<Y^R9GW^3\S:/AGBITLCG=:1M(
M(]1#-,IZ^I>T&.C9\Z/!>%>(AF;H=OQG0::Q=\MX3-?X8NCJ##26N@N8031O
MPZ/O]9 2[8>['G_3QR<3K.>M,&O;-*'+D+=1"XZ1G':"+5CD!FQN/WC5C5[!
M]><K9("4<1M):1\/LPOJ"V&>G%_"Q1,"$2:P%F1/OR9,P!2%=N:IDH7S\J[]
M#F$P=*\'7B-II;B=43T:58A84YYUW/DXAP$=?*HGF8^6K57> BPPO!+@@[]K
M@!$=D.#FW&<\70UG'H%9&YYRV>VS;G?IX0A7"86U,A;23'#+5^CHQWH" B4$
MA-6[,ZEG<V0&.)8L5RK>'?&89!=Y>J&AWH)CXG$,!,.BZ6H&E.Z\']XX/3W-
MCERX&EE,C$DXT)H>M:CJC)F0-G;:X>/FJ1$$:K/C+ZHBRDK>O\,XXAX=?"7D
M\NN348(-+\UD=Y#>NB 3\)I&CA1FQ-:'2JY@CKX&<,Y53$8?'.BJ0%9DC(U-
M&P9U9YE!9J9@#,):+UED&^/7,96'GGB-0?U459=*96BDNP:T-#/I<B1:G]%1
M_";'GCL4Y"]0 %1!L,LRB]!N@B3N',VA)ZW3B);E*LW72OEYLP=N3A_@(%UQ
M.)C!M$@N.$<NM5JV0#AL"(W.M,AK0E\(,$$MHG3.(UOE\SB630;C!AC=PYE!
MFO$DKD'HD62GKM9;OS!+HV091#3&H:*C6"0$Y6]/0+PN"F# \2[)<7$TY/EW
M69,>K7>.*>W,0DC,4#FPK%$"1S7.9Z"D,B7=5-8[-P.'9$A2SC<IS?9BAB[C
M*EQ$.X;K2TTO5@N[\O,7 5$Z<V^%QIG6CB^7M9>K0D5SDE-NQ>&O&G8<6[QH
MTM(W"J@>*&L$]1O5-]Q>G!]\1$K2XA#QYNN*9.Z;?I4B07;F(@25\)#DQM#D
M3'9J9XL\F7'QAF_8"B!9Y3?2MG84H57XT\*5&E+]+87/XE-ARQM."3)VX0:&
M@%^R,0>&FM_)&;,?6*U7_&@HZW6"#82_\+M!#YJ+S2)P+E07'AD#8MZ:SIU!
MKY\EC3Q1V%-M!!T)*3=%9!&AQ47,R (+Y2"\--LY!?<T=?2-T,TF=-[ U2YI
MAJ=4XDEVQ"#C9K:?U6T*H P\1,(\Z(U28CB&TSQS"H?TST62JJ9V<<^(06W&
MO !F4=^^-?A]+(F1JP$^<8)L" TTC!ER _=,,7XOE?J\18BDSU$?ITRR%+%@
MT<Q4;GMN>NT5&>K>@JH9N",9#> %2>&A0OJIG*?0,WMEIV(&,_#6)WH5O"Q7
M=934HJD_>*D*0;>)&[=UD;JC@Y_G9E7/'5XV[6EFH MF>APV0CJ40\B(08-&
M<QQ/!/?5%!BBA;@(.M.C!#NVH3W"NE@VAC,=1BCTZ.*>G;9#>Q;OD_)S\ MW
M=Q^X__H +O]K2SE015]0P2=87.2C?O,9D#[P.>C YZ,9?1UCTD@GR,G_$Q\Q
MY!YS(>W.9S)>%>=8T\= FJ1'L&"H6L6]"^SG8<LZK&NZEN['4A)GUDX:2;P0
M6(!(F_C4;[4S_UXH!CZHXD(W:AA?]2,XXF ^U^ Q8 &!^<)M)T?TA>QX#5:2
M'<Y^H,\#H>>^!#KVP)]A0]#E"9Z+R9!/HF4B!Z1059$3&WEC8NV+;0>)W4<'
MXK0YQ?5M1AQEL&IJ&I4I4.+9\.UY<"ZZ:LLHYL?7?Z*<;/)920B3(Y4(CYAB
M2H'&K"NX&?$X"=>$$$F@35T0("HD\H&01ZI'E,M=$K." #6BR@Z0#81I*H-7
M;'91@)<J(Z!%R)A\&FU@2#?T#LM'X;4OZ_2<+#MF8GF4/ N0Z6F%/[BW:1IT
M2WI!7;48E]%P6*X3L>].H+!6AHBN9L(Y6BF/#'<86I@R@J;4NF/FF>>";U)0
M2),'<,S 5?^;_!R(4I)SQF"MM4RX;"6SED*.+CG%;4/8%=*$LB>%OF(^/PPO
MQ2=LM^[9>PZ!DVPNIK>@J(SG<F@)UN(;.U0JX@"3ZXV3D3'S"8(*1G@M4V^L
MS7:99WG@U0S/^+>-WO2V^L$/W%LC%U9^=I6<Y[;@A2*21E.JBL.?7H3;1(H2
M+9H0)[M2M)J@M")**"*>L@U&C8JY,AZ[VZ(C,!;\%\E(O5<E&'@P\^NR4DO*
M3Q1J16DV' ^%EQ8V0QKMX=@Z^EMH.!7D;-%@G7*%'3%B'"%F13,TQ;*WV4E<
M%F]>R3OI7B0,E'0;X.!(I&*H5ZF-0GGW. M)GD>IZ<L=QCJAEK(^-+,0D:D7
MOX("<CG'<Y.SDY>*ES/,=D@F1L@%X8-B&)#*!/1?,K.DC6J_K6S^I%3TGYJ-
M:=H P)0V5TF@29UM2-G*^U#H$:A7+L%'917N\+I),^5S;+<CIUQ7#'1](I),
M[-JREV )00B_C%M)3&2F[$^P'7-K*5?@4<:TJZ.#"I6JBR@STVFGBK/MTR2O
MU&R1P1:>KVTJ6-<6$.:$N(38;3-O$)(UE94;DE >\9(RJ8H#$[L7(2:&VXZX
M4^)UW!=LR4576)#0\(JB<^HHL#G\BG B0CJ#.;X:VQ</.8'GH=8'![4^]E!K
M#[7V4.M[AEH_*4_S)YU;AY-1U*O*00>6B$<FHD]CZ(166!.M;LG'<Y56Y[\X
MSZA-+PW]*#U8Z= =U7>66M@I)N>E 8Z^?O\.?OWZS6_O2B<)3@A;X4;F89P9
MNFK@H95A9\@#7E^U^'<=?4;GB]MNRT4.8><Y_J+"SK5\N:PS27^7>J@ZNFI1
MU?ST/,WS&/Z[J(L"O4ZZPGJUR.D)Y@E]"W8<6X7!RXSTBEFJ,4C&+#62NZ^2
M6$$([#X9S5F/9'9-UJ/T.)PI<.0%GF&J6!36Z[,6.G@<Z7C 9#CU&5(%HU3I
M'.2KA&>*&=E+Z?1"0WL)WJ,1OM.O.LWV_7W3269<T ;*T0[+KK$\H4S1H6-,
MBGGSLFY,+S$(R%FC>4JY8,$U!TXZ:BR"V?O<OA+]&BQ(IO-=;$U4W+&M")*8
MFYL_#:>?ZHP!!2K^!)[<?/X)Q1O=AWTMC+_%!-GPIW[P+[-R!!K.T?'AE7O-
MV=BPW_,J>&7 *)M!VG_^1_(%K_![O80C.R/I^.738*BFIU%TTAO$T^/>9*@F
MO6AZ/.F-AFIT-AG%@_AL^!WW!7RIWJ-;_?I3-)BJ\4Q->Z?3L>I-XC/XZ7@X
MZ*F3Z2!2LS-U,HZ^@U.RQ-U8QR]?KY%PD2/_-0(=?C.!\1]<$U7E+WGQ"O^+
MJ<"W^.I@9^''5UE,'X8?/RX0CUA^A'7\A.[U=X$J9]$*7WA1J^],MC1^5>WZ
M8)^&.\9^MWP<9Y]F[I;L]Q%\W0\:+]!UB0_MS#U,5>QS8 6>3-R'"C/OYXVM
M=**UKUC9=]VG^F1Z-IT>S8:]R7@")_0XCGJGT33J#4Y/!]/)X/3XY&AR'Z<:
M\0WG^*SQMF-[>#)TVZ?L3XQ[9OEYAJ5U*H\OL0<J$C^LC.;JO(X*PWFDM]S!
M6B":%SQ2*BJ!YU?F\PJ!I0A=J"[SXK/XT9KYT^10$=&,*-T_I6L2[LP,*"K6
M:!7IPDJL2@[I:Z2HI50EJ5*LQ[DRP64:^HANR^P*SKY=VJ?QT30^F9_T1M-A
MW)L<C<]Z9Z#C>[$:G!Y-CH]G\>GH?J7]ES0Z_X[ )1$8H^1+!>_\BXI[(O+[
M(';NNXXZ7IR3O499@.=:&G75> G_N5?):=TVD2 ,=\G>NSE>L9T&0[W5<*HD
M1(&G4W12=&2B6PK+0$B!3/M "1]U>RS;?_\]$ESOVPST3%4S>/A#XWX?[1E\
M_OO;#Q]?-$UL\(M>S]YF_GV7,D:G.QV;ICA%058C 3E//0!5GRE*4AB!"B&*
MK*AOAS *Q)P<BCQS<<[<T Q-).UN4!&6?RB4YG]4E5T7H!6S.F<9MF;BHDX1
MF6SF,N' (*4-27:>XXV6>994>2$$A3,L[&%@SGJ?F8(:&U2Q"Q_4I2 68<OY
M ?,4ITT93'RZMJW\346E092,=N!XOW$/:JF@&!R<+*9%F+O=C$$LT]HS:IW6
M0 8"H5'9HM_(^;957;.*\51E_T^L[B:9=)TV==?;;$;> H)=&)GR1QIEA)1\
M_?;]'[K4F9325L+4X#CC2<FT+0?0@E?&HT%7;+2V$R#1@!!C,Z2#9DF9;ORF
M;)@+Z4&@A&BUX#+C08G?1(N.HRKB!!DN7WM"Q'!%6$:0B"2NH[34*T],GQ6/
MEZ8SK;?+>$VV<.[0A5'!A3>D>^5F=QH6"!SJU#3%5?F,3A.\(QJ9=C<^UV R
M.YG.HJ@W.QY#>#V/X][9Z4CUCD9J/)P,Y\?'\=D=^EP?%TD1_Q$5U?IGG&]S
M$!X73>)1A^!$P2MC6'J%V]Q#T/G:3:D+_1R-G2L9L8YA!_4IE6!RX/CH+BE5
MNE1S2:FU-K'6.IS,-"803D:::YB^-C)-0P2BGI6FF])9$LDZ6#L4 7U1U[+I
M:*EQK,1"F^4Q>A_)0G 9N@^.6P0%["_7>?O16M$EP?/%##?C)M+>Y S(3!/P
M#\'?V^;N-:>@Z6%+Z-'"NTGA6I2=+]2Y6"ZE:8#8Y IE8,/4LTKK[Z7K]NUJ
M:#X^FDZ&9ZHWFYV,0*6 !IK&XUEO<'0\.9K/9X-1/+UU-625SSM"^YPOJE=9
M+%E+*1C9Q.;^*Z97)1%3=1^1+4ZMM#,F9C*6"'U4Y#6Y4U9Q7*@LQN:#YH5<
M Q;9 (Q.S5)2OHW+;'5@'>'>8YU*:#?SF%KC1%+"(A"FL&7"(S-1&'9H+W+V
M@@61+"=<3C6JBQ\T=0+\M77X]1:KLJV5= )'4&BHV'1ZJ:T@$1LH'>NDX.TK
M29H#8R)'0T8749(24,7ZY35"J0N%N2U]9]M@:XJ%=#VM_.QKMDS+I9EY!RLK
MF>D-N<%6!3;/^GCY'I3NR71X/)T<1[WYT=%9;W)R-.N=QM%Q[W1\',?Q_.SX
M;')\![X?^"0$$'TEA=EWQ7LPO! N3M/UK]0@]C%O?^H]]M\A*U2U30_/P7'8
M%T7\I\->)\UP^G$:Y>C.J)H\_F6T%H) Y/JC_K\$TU46'FN"<&QSR.*@(SAR
MHA"BA8  R&@<S$V YH]S621H+P;WKZEH7I@WXO3L;3Q%L_NVE&I(:"=)SQOU
M^>+*YMQ]5OJ_:%+'AE9>I01[*!7G^\DPZL'>Z$-4V'Y!=-B#']^12A=W?#/5
MGVLBR;I!$&>M)L)E+#[!A<E0CXR#DL%.#02YT'B4FGCAMD3/(8L$\^XHY_)U
M)EVH?TNOXQ(5,TUD0>NSM:O12(B#+]'I5 FB7=_C"L0'[=J0F=]E!U]O>X@T
M+^E*]##THF)CC)COP7EG-C&V"8'!UP)'+BD;[[E]C(R\.W-<]9!6WA^JH.@D
M6N/N[EZYZ/;F=E$3$[:N,K9?P#0L';@*TPO:?!'7]\9S6@9$CY:C]QA6PQ7B
M5[T&?0'C_\';><51V'NR^1CN_8*Q&2C]_WT;X<B3@E/^@_JOL"9X9S7CX\%X
M>CJ8#WJGP]FL-SE68S#H1R>]:!P/X]-!-(R&MV_5W^>I>C=W\CH[HCMV66P3
MW?' U>5O?S^3T7PXG9^.>Y/I6=R;G,:J=S8:37I'XV@XB8ZCX> .WH]3Y110
M>/FN0  6SN)2Y7N;\=Q>X+_=;0#_<G)R,CCN38X&T]XD4H/>67PV[)VJTR@Z
MFXVBZ?@AM^$ PGUT*?ZI(F*-?>O8*Z<H22 5>7YR,LSG/X;4&P;1UA)Y]DS*
MF[-SE/6.UG"&>C$-QS9I@Z_*+1R":V<#7_#F8MT %Q-;%,XICI8M'\(%7L"#
MSM'@8ZV+3+-4TCH!%#15'1D0\8(?/X#A/PC?]V[J#O'I-#X>G:G>Z6AVU)N
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MLP8^3("WP7(?\NW&!0W^Q+C.++QKMR[%-218%C73EV8'OS2WD'W6WA_P!PQ
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MO3[U^O1QB:'7IP;U,1S?A&/[J2C4@T>&N*,)1WB3.];?LK\T@([NYRY =O#
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MJK10'+";R#)+1#[B*>0().%NF7)<B', IP)C%MULP*JBL59Z7#33[#=%-"U
M30,[5Q(7*22]"?^/W(-XQ)Q5Q6V^OKT.X+T,4![TNT>?\E(2R,!@C9&?Q/@O
M,IOI:M[#%65D+YR4\ &I__1H[XBN1[_F WP5](X[P==$G6(PMLRUR.D??7,=
M?8AH<[@"IGF$_%65P('Y"@FU"\=_B4L-[5;0B90,*-[;"3X,R5$HD(<[\BO2
M 8IR7.35:,SA'_V*;!0VW8](JAFP&OH1<.(45JL*XKQF7ZMNR  'D<O93BS!
M,$M5@(A56,&]B)V==78F/GG1TN"&^^W*(%YQHI@YL@>UEMFUT@&_8(40@YV
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MK'_X>$1-8;2J38H\X["5-AA7!U1WU/L<A*0!+#87K3+S^25@KJENCEVTJO@
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M_X-C?W/\6CU2C2+Y$0=_N TZAX,<I41'@,HB&8TP[\7DY?+TCH4\8#>"ASD
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MN^'.SKWZ)3W/\SS/\[SU0*LGR?/VM\/M^\V!?,0L[]Y#_&Z'K#ZN<'N,U6U
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MM-JE*"UK4[961#2>Z#E/.(X3:KI@M4SM62)=#AV3U&6J)K@<B<B6[ )'7 9
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MBF2Z"CZ@LI,1&8LT#*9I!+=Y'(DX:?LM?HD,XE-> I2 1\+UT== ]OBMNQ.
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M.WC SX"F&A'V.LW5!Z!Z9L0@(U #X3?.I3O@:$)\F!0*U$6 2WZ.N_I5%&=
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M^&8J<U2_->X3@B(@W\"#,0=DT.\ .YO"V@G*-5Q_DA=D*63!3ST@&+!XT%)
M1TY6(<'@';>$6?2VW=L@S?Y,%&A].V8V[!10!A05I4,]O'Q")JQVOU)D%ZS2
M"8"6-?YWB1()&_A_E#'\-]$\7"2R-'@EV,TS*1 O^!YT?@Z0;TNH?.%2_V=G
M&;P_R:K(R0*NP^*P.\3J]@@*AL: TR.2O19P"N"RN,))5!M&ACYTM 5^D<"%
M@%5:7F*Z6=#>P)6.!*% JE%:#R!DDTO6U*#91VBH6G,9ETY5-9T"@-'[HV_)
MDK.FK]F*$?)U$$S>EWZ=</WRKHYK<:?7=J+/G.0@.AS'K.$]S3.C(:#0TX'B
M[H\_WB#".W[JGL,JD89#YX5M4>BW=<C7#4-_0$>(,DQ$M<=JV77H+F[$A7($
MOI$2*/B'(,&9*=="_*L<52E&+&=VN3!X8T+2GQWRMQ]J1JC=TJ\3T)[@-XI<
M@.23Q!#]B1A*9&H6'.A&0G5DV?G:077"4O6?*%6_6*F*J_PJ!=VE<X!CUA5(
MKGW*013!KH+/QATZ#[_N@=7!&E!UH=@F,=&CQ J6K'VM1;T+K;',:V7V< Z.
M+N1SU8A)N@%0BVC+QV*L977HDRP+"@#CI32^02A]!%TH@IT5P3<YF6*8O!'Z
MM]$C-XP YC78V56I-0%7%=]Q#]+P?>IH<LDB3SO">9'7%8@,@&(Y%PD/2/(#
MA>M\D;%V\&**%^FGKU%K ,$KRK$.R^.)Q&3"Z;KZ2K^BM/ZU&E6 *MG/;T#[
ME76X&]6?J$XN@)=^ 0T%8/"^P"\ZP0G OW$0&PV'W]KK9<?K!"ZX1B5:]ZU4
M$> 9X+#CIEU<I2U0SD"\C72UU1RT7BX_6KG<VF+K,;@!C%F-/@"D5(I7+NCZ
M'+I!U)A*P@_]PGJ1_P&X8 ([O?1$3LO:N0!FQQ__4TN)A=#SK@UR@5&_!;^[
MD"'W>9_C9CJ?<_*+]RG?OW_WYMOGKVUKF(AA3[-J9,>TM3_D#WP7"&(G3,>_
M(6:C/0[6KI^+J+Y'18>= !\-W^9PJLY!UEC5?J!:ES',G8S.I=H-VD:)+ !9
M+<A-#-($C@(=.#*)<3H7<&G<V(DL6LAL@P#%=#-BY(M1Y%]2\2,_F8#E^#OY
ME3&$SV>&"WRO7]?C>&EO-VR P5%._ODEA%>1H>2<%>LFX'2S'XLF(Q <R%N*
M_^.&T&R'W9#=ZP:R>RZZIV3UHV$M.90(/&NLLR1M\IN&D158TP)EY$3ABBGI
M7)A=G6&(K8E.W6U]RAXOB3!-90EKZASRM,8*5KN,%/S97J 5F:)LB7R^0>F6
M X\ @^$$\)]D(B8I:@?11% B?$E*U_(TOWS80,]:K<.P-RZ..1I&16UFE/8.
M#W?YE-U^$Z6MZ8[>$OKMARQ.1";FHZXFVWU)=-<]XUMQEJAVD6^6O26A[]KU
MJLYG;41+&W%5+^@W7- OZ9^R%M=Y31%O?.4[[.6W9Z/WU=[)[5UV^.$KEJ</
MU RPUGTU0S\&"P&,"4Y R=$^M-GN>V$S9[EI:"Y++46UXEN5M#@&ZZQPY-^K
M97MU@M<2\-18'NR1Z!Z$;NC ^.1JBQ8XZ1@)'?C+ER%<:*$E('K]8DIYK@I9
MOP^.[AXO- \99MH)?DU4TT>;2.,M@$TLA!Y,8 +AI!V';>GLFM-;$]FX"^>\
MB(T$^']08CL>I+9HPD8$1?]<IYAP? +EUH",KO_X6V]_YRAX,17I((] KT@&
M+T,G'3V:X4ZW:EWL-,D$@-+4>KUY^[NI\0IV?MXS^5P8)J'J ZKP:KK:WU4%
M;,=&8"@ (S.\ 7L_X1R2MS@"%KS5^(V^*$=7,P[]MG1,5]O[DA<EZ$))#M+7
M>&E)H:USIM[4V9&LH&!U9Z2+(&0M3*EFP[G5*?IV&$6XWL.^T5QP,[O+5@W,
M0Z$1.G ,V#J*H$%M43].0,@B&.#4[](D^"-)4SZ7SNF:R[[4.GE#$7?B/\<?
MOQQ_^Y73^C+XK$RJ24OLIC)"WQQY+$6*T0?R+@#R?\R31L$ _OT-RX--BM)7
M.43E-PU^S17EQ]:EN;^@RRXS)0J_RVPFS'T ?*984)P F!1P,="8*#&!EX^H
M('>FP*A1S02I@$L U3QK;:OB<-Y%6*69+'HS4 ]$%'XW0>)U0Q:_RE9KK)$@
MVI9$BI4V,693MB8[VFPQ1HSEBC^QG957Q>(88(.?0=Z\GG^EDY^ZS PQ*<$F
M?'B)54+ 66ZOKI!I"T ZD]E?^9PQN  ?NT'>D5U_[M+;[=&5TI!_Z2WL80$0
M-HF7:L^ =$#/>@.\;P7 7@+),/A6D0("O R0<4E:\25OA]-'FF/,Y<>&P7L4
MZU\*=$Y?[]W+MOWNY/CKY^6O,3NQJ;L7@6 "S >,C14)9C'_%MC_?_\O(K[]
M*I'N$5=X!=<[ >UC53$7:<G@;2)&6:XNVD_$/MB1J>JR&#HG!=@8RQKYL(NV
MUDE> <M](PH0:AE[CD$\9;J$RA03?S'LJ\TF72N]V6=X;GJ&Y[;/\/09GC[#
M\\89GFOIY;EM0+!)48LO,+_&(-#!(DBPML1Q&S:EX\H^P]=&A7M;YP,)+@RZ
M)!MH(4(8SND!5&315%!T#-$:1+# :9:?IS(>$5G5F7>D%YI\ GC2M?.:AF1M
M>KK6YD24:&3=4IN-@T>#4-_8<0[_G^4!ORU@3@.6'T 7T\'*<RDSZA@UR<D2
MG1EL<?3\PBF;R=G)!9;C-ZJV-C7N>115T]H!@3D%^8RN)S9II_!SC-H/\376
M94<MLA:61/\%6)Q%0MA)P0_Z882.&/DCDM.24BMU!P6!-CYYKI@*"&4!X8XY
M5_&K!*PI$<W?Y\4DZ'6W?N>2=F$QBO3_8BZI%KWS\)8L+[D;$'G&5#5029Q@
M$! ?P.@$9G8D*?47@)-4 )MW=HNQ5%&1#'A3VH/T 0QRV$6G)L1PT8VHM-/"
M8#Q[ 5!AIM?T>D?!!S[QS/@0WIV)M.+$9%L$]PDTZTP"Q6J?E0ZGT+$ -PJ1
MZ1K<O. N QA>H306@QRM.,&ACYD^_Y14?WP%_TN!15.H"AD),"3CJJ!.86-:
M&SX=H&,UA=<9>].\?#-B$7?#06[2U/HF48>58-&"HG^.\^ 8T.D3D(A%YIO<
MWYT?XG:"2WN/24@X$7'J?EES4FZAL<C\0TWW%(#!N@O\ZQSC#< KD9X'P*Q"
M[84KE6X("#]*ZH:)3KTU_,S*@]HOKAOV\%-@77!+CZ&3DW<0.GD8I@<B[RR6
M$].ZT6VAN.F\Y09XMX8M1QG;FE8P;I/-W*9_ P^#/]\"ZR^O]$]XI5ZWV^D^
M-[^'VTS%5,E7BFM8I $*]ZFEYY[-3_S F %7'KPRS[>,\N#EMKN=P[WGKJFF
MC\FVVL]+'NMU#J_^T,Y.Y[!_G;5V=J[QU#4>@94.[F>E^SK2=N?@.K=[V2,7
MS)DYN/K(T5;"76GVS%VT=SY8@Y$>"XK#:C:WF,AKM,W>-" ^5(/[E>%DG5W&
M 0W&$SG\ G/SE[5Q-\>^0\C>S+M\/03]TM"26.]6P:\8/"$+EI2D![H9YE#=
M[?6]F[O%>[AY_.;OS_K// W<(0V8O*H33 OSN/X@N/ZT\=OSD<? 1XY'GGO<
M.X;[^9IK,<SP-X$.^N,.IBRF:;X>4YC6*JZ]<3.L-ATE.7W^/3?JPY)RIUW^
M-RSPQ4[:3Q;4ZX"H3WDBF)])=PLD[H=O;A@.>D:W4;#;3"1[A(QN=\]CX#V:
MB!?&QKR)>#T<_M^\@#?_;UR(,ZE.$S,1HS%YRTLG;R\^K+WX!XTXI;%6IFC5
M-1Q/9%3(4A2S)POS=<#8IRS-O#YU.X9CS^/@!N&@9W0;!;O-1+)'R.AV=ST&
M^MCBIBOFQ4SA1+\_\@I[FW[4DQ2_='[UAJ,W'-< /]TNE-I:?+*@70?$?,I"
MRZM-/K#X]'#0,[J-@MUF(MDC9'0[AQX#;VP?PO]BZ>BJ1;;WVDCGCDMLKU?>
M?FT(;%[CY"6)L=?9_1TW3L92_)5R)A='%>RT#&K3Y?742Z\Q^* _-SUHAYNR
M,GRH,TO=VG]A)Z&SC48\COH9P2<R;1MA8'?'/VFL6$-@M=-C)T"182NAX/AU
MR_EH.I*=']$/]3Y;Q@F%JZ]X?"H'2>M(GH4-]*BQONTZC<,4YN!+S4'K;AO7
MWQ2V/LY5VZY>8$L$6:0S:LI$31S^]\/G+[\>?_UHFS[S3U^:@4#4)YJ00_][
MVS30UK#L=G63:=VYN]=KN\<DN^HL0)Y1\-=L(FT['&S/\\*=E  WG@^3E^X4
MR@NO]#B*<MRL,\.SV6X'N[X5>9HB2E.S&S-Q 9'_Q/:NJF_AQ RI1(_CU$Z0
MLLUOW-:J.'/+-!G&ADDIC7W7A[0-FN%^1J8/D#.F@C_@-A=U$RT:>2DB/9*K
MA@)N%QMPSW6!QFMDF%W8B=E<W10[=@!;TGTZS!A5TY];GT5/1%" @-2G:%K@
MAB):^ZU,<VPE'?(T3VYF;A !!W->@@0&GOI6/]+42]@A%04&GZ,RU]2UOX1Y
MS#>T;>F&AB2#F-!"+_40K+F!(?\KS^:[%</!G";R_6W;D9OZ$$]X3B6]"JZ(
MIK!PD^T&'R!\:S8!;]\Q2I9WV2C%15Z+*<Y;LSVDG0$H-.5BR5[PY?^-+>3,
MS(I"UJV_^4[G@,=H+Y?V"V\<I9ZBY;1A%34!\BRP7)5PSC=(<B-^<8*7]@85
M5VKJ]86:Y!K*Q=Y2&@UQU3P[YX[;. T$,%!$XTK)LE2;T?'%3[:X45K:.MQM
MN%1=6S5EJ6T*58\'R38F7I@1MXCK*;X;>-27YL $9Y;P*M.O[;RWB]5$.\MZ
MOZ%"]7@,DKVBUB%0-1"^U6TCZRF2[I#+C\#9@<#;.EK; 1K <<"D2]182V2"
M T] IB'19B@R2%:!70)+%UK8N#[%UG/8''"*HQD*/<V'AAPEQ-H&.$QI((<(
M=F*!V&K7[,W*:!KL#9 J407@-M[8)4MBRT,'FOHQ&C=@-.B6T97'2N41]1'$
MH4PX#> -\#H%.C,VV9\FI /56N5O55HK9?7EM-RB?I;''6#SB*E M TB_7JG
M&5<9?"B F^8Y3\\PFI=[&9VY^W;Z<S-S?S.6DP012@N/UYWWV+>;1!3^ WYR
M7)@A*N:GK"AC#V^<*O!1EN,\1F'FCDT01/WZI]5PF*>G;@/O/\2Y'B&IE39F
M$S0R,L%1TNY2> <-4>$,AP1<^>:'(ST6$;)*@'H=[G:Y")D+7LX/0;S,OG?5
M46W!Z?&N.\R["3"6,YW\\PM-"*_GFK;/[BE!^\WP,M22&>AV4^9W[FKU.7%:
MGIG::TYJ1O:BV^#KAY,ORR<?:B[(=GWCI-H^=8R#/?)MF =:=G,MZ_2-3&DR
M_%+K]'4!?"=/@X\SM.=.X(O!P,RC:=BLM=%O=/P0'P+3*89/%.P >R_37*$Y
M0(6MS]:F?-LSW#2VY;$O@HX+D/[YEP]F81#A(FY_D09TP\NQ@Z!V08_0UL!V
MC1NME* )B(!>.B4*Y/2_8'MN=V@[7!Z5!ED4"6#@Z66H:.C#Z#SS!+!DRB V
MI)0_V F5QH7,K K0'"3<'(5HO (AF&8S8"K6OG&&%C;&2N?%:6WPT2C'!B#0
M.CO^NO4MB$"!H5:^8DHS'>,JXCZ;NN5$68&^"&H0<FQT4$@MM/F<C;G&]?C"
M;Q58D8V)&'H><V.W](R>Q?Q6C@I)BJ6VSGYE*^S2US5_SIZK?$H77Z_$@Y0*
MJS-\R7'N&,^)9HV6-8IYI:/6),ZEHAE%[M!&]";EQ4B6^3GPQV__LU8BP _]
MV/BA'\W$!#_TPP_]\$,_KC/T8U,,FKOHR'V[<Q46&WC?=,"";O!]MT,4OMU@
M4D'+D:\UL@#A!+]I'UF0+2ZSULK$'0\O>$#'P$K@X/B)C5'X.06;Q!4_MX^*
M1H>)ZPO&>03-J)J>23F5F6*.U/@&!P]F/#*E.6!H5(];<1\@IV)C[FVKP>K$
M]-YI1HQ\>F%K[1NC]UYI9]KA#[ ESHA'!BNXY!$-98 +*)KG0+N83L'VTKWW
MX=T 5#M.^.3=&UKNDU"Q^+?>O:I0,MBU<%RH/%<4PD1G"!H9P '-BH)L=(56
M.T[?26>=X-A.?8CRZ<R&HO4#:+7*JT,IO,[E7>'JD.F#LE;6]GCK HIM+"-X
MSB5(ME(^%&^YIH<T.#\_[Y0J$ED'SK].,NPI"]2'F@9T320Z)KJU\G732, +
MW 8\?D?&*H*W>5&B@?"+&("QD(K@EZ)*!/HSBX$H1/![*K/HE$76UT[PNT23
MX,\\C[5+W?#.!:;.*G:B,U'83_X1O92T8">X0.#'$L0&CC6+6;R1\&@FJ,PM
MA^OHX6MXDR!-\#K-2#040/,/@#4 S)^'#M$BN"2^)I9#6GDP8[]UI5.7%J6G
MF>!N=DC!G0KMA 0%33T-$8ROH<TC(Q4#-X-B38\VK,<ZMD/S$FCA8$>!<JR&
MK[9?-$SF#U_OAK('2CL\3M3G9T5C3I^8AP8L5UNIPT2AL$43-< +B(.W,N);
MV^Z%.AK5=GD3J:W;$K&9)P_._T:0SYYC9BV ($L5%9:<_,# 7,PN,1E@5.C4
M)WRZ/CQH1R69G.J(OG&R ^A]J<UI*.2H2D6)*7"%I+B/?@Q7T-,Y(V&3\PP&
M:@\V@)@F5&61K'=EL11?GJ ;&P"F,PS<Y*FDF/ R?,^<.07[I!T(5S4I$G6*
M<))*V:@*?<;9$O@9YFSA'$@SW@M6P&%?U2)])*H.A*622(CU0J.-Q7#;E:*(
M&0$+7U(OQ/<< ZQH%#=Z-H9#5B0Y@<4,'%11FF-":Q!Q0J8RP:!(QO#Q,FS
M )/>@52M&R X707*O&6>*,GK35/!\%:@UM+5\>>8]7A&4TM#_14Q@F2"KS(,
MRGW1!9AGF BJW:I*2]7@<"$B%RK1--J3U?(+7H;O"HGTIYCV4J"W)=3I*V@\
M)!GB;D+_ I9C1JHY&33--PL3_ON\&H982\T@"5&CE/AG?:7T4SYQ)),I'+*0
M*)2,#ZS$T*0)AZ%'A^@2-DKVR AHGUYO;X\3?@H<+>M<J<4GP_P=?DLP.I>4
M/&1W P\,V05FN#3(S]D$0\6J&DP2P'5T(X%<( <4.>HD<T-X%&"9N=O[=P7
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MJ#.1V"8QH$&Y1M&NF4RVARCGVIV>X<$&\>"! IV1X%LB*^K0L0G%&I8WU#.
ML<'6#89B7:<>%#Y0_C16DQ'C1U92;%M.RQCO36)#@W6-HETSF6P/L:YM=?J/
M-5<,$QJD,TBW5TRVATC7M0?FH%.3>/! @<Y(\"WAE3[6*%AIK]P_'#NB_QUX
M.':K"_0;EW'$SFQV-A%A&-=#$ R,&!A9A)%C<ZO7<_.GL:6,&*_CPFNEMX=Q
MZ)NTLCWE2 -[C:)=,YFL6;"W$7G[77/-5]/8T&!=HVC73";;0ZSKVHXY$=4D
M'CQ0H#,2O#8)_HUC;OFJ<<3V?)S,9,I#]C'. FFQ3_8[&_][8?]JUT,H#*08
M2*G6FG_CNB9\^]S\:>PJ(\8F?'NX'&E@KU&T:R:3-0OV-LNW'9CP;=/8T&!=
MHVC73";;0ZP;V#V3<=LD'CQ0H#,2O'8#9H/P+?S)AZ&@O]:'>U3?+O1]6W>/
M8#2<KA]<,2_D4O[T L8Q.0H#F1Z)4$P$>L$PEJE(7N1C]0,Y#?GL9!2*FRI!
M_LED&HQF>6_TQI%,>9*>TM2/L'%Y,N12A &.<8%(\S%W[&Z[_[),-=WV0[ED
MOH0/):,>4BEF_UV(*8PN/,TI$D0XK2,BS"VT>/%_7CFO\Q5 TN=,0/TXK=;+
MA1:?;])5WOF9>V,6CU@Z%BR>ID$<,7[-$U^R*R%3QB4;Q6$87\L3YG9?YF_*
M,4^$?@6^P$>C(,'WHR@ I)(\F>7OXDLP#.;%$^ ]CQB0^3P5%KSM,^=-9Y".
M5S6<3773\.4T%#0V>$W@B"<P ?H(9Q)$69Q))D5R%7@"/X&U' '(V8RF)VZ$
MEZ4P+A9(!FQZ&0 FL#1FB? $/N:>!Y*1<.HBT)T"1U,'@+L\P,=7<9A%*<X,
MF@9ZTNL27N9 !,_+$OP4QA,)CQJZ#F"(G'EC'ET*_5N:Q*&%5/6%]))@*'R6
M1;Y(J,O_^F'@NJW3L\M$$)6D:N(SM/P'G\"K/Q<3^3P:P503222\B'$Q QZR
M"SY3'Q+MOLV'R>*$G:N!P)S.U4"H/^<4"*<&/!2PT/.M%6!C_=\%/)GR2P$2
MGL"XB4=A=5]4N/X_1P%,ZN;DJ'U*,N('B>KB!-@\FT2G%;Q9U&%V%Q06\JO>
M<%,/5@J?B/S3:2P#:CL1(4?BG [C&Y03Y'T]2GBRH<*[4[1NT0)SS5H'R786
M2@-5EW-<;&OJ"6F@(S@[X5D:GU9_ %*KQVKU:6^3A.R$A]=\)D]?O,GYY&DL
M-<[&B1C]].*'-/;^QD&MISN>I-DH(DS=^,*+%1:<D&SB])F,P\!?U K#,/:^
M[V;UOJ'=DLLJBG2QEKRTGKE@KK0E46I*DK@D4=L5G">UG;9'YQ5&>D[83=!B
M\'"T>,S^^=(NQM;- M"X,>D2Q@MUE%.IEB-F"_;O!JO7:][B45<G00JC\.Y!
MG"<S*9Z+11Y(E[5,0TN-T F6!GH)[9>+0]H.'SV["U2EQU^"D0T#C!%$8""+
M53"@6$AHQR$&5HJ(E>9F=JQ9B2Q=F4V  #!07QN8[!O8NJM;GB;Q5>"#,P&\
MQ8$C@C"LO!GY%HO1OD>K>VZJX_AO4AP-+]OF-- X2\&6S]"8AS;!Y)= =_4S
M]G(9QSX\I,.AKVBT,"UL ^0@$6"FCT#1^WE/*T?]VF(3/H/)%7W#!QQ'"YX"
M+(6:L!3@%W'P?TB^*A['4$3039J[$K<0E,:$@IF&\#LL$/Y[B<"/$<(:P'(3
ME>J6</D7?@6<]HE[;P5/QQ:[&-OO'K6<!E.?70(6,15&M I&+"9&(_22,1XA
M$<O.IDD0,K=M,2S;:"D.>9?8!7^P5Z6H ;XS_Z5@+.WCO[;919;(C$.7, ;\
M3H&<CKNL'E&E,QTL\7$"/(HRL TPZL<D#S$F@JBV+KR"2(W.,?YC*A+ W0DA
MX3".,JE@6TZ%%XP":!Y>P'>YLBO&@5S1&Q!C' !0JP;X),Y@X %&510$(Q3.
M"$F',4]\;$C%(&)MW_AB*H@3\_ 5:+, $)HH &_KX7@4>P(@MX!<?*(F&8&#
M$/@XHO)<XN$_:O5D,_#W7M)X9["Z.>+X ;@7O&14O L,#OU>!7$FPUE58)&-
M9 I+CYP$%@J(I: P8!#1ZJN@*7'&%3(Y!@5+0J0X%0?  _@%QG8T$SQAX'ZG
M1V5K!89]A&$&#R"W:!,?(@^*E(:L+"2)?5BYM>0KNX$LEWGK(@G LB$+"L,V
M.$R/AR'9*; XR/V^LK/F! &6IH]5R!>#MA23%5.N+14,V[)@5*4;QH*\,2P'
M9R.0"R] VOA9.LN1YES)$!I@613RZU&&XTCY=X&3&,^D'AG\#D:1!WY$I)Y8
M9$,AR462SLBZB2YI6)6&;?9!FV=76GS+XT,$=/JG\G;+\#:[4!M_Z1C65$6>
MT5(-X"WDCH0Y;OYT3KB5<5]H134%O:5)H,#>BV'4'$T -.:BF.$DP<(5R%V>
MP#B0090Z(TI%&*Y!=_/I- ;D0%4I"3VX1SL@YZ!B1LL>][+F_\03D&5W0)J_
M33B [88@?4FU]0V:_ 2^B=M139&D+&Y1$'#H5C5D+9HL+ *ZK+(1%DV0]BTF
MB 4]@2!+X>?(LL9F,>Q>9W;_IA9NU4KG&DE6%83BLL+_+=S=8%11#X7W+,GJ
M*[';&K26*SUX"DP4;KRR"BM._)K! W^*?Z-5!PS_*GB=V[5Z@U%KY)2&5K9[
M<0CD9 G ]B4UL* _49)?!=#X5$75JN8W"#?M?U(\[?/;+V=HDDR";*(FFDUQ
M: M]H5"1Y8F_5:BNHP>DBRZ!Y E,+0']FN]KACS (,<E6B7I@CH=*0*61KZT
M!(NDIQU0Y<:NUY=W*4N]H3M7E@M\!,;,<"$ PL)L,L482$'3RBJB0014/\(_
MQSP<L5>.W7U-<1G%9J]N7E?6<QJ"1_%J]CKW.L#2NQ2I\C0L_2NM8!(? 6UX
MY85\@4LKO'8AG8$F!-&[+ B!+"_J"N)H:_,6*J?7(KP2RY2NT#.0Y8C5ID*F
M5P9S&LAU@P%G$6[80QMZ^QY%XM]9 ":;SB6 Y[!TP60"V ^=@:VGL@LB#%F1
MC0N=C$1 V3HJ7J:)45AO\1# 4/$B$&4"QF,)4J9YD-K/DESL0*.!+4W;:*47
M2V:Q1Z)0'A2%N%?:CA-4O1@.5\9N[IFNL>,P%R%%NB&1H_+:%@T^V*%HAG(T
MT;T5T;TU)0@;,AOV>,;;7LJ;"3)N*<CX&P<M!]#C'I.'T%&<^BG)F;1BX.M'
MI<WA^\89;VG!*O?Z3TP66R9S%THY.N]!5T4>XK!V=#!\MS@%N]S0^I#D^A@F
M#V5\QU=;BF*6U#R]4@U"YJEGY<XF A6.Q"^&I./ XJ:8+!!KZI,B7Q_Y)+52
M&D@@*[2B><_#O&0[H:'$T Y M5K,],<>G12R637R4FH+[$Q0\;DY.#?ZX&/5
M [9'1J9J]%5I6\_/A#)\'KF7=Z<G< LWOGY=X<?<]$S0KDF4Z9F =3S3AG*9
M0,W0T <*E.OVGA7S%_YK9>FW[;W"EZ7VU_FR#W5&5SE8Z]S0!><$3=@$(:OD
MI;AE+^6A7N&M$=15#@[\L@0=N#>>;.0UKA#<LL^(!"WYC1Z7XV7G$9A(>XGH
M(2X2NO 22\A>]12)OO@K\!1;=A214$B2*)L,48T!3/,9X&6<?)_CTRB07AZ3
MCY>H;VE/\QZ+J%?^ZO4\ 0%ZRS.T484!M>;>7!I[WXNL</BRXM39[*L:SY(3
MIMPZ+288SX#541L,J-+1QRHMT!UA"AR0#E70+@=0!9,MQAS5\:K8Q;/ZCO-Y
MW>8Y8@_W=?N H.#3 V^/ [4-69YT+15.'=T$D\3>M"3V=LLDL9LD=I/$_N@D
M]@.U]Q?=V\/-[$"#EAJHNA\BN@38(1,=W1C<JKY"(P_^?17$(<^/W=$@YF.T
M3>3W'I'?#4L9&H%]=+IDIQS&Q*T<HG@EBJF>/"*(N;X!J]3EFA#F)_ 8O&H
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MWV"K9MQ5M:/GHRJ*ME*?U>+;>C3%1%&:JV><%PXW%X-<<8%,,2:J$%T:U5"
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MU,$P^"2 P4";@2?R4%X^3%NK28H%KMF_(K%?V@Q:Y /Z>E/5@4RP@I'P\9/
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M=O$FDYUS/WZ_5M0<QJ%_#P'X%J<\-(IRGQ1E78A;-SH>9([.$BHT,WQD>-I
M[YY!;]TMMAHC:RW\BX?96\[ ZO;[5L><>VH4:QJ W"\NK KY(^3YQWKPYT%
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M; *!AR<)X*_$3P",O3'B4S;%?_9Q:PFW]0&5 1DE?HE-GBLH^Y=D?\;4&SP
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M=-).82&Y=J,LH2A56 1*))Y,H),%.5M5W.&YHPK_*/G5*I?WMB]7N+E#41V
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M.04#1'.TF'0.2$FC:54V7P!<E>$_J/9@L:Y$,BNP704745D8=*XS.O\E5*(
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M76^-*QSH6N;38HV5Z8'&A+8]>,X26/X>3!C5)GX$W1^I?Q75M]5]28G0]X>
MZ8L7;^L;,,@_]<54T%K@1=Q@*M,M!]-L"(,I6S*C()F@H0YFT52QHK9D9/6"
M&KH@*KH$U7#_]G&0B:!Z^=KG3E;-*8M"LKF %OH97DN"MTO11<=X0["BD3+E
M\OL[](P7EL!BVLM7@Z8[#0)9O>YAFB4RXW1+EKK3"?BD6(5BI1C0PDN"(1(7
M##MSZU*MI?$]EKQ/X7-:5/C36L4==+O/?+E%SF7H"<RF@B[^6I8UO%_#2XM+
M>PJ37UU8_1#)*Q?/CX"FS''Q@NMT#,XS7N2F[KHHLZ4O4AZ$2DKPCIW RT)>
ME.4GIH<)5,=?'2U=<J*OU[E4%XN%L_)]-KRX\L+'0NR)O@O$\'V=^?Z=8B3D
MP$HXI1)IL3 ,4_ %.<#+3%S<%Y%?2</5%2_ N8E/B'N-]^PN ^8:/3>'3SX$
M4:LU&QG'O'&.^;%QS(UC;ASS'3KF=:D>OFVJ7)Q]^<8^_/F 6[NV83:4+N[J
M_BUNQL$P2.7?Q7[BWS*=I']+;PQ:-+Q%ZNMP@U?79C_K"5CL?1#5.GRAMVN_
MYMNU[*NFL7Q,HH%><7/GN;GS?+5;BGM*+-0[J?E]H^LS!W#C-,#+7\%7_8#*
M+8]1G)?O:WM?M/%UWD8<,304V/LC1_4%SMZ9RF[X0ND'Y>R#WRFE0%_<FL=%
MZ!,2;;IG=@1C ;/?WL:^K)$3(R>W7_ZQ)!4L5X)2W=@Z%"+"&^;5O<O"XYFD
M>^IG*D83D->*X4I]B:JOPHTI!@_!0U4FIXH-!A%&3=5]ZD$U;V>SNQ%U.] Z
MQ8E 4-+8R(F1DYW+26YOG:QAM@/R99I[C>7@2>YM/&[ !8S!/>YK6CRCZ2X?
MD:W#[4V[3:77\E]VZ?=LAG]D>'OPO<X*;(N+BJ.^N^6;G=?$8<]"O8.1P7>T
ML3%%Z_$)"D-M!U;A\:KUK/$!ZLUJ!=C.(WG]7H3I[=71O[IQ2;[G,4[3J3QY
M\^;Z^MJ6PK,OXZLW9XDW#JZ$?"/\2YZ\ =>,OP'^ >^@W78']%?GN.VXX#"X
MSG'ON/?&=_INWVW[XJ;MV.-T\L -E,TRO2:X\:^VV+\(\A-]=HZTQ026E+8Z
M/A3AEH!.=K!O7ST8#J;*\ZG(8!FDA2_9[%4E,E,.Q6 P2%L #%@_CPU]H72#
MA$<I>C9._U2R\RQ)T(=>B/P,,/ S"D)HM]C,_2J\+ G2? ?WYQMOS*-+H1+7
MI*311NRW+)PQMV7AYK+SVE[:L+D%_.H/>$:N#3'VB!C& GE*"\0U_&@LD#LL
M$/=9+)"WLY!?RZW8&JZQ-8P$&V(88AA;X_ELC8Z)=AA;8\'6<-QCM]<!6Z/5
M'_1[8&MT=FYKO(^S!/3Y2I/C0P3#3N-$:NN ?4$HD.SL,A&TXVTQM:W^&X\R
MGLR8TU5JWD+C YOBDU@?C)B;&JK$P#A/3:?S#_.-]PV-F,ZM1DS^B*(S\R2Q
MW)CY>N0\S)8YFR9!R-RV,6;V'B(,,9I.#&/,/*4Q8P(GQIBYRYAI[]J8J>C]
M16.%3;@O&*<0RJ+!DMLK0Y%>8V;B3BR6MK%8# X88AAB&(NE#A;+_4K8'B(_
M-H9+=F:Q=)YEJ^>/&%Y796660BU:H;L;!%HL]I;#(-C;A.P6R3X&([ ;O !-
M$VFQC_:%31_W>GW]KTU-F8XQ90Q &&(88AA3I@ZF3,?PXZ&:,B4[IG7<!;.F
MY;JM5MOI=]^D7G)S!$;,WSNW8DI)]/G)Z!6&@9RK^4I-K7G]MJ^J]@X6T-+-
MK#,-SCPZ@PV66\?"F [7=M0C#)A_W7["^D$VRR<.2\:.R61QC<FRQT!@B-%T
M8AB3Y2E-EJ[A1V.R%*&7MM/MMUO]-WZGWVNIT,O.S_F0;@<; BLYO\_(>OB+
M)[3?LZD5L>+0SK]VD$+[B<]8VR$CHFV,B#T634.,IA/#&!%/:43T##\>@A$1
MW/Q_?NS]=(^MG$[K>-!M';_Q!T[ON'OL#[X;:Z*ZC^+TR9[HO+ZKE//C2<.,
MQ;*W.&"(T71B&(OE*2V6ON%'8[&LM%C<0:?7=\!BZ3ENNV<LEI+%\DYX NN(
M,;=GC!8#!888!T\,8[0\G='BM,Q)Y<.P6NZV5O(4$Z?5ZAP/^GF*B=/Z>^?;
M-1\%E\):/*BSMA8*OO3V_[\ DR9,QWS"_HIC7[*/'\_S1-H_XBMM5!SK,T";
M63TH#D]9/V5N_)C$U[T7=T.,IA/#6"9/:IFX/QB.-*;)[:=XG-;.JZBX+6?
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M.46=3-_\Z0E]TH7,OG,ZTH)$C[2<Y6KBZG^8^J?_3,FKV]3>^YQ3U=NQ &P
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MR@B ?/ :!D#^C9B@H$IX&9&[H %QI32*WC1!EA8B.LC8&+>VG/!([[E+(.<
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M/%<\G:1MD)&%,JH0T6/-MYJ'_R*M09I%"E>[L#TNHZ4T/JMON'*W_H"#H'<
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MGV;CJH&Z@0/E?'I"$VZX:F;&OG>LO^E4_[_LF?X?(-4#= #VM408M*)&1O^
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M 3 Q"@[8P3A@  _?"L#.HGLP!7@ >!B4Y  >P'OH@? !'OHI.8 '\!YZ('R
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M_?QTT-^\K3Y-VJ>T!X5VM'BG1H(K6+L#TP7* +T;HMZ!KPP*", '>G=T>@?
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M.\-LE'PS>_5=7+#99_6ZK-[-5<4PI\GPJ=];-G4@13Z9!%'D5'FGRCL9X&2
MDP']M'"E_8PE&8E3'"3,?$%R*00)=,I"BM%6N1%8O4E:^!AD0!A0)P-&FT+N
M#,'[,03?+RN@N-JDE,^K$F@.K<&9-,TYYYAY[A4SCPD!)[>HO3F[8MAV!Z^
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M!YEY^E8MT&-RJ7X'Z.Q,@DT&2;#Q$R-WX+<?9<.&Z5F\,QEV#(3HP?U3@W:
MB"> %HF0<:2BA$1!+@@%'"%,!XPD09SQ( RI"C;RI6]2%G6G:)'E9[MG)XX*
M*UJ?$+H):T\9UMQQNRB8K#@>_!*A=*WG:,.!PG=UYIT;9K-Q_3H+DYC8!3K
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M\V\ 3%LP^,R6#>('VTEF%X0&A6W%;/^)OSMJUX*CU*[==D2W \L=@V7+%K:
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M+]G&J].>C&1[O82+NNDI&E 2?K_FJ$X5:$ZVW4RV,990QGA$0JDC&X#B2H*
M8R*4G/E)K#?Z56C.@RP+?6RJD>+H845R7V4D2,-(9IKQ,#\9QGD"LBW/DBC3
MRB?<EQS +21AFJ=P8I%B- _\F&^$*D"&2<U83E*54$*C"-0/!2J+##730>0'
M8:A.Y8@>IFQS5MNMS^<==M9MI]5<SI>8Y^S,-R?BUOAG2+,@B6*?J!RX)M4@
MXO)$,@*?94F>15KE&[9!"A9 'E!)HD0!_]3 /S,A*?'SC$H>1G[(_%/AGR<@
MXN %+/ #2H2@H%8$<%@\3'VB12Y31J66^<9<)1G$:9B"VN$'*1Q1)F*2@^%'
M\CS)62P#%?'H5(XH]HYU1LYR&ZMT^U#J!4Z$=X+,";+6#\DS#=P-K*TH1I^B
M)AG^&8<JIEII$&4;I49)QN*8)NB"1-]EP#/"F *YQL$<T"RG0>+\D <49(JK
M4"8)B;'5!!5@<F74IR2-J1^F3$0AI^M'Y$>*TX!E(+E\."+L(P\&-B<QB](\
MBGE(N;/5G*UV;VQZ>$J(.:3X3BX**=7LV>N_1WG*8\HUX<9MSB))6))PPJ1/
M=1JD///9W0;KL*;>%'$4EU@R;ROKNU,?_G!"\]$(S;O1PBZPB+!J4]=,OMK_
MKK<EN&G5S;Y2E\WP']O^ 4N=]F5*\!=F2]TMV&Z86W:GC:#W;]:_+?W<-?%W
M3?P/L)K,-?%W3?Q=$_]C-?$/;];$/WKRM^M>_?.U,T?-\#X6[_N#_0/[$30C
M66WU/S?-8YIFN]@YELU-H<J_E'QN.^Q*DUQ@Q_UBW^*B:L<,FX)K9GKEVL&-
MLC15;(W2;B90?H=+;'F:U9]VU =,VK:U5=-Y8&/\*E80%+;EDCSS/F&?">R<
M4-FB.W@5%JI/!A793>D!,JBRMMT*5_V$;6^(X?COI@RBG4L_Z+E@&TY<PK[D
MJF'BH.4[,U.9L(,N+ONSF3Y:-9TFA@T;S&?F(:NA5.-NL;-%&3ML<;H03*DX
M4<1GV&1'YR'A/$F(%CY7-)51%B6'J-9[TS4;>%>]-(C!IN_T[^7L,]85R7.#
M,G<S?>]QE>"M (UTAP F!L*>!?$IU^(]]NHR<YA3<Y@-B[6ESA<*Q_;.C,4L
M)PW',[W8MY:C69Z_4%VGG%XC$)Q_J[Z:7AQ&-,&WNWJ:MUTZ>I-[!:LJ,PK$
M=HL?F/:#X<Q++ /OVGI,U9GWRK97[W7FW][UPS[+-D*'7]";.!\T9X%C:ET(
M> \.!K;=?7"SS01E+"S76!/7DQN=;%G6ZMJ7M0-*#(2P+-S*N<(.(7QCV\.8
M+]L"?ARMO'HE A_A@/+5=(:SA]B;9FPF!8JNY.]:J X7A_U4^L=I!-ZW=G#U
MH($-5N777>%@]P[;B:AMJV*>U**;+4+$K6OXU%ZY5D]?2+,U7'UE!?/:8FSC
M_^D&(O=&"=@! CAIVHP/!:WC]A+Z<+5[]]T$CV62LBC7H%VK /X1*<D3BNEF
M =5<"9W'!YEZ]1I.Z;_P1-_IKAG%FU4O"M</[\8B#"'K&=!Z?RB&G2\&7O43
MV843Q/T6/R!4T<S8-7&EL@RUL/7>*V[93!_IYLF^7GT#(DPJ7<QL*["&01O)
MV[3,,K*D8^7 897AGZ;3W6PE#(#;&HEBYF#A(!'6+>W*^Q6%X_>BZ<+UM)TQ
M.[<#VD"4P0,N376ZQ+$J[+,JEW778[[QP7>O6CVWL+-3T$L#<KTW@@O-W&\X
M?ZOM_L4PW@&OFMDV,OB\RQ51F$;X9X98K"JP4.)B5OQS"4!%W<;TY[.7]Z%Z
M"=@!;_A>7,(YMS+<!!9*CDUHC?NJF,V7S5G!L0XNM7K"QK5GO0FY.TYZ^RD;
M]<H(]7Z#M]7H'FN,8MN<1L[:"GTK "N%G66_JFDGFWM/OBA (:K$Q949XFN-
M?W-)40$(%M]*BWM-YS84]JM-M28X+,DTN.E=U=_\>-L$]"(0\/Y+4"#J!5%3
M@SEF#: Y/-DAD,+LEV'088TO;8TN&/_S<\.!"+ZQ?H8:%'I;-WC5:@/(!M-?
M1L6\Z%D:AT&:)30/HY2F8?Q+/^+^1:DY+'6Z[E$V<+H&,.BPS,(PZ3R6/<6G
M:T/PR]I3CR&X]XQ] \UYP9BPW[3?"I]_FG5]3?^Y+/&'8=_-9#+CS+/LM1TM
M5AD'&6CW!=)]T_UP-:$+^U6B3;C8RGZM16B:6HJ=C.]L19BK4(XC4$>@=TZ@
MX0@)](U5+7H=>W]$I_O0V(J8>T)<%>8E-J".K?PJXX9I_L+'XJC4!>A7A6FU
M9Y2#Y71J,B4V/ >=!G?F-=!MU:3^I-9..WEV6*K/S_PD?M14GV=YF&9^'*<Q
M#?S\](C^T 0UI!N#SJ"I3UFUBT8V2<NAJ$/1^T71%2/?Q-<>DVW0=4-50X=I
M@\,.=QWNWB7N;KI#=NHL'7HN&W<%:@(;,9H-30*1_%=U]OELLNI5CQWG/,^P
M[JL"0U5BB8.!S/MJVQ#Q\K*<@;;2+,'<">^JGSJ*<!1QIQ31D$&'[5)5QJW:
MN411JS8)(SC)I*I*T\T*YS1=]=7RQKT)]C/#;_#*IKTSWMC,KU9L=F#UQ-G-
MSF[>TVX>U42USK&U*9 &489Z&&;XM3A3(%CJY;R9/\1QW.YB,34I;[-R-; 7
MM"FXX6EKUD;K9NVJ;7S7XAYGSO>&JWN,E\M%NY3NTZ;I_&8PPT9F,)@ LA)E
M:!O.WA(N^765H;'Y1NP?_W2[?^T>PLU 2U)C+F@0F$FY-"!9DFB2AGZ8:A$G
M?IP>(MS\NP*P*%-O])/#U/=9H>O7_C,%7RX4?<*AZ'[ZC4V[J6UM5-T$F\\_
M?/+>EF=>Z <)\</[&G)[-(0\> CRUX_E'/AC1L.GF!Y7*7XU&,;2#=P"\:)-
M++ZJ,&YOQZS9%#IXFAT!UXXM-@/8U-SFC+U&Z6#/S$P+89VW-@AQSOOBP@I"
MX)G#$5TXC0OTQ#:+K$V]^CS#X#;S3 T?*359UGTY9%;0<_UN&_BR2@-O%F;3
ML)MGRSU&EV(:@U5\9]W$WB[IO!D-V'S:,QXGO<EFO?L&H:>M$UPN&.:TPR=V
M6HQJUCWN[.Y#35,ZX R^7:4>>XO=,0#ZSPW$QTS/)J%PZUAQ0RIFU@_>,;.\
M<WK5J&B][)=5W:GU10^(";T?U[^GY #T)K<%]=4O[1/G[*HM!BGJ03ZJ^?[,
M>S>DR"W$7>]8T1KI-G%?>YT93 3DL@K_#I)$VZUT6:%KB^UR5%=@,;.=3< 9
MGU9<SD$ X(#HV59X]+B+Y5Y,XH2JEJ>B93!D>4L[/G.0XVOGG@H;Q,812VBH
MFW2:J@UHFZ&+R*/:KQI6BZ^I.Z=M$RKOG?$ &L7,]GTH^F,X?P1/, ?:W709
MKM=#=<^SGM;E($RGM,9Y5:;8YFK]H"Z95/W,\"U?FU@*YGV)WIH&^S%9Y-_-
M&YN3,U)LAK[KAB^O0%>;A.]V@65K/Y5M:1+2DSWCA>H!$!/0FPE<@ QUB2AP
MY8DFX:[+-&_1X5LQG<(3<;96W>3(E8U4-:I$5\5DGM<77\P;#EJ!DRZV(_3I
MS>9R9=RNC/MN5I.[,FY7QNW*N(]5QAW=K(R;/CETU:CTLS@/%-%I$!-* TIR
MGH%Q(#.5YG&6^BPZA)OP3U"4,-_9S*S[JJ:E*6![967ZUIJ4=?CLLU+G+MS7
MKFJ.PVB"O0/Q<*[@2;L13VNV\=Y(/0:588 TLH<TV"[ FGZ-DBZ'O09^<&,7
MLS4E+T/C!>PG8ZKAG[\:K]S5T_4V"_@RAK:8N;_K=K#J/Z!Z8Q<Q3(55.+8X
ML2W1:3ZUF\#>"X7LE2N>CKUP4-G@:YZ%422)XDH2FC*)(P\XX4H$G.=4IM&M
M9(,9<GHN!'![V9,/?[#94C.Q,(6DJ.%4\(?A2S\77]IG^4Y@[(EES3$-27EP
M4EY[5$Z&W*\,V1O/Q\"M/JX'/4QNF<D4*[VO#'CRTM3R;Y<7MFM.'^E$@W36
M:X5L_W.EU*H;SV<U:V;5"Y0A4^N'Q.>T#6QZ_EK5!-Y6I9LF_Z>>ES/9:Z1C
M+UV)M_]&3Y=J4NK:9 &I_KED8M7MH*&?082D[_]B,S:]^I?":OD2ME#W)P%;
M8-2+I40O,(:AP,(T>:J+JF#3>@M<FLP)\YJ5L]#X+"_0'V9B69?SJ6J3 &V;
M"+SX:VDD85>8:F='6# K:67VF?<!,+30L @XEG\LY><&ANA8;!RZ%DRM0W+=
M==H"I(DUU:WWU7@4==,*J"UTLL+ZS#L7ID^#[?6 A8^8JB$+C>6QG9M]W3/=
MK6=[@.RBJ!=E9<LW<$WP<[4#$XRRO2Y,[2OLP99CV)<B3O9:&9G%B3[W&[7F
M,-Z0VF$S85+)HUCC</8T)%3P@/ 4#.N,)3$'TYK%P:T:+]A9[0SW<0,M99_5
M.2UEWZGMYA2< G*_"LC>*#P&/G,^G8+(-V/%6PW 6J&M/#?MD<K9S 9(;'!1
M@\A&H3K#?.(20Y!6+%ET8W,,C;(F]V^'%>S)95?!NYPU83 LWNVR$YM.09W*
MT.L=")+OTK;)ZQYG;.!>4X*Z576LX2M1U&)<S)2CM(K+75JT=]29IW6T;HXL
MRFD@1<;A?5E.J!8!81DPZS26B61!RH)<'<9S"9K14OUI8XX(K)]C\/NLTS'X
MO5U0YC"\WFF<,I\_-D<_-C/N6X-=)U#;)M6>\T;F(R5!/AEYZF.+I,8R:+TB
M39K*"SB $MC8R#(CSS^\\!(_>0J"QOYFA9HR>1Y@\*SL;+L-T6YC8MK/S6U:
MU>JBSJ6+5S<U9[4HY\:G:Y,"L;9=LDK6$]M8C[4Y1&B#ULO*ML5M\T4 -%,[
M@-ZVDNT2,^MF:&_;WZ=8M3I;;:;QZ**;6(,\A(-5<S@>X//?RNI+EPS:8MTP
MQ<0DLIBME5/CDH9C+5"Z?RZQNYW)26J\QW!CVZZILIF<K ,5&KB84VI;_QD
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M"0!M1^\%HK;69XN:SH[M!!@6%J15@)EO/[>(>H5/X7^ K_GNY@0>UJWJQ,Z
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MI";R^5^:VPLI!ACM]6;#2RI)<A9KE$P $-<1Q$OGXLY*8>55--JZ0W6IHGH
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M.*^08=:C1$W42F''V6$].3&@^.:2[+V0U.>@#-9].?B<CX7>T#"XE ^X<_F
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M8#3IW"_X)HS.UR:YGA+'AX*QK_>1%_=_\V8V2A=WA\[N]11>_Z4W/H9T_:#
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M95%(CE%BD@+'A #N0= (6Y.(25:IV&HQ.1['$'YV\QCX+K',-J+G< G ?%,
MX7K2YO2@6K)LG873D*Q86D\,]QE366;D/H*TE1B%E(B.4@7IZ?5S0K'A(4J"
M*)?@1CMAD<.6H^2M #TC;<"M=H8E+&YS7O9U!NBI0%0!!Z\ NAON'ZX[V4^
M462P*ED<P#W+L1,O@%$"LPAK^)1$S()KU8SL@5%^F];1J/VAFIV(U,P.2.D\
MJ7,TX$B,I[FN'"SHW3;PO>I*3[1T^(&%I;]-/^7,Z=&JA1^X[#UD@)Y/+>PO
M^ZB%W?QFCL.BT1=T/@I RU<__R.#C%%&%0H:@\/ J %5R"VB3FN9K.%<FJY0
MXZ_%G0;3 Z]X9.L_75CC/<I1=Q;WUZ6HR[.[68U:;,75'WZ9 */.,Y)*P2WX
M<33]:PRE<&D9@Q\VI:W+KY1ZUG5J/#9!EM%&F49,N9*HY-'#J/(UZLZZ=&,P
MF69,B ]O?D<?"N* O1R5QM@ZG+%J8"Q :LL82_M5ANO/,@9##K.D-!J/2G;H
M/(ZOH>^LV[-3#4924$BZ;SO00+!A&1"=&PSNNZ%(IYA0$BPZPH3FH64[!&$#
MC8P@3TD$>P,<>6W .J5:>^:PBU:W,%'_.IKDMM*K92__NR7EWJ]@E'Z\>F];
MUL3E8A97Y@2BF_8$O<V<Z';<]]ME+*TYAG6YA9U_=0##BB<+!X[KJ.%I,!JS
MQ%OP^K5- EP:DU$Q$D-*9$Q>"NQ&XW5&BP$,46<4F+,V@0>$X2?L*?+$A^"=
MD5&U "2/P&@WS#GA.#IE.,(I!#@E\,)&PD&+@2;L&0_4M5Z82Q<9I@)1$8%(
M8(LC&[V#+R9BE>-1X%:8HRLGJ]-';5T!<@$;5*#+JE*=-+<%[6>SH6&7+MA*
MM]OJ6M-%047*+QYGN0X#5$]UAR:*^L"O*EE*4:&=C4HUQBIQ<:WMXL/.]=6
M0:'!RMJL,M_H@T@QGD@/!!>&2Q\-R(:0&S&I15986Q232(R!R]H:<T"$5T[
ME2*?%TX81YH[A>#8\!BC9,*R@V0?_P\]E03C<,U,:8EQE4M<\@\GP!4J,>Q3
MGC.&:>8*!ZK$LX#@MQ1R8AJ[%B:M9TQ)+0,L6^<0FM/(*.=0\MP)QCEH$W57
MKM@%/'033Y#3X8E2O+PC%;N2(G6B\F/I0%AW'F1F^I@+EZ:S6@+6O0)-YTN?
M"KQC!?V=JPIW5@W>4'N;D[AVW0.XK%M^<&E@[3:M:P.'ZZSOLM*SJ>[;KN.K
M"]PV<%)7176KPKGZ"\7EN[@<QWG<_?H]/]VIMJAAJ!,0YL(FZE*02)D\E<B
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M.3;FNBEVEW454ZP+S/]NDJWY.E33P#+O'O/3@7$X75K6]>+[^K0#WTQ"X]3
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MJLZ7X9@3X*M 54:G42CFV10\<0]^2=1("ITGVRE/<0OAYB%ZZM] *%>_ JW
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MQRI^)O6WF_Y.\\JUP_/GKWR5/.QKE)TQ>L G_N7/\]DNRC0>7^%(9_T_/\[
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M#GLT?L_SCQ?QU5/*J9=Y#/8E:'KJ]8;%$QL6CV"YO8G&SO-<3[X.(?)L)NC
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M'SKCC?0YD8YX(ST03:^=3E$[>4^RPQ$0C;F=D\)/!GN'(I<V81>B)2UGY"%
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M .()RV^>!QS[+]GEBM5\W8?<V!'#P23.^]*T;OO<+\6CWNWO1I84BS*@1&)
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MN5DV\*GQ0,W,9G(W'KRLIN7D$U!+ P04    " #6.V5:PXRUD4IK 0"I<14
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MT&U$US2*X.]LD>&9+VSE.6-FY25M'P'# S6<HW_M<(ZTV1 U'7ZZN*Q1<LY
MB,!9???V[)@\@4[\=.F'+VU?F+1]PWGX<Y?SP(@2I/JVEZV4VL,C^S*$0'[G
MQ;]]=@)G@^MYG[!GF6X.[+O^%+*/+. .IYRZVK5_S5[_]-,?__#'/Q8447T$
M D.0=(P%D:,L\'-/!WK;_B9#HEKD&U#EF<;W<1][ 8U!X/OHQ![[1&^U==&-
MBEV[-FSZGPJ;SNG"!RTIX_8B;?BM3OUMIUOO]/U^NW6B Q/NO$W@L3?0"9+3
MU2K<HVWGEMVI8-TIW>F671MV^E\+.RWHHDR84B8I:2)IO^USFPO]-@J9/I7
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M"C)\_N\-VU(TA @*1)%XVYCVMF>:@(O_ED;W3TY$RXW,N38-&U2T>S "&$A
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MNCXTO68_B=9 O7+./_+!H:&B[B7009')CDHAJL"EK@:KI08.5YFF[-].$I9
M]K0,EH#?I/$&XA?_4$DW;&[TBOVH=A%G_)=O:AJ^FVK2Y_0QN0KB)-KS@##V
MB-$XP3QO)OD'&W8NO="M8*1EYYDP=_KJ5>U(24,CDX[IZOM-^/QN=7#Y?-D/
MZ339/_Y12$KZ&#J1"Q%5$5TQXC$D>L0@D#RP _Z1#?E;CH>^5";;%9Z0%F/@
M&$]$VX(Q5.2I4?=]Q28U]YN,)7C8;YPM/<\@O>7FGVLTX5>1 S60O^!&F<I/
MI+Z7T>_%I1[GA/V0,L#^\0^>K\ND"G;3Q+=AG#C^__%V9Z&;GW=#X[[3+3[[
M\)M_G&XW-& K\3D#GB>F4M9BTNN%&ZT22I?1_?YQ)?]U1^-=R /SF-(SX.+I
M2W^R3T+I:64H'\()X"Z9HL(8A8>--;@)@TC^$TT1:(NI^'C,T;?ZF<&G'>U$
MV =*+6=PXT:'VN^MOM=D>WQ'GVFPI_'I(WOGG552L56%9I--6,I3MXX'6D+%
M?/.M#%]L#R_APU.XCYW 98?RX86)1X=E0"^8A!\>*-?T;_?1ZHEI^_# 55^
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M;FO&^&B0^=B%#J&N3(\)$3]^N?X2\S)&Y?;C-ATG5(;28MR56I#69 8W3[Z
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M@SC^;<@1G1KM7"VZSLML4I/25-U^+N#.E4;3;*OIIGN[K/5WIW^W*B^FP4^
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M.=VS50NC2R_:7N5C)(I_MQIE]MD+O.U^6RJ>%/\^A]RV!@M%OIUA+49*F\O
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M,R'+@*BY8"M]-@2GP]8/)O3U+IV?7[6%MB9.?DU&7HWTK8&W/MH)^Q3:2LY
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MY>,S*#"RIN-%.IOC)",!B6F/#\PC*E,.5%\$I!!0LJ6Y,.7]$D0"5T0L]HS
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M<KLAAGH*%X&1%!,DCQJS-L 1LN77<Z3<*G8*"H7/-'""!$#X8\!LD3YJP!(
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MK-V[/TQ:]@N_#H/-"61R,64L:]D_&H;J'2XIW6E\+F;0^XINEVE ^XPQ5^F
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MSVR>^ZW$\]]A.5+PY@^2H24A@CAU]N3E^:R&.5N$YM+7)K<@:HUA?G8C28:
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MRS51PQ$Q'OP2+&,X)+9@*R%&Q1RRKV E:C&ENI^-T0.75+4F<VFV:>TF<&-
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MGV%DN2:"(KDZ,D9RWT_=SHS^K>CUS=A]<;H%W.Q_&BY4Q_[E4_4PZ&- J<E
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MZH*6M;B<01SDO0EW=M;]GFY$VAD$P02;L]#=WD;AVDNNPSC^S([R/J)_#5_
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MY"P?34I\MFL$2Q!H 53'PY#?8I>F 7OFT&#L"[L*P#_(O@OXY 0 WC@0CE.
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M)O11/#HGEW@OP_T"D27)!F%FP! ,!0/Q>RBBYNQS L9Y'3=@ID#]*PK.OO6
MQ2BH\"@99#*)1;I*"59T*# H%I,,#[L@R"LH.AD[:,<125;2_@LAO18"\?G
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M!O@S$O$ >15+_.-3 K\2'O\UD\3E.TJ788;NT[ ?D%\U+OJ5T.$E*2GX!(3
M2Q-^>]*L8LII\ @1GR(>.:B?,D#?7,+D_""34S$369HI\$U<L-,T XC*=)M
MX=8 HIBQ)@JQU8-X*8N/>.)70([%=V;)8V3,WJ0^S<.]\FSM_@(!IUA:%-QQ
MFI.,?!-"^5T_MNP)K\,9I0]Y$ XI2BW@PE)ZK<N?^+#90QD2<6'3 @@.@S9G
M^8R+E&1"^!'[MY"#T<O5S5_HY,L>_[1'OUTD4^+KEGV^^)5 P(>34+6F(193
M8<@@=HHB/6GKA^-CW<.:?F[7*I[;L]5J6_,!07T2_/OS)";/HIT?01S'M^'.
M./VE7Q#@"11,8IR=@5!'T,\.F0V@?>H(JV&@CF15">WA&PW,H]V0N%]0C-=,
MA)\JI\$&KQFPJH"]:+!"LNP#Y"E1_<0L68O:N)JL]F^9SOF*XAU!YG^):4'#
M038=&]?&#AN<I4JA=\:7,/KH6D]AN"3^F>+D9\DG1!%J7%)9WZ+A>GB-Z2J&
MUVI#G&X2K-O]LP]RB*16QHDGCCL?CJI8XW/DH%')G<T-U'WQV=SXPOBC9=[P
MW7:]P<I\"B0M4KSSMDGF1XL5I <#K%% .1[FC"P_!>\J_C'PBY$D:_*]8H':
MTUBFD$C%_R^(12(*.X[Q7_V4V N&\X2*/O$M/FM7$-X0>&_L0PZXQOMS+_6#
MBQ$/?.!YL64:ZF!_6I?[X+?S_3,L0N)>WS^$V=\?$LA@NO5CGU[F?<^QR@<\
M^(('GZ#A#?PCD]B!*4B$_PQVZ"3=/^ZVVRA$V0/*$-1DO<7Z4AKZ$: 1/^:[
M(.R9Y5I^R>.?\OBWO.)C!(V9?6X:Y^4$$JC#9W26Q+@IM!-(H!('VV3_1,:_
M7_(_"4X*N3$'F> (KF&"CT*TLI%GKS_Y?(<6:#5DK(FV7W_R*XNK$#T9<.RK
M\G1),(FAX!KH='BI]GQ*E@-Z?,0)(\';4G:)G9I91EEQX?UPB*N/N\W&3TFD
MGV@0YV6,1\]5FYY[,_L!-T:?%)*8$+*W>-CPVI2#!9H)!3LG#3>KU$->)U&
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MA80IH7A9\<KU?IP(7R$AD)7O5&_(437^D5F.CHK;VLX4N88K8EGANG15CY[
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MP]_Q^(<LUF@;B??*T<.Y9#KT!*#BM61U&8/\ONUEFBJRZ%(JS9FSQE:L!,,
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M1\GP"CH@#UO$?B6@-1.4P+0GLIHN4XM9$NI?;D%T8>PMF>@0%=VR$%VM(E<
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M6'?*PJ7R=IGBNTX(6)MU().,MH,3+(DA(WI8.WE+^_?L:8I\5E(FP(H^)/^
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MA40 J4J?DK>ZA4G7T@:A]TF6^]'_";?:@T':>"H-55+26]1*Q3]/1)*J**)
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MEU](O,HA_8[Y_:ZZOD6Q!X1/]<2K'02 ?S$6=9Q9W,.M3^3-T->6R2EW)3X
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M?_WZ#^ $R?X[H@RR)NCWJ?)&&B$H.5=7MH89PK"BDPRLT88PKB7WO]:I>.M
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M4;IU@@!X-^=B7?.!G01JA[>:84@(U4C5DN *[+D7:G8QN51+U+G35L(2N)3
MLD3U(NH650M[X?;N(B<7L0+C6$O"=5A&-?SXQ%6W@2:IP30TW_42(?<W\9T
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M2#191E7!;I.9.=YR%!L\9VX!^9NC5<-5T?K%;KO_!-#UXTN.H 8:=X)9XJJ
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M-_5E!4;36>H</:UPH%;HVN!,2S#FG9+OAK(E9^"OG:FNG:DXJ#,*$S"RE.(
M2Y&<(A-:VQWLE+O1%.3*"FI2ON"3&@O9BR,WN]_)9.C%2980CJ=#M5#.#E7<
MY["OFL)KFA$SBUXMG=PCF1(/R^DQDG^DL7_:!,03F4#U0A-+D9S:!&+4O9A,
M/;WRN6%>6=XMJ*=@%A4A64X5L\-7[;HFD\EMAC75,'<M[]5D&']*E8V93'(S
M>%1#,Z )C]R/P[,]*O0L;ZIDV-ZGEOU9WJK),!)W*QBTO$O4B+2?HJ+0\OY4
M:JD_7EVBY7VN3"*S7-&C[0VRQA$K$U5(VMZ4RS+B,VHH1UF%Y08UNA=7VMZ/
MS;8%:)9>SJJ]U5MZ.#CP7/3I;3[.FWI=^UVQ7WSM=V5NOZM50-X+/#H&.7<S
M\)><K VYQQ!M?E!&RY[P1_"RL!L\\&:8A@:W;P-_SGQ0T=\Q"@<0D6[?KT+O
M#IQ $!U)9#;C?5%W .%,;6A] 2& 3H!@6WD'I(*1\G=P;84,8G)SKT<DKD<D
M)J2OK*8SFGA2M8X2:J]V(S-?)EM"#UX)HTJ"7"L3Y?.47+J;3#X)(25ER33J
MI\1V@LG55&,01=+*F'% (0NAK%R$-4+P&D:XAA%L#".8U3:[.#9+*A'+7P<W
M!.S]6OM.V^>!W4J-UCB-"YC?T<[)QK?7'K/N^]H^5T/[W"Y1VQGUJA6(!E([
M$Q>YI2\PBI6;&)POF=G=M9KTKUQY1Z=*]Q=9RRL/$=P"'Q=QYI>V^9"\(1ZK
M*XST=ZTE:9;:S:_ P\4^FPC_-)5A(/UY:PF<;SMLOH]*R?9WK"599?4;A9:U
M>R_'MU6Y7S>7O$QKC:H(QR"Q0@CL)7.!AU9*=P/"7&(/U= :!,DPF*Q="K%*
MU[ 6 X&R=C$J5H$&JLM^W=K^TFS^>04X"()^OXW"!#INDCH!/K'P*X_4$T-B
M+=D[[V86#;B-Z<T T-I%8F_^J5>C#R362OP*CSTBG/PP]EUAD_M1OF<M"<6[
M=[7;0;!S$C )B?O#,P?A44=I AG1_."UCO%:QTBEKWS+G/X):\M)9-A))W;:
MVV@Z+Z_]LSEMT6;9&9:;9UYVUU0S*FLGZ%)E_;'O42H/3*:T&:PY?CM:^X_"
M]RCN,+DKFK5;7*)@Y-H$; 2ZRU>57!N$C4!^2LW)M1G8N'XD/[MV;0:FU+?H
M4<=R[1,VQ@IT+'&Y]@[38N1H6!3[37C-53#7%E<C&T8:R&]]CV4MY3*C+,4\
M/#0S*E3&6:%Y.'%3U\^,LA17/X]=4S,*P>?O6(Q7@3-*0'H>/L9(]3BV-.^X
M].W(VIALG$_D,7F>GP'[&&XC>,CZF6CNTH$@NX4  7;K0'A&8,ETX!!,TE8*
M1H6+URZ#,\$L)(3GZD6SM/<TE&I?J/LP?+E;\^O:D[.PP6=KL%K@8YA4 $=_
M78#&E\*5_9&^@&@'G>/>=YV  C-_[+0@9[6'52"HG,T?:Q_(^MN+WF^W #>'
MNBBE5\01V++WPQ09.NLCR,-Y#([O\ *SQ"=G%[/'FX7"4 V@EOUBX/YY%YW^
M$B='F*&$_U79->BO/[ZNFOLC_]4@^2[1+I@RW'8$],LB! >^6\>]C5)DY)^Y
MU@%]K&%B%-_;$;I^X&?N3O( /-R.$"O=%,%PK@WN)%^[O5ECFQGT>>1'XTZ-
MP?])H1][OENM8:6B+)JE#1WL<F8$#X+H ]_B=P>V "()B[=3'(/D=H\]VL=P
M=<!\R<"O\VNT(9PK[W#W%,5Q58>P-"=G@N)^?.TO/>1?NJ0@?T<.1 /0;G/-
M4O=<IN+-4-T*D?8I,=5EIFDC^+<0EO<N(4!O0 BV/J[NR.7H"PB=(/%)COLQ
M3 !$VF?ENC!E=L8:\D;]ML3]IW/PPSP<%;O0)S$UD4G!F&7M$3:Y2%@UTLD+
M-YE\[D B-"SI@M":4MMP9$6ZO%T<46PW*6^'CTPF!?_TCE2,"9- $":QA *T
MSO]J2&!'K_^^DH$K)KN$G8PFCM0Y-V'\2:A!;#F^)GECADJ"6+^+I*+)1)@4
M 32C$>UPAPPKJ<+7GS/:!\/)8#WWRT8QJ\1@! IG<7A2SKH4&" F4V)">Z)C
M_-5RJG790<+ K,D':T?RU#A&B<G4&&4_=8]T6WZ N#N)>+'Q,8@Q8?F^/#$Z
MAN(M/^VL*!PXYI:9L&Z](Y=(90TL/R?<G4$&Y1TL/]?;G5K"](0MQ<"-F_QN
MHR!PWJ-L)V"SS'?Q_82K'0390=@QZH09V3TA+*T5JB;Y.LQ6G)44?IE6]-ME
MIK[KF"HGHA%XSX@-+K]LT+]BA]CN,;>JHNM;%"]/D0IZ2,D!"O:->/2!D]9V
MDK@"@$<')F?&96W,89,"^@J.*2*54V'6)E#,HE3YN?-#::1:-Q%J>+=1&;_Y
M=%*POCJ?_B$], &K/]=7$H/>O=Y6I!BO@)<Z=OK%9@B.RS/%0K:IN>[:=87L
M<9.29_T1 ACO_2-S,S='*";5ZK #84D MCJBCM-#*@8WU9^;O8J#!2]O-9%W
M(%C'RXAI)2QR)+@2MO9\')GP[8B<KS#)#U>^ A?XIU;MFL0$Q= ]1R>DFOU8
M8B>RAHX$D1B0R=>+Y<"(IDP!H31<JJ%YB1+<M]P)OOH!B),H!!R(V(-5<Q%I
M?+?>;ARX TG\Z.'/;GWZCF,/UF9M(9%$ BE%S*F4XR\ XC[QS@[<G%\<V*9S
MGS<H)GZYN%]!LH^\5W "84JR@5F@C;8&PCECABNHU\<RAZEF5;"+$E\ 1WN0
M8BBR5@MQX?WCAB(T.&C#E$<JJDM/DJ)UWJC*#BQ?J8&P'F]13=$X\0_(L/<*
M8MU&<1)7(CVTN]>ZS-1X?IS0]@%&AZ('S0\_V=^FB)X' .\_W2 E73KB&*#_
MX< Z0TCU>9.^\W%Y"C8'FH%2<Y3RW>$?WE,8Y]&5F*IFVX/T'V'"D@,9(\*3
M2^4X4];Y-H4<-<L8; KPSU'H=H&_,MZZ4R,]TR=EAE0V@V%YI5_/=$9))D8F
MP6BJ" ]4\%(.1<%?A]"X)<1@G:U02@WK2V09N8."$(WXO=%(RAV7X$7Z:]?4
M=)4D]M*&FE(HMT*5.8S&D<WD0Y4G/?5A*3$XL?4287H"PVB$A1Q.37447-XB
MB"6XLI1<%V3GH<.ZIO;KO%Y)[YA,!&%U>H]JI8(KZ':1I><61&9-/6EF*9**
MU!HK>V<I563T&S,S:#'._25@,RMI,A'&DH "_\#20SHC2HCQPD63'>4:H"PK
M[I*EAY-&80VSJ3$F0S0,;DL/:0UE"DZ]A*7'LX92A%.K8>D1K0$4Z54 8NFQ
MK:&,(ZXSL?2$EM),UIA7W4YP5<E@Z=(NK['U(L*AI*#6^(Q"# L\^SYE1K9>
MECB8<21+F6R]ME"!ONY5$V7K/8,*Z-4JIK+UHK_A<JA5T&7KC7H*V()2+F;K
MI7;J-TE9B38*2<RV:R7JVZQM/G X^$E11)'UX-R!T/7'N9Z,60_/A.(":FME
MZJ7RG=Z@O)Y?XNN<%@32LT<ZJ/($'"3M'AS<+@WW&Z%!R1Q[/48]U2&_P?6Y
M-TZ VWF][0%(</<W(@39)ZF9PXU"@'OA#6?"')#0V,M@\N/M4;C#00/2@(Y]
M/I,V3-M*9QV.<EG)OYF).E0;X$\@2;"PSZ#BMI:A#M5X.BB+$2!%>H>,M" Z
MDASQ)5U<^,>;Z 5 ;-8\1'"=[ &,<6:9NT1JWJV/--'9"9)S:>KB7<+O&L2;
M8<B>XF@ORD ;V?+FC)F'@Z>:=]M(FFEVK/Z[\9Y '".XRDZ;V (77\PCFG7M
M,T2C-"+2I2\EKB/_A4E>RE"=NRB!/KZN_M:)]\*#=\SA&H\.'J/81QXPMMMB
MB9.#C.%:-RD ?38I;Y;J5CEAF#K!@_^)8UCT+AG-(:H[=I05!.OM8^A"C/!C
M* &7W$3%T#(_M-G#*-WMU]#?^:$38,LH#XW08._S&J,8.0.LT)8=>+DQ4:]@
MIYQ8;S\?D=]7.V1)[_#=!)EAO=X^@^3-"4",GH7G%QAYJ9N\10&U"T?/-^D_
M?$]H^^KO]LEZ^RT&1&0SEH$_QQ!4GGSGG?@44DA<1ANUHY'T 1^9Q.FPG:NS
M5,=W\/O?CHX+D U>>&W4" ]UH')HVLCC.#T.RX<[9FM%\2RCF "G%_ 1!,X5
MU,)IJN4E!$?')\KQ%;B!0\H5(K[TZ##1$!&25]V*;U*N#38$^!\ $Q5XJQ/Z
M=8=D O:2JPJ?Y3)U?HUBWN)^G]AHF,Y.<!-!&'V@<9C!<[5+8[E![[.UPTF?
M3&VE-E0^46KR.4]QF<$@,K'SLI821?]QSVF[6(@2K=6B$EXZT!)*\*XY5$,*
M2\[ +[N-AWR"^W)*C9;5M1Q]7M:WRNWT)*OER"M-Y]1JG'GI2Y.))GNJL6L)
M694XM*2HR321TZ)*LZ;U>GDE3&H)A7G:V6P2ST'KB^L6V!MY3$:;[I147U=(
M.OUM*7GTM_:;NNG'$!7']B-,[G$QQ>Z@E2R83),QN656O3^&L@:[*,1DNDPA
M3!29/79W$1G*7NR2';M[B:BP5[B50'8W%AD4V6X5^MC=/600+21+H>QN(S*(
M0KW*K^QN-3*&\&E6;UG>@D2)Q3SB87?S/>M!E6F6]R$9RCV"LC;+NY"HI4ZE
M4L[R;B-CB.5:"9[E'4@&22)&Z9_EG4@&DD1<?VAY;Y)1W*Q:0:/EG4J&:7>Y
M.LI12&2/M<RJRAPE?&J/A=R]WG,4@EEB2 \K*[6E<5"%$I&#6R>] 3?%@%]Z
M)XW1,4C!P<+WY#&,$YAB&%NKV#I72!^M\5QD%2!:#R'>2$/ YIQ>IPPT!.CV
MA0Q<T"O#;4? @!/O:.,5A7&%0Y#GPTLI>NL@CX%]"JO3*Q0?-,#-2=T]6(?T
M5E7T,=J(_=V!/I866"UQ^84R4!O0+] _$$"X'4R:HZZ]RO2V8M#:6,K:=DX,
M*?-?O_X#.$&R_XZ$-S++Z+U\>".-D#@<VZ US B .XI(_<K4RHY)==ODUH'P
MC!M8'W!T1\J<:4P91\-O/B*AAK^,F6%+2@9YWA 'N5'XW0D"<+YQPI]L*K&&
M&L)YWT+DDWLMB[$#(_+?,!)?HD%BV[,Z2C$<A1!Y .#%\:G]+)I#E!\D]T/7
M/SI!1NBBE."2]:3!))YD"%M^=1(2?*%T(I"8H+Q+3GY-4!B<\Q@JI:\$=^CX
M$-WG$; .D-6F&++P!9C8P'A+\+483([N\0)#D+QQ8C]^.Z*]YZW#JDG%ZBP@
M/=T0!*N+<(?V9;@KK@?JN(*UR88@=QN%)P 3'Q$]^R<NX267M,@M'V^^(2B^
MDN1:J2VDT&K.42SRZA^[_T2&/*#J./K 4:$AR4@B4J5@J@\?L2$7SF34/D:"
M#%3#0#Q+&VM^05YF_!3ANWW6(=)92""D?KS'P*VWF+(,]A3/4VT4XEI-;.YQ
M;3#***V[_B*#BG)3_&MF(/($&G^>(2CELA9XE]WWMG>0=GF,XQ1X<O@)7S+E
M%GX,-Q\@.(&O49CLJ3=9=)D^+>2_ P=N/J(>0!<SIX5WM4662'^@:],-T>Q5
M/TG<OE5NKB&H5?PMN6QL;8)1N<#;Z 1"AX^+>)[R6X J+_\6PMKI.UQ8@O[O
M_G]2_^0$H-W[K=<KE%MM)%1==3#HUEI[F#;V**#([VPK&LIP[![>#.NZLDF6
MN=3/[5%*2NQOL, N.6$C7RV1L(0"O&X>PTA@2;<-<0^B#GN!IB38A2:SHDN[
M/*BL:&S7KUB..3M_6V6&5DV)I5CK;RQR;:BGL-^!1"GH1*TO#&JBQZV ,1IW
M*6.&52%3%5<TH68)YCPCIA_JEA@OUU9ARDPW?H70K.@@-M4JA4B68JZ_1?1D
MW= D%3K/JS,9?U7:G5E$9G)SLS%EG* 6;59DD1!YU1HWDW%7+0^F:O8[0=>)
M#EN"7E9H,MZJU[UM&%O:?Z[KJDN4<EK:<6ZP2JC7@5K:6*XK/S#K32UM)J<
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M\<IU<1ENC-Q+',&P#4FV)*K[BJ0SP'J+S$TRHQHV,AH_.>&#V#;;FF3X=R?
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M]L8S2(CV1<_",U)77NHF;U'@T6RU+K,--=O*1GW95BTZT[2K;R0&JD=11>.
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M8K$CGOIB'+)'.QP"20[&HA\R^ ZA^2?_%_<M+PK8#QZ$@IX_&\+Y@_#!NB'
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M#\(/9B%9"KU[O@=HW ><=@WVP/N(YXA8 U_$-WKLVYZO@EN3&%A@$X&'=C-
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M3HE[.+36V V@Y%MM^S9W7D>QWJ)'Q>??>IXU^?W?/O\V#$?.[_\/4$L#!!0
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M4E<RNI!Q7?#<3C3^?Y'))98Y^^.=AT3&S>:K 8JEH!5"B<..G-YMUPJ_$]
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M(U\U C]?2<H9(%?!?S.-[V[4#].Z-P] A8?-HKPQ/$!0.)9]LY:"C;Q9-O)
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MBO[ P5(^!%LE.?:)XG_4<0L:J#&>>B?B?]6*"_1Y*GMIZ_6770KG2#,XFB1
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MH,V^AS9[.PQM=IZ23Q)]R('9/J"1:&+=/Y,$# K,@S0P)[=(/+S]S);E)DZ
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M2G2D" +[R$Q0Z5R!U&'249=YTF[TO9*N:=G62@,K2DR?MYV7W\<7XV@J$Y-
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M7-C,?*\788>I&1&1VXVAA)&11&X[VV@UC6_"T?R[;6[?POZ2\(R(*;ML<Y#
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MDU:2O(LZ! PV:P![NH!>>UR?@0A12] HJX"1.O"7/)'=-,JM  X+LGW#9/M
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MDF3^Q"+SYF<B_JC*446.0(I&9KQ"&Y]TAI5F(7 VR,#9BTT*G*VNXS\<'X;
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M(6O?-*9T$$;X\0L>Z</H_Q-02P,$%     @ UCME6BS:F,%B P  RQ    \
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MV:/M'LDO@N3O <H;1ZU'B-X\WFT,;)@,QCQ&O%*C),7 #MZ>:UQ?(HBICDM
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M!%-30/F,+I2MD+IUL^WL[%FW;C>L_0502P,$%     @ UCME6F4/0IFU!0
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M2P$"% ,4    " #6.V5:P7QFSI/Q @!1U@, $@              @ $
M:6UG,3@Q,#$R,C0W7S N:G!G4$L! A0#%     @ UCME6II4@ 3>;P$ KHD!
M !(              ( !P_$" &EM9S$X,3 Q,C(T-U\Q+FIP9U!+ 0(4 Q0
M   ( -8[95J@T9P-YY@# (_; P 3              "  =%A! !I;6<Q.#$P
M,3(R-#=?,3 N:G!G4$L! A0#%     @ UCME6OOR S*KPP( 10H# !,
M         ( !Z?H' &EM9S$X,3 Q,C(T-U\Q,2YJ<&=02P$"% ,4    " #6
M.V5:6UI)X0IS P"(L@, $P              @ '%O@H :6UG,3@Q,#$R,C0W
M7S$R+FIP9U!+ 0(4 Q0    ( -8[95H]OA<!3H(" ,.X @ 3
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M,3 Q,C(T-U\U+FIP9U!+ 0(4 Q0    ( -8[95KT,9 _U&0# *6/ P 2
M          "  =55&@!I;6<Q.#$P,3(R-#=?-BYJ<&=02P$"% ,4    " #6
M.V5:R PG6%B4 P#Y" 0 $@              @ '9NAT :6UG,3@Q,#$R,C0W
M7S<N:G!G4$L! A0#%     @ UCME6O'-.L&K7P( ^I4" !(
M ( !84\A &EM9S$X,3 Q,C(T-U\X+FIP9U!+ 0(4 Q0    ( -8[95IZ 7#-
M"=\' )!_"  2              "  3RO(P!I;6<Q.#$P,3(R-#=?.2YJ<&=0
M2P$"% ,4    " #6.V5:B8[LTQ9L!0!?"SL $0              @ %UCBL
M=&-R>"TR,#(T,3(S,2YH=&U02P$"% ,4    " #6.V5:PXRUD4IK 0"I<14
M$0              @ &Z^C  =&-R>"TR,#(T,3(S,2YX<V102P$"% ,4
M" #6.V5:H/'7&Q<F  "PCP$ #P              @ $S9C( =&-R>"UE>#$P
M7SDN:'1M4$L! A0#%     @ UCME6JU-&MZR2@  R^$#  T
M ( !=XPR '1C<G@M97@Q.2YH=&U02P$"% ,4    " #6.V5:I4;X^^X"   !
M$   #0              @ %4US( =&-R>"UE>#(Q+FAT;5!+ 0(4 Q0    (
M -8[95HLVIC!8@,  ,L0   /              "  6W:,@!T8W)X+65X,C-?
M,2YH=&U02P$"% ,4    " #6.V5:,F*4,X8)  ",20  #P
M@ '\W3( =&-R>"UE>#,Q7S$N:'1M4$L! A0#%     @ UCME6F;:^U-D"0
M:D0   \              ( !K^<R '1C<G@M97@S,5\R+FAT;5!+ 0(4 Q0
M   ( -8[95K66(PHK04  +<F   /              "  4#Q,@!T8W)X+65X
M,S)?,2YH=&U02P$"% ,4    " #6.V5:90]"F;4%  #1)@  #P
M    @ $:]S( =&-R>"UE>#,R7S(N:'1M4$L%!@     8 !@ Y@4  /S\,@
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>tcrx-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:tcrx="http://www.tscan.com/20241231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="tcrx-20241231.xsd" xlink:type="simple"/>
    <context id="C_80888537-091b-4982-a3a1-aa3b6067c04e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-15</startDate>
            <endDate>2021-07-15</endDate>
        </period>
    </context>
    <context id="C_80adfaa9-7e64-4331-ae56-d2faf130122e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_818e4bd0-25da-4c16-803e-b15c22766a34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_836b34f7-350d-42ee-8942-99d2e7240d11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_83a90602-679a-44dc-a030-989afce6a82d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_846a05b5-9501-4749-9b63-f20303696a58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_874977e6-74c8-4492-baa5-8b92c0c45d13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tcrx:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-24</instant>
        </period>
    </context>
    <context id="C_878ab1e3-bef4-47de-91e0-8a585da44965">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:PersonnelExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_88f996d7-3176-4d96-acc4-bca75e20d973">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8a10b701-7769-47a2-87ad-7867a7c281c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8a2e7250-3d27-46fd-80fc-d497b85993ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8e328758-f2ae-4a01-a2b8-6f6ee7b7ece5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8e8d9511-84eb-4a2f-b5e9-8f63d38450b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-14</instant>
        </period>
    </context>
    <context id="C_8e91d61a-7205-4849-ab44-bbb90d9d7dbc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_901900fe-6930-49a3-b719-454de9021201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-09</startDate>
            <endDate>2022-09-09</endDate>
        </period>
    </context>
    <context id="C_9426554d-c3a3-495e-89a1-e0ff0f0562ec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_95966560-3a74-4921-9ee9-1cddcc96757d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9a6fdb37-0d38-4efb-bcdc-bcac4dfcba88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_9ef145db-1e48-427f-ba89-3edcc3e04fab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-09</instant>
        </period>
    </context>
    <context id="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a40cc202-27f4-4dcd-b6c9-0784f4fc3205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <startDate>2024-04-24</startDate>
            <endDate>2024-04-24</endDate>
        </period>
    </context>
    <context id="C_a5bfb76e-5ddb-45ec-a10d-3be626faa8a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_a91d2167-0cf7-47f7-be6c-7f55b7976009">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:AmgenIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:AmgenAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-08</startDate>
            <endDate>2023-05-08</endDate>
        </period>
    </context>
    <context id="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-20</startDate>
            <endDate>2024-12-20</endDate>
        </period>
    </context>
    <context id="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-09</instant>
        </period>
    </context>
    <context id="C_aed4f300-d032-41f1-b165-0845aef59189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:ClinicalStudiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_af039233-7db2-4aeb-8cc9-c9ea8e5f25e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_af892904-1677-4b5c-bfa4-d77070df30ae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <instant>2024-10-28</instant>
        </period>
    </context>
    <context id="C_b0702c7d-48d2-4169-904c-8f9b8552db95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b2dd2d19-d373-450a-b7db-9467c2752ca1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b5d97542-6fb5-42e4-a0c9-e6757cce391a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b699eca8-c73b-466a-b522-9fe9e9a9ad35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b6ea31a6-d30f-4f27-baef-ea2115d03cdf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b78729c9-8909-4f4c-9a42-47160fbaf8ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b93aece8-a971-452c-bfad-9ca3124815c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ba7a6494-c61e-47ca-8fa7-218c1cdf4d7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bba2662b-9ecc-409c-9943-54cd0c91a519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_be6fc315-0b98-4523-a42d-bcf78bc16296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-01</instant>
        </period>
    </context>
    <context id="C_bf7b2383-6668-4795-a6b0-55806e641321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_bf8bbac7-91a5-4162-9f6f-1c2c9d31aa38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_bfb0ef5e-b57c-4a0a-a092-a98856d36448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c042479b-b737-4e26-b3ca-35e98d7d1ce2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c18aa170-88bc-4410-a5a3-854b425c1c5d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:OfficeAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c2b1d23e-b281-4f16-828a-e82b56e3f3ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c337686d-fa86-4eb8-97bb-fc4b534480c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:NovartisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tcrx:ResearchFundingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_c3b11d96-c0b1-4481-9a60-4395a254fe3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-01</instant>
        </period>
    </context>
    <context id="C_c42f4a3b-18a2-4352-9d50-5db3b2991bb9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c4c91cdd-5048-4fbf-83f0-0e66b2d854d4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_cdeccc8f-9224-4c97-9f7a-3c445b23e58a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tcrx:WedbushSecuritiesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tcrx:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_ce86777f-8d50-4ea4-a1de-67ffd1ad8ce1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-27</instant>
        </period>
    </context>
    <context id="C_cef715b9-0023-4326-a474-9157cf7c6faa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d15727e8-0174-48c5-9477-9969a5d1e3b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:OfficeAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d31ec83e-19e4-4031-83bc-b96faa6d3fd3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_d3be5aa9-5dfb-4969-963a-9472152a5c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:ClinicalStudiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d4c09ebb-c7e3-4e42-8f5e-44b4747af4be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d5ad2e31-c21e-4c2b-89a1-288c3b0bea88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:NovartisAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_d64f6a5d-5103-4e27-8e28-50297b0314a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tcrx:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-24</startDate>
            <endDate>2024-04-24</endDate>
        </period>
    </context>
    <context id="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_d9dfa2cb-1ca0-4680-9350-28dac51ee6d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:FacilityRelatedAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_dd4d0c32-dea8-4923-a9f1-ea5f1fab19f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_de26ea6d-2d44-490b-b9c4-ac54b2019aaf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_dffc028f-7182-46b3-bb44-cd753163cfd5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="C_e012286d-5a3c-48f3-9f8b-f6f2434cc024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <startDate>2024-10-28</startDate>
            <endDate>2024-10-28</endDate>
        </period>
    </context>
    <context id="C_e4bef360-1194-4876-bd72-1ba957b48289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_e646531e-fd6d-4b4a-a38b-4580a5b023cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-27</instant>
        </period>
    </context>
    <context id="C_e687bdb4-a5f4-4929-88c0-7990ae1b71a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e798deb2-ca9c-4e28-89b6-772abe4bb270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_e909c65f-32e5-477f-948c-5fbf09b1bfec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:StockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ece742b4-8819-47df-8c84-c8b14935ab7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-01</instant>
        </period>
    </context>
    <context id="C_ecf6ccb4-e42d-49a5-88f5-a3479b52cfb1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-15</startDate>
            <endDate>2021-07-15</endDate>
        </period>
    </context>
    <context id="C_ed049b2f-3575-4247-9693-a137665029cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-20</startDate>
            <endDate>2024-12-20</endDate>
        </period>
    </context>
    <context id="C_ed36ab97-8daf-4e07-80c2-c1cddcb96e73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:NovartisAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ed51e302-8869-4a0f-962b-de9484e3aa0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ed8ad1a6-62b7-4058-824e-b48462749a75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tcrx:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="C_eddbe2e8-9268-426b-a979-bd5adb43d23b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ee786513-1c43-4280-a1f0-021ef922f07e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:LegalAndProfessionalFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_f113cfc8-bb00-4b79-a4d9-fb6c7cf9dd11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-20</startDate>
            <endDate>2024-11-20</endDate>
        </period>
    </context>
    <context id="C_f2e7699a-775b-485c-844c-dcfb47970cac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f5d697f7-128e-4876-a4f5-90f1a98fe9b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-27</startDate>
            <endDate>2024-12-27</endDate>
        </period>
    </context>
    <context id="C_f89cf5f2-e2a0-41fd-aa77-165139327dd5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:PersonnelExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f9a562f2-21ee-4a9b-a421-f3871446c2f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:NovartisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_fb5bb604-09b8-4938-997b-19cc6a0d0d04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="C_fbb18820-4b97-463e-90e8-1723d8fab29c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fbfc4486-e4d3-49f0-973d-16204216ca9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fdf71ac3-3b5b-4e4e-9f5b-32fe46c5a168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fdf7f67a-bc90-4d6f-a82f-8fb0241be3b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_003184ab-3c81-4f7b-9c86-6fc2202ca43e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-09</startDate>
            <endDate>2022-09-09</endDate>
        </period>
    </context>
    <context id="C_034fde6a-ad94-4842-9909-97bb9d9de862">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tcrx:WedbushSecuritiesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tcrx:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-16</instant>
        </period>
    </context>
    <context id="C_03eb41a8-990a-4e35-bb1b-5a37935b24be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_043660e4-f867-48a8-898e-eecc448695b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-09</startDate>
            <endDate>2022-09-09</endDate>
        </period>
    </context>
    <context id="C_09f0d8e0-903f-4e84-86fc-40c0b86d33f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:FacilityRelatedAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0d869bf5-158b-47a4-9b8b-51e8110fb2d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_12bf6ad2-0a5b-44a7-a68c-7aaa96219405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_15c7b52a-5ecb-4134-84b7-1a74eee635a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:NovartisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_169ccb09-f794-4b53-b335-3240e68654d4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_197387ea-3040-4c38-8433-659c61aae89f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-26</startDate>
            <endDate>2024-09-26</endDate>
        </period>
    </context>
    <context id="C_1ae85ee9-048d-4bdf-b70c-933ca1975ec4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tcrx:WedbushSecuritiesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tcrx:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <context id="C_1d992a94-aafd-45cd-b390-139470ececc8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-14</instant>
        </period>
    </context>
    <context id="C_1daea7ab-e482-4c92-8f38-cdfc5e71c091">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="C_1dbc7479-5045-494d-a301-5d8982738033">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:LaboratorySuppliesResearchMaterialsAndStudiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_1f54b526-5c78-40d4-b51e-3bb57d254eee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:NovartisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-31</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_1fd87468-b7a0-44c8-958d-699705148443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="C_2094de61-2463-4b5a-b0a4-fca50236ad0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:AmgenIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:AmgenAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_21496e54-0681-4b2a-a747-485e2a96f47c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_21f58568-ecea-492b-a352-08d9e9a7f42b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_25583bb8-7b3e-423a-98e6-e7ade07bd068">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">tcrx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_261fba08-f9db-48e2-b812-47707c7e98ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_27fc5f66-3d18-42fb-8a66-2da06b8921bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="C_2862a7f8-f1a2-48bd-bc36-db1c53bfedf9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_289ecc5d-92a2-42ce-b62b-77ce749bb8ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_2a2ebcf4-40ec-47ac-8e0a-274ca41d986c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-27</startDate>
            <endDate>2024-12-27</endDate>
        </period>
    </context>
    <context id="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_2b9a5142-5c09-4228-8993-64954bfc0d19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2c53342d-2049-4853-81f6-ec35e8e6267f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_2c6c9c99-f3b5-4d27-93cc-9263f4bf5003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_320b3a46-ac25-4647-8016-94baaf69c8d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3314d2d1-6f78-49b7-8dc7-033a9967337c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:LaboratorySuppliesResearchMaterialsAndStudiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_331dd2a3-95d1-44e8-add3-bfa57011870e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_332482d9-8141-410d-8864-204366a2aed0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-08</startDate>
            <endDate>2023-11-08</endDate>
        </period>
    </context>
    <context id="C_34147130-543b-4bb3-9ad4-1f11d70023ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-09</instant>
        </period>
    </context>
    <context id="C_34b3c74f-add1-4a1b-b372-3aa22b07f70c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-08</startDate>
            <endDate>2023-11-08</endDate>
        </period>
    </context>
    <context id="C_379aeeb9-bc7c-43c4-9634-0092d863e599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3893ceb7-51f2-43b7-a23b-018b3f1f7b4f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_3bf172b3-d914-487d-92f6-91b61a2ded94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3d025609-eb03-453e-8fb0-40e7424de1c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-30</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="C_3d8664d3-d512-4213-ac6c-cd3db870f7c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="C_3df7ac2b-49aa-499b-bf47-812e00e80ff4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:AmgenIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:AmgenAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3e156d80-5523-4597-bd1f-80a161d4d41c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3fda7817-04f6-40d1-b034-58df0d9f5ec2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3ffa6fa9-6b57-4d35-bd3a-b88d3505d57f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4368cad2-f9e8-40de-bd6d-33ad7e1e108f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:LegalAndProfessionalFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_460d78bc-0419-42c2-a4cd-42262517b953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-09</instant>
        </period>
    </context>
    <context id="C_46be3025-25e5-4ca5-aecb-96f1a7b4e50d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:NovartisAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_47d4a7b8-0689-4bad-9d3a-73d2b5ff4403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tcrx:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="C_48705e18-c435-4ea3-8f65-3174ccb08c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_48c5a331-9cb5-4678-b525-bcdd61cc8454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_4a97a8a0-1e04-4ff3-a4c3-35e097fb1306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-15</instant>
        </period>
    </context>
    <context id="C_4c8ea6f2-9fff-4333-984a-67566fab4877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_523e5640-f362-49dd-8cd8-0a9f19fa77ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tcrx:AmgenIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">tcrx:AmgenAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_52a3b19e-f226-4939-bba1-6190de6d2bba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_540ebf28-46d3-4e16-843f-afe078c63280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:DepreciationExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_5458543f-e28b-4c69-8779-01decdc01ab6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:OfficeAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5dc478f0-33ed-4f00-97fe-edffa3ee70cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <instant>2023-11-08</instant>
        </period>
    </context>
    <context id="C_5fce13ba-5c69-4650-bed4-a3ea2c8f6f3e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <startDate>2023-11-08</startDate>
            <endDate>2023-11-08</endDate>
        </period>
    </context>
    <context id="C_6003d2b4-d18b-4884-abfc-799d0a8bb89d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tcrx:DepreciationExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tcrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_61ed6f0b-459e-4d88-9516-a58d66772426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_64da7f3d-8b21-4b26-8c42-acd6857d10cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-24</startDate>
            <endDate>2024-04-24</endDate>
        </period>
    </context>
    <context id="C_653bc1a9-0ec3-4132-946f-23cdbffd6e8c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-15</instant>
        </period>
    </context>
    <context id="C_66e41251-c3d9-4ef4-96d0-e6b667f2d454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_67b999bc-f4c8-49b5-89ed-d7a3accc676d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_68816447-84c0-44e4-a1c7-b78689002f3a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_68a5546e-4aca-41b8-aaed-3be56fa94165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_69f2d878-b10b-4938-9603-81cf10c7f68a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tcrx:VotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-24</instant>
        </period>
    </context>
    <context id="C_6c96b539-1a31-47e8-94ff-6a44016523a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tcrx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NonvotingCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7161914d-36e4-4f31-8cd4-0984db2302a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:OfficeAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_76bbc888-71d6-4496-aac8-fb489f0bd98f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tcrx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_78a26315-739e-4dd5-ae26-f5f8ac025ff6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:K2HealthVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-20</instant>
        </period>
    </context>
    <context id="C_7c36265d-e56e-41bb-b9a4-c45feaed4d8c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7dd0c966-6e37-4efa-b9a2-7c425a19b0ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001783328</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">tcrx:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_Segment">
        <measure>tcrx:Segment</measure>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Facility">
        <measure>tcrx:Facility</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_2ad2c9c9-dc61-47dd-ad6d-a55ef5249627">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_59f3ee8b-e621-4dd4-ab25-4fcca5d19985">0001783328</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_bd1b4663-68c9-4379-a94e-77356b42b1b9">false</dei:AmendmentFlag>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_67b999bc-f4c8-49b5-89ed-d7a3accc676d"
      id="F_932e05b7-27e6-43f0-b747-18268e09c280"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      id="F_cab03e13-a6ef-4d41-874e-e22967c6a34b"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_454fce7d-d7b0-40b3-a92d-04bed9475480">http://www.tscan.com/20241231#CollaborationAndLicenseRevenue</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      id="F_009427c9-5661-4694-967b-b879b975ff06">http://www.tscan.com/20241231#CollaborationAndLicenseRevenue</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration
      contextRef="C_dd4d0c32-dea8-4923-a9f1-ea5f1fab19f8"
      id="F_397b54bf-b523-4a3d-a66b-ad04f717b80a">http://fasb.org/us-gaap/2024#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember</us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="INF"
      id="F_b6b6acc4-5182-4b15-9f8c-8955c5b3abae"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <tcrx:LicenseAgreementDate
      contextRef="C_15c7b52a-5ecb-4134-84b7-1a74eee635a3"
      id="F_cbe52327-d80a-4329-8a4a-2b886fa94469">2020-03-31</tcrx:LicenseAgreementDate>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_026c18d0-35e8-4519-bb36-24650b15093c">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="INF"
      id="F_5592acb1-cb7d-4895-8078-3175a9a958ae"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <dei:DocumentType
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_c858a10c-29f9-4057-acf5-3d259cdd3343">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_4a445587-c256-4c36-8cd2-1410624d3c50">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_70fffb19-1111-4217-9e95-145df2f013ea">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_8e285191-5d69-4b4c-8bff-747794985cbc">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_a9351877-4f7e-4fad-922d-adef67e0fc1e">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_640ee51a-cb9d-4fed-b88b-22a1cd9ccc49">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_5bcc1695-03c9-4782-9a6e-23604e838eb4">001-40603</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_d5fa51bf-01be-4bc9-9fc2-0ca2c13b05f0">TScan Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_41f150f2-a48c-46e6-9691-ca99a01936e3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_9e6f7003-c908-4d5d-95c5-a56062610e5f">82-5282075</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_da6d1563-9b7d-4dd2-9e59-8e53b050a8c1">830 Winter Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e2203f98-4ec7-4a20-84c0-d9b99b5943f8">Waltham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_11818e95-62a2-43b9-918c-ca3f56434051">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_4f4e4ea0-aeac-4aaa-815f-70bdb9c982a1">02451</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e198d43b-4e44-482c-945c-8702d9bd5b35">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_0010419c-bcd3-4a70-848b-a5b48c33616b">399-9500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e0a76e2f-06ed-4304-b282-80c04655eaa3">Voting Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_2cfc7a2e-09c8-4828-8ddb-0c3ca212a6a8">TCRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_c3bc1856-7f6c-42db-92ea-f692de5a1589">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_4d38b922-a5b7-4970-b6c0-41936b6fe959">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_804ea366-8071-4116-90e2-c31b2b4fd8b7">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_532612fc-af30-471f-b40f-7f95f55463e1">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_d4557f49-2286-421c-82f7-e6c0763ed06b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_c20bc9fc-359a-46d0-8784-f60cf3b78a79">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_f69be7c4-8fa7-4181-9d76-dc812a3890fc">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_6de6fd17-64cc-4281-90e4-bae804452223">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_fb6ee188-ec14-48b6-a162-243edca63c75">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_463cd22b-2490-40ac-9e0d-e109372a3697">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_93c0b8ee-a4d6-4fb3-bbc2-4ee093a21a10">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_3e360cbb-4aaf-4147-824b-4449732ee6ed">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_289ecc5d-92a2-42ce-b62b-77ce749bb8ad"
      decimals="-3"
      id="F_cb357501-1ee9-4371-9760-dc41f5e8267d"
      unitRef="U_USD">201649026000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_dffc028f-7182-46b3-bb44-cd753163cfd5"
      decimals="INF"
      id="F_f685f9eb-cf2a-4f7c-8f5f-29e3ed83f94f"
      unitRef="U_shares">52314039</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_c4c91cdd-5048-4fbf-83f0-0e66b2d854d4"
      decimals="INF"
      id="F_7681701f-41c1-43aa-bc4c-5479a6f64c17"
      unitRef="U_shares">4276588</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_9e755f51-415e-4446-b989-7df9e900b168">&lt;p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;None.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_01eb8aa7-0db6-41e4-ab64-21e2942d0d91">&lt;p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Item 1C. Cybersecurity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk Management and Strategy&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We recognize the importance of safeguarding the security of our computer systems, software, networks, and other technology assets. We have implemented processes for identifying, assessing, and mitigating cybersecurity risks and we have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;implemented a cybersecurity risk management program&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; that is informed by recognized industry standards and frameworks and incorporates elements of the same, including elements of the National Institute of Standards and Technology (NIST) Cybersecurity Framework.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk management program incorporates a number of components, including, but not limited to, information security policies and operating procedures, periodic information security risk assessments and other vulnerability analyses, and ongoing monitoring of critical risks from cybersecurity threats using automated tools. Additionally, we have implemented a process to conduct cybersecurity awareness training for employees during onboarding and thereafter.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We maintain a Cybersecurity Incident Response Plan, or CIRP, which is designed to guide our response to cyber incidents, including to mitigate and contain any potential cybersecurity incidents that could affect our systems, network, or data. The CIRP identifies the individuals responsible for developing, maintaining, and following procedures related to cybersecurity incident response, including escalation protocols. We also &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;engage&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; external third-party consultants to provide services, such as penetration testing, which is conducted on an annual basis, along with ongoing vulnerability scans. These consultants also perform annual assessments of our cybersecurity program, which involve, among other things, review of our IT security measures and processes for alignment with the NIST Cybersecurity Framework and provision of threat intelligence regarding emerging risks to our information systems.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of our cybersecurity risk management program, we maintain processes around third-party vendor risk management, including a framework for managing third-party information security risks.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; This framework, which applies to select third parties who have access to our systems and/or process our information, includes processes for assessing and reviewing the cybersecurity practices of such third-parties, including a review of available security audit reporting and certifications and inclusion of security requirements in contracts, as appropriate.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have not been materially affected by cybersecurity threats. We may, from time to time, experience threats to and security incidents related to our data systems but we do not believe they are reasonably likely to materially affect our business strategy, results of operations or financial condition.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; For more information, please see the risk factors entitled &#x201c;Our internal computer systems, or those used by our third-party CROs or other contractors or consultants, may fail or suffer cybersecurity incidents, data breaches or other unauthorized or improper access, which could result in a material disruption of the development programs of our product candidates&#x201d; and &#x201c;Cybersecurity incidents, loss of data or modification of information, and other disruptions could compromise information related to our business or prevent us from accessing critical information, result in a significant disruption of our activities and expose us to liability, which could adversely affect our business and our reputation&#x201d; in Item 1A- Risk Factors in this Annual Report on Form 10-K.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Governance&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Head of Information Technology and Security, or Head of IT, has primary responsibility for day-to-day management of our cybersecurity risk management program,&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; including leading a dedicated team of information technology professionals to monitor cybersecurity risks on behalf of TScan.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Head of IT has over 16 years&#x2019; experience with information technology and cybersecurity risk management programs. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;This team is responsible for assessing potential vulnerabilities and exposures to cybersecurity threats, implementing controls and measures designed to mitigate these risks, and regularly monitoring and updating these policies, to adapt to evolving threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; If an incident arises, the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Head of IT notifies our Chief Legal and Compliance Officer, and Chief Financial Officer, who will raise issues to those charged with governance, as appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors, as a whole and through its committees, is responsible for our overall enterprise risk management program, which incorporates as an element our cybersecurity risk management program. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our audit committee, a subcommittee of our board of directors, has been delegated responsibility for oversight of cybersecurity risk management, which includes reviewing our cybersecurity and other information, technology risks, controls and procedures, including our plans to mitigate and respond to cybersecurity risks. The Head of IT, alongside the Chief Legal and Compliance Officer, and Chief Financial Officer, provide quarterly reports to the audit committee covering cybersecurity and other information technology risks affecting us. These reports may include reviewing our current infrastructure and the status of key cybersecurity initiatives, including the status of ongoing mitigation efforts, providing insights into the latest cybersecurity threats, and discussing any recent security incidents impacting our peer companies. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Periodically, or in the event of a critical cybersecurity incident, the Chief Legal and Compliance Officer, and Chief Financial Officer will provide our full board of directors with findings and recommendations from these reports.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_7b9bb5c1-434e-46da-8aba-0880b4086754">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We recognize the importance of safeguarding the security of our computer systems, software, networks, and other technology assets. We have implemented processes for identifying, assessing, and mitigating cybersecurity risks and we have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;implemented a cybersecurity risk management program&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; that is informed by recognized industry standards and frameworks and incorporates elements of the same, including elements of the National Institute of Standards and Technology (NIST) Cybersecurity Framework.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk management program incorporates a number of components, including, but not limited to, information security policies and operating procedures, periodic information security risk assessments and other vulnerability analyses, and ongoing monitoring of critical risks from cybersecurity threats using automated tools. Additionally, we have implemented a process to conduct cybersecurity awareness training for employees during onboarding and thereafter.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_bd5bd7f7-2b1d-4539-9294-de085466cd82">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_04c7bcaa-c636-4fdd-982e-52e3141f66d9">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_f35b419e-cc72-4d2e-bd3c-05645ffc02db">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_7b16b46a-f559-475c-8da6-836dddf96946">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_603b80f0-81cc-46e3-8357-a3d1d80a1a16">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Head of Information Technology and Security, or Head of IT, has primary responsibility for day-to-day management of our cybersecurity risk management program,&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; including leading a dedicated team of information technology professionals to monitor cybersecurity risks on behalf of TScan.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Head of IT has over 16 years&#x2019; experience with information technology and cybersecurity risk management programs. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;This team is responsible for assessing potential vulnerabilities and exposures to cybersecurity threats, implementing controls and measures designed to mitigate these risks, and regularly monitoring and updating these policies, to adapt to evolving threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; If an incident arises, the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Head of IT notifies our Chief Legal and Compliance Officer, and Chief Financial Officer, who will raise issues to those charged with governance, as appropriate.&lt;/span&gt;&lt;/span&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_42f1bf83-4b9d-48de-9224-53a14a6a1016">&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Head of Information Technology and Security, or Head of IT, has primary responsibility for day-to-day management of our cybersecurity risk management program,&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; including leading a dedicated team of information technology professionals to monitor cybersecurity risks on behalf of TScan.&lt;/span&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_df947706-450b-4ae0-9d91-8e8aa9c2ab36">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_d8bd629e-82c5-414a-932c-0967932b35d7">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Head of IT has over 16 years&#x2019; experience with information technology and cybersecurity risk management programs. &lt;/span&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_ea76ce46-92d0-4efa-99b1-5e6ae173d528">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;This team is responsible for assessing potential vulnerabilities and exposures to cybersecurity threats, implementing controls and measures designed to mitigate these risks, and regularly monitoring and updating these policies, to adapt to evolving threats.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_9b66cd9e-d7ac-4b9f-a412-72be570d4d6d">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_3f67f54a-26f1-4679-85ce-f6edcc05210b">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our board of directors, as a whole and through its committees, is responsible for our overall enterprise risk management program, which incorporates as an element our cybersecurity risk management program. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our audit committee, a subcommittee of our board of directors, has been delegated responsibility for oversight of cybersecurity risk management, which includes reviewing our cybersecurity and other information, technology risks, controls and procedures, including our plans to mitigate and respond to cybersecurity risks. The Head of IT, alongside the Chief Legal and Compliance Officer, and Chief Financial Officer, provide quarterly reports to the audit committee covering cybersecurity and other information technology risks affecting us. These reports may include reviewing our current infrastructure and the status of key cybersecurity initiatives, including the status of ongoing mitigation efforts, providing insights into the latest cybersecurity threats, and discussing any recent security incidents impacting our peer companies. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Periodically, or in the event of a critical cybersecurity incident, the Chief Legal and Compliance Officer, and Chief Financial Officer will provide our full board of directors with findings and recommendations from these reports.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_66473f7d-8f10-4b65-be2f-e0bb8ee2229f">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our audit committee, a subcommittee of our board of directors, has been delegated responsibility for oversight of cybersecurity risk management, which includes reviewing our cybersecurity and other information, technology risks, controls and procedures, including our plans to mitigate and respond to cybersecurity risks. The Head of IT, alongside the Chief Legal and Compliance Officer, and Chief Financial Officer, provide quarterly reports to the audit committee covering cybersecurity and other information technology risks affecting us. These reports may include reviewing our current infrastructure and the status of key cybersecurity initiatives, including the status of ongoing mitigation efforts, providing insights into the latest cybersecurity threats, and discussing any recent security incidents impacting our peer companies. &lt;/span&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_908eadf6-ea56-45a9-b1a9-d3ddbcd282eb">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Periodically, or in the event of a critical cybersecurity incident, the Chief Legal and Compliance Officer, and Chief Financial Officer will provide our full board of directors with findings and recommendations from these reports.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_8a2e7250-3d27-46fd-80fc-d497b85993ad"
      id="F_1bd949c8-53a7-4d48-a003-a2af6c1a6ad8">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_8a2e7250-3d27-46fd-80fc-d497b85993ad"
      id="F_7d351c3f-1ebf-4e82-893d-3955fb686305">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_8a2e7250-3d27-46fd-80fc-d497b85993ad"
      id="F_a3e07261-13f3-4fbc-a172-b349d110abf3">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_8a2e7250-3d27-46fd-80fc-d497b85993ad"
      id="F_44f15190-f0fb-48f5-93c1-cde8fc7f0b7e">false</ecd:NonRule10b51ArrTrmntdFlag>
    <dei:AuditorFirmId
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_19bca5a7-6834-4073-8c0e-d151f9740da0">34</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_3e4a3c0d-6415-44d3-a6d8-213990b9b4ba">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheets of TScan Therapeutics, Inc. and subsidiary (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, stockholders' equity, and cash flows for the years then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_d2be3a10-f26f-4096-9928-b9b76e58ee0a">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_494f3b45-49f0-47ec-baff-44c6232454f0">Boston, Massachusetts</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_847bbcbd-0b91-4f8f-8eb4-9cca7458be1f"
      unitRef="U_USD">178689000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_712d2bb4-1f2c-4345-9e58-225c117fc8e0"
      unitRef="U_USD">133359000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_923f829c-90c5-467b-8bce-2cd96ef8cbaf"
      unitRef="U_USD">111421000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_df7a9231-3a1e-48f9-a6f2-24121dbbffdd"
      unitRef="U_USD">58685000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_f1153738-8a09-45cc-844d-a429889c55f2"
      unitRef="U_USD">2612000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_7b09ca66-1151-4879-a18f-2e9750bc6c3a"
      unitRef="U_USD">2193000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_08de269e-3746-4dc4-8fcc-4a17c208fba2"
      unitRef="U_USD">292722000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_b05a5784-a60c-4b52-ad5e-ea09562dc79f"
      unitRef="U_USD">194237000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_1aebd406-33e5-4eaf-b6de-192d31862c2f"
      unitRef="U_USD">7242000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_4888f001-9377-4184-b102-f876368164c1"
      unitRef="U_USD">7742000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_80d38919-f4db-4a1d-bf97-fb863970d203"
      unitRef="U_USD">64357000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_2ec718b5-fe18-4057-ac1b-028c031b995c"
      unitRef="U_USD">63492000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_c275ae49-64d0-4759-81f0-3f40030e3f3b"
      unitRef="U_USD">5031000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_726572a6-559b-4ab9-94c3-39333625c577"
      unitRef="U_USD">5031000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_96afe660-52da-4e65-ae7f-7a06ff5ed3b9"
      unitRef="U_USD">1766000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_7796987c-5d1d-471e-8bb7-8efe9568fa6c"
      unitRef="U_USD">1647000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_c3601bad-3c05-4fa1-9723-480b4ac70a25"
      unitRef="U_USD">371118000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_9d40257f-ab78-4987-8908-9915ad04d217"
      unitRef="U_USD">272149000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_dba1879b-e62c-41c2-a2b2-4e7010e2235e"
      unitRef="U_USD">4278000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_1c281b53-e147-4337-9fc6-2fdb0e7494db"
      unitRef="U_USD">2374000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_a56ebff8-dff0-4a8d-81a4-eb7adfe9fbd4"
      unitRef="U_USD">15410000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_33a6f854-5f81-4a63-9b49-7c23b60762c2"
      unitRef="U_USD">10716000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_dca01456-36de-4141-9996-19011c6bfb35"
      unitRef="U_USD">4570000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_5bdcb054-0e51-49e6-b7e6-6ba8b95b82fb"
      unitRef="U_USD">3246000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_2bf73cfe-6a4a-4c83-916a-fef3f150656e"
      unitRef="U_USD">11698000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_e245abac-1ec2-4012-8f50-e2fbeb6f47c2"
      unitRef="U_USD">10137000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_13023444-2a8e-4a89-b221-293323c07afb"
      unitRef="U_USD">3347000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_77d02377-2e8d-4df8-94e1-e82489678afe"
      unitRef="U_USD">35956000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_d95ac6d9-01d1-476b-ae8e-d9938c4e031c"
      unitRef="U_USD">29820000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_a1cdaaba-b1c5-4236-8bc5-b7403be33295"
      unitRef="U_USD">1246000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_e8734508-3ee7-4666-a064-ef68523ce0da"
      unitRef="U_USD">5622000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_9933c1c8-15e9-4a00-b699-b447a3c4b858"
      unitRef="U_USD">60739000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_6c219d46-1dfb-45ec-a17e-19f4987eac95"
      unitRef="U_USD">59140000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_c1211948-4a08-4af0-a014-a53d9feacf3e"
      unitRef="U_USD">32072000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_5529e4f4-1278-461e-be34-298daf7069c4"
      unitRef="U_USD">26700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_14839591-db87-43f0-820b-054ba356050a"
      unitRef="U_USD">135000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_af747e2c-a076-4d04-b2cb-fd0505f3e25a"
      unitRef="U_USD">130148000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_a7aa3947-0e69-4a9c-9e21-b6251c0b2ffe"
      unitRef="U_USD">121282000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="INF"
      id="F_1756bf26-6a86-4825-9f3e-489f70e2256a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="INF"
      id="F_627091c1-8c57-44b1-83c1-c19b82322549"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="INF"
      id="F_13776cb6-155e-4e2e-b596-e5a22af02a48"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="INF"
      id="F_ba03000a-0989-4cd8-af63-f64fd9a36a79"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="INF"
      id="F_ff20bf82-c139-4451-8fc6-996ce97b93f0"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="INF"
      id="F_7f56ccc3-882d-4234-958b-b21c602d37dc"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="INF"
      id="F_1034f01f-92ab-4340-a66c-dc1b8dd8eb5e"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="INF"
      id="F_8c0d084c-274b-48be-a307-288b0d37e273"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_f1c8eb90-24eb-4a13-a280-0a4dfa727c05"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_deef4567-94f6-4aa2-ab7b-88f6db5e9f06"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973"
      decimals="INF"
      id="F_918c0860-cde5-4cc2-9596-957cc32de892"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80"
      decimals="INF"
      id="F_e900a7e9-6781-4647-ae67-2c9d27251c1d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80"
      decimals="INF"
      id="F_1bb19474-20ad-4808-98c0-0e3befd334c8"
      unitRef="U_shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973"
      decimals="INF"
      id="F_e647e288-de8f-4d3a-a0e0-3be5c4071240"
      unitRef="U_shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973"
      decimals="INF"
      id="F_53c354a8-902d-4322-87d1-4efc9fea2fe4"
      unitRef="U_shares">52314039</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973"
      decimals="INF"
      id="F_2d4db22a-70e7-42df-8310-0a4e1625addb"
      unitRef="U_shares">52314039</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80"
      decimals="INF"
      id="F_fb1d430d-8041-4aa7-9a5c-2459674e1ca7"
      unitRef="U_shares">43552941</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80"
      decimals="INF"
      id="F_cfcb0d97-d38d-464f-909f-3f6176c7f1ff"
      unitRef="U_shares">43552941</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_88f996d7-3176-4d96-acc4-bca75e20d973"
      decimals="-3"
      id="F_13884a2b-2c13-4f46-ac68-1467cd5eab5e"
      unitRef="U_USD">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_a0142b6d-5ecd-43e4-b387-7314a28ddf80"
      decimals="-3"
      id="F_f7295e88-172f-499a-b0d1-c275b6d0bbd6"
      unitRef="U_USD">4000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a"
      decimals="INF"
      id="F_8a18cbad-dbc9-4058-93f9-3acff1b4edd0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7"
      decimals="INF"
      id="F_db1c21a8-7f22-4c7b-81fb-12df864d6c2a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7"
      decimals="INF"
      id="F_98094f56-3e74-4689-bbcb-df509e5f778c"
      unitRef="U_shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a"
      decimals="INF"
      id="F_c40c6db5-47b0-4ea1-9453-9fd6de01f28f"
      unitRef="U_shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7"
      decimals="INF"
      id="F_9e988228-801d-475c-b9c3-aae978c26d48"
      unitRef="U_shares">4276588</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7"
      decimals="INF"
      id="F_4b2bc226-1817-4853-8fcf-ac81805a4623"
      unitRef="U_shares">4276588</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a"
      decimals="INF"
      id="F_303c35ed-d91a-4f3e-869c-620c12fd4c7b"
      unitRef="U_shares">4276588</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a"
      decimals="INF"
      id="F_99e1aa23-203d-42ba-903f-f0b13885e821"
      unitRef="U_shares">4276588</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_6cfcec60-e55d-4083-a515-4a3ee6fefaf7"
      decimals="-3"
      id="F_402b0227-ed4d-4425-967a-bcf8c89ecebf"
      unitRef="U_USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_4383ef7f-bf82-46ef-a75b-4b54d7ebf40a"
      decimals="-3"
      id="F_ddec6d4a-df6a-4a7b-b693-8177bd148e4b"
      unitRef="U_USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_84a27b2e-d192-4ff7-b633-35f75ca29ddc"
      unitRef="U_USD">616009000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_2423841e-1aed-485f-b057-f58c67b26213"
      unitRef="U_USD">398459000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_a319dacc-3b95-418c-832f-6310de1cdfa5"
      unitRef="U_USD">51000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_6476db62-937f-4d05-b258-5438286a8c3e"
      unitRef="U_USD">-375096000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_4a817924-7abc-4863-b6ee-2476e3da6ec0"
      unitRef="U_USD">-247597000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_a56f6f3e-1a1d-42f9-824f-ea75a343faf8"
      unitRef="U_USD">240970000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_85e630be-08a7-4853-8dfc-1e8ac99e9f88"
      unitRef="U_USD">150867000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_642e3508-8360-44b4-a9f1-30e93a8fb4f0"
      unitRef="U_USD">371118000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_506ff4ef-87b5-4079-aeca-04b2360b9132"
      unitRef="U_USD">272149000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_ef1a6991-a002-45ac-898b-32807e0b38e7"
      unitRef="U_USD">2816000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_1811c07d-04c2-4249-9c26-dce370a4c46a"
      unitRef="U_USD">21049000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_33916257-e4aa-43be-95b5-2a76d1693adf"
      unitRef="U_USD">107350000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_9fd8a861-877b-46df-8295-eaa7b24508d1"
      unitRef="U_USD">88153000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_b8d2d2c4-8fd4-4ae0-a804-8e784dc835d8"
      unitRef="U_USD">30287000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_b1cfd43e-c559-4c82-92d2-1fd58861c40b"
      unitRef="U_USD">26354000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_fc92d9c4-87b5-40fa-9425-7bc29713b3c7"
      unitRef="U_USD">137637000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_b5fc971d-3898-4fbb-a29e-b1890de91040"
      unitRef="U_USD">114507000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_99cc39e9-7bc1-4386-9448-0a3475edc7e8"
      unitRef="U_USD">-134821000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_ef3190f0-3665-44dd-ae79-fc59790a84b9"
      unitRef="U_USD">-93458000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_5aec1403-ddda-492e-a6b1-56d3128a41bb"
      unitRef="U_USD">12065000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_1c2ac4a8-caa9-4a29-90b5-359fc1d95d98"
      unitRef="U_USD">7999000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestExpense
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_6d3d75e4-fd80-4cf4-be22-97a86568c15b"
      unitRef="U_USD">3653000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_63009f8e-6f27-4d66-90ff-8c0860d2638d"
      unitRef="U_USD">3759000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_91e23306-db1b-4ab2-b787-003ab9495061"
      unitRef="U_USD">-1090000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_b9afff08-2352-45e9-ac1a-5c0345ec3f7d"
      unitRef="U_USD">7322000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_a593be1d-7b2d-45b0-922e-fee07e726574"
      unitRef="U_USD">4240000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_fa92b8ac-1a62-45f2-a16b-8837bbb31a41"
      unitRef="U_USD">-127499000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_5e942d3c-9fee-48fa-aef0-739eea89e8a5"
      unitRef="U_USD">-89218000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="2"
      id="F_05850cf6-5150-4eab-a3e3-93ec899ed9ce"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="2"
      id="F_46b4579c-080c-4738-af78-4e6e108fca61"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="2"
      id="F_268a6903-8511-4d35-ad3b-babe650ec554"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="2"
      id="F_96ae14b2-51b5-4b49-9f2f-b723c1bb339e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="0"
      id="F_f5ae9ffd-e4ad-46b5-ae05-b780d65acb2c"
      unitRef="U_shares">111990417</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="0"
      id="F_5762c584-7294-4e1b-b4ae-03b4dfd20182"
      unitRef="U_shares">111990417</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="0"
      id="F_73bc72e9-6cc6-494f-be32-453cd01a81bd"
      unitRef="U_shares">65599858</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="0"
      id="F_3ccd0d18-d3c2-458c-8f35-e32634b8ac19"
      unitRef="U_shares">65599858</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_00c0ae65-a50b-4af4-8dd9-5a359b26bb46"
      unitRef="U_USD">-127499000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_4028c84a-2ff2-4dc9-a8f8-d80687a40771"
      unitRef="U_USD">-89218000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_8508a598-63f8-43e5-affb-9f2d15cf57a2"
      unitRef="U_USD">51000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_2d4c0ffc-930f-4fae-a3e2-d040e649e4da"
      unitRef="U_USD">-127448000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_aed3149e-9e7e-4aa0-8166-d1971779f112"
      unitRef="U_USD">-89218000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_9a6fdb37-0d38-4efb-bcdc-bcac4dfcba88"
      decimals="0"
      id="F_273f109d-384a-4691-bc49-ba21a8a724e5"
      unitRef="U_shares">19082820</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_9a6fdb37-0d38-4efb-bcdc-bcac4dfcba88"
      decimals="-3"
      id="F_141f90b0-2f53-4a12-ab8b-1ef4bfdd17df"
      unitRef="U_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_3893ceb7-51f2-43b7-a23b-018b3f1f7b4f"
      decimals="0"
      id="F_10777a2a-1930-4d89-b45f-6971f1e38ca4"
      unitRef="U_shares">5143134</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_3893ceb7-51f2-43b7-a23b-018b3f1f7b4f"
      decimals="-3"
      id="F_fc55d590-e607-4953-964b-cf9ccf265ae4"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9426554d-c3a3-495e-89a1-e0ff0f0562ec"
      decimals="-3"
      id="F_2444112d-6a13-44c7-8513-e86b6e2b99ac"
      unitRef="U_USD">257810000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b6ea31a6-d30f-4f27-baef-ea2115d03cdf"
      decimals="-3"
      id="F_69942b34-af5d-4d38-83ec-8cf2e1b00117"
      unitRef="U_USD">-158379000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_67b999bc-f4c8-49b5-89ed-d7a3accc676d"
      decimals="-3"
      id="F_cdb3e88b-9379-49dd-a2f3-ec6261a6ef35"
      unitRef="U_USD">99434000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a"
      decimals="0"
      id="F_fa19264a-328d-4aa5-8481-1a831d988449"
      unitRef="U_shares">316441</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_169ccb09-f794-4b53-b335-3240e68654d4"
      decimals="-3"
      id="F_e2f30ef2-0a81-4d10-bf94-ff23d8f0cb6c"
      unitRef="U_USD">711000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_d6e0cb7d-f3d1-485f-aed3-eba064d3bad4"
      unitRef="U_USD">711000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a"
      decimals="0"
      id="F_570680fe-1120-4041-ab40-a17369fa09c8"
      unitRef="U_shares">23287134</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a"
      decimals="-3"
      id="F_06702ddd-94ca-466f-9038-f75dd0550651"
      unitRef="U_USD">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_169ccb09-f794-4b53-b335-3240e68654d4"
      decimals="-3"
      id="F_e615f32a-1ac8-489f-8cf7-83b47721a984"
      unitRef="U_USD">42412000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_b6ad0d50-1f75-45a3-af92-d6f12c861e5d"
      unitRef="U_USD">42414000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="C_169ccb09-f794-4b53-b335-3240e68654d4"
      decimals="-3"
      id="F_d7108574-6bd0-45c4-bcd0-09fa905205f7"
      unitRef="U_USD">92318000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_7d698129-87c4-4cf5-a282-37e6b56ea7cc"
      unitRef="U_USD">92318000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_a6cb142e-0dae-4ba5-bae0-9af447b2543a"
      decimals="0"
      id="F_7720c58f-1029-4e69-8038-5ebeafdbd84c"
      unitRef="U_shares">866546</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_eddbe2e8-9268-426b-a979-bd5adb43d23b"
      decimals="0"
      id="F_0bee5f32-2fd9-401a-928f-a12f89913f85"
      unitRef="U_shares">-866546</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_169ccb09-f794-4b53-b335-3240e68654d4"
      decimals="-3"
      id="F_f82a04ee-c451-4c0f-bf16-9cf1ae5cd0a4"
      unitRef="U_USD">5208000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_1136f689-a96a-48cf-aeb9-07bb132c0b08"
      unitRef="U_USD">5208000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_bfb0ef5e-b57c-4a0a-a092-a98856d36448"
      decimals="-3"
      id="F_df7e9faa-bd08-40a6-a97c-d8ff3bdd945d"
      unitRef="U_USD">-89218000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_1459c216-291f-49c0-a6b0-11377004fd2e"
      unitRef="U_USD">-89218000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_fdf7f67a-bc90-4d6f-a82f-8fb0241be3b3"
      decimals="0"
      id="F_b0ebb08c-2804-427a-9514-2f74473e91de"
      unitRef="U_shares">43552941</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_fdf7f67a-bc90-4d6f-a82f-8fb0241be3b3"
      decimals="-3"
      id="F_3885dfea-6dfd-43ff-9e31-f5ad509c3560"
      unitRef="U_USD">4000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_c042479b-b737-4e26-b3ca-35e98d7d1ce2"
      decimals="0"
      id="F_f513ee0b-f01e-47a7-af0d-71f77b9d5364"
      unitRef="U_shares">4276588</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_c042479b-b737-4e26-b3ca-35e98d7d1ce2"
      decimals="-3"
      id="F_3ca8bc63-89c2-44c5-a053-ada52c5df5ab"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c2b1d23e-b281-4f16-828a-e82b56e3f3ac"
      decimals="-3"
      id="F_09555e94-c921-44a0-8f2d-efdcbc19b4b7"
      unitRef="U_USD">398459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3bf172b3-d914-487d-92f6-91b61a2ded94"
      decimals="-3"
      id="F_499f78be-30d7-4a3d-b5de-6d66ec3f3b5b"
      unitRef="U_USD">-247597000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_60ca89e2-a1a6-432d-b728-e53c77f03a20"
      unitRef="U_USD">150867000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_846a05b5-9501-4749-9b63-f20303696a58"
      decimals="0"
      id="F_9ba967c3-7fff-493d-a36a-1bd6135bf6cb"
      unitRef="U_shares">586081</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac"
      decimals="-3"
      id="F_dffab4e0-5f60-4c29-94dc-e9ad69831ba7"
      unitRef="U_USD">1717000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_199d4335-f650-4a00-ade7-e0e8034335f5"
      unitRef="U_USD">1717000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_846a05b5-9501-4749-9b63-f20303696a58"
      decimals="0"
      id="F_f5db3093-881a-41d5-8ada-82e86157eb0e"
      unitRef="U_shares">82153</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac"
      decimals="-3"
      id="F_5952944c-97cc-4c63-a444-f6edc5a3c70f"
      unitRef="U_USD">333000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_7710fd19-5a45-4eef-aaa7-f74747878fed"
      unitRef="U_USD">333000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_846a05b5-9501-4749-9b63-f20303696a58"
      decimals="0"
      id="F_e28830f1-c84e-4eae-b378-b2c69cb5be57"
      unitRef="U_shares">4958068</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_846a05b5-9501-4749-9b63-f20303696a58"
      decimals="-3"
      id="F_a93dd2b6-d832-42cd-a68c-101ebfa0ec28"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac"
      decimals="-3"
      id="F_1aec4d47-e041-42de-b9bf-767b51b904bd"
      unitRef="U_USD">33130000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_b1c99f3e-7dbe-4543-a632-5c5bdda39aeb"
      unitRef="U_USD">33131000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac"
      decimals="-3"
      id="F_197d10e1-1cac-4e2d-bb40-a3e835878440"
      unitRef="U_USD">158071000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_f1afa491-444f-41ef-a665-db804381e57c"
      unitRef="U_USD">158071000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <tcrx:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares
      contextRef="C_846a05b5-9501-4749-9b63-f20303696a58"
      decimals="0"
      id="F_77713429-9527-48d2-a731-dfd42b55184f"
      unitRef="U_shares">3134796</tcrx:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac"
      decimals="-3"
      id="F_3cc1c056-c27e-40cf-a65e-84c8861c6bc6"
      unitRef="U_USD">14750000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_1a26845f-77b3-417f-8b3b-a5b91f41919b"
      unitRef="U_USD">14750000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_f2e7699a-775b-485c-844c-dcfb47970cac"
      decimals="-3"
      id="F_b98271c8-a03b-4bbd-bc3f-b1e3ceca51d5"
      unitRef="U_USD">9549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_f081d8f1-b7a8-445f-a60c-d2b9df056e40"
      unitRef="U_USD">9549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_a5bfb76e-5ddb-45ec-a10d-3be626faa8a8"
      decimals="-3"
      id="F_a389b7b3-03ea-4d1c-aac3-db1d37a0859a"
      unitRef="U_USD">-127499000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_44b822d3-fd28-4568-9142-244f40e7e11a"
      unitRef="U_USD">-127499000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_d4c09ebb-c7e3-4e42-8f5e-44b4747af4be"
      decimals="-3"
      id="F_4fec7b4d-de3e-4e44-8c4d-466124c384f2"
      unitRef="U_USD">51000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_18f5d0aa-d572-461a-8d5f-e83ea9973946"
      unitRef="U_USD">51000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_331dd2a3-95d1-44e8-add3-bfa57011870e"
      decimals="0"
      id="F_41aa9edb-47d8-44e5-81c9-d99831fb1f42"
      unitRef="U_shares">52314039</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_331dd2a3-95d1-44e8-add3-bfa57011870e"
      decimals="-3"
      id="F_567e38a4-1d46-42fb-80d6-a42acecd6bc4"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_2b9a5142-5c09-4228-8993-64954bfc0d19"
      decimals="0"
      id="F_5135e3ed-4fcf-4118-9b32-18260f274dd0"
      unitRef="U_shares">4276588</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_2b9a5142-5c09-4228-8993-64954bfc0d19"
      decimals="-3"
      id="F_72ad9d95-3ef0-4d92-9436-f6adf6d26847"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2c6c9c99-f3b5-4d27-93cc-9263f4bf5003"
      decimals="-3"
      id="F_367f4a73-95ab-4a3a-92d3-9cb825fe074d"
      unitRef="U_USD">616009000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_cef715b9-0023-4326-a474-9157cf7c6faa"
      decimals="-3"
      id="F_d219cb7e-c6cf-457b-af65-2877baf521d8"
      unitRef="U_USD">51000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_7c36265d-e56e-41bb-b9a4-c45feaed4d8c"
      decimals="-3"
      id="F_a247287d-b9dc-45b9-b76e-9c43d0d934bb"
      unitRef="U_USD">-375096000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_7df6d485-6344-4a81-8830-3d837d85679a"
      unitRef="U_USD">240970000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_be7df806-bb08-415d-8d3c-3187f4024785"
      unitRef="U_USD">-127499000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_31a84d30-5dc6-4e64-8995-f5d470198f5c"
      unitRef="U_USD">-89218000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_9a5ab502-72e3-4c27-a505-49cdb6af09a0"
      unitRef="U_USD">4108000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_2b222319-8a16-4741-9d42-9ebb3a5f0cd5"
      unitRef="U_USD">5361000</us-gaap:Depreciation>
    <tcrx:AccretionOfMarketableSecurities
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_f1fb09d9-9416-409f-aa86-56a58e546f94"
      unitRef="U_USD">-3897000</tcrx:AccretionOfMarketableSecurities>
    <tcrx:AccretionOfMarketableSecurities
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_458f44c2-f9e2-4786-adce-629a62bd0366"
      unitRef="U_USD">-1072000</tcrx:AccretionOfMarketableSecurities>
    <tcrx:NonCashInterestExpenseOnLoanPayable
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_ba179873-196f-4557-9225-108e88947b40"
      unitRef="U_USD">773000</tcrx:NonCashInterestExpenseOnLoanPayable>
    <tcrx:NonCashInterestExpenseOnLoanPayable
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_38f78ef2-bf34-4701-9a7f-71dfd61979e9"
      unitRef="U_USD">757000</tcrx:NonCashInterestExpenseOnLoanPayable>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_f2842d0d-5aaf-40dc-889c-f34bb5c5fc4a"
      unitRef="U_USD">-1090000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_c3efff1d-05b4-4ec1-a947-2dfb9190ab51"
      unitRef="U_USD">9549000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_17801b64-57cb-409f-956c-2fd558cf8fa4"
      unitRef="U_USD">5208000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_9a4f7bac-d2c5-4b97-9670-072f73eea115"
      unitRef="U_USD">538000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_1ad42e2f-b38f-4f91-a74a-776d275b4958"
      unitRef="U_USD">-985000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_ad634820-51cb-4f9c-8a0b-8e99fdc4a376"
      unitRef="U_USD">1881000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_1c42638e-5c10-4925-adbb-15f378e69838"
      unitRef="U_USD">935000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_ec3d73a0-c659-4ad2-ae99-5813d151c1d8"
      unitRef="U_USD">1994000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_e73368f7-adaf-4d95-8ae2-d1c9bfd5f592"
      unitRef="U_USD">-52000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_d07fe71b-3ba0-4352-97c9-58f5cc687c4c"
      unitRef="U_USD">4532000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_49c09683-2d1d-4c47-b527-879b0556c19b"
      unitRef="U_USD">3853000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_c94d482c-dabb-4053-a371-51d583f6131e"
      unitRef="U_USD">-2815000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_6c9cacb9-f9b9-438a-9813-a37591c7667e"
      unitRef="U_USD">11885000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_f6dd01cd-6f12-4d6e-9dcd-722990dc1bdf"
      unitRef="U_USD">-110822000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_04d23fd0-71d0-4ffa-858b-6f2fdcfb15e2"
      unitRef="U_USD">-61358000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_41593f20-a40a-48eb-bf2f-e3275eea5307"
      unitRef="U_USD">3825000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_7b4f072d-994e-4949-ba50-59f1805b5d81"
      unitRef="U_USD">3146000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_84adc221-c2a1-485a-b469-af544218e5b3"
      unitRef="U_USD">241445000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_6d8c3ecd-4fcd-4d6c-bac0-fb87b2b5e305"
      unitRef="U_USD">77613000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_291ec103-5217-4602-a4f2-da314a2e5933"
      unitRef="U_USD">192657000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_a1e515c1-5c4b-4eed-bd0b-e2ababedf8dc"
      unitRef="U_USD">20000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_6ec4e330-6ed9-49fb-ab24-6768a88fad18"
      unitRef="U_USD">-52613000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_31bf7c43-fdd5-44ea-8ebb-e77988cd9a7a"
      unitRef="U_USD">-60759000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_993bd262-1881-4d0c-81a2-056601588ff0"
      unitRef="U_USD">17144000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_737f5deb-dcf8-4e7b-a45e-0e623a4ab832"
      unitRef="U_USD">32457000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_aba31585-ef47-401e-b58d-2cd0686d1656"
      unitRef="U_USD">33131000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_ca954d7a-6612-4547-8146-9d9700fed2c9"
      unitRef="U_USD">42414000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_fdc1e2b0-08a9-47e0-8b60-a08466add628"
      unitRef="U_USD">158271000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_bd8b4cf0-3752-43c3-b591-e3f12cd89c0d"
      unitRef="U_USD">92318000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_64791f08-868b-434f-9bcb-bf57d3d651dc"
      unitRef="U_USD">333000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_60c7fcc3-b138-41fb-9514-ec3f530aeb31"
      unitRef="U_USD">1717000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_992fbadb-5c2d-48c8-aedf-68d626c2dfe3"
      unitRef="U_USD">711000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_8d916140-b81c-4680-8e2e-f9b28bd756ea"
      unitRef="U_USD">208765000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_8b471731-a58f-4df2-95c2-4855e30688a5"
      unitRef="U_USD">135443000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_a3bd5703-5775-451c-8459-cb4b9227fde2"
      unitRef="U_USD">45330000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_13e1dfa1-d635-4049-8c43-1f464c544ee6"
      unitRef="U_USD">13326000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_033d98b4-c16b-4bad-b9a6-a62bb51a1b88"
      unitRef="U_USD">138390000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_67b999bc-f4c8-49b5-89ed-d7a3accc676d"
      decimals="-3"
      id="F_07e0c670-9609-4b41-beb6-87d503f1d4e3"
      unitRef="U_USD">125064000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_bd5f1dc2-fd23-4aa5-89ec-f9f5a050b7d1"
      unitRef="U_USD">183720000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_1606b606-028a-41e7-b8f3-aaf81f352a03"
      unitRef="U_USD">138390000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_703e4b98-e45b-4d04-83a2-ad4eb2bca515"
      unitRef="U_USD">178689000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_59c7f6e7-d6ef-4e59-970a-2f54cf922512"
      unitRef="U_USD">133359000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_6b4e3cf6-7079-451d-b7dd-36629735f361"
      unitRef="U_USD">5031000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_13ac584e-0f54-40f1-ac12-ccc813973f28"
      unitRef="U_USD">5031000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_752be7f1-fe44-493c-a2ae-6621754105a3"
      unitRef="U_USD">183720000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_c81ed050-9363-4308-aade-a997ba888e1b"
      unitRef="U_USD">138390000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_ff6464c5-d805-46d8-867a-42f0b3254d1f"
      unitRef="U_USD">2881000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_a2e1d0bc-b761-4d49-a24c-6e41f7572de5"
      unitRef="U_USD">3002000</us-gaap:InterestPaidNet>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_f32fa429-2afa-462f-8768-e3dda405fb0c"
      unitRef="U_USD">400000</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <tcrx:FinancingCostsNotYetPaid
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_c708d10a-7fad-4514-a470-8d6044f82af3"
      unitRef="U_USD">200000</tcrx:FinancingCostsNotYetPaid>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_6a4fac64-fa3b-46ff-99a5-5048db79e1ca"
      unitRef="U_USD">6133000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_aef08a68-578a-4a0c-9dcc-1f7a242afadc"
      unitRef="U_USD">6214000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_443ffcf4-c2ff-4c51-9d41-bbdafa0a2c1d"
      unitRef="U_USD">84000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_80d895d2-3070-4975-b087-339137eef42c"
      unitRef="U_USD">301000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_de346595-1abe-4b5e-b517-8e7d710a7077"
      unitRef="U_USD">14750000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_d12ba335-fff9-4638-887b-65faf7bbef65">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1. Nature of Business and Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Nature of Business&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;TScan Therapeutics, Inc. (the Company) is a biotechnology company that was incorporated in Delaware on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;April 17, 2018&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and has a principal place of business in Waltham, Massachusetts. The Company is a biopharmaceutical company focused on developing a pipeline of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risks, Uncertainties and Going Concern&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to risks common to companies in the biotechnology industry, including, but not limited to, successful development of technology, obtaining additional funding, protection of proprietary technology, compliance with government regulations, risks of failure of preclinical studies, clinical studies and clinical trials, the need to obtain marketing approval for its product candidates and the ability to successfully market its therapies any products that receive approval, fluctuations in operating results, economic pressure impacting therapeutic pricing, dependence on key personnel, risks associated with changes in technologies, development by competitors of technological innovations and the ability to scale manufacturing to large scale production. Product candidates currently under development will require significant additional research and development efforts, including preclinical and clinical testing and regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel and infrastructure and extensive compliance-reporting capabilities. Even if the Company&#x2019;s development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from therapy sales.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has primarily funded its operations with proceeds from sales of capital stock, including the IPO completed in July 2021, issuance of convertible debt in September 2022, issuance of term loan in December 2024 and with payments received under its license and collaboration agreements. Since its inception, the Company has incurred recurring losses, including net losses of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;127.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024, the Company had an accumulated deficit of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;375.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company expects to continue to generate operating losses in the foreseeable future. The Company expects that its cash and cash equivalents and marketable securities as of December 31, 2024 will be sufficient to fund the Company&#x2019;s operations for at least the next twelve months from the date of the issuance of the financial statements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company will need to obtain substantial additional funding through equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements in order to fund its research and development and ongoing operating expenses. The Company may not be able to obtain financing on acceptable terms, when needed or at all, and the Company may not be able to enter into collaborations, strategic alliances or licensing arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company&#x2019;s stockholders. Any collaborations, strategic alliances or licensing arrangements may require the Company to relinquish rights to certain of its technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to the Company. If the Company is unable to obtain funding, the Company could be forced to delay, limit, reduce or eliminate some or all of its research and development programs, pipeline expansion or future commercialization efforts or grant rights to develop and market product candidates, which could adversely affect its business prospects. Although management will continue to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations when needed or at all.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_ddc2de20-671b-48e6-964f-30a603d98feb">2018-04-17</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:NetIncomeLoss
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-5"
      id="F_cd657cd2-c301-4b41-a458-4308b4e8caef"
      unitRef="U_USD">-127500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-5"
      id="F_6cd53e36-319c-4657-af1a-6158b1224e17"
      unitRef="U_USD">-89200000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-5"
      id="F_2039dfa4-ed1a-42c7-be23-422173b45822"
      unitRef="U_USD">-375100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_5e86a856-2828-4b98-9e19-c09143705309">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements reflect the operations of the Company and the Company&#x2019;s wholly owned subsidiary, TScan Securities Corporation. The accompanying consolidated financial statements have been prepared in conformity with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification, or ASC, and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience, known trends and other market-specific or relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash includes cash in readily available checking and money market accounts. Cash equivalents include all highly liquid investments maturing within 90 days from the date of purchase. The cash equivalents consisted of money market funds and government securities.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the Company&#x2019;s facility lease agreements, the Company is required to provide letters of credit totaling of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the benefit of the landlords to serve as security deposits. As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the cash securing the letter of credit was classified as restricted cash (non-current) on the consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company classifies all of its marketable securities as available-for-sale based upon its intent with regard to such investments.  Unrealized gains on available-for-sale debt securities are reported as a component of accumulated other comprehensive loss in stockholders&#x2019; equity. The amortized cost of debt securities in this category is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in interest and other income, net. Realized gains and losses and declines in value judged to be other than temporary on available-for-sale securities, are included in interest and investment income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest and other income, net. To determine whether an other-than-temporary impairment exists, the Company considers whether it has the ability and intent to hold the investment until a market price recovery, and whether evidence indicating the recoverability of the cost of the investment outweighs evidence to the contrary.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company&#x2019;s cash deposits on hand at any one financial institution often exceed federally insured limits. The Company places its cash in financial institutions that management believes to be of high credit quality. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the respective assets as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:44%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:55%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_397b54bf-b523-4a3d-a66b-ad04f717b80a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of the asset's estimated useful life or the remaining lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Major additions and betterments are capitalized; expenditures for repairs and maintenance, which do not improve or extend the life of the respective assets, are charged to operating expense as incurred. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Long-lived assets to be held and used, including property and equipment, are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. Evaluation of the recoverability of the asset or asset group is based on an estimate of undiscounted future cash flows resulting from the use of the asset or asset group and its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the asset or asset group, an impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. The Company did not record any impairment losses on long-lived assets during the periods presented.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain assets and liabilities are carried at fair value under US GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the user of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;quoted prices for similar assets and liabilities in active markets &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;quoted prices for identical or similar assets or liabilities in markets that are not active &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g., interest rate   and yield curve quotes at commonly quoted intervals) &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;inputs that are derived principally from or corroborated by observable market data by correlation or other means &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Unobservable inputs for the assets or liability (i.e., supported by little or no market activity). Level 3 inputs include management&#x2019;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records leases under ASU No. 2016-02 &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (Topic 842) whereby the Company determines if an arrangement is or contains a lease at inception. For leases with a term of 12 months or less, the Company has elected to not recognize a right-of-use asset or lease liability. The Company&#x2019;s operating leases are recognized on the consolidated balance sheets as other noncurrent assets, other current liabilities, and other noncurrent liabilities. The Company does not have any finance leases.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the rate implicit on the Company&#x2019;s leases are not readily determinable, the Company uses an estimate of its incremental borrowing rate for secured borrowings with terms similar to the lease term based on the information available at the lease commencement date in determining the present value of lease payments. Operating lease right-of-use assets also include the effect of any lease payments made, including lease payments made in advance of lease commencement and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development costs are expensed as incurred. Research and development costs that are paid in advance of performance (if any) are capitalized as a prepaid expense and amortized over the service period as the services are provided.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accrued Research and Manufacturing Contract Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has entered into various research and development and manufacturing contracts. These agreements are generally cancelable, and related payments are recorded as the corresponding expenses are incurred. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research studies or clinical trials and manufacturing activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#x2019;s estimates. The Company&#x2019;s historical accrual estimates have not been materially different from the actual costs&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for revenue under ASU No. 2014-19, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (ASC 606). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, certain collaboration arrangements and financial instruments. ASC 606 provides a five-step framework whereby revenue is recognized when control of promised goods or services is transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(i)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;identify the contract(s) with a customer; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(ii)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;identify the performance obligations in the contract; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(iii)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;determine the transaction price; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(iv)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;allocate the transaction price to the performance obligations in the contract; and &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(v)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;recognize revenue when (or as) the performance obligations are satisfied. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration that it is entitled to in exchange for the goods or services the Company transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined with other promised goods and services until a distinct combined performance obligation is identified.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company then allocates the transaction price (that is, the amount of consideration the Company expects to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated revenue when (or as) each performance obligation is satisfied. The allocation is based upon standalone selling price. The standalone selling price is the price at which an entity would sell a promised good or service separately to a customer. Because the Company have not sold the same goods or services in our contracts separately to any customers on a standalone basis, the Company estimated the standalone selling price of each performance obligation by taking into consideration internal estimates of research and development personnel needed to perform the research and development services, estimates of expected cash outflows to third parties for services and supplies and typical gross profit margins.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company enters into collaboration and licensing arrangements that are within the scope of ASC 606, under which the Company may exclusively license to third parties&#x2019; rights to develop, manufacture and commercialize its product candidates as well as options to acquire additional rights. The terms of these arrangements typically include payment to the Company of one or more of the following: nonrefundable, upfront license fees; development, regulatory and sales milestone payments; and royalties on net sales of licensed products.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue is typically recognized using a cost-to-cost input model as the measure of progress. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete the Company&#x2019;s performance obligations under an arrangement. The Company evaluates the measure of progress each reporting&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;period and, if necessary, adjusts the measure of performance and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts received prior to revenue recognition are recorded as deferred revenue in the balance sheets. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue in the balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion in the balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Customer Options&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options that are not determined to be material rights are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement. To date, none of our arrangements have included any material rights. The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The observable price of a good or service sold separately provides the best evidence of standalone selling price. However, when standalone selling prices are not readily available, the Company is required to estimate the standalone selling price of each performance obligation. Key assumptions to determine the standalone selling price. Amounts allocated to a material right are not recognized as revenue until the option is exercised or terminates.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Milestone Payments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For each arrangement that includes milestone payments upon the achievement of performance-based milestones, such as development and regulatory milestones, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant reversal of revenue would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#x2019;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. Upfront and ongoing development milestones per the Company&#x2019;s collaboration and license agreement are not subject to refund if the development activities are not successful. The Company reevaluates the probability of achievement of such milestones and any related constraint at each reporting period, and any adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. To date, the Company has not recognized any milestone revenues.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Royalties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license to the Company&#x2019;s intellectual property is deemed to be the predominant item to which the royalties relate as it is the primary driver of value, the Company recognizes revenue when the related sales occur in accordance with the sales-based royalty exception. To date, the Company has not recognized any royalty revenue resulting from the Company&#x2019;s collaboration and licensing agreements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided to reduce the deferred tax asset to an amount, which, more likely than not, will be realized.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes the tax benefit from any uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. Interest and penalties associated with uncertain tax positions are recorded as a component of income tax expense. As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t identified any uncertain tax positions for which reserves would be required.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are defined as components of an entity for which discrete information is available for evaluation by the chief operating decision maker, who is the CEO, in deciding how to allocate resources and in assessing performance. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. All of the Company&#x2019;s assets are held in the U.S.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for stock option awards at fair value, which is measured using the Black-Scholes option-pricing model. The measurement date is generally the date of grant.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes stock-based compensation expense over the requisite service period, which is generally the vesting period of the respective award. For awards that include performance-based vesting conditions, stock-based compensation expense is recognized using the accelerated attribution method when the performance condition is deemed to be probable. The Company accounts for forfeitures as they occur. The Company determines the fair value of restricted stock awards in reference to the fair value of its common stock less any applicable purchase price&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#x2019;s salary and related costs are classified or in which the award recipient&#x2019;s service payments are classified.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive loss includes net loss as well as other changes in stockholders&#x2019; equity that result from transactions and economic events other than those with stockholders. The Company&#x2019;s only element of other comprehensive income was unrealized gains on marketable securities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net loss per share is calculated by dividing net loss by the weighted average common shares outstanding during the period.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Diluted net loss per share is calculated by adjusting weighted average common shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, determined using the treasury-stock and if-converted methods. For purposes of the diluted net income (loss) per share calculation, convertible debt and stock options are considered to be common stock equivalents. All common stock equivalents have been excluded from the calculation of diluted net loss per share as their effect would be anti-dilutive for all periods presented. Therefore, basic and diluted net loss per share were the same for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-07, &#x201c;Segment Reporting - Improvements to Reportable Segment Disclosures.&#x201d; The ASU requires disclosure of incremental segment information on an annual and interim basis and also requires companies with a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_b6b6acc4-5182-4b15-9f8c-8955c5b3abae;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;single&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segment to provide all disclosures required by this ASU and all existing segment disclosures in Accounting Standard Codification (&#x201c;ASC&#x201d;) 280, &#x201c;Segment Reporting.&#x201d; The Company adopted this standard for this fiscal year ended December 31, 2024. The adoption of ASU 2023-07 did not have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Pronouncements Not Yet Effective&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#x201d; This ASU updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. This ASU is effective for annual periods beginning after December 15, 2024, and is applicable to the Company&#x2019;s fiscal year beginning January 1, 2025, with early application permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-04, Debt-Debt with Conversions and Other Options. ASU 2024-04 is intended to clarify requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion. This ASU is effective for all entities for annual reporting periods beginning after&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures. ASU 2024-03 is intended to improve disclosures about a public business entity&#x2019;s expense and provide more detailed information to investors about the types of expenses in commonly presented expense captions. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_97b7dbad-607a-4f54-8e35-fa7e4c81fd08">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements reflect the operations of the Company and the Company&#x2019;s wholly owned subsidiary, TScan Securities Corporation. The accompanying consolidated financial statements have been prepared in conformity with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification, or ASC, and Accounting Standards Update, or ASU, of the Financial Accounting Standards Board, or FASB.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_1da78fd1-f632-478f-8503-f21894d0f36d">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_186a8bd6-5a2b-42f9-b85f-54e7e1566651">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience, known trends and other market-specific or relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_5391b744-e82f-458c-bd35-d8a807cfa110">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash includes cash in readily available checking and money market accounts. Cash equivalents include all highly liquid investments maturing within 90 days from the date of purchase. The cash equivalents consisted of money market funds and government securities.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_71059b9e-67cf-4da4-a372-1756217732c1">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the Company&#x2019;s facility lease agreements, the Company is required to provide letters of credit totaling of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the benefit of the landlords to serve as security deposits. As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the cash securing the letter of credit was classified as restricted cash (non-current) on the consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_21496e54-0681-4b2a-a747-485e2a96f47c"
      decimals="-5"
      id="F_e90bd30f-e75d-42a1-b5d0-ec8f5d110a38"
      unitRef="U_USD">5000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_98f3e251-6822-40b4-b26f-b2642337628c">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company classifies all of its marketable securities as available-for-sale based upon its intent with regard to such investments.  Unrealized gains on available-for-sale debt securities are reported as a component of accumulated other comprehensive loss in stockholders&#x2019; equity. The amortized cost of debt securities in this category is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in interest and other income, net. Realized gains and losses and declines in value judged to be other than temporary on available-for-sale securities, are included in interest and investment income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest and other income, net. To determine whether an other-than-temporary impairment exists, the Company considers whether it has the ability and intent to hold the investment until a market price recovery, and whether evidence indicating the recoverability of the cost of the investment outweighs evidence to the contrary.&lt;/span&gt;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_3289e425-2654-479d-86a2-19022e8f7cb1">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company&#x2019;s cash deposits on hand at any one financial institution often exceed federally insured limits. The Company places its cash in financial institutions that management believes to be of high credit quality. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_d45f6f6c-c63b-4e9b-a47f-64a4d0baff1a">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the respective assets as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:44%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:55%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_397b54bf-b523-4a3d-a66b-ad04f717b80a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of the asset's estimated useful life or the remaining lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Major additions and betterments are capitalized; expenditures for repairs and maintenance, which do not improve or extend the life of the respective assets, are charged to operating expense as incurred. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <tcrx:PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_64ceefbd-6b10-4396-9451-2db8e48189d8">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the respective assets as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:44%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:55%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_397b54bf-b523-4a3d-a66b-ad04f717b80a;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of the asset's estimated useful life or the remaining lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</tcrx:PropertyAndEquipmentStatedAtCostAndDepreciatedUsingStraightLineMethodOverEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_8e328758-f2ae-4a01-a2b8-6f6ee7b7ece5"
      id="F_601f5a36-7dca-4b7f-9256-c733422d1140">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_3e156d80-5523-4597-bd1f-80a161d4d41c"
      id="F_cc3724f2-4d43-4776-8300-1874af4abf69">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_fbb18820-4b97-463e-90e8-1723d8fab29c"
      id="F_aa64aab3-2df3-479d-bedf-9ac2dba065fd">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_80adfaa9-7e64-4331-ae56-d2faf130122e"
      id="F_98638fe0-b0db-46cd-afb7-2d3ea49105ba">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_7161914d-36e4-4f31-8cd4-0984db2302a0"
      id="F_24816350-e9b7-4f9d-96da-63586983fe99">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_d15727e8-0174-48c5-9477-9969a5d1e3b3"
      id="F_acea1014-cc40-4150-b270-fc9d7a4dfd9f">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_68a5546e-4aca-41b8-aaed-3be56fa94165"
      id="F_60b8f969-9035-4a0f-8969-52e54fef83fc">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_03eb41a8-990a-4e35-bb1b-5a37935b24be"
      id="F_aebe2d66-5d35-4c56-8404-754027ac32b4">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_ccaee56e-0a22-4f92-bb66-fc0be47d3836">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Long-lived assets to be held and used, including property and equipment, are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. Evaluation of the recoverability of the asset or asset group is based on an estimate of undiscounted future cash flows resulting from the use of the asset or asset group and its eventual disposition. In the event that such cash flows are not expected to be sufficient to recover the carrying amount of the asset or asset group, an impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. The Company did not record any impairment losses on long-lived assets during the periods presented.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_a8d4a39f-4ee1-4ec7-9646-d214fbecf95d">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain assets and liabilities are carried at fair value under US GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the user of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;quoted prices for similar assets and liabilities in active markets &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;quoted prices for identical or similar assets or liabilities in markets that are not active &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g., interest rate   and yield curve quotes at commonly quoted intervals) &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;inputs that are derived principally from or corroborated by observable market data by correlation or other means &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;Unobservable inputs for the assets or liability (i.e., supported by little or no market activity). Level 3 inputs include management&#x2019;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_786dfb98-11cf-4d41-866f-72027fc56057">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records leases under ASU No. 2016-02 &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (Topic 842) whereby the Company determines if an arrangement is or contains a lease at inception. For leases with a term of 12 months or less, the Company has elected to not recognize a right-of-use asset or lease liability. The Company&#x2019;s operating leases are recognized on the consolidated balance sheets as other noncurrent assets, other current liabilities, and other noncurrent liabilities. The Company does not have any finance leases.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the rate implicit on the Company&#x2019;s leases are not readily determinable, the Company uses an estimate of its incremental borrowing rate for secured borrowings with terms similar to the lease term based on the information available at the lease commencement date in determining the present value of lease payments. Operating lease right-of-use assets also include the effect of any lease payments made, including lease payments made in advance of lease commencement and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.&lt;/span&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_cd08591e-f715-4414-9b88-1d8e795870a3">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development costs are expensed as incurred. Research and development costs that are paid in advance of performance (if any) are capitalized as a prepaid expense and amortized over the service period as the services are provided.&lt;/span&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <tcrx:AccruedResearchAndManufacturingContractCostsPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_0fb8233d-ebed-47ad-9acb-bec1bb94d733">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Accrued Research and Manufacturing Contract Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has entered into various research and development and manufacturing contracts. These agreements are generally cancelable, and related payments are recorded as the corresponding expenses are incurred. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research studies or clinical trials and manufacturing activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#x2019;s estimates. The Company&#x2019;s historical accrual estimates have not been materially different from the actual costs&lt;/span&gt;</tcrx:AccruedResearchAndManufacturingContractCostsPolicyTextBlock>
    <tcrx:PatentCostsPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_77db35f1-2d72-4cb1-b719-8a65b143a51d">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses.&lt;/span&gt;</tcrx:PatentCostsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_2941dc8b-fa89-4fc1-a83e-75d6da17a19e">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for revenue under ASU No. 2014-19, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (ASC 606). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, certain collaboration arrangements and financial instruments. ASC 606 provides a five-step framework whereby revenue is recognized when control of promised goods or services is transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(i)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;identify the contract(s) with a customer; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(ii)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;identify the performance obligations in the contract; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(iii)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;determine the transaction price; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(iv)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;allocate the transaction price to the performance obligations in the contract; and &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(v)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;recognize revenue when (or as) the performance obligations are satisfied. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration that it is entitled to in exchange for the goods or services the Company transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined with other promised goods and services until a distinct combined performance obligation is identified.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company then allocates the transaction price (that is, the amount of consideration the Company expects to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated revenue when (or as) each performance obligation is satisfied. The allocation is based upon standalone selling price. The standalone selling price is the price at which an entity would sell a promised good or service separately to a customer. Because the Company have not sold the same goods or services in our contracts separately to any customers on a standalone basis, the Company estimated the standalone selling price of each performance obligation by taking into consideration internal estimates of research and development personnel needed to perform the research and development services, estimates of expected cash outflows to third parties for services and supplies and typical gross profit margins.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company enters into collaboration and licensing arrangements that are within the scope of ASC 606, under which the Company may exclusively license to third parties&#x2019; rights to develop, manufacture and commercialize its product candidates as well as options to acquire additional rights. The terms of these arrangements typically include payment to the Company of one or more of the following: nonrefundable, upfront license fees; development, regulatory and sales milestone payments; and royalties on net sales of licensed products.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue is typically recognized using a cost-to-cost input model as the measure of progress. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete the Company&#x2019;s performance obligations under an arrangement. The Company evaluates the measure of progress each reporting&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;period and, if necessary, adjusts the measure of performance and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts received prior to revenue recognition are recorded as deferred revenue in the balance sheets. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as the current portion of deferred revenue in the balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion in the balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_11fd80c6-5758-45b2-9054-06503514d972">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Customer Options&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options that are not determined to be material rights are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement. To date, none of our arrangements have included any material rights. The transaction price is allocated to each performance obligation on a relative standalone selling price basis. The observable price of a good or service sold separately provides the best evidence of standalone selling price. However, when standalone selling prices are not readily available, the Company is required to estimate the standalone selling price of each performance obligation. Key assumptions to determine the standalone selling price. Amounts allocated to a material right are not recognized as revenue until the option is exercised or terminates.&lt;/span&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <tcrx:RevenueMilestonePaymentsPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_af05ca69-23c3-43bb-90b2-3b399f4584e6">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Milestone Payments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For each arrangement that includes milestone payments upon the achievement of performance-based milestones, such as development and regulatory milestones, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant reversal of revenue would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#x2019;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. Upfront and ongoing development milestones per the Company&#x2019;s collaboration and license agreement are not subject to refund if the development activities are not successful. The Company reevaluates the probability of achievement of such milestones and any related constraint at each reporting period, and any adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. To date, the Company has not recognized any milestone revenues.&lt;/span&gt;</tcrx:RevenueMilestonePaymentsPolicyTextBlock>
    <tcrx:RevenueFromRoyaltiesPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_fd41eb48-dd82-4f4d-8d5d-edcd85b16b63">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Royalties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license to the Company&#x2019;s intellectual property is deemed to be the predominant item to which the royalties relate as it is the primary driver of value, the Company recognizes revenue when the related sales occur in accordance with the sales-based royalty exception. To date, the Company has not recognized any royalty revenue resulting from the Company&#x2019;s collaboration and licensing agreements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</tcrx:RevenueFromRoyaltiesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_fbd0bfe3-b8bb-4a7d-b5f8-4179cf6a160b">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided to reduce the deferred tax asset to an amount, which, more likely than not, will be realized.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes the tax benefit from any uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. Interest and penalties associated with uncertain tax positions are recorded as a component of income tax expense. As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t identified any uncertain tax positions for which reserves would be required.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="INF"
      id="F_60b12656-3fc0-465e-80b8-167bb1912bd4"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="INF"
      id="F_4146f26b-0f21-448d-9177-a23615673fc1"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_5b91a8fb-2155-487b-b94d-ce1b4cd8cb91">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are defined as components of an entity for which discrete information is available for evaluation by the chief operating decision maker, who is the CEO, in deciding how to allocate resources and in assessing performance. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. All of the Company&#x2019;s assets are held in the U.S.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_d3a6fa60-e7dd-48c7-8943-24ca3dc201b4">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for stock option awards at fair value, which is measured using the Black-Scholes option-pricing model. The measurement date is generally the date of grant.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes stock-based compensation expense over the requisite service period, which is generally the vesting period of the respective award. For awards that include performance-based vesting conditions, stock-based compensation expense is recognized using the accelerated attribution method when the performance condition is deemed to be probable. The Company accounts for forfeitures as they occur. The Company determines the fair value of restricted stock awards in reference to the fair value of its common stock less any applicable purchase price&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#x2019;s salary and related costs are classified or in which the award recipient&#x2019;s service payments are classified.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_877538bb-9d20-4818-9560-540d32a0c304">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive loss includes net loss as well as other changes in stockholders&#x2019; equity that result from transactions and economic events other than those with stockholders. The Company&#x2019;s only element of other comprehensive income was unrealized gains on marketable securities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_5acd4b4f-3536-4c0d-95c9-7292e0fe8ca0">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net loss per share is calculated by dividing net loss by the weighted average common shares outstanding during the period.&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Diluted net loss per share is calculated by adjusting weighted average common shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, determined using the treasury-stock and if-converted methods. For purposes of the diluted net income (loss) per share calculation, convertible debt and stock options are considered to be common stock equivalents. All common stock equivalents have been excluded from the calculation of diluted net loss per share as their effect would be anti-dilutive for all periods presented. Therefore, basic and diluted net loss per share were the same for all periods presented.&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_a5f51676-26d4-4be9-8e56-6b3726eb3740">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-07, &#x201c;Segment Reporting - Improvements to Reportable Segment Disclosures.&#x201d; The ASU requires disclosure of incremental segment information on an annual and interim basis and also requires companies with a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_b6b6acc4-5182-4b15-9f8c-8955c5b3abae;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;single&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segment to provide all disclosures required by this ASU and all existing segment disclosures in Accounting Standard Codification (&#x201c;ASC&#x201d;) 280, &#x201c;Segment Reporting.&#x201d; The Company adopted this standard for this fiscal year ended December 31, 2024. The adoption of ASU 2023-07 did not have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Pronouncements Not Yet Effective&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax Disclosures.&#x201d; This ASU updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. This ASU is effective for annual periods beginning after December 15, 2024, and is applicable to the Company&#x2019;s fiscal year beginning January 1, 2025, with early application permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-04, Debt-Debt with Conversions and Other Options. ASU 2024-04 is intended to clarify requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion. This ASU is effective for all entities for annual reporting periods beginning after&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures. ASU 2024-03 is intended to improve disclosures about a public business entity&#x2019;s expense and provide more detailed information to investors about the types of expenses in commonly presented expense captions. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of this guidance on its disclosures.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_154e5e5d-1919-4231-a0d4-3220fa5f17dc">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3. Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment consist of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,519&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Construction-in-progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,597&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,242&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,742&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization expense for the years ended December 31, 2024 and 2023 was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e94b3a4d-3670-45de-b4c9-1c458b4932ba">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment consist of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,519&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Construction-in-progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,597&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,242&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,742&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_76bbc888-71d6-4496-aac8-fb489f0bd98f"
      decimals="-3"
      id="F_9075662d-689f-46f9-b38b-d9176688265f"
      unitRef="U_USD">19371000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_b78729c9-8909-4f4c-9a42-47160fbaf8ff"
      decimals="-3"
      id="F_fe4f1978-e61f-45c1-b6e3-debf94ca89f4"
      unitRef="U_USD">15653000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_dd4d0c32-dea8-4923-a9f1-ea5f1fab19f8"
      decimals="-3"
      id="F_25b68454-60df-47d5-93ab-3866f44656e0"
      unitRef="U_USD">3258000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_ba7a6494-c61e-47ca-8fa7-218c1cdf4d7c"
      decimals="-3"
      id="F_cc9719f4-1473-4372-b724-e77b23e8740c"
      unitRef="U_USD">3159000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_b93aece8-a971-452c-bfad-9ca3124815c4"
      decimals="-3"
      id="F_ddf0a75b-073a-4e08-a946-9195b6060bd6"
      unitRef="U_USD">1721000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_e687bdb4-a5f4-4929-88c0-7990ae1b71a5"
      decimals="-3"
      id="F_93755cef-b436-436c-8b1b-3705668e8e3a"
      unitRef="U_USD">1519000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_c18aa170-88bc-4410-a5a3-854b425c1c5d"
      decimals="-3"
      id="F_a1c69a90-5a9f-424e-bc0b-f145fb4d02ed"
      unitRef="U_USD">1496000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_5458543f-e28b-4c69-8779-01decdc01ab6"
      decimals="-3"
      id="F_58d98ee3-f16f-49e0-a149-a684c14f0ac9"
      unitRef="U_USD">1460000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_fbfc4486-e4d3-49f0-973d-16204216ca9a"
      decimals="-3"
      id="F_c8343da8-26ae-4ecf-8d48-95e3d4935641"
      unitRef="U_USD">100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_8e91d61a-7205-4849-ab44-bbb90d9d7dbc"
      decimals="-3"
      id="F_e68af088-579c-4ade-8e49-93ac88d1aa31"
      unitRef="U_USD">548000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_c46e1f6e-a0ad-40dd-afcc-62333fa49e64"
      unitRef="U_USD">25946000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_3d5a05f8-ed8b-424d-b92e-66b3ed2f7e3e"
      unitRef="U_USD">22339000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_1c4e3322-3209-4bb4-b64f-e3a41e7e71f7"
      unitRef="U_USD">18704000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_7978653a-e6c0-43fe-9cbe-6bfafb475cbb"
      unitRef="U_USD">14597000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_1c29c763-616d-46b6-bc13-d7b658b41f9c"
      unitRef="U_USD">7242000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_6d0235ba-7f1f-4128-b0d7-bc19c26caa47"
      unitRef="U_USD">7742000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-5"
      id="F_6a88efe9-2da3-4912-95ae-0a5de237611c"
      unitRef="U_USD">4100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-5"
      id="F_52eeb735-a233-4384-b374-cc58993f0395"
      unitRef="U_USD">5400000</us-gaap:DepreciationAndAmortization>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e7552f9f-ca34-4a70-9d94-f74dbcc52f58">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;4. Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables set forth by level, within the fair value hierarchy, the assets carried at fair value (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair value measurements at December 31, 2024 using:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Active &lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents &#x2013; money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;169,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;169,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;281,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;281,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair value measurements at December 31, 2023 using:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Active &lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents &#x2013; money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents &#x2013; government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Money market funds and government securities are valued by the Company based on quoted market prices, which represent a Level 1 measurement within the fair value hierarchy. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; transfers among Level 1, Level 2, or Level 3 categories in the periods presented.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets and Liabilities Not Carried at Fair Value&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company's convertible long-term debt was carried at amortized cost. The fair value of the convertible long-term debt was estimated to be $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million at December 31, 2023. Fair value was determined using a convertible bond model using a binomial lattice approach. We classified the fair value disclosures for the long-term debt within level 3 of the fair value hierarchy because the fair value is derived using significant unobservable inputs, which include discount rates and volatility. The Company's convertible long-term debt was extinguished on December 20, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying value of accounts payable and accrued expenses that are reported on the consolidated balance sheets approximate fair value due to the short-term nature of these liabilities. Based on the borrowing rates currently available to the Company for bank loans with similar maturities, the fair value of long-term debt is approximately equal to its carrying amount as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e0fd44ce-b371-49fc-9fe6-60d8f9b90289">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables set forth by level, within the fair value hierarchy, the assets carried at fair value (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair value measurements at December 31, 2024 using:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Active &lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents &#x2013; money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;169,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;169,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;281,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;281,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair value measurements at December 31, 2023 using:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Active &lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents &#x2013; money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents &#x2013; government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_8a10b701-7769-47a2-87ad-7867a7c281c4"
      decimals="-3"
      id="F_a5a6ac72-d2ee-4b6b-a7be-c3b6213b1234"
      unitRef="U_USD">169744000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_379aeeb9-bc7c-43c4-9634-0092d863e599"
      decimals="-3"
      id="F_1647326b-7448-4810-9786-f1a31dacc514"
      unitRef="U_USD">169744000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
      contextRef="C_b2dd2d19-d373-450a-b7db-9467c2752ca1"
      decimals="-3"
      id="F_e06d5d21-c11b-4c76-be79-c38a90e8a4bf"
      unitRef="U_USD">111421000</us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure>
    <us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
      contextRef="C_de26ea6d-2d44-490b-b9c4-ac54b2019aaf"
      decimals="-3"
      id="F_2f5b84f7-d160-4af6-8715-4bff7ebc712d"
      unitRef="U_USD">111421000</us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_836b34f7-350d-42ee-8942-99d2e7240d11"
      decimals="-3"
      id="F_7c3af41f-6979-40c1-b43b-64e97d33b98b"
      unitRef="U_USD">281165000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_c40d36eb-ad62-4c25-8e30-5ca0c0381a40"
      unitRef="U_USD">281165000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_2c53342d-2049-4853-81f6-ec35e8e6267f"
      decimals="-3"
      id="F_8379f7eb-7fd7-4188-8212-485c0afbebe3"
      unitRef="U_USD">52299000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_12bf6ad2-0a5b-44a7-a68c-7aaa96219405"
      decimals="-3"
      id="F_627d8ef6-a8c6-4b74-af4b-2aeeed48848f"
      unitRef="U_USD">52299000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_2862a7f8-f1a2-48bd-bc36-db1c53bfedf9"
      decimals="-3"
      id="F_37274fb3-7f7c-4e48-ba3e-c6670b903fba"
      unitRef="U_USD">76483000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_61ed6f0b-459e-4d88-9516-a58d66772426"
      decimals="-3"
      id="F_7f3698ef-520b-424b-be57-dc5ab9f6c99a"
      unitRef="U_USD">76483000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
      contextRef="C_2862a7f8-f1a2-48bd-bc36-db1c53bfedf9"
      decimals="-3"
      id="F_f66e8ac0-5451-41f5-8d34-96ad6c9e9061"
      unitRef="U_USD">58685000</us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure>
    <us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
      contextRef="C_61ed6f0b-459e-4d88-9516-a58d66772426"
      decimals="-3"
      id="F_b97f928b-c2b7-4bb9-b6b6-cc33ea07ee8d"
      unitRef="U_USD">58685000</us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_3fda7817-04f6-40d1-b034-58df0d9f5ec2"
      decimals="-3"
      id="F_ad055004-4ad3-4fc7-8de2-5d6b75c2d2bf"
      unitRef="U_USD">187467000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_af0e0408-466a-4f25-bd69-314c7764c620"
      unitRef="U_USD">187467000</us-gaap:AssetsFairValueDisclosure>
    <tcrx:FairValueAssetLevel1ToLevel2TransfersAmount
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_e536919e-d56c-48f7-a6e0-1f99c0133883"
      unitRef="U_USD">0</tcrx:FairValueAssetLevel1ToLevel2TransfersAmount>
    <tcrx:FairValueAssetLevel2ToLevel1TransfersAmount
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_2de17632-d625-4ef2-9ff4-b20a363c4d66"
      unitRef="U_USD">0</tcrx:FairValueAssetLevel2ToLevel1TransfersAmount>
    <tcrx:FairValueAssetLevel1ToLevel2TransfersAmount
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_9319856f-8a21-4a30-9c16-5b708ce52cbb"
      unitRef="U_USD">0</tcrx:FairValueAssetLevel1ToLevel2TransfersAmount>
    <tcrx:FairValueAssetLevel2ToLevel1TransfersAmount
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_44fb260b-48d0-44af-9e66-49662b2abde9"
      unitRef="U_USD">0</tcrx:FairValueAssetLevel2ToLevel1TransfersAmount>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_5c420671-ed2a-45f8-9814-27c713f06d09"
      unitRef="U_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_b04d5bb4-82a5-46cc-8035-54900b94cd6f"
      unitRef="U_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_90ecca4c-c828-4c29-b9b4-983835613443"
      unitRef="U_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_f4eaa188-6abe-4754-9338-fec939bd417e"
      unitRef="U_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_c42f4a3b-18a2-4352-9d50-5db3b2991bb9"
      decimals="-5"
      id="F_33362e5c-b70b-4fd9-b3ba-40e5ccd81c51"
      unitRef="U_USD">38400000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_66fd7856-7ee9-4096-97ac-027d16fc5ee3">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;5. Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued employee compensation and benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,478&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,735&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued consulting and professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued legal services and license fee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;425&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,716&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_11987a5f-b564-447d-ba06-b7e759158594">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued employee compensation and benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,478&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,735&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued consulting and professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued legal services and license fee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;425&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,716&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_575c55a7-6147-48a5-8a73-5d902f185521"
      unitRef="U_USD">6845000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_ba4c7f67-2255-4b40-912e-c874859e5a49"
      unitRef="U_USD">5478000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <tcrx:AccruedResearchAndDevelopment
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_3c09636e-defa-4277-b77b-e2d59408b737"
      unitRef="U_USD">6735000</tcrx:AccruedResearchAndDevelopment>
    <tcrx:AccruedResearchAndDevelopment
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_6446f5d6-38bf-4ada-8d0a-3b60ab07ce07"
      unitRef="U_USD">3537000</tcrx:AccruedResearchAndDevelopment>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_6a563910-84c5-40c2-bd2f-5b8cce8161cb"
      unitRef="U_USD">1473000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_a4c9ae49-b94c-4549-aa97-8889da8c06f4"
      unitRef="U_USD">1026000</us-gaap:AccruedProfessionalFeesCurrent>
    <tcrx:AccruedLegalServicesAndLicenseFeeCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_2fca2ec7-1282-416e-a293-73a0c8c7cbdd"
      unitRef="U_USD">281000</tcrx:AccruedLegalServicesAndLicenseFeeCurrent>
    <tcrx:AccruedLegalServicesAndLicenseFeeCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_f6abab3f-cc69-463a-b9b3-4aa7cd6977ad"
      unitRef="U_USD">250000</tcrx:AccruedLegalServicesAndLicenseFeeCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_48c6c580-0bd3-4816-8ef6-8c883c09b566"
      unitRef="U_USD">76000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_c76e9baf-7d98-4bca-a6b3-aa3ec1e5b011"
      unitRef="U_USD">425000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_c7a3dd75-78f4-4bc4-ac13-25f64b9b6e97"
      unitRef="U_USD">15410000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_9e668dce-4a03-464d-b8d1-741ff1224caa"
      unitRef="U_USD">10716000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e9dece03-c80c-4fc4-9fa6-347cf5576b5c">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;6. Stockholders' Equity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;ATM Program&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 16, 2023, the Company entered into a sales agreement (the Sales Agreement) with Wedbush Securities, Inc. (Wedbush), as sales agent, pursuant to which the Company could offer, issue and sell up to an aggregate amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of shares of the Company's voting common stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share (Voting Common Stock), from time to time in &#x201c;at-the-market&#x201d; (ATM) offerings during the term of the Sales Agreement under a registration statement on Form S-3 (File No. 333-268260) filed with the SEC, which was declared effective on May 16, 2023. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Voting Common Stock has been sold under this Sales Agreement to date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Offerings&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On June 1, 2023, the Company completed an underwritten public offering resulting in the issuance and sale of (a) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,287,134&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Voting Common Stock, at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, and (b) pre-funded warrants (Pre-Funded Warrants) to purchase up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,010,526&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Voting Common Stock, at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.9999&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per warrant with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. The Company received aggregate net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;134.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting underwriting discounts, commissions and other offering expenses, with $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million allocated to the Voting Common Stock and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million allocated to Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 24, 2024, the Company completed an underwritten public offering resulting in the issuance and sale of (a) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,958,068&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Voting Common Stock, including the partial exercise of the underwriters&#x2019; option to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,485,487&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; additional shares of Voting Common Stock, at the closing market price on April 16, 2024, of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.13&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, and (b) Pre-Funded Warrants to purchase up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,577,419&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Voting Common Stock, at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.1299&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per warrant with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. The Company received aggregate net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;161.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting underwriting discounts, commissions and other offering expenses, with $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million allocated to the Voting Common Stock and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;128.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million allocated to Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On December 27, 2024, the Company completed a registered direct offering with an existing investor for the issuance of pre-funded warrants to purchase up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,500,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company's Voting Common Stock, with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per warrant. The pre-funded warrants were issued at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per warrant, resulting in gross proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, before deducting offering expenses of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Pre-Funded Warrants are immediately exercisable subject to certain ownership limitations, have an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;share, may be exercised at any time and do not expire. The Pre-Funded Warrants were determined to be equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#x2019;s common stock and meet the equity classification criteria. In&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;addition, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the Pre-Funded Warrants do not provide any guarantee of value or return. As such, proceeds received from the issuance from the Pre-Funded Warrants were recorded as a component of stockholders&#x2019; equity within additional paid-in capital. As of December 31, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Pre-Funded Warrants have been exercised.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <tcrx:CommonStockSharesReservedForFutureIssuance
      contextRef="C_1ae85ee9-048d-4bdf-b70c-933ca1975ec4"
      decimals="-5"
      id="F_a75f6880-a141-46c3-b288-ee6c308be7ae"
      unitRef="U_USD">75000000</tcrx:CommonStockSharesReservedForFutureIssuance>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_034fde6a-ad94-4842-9909-97bb9d9de862"
      decimals="INF"
      id="F_58b10157-6caf-4c64-b876-ae4010eb4dad"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_cdeccc8f-9224-4c97-9f7a-3c445b23e58a"
      decimals="INF"
      id="F_95be894e-2704-4165-aac7-7715e05250b1"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_ed8ad1a6-62b7-4058-824e-b48462749a75"
      decimals="INF"
      id="F_6d0e9a0a-ee5a-4006-a636-56d28dc15fbb"
      unitRef="U_shares">23287134</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_ece742b4-8819-47df-8c84-c8b14935ab7f"
      decimals="INF"
      id="F_6ae7742d-4581-4e10-8f73-687e07887bed"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_be6fc315-0b98-4523-a42d-bcf78bc16296"
      decimals="INF"
      id="F_3e0c9f94-2289-484e-87e0-16d63b886052"
      unitRef="U_shares">47010526</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <tcrx:CommonStockPricePerWarrant
      contextRef="C_1fd87468-b7a0-44c8-958d-699705148443"
      decimals="4"
      id="F_253d26dd-7947-48a2-b471-84cbe161b59e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.9999</tcrx:CommonStockPricePerWarrant>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_be6fc315-0b98-4523-a42d-bcf78bc16296"
      decimals="4"
      id="F_a34773dd-c6be-49f5-a4ca-a3e7d683ce96"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <tcrx:ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses
      contextRef="C_3d8664d3-d512-4213-ac6c-cd3db870f7c3"
      decimals="-5"
      id="F_f346e8d8-02b4-4958-b8f0-5355f6c0b829"
      unitRef="U_USD">134700000</tcrx:ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_3d8664d3-d512-4213-ac6c-cd3db870f7c3"
      decimals="-5"
      id="F_e2e88959-df9f-4ee2-993c-e4d9c5516d87"
      unitRef="U_USD">42400000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_3d8664d3-d512-4213-ac6c-cd3db870f7c3"
      decimals="-5"
      id="F_ce2d8118-5891-430b-b6a2-6bd425446d85"
      unitRef="U_USD">92300000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_d64f6a5d-5103-4e27-8e28-50297b0314a4"
      decimals="INF"
      id="F_568054a4-6481-40e8-ae74-160532f458f8"
      unitRef="U_shares">4958068</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <tcrx:UnderwriterOptionToPurchaseNumberOfAdditionalShares
      contextRef="C_d64f6a5d-5103-4e27-8e28-50297b0314a4"
      decimals="INF"
      id="F_9c9d49ed-2068-4641-9b2d-f7e224a7b9d2"
      unitRef="U_shares">2485487</tcrx:UnderwriterOptionToPurchaseNumberOfAdditionalShares>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_874977e6-74c8-4492-baa5-8b92c0c45d13"
      decimals="INF"
      id="F_0930390c-c180-4189-a99f-ce12bbcafb4f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.13</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_69f2d878-b10b-4938-9603-81cf10c7f68a"
      decimals="INF"
      id="F_50c45856-5c39-48ce-a3ad-8e3437db6f07"
      unitRef="U_shares">18577419</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <tcrx:CommonStockPricePerWarrant
      contextRef="C_64da7f3d-8b21-4b26-8c42-acd6857d10cc"
      decimals="4"
      id="F_2ff75ad8-e317-4b2c-b2c6-90e193c0db9e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.1299</tcrx:CommonStockPricePerWarrant>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_69f2d878-b10b-4938-9603-81cf10c7f68a"
      decimals="4"
      id="F_405d4072-49d2-499d-bc42-52d0f1521ab4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <tcrx:ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses
      contextRef="C_a40cc202-27f4-4dcd-b6c9-0784f4fc3205"
      decimals="-5"
      id="F_e1ebb94e-9e5f-45c6-b37c-e7ececbd4acb"
      unitRef="U_USD">161400000</tcrx:ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfUnderwritingDiscountsAndExpenses>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_a40cc202-27f4-4dcd-b6c9-0784f4fc3205"
      decimals="-5"
      id="F_40bf579f-67a7-4222-81f2-393d91e73d81"
      unitRef="U_USD">33100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_a40cc202-27f4-4dcd-b6c9-0784f4fc3205"
      decimals="-5"
      id="F_2381b7aa-df89-4bb1-afdb-8f39d9d45066"
      unitRef="U_USD">128300000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_e646531e-fd6d-4b4a-a38b-4580a5b023cc"
      decimals="INF"
      id="F_e1be4e0c-c206-43ca-bd6a-ca51ac08065b"
      unitRef="U_shares">7500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_ce86777f-8d50-4ea4-a1de-67ffd1ad8ce1"
      decimals="4"
      id="F_f1f744ce-270f-40d0-9b91-04752c337752"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <tcrx:CommonStockPricePerWarrant
      contextRef="C_2a2ebcf4-40ec-47ac-8e0a-274ca41d986c"
      decimals="2"
      id="F_24cbfe0a-f265-420a-abea-938d215adb89"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4</tcrx:CommonStockPricePerWarrant>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_f5d697f7-128e-4876-a4f5-90f1a98fe9b1"
      decimals="-5"
      id="F_39a9bb06-a8c2-40fc-8d31-6826f716c6de"
      unitRef="U_USD">30000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <tcrx:WarrantIssuanceCostsOfferingExpenses
      contextRef="C_f5d697f7-128e-4876-a4f5-90f1a98fe9b1"
      decimals="-5"
      id="F_48b3e0c8-15cb-49ae-8901-ff406631ce78"
      unitRef="U_USD">200000</tcrx:WarrantIssuanceCostsOfferingExpenses>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_c3b11d96-c0b1-4481-9a60-4395a254fe3f"
      decimals="INF"
      id="F_890f704b-30d2-4056-a106-0a833ca4f843"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <tcrx:ClassOfStockWarrantsExercised
      contextRef="C_6c96b539-1a31-47e8-94ff-6a44016523a3"
      decimals="INF"
      id="F_a959db65-76b7-431a-b11e-0b8404525ee5"
      unitRef="U_shares">0</tcrx:ClassOfStockWarrantsExercised>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_4bc1e304-dadf-4bc1-be39-839cd2234acb">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7. Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2021 Equity Incentive Plan&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2021 Equity Incentive Plan (the 2021 Plan) was approved by the Company&#x2019;s Board on April 22, 2021 and became effective immediately, although &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; awards were permitted to be granted under the 2021 Plan until July 15, 2021. The 2021 Plan replaced the 2018 Plan, however, awards outstanding under the 2018 Plan continue to be go&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;verned by their existing terms. In addition, shares of common stock subject to awards granted under the 2018 Plan that cease to be subject to such awards by forfeiture or otherwise after the termination of the 2018 Plan will be available for issuance under the 2021 Plan.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,278,048&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock initially reserved for issuance under the 2021 Plan and as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,781,492&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; sh&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ares of common stock available for issuance. The number of shares reserved for issuance under the 2021 Plan will be increased automatically on the first business day of each fiscal year, commencing in 2022 and ending in 2031. The aggregate number of common shares that may be issued under the 2021 Plan shall automatically increase by a number equal to the least of (a) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the number of the total outstanding common shares on the last day of the preceding fiscal year, or (b) a number of shares common stock determined by the Company&#x2019;s Board.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2021 Employee Stock Purchase Plan (the "2021 ESPP") was approved by the Company&#x2019;s Board on April 22, 2021 and became effective immediately, although &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; awards were permitted to be granted under the 2021 Plan until July 15, 2021. A total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;254,390&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock were initially reserved for issuance under the 2021 ESPP. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;228,533&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;146,380&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares issued under the 2021 ESPP, respectively. As of December 31, 2024, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;985,486&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock available for issuance under the 2021 ESPP.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The number of shares reserved for issuance will automatically be increased on the first business day of each fiscal year, commencing on January 1, 2022 and ending on January 1, 2041. The aggregate number of shares of common stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the least of (i) one percent (&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%) of the total number of shares of common stock actually issued and outstanding on the last day of the preceding fiscal year, or (ii) a number of shares of common stock determined by the Company&#x2019;s Board.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock Compensation&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense related to stock options and the stock purchase plan for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;years ended December 31, 2024 and 2023 was classified in the consolidated statement of operations as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,549&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company typically grants stock options at exercise prices deemed by the Board to be equal to the fair value of the common stock at the time of grant, based upon the quoted price of the Company&#x2019;s common stock.
&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of stock option grants is estimated using the Black-Scholes option-pricing model. The Company lacks sufficient company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. For options with service-based vesting conditions, the expected term of the Company&#x2019;s stock options has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain-vanilla&#x201d; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t expect to pay any cash dividends in the foreseeable future.
&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The weighted-average for each of the assumptions the Company used to determine the grant-date fair value of options granted were as follows&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.03&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.19&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.36&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected volatility of underlying common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the stock option a&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ctivity:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.664%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.844000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.664%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Stock&lt;br/&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Life &lt;br/&gt;(in Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding January 1, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,398,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.34&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.87&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,278&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,501,849&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;586,081&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;846,236&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,467,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.29&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options vested or expected to vest as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,467,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.29&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options exercisable as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,463,893&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.32&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other information related to the option activity for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;years ended December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average fair value of options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intrinsic value of options exercised (in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the unrecognized compensation cost related to outstanding options was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2.66&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_1d992a94-aafd-45cd-b390-139470ececc8"
      decimals="INF"
      id="F_15640ac2-1a71-415f-97ce-b23501fa8356"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_4a97a8a0-1e04-4ff3-a4c3-35e097fb1306"
      decimals="INF"
      id="F_59d7aed1-80ba-4fea-a68d-15f8c8ba6e99"
      unitRef="U_shares">3278048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_3ffa6fa9-6b57-4d35-bd3a-b88d3505d57f"
      decimals="INF"
      id="F_d54341bd-e29d-432e-a5df-2843cbe2ab20"
      unitRef="U_shares">5781492</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_ecf6ccb4-e42d-49a5-88f5-a3479b52cfb1"
      decimals="INF"
      id="F_dfa905c3-1ba8-4a22-86b6-258d0e9f7643"
      unitRef="U_pure">0.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_8e8d9511-84eb-4a2f-b5e9-8f63d38450b0"
      decimals="INF"
      id="F_920de4a4-ab5c-417d-8920-b89509f21d7f"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_653bc1a9-0ec3-4132-946f-23cdbffd6e8c"
      decimals="INF"
      id="F_c819bab9-c447-4882-b334-6332e0f97e28"
      unitRef="U_shares">254390</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_261fba08-f9db-48e2-b812-47707c7e98ab"
      decimals="INF"
      id="F_a7209f33-bfc7-4fc5-a1d2-687734ebc8ad"
      unitRef="U_shares">228533</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_4c8ea6f2-9fff-4333-984a-67566fab4877"
      decimals="INF"
      id="F_29d9a0fb-ed71-4cfe-a2d5-d3eb183b8ba0"
      unitRef="U_shares">146380</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_b699eca8-c73b-466a-b522-9fe9e9a9ad35"
      decimals="INF"
      id="F_dda8b339-52bb-455f-88f6-b5bceff9bafb"
      unitRef="U_shares">985486</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_80888537-091b-4982-a3a1-aa3b6067c04e"
      decimals="INF"
      id="F_7d4e8937-d198-4bd8-b8dd-9c491c174aa8"
      unitRef="U_pure">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_efdebbe5-b88c-41be-8343-2513819e4311">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense related to stock options and the stock purchase plan for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;years ended December 31, 2024 and 2023 was classified in the consolidated statement of operations as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,549&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_b5d97542-6fb5-42e4-a0c9-e6757cce391a"
      decimals="-3"
      id="F_41527c88-d6f7-46a8-b603-e65daafbff0d"
      unitRef="U_USD">4846000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ed51e302-8869-4a0f-962b-de9484e3aa0c"
      decimals="-3"
      id="F_bcf5b5ac-dca7-4723-9bd8-75e04eefd2ea"
      unitRef="U_USD">2876000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_21f58568-ecea-492b-a352-08d9e9a7f42b"
      decimals="-3"
      id="F_68fee488-d77c-4149-946c-ec6cb53da657"
      unitRef="U_USD">4703000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e4bef360-1194-4876-bd72-1ba957b48289"
      decimals="-3"
      id="F_0bbb16ce-d6e2-4859-98b8-01e4c91c40fb"
      unitRef="U_USD">2332000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_93d9cc18-d706-405f-bbed-08369ad97bc2"
      unitRef="U_USD">9549000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_f09f5232-214c-4d67-a449-bc46cd575bd8"
      unitRef="U_USD">5208000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
      contextRef="C_95966560-3a74-4921-9ee9-1cddcc96757d"
      decimals="INF"
      id="F_d3030714-e52e-498b-adce-7a72deae6f99"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_539af728-f58d-40f0-af73-dab97b5dd778">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The weighted-average for each of the assumptions the Company used to determine the grant-date fair value of options granted were as follows&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.03&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.19&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.36&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected volatility of underlying common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="4"
      id="F_a960c7e7-a8cd-4d26-9d47-842eed2eb1dd"
      unitRef="U_pure">0.0403</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="4"
      id="F_e99b5fcb-3d2b-4678-9da3-ca19744d8446"
      unitRef="U_pure">0.0395</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_0477b96e-6d0a-4b4a-bc59-3002a8d6ac79">P6Y2M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      id="F_f26be8b3-3185-4cba-9ae0-0dc082a38e77">P6Y4M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="2"
      id="F_65088a65-d178-493b-8195-a5a42e154c6f"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="2"
      id="F_f5b45549-6f56-43f2-8472-2a027a0b40e5"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="2"
      id="F_d4c4e4b3-4492-426d-9570-34fdb1c56814"
      unitRef="U_pure">0.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="2"
      id="F_c6f1695e-45bd-4225-8461-36e65380f466"
      unitRef="U_pure">0.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_c660d426-3f8c-4149-93ab-23d177d3857c">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the stock option a&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ctivity:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.664%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.844000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.664%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Stock&lt;br/&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Life &lt;br/&gt;(in Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding January 1, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,398,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.34&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.87&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,278&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,501,849&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;586,081&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;846,236&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,467,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.29&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options vested or expected to vest as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,467,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.29&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options exercisable as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,463,893&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.32&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_66e41251-c3d9-4ef4-96d0-e6b667f2d454"
      decimals="INF"
      id="F_cb165a40-652e-4c60-9c2d-f53fcb4d2c1d"
      unitRef="U_shares">10398250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_66e41251-c3d9-4ef4-96d0-e6b667f2d454"
      decimals="2"
      id="F_a4c1490b-f845-4b30-8c8b-532c3ea6b579"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_320b3a46-ac25-4647-8016-94baaf69c8d5"
      id="F_ac1f438a-31b3-4cfa-89fd-09f11d3786d4">P8Y10M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_66e41251-c3d9-4ef4-96d0-e6b667f2d454"
      decimals="-3"
      id="F_bc3c59d2-c72e-4651-aaab-47646f03d735"
      unitRef="U_USD">28278000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"
      decimals="INF"
      id="F_bb18ef9a-6a63-459c-ac89-ce8fe99b3c85"
      unitRef="U_shares">3501849</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"
      decimals="2"
      id="F_90f3fbcc-a57a-493e-a991-342d9c667317"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"
      decimals="INF"
      id="F_e86d6f5d-0aa2-4780-925c-e03a56c84f90"
      unitRef="U_shares">586081</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"
      decimals="2"
      id="F_74cf9bfa-341a-495e-bfb3-266cc128a0d2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"
      decimals="INF"
      id="F_c9767b13-600f-476f-a5ca-4d37f9d92fd1"
      unitRef="U_shares">846236</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"
      decimals="2"
      id="F_a1e4bdfd-a965-4d21-9db0-a2feb2f61994"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"
      decimals="INF"
      id="F_7680127c-cee3-4154-8a6d-3d27d674f476"
      unitRef="U_shares">12467782</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"
      decimals="2"
      id="F_fd28cea1-9830-422d-bcef-ab16c3e73157"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"
      id="F_d4ea92eb-e275-4954-83c9-bdedb142b6e2">P8Y3M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"
      decimals="-3"
      id="F_6f479241-aa4c-4ef7-8c33-c54c61fcc29d"
      unitRef="U_USD">3912000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"
      decimals="INF"
      id="F_a5e45895-b69d-4278-a848-4875fa3fcb37"
      unitRef="U_shares">12467782</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"
      decimals="2"
      id="F_3cfcfc43-85ea-4921-99f1-815813752486"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"
      id="F_a95bb862-c3d7-4170-9fc5-3d6468b4b54f">P8Y3M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"
      decimals="-3"
      id="F_d1ca3d25-9a6d-458c-b0e0-a0f7b415b47a"
      unitRef="U_USD">3912000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"
      decimals="INF"
      id="F_4ec57431-13f6-4963-80c2-203b6fc066fc"
      unitRef="U_shares">3463893</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"
      decimals="2"
      id="F_a6233b83-18f4-477e-9427-2b8e81a21eb7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_2ae95bb1-5d4e-4aaa-92bb-e6b0ba84f333"
      id="F_3c345294-ea6a-45ea-a812-2db435286549">P7Y3M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_d7f37bc8-3ca9-454c-a43d-aa9c48623811"
      decimals="-3"
      id="F_caee9bfc-d6e6-476a-90a1-e8c7ca6a7c72"
      unitRef="U_USD">1116000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_664c8319-ad82-46ad-be9f-d9836f6f92dc">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other information related to the option activity for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;years ended December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average fair value of options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intrinsic value of options exercised (in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="2"
      id="F_98776686-4433-418d-abb3-fb5371792aff"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="2"
      id="F_5b945b12-b108-49aa-bdae-de966f3135cf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_9b621849-e43c-43f2-a297-ac4cb2d230cc"
      unitRef="U_USD">1954000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_54398381-d65c-47c8-99b8-a8b4055c2eee"
      unitRef="U_USD">152000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-5"
      id="F_03e62083-67fb-4e09-a4c9-875d56bf5bd9"
      unitRef="U_USD">24000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_d562f89c-5c29-4f06-8832-d3577117cdbc">P2Y7M28D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_ecf99d0d-67fe-464a-bdee-d5b9ca4c387c">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;8. Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the years ended December 31, 2024 and 2023, the Company did not record an income tax provision due to the losses incurred and a full valuation allowance provided on the net deferred tax assets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the federal statutory income tax rate to the effective tax rate is as follows&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.96%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.620000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Taxes at U.S. statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Changes from statutory rate:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Share-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets and liabilities reflect the net tax effects of net operating loss carryovers and temporary differences between the carrying amount of assets and liabilities for financial reporting and the amounts used for income tax purposes. &lt;/span&gt;&lt;span style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities were as follows (in thousands): &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.946%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.178%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.218999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,201&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,939&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,536&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitalized R&amp;amp;D costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,515&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;139,172&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;99,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right of use Asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,590&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets and liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In determining the need for a valuation allowance, the Company has given consideration to its cumulative book income and loss positions. The Company has assessed the available means of recovering deferred tax assets, including the ability to carryback net operating losses, the existence of reversing taxable temporary differences, the availability of tax planning strategies and forecasted future taxable income. As of December 31, 2024, the Company maintains a full valuation allowance against its net deferred tax assets. The valuation allowance increased by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the Company had U.S. federal net operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;113.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The U.S. federal net operating losses have an indefinite life carryforward. As of December 31, 2024, the Company had Massachusetts net operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million that expire at various dates through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2043&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the Company had U.S. R&amp;amp;D federal credit carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;17.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million that expire at various dates through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2043&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the Company had U.S. state R&amp;amp;D tax credit carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million that expire at various dates through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2038&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under Sections 382 and 383 of the U.S. Internal Revenue Code, if a corporation undergoes an ownership change, the corporation's ability to use its pre-change net operating loss carryforwards and other pre-change attributes, such as net operating losses and research tax credits, to offset its post-change income and taxes may be limited. In general, an ownership change generally occurs if there is a cumulative change in ownership by 5% stockholders that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under U.S. state tax laws. The Company has experienced an ownership change in the past and may experience ownership changes in the future as a result of future transactions in its share capital, some of which may be outside the control of the Company. As a result, if the Company earns net taxable income, its ability to use its pre-change net operating loss carryforwards, or other pre-change tax attributes, to offset U.S. federal and state taxable income and taxes is subject to significant limitations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounted for uncertain tax positions using a more likely than not threshold for recognizing and resolving uncertain tax positions. The evaluation of uncertain tax positions is based on factors that include, but are not limited to, changes in tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, new audit activity and changes in facts or circumstances related to a tax position. The Company evaluates uncertain tax positions on an annual basis and adjusts the level of the liability to reflect any subsequent changes in the relevant facts surrounding the uncertain positions. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes. For the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accrued interest or penalties in the consolidated statements of operations.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to taxation for federal and Massachusetts purposes. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the Company is subject to examination by these taxing authorities for all years since inception. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_c6eb08ce-20fd-407d-a0ae-7620cd5a5c23">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the federal statutory income tax rate to the effective tax rate is as follows&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.96%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.620000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Taxes at U.S. statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Changes from statutory rate:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Share-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="INF"
      id="F_cbaaa4c5-029d-4621-a974-3aaf455db881"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="INF"
      id="F_557e1657-cd24-4979-908f-5a48e9c03311"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="3"
      id="F_d522e8c0-75ab-476b-857b-56537df91339"
      unitRef="U_pure">0.075</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="3"
      id="F_cec6fe13-5eec-4f60-ad7b-8762f6cc8b9a"
      unitRef="U_pure">0.085</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="3"
      id="F_b0116800-9a16-47f3-9ff2-7a1d5c68c025"
      unitRef="U_pure">-0.05</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="3"
      id="F_42ab320e-c2b1-4166-9521-8f04b9fa6012"
      unitRef="U_pure">-0.054</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="3"
      id="F_e04933ca-cb26-42ec-81bf-434fbb186cc0"
      unitRef="U_pure">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="3"
      id="F_3ddc581a-2d88-44f1-a7ac-8afc762fbd19"
      unitRef="U_pure">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="3"
      id="F_6254ede8-807c-4a2e-bdb7-2ac267027f62"
      unitRef="U_pure">-0.309</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="3"
      id="F_018a3a6e-ae54-4270-8a63-104b57c65ac2"
      unitRef="U_pure">-0.341</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="3"
      id="F_c9aa9300-9622-4c30-8ab9-34896a50bf5a"
      unitRef="U_pure">-0.017</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="3"
      id="F_4d7f4879-94f1-4a4c-a567-ef89e5980195"
      unitRef="U_pure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="3"
      id="F_e0907587-cfca-4bfc-b120-f49f35d0163a"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="3"
      id="F_99437632-6c2a-40a3-9022-74dbafc54927"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_389400ee-c991-4b9c-b8af-d844e1821524">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities were as follows (in thousands): &lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.946%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.178%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.138%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.218999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,201&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,939&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,536&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitalized R&amp;amp;D costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,515&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;139,172&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;99,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right of use Asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,590&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets and liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_1a4b370e-aeac-4c64-9e64-7f2abdc3d7c7"
      unitRef="U_USD">31332000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_fb9b5d3f-1ccc-4f93-8c98-95f615762dcd"
      unitRef="U_USD">23201000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_87d955d4-252f-41b2-b42f-5b55cf33cbe4"
      unitRef="U_USD">25427000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_b436c568-a7d3-4adf-93c6-0cbf8a00c953"
      unitRef="U_USD">16939000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_f97c0896-5475-4c31-b2a2-7c394157a9cc"
      unitRef="U_USD">3536000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_988fc336-28a3-4158-a41b-36ff6951ddcc"
      unitRef="U_USD">4305000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <tcrx:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_0f299419-9862-4c99-aaf4-c2f956a00811"
      unitRef="U_USD">1216000</tcrx:DeferredTaxAssetsDepreciationAndAmortization>
    <tcrx:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_e25c78cb-546f-4b0b-9a61-11aa932ae79d"
      unitRef="U_USD">1159000</tcrx:DeferredTaxAssetsDepreciationAndAmortization>
    <tcrx:DeferredTaxAssetsAmortization
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_5f7da7ca-db08-4b09-a921-eac43e7b3341"
      unitRef="U_USD">432000</tcrx:DeferredTaxAssetsAmortization>
    <tcrx:DeferredTaxAssetsAmortization
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_bfd8cf76-e085-461f-911f-f753253c070d"
      unitRef="U_USD">479000</tcrx:DeferredTaxAssetsAmortization>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_36268737-f129-45b6-8158-2748b35aebb5"
      unitRef="U_USD">1681000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_de111f0b-cdf7-40fc-acde-9d24cbce8b11"
      unitRef="U_USD">1126000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <tcrx:DeferredTaxAssetsLeaseholdLiability
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_f77abe67-3702-474c-8db4-61c3a28c9b6a"
      unitRef="U_USD">17842000</tcrx:DeferredTaxAssetsLeaseholdLiability>
    <tcrx:DeferredTaxAssetsLeaseholdLiability
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_a15358b6-fccf-4949-a7b4-4e8430e2a378"
      unitRef="U_USD">17044000</tcrx:DeferredTaxAssetsLeaseholdLiability>
    <tcrx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_29a90439-1b3f-45d6-9840-70195ff445e8"
      unitRef="U_USD">48315000</tcrx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts>
    <tcrx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_6d13346e-becf-4712-80b8-139e6998c5c3"
      unitRef="U_USD">31515000</tcrx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_d16898f7-ade3-4c85-8396-f034d5dbad70"
      unitRef="U_USD">9391000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_2239bb3d-3092-4347-b373-bdb51cb67cb6"
      unitRef="U_USD">3824000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_4698c0bb-7971-4bce-ac06-ff697c2be5a8"
      unitRef="U_USD">139172000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_646498d2-b52f-4fc5-86b9-901b5dbf22e4"
      unitRef="U_USD">99592000</us-gaap:DeferredTaxAssetsNet>
    <tcrx:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_c00336d2-48c8-406a-905d-b25fc4eab9ce"
      unitRef="U_USD">17582000</tcrx:DeferredTaxLiabilitiesRightOfUseAsset>
    <tcrx:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_b2d4a851-1bd8-450e-9459-959c34c7284d"
      unitRef="U_USD">17346000</tcrx:DeferredTaxLiabilitiesRightOfUseAsset>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_73bffae2-1b73-4a67-84f5-cb90ad66bdeb"
      unitRef="U_USD">121590000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_3c75f980-9203-426d-ad86-a127843b3ddf"
      unitRef="U_USD">82246000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-5"
      id="F_42a650f2-437e-4aa2-8e89-8e42872eca94"
      unitRef="U_USD">39300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-5"
      id="F_4d43bae6-b8a3-4078-8923-631ea01cc729"
      unitRef="U_USD">30400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_bf7b2383-6668-4795-a6b0-55806e641321"
      decimals="-5"
      id="F_07bbc537-b09a-494a-940f-0ef9a85ec635"
      unitRef="U_USD">113600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_48705e18-c435-4ea3-8f65-3174ccb08c15"
      decimals="-5"
      id="F_ac2533a5-738a-4d72-99e8-4dd935ab47f0"
      unitRef="U_USD">118300000</us-gaap:OperatingLossCarryforwards>
    <tcrx:OperatingLossCarryForwardsExpirationYear
      contextRef="C_68816447-84c0-44e4-a1c7-b78689002f3a"
      id="F_cfb29f46-8053-4c86-8993-7afca732fd6f">2043</tcrx:OperatingLossCarryForwardsExpirationYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_fdf71ac3-3b5b-4e4e-9f5b-32fe46c5a168"
      decimals="-5"
      id="F_506709bb-0a4e-4299-afe0-d9e949ed8bc5"
      unitRef="U_USD">17900000</us-gaap:TaxCreditCarryforwardAmount>
    <tcrx:TaxCreditCarryforwardExpirationYear
      contextRef="C_83a90602-679a-44dc-a030-989afce6a82d"
      id="F_fe097440-8826-45df-a99d-c9210802b191">2043</tcrx:TaxCreditCarryforwardExpirationYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_af039233-7db2-4aeb-8cc9-c9ea8e5f25e3"
      decimals="-5"
      id="F_989c3e46-2220-4273-b263-2cbe5580e9ca"
      unitRef="U_USD">9500000</us-gaap:TaxCreditCarryforwardAmount>
    <tcrx:TaxCreditCarryforwardExpirationYear
      contextRef="C_b0702c7d-48d2-4169-904c-8f9b8552db95"
      id="F_75e8acbc-b230-4053-8d1b-3723d73c9d36">2038</tcrx:TaxCreditCarryforwardExpirationYear>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="INF"
      id="F_506215bc-7dea-4e28-85f3-a9e052f6a454"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="INF"
      id="F_872dc3cc-c3ff-47c9-a32e-df90b88bb7d1"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationDescription
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_40e7a8e5-8618-4f69-b02c-a1c73f1cf55c">the Company is subject to examination by these taxing authorities for all years since inception. </us-gaap:IncomeTaxExaminationDescription>
    <tcrx:CollaborativeAndLicenseArrangementDisclosureTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e6715c07-b2b1-437c-9774-78b75be24f65">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;9. Collaboration and License Agreements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Amgen&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;May 8, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company entered into a Collaboration Agreement with Amgen Inc. (the Amgen Agreement) to identify antigens recognized by T cells in patients with Crohn&#x2019;s disease in accordance with a research plan. Under the terms of the Amgen Agreement, Amgen will retain all global development and commercialization rights. The proceeds from the Amgen Agreements included an upfront payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which was collected in July 2023. In addition, the Company is eligible to earn success-based milestone payments of over $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, based upon the achievement of certain clinical development and commercial milestones, as well as tiered single-digit royalty payments on net sales of products developed from the collaboration, subject to reductions set forth in the Amgen Agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company concluded that Amgen meets the definition of a customer, as the Company is delivering research and development activities and a license of intellectual property. The Company identified performance obligations for research and development activities, the license, data reporting and participation in joint steering and research committees, which were determined to be a single combined performance obligation due to the services and licenses being highly interrelated.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For a certain time period during the term of the Amgen Agreement, Amgen has an option to add targets to the collaboration for payments specified in the agreement. Pursuant to the Amgen Agreement, the option for Amgen to select additional targets and to license, develop, and commercialize targets is not a performance obligation at the outset as these are customer options that do not represent material rights.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company looked to the promises in the arrangement to determine the method of recognition that best depicted the transfer of the services and the satisfaction of the combined performance obligations. The Company concluded that the performance of the research services over the expected research term was the predominant promise within the performance obligation. The Company will recognize the revenue associated with the performance obligation using an input method. The method of measuring progress towards delivery of the services incorporates actual internal and external costs incurred, relative to total internal and external costs expected to be incurred to satisfy the performance obligation. Changes in estimates of total internal and external costs expected to be incurred are recognized in the period of change as a cumulative catch-up adjustment. As costs are incurred, the Company will recognized revenue over time. At this time, it is estimated that the research term will be approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company determined the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million upfront payment to be the entirety of the consideration to be included in the transaction price. The option to add additional targets was not included in the transaction price as this option was assessed to be improbable at this time. The potential milestone and royalty payments that the Company is eligible to receive were also excluded from the transaction price, as all milestone and royalty amounts were fully constrained based on the assessed probability of achievement. The Company will continue to assess the probability of the option to add additional targets and the probability of milestone achievement throughout the research term and will adjust the consideration in the contract accordingly.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the year ended December 31, 2024 and 2023 the Company recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, of revenue associated with the Amgen Agreement. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the Company recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of deferred revenue, of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million is classified as long-term.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Novartis&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_cbe52327-d80a-4329-8a4a-2b886fa94469;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company entered into a Collaboration and License Agreement (the Novartis Agreement) with Novartis Institutes For BioMedical Research, Inc. (Novartis) to collaborate on their research efforts to discover and develop novel TCR-T therapies. At the inception date of the Novartis Agreement, Novartis or its affiliates held an ownership interest of more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% in the Company, and at December 31, 2024 and 2023, Novartis held less than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the common shares outstanding. Under the Novartis Agreement, the Company was to identify and characterize TCRs in accordance with a research plan, and transfer data arising from the research plan. The Novartis Agreement provided for payments of an upfront fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, research funding totaling $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, and potential milestone payments contingent on clinical, regulatory and sales success.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company concluded that the performance of the research services was the predominant performance obligation and was recognizing the revenue associated with the performance obligation using the input method, according to the actual costs incurred as a percentage of total expected costs to complete the research services.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company determined that the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million upfront payment, together with the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of estimated research costs to be reimbursed by Novartis to be the entirety of the consideration to be included in the transaction price as of the outset of the arrangement. The potential milestone payments that the Company is eligible to receive were excluded from the transaction price, as all milestone amounts were fully constrained based on the assessed probability of achievement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 202&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3 the Company recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of revenue associated with the Novartis Agreement, of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million r&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;elated to cost reimbursements under the Novartis Agreement that offset costs incurred within research and development expenses in the statements of operations. The research term ended in March 2023.&lt;/span&gt;&lt;/p&gt;</tcrx:CollaborativeAndLicenseArrangementDisclosureTextBlock>
    <tcrx:LicenseAgreementDate
      contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009"
      id="F_9b522a76-e5be-472d-b4a9-5cbd095266fd">2023-05-08</tcrx:LicenseAgreementDate>
    <tcrx:LicenseUpfrontPaymentReceivable
      contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009"
      decimals="-5"
      id="F_bb54eac8-0249-4044-94cf-32c04086edc5"
      unitRef="U_USD">30000000</tcrx:LicenseUpfrontPaymentReceivable>
    <tcrx:PotentialMilestonePayment
      contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009"
      decimals="-6"
      id="F_868a63c2-8b12-46f2-a6b9-18da925561df"
      unitRef="U_USD">500000000</tcrx:PotentialMilestonePayment>
    <tcrx:ExpectsResearchTerm
      contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009"
      id="F_61b8c938-cb83-46b0-8c50-67a54fa2b4bd">P3Y</tcrx:ExpectsResearchTerm>
    <tcrx:LicenseUpfrontPaymentReceivable
      contextRef="C_a91d2167-0cf7-47f7-be6c-7f55b7976009"
      decimals="-5"
      id="F_3ec23798-2c54-4577-b970-18d223372e3a"
      unitRef="U_USD">30000000</tcrx:LicenseUpfrontPaymentReceivable>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_3df7ac2b-49aa-499b-bf47-812e00e80ff4"
      decimals="-5"
      id="F_7c1fcb7a-a42b-4fa8-8191-4e5f88824838"
      unitRef="U_USD">2800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_523e5640-f362-49dd-8cd8-0a9f19fa77ed"
      decimals="-5"
      id="F_d61b433f-5bed-47b0-8854-236ea001bd51"
      unitRef="U_USD">14200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DeferredRevenue
      contextRef="C_2094de61-2463-4b5a-b0a4-fca50236ad0a"
      decimals="-5"
      id="F_06ac194c-4aa6-4ea1-8a60-dff18e67d6c2"
      unitRef="U_USD">12900000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="C_2094de61-2463-4b5a-b0a4-fca50236ad0a"
      decimals="-5"
      id="F_6da7fa0d-1883-4c51-8d3a-08fa01e03db5"
      unitRef="U_USD">1200000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="C_d5ad2e31-c21e-4c2b-89a1-288c3b0bea88"
      decimals="2"
      id="F_2d10930f-0490-4f92-8fef-f53eb13584d5"
      unitRef="U_pure">0.10</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="C_ed36ab97-8daf-4e07-80c2-c1cddcb96e73"
      decimals="2"
      id="F_23a1ca3f-8af5-4a9e-b1f3-75709b253e2e"
      unitRef="U_pure">0.10</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="C_46be3025-25e5-4ca5-aecb-96f1a7b4e50d"
      decimals="2"
      id="F_440eb794-0fdd-4c9e-960f-ed2f0c34d2be"
      unitRef="U_pure">0.10</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <tcrx:LicenseUpfrontPaymentReceivable
      contextRef="C_15c7b52a-5ecb-4134-84b7-1a74eee635a3"
      decimals="-5"
      id="F_45946ce9-75d1-432a-a5aa-8fef5f332460"
      unitRef="U_USD">20000000.0</tcrx:LicenseUpfrontPaymentReceivable>
    <tcrx:LicenseUpfrontPaymentReceived
      contextRef="C_c337686d-fa86-4eb8-97bb-fc4b534480c7"
      decimals="-5"
      id="F_7f30cff2-4021-43bf-8c3d-021fd18d20b6"
      unitRef="U_USD">10000000.0</tcrx:LicenseUpfrontPaymentReceived>
    <tcrx:LicenseUpfrontPaymentReceivable
      contextRef="C_1f54b526-5c78-40d4-b51e-3bb57d254eee"
      decimals="-5"
      id="F_5af2bfd6-7935-49f2-9e08-5af6ff0f7cfa"
      unitRef="U_USD">20000000.0</tcrx:LicenseUpfrontPaymentReceivable>
    <tcrx:LicenseUpfrontPaymentReceived
      contextRef="C_c337686d-fa86-4eb8-97bb-fc4b534480c7"
      decimals="-5"
      id="F_0237d27e-0d50-40fb-81a6-3b598f39a09d"
      unitRef="U_USD">10000000.0</tcrx:LicenseUpfrontPaymentReceived>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_f9a562f2-21ee-4a9b-a421-f3871446c2f8"
      decimals="-5"
      id="F_d4315028-b41a-4509-bbe4-b7c55d474b64"
      unitRef="U_USD">5800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <tcrx:ReimbursementCost
      contextRef="C_f9a562f2-21ee-4a9b-a421-f3871446c2f8"
      decimals="-5"
      id="F_19ba24f4-372c-4a0b-9408-16da51fedb41"
      unitRef="U_USD">1900000</tcrx:ReimbursementCost>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_4d89a9dc-8cdd-4609-ab88-3ded2a9630bd">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company leases &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; facilities at 880 Winter Street and 830 Winter Street in Waltham, Massachusetts. Each lease has specified terms and includes renewal options. Given uncertainty as to the Company's intentions with respect to these leases, the renewal options were not deemed reasonably certain.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 8, 2023, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the Company&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; entered into a lease amendment extending the expiration date of the 830 Winter Street Lease from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 30, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;October 31, 2029&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and provides for one option to renew the 830 Winter Street Lease for a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; period commencing on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 1, 2029&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, resulting&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in an increase in the lease liability of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 28, 2024, the Company entered into a second lease amendment expanding the rentable space of 830 Winter Street. The amendment provides for an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,628&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of space with a commencement date of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and an expiration date of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;October 31, 2029&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; with one option to review for a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; period. This amendment resulted in an increase in the lease liability of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Summary of lease cost&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the presentation in the Company's consolidated balance sheets of its operating leases (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,570&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,739&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59,140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the effect of lease costs in the Company's consolidated statement of operations (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,408&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,120&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,790&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the years ended December 31, 2024 and 2023, the Company made cash payments for operating leases of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, future payments of operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029 and thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,994&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total future payments of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,773&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the weighted average remaining lease term was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7.3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years and the weighted average incremental borrowing rate used to determine the operating lease liability was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of December 31, 2023, the weighted average remaining lease term was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;8.6&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years and the weighted average incremental borrowing rate used to determine the operating lease liability was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Brigham and Women&#x2019;s License Agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company obtained the worldwide exclusive license to its foundational technology from The Brigham and Women&#x2019;s Hospital, Inc. (or BWH). The license, as amended, grants worldwide exclusive use to the patent underlying the TargetScan technology in exchange for fees including development milestones and various royalties on product sales should they occur in the future.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Royalty Agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In June 2018, the Company amended and restated an existing royalty agreement with one of its founders. Under the amended and restated royalty agreement, the Company agreed to pay the founder an aggregate royalty of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of net sales of any product sold by the Company or by any of its direct or indirect licensees for use in the treatment of any disease or disorder covered by a pending patent application or issued patent held or controlled by the Company as of the last date that the founder was providing services to the Company as a director or consultant under a written agreement in perpetuity. Royalties are payable with respect to each applicable product for a defined period of time set forth in the royalty agreement. The founder assigned his rights and obligations under the royalty agreement to one of his affiliated entities in January 2021.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <tcrx:NumberOfLeasesFacilities
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="INF"
      id="F_dfaf0241-9067-4064-a4ac-0459d34f26e8"
      unitRef="U_Facility">2</tcrx:NumberOfLeasesFacilities>
    <us-gaap:LessorOperatingLeaseDescription
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_c8e873d6-7e7c-4bd7-a347-df8babe44ba5">On November 8, 2023, the Company entered into a lease amendment extending the expiration date of the 830 Winter Street Lease from September 30, 2024 to October 31, 2029 and provides for one option to renew the 830 Winter Street Lease for a five-year period commencing on November 1, 2029, resulting in an increase in the lease liability of $6.2 million.On October 28, 2024, the Company entered into a second lease amendment expanding the rentable space of 830 Winter Street. The amendment provides for an additional 25,628 square feet of space with a commencement date of December 1, 2024 and an expiration date of October 31, 2029 with one option to review for a five-year period. This amendment resulted in an increase in the lease liability of $6.1 million. </us-gaap:LessorOperatingLeaseDescription>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_34b3c74f-add1-4a1b-b372-3aa22b07f70c"
      id="F_84fc213e-3ebb-419d-b635-db506c4729ff">2024-09-30</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_332482d9-8141-410d-8864-204366a2aed0"
      id="F_749a9336-cfa3-4abb-8c89-f7775ab0eb46">2029-10-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_5dc478f0-33ed-4f00-97fe-edffa3ee70cb"
      id="F_1d68bc2f-4ca1-4ab9-8c4c-5c7a42cfde95">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <tcrx:LesseeOperatingLeaseCommencingDate
      contextRef="C_5fce13ba-5c69-4650-bed4-a3ea2c8f6f3e"
      id="F_f4187b9b-74ef-4f54-8d2e-4e6bbeac2b4f">2029-11-01</tcrx:LesseeOperatingLeaseCommencingDate>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_5dc478f0-33ed-4f00-97fe-edffa3ee70cb"
      decimals="-5"
      id="F_121c7574-19a4-4e91-82a9-daacf9ca6046"
      unitRef="U_USD">6200000</us-gaap:OperatingLeaseLiability>
    <tcrx:LeaseSpaceForFacility
      contextRef="C_af892904-1677-4b5c-bfa4-d77070df30ae"
      decimals="INF"
      id="F_ef8abf03-6be9-40e9-8e02-6c4dfc3c9cc4"
      unitRef="U_sqft">25628</tcrx:LeaseSpaceForFacility>
    <tcrx:LesseeOperatingLeaseCommencingDate
      contextRef="C_e012286d-5a3c-48f3-9f8b-f6f2434cc024"
      id="F_c6b34091-2a76-40e7-a058-c2bd8e023b48">2024-12-01</tcrx:LesseeOperatingLeaseCommencingDate>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_e012286d-5a3c-48f3-9f8b-f6f2434cc024"
      id="F_edf2aa2a-f614-461f-98f9-6103c5dd5e86">2029-10-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_af892904-1677-4b5c-bfa4-d77070df30ae"
      id="F_7d9e8a6d-1373-48b0-b34c-81c3f2fc26a0">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_af892904-1677-4b5c-bfa4-d77070df30ae"
      decimals="-5"
      id="F_d9bf9f74-e719-4228-886d-f66012d5b235"
      unitRef="U_USD">6100000</us-gaap:OperatingLeaseLiability>
    <tcrx:SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e1820cbd-4279-42e3-9d4a-96b4f390420c">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the presentation in the Company's consolidated balance sheets of its operating leases (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,570&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60,739&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59,140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tcrx:SummaryOfPresentationOfOperatingLeaseInConsolidatedBalanceSheetTabletextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_8f4c5a5b-286f-40a1-af34-58c01c02f429"
      unitRef="U_USD">64357000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_3bafaf3a-1fc1-4c0b-8917-7564bc8541da"
      unitRef="U_USD">63492000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_e3ff564d-5ff2-4067-9eea-11e2a0784354"
      unitRef="U_USD">4570000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_7153afdd-3fd6-45b6-93a0-8f2028e2dd5e"
      unitRef="U_USD">3246000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_82393441-e546-4ef9-b7db-2aae1316d62e"
      unitRef="U_USD">60739000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_7ff906d4-60a2-4889-8174-8b58087f8911"
      unitRef="U_USD">59140000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_21869b90-91cb-4a77-83cd-66e3a1ef5043"
      unitRef="U_USD">65309000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="-3"
      id="F_2a845928-4af8-46e2-aaad-17b82bbeac92"
      unitRef="U_USD">62386000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_74845fbf-b6dc-4b78-ba11-cee4414dbfc0">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the effect of lease costs in the Company's consolidated statement of operations (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.313%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.843%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,408&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,120&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,790&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_aee6347c-b8a9-4895-afec-5b2b8ca22656"
      unitRef="U_USD">11564000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_de6f09b5-8a6a-45cb-8d86-d2b05280fe6c"
      unitRef="U_USD">10626000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_c5e187d2-f10f-454f-b0af-56440ea731b6"
      unitRef="U_USD">44000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_12c0e380-b4ac-45db-85ed-619289760f72"
      unitRef="U_USD">3408000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_118ad7a0-360b-4979-b831-c75ff00b099e"
      unitRef="U_USD">5120000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_b05eb00d-0c56-42b3-b59a-f542f1c782ae"
      unitRef="U_USD">14972000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_55b2451e-5dae-4712-b530-ef75a9c4abe6"
      unitRef="U_USD">15790000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-5"
      id="F_7cfe531b-e2bf-4afe-84b2-712f33f3dd17"
      unitRef="U_USD">9800000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-5"
      id="F_5c348a86-5986-4e43-9d34-a0e88829e419"
      unitRef="U_USD">9400000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_bd611a15-74e7-4e88-9941-36056f54d6c4">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, future payments of operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.444%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.757%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029 and thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,994&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total future payments of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,773&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_4bc51460-f9b1-4418-b4ec-00fcd9fc8d47"
      unitRef="U_USD">10089000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_1410bc6b-fbd8-4d5f-bac8-6cf0611779a2"
      unitRef="U_USD">12958000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_25fd8c65-523c-4dab-b3c0-f9115e4a83d0"
      unitRef="U_USD">13329000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_44211f7f-6a28-4816-be44-abbd2598d5ff"
      unitRef="U_USD">13712000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <tcrx:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_83f199da-1974-4453-b1aa-4c909b4c1b7b"
      unitRef="U_USD">43994000</tcrx:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_f1562cfd-b285-45fe-87b5-18f06d7f40be"
      unitRef="U_USD">94082000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_5cfb37dd-9e78-49d4-b75c-590f974d1910"
      unitRef="U_USD">28773000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_3730a8a0-ae13-4e72-a1f8-d9b27563c67f"
      unitRef="U_USD">65309000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      id="F_f0bb82bb-0dd7-4356-b3ee-f7fd4edb265c">P7Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <tcrx:OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="3"
      id="F_f10b9f90-f5d8-4b20-888c-88e0f4903428"
      unitRef="U_pure">0.10</tcrx:OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      id="F_3a45c242-a720-444b-9020-044b0b42ca73">P8Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <tcrx:OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent
      contextRef="C_7c8a21f5-abca-4beb-ac87-d5abe7f3201d"
      decimals="3"
      id="F_7a81556c-3344-4d7b-8f7f-05e8962bb15b"
      unitRef="U_pure">0.103</tcrx:OperatingLeaseWeightedAverageIncrementalBorrowingRatePercent>
    <tcrx:PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold
      contextRef="C_3d025609-eb03-453e-8fb0-40e7424de1c0"
      decimals="2"
      id="F_4ab378b8-2634-4992-aadf-118a8754f85e"
      unitRef="U_pure">0.01</tcrx:PercentageOfAggregateRoyaltyOfNetSalesOfAnyProductSold>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_b6d7bc37-d2e2-47fb-ab5f-2a32a675a7c2">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;11. Loan and Security Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;K2 HealthVentures LLC&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 9, 2022 (the Closing Date), the Company entered into a Loan and Security Agreement (the Loan Agreement) with K2 HealthVentures LLC (K2HV), pursuant to which convertible term loans in an aggregate principal amount of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million is available to the Company in three tranches, subject to certain terms and conditions. The Company drew the first tranche of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from K2HV on the Closing Date. The Company had the option to draw the second tranche of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million upon the achievement of certain financial and clinical milestones and an uncommitted third tranche of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million could be funded by joint agreement of the Company and K2HV. On the Closing Date, the Company paid a facility fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to K2HV and is subject to an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the principal amount of any amount drawn on third tranche.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The term loan was expected to mature on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 1, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the Maturity Date), and was subject to interest only payments for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months, which could be extended to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months upon achievement of certain financial and clinical milestones, following which the term loans would amortize in equal monthly installments until maturity. The Company had the ability to repay the loan at any time either in cash or in shares, subject to applicable premiums as specified in the Loan Agreement. The term loans accrued interest at a per annum rate equal to the greater of (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and (ii) the sum of (A) the prime rate (as last quoted in The Wall Street Journal) and (B) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, subject to a cap of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.90&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 26, 2024, K2HV confirmed to the Company that the amortization commencement date would be October 1, 2025, thereby extending the interest-only period under the Loan Agreement for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months. This extension met the definition of an accounting debt modification in accordance with ASC 470-50 and was accounted for prospectively as a yield adjustment, with no resulting gain or loss recognized.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The lenders could elect at any time following the closing prior to the payment in full of the term loans to convert any portion of the principal amount of the term loans then outstanding into shares of the Company's common stock. The first tranche of the loan was convertible at the option of K2HV at a conversion price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.785&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and future tranches could be convertible as specified in the agreement, provided that, such price shall be subject to the applicable conversion price floor and other adjustments in accordance with the Loan Agreement. The embedded conversion option met the derivative accounting scope exception since the embedded conversion option was indexed to the Company&#x2019;s own common stock and qualifies for classification within stockholders&#x2019; equity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company had the option to prepay all, but not less than all, of the outstanding principal balance of the term loans under the Loan Agreement subject to a prepayment fee ranging from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% depending upon when the prepayment occurs. The Company was obligated to pay a final fee equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the aggregate amount of the term loans funded (the Exit Fee), to occur upon the earliest of (i) the maturity date, (ii) the acceleration of the term loans, and (iii) the prepayment of the term loans. If, upon equity conversion, K2HV received gross proceeds in an amount equal to at least 1.5 multiplied by the principal amount converted from the sale or other disposition of such Conversion Shares (as defined in the Loan Agreement), then as to such principal amount, the Exit Fee would be reduced to zero.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 20, 2024, K2HV elected to convert $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of the outstanding principal balance into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,134,796&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company's voting common stock at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.785&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in accordance with the agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On December 20, 2024 the Company repaid the remaining obligation of the debt agreement, which included $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in remaining principal, a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million Exit Fee, and a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million prepayment fee. The Company recognized a loss from extinguishment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in interest expense for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. The effective interest rate on the Loan Agreement, including the amortization of the debt discount and issuance costs, and accretion of the Exit Fee, was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.61&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% upon extinguishment.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Silicon Valley Bank&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On December 20, 2024 (the effective date), the Company entered into a Loan and Security Agreement (SVB Loan Agreement) with Silicon Valley Bank, a division of First-Citizens Bank &amp;amp; Trust Company (SVB). Under the SVB Loan Agreement, SVB will extend up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in a term loan facility, consisting of a first tranche of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million fully funded on the Effective Date and a second tranche of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to be available to the Company at the Lender&#x2019;s sole discretion on or prior to June 30, 2026.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The term loans will mature on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 1, 2029&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and will be subject to monthly interest only payments until September 30, 2027, provided the Company achieves certain financial and clinical milestones, following which the term loans will amortize in equal monthly installments until maturity. If the Company does not achieve such financial and clinical milestones by June 30, 2026, the maturity date will be September 1, 2028, and the interest only period will end on September 30, 2026, following which the term loans will amortize in equal monthly installments until maturity. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The term loans will accrue interest at a per annum rate equal to the greater of (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and (ii) the prime rate (as last quoted in The Wall Street Journal), minus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%; provided that such interest rate shall not exceed &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum. The Company will be liable for a final payment that is due on the earliest to occur of (a) the maturity date, (b) the repayment of the term loans in full, and (c) the date upon which the term loans are accelerated by the Lender, in an amount equal to the aggregate original principal amount of the term loans extended by the Lender to the Company, multiplied by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% (Exit Fee). In addition, the Company will be liable for a prepayment fee equal to (x) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the principal amount of term loans prepaid during the first year of the term, (y) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the principal amount of term loans prepaid during the second year of the term, and (z) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the principal amount of term loans prepaid thereafter. The term loans will automatically accelerate upon the occurrence of a bankruptcy or insolvency event involving the Company or its subsidiaries.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The SVB Loan Agreement contains customary representations and warranties, events of default and affirmative and negative covenants, including covenants that limit or restrict the Company&#x2019;s and its subsidiaries&#x2019; ability to, among other things, dispose of assets, make changes to its business, management, ownership or business locations, merge or consolidate, incur additional indebtedness, grant liens on its assets, pay dividends or other distributions, repurchase equity, make investments, and enter into certain transactions with affiliates, in each case subject to certain thresholds and exceptions. The New Loan Agreement does not require the Company to comply with a financial maintenance covenant. As collateral for its obligations under the New Loan Agreement, the Company granted the Lender a first-priority security interest on substantially all of the Company&#x2019;s assets (other than intellectual property), subject to certain exceptions. The Company&#x2019;s obligations under the SVB Loan Agreement will be guaranteed by each of the Company&#x2019;s future direct or indirect subsidiaries, subject to certain exceptions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in interest expense for the year ended December 31, 2024. The effective interest rate on the SVB Loan Agreement, including the amortization of the debt discount and issuance costs, and accretion of the Exit Fee, was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.46&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% at December 31, 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future principal payments as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:74.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:23.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,063&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total principal payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Plus: Final payment fee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: unamortized debt discount and final fee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,053&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad"
      decimals="INF"
      id="F_1e38b679-bf5c-4db9-9100-038528b19200"
      unitRef="U_USD">60000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_34147130-543b-4bb3-9ad4-1f11d70023ea"
      decimals="-5"
      id="F_2d526211-faff-4851-940e-99dfd0d76f8a"
      unitRef="U_USD">30000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="C_460d78bc-0419-42c2-a4cd-42262517b953"
      decimals="-5"
      id="F_ade80599-7da2-4a36-8878-d815c43fb78e"
      unitRef="U_USD">10000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="C_9ef145db-1e48-427f-ba89-3edcc3e04fab"
      decimals="-5"
      id="F_4159351b-d1d7-4205-a797-3edad1dccf0c"
      unitRef="U_USD">20000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <tcrx:FacilityFeePaid
      contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad"
      decimals="-5"
      id="F_090a92fa-cb69-4d1c-a650-856db5731e3d"
      unitRef="U_USD">400000</tcrx:FacilityFeePaid>
    <tcrx:PrincipalAmountIncreasePercentage
      contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad"
      decimals="2"
      id="F_12a3146a-3060-41a3-a979-3b274146bf82"
      unitRef="U_pure">0.01</tcrx:PrincipalAmountIncreasePercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_901900fe-6930-49a3-b719-454de9021201"
      id="F_2dd3eed8-cfb9-4c23-b7eb-3dbbe0ca7586">2026-09-01</us-gaap:DebtInstrumentMaturityDate>
    <tcrx:InterestOnlyPaymentTerm
      contextRef="C_901900fe-6930-49a3-b719-454de9021201"
      id="F_1b1ba8dd-9cc3-4e6d-993a-f4053ffa369f">P24M</tcrx:InterestOnlyPaymentTerm>
    <tcrx:InterestOnlyPaymentExtendedTerm
      contextRef="C_901900fe-6930-49a3-b719-454de9021201"
      id="F_38aae029-b5b4-459e-a96c-c31ca15a52a2">P36M</tcrx:InterestOnlyPaymentExtendedTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad"
      decimals="INF"
      id="F_0d0bbb26-6a66-443b-a9dc-8f69e7235bbb"
      unitRef="U_pure">0.0875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_901900fe-6930-49a3-b719-454de9021201"
      decimals="4"
      id="F_65fa59b3-b4a1-4a76-9b9b-940cd5cf7c81"
      unitRef="U_pure">0.0475</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_901900fe-6930-49a3-b719-454de9021201"
      decimals="4"
      id="F_f9df463b-6259-43b2-bc4d-754277563963"
      unitRef="U_pure">0.099</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <tcrx:InterestOnlyPaymentExtendedTerm
      contextRef="C_197387ea-3040-4c38-8433-659c61aae89f"
      id="F_eff69a13-0977-4ec1-bc0d-648ed543d5b5">P12M</tcrx:InterestOnlyPaymentExtendedTerm>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_ab8b44f9-7cfd-4a27-a3eb-18379970b0ad"
      decimals="INF"
      id="F_fb01331b-e705-4926-b6dd-cf4ba298c535"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.785</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <tcrx:PercentageOfLoanPrepaymentFeeRange
      contextRef="C_003184ab-3c81-4f7b-9c86-6fc2202ca43e"
      decimals="INF"
      id="F_eeb3f882-8c5a-4a94-b946-58d9a9f4fc91"
      unitRef="U_pure">0.04</tcrx:PercentageOfLoanPrepaymentFeeRange>
    <tcrx:PercentageOfLoanPrepaymentFeeRange
      contextRef="C_043660e4-f867-48a8-898e-eecc448695b5"
      decimals="INF"
      id="F_09a87bd8-66c4-4dba-9e11-5183ade2f9a2"
      unitRef="U_pure">0.01</tcrx:PercentageOfLoanPrepaymentFeeRange>
    <tcrx:FinalFeePercentage
      contextRef="C_901900fe-6930-49a3-b719-454de9021201"
      decimals="4"
      id="F_0d7509ec-2d0c-4d6e-b245-bab308b59865"
      unitRef="U_pure">0.06</tcrx:FinalFeePercentage>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="C_f113cfc8-bb00-4b79-a4d9-fb6c7cf9dd11"
      decimals="-5"
      id="F_e883c054-2297-480d-b6fd-716d64c0e89c"
      unitRef="U_USD">15000000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_f113cfc8-bb00-4b79-a4d9-fb6c7cf9dd11"
      decimals="INF"
      id="F_fd3e61b7-0f57-405d-93cf-63fb7b682519"
      unitRef="U_shares">3134796</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_78a26315-739e-4dd5-ae26-f5f8ac025ff6"
      decimals="INF"
      id="F_9133819a-47ef-4e72-986d-280d74294109"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.785</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentRepaidPrincipal
      contextRef="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4"
      decimals="-5"
      id="F_5d939e73-aa93-4722-9d1b-6d37e41fb0fd"
      unitRef="U_USD">15000000</us-gaap:DebtInstrumentRepaidPrincipal>
    <tcrx:DebtInstrumentExitFee
      contextRef="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4"
      decimals="-5"
      id="F_4ed3f77b-da2b-401a-b7ff-561edf727ff7"
      unitRef="U_USD">1800000</tcrx:DebtInstrumentExitFee>
    <tcrx:DebtInstrumentPrepaymentFee
      contextRef="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4"
      decimals="-5"
      id="F_4561a8ea-e526-40b7-913f-952adb559b29"
      unitRef="U_USD">300000</tcrx:DebtInstrumentPrepaymentFee>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_a9e2661b-229d-4a88-a51d-e0fe0cb222b4"
      decimals="-5"
      id="F_d27a4cd7-ed7b-4f4c-a4e8-658ffff7c20e"
      unitRef="U_USD">-1100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseLongTermDebt
      contextRef="C_bba2662b-9ecc-409c-9943-54cd0c91a519"
      decimals="-5"
      id="F_84a1fb01-69ae-40d6-ba2d-2d60005c05e1"
      unitRef="U_USD">3600000</us-gaap:InterestExpenseLongTermDebt>
    <us-gaap:InterestExpenseLongTermDebt
      contextRef="C_d31ec83e-19e4-4031-83bc-b96faa6d3fd3"
      decimals="-5"
      id="F_b1836b5e-dd5a-4177-9cba-6d04481e5197"
      unitRef="U_USD">3800000</us-gaap:InterestExpenseLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_bba2662b-9ecc-409c-9943-54cd0c91a519"
      decimals="4"
      id="F_cc61c94a-a5f5-4d66-b077-4eb3262a4cbf"
      unitRef="U_pure">0.1261</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_1daea7ab-e482-4c92-8f38-cdfc5e71c091"
      decimals="INF"
      id="F_5818e6b2-eb30-4380-9853-8d3a597cc642"
      unitRef="U_USD">52500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_fb5bb604-09b8-4938-997b-19cc6a0d0d04"
      decimals="-5"
      id="F_d7914293-100b-4051-8b44-d39a4960e86d"
      unitRef="U_USD">32500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="C_47d4a7b8-0689-4bad-9d3a-73d2b5ff4403"
      decimals="-5"
      id="F_c713838e-a8f9-432e-8582-1d06c4dc825c"
      unitRef="U_USD">20000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="C_7dd0c966-6e37-4efa-b9a2-7c425a19b0ba"
      id="F_e0983faf-b391-4023-ac79-9a776bab2c6f">The term loans will mature on September 1, 2029, and will be subject to monthly interest only payments until September 30, 2027, provided the Company achieves certain financial and clinical milestones, following which the term loans will amortize in equal monthly installments until maturity. If the Company does not achieve such financial and clinical milestones by June 30, 2026, the maturity date will be September 1, 2028, and the interest only period will end on September 30, 2026, following which the term loans will amortize in equal monthly installments until maturity. </us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_ed049b2f-3575-4247-9693-a137665029cf"
      id="F_2276ea46-2450-482e-9fbe-3dd364a961f2">2029-09-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_1daea7ab-e482-4c92-8f38-cdfc5e71c091"
      decimals="INF"
      id="F_45e6323a-0d49-4db5-ae4b-2a83f74523fd"
      unitRef="U_pure">0.07</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_ed049b2f-3575-4247-9693-a137665029cf"
      decimals="4"
      id="F_a2fe2ae4-2a54-46a2-af0f-4a42d41420b5"
      unitRef="U_pure">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_27fc5f66-3d18-42fb-8a66-2da06b8921bc"
      decimals="INF"
      id="F_d3ce7ebd-0163-4dcb-815f-79f8e4b416eb"
      unitRef="U_pure">0.0975</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <tcrx:FinalFeePercentage
      contextRef="C_ed049b2f-3575-4247-9693-a137665029cf"
      decimals="3"
      id="F_eed9077c-c736-4a22-936e-e070a9aff038"
      unitRef="U_pure">0.05</tcrx:FinalFeePercentage>
    <tcrx:PercentageOfLoanPrepaymentFeeInTwelveMonths
      contextRef="C_ed049b2f-3575-4247-9693-a137665029cf"
      decimals="3"
      id="F_29ad648a-752e-499e-8bef-d5f1feacb67b"
      unitRef="U_pure">0.03</tcrx:PercentageOfLoanPrepaymentFeeInTwelveMonths>
    <tcrx:PercentageOfLoanPrepaymentFeeInYearTwo
      contextRef="C_ed049b2f-3575-4247-9693-a137665029cf"
      decimals="3"
      id="F_be018253-f17f-442d-a977-9a7901c0ea60"
      unitRef="U_pure">0.02</tcrx:PercentageOfLoanPrepaymentFeeInYearTwo>
    <tcrx:PercentageOfLoanPrepaymentFeeInAfterYearTwo
      contextRef="C_ed049b2f-3575-4247-9693-a137665029cf"
      decimals="3"
      id="F_c8aebe53-1108-4bce-a537-ae67f98bd5da"
      unitRef="U_pure">0.01</tcrx:PercentageOfLoanPrepaymentFeeInAfterYearTwo>
    <us-gaap:InterestExpenseLongTermDebt
      contextRef="C_7dd0c966-6e37-4efa-b9a2-7c425a19b0ba"
      decimals="-5"
      id="F_29ef0d5d-542d-4d87-bdf2-cda8886003f4"
      unitRef="U_USD">100000</us-gaap:InterestExpenseLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_7dd0c966-6e37-4efa-b9a2-7c425a19b0ba"
      decimals="4"
      id="F_cf245ad5-a9f8-478e-9f89-0b163567ed90"
      unitRef="U_pure">0.0846</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_e711d439-fe44-4821-a768-acc0cc4283aa">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future principal payments as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:74.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:23.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,063&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total principal payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Plus: Final payment fee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: unamortized debt discount and final fee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,053&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_e1f99b85-a2e3-418d-908d-2c90933c960d"
      unitRef="U_USD">4063000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_ad0e5ef3-a712-4f2d-a597-6e39db2a5271"
      unitRef="U_USD">16250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_c9479940-4e78-4414-a9ca-2b8e5fa804a7"
      unitRef="U_USD">12187000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_8f3f03a1-fb44-4b58-a17b-9663c50c6423"
      unitRef="U_USD">32500000</us-gaap:DebtInstrumentCarryingAmount>
    <tcrx:LongTermDebtFinalPaymentFee
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_7931540e-387d-4a34-a5d4-dc07fe40f3cc"
      unitRef="U_USD">1625000</tcrx:LongTermDebtFinalPaymentFee>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_a6b60f3e-7844-4bf2-b0a4-7155c0c032ec"
      unitRef="U_USD">2053000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="C_818e4bd0-25da-4c16-803e-b15c22766a34"
      decimals="-3"
      id="F_d6c2dd37-f875-495f-b778-00522b8f0bf7"
      unitRef="U_USD">32072000</us-gaap:LongTermDebt>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_8e9e6cd7-09c0-4970-a530-200d9288e81c">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12. Retirement Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company initiated a defined contribution plan under Section 401(k) of the IRC (the Plan) covering all qualified employees effective January 1, 2019. Employee contributions are voluntary and are determined on an individual basis subject to the maximum allowable under federal tax regulations. The Company made contributions to the Plan of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-5"
      id="F_e0d86cb1-1330-4e9e-90b0-a941d3930a62"
      unitRef="U_USD">1000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-5"
      id="F_2df67b1a-9a40-441c-98cb-62f2d4d3f391"
      unitRef="U_USD">700000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_d0e9bdf2-42a2-4394-b426-9b2890dea8e4">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;13. Segment Reporting&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are defined as components of the entity for which separate financial information is made available and that is regularly evaluated by the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_026c18d0-35e8-4519-bb36-24650b15093c;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;chief operating decision maker (CODM)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in making decisions regarding resource allocation and assessing performance. The Company's CODM is its chief executive officer and the Company manages its operations as a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_5592acb1-cb7d-4895-8078-3175a9a958ae;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;single&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; segment for the purposes of assessing performance and making operating decisions. The Company is focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CODM assesses the Company's performance by reviewing GAAP net loss and significant expenses by function along with the annual budget. The chief operating decision maker considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides information about the Company's single operating segment which includes significant expenses by function along with significant non-cash expense items.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Revenue:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Collaboration and license revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,816&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,742&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory supplies, research materials and studies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Clinical studies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,245&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Facility-related and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,298&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Legal and professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Facility-related and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,576&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation Expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;862&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;134,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;93,458&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Other (expense) income:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest and other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,999&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,759&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,090&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;127,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_63ae97c4-e83d-4979-84eb-3bd03dacbfcd">The CODM assesses the Company's performance by reviewing GAAP net loss and significant expenses by function along with the annual budget. The chief operating decision maker considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_ce962c67-3a3a-4e36-b514-db82e839b080">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides information about the Company's single operating segment which includes significant expenses by function along with significant non-cash expense items.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Revenue:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Collaboration and license revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,816&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,742&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory supplies, research materials and studies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Clinical studies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,245&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Facility-related and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,669&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,298&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Legal and professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Facility-related and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,576&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation Expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;862&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;134,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;93,458&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Other (expense) income:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest and other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,999&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,759&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,090&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;127,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc"
      decimals="-3"
      id="F_9fd6eca7-fde1-42f5-b348-9c86d9c78c2f"
      unitRef="U_USD">2816000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454"
      decimals="-3"
      id="F_af5deda2-6269-4abf-935c-44793d3f81be"
      unitRef="U_USD">21049000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_f89cf5f2-e2a0-41fd-aa77-165139327dd5"
      decimals="-3"
      id="F_7d4c0b7a-24e8-4d33-84cc-95a997824ad6"
      unitRef="U_USD">31742000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_878ab1e3-bef4-47de-91e0-8a585da44965"
      decimals="-3"
      id="F_029237cb-f96a-44aa-989c-4f7d806e48ac"
      unitRef="U_USD">24165000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_3314d2d1-6f78-49b7-8dc7-033a9967337c"
      decimals="-3"
      id="F_21fea491-8d36-4058-82df-16d9693acd5f"
      unitRef="U_USD">31468000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_1dbc7479-5045-494d-a301-5d8982738033"
      decimals="-3"
      id="F_d64dc12a-bf6f-4f82-a82a-841d74bd6c40"
      unitRef="U_USD">30101000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_d3be5aa9-5dfb-4969-963a-9472152a5c98"
      decimals="-3"
      id="F_f698f34b-586e-4b55-9812-dbc0723461d0"
      unitRef="U_USD">19245000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_aed4f300-d032-41f1-b165-0845aef59189"
      decimals="-3"
      id="F_db0b371c-64a2-43de-b750-a1c94d438202"
      unitRef="U_USD">10214000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_09f0d8e0-903f-4e84-86fc-40c0b86d33f4"
      decimals="-3"
      id="F_bb5c9f46-5c2d-4a17-a955-b1884b6f8d0e"
      unitRef="U_USD">16669000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_d9dfa2cb-1ca0-4680-9350-28dac51ee6d0"
      decimals="-3"
      id="F_b27b5170-6468-4f17-bdc2-a96efe3c131e"
      unitRef="U_USD">16298000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_bf8bbac7-91a5-4162-9f6f-1c2c9d31aa38"
      decimals="-3"
      id="F_f11035d7-ad62-42b8-b9dd-a6275abf18ba"
      unitRef="U_USD">4846000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_e909c65f-32e5-477f-948c-5fbf09b1bfec"
      decimals="-3"
      id="F_938bf6cf-a031-45bb-b7b1-ea49dbeaabae"
      unitRef="U_USD">2876000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_540ebf28-46d3-4e16-843f-afe078c63280"
      decimals="-3"
      id="F_b91d88b0-abca-48f2-a365-56f5b13cae9e"
      unitRef="U_USD">3380000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_6003d2b4-d18b-4884-abfc-799d0a8bb89d"
      decimals="-3"
      id="F_f63a5a30-150b-47b6-990a-4d2a5be81acf"
      unitRef="U_USD">4499000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_f89cf5f2-e2a0-41fd-aa77-165139327dd5"
      decimals="-3"
      id="F_85239dce-905a-47e9-a067-5af557c9cf59"
      unitRef="U_USD">10900000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_878ab1e3-bef4-47de-91e0-8a585da44965"
      decimals="-3"
      id="F_1ea96dc4-a9c4-416c-9d6d-334aa62b459e"
      unitRef="U_USD">9065000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_4368cad2-f9e8-40de-bd6d-33ad7e1e108f"
      decimals="-3"
      id="F_afcc06d0-d5f5-46e5-bbe2-97180cef19f8"
      unitRef="U_USD">7380000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_ee786513-1c43-4280-a1f0-021ef922f07e"
      decimals="-3"
      id="F_d6494111-4d5a-47f3-99b8-9b2e06f1aa91"
      unitRef="U_USD">7119000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_09f0d8e0-903f-4e84-86fc-40c0b86d33f4"
      decimals="-3"
      id="F_cc1f19fd-2ea5-42fd-90cb-e46af0bdea18"
      unitRef="U_USD">6576000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_d9dfa2cb-1ca0-4680-9350-28dac51ee6d0"
      decimals="-3"
      id="F_b05fdc5b-1f1a-4eda-a09f-bccd4a8929d4"
      unitRef="U_USD">6976000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_bf8bbac7-91a5-4162-9f6f-1c2c9d31aa38"
      decimals="-3"
      id="F_d78cbe4d-4880-4d18-99e8-e8182d5a1025"
      unitRef="U_USD">4703000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_e909c65f-32e5-477f-948c-5fbf09b1bfec"
      decimals="-3"
      id="F_a041d703-f3d2-4925-b971-dda03d35027c"
      unitRef="U_USD">2332000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_540ebf28-46d3-4e16-843f-afe078c63280"
      decimals="-3"
      id="F_540120f2-38c9-4a72-9e55-925f58acfc5b"
      unitRef="U_USD">728000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_6003d2b4-d18b-4884-abfc-799d0a8bb89d"
      decimals="-3"
      id="F_df441fa6-ed89-4d6b-a39d-d77a4d229b79"
      unitRef="U_USD">862000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc"
      decimals="-3"
      id="F_af8dac8e-1124-4c1f-ab67-be875cf08fb2"
      unitRef="U_USD">-134821000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454"
      decimals="-3"
      id="F_20abec85-8963-4255-9f4d-9d5cec70b1c1"
      unitRef="U_USD">-93458000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc"
      decimals="-3"
      id="F_e3f73e6d-f1ed-4dde-aeab-2dbeeed08867"
      unitRef="U_USD">12065000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454"
      decimals="-3"
      id="F_7edd31c2-605a-4dd5-83b4-015762d68e4f"
      unitRef="U_USD">7999000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestExpense
      contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc"
      decimals="-3"
      id="F_b8e494f8-c5c3-4c4b-8b3a-fd37bc703870"
      unitRef="U_USD">-3653000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454"
      decimals="-3"
      id="F_a88a082e-316a-4ebf-a0aa-fa7aa1e04b30"
      unitRef="U_USD">-3759000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc"
      decimals="-3"
      id="F_5349ae29-a85e-4a10-ab99-cb3ebe55951f"
      unitRef="U_USD">-1090000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NetIncomeLoss
      contextRef="C_c74a51d4-f48e-488a-8ef8-eeaf8492eddc"
      decimals="-3"
      id="F_0bfc5df9-97fe-41c4-8e10-2b55546ae538"
      unitRef="U_USD">-127499000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_48c5a331-9cb5-4678-b525-bcdd61cc8454"
      decimals="-3"
      id="F_d273ff55-80f0-43a0-bdf5-db3857ad6ba6"
      unitRef="U_USD">-89218000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_ff0d9ca6-4ac7-4917-ae9d-5412e4ab73f7">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;14. Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted net loss per share was calculated as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;127,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,990,417&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,599,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,087,945&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company's common stock issuable upon exercise of the Pre-Funded Warrants described in Note 6 are included as outstanding common stock in the calculation of basic and diluted net loss per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has two classes of common stock, each with identical participation rights to earnings and liquidation preferences, and therefore the calculation of net loss per share as described above is identical to the calculation under the two-class method. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,467,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,398,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Potential shares issuable under the ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;138,133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock issuable upon conversion of Loan Agreement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,269,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,605,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,667,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_a6a8e439-e7a2-4fbe-963c-8b2f495c2b73">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted net loss per share was calculated as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;127,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,990,417&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,599,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="-3"
      id="F_b174d30d-9f75-49d2-a7e0-79ce23e6b5f1"
      unitRef="U_USD">-127499000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="-3"
      id="F_920c8d4b-9adb-4abb-b6a1-ce0e5b080da0"
      unitRef="U_USD">-89218000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="0"
      id="F_841d4874-e089-4865-833e-3bbfdc04e59b"
      unitRef="U_shares">111990417</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="0"
      id="F_7c5cba1a-17e4-45d1-af8e-1718a91d96bc"
      unitRef="U_shares">111990417</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="0"
      id="F_10c03447-1ba7-4e36-8f63-1e7d432e721f"
      unitRef="U_shares">65599858</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="0"
      id="F_e45f6f82-0bf4-49eb-abb8-5dc85768fbf5"
      unitRef="U_shares">65599858</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="2"
      id="F_12f10b37-99fb-4d66-bc44-166506c68825"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="2"
      id="F_e6ea574e-37f2-4cac-9bd2-e20e22d0f7da"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="2"
      id="F_87da4b93-0d15-46ef-a99f-f49f32ea6b9a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="2"
      id="F_32e6dc89-6c38-4526-8423-d5267c177d9e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_6c96b539-1a31-47e8-94ff-6a44016523a3"
      decimals="INF"
      id="F_34ac23ec-bad8-4547-ae27-349f6c54b2ea"
      unitRef="U_shares">73087945</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      id="F_bd362657-8905-4b39-962d-8ae9715a400c">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: &lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,467,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,398,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Potential shares issuable under the ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;138,133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock issuable upon conversion of Loan Agreement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,269,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,605,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,667,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_e798deb2-ca9c-4e28-89b6-772abe4bb270"
      decimals="0"
      id="F_156aa11a-d543-4c90-90b2-0c714d82a24a"
      unitRef="U_shares">12467782</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_52a3b19e-f226-4939-bba1-6190de6d2bba"
      decimals="0"
      id="F_1b3e8153-33a7-4b41-a1fd-a8065f6e1554"
      unitRef="U_shares">10398250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_25583bb8-7b3e-423a-98e6-e7ade07bd068"
      decimals="0"
      id="F_fa6fe4a7-3c4a-45e1-839e-99cec1cc4711"
      unitRef="U_shares">138133</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0d869bf5-158b-47a4-9b8b-51e8110fb2d8"
      decimals="0"
      id="F_f6dd1bb0-a96b-4ef4-ba14-8923c8f7141e"
      unitRef="U_shares">6269592</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_a0be3ceb-8b3e-4d9b-8610-e7b0aec9e73a"
      decimals="0"
      id="F_6d5cf0c3-54a8-4233-8660-94ca690cb4f3"
      unitRef="U_shares">12605915</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_d8c8dd7a-c506-4bc7-93ac-f29e8770b439"
      decimals="0"
      id="F_8feae428-c578-4088-b0bb-54c78ad7d30c"
      unitRef="U_shares">16667842</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
